PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Siddiq, MM; Hannila, SS; Carmel, JB; Bryson, JB; Hou, JW; Nikulina, E; Willis, MR; Mellado, W; Richman, EL; Hilaire, M; Hart, RP; Filbin, MT				Siddiq, Mustafa M.; Hannila, Sari S.; Carmel, Jason B.; Bryson, John B.; Hou, Jianwei; Nikulina, Elena; Willis, Matthew R.; Mellado, Wilfredo; Richman, Erica L.; Hilaire, Melissa; Hart, Ronald P.; Filbin, Marie T.			Metallothionein-I/II Promotes Axonal Regeneration in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						central nervous system (CNS); cyclic AMP (cAMP); myelin; neurite outgrowth; regeneration; axonal regeneration; metallothionein	MYELIN-ASSOCIATED GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCANS; RECEPTOR FAMILY-MEMBER; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; NOGO RECEPTOR; CYCLIC-AMP; EXTRACELLULAR METALLOTHIONEINS; INHIBITORY-ACTIVITY; ZINC TOXICITY	Background: MT-I/II are zinc-binding proteins that are also neuro-protective. Results: MT-I/II can overcome myelin-mediated inhibition in vitro and in vivo. MT-I/II-deficient mice have reduced spinal axon regeneration. Conclusion: MT-I/II are required for the conditioning lesion effect and can promote axonal regeneration in the injured CNS. Significance: MT-I/II have therapeutic potential for the treatment of spinal cord injury. The adult CNS does not spontaneously regenerate after injury, due in large part to myelin-associated inhibitors such as myelin-associated glycoprotein (MAG), Nogo-A, and oligodendrocyte-myelin glycoprotein. All three inhibitors can interact with either the Nogo receptor complex or paired immunoglobulin-like receptor B. A conditioning lesion of the sciatic nerve allows the central processes of dorsal root ganglion (DRG) neurons to spontaneously regenerate in vivo after a dorsal column lesion. After a conditioning lesion, DRG neurons are no longer inhibited by myelin, and this effect is cyclic AMP (cAMP)- and transcription-dependent. Using a microarray analysis, we identified several genes that are up-regulated both in adult DRGs after a conditioning lesion and in DRG neurons treated with cAMP analogues. One gene that was up-regulated under both conditions is metallothionein (MT)-I. We show here that treatment with two closely related isoforms of MT (MT-I/II) can overcome the inhibitory effects of both myelin and MAG for cortical, hippocampal, and DRG neurons. Intrathecal delivery of MT-I/II to adult DRGs also promotes neurite outgrowth in the presence of MAG. Adult DRGs from MT-I/II-deficient mice extend significantly shorter processes on MAG compared with wild-type DRG neurons, and regeneration of dorsal column axons does not occur after a conditioning lesion in MT-I/II-deficient mice. Furthermore, a single intravitreal injection of MT-I/II after optic nerve crush promotes axonal regeneration. Mechanistically, MT-I/II ability to overcome MAG-mediated inhibition is transcription-dependent, and MT-I/II can block the proteolytic activity of -secretase and the activation of PKC and Rho in response to soluble MAG.	[Siddiq, Mustafa M.; Hannila, Sari S.; Bryson, John B.; Hou, Jianwei; Nikulina, Elena; Willis, Matthew R.; Mellado, Wilfredo; Richman, Erica L.; Hilaire, Melissa; Filbin, Marie T.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Carmel, Jason B.; Hart, Ronald P.] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Carmel, Jason B.; Hart, Ronald P.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	City University of New York (CUNY) System; Hunter College (CUNY); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Siddiq, MM (corresponding author), Mt Sinai Sch Med, Icahn Med Inst Pharmacol & Syst Therapeut 12 52, 1425 Madison Ave, New York, NY 10029 USA.	mustafa.siddiq@mssm.edu	Hart, Ronald P/D-5219-2009; Hart, Ronald P/G-6530-2019	Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712	National Institutes of Health Shared Instrumentation [1S10RR026639-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026639, G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037060, F32NS054511, U54NS041073, K08NS073796] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Multiphoton microscopy was performed in the Microscopy CORE at the Icahn School of Medicine at Mount Sinai and was supported with funding from National Institutes of Health Shared Instrumentation Grant 1S10RR026639-01. We thank Saranna Belgrave and Dr. Nagarathnamma Chaudhry for their outstanding technical support and Drs. Rajiv R. Ratan (Burke-Cornell Medical Research Institute, White Plains, NY) and Ravi Iyengar (Mount Sinai School of Medicine, New York) for assistance with this manuscript. We also thank Drs. Larry Benowitz and Barbara Lorber (Harvard University, Cambridge, MA) for providing instruction in the optic nerve crush surgery and the GAP-43 antibody. We also thank Drs. Frank Bradke and Farida Hellal at Axonal Growth and Regeneration, German Center for Neurodegenerative Diseases (Bonn, Germany), for their instruction on performing chemical clearing.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Davis SR, 2000, J NUTR, V130, P1085; Deng KW, 2009, J NEUROSCI, V29, P9545, DOI 10.1523/JNEUROSCI.1175-09.2009; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Esch F, 1998, J NEUROSCI, V18, P4083; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; GILAD GM, 1988, DEV BRAIN RES, V38, P175, DOI 10.1016/0165-3806(88)90042-9; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hannila SS, 2013, J NEUROSCI, V33, P5138, DOI 10.1523/JNEUROSCI.5321-12.2013; Kelly EJ, 1996, J NUTR, V126, P1782; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Miyazaki I, 2011, GLIA, V59, P435, DOI 10.1002/glia.21112; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Niederost B, 2002, J NEUROSCI, V22, P10368; NISHIMURA N, 1989, J HISTOCHEM CYTOCHEM, V37, P1601, DOI 10.1177/37.11.2809172; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Siddiq MM, 2004, MOL CELL NEUROSCI, V25, P162, DOI 10.1016/j.mcn.2003.10.007; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Suzuki Keiji, 1994, Biological Signals, V3, P188; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; UDOM AO, 1980, BIOCHEM J, V187, P329, DOI 10.1042/bj1870329; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; West AK, 2004, REV NEUROSCIENCE, V15, P157; ZENG J, 1991, P NATL ACAD SCI USA, V88, P9984, DOI 10.1073/pnas.88.22.9984	51	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16343	16356		10.1074/jbc.M114.630574	http://dx.doi.org/10.1074/jbc.M114.630574			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25947372	Green Published, hybrid			2022-12-26	WOS:000356930100036
J	Arish, N; Cohen, PY; Golan-Gerstl, R; Fridlender, Z; Dayan, MR; Zisman, P; Breuer, R; Wallach-Dayan, SB				Arish, Nissim; Cohen, Pazit Y.; Golan-Gerstl, Regina; Fridlender, Zvi; Dayan, Mark Richter; Zisman, Philip; Breuer, Raphael; Wallach-Dayan, Shulamit B.			Overexpression of Telomerase Protects Human and Murine Lung Epithelial Cells from Fas- and Bleomycin-Induced Apoptosis via FLIP Upregulation	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; MEDIATED APOPTOSIS; SURFACE ANTIGEN; LIFE-SPAN; EXPRESSION; MICE; FIBROBLASTS; MYOFIBROBLASTS; PROLIFERATION; GROWTH	High doses of bleomycin administered to patients with lymphomas and other tumors lead to significant lung toxicity in general, and to apoptosis of epithelial cells, in particular. Apoptosis of alveolar epithelium is an important step in the pathogenesis of bleomycin-induced pulmonary fibrosis. The Fas-FasL pathway is one of the main apoptotic pathways involved. Telomerase is a ribonucleoprotein RNA-dependent DNA polymerase complex consisting of an RNA template and a catalytic protein, telomerase reverse transcriptase (TERT). Telomerase also possess extra-telomeric roles, including modulation of transcription of antiapoptotic genes, differentiation signals, and more. We hypothesized that telomerase overexpression affects Fas-induced epithelial cell apoptosis by an extra-telomeric role such as regulation of anti-apoptotic genes, specifically FLICE-like inhibitory protein (FLIP). Telomerase in mouse (MLE) and human (A549) lung epithelial cell lines was upregulated by transient transfection using cDNA hTERT expression vector. Telomerase activity was detected using a real-time PCR-based system. Bleomycin, and bleomycin-induced Fas-mediated apoptosis following treatment with anti-Fas activating mAb or control IgG, were assessed by Annexin V staining, FACS analysis, and confocal microscopy; caspase cleavage by Western blot; FLIP or Fas molecule detection by Western blot and flow cytometry. hTERT transfection of lung epithelial cells resulted in a 100% increase in their telomerase activity. Fas-induced lung epithelial cell apoptosis was significantly reduced in hTERT-transfected cells compared to controls in all experiments. Lung epithelial cells with increased telomerase activity had higher levels of FLIP expression but membrane Fas expression was unchanged. Upregulation of hTERT+ in human lung epithelial cells and subsequent downregulation of FLIP by shFLIP-RNA annulled hTERT-mediated resistance to apoptosis. Telomerase-mediated FLIP overexpression may be a novel mechanism to confer protection from apoptosis in bleomycin-exposed human lung epithelial cells.	[Arish, Nissim; Cohen, Pazit Y.; Golan-Gerstl, Regina; Fridlender, Zvi; Zisman, Philip; Breuer, Raphael; Wallach-Dayan, Shulamit B.] Hadassah Hebrew Univ Med Ctr, Inst Pulm Med, Lab Lung Cellular & Mol Biol, Jerusalem, Israel; [Fridlender, Zvi] Hosp Univ Penn, Dept Pulm & Crit Care Med, Philadelphia, PA 19104 USA; [Dayan, Mark Richter] Shaare Zedek Med Ctr, Dept Emergency Med, Jerusalem, Israel; [Breuer, Raphael] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA	Hebrew University of Jerusalem; University of Pennsylvania; Pennsylvania Medicine; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Boston University	Wallach-Dayan, SB (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Pulm Med, Lab Lung Cellular & Mol Biol, Jerusalem, Israel.	wallach-dayan@hadassah.org.il	Gerstl, Regina Golan/ADT-3989-2022	Wallach-Dayan, Shulamit/0000-0003-1708-2359	Israel Science Foundation [ISF 855/10]; David Shainberg Foundation	Israel Science Foundation(Israel Science Foundation); David Shainberg Foundation	This work was supported in part with funding from the Israel Science Foundation (ISF 855/10) and the David Shainberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bloor AJC, 1998, CLIN LAB HAEMATOL, V20, P119, DOI 10.1046/j.1365-2257.1998.00100.x; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Buhling F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-37; Cha SI, 2010, AM J RESP CELL MOL, V42, P140, DOI 10.1165/rcmb.2008-0419OC; Chen C, 2014, EMBO MOL MED, V6, P322, DOI 10.1002/emmm.201303000; Cohen PY, 2009, AM J RESP CELL MOL, V40, P231, DOI 10.1165/rcmb.2007-0348OC; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Degryse AL, 2012, EXP LUNG RES, V38, P124, DOI 10.3109/01902148.2012.658148; Dudognon C, 2004, ONCOGENE, V23, P7469, DOI 10.1038/sj.onc.1208029; Fakhoury J, 2010, J CELL SCI, V123, P1693, DOI 10.1242/jcs.063636; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Golan-Gerstl R, 2007, AM J RESP CELL MOL, V36, P270, DOI 10.1165/rcmb.2006-0133OC; Golan-Gerstl R, 2012, AM J RESP CELL MOL, V47, P271, DOI 10.1165/rcmb.2010-0284RC; Hagimoto N, 1997, AM J RESP CELL MOL, V16, P91, DOI 10.1165/ajrcmb.16.1.8998084; Hamad NM, 2002, ONCOGENE, V21, P7121, DOI 10.1038/sj.onc.1205860; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jelaska A, 1998, J CELL PHYSIOL, V175, P19, DOI 10.1002/(SICI)1097-4652(199804)175:1<19::AID-JCP3>3.0.CO;2-F; Jung YJ, 2004, INT J MOL MED, V13, P99; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Kuwano K, 1999, INT ARCH ALLERGY IMM, V119, P112, DOI 10.1159/000024185; Le Saux CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058423; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Mondello C, 2004, BIOCHEM CELL BIOL, V82, P498, DOI 10.1139/O04-048; OEHM A, 1992, J BIOL CHEM, V267, P10709; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Ren JG, 2001, FEBS LETT, V488, P133, DOI 10.1016/S0014-5793(00)02397-8; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; Wallach-Dayan SB, 2007, P NATL ACAD SCI USA, V104, P20460, DOI 10.1073/pnas.0705582104; Yuan J, 2009, ONCOGENE, V28, P2678, DOI 10.1038/onc.2009.136	39	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126730	10.1371/journal.pone.0126730	http://dx.doi.org/10.1371/journal.pone.0126730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951185	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400106
J	Bruniera, CP; Kallunki, JA; Groppo, M				Bruniera, Carla Poleselli; Kallunki, Jacquelyn A.; Groppo, Milton			Almeidea A. St.-Hil. Belongs to Conchocarpus JC Mikan (Galipeinae, Rutaceae): Evidence from Morphological and Molecular Data, with a First Analysis of Subtribe Galipeinae	PLOS ONE			English	Article							NONCODING REGIONS; POLLEN MORPHOLOGY; CLASSIFICATION; CUSPARIINAE; PHYLOGENIES; FLAVONOIDS; REVISION	Subtribe Galipeinae (tribe Galipeeae, subfamily Rutoideae) is the most diverse group of Neotropical Rutaceae, with 28 genera and approximately 130 species. One of its genera is Almeidea, whose species are morphologically similar to those of the genus Conchocarpus. Species of Almeidea occur in the Atlantic Rain Forest of Eastern Brazil, with one species (Almeidea rubra) also present in Bolivia. The objective of this study was to perform a phylogenetic analysis of Almeidea, using a broader sampling of Galipeinae and other Neotropical Rutaceae, the first such study focused on this subtribe. To achieve this objective, morphological data and molecular data from the nuclear markers ITS-1 and ITS-2 and the plastid markers trnL-trnF and rps16 were obtained. Representatives of eight genera of Galipeinae and three genera of Pilocarpinae (included also in Galipeeae) and Hortia (closely related to Galipeeae) were used. Five species of Almeidea and seven of Conchocarpus were included, given the morphological proximity between these two genera. Individual (for each molecular marker) and combined phylogenetic analyses were made, using parsimony and Bayesian inference as optimization criteria. Results showed Galipeinae as monophyletic, with the species of Almeidea also monophyletic (supported by the presence of pantocolporate pollen) and nested in a clade with a group of species of Conchocarpus, a non-monophyletic group. Additionally, C. concinnus appeared in a group with Andreadoxa, Erythrochiton, and Neoraputia, other members of Galipeinae. As a result, Conchocarpus would be monophyletic only with the exclusion of a group of species related to C. concinnus and with the inclusion of all species of Almeidea with the group of species of Conchocarpus that includes its type species, C. macrophyllus. Thus, species of Almeidea are transferred to Conchocarpus, and the new combinations are made here.	[Bruniera, Carla Poleselli] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Kallunki, Jacquelyn A.] New York Bot Garden, Bronx, NY 10458 USA; [Groppo, Milton] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; New York Botanical Garden; Universidade de Sao Paulo	Groppo, M (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Sao Paulo, Brazil.	groppo@ffclrp.usp.br	Bruniera, Carla Poleselli/F-2339-2015; Groppo, Milton/G-2175-2012	Groppo, Milton/0000-0003-2932-7798; Poleselli Bruniera, Carla/0000-0002-2832-9540	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) [2007/06336-0, 2006/03170-0, 2011/10446-0]; Conselho Nacional de Pesquisa (CNPq) [309994/2012-8]	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: The Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) granted CPB (funding number 2007/06336-0) and MG (funding number 2006/03170-0 and 2011/10446-0). The Conselho Nacional de Pesquisa (CNPq) granted MG with Productivity in Research Grant (funding number 309994/2012-8). The Universidade de Sao Paulo provided the facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth O. M., 1982, Boletin del Instituto de Geociencias, USP, V13, P129; Bruniera CP, 2011, BRITTONIA, V63, P281, DOI 10.1007/s12228-010-9162-0; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emmerich M, 1978, RODRIGUESIA, V30, P224; Engler A., 1896, NATURLICHEN PFLANZEN, P95; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; Engler HGA, 1874, FLORA BRASILIENSIS, V12, P75; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Goloboff P., 2003, T N T TREE ANALYSIS; Groppo M, 2005, BRITTONIA, V57, P28, DOI 10.1663/0007-196X(2005)057[0028:SOHAWH]2.0.CO;2; Groppo M, 2010, RUTACEAE NEOTROPIKEY; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Groppo M, 2012, PHYTOKEYS, V19, P9, DOI 10.3897/phytokeys.19.3912; Groppo Milton, 2010, Braz. J. Bot., V33, P13, DOI 10.1590/S0100-84042010000100003; Groppo M, 2012, SYST BOT, V37, P197, DOI 10.1600/036364412X616765; Groppo M, 2010, ACTA BOT BRAS, V24, P1107, DOI 10.1590/S0102-33062010000400028; Hall TA, 1997, BIOEDIT BIOLOGICAL S; Hesse M, 2009, POLLEN TERMINOLOGY A; HOLMSTEDT B, 1979, J ETHNOPHARMACOL, V1, P3, DOI 10.1016/0378-8741(79)90014-X; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Judd WS, 2008, PLANT SYSTEMATICS A; Kaastra RC, 1982, FLORA NEOTROPICA MON, DOI DOI 10.2307/2805360; Kallunki JA, 1998, BRITTONIA, V50, P59, DOI 10.2307/2807718; KALLUNKI JA, 1992, BRITTONIA, V44, P107, DOI 10.2307/2806828; Kallunki JA, 2007, PLANT BIOLOGY AND BO, P180; Kallunki Jacquelyn A., 1998, Kew Bulletin, V53, P257, DOI 10.2307/4114501; Kallunki JA, 2009, BRITTONIA, V61, P28, DOI 10.1007/s12228-008-9054-8; Kubitzki K., 2011, V10, P276; El Ottra JHL, 2013, ANN BOT-LONDON, V111, P821, DOI 10.1093/aob/mct039; Maddison WP, 2010, MESQUITE A MODULAR S; Mandalari G, 2007, J APPL MICROBIOL, V103, P2056, DOI 10.1111/j.1365-2672.2007.03456.x; Moraes VRD, 2003, J BRAZIL CHEM SOC, V14, P380, DOI 10.1590/S0103-50532003000300007; MORTON CM, 1993, BRITTONIA, V45, P286, DOI 10.2307/2807604; Morton CM, 2014, ANN MO BOT GARD, V99, P620, DOI 10.3417/2010034; Nixon KC, 1996, CLADISTICS, V12, P221, DOI 10.1111/j.1096-0031.1996.tb00010.x; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Pirani Jose Rubens, 2011, Kew Bulletin, V66, P521; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Radford AE., 1986, VASCULAR PLANT SYSTE; Rambaut A, 2013, MCMC TRACE ANALYSIS; Rutaceae Pirani JR., 2002, FLORA FANEROGAMICA D, V2, P281; Scotland RE, 2000, THE SYSTEMATICS ASSO, V58; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Silva IM, 1988, THESIS; Simmons MP, 2004, MOL BIOL EVOL, V21, P188, DOI 10.1093/molbev/msh014; Simpson MG, 2010, PLANT SYSTEMATICS, 2ND EDITION, P1; Skorupa LA, 1996, THESIS; Smith JF, 2000, PLANT SYST EVOL, V221, P179, DOI 10.1007/BF01089293; STACE HM, 1993, PLANT SYST EVOL, V187, P1, DOI 10.1007/BF00994089; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thiers B, 2012, INDEX HERBARIORUM A; Thorne RF, 2007, BOT REV, V73, P67, DOI 10.1663/0006-8101(2007)73[67:AUCOTC]2.0.CO;2; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	61	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125650	10.1371/journal.pone.0125650	http://dx.doi.org/10.1371/journal.pone.0125650			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951371	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400041
J	Kaur, K; Zheng, NY; Smith, K; Huang, M; Li, L; Pauli, NT; Dunand, CJH; Lee, JH; Morrissey, M; Wu, YX; Joachims, ML; Munroe, ME; Lau, D; Qu, XY; Krammer, F; Wrammert, J; Palese, P; Ahmed, R; James, JA; Wilson, PC				Kaur, Kaval; Zheng, Nai-Ying; Smith, Kenneth; Huang, Min; Li, Lie; Pauli, Noel T.; Dunand, Carole J. Henry; Lee, Jane-Hwei; Morrissey, Michael; Wu, Yixuan; Joachims, Michelle L.; Munroe, Melissa E.; Lau, Denise; Qu, Xinyan; Krammer, Florian; Wrammert, Jens; Palese, Peter; Ahmed, Rafi; James, Judith A.; Wilson, Patrick C.			High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNODEFICIENCY-VIRUS-INFECTION; HUMAN MONOCLONAL-ANTIBODIES; B-CELL TOLERANCE; SOMATIC MUTATION; HUMAN-IGG; HIV-1; AUTOANTIBODIES; NEUTRALIZATION; SUSCEPTIBILITY	Breakdown of B cell tolerance is a cardinal feature of systemic lupus erythematosus (SLE). Increased numbers of autoreactive mature naive B cells have been described in SLE patients and autoantibodies have been shown to arise from autoreactive and non-autoreactive precursors. How these defects, in the regulation of B cell tolerance and selection, influence germinal center (GC) reactions that are directed towards foreign antigens has yet to be investigated. Here, we examined the characteristics of post-GC foreign antigen-specific B cells from SLE patients and healthy controls by analyzing monoclonal antibodies generated from plasmablasts induced specifically by influenza vaccination. We report that many of the SLE patients had anti-influenza antibodies with higher binding affinity and neutralization capacity than those from controls. Although overall frequencies of autoreactivity in the influenza-specific plasmablasts were similar for SLE patients and controls, the variable gene repertoire of influenza-specific plasmablasts from SLE patients was altered, with increased usage of JH6 and long heavy chain CDR3 segments. We found that high affinity anti-influenza antibodies generally characterize the plasmablast responses of SLE patients with low levels of autoreactivity; however, certain exceptions were noted. The high-avidity antibody responses in SLE patients may also be correlated with cytokines that are abnormally expressed in lupus. These findings provide insights into the effects of dysregulated immunity on the quality of antibody responses following influenza vaccination and further our understanding of the underlying abnormalities of lupus.	[Kaur, Kaval; Pauli, Noel T.; Lau, Denise; Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Kaur, Kaval; Zheng, Nai-Ying; Huang, Min; Li, Lie; Pauli, Noel T.; Dunand, Carole J. Henry; Lee, Jane-Hwei; Morrissey, Michael; Wu, Yixuan; Lau, Denise; Qu, Xinyan; Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Knapp Ctr Lupus & Immunol, Chicago, IL 60637 USA; [Smith, Kenneth; Munroe, Melissa E.; James, Judith A.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Joachims, Michelle L.] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Wrammert, Jens; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol & Med, Oklahoma City, OK USA	University of Chicago; University of Chicago; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Icahn School of Medicine at Mount Sinai; Emory University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wilson, PC (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	wilsonp@uchicago.edu	Krammer, Florian/H-3237-2019; Wilson, Patrick/HGC-3157-2022; Wu, Yixuan/GXG-9879-2022	Krammer, Florian/0000-0003-4121-776X; Wu, Yixuan/0000-0001-9637-9219; Palese, Peter/0000-0002-0337-5823; Munroe, Melissa/0000-0002-6933-9745	National Science Scholarship (PhD) from Agency of Science, Technology and Research (A*STAR), Singapore; Austrian Science Fund (FWF) [J3232]; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101934, T32AI007090, U19AI109946, U19AI090023, U19AI082714, U54AI057158, P01AI097092, U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510, U54GM104938] Funding Source: NIH RePORTER	National Science Scholarship (PhD) from Agency of Science, Technology and Research (A*STAR), Singapore; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This research was supported by National Institutes of Health grants 1U19AI08724 (PCW), HHSN266200500026C (PCW, JAJ), 5U54AI057158 (PCW, RA), 5U19AI057266 (PCW, RA, JW), 1U19AI090023 (PCW, RA, JW), 1P01AI097092 (PCW, RA, PP), P30AR053483 (JAJ), U01AI101934 (JAJ), U19AI082714 (JAJ), P30GM103510 (JAJ), U54GM104938 (JAJ), HHSN26620070010C (PP), HHSN272201400008C (FK), and by funds provided by the Gwen Knapp Center for Lupus and Immunology Research. KK was supported by a National Science Scholarship (PhD) from the Agency of Science, Technology and Research (A*STAR), Singapore. Florian Krammer was supported by an Erwin Schrodinger fellowship (J3232) from the Austrian Science Fund (FWF). Judith James was supported in part by the Lou Kerr Chair in Biomedical Research at Oklahoma Medical Research Foundation (http://www.nih.gov/http://www.uchospitals.edu/about/fact/cbd-sheet.html http://www.a-star.edu.sg/, https://www.fwf.ac.at/en/researchfunding/fwf-programmes/, http://omrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shakra M, 2002, J RHEUMATOL, V29, P2555; Abu-Shakra M, 2002, CLIN RHEUMATOL, V21, P369, DOI 10.1007/s100670200099; Abu-Shakra M, 2000, J RHEUMATOL, V27, P1681; Abu-Shakra M, 2007, AUTOIMMUN REV, V6, P543, DOI 10.1016/j.autrev.2006.12.004; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; BENSIMON C, 1994, EMBO J, V13, P2951, DOI 10.1002/j.1460-2075.1994.tb06593.x; BERMAS BL, 1994, J CLIN IMMUNOL, V14, P169, DOI 10.1007/BF01533366; Bonsignori M, 2014, J CLIN INVEST, V124, P1835, DOI 10.1172/JCI73441; BUTCHER GA, 1991, J ROY SOC MED, V84, P451, DOI 10.1177/014107689108400802; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Carugati M, 2013, CLIN RHEUMATOL, V32, P1399, DOI 10.1007/s10067-013-2271-x; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Crispin JC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943254; Crowe SR, 2011, ARTHRITIS RHEUM-US, V63, P2396, DOI 10.1002/art.30388; Del Porto F, 2006, VACCINE, V24, P3217, DOI 10.1016/j.vaccine.2006.01.028; Detanico T, 2013, AUTOIMMUNITY, V46, P102, DOI 10.3109/08916934.2012.757597; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; Fox RA, 1997, ARTHRITIS RHEUM-US, V40, P1168, DOI 10.1002/art.1780400623; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Garcia-Ortiz H, 2010, ANN RHEUM DIS, V69, P1861, DOI 10.1136/ard.2009.124313; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2014, P NATL ACAD SCI USA, V111, P9022, DOI 10.1073/pnas.1407877111; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Holvast A, 2006, ANN RHEUM DIS, V65, P913, DOI 10.1136/ard.2005.043943; Holvast A, 2009, ARTHRITIS RHEUM, V60, P2438, DOI 10.1002/art.24679; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Kariuki SN, 2010, TRANSL RES, V155, P109, DOI 10.1016/j.trsl.2009.08.012; Kaur K, 2011, TRENDS IMMUNOL, V32, P524, DOI 10.1016/j.it.2011.08.007; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; Lertchaisataporn K, 2013, JCR-J CLIN RHEUMATOL, V19, P115, DOI 10.1097/RHU.0b013e318289bb9b; Mathian A, 2011, ARTHRITIS RHEUM-US, V63, P3502, DOI 10.1002/art.30576; Meffre E, 2000, NAT IMMUNOL, V1, P207, DOI 10.1038/79739; Mercado U, 2004, REV INVEST CLIN, V56, P16; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Millet A, 2009, EUR J INTERN MED, V20, P236, DOI 10.1016/j.ejim.2008.07.017; Miner JJ, 2014, NAT GENET, V46, P418, DOI 10.1038/ng.2959; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Palacios R, 2004, INT J STD AIDS, V15, P277, DOI 10.1258/095646204773557857; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Quach TD, 2011, J IMMUNOL, V186, P4640, DOI 10.4049/jimmunol.1001946; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; Wang C, 2014, FRONT MATER SCI, V8, P3, DOI 10.1007/s11706-014-0241-0; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wiesik-Szewczyk E, 2010, CLIN RHEUMATOL, V29, P605, DOI 10.1007/s10067-010-1373-y; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zheng NY, 2004, J CLIN INVEST, V113, P1188, DOI 10.1172/JCI200420255	66	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125618	10.1371/journal.pone.0125618	http://dx.doi.org/10.1371/journal.pone.0125618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951191	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400039
J	Ao, D; Guo, HC; Sun, SQ; Sun, DH; Fung, TS; Wei, YQ; Han, SC; Yao, XP; Cao, SZ; Liu, DX; Liu, XT				Ao, Da; Guo, Hui-Chen; Sun, Shi-Qi; Sun, De-Hui; Fung, To Sing; Wei, Yan-Quan; Han, Shi-Chong; Yao, Xue-Ping; Cao, Sui-Zhong; Liu, Ding Xiang; Liu, Xiang-Tao			Viroporin Activity of the Foot-and-Mouth Disease Virus Non-Structural 2B Protein	PLOS ONE			English	Article							ESCHERICHIA-COLI-CELLS; KINASE KINASE-BETA; MEMBRANE-PERMEABILITY; ENDOPLASMIC-RETICULUM; ION-CHANNEL; TRITON X-100; P7 PROTEIN; PORE FORMATION; AUTOPHAGY; EXPRESSION	Viroporins are a family of low-molecular-weight hydrophobic transmembrane proteins that are encoded by various animal viruses. Viroporins form transmembrane pores in host cells via oligomerization, thereby destroying cellular homeostasis and inducing cytopathy for virus replication and virion release. Among the Picornaviridae family of viruses, the 2B protein encoded by enteroviruses is well understood, whereas the viroporin activity of the 2B protein encoded by the foot-and-mouth disease virus (FMDV) has not yet been described. An analysis of the FMDV 2B protein domains by computer-aided programs conducted in this study revealed that this protein may contain two transmembrane regions. Further biochemical, biophysical and functional studies revealed that the protein possesses a number of features typical of a viroporin when it is overexpressed in bacterial and mammalian cells as well as in FMDV-infected cells. The protein was found to be mainly localized in the endoplasmic reticulum (ER), with both the N-and C-terminal domains stretched into the cytosol. It exhibited cytotoxicity in Escherichia coli, which attenuated 2B protein expression. The release of virions from cells infected with FMDV was inhibited by amantadine, a viroporin inhibitor. The 2B protein monomers interacted with each other to form both intracellular and extracellular oligomers. The Ca2+ concentration in the cells increased, and the integrity of the cytoplasmic membrane was disrupted in cells that expressed the 2B protein. Moreover, the 2B protein induced intense autophagy in host cells. All of the results of this study demonstrate that the FMDV 2B protein has properties that are also found in other viroporins and may be involved in the infection mechanism of FMDV.	[Ao, Da; Guo, Hui-Chen; Sun, Shi-Qi; Sun, De-Hui; Wei, Yan-Quan; Han, Shi-Chong; Liu, Ding Xiang; Liu, Xiang-Tao] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Ao, Da; Guo, Hui-Chen; Sun, Shi-Qi; Sun, De-Hui; Wei, Yan-Quan; Han, Shi-Chong; Liu, Ding Xiang; Liu, Xiang-Tao] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, OIE Natl Foot & Mouth Dis Reference Lab, Lanzhou, Gansu, Peoples R China; [Ao, Da; Yao, Xue-Ping; Cao, Sui-Zhong] Sichuan Agr Univ, Coll Vet Med, Yaan, Sichuan, Peoples R China; [Fung, To Sing; Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Sichuan Agricultural University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	shiqisun21@hotmail.com	FUNG, TO SING/AAE-7592-2022; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; FUNG, To Sing/0000-0003-3776-5763	National Science and Technology Support Program [2013BAD12B00]; Fundamental Research Funds for the Chinese Academy of Agricultural Sciences [2015ZL062]; International Science & Technology Cooperation Program of China [2014DFA31890]; "Twelfth Five-Year" National Science and technology program in rural areas [2011AA10A211]	National Science and Technology Support Program; Fundamental Research Funds for the Chinese Academy of Agricultural Sciences; International Science & Technology Cooperation Program of China; "Twelfth Five-Year" National Science and technology program in rural areas	This research was supported by grants from the National Science and Technology Support Program (2013BAD12B00), the Fundamental Research Funds for the Chinese Academy of Agricultural Sciences (2015ZL062), the International Science & Technology Cooperation Program of China (2014DFA31890), and the "Twelfth Five-Year" National Science and technology program in rural areas (2011AA10A211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre A, 2002, J BIOL CHEM, V277, P40434, DOI 10.1074/jbc.M205393200; Agirre A, 2008, BBA-BIOMEMBRANES, V1778, P2621, DOI 10.1016/j.bbamem.2008.06.013; Ahyayauch H, 2013, CHEM PHYS LIPIDS, V167, P57, DOI 10.1016/j.chemphyslip.2013.02.003; Ahyayauch H, 2012, BIOPHYS J, V102, P2510, DOI 10.1016/j.bpj.2012.04.041; Aldabe R, 1997, J VIROL, V71, P6214, DOI 10.1128/JVI.71.8.6214-6217.1997; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Brisac C, 2010, J VIROL, V84, P12226, DOI 10.1128/JVI.00994-10; Burchiel SW, 2000, METHODS, V21, P221, DOI 10.1006/meth.2000.1002; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Crawford SE, 2012, P NATL ACAD SCI USA, V109, pE3405, DOI 10.1073/pnas.1216539109; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; de Jong AS, 2003, J BIOL CHEM, V278, P1012, DOI 10.1074/jbc.M207745200; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Garcia-Briones M, 2006, VIROLOGY, V349, P409, DOI 10.1016/j.virol.2006.02.042; Gladue DP, 2012, J VIROL, V86, P6778, DOI 10.1128/JVI.00560-12; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; GUINEA R, 1994, FEBS LETT, V343, P242, DOI 10.1016/0014-5793(94)80564-4; Guo HC, 2013, INT J BIOCHEM CELL B, V45, P1186, DOI 10.1016/j.biocel.2013.03.021; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hu D, 2012, MOL MED REP, V6, P783, DOI 10.3892/mmr.2012.988; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; Intharathep P, 2008, J MOL GRAPH MODEL, V27, P342, DOI 10.1016/j.jmgm.2008.06.002; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; LAMA J, 1992, J BIOL CHEM, V267, P15932; Liao Y, 2004, BIOCHEM BIOPH RES CO, V325, P374, DOI 10.1016/j.bbrc.2004.10.050; Ljubicic V, 2013, TRENDS MOL MED, V19, P614, DOI 10.1016/j.molmed.2013.07.002; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Madan V, 2007, J MOL BIOL, V374, P951, DOI 10.1016/j.jmb.2007.09.058; Madan V, 2010, CELL MICROBIOL, V12, P1144, DOI 10.1111/j.1462-5822.2010.01460.x; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Martinez-Gil L, 2011, J VIROL, V85, P11315, DOI 10.1128/JVI.05421-11; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Vicencio JM, 2010, CELL CALCIUM, V47, P112, DOI 10.1016/j.ceca.2009.12.013; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Nieva JL, 2003, FEBS LETT, V552, P68, DOI 10.1016/S0014-5793(03)00852-4; Paloheimo O, 2011, J VIROL, V85, P6714, DOI 10.1128/JVI.00247-10; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Premkumar A, 2006, ANTIVIR THER, V11, P289; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; Satakarni M, 2011, PROTEIN EXPRES PURIF, V78, P113, DOI 10.1016/j.pep.2011.04.015; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; Tian ZG, 2009, APPL MICROBIOL BIOT, V83, P143, DOI 10.1007/s00253-009-1893-z; Tong WJ, 2005, CHEM MATER, V17, P4610, DOI 10.1021/cm0507516; van Kuppeveld FJM, 2005, TRENDS MICROBIOL, V13, P41, DOI 10.1016/j.tim.2004.12.005; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; vanKuppeveld FJM, 1996, J VIROL, V70, P3876, DOI 10.1128/JVI.70.6.3876-3886.1996; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005; Zuo Xun, 2005, Journal of Structural and Functional Genomics, V6, P103, DOI 10.1007/s10969-005-2664-4	63	38	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125828	10.1371/journal.pone.0125828	http://dx.doi.org/10.1371/journal.pone.0125828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946195	Green Published, gold			2022-12-26	WOS:000354049700091
J	Orr, JM; Smolker, HR; Banich, MT				Orr, Joseph M.; Smolker, Harry R.; Banich, Marie T.			Organization of the Human Frontal Pole Revealed by Large-Scale DTI-Based Connectivity: Implications for Control of Behavior	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; DIFFUSION MRI; HUMAN BRAIN; PARCELLATION; CINGULATE; TRACTOGRAPHY; AREAS	The goal of the current study was to examine the pattern of anatomical connectivity of the human frontal pole so as to inform theories of function of the frontal pole, perhaps one of the least understood region of the human brain. Rather than simply parcellating the frontal pole into subregions, we focused on examining the brain regions to which the frontal pole is anatomically and functionally connected. While the current findings provided support for previous work suggesting the frontal pole is connected to higher-order sensory association cortex, we found novel evidence suggesting that the frontal pole in humans is connected to posterior visual cortex. Furthermore, we propose a functional framework that incorporates these anatomical connections with existing cognitive theories of the functional organization of the frontal pole. In addition to a previously discussed medial-lateral distinction, we propose a dorsal-ventral gradient based on the information the frontal pole uses to guide behavior. We propose that dorsal regions are connected to other prefrontal regions that process goals and action plans, medial regions are connected to other brain regions that monitor action outcomes and motivate behaviors, and ventral regions connect to regions that process information about stimuli, values, and emotion. By incorporating information across these different levels of information, the frontal pole can effectively guide goal-directed behavior.	[Orr, Joseph M.; Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Smolker, Harry R.; Banich, Marie T.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Orr, JM (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	joseph.orr@colorado.edu	Orr, Joseph M./K-6841-2016	Orr, Joseph M./0000-0002-6539-339X; BANICH, MARIE/0000-0001-9373-9194	National Institute of Mental Health [P50 079485]; National Institute on Drug Abuse [1-F32-DA034412]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA034412] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health (http://www.nimh.nih.gov; grant number: P50 079485 to M.T.B.) and the National Institute on Drug Abuse (http://www.drugabuse.gov; grant number: 1-F32-DA034412 to J.M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bludau S, 2014, NEUROIMAGE, V93, P260, DOI 10.1016/j.neuroimage.2013.05.052; Brodmann K, 1909, VERGLEICHENDE LOKALI; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2005, MEASURING MIND SPEED, P217, DOI DOI 10.1093/ACPR0F:0S0/9780198566427.003.0009; Burman KJ, 2011, CEREB CORTEX, V21, P1712, DOI 10.1093/cercor/bhq239; Caverzasi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100274; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Demanet J, 2013, NEUROIMAGE, V72, P207, DOI 10.1016/j.neuroimage.2013.01.052; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gilbert SJ, 2010, NEUROIMAGE, V53, P1359, DOI 10.1016/j.neuroimage.2010.07.032; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Henseler I, 2011, NEUROIMAGE, V56, P1666, DOI 10.1016/j.neuroimage.2011.02.056; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; KELLY JP, 1974, J PHYSIOL-LONDON, V238, P515, DOI 10.1113/jphysiol.1974.sp010541; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Liu HG, 2013, J NEUROSCI, V33, P6782, DOI 10.1523/JNEUROSCI.4882-12.2013; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Moayedi M, 2015, BRAIN STRUCT FUNCT, V220, P2603, DOI 10.1007/s00429-014-0809-6; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; O'Reilly RC, 2010, TRENDS NEUROSCI, V33, P355, DOI 10.1016/j.tins.2010.05.002; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Orr JM, 2014, NEUROIMAGE, V84, P191, DOI 10.1016/j.neuroimage.2013.08.047; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sarubbo S, 2013, BRAIN STRUCT FUNCT, V218, P21, DOI 10.1007/s00429-011-0372-3; Schmahmann J. D., 2009, FIBER PATHWAYS BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195104233.001.0001, 10.1093/acprof:oso/9780195104233.001.0001]; Schmahmann JD, 2007, J HIST NEUROSCI, V16, P362, DOI 10.1080/09647040600620468; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Thiebaut de Schotten Michel, 2011, Nat Neurosci, V14, P1245, DOI 10.1038/nn.2905; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; Van Essen DC, 1983, J NEUROPHYSIOL, V6, P1042; VANESSEN DC, 1979, ANNU REV NEUROSCI, V2, P227, DOI 10.1146/annurev.ne.02.030179.001303; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	53	48	49	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124797	10.1371/journal.pone.0124797	http://dx.doi.org/10.1371/journal.pone.0124797			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945925	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700049
J	Florez, AB; Mayo, B				Belen Florez, Ana; Mayo, Baltasar			The Plasmid Complement of the Cheese Isolate Lactococcus garvieae IPLA 31405 Revealed Adaptation to the Dairy Environment	PLOS ONE			English	Article							MOLECULAR ANALYSIS; SEQUENCE-ANALYSIS; LACTIS; BACTERIA; ORIGIN; REPLICATION; RESISTANCE; DIVERSITY; FISH; DNA	Lactococcus garvieae is a lactic acid bacterium found in raw-milk dairy products as well as a range of aquatic and terrestrial environments. The plasmids in L. garvieae have received little attention compared to those of dairy Lactococcus lactis, in which the genes carried by these extrachromosomal elements are considered of adaptive value. The present work reports the sequencing and analysis of the plasmid complement of L. garvieae IPLA 31405, a strain isolated from a traditional, Spanish, starter-free cheese made from raw-milk. It consists of pLG9 and pLG42, of 9,124 and 42,240 nucleotides, respectively. Based on sequence and structural homology in the putative origin of replication (ori) region, pLG9 and pLG42 are predicted to replicate via a theta mechanism. Real-time, quantitative PCR showed the number of copies per chromosome equivalent of pLG9 and pLG42 to be around two and five, respectively. Sequence analysis identified eight complete open reading frames (orfs) in pLG9 and 36 in pLG42; these were organized into functional modules or cassettes containing different numbers of genes. These modules were flanked by complete or interrupted insertion sequence (IS)-like elements. Among the modules of pLG42 was a gene cluster encoding specific components of a phosphoenolpyruvate-phosphotransferase (PEP-PTS) system, including a phospho-beta-galacosidase. The cluster showed a complete nucleotide identity respect to that in plasmids of L. lactis. Loss of pLG42 showed this to be involved in lactose assimilation. In the same plasmid, an operon encoding a type I restriction/modification (R/M) system was also identified. The specificity of this R/M system might be broadened by different R/M specificity subunits detected in pLG9 and in the bacterial chromosome. However, challenges of L. garvieae IPLA 31405 against L. lactis phages proved that the R/M system was not involved in phage resistance. Together, these results support the hypothesis that, as in L. lactis, pLG42 contribute towards the adaptation of L. garvieae to the dairy environment.	[Belen Florez, Ana; Mayo, Baltasar] CSIC, IPLA, Dept Microbiol Bioquim, Villaviciosa 33300, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Mayo, B (corresponding author), CSIC, IPLA, Dept Microbiol Bioquim, Carretera Infiesto S-N, Villaviciosa 33300, Asturias, Spain.	baltasar.mayo@ipla.csic.es	Mayo, Baltasar/D-4855-2011	Mayo, Baltasar/0000-0001-5634-6543	Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2011-24300]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [RM2011-00005-00-00]; Consejo Superior de Investigaciones Cientificas (CSIC) [JCI-2010-07457]	Spanish Ministry of Economy and Competitiveness (MINECO); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Consejo Superior de Investigaciones Cientificas (CSIC)	This research was partially funded by projects from the Spanish Ministry of Economy and Competitiveness (MINECO) (Ref. AGL2011-24300) and Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) (Ref. RM2011-00005-00-00). AB Florez was supported by research contracts under Juan de la Cierva Program from the Consejo Superior de Investigaciones Cientificas (CSIC) (Ref. JCI-2010-07457).	Aguado-Urda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040119; Aguado-Urda M, 2010, INT MICROBIOL, V13, P189, DOI 10.2436/20.1501.01.125; Ainsworth S, 2014, FEMS MICROBIOL REV, V38, P1066, DOI 10.1111/1574-6976.12074; Alegria A, 2009, INT J FOOD MICROBIOL, V136, P44, DOI 10.1016/j.ijfoodmicro.2009.09.023; Florez AB, 2012, J BACTERIOL, V194, P5118, DOI 10.1128/JB.00975-12; Bounaix S, 1999, APPL ENVIRON MICROB, V62, P1112; Callon C, 2004, J DAIRY RES, V71, P231, DOI 10.1017/S0022029904000159; Chan JFW, 2011, INFECTION, V39, P259, DOI 10.1007/s15010-011-0094-8; Chang SM, 2007, BIOTECHNOL LETT, V29, P1519, DOI 10.1007/s10529-007-9418-2; COLLINS MD, 1983, J GEN MICROBIOL, V129, P3427; El-Baradei G, 2008, INT J FOOD MICROBIOL, V121, P295, DOI 10.1016/j.ijfoodmicro.2007.11.014; Fallico V, 2011, APPL ENVIRON MICROB, V77, P6451, DOI 10.1128/AEM.00661-11; Fernandez E, 2010, INT DAIRY J, V20, P142, DOI 10.1016/j.idairyj.2009.11.004; Ferrario C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084796; Foley S, 1996, PLASMID, V36, P125, DOI 10.1006/plas.1996.0040; Fortina MG, 2007, J APPL MICROBIOL, V103, P445, DOI 10.1111/j.1365-2672.2006.03265.x; Fortina MG, 2009, J FOOD PROTECT, V72, P1248, DOI 10.4315/0362-028X-72.6.1248; Fortina MG, 2003, FOOD MICROBIOL, V20, P397, DOI 10.1016/S0740-0020(02)00149-1; Foschino R, 2006, ITAL J FOOD SCI, V18, P33; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Ghasemi SM, 2014, ARCH VIROL, V159, P2909, DOI 10.1007/s00705-014-2142-z; Godon JJ, 1995, DEV BIOL STAND, V85, P423; Gorecki RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022238; GRAVESEN A, 1995, PLASMID, V34, P105, DOI 10.1006/plas.1995.9996; Ibryashkina EM, 2009, J MOL BIOL, V387, P10, DOI 10.1016/j.jmb.2009.01.048; Jokovic N, 2008, INT J FOOD MICROBIOL, V127, P305, DOI 10.1016/j.ijfoodmicro.2008.07.026; Kelly WJ, 2010, GENOME BIOL EVOL, V2, P729, DOI 10.1093/gbe/evq056; KIEWIET R, 1993, MOL MICROBIOL, V10, P319, DOI 10.1111/j.1365-2958.1993.tb01958.x; Klare I, 2005, APPL ENVIRON MICROB, V71, P8982, DOI 10.1128/AEM.71.12.8982-8986.2005; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Lee K, 2003, CURR MICROBIOL, V47, P17, DOI 10.1007/s00284-002-3932-1; Madera C, 2004, APPL ENVIRON MICROB, V70, P7365, DOI 10.1128/AEM.70.12.7365-7371.2004; Maki T, 2009, APPL ENVIRON MICROB, V75, P3370, DOI 10.1128/AEM.00039-09; Menendez A, 2006, RES MICROBIOL, V157, P575, DOI 10.1016/j.resmic.2005.11.016; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Nakai T, 1999, DIS AQUAT ORGAN, V37, P33, DOI 10.3354/dao037033; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; OSULLIVAN DJ, 1993, APPL ENVIRON MICROB, V59, P2730, DOI 10.1128/AEM.59.8.2730-2733.1993; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Sambrook J., 2001, MOL CLONING LAB MANU; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Tanous C, 2007, MICROBIOL-SGM, V153, P1664, DOI 10.1099/mic.0.2006/002246-0; van Kranenburg R, 1998, J BACTERIOL, V180, P5285, DOI 10.1128/JB.180.20.5285-5290.1998; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Wegmann U, 2012, MICROBIOL-SGM, V158, P2936, DOI 10.1099/mic.0.062554-0; Wyder AB, 2011, RES VET SCI, V91, P349, DOI 10.1016/j.rvsc.2010.09.006; Yu WZ, 1996, PLASMID, V35, P145, DOI 10.1006/plas.1996.0017	49	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126101	10.1371/journal.pone.0126101	http://dx.doi.org/10.1371/journal.pone.0126101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942497	Green Published, gold			2022-12-26	WOS:000353943400061
J	Bennett, H; McEwan, P; Sugrue, D; Kalsekar, A; Yuan, Y				Bennett, Hayley; McEwan, Phil; Sugrue, Daniel; Kalsekar, Anupama; Yuan, Yong			Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections	PLOS ONE			English	Article							OPIATE SUBSTITUTION THERAPY; GENOTYPE 1; ANTIVIRAL TREATMENT; SYRINGE PROGRAMS; USERS; HCV; SOFOSBUVIR; PREVALENCE; NEEDLE; SPREAD	Objective The prevalence of the hepatitis C virus (HCV) remains high amongst people who inject drugs (PWID) and accounts for the majority of newly acquired infections. This study aims to quantify the value of treatment amongst PWID with more efficacious treatments and at increased uptake rates, with respect to the avoidance of future infections and subsequent long-term complications of HCV. Methods A dynamic HCV transmission and disease progression model was developed, incorporating acute and chronic infection and their long-term complications (decompensated cirrhosis, cancer, liver transplant and mortality), with the potential for HCV transmission to other PWID prior to successful treatment. The model was populated with prevalence and therapy data from a UK setting. Scenarios of current standard of care (SoC) treatment efficacy and uptake were compared to anticipated sustained virologic response (SVR) rates of 90-100% and increased uptake over varied horizons. Results SoC led to modest reductions in prevalence; >5% after 200 years. New treatments achieving 90% SVR could reduce prevalence below 5% within 60 years at current uptake rates or within 5 years if all patients are treated. Amongst 4,240 PWID, chronic HCV infections avoided as a result of increasing treatment uptake over the period 2015-2027 ranged from 20-580 and 34-912 with SoC and 90% SVR rates respectively. The reduction in downstream HCV infections due to increasing treatment uptake resulted in an approximate discounted gain of 300 life-years (from avoiding reduced life expectancy from HCV infection) and a gain of 1,700 QALYs (from avoiding the disutility of HCV infection and related complications), with a projected 5.4 pound million cost saving. Conclusion While improved SVR profiles led to reductions in modelled prevalence, increased treatment uptake was the key driver of future infections avoided. Increased treatment among PWID with new more efficacious therapies could significantly change the future dynamics, cost and health burden of HCV-related disease.	[Bennett, Hayley; McEwan, Phil; Sugrue, Daniel] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales; [McEwan, Phil] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Kalsekar, Anupama; Yuan, Yong] BMS Global Hlth Econ & Outcomes Res, Princeton, NJ USA	Health Economics & Outcomes Research Ltd; Swansea University	Bennett, H (corresponding author), Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales.	hayley.bennettwilton@heor.co.uk			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funding for this study and writing of the manuscript was provided to Health Economics & Outcomes Research Ltd by Bristol-Myers Squibb. Bristol-Myers Squibb provided support in the form of salaries for authors AK & YY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors jointly decided to publish the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Allen EJ, 2012, INT J DRUG POLICY, V23, P346, DOI 10.1016/j.drugpo.2012.07.006; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Cornish R, 2010, BMJ, V341; Corson S, 2012, MATH MED BIOL, V29, P205, DOI 10.1093/imammb/dqr011; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Dore GJ, 2012, MED J AUSTRALIA, V196, P629, DOI 10.5694/mja11.11531; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Grebely J, 2010, EUR J GASTROEN HEPAT, V22, P270, DOI 10.1097/MEG.0b013e32832a8c4c; Hallinan R, 2007, DRUG ALCOHOL DEPEN, V88, P49, DOI 10.1016/j.drugalcdep.2006.09.018; Harris KA, 2010, J ADDICT MED, V4, P20, DOI 10.1097/ADM.0b013e3181add3de; Hay G, 2004, ESTIMATING THE NATIO; Health Protection Scotland and University of the West of Scotland, 2007, NEEDLE EXCHANGE SURV; Hellard M, 2014, HEPATOLOGY, V59, P366, DOI 10.1002/hep.26623; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Hickman M, 2009, J PUBLIC HEALTH-UK, V31, P374, DOI 10.1093/pubmed/fdp067; Hutchinson SJ, 2006, INT J DRUG POLICY, V17, P211, DOI 10.1016/j.drugpo.2006.02.008; Innes HA, 2012, EUR J GASTROEN HEPAT, V24, P646, DOI 10.1097/MEG.0b013e32835201a4; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kemp PA, 2006, HEALTH SOC CARE COMM, V14, P319, DOI 10.1111/j.1365-2524.2006.00624.x; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lindenburg CEA, 2011, EUR J GASTROEN HEPAT, V23, P23, DOI 10.1097/MEG.0b013e328340c451; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; McEwan P, 2013, VALUE HLTH REGIONAL, V3, P5; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mondelli MU, 2005, J HEPATOL, V42, pS108, DOI 10.1016/j.jhep.2004.10.017; National Institute for Health and Care Excellence (NICE, TECHNOLOGY APPRAISAL; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Public Health England, HEPATITIS C IN THE U; Public Health England, DATA TABLES OF THE U; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sweeting MJ, 2009, AM J EPIDEMIOL, V170, P352, DOI 10.1093/aje/kwp141; The All-Party Parliamentary Hepatology Group, IN THE DARK AN AUDIT; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; University of the West of Scotland, 2008, THE NEEDLE EXCHANGE; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Vickerman P, 2011, DRUG ALCOHOL DEPEN, V113, P83, DOI 10.1016/j.drugalcdep.2010.08.001; Zeiler I, 2010, DRUG ALCOHOL DEPEN, V110, P228, DOI 10.1016/j.drugalcdep.2010.03.006	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125846	10.1371/journal.pone.0125846	http://dx.doi.org/10.1371/journal.pone.0125846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938458	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000106
J	Leite, BRD; Tribst, AAL; Cristianini, M				de Castro Leite Junior, Bruno Ricardo; Lima Tribst, Alline Artigiani; Cristianini, Marcelo			High Pressure Homogenization of Porcine Pepsin Protease: Effects on Enzyme Activity, Stability, Milk Coagulation Profile and Gel Development	PLOS ONE			English	Article							RHEOLOGICAL PROPERTIES; NEUTRAL PROTEASE; GLUCOSE-OXIDASE; WHEY SEPARATION; CHEESE; RENNET; PROTEOLYSIS; SYNERESIS; KINETICS	This study investigated the effect of high pressure homogenization (HPH) (up to 190 MPa) on porcine pepsin (proteolytic and milk-clotting activities), and the consequences of using the processed enzyme in milk coagulation and gel formation (rheological profile, proteolysis, syneresis, and microstructure). Although the proteolytic activity (PA) was not altered immediately after the HPH process, it reduced during enzyme storage, with a 5% decrease after 60 days of storage for samples obtained with the enzyme processed at 50, 100 and 150 MPa. HPH increased the milk-clotting activity (MCA) of the enzyme processed at 150 MPa, being 15% higher than the MCA of non-processed samples after 60 days of storage. The enzyme processed at 150 MPa produced faster aggregation and a more consistent milk gel (G' value 92% higher after 90 minutes) when compared with the non-processed enzyme. In addition, the gels produced with the enzyme processed at 150 MPa showed greater syneresis after 40 minutes of coagulation (forming a more compact protein network) and lower porosity (evidenced by confocal microscopy). These effects on the milk gel can be associated with the increment in MCA and reduction in PA caused by the effects of HPH on pepsin during storage. According to the results, HPH stands out as a process capable of changing the proteolytic characteristics of porcine pepsin, with improvements on the milk coagulation step and gel characteristics. Therefore, the porcine pepsin submitted to HPH process can be a suitable alternative for the production of cheese.	[de Castro Leite Junior, Bruno Ricardo; Lima Tribst, Alline Artigiani; Cristianini, Marcelo] Univ Campinas UNICAMP, Sch Food Engn FEA, Dept Food Technol DTA, Campinas, SP, Brazil	Universidade Estadual de Campinas	Leite, BRD (corresponding author), Univ Campinas UNICAMP, Sch Food Engn FEA, Dept Food Technol DTA, Campinas, SP, Brazil.	brunorclj@gmail.com	de Castro Leite Júnior, Bruno Ricardo/O-3011-2014; Tribst, Alline A.L./B-2919-2014; Cristianini, Marcelo/D-1258-2012	de Castro Leite Júnior, Bruno Ricardo/0000-0001-9030-2819; Tribst, Alline A.L./0000-0003-1946-9354; Cristianini, Marcelo/0000-0001-7740-0449	Sao Paulo Research Foundation (FAPESP) [2012/13509-6, 2010/02540-1]; Coordination for Improvement of Personal Higher Education (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for Improvement of Personal Higher Education (CAPES)	This work was financially supported by the Sao Paulo Research Foundation (FAPESP-project #2012/13509-6 and #2010/02540-1) and by the Coordination for Improvement of Personal Higher Education (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo RA, 2004, J SCI FOOD AGR, V84, P325, DOI 10.1002/jsfa.1662; Albillos SM, 2006, J AGR FOOD CHEM, V54, P8281, DOI 10.1021/jf0613381; Alves LS, 2013, J DAIRY SCI, V96, P7490, DOI 10.3168/jds.2013-7119; Andren A., 2011, ENCY DAIRY SCI, V2nd ed., P574, DOI [10.1016/B978-0-12-374407-4.00069-8, DOI 10.1016/B978-0-12-374407-4.00069-8, 10.1016/ B978-0-12-374407-4.00069-8]; Castillo M, 2006, INT DAIRY J, V16, P153, DOI 10.1016/j.idairyj.2005.02.004; Leite BRD, 2014, INNOV FOOD SCI EMERG, V26, P517, DOI 10.1016/j.ifset.2014.05.007; Leite BRD, 2014, INNOV FOOD SCI EMERG, V21, P44, DOI 10.1016/j.ifset.2013.11.006; Euromonitor International-Related Analysis, 2012, REL AN; Food Agriculture Organization, 2010, MILK MILK PROD; Fox P. F., 2004, Proteins in food processing, P29, DOI 10.1533/9781855738379.1.29; Fox PF, 2004, CHEESE CHEM PHYS MET; Harboe M., 2010, Technology of cheesemaking, P98, DOI 10.1002/9781444323740.ch3; Hassan F.A.M., 2013, RES PRECIS INSTRUM M, V2, P15, DOI [10.7813/2075-4124.2012/4-5/A.20, DOI 10.7813/2075-4124.2012/4-5/A.20]; Home D.S., 2004, GEN ASPECTS, V1, P47, DOI [DOI 10.1016/S1874-558X(04)80062-9, 10.1016/S1874-558X(04)80062-9]; Kumar A, 2010, CRIT REV BIOTECHNOL, V30, P243, DOI 10.3109/07388551.2010.483459; Tribst AAL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103410; Tribst AAL, 2012, INNOV FOOD SCI EMERG, V16, P355, DOI 10.1016/j.ifset.2012.08.002; Tribst AAL, 2012, INNOV FOOD SCI EMERG, V16, P21, DOI 10.1016/j.ifset.2012.03.002; Tribst AAL, 2012, INNOV FOOD SCI EMERG, V13, P107, DOI 10.1016/j.ifset.2011.10.006; Liu W, 2010, FOOD CHEM, V123, P616, DOI 10.1016/j.foodchem.2010.04.079; Liu W, 2009, J AGR FOOD CHEM, V57, P5376, DOI 10.1021/jf9006642; Liu W, 2009, INNOV FOOD SCI EMERG, V10, P142, DOI 10.1016/j.ifset.2008.11.009; Lodaite K, 2000, INT DAIRY J, V10, P829, DOI 10.1016/S0958-6946(01)00027-9; Lucey JA, 2001, FOOD HYDROCOLLOID, V15, P603, DOI 10.1016/S0268-005X(01)00043-1; Lucey JA, 2000, J DAIRY RES, V67, P415, DOI 10.1017/S0022029900004246; Merheb-Dini C, 2010, FOOD CHEM, V120, P87, DOI 10.1016/j.foodchem.2009.09.075; Moller KK, 2012, J AGR FOOD CHEM, V60, P5454, DOI 10.1021/jf300557d; NIELSEN PK, 1995, ARCH BIOCHEM BIOPHYS, V322, P417, DOI 10.1006/abbi.1995.1483; Ortega N, 2003, FOOD CONTROL, V14, P307, DOI 10.1016/S0956-7135(02)00095-6; Papoff CM, 2004, MILCHWISSENSCHAFT, V59, P414; Pinho Claudia Regina Gonçalves, 2011, Braz. J. Food Technol., V14, P232, DOI 10.4260/BJFT2011140300028; Sousa MJ, 2001, INT DAIRY J, V11, P327, DOI 10.1016/S0958-6946(01)00062-0; Tribst AAL, 2013, INNOV FOOD SCI EMERG, V18, P83, DOI 10.1016/j.ifset.2013.01.002; Tribst AAL, 2012, J IND MICROBIOL BIOT, V39, P1587, DOI 10.1007/s10295-012-1179-9; Tribst AAL, 2012, INT J FOOD SCI TECH, V47, P716, DOI 10.1111/j.1365-2621.2011.02898.x; Velazquez-Estrada RM, 2012, INNOV FOOD SCI EMERG, V13, P100, DOI 10.1016/j.ifset.2011.09.001	36	8	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125061	10.1371/journal.pone.0125061	http://dx.doi.org/10.1371/journal.pone.0125061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938823	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000042
J	Li, AQ; Zhou, SL; Li, M; Xu, Y; Shui, RH; Yu, BH; Yang, WT				Li, An-qi; Zhou, Shu-ling; Li, Ming; Xu, Yan; Shui, Ruo-hong; Yu, Bao-hua; Yang, Wen-tao			Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China	PLOS ONE			English	Article							ADJUVANT TAMOXIFEN; ENDOCRINE THERAPY; HORMONE-RECEPTOR; PREDICTIVE-VALUE; EXPRESSION; KI67; ASSOCIATION; PROGNOSIS; EFFICACY; INVASION	Purpose A lack of progesterone receptor (PgR) expression in oestrogen receptor-positive (ER+) tumours is associated with worse survival. PgR status is usually defined as positive or negative using 1% positive nuclei as a cut-off point. In this study, we aimed to assess the clinicopathologic characteristics of ER+/PgR-/HER2-tumours by comparing them with ER +/PgR+/HER2-tumours using a PgR cut-off point of 20% as a divisive criterion. Methods We analysed 1,522 patients with primary breast cancer who had undergone surgery at the Cancer Center of Fudan University between 2012 and 2014. Age, grade, tumour size, lymph node status and lymphovascular invasion were assessed. Multinomial logistic regression, linear regression and chi-square test models were applied to assess associations between ER, PR and clinical features. Results ER+/PgR-/HER2-tumours showed poorer clinicopathologic characteristics relative to ER +/PgR+/HER2-tumours using a PgR threshold of 20% instead of 1%. The clinicopathologic characteristics did not differ between tumours with purely negative PgR expression and tumours with a PgR percentage ranging from 1% to 19%. The prognostic significance of PR expression appeared more pronounced in patients under a high Ki-67 status than those under a low Ki-67 status. Conclusions Based on these findings, we propose the use of a novel threshold of 20% to define PgR status. Nevertheless, the impact of this new criterion on patient management and clinical treatment requires additional study.	[Li, An-qi; Zhou, Shu-ling; Li, Ming; Xu, Yan; Shui, Ruo-hong; Yu, Bao-hua; Yang, Wen-tao] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Li, An-qi; Zhou, Shu-ling; Li, Ming; Xu, Yan; Shui, Ruo-hong; Yu, Bao-hua; Yang, Wen-tao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yang, WT (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.	yangwt2000@163.com						Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Assersohn L, 2003, BREAST CANCER RES TR, V82, P113, DOI 10.1023/B:BREA.0000003968.45511.3f; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Creighton CJ, 2009, BREAST CANCER RES TR, V114, P287, DOI 10.1007/s10549-008-0017-2; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; HORWITZ KB, 1975, SCIENCE, V189, P726, DOI 10.1126/science.168640; Jacquemier J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2249; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Liu SZ, 2010, BREAST CANCER RES TR, V119, P53, DOI 10.1007/s10549-009-0318-0; Luoh SW, 2014, BREAST J, V20, P46, DOI 10.1111/tbj.12200; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Mohammed RAA, 2011, J PATHOL, V223, P358, DOI 10.1002/path.2810; Park S, 2013, ANN SURG ONCOL, V20, P1505, DOI 10.1245/s10434-012-2772-x; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Purdie CA, 2014, BRIT J CANCER, V110, P565, DOI 10.1038/bjc.2013.756; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	26	11	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125067	10.1371/journal.pone.0125067	http://dx.doi.org/10.1371/journal.pone.0125067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938238	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000043
J	Wong, AD; Ye, M; Ulmschneider, MB; Searson, PC				Wong, Andrew D.; Ye, Mao; Ulmschneider, Martin B.; Searson, Peter C.			Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFT; OF-THE-ART; LIPOSOMAL DOXORUBICIN; POLYETHYLENE-GLYCOL; SOLID TUMORS; PHARMACOKINETICS; CANCER; PERMEABILITY; PENETRATION; GROWTH	Tumor vasculature is characterized by a variety of abnormalities including irregular architecture, poor lymphatic drainage, and the upregulation of factors that increase the paracellular permeability. The increased permeability is important in mediating the uptake of an intravenously administered drug in a solid tumor and is known as the enhanced permeation and retention (EPR) effect. Studies in animal models have demonstrated a cut-off size of 500 nm - 1 mu m for molecules or nanoparticles to extravasate into a tumor, however, surprisingly little is known about the kinetics of the EPR effect. Here we present a pharmacokinetic model to quantitatively assess the influence of the EPR effect on the uptake of a drug into a solid tumor. We use pharmacokinetic data for Doxil and doxorubicin from human clinical trials to illustrate how the EPR effect influences tumor uptake. This model provides a quantitative framework to guide preclinical trials of new chemotherapies and ultimately to develop design rules that can increase targeting efficiency and decrease unwanted side effects in normal tissue.	[Wong, Andrew D.; Ulmschneider, Martin B.; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Wong, Andrew D.; Ulmschneider, Martin B.; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol INBT, Baltimore, MD USA; [Ye, Mao; Searson, Peter C.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	searson@jhu.edu		Searson, Peter/0000-0002-5417-0828	National Institutes of Health [U54CA151838, R01CA170629]; NATIONAL CANCER INSTITUTE [U54CA151838, R01CA170629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (U54CA151838 and R01CA170629) to PCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; CAMERON JR, 1999, PHYS BODY; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Dawidczyk CM, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00069; Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036; ERTTMANN R, 1988, J CANCER RES CLIN, V114, P509, DOI 10.1007/BF00391502; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Folarin AA, 2010, MICROVASC RES, V80, P89, DOI 10.1016/j.mvr.2010.03.007; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Gibaldi M, 2006, PHARMACOKINETICS; Gustafson DL, 2002, J PHARM SCI, V91, P1488, DOI 10.1002/jps.10161; Harrington KJ, 2000, BRIT J CANCER, V83, P684, DOI 10.1054/bjoc.2000.1320; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; JACQUET JM, 1990, CANCER CHEMOTH PHARM, V27, P219, DOI 10.1007/BF00685716; JAIN RK, 1988, CANCER RES, V48, P2641; Koukourakis MI, 1999, J CLIN ONCOL, V17, P3512, DOI 10.1200/JCO.1999.17.11.3512; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Northfelt DW, 1996, J CLIN PHARMACOL, V36, P55, DOI 10.1002/j.1552-4604.1996.tb04152.x; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; PISCITELLI SC, 1993, CLIN PHARMACOL THER, V53, P555, DOI 10.1038/clpt.1993.69; Stapleton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081157; YUAN F, 1995, CANCER RES, V55, P3752; YUAN F, 1994, CANCER RES, V54, P3352; Yuan ZP, 2006, CLIN CANCER RES, V12, P3193, DOI 10.1158/1078-0432.CCR-05-2365	29	98	98	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123461	10.1371/journal.pone.0123461	http://dx.doi.org/10.1371/journal.pone.0123461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938565	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000009
J	Harris, TL; McGargill, MA				Harris, Tarsha L.; McGargill, Maureen A.			Drak2 Does Not Regulate TGF-beta Signaling in T Cells	PLOS ONE			English	Article							SERINE/THREONINE KINASE; AUTOIMMUNE-DISEASE; PROTEIN-KINASE; APOPTOSIS; RESISTANCE; INFECTION; RESPONSES; SURVIVAL; BINDING	Drak2 is a serine/threonine kinase expressed highest in T cells and B cells. Drak2(-/-) mice are resistant to autoimmunity in mouse models of type 1 diabetes and multiple sclerosis. Resistance to these diseases occurs, in part, because Drak2 is required for the survival of autoreactive T cells that induce disease. However, the molecular mechanisms by which Drak2 affects T cell survival and autoimmunity are not known. A recent report demonstrated that Drak2 negatively regulated transforming growth factor-beta (TGF-beta) signaling in tumor cell lines. Thus, increased TGF-beta signaling in the absence of Drak2 may contribute to the resistance to autoimmunity in Drak2(-/-) mice. Therefore, we examined if Drak2 functioned as a negative regulator of TGF-beta signaling in T cells, and whether the enhanced susceptibility to death of Drak2(-/-) T cells was due to augmented TGF-beta signaling. Using several in vitro assays to test TGF-beta signaling and T cell function, we found that activation of Smad2 and Smad3, which are downstream of the TGF-beta receptor, was similar between wildtype and Drak2(-/-) T cells. Furthermore, TGF-beta-mediated effects on naive T cell proliferation, activated CD8(+) T cell survival, and regulatory T cell induction was similar between wildtype and Drak2(-/-) T cells. Finally, the increased susceptibility to death in the absence of Drak2 was not due to enhanced TGF-beta signaling. Together, these data suggest that Drak2 does not function as a negative regulator of TGF-beta signaling in primary T cells stimulated in vitro. It is important to investigate and discern potential molecular mechanisms by which Drak2 functions in order to better understand the etiology of autoimmune diseases, as well as to validate the use of Drak2 as a target for therapeutic treatment of these diseases.	[Harris, Tarsha L.; McGargill, Maureen A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Harris, Tarsha L.; McGargill, Maureen A.] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	McGargill, MA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Maureen.mcgargill@stjude.org	McGargill, Maureen/N-8131-2018	McGargill, Maureen/0000-0002-0916-0372	Juvenile Diabetes Research Foundation Career Development Award [2-2007-105]; ALSAC charities	Juvenile Diabetes Research Foundation Career Development Award(Juvenile Diabetes Research Foundation); ALSAC charities	This work was supported by a Juvenile Diabetes Research Foundation Career Development Award to MAM, 2-2007-105 and ALSAC charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doherty GA, 2009, BRIT J CANCER, V101, P483, DOI 10.1038/sj.bjc.6605144; Edwards BA, 2015, INT IMMUNOL, V27, P161, DOI 10.1093/intimm/dxu146; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kuwahara H, 2006, BIOL PHARM BULL, V29, P225, DOI 10.1248/bpb.29.225; Mao JN, 2009, J IMMUNOL, V182, P4762, DOI 10.4049/jimmunol.0802255; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; McGargill MA, 2008, J IMMUNOL, V181, P7593, DOI 10.4049/jimmunol.181.11.7593; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Newton RH, 2011, J IMMUNOL, V186, P940, DOI 10.4049/jimmunol.1000942; Oh SA, 2013, J IMMUNOL, V191, P3973, DOI 10.4049/jimmunol.1301843; Ramos SJ, 2007, AUTOIMMUNITY, V40, P54, DOI 10.1080/08916930600996700; Ramos SJ, 2008, J IMMUNOL, V181, P7606, DOI 10.4049/jimmunol.181.11.7606; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Schaumburg CS, 2007, AUTOIMMUNITY, V40, P483, DOI 10.1080/08916930701651139; Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084; Yang KM, 2012, CELL REP, V2, P1286, DOI 10.1016/j.celrep.2012.09.028; Ye P, 2013, LEUKEMIA RES, V37, P595, DOI 10.1016/j.leukres.2013.01.012	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0123650	10.1371/journal.pone.0123650	http://dx.doi.org/10.1371/journal.pone.0123650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951457	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400008
J	Kwong, AKY; Ho, ACC; Fung, CW; Wong, VCN				Kwong, Anna Ka-Yee; Ho, Alvin Chi-Chung; Fung, Cheuk-Wing; Wong, Virginia Chun-Nei			Analysis of Mutations in 7 Genes Associated with Neuronal Excitability and Synaptic Transmission in a Cohort of Children with Non-Syndromic Infantile Epileptic Encephalopathy	PLOS ONE			English	Article							DE-NOVO MUTATIONS; KCNQ2 ENCEPHALOPATHY; CLINICAL SPECTRUM; EPILEPSIES-REPORT; ONSET; CDKL5; PHENOTYPE; SPASMS; SCN2A; ARX	Epileptic Encephalopathy (EE) is a heterogeneous condition in which cognitive, sensory and/or motor functions deteriorate as a consequence of epileptic activity, which consists of frequent seizures and/or major interictal paroxysmal activity. There are various causes of EE and they may occur at any age in early childhood. Genetic mutations have been identified to contribute to an increasing number of children with early onset EE which had been previously considered as cryptogenic. We identified 26 patients with Infantile Epileptic Encephalopathy (IEE) of unknown etiology despite extensive workup and without any specific epilepsy syndromic phenotypes. We performed genetic analysis on a panel of 7 genes (ARX, CDKL5, KCNQ2, PCDH19, SCN1A, SCN2A, STXBP1) and identified 10 point mutations [ARX (1), CDKL5 (3), KCNQ2 (2), PCDH19 (1), SCN1A (1), STXBP1 (2)] as well as one microdeletion involving both SCN1A and SCN2A. The high rate (42%) of mutations suggested that genetic testing of this IEE panel of genes is recommended for cryptogenic IEE with no etiology identified. These 7 genes are associated with channelopathies or synaptic transmission and we recommend early genetic testing if possible to guide the treatment strategy.	[Kwong, Anna Ka-Yee; Ho, Alvin Chi-Chung; Fung, Cheuk-Wing; Wong, Virginia Chun-Nei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Div Paediat Neurol Dev Behav Paediat Neurohabilta, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wong, VCN (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Div Paediat Neurol Dev Behav Paediat Neurohabilta, Hong Kong, Hong Kong, Peoples R China.	vcnwong@hku.hk			Society for the Relief of Disabled Children; University Research Committee of The University of Hong Kong	Society for the Relief of Disabled Children; University Research Committee of The University of Hong Kong(University of Hong Kong)	Funding was provided by the donation via The Society for the Relief of Disabled Children and the project funding of the University Research Committee of The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Auvin S, 2010, EPILEPSIA, V51, P1290, DOI 10.1111/j.1528-1167.2010.02534.x; Bahi-Buisson N, 2011, MOL SYNDROMOL, V2, P137, DOI 10.1159/000331333; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Bechi G, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2011.03346.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bettella E, 2013, CLIN GENET, V84, P82, DOI 10.1111/cge.12034; Claes LRF, 2009, HUM MUTAT, V30, pE904, DOI 10.1002/humu.21083; Covanis A, 2012, EPILEPSIA, V53, P114, DOI 10.1111/j.1528-1167.2012.03621.x; Depienne C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000381; Deprez L, 2010, NEUROLOGY, V75, P1159, DOI 10.1212/WNL.0b013e3181f4d7bf; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Friocourt G, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00004; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Kamien BA, 2012, J CLIN NEUROSCI, V19, P934, DOI 10.1016/j.jocn.2012.01.017; Kapur Jaideep, 2008, Epilepsy Curr, V8, P139, DOI 10.1111/j.1535-7511.2008.00271.x; Katherine D, 2010, NEUROLOGY, V75, P2; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Kwong AKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041802; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; Mei D, 2010, EPILEPSIA, V51, P647, DOI 10.1111/j.1528-1167.2009.02308.x; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mignot C, 2011, EPILEPSIA, V52, P1820, DOI 10.1111/j.1528-1167.2011.03163.x; Milh M, 2011, EPILEPSIA, V52, P1828, DOI 10.1111/j.1528-1167.2011.03181.x; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nabbout R, 2003, J CLIN NEUROPHYSIOL, V20, P393, DOI 10.1097/00004691-200311000-00002; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Nalla VK, 2005, HUM MUTAT, V25, P334, DOI 10.1002/humu.20151; Nemos C, 2009, CLIN GENET, V76, P357, DOI 10.1111/j.1399-0004.2009.01194.x; Nordli DR, 2012, J CLIN NEUROPHYSIOL, V29, P420, DOI 10.1097/WNP.0b013e31826bd961; Numis AL, 2014, NEUROLOGY, V82, P368, DOI 10.1212/WNL.0000000000000060; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Ottman R, 2010, EPILEPSIA, V51, P655, DOI 10.1111/j.1528-1167.2009.02429.x; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Rosas-Vargas H, 2008, J MED GENET, V45, P172, DOI 10.1136/jmg.2007.053504; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Saitsu H, 2012, ANN NEUROL, V72, P298, DOI 10.1002/ana.23620; Sartori S, 2011, J CHILD NEUROL, V26, P683, DOI 10.1177/0883073810387827; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Shi XY, 2012, BRAIN DEV-JPN, V34, P541, DOI 10.1016/j.braindev.2011.09.016; Shi XY, 2009, BRAIN DEV-JPN, V31, P758, DOI 10.1016/j.braindev.2009.08.009; Soldovieri MV, 2014, HUM MUTAT, V35, P356, DOI 10.1002/humu.22500; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014; Wallerstein R, 2008, CLIN NEUROL NEUROSUR, V110, P631, DOI 10.1016/j.clineuro.2008.03.007; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wolverton T, 2001, GENOMICS, V76, P66, DOI 10.1006/geno.2001.6592; Wong VCN, 2014, BRAIN DEV IN PRESS; Yagi T, 2000, GENE DEV, V14, P1169	57	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126446	10.1371/journal.pone.0126446	http://dx.doi.org/10.1371/journal.pone.0126446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951140	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400093
J	Marek-Trzonkowska, N; Kwieczynska, A; Reiwer-Gostomska, M; Kolinski, T; Molisz, A; Siebert, J				Marek-Trzonkowska, Natalia; Kwieczynska, Anna; Reiwer-Gostomska, Magdalena; Kolinski, Tomasz; Molisz, Andrzej; Siebert, Janusz			Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYTOMETRIC BEAD ARRAY; BLOOD-PRESSURE; ENDOSTATIN; PLASMA; SERUM; INFLAMMATION; CYTOKINES; STATINS; VEGF	Objective Hypertension is the most common cardiovascular disease and the main risk factor for stroke, peripheral arterial disease, arterial aneurysms and kidney disease. It has been reported recently that hypertensive patients and animals are characterized by decreased density of arterioles and capillaries in the tissues, called rarefaction. Rarefaction significantly increases peripheral resistance which results in elevated blood pressure, leads to vessel damage and induction of inflammation. Therefore, we hypothesized that hypertension is associated with decreased serum concentration of physiological pro-angiogenic factors and concomitant increased production of angiogenesis inhibitors. Materials and Methods 82 patients diagnosed with hypertension and 34 healthy volunteers were recruited to the study. Flow cytometry and enzyme-linked immunosorbent assay (ELISA) techniques were used to measure serum levels of the following cytokines: endostatin, vascular endothelial growth factor (VEGF), interleukin 8 (IL-8), angiogenin, and basic fibroblast growth factor (bFGF). Results Hypertensive patients were characterized by increased serum concentration of endostatin which is an anti-angiogenic factor. In addition, hypertension was associated with decreased levels of physiological pro-angiogenic mediators such as: angiogenin and bFGF. The hypertensive group was also characterized by elevated levels of CRP, VEGF and IL-8 that are the hallmarks of inflammation. Conclusions Presented results show that hypertension is characterized by imbalance of pro-angiogenic and anti-angiogenic factors in the background of inflammation.	[Marek-Trzonkowska, Natalia; Kolinski, Tomasz] Med Univ Gdansk, Dept Family Med, Lab Immunoregulat & Cellular Therapies, Gdansk, Poland; [Kwieczynska, Anna; Kolinski, Tomasz] Med Univ Gdansk, Dept Clin Immunol & Transplantol, Gdansk, Poland; [Reiwer-Gostomska, Magdalena; Molisz, Andrzej; Siebert, Janusz] Med Univ Gdansk, Dept Family Med, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Marek-Trzonkowska, N (corresponding author), Med Univ Gdansk, Dept Family Med, Lab Immunoregulat & Cellular Therapies, Gdansk, Poland.	natalia.marek@gumed.edu.pl	Molisz, Andrzej/F-3464-2012; Siebert, Janusz/S-1751-2018	Molisz, Andrzej/0000-0003-3662-1581; Marek- Trzonkowska, Natalia/0000-0003-1201-295X; Siebert, Janusz/0000-0002-7254-271X; Kolinski, Tomasz/0000-0001-7839-0609	Polish National Science Centre [DEC-2012/07/B/NZ5/00017]	Polish National Science Centre	The study was supported by funds of the Polish National Science Centre granted to JS on the basis of the decision no. DEC-2012/07/B/NZ5/00017. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgore FM, 2001, AM J HEMATOL, V66, P59, DOI 10.1002/1096-8652(200101)66:1<59::AID-AJH1011>3.3.CO;2-Q; Bermudez B, 2008, CARDIOVASC RES, V79, P294, DOI 10.1093/cvr/cvn082; Bobik A, 2005, J HYPERTENS, V23, P1473, DOI 10.1097/01.hjh.0000174970.56965.4f; Bomert M, 2011, CLIN CHEM LAB MED, V49, P1691, DOI 10.1515/CCLM.2011.631; Cimato TR, 2015, PEERJ, V3, DOI 10.7717/peerj.764; Debnath J, 2014, BIOORG CHEM, V52, P56, DOI 10.1016/j.bioorg.2013.11.005; Emanueli C, 2001, HYPERTENSION, V38, P136, DOI 10.1161/01.HYP.38.1.136; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Engstrom G, 2002, STROKE, V33, P2744, DOI 10.1161/01.STR.0000034787.02925.1F; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Felmeden DC, 2003, AM J HYPERTENS, V16, P11, DOI 10.1016/S0895-7061(02)03149-7; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Fujimoto M, 2015, INT J MED SCI, V12, P223, DOI 10.7150/ijms.10656; Garcia-Alfonso P, 2015, TARGET ONCOL, V10, P453, DOI 10.1007/s11523-015-0362-0; Grabysa Radoslaw, 2008, Pol Merkur Lekarski, V24, P487; HALLAHAN TW, 1991, P NATL ACAD SCI USA, V88, P2222, DOI 10.1073/pnas.88.6.2222; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277; Humar R, 2009, J HUM HYPERTENS, V23, P773, DOI 10.1038/jhh.2009.63; Ikeda M, 2000, J PATHOL, V191, P426; Jamison S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120252; Jiang H, 2014, J CELL MOL MED, V18, P2189, DOI 10.1111/jcmm.12344; Jimenez R, 2005, CYTOKINE, V32, P45, DOI 10.1016/j.cyto.2005.07.009; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Keglowich L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081494; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Labonte L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112965; Leong XF, 2014, SCI WORLD J, DOI 10.1155/2014/768237; Lichtenauer M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/940910; Lip GYH, 2000, J HUM HYPERTENS, V14, P687, DOI 10.1038/sj.jhh.1001051; Llevadot J, 2002, REV ESP CARDIOL, V55, P838, DOI 10.1016/S0300-8932(02)76713-4; Lv S, 2015, CLIN EXP RHEUMATOL, V33, P69; Maitland ML, 2010, JNCI-J NATL CANCER I, V102, P596, DOI 10.1093/jnci/djq091; Malago JJ, 2010, BENEF MICROBES, V1, P121, DOI 10.3920/BM2009.0021; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marek N, 2011, MICROVASC RES, V82, P1, DOI 10.1016/j.mvr.2011.04.006; Marek N, 2010, CLIN IMMUNOL, V137, P261, DOI 10.1016/j.clim.2010.07.007; Marketou ME, 2006, ANGIOLOGY, V57, P211, DOI 10.1177/000331970605700212; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Michailidou M, 2015, ANN ONCOL         S2, V26, pii36, DOI [10.1093/annonc/mdv098.3, DOI 10.1093/ANNONC/MDV098.3]; Mitsuma W, 2007, AM J CARDIOL, V99, P494, DOI 10.1016/j.amjcard.2006.09.095; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nakagawa T, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/184539; Oh SY, 2012, CHEMOTHERAPY, V58, P426, DOI 10.1159/000345918; Pastore AL, 2015, BMC CANCER, V5, P1152; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Polec A, 2014, PLACENTA, V35, P249, DOI 10.1016/j.placenta.2014.02.002; Remkova A, 2010, PHYSIOL RES, V59, P13, DOI 10.33549/physiolres.931525; Rusiecka E, 2005, POL PRZEG KARDIOL, V7, P351; Sas AA, 2012, CYTOKINE, V60, P108, DOI 10.1016/j.cyto.2012.04.047; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Siebert J, 2010, DIABETES CARE, V33, P1829, DOI 10.2337/dc10-0130; Srivastava S, 2003, AM J PHYSIOL-HEART C, V285, pH1190, DOI 10.1152/ajpheart.00280.2003; Stapleton RD, 2010, CHEST, V138, P568, DOI 10.1378/chest.10-0014; Szczeniak P, 2009, FARM POL, V65, P83; Tan PHS, 2014, TISSUE ENG PT A, V20, P1758, DOI [10.1089/ten.tea.2013.0245, 10.1089/ten.TEA.2013.0245]; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Viasus D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006251; Vilar J, 2008, CIRC RES, V103, P761, DOI 10.1161/CIRCRESAHA.108.182758; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wallace CK, 2005, J HEART LUNG TRANSPL, V24, P46, DOI 10.1016/j.healun.2003.09.037; Wong JYY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087348; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873; Zarei M, 2011, J RES MED SCI, V16, P269; Zhu XJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4377	70	32	33	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126190	10.1371/journal.pone.0126190	http://dx.doi.org/10.1371/journal.pone.0126190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951297	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400073
J	Osman, M; El Safadi, D; Benamrouz, S; Guyot, K; Dei-Cas, E; Aliouat, E; Creusy, C; Mallat, H; Hamze, M; Dabboussi, F; Viscogliosi, E; Certad, G				Osman, Marwan; El Safadi, Dima; Benamrouz, Sadia; Guyot, Karine; Dei-Cas, Eduardo; Aliouat, El Moukhtar; Creusy, Colette; Mallat, Hassan; Hamze, Monzer; Dabboussi, Fouad; Viscogliosi, Eric; Certad, Gabriela			Initial Data on the Molecular Epidemiology of Cryptosporidiosis in Lebanon	PLOS ONE			English	Article							HUMANS; CHILDREN; SUBTYPES; PARVUM; CATTLE	Cryptosporidium spp. represent a major public health problem worldwide and infect the gastrointestinal tract of both immunocompetent and immunocompromised persons. The prevalence of these parasites varies by geographic region, and no data are currently available in Lebanon. To promote an understanding of the epidemiology of cryptosporidiosisin this country, the main aim of this study was to determine the prevalence Cryptosporidium in symptomatic hospitalized patients, and to analyze the genetic diversity of the corresponding isolates. Fecal specimens were collected in four hospitals in North Lebanon from 163 patients (77 males and 86 females, ranging in age from 1 to 88 years, with a mean age of 22 years) presenting gastrointestinal disorders during the period July to December 2013. The overall prevalence of Cryptosporidium spp. infection obtained bymodified Ziehl-Neelsen staining and/or nested PCR was 11%, and children < 5 years old showed a higher rate of Cryptosporidium spp. The PCR products of the 15 positive samples were successfully sequenced. Among them, 10 isolates (66.7%) were identified as C. hominis, while the remaining 5 (33.3%) were identified as C. parvum. After analysis of the gp60 locus, C. hominis IdA19, a rare subtype, was found to be predominant. Two C. parvum subtypes were found: IIaA15G1R1 and IIaA15G2R1. The molecular characterization of Cryptosporidium isolates is an important step in improving our understanding of the epidemiology and transmission of the infection.	[Osman, Marwan; El Safadi, Dima; Benamrouz, Sadia; Guyot, Karine; Dei-Cas, Eduardo; Aliouat, El Moukhtar; Viscogliosi, Eric; Certad, Gabriela] Univ Lille Nord France, INSERM,UMR CNRS 8204, Inst Pasteur Lille,Ctr Infect & Immunite Lille, Biol & Div Pathogenes Eucaryotes Emergents,U1019, Lille, France; [Osman, Marwan; El Safadi, Dima; Mallat, Hassan; Hamze, Monzer; Dabboussi, Fouad] Univ Libanaise, Ctr AZM Rech Biotechnol & Ses Applicat, Lab Microbiol Sante & Environm, Tripoli, Libya; [Benamrouz, Sadia] Univ Lille Nord France, Univ Catholique Lille, Fac Libre Sci & Technol Lille, Lab Ecol & Biodivers, Lille, France; [Dei-Cas, Eduardo] CHRU Lille, Lille, France; [Dei-Cas, Eduardo] Univ Lille Nord France, Fac Med Lille, Ctr Biol & Pathol, Lab Parasitol Mycol, Lille, France; [Aliouat, El Moukhtar] Univ Lille Nord France, Fac Sci Pharmaceut & Biol, Dept Parasitol Mycol, Lille, France; [Creusy, Colette] Univ Catholique Lille, Grp Hosp, Serv Anat & Cytol Pathol, F-59020 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Benghazi; Universite Catholique de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite Catholique de Lille	Certad, G (corresponding author), Univ Lille Nord France, INSERM,UMR CNRS 8204, Inst Pasteur Lille,Ctr Infect & Immunite Lille, Biol & Div Pathogenes Eucaryotes Emergents,U1019, Lille, France.	Gabriela.certad@pasteur-lille.fr	Osman, Marwan/AAD-3784-2021; Safadi, Dima El/C-1022-2014; B, S/HGC-3038-2022; Aliouat, El Moukhtar/D-2859-2018	Osman, Marwan/0000-0002-6235-2760; Safadi, Dima El/0000-0001-6852-3682; B, S/0000-0003-1791-4389; Aliouat, El Moukhtar/0000-0003-2905-7126; Viscogliosi, Eric/0000-0002-5805-7179	Programme "Orientations Strategiques" from the University of Lille 2; Centre National de la Recherche Scientifique; Institut Pasteur of Lille; Conseil National de la Recherche Scientifique; Azm & Saade Association from Lebanon	Programme "Orientations Strategiques" from the University of Lille 2; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur of Lille; Conseil National de la Recherche Scientifique; Azm & Saade Association from Lebanon	Funding: This work was supported by grants from the Programme "Orientations Strategiques" from the University of Lille 2, the Centre National de la Recherche Scientifique and the Institut Pasteur of Lille. MO and DES were both supported by PhD fellowships from the Conseil National de la Recherche Scientifique and the Azm & Saade Association from Lebanon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjampur SSR, 2010, J CLIN MICROBIOL, V48, P2075, DOI 10.1128/JCM.02509-09; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Alyousefi NA, 2013, PARASITOLOGY, V140, P729, DOI 10.1017/S0031182012001953; ANOFEL Cryptosporidium National Network, 2010, Euro Surveill, V15, P19642; [Anonymous], GUIDELINES FOR DRINK; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Boujaoude J, 2000, J Med Liban, V48, P298; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; Chalmers RM, 2010, EXP PARASITOL, V124, P138, DOI 10.1016/j.exppara.2009.02.003; CURRENT WL, 1991, CLIN MICROBIOL REV, V4, P325, DOI 10.1128/CMR.4.3.325-358.1991; Feng YY, 2012, EMERG INFECT DIS, V18, P312, DOI 10.3201/eid1802.110666; Guyot K, 2012, FEUILLETS DE BIOLOGI, V53, P21; Hamze M, 2004, East Mediterr Health J, V10, P343; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Iqbal J, 2011, J MED MICROBIOL, V60, P647, DOI 10.1099/jmm.0.028001-0; Jex AR, 2008, BIOTECHNOL ADV, V26, P304, DOI 10.1016/j.biotechadv.2008.02.003; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Medema G, 2009, RISK ASSESSMENT OF C; Naba Mazen R, 2010, J Infect Public Health, V3, P130, DOI 10.1016/j.jiph.2010.07.005; Nazemalhosseini-Mojarad E, 2011, VET PARASITOL, V179, P250, DOI 10.1016/j.vetpar.2011.01.051; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	26	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125129	10.1371/journal.pone.0125129	http://dx.doi.org/10.1371/journal.pone.0125129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950832	gold, Green Submitted, Green Published			2022-12-26	WOS:000354214400024
J	Song, XP; Huang, CQ; Saatchi, SS; Hansen, MC; Townshend, JR				Song, Xiao-Peng; Huang, Chengquan; Saatchi, Sassan S.; Hansen, Matthew C.; Townshend, John R.			Annual Carbon Emissions from Deforestation in the Amazon Basin between 2000 and 2010	PLOS ONE			English	Article							FOREST COVER CHANGE; TROPICAL DEFORESTATION; LAND-USE; INTERANNUAL VARIABILITY; CO2 EMISSIONS; DENSITY; BIOMASS; CLOUD; RATES; MAP	Reducing emissions fromdeforestation and forest degradation (REDD+) is considered one of themost cost-effective strategies for mitigating climate change. However, historical deforestation and emission rates. critical inputs for setting reference emission levels for REDD+. are poorly understood. Here we use multi-source, time-series satellite data to quantify carbon emissions from deforestation in the Amazon basin on a year-to-year basis between 2000 and 2010. We first derive annual deforestation indicators by using the Moderate Resolution Imaging Spectroradiometer Vegetation Continuous Fields (MODIS VCF) product. MODIS indicators are calibrated by using a large sample of Landsat data to generate accurate deforestation rates, which are subsequently combined with a spatially explicit biomass dataset to calculate committed annual carbon emissions. Across the study area, the average deforestation and associated carbon emissions were estimated to be 1.59 +/- 0.25M ha.yr(-1) and 0.18 +/- 0.07 Pg C.yr(-1) respectively, with substantially different trends and inter-annual variability in different regions. Deforestation in the Brazilian Amazon increased between 2001 and 2004 and declined substantially afterwards, whereas deforestation in the Bolivian Amazon, the Colombian Amazon, and the Peruvian Amazon increased over the study period. The average carbon density of lost forests after 2005 was 130 Mg C.ha(-1), similar to 11% lower than the average carbon density of remaining forests in year 2010 (144 Mg C.ha(-1)). Moreover, the average carbon density of cleared forests increased at a rate of 7 Mg C.ha(-1).yr(-1) from 2005 to 2010, suggesting that deforestation has been progressively encroaching into high-biomass lands in the Amazon basin. Spatially explicit, annual deforestation and emission estimates like the ones derived in this study are useful for setting baselines for REDD+ and other emission mitigation programs, and for evaluating the performance of such efforts.	[Song, Xiao-Peng; Huang, Chengquan; Hansen, Matthew C.; Townshend, John R.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Song, Xiao-Peng; Huang, Chengquan; Townshend, John R.] Univ Maryland, Global Land Cover Facil, College Pk, MD 20742 USA; [Saatchi, Sassan S.] CALTECH, Jet Prop Lab, Pasadena, CA USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Song, XP (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	xpsong@umd.edu	Song, Xiao-Peng/F-4894-2014; Song, Xiao-Peng/K-6335-2019; Saatchi, Sassan/AAQ-2649-2021; Hansen, Matthew C/ABE-7226-2020	Song, Xiao-Peng/0000-0002-5514-0321; Song, Xiao-Peng/0000-0002-5514-0321; 	NASA's Earth and Space Science Fellowship (NESSF) Program [NNX12AN92H]; Making Earth System Data Records for Use in Research Environments (MEaSUREs) Program [NNX08AP33A]; Land Cover and Land Use Change Program [NNH07ZDA001N-LCLUC]; NASA's	NASA's Earth and Space Science Fellowship (NESSF) Program; Making Earth System Data Records for Use in Research Environments (MEaSUREs) Program; Land Cover and Land Use Change Program; NASA's(National Aeronautics & Space Administration (NASA))	This study was funded by NASA's Earth and Space Science Fellowship (NESSF) Program (NNX12AN92H), Making Earth System Data Records for Use in Research Environments (MEaSUREs) Program (NNX08AP33A), and Land Cover and Land Use Change Program (NNH07ZDA001N-LCLUC). Additional support was provided by NASA's	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Angelsen A, 2008, INT FOREST REV, V10, P465, DOI 10.1505/ifor.10.3.465; [Anonymous], 2011, MODIS VEGETATION CON; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2001, INT J REMOTE SENS, V22, P3855, DOI 10.1080/01431160010006926; Asner GP, 2013, P NATL ACAD SCI USA, V110, P18454, DOI 10.1073/pnas.1318271110; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Broich M, 2011, INT J APPL EARTH OBS, V13, P277, DOI 10.1016/j.jag.2010.11.004; Brown S, 2013, SCIENCE, V342, P805, DOI 10.1126/science.1241277; Chomitz KM, 1996, WORLD BANK ECON REV, V10, P487, DOI 10.1093/wber/10.3.487; Ciais P., 2013, CLIMATE CHANGE 2013, P465, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CBO9781107415324.015]; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; DeFries RS, 1994, ENV REMOTE SENSING R, P84; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Dong J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082342, 10.1371/journal.pone.0085801]; Aguiar APD, 2012, GLOBAL CHANGE BIOL, V18, P3346, DOI 10.1111/j.1365-2486.2012.02782.x; Environmental Defense the Instituto de Pesquisa Ambiental da Amazonia, 2007, 26 SESS SUBS BOD SCI; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; FAO, 2012, GLOB FOR RES ASS 201; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; GOFC-GOLD, 2012, SOURC METH PROC MON; Gonzalez Posso D., 2000, Unasylva (English ed.), V51, P32; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Griscom B, 2009, ENVIRON SCI POLICY, V12, P897, DOI 10.1016/j.envsci.2009.07.008; Gutman G, 2013, REMOTE SENS ENVIRON, V134, P249, DOI 10.1016/j.rse.2013.02.026; Hansen MC, 2003, EARTH INTERACT, V7; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P3784, DOI 10.1016/j.rse.2008.05.012; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Herold M., 2012, ANAL REDD CHALLENGES, P279; Herold M., 2009, REALISING REDD, P85; Herold M., 2009, ASSESSMENT NATL FORE; Houghton, 2012, WINROCK INT; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Houghton RA, 2000, J GEOPHYS RES-ATMOS, V105, P20121, DOI 10.1029/2000JD900041; Huang CQ, 2008, REMOTE SENS ENVIRON, V112, P970, DOI 10.1016/j.rse.2007.07.023; Huang CQ, 2010, INT J REMOTE SENS, V31, P5449, DOI 10.1080/01431160903369642; Huang CQ, 2009, REMOTE SENS ENVIRON, V113, P1430, DOI 10.1016/j.rse.2008.06.016; Huettner Michael, 2009, Carbon Balance Manag, V4, P4, DOI 10.1186/1750-0680-4-4; INPE, 2014, PRODES ASS DEF BRAZ; IPCC, 2006, ENERGY, V2; Ju JC, 2008, REMOTE SENS ENVIRON, V112, P1196, DOI 10.1016/j.rse.2007.08.011; KAIMOWITZ D., 1998, EC MODELS TROPICAL D; Karstensen J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024005; Kindermann GE, 2008, SILVA FENN, V42, P387, DOI 10.14214/sf.244; Loarie SR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037526; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Masek JG, 2013, ECOSYSTEMS, V16, P1087, DOI 10.1007/s10021-013-9669-9; Matthews E., 2002, Unasylva (English ed.), V53, P42; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; MAYAUX P, 1995, REMOTE SENS ENVIRON, V53, P1, DOI 10.1016/0034-4257(95)00038-3; Mayaux P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0300; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Mollicone D, 2007, CLIMATIC CHANGE, V83, P477, DOI 10.1007/s10584-006-9231-2; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Ometto JP, 2014, CLIMATIC CHANGE, V124, P545, DOI 10.1007/s10584-014-1058-7; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pelletier J, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024005; Perz SG, 2013, LAND USE POLICY, V34, P27, DOI 10.1016/j.landusepol.2013.01.009; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Rayner PJ, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003068; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Research Joanneum, 2006, REDUCING EMISSIONS D; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Salvini G, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074004; Sexton JO, 2015, REMOTE SENS ENVIRON, V156, P418, DOI 10.1016/j.rse.2014.08.038; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Shimabukuro Y.E., 2012, GLOBAL EST MONITO, P153, DOI [10.1201/b13040, DOI 10.1201/B13040, 10.1007/978-1-4020-6358-9, DOI 10.1007/978-1-4020-6358-9]; Shimada M, 2014, REMOTE SENS ENVIRON, V155, P13, DOI 10.1016/j.rse.2014.04.014; Song XP, 2014, REMOTE SENS-BASEL, V6, P8878, DOI 10.3390/rs6098878; Souza CM, 2013, REMOTE SENS-BASEL, V5, P5493, DOI 10.3390/rs5115493; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; Terrestrial Carbon Group, 2008, INCL TERR CARB DEV N; Townshend JR, 2012, INT J DIGIT EARTH, V5, P373, DOI 10.1080/17538947.2012.713190; Tyukavina A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044039; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717; Woods Hole Research Center Amazon Institute for Environmental Research, 2008, UN FRAM CONV CLIM CH	91	42	42	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126754	10.1371/journal.pone.0126754	http://dx.doi.org/10.1371/journal.pone.0126754			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951328	gold, Green Published			2022-12-26	WOS:000354214400108
J	Chelvam, KK; Yap, KP; Chai, LC; Thong, KL				Chelvam, Kalaivani Kalai; Yap, Kien Pong; Chai, Lay Ching; Thong, Kwai Lin			Variable Responses to Carbon Utilization between Planktonic and Biofilm Cells of a Human Carrier Strain of Salmonella enterica Serovar Typhi	PLOS ONE			English	Article							PHENOTYPE MICROARRAY; GENOME SEQUENCE; DEVICE; SPP.	Salmonella enterica serovar Typhi (S. Typhi) is a foodborne pathogen that causes typhoid fever and infects only humans. The ability of S. Typhi to survive outside the human host remains unclear, particularly in human carrier strains. In this study, we have investigated the catabolic activity of a human carrier S. Typhi strain in both planktonic and biofilm cells using the high-throughput Biolog Phenotype MicroArray, Minimum Biofilm Eradication Concentration (MBEC) biofilm inoculator (96-well peg lid) and whole genome sequence data. Additional strains of S. Typhi were tested to further validate the variation of catabolism in selected carbon substrates in the different bacterial growth phases. The analyzes of the carbon utilization data indicated that planktonic cells of the carrier strain, S. Typhi CR0044 could utilize a broader range of carbon substrates compared to biofilm cells. Pyruvic acid and succinic acid which are related to energy metabolism were actively catabolised in the planktonic stage compared to biofilm stage. On the other hand, glycerol, L-fucose, L-rhamnose (carbohydrates) and D-threonine (amino acid) were more actively catabolised by biofilm cells compared to planktonic cells. Notably, dextrin and pectin could induce strong biofilm formation in the human carrier strain of S. Typhi. However, pectin could not induce formation of biofilm in the other S. Typhi strains. Phenome data showed the utilization of certain carbon substrates which was supported by the presence of the catabolism-associated genes in S. Typhi CR0044. In conclusion, the findings showed the differential carbon utilization between planktonic and biofilm cells of a S. Typhi human carrier strain. The differences found in the carbon utilization profiles suggested that S. Typhi uses substrates mainly found in the human biliary mucus glycoprotein, gallbladder, liver and cortex of the kidney of the human host. The observed diversity in the carbon catabolism profiles among different S. Typhi strains has suggested the possible involvement of various metabolic pathways that might be related to the virulence and pathogenesis of this host-restricted human pathogen. The data serve as a caveat for future in-vivo studies to investigate the carbon metabolic activity to the pathogenesis of S. Typhi.	[Chelvam, Kalaivani Kalai; Yap, Kien Pong; Chai, Lay Ching; Thong, Kwai Lin] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Thong, KL (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	thongkl@um.edu.my	Chai, Lay Ching/A-7761-2011; Thong, Kwai Lin/B-3946-2009; Thong, Kwai-Lin/Q-2458-2019	Chai, Lay Ching/0000-0001-8280-3226; Thong, Kwai-Lin/0000-0001-8557-5185	High Impact Research Grant from University of Malaya [UM.C/625/1/HIR/MOHE/02 (H-50001-00-A000016-000001)]; University of Malaya Fellowship; High Impact Research Grant	High Impact Research Grant from University of Malaya; University of Malaya Fellowship; High Impact Research Grant	This study is funded by the High Impact Research Grant UM.C/625/1/HIR/MOHE/02 (H-50001-00-A000016-000001) from University of Malaya. KK was supported by University of Malaya Fellowship (2011-2013) and High Impact Research Grant (2014-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Tomoya, 2008, V416, P183, DOI 10.1007/978-1-59745-321-9_12; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chai LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036201; Clamp J R, 1977, Adv Exp Med Biol, V89, P1; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; Farrugia DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058628; Gonzalez-Escobedo G, 2013, INFECT IMMUN, V81, P2920, DOI 10.1128/IAI.00258-13; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; HARVEY PRC, 1986, GUT, V27, P374, DOI 10.1136/gut.27.4.374; Hobden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077128; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Kaiser BLD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067155; Kalai Chelvam Kalaivani, 2014, Gut Pathog, V6, P2, DOI 10.1186/1757-4749-6-2; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Maric S, 2007, PERIOD BIOL, V109, P115; Mascher T, 2007, J BACTERIOL, V189, P6919, DOI 10.1128/JB.00904-07; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Mukherjee A, 2008, J BACTERIOL, V190, P1710, DOI 10.1128/JB.01737-07; Ong SY, 2013, STAND GENOMIC SCI, V7, P483, DOI 10.4056/sigs.3286690; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Santopolo L, 2012, BIOFOULING, V28, P1023, DOI 10.1080/08927014.2012.726352; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Thong KL, 2014, TROP BIOMED, V31, P689; Thong KL, 1996, APPL ENVIRON MICROB, V62, P271, DOI 10.1128/AEM.62.1.271-274.1996; Yap KP, 2012, J BACTERIOL, V194, P5970, DOI 10.1128/JB.01416-12; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	37	12	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126207	10.1371/journal.pone.0126207	http://dx.doi.org/10.1371/journal.pone.0126207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946205	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700118
J	Cooley, SR; Rheuban, JE; Hart, DR; Luu, V; Glover, DM; Hare, JA; Doney, SC				Cooley, Sarah R.; Rheuban, Jennie E.; Hart, Deborah R.; Luu, Victoria; Glover, David M.; Hare, Jonathan A.; Doney, Scott C.			An Integrated Assessment Model for Helping the United States Sea Scallop (Placopecten magellanicus) Fishery Plan Ahead for Ocean Acidification and Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; ARGOPECTEN-IRRADIANS; MARINE FISH; CO2; IMPACTS; TEMPERATURE; DYNAMICS; COASTAL; GROWTH; FUTURE	Ocean acidification, the progressive change in ocean chemistry caused by uptake of atmospheric CO2, is likely to affect somemarine resources negatively, including shellfish. The Atlantic sea scallop (Placopectenmagellanicus) supports one of the most economically important single-species commercial fisheries in the United States. Careful management appears to be the most powerful short-term factor affecting scallop populations, but in the coming decades scallops will be increasingly influenced by global environmental changes such as ocean warming and ocean acidification. In this paper, we describe an integrated assessment model (IAM) that numerically simulates oceanographic, population dynamic, and socioeconomic relationships for the U.S. commercial sea scallop fishery. Our primary goal is to enrich resource management deliberations by offering both short-and long-term insight into the system and generating detailed policy-relevant information about the relative effects of ocean acidification, temperature rise, fishing pressure, and socioeconomic factors on the fishery using a simplified model system. Starting with relationships and data used now for sea scallop fishery management, the model adds socioeconomic decision making based on static economic theory and includes ocean biogeochemical change resulting from CO2 emissions. The model skillfully reproduces scallop population dynamics, market dynamics, and seawater carbonate chemistry since 2000. It indicates sea scallop harvests could decline substantially by 2050 under RCP 8.5 CO2 emissions and current harvest rules, assuming that ocean acidification affects P. magellanicus by decreasing recruitment and slowing growth, and that ocean warming increases growth. Future work will explore different economic and management scenarios and test how potential impacts of ocean acidification on other scallop	[Cooley, Sarah R.] Ocean Conservancy, Washington, DC 20036 USA; [Cooley, Sarah R.; Rheuban, Jennie E.; Glover, David M.; Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Hart, Deborah R.] NOAA, Natl Marine Fisheries Serv, NEFSC, Woods Hole Lab, Woods Hole, MA 02543 USA; [Luu, Victoria] Boston Coll, Dept Earth & Environm Sci, Chestnut Hill, MA 02167 USA; [Hare, Jonathan A.] NOAA, Natl Marine Fisheries Serv, NEFSC, Narragansett Lab, Narragansett, RI 02882 USA	Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA; Woods Hole Oceanographic Institution; Boston College; National Oceanic Atmospheric Admin (NOAA) - USA	Cooley, SR (corresponding author), Ocean Conservancy, Washington, DC 20036 USA.	scooley@oceanconservancy.org	Hart, Deborah/E-6917-2016; Doney, Scott C/F-9247-2010; Cooley, Sarah R/K-7373-2012; /AAL-3738-2021	Doney, Scott C/0000-0002-3683-2437; Cooley, Sarah R/0000-0002-1034-0653; Hart, Deborah/0000-0002-0406-0751	NOAA [t NA12NOS4780145]; Center for Climate and Energy Decision Making (CEDM) [NSF SES-0949710]; WHOI Summer Student Fellowship; Direct For Social, Behav & Economic Scie [1463492, 0949710] Funding Source: National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Center for Climate and Energy Decision Making (CEDM); WHOI Summer Student Fellowship; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Cooley, Rheuban, and Doney were supported by NOAA Grant NA12NOS4780145 (www.noaa. gov) and the Center for Climate and Energy Decision Making (CEDM, NSF SES-0949710) (www. nsf.gov). Luu was supported by a WHOI Summer Student Fellowship (www.whoi.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2013, BIOGEOSCIENCES, V10, P6161, DOI 10.5194/bg-10-6161-2013; ARCHER D, 1995, ECOL APPL, V5, P724, DOI 10.2307/1941980; Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bindoff N.L., 2007, CLIMATE CHANGE 2007; Brey T., 2001, POPULATION DYNAMICS; Calosi P, 2009, COMP BIOCHEM PHYS A, V153A, pS169, DOI 10.1016/j.cbpa.2009.04.351; Caswell, 2000, MATRIX POPULATION MO; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cooley SR, 2012, FISH FISH, V13, P182, DOI 10.1111/j.1467-2979.2011.00424.x; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Doney SC, 2009, OCEANOGRAPHY, V22, P16, DOI 10.5670/oceanog.2009.93; Duarte C, 2014, J SEA RES, V85, P308, DOI 10.1016/j.seares.2013.06.002; Edwards S. F., 2001, Marine Resource Economics, V16, P263; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gilbert CS, 2010, PROG OCEANOGR, V87, P37, DOI 10.1016/j.pocean.2010.09.021; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hart D. R., 2004, NMFSNE189 NOAA; Hart DR, 2006, N AM J FISH MANAGE, V26, P490, DOI 10.1577/M04-116.1; Hart DR, 2013, FISH RES, V144, P74, DOI 10.1016/j.fishres.2012.11.004; Hart DR, 2009, ICES J MAR SCI, V66, P2165, DOI 10.1093/icesjms/fsp188; Hart DR, 2003, FISH B-NOAA, V101, P44; Heilmayer O, 2004, FUNCT ECOL, V18, P641, DOI 10.1111/j.0269-8463.2004.00905.x; Hennen DR, 2012, J SHELLFISH RES, V31, P1133, DOI 10.2983/035.031.0424; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Fernandez-Reiriz MJ, 2011, MAR ECOL PROG SER, V433, P97, DOI 10.3354/meps09062; Kaplan IC, 2010, CAN J FISH AQUAT SCI, V67, P1968, DOI 10.1139/F10-118; KEMP PF, 1994, DEEP-SEA RES PT II, V41, P629, DOI 10.1016/0967-0645(94)90038-8; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kuhlbrodt T. T, 2001, OCEAN DYNAM, V52, DOI [DOI 10.1007/S10236-001-8175-3, 10.1007/s10236-001-8175-3]; Long MC, 2013, J CLIMATE, V26, P6775, DOI 10.1175/JCLI-D-12-00184.1; MACDONALD BA, 1985, MAR ECOL PROG SER, V25, P295, DOI 10.3354/meps025295; MacKinnon JA, 2003, J PHYS OCEANOGR, V33, P1476, DOI 10.1175/1520-0485(2003)033<1476:MOTLNE>2.0.CO;2; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Moore C., 2011, 1106 NAT CTR ENV EC; Narita D, 2012, CLIMATIC CHANGE, V113, P1049, DOI 10.1007/s10584-011-0383-3; National Marine Fisheries Service F.S.D., 2012, FISH US 2012; New England Fishery Management Council, 2011, FIN FRAM 22 SCALL FM; New England Fishery Management Council, 2012, FRAM 24 SCALL FMP FR; Nobre AM, 2009, ECOL ECON, V68, P3007, DOI 10.1016/j.ecolecon.2009.06.019; Northeast Fisheries Science Centre (NEFSC), 2010, 50 NE REG STOCK ASS; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Punt AE, 2014, ECOL MODEL, V285, P39, DOI 10.1016/j.ecolmodel.2014.04.017; Rahmstorf S, 2001, OCEAN DYNAM, V52, DOI [10.1007/s10236-001-8174-4, DOI 10.1007/S10236-001-8174-4]; Range P, 2011, J EXP MAR BIOL ECOL, V396, P177, DOI 10.1016/j.jembe.2010.10.020; Rebuck N, CONT SHELF RES UNPUB; Richards RG, 2015, FISH RES, V161, P42, DOI 10.1016/j.fishres.2014.06.013; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Sampson DB, 2011, CAN J FISH AQUAT SCI, V68, P1077, DOI 10.1139/F2011-044; Sanders MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074118; Schalkhausser B, 2013, MAR BIOL, V160, P1995, DOI 10.1007/s00227-012-2057-8; Schouten M, 2014, ENVIRON MODELL SOFTW, V54, P196, DOI 10.1016/j.envsoft.2014.01.003; Shephard S, 2010, MAR BIOL, V157, P91, DOI 10.1007/s00227-009-1298-7; Signorini SR, 2013, J GEOPHYS RES-OCEANS, V118, P5439, DOI 10.1002/jgrc.20369; Stokesbury KDE, 2011, MAR ECOL PROG SER, V425, P167, DOI 10.3354/meps09020; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; U.S. Bureau of Economic Analysis, TABL 2 1 PERS INC IT; U.S. National Marine Fisheries Service, 2013, COMM LAND; U.S. National Marine Fisheries Service, 2013, FOR TRAD; van Heuven S., 2011, ORNLCDIAC105B, DOI [10.3334/CDIAC/otg.CO2SYS_MATLAB_v1.1, DOI 10.3334/CDIAC/OTG.CO2SYS_MATLAB_V1.1]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wang ZHA, 2013, LIMNOL OCEANOGR, V58, P325, DOI 10.4319/lo.2013.58.1.0325; Wanninkhof R, 2013, BIOGEOSCIENCES, V10, P1983, DOI 10.5194/bg-10-1983-2013; White MM, 2014, MAR ECOL PROG SER, V498, P173, DOI 10.3354/meps10621; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Zhang ML, 2011, J SHELLFISH RES, V30, P267, DOI 10.2983/035.030.0211	91	47	48	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124145	10.1371/journal.pone.0124145	http://dx.doi.org/10.1371/journal.pone.0124145			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945497	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700035
J	Jorgenson, AK; Givens, J				Jorgenson, Andrew K.; Givens, Jennifer			The Changing Effect of Economic Development on the Consumption-Based Carbon Intensity of Well-Being, 1990-2008	PLOS ONE			English	Article							ENVIRONMENTAL LOAD DISPLACEMENT; INTERNATIONAL-TRADE; WORLD-ECONOMY; GROWTH; EMISSIONS; ENERGY; OVERURBANIZATION; SUSTAINABILITY; URBANIZATION; POLLUTION	Recent sustainability science research focuses on tradeoffs between human well-being and stress placed on the environment from fossil fuel consumption, a relationship known as the carbon intensity of well-being (CIWB). In this study we assess how the effect of economic development on consumption-based CIWB-a ratio of consumption-based carbon dioxide emissions to average life expectancy-changed from 1990 to 2008 for 69 nations throughout the world. We examine the effect of development on consumption-based CIWB for the overall sample as well as for smaller samples restricted to mostly high-income OECD nations, Non-OECD nations, and more nuanced regional samples of Non-OECD nations in Africa, Asia, and Latin America. We find that the effect of economic development on CIWB increased through time for the overall sample. However, analyses of the Non-OECD and OECD samples indicate that while the effect of development on CIWB increased from null to a moderate level for the Non-OECD nations, the effect of economic development was much larger, relatively stable through time, and more unsustainable for the OECD nations. Additional findings reveal important regional differences for Non-OECD nations. In the early 1990s, increased development led to a reduction in CIWB for Non-OECD nations in Africa, but in more recent years the relationship changed, becoming less sustainable. For the samples of Non-OECD nations in Asia and Latin America, we find that economic development increased consumption-based CIWB, and increasingly so throughout the 19 year period of study.	[Jorgenson, Andrew K.] Boston Coll, Dept Sociol & Environm Studies Program, Chestnut Hill, MA 02167 USA; [Givens, Jennifer] Washington State Univ, Dept Sociol, Pullman, WA 99164 USA	Boston College; Washington State University	Jorgenson, AK (corresponding author), Boston Coll, Dept Sociol & Environm Studies Program, Chestnut Hill, MA 02167 USA.	andrew.jorgenson@soc.utah.edu		Givens, Jennifer/0000-0003-3103-9795; Jorgenson, Andrew/0000-0002-5902-3704				Allison PD, 2009, FIXED EFFECT REGRESS; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Brady D, 2007, STUD COMP INT DEV, V42, P1, DOI 10.1007/s12116-007-9003-7; Ciplet D, 2013, GLOBAL ENVIRON POLIT, V13, P49, DOI 10.1162/GLEP_a_00153; Cole MA, 2004, ECOL ECON, V48, P439, DOI 10.1016/j.ecolecon.2003.10.016; Dietz T.J., 2013, STRUCTURAL HUMAN ECO; Dietz T, 2009, HUM ECOL REV, V16, P114; Dietz T, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/031001; Dietz T, 2012, APPL GEOGR, V32, P21, DOI 10.1016/j.apgeog.2010.10.011; Elliott JR, 2014, SOC SCI QUART, V95, P795, DOI 10.1111/ssqu.12079; Grant D, 2010, AM SOCIOL REV, V75, P479, DOI 10.1177/0003122410374822; Grasso M, 2014, NAT CLIM CHANGE, V4, P543, DOI 10.1038/NCLIMATE2259; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; Hornborg A, 2009, INT J COMP SOCIOL, V50, P237, DOI 10.1177/0020715209105141; Jorgenson AK., 2004, HUMBOLDT J SOCIAL RE, V28, P47; Jorgenson AK, 2015, SUSTAIN SCI, V10, P149, DOI 10.1007/s11625-014-0264-6; Jorgenson AK, 2014, CLIMATIC CHANGE, V127, P561, DOI 10.1007/s10584-014-1267-0; Jorgenson AK, 2014, NAT CLIM CHANGE, V4, P186, DOI 10.1038/NCLIMATE2110; Jorgenson AK, 2014, ENERG POLICY, V66, P419, DOI 10.1016/j.enpol.2013.11.020; Jorgenson AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057107; Jorgenson AK, 2012, AM J SOCIOL, V118, P1, DOI 10.1086/665990; Kanemoto K, 2014, GLOBAL ENVIRON CHANG, V24, P52, DOI 10.1016/j.gloenvcha.2013.09.008; Knight KW, 2014, POPUL ENVIRON, V36, P32, DOI 10.1007/s11111-013-0200-1; Knight KW, 2014, SUSTAINABILITY-BASEL, V6, P3722, DOI 10.3390/su6063722; Knight KW, 2011, SOC SCI RES, V40, P931, DOI 10.1016/j.ssresearch.2010.11.002; Lamb WF, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014011; Mahutga MC, 2011, SOC SCI RES, V40, P257, DOI 10.1016/j.ssresearch.2010.08.012; Marcotullio PJ, 2012, GLOBAL ENVIRON CHANG, V22, P944, DOI 10.1016/j.gloenvcha.2012.07.002; MAZUR A, 1974, SCIENCE, V186, P607, DOI 10.1126/science.186.4164.607; Mazur A, 2011, ENERG POLICY, V39, P2568, DOI 10.1016/j.enpol.2011.02.024; Minx J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035039; Muradian R, 2002, ECOL ECON, V41, P51, DOI 10.1016/S0921-8009(01)00281-6; Pamuk ER, 2011, POPUL DEV REV, V37, P637, DOI 10.1111/j.1728-4457.2011.00451.x; Peters GP, 2008, ENVIRON SCI TECHNOL, V42, P1401, DOI 10.1021/es072023k; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Rice J, 2008, SOC SCI RES, V37, P1292, DOI 10.1016/j.ssresearch.2008.05.006; Roberts J.Timmons., 2007, CLIMATE INJUSTICE GL; Rosa EA., 2010, HUMAN FOOTPRINTS GLO; Rudel T., 2005, TROPICAL FORESTS REG; Sarzynski A, 2012, URBAN STUD, V49, P3121, DOI 10.1177/0042098011432557; Shandra JM, 2003, SOCIOL PERSPECT, V46, P309, DOI 10.1525/sop.2003.46.3.309; Sheng Y, 2014, ENERG POLICY, V71, P31, DOI 10.1016/j.enpol.2014.04.001; Steinberger JK, 2012, NAT CLIM CHANGE, V2, P81, DOI [10.1038/NCLIMATE1371, 10.1038/nclimate1371]; Steininger K, 2014, GLOBAL ENVIRON CHANG, V24, P75, DOI 10.1016/j.gloenvcha.2013.10.005; TIMBERLAKE M, 1983, SOCIOL QUART, V24, P489, DOI 10.1111/j.1533-8525.1983.tb00715.x; Victor DG, 2014, SCIENCE, V345, P34, DOI 10.1126/science.1255302; York R, 2012, NAT CLIM CHANGE, V2, P762, DOI 10.1038/nclimate1699	47	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123920	10.1371/journal.pone.0123920	http://dx.doi.org/10.1371/journal.pone.0123920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25945936	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700025
J	Mimura, S; Kamigaki, T; Takahashi, Y; Umenai, T; Kudou, M; Oshitani, H				Mimura, Satoshi; Kamigaki, Taro; Takahashi, Yoshihiro; Umenai, Takamichi; Kudou, Mataka; Oshitani, Hitoshi			Role of Preschool and Primary School Children in Epidemics of Influenza A in a Local Community in Japan during Two Consecutive Seasons with A(H3N2) as a Predominant Subtype	PLOS ONE			English	Article							NATURALLY ACQUIRED-IMMUNITY; REPRODUCTION NUMBER; H1N1; VACCINATION; POPULATION; INFECTION; VIRUSES; DRIVE	Enhanced influenza surveillance was implemented to analyze transmission dynamics particularly driving force of influenza transmission in a community during 2011/12 and 2012/13 seasons in Odate City, Japan. In these two consecutive seasons, influenza A(H3N2) was the predominant influenza A subtype. Suspected influenza cases were tested by commercial rapid test kits. Demographic and epidemiological information of influenza positive cases were recorded using a standardized questionnaire, which included age or age group, date of visit, date of fever onset, and the result of rapid test kit. Epidemiological parameters including epidemic midpoint (EM) and growth rate (GR) were analyzed. In 2012/13 season, numbers of influenza A positive cases were significantly lower among preschool (212 cases) and primary school (224 cases) children than in 2011/12 season (461 and 538 cases, respectively). Simultaneously, total influenza A cases were also reduced from 2,092 in 2011/12 season to 1,846 in 2012/13 season. The EMs in preschool and primary school children were earlier than EMs for adult and all age group in both 2011/12 and 2012/13 seasons. The GR in 2012/13 season was significantly lower than that in 2011/12 season (0.11 and 0.18, respectively, p = 0.003). Multiple linear regression analysis by school districts revealed that GRs in both seasons were significantly correlated with the incidence of school age children. Our findings suggest that preschool and primary school children played an important role as a driving force of epidemics in the community in both 2011/12 and 2012/13 seasons. The reduction of total influenza A cases in 2012/13 season can be explained by decreased susceptible population in these age groups due to immunity acquired by infections in 2011/12 season. Further investigations are needed to investigate the effect of pre-existing immunity on influenza transmission in the community.	[Mimura, Satoshi; Kamigaki, Taro; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Takahashi, Yoshihiro] Odate Municipal Gen Hosp, Div Pediat, Odate, Japan; [Umenai, Takamichi] Umenai Pediat Clin, Odate, Japan; [Kudou, Mataka] Kudou Pediat Clin, Odate, Japan	Tohoku University	Kamigaki, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019		Health and Labour Sciences Research Grants for the Research on Emerging and Re-emerging Infectious Diseases, Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI [24249041]	Health and Labour Sciences Research Grants for the Research on Emerging and Re-emerging Infectious Diseases, Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors were supported by the Health and Labour Sciences Research Grants for the Research on Emerging and Re-emerging Infectious Diseases, Ministry of Health, Labour and Welfare, Japan, and JSPS KAKENHI Grant Number 24249041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S8; Ambrose CS, 2011, PEDIATR INFECT DIS J, V30, P900, DOI 10.1097/INF.0b013e31821ffe43; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Chan KH, 2012, J VIROL METHODS, V186, P184, DOI 10.1016/j.jviromet.2012.09.001; Cowling BJ, 2014, CLIN INFECT DIS; Fantoni A, 2014, J MED VIROL, V86, P585, DOI 10.1002/jmv.23745; GILL PW, 1985, MED J AUSTRALIA, V142, P94, DOI 10.5694/j.1326-5377.1985.tb133042.x; GILL PW, 1977, MED J AUSTRALIA, V2, P761, DOI 10.5694/j.1326-5377.1977.tb99276.x; GRILLI EA, 1986, J HYG-CAMBRIDGE, V96, P335, DOI 10.1017/S0022172400066080; HOSKINS TW, 1976, LANCET, V1, P105; Huo X, 2014, J INFECT CHEMOTHER; Kucharski AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004206; Li TG, 2011, J CLIN VIROL, V50, P235, DOI 10.1016/j.jcv.2010.11.012; Lunelli A, 2013, INFLUENZA OTHER RESP, V7, P286, DOI 10.1111/j.1750-2659.2012.00388.x; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Ministry of Health Labor and Welfare National Institute of Infectious Diseases, 2013, INFECT AGENTS SURVEI, V34, P325; Ministry of Health Labor and Welfare National Institute of Infectious Diseases., 2012, INFECT AGENTS SURVEI, V33, P285; Ministry of Land Inflastructure Transport and Tourism, 2010, MAP PRIM SCH DISTR J; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; National Instutute of Infectious Disease, 2014, SIT UPD INFL SURV; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Stockmann C, 2014, J PEDIATR INFECT DIS, V3, P163, DOI 10.1093/jpids/pit004; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754	28	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125642	10.1371/journal.pone.0125642	http://dx.doi.org/10.1371/journal.pone.0125642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942315	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400048
J	Viollet, C; Davis, DA; Reczko, M; Ziegelbauer, JM; Pezzella, F; Ragoussis, J; Yarchoan, R				Viollet, Coralie; Davis, David A.; Reczko, Martin; Ziegelbauer, Joseph M.; Pezzella, Francesco; Ragoussis, Jiannis; Yarchoan, Robert			Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; NF-KAPPA-B; HERPESVIRUS-INFECTION; DNA-SEQUENCES; FEEDBACK LOOP; SARCOMA; MICRORNA; HYPOXIA; PROTEIN; DYSREGULATION	Kaposi's sarcoma associated herpesvirus (KSHV) causes several tumors, including primary effusion lymphoma (PEL) and Kaposi's sarcoma (KS). Cellular and viral microRNAs (miRNAs) have been shown to play important roles in regulating gene expression. A better knowledge of the miRNA-mediated pathways affected by KSHV infection is therefore important for understanding viral infection and tumor pathogenesis. In this study, we used deep sequencing to analyze miRNA and cellular mRNA expression in a cell line with latent KSHV infection (SLKK) as compared to the uninfected SLK line. This approach revealed 153 differentially expressed human miRNAs, eight of which were independently confirmed by qRT-PCR. KSHV infection led to the dysregulation of similar to 15% of the human miRNA pool and most of these cellular miRNAs were down-regulated, including nearly all members of the 14q32 miRNA cluster, a genomic locus linked to cancer and that is deleted in a number of PEL cell lines. Furthermore, we identified 48 miRNAs that were associated with a total of 1,117 predicted or experimentally validated target mRNAs; of these mRNAs, a majority (73%) were inversely correlated to expression changes of their respective miRNAs, suggesting miRNA-mediated silencing mechanisms were involved in a number of these alterations. Several dysregulated miRNA-mRNA pairs may facilitate KSHV infection or tumor formation, such as up-regulated miR-708-5p, associated with a decrease in pro-apoptotic caspase-2 and leukemia inhibitory factor LIF, or down-regulated miR-409-5p, associated with an increase in the p53-inhibitor MDM2. Transfection of miRNA mimics provided further evidence that changes in miRNAs are driving some observed mRNA changes. Using filtered datasets, we also identified several canonical pathways that were significantly enriched in differentially expressed miRNA-mRNA pairs, such as the epithelial-to-mesenchymal transition and the interleukin-8 signaling pathways. Overall, our data provide a more detailed understanding of KSHV latency and guide further studies of the biological significance of these changes.	[Viollet, Coralie; Davis, David A.; Ziegelbauer, Joseph M.; Yarchoan, Robert] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Viollet, Coralie; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Reczko, Martin; Ragoussis, Jiannis] Alexander Fleming Biomed Sci Res Ctr, Inst Mol Oncol, Vari, Greece; [Pezzella, Francesco] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford, England; [Ragoussis, Jiannis] McGill Univ, Montreal, PQ, Canada; [Ragoussis, Jiannis] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; Wellcome Centre for Human Genetics; Alexander Fleming Biomedical Sciences Research Center; University of Oxford; McGill University	Ragoussis, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	ioannis.ragoussis@mcgill.ca; robert.yarchoan@nih.gov	Ragoussis, Ioannis/AAD-9790-2022; Reczko, Martin/O-8935-2019; Ziegelbauer, Joseph/L-2628-2013	Ragoussis, Ioannis/0000-0002-8515-0934; Ziegelbauer, Joseph/0000-0001-6464-6941; Reczko, Martin/0000-0002-0005-8718	National Institutes of Health, National Cancer Institute; Wellcome Trust [095493]; NATIONAL CANCER INSTITUTE [ZIABC011176, ZIABC010885] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (https://ccr.cancer. gov/), and by the Wellcome Trust PhD Studentship http://www.wellcome.ac.uk/Funding/Biomedicalscience/index. htm), Award Number 095493. The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2012, J VIROL, V86, P11663, DOI 10.1128/JVI.01147-12; Abend JR, 2010, J VIROL, V84, P12139, DOI 10.1128/JVI.00884-10; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Boss IW, 2011, J VIROL, V85, P9877, DOI 10.1128/JVI.05558-11; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cai QI, 2006, J VIROL, V80, P7965, DOI 10.1128/JVI.00689-06; Camps C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-28; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Carroll PA, 2006, J VIROL, V80, P10802, DOI 10.1128/JVI.00673-06; Catrina AM, 2014, PATHOL ONCOL RES, V20, P153, DOI 10.1007/s12253-013-9678-1; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chang TY, 2011, NUCLEIC ACIDS RES, V39, P6970, DOI 10.1093/nar/gkr405; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Dyson OF, 2008, CELL MICROBIOL, V10, P1546, DOI 10.1111/j.1462-5822.2008.01149.x; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Gasperini P, 2012, CANCER RES, V72, P1157, DOI 10.1158/0008-5472.CAN-11-3067; Godshalk SE, 2008, CELL CYCLE, V7, P3595, DOI 10.4161/cc.7.22.7120; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan SL, 2010, J PATHOL, V222, P166, DOI 10.1002/path.2752; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Moore PS, 2007, KSHV MANIPULATION CE; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Song T, 2013, J CANCER RES CLIN, V139, P1189, DOI 10.1007/s00432-013-1392-6; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Sturzl M, 2013, INT J CANCER, V132, P1954, DOI 10.1002/ijc.27849; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Ueda Keiji, 2011, Leuk Res Treatment, V2011, P726964, DOI 10.4061/2011/726964; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wu XJ, 2015, TUMOR BIOL, V36, P437, DOI 10.1007/s13277-014-2626-1; Wu YH, 2011, BLOOD, V118, P2896, DOI 10.1182/blood-2011-01-330589; Xiang M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004497; Zhang JF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/187105; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	59	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126439	10.1371/journal.pone.0126439	http://dx.doi.org/10.1371/journal.pone.0126439			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942495	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400071
J	Bishop, PJ; Walmsley, CW; Phillips, MJ; Quayle, MR; Boisvert, CA; McHenry, CR				Bishop, Peter J.; Walmsley, Christopher W.; Phillips, Matthew J.; Quayle, Michelle R.; Boisvert, Catherine A.; McHenry, Colin R.			Oldest Pathology in a Tetrapod Bone Illuminates the Origin of Terrestrial Vertebrates	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; STEM TETRAPOD; OSSINODUS-PUERI; TRABECULAR BONE; EARLY EVOLUTION; PECTORAL FIN; PANDERICHTHYS; MAINTENANCE; SKELETON; BEHAVIOR	The origin of terrestrial tetrapods was a key event in vertebrate evolution, yet how and when it occurred remains obscure, due to scarce fossil evidence. Here, we show that the study of palaeopathologies, such as broken and healed bones, can help elucidate poorly understood behavioural transitions such as this. Using high-resolution finite element analysis, we demonstrate that the oldest known broken tetrapod bone, a radius of the primitive stem tetrapod Ossinodus pueri from the mid-Visean (333 million years ago) of Australia, fractured under a high-force, impact-type loading scenario. The nature of the fracture suggests that it most plausibly occurred during a fall on land. Augmenting this are new osteological observations, including a preferred directionality to the trabecular architecture of cancellous bone. Together, these results suggest that Ossinodus, one of the first large (>2m length) tetrapods, spent a significant proportion of its life on land. Our findings have important implications for understanding the temporal, biogeographical and physiological contexts under which terrestriality in vertebrates evolved. They push the date for the origin of terrestrial tetrapods further back into the Carboniferous by at least two million years. Moreover, they raise the possibility that terrestriality in vertebrates first evolved in large tetrapods in Gondwana rather than in small European forms, warranting a re-evaluation of this important evolutionary event.	[Bishop, Peter J.] Queensland Museum, Ancient Environm Program, Hendra, Qld 4011, Australia; [Bishop, Peter J.; Phillips, Matthew J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4000, Australia; [Bishop, Peter J.] Griffith Univ, Ctr Musculoskeletal Res, Southport, Qld 4222, Australia; [Walmsley, Christopher W.; Quayle, Michelle R.; McHenry, Colin R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Boisvert, Catherine A.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Queensland Museum; Queensland University of Technology (QUT); Griffith University; Monash University; Australian Regenerative Medicine Institute; Monash University	Bishop, PJ (corresponding author), Queensland Museum, Ancient Environm Program, 122 Gerler Rd, Hendra, Qld 4011, Australia.	peter.bishop@qm.qld.gov.au; m9.phillips@qut.edu.au	Phillips, Matthew J/J-1365-2012; Boisvert, Catherine A/A-9782-2019	Phillips, Matthew J/0000-0003-1532-449X; Boisvert, Catherine A/0000-0002-0618-7270	QUT research grant; ARC grant [DR0986471]; Monash University research grant; ARC QEII Fellowship [DP110101127]; Human Frontiers Research Program [LT000130/2009-L]; ARC Discovery Project [DP 1096002]	QUT research grant; ARC grant(Australian Research Council); Monash University research grant; ARC QEII Fellowship(Australian Research Council); Human Frontiers Research Program; ARC Discovery Project(Australian Research Council)	MJP is supported by a QUT research grant, CRM by an ARC grant (DR0986471) and a Monash University research grant, and CAB by an ARC QEII Fellowship DP110101127, a Human Frontiers Research Program (LT000130/2009-L), and an ARC Discovery Project DP 1096002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Ahlberg PE, 2011, SPEC PAP PALAEONTOL, P17, DOI 10.1111/j.1475-4983.2011.01077.x; AMIS AA, 1995, INJURY, V26, P163, DOI 10.1016/0020-1383(95)93494-3; Anderson E.M., 1951, DYNAMICS FAULTING; Anonymous, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P1; BIEWENER AA, 1986, J EXP BIOL, V123, P383; Bishop PJ, 2014, ALCHERINGA, V38, P209, DOI 10.1080/03115518.2014.861320; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Clack J. A., 2012, GAINING GROUND ORIGI; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Coates MI, 1995, B MUS NATL HIST NA C, V17C, P359; Currey J.D., 2002, BONES STRUCTURE MECH; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Donoghue OA, 2011, SPORTS HEALTH, V3, P303, DOI 10.1177/1941738111403872; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145; Hanna RR, 2002, J VERTEBR PALEONTOL, V22, P76, DOI 10.1671/0272-4634(2002)022[0076:MIAIIA]2.0.CO;2; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; International Commission on Radiological Protection, 1975, ICRP PUBLICATION, V23; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Milner AC, 1998, ZOOL J LINN SOC-LOND, V122, P211, DOI 10.1111/j.1096-3642.1998.tb02530.x; Paton RL, 1999, NATURE, V398, P508, DOI 10.1038/19071; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; ROLFE WDI, 1994, T ROY SOC EDIN-EARTH, V84, P175; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Smithson TR, 2012, P NATL ACAD SCI USA, V109, P4532, DOI 10.1073/pnas.1117332109; Thulborn T, 1996, NATURE, V381, P777, DOI 10.1038/381777a0; Tsafnat N, 2011, J ANAT, V218, P40, DOI 10.1111/j.1469-7580.2010.01289.x; Tsubota K, 2009, J BIOMECH, V42, P1088, DOI 10.1016/j.jbiomech.2009.02.030; Vogel S., 2003, COMP BIOMECHANICS LI; Walmsley CW, 2013, PEERJ, V1, DOI 10.7717/peerj.204; Wang H, 2012, J BIOMECH, V45, P2417, DOI 10.1016/j.jbiomech.2012.06.024; Wang XMM, 2004, ORYX, V38, P197, DOI 10.1017/S0030605304000341; Warren A, 2004, PALAEONTOLOGY, V47, P151, DOI 10.1111/j.0031-0239.2004.00353.x; Warren A, 2002, ALCHERINGA, V26, P459, DOI 10.1080/03115510208619536; Warren A, 2007, J VERTEBR PALEONTOL, V27, P850, DOI 10.1671/0272-4634(2007)27[850:NDOOPA]2.0.CO;2; Wirtz DC, 2000, J BIOMECH, V33, P1325, DOI 10.1016/S0021-9290(00)00069-5	43	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125723	10.1371/journal.pone.0125723	http://dx.doi.org/10.1371/journal.pone.0125723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938463	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000096
J	Ide, T; Komoto, S; Higo-Moriguchi, K; Htun, KW; Myint, YY; Myat, TW; Thant, KZ; Thu, HM; Win, MM; Oo, HN; Htut, T; Wakuda, M; Dennis, FE; Haga, K; Fujii, Y; Katayama, K; Rahman, S; Van Nguyen, S; Umeda, K; Oguma, K; Tsuji, T; Taniguchi, K				Ide, Tomihiko; Komoto, Satoshi; Higo-Moriguchi, Kyoko; Htun, Khaing Win; Myint, Yi Yi; Myat, Theingi Win; Thant, Kyaw Zin; Hlaing Myat Thu; Win, Mo Mo; Oo, Htun Naing; Than Htut; Wakuda, Mitsutaka; Dennis, Francis Ekow; Haga, Kei; Fujii, Yoshiki; Katayama, Kazuhiko; Rahman, Shofiqur; Sa Van Nguyen; Umeda, Kouji; Oguma, Keiji; Tsuji, Takao; Taniguchi, Koki			Whole Genomic Analysis of Human G12P[6] and G12P[8] Rotavirus Strains that Have Emerged in Myanmar	PLOS ONE			English	Article							HOSPITAL-BASED SURVEILLANCE; GROUP-A ROTAVIRUSES; PHYLOGENETIC ANALYSIS; GENOTYPE CONSTELLATION; CLOSE RELATIONSHIP; G12 GENOTYPE; CHILDREN; DIARRHEA; PORCINE; INDIA	G12 rotaviruses are emerging rotavirus strains causing severe diarrhea in infants and young children worldwide. However, the whole genomes of only a few G12 strains have been fully sequenced and analyzed. In this study, we sequenced and characterized the complete genomes of six G12 strains (RVA/Human-tc/MMR/A14/2011/G12P[8], RVA/ Human-tc/MMR/A23/2011/G12P[6], RVA/Human-tc/MMR/A25/2011/G12P[8], RVA/ Human-tc/MMR/P02/2011/G12P[8], RVA/Human-tc/MMR/P39/2011/G12P[8], and RVA/ Human-tc/MMR/P43/2011/G12P[8]) detected in six stool samples from children with acute gastroenteritis in Myanmar. On whole genomic analysis, all six Myanmarese G12 strains were found to have a Wa-like genetic backbone: G12-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 for strains A14, A25, P02, P39, and P43, and G12-P[6]-I1-R1-C1-M1-A1-N1-T1-E1-H1 for strain A23. Phylogenetic analysis showed that most genes of the six strains examined in this study were genetically related to globally circulating human G1, G3, G9, and G12 strains. Of note is that the NSP4 gene of strain A23 exhibited the closest relationship with the cognate genes of human-like bovine strains as well as human strains, suggesting the occurrence of reassortment between human and bovine strains. Furthermore, strains A14, A25, P02, P39, and P43 were very closely related to one another in all the 11 gene segments, indicating derivation of the five strains from a common origin. On the other hand, strain A23 consistently formed distinct clusters as to all the 11 gene segments, indicating a distinct origin of strain A23 from that of strains A14, A25, P02, P39, and P43. To our knowledge, this is the first report on whole genome-based characterization of G12 strains that have emerged in Myanmar. Our observations will provide important insights into the evolutionary dynamics of spreading G12 rotaviruses in Asia.	[Ide, Tomihiko; Komoto, Satoshi; Higo-Moriguchi, Kyoko; Wakuda, Mitsutaka; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Htun, Khaing Win] Nay Pyi Taw Gen Hosp Cent Myanmar, Nay Pyi Taw, Myanmar; [Myint, Yi Yi] Dept Med Res Upper Myanmar, Pyin Oo Lwin, Myanmar; [Myat, Theingi Win; Thant, Kyaw Zin; Hlaing Myat Thu; Win, Mo Mo] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Oo, Htun Naing] Dept Tradit Med Cent Myanmar, Nay Pyi Taw, Myanmar; [Than Htut] Minist Hlth Cent Myanmar, Nay Pyi Taw, Myanmar; [Dennis, Francis Ekow; Haga, Kei; Fujii, Yoshiki; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Dennis, Francis Ekow] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Ghana; [Rahman, Shofiqur; Sa Van Nguyen; Umeda, Kouji] EW Nutr Japan, Immunol Res Inst Gifu, Gifu, Japan; [Oguma, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Okayama, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan	Fujita Health University; National Institute of Infectious Diseases (NIID); University of Ghana; Okayama University; Fujita Health University	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp	Fujii, Yoshiki/GOE-3566-2022	Katayama, Kazuhiko/0000-0002-7692-1151	MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [26461516] Funding Source: KAKEN	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), and Grants-in-Aid for Research on Emerging and Reemerging Infectious Diseases from the Ministry of Health, Labor, and Welfare of Japan (KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2010, VIRUS GENES, V40, P347, DOI 10.1007/s11262-010-0463-x; Ahmed K, 2010, ARCH VIROL, V155, P71, DOI 10.1007/s00705-009-0552-0; Ahmed S, 2012, Mymensingh Med J, V21, P497; Alam MM, 2009, VIRUS RES, V144, P280, DOI 10.1016/j.virusres.2009.03.015; Ansari S, 2013, J MED MICROBIOL, V62, P114, DOI 10.1099/jmm.0.048124-0; Chakravarti A, 2010, SE ASIAN J TROP MED, V41, P1145; Das S, 2003, J CLIN MICROBIOL, V41, P2760, DOI 10.1128/JCM.41.6.2760-2762.2003; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Ghosh S, 2011, INFECT GENET EVOL, V11, P1481, DOI 10.1016/j.meegid.2011.05.014; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Kang G, 2013, VACCINE, V31, P2879, DOI 10.1016/j.vaccine.2013.04.030; Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Khananurak K, 2010, INFECT GENET EVOL, V10, P537, DOI 10.1016/j.meegid.2010.02.003; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Komoto S, 2013, J GEN VIROL, V94, P1568, DOI 10.1099/vir.0.051011-0; Le VP, 2008, J MED VIROL, V80, P175, DOI 10.1002/jmv.21044; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malik YS, 2014, INFECT GENET EVOL, V25, P20, DOI 10.1016/j.meegid.2014.04.004; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Moe K, 2005, J INFECT DIS, V192, pS111, DOI 10.1086/431509; Moe K, 2009, VACCINE, V27, pF89, DOI 10.1016/j.vaccine.2009.08.068; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Mullick S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112970; Park J, 2014, ACCIDENT ANAL PREV, V70, P167, DOI 10.1016/j.aap.2014.03.016; Paul S K, 2010, Mymensingh Med J, V19, P16; Paul S K, 2009, Mymensingh Med J, V18, P190; Paul SK, 2008, ARCH VIROL, V153, P1999, DOI 10.1007/s00705-008-0212-9; Phan VTM, 2011, AM J TROP MED HYG, V85, P768, DOI 10.4269/ajtmh.2011.11-0364; Pietsch C, 2009, EMERG INFECT DIS, V15, P1512, DOI 10.3201/eid1509.090497; Pongsuwanna Y, 2002, J CLIN MICROBIOL, V40, P1390, DOI 10.1128/JCM.40.4.1390-1394.2002; Pongsuwannna Y, 2010, J MED VIROL, V82, P157, DOI 10.1002/jmv.21596; Pun SB, 2007, EMERG INFECT DIS, V13, P482, DOI 10.3201/eid1303.061367; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Ramani S, 2007, J CLIN MICROBIOL, V45, P432, DOI 10.1128/JCM.01710-06; Ray P, 2007, J CLIN MICROBIOL, V45, P3824, DOI 10.1128/JCM.01288-07; Samajdar S, 2006, J CLIN VIROL, V36, P183, DOI 10.1016/j.jcv.2006.03.006; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sharma S, 2008, J CLIN MICROBIOL, V46, P1343, DOI 10.1128/JCM.02358-07; Sherchand JB, 2009, J INFECT DIS, V200, pS182, DOI 10.1086/605046; Shinozaki K, 2004, J MED VIROL, V73, P612, DOI 10.1002/jmv.20134; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tamim S, 2013, INFECT GENET EVOL, V14, P161, DOI 10.1016/j.meegid.2012.10.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANIGUCHI K, 1990, J VIROL, V64, P5640, DOI 10.1128/JVI.64.11.5640-5644.1990; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Uchida R, 2006, J CLIN MICROBIOL, V44, P3499, DOI 10.1128/JCM.01089-06; URASAWA S, 1990, ARCH VIROL, V113, P279, DOI 10.1007/BF01316680; Vainio K, 2013, APMIS, V121, P447, DOI 10.1111/apm.12014; Wakuda M, 2003, J CLIN MICROBIOL, V41, P5764, DOI 10.1128/JCM.41.12.5764-5769.2003; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795; Wulan WN, 2010, EMERG INFECT DIS, V16, P159, DOI 10.3201/eid1601.091010; Zhirakovskaia EV, 2012, MOL GENET MIKROBIOL, V4, P33	65	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124965	10.1371/journal.pone.0124965	http://dx.doi.org/10.1371/journal.pone.0124965			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938434	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000035
J	Kosai, H; Tamaki, R; Saito, M; Tohma, K; Alday, PP; Tan, AG; Inobaya, MT; Suzuki, A; Kamigaki, T; Lupisan, S; Tallo, V; Oshitani, H				Kosai, Hisato; Tamaki, Raita; Saito, Mayuko; Tohma, Kentaro; Parian Alday, Portia; Gue Tan, Alvin; Tawat Inobaya, Marianette; Suzuki, Akira; Kamigaki, Taro; Lupisan, Soccoro; Tallo, Veronica; Oshitani, Hitoshi			Incidence and Risk Factors of Childhood Pneumonia-Like Episodes in Biliran Island, Philippines-A Community-Based Study	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; RESPIRATORY-TRACT INFECTIONS; CARE-SEEKING BEHAVIOR; HOSPITALIZED CHILDREN; HEALTH-CARE; RECURRENT PNEUMONIA; ACQUIRED PNEUMONIA; NORTHERN INDIA; URBAN-POOR; MORTALITY	Pneumonia is a leading cause of deaths in infants and young children in developing countries, including the Philippines. However, data at the community level remains limited. Our study aimed to estimate incidence and mortality rates and to evaluate risk factors and health-seeking behavior for childhood pneumonia. A household level interview survey was conducted in Biliran Island, the Philippines. Caregivers were interviewed using a semistructured questionnaire to check if children had symptoms suggesting pneumonia-like episodes from June 2011 to May 2012. Of 3,327 households visited in total, 3,302 (99.2%) agreed to participate, and 5,249 children less than 5 years of age were included in the study. Incidence rates of pneumonia-like episodes, severe pneumonia-like episodes, and pneumonia-associated mortality were 105, 61, and 0.9 per 1,000 person-years, respectively. History of asthma [hazard ratio (HR): 5.85, 95% confidence interval (CI): 4.83-7.08], low socioeconomic status (SES) (HR: 1.11, 95% CI: 1.02-1.20), and long travel time to the healthcare facility estimated by cost distance analysis (HR: 1.32, 95% CI: 1.09-1.61) were significantly associated with the occurrence of pneumonia-like episodes by the Cox proportional hazards model. For severe pneumonia-like episodes, a history of asthma (HR: 8.39, 95% CI: 6.54-10.77) and low SES (HR: 1.30, 95% CI: 1.17-1.45) were significant risk factors. Children who had a long travel time to the hospital were less likely to seek hospital care (Odds ratio: 0.32, 95% CI: 0.19-0.54) when they experienced severe pneumonia-like episodes. Incidence of pediatric pneumonia-like episodes was associated with a history of asthma, SES, and the travel time to healthcare facilities. Travel time was also identified as a strong indicator for health-seeking behavior. Improved access to healthcare facilities is important for early and effective management. Further studies are warranted to understand the causal relationship between asthma and pneumonia.	[Kosai, Hisato; Tamaki, Raita; Saito, Mayuko; Tohma, Kentaro; Kamigaki, Taro; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Parian Alday, Portia; Gue Tan, Alvin; Tawat Inobaya, Marianette; Lupisan, Soccoro; Tallo, Veronica] Res Inst Trop Med, Manila, Philippines; [Suzuki, Akira] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan	Tohoku University; Research Institute for Tropical Medicine - Philippines; Tohoku University	Oshitani, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Tohma, Kentaro/AAE-4751-2019; Saito, Mayuko/J-4508-2018; Oshitani, Hitoshi/AAE-4349-2019	Tohma, Kentaro/0000-0002-0456-9355; Saito, Mayuko/0000-0003-4622-7027; Suzuki, Akira/0000-0002-8223-0314	Japan Science and Technology Agency; Japan International Cooperation Agency; Japan Society for the Promotion of Science [21790570]; Science and Technology Research Partnership for Sustainable Development	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science and Technology Research Partnership for Sustainable Development	This work was supported by Japan Science and Technology Agency and Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development, research name Comprehensive Etiological and Epidemiological Study on Acute Respiratory Infections in Children: Providing Evidence for the Prevention and Control of Childhood Pneumonia in the Philippines, no grant number, URL http://www.jst.go.jp/global/. HO received it. This work was also supported by Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Grant Number 21790570, URL http://www.jsps.go.jp/j-grantsinaid/index.html. RT received it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, TOT POP PROV CIT MUN; Authority PS International I, 2014, PHIL NAT DEM HLTH SU; Awasthi S, 2008, J PERINATOL, V28, pS69, DOI 10.1038/jp.2008.169; Bailie R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-147; Barsam FJBG, 2013, EUR J PEDIATR, V172, P493, DOI 10.1007/s00431-012-1909-z; Bhat RY, 2013, INT J TUBERC LUNG D, V17, P418, DOI 10.5588/ijtld.12.0117; Bhat YR, 2012, PAEDIATR INT CHILD H, V32, P132, DOI 10.1179/2046905512Y.0000000027; Cardoso AM, 2013, TROP MED INT HEALTH, V18, P596, DOI 10.1111/tmi.12081; Cardoso MRA, 2011, ARCH DIS CHILD, V96, P58, DOI 10.1136/adc.2010.189894; Department of Health P, 2014, LEAD CAUS CHILD MORT; Diaz T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-157; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Enrique AT, 2012, FIELD HLTH SERVICE I; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-130; Etten JV, 2012, R PACKAGE GDISTANCE; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Hasan R, 2014, PEDIATR INFECT DIS J, V33, pE45, DOI 10.1097/INF.0000000000000062; Hortal M, 2007, INT J INFECT DIS, V11, P273, DOI 10.1016/j.ijid.2006.05.006; Hoving MFP, 2013, J PAEDIATR CHILD H, V49, pE208, DOI 10.1111/jpc.12114; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; King R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-319; Kristiansson C, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-11; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Murray EL, 2012, INDOOR AIR, V22, P132, DOI 10.1111/j.1600-0668.2011.00754.x; Nantanda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081562; Narman N, 2007, SAMJ S AFR MED J, V97, P733; Nascimento-Carvalho CM, 2002, PEDIATR PULM, V33, P244, DOI 10.1002/ppul.10078; Newbrander W, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-46; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; Owayed AF, 2000, ARCH PEDIAT ADOL MED, V154, P190, DOI 10.1001/archpedi.154.2.190; Patria F, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-60; Paynter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067528; Ramachandran P, 2012, INDIAN PEDIATR, V49, P889, DOI 10.1007/s13312-012-0221-3; Ray N, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-63; Root ED, 2014, P NATL ACAD SCI USA, V111, P3520, DOI 10.1073/pnas.1313748111; Roovali L, 2006, HEALTH PLACE, V12, P195, DOI 10.1016/j.healthplace.2004.12.001; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Schreiner M., 2009, SIMPLE POVERTY SCORE; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Thorn LKAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-180; Tobler W, 1993, 931 NCGIA; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	49	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125009	10.1371/journal.pone.0125009	http://dx.doi.org/10.1371/journal.pone.0125009			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938584	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000039
J	Lee, MS; Yu, M; Kim, KY; Park, GH; Kwack, K; Kim, KP				Lee, Min-Soo; Yu, Mi; Kim, Kyoung-Yeon; Park, Geun-Hee; Kwack, KyuBum; Kim, Keun P.			Functional Validation of Rare Human Genetic Variants Involved in Homologous Recombination Using Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE HOLLIDAY JUNCTIONS; RAD51 FILAMENT FORMATION; DOUBLE-STRAND BREAK; DNA-DAMAGE; REPAIR GENES; BRCA2; PROTEIN; REPLICATION; BINDING; MUTATIONS	Systems for the repair of DNA double-strand breaks (DSBs) are necessary to maintain genome integrity and normal functionality of cells in all organisms. Homologous recombination (HR) plays an important role in repairing accidental and programmed DSBs in mitotic and meiotic cells, respectively. Failure to repair these DSBs causes genome instability and can induce tumorigenesis. Rad51 and Rad52 are two key proteins in homologous pairing and strand exchange during DSB-induced HR; both are highly conserved in eukaryotes. In this study, we analyzed pathogenic single nucleotide polymorphisms (SNPs) in human RAD51 and RAD52 using the Polymorphism Phenotyping (PolyPhen) and Sorting Intolerant from Tolerant (SIFT) algorithms and observed the effect of mutations in highly conserved domains of RAD51 and RAD52 on DNA damage repair in a Saccharomyces cerevisiae-based system. We identified a number of rad51 and rad52 alleles that exhibited severe DNA repair defects. The functionally inactive SNPs were located near ATPase active site of Rad51 and the DNA binding domain of Rad52. The rad51-F317I, rad52-R52W, and rad52-G107C mutations conferred hypersensitivity to methyl methane sulfonate (MMS)-induced DNA damage and were defective in HR-mediated DSB repair. Our study provides a new approach for detecting functional and loss-of-function genetic polymorphisms and for identifying causal variants in human DNA repair genes that contribute to the initiation or progression of cancer.	[Lee, Min-Soo; Yu, Mi; Park, Geun-Hee; Kim, Keun P.] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Kim, Kyoung-Yeon; Kwack, KyuBum] CHA Univ, Dept Biomed Sci, Songnam, South Korea	Chung Ang University; Pochon Cha University	Kwack, K (corresponding author), CHA Univ, Dept Biomed Sci, Songnam, South Korea.	kbkwack@cha.ac.kr; kpkim@cau.ac.kr	LEE, MINSOO/HGE-5845-2022		National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [2012-M3A9C6050367, 2012R1A1A1010578, 2014R1A2A1A11051584]; NRF of Korea - Ministry of Education [2009-0093821]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning; NRF of Korea - Ministry of Education	This research was supported by a National Research Foundation (NRF) of Korea grant funded by the Ministry of Science, ICT & Future Planning (2012-M3A9C6050367; 2012R1A1A1010578; 2014R1A2A1A11051584). KBK was supported by a NRF of Korea funded by the Ministry of Education (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai N, 2011, J BIOL CHEM, V286, P17607, DOI 10.1074/jbc.M110.216739; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; BURTSCHER HJ, 1988, MUTAT RES, V194, P1, DOI 10.1016/0167-8817(88)90050-8; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; CALDERON IL, 1983, CURR GENET, V7, P93, DOI 10.1007/BF00365632; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Cha RS, 2000, GENE DEV, V14, P493; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Esta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003833; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Flott S, 2011, EMBO REP, V12, P833, DOI 10.1038/embor.2011.127; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Honda M, 2011, EMBO J, V30, P3368, DOI 10.1038/emboj.2011.238; Hong S, 2013, MOL CELLS, V36, P446, DOI 10.1007/s10059-013-0215-6; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lee SE, 2003, MOL CELL BIOL, V23, P8913, DOI 10.1128/MCB.23.23.8913-8923.2003; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Miyagawa K, 2002, EMBO J, V21, P175, DOI 10.1093/emboj/21.1.175; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; North JA, 2013, NUCLEIC ACIDS RES, V41, P7302, DOI 10.1093/nar/gkt411; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; PRAKASH L, 1977, GENETICS, V86, P33; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Tanaka K, 2000, J BIOL CHEM, V275, P26316, DOI 10.1074/jbc.M910306199; Tischfield JA, 1997, AM J HUM GENET, V61, P995, DOI 10.1086/301617; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124152	10.1371/journal.pone.0124152	http://dx.doi.org/10.1371/journal.pone.0124152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938495	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000018
J	Ren, DR; Lu, GQ; Moriyama, H; Mustoe, AC; Harrison, EB; French, JA				Ren, Dongren; Lu, Guoqing; Moriyama, Hideaki; Mustoe, Aaryn C.; Harrison, Emily B.; French, Jeffrey A.			Genetic Diversity in Oxytocin Ligands and Receptors in New World Monkeys	PLOS ONE			English	Article							MOLECULAR EVOLUTION; SOCIAL MONOGAMY; VASOPRESSIN; COEVOLUTION; AGONIST; MAMMALS	Oxytocin (OXT) is an important neurohypophyseal hormone that influences wide spectrum of reproductive and social processes. Eutherian mammals possess a highly conserved sequence of OXT (Cys-Tyr-IIe-Gln-Asn-Cys-Pro-Leu-Gly). However, in this study, we sequenced the coding region for OXT in 22 species covering all New World monkeys (NWM) genera and clades, and characterize five OXT variants, including consensus mammalian Leu(8)-OXT, major variant Pro(8)-OXT, and three previously unreported variants: Ala(8)-OXT, Thr(8)-OXT, and Phe(2)-OXT. Pro(8)-OXT shows clear structural and physicochemical differences from Leu(8)-OXT. We report multiple predicted amino acid substitutions in the G protein-coupled OXT receptor (OXTR), especially in the critical N-terminus, which is crucial for OXT recognition and binding. Genera with same Pro(8)-OXT tend to cluster together on a phylogenetic tree based on OXTR sequence, and we demonstrate significant coevolution between OXT and OXTR. NWM species are characterized by high incidence of social monogamy, and we document an association between OXTR phylogeny and social monogamy. Our results demonstrate remarkable genetic diversity in the NWM OXT/OXTR system, which can provide a foundation for molecular, pharmacological, and behavioral studies of the role of OXT signaling in regulating complex social phenotypes.	[Ren, Dongren; Mustoe, Aaryn C.; Harrison, Emily B.; French, Jeffrey A.] Univ Nebraska, Dept Psychol, Callitrichid Res Ctr, Omaha, NE 68182 USA; [Ren, Dongren] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang 330045, Jiangxi, Peoples R China; [Ren, Dongren] Jiangxi Agr Univ, Minist Agr China, Nanchang 330045, Jiangxi, Peoples R China; [Ren, Dongren; Lu, Guoqing; Harrison, Emily B.; French, Jeffrey A.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Moriyama, Hideaki] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of Nebraska System; Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; University of Nebraska System; University of Nebraska System; University of Nebraska Lincoln	Ren, DR (corresponding author), Univ Nebraska, Dept Psychol, Callitrichid Res Ctr, Omaha, NE 68182 USA.	dren@unomaha.edu	Harrison, Emily B./AAW-1826-2021	Harrison, Emily B./0000-0002-6934-3875; Mustoe, Aaryn/0000-0001-7618-8810; French, Jeffrey/0000-0001-5304-1592	National Institutes of Health [HD042882]; Nebraska Research Initiative; College of Arts and Sciences at the University of Nebraska at Omaha; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042882] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative; College of Arts and Sciences at the University of Nebraska at Omaha; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by funds from the National Institutes of Health (grant number HD042882) (J.A.F.); the Nebraska Research Initiative (J.A.F.); and the College of Arts and Sciences at the University of Nebraska at Omaha (J.A.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker AMJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00185; Arrowsmith S, 2014, J NEUROENDOCRINOL, V26, P356, DOI 10.1111/jne.12154; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Cavanaugh J, 2014, PSYCHONEUROENDOCRINO, V49, P1, DOI 10.1016/j.psyneuen.2014.06.020; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; GAZIS D, 1978, P SOC EXP BIOL MED, V158, P663; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gruber CW, 2012, FUTURE MED CHEM, V4, P1791, DOI [10.4155/FMC.12.108, 10.4155/fmc.12.108]; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Huck M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0195; Koehbach J, 2013, BIOCHEM SOC T, V41, P197, DOI 10.1042/BST20120256; Lee AG, 2011, BIOL LETTERS, V7, P584, DOI 10.1098/rsbl.2011.0107; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Li Y, 2005, J MOL ENDOCRINOL, V35, P411, DOI 10.1677/jme.1.01798; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Osterholz M, 2009, MOL PHYLOGENET EVOL, V50, P507, DOI 10.1016/j.ympev.2008.12.014; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Postina R, 1996, J BIOL CHEM, V271, P31593, DOI 10.1074/jbc.271.49.31593; Ragen BJ, 2013, OXYTOCIN, VASOPRESSIN AND RELATED PEPTIDES IN THE REGULATION OF BEHAVIOR, P288; Ren D, 2014, AUSTIN J BIOTECHNOL, V1, P3; Ren DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111638; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider H, 2015, MOL PHYLOGENET EVOL, V82, P348, DOI 10.1016/j.ympev.2013.10.017; Smith AS, 2010, HORM BEHAV, V57, P255, DOI 10.1016/j.yhbeh.2009.12.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walker JM, 2005, THE PROTEOMICS PROTO; Wallis M, 2012, GEN COMP ENDOCR, V179, P313, DOI 10.1016/j.ygcen.2012.07.030; Wesley VJ, 2002, BIOCHEMISTRY-US, V41, P5086, DOI 10.1021/bi015990v; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	35	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125775	10.1371/journal.pone.0125775	http://dx.doi.org/10.1371/journal.pone.0125775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938568	gold, Green Published			2022-12-26	WOS:000353943000099
J	Schonbeck, Y; van Dommelen, P; HiraSing, RA; van Buuren, S				Schoenbeck, Yvonne; van Dommelen, Paula; HiraSing, Remy A.; van Buuren, Stef			Trend in Height of Turkish and Moroccan Children Living in The Netherlands	PLOS ONE			English	Article							BODY-MASS INDEX; REFERENCE VALUES; LMS METHOD; GROWTH; WEIGHT; REFERENCES; OBESITY; CURVES; ORIGIN	Objectives To study trends in height of Turkish and Moroccan immigrant children living in The Netherlands, to investigate the association between height and background characteristics in these children, and to calculate height-for-age-references data for these groups. Design Nationwide cross-sectional data collection from children aged 0 to 18 years by trained professionals in 1997 and 2009. The study population consisted of 2,822 Turkish 2,779 Moroccan, and 13,705 Dutch origin children in 1997and 2,548 Turkish, 2,594 Moroccan, and 11,255 Dutch origin children in 2009. Main outcome measures: Mean height in cm, and mean height standard deviation scores. Results In 2009, mean height at the age of 18y was similar for Turkish and Moroccan children: 177 cm for boys and 163 cm for girls, which was 2 to 3 cm taller than in 1997. Still, Turkish and Moroccan adolescents were 5.5 cm (boys) to 7 cm (girls) shorter than their Dutch peers. No significant differences were found in mean height standard deviation scores across the educational level of the parents, geographical region, primary language spoken at home, and immigrant generation. Conclusions While the secular height increase in Dutch children came to a halt, the trend in Turkish and Moroccan children living in The Netherlands continued. However, large differences in height between Turkish and Moroccan children and Dutch children remain. We found no association with the background characteristics. We recommend the use of the new growth charts for children of Turkish and Moroccan origin who have a height-for-age below -2SD on the growth chart for Dutch children.	[Schoenbeck, Yvonne] TNO Child Hlth, Leiden, Netherlands; [van Dommelen, Paula; van Buuren, Stef] TNO Life Style, Leiden, Netherlands; [HiraSing, Remy A.] Vrije Univ Amsterdam, Med Ctr Amsterdam, EMGO Inst Hlth Care Res, Amsterdam, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; Utrecht University	Schonbeck, Y (corresponding author), TNO Child Hlth, Leiden, Netherlands.	yvonne.schonbeck@tno.nl		van Buuren, Stef/0000-0003-1098-2119; Schonbeck, Yvonne/0000-0002-4998-5117	Dutch Ministry of Health, Welfare and Sports [310434/312617/315319]	Dutch Ministry of Health, Welfare and Sports	This study was funded by the Dutch Ministry of Health, Welfare and Sports (grant numbers 310434/312617/315319). The researchers were independent from the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourquia A, 1995, MED MAGHRED, V51, P6; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Committee on the Health Adjustment of Immigrant Children and Families National Research Council, 1999, CHILDREN IMMIGRANTS; DELEMARREVANDEWAAL HA, 1993, ENVIRON HEALTH PERSP, V101, P39, DOI 10.1289/ehp.93101s239; Eveleth PB, 1990, WORLDWIDE VARIATION; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; FREDRIKS AM, 2004, GROWTH DIAGRAMS MANU; Gokcay G, 2008, CHILD CARE HLTH DEV, V34, P454, DOI 10.1111/j.1365-2214.2008.00813.x; Huijnk W, 2010, SOCIAAL CULTUREEL RA, P299; Iversen T, 2013, ECON HUM BIOL, V11, P1, DOI 10.1016/j.ehb.2012.02.003; Kaplan MS, 2004, AM J PREV MED, V27, P323, DOI 10.1016/j.amepre.2004.07.005; Keij I., 2000, INDEX, V10, P24; Lindstrom M, 2005, SCAND J PUBLIC HEALT, V33, P276, DOI 10.1080/14034940510005653; Ministerie van Volksgezondheid Welzijn en Sport, 2002, BAS JEUGDG 0 19 JAAR, DOI DOI 10.1136/ARCHDISCHILD-2014-307448; MJONES S, 1987, ANN HUM BIOL, V14, P337, DOI 10.1080/03014468700009121; Mjones S, 1986, Scand J Prim Health Care, V4, P183, DOI 10.3109/02813438609014827; Neyzi O, 2006, ACTA PAEDIATR, V95, P1635, DOI 10.1080/08035250600652013; Ozer BK, 2007, ECON HUM BIOL, V5, P280, DOI 10.1016/j.ehb.2007.03.007; Redlefsen T, 2007, ANTHROPOL ANZ, V65, P263, DOI 10.1127/anthranz/65/2007/263; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Simsek F, 2005, CHILD CARE HLTH DEV, V31, P441, DOI 10.1111/j.1365-2214.2005.00531.x; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Dommelen P, 2014, PLOS ONE, V9; Verweij A, 2008, CATEGORISING ED LEVE; World Health Organization, CHILD GROWTH STAND	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124686	10.1371/journal.pone.0124686	http://dx.doi.org/10.1371/journal.pone.0124686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938671	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000031
J	Singh, AK; Manjasetty, B; Balasubramani, GL; Koul, S; Kaushik, A; Ekka, MK; Singh, V; Kumaran, S				Singh, Appu Kumar; Manjasetty, Babu; Balasubramani, G. L.; Koul, Sukirte; Kaushik, Abhishek; Ekka, Mary Krishna; Singh, Vijay; Kumaran, S.			Crystal Structure of Fad35R from Mycobacterium tuberculosis H37Rv in the Apo-State	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TRANSCRIPTIONAL REGULATOR; TETR FAMILY; TETRACYCLINE REPRESSOR; ETHIONAMIDE RESISTANCE; ACID BIOSYNTHESIS; ESCHERICHIA-COLI; BINDING; PROTEINS; REFINEMENT	Fad35R from Mycobacterium tuberculosis binds to the promoter site of Fad35 operon and its DNA binding activities are reduced in the presence of tetracycline and palmitoyl-CoA. We resolved the crystal structure of Fad35R using single-wavelength anomalous diffraction method (SAD). Fad35R comprises canonical DNA binding domain (DBD) and ligand binding domain (LBD), but displays several distinct structural features. Two recognition helices of two monomers in the homodimer are separated by similar to 48 angstrom and two core triangle-shaped ligand binding cavities are well exposed to solvent. Structural comparison with DesT and QacR structures suggests that ligand binding-induced movement of alpha 7, which adopts a straight conformation in the Fad35R, may be crucial to switch the conformational states between repressive and derepressive forms. Two DBDs are packed asymmetrically, creating an alternative dimer interface which coincides with the possible tetramer interface that connects the two canonical dimers. Quaternary state of alternative dimer mimics a closed-state structure in which two recognition helices are distanced at similar to 35 and ligand binding pockets are inaccessible. Results of biophysical studies indicate that Fad35R has the propensity to oligomerize in solution in the presence of tetracycline. We present the first structure of a FadR homologue from mycobacterium and the structure reveals DNA and ligand binding features of Fad35R and also provides a view on alternative quaternary states that mimic open and closed forms of the regulator.	[Singh, Appu Kumar; Balasubramani, G. L.; Koul, Sukirte; Kaushik, Abhishek; Ekka, Mary Krishna; Singh, Vijay; Kumaran, S.] CSIR, GN Ramachandran Prot Ctr, Inst Microbial Technol, Chandigarh 160036, India; [Manjasetty, Babu] European Mol Biol Lab, Grenoble Outstn, F-38000 Grenoble, France; [Manjasetty, Babu] Univ Grenoble Alpes, CNRS, EMBL, Unit Virus Host Cell Interact, F-38000 Grenoble, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Kumaran, S (corresponding author), CSIR, GN Ramachandran Prot Ctr, Inst Microbial Technol, Chandigarh 160036, India.	skumaran@imtech.res.in	Manjasetty, Babu A/F-8366-2013	Manjasetty, Babu A/0000-0002-8229-4748	CSIR, India; DST, India; Department of Biotechnology (DBT), India; CSIR; DBT India	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); DST, India(Department of Science & Technology (India)); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT India(Department of Biotechnology (DBT) India)	AKS, SK, AK and MM received research fellowships from CSIR, India. GLB received a fellowship from DST, India. VS received one from the Department of Biotechnology (DBT), India. CSIR and DBT India funded this research and DBT, India, sponsored data collection at ESRF, Grenoble, France. We gratefully acknowledge access to In-house X-ray and 3-D structural biology facilities at IMTECH and ESRF, Grenoble, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Biswas RK, 2013, MICROBIOL-SGM, V159, P913, DOI 10.1099/mic.0.066654-0; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Ezezika OC, 2007, ACTA CRYSTALLOGR F, V63, P361, DOI 10.1107/S1744309107019185; Filippova Ekaterina V., 2011, Journal of Structural and Functional Genomics, V12, P149, DOI 10.1007/s10969-011-9112-4; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Hayes D, 1995, PROGRAM SEDNTERP SED; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Krissinel E, 1995, J COMPUT CHEM, V31, P133; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Le TBK, 2011, J MOL BIOL, V408, P40, DOI 10.1016/j.jmb.2011.02.035; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Mondino S, 2013, MOL MICROBIOL, V89, P372, DOI 10.1111/mmi.12282; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Vindal V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-289; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124333	10.1371/journal.pone.0124333	http://dx.doi.org/10.1371/journal.pone.0124333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938298	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000023
J	Yousif, AM; Minopoli, M; Bifulco, K; Ingangi, V; Di Carluccio, G; Merlino, F; Motti, ML; Grieco, P; Carriero, MV				Yousif, Ali Munaim; Minopoli, Michele; Bifulco, Katia; Ingangi, Vincenzo; Di Carluccio, Gioconda; Merlino, Francesco; Motti, Maria Letizia; Grieco, Paolo; Carriero, Maria Vincenza			Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; TRANSENDOTHELIAL MIGRATION; CELL-MIGRATION; DEFICIENT MICE; IN-VITRO; FORM; UPAR; ANGIOGENESIS; RECRUITMENT; THERAPIES	The receptor for the urokinase-type plasminogen activator (uPAR) is a widely recognized master regulator of cell migration and uPAR(88-92) is the minimal sequence required to induce cell motility. We and others have previously documented that the uPAR88-92 sequence, even in the form of synthetic linear peptide (SRSRY), interacts with the formyl peptide receptor type 1 (FPR1), henceforth inducing cell migration of several cell lines, including monocytes. FPR1 is mainly expressed by mammalian phagocytic leukocytes and plays a crucial role in chemotaxis. In this study, we present evidence that the cyclization of the SRSRY sequence generates a new potent and stable inhibitor of monocyte trafficking. In rat basophilic leukaemia RBL-2H3/ETFR cells expressing high levels of constitutively activated FPR1, the cyclic SRSRY peptide ([SRSRY]) blocks FPR1 mediated cell migration by interfering with both internalization and ligand-uptake of FPR1. Similarly to RBL-2H3/ETFR cells, [SRSRY] competes with fMLF for binding to FPR1 and prevents agonist-induced FPR1 internalization in human monocyte THP-1 cells. Unlike scramble [RSSYR], [SRSRY] inhibits fMLF-directed migration of monocytes in a dose-dependent manner, with IC50 value of 0.01 nM. PMA-differentiated THP-1 cell exposure to fMLF gradient causes a marked cytoskeletal re-organization with the formation of F-actin rich pseudopodia that are prevented by the addition of [SRSRY]. Furthermore, [SRSRY] prevents migration of human primary monocytes and trans-endothelial migration of monocytes. Our findings indicate that [SRSRY] is a new FPR1 inhibitor which may suggest the development of new drugs for treating pathological conditions sustained by increased motility of monocytes, such as chronic inflammatory diseases.	[Yousif, Ali Munaim; Merlino, Francesco; Grieco, Paolo] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Minopoli, Michele; Bifulco, Katia; Ingangi, Vincenzo; Di Carluccio, Gioconda; Carriero, Maria Vincenza] IRCCS Ist Nazl Tumori Fdn G Pascale, Dept Expt Oncol, Neoplast Progress Unit, Naples, Italy; [Ingangi, Vincenzo] Univ Naples 2, SUN, Naples, Italy; [Motti, Maria Letizia] Univ Parthenope, Naples, Italy; [Grieco, Paolo] Univ Naples Federico II, CIRPEB Ctr Interuniv Ric Peptidi Bioattivi, CNR, Inst Biostruct & Bioimaging,DFM Scarl, I-80134 Naples, Italy	University of Naples Federico II; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; Parthenope University Naples; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II	Carriero, MV (corresponding author), IRCCS Ist Nazl Tumori Fdn G Pascale, Dept Expt Oncol, Neoplast Progress Unit, Naples, Italy.	mariolinacarriero@yahoo.it	Carriero, Maria Vincenza/K-1240-2018; Minopoli, Michele/ABE-5674-2020; Ingangi, Vincenzo/I-2422-2018; Minopoli, Michele/J-8633-2018; Grieco, Paolo/AAB-9034-2019; Ingangi, Vincenzo/AAA-3512-2019; Merlino, Francesco/K-7866-2019	Carriero, Maria Vincenza/0000-0002-9768-2997; Minopoli, Michele/0000-0002-5407-481X; Ingangi, Vincenzo/0000-0001-5237-8353; Minopoli, Michele/0000-0002-5407-481X; Grieco, Paolo/0000-0002-6854-8123; Merlino, Francesco/0000-0002-9607-229X; Yousif, Ali Munaim/0000-0002-5651-0961; Di Carluccio, Gioconda/0000-0002-3571-9889	AIRC (Associazione Italiana per la Ricerca sul Cancro) [14225]; Italian Ministry of Health [RF-2010-2316780]; Regione Campania-Laboratori Pubblici project "Hauteville"	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Regione Campania-Laboratori Pubblici project "Hauteville"	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) 2013, project 14225, by Italian Ministry of Health RF-2010-2316780 and by Regione Campania-Laboratori Pubblici project "Hauteville". Authors did not receive any funding from commercial sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2003, MOL PHARMACOL, V64, P841, DOI 10.1124/mol.64.4.841; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bifulco K, 2010, J THROMB HAEMOST, V8, P2789, DOI 10.1111/j.1538-7836.2010.04075.x; Bifulco K, 2008, FEBS LETT, V582, P1141, DOI 10.1016/j.febslet.2008.03.001; Bifulco K, 2014, ONCOTARGET, V5, P4154, DOI 10.18632/oncotarget.1930; Bifulco K, 2013, MOL CANCER THER, V12, P1981, DOI 10.1158/1535-7163.MCT-13-0077; Bifulco K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044806; Blasi F, 1997, IMMUNOL TODAY, V18, P415, DOI 10.1016/S0167-5699(97)01121-3; Carriero MV, 2014, MOL CANCER THER, V13, P1092, DOI 10.1158/1535-7163.MCT-13-0949; Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944; Carriero MV, 2009, MOL CANCER THER, V8, P2708, DOI 10.1158/1535-7163.MCT-09-0174; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gargiulo L, 2005, J BIOL CHEM, V280, P25225, DOI 10.1074/jbc.M412605200; Griffith JW, 2013, EUR J IMMUNOL, V43, P1430, DOI 10.1002/eji.201243183; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Gyetko MR, 2001, J IMMUNOL, V167, P5539, DOI 10.4049/jimmunol.167.10.5539; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee HY, 2013, BIOCHEM BIOPH RES CO, V433, P255, DOI 10.1016/j.bbrc.2013.03.002; Liu MY, 2012, INT IMMUNOPHARMACOL, V14, P283, DOI 10.1016/j.intimp.2012.07.015; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Miettinen HM, 1997, J IMMUNOL, V159, P4045; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2012, INFEZ MED S2, V20, P8; Montuori N, 2011, CELL MOL LIFE SCI, V68, P2453, DOI 10.1007/s00018-010-0564-7; Plesner T, 1997, STEM CELLS, V15, P398, DOI 10.1002/stem.150398; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Rao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059415; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Ronald JA, 2001, J LEUKOCYTE BIOL, V70, P601; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tsubota Y, 2013, J IMMUNOL, V190, P4236, DOI 10.4049/jimmunol.1300046; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yuan C, 2007, CELL MOL LIFE SCI, V64, P1033, DOI 10.1007/s00018-007-6498-z	41	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126172	10.1371/journal.pone.0126172	http://dx.doi.org/10.1371/journal.pone.0126172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938482	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000147
J	Calabuig-Navarro, V; Yamauchi, J; Lee, S; Zhang, T; Liu, YZ; Sadlek, K; Coudriet, GM; Piganelli, JD; Jiang, CL; Miller, R; Lowe, M; Harashima, H; Dong, HH				Calabuig-Navarro, Virtu; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Liu, Yun-Zi; Sadlek, Kelsey; Coudriet, Gina M.; Piganelli, Jon D.; Jiang, Chun-Lei; Miller, Rita; Lowe, Mark; Harashima, Hideyoshi; Dong, H. Henry			Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; gluconeogenesis; glucose metabolism; liver; obesity; FoxO6; glucose metabolism; mice	TRANSCRIPTION FACTOR FKHR; INSULIN-RESPONSE SEQUENCE; ADIPOSE-TISSUE; GENE-EXPRESSION; VLDL PRODUCTION; IN-VIVO; METABOLISM; PHOSPHORYLATION; OBESITY; LIVER	Background: Excessive endogenous glucose production is a major contributing factor for fasting hyperglycemia in diabetes. Results: FoxO6 deficiency attenuates hepatic gluconeogenesis and protects against fat-induced glucose disorder in mice. Conclusion: FoxO6 plays a significant role in regulating gluconeogenesis in the liver. Significance: FoxO6 is a potential therapeutic target for improving glucose metabolism in diabetes. Excessive endogenous glucose production contributes to fasting hyperglycemia in diabetes. FoxO6 is a distinct member of the FoxO subfamily. To elucidate the role of FoxO6 in hepatic gluconeogenesis and assess its contribution to the pathogenesis of fasting hyperglycemia in diabetes, we generated FoxO6 knock-out (FoxO6-KO) mice followed by determining the effect of FoxO6 loss-of-function on hepatic gluconeogenesis under physiological and pathological conditions. FoxO6 depletion attenuated hepatic gluconeogenesis and lowered fasting glycemia in FoxO6-KO mice. FoxO6-deficient primary hepatocytes were associated with reduced capacities to produce glucose in response to glucagon. When fed a high fat diet, FoxO6-KO mice exhibited significantly enhanced glucose tolerance and reduced blood glucose levels accompanied by improved insulin sensitivity. These effects correlated with attenuated hepatic gluconeogenesis in FoxO6-KO mice. In contrast, wild-type littermates developed fat-induced glucose intolerance with a concomitant induction of fasting hyperinsulinemia and hyperglycemia. Furthermore, FoxO6-KO mice displayed significantly diminished macrophage infiltration into liver and adipose tissues, correlating with the reduction of macrophage expression of C-C chemokine receptor 2 (CCR2), a factor that is critical for regulating macrophage recruitment in peripheral tissues. Our data indicate that FoxO6 depletion protected against diet-induced glucose intolerance and insulin resistance by attenuating hepatic gluconeogenesis and curbing macrophage infiltration in liver and adipose tissues in mice.	[Calabuig-Navarro, Virtu; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Liu, Yun-Zi; Sadlek, Kelsey; Miller, Rita; Lowe, Mark; Dong, H. Henry] Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Sch Med,Dept Pediat, Pittsburgh, PA 15224 USA; [Yamauchi, Jun; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 0600812, Japan; [Liu, Yun-Zi; Jiang, Chun-Lei] Second Mil Med Univ, Fac Psychol & Mental Hlth, Lab Stress Med, Shanghai 200433, Peoples R China; [Coudriet, Gina M.; Piganelli, Jon D.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hokkaido University; Naval Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dong, HH (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dongh@pitt.edu	Regan, Clinton/E-6250-2012; Zhang, Ting/J-5074-2015; Calabuig, Virtu/AAB-2990-2021	Calabuig, Virtu/0000-0001-6277-7040; Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK087764]; Japan Society for the Promotion of Science [24-3549]; Chinese Natural Science Foundation Fellowship [201306580015]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087764, R01DK098437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chinese Natural Science Foundation Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK087764. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Grant-in-aid scholarship 24-3549 from the Japan Society for the Promotion of Science.; Supported by Chinese Natural Science Foundation Fellowship 201306580015.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Edgerton DS, 2009, FRONT BIOSCI-LANDMRK, V14, P1169, DOI 10.2741/3301; Ekberg K, 1999, DIABETES, V48, P292, DOI 10.2337/diabetes.48.2.292; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamagate A, 2010, ENDOCRINOLOGY, V151, P3521, DOI 10.1210/en.2009-1306; Kim DH, 2013, J DIABETES, V5, P233, DOI 10.1111/1753-0407.12027; Kim DH, 2011, DIABETES, V60, P2763, DOI 10.2337/db11-0548; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Massillon D, 1995, AM J PHYSIOL-ENDOC M, V269, pE1037, DOI 10.1152/ajpendo.1995.269.6.E1037; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Scott DK, 1998, J BIOL CHEM, V273, P24145, DOI 10.1074/jbc.273.37.24145; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Tonelli J, 2005, CURR OPIN CLIN NUTR, V8, P450, DOI 10.1097/01.mco.0000172588.47811.63; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	53	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15581	15594		10.1074/jbc.M115.650994	http://dx.doi.org/10.1074/jbc.M115.650994			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944898	Green Published, hybrid			2022-12-26	WOS:000356527400023
J	Feng, J; Yang, WS; Xie, ZL; Xiang, F; Cao, ZJ; Li, WX; Hu, HZ; Chen, ZY; Wu, YL				Feng, Jing; Yang, Weishan; Xie, Zili; Xiang, Fang; Cao, Zhijian; Li, Wenxin; Hu, Hongzhen; Chen, Zongyun; Wu, Yingliang			Kv Channel S1-S2 Linker Working as a Binding Site of Human -Defensin 2 for Channel Activation Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						defensin; immunology; ligand-binding protein; toxin; voltage-dependent anion channel (VDAC); Kv channel; S1-S2 linker; human beta-defensin 2; electrostatic interaction; gating modifier	GATED POTASSIUM CHANNELS; VOLTAGE-SENSOR; STRUCTURAL BASIS; GATING MODIFIER; RECEPTOR-SITE; K+ CHANNELS; TOXIN; INHIBITOR; CHARYBDOTOXIN; HANATOXIN	Background: The functional role of the Kv channel S1-S2 linker remains unclear. Results: The S1-S2 linker-hBD2 interaction modifies Kv1.3 channel activation through electrostatic repulsion between positively charged hBD2 and the channel S4 segment. Conclusion: The Kv1.3 channel S1-S2 linker is a novel peptide-binding site. Significance: These findings could define the function of S1-S2 linkers in Kv channel gating modification among different Kv channels. Among the three extracellular domains of the tetrameric voltage-gated K+ (Kv) channels consisting of six membrane-spanning helical segments named S1-S6, the functional role of the S1-S2 linker still remains unclear because of the lack of a peptide ligand. In this study, the Kv1.3 channel S1-S2 linker was reported as a novel receptor site for human -defensin 2 (hBD2). hBD2 shifts the conductance-voltage relationship curve of the human Kv1.3 channel in a positive direction by nearly 10.5 mV and increases the activation time constant for the channel. Unlike classical gating modifiers of toxin peptides from animal venoms, which generally bind to the Kv channel S3-S4 linker, hBD2 only targets residues in both the N and C termini of the S1-S2 linker to influence channel gating and inhibit channel currents. The increment and decrement of the basic residue number in a positively charged S4 sensor of Kv1.3 channel yields conductance-voltage relationship curves in the positive direction by approximate to 31.2 mV and 2-4 mV, which suggests that positively charged hBD2 is anchored in the channel S1-S2 linker and is modulating channel activation through electrostatic repulsion with an adjacent S4 helix. Together, these findings reveal a novel peptide ligand that binds with the Kv channel S1-S2 linker to modulate channel activation. These findings also highlight the functional importance of the Kv channel S1-S2 linker in ligand recognition and modification of channel activation.	[Feng, Jing; Yang, Weishan; Xie, Zili; Xiang, Fang; Cao, Zhijian; Li, Wenxin; Chen, Zongyun; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Ctr BioDrug Res, Wuhan 430072, Peoples R China; [Hu, Hongzhen] Washington Univ, Sch Med, Dept Anesthesiol, Pain Ctr,Ctr Study Itch, St Louis, MO 63110 USA	Wuhan University; Wuhan University; Washington University (WUSTL)	Chen, ZY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	chenzy2005@126.com; ylwu@whu.edu.cn	Feng, Jing/C-1729-2018	Feng, Jing/0000-0001-6726-7912; Hu, Hongzhen/0000-0002-8967-7522	National Natural Sciences Foundation of China [31470812, 31170789]; National Science Fund for Excellent Young Scholars [31422049]; Wuhan University Natural Sciences Foundation [2042015kf0168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101218] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Wuhan University Natural Sciences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Natural Sciences Foundation of China (Nos. 31470812 and 31170789), National Science Fund for Excellent Young Scholars (No. 31422049), and Wuhan University Natural Sciences Foundation (No. 2042015kf0168).	Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; DeSimone CV, 2011, MOL PHARMACOL, V80, P345, DOI 10.1124/mol.111.072405; DeSimone CV, 2009, MOL PHARMACOL, V76, P125, DOI 10.1124/mol.109.055657; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Hou PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089975; Huang PT, 2007, TOXICON, V49, P285, DOI 10.1016/j.toxicon.2006.09.015; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Shiau YS, 2002, J MOL MODEL, V8, P253, DOI 10.1007/s00894-002-0095-8; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Wee CL, 2007, BIOPHYS J, V92, pL7, DOI 10.1529/biophysj.106.098681; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	25	14	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15487	15495		10.1074/jbc.M115.639500	http://dx.doi.org/10.1074/jbc.M115.639500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944908	hybrid, Green Published			2022-12-26	WOS:000356527400015
J	Fan, XQ; Guo, Q; Xu, P; Gong, YY; Shu, HM; Yang, Y; Ni, WC; Zhang, XG; Shen, XL				Fan, Xinqi; Guo, Qi; Xu, Peng; Gong, YuanYong; Shu, Hongmei; Yang, Yang; Ni, Wanchao; Zhang, Xianggui; Shen, Xinlian			Transcriptome-Wide Identification of Salt-Responsive Members of the WRKY Gene Family in Gossypium aridum	PLOS ONE			English	Article							DROUGHT TOLERANCE; ARABIDOPSIS; EXPRESSION; STRESS; RICE; REVEALS; PROTEIN	WRKY transcription factors are plant-specific, zinc finger-type transcription factors. The WRKY superfamily is involved in abiotic stress responses in many crops including cotton, a major fiber crop that is widely cultivated and consumed throughout the world. Salinity is an important abiotic stress that results in considerable yield losses. In this study, we identified 109 WRKY genes (GarWRKYs) in a salt-tolerant wild cotton species Gossypium aridum from transcriptome sequencing data to elucidate the roles of these factors in cotton salt tolerance. According to their structural features, the predicted members were divided into three groups (Groups I-III), as previously described for Arabidopsis. Furthermore, 28 salt-responsive GarWRKY genes were identified from digital gene expression data and subjected to real-time quantitative RT-PCR analysis. The expression patterns of most GarWRKY genes revealed by this analysis are in good agreement with those revealed by RNA-Seq analysis. RT-PCR analysis revealed that 27 GarWRKY genes were expressed in roots and one was exclusively expressed in roots. Analysis of gene orthology and motif compositions indicated that WRKY members from Arabidopsis, rice and soybean generally shared the similar motifs within the same subgroup, suggesting they have the similar function. Overexpression-GarWRKY17 and -GarWRKY104 in Arabidopsis revealed that they could positively regulate salt tolerance of transgenic Arabidopsis during different development stages. The comprehensive data generated in this study provide a platform for elucidating the functions of WRKY transcription factors in salt tolerance of G. aridum. In addition, GarWRKYs related to salt tolerance identified in this study will be potential candidates for genetic improvement of cultivated cotton salt stress tolerance.	[Fan, Xinqi] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Fan, Xinqi; Guo, Qi; Xu, Peng; Gong, YuanYong; Shu, Hongmei; Yang, Yang; Ni, Wanchao; Zhang, Xianggui; Shen, Xinlian] Minist Agr, Key Lab Cotton & Rapeseed Nanjing, Nanjing, Jiangsu, Peoples R China; [Fan, Xinqi; Guo, Qi; Xu, Peng; Gong, YuanYong; Shu, Hongmei; Yang, Yang; Ni, Wanchao; Zhang, Xianggui; Shen, Xinlian] Jiangsu Acad Agr Sci, Inst Ind Crops, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Jiangsu Academy of Agricultural Sciences	Shen, XL (corresponding author), Minist Agr, Key Lab Cotton & Rapeseed Nanjing, Nanjing, Jiangsu, Peoples R China.	xlshen68@126.com		yang, yang/0000-0003-0926-9359	Major Project of the National Transgene [2014ZX08005-004]; National Natural Science Foundation of China (NSFC) [31171595]; Jiangsu Independent Innovation Funds of Agricultural Technology [CX (13) 3059]	Major Project of the National Transgene; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Independent Innovation Funds of Agricultural Technology	This work was supported by grants from the Major Project of the National Transgene (2014ZX08005-004), the National Natural Science Foundation of China (NSFC) (31171595) and the Jiangsu Independent Innovation Funds of Agricultural Technology (CX (13) 3059).	Ashida Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2511, DOI 10.1271/bbb.66.2511; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Borrone JW, 2004, THEOR APPL GENET, V109, P495, DOI 10.1007/s00122-004-1662-4; Cai C, 2014, THE CROP JOURNAL; Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7; Dou L, 2014, MOLECULAR GENETICS A, P1; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Guo RY, 2011, MOL BIOL REP, V38, P49, DOI 10.1007/s11033-010-0076-4; Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jones P, 2014, BIOINFORMATICS; Kalde M, 2003, MOL PLANT MICROBE IN, V16, P295, DOI 10.1094/MPMI.2003.16.4.295; Lambais MR, 2001, GENET MOL BIOL, V24, P103, DOI 10.1590/S1415-47572001000100015; Li HE, 2010, PLANTA, V232, P1325, DOI 10.1007/s00425-010-1258-y; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu RX, 2008, AGR WATER MANAGE, V95, P1261, DOI 10.1016/j.agwat.2008.05.002; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi W, 2014, PLANT CELL TISSUE AN, V18, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang CH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055773, 10.1371/journal.pone.0073985]; Wu XL, 2009, PLANT BIOTECHNOL-NAR, V26, P431, DOI 10.5511/plantbiotechnology.26.431; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou Y, 2014, IEEE INT CONGR BIG, P1, DOI 10.1109/BigData.Congress.2014.11; 胡根海, 2007, [棉花学报, Cotton Science], V19, P69	44	56	68	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126148	10.1371/journal.pone.0126148	http://dx.doi.org/10.1371/journal.pone.0126148			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951083	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400070
J	Ober, U; Huang, W; Magwire, M; Schlather, M; Simianer, H; Mackay, TFC				Ober, Ulrike; Huang, Wen; Magwire, Michael; Schlather, Martin; Simianer, Henner; Mackay, Trudy F. C.			Accounting for Genetic Architecture Improves Sequence Based Genomic Prediction for a Drosophila Fitness Trait	PLOS ONE			English	Article							QUANTITATIVE TRAIT; MISSING HERITABILITY; SELECTION; MELANOGASTER; EPISTASIS; REGRESSION; ASSOCIATION; VALIDATION; CHOICE; PLANT	The ability to predict quantitative trait phenotypes from molecular polymorphism data will revolutionize evolutionary biology, medicine and human biology, and animal and plant breeding. Efforts to map quantitative trait loci have yielded novel insights into the biology of quantitative traits, but the combination of individually significant quantitative trait loci typically has low predictive ability. Utilizing all segregating variants can give good predictive ability in plant and animal breeding populations, but gives little insight into trait biology. Here, we used the Drosophila Genetic Reference Panel to perform both a genome wide association analysis and genomic prediction for the fitness-related trait chill coma recovery time. We found substantial total genetic variation for chill coma recovery time, with a genetic architecture that differs between males and females, a small number of molecular variants with large main effects, and evidence for epistasis. Although the top additive variants explained 36% (17%) of the genetic variance among lines in females (males), the predictive ability using genomic best linear unbiased prediction and a relationship matrix using all common segregating variants was very low for females and zero for males. We hypothesized that the low predictive ability was due to the mismatch between the infinitesimal genetic architecture assumed by the genomic best linear unbiased prediction model and the true genetic architecture of chill coma recovery time. Indeed, we found that the predictive ability of the genomic best linear unbiased prediction model is markedly improved when we combine quantitative trait locus mapping with genomic prediction by only including the top variants associated with main and epistatic effects in the relationship matrix. This trait-associated prediction approach has the advantage that it yields biologically interpretable prediction models.	[Ober, Ulrike; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany; [Huang, Wen; Magwire, Michael; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Schlather, Martin] Univ Mannheim, Inst Math, D-68131 Mannheim, Germany	University of Gottingen; University of North Carolina; North Carolina State University; University of Mannheim	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Simianer, Henner/A-6574-2015	Simianer, Henner/0000-0002-7551-3797; Huang, Wen/0000-0001-6788-8364	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" [FKZ 0315528C]; Deutsche Forschungsgemeinschaft (DFG) research training group "Scaling problems in statistics" [RTG 1644]; National Institutes of Health [R01GM 45146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) research training group "Scaling problems in statistics"(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the German Federal Ministry of Education and Research (BMBF) within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" (FKZ 0315528C) in association with the Deutsche Forschungsgemeinschaft (DFG) research training group "Scaling problems in statistics" (RTG 1644) to HS and by National Institutes of Health grant R01GM 45146 to TFCM. The funders had no role in study design, data	Allen D., 1977, TECHNOMETRICS, V16, P125; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2014, P 10 WORLD C GEN APP; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Falconer D. S., 1996, INTRO QUANTITATIVE G; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Goddard M, 2009, GENETICA, V185, P1021; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hu ZQ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-15; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Kauffman S.A., 1993, ORIGINS ORDER; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Long NY, 2011, GENETICA, V139, P843, DOI 10.1007/s10709-011-9588-7; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Meuwissen THE, 2001, GENETICS, V157, P1819; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; SAS Institute Inc, 2013, SAS 9 2 HELP DOC; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schupbach T, 2010, BIOINFORMATICS, V26, P1468, DOI 10.1093/bioinformatics/btq147; Shen X, 2013, GENETICS, V193, P1255, DOI 10.1534/genetics.112.146720; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Stam LF, 1996, GENETICS, V144, P1559; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stone EA, 2012, GENOME RES, V22, P966, DOI 10.1101/gr.129122.111; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	56	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126880	10.1371/journal.pone.0126880	http://dx.doi.org/10.1371/journal.pone.0126880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950439	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400111
J	Wang, L; Long, W; Li, PF; Lin, YB; Liang, Y				Wang, Liang; Long, Wen; Li, Peng-fei; Lin, Yong-bin; Liang, Ying			An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NEUTROPHIL/LYMPHOCYTE RATIO; LUNG-CANCER; CELL; ASSOCIATION; TUMOR; INFLAMMATION; EXPRESSION; SURVIVAL; ORIGIN	Primary pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare type of non-small cell lung cancer. In this study, we retrospectively reviewed the data from 74 consecutive patients with pulmonary LELC and investigated the prognostic value of pretreatment monocyte-to-lymphocyte ratio (MLR). The cut-off value determined by ROC curve for MLR was 0.262. According to this cut-off value, 36 (48.6%) patients had lower MLR value (< 0.262) at diagnosis. There was no significant correlation between MLR level and gender, age, smoking history, stage, and lactate dehydrogenase (LDH) level. The 2-year, 5-year, and 10-year OS rate were 86%, 72%, and 61%, respectively; the 2-year, 5-year, and 10-year PFS rate were 71%, 63%, and 49%, respectively. In univariate analysis, advanced stage, elevated LDH level, and higher MLR value (> = 0.262) were significantly associated with poor OS and PFS. In a multivariate Cox regression model that included stage, LDH and MLR level, all of these three factors were found to be independent prognostic factors for both PFS and OS. In patients who received radical surgery, MLR level remained significantly correlated with OS and PFS. In conclusion, we firstly demonstrated that pretreatment MLR can be used as a useful independent prognostic marker in patients with pulmonary LELC, and might guide us to optimize the treatment strategies. However, due to the relatively rarity of this disease and the limitation of a retrospective study, further prospective studies performed in multicenter are necessary to validate the prognostic value of MLR in pulmonary LELC.	[Wang, Liang; Long, Wen; Li, Peng-fei; Lin, Yong-bin; Liang, Ying] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Wang, Liang] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Long, Wen] Sun Yat Sen Univ, Ctr Canc, Dept Nucl Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Peng-fei] Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Yong-bin] Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Ying] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Liang, Y (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	liangyingsysucc@126.com			National Natural Science Foundation of China [81400159]; Medical Research Foundation of Guangdong Province [B2014158]; Department of Health of Guangdong Province [B2009089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Research Foundation of Guangdong Province; Department of Health of Guangdong Province	LW received grant support from National Natural Science Foundation of China (contract/grant number: 81400159, http://www.nsfc.gov.cn/), and Medical Research Foundation of Guangdong Province (grant number: B2014158, http://www.medste.gd.cn/); YL received grant support from Department of Health of Guangdong Province (grant number: B2009089, http://www.medste.gd.cn/).	Afanasiev OK, 2013, J INVEST DERMATOL, V133, P2065, DOI 10.1038/jid.2013.36; Anoceto Martinez A, 2012, An Pediatr (Barc), V76, DOI 10.1016/j.anpedi.2011.07.001; BEGIN LR, 1987, J SURG ONCOL, V36, P280, DOI 10.1002/jso.2930360413; Chang YL, 2011, CANCER SCI, V102, P282, DOI 10.1111/j.1349-7006.2010.01768.x; Feng JH, 2012, INT J HEMATOL, V95, P143, DOI 10.1007/s12185-011-0993-6; Franklin WA, 2000, CHEST, V117, p80S, DOI 10.1378/chest.117.4_suppl_1.80S; Han AJ, 2000, AM J CLIN PATHOL, V114, P220, DOI 10.1309/148K-ND54-6NJX-NA61; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho JC, 2006, RESPIROLOGY, V11, P539, DOI 10.1111/j.1440-1843.2006.00910.x; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Li YL, 2014, ANN HEMATOL, V93, P617, DOI 10.1007/s00277-013-1916-9; Liang Y, 2012, CANCER-AM CANCER SOC, V118, P4748, DOI 10.1002/cncr.27452; Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Milne K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-33; Porrata LF, 2012, LEUKEMIA LYMPHOMA, V53, P2159, DOI 10.3109/10428194.2012.690605; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shepherd FA, 2007, J THORAC ONCOL, V2, P1067, DOI 10.1097/JTO.0b013e31815bdc0d; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135	21	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126269	10.1371/journal.pone.0126269	http://dx.doi.org/10.1371/journal.pone.0126269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950432	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400075
J	Wang, Y; Chen, H; Wang, NL; Guo, HY; Fu, YL; Xue, SG; Ai, A; Lyu, QF; Kuang, YP				Wang, Yun; Chen, Hong; Wang, NingLing; Guo, HaiYan; Fu, Yonglun; Xue, Songguo; Ai, Ai; Lyu, Qifeng; Kuang, Yanping			Combined 17 beta-Estradiol with TCDD Promotes M2 Polarization of Macrophages in the Endometriotic Milieu with Aid of the Interaction between Endometrial Stromal Cells and Macrophages	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; ARYL-HYDROCARBON RECEPTOR; PERITONEAL-MACROPHAGES; AH RECEPTOR; DIOXIN; EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ESTRADIOL; EXPOSURE; CYP1A1	The goal of this study is to elucidate the effects of 17 beta-estradiol and TCDD (2,3,7,8-tetra-chlorodibenzo-p-dioxin) on macrophage phenotypes in the endometriotic milieu. Co-culture of endometrial stromal cells (ESCs) and U937 cells (macrophage cell line) was performed to simulate the endometriotic milieu and to determine the effects of 17 beta-estradiol and/or TCDD on IL10, IL12 production and HLA-DR, CD86 expression by U937 macrophages. We found that combining 17 beta-estradiol with TCDD has a synergistic effect on inducing M2 activation when macrophages are co-cultured with ESCs. Moreover, the combination of 17 beta-estradiol and TCDD significantly enhanced STAT3 and P38 phosphorylation in macrophages. Differentiation of M2 macrophages induced by 17 beta-estradiol and TCDD were effectively abrogated by STAT3 and P38MAPK inhibitors, but not by ERK1/2 and JNK inhibitors. In conclusion, 17 beta-estradiol and TCDD in the ectopic milieu may lead to the development of endometriosis by inducing M2 polarization of macrophages through activation of the STAT3 and P38MAPK pathways.	[Wang, Yun; Chen, Hong; Wang, NingLing; Guo, HaiYan; Fu, Yonglun; Xue, Songguo; Ai, Ai; Lyu, Qifeng; Kuang, Yanping] Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Assisted Reprod, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, Y (corresponding author), Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Assisted Reprod, Shanghai 200030, Peoples R China.	sammy20080228@aliyun.com; kuangyanp@126.com	Fu, Yonglun/AAF-6993-2019		Shanghai Natural Science Foundation of China [14ZR1423900]; National Natural Science Foundation of China (NSFC) [81470064, 81270749]	Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from Shanghai Natural Science Foundation of China (14ZR1423900 to YW) and National Natural Science Foundation of China (NSFC) (81470064 to YW, and 81270749 to Y-PK).	Akoum A, 2001, MOL HUM REPROD, V7, P859, DOI 10.1093/molehr/7.9.859; Altintas D, 2008, FERTIL STERIL, V90, P401, DOI 10.1016/j.fertnstert.2007.06.057; BIRNBAUM LS, 1994, ENVIRON HEALTH PERSP, V102, P157, DOI 10.1289/ehp.94102s9157; Brown NM, 1998, CARCINOGENESIS, V19, P1623, DOI 10.1093/carcin/19.9.1623; Charles GD, 1997, BIOCHEM BIOPH RES CO, V238, P338, DOI 10.1006/bbrc.1997.7291; CRAMER DW, 1986, JAMA-J AM MED ASSOC, V255, P1904; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; Davis BJ, 2000, CANCER RES, V60, P5414; DIZEREGA GS, 1980, FERTIL STERIL, V33, P649; DMOWSKI WP, 1990, PROG CLIN BIOL RES, V323, P99; GIBBONS A, 1993, SCIENCE, V262, P1373, DOI 10.1126/science.8248776; GREENLEE WF, 1994, PROG CLIN BIOL RES, V387, P47; Guo SW, 2004, GYNECOL OBSTET INVES, V57, P157, DOI 10.1159/000076374; Hakkola J, 1997, CARCINOGENESIS, V18, P391, DOI 10.1093/carcin/18.2.391; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hong M, 2004, EXP TOXICOL PATHOL, V55, P385, DOI 10.1078/0940-2993-00335; Itoh H, 2011, CYTOTECHNOLOGY, V63, P133, DOI 10.1007/s10616-010-9321-x; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Khan KN, 2004, FERTIL STERIL, V81, P652, DOI 10.1016/j.fertnstert.2003.07.037; KIESEL L, 1990, PROG CLIN BIOL RES, V323, P179; Kress S, 1997, CANCER RES, V57, P1264; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Lai ZW, 1997, MOL PHARMACOL, V52, P30, DOI 10.1124/mol.52.1.30; LANDERS JP, 1991, BIOCHEM J, V276, P273, DOI 10.1042/bj2760273; Li MQ, 2012, HUM REPROD, V27, P2107, DOI 10.1093/humrep/des132; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Park SJ, 2005, ANTICANCER RES, V25, P2831; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Quintana FJ, 2008, NATURE, V453, P106, DOI [10.1038/nature06881, DOI 10.1038/NATURE06881]; Raiter-Tenenbaum A, 1998, ARCH GYNECOL OBSTET, V261, P147, DOI 10.1007/s004040050214; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Sensky T E, 1980, Int J Gynaecol Obstet, V17, P573; Shi YL, 2007, FERTIL STERIL, V88, P317, DOI 10.1016/j.fertnstert.2006.11.129; Shi YL, 2006, HUM REPROD, V21, P870, DOI 10.1093/humrep/dei414; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; SPINK DC, 1992, ARCH BIOCHEM BIOPHYS, V293, P342, DOI 10.1016/0003-9861(92)90404-K; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; VOGEL C, 1995, ARCH TOXICOL, V69, P259, DOI 10.1007/s002040050168; Vogel C, 1997, ARCH TOXICOL, V71, P372, DOI 10.1007/s002040050401; Wang XQ, 2010, J MOL ENDOCRINOL, V45, P291, DOI 10.1677/JME-09-0177; Wang Y, 2014, INT J CLIN EXP PATHO, V7, P194; Warren TK, 2000, TOXICOL SCI, V56, P114, DOI 10.1093/toxsci/56.1.114; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Wu MH, 2002, MOL HUM REPROD, V8, P1103, DOI 10.1093/molehr/8.12.1103; Yu J, 2008, HUM REPROD, V23, P1614, DOI 10.1093/humrep/den125; Zhao D, 2002, MOL HUM REPROD, V8, P849, DOI 10.1093/molehr/8.9.849	52	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125559	10.1371/journal.pone.0125559	http://dx.doi.org/10.1371/journal.pone.0125559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950905	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400035
J	Zhao, J; Jiang, CQ; Lam, TH; Liu, B; Cheng, KK; Xu, L; Yeung, SLA; Zhang, WS; Leung, GM; Schooling, CM				Zhao, Jie; Jiang, Chaoqiang; Lam, Tai Hing; Liu, Bin; Cheng, Kar Keung; Xu, Lin; Yeung, Shiu Lun Au; Zhang, Weisen; Leung, Gabriel M.; Schooling, C. Mary			Genetically Predicted Testosterone and Systemic Inflammation in Men: A Separate-Sample Mendelian Randomization Analysis in Older Chinese Men	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; GUANGZHOU BIOBANK COHORT; C-REACTIVE PROTEIN; BLOOD-CELL COUNT; MIDDLE-AGED MEN; HYPOGONADAL MEN; THERAPY; MARKERS; MORTALITY; STRENGTH	Objectives Observationally, testosterone is negatively associated with systemic inflammation, but this association is open to both residual confounding and reverse causality. Large-scale randomized controlled trials (RCTs), assessing exogenous effects, are presently unavailable. We examined the association of endogenous testosterone with well-established systemic inflammatory markers (white blood cell, granulocyte, lymphocyte and high-sensitivity C-reactive protein (hsCRP)) using a separate-sample Mendelian randomization analysis to minimize reverse causality. Methods A genetic prediction rule for serum testosterone was developed in 289 young Chinese men with mean age of 21.0, using selected testosterone-related SNPs (rs10046, rs1008805 and rs1256031). Multivariable linear regression was used to examine the association of genetically predicted serum testosterone with inflammatory markers among 4,212 older Chinese men from the Guangzhou Biobank Cohort Study. Results Genetically predicted testosterone was unrelated to white blood cell count (-0.01 109/L per nmol/L testosterone, 95% confidence interval (CI) -0.05 to 0.04), granulocyte count (-0.02 109/L, 95% CI -0.06 to 0.02), lymphocyte count (0.005 109/L, 95% CI -0.01 to 0.02) and hsCRP (-0.05 mg/L, 95% CI -0.15 to 0.06). Conclusion Our findings did not corroborate any anti-inflammatory effects of testosterone or corresponding potentially protective effects of testosterone on chronic diseases resulting from reduced low-grade systemic inflammation.	[Zhao, Jie; Lam, Tai Hing; Xu, Lin; Yeung, Shiu Lun Au; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chaoqiang; Liu, Bin; Zhang, Weisen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY Hunter Coll, Sch Publ Hlth, Sch Urban Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System; Hunter College (CUNY)	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Cheng, Kar/AAL-8899-2021; SL, Au Yeung/ABD-3938-2021; Liu, Bin/AAP-2376-2020; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; SL, Au Yeung/0000-0001-6136-1836; Liu, Bin/0000-0001-5785-2579; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971; Zhao, Jie/0000-0002-1564-0057; Leung, Gabriel/0000-0002-2503-6283	University of Hong Kong Foundation for Development and Research (Hong Kong, China); University of Hong Kong University Research Committee Strategic Research Theme of Public Health (Hong Kong, China); Guangzhou Public Health Bureau (Guangzhou, China; Key technology collaboration project) [2012J5100041]; Guangzhou Science and Technology Bureau (Guangzhou, China); University of Birmingham (Birmingham, United Kingdom); Research Grant Council General Research Fund, Research Grant Council of Hong Kong, Hong Kong SAR, People's Republic of China [769710]	University of Hong Kong Foundation for Development and Research (Hong Kong, China); University of Hong Kong University Research Committee Strategic Research Theme of Public Health (Hong Kong, China); Guangzhou Public Health Bureau (Guangzhou, China; Key technology collaboration project); Guangzhou Science and Technology Bureau (Guangzhou, China); University of Birmingham (Birmingham, United Kingdom); Research Grant Council General Research Fund, Research Grant Council of Hong Kong, Hong Kong SAR, People's Republic of China	The Guangzhou Biobank Cohort Study was funded by the University of Hong Kong Foundation for Development and Research (Hong Kong, China); the University of Hong Kong University Research Committee Strategic Research Theme of Public Health (Hong Kong, China); Guangzhou Public Health Bureau (Guangzhou, China; Key technology collaboration project, grant number 2012J5100041), Guangzhou Science and Technology Bureau (Guangzhou, China) and the University of Birmingham (Birmingham, United Kingdom). This sub-study was funded by the Research Grant Council General Research Fund (grant number 769710), Research Grant Council of Hong Kong, Hong Kong SAR, People's Republic of China. The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Bennett DA, 2010, NEUROEPIDEMIOLOGY, V35, P307, DOI 10.1159/000321179; Brand JS, 2012, MATURITAS, V71, P274, DOI 10.1016/j.maturitas.2011.12.007; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; DOUGHERTY TF, 1952, PHYSIOL REV, V32, P379, DOI 10.1152/physrev.1952.32.4.379; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Frederiksen L, 2013, HORM METAB RES, V45, P308, DOI 10.1055/s-0032-1323647; Freeman G, 2013, INT J EPIDEMIOL, V42, P1157, DOI 10.1093/ije/dyt110; Gannage-Yared MH, 2011, CLIN ENDOCRINOL, V74, P720, DOI 10.1111/j.1365-2265.2011.03987.x; Haring R, 2012, J ANDROL, V33, P944, DOI 10.2164/jandrol.111.015065; Jee SH, 2005, AM J EPIDEMIOL, V162, P1062, DOI 10.1093/aje/kwi326; Jiang CQ, 2010, J HUM HYPERTENS, V24, P139, DOI 10.1038/jhh.2009.52; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111/j.1365-2265.2010.03845.x; Kapoor D, 2007, EUR J ENDOCRINOL, V156, P595, DOI 10.1530/EJE-06-0737; Korenchevsky V, 1932, BIOCHEM J, V26, P1306, DOI 10.1042/bj0261306; Laaksonen DE, 2005, EUR HEART J, V26, P1783, DOI 10.1093/eurheartj/ehi237; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Muraleedharan V, 2010, THER ADV ENDOCRINOL, V1, P207, DOI 10.1177/2042018810390258; Nakhai-Pour HR, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.09.001; Panizzon MS, 2013, PSYCHONEUROENDOCRINO, V38, P2163, DOI 10.1016/j.psyneuen.2013.04.003; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; Schooling CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-345; Schooling CM, 2013, AM J HUM BIOL, V25, P622, DOI 10.1002/ajhb.22421; Schroderus E, 2010, AM NAT, V176, pE90, DOI 10.1086/656264; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Shi ZM, 2013, J CLIN ENDOCR METAB, V98, P3289, DOI 10.1210/jc.2012-3842; Stock JH, 2002, TESTING FOR WEAK INS; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Taylor AE, 2014, ECON HUM BIOL, V13, P99, DOI 10.1016/j.ehb.2013.12.002; Tchetgen EJT, 2013, INT J EPIDEMIOL, V42, P328, DOI 10.1093/ije/dyt023; Tsang S., 2004, MODERN HIST HONG KON; Vandenput L, 2007, J BONE MINER RES, V22, P220, DOI 10.1359/JBMR.061018; VANDERPOLL T, 1993, METABOLISM, V42, P303, DOI 10.1016/0026-0495(93)90078-3; Yeung SLA, 2012, AM J EPIDEMIOL, V175, P1021, DOI 10.1093/aje/kwr462; Zhao J, 2014, INT J EPIDEMIOL, V43, P140, DOI 10.1093/ije/dyt239	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126442	10.1371/journal.pone.0126442	http://dx.doi.org/10.1371/journal.pone.0126442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950910	gold, Green Published			2022-12-26	WOS:000354214400091
J	Hocking, DP; Salverson, M; Evans, AR				Hocking, David P.; Salverson, Marcia; Evans, Alistair R.			Foraging-Based Enrichment Promotes More Varied Behaviour in Captive Australian Fur Seals (Arctocephalus pusillus doriferus)	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; HABITAT	During wild foraging, Australian fur seals (Arctocephalus pusillus doriferus) encounter many different types of prey in a wide range of scenarios, yet in captive environments they are typically provided with a narrower range of opportunities to display their full repertoire of behaviours. This study aimed to quantitatively explore the effect of foraging-based enrichment on the behaviour and activity patterns displayed by two captive Australian fur seals at Melbourne Zoo, Australia. Food was presented as a scatter in open water, in a free-floating ball device, or in a static box device, with each treatment separated by control trials with no enrichment. Both subjects spent more time interacting with the ball and static box devices than the scatter feed. The total time spent pattern swimming was reduced in the enrichment treatments compared to the controls, while the time spent performing random swimming behaviours increased. There was also a significant increase in the total number of bouts of behaviour performed in all three enrichment treatments compared to controls. Each enrichment method also promoted a different suit of foraging behaviours. Hence, rather than choosing one method, the most effective way to increase the diversity of foraging behaviours, while also increasing variation in general activity patterns, is to provide seals with a wide range of foraging scenarios where food is encountered in different ways.	[Hocking, David P.; Evans, Alistair R.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Hocking, David P.; Evans, Alistair R.] Museum Victoria, Geosci, Melbourne, Vic, Australia; [Hocking, David P.; Salverson, Marcia] Zoos Victoria, Wild Sea Precinct, Melbourne, Vic, Australia	Monash University; Museum Victoria	Hocking, DP (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	email@david-hocking.com	Evans, Alistair R/D-4239-2011; Hocking, David Philip/A-2666-2017	Evans, Alistair R/0000-0002-4078-4693; Hocking, David Philip/0000-0001-6848-1208	Holsworth Wildlife Research Endowment; Monash University; Australian Research Council	Holsworth Wildlife Research Endowment; Monash University(Monash University); Australian Research Council(Australian Research Council)	This study was supported by the Holsworth Wildlife Research Endowment and Monash University. ARE acknowledges the support of the Australian Research Council and Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 2006, LOW WAKE FI, P309; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Clark FE, 2013, J ZOO AQUAR RES, V1, P1; Franks B, 2010, ZOO BIOL, V29, P397, DOI 10.1002/zoo.20272; Grindrod JAE, 2001, ANIM WELFARE, V10, P53; Hocking DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112521; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Hunter SA, 2002, ZOO BIOL, V21, P375, DOI 10.1002/zoo.10042; Kastelein R.A., 1989, Aquatic Mammals, V15, P9; Kirkwood R, 2013, AUSTRAL NAT HIST SER, P1; Laule Gail, 1998, P302; Lindburg Donald G., 1998, P262; Markowitz H, 1997, ZOO BIOL, V16, P1, DOI 10.1002/(SICI)1098-2361(1997)16:1<1::AID-ZOO1>3.0.CO;2-E; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Morgan Kathleen N., 1998, P153; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Parrish FA, 2007, MAR TECHNOL SOC J, V41, P30, DOI 10.4031/002533207787441944; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Smith BP, 2010, J APPL ANIM WELF SCI, V13, P103, DOI 10.1080/10888700903371863; Whitham JC, 2013, APPL ANIM BEHAV SCI, V147, P247, DOI 10.1016/j.applanim.2013.02.004	23	10	11	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124615	10.1371/journal.pone.0124615	http://dx.doi.org/10.1371/journal.pone.0124615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946412	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700046
J	Lee, CC; Chang, TS; Wu, CJ; Yang, CC; Chen, PC				Lee, Ching-Chih; Chang, Ting-Shou; Wu, Cheng-Jung; Yang, Ching-Chieh; Chen, Po-Chun			Determinants of End-of-Life Expenditures in Patients with Oral Cancer in Taiwan: A Population-Based Study	PLOS ONE			English	Article							COMORBIDITY; NECK; HEAD; CARE; VOLUME; AGGRESSIVENESS; QUALITY; IMPACT	Background To investigate the association of basic demographic data, socioeconomic status, medical services, and hospital characteristics with end-of-life expenditure in patients with oral cancer in Taiwan who died between 2009 to 2011. Methods This nationwide population-based, retrospective cohort study identified 5,386 patients who died from oral cancer. We evaluated medical cost in the last month of life by universal health insurance. The impact of each variable on the end-of-life expenditure was examined by hierarchical generalized linear model (HGLM) using a hospital-level random-intercept model. Results The mean medical cost in the last six months of life was $2,611 +/- 3,329 (U.S. dollars). In HGLM using a random-intercept model, we found that patients younger than 65 years had an additional cost of $819 over those aged >= 65 years. Patients who had a high Charlson Comorbidity Index Score (CCIS) had an additional $616 cost over those with a low CCIS. Those who survived post-diagnosis less than 6 months had an additional $659 in expenses over those who survived more than 24 months. Medical cost was $249 more for patients who had medium to high individual SES, and $319 more for those who were treated by nononcologists. Conclusion This study provides useful information for decision makers in understanding end-of-life expenditure in oral cancer. We found significantly increased end-of-life expenditure in patients if they were younger than 65 years or treated by non-oncologists, or had high CCIS, medium to high individual SES, and survival of less than 6 months after diagnosis.	[Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chang, Ting-Shou] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Wu, Cheng-Jung] Taipei Med Univ, Shung Ho Hosp, Dept Otolaryngol, Taipei, Taiwan; [Yang, Ching-Chieh] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Chen, Po-Chun] Pingtung Christian Hosp, Dept Radiat Oncol, Pingtung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Kaohsiung Veterans General Hospital; Taipei Medical University; Chi Mei Hospital	Chen, PC (corresponding author), Pingtung Christian Hosp, Dept Radiat Oncol, Pingtung, Taiwan.	salmon901@hotmail.com						Al-Refaie WB, 2012, J AM COLL SURGEONS, V214, P81, DOI 10.1016/j.jamcollsurg.2011.10.003; Amonkar Mayur M, 2011, J Med Econ, V14, P421, DOI 10.3111/13696998.2011.584096; Boje CR, 2013, ACTA ONCOL, V52, P285, DOI 10.3109/0284186X.2012.742964; Chang TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073889; Chen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065077; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fiorentino A, 2013, CLIN TRANSL ONCOL, V15, P665, DOI 10.1007/s12094-012-0986-9; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim K, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-47; Kong AL, 2011, ANN SURG ONCOL, V18, P3220, DOI 10.1245/s10434-011-2001-z; Lang K, 2004, ARCH OTOLARYNGOL, V130, P1269, DOI 10.1001/archotol.130.11.1269; Lee Y, 1996, J ROY STAT SOC B MET, V58, P619; Lin CC, 2008, SURGERY, V143, P343, DOI 10.1016/j.surg.2007.09.033; Nao EEM, 2011, EUR ANN OTORHINOLARY, V128, P47, DOI 10.1016/j.anorl.2010.12.001; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Rietjens JAC, 2012, SOC SCI MED, V74, P1282, DOI 10.1016/j.socscimed.2011.12.046; Setoguchi S, 2008, J CLIN ONCOL, V26, P5671, DOI 10.1200/JCO.2008.16.3956; Singh B, 1998, HEAD NECK-J SCI SPEC, V20, P1; Stryhn H, 2014, PREV VET MED, V113, P304, DOI 10.1016/j.prevetmed.2013.10.001; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096	25	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126482	10.1371/journal.pone.0126482	http://dx.doi.org/10.1371/journal.pone.0126482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946011	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700134
J	Li, QX; Jia, ZQ; Zhu, YJ; Wang, YS; Li, H; Yang, DF; Zhao, XB				Li, Qingxue; Jia, Zhiqing; Zhu, Yajuan; Wang, Yongsheng; Li, Hong; Yang, Defu; Zhao, Xuebin			Spatial Heterogeneity of Soil Nutrients after the Establishment of Caragana intermedia Plantation on Sand Dunes in Alpine Sandy Land of the Tibet Plateau	PLOS ONE			English	Article							MICROBIOLOGICAL PROPERTIES; RETAMA SPHAEROCARPA; CHIHUAHUAN DESERT; LEGUMINOUS SHRUB; TENGGER DESERT; MICROPHYLLA; VEGETATION; GRASSLAND; CANOPY; DIVERSITY	The Gonghe Basin region of the Tibet Plateau is severely affected by desertification. Compared with other desertified land, the main features of this region is windy, cold and short growing season, resulting in relatively difficult for vegetation restoration. In this harsh environment, identification the spatial distribution of soil nutrients and analysis its impact factors after vegetation establishment will be helpful for understanding the ecological relationship between soil and environment. Therefore, in this study, the 12-year-old C. intermediaplantation on sand dunes was selected as the experimental site. Soil samples were collected under and between shrubs on the windward slopes, dune tops and leeward slopes with different soil depth. Then analyzed soil organic matter (SOM), total nitrogen (TN), total phosphorus (TP), total potassium (TK), available nitrogen (AN), available phosphorus (AP) and available potassium (AK). The results showed that the spatial heterogeneity of soil nutrients was existed in C. intermedia plantation on sand dunes. (1) Depth was the most important impact factor, soil nutrients were decreased with greater soil depth. One of the possible reasons is that windblown fine materials and litters were accumulated on surface soil, when they were decomposed, more nutrients were aggregated on surface soil. (2) Topography also affected the distribution of soil nutrients, more soil nutrients distributed on windward slopes. The herbaceous coverage were higher and C. intermedia ground diameter were larger on windward slopes, both of them probably related to the high soil nutrients level for windward slopes. (3) Soil "fertile islands" were formed, and the "fertile islands" were more marked on lower soil nutrients level topography positions, while it decreased towards higher soil nutrients level topography positions. The enrichment ratio (E) for TN and AN were higher than other nutrients, most likely because C. intermediais a leguminous shrub.	[Li, Qingxue; Jia, Zhiqing; Zhu, Yajuan; Wang, Yongsheng] Chinese Acad Forestry, Inst Desertificat Studies, Beijing 100091, Peoples R China; [Li, Hong] Chinese Acad Forestry, Res Inst Forestry, Beijing 100091, Peoples R China; [Yang, Defu; Zhao, Xuebin] Sand Control Expt Stn Qinghai Prov, Gonghe 813005, Qinghai, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Jia, ZQ (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing 100091, Peoples R China.	jiazq369@caf.ac.cn			National Science & Technology Pillar Program during the Twelfth Five-year Plan [2012BAD16B0102]; Forestry Public Benefit Scientific Research Special Project of P.R.China [201204203]	National Science & Technology Pillar Program during the Twelfth Five-year Plan; Forestry Public Benefit Scientific Research Special Project of P.R.China	This research was supported by the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period: Excellent sand-fixation plant materials selecting and matching techniques researching (2012BAD16B0102); and the Forestry Public Benefit Scientific Research Special Project of P.R.China (201204203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2004, OECOLOGIA, V139, P277, DOI 10.1007/s00442-004-1499-1; Bhark EW, 2003, ECOSYSTEMS, V6, P185, DOI 10.1007/s10021-002-0210-9; Cao CY, 2008, APPL SOIL ECOL, V40, P78, DOI 10.1016/j.apsoil.2008.03.008; Cao CY, 2011, ECOL ENG, V37, P1467, DOI 10.1016/j.ecoleng.2011.03.012; Chen BM, 2007, J INTEGR PLANT BIOL, V49, P1537, DOI 10.1111/j.1774-7909.2007.00531.x; Doblas-Miranda E, 2009, APPL SOIL ECOL, V41, P329, DOI 10.1016/j.apsoil.2008.12.008; Dong XW, 2009, PLANT SOIL ENVIRON, V55, P288, DOI 10.17221/13/2009-PSE; El-Bana MI, 2002, PLANT SOIL, V247, P283, DOI 10.1023/A:1021548711206; Fu KJ, 1993, FLORA; Gao LF, 2002, LETT APPL MICROBIOL, V35, P347, DOI 10.1046/j.1472-765X.2002.01192.x; Gei MG, 2013, SOIL BIOL BIOCHEM, V57, P264, DOI 10.1016/j.soilbio.2012.09.013; Huang Gang, 2007, Scientia Silvae Sinicae, V43, P138; Institute of Soil Sciences Chinese Academy of Sciences (ISSCAS), 1978, PHYS CHEM AN METH SO; Isselin-Nondedeu F, 2007, CATENA, V71, P330, DOI 10.1016/j.catena.2007.02.001; Jia ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045902; Li CJ, 2010, J ARID LAND, V2, P257, DOI 10.3724/SP.J.1227.2010.00257; Li PX, 2008, J ARID ENVIRON, V72, P953, DOI 10.1016/j.jaridenv.2007.11.004; Li XR, 2004, RESTOR ECOL, V12, P376, DOI 10.1111/j.1061-2971.2004.00313.x; Lu SL, 1996, FLORA QINGHAIICA; Maestre FT, 2003, ECOSYSTEMS, V6, P630, DOI 10.1007/s10021-002-0222-5; MartinezMeza E, 1996, J ARID ENVIRON, V32, P271, DOI 10.1006/jare.1996.0023; Moro MJ, 1997, FUNCT ECOL, V11, P425, DOI 10.1046/j.1365-2435.1997.00106.x; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Pugnaire FI, 1996, OIKOS, V76, P455, DOI 10.2307/3546339; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Sebastia MT, 2004, BASIC APPL ECOL, V5, P331, DOI 10.1016/j.baae.2003.10.001; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; Su YZ, 2005, ENVIRON MANAGE, V36, P272, DOI 10.1007/s00267-004-4083-x; Titus JH, 2002, J ARID ENVIRON, V52, P269, DOI 10.1006/jare.2002.1010; Wang XP, 2006, ECOL RES, V21, P415, DOI 10.1007/s11284-005-0135-9; Xie GH, 2001, SOIL BIOL BIOCHEM, V33, P1371, DOI 10.1016/S0038-0717(01)00042-6; Yang ZP, 2011, J ARID ENVIRON, V75, P538, DOI 10.1016/j.jaridenv.2011.01.007; Zhang DS, 2009, SANDY DESERTIFICATIO, P39; Zhang PJ, 2011, PLANT SOIL, V347, P79, DOI 10.1007/s11104-011-0813-z; Zuo XA, 2009, PLANT SOIL, V318, P153, DOI 10.1007/s11104-008-9826-7	36	16	20	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124456	10.1371/journal.pone.0124456	http://dx.doi.org/10.1371/journal.pone.0124456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946170	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700043
J	Lubker, C; Seifert, R				Luebker, Carolin; Seifert, Roland			Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; CALCIUM-DEPENDENT ACTIVATOR; LONG-TERM POTENTIATION; RAT-BRAIN; PHYSIOLOGICAL ROLES; TRANSPORT ATPASE; STRUCTURAL BASIS; MUTANT MICE; ANTAGONISTS; INHIBITION	Adenylyl cyclases (ACs) catalyze the conversion of ATP into the second messenger cAMP. Membranous AC1 (AC1) is involved in processes of memory and learning and in muscle pain. The AC toxin edema factor (EF) of Bacillus anthracis is involved in the development of anthrax. Both ACs are stimulated by the eukaryotic Ca2+-sensor calmodulin (CaM). The CaM-AC interaction could constitute a potential target to enhance or impair the AC activity of AC1 and EF to intervene in above (patho)physiological mechanisms. Thus, we analyzed the impact of 39 compounds including typical CaM-inhibitors, an anticonvulsant, an anticholinergic, antidepressants, antipsychotics and Ca2+-antagonists on CaM-stimulated catalytic activity of AC1 and EF. Compounds were tested at 10 mu M, i.e., a concentration that can be reached therapeutically for certain antidepressants and antipsychotics. Calmidazolium chloride decreased CaM-stimulated AC1 activity moderately by about 30%. In contrast, CaM-stimulated EF activity was abrogated by calmidazolium chloride and additionally decreased by chlorpromazine, felodipine, penfluridol and trifluoperazine by about 20-40%. The activity of both ACs was decreased by calmidazolium chloride in the presence and absence of CaM. Thus, CaM-stimulated AC1 activity is more insensitive to inhibition by small molecules than CaM-stimulated EF activity. Inhibition of AC1 and EF by calmidazolium chloride is largely mediated via a CaM-independent allosteric mechanism.	[Luebker, Carolin; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany	Hannover Medical School	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Seifert, Roland/G-3189-2013					AHLIJANIAN MK, 1987, J PHARMACOL EXP THER, V241, P407; ANDERSON KW, 1984, J BIOL CHEM, V259, P1487; Appl H, 2012, N-S ARCH PHARMACOL, V385, P145, DOI 10.1007/s00210-011-0704-0; Bartlett RK, 2003, BIOCHEMISTRY-US, V42, P3231, DOI 10.1021/bi026956z; BOSTROM SL, 1981, NATURE, V292, P777, DOI 10.1038/292777a0; BROSTROM CO, 1977, J BIOL CHEM, V252, P5677; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Cervetto C, 2012, NEUROCHEM INT, V60, P768, DOI 10.1016/j.neuint.2012.02.034; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Diel S, 2008, BIOCHEM J, V411, P449, DOI 10.1042/BJ20071204; Dikici E, 2008, ANAL BIOANAL CHEM, V390, P2073, DOI 10.1007/s00216-008-1983-2; Douglass PM, 2002, BIOCONJUGATE CHEM, V13, P1186, DOI 10.1021/bc010080b; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Erdorf M, 2011, N-S ARCH PHARMACOL, V383, P357, DOI 10.1007/s00210-011-0600-7; GIETZEN K, 1981, BIOCHEM BIOPH RES CO, V101, P418, DOI 10.1016/0006-291X(81)91276-6; GIETZEN K, 1980, BIOCHEM BIOPH RES CO, V94, P674, DOI 10.1016/0006-291X(80)91285-1; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Guo Q, 2004, J BIOL CHEM, V279, P29427, DOI 10.1074/jbc.M402689200; HARDMAN JG, 1971, ANNU REV PHYSIOL, V33, P311, DOI 10.1146/annurev.ph.33.030171.001523; Haunso A, 2003, MOL PHARMACOL, V63, P624, DOI 10.1124/mol.63.3.624; Hicks CW, 2012, INTENS CARE MED, V38, P1092, DOI 10.1007/s00134-012-2541-0; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; HIDAKA H, 1979, MOL PHARMACOL, V15, P49; Hodneland CD, 2002, P NATL ACAD SCI USA, V99, P5048, DOI 10.1073/pnas.072685299; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hu BA, 2002, J BIOL CHEM, V277, P33139, DOI 10.1074/jbc.M112373200; ITOH H, 1984, J BIOCHEM-TOKYO, V96, P1721, DOI 10.1093/oxfordjournals.jbchem.a135004; James LR, 2009, BRIT J PHARMACOL, V158, P1454, DOI 10.1111/j.1476-5381.2009.00416.x; Jaszczyszyn A, 2012, PHARMACOL REP, V64, P16, DOI 10.1016/S1734-1140(12)70726-0; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; KAKIUCHI S, 1968, MOL PHARMACOL, V4, P367; Khan SZ, 2000, BIOCHEM PHARMACOL, V60, P1797, DOI 10.1016/S0006-2952(00)00505-0; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; Lee YS, 2004, CHEM BIOL, V11, P1139, DOI 10.1016/j.chembiol.2004.05.020; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEVIN RM, 1979, J PHARMACOL EXP THER, V208, P454; LEVIN RM, 1976, MOL PHARMACOL, V12, P581; LEVIN RM, 1977, MOL PHARMACOL, V13, P690; LEVIN RM, 1978, BIOCHIM BIOPHYS ACTA, V540, P197, DOI 10.1016/0304-4165(78)90132-0; Liao WC, 2009, ARCH TOXICOL, V83, P61, DOI 10.1007/s00204-008-0328-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masada N, 2009, J BIOL CHEM, V284, P4451, DOI 10.1074/jbc.M807359200; McElroy SP, 2009, CELL CALCIUM, V46, P99, DOI 10.1016/j.ceca.2009.05.006; Michel MC, 2015, AM J PHYSL CELL PHYS; MILLER RJ, 1974, J PHARM PHARMACOL, V26, P142, DOI 10.1111/j.2042-7158.1974.tb09243.x; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; NORMAN JA, 1979, MOL PHARMACOL, V16, P1089; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Post SR, 1999, ANNU REV PHARMACOL, V39, P343, DOI 10.1146/annurev.pharmtox.39.1.343; RAESS BU, 1980, MOL PHARMACOL, V18, P253; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Schimmer B P, 1979, Methods Enzymol, V58, P570; Schuler D, 2012, BIOCHEM PHARMACOL, V83, P839, DOI 10.1016/j.bcp.2012.01.005; Seifert R, 1998, EUR J BIOCHEM, V255, P369, DOI 10.1046/j.1432-1327.1998.2550369.x; Seifert R, 2013, PHARMACOL THERAPEUT, V140, P200, DOI 10.1016/j.pharmthera.2013.07.002; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Shen YQ, 2004, P NATL ACAD SCI USA, V101, P3242, DOI 10.1073/pnas.0306552101; Shen YQ, 2002, EMBO J, V21, P6721, DOI 10.1093/emboj/cdf681; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Soelaiman S, 2003, J BIOL CHEM, V278, P25990, DOI 10.1074/jbc.M301232200; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Taha HM, 2009, MOL PHARMACOL, V75, P693, DOI 10.1124/mol.108.052340; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Tzavara ET, 1996, P NATL ACAD SCI USA, V93, P11208, DOI 10.1073/pnas.93.20.11208; UZUNOV P, 1971, NEUROPHARMACOLOGY, V10, P697, DOI 10.1016/0028-3908(71)90084-0; Vadakkan KI, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-7; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; VOLPI M, 1981, P NATL ACAD SCI-BIOL, V78, P795, DOI 10.1073/pnas.78.2.795; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; WEISS B, 1982, BIOCHEM PHARMACOL, V31, P2217, DOI 10.1016/0006-2952(82)90104-6; Weiss B, 1978, Adv Cyclic Nucleotide Res, V9, P285; Weiss B, 1980, Ann N Y Acad Sci, V356, P319, DOI 10.1111/j.1749-6632.1980.tb29621.x; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; ZIMMER M, 1984, EUR J BIOCHEM, V142, P393, DOI 10.1111/j.1432-1033.1984.tb08300.x	84	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124017	10.1371/journal.pone.0124017	http://dx.doi.org/10.1371/journal.pone.0124017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946093	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700029
J	Oluwagbemigun, K; Dietrich, T; Pischon, N; Bergmann, M; Boeing, H				Oluwagbemigun, Kolade; Dietrich, Thomas; Pischon, Nicole; Bergmann, Manuela; Boeing, Heiner			Association between Number of Teeth and Chronic Systemic Diseases: A Cohort Study Followed for 13 Years	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE; PERIODONTAL-DISEASE; TOOTH LOSS; EPIC-GERMANY; RISK; HEALTH; CANCER; POPULATION; INFECTION	Background There is growing evidence of an association between oral health, specifically dental status, and chronic systemic diseases. However, varying measures of dental status across different populations and low study sample has made comparison of studies and conclusion of findings unclear. Our aim is to examine whether the number of teeth as a measure of dental status is associated with incident chronic diseases in a cohort setting. Methods We conducted a cohort study among 24,313 middle-aged Germans followed up for 13 years. Data on number of teeth as a measure of dental status were obtained through self-reports. Outcomes were clinically-verified incident non-fatal myocardial infarction, stroke, type 2 diabetes mellitus, and cancer. Hazard ratio (HR) and 95% confidence intervals (CI) were obtained from Cox regression models. Results Increasing number of teeth is inversely related to risk of myocardial infarction (HR: 0.97; 95% CI: 0.96, 0.99). The full multivariate model of teeth groups showed a strong linear trend for myocardial infarction, a less strong trend for stroke, and no relation with type 2 diabetes mellitus and cancer in a competing risk model. Participants with 18-23 teeth and those without teeth were at 76% (95% CI: 1.04, 3) and 2.93 times (95% CI: 1.61, 5.18) higher risk of myocardial infarction compared to those with nearly all teeth (28-32 teeth). Conclusions Number of teeth is specifically associated with myocardial infarction and not with other chronic disease indicating that dental status further strengthens the link between oral health and cardiovascular diseases.	[Oluwagbemigun, Kolade; Bergmann, Manuela; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Dietrich, Thomas] Univ Birmingham, Sch Dent, Dept Oral Surg, Birmingham, W Midlands, England; [Pischon, Nicole] Charite, Dept Periodontol, D-13353 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Birmingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Oluwagbemigun, K (corresponding author), German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany.	Kolade.Oluwagbemigun@dife.de	Oluwagbemigun, Kolade/AAV-2041-2021	Oluwagbemigun, Kolade/0000-0002-9454-5970; Dietrich, Thomas/0000-0002-2557-7645	German Federal Ministry of Science [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-HaI]; European Community [SOC 98200769 05F02]; European Union FP7-PEOPLE grant [290246]	German Federal Ministry of Science; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); European Union FP7-PEOPLE grant	The recruitment part of the EPIC-Potsdam Study was supported by the German Federal Ministry of Science (01 EA 9401) and the European Union (SOC 95201408 05F02) while the follow-up was supported by the German Cancer Aid (70-2488-HaI) and the European Community (SOC 98200769 05F02). KO is supported by the European Union FP7-PEOPLE grant (project reference: 290246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai T, ASS TOOTH LOSS CANC, DOI [10.5772/35259.2012;53-66, DOI 10.5772/35259.2012;53-66]; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Cabrera C, 2005, EUR J EPIDEMIOL, V20, P229, DOI 10.1007/s10654-004-5961-5; Demmer RT, 2012, DIABETES CARE, V35, P2036, DOI 10.2337/dc11-2453; Dietrich T, 2007, J PERIODONTOL, V78, P1421, DOI 10.1902/jop.2007.060212; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Dietrich T, 2013, J CLIN PERIODONTOL, V40, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Heitmann BL, 2008, PREV MED, V47, P156, DOI 10.1016/j.ypmed.2008.04.007; Hiraki A, 2008, CANCER EPIDEM BIOMAR, V17, P1222, DOI 10.1158/1055-9965.EPI-07-2761; Holmlund A, 2012, J PERIODONTOL, V83, P287, DOI 10.1902/jop.2011.110100; Holmlund A, 2010, J PERIODONTOL, V81, P870, DOI 10.1902/jop.2010.090680; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Hung HC, 2004, J PUBLIC HEALTH DENT, V64, P209, DOI 10.1111/j.1752-7325.2004.tb02755.x; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; Listl S, 2014, AM J PUBLIC HEALTH, V104, pE55, DOI 10.2105/AJPH.2014.301918; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Mitsuyoshi Y, 2011, JPN DENT SCI REV, V47, P157, DOI 10.1016/j.jdsr.2011.01.001; Mohamed HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082158; Nibali L, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.22962; Ramos Renato Quirino, 2013, Rev. bras. epidemiol., V16, P716, DOI 10.1590/S1415-790X2013000300015; Samani MK, 2013, CASP J INTERN MED, V4, P667; Schenkein HA, 2013, J CLIN PERIODONTOL, V40, pS51, DOI [10.1111/jcpe.12060, 10.1902/jop.2013.134006]; Sim SJ, 2008, J PERIODONTOL, V79, P1652, DOI [10.1902/jop.2008.080015, 10.1902/jop.2008.080015 ]; Slots J, 1998, J DENT RES, V77, P1764, DOI 10.1177/00220345980770100101; Syrjala AMH, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-6; Bui TC, 2013, CANCER PREV RES, V6, P917, DOI 10.1158/1940-6207.CAPR-13-0081; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tu YK, 2008, HEART, V94, P368; Unell L, 1997, ACTA ODONTOL SCAND, V55, P127, DOI 10.3109/00016359709115404; Vedin O, 2014, EUR J PREV CARDIOL; Watt RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030797; Wiener RC, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/421567	37	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123879	10.1371/journal.pone.0123879	http://dx.doi.org/10.1371/journal.pone.0123879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945503	Green Published, gold			2022-12-26	WOS:000354049700023
J	Rodil, IF; Jaramillo, E; Hubbard, DM; Dugan, JE; Melnick, D; Velasquez, C				Rodil, Ivan F.; Jaramillo, Eduardo; Hubbard, David M.; Dugan, Jenifer E.; Melnick, Daniel; Velasquez, Carlos			Responses of Dune Plant Communities to Continental Uplift from a Major Earthquake: Sudden Releases from Coastal Squeeze	PLOS ONE			English	Article							SAND DUNES; SALT SPRAY; VEGETATION; CHILE; ZONATION; HABITAT; HISTORY	Vegetated dunes are recognized as important natural barriers that shelter inland ecosystems and coastlines suffering daily erosive impacts of the sea and extreme events, such as tsunamis. However, societal responses to erosion and shoreline retreat often result in man-made coastal defence structures that cover part of the intertidal and upper shore zones causing coastal squeeze and habitat loss, especially for upper shore biota, such as dune plants. Coseismic uplift of up to 2.0 m on the Peninsula de Arauco (South central Chile, ca. 37.5 degrees S) caused by the 2010 Maule earthquake drastically modified the coastal landscape, including major increases in the width of uplifted beaches and the immediate conversion of mid to low sandy intertidal habitat to supralittoral sandy habitat above the reach of average tides and waves. To investigate the early stage responses in species richness, cover and across-shore distribution of the hitherto absent dune plants, we surveyed two formerly intertidal armoured sites and a nearby intertidal unarmoured site on a sandy beach located on the uplifted coast of Llico (Peninsula de Arauco) over two years. Almost 2 years after the 2010 earthquake, dune plants began to recruit, then rapidly grew and produced dune hummocks in the new upper beach habitats created by uplift at the three sites. Initial vegetation responses were very similar among sites. However, over the course of the study, the emerging vegetated dunes of the armoured sites suffered a slowdown in the development of the spatial distribution process, and remained impoverished in species richness and cover compared to the unarmoured site. Our results suggest that when released from the effects of coastal squeeze, vegetated dunes can recover without restoration actions. However, subsequent human activities and management of newly created beach and dune habitats can significantly alter the trajectory of vegetated dune development. Management that integrates the effects of natural and human induced disturbances, and promotes the development of dune vegetation as natural barriers can provide societal and conservation benefits in coastal ecosystems.	[Rodil, Ivan F.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal; [Jaramillo, Eduardo; Velasquez, Carlos] Univ Austral Chile, Fac Ciencias, Valdivia, Chile; [Hubbard, David M.; Dugan, Jenifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Melnick, Daniel] Univ Potsdam, Inst Erd & Umweltwissensch, Potsdam, Germany	Universidade do Porto; Universidad Austral de Chile; University of California System; University of California Santa Barbara; University of Potsdam	Rodil, IF (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ifrodil@gmail.com	Melnick, Daniel/G-8484-2011; Rodil, Iván F./I-5305-2013	Melnick, Daniel/0000-0001-8397-7391; Rodil, Iván F./0000-0001-6375-1598; Velasquez Gallardo, Carlos Felipe/0000-0002-5726-5136	CONICYT Chile (National Commission for Science) through Proyectos Fondecyt [1090650, 1121043]; Santa Barbara Coastal LTER; National Science Foundation [OCE-0620276]; Division Of Ocean Sciences [1232779] Funding Source: National Science Foundation	CONICYT Chile (National Commission for Science) through Proyectos Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Santa Barbara Coastal LTER; National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by CONICYT Chile (National Commission for Science, Chile; www.conicyt.cl) through Proyectos Fondecyt 1090650 and 1121043 granted to EJ. Support for JED was provided by The Santa Barbara Coastal LTER funded by the National Science Foundation (award no. OCE-0620276). IFR is a postdoctoral fellow from the Portuguese Foundation for Science and Technology-FCT (SFRH/BPD/87042/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2014, R LANG ENV STAT COMP; BARBOUR MG, 1977, B TORREY BOT CLUB, V104, P29, DOI 10.2307/2484662; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown AC, 2001, ENCY OCEAN SCI, V5, P2496; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Campbell LM, 2009, ECOL SOC, V14; Castilla JC, 2010, MAR ECOL PROG SER, V418, P17, DOI 10.3354/meps08830; Charlier RH, 2005, J COASTAL RES, V21, P79, DOI 10.2112/03561.1; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DOING H, 1985, VEGETATIO, V61, P65, DOI 10.1007/BF00039811; Dugan J.E., 2006, SHORE BEACH, V74, P10, DOI DOI 10.1111/J.1439-0485.2008.00231.X; Dugan JE, TREATISE ESTUARINE C, V8, P17; Dugan JE, 2008, MAR ECOL-EVOL PERSP, V29, P160, DOI 10.1111/j.1439-0485.2008.00231.x; Dugan JE, 2010, ESTUAR COAST, V33, P67, DOI 10.1007/s12237-009-9239-8; Duran O, 2013, P NATL ACAD SCI USA, V110, P17217, DOI 10.1073/pnas.1307580110; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Farris E, 2013, PLANT BIOSYST, V147, P931, DOI [10.1080/11263504.2013.861540, 10.1080/11263504.2013.778911]; Feagin RA, 2001, FRONT ECOL ENVIRON, V3, P359; Fenu G, 2013, FLORA, V208, P104, DOI 10.1016/j.flora.2013.02.003; Figueroa JA, 2004, REV CHIL HIST NAT, V77, P465; Frederiksen L, 2006, PHYTOCOENOLOGIA, V36, P321, DOI 10.1127/0340-269X/2006/0036-0321; HALL MJ, 1991, J COASTAL RES, V7, P771; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Liu PLF, 2005, SCIENCE, V308, P1595, DOI 10.1126/science.1110730; Long ZT, 2013, J COAST CONSERV, V17, P493, DOI 10.1007/s11852-013-0249-0; Looney PB, 1995, J VEG SCI, V6, P825, DOI 10.2307/3236396; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Mascarenhas A, 2008, J ENVIRON MANAGE, V89, P24, DOI 10.1016/j.jenvman.2007.01.053; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Melnick D, 2012, QUATERNARY SCI REV, V42, P29, DOI 10.1016/j.quascirev.2012.03.012; Miller TE, 2010, PLANT ECOL, V206, P97, DOI 10.1007/s11258-009-9626-z; Moreno M, 2012, EARTH PLANET SC LETT, V305, P413; MORENOCASASOLA P, 1988, J BIOGEOGR, V15, P787, DOI 10.2307/2845340; Nordstrom K.F, 2000, BEACHES DUNES DEV CO; Nordstrom KF, 2014, ESTUAR COAST SHELF S, V150, P11, DOI 10.1016/j.ecss.2013.11.003; RICKARD CA, 1994, OCEAN COAST MANAGE, V23, P225, DOI 10.1016/0964-5691(94)90021-3; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; SYKES MT, 1991, J VEG SCI, V2, P531, DOI 10.2307/3236035; THILENIUS JF, 1990, FOREST ECOL MANAG, V33-4, P439, DOI 10.1016/0378-1127(90)90209-T; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vargas G, 2011, ANDEAN GEOL, V38, P219, DOI 10.5027/andgeoV38n1-a12; Walker SJ, 2008, ESTUAR COAST SHELF S, V79, P24, DOI 10.1016/j.ecss.2008.03.011; Wilson JB, 1999, ECOL LETT, V2, P233; Witmer AD, 2014, OCEAN COAST MANAGE, V87, P52, DOI 10.1016/j.ocecoaman.2013.11.005	49	12	12	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124334	10.1371/journal.pone.0124334	http://dx.doi.org/10.1371/journal.pone.0124334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946057	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700040
J	Cozzi, R; Malito, E; Lazzarin, M; Nuccitelli, A; Castagnetti, A; Bottomley, MJ; Margarit, I; Maione, D; Rinaudo, CD				Cozzi, Roberta; Malito, Enrico; Lazzarin, Maddalena; Nuccitelli, Annalisa; Castagnetti, Andrea; Bottomley, Matthew J.; Margarit, Immaculada; Maione, Domenico; Rinaudo, C. Daniela			Structure and Assembly of Group B Streptococcus Pilus 2b Backbone Protein	PLOS ONE			English	Article							MAJOR PILIN PROTEIN; ISOPEPTIDE BONDS; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; MOLECULAR-REPLACEMENT; CRYSTAL-STRUCTURE; IDENTIFICATION; ADHESIN; SURFACE; COLONIZATION	Group B Streptococcus (GBS) is a major cause of invasive disease in infants. Like other Gram-positive bacteria, GBS uses a sortase C-catalyzed transpeptidation mechanism to generate cell surface pili from backbone and ancillary pilin precursor substrates. The three pilus types identified in GBS contain structural subunits that are highly immunogenic and are promising candidates for the development of a broadly-protective vaccine. Here we report the X-ray crystal structure of the backbone protein of pilus 2b (BP-2b) at 1.06 angstrom resolution. The structure reveals a classical IgG-like fold typical of the pilin subunits of other Gram-positive bacteria. The crystallized portion of the protein (residues 185-468) encompasses domains D2 and D3 that together confer high stability to the protein due to the presence of an internal isopeptide bond within each domain. The D2+D3 region, lacking the N-terminal D1 domain, was as potent as the entire protein in conferring protection against GBS challenge in a well-established mouse model. By site-directed mutagenesis and complementation studies in GBS knock-out strains we identified the residues and motives essential for assembly of the BP-2b monomers into high-molecular weight complexes, thus providing new insights into pilus 2b polymerization.	[Cozzi, Roberta; Malito, Enrico; Lazzarin, Maddalena; Nuccitelli, Annalisa; Castagnetti, Andrea; Bottomley, Matthew J.; Margarit, Immaculada; Maione, Domenico; Rinaudo, C. Daniela] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	Rinaudo, CD (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	daniela.rinaudo@novartis.com			Novartis Vaccines	Novartis Vaccines	This work was supported by internal funding from Novartis Vaccines. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adderson EE, 2003, INFECT IMMUN, V71, P6857, DOI 10.1128/IAI.71.12.6857-6863.2003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker CJ, 2013, VACCINE, V31, pD3, DOI 10.1016/j.vaccine.2013.02.030; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Cozzi R, 2012, FASEB J, V26, P2008, DOI 10.1096/fj.11-196378; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gentile MA, 2011, J BIOL CHEM, V286, P14588, DOI 10.1074/jbc.M110.202739; Hagan RM, 2010, ANGEW CHEM INT EDIT, V49, P8421, DOI 10.1002/anie.201004340; Harding MM, 2010, CRYSTALLOGRAPHY REVI; Heath PT, 2007, BEST PRACT RES CL OB, V21, P411, DOI 10.1016/j.bpobgyn.2007.01.003; Hendrickx APA, 2012, MOL MICROBIOL, V85, P152, DOI 10.1111/j.1365-2958.2012.08098.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2014, ACTA CRYSTALLOGR D, V70, P1190, DOI 10.1107/S1399004714001400; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Khare B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022995; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krishnan V, 2013, ACTA CRYSTALLOGR D, V69, P1073, DOI 10.1107/S0907444913004642; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; MCLENDON G, 1978, J BIOL CHEM, V253, P6335; Mishra A, 2011, MOL MICROBIOL, V81, P1205, DOI 10.1111/j.1365-2958.2011.07745.x; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Papasergi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018747; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Persson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048364; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Sorensen UBS, 2010, MBIO, V1, DOI 10.1128/mBio.00178-10; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	68	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125875	10.1371/journal.pone.0125875	http://dx.doi.org/10.1371/journal.pone.0125875			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942637	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400054
J	Lee, PY; Liew, SM; Abdullah, A; Abdullah, N; Ng, CJ; Hanafi, NS; Chia, YC; Lai, PSM; Wong, SSL; Khoo, EM				Lee, Ping Yein; Liew, Su May; Abdullah, Adina; Abdullah, Nurdiana; Ng, Chirk Jenn; Hanafi, Nik Sherina; Chia, Yook Chin; Lai, Pauline S. M.; Wong, Stalia S. L.; Khoo, Ee Ming			Healthcare Professionals' and Policy Makers' Views on Implementing a Clinical Practice Guideline of Hypertension Management: A Qualitative Study	PLOS ONE			English	Article							GPS ATTITUDES	Introduction Most studies have reported barriers to guideline usage mainly from doctors' perspective; few have reported the perspective of other stakeholders. This study aimed to determine the views and barriers to adherence of a national clinical practice guideline (CPG) on management of hypertension from the perspectives of policymakers, doctors and allied healthcare professionals. Methods This study used a qualitative approach with purposive sampling. Seven in depth interviews and six focus group discussions were conducted with 35 healthcare professionals (policy makers, doctors, pharmacists and nurses) at a teaching hospital in Kuala Lumpur, Malaysia, between February and June 2013. All interviews were audio-recorded, transcribed verbatim and checked. Thematic approach was used to analyse the data. Results Two main themes and three sub-themes emerged from this study. The main themes were (1) variation in the use of CPG and (2) barriers to adherence to CPG. The three sub-themes for barriers were issues inherent to the CPG, systems and policy that is not supportive of CPG use, and attitudes and behaviour of stakeholders. The main users of the CPG were the primary care doctors. Pharmacists only partially use the guidelines, while nurses and policy makers were not using the CPG at all. Participants had suggested few strategies to improve usage and adherence to CPG. First, update the CPG regularly and keep its content simple with specific sections for allied health workers. Second, use technology to facilitate CPG accessibility and provide protected time for implementation of CPG recommendations. Third, incorporate local CPG in professional training, link CPG adherence to key performance indicators and provide incentives for its use. Conclusions Barriers to the use of CPG hypertension management span across all stakeholders. The development and implementation of CPG focused mainly on doctors with lack of involvement of other healthcare stakeholders. Guidelines should be made simple, current, reliable, accessible, inclusive of all stakeholders and with good policy support.	[Lee, Ping Yein] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia; [Liew, Su May; Abdullah, Adina; Abdullah, Nurdiana; Ng, Chirk Jenn; Hanafi, Nik Sherina; Chia, Yook Chin; Lai, Pauline S. M.; Khoo, Ee Ming] Univ Malaya, Fac Med, Dept Primary Care Med, Primary Care Res Grp, Kuala Lumpur, Malaysia; [Wong, Stalia S. L.] Klin Perubatan Keluarga SL Wong, Klang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Malaya	Khoo, EM (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, Primary Care Res Grp, Kuala Lumpur, Malaysia.	khooem@um.edu.my	abdullah, adina/E-1052-2014; NG, CHIRK JENN/C-1344-2010; Hanafi, Nik Sherina/B-9250-2010; Lee, Ping Yein/C-1923-2012; Abdullah, Adina/J-1647-2012; Chia, Yook Chin/L-2977-2019; Lai, Pauline Siew Mei/B-1031-2012; Abdullah, Nurdiana/AGZ-5524-2022; KHOO, EE MING/B-8785-2010; LIEW, Su May/B-8852-2010; Chin, Chia Yook/B-8379-2010	Hanafi, Nik Sherina/0000-0001-9140-0955; Lee, Ping Yein/0000-0002-0912-6043; Abdullah, Adina/0000-0003-1545-7110; Lai, Pauline Siew Mei/0000-0002-9940-9644; Abdullah, Nurdiana/0000-0002-6754-530X; KHOO, EE MING/0000-0003-3191-1264; LIEW, Su May/0000-0003-2865-7955; Chin, Chia Yook/0000-0003-1995-0359; Ng, Chirk Jenn/0000-0002-8320-1603	University of Malaya Research Grant (UMRG) [RG 335-11HTM, RG513-13HTM]	University of Malaya Research Grant (UMRG)	This study was funded by University of Malaya Research Grant (UMRG); grant number RG 335-11HTM, RG513-13HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson KA, 2012, AM J NURS, V112, P26, DOI 10.1097/01.NAJ.0000415957.46932.bf; [Anonymous], 2011, HYP CLIM MAN PRIM HY; Bloor M, 1997, CONTEXT METHOD QUALI, P37; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Carlsen B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-218; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Drouin D, 2010, ALLERGY ASTHMA CL S4, V6, pA10; Feldman RD, 2008, CAN J CARDIOL, V24, P477, DOI 10.1016/S0828-282X(08)70621-4; Fretheim A, 2006, PLOS MED, V3, P783, DOI 10.1371/journal.pmed.0030134; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Green LA, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-41; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kementerian Kesihatan Malaysia, 2018, CLIN PRACTICE GUIDEL, V5th Edition; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; McCormack T, 2013, BR J CARDIOL S1, V20, pS1; Mickan S, 2011, POSTGRAD MED J, V87, P670, DOI 10.1136/pgmj.2010.116012; Murphy E., 2003, QUALITATIVE METHODS; Pope C, 2000, QUALITATIVE RES HEAL; Rosenstock I. M., 1974, HLTH ED MONOGR, V2, P354, DOI DOI 10.1177/109019817400200405; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sola I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086065; Tuckett Anthony G, 2004, Nurse Res, V12, P47; Upshur REG, 2014, ANN FAM MED, V12, P202, DOI 10.1370/afm.1654; Watters WC, DEFIINING EVIDENCE B; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x	29	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126191	10.1371/journal.pone.0126191	http://dx.doi.org/10.1371/journal.pone.0126191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PT	25942686	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943400063
J	Lewandowski, D; Lewandowska, M; Ruszkowski, P; Pinska, A; Schroeder, G				Lewandowski, Dawid; Lewandowska, Marta; Ruszkowski, Piotr; Pinska, Anita; Schroeder, Grzegorz			Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity	PLOS ONE			English	Article							IN-VITRO; SURFACE FUNCTIONALIZATION; NUCLEOSIDE ANALOGS; CONTROLLED-RELEASE; PH; 5-FLUOROURACIL; NANOPARTICLES; ADSORPTION; AGENTS; VIVO	Novel zidovudine derivatives, able to be covalently conjugated to silica surface, have been obtained and grafted to SBA-15 mesoporous silica. Cytotoxic activity of the hybrid organic-inorganic (zidovudine derivatives-silica) systems against HeLa and KB cell lines has been analyzed. Addition of folic acid had a positive influence on the cytotoxicity. Up to 69% of HeLa and 65% of KB tumor cells growth inhibition has been achieved at low silica concentration used (10 mu g/mL).	[Lewandowski, Dawid; Lewandowska, Marta; Schroeder, Grzegorz] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland; [Ruszkowski, Piotr; Pinska, Anita] Poznan Univ Med Sci, Fac Pharm, Poznan, Poland	Adam Mickiewicz University; Poznan University of Medical Sciences	Lewandowski, D (corresponding author), Adam Mickiewicz Univ, Fac Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	dawid_le@amu.edu.pl		Schroeder, Grzegorz/0000-0002-6626-9542; Ruszkowski, Piotr/0000-0002-5106-8510	institution Narodowe Centrum Nauki (PL) [2011/03/B/ST5/01573]	institution Narodowe Centrum Nauki (PL)	Funding for this work came from the institution Narodowe Centrum Nauki (PL), www.ncn.gov.pl/, grant number: 2011/03/B/ST5/01573. The funding was received by author GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard F, 2009, CHEM REV, V109, P4207, DOI 10.1021/cr9001462; Bahrami Z, 2014, CHEM ENG RES DES, V92, P1296, DOI 10.1016/j.cherd.2013.11.007; Bernardos A, 2008, J CONTROL RELEASE, V131, P181, DOI 10.1016/j.jconrel.2008.07.037; Blumenthal, 2006, GOODMAN GILMANS PHAR; BRUNETTI I, 1990, CANCER RES, V50, P4026; Chen MJ, 2012, CHEM COMMUN, V48, P9522, DOI 10.1039/c2cc34290a; DARNOWSKI JW, 1994, BIOCHEM PHARMACOL, V48, P1797, DOI 10.1016/0006-2952(94)90466-9; Dauzonne D, 1997, EUR J MED CHEM, V32, P71, DOI 10.1016/S0223-5234(97)84363-2; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Fan JQ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455102; Galmarini CM, 2008, CURR MED CHEM, V15, P1072, DOI 10.2174/092986708784221449; Halamova D, 2012, J INCL PHENOM MACRO, V72, P15, DOI 10.1007/s10847-011-9990-x; Iyer VV, 2000, J MED CHEM, V43, P2266, DOI 10.1021/jm000110g; Jain N, 2013, J MOL STRUCT, V1036, P414, DOI 10.1016/j.molstruc.2012.10.063; Katiyar A, 2005, J CHROMATOGR A, V1069, P119, DOI 10.1016/j.chroma.2004.10.077; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Ma CM, 2005, EUR J MED CHEM, V40, P582, DOI 10.1016/j.ejmech.2005.01.001; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Miyahara M, 2006, THIN SOLID FILMS, V499, P13, DOI 10.1016/j.tsf.2005.07.046; Panda S, 2013, ASIAN J PHARM CLIN R, V6, P191; PERIGAUD C, 1992, NUCLEOS NUCLEOT NUCL, V11, P903, DOI 10.1080/07328319208021748; Raghavendra Rao NG, 2011, INT J PHARM BIO SCI, V2, P269; Rao KR, 2005, J MICROENCAPSUL, V22, P863, DOI 10.1080/02652040500273498; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sharma KK, 2008, J AM CHEM SOC, V130, P218, DOI 10.1021/ja074128t; Silaghi MC, 2014, MICROPOR MESOPOR MAT, V191, P82, DOI 10.1016/j.micromeso.2014.02.040; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u; Wagner CR, 2000, MED RES REV, V20, P417, DOI 10.1002/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z; Wani A, 2012, PHARM RES-DORDR, V29, P2407, DOI 10.1007/s11095-012-0766-9; Wannachaiyasit S, 2008, AAPS PHARMSCITECH, V9, P840, DOI 10.1208/s12249-008-9122-0; Weber CJ, 2013, SURGERY, V154, P1385, DOI 10.1016/j.surg.2013.06.045; Xia Y, 2000, BIOORG MED CHEM LETT, V10, P699, DOI 10.1016/S0960-894X(00)00072-X	36	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126251	10.1371/journal.pone.0126251	http://dx.doi.org/10.1371/journal.pone.0126251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942021	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943400065
J	Bi, FG; Shi, ZL; Liu, A; Guo, P; Yan, SG				Bi, Fanggang; Shi, Zhongli; Liu, An; Guo, Peng; Yan, Shigui			Anterior Cruciate Ligament Reconstruction in a Rabbit Model Using Silk-Collagen Scaffold and Comparison with Autograft	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; POLYMER FIBER SCAFFOLD; IN-VITRO EVALUATION; CROSS-LINKING; TENDON AUTOGRAFT; PATELLAR TENDON; HYBRID SCAFFOLD; REGENERATION; MATRIX; DESIGN	The objective of the present study was to perform an in vivo assessment of a novel silk-collagen scaffold for anterior cruciate ligament (ACL) reconstruction. First, a silk-collagen scaffold was fabricated by combining sericin-extracted knitted silk fibroin mesh and type I collagen to mimic the components of the ligament. Scaffolds were electron-beam sterilized and rolled up to replace the ACL in 20 rabbits in the scaffold group, and autologous semitendinosus tendons were used to reconstruct the ACL in the autograft control group. At 4 and 16 weeks after surgery, grafts were retrieved and analyzed for neoligament regeneration and tendon-bone healing. To evaluate neoligament regeneration, H&E and immunohistochemical staining was performed, and to assess tendon-bone healing, micro-CT, biomechanical test, H&E and Russell-Movat pentachrome staining were performed. Cell infiltration increased over time in the scaffold group, and abundant fibroblast-like cells were found in the core of the scaffold graft at 16 weeks postoperatively. Tenascin-C was strongly positive in newly regenerated tissue at 4 and 16 weeks postoperatively in the scaffold group, similar to observations in the autograft group. Compared with the autograft group, tendon-bone healing was better in the scaffold group with trabecular bone growth into the scaffold. The results indicate that the silk-collagen scaffold has considerable potential for clinical application.	[Bi, Fanggang; Shi, Zhongli; Liu, An; Guo, Peng; Yan, Shigui] Zhejiang Univ, Sch Med, Dept Orthoped Surg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yan, SG (corresponding author), Zhejiang Univ, Sch Med, Dept Orthoped Surg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	zjubfg@163.com	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Yan, Shigui/0000-0001-9096-2868; Guo, Peng/0000-0002-2006-6205	National Natural Science Foundation of China [81171687]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81171687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280; Bach BR, 1998, AM J SPORT MED, V26, P30, DOI 10.1177/03635465980260012201; Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682; Buma P, 2004, INT ORTHOP, V28, P91, DOI 10.1007/s00264-003-0515-0; Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011; Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120; Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017; Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014; Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104; Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893; Dong Y, 2012, INT J MOL SCI, V13, P13605, DOI 10.3390/ijms131013605; Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012; Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295; Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025; Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/0363546504272689; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020; Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030; James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16; Kaeding CC, 2011, SPORTS HEALTH, V3, P73, DOI 10.1177/1941738110386185; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073; Lee AJ, 2012, J SURG RES, V178, P206, DOI 10.1016/j.jss.2012.01.052; Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035; Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443; Little D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096526; Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050; Mackie EJ, 1996, J ANAT, V188, P157; Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203; Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y; Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062; Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039; Nistor MT, 2011, COLLOID SURFACE B, V87, P382, DOI 10.1016/j.colsurfb.2011.05.046; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]; Ouyang HW, 2004, AM J SPORT MED, V32, P321, DOI 10.1177/0095399703258682; Park MJ, 2001, INT ORTHOP, V25, P35, DOI 10.1007/s002640000199; Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Piontek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082462; Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292; Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91; Soon MYH, 2007, AM J SPORT MED, V35, P962, DOI 10.1177/0363546507300057; Torres DS, 2000, BIOMATERIALS, V21, P1607; Tovar N, 2012, J BIOMED MATER RES A, V100A, P2913, DOI 10.1002/jbm.a.34229; Walters VI, 2012, CONNECT TISSUE RES, V53, P255, DOI 10.3109/03008207.2011.634532; Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008; Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M; Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312; Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013	54	45	48	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125900	10.1371/journal.pone.0125900	http://dx.doi.org/10.1371/journal.pone.0125900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938408	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000114
J	Ning, WS; Shen, HH; Jin, YF; Yang, XZ				Ning, Wensheng; Shen, Hehong; Jin, Yangfu; Yang, Xiazhen			Effects of Weak Surface Modification on Co/SiO2 Catalyst for Fischer-Tropsch Reaction	PLOS ONE			English	Article							CAPSULE CATALYST; HYDROGENATION; SUPPORT	A weak surface modification is applied to Co/SiO2 catalyst by hydrothermal treatment at 180 degrees C for 5 h. Aluminum is introduced to Co/SiO2 catalysts during the surface modification. The effects of surface modification on Co/SiO2 catalyst are studied by changing the operating sequences of surface modification and cobalt impregnation in the catalyst preparation. Surface modification before cobalt impregnation makes Co3O4 particle small and dispersed into the deep part of enlarged pore in SiO2, while surface modification after cobalt impregnation does not obviously change the particle size of Co3O4. The improved amplitude of catalytic activity is similar for the two kinds of catalysts, but they are benefited from different factors. The content of iso-hydrocarbons in the products is increased by the surface modifications.	[Ning, Wensheng; Shen, Hehong; Yang, Xiazhen] Zhejiang Univ Technol, Coll Chem Engn, Hangzhou, Zhejiang, Peoples R China; [Jin, Yangfu] Zhejiang Univ Technol, Coll Mat Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University of Technology	Ning, WS (corresponding author), Zhejiang Univ Technol, Coll Chem Engn, Hangzhou, Zhejiang, Peoples R China.	wenshning@sohu.com	Ning, Wensheng/G-8598-2012	Ning, Wensheng/0000-0002-6558-4831	Zhejiang Provincial Natural Science Foundation of China [LY14B030003]; National Ministry of Science and Technology of China [2014BAD02B05]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Zhejiang Provincial Natural Science Foundation of China (LY14B030003), WN, and National Ministry of Science and Technology of China (2014BAD02B05), WN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezemer GL, 2006, J AM CHEM SOC, V128, P3956, DOI 10.1021/ja058282w; Dry ME, 2002, CATAL TODAY, V71, P227, DOI 10.1016/S0920-5861(01)00453-9; Dry ME, 1999, APPL CATAL A-GEN, V189, P185, DOI 10.1016/S0926-860X(99)00275-6; Ernst B, 1999, APPL CATAL A-GEN, V186, P145, DOI 10.1016/S0926-860X(99)00170-2; Espinoza RL, 1999, APPL CATAL A-GEN, V186, P13, DOI 10.1016/S0926-860X(99)00161-1; He JJ, 2005, LANGMUIR, V21, P1699, DOI 10.1021/la047217h; Jacobs G, 2004, APPL CATAL A-GEN, V264, P203, DOI 10.1016/j.apcata.2003.12.049; Jacobs G, 2002, APPL CATAL A-GEN, V233, P263, DOI 10.1016/S0926-860X(02)00195-3; Kang SH, 2012, ENERG FUEL, V26, P6061, DOI 10.1021/ef301251d; Keyvanloo K, 2014, ACS CATAL, V4, P1071, DOI 10.1021/cs401242d; Koizumi N, 2011, APPL CATAL A-GEN, V395, P138, DOI 10.1016/j.apcata.2011.01.035; Mochizuki T, 2007, APPL CATAL A-GEN, V317, P97, DOI 10.1016/j.apcata.2006.10.005; Ning W., 2012, CURR CATAL, V1, P88, DOI [10.2174/2211544711201020088, DOI 10.2174/2211544711201020088]; Ning WS, 2013, CATAL COMMUN, V39, P74, DOI 10.1016/j.catcom.2013.05.013; Rodrigues EL, 2004, APPL CATAL A-GEN, V257, P201, DOI 10.1016/j.apcata.2003.07.002; SCHERER GW, 1990, J AM CERAM SOC, V73, P3, DOI 10.1111/j.1151-2916.1990.tb05082.x; Schulz H, 1999, APPL CATAL A-GEN, V186, P3, DOI 10.1016/S0926-860X(99)00160-X; Vosloo AC, 2004, 21 INT PITTSB COAL C; Wang WJ, 2005, J POROUS MAT, V12, P5, DOI 10.1007/s10934-005-5227-y; Wang XQ, 2012, CATAL COMMUN, V24, P61, DOI 10.1016/j.catcom.2012.03.016; Yang GH, 2008, ENERG FUEL, V22, P1463, DOI 10.1021/ef700682y; Yang JI, 2010, FUEL, V89, P237, DOI 10.1016/j.fuel.2009.07.008	22	2	4	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124228	10.1371/journal.pone.0124228	http://dx.doi.org/10.1371/journal.pone.0124228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938725	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000022
J	Todd, DA; Gulledge, TV; Britton, ER; Oberhofer, M; Leyte-Lugo, M; Moody, AN; Shymanovich, T; Grubbs, LF; Juzumaite, M; Graf, TN; Oberlies, NH; Faeth, SH; Laster, SM; Cech, NB				Todd, Daniel A.; Gulledge, Travis V.; Britton, Emily R.; Oberhofer, Martina; Leyte-Lugo, Martha; Moody, Ashley N.; Shymanovich, Tatsiana; Grubbs, Laura F.; Juzumaite, Monika; Graf, Tyler N.; Oberlies, Nicholas H.; Faeth, Stanley H.; Laster, Scott M.; Cech, Nadja B.			Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria	PLOS ONE			English	Article							VITRO MACROPHAGE ACTIVATION; CAFFEIC ACID-DERIVATIVES; INFLAMMATORY CYTOKINES; CELL-CULTURES; PATHOGENESIS; ALKAMIDES; LIPOPOLYSACCHARIDES; LIPOPROTEINS; ALKYLAMIDES; INFECTIONS	Echinacea preparations, which are used for the prevention and treatment of upper respiratory infections, account for 10% of the dietary supplement market in the U.S., with sales totaling more than $ 100 million annually. In an attempt to shed light on Echinacea's mechanism of action, we evaluated the effects of a 75% ethanolic root extract of Echinacea purpurea, prepared in accord with industry methods, on cytokine and chemokine production from RAW 264.7 macrophage-like cells. We found that the extract displayed dual activities; the extract could itself stimulate production of the cytokine TNF-alpha, and also suppress production of TNF-alpha in response to stimulation with exogenous LPS. Liquid: liquid partitioning followed by normal-phase flash chromatography resulted in separation of the stimulatory and inhibitory activities into different fractions, confirming the complex nature of this extract. We also studied the role of alkylamides in the suppressive activity of this E. purpurea extract. Our fractionation method concentrated the alkylamides into a single fraction, which suppressed production of TNF-alpha, CCL3, and CCL5; however fractions that did not contain detectable alkylamides also displayed similar suppressive effects. Alkylamides, therefore, likely contribute to the suppressive activity of the extract but are not solely responsible for that activity. From the fractions without detectable alkylamides, we purified xanthienopyran, a compound not previously known to be a constituent of the Echinacea genus. Xanthienopyran suppressed production of TNF-alpha suggesting that it may contribute to the suppressive activity of the crude ethanolic extract. Finally, we show that ethanolic extracts prepared from E. purpurea plants grown under sterile conditions and from sterilized seeds, do not contain LPS and do not stimulate macrophage production of TNF-alpha, supporting the hypothesis that the macrophage-stimulating activity in E. purpurea extracts can originate from endophytic bacteria. Together, our findings indicate that ethanolic E. purpurea extracts contain multiple constituents that differentially regulate cytokine production by macrophages.	[Todd, Daniel A.; Britton, Emily R.; Leyte-Lugo, Martha; Moody, Ashley N.; Graf, Tyler N.; Oberlies, Nicholas H.; Cech, Nadja B.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA; [Gulledge, Travis V.; Juzumaite, Monika; Laster, Scott M.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Oberhofer, Martina; Shymanovich, Tatsiana; Grubbs, Laura F.; Faeth, Stanley H.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Greensboro	Cech, NB (corresponding author), Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA.	nadja_cech@uncg.edu	Oberlies, Nicholas/D-8162-2011; Leyte-Lugo, Martha/O-6682-2019; Shymanovich, Tatsiana/R-4958-2019	Oberlies, Nicholas/0000-0002-0354-8464; Graf, Tyler/0000-0003-4145-2815; Leyte-Lugo, Martha/0000-0003-4940-6194; Britton, Emily/0000-0002-5331-7963; Todd, Daniel/0000-0003-2199-1029	National Center for Complementary and Alternative Medicine (NCCAM) [1R15AT007259]; National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R15AT007259] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This project was supported by grant # 1R15AT007259 from the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health.	Barrett B, 2010, ANN INTERN MED, V153, P769, DOI 10.7326/0003-4819-153-12-201012210-00003; BAUER R, 1991, PLANTA MED, V57, P447, DOI 10.1055/s-2006-960147; BAUER R, 1989, PLANTA MED, P367, DOI 10.1055/s-2006-962030; Cech NB, 2010, INT IMMUNOPHARMACOL, V10, P1268, DOI 10.1016/j.intimp.2010.07.009; Cech NB, 2006, J CHROMATOGR A, V1103, P219, DOI 10.1016/j.chroma.2005.11.008; Coimbra S, 2012, INT J DERMATOL, V51, P389, DOI 10.1111/j.1365-4632.2011.05154.x; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Eads D, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-2; EMMENDORFFER AC, 1999, IMMUNOMODULATORY AGE, P89; Fonseca FN, 2014, INT IMMUNOPHARMACOL, V19, P94, DOI 10.1016/j.intimp.2013.12.019; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Jawad M, 2012, EVID-BASED COMPL ALT, V2012, P7; Karsch-Volk M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000530.pub3; Kennedy JL, 2012, CURR OPIN VIROL, V2, P287, DOI 10.1016/j.coviro.2012.03.008; Lalone CA, 2007, J AGR FOOD CHEM, V55, P7314, DOI 10.1021/jf063711a; LaLone CA, 2009, J AGR FOOD CHEM, V57, P8820, DOI 10.1021/jf901202y; Lee CL, 2008, PLANTA MED, V74, P1276, DOI 10.1055/s-2008-1081295; LEUCHTMANN A, 1988, MYCOLOGIA, V80, P192, DOI 10.2307/3807793; LUETTIG B, 1989, J NATL CANCER I, V81, P669, DOI 10.1093/jnci/81.9.669; MAHMOUD AA, 1995, TETRAHEDRON LETT, V36, P8985, DOI 10.1016/0040-4039(95)01966-L; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Pugh ND, 2008, INT IMMUNOPHARMACOL, V8, P1023, DOI 10.1016/j.intimp.2008.03.007; Pugh ND, 2013, PLANTA MED, V79, P9, DOI 10.1055/s-0032-1328023; Raduner S, 2006, J BIOL CHEM, V281, P14192, DOI 10.1074/jbc.M601074200; Sasagawa M, 2006, INT IMMUNOPHARMACOL, V6, P1214, DOI 10.1016/j.intimp.2006.02.003; Sharma M, 2009, ANTIVIR RES, V83, P165, DOI 10.1016/j.antiviral.2009.04.009; Spelman K, 2009, INT IMMUNOPHARMACOL, V9, P1260, DOI 10.1016/j.intimp.2009.08.009; Tamta H, 2008, J AGR FOOD CHEM, V56, P10552, DOI 10.1021/jf8023722; Taylor JA, 2003, JAMA-J AM MED ASSOC, V290, P2824, DOI 10.1001/jama.290.21.2824; U.S. Nutrition Industry Overview, 2009, NUTRITION BUSINESS J, V14, P1; Vohra S, 2009, CAN J PHYSIOL PHARM, V87, P371, DOI [10.1139/Y09-021, 10.1139/y09-021]; WAGNER H, 1988, PHYTOCHEMISTRY, V27, P119, DOI 10.1016/0031-9422(88)80601-0	36	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124276	10.1371/journal.pone.0124276	http://dx.doi.org/10.1371/journal.pone.0124276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933416	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100035
J	Zafar, A; Ahmad, S; Rizvi, A; Ahmad, M				Zafar, Atif; Ahmad, Sabahuddin; Rizvi, Asim; Ahmad, Masood			Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURES; CYSTEINE PROTEINASES; SCORING FUNCTION; MODELS; CHEMOTHERAPY; RECOGNITION; PREDICTION; DIGESTION; ALIGNMENT; QUALITY	Schistosomiasis is a major endemic disease known for excessive mortality and morbidity in developing countries. Because praziquantel is the only drug available for its treatment, the risk of drug resistance emphasizes the need to discover new drugs for this disease. Cathepsin SmCL1 is the critical target for drug design due to its essential role in the digestion of host proteins for growth and development of Schistosoma mansoni. Inhibiting the function of SmCL1 could control the wide spread of infections caused by S. mansoni in humans. With this objective, a homology modeling approach was used to obtain theoretical three-dimensional (3D) structure of SmCL1. In order to find the potential inhibitors of SmCL1, a plethora of in silico techniques were employed to screen non-peptide inhibitors against SmCL1 via structure-based drug discovery protocol. Receiver operating characteristic (ROC) curve analysis and molecular dynamics (MD) simulation were performed on the results of docked protein-ligand complexes to identify top ranking molecules against the modelled 3D structure of SmCL1. MD simulation results suggest the phytochemical Simalikalactone-D as a potential lead against SmCL1, whose pharmacophore model may be useful for future screening of potential drug molecules. To conclude, this is the first report to discuss the virtual screening of non-peptide inhibitors against SmCL1 of S. mansoni, with significant therapeutic potential. Results presented herein provide a valuable contribution to identify the significant leads and further derivatize them to suitable drug candidates for antischistosomal therapy.	[Zafar, Atif; Rizvi, Asim; Ahmad, Masood] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Ahmad, Sabahuddin] Jamia Millia Islamia, Fac Nat Sci, Dept Comp Sci, New Delhi 110025, India	Aligarh Muslim University; Jamia Millia Islamia	Ahmad, M (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.	masood_amua@yahoo.co.in	Ahmad, Sabahuddin/I-4919-2015	Ahmad, Sabahuddin/0000-0002-8762-4670; Rizvi, Asim/0000-0003-0771-0227				Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blau L, 2013, EUR J MED CHEM, V67, P142, DOI 10.1016/j.ejmech.2013.04.022; Botros SS, 2007, EXPERT OPIN DRUG DIS, V2, pS35, DOI 10.1517/17460441.2.S1.S35; Brady CP, 2000, ARCH BIOCHEM BIOPHYS, V380, P46, DOI 10.1006/abbi.2000.1905; Brady CP, 1999, INFECT IMMUN, V67, P368, DOI 10.1128/IAI.67.1.368-374.1999; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DALTON JP, 1995, PARASITOL TODAY, V11, P299, DOI 10.1016/0169-4758(95)80045-X; Dalton JP, 1996, INFECT IMMUN, V64, P1328, DOI 10.1128/IAI.64.4.1328-1334.1996; Burger MCD, 2014, J NAT PROD, V77, P2418, DOI 10.1021/np500453x; DeLano WL, 1997, PYMOL MOL GRAPHIC SY; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Farid A, 2013, Pak J Biol Sci, V16, P1849, DOI 10.3923/pjbs.2013.1849.1861; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Filimonov DA, 1996, BIOACTIVE COMPOUND D, P47; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Moreira DRM, 2014, CHEMMEDCHEM, V9, P177, DOI 10.1002/cmdc.201300354; MCKERROW JH, 1988, PARASITOL TODAY, V4, P334, DOI 10.1016/0169-4758(88)90002-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mugumbate G, 2013, J COMPUT AID MOL DES, V27, P859, DOI 10.1007/s10822-013-9685-z; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Perez B, 2013, J COMPUT AID MOL DES, V27, P823, DOI 10.1007/s10822-013-9682-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SMITH AM, 1994, MOL BIOCHEM PARASIT, V67, P11, DOI 10.1016/0166-6851(94)90091-4; Southan C, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-20; Stirewalt M.A., 1974, Advances Parasit, V12, P115, DOI 10.1016/S0065-308X(08)60388-7; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wasilewski MM, 1996, MOL BIOCHEM PARASIT, V81, P179, DOI 10.1016/0166-6851(96)02703-X; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wiggers HJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002370; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	65	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123996	10.1371/journal.pone.0123996	http://dx.doi.org/10.1371/journal.pone.0123996			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933436	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100028
J	Bara, J; Rapti, Z; Caceres, CE; Muturi, EJ				Bara, Jeffrey; Rapti, Zoi; Caceres, Carla E.; Muturi, Ephantus J.			Effect of Larval Competition on Extrinsic Incubation Period and Vectorial Capacity of Aedes albopictus for Dengue Virus	PLOS ONE			English	Article							WEST-NILE-VIRUS; BODY-SIZE; ENVIRONMENTAL-TEMPERATURE; ALTERS SUSCEPTIBILITY; NUTRITIONAL STRESS; AEGYPTI COMPETENCE; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; MOSQUITOS DIPTERA; CULEX-TARSALIS	Despite the growing awareness that larval competition can influence adult mosquito life history traits including susceptibility to pathogens, the net effect of larval competition on human risk of exposure to mosquito-borne pathogens remains poorly understood. We examined how intraspecific larval competition affects dengue-2 virus (DENV-2) extrinsic incubation period and vectorial capacity of its natural vector Aedes albopictus. Adult Ae. albopictus from low and high-larval density conditions were orally challenged with DENV-2 and then assayed for virus infection and dissemination rates following a 6, 9, or 12-day incubation period using real-time quantitative reverse transcription PCR. We then modeled the effect of larval competition on vectorial capacity using parameter estimates obtained from peer-reviewed field and laboratory studies. Larval competition resulted in significantly longer development times, lower emergence rates, and smaller adults, but did not significantly affect the extrinsic incubation period of DENV-2 in Ae. albopictus. Our vectorial capacity models suggest that the effect of larval competition on adult mosquito longevity likely has a greater influence on vectorial capacity relative to any competition-induced changes in vector competence. Furthermore, we found that large increases in the viral dissemination rate may be necessary to compensate for small competition-induced reductions in daily survivorship. Our results indicate that mosquito populations that experience stress from larval competition are likely to have a reduced vectorial capacity, even when susceptibility to pathogens is enhanced.	[Bara, Jeffrey; Muturi, Ephantus J.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Rapti, Zoi] Univ Illinois, Dept Math, Champaign, IL 61820 USA; [Caceres, Carla E.] Univ Illinois, Sch Integrat Biol, Champaign, IL 61820 USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bara, J (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	jjbara@illinois.edu			Used Tire Fund from the State of Illinois; Emergency Public Health Fund from the State of Illinois; University of Illinois Research Board [RB 14038]	Used Tire Fund from the State of Illinois; Emergency Public Health Fund from the State of Illinois; University of Illinois Research Board	This study was supported by the Used Tire Fund and Emergency Public Health Fund from the State of Illinois and the University of Illinois Research Board grant RB 14038 to Z. Rapti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUDELOSILVA F, 1984, AM J TROP MED HYG, V33, P1267, DOI 10.4269/ajtmh.1984.33.1267; Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Alto BW, 2015, J MED ENTOMOL, V52, P163, DOI 10.1093/jme/tju062; Alto BW, 2013, ECOL CONT VECTOR-BOR, V3, P81; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; Bevins SN, 2007, J VECTOR ECOL, V32, P252, DOI 10.3376/1081-1710(2007)32[252:TORIAL]2.0.CO;2; Breaux JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0459; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Dodson BL, 2011, VECTOR-BORNE ZOONOT, V11, P1493, DOI 10.1089/vbz.2011.0662; Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405; DYE C, 1986, Parasitology Today, V2, P203; Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; GOULD DJ, 1970, J MED ENTOMOL, V7, P499, DOI 10.1093/jmedent/7.4.499; GRIMSTAD PR, 1991, J MED ENTOMOL, V28, P378, DOI 10.1093/jmedent/28.3.378; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946; Juliano SA, 2014, MEM I OSWALDO CRUZ, V109, P1070, DOI 10.1590/0074-02760140455; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LAMBRECHT FL, 1971, B ENTOMOL RES, V60, P513, DOI 10.1017/S000748530004044X; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lefevre T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003365; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Lord CC, 1998, J MED ENTOMOL, V35, P825, DOI 10.1093/jmedent/35.5.825; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Makiya K., 1974, Japanese Journal of Sanitary Zoology, V25, P41; Moller-Jacobs LL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0593-4; MORI A, 1979, Tropical Medicine, V21, P85; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; Muturi EJ, 2012, J VECTOR ECOL, V37, P154, DOI 10.1111/j.1948-7134.2012.00212.x; Muturi EJ, 2011, VECTOR-BORNE ZOONOT, V11, P1157, DOI 10.1089/vbz.2010.0209; NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522; NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61; Nidelet T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-65; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; REISEN WK, 1984, MOSQ NEWS, V44, P385; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283; Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249; Telang A, 2012, MED VET ENTOMOL, V26, P271, DOI 10.1111/j.1365-2915.2011.00993.x; TOMA T, 1982, MOSQ NEWS, V42, P179; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; WASHBURN JO, 1995, J AM MOSQUITO CONTR, V11, P279; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035; Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632; World Health Organization, 2009, DENGUE GUIDELINES DI; XUE RD, 1995, J AM MOSQUITO CONTR, V11, P50; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319; Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227	75	36	38	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126703	10.1371/journal.pone.0126703	http://dx.doi.org/10.1371/journal.pone.0126703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951173	Green Submitted, gold, Green Published			2022-12-26	WOS:000354214400105
J	Kwiatek, M; Geca, T; Krzyzanowski, A; Malec, A; Kwasniewska, A				Kwiatek, Maciej; Geca, Tomasz; Krzyzanowski, Arkadiusz; Malec, Agnieszka; Kwasniewska, Anna			Peripheral Dendritic Cells and CD4+CD25+Foxp3+Regulatory T Cells in the First Trimester of Normal Pregnancy and in Women with Recurrent Miscarriage	PLOS ONE			English	Article							SPONTANEOUS-ABORTION; FETAL TOLERANCE; ACTIVATION; BLOOD; EXPRESSION; MOLECULES; ANTIGEN	The development of pregnancy is possible due to initiation of immune response in the body of the mother resulting in immune tolerance. Miscarriage may be caused by the impaired maternal immune response to paternal alloantigens located on the surface of trophoblast and fetal cells. The aim of the study was to compare the population of circulating dendritic cells (DCs) and CD4+CD25+Foxp3+ regulatory T cells (TREGs) in the first trimester of a normal pregnancy and in women with recurrent miscarriage and an attempt to determine the relationship between these cells and the role they may play in human reproductive failures. The study was conducted in a group of 33 first trimester pregnant women with recurrent miscarriage and in a group of 20 healthy pregnant women in the first trimester of normal pregnancy. Among mononuclear cells isolated from peripheral blood, the populations of DCs and TREGs were assessed by flow cytometry. The percentage of myeloid DCs and lymphoid DCs showed no significant difference between study and control group. Older maternal age and obesity significantly reduced the pool of circulating myeloid and lymphoid DCs (R=-0.39, p=0.02). In miscarriages the percentage of circulating TREGs was significantly lower compared to normal pregnancies (p=0.003). Among the analysed factors the percentage of TREGs was the most sensitive and the most specific parameter which correlated with the pregnancy loss. The reduction in the population of circulating TREGs suggests immunoregulatory mechanisms disorder in a pregnancy complicated by miscarriage.	[Kwiatek, Maciej; Geca, Tomasz; Krzyzanowski, Arkadiusz; Malec, Agnieszka; Kwasniewska, Anna] Med Univ Lublin, Dept Obstet & Pathol Pregnancy, Lublin, Poland	Medical University of Lublin	Kwiatek, M (corresponding author), Med Univ Lublin, Dept Obstet & Pathol Pregnancy, Lublin, Poland.	kwiatula1@wp.pl	Kwiatek, Maciej/AAS-7745-2021; Gęca, Tomasz/GWZ-4329-2022	Geca, Tomasz/0000-0002-1940-4342; Krzyzanowski, Arkadiusz/0000-0003-1147-3359; Kwiatek, Maciej/0000-0002-0842-9106	Medical University of Lublin, Lublin, Poland [Dz. St. 128/14]	Medical University of Lublin, Lublin, Poland	The study was supported by a grant from the Medical University of Lublin, Lublin, Poland (Dz. St. 128/14) to Anna Kwasniewska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Arruvito L, 2009, J REPROD IMMUNOL, V82, P158, DOI 10.1016/j.jri.2009.04.010; Arruvito L, 2010, CLIN IMMUNOL, V136, P432, DOI 10.1016/j.clim.2010.05.002; Blois SM, 2007, BIOL REPROD, V77, P590, DOI 10.1095/biolreprod.107.060632; Cappelletti M, 2013, PLACENTA, V34, P35, DOI 10.1016/j.placenta.2012.10.016; Carrington B, 2005, CURR OPIN OBSTET GYN, V17, P591, DOI 10.1097/01.gco.0000194112.86051.26; Cianga C, 2011, HUM IMMUNOL, V72, P1176, DOI 10.1016/j.humimm.2011.08.020; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; Darmochwal-Kolarz DA, 2012, AM J REPROD IMMUNOL, V67, P474, DOI 10.1111/j.1600-0897.2012.01126.x; Della Bella S, 2011, CLIN EXP IMMUNOL, V164, P180, DOI 10.1111/j.1365-2249.2011.04330.x; Farazi M, 2014, J LEUKOCYTE BIOL, V96, P245, DOI 10.1189/jlb.1A0114-066R; Imam Syed Nazar, 2011, J Reprod Infertil, V12, P267; Lewkowicz Przemyslaw, 2005, Postepy Hig Med Dosw (Online), V59, P362; Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Moldenhauer LM, 2009, J IMMUNOL, V182, P8080, DOI 10.4049/jimmunol.0804018; O'Shea D, 2013, INT J OBESITY, V37, P1510, DOI 10.1038/ijo.2013.16; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Robertson SA, 2009, BIOL REPROD, V80, P1036, DOI 10.1095/biolreprod.108.074658; Sakaguchi S, 1996, J AUTOIMMUN, V9, P211, DOI 10.1006/jaut.1996.0026; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tan Kian Hwa, 2011, Chimerism, V2, P16, DOI 10.4161/chim.2.1.14692; Tirado-Gonzalez I, 2010, PLACENTA, V31, P1019, DOI 10.1016/j.placenta.2010.09.008; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Vassiliadou N, 1999, HUM REPROD, V14, P1194, DOI 10.1093/humrep/14.5.1194; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Winger EE, 2011, AM J REPROD IMMUNOL, V66, P320, DOI 10.1111/j.1600-0897.2011.00992.x; Wong LF, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000112.pub3; Yang H, 2008, FERTIL STERIL, V89, P656, DOI 10.1016/j.fertnstert.2007.03.037; Zylicz Marta, 2005, Postepy Hig Med Dosw (Online), V59, P160	32	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124747	10.1371/journal.pone.0124747	http://dx.doi.org/10.1371/journal.pone.0124747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945787	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700048
J	Zhang, JB; Ahn, J; Suh, Y; Hwang, S; Davis, ME; Lee, K				Zhang, Jibin; Ahn, Jinsoo; Suh, Yeunsu; Hwang, Seongsoo; Davis, Michael E.; Lee, Kichoon			Identification of CTLA2A, DEFB29, WFDC15B, SERPINA1F and MUP19 as Novel Tissue-Specific Secretory Factors in Mouse	PLOS ONE			English	Article							ALPHA-TRYPSIN INHIBITOR; HYPOXIA-INDUCIBLE PROTEIN-2; HUMAN ADIPOSE-TISSUE; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; MOLECULAR-CLONING; PLASMA KALLIKREIN; BINDING PROTEIN	Secretory factors in animals play an important role in communication between different cells, tissues and organs. Especially, the secretory factors with specific expression in one tissue may reflect important functions and unique status of that tissue in an organism. In this study, we identified potential tissue-specific secretory factors in the fat, muscle, heart, lung, kidney and liver in the mouse by analyzing microarray data from NCBI's Gene Expression Omnibus (GEO) public repository and searching and predicting their subcellular location in GeneCards and WoLF PSORT, and then confirmed tissue-specific expression of the genes using semi-quantitative PCR reactions. With this approach, we confirmed 11 lung, 7 liver, 2 heart, 1 heart and muscle, 7 kidney and 2 adipose and liver-specific secretory factors. Among these genes, 1 lung-specific gene - CTLA2A (cytotoxic T lymphocyte-associated protein 2 alpha), 3 kidney-specific genes - SERPINA1F (serpin peptidase inhibitor, Clade A, member 1F), WFDC15B (WAP four-disulfide core domain 15B) and DEFB29 (defensin beta 29) and 1 liver-specific gene - MUP19 (major urinary protein 19) have not been reported as secretory factors. These genes were tagged with hemagglutinin at the 3'end and then transiently transfected to HEK293 cells. Through protein detection in cell lysate and media using Western blotting, we verified secretion of the 5 genes and predicted the potential pathways in which they may participate in the specific tissue through data analysis of GEO profiles. In addition, alternative splicing was detected in transcripts of CTLA2A and SERPINA1F and the corresponding proteins were found not to be secreted in cell culture media. Identification of novel secretory factors through the current study provides a new platform to explore novel secretory factors and a general direction for further study of these genes in the future.	[Zhang, Jibin; Ahn, Jinsoo; Suh, Yeunsu; Davis, Michael E.; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Ahn, Jinsoo] Ohio State Univ, Interdisciplinary PhD Program Nutr, Columbus, OH 43210 USA; [Hwang, Seongsoo] Natl Inst Anim Sci, RDA, Anim Biotechnol Div, Gyeonggi, South Korea	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu	Lee, Kichoon/G-2234-2012; Zhang, Jibin/D-7124-2016	Zhang, Jibin/0000-0003-3099-6665; Davis, Mike/0000-0001-7666-4856	Agriculture and Food Research Initiative Competitive Grant from United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2010-65206-20716]; National Research Foundation of Korea Agenda Program [PJ009457]; Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants Program at The Ohio State University [2014-090, 2013-044]	Agriculture and Food Research Initiative Competitive Grant from United States Department of Agriculture (USDA) National Institute of Food and Agriculture; National Research Foundation of Korea Agenda Program(National Research Foundation of Korea); Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants Program at The Ohio State University	This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-65206-20716 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture: KL, http://www.csrees.usda.gov/fo/funding.cfm; The National Research Foundation of Korea Agenda Program no. PJ009457: KL, http://www.nrf.re.kr/nrf_eng_cms; SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants Program no. 2014-090 and 2013-044 at The Ohio State University: JA and KL, http://oardc.osu.edu/seeds/t08_pageview/Home.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Andersen JD, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-21; Assis DM, 2013, PROTEIN PEPTIDE LETT, V20, P1098; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH234, DOI 10.1152/ajpheart.00227.2012; BALDUYCK M, 1991, ANN BIOL CLIN-PARIS, V49, P273; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Benjamin JT, 2009, DEV BIOL, V335, P407, DOI 10.1016/j.ydbio.2009.09.021; Bjorkqvist J, 2013, THROMB HAEMOSTASIS, V110, P399, DOI 10.1160/TH13-03-0258; BORGES DR, 1981, BIOCHEM PHARMACOL, V30, P1065, DOI 10.1016/0006-2952(81)90443-3; BOURGUIGNON J, 1989, BIOCHEM J, V261, P305, DOI 10.1042/bj2610305; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; BRUNET JF, 1988, IMMUNOL REV, V103, P21, DOI 10.1111/j.1600-065X.1988.tb00747.x; Campbell W, 2001, IMMUNOL REV, V180, P162, DOI 10.1034/j.1600-065X.2001.1800114.x; Chen K, 2013, ANNU REV IMMUNOL, V31, P605, DOI 10.1146/annurev-immunol-032712-100019; Chim SM, 2011, J BIOL CHEM, V286, P22035, DOI 10.1074/jbc.M110.187633; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Dajani R, 2005, AM J RESP CELL MOL, V32, P548, DOI 10.1165/rcmb.2005-0059OC; Devnath S, 2009, EUR J CELL BIOL, V88, P521, DOI 10.1016/j.ejcb.2009.04.003; EATON DL, 1991, J BIOL CHEM, V266, P21833; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Flowers MT, 2006, J LIPID RES, V47, P2668, DOI 10.1194/jlr.M600203-JLR200; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Glick B, 1988, CELL, V95, P883; Hagiwara K, 2003, J IMMUNOL, V170, P1973, DOI 10.4049/jimmunol.170.4.1973; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kegel L, 2013, ASN NEURO, V5, DOI 10.1042/AN20120095; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kim HY, 2012, ORGANOGENESIS, V8, P56, DOI 10.4161/org.19813; Kim HA, 2013, CYTOKINE, V62, P206, DOI 10.1016/j.cyto.2013.03.012; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Kuang XL, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-137; Kuloglu T, 2014, PEPTIDES, V55, P85, DOI 10.1016/j.peptides.2014.02.008; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Lisowska-Myjak B, 1999, SCAND J CLIN LAB INV, V59, P93, DOI 10.1080/00365519950185814; Lodish H, 2000, MOL CELL BIOL; Lu B, 2012, EUR J HEART FAIL, V14, P5, DOI 10.1093/eurjhf/hfr152; Madden SL, 1996, CANCER RES, V56, P5384; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Manoli I, 2013, P NATL ACAD SCI USA, V110, P13552, DOI 10.1073/pnas.1302764110; Martin-Vandelet N, 1999, EUR J BIOCHEM, V259, P476, DOI 10.1046/j.1432-1327.1999.00067.x; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; NG SC, 1987, J IMMUNOL, V139, P3021; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ohashi K, 2014, J BIOL CHEM, V289, P14132, DOI 10.1074/jbc.M114.555789; Os I, 1997, NEPHRON, V77, P235, DOI 10.1159/000190278; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Park WJ, 2010, NEUROCHEM RES, V35, P789, DOI 10.1007/s11064-010-0136-0; Pastore N, 2013, AUTOPHAGY, V9, P1094, DOI 10.4161/auto.24469; Paterson T, 1996, BIOCHEM BIOPH RES CO, V219, P64, DOI 10.1006/bbrc.1996.0182; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; QUINET E, 1993, J BIOL CHEM, V268, P16891; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Raharjo SB, 2001, J BIOL CHEM, V276, P25612, DOI 10.1074/jbc.M101703200; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; SHAW PH, 1983, CELL, V32, P755, DOI 10.1016/0092-8674(83)90061-2; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Sipione S, 2006, J IMMUNOL, V177, P5051, DOI 10.4049/jimmunol.177.8.5051; Slentz-Kesler KA, 1998, GENOMICS, V47, P327, DOI 10.1006/geno.1997.5151; Song HM, 2008, ENVIRON TOXICOL, V23, P110, DOI 10.1002/tox.20319; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064483; Sonnen Andreas F-P, 2014, Subcell Biochem, V80, P83, DOI 10.1007/978-94-017-8881-6_6; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Taniguchi M, 2005, GENES CELLS, V10, P785, DOI 10.1111/j.1365-2443.2005.00877.x; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Velleman SG, 2013, COMP BIOCHEM PHYS A, V164, P36, DOI 10.1016/j.cbpa.2012.10.007; Velleman SG, 2006, DEV GROWTH DIFFER, V48, P271, DOI [10.1111/j.1440-169X.2006.00860.x, 10.1111/j.1440-169x.2006.00860.x]; Wang J, 2008, HISTOCHEM CELL BIOL, V130, P387, DOI 10.1007/s00418-008-0425-8; Wang T, 2014, J INVEST DERMATOL, V134, P1108, DOI 10.1038/jid.2013.437; Wang T, 2012, J LEUKOCYTE BIOL, V91, P449, DOI 10.1189/jlb.1011498; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Will C, 2010, AM J PHYSIOL-RENAL, V298, pF1152, DOI 10.1152/ajprenal.00499.2009; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yamazaki K, 2006, BIOL REPROD, V75, P462, DOI 10.1095/biolreprod.105.048058; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zager RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098380; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	93	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124962	10.1371/journal.pone.0124962	http://dx.doi.org/10.1371/journal.pone.0124962			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946105	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700053
J	McNabb, M; Chukwu, E; Ojo, O; Shekhar, N; Gill, CJ; Salami, H; Jega, F				McNabb, Marion; Chukwu, Emeka; Ojo, Oluwayemisi; Shekhar, Navendu; Gill, Christopher J.; Salami, Habeeb; Jega, Farouk			Assessment of the Quality of Antenatal Care Services Provided by Health Workers Using a Mobile Phone Decision Support Application in Northern Nigeria: A Pre/Post-Intervention Study	PLOS ONE			English	Article								Background Given the shortage of skilled healthcare providers in Nigeria, frontline community health extension workers (CHEWs) are commonly tasked with providing maternal and child health services at primary health centers. In 2012, we introduced a mobile case management and decision support application in twenty primary health centers in northern Nigeria, and conducted a pre-test/post-test study to assess whether the introduction of the app had an effect on the quality of antenatal care services provided by this lower-level cadre. Methods Using the CommCare mobile platform, the app dynamically guides CHEWs through antenatal care protocols and collects client data in real time. Thirteen health education audio clips are also embedded in the app for improving and standardizing client counseling. To detect changes in quality, we developed an evidence-based quality score consisting of 25 indicators, and conducted a total of 266 client exit interviews. We analyzed baseline and endline data to assess changes in the overall quality score as well as changes in the provision of key elements of antenatal care. Results Overall, the quality score increased from 13.3 at baseline to 17.2 at endline (p<0.0001), out of a total possible score of 25, with the most significant improvements related to health counseling, technical services provided, and quality of health education. Conclusion These study results suggest that the introduction of a low-cost mobile case management and decision support application can spur behavior change and improve the quality of services provided by a lower level cadre of healthcare workers. Future research should employ a more rigorous experimental design to explore potential longer-term effects on client health outcomes.	[McNabb, Marion; Shekhar, Navendu] Pathfinder Int, Watertown, MA 02472 USA; [Chukwu, Emeka; Ojo, Oluwayemisi; Salami, Habeeb; Jega, Farouk] Pathfinder Int Nigeria, Abuja, Nigeria; [Gill, Christopher J.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Boston University	McNabb, M (corresponding author), Pathfinder Int, Watertown, MA 02472 USA.	mmcnabb@pathfinder.org		gill, christopher/0000-0003-3353-0617; Chukwu, Emeka/0000-0003-3474-8108	Pathfinder International Advisory Board	Pathfinder International Advisory Board	The Pathfinder International Advisory Board funded this project and research study.	Boller C, 2003, B WHO, V81; Chatfield A, 2013, COM MCARE EV BAS; DeRenzi B, 2008, E IMCI IMPROVING PED; DeRenzi B, 2011, MT SINAI J MED, V78, P406, DOI 10.1002/msj.20256; Dimagi Inc, 2014, COMMCARE HQ; Florez-Arango JF, 2011, J AM MED INFORM ASSN, V18, P131, DOI 10.1136/jamia.2010.010025; ICF Macro International; National Population Commission N, 2008, NIG DEM HLTH SURV 20; Lincetto O, ANTENATAL CARE, P51; Medhi I, 2012, P 7 NORD C HUM COMP, V12, P635; Mitchell M, 2012, INT J MED INFORM, V81, P166, DOI 10.1016/j.ijmedinf.2011.11.003; NCC, 2013, TELECOMS SUBSCRIBERS; Pathfinder International, 2011, MAT HLTH CAR IMPR IN; Tetui M, 2012, PAN AFR MED J, V13; WHO, NIG LAUNCH SAV ON MI; WHO, 2010, TRENDS MAT MORT 1990; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	16	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0123940	10.1371/journal.pone.0123940	http://dx.doi.org/10.1371/journal.pone.0123940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942018	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400009
J	Misic, VV; Chan, TCY				Misic, Velibor V.; Chan, Timothy C. Y.			The Perils of Adapting to Dose Errors in Radiation Therapy	PLOS ONE			English	Article							IMRT OPTIMIZATION; ORGAN MOTION; RADIOTHERAPY; PATIENT; SETUP; IMPLEMENTATION; COMPENSATION; ALGORITHM; DELIVERY; CANCER	We consider adaptive robust methods for lung cancer that are also dose-reactive, wherein the treatment is modified after each treatment session to account for the dose delivered in prior treatment sessions. Such methods are of interest because they potentially allow for errors in the delivered dose to be corrected as the treatment progresses, thereby ensuring that the tumor receives a sufficient dose at the end of the treatment. We show through a computational study with real lung cancer patient data that while dose reaction is beneficial with respect to the final dose distribution, it may lead to exaggerated daily underdose and overdose relative to non-reactive methods that grows as the treatment progresses. However, by combining dose reaction with a mechanism for updating an estimate of the uncertainty, the magnitude of this growth can be mitigated substantially. The key finding of this paper is that reacting to dose errors - an adaptation strategy that is both simple and intuitively appealing - may backfire and lead to treatments that are clinically unacceptable.	[Misic, Velibor V.] MIT, Ctr Operat Res, Cambridge, MA 02139 USA; [Chan, Timothy C. Y.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada	Massachusetts Institute of Technology (MIT); University of Toronto	Misic, VV (corresponding author), MIT, Ctr Operat Res, Cambridge, MA 02139 USA.	vvmisic@mit.edu			NSERC [398106-2011]; CIHR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	Collaborative Health Research Projects Grant 398106-2011, sponsored by NSERC (http:// www.nserc-crsng.gc.ca) and CIHR (http://www.cihrirsc.gc.ca), received by TCYC (Principal Investigator) and VVM (advisee of TCYC during time of research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, IIE T HEALTHC SYST E; Birkner M, 2003, MED PHYS, V30, P2822, DOI 10.1118/1.1610751; BORTFELD T, 1993, MED PHYS, V20, P311, DOI 10.1118/1.597070; Bortfeld T, 2008, OPER RES, V56, P1461, DOI 10.1287/opre.1070.0484; Chan TCY, 2006, PHYS MED BIOL, V51, P2567, DOI 10.1088/0031-9155/51/10/014; Chan TCY, 2013, EUR J OPER RES, V231, P745, DOI 10.1016/j.ejor.2013.06.003; de la Zerda A, 2007, PHYS MED BIOL, V52, P4137, DOI 10.1088/0031-9155/52/14/008; Deng G, 2008, SPRINGER SER OPTIM A, V12, P47; Dink D, 2011, AM J OPER RES, V1, P160, DOI [10.4236/ajor.2011.13018, DOI 10.4236/AJOR.2011.13018]; Ebert MA, 2000, PHYS MED BIOL, V45, P441, DOI 10.1088/0031-9155/45/2/313; Ferris MC, 2004, MATH PROGRAM, V101, P387, DOI 10.1007/s10107-004-0530-y; Lof J, 1998, PHYS MED BIOL, V43, P1605, DOI 10.1088/0031-9155/43/6/018; Lu WG, 2006, PHYS MED BIOL, V51, P4357, DOI 10.1088/0031-9155/51/17/015; Lujan AE, 1999, MED PHYS, V26, P715, DOI 10.1118/1.598577; Mar PA, 2015, PHYS MED BIOL, V60, P3599, DOI 10.1088/0031-9155/60/9/3599; Misic VV, 2012, THESIS U TORONTO; Mohan R, 2005, INT J RADIAT ONCOL, V61, P1258, DOI 10.1016/j.ijrobp.2004.11.033; Rehbinder H, 2004, MED PHYS, V31, P3363, DOI 10.1118/1.1809768; Sir MY, 2012, ANN OPER RES, V196, P767, DOI 10.1007/s10479-010-0779-x; Trofimov A, 2005, PHYS MED BIOL, V50, P2779, DOI 10.1088/0031-9155/50/12/004; Webb S, 2008, PHYS MED BIOL, V53, P1, DOI 10.1088/0031-9155/53/1/001; Wu QW, 2006, PHYS MED BIOL, V51, P1405, DOI 10.1088/0031-9155/51/6/003; Yan D, 1997, PHYS MED BIOL, V42, P123, DOI 10.1088/0031-9155/42/1/008; Yan D, 1997, INT J RADIAT ONCOL, V38, P197, DOI 10.1016/S0360-3016(97)00229-0; Yan D, 1998, INT J RADIAT ONCOL, V41, P715, DOI 10.1016/S0360-3016(97)00567-1	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125335	10.1371/journal.pone.0125335	http://dx.doi.org/10.1371/journal.pone.0125335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942407	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400030
J	Badugu, SB; Nabi, SA; Vaidyam, P; Laskar, S; Bhattacharyya, S; Bhattacharyya, MK				Badugu, Sugith Babu; Nabi, Shaik Abdul; Vaidyam, Pratap; Laskar, Shyamasree; Bhattacharyya, Sunanda; Bhattacharyya, Mrinal Kanti			Identification of Plasmodium falciparum DNA Repair Protein Mre11 with an Evolutionarily Conserved Nuclease Function	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; TELOMERE SIZE CONTROL; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; SULFOLOBUS-SOLFATARICUS; TRYPANOSOMA-BRUCEI; UV DAMAGE; COMPLEX; YEAST; MAINTENANCE	The eukaryotic Meiotic Recombination protein 11 (Mre11) plays pivotal roles in the DNA damage response (DDR). Specifically, Mre11 senses and signals DNA double strand breaks (DSB) and facilitates their repair through effector proteins belonging to either homologous recombination (HR) or non-homologous end joining (NHEJ) repair mechanisms. In the human malaria parasite Plasmodium falciparum, HR and alternative-NHEJ have been identified; however, little is known about the upstream factors involved in the DDR of this organism. In this report, we identify a putative ortholog of Mre11 in Plasmodium falciparum (PfalMre11) that shares 22% sequence similarity to human Mre11. Homology modeling reveals striking structural resemblance of the predicted PfalMre11 nuclease domain to the nuclease domain of Saccharomyces cerevisiae Mre11 (ScMre11). Complementation analyses reveal functional conservation of PfalMre11 nuclease activity as demonstrated by the ability of the PfalMre11 nuclease domain, in conjunction with the C-terminal domain of ScMre11, to functionally complement an mre11 deficient yeast strain. Functional complementation was virtually abrogated by an amino acid substitution in the PfalMre11 nuclease domain (D398N). PfalMre11 is abundant in the mitotically active trophozoite and schizont stages of Plasmodium falciparum and is up-regulated in response to DNA damage, suggesting a role in the DDR. PfalMre11 exhibits physical interaction with PfalRad50. In addition, yeast 2-hybrid studies show that PfalMre11 interacts with ScRad50 and ScXrs2, two important components of the well characterized Mre11-Rad50-Xrs2 complex which is involved in DDR signaling and repair in Saccharomyces cerevisiae, further supporting a role for PfalMre11 in the DDR. Taken together, these findings provide evidence that PfalMre11 is an evolutionarily conserved component of the DDR in Plasmodium.	[Badugu, Sugith Babu; Nabi, Shaik Abdul; Vaidyam, Pratap; Bhattacharyya, Mrinal Kanti] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Laskar, Shyamasree; Bhattacharyya, Sunanda] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Bhattacharyya, MK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	mkbsl@uohyd.ernet.in		Vydyam, Pratap/0000-0003-4944-6006; Laskar, Shyamasree/0000-0002-0497-0309	Indian funding agency DBT [BT/PR11174/MED/29/98/2008]; Indian funding agency CSIR [37(1343)/08/EMR-II]	Indian funding agency DBT; Indian funding agency CSIR	This work is partly supported by the grant from Indian funding agencies DBT [BT/PR11174/MED/29/98/2008] and CSIR [37(1343)/08/EMR-II] to MKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041925; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Bartkova J, 2008, MOL ONCOL, V2, P296, DOI 10.1016/j.molonc.2008.09.007; Bhattacharyya MK, 2008, CHROMOSOMA, V117, P357, DOI 10.1007/s00412-008-0153-9; Bhattacharyya MK, 2006, TRENDS BIOCHEM SCI, V31, P114, DOI 10.1016/j.tibs.2005.12.001; Bhattacharyya MK, 2005, MOL BIOCHEM PARASIT, V139, P33, DOI 10.1016/j.molbiopara.2004.09.007; Bhattacharyya MK, 2003, INT J PARASITOL, V33, P1385, DOI 10.1016/S0020-7519(03)00212-1; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bucholc M, 2001, MOL CELL BIOL, V21, P6559, DOI 10.1128/MCB.21.19.6559-6573.2001; Chalapareddy S, 2014, ANTIMICROB AGENTS CH, V58, P4341, DOI 10.1128/AAC.02519-13; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; FRANKENBERGSCHWAGER M, 1990, INT J RADIAT BIOL, V58, P569, DOI 10.1080/09553009014551931; Frols S, 2007, J BACTERIOL, V189, P8708, DOI 10.1128/JB.01016-07; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; James P, 1996, GENETICS, V144, P1425; Joseph IS, 2010, GENETICS, V185, P761, DOI 10.1534/genetics.110.117598; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Laskar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023406; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Palmbos PL, 2005, MOL CELL BIOL, V25, P10782, DOI 10.1128/MCB.25.24.10782-10790.2005; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Ritchie KB, 2000, GENETICS, V155, P475; Robinson NP, 2002, J BIOL CHEM, V277, P26185, DOI 10.1074/jbc.M203205200; Rolfsmeier ML, 2010, J BACTERIOL, V192, P4954, DOI 10.1128/JB.00667-10; Roy N, 2014, MOL MICROBIOL, V94, P353, DOI 10.1111/mmi.12762; Saito Y, 2013, TRANSL CANCER RES, V2, P178, DOI 10.3978/j.issn.2218-676X.2013.04.05; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Tan KSW, 2002, MOL BIOCHEM PARASIT, V125, P11, DOI 10.1016/S0166-6851(02)00165-2; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varunan SM, 2013, MOL BIOCHEM PARASIT, V191, P28, DOI 10.1016/j.molbiopara.2013.08.004; Williams B, 2005, DNA REPAIR, V4, P994, DOI 10.1016/j.dnarep.2005.04.016; Wongsrichanalai C, 2013, CLIN MICROBIOL INFEC, V19, P908, DOI 10.1111/1469-0691.12316; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	52	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125358	10.1371/journal.pone.0125358	http://dx.doi.org/10.1371/journal.pone.0125358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938776	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000060
J	Brockett, AT; LaMarca, EA; Gould, E				Brockett, Adam T.; LaMarca, Elizabeth A.; Gould, Elizabeth			Physical Exercise Enhances Cognitive Flexibility as Well as Astrocytic and Synaptic Markers in the Medial Prefrontal Cortex	PLOS ONE			English	Article							VOLUNTARY EXERCISE; DENTATE GYRUS; BRAIN; MEMORY; MICE; NEUROGENESIS; HIPPOCAMPUS; PLASTICITY; PROLIFERATION; PROTEIN	Physical exercise enhances a wide range of cognitive functions in humans. Running-induced cognitive enhancement has also been demonstrated in rodents but with a strong emphasis on tasks that require the hippocampus. Additionally, studies designed to identify mechanisms that underlie cognitive enhancement with physical exercise have focused on running-induced changes in neurons with little attention paid to such changes in astrocytes. To further our understanding of how the brain changes with physical exercise, we investigated whether running alters performance on cognitive tasks that require the prefrontal cortex and whether any such changes are associated with astrocytic, as well as neuronal, plasticity. We found that running enhances performance on cognitive tasks known to rely on the prefrontal cortex. By contrast, we found no such improvement on a cognitive task known to rely on the perirhinal cortex. Moreover, we found that running enhances synaptic, dendritic and astrocytic measures in several brain regions involved in cognition but that changes in the latter measures were more specific to brain regions associated with cognitive improvements. These findings suggest that physical exercise induces widespread plasticity in both neuronal and nonneuronal elements and that both types of changes may be involved in running-induced cognitive enhancement.	[Gould, Elizabeth] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu			National Institutes of Health [R21NS087460]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institutes of Health R21NS087460. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaei Hojjatallah, 2007, Pathophysiology, V14, P105, DOI 10.1016/j.pathophys.2007.07.001; Allen A, 2013, BEHAV BRAIN RES, V240, P95, DOI 10.1016/j.bbr.2012.11.025; Alves CRR, 2014, PERCEPT MOTOR SKILL, V118, P63, DOI 10.2466/22.06.PMS.118k10w4; ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X; Aoyama M, 2012, J NEUROSCI RES, V90, P2272, DOI 10.1002/jnr.23117; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bernardi C, 2014, NEURAL PLAST, V2013, P709; Birrell JM, 2000, J NEUROSCI, V20, P4320; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Greenwood BN, 2009, HIPPOCAMPUS, V19, P988, DOI 10.1002/hipo.20534; Gurden H, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00021; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Leuner B, 2010, J NEUROSCI, V30, P13499, DOI 10.1523/JNEUROSCI.3388-10.2010; Lima A, 2014, MOL PSYCHIATR, V19, P834, DOI 10.1038/mp.2013.182; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Masley S, 2009, J CLIN PSYCHOL MED S, V16, P186, DOI 10.1007/s10880-009-9159-6; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Salis AS, 2013, PERCEPT MOTOR SKILL, V116, P918, DOI 10.2466/29.22.PMS.116.3.918-928; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Schmidt-Kassow M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064172; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Turner KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093411; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Viola GG, 2009, BRAIN RES, V1274, P47, DOI 10.1016/j.brainres.2009.04.007; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001	35	78	80	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124859	10.1371/journal.pone.0124859	http://dx.doi.org/10.1371/journal.pone.0124859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938418	Green Published, gold			2022-12-26	WOS:000353943000034
J	Chien, JY; Chang, TC; Chiu, WY; Yu, CJ; Hsueh, PR				Chien, Jung-Yien; Chang, Tsung-Chain; Chiu, Wei-Yih; Yu, Chong-Jen; Hsueh, Po-Ren			Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; PULMONARY INFECTION; CLINICAL-FEATURES; ABSCESSUS; COMPLEX; ASSAY; SUSCEPTIBILITIES; SYSTEM; MEDIA	The performance of the BluePoint MycoID plus kit (Bio Concept Corporation, Taichung, Taiwan), which was designed to simultaneously detect Mycobacterium tuberculosis (MTB), rifampin- and isoniazid-resistant MTB, and nontuberculous mycobacteria (NTM) was first evaluated with 950 consecutive positive cultures in Mycobacterium Growth Indicator Tube (MGIT) system (BACTEC, MGIT 960 system, Becton-Dickinson, Sparks) from clinical respiratory specimens. The discrepant results between kit and culture-based identification were finally assessed by 16S rRNA gene sequencing and clinical diagnosis. The accuracy rate of this kit for identification of all Mycobacterium species was 96.3% (905/940). For MTB identification, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the kit were 99.7%, 99.3%, 99.0% and 99.8%, respectively. For rifampicin-resistant MTB identification, the sensitivity, specificity, PPV, and NPV of the kit were 100.0%, 99.4%, 91.3%, and 100.0%, respectively, while the corresponding values of isoniazid-resistant MTB identification were 82.6%, 99.4%, 95.0%, and 97.6%, respectively. In identifying specific NTM species, the kit correctly identified 99.3% of M. abscessus (147/148) complex, 100% of M. fortuitum (32/32), M. gordonae (38/38), M. avium (39/39), M. intracellulare (90/90), M. kansasii (36/36), and M. avium complex species other than M. avium and M. intracellulare (94/94). In conclusions, the diagnostic value of the BluePoint MycoID plus kit was superior to culture method for recoveries and identification of NTM to species level. In addition, the diagnostic accuracy of BluePoint MycoID plus kit in MTB identification was similar to conventional culture method with high accuracy rate of rifampicin-resistant M. tuberculosis identification.	[Chien, Jung-Yien; Chiu, Wei-Yih] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chien, Jung-Yien; Chiu, Wei-Yih; Yu, Chong-Jen; Hsueh, Po-Ren] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Chien, Jung-Yien] Chest Hosp, Minist Hlth & Welf, Tainan, Taiwan; [Chang, Tsung-Chain] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital	Hsueh, PR (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan.	hsporen@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021; Chang, Tsung Chain/F-5742-2011	CHIEN, JUNG-YIEN/0000-0002-7718-0594; Yu, Chong-Jen/0000-0001-5664-9392; HSUEH, PO-REN/0000-0002-7502-9225; CHIU, WEI-YIH/0000-0003-3124-7121				Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170; Chien JY, 2014, EMERG INFECT DIS, V20, P1382, DOI 10.3201/eid2008.131673; Chien JY, 2013, CHEST, V143, P1725, DOI 10.1378/chest.12-2051; da Costa ARF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002340; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hettick JM, 2006, PROTEOMICS, V6, P6416, DOI 10.1002/pmic.200600335; Hillemann D, 2006, J CLIN MICROBIOL, V44, P4014, DOI 10.1128/JCM.00829-06; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Huang WL, 2014, CLIN MICROBIOL INFEC, V20, pO542, DOI 10.1111/1469-0691.12517; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Lai CC, 2014, FUTURE MICROBIOL, V9, P93, DOI 10.2217/fmb.13.138; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lee MR, 2014, INT J ANTIMICROB AG, V43, P438, DOI 10.1016/j.ijantimicag.2014.02.007; Lee MR, 2012, J CLIN MICROBIOL, V50, P3754, DOI 10.1128/JCM.01049-12; Lee MR, 2012, J CLIN MICROBIOL, V50, P3398, DOI 10.1128/JCM.01862-12; Lee MR, 2012, J ANTIMICROB CHEMOTH, V67, P222, DOI 10.1093/jac/dkr420; Lotz A, 2010, J CLIN MICROBIOL, V48, P4481, DOI 10.1128/JCM.01397-10; Lu PL, 2013, DIAGN MICR INFEC DIS, V75, P337, DOI 10.1016/j.diagmicrobio.2013.01.009; Murray PR, MANUAL CLIN MICROBIO, V8th; Negi Sanjay Singh, 2006, Indian Journal of Experimental Biology, V44, P547; Shenai S, 2010, INT J TUBERC LUNG D, V14, P1001; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; Springer B, 2008, J CLIN MICROBIOL, V46, P4064, DOI 10.1128/JCM.01114-08; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Teng SH, 2013, J CLIN MICROBIOL, V51, P3113, DOI 10.1128/JCM.01239-13; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Wang JY, 2004, J CLIN MICROBIOL, V42, P4599, DOI 10.1128/JCM.42.10.4599-4603.2004; World Health Organization, 2013, WHO GLOB TUB CONTR; Zeigler D, 2013, ADDICTION, V108, P457, DOI 10.1111/j.1360-0443.2012.03999.x	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125016	10.1371/journal.pone.0125016	http://dx.doi.org/10.1371/journal.pone.0125016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938668	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000040
J	Jasmin, C; Anas, A; Nair, S				Jasmin, C.; Anas, Abdulaziz; Nair, Shanta			Bacterial Diversity Associated with Cinachyra cavernosa and Haliclona pigmentifera, Cohabiting Sponges in the Coral Reef Ecosystem of Gulf of Mannar, Southeast Coast of India	PLOS ONE			English	Article							MICROBIAL COMMUNITY; IDENTIFICATION; ABUNDANCE; TRANSMISSION; PROFILES; INSIGHTS; DISTANCE; SEA	Sponges are abundant, diverse and functionally important organisms of coral reef ecosystems. Sponge-associated microorganisms have been receiving greater attention because of their significant contribution to sponge biomass, biogeochemical cycles and biotechnological potentials. However, our understanding of the sponge microbiome is limited to a few species of sponges from restricted geographical locations. Here, we report for the first time the bacterial diversity of two cohabiting sponges, viz. Cinachyra cavernosa and Haliclona pigmentifera, as well as that in the ambient water from the coral reef ecosystems of the Gulf of Mannar, located along the southeast coast of India. Two hundred and fifty two clones in the 16S rRNA gene library of these sponges were grouped into eight distinct phyla, of which four belonged to the core group that are associated only with sponges. Phylogenetic analysis of the core bacteria showed close affinity to other sponge-associated bacteria from different geographical locations. gamma-Proteobacteria, Chloroflexi, Planctomycetes and Deferribacter were the core groups in C. cavernosa while beta and delta-Proteobacteria performed this role in H. pigmentifera. We observed greater OTU diversity for C. cavernosa (H-I 2.07) compared to H. pigmentifera (H-I 1.97). UniFrac analysis confirmed the difference in bacterial diversity of the two sponge species and also between the sponges and the reef water (p<0.001). The results of our study restate the existence of a host driven force in shaping the sponge microbiome.	[Jasmin, C.; Anas, Abdulaziz] CSIR, Natl Inst Oceanog, Reg Ctr, Cochin 682018, Kerala, India; [Nair, Shanta] CSIR, Natl Inst Oceanog, Panaji 403004, Goa, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Anas, A (corresponding author), CSIR, Natl Inst Oceanog, Reg Ctr, Cochin 682018, Kerala, India.	anas@nio.org	Abdulaziz, Anas/AAI-5681-2020	Abdulaziz, Anas/0000-0002-1396-3645	Department of Science and Technology, Government of India [SR/WOS-A/LS-339/2009]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	CJ is grateful to Department of Science and Technology, Government of India for the research grant SR/WOS-A/LS-339/2009. This is NIO contribution No. 5718.	Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Althoff K, 1998, MAR BIOL, V130, P529, DOI 10.1007/s002270050273; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Avila E, PORIFERA RES BIODIVE, P147; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cuvelier ML, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00581; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Dupont S, 2013, FEMS MICROBIOL ECOL, V86, P520, DOI 10.1111/1574-6941.12178; Erwin PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026806; Fieseler L, 2006, ENVIRON MICROBIOL, V8, P612, DOI 10.1111/j.1462-2920.2005.00937.x; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Giles EC, 2013, FEMS MICROBIOL ECOL, V83, P232, DOI 10.1111/j.1574-6941.2012.01467.x; Hardoim CCP, 2009, APPL ENVIRON MICROB, V75, P3331, DOI 10.1128/AEM.02101-08; Hardoim CCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053029; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Izumi H, 2013, ANTON LEEUW INT J G, V104, P533, DOI 10.1007/s10482-013-0003-5; Kamke J, 2010, ISME J, V4, P498, DOI 10.1038/ismej.2009.143; Kim IG, 2005, INT J SYST EVOL MICR, V55, P885, DOI 10.1099/ijs.0.63308-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ouyang YC, 2010, MAR BIOTECHNOL, V12, P318, DOI 10.1007/s10126-009-9223-0; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Selvin J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-72; Selvin J, 2009, MICROBIOL RES, V164, P352, DOI 10.1016/j.micres.2007.05.005; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sipkema D, 2010, MAR BIOL, V157, P627, DOI 10.1007/s00227-009-1347-2; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Stabili L, 2014, MICROB ECOL, V67, P186, DOI 10.1007/s00248-013-0312-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Thomas P.A., 1986, P205; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Webster N, 2013, MOL ECOL, V22, P1854, DOI 10.1111/mec.12213; Webster NS, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00444; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; WILKINSON CR, 1980, HYDROBIOLOGIA, V75, P241, DOI 10.1007/BF00006488; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wright JJ, 2014, ISME J, V8, P455, DOI 10.1038/ismej.2013.152; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	57	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123222	10.1371/journal.pone.0123222	http://dx.doi.org/10.1371/journal.pone.0123222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938436	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000005
J	Lee, JH; Park, CM; Park, SJ; Bae, JS; Lee, SM; Goo, JM				Lee, Jong Hyuk; Park, Chang Min; Park, Sang Joon; Bae, Jae Seok; Lee, Sang Min; Goo, Jin Mo			Value of Computerized 3D Shape Analysis in Differentiating Encapsulated from Invasive Thymomas	PLOS ONE			English	Article							THYMIC EPITHELIAL TUMORS; NONINVASIVE THYMOMA; CT; TOMOGRAPHY	Objectives To retrospectively investigate the added value of quantitative 3D shape analysis in differentiating encapsulated from invasive thymomas. Materials and Methods From February 2002 to October 2013, 53 patients (25 men and 28 women; mean age, 53.94 +/- 13.13 years) with 53 pathologically-confirmed thymomas underwent preoperative chest CT scans (slice thicknesses <= 2.5 mm). Twenty-three tumors were encapsulated thymomas and 30 were invasive thymomas. Their clinical and CT characteristics were evaluated. In addition, each thymoma was manually-segmented from surrounding structures, and their 3D shape features were assessed using an in-house developed software program. To evaluate the added value of 3D shape features in differentiating encapsulated from invasive thymomas, logistic regression analysis and receiver-operating characteristics curve (ROC) analysis were performed. Results Significant differences were observed between encapsulated and invasive thymomas, in terms of cystic changes (p=0.004), sphericity (p=0.016), and discrete compactness (p=0.001). Subsequent binary logistic regression analysis revealed that absence of cystic change (adjusted odds ratio (OR) = 6.636; p=0.015) and higher discrete compactness (OR = 77.775; p=0.012) were significant differentiators of encapsulated from invasive thymomas. ROC analyses revealed that the addition of 3D shape analysis to clinical and CT features (AUC, 0.955; 95% CI, 0.935-0.975) provided significantly higher performance in differentiating encapsulated from invasive thymomas than clinical and CT features (AUC, 0.666; 95% CI, 0.626-0.707) (p<0.001). Conclusion Addition of 3D shape analysis, particularly discrete compactness, can improve differentiation of encapsulated thymomas from invasive thymomas.	[Lee, Jong Hyuk; Park, Chang Min; Park, Sang Joon; Bae, Jae Seok; Lee, Sang Min; Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Jong Hyuk; Park, Chang Min; Park, Sang Joon; Bae, Jae Seok; Lee, Sang Min; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, CM (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	cmpark@radiol.snu.ac.kr		Lee, Jong Hyuk/0000-0002-9594-683X	Research of the Korean Foundation for Cancer Research [CB-2011-02-01]	Research of the Korean Foundation for Cancer Research	This study has received funding by the Research of the Korean Foundation for Cancer Research (grant number: CB-2011-02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252; Benveniste MFK, 2011, RADIOGRAPHICS, V31, P1847, DOI 10.1148/rg.317115505; Braumann U-D, 2004, BULLETIN, V1, P9; Bribiesca E, 2008, PATTERN RECOGN, V41, P543, DOI 10.1016/j.patcog.2007.06.029; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Jeong YJ, 2004, AM J ROENTGENOL, V183, P283, DOI 10.2214/ajr.183.2.1830283; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lew R., 2010, AM J BIOSTAT, V1, P1, DOI [10.3844/amjbsp.2010.1.8, DOI 10.3844/AMJBSP.2010.1.8]; Liu GB, 2012, ASIAN PAC J CANCER P, V13, P5581, DOI 10.7314/APJCP.2012.13.11.5581; Marom EM, 2013, J THORAC IMAG, V28, P69, DOI 10.1097/RTI.0b013e31828609a0; Marom EM, 2011, J THORAC ONCOL, V6, P1274, DOI 10.1097/JTO.0b013e31821c4203; Marom EM, 2010, J THORAC ONCOL, V5, pS296, DOI 10.1097/JTO.0b013e3181f209ca; Nasseri F, 2010, RADIOGRAPHICS, V30, P413, DOI 10.1148/rg.302095131; Nishino M, 2006, RADIOGRAPHICS, V26, P335, DOI 10.1148/rg.262045213; Priola AM, 2010, RADIOL MED, V115, P1, DOI 10.1007/s11547-009-0478-3; Qu YJ, 2013, ACAD RADIOL, V20, P66, DOI 10.1016/j.acra.2012.08.002; Ruffini E, 2011, EUR J CARDIO-THORAC, V40, P146, DOI 10.1016/j.ejcts.2010.09.042; Sadohara J, 2006, EUR J RADIOL, V60, P70, DOI 10.1016/j.ejrad.2006.05.003; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Takahashi K, 2010, J MAGN RESON IMAGING, V32, P1325, DOI 10.1002/jmri.22377; Tomiyama N, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1790881; Tomiyama N, 2001, J COMPUT ASSIST TOMO, V25, P388, DOI 10.1097/00004728-200105000-00010	24	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126175	10.1371/journal.pone.0126175	http://dx.doi.org/10.1371/journal.pone.0126175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938505	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000148
J	Kalinowska, M; Chavez, AE; Lutzu, S; Castillo, PE; Bukauskas, FF; Francesconi, A				Kalinowska, Magdalena; Chavez, Andres E.; Lutzu, Stefano; Castillo, Pablo E.; Bukauskas, Feliksas F.; Francesconi, Anna			Actinin-4 Governs Dendritic Spine Dynamics and Promotes Their Remodeling by Metabotropic Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ca2+; calmodulin-dependent protein kinase II (CaMKII); dendritic spine; metabotropic glutamate receptor (mGluR); neuron; synaptic plasticity; actin-binding proteins; actinin; dendritic protrusion dynamics	LONG-TERM DEPRESSION; PROTEIN-KINASE-II; DEPENDENT MORPHOLOGICAL PLASTICITY; FRAGILE-X-SYNDROME; ALPHA-ACTININ; STRUCTURAL PLASTICITY; CYTOSKELETAL PROTEIN; PROTEOMIC ANALYSIS; SYNAPSE FORMATION; F-ACTIN	Background: Group 1 mGluRs induce dendritic spine remodeling, but the underlying molecular mechanisms remain uncharacterized. Results: -Actinin-4 regulates dendritic protrusion dynamics and morphogenesis and is required for the receptor-induced dynamic remodeling of dendritic protrusions. Conclusion: -Actinin-4 is a novel molecular effector of mGluR-dependent spine remodeling. Significance: mGluR signaling via actinins could contribute to synaptic plasticity and spine dysmorphogenesis in neurodevelopmental disorders. Dendritic spines are dynamic, actin-rich protrusions in neurons that undergo remodeling during neuronal development and activity-dependent plasticity within the central nervous system. Although group 1 metabotropic glutamate receptors (mGluRs) are critical for spine remodeling under physiopathological conditions, the molecular components linking receptor activity to structural plasticity remain unknown. Here we identify a Ca2+-sensitive actin-binding protein, -actinin-4, as a novel group 1 mGluR-interacting partner that orchestrates spine dynamics and morphogenesis in primary neurons. Functional silencing of -actinin-4 abolished spine elongation and turnover stimulated by group 1 mGluRs despite intact surface receptor expression and downstream ERK1/2 signaling. This function of -actinin-4 in spine dynamics was underscored by gain-of-function phenotypes in untreated neurons. Here -actinin-4 induced spine head enlargement, a morphological change requiring the C-terminal domain of -actinin-4 that binds to CaMKII, an interaction we showed to be regulated by group 1 mGluR activation. Our data provide mechanistic insights into spine remodeling by metabotropic signaling and identify -actinin-4 as a critical effector of structural plasticity within neurons.	[Kalinowska, Magdalena; Chavez, Andres E.; Lutzu, Stefano; Castillo, Pablo E.; Bukauskas, Feliksas F.; Francesconi, Anna] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Francesconi, A (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	anna.francesconi@einstein.yu.edu	Regan, Clinton/E-6250-2012	Castillo, Pablo/0000-0002-9834-1801	National Institutes of Health [MH082870, NS072238, MH081935]; NICHD/National Institutes of Health [P30 HD071593]; NARSAD Young Investigator grant from the Brain and Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082870, R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD Young Investigator grant from the Brain and Behavior Research Foundation(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH082870 (to A.F.), NS072238 (to F.F.B.), MH081935 (to P.E.C), and NICHD/National Institutes of Health Grant P30 HD071593. This work was also supported by a NARSAD Young Investigator grant from the Brain and Behavior Research Foundation (to A.E.C.). The authors declare that they have no conflicts of interest with the contents of this article.	ABE T, 1992, J BIOL CHEM, V267, P13361; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cruz-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032446; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Deller T, 2000, HIPPOCAMPUS, V10, P569, DOI 10.1002/1098-1063(2000)10:5<569::AID-HIPO7>3.3.CO;2-D; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Foley KS, 2014, BIOCHEM J, V459, P1, DOI 10.1042/BJ20131511; Fraley TS, 2003, J BIOL CHEM, V278, P24039, DOI 10.1074/jbc.M213288200; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Francesconi A, 2009, J NEUROCHEM, V108, P1515, DOI 10.1111/j.1471-4159.2009.05913.x; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Herman E J, 2012, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-642-25758-2_11; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hunt DL, 2013, NAT NEUROSCI, V16, P1049, DOI 10.1038/nn.3461; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Jin DZ, 2013, J NEUROSCI, V33, P3402, DOI 10.1523/JNEUROSCI.3192-12.2013; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kremerskothen J, 2005, J NEUROCHEM, V92, P597, DOI 10.1111/j.1471-4159.2004.02888.x; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Merrill MA, 2007, BIOCHEMISTRY-US, V46, P8485, DOI 10.1021/bi0623025; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PAPA M, 1995, J NEUROSCI, V15, P1; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Ramiro-Cortes Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071155; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Uesaka N, 2014, SCIENCE, V344, P1020, DOI 10.1126/science.1252514; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wijetunge LS, 2008, J NEUROSCI, V28, P13028, DOI 10.1523/JNEUROSCI.2600-08.2008; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yun-Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007138; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang XL, 2013, J NEUROSCI, V33, P12510, DOI 10.1523/JNEUROSCI.2983-12.2013; Zhou ZK, 2011, J NEUROSCI, V31, P819, DOI 10.1523/JNEUROSCI.3869-10.2011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	80	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15909	15920		10.1074/jbc.M115.640136	http://dx.doi.org/10.1074/jbc.M115.640136			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944910	hybrid, Green Published			2022-12-26	WOS:000356930100002
J	Mayor, SJ; Cahill, JF; He, FL; Boutin, S				Mayor, Stephen J.; Cahill, James F., Jr.; He, Fangliang; Boutin, Stan			Scaling Disturbance Instead of Richness to Better Understand Anthropogenic Impacts on Biodiversity	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIP; HABITAT FRAGMENTATION; DIVERSITY; EXTINCTION; CONSERVATION; PATTERNS; INVASION; PLANTS; COMMUNITIES; MECHANISMS	A primary impediment to understanding how species diversity and anthropogenic disturbance are related is that both diversity and disturbance can depend on the scales at which they are sampled. While the scale dependence of diversity estimation has received substantial attention, the scale dependence of disturbance estimation has been essentially overlooked. Here, we break from conventional examination of the diversity-disturbance relationship by holding the area over which species richness is estimated constant and instead manipulating the area over which human disturbance is measured. In the boreal forest ecoregion of Alberta, Canada, we test the dependence of species richness on disturbance scale, the scale-dependence of the intermediate disturbance hypothesis, and the consistency of these patterns in native versus exotic species and among human disturbance types. We related field observed species richness in 1 ha surveys of 372 boreal vascular plant communities to remotely sensed measures of human disturbance extent at two survey scales: local (1 ha) and landscape (18 km(2)). Supporting the intermediate disturbance hypothesis, species richness-disturbance relationships were quadratic at both local and landscape scales of disturbance measurement. This suggests the shape of richness-disturbance relationships is independent of the scale at which disturbance is assessed, despite that local diversity is influenced by disturbance at different scales by different mechanisms, such as direct removal of individuals (local) or indirect alteration of propagule supply (landscape). By contrast, predictions of species richness did depend on scale of disturbance measurement: with high local disturbance richness was double that under high landscape disturbance.	[Mayor, Stephen J.; Cahill, James F., Jr.; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta; University of Alberta	Mayor, SJ (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada.	sjmayor@gmail.com	Mayor, Stephen/A-3587-2008; Boutin, Stan/A-2619-2014; Cahill, James/B-6147-2015	Mayor, Stephen/0000-0002-9479-4221; Boutin, Stan/0000-0001-6317-038X; Cahill, James/0000-0002-4110-1516	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity Fund; Alberta Biodiversity Monitoring Institute; Alberta Sport Recreation Parks & Wildlife Foundation; Canadian Circumpolar Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity Fund; Alberta Biodiversity Monitoring Institute; Alberta Sport Recreation Parks & Wildlife Foundation; Canadian Circumpolar Institute	Funding: Funding provided to SJM by Natural Sciences and Engineering Research Council of Canada, Alberta Ingenuity Fund, Alberta Biodiversity Monitoring Institute, Alberta Sport Recreation Parks & Wildlife Foundation, and Canadian Circumpolar Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABMI, 2009, TERR FIELD DAT COLL; ABMI, 2007, HUM FOOTPR MAP LAYER; Allcock KG, 2003, OIKOS, V102, P173, DOI 10.1034/j.1600-0706.2003.12345.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; AUSTIN MP, 1968, J ECOL, V56, P827, DOI 10.2307/2258109; Blackburn TM, 2002, GLOBAL ECOL BIOGEOGR, V11, P185, DOI 10.1046/j.1466-822X.2002.00290.x; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Caley MJ, 1997, OIKOS, V79, P612, DOI 10.2307/3546905; CHANETON EJ, 1991, VEGETATIO, V93, P143, DOI 10.1007/BF00033208; Clements F.E., 1916, PLANT SUCCESSION ANA; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; de Candolle A., 1855, GEOGRAPHIE BOT RAISO; de Grandpre L, 1997, J ECOL, V85, P777, DOI 10.2307/2960601; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DENSLOW JS, 1980, OECOLOGIA, V46, P18, DOI 10.1007/BF00346960; Desmet P, 2004, ECOL SOC, V9; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Dodds WK, 2009, LAWS, THEORIES, AND PATTERNS IN ECOLOGY, P1; Dumbrell AJ, 2008, J APPL ECOL, V45, P1531, DOI 10.1111/j.1365-2664.2008.01533.x; Elton C., 1958; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Fridley JD, 2004, ECOLOGY, V85, P3215, DOI 10.1890/03-0676; Garcia D, 2007, CONSERV BIOL, V21, P400, DOI 10.1111/j.1523-1739.2006.00593.x; Gleason HA, 1925, ECOLOGY, V6, P66, DOI 10.2307/1929241; Glenn-Lewin D.C., 1992, PLANT SUCCESSION; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; Greig-Smith P., 1964, QUANTITATIVE PLANT E; GREIGSMITH P, 1979, J ECOL, V67, P755, DOI 10.2307/2259213; Halley JM, 2013, SCIENCE, V339, P271, DOI 10.1126/science.1231438; Hamer KC, 2000, CONSERV BIOL, V14, P1435, DOI 10.1046/j.1523-1739.2000.99417.x; Hanski I, 1999, METAPOPULATION ECOLO; Harris L.D., 1984, FRAGMENTED FOREST IS; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; He FL, 2005, ECOLOGY, V86, P360, DOI 10.1890/04-1449; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Jaccard P., 1902, B SOC VAUD SCI NAT, V38, P69, DOI [DOI 10.5169/SEALS-266762, 10.5169/seals-266762]; Johnston A. H., 2007, Proceedings of the 8th European Conference on Radiation and its Effects on Components and Systems, P1; Kinzig AP, 2000, ECOLOGY, V81, P3305, DOI 10.1890/0012-9658(2000)081[3305:IOEARF]2.0.CO;2; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2007, INVASION ECOLOGY; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Lomolino MV, 2001, J BIOGEOGR, V28, P431, DOI 10.1046/j.1365-2699.2001.00550.x; Losos JB, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P1; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Mayor SJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2145; MCINTYRE S, 1994, CONSERV BIOL, V8, P521, DOI 10.1046/j.1523-1739.1994.08020521.x; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Natural Regions Committee, 2006, PUBL GOV ALB T, V852; Ozinga WA, 2005, OIKOS, V108, P555, DOI 10.1111/j.0030-1299.2005.13632.x; PALMER MW, 1994, AM NAT, V144, P717, DOI 10.1086/285704; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; Roxburgh SH, 2004, ECOLOGY, V85, P359, DOI 10.1890/03-0266; Sandel B, 2010, OIKOS, V119, P1281, DOI 10.1111/j.1600-0706.2010.18230.x; Schetter TA, 2013, ENVIRON MANAGE, V52, P581, DOI 10.1007/s00267-013-0120-y; Schoener T.W., 1976, P 16 INT ORNITHOLOGI, V1, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shnberloff D.S., 1974, Annual Rev Ecol Syst, V5, P161; SOULE ME, 1986, BIOL CONSERV, V35, P19, DOI 10.1016/0006-3207(86)90025-X; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; WAGNER RH, 1965, ECOLOGY, V46, P517, DOI 10.2307/1934884; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Zobel M, 2000, ECOLOGY, V81, P3274, DOI 10.1890/0012-9658(2000)081[3274:ISSSRL]2.0.CO;2	91	7	8	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125579	10.1371/journal.pone.0125579	http://dx.doi.org/10.1371/journal.pone.0125579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951058	Green Published, gold, Green Accepted			2022-12-26	WOS:000354214400036
J	Poulard, C; Rambaud, J; Lavergne, E; Jacquemetton, J; Renoir, JM; Tredan, O; Chabaud, S; Treilleux, I; Corbo, L; Le Romancer, M				Poulard, Coralie; Rambaud, Juliette; Lavergne, Emilie; Jacquemetton, Julien; Renoir, Jack-Michel; Tredan, Olivier; Chabaud, Sylvie; Treilleux, Isabelle; Corbo, Laura; Le Romancer, Muriel			Role of JMJD6 in Breast Tumourigenesis	PLOS ONE			English	Article							ARGININE METHYLATION; PROTEIN; RECEPTOR; CANCER; PRMT1; PROLIFERATION; ACTIVATION; SURVIVAL; CARM1; CELLS	Background Protein arginine methylation is a common post translational modification that regulates protein properties. This modification is carried out by a family of nine arginine methyltransferases (PRMTs). Arginine methylation has already been linked to tumourigenesis as overexpression of these enzymes was associated with various cancers, notably in breast cancers. Since the Jumonji Domain Containing 6 protein (JMJD6) possesses an arginine demethylase activity able to remove the methyl mark, we wanted to assess its potential role in breast tumourigenesis. Methods The expression of the protein by tissue microarray immunohistochemical staining was performed on a cohort of 133 breast tumours. Using cell lines stably overexpressing or knocked down for JMJD6, we evaluated its role on cell proliferation, cell migration, colony formation and mice tumour xenografts. Results The analysis of JMJD6 expression in a cohort of breast tumour samples indicates that JMJD6 was highly expressed in aggressive breast tumours. Moreover, high expression of JMJD6 was associated with poor disease-free survival of patients in this cohort. JMJD6 silencing in breast tumoural cells promotes certain characteristics of tumourigenesis including proliferation, migration in vitro, and tumour growth in vivo. These effects are dependent on its demethylase activity as an enzymatic dead mutant lost these properties. Conclusions Although JMJD6 displays anti-tumoral properties in cell lines, its expression in breast tumours may be a marker of poor prognosis, suggesting that its function could be altered in breast cancer.	[Poulard, Coralie; Rambaud, Juliette; Jacquemetton, Julien; Corbo, Laura; Le Romancer, Muriel] Univ Lyon, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Jacquemetton, Julien; Corbo, Laura; Le Romancer, Muriel] Univ Lyon 1, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Jacquemetton, Julien; Corbo, Laura; Le Romancer, Muriel] Ctr Rech Cancerol Lyon, INSERM, U1052, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Jacquemetton, Julien; Corbo, Laura; Le Romancer, Muriel] Ctr Rech Cancerol Lyon, CNRS, UMR5286, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Jacquemetton, Julien; Corbo, Laura; Le Romancer, Muriel] Equipe Labellisee La Ligue, F-69000 Lyon, France; [Lavergne, Emilie; Chabaud, Sylvie] Ctr Leon Berard, Biostat Unit, F-69000 Lyon, France; [Renoir, Jack-Michel] Inst Gustave Roussy, CNRS, UMR Vectorol & Anticanc Therapeut 8203, F-94805 Villejuif, France; [Tredan, Olivier] Ctr Leon Berard, Dept Med Oncol, F-69000 Lyon, France; [Treilleux, Isabelle] Ctr Leon Berard, Dept Pathol, F-69000 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard	Le Romancer, M (corresponding author), Univ Lyon, F-69000 Lyon, France.	muriel.leromancer@lyon.unicancer.fr	Tredan, Olivier/N-9794-2017	Tredan, Olivier/0000-0001-5881-9383; Le Romancer, Muriel/0000-0002-8491-4015; Poulard, coralie/0000-0003-4821-908X; Jacquemetton, Julien/0000-0003-0513-6604; Migliaccio, Antimo/0000-0002-4197-2055	"Fondation Arc Cancer" (ARC); Fondation de France (FDF); Ligue contre le cancer, comite de Saone-et-Loire; French Ministry of Research; ARC	"Fondation Arc Cancer" (ARC)(Australian Research Council); Fondation de France (FDF)(Fondation de France); Ligue contre le cancer, comite de Saone-et-Loire; French Ministry of Research(Ministry of Research, FranceEuropean Commission); ARC(Australian Research Council)	This study was supported by the "Fondation Arc Cancer" (ARC) and Fondation de France (FDF) and the Ligue contre le cancer, comite de Saone-et-Loire. CP was supported by the French Ministry of Research and by Arc, KBB, JR by FDF and JJ by ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Baldwin RM, 2012, CELL CYCLE, V11, P4597, DOI 10.4161/cc.22871; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bouchekioua-Bouzaghou K, 2014, INT J CANCER, V135, P1307, DOI 10.1002/ijc.28781; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Guendel I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011379; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	28	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126181	10.1371/journal.pone.0126181	http://dx.doi.org/10.1371/journal.pone.0126181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951181	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400072
J	Abdelhaq, M; Alsaqour, R; Abdelhaq, S				Abdelhaq, Maha; Alsaqour, Raed; Abdelhaq, Shawkat			Securing Mobile Ad Hoc Networks Using Danger Theory-Based Artificial Immune Algorithm	PLOS ONE			English	Article							MISBEHAVIOR DETECTION; SYSTEM	A mobile ad hoc network (MANET) is a set of mobile, decentralized, and self-organizing nodes that are used in special cases, such as in the military. MANET properties render the environment of this network vulnerable to different types of attacks, including black hole, wormhole and flooding-based attacks. Flooding-based attacks are one of the most dangerous attacks that aim to consume all network resources and thus paralyze the functionality of the whole network. Therefore, the objective of this paper is to investigate the capability of a danger theory-based artificial immune algorithm called the mobile dendritic cell algorithm (MDCA) to detect flooding-based attacks in MANETs. The MDCA applies the dendritic cell algorithm (DCA) to secure the MANET with additional improvements. The MDCA is tested and validated using Qualnet v7.1 simulation tool. This work also introduces a new simulation module for a flooding attack called the resource consumption attack (RCA) using Qualnet v7.1. The results highlight the high efficiency of the MDCA in detecting RCAs in MANETs.	[Abdelhaq, Maha; Alsaqour, Raed] Univ Kebangsaan Malaysia, Sch Comp Sci, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia; [Abdelhaq, Shawkat] Indiana Wesleyan Univ, Fac Business Adm, Marion, IN 46953 USA	Universiti Kebangsaan Malaysia	Abdelhaq, M (corresponding author), Univ Kebangsaan Malaysia, Sch Comp Sci, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia.	maha.ukm@gmail.com	Alsaqour, Raed/AGE-6309-2022	Alsaqour, Raed/0000-0003-2350-5661; Abdelhaq, Maha/0000-0002-4504-9508	Ministry of Higher Education, Malaysia & University Kebangsaan Malaysia (UKM), Malaysia [FRGS/1/2012/SG05/UKM/02/7, DIP-2014-037]	Ministry of Higher Education, Malaysia & University Kebangsaan Malaysia (UKM), Malaysia	This research was supported in part by the Ministry of Higher Education, Malaysia & University Kebangsaan Malaysia (UKM), Malaysia under the research Grant numbers: FRGS/1/2012/SG05/UKM/02/7 and DIP-2014-037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaq M, 2014, INT J COMMUN SYST, V27, P4328, DOI 10.1002/dac.2615; Abdelhaq M, 2011, COMM COM INF SC, V181, P429; Aickelin U, 2003, LECT NOTES COMPUT SC, V2787, P147; Aickelin U, ARXIV200808013549; Anantvalee T, 2007, SIGNALS COMMUN TECHN, P159, DOI 10.1007/978-0-387-33112-6_7; Chaki N, 2014, INTRUSION DETECTION; Chung-Ming O, 2010, NEUROCOMPUTING, V88, P78; Das R, 2003, IETF MANET INTERNET; Dasgupta D, 2011, APPL SOFT COMPUT, V11, P1574, DOI 10.1016/j.asoc.2010.08.024; Drozda M, 2010, STUD COMPUT INTELL, V260, P1, DOI 10.1007/978-3-642-04584-4_1; Fanelli RL, 2010, LECT NOTES COMPUT SC, V6209, P264, DOI 10.1007/978-3-642-14547-6_21; Greensmith J, 2005, LECT NOTES COMPUT SC, V3627, P153; Greensmith J, 2010, INFORM FUSION, V11, P21, DOI 10.1016/j.inffus.2009.04.006; Kant L, 2008, IEEE COMMUN MAG, V46, P55, DOI 10.1109/MCOM.2008.4689245; Marti S., 2000, P 6 ANN INT C MOB CO; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Meisel M, 2010, COMPUT NETW, V54, P901, DOI 10.1016/j.comnet.2009.08.022; Sarafijanovic S, 2005, IEEE T NEURAL NETWOR, V16, P1076, DOI 10.1109/TNN.2005.853419; Sarafijanovic S, 2004, LECT NOTES COMPUT SC, V3239, P342; Simulator QN, 2011, SCAL NETW TECHN; Taneja S., 2010, INT J INNOVATION MAN, V1, P279; Wallenta C, 2010, APPL INTELL, V32, P1, DOI 10.1007/s10489-008-0132-0; Wu SX, 2010, APPL SOFT COMPUT, V10, P1, DOI 10.1016/j.asoc.2009.06.019; Zhang Y, 2000, P 6 ANN INT C MOB CO	25	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0120715	10.1371/journal.pone.0120715	http://dx.doi.org/10.1371/journal.pone.0120715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946001	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700002
J	Ding, F; Duan, YP; Paul, C; Brlansky, RH; Hartung, JS				Ding, Fang; Duan, Yongping; Paul, Cristina; Brlansky, Ronald H.; Hartung, John S.			Localization and Distribution of 'Candidatus Liberibacter asiaticus' in Citrus and Periwinkle by Direct Tissue Blot Immuno Assay with an Anti-OmpA Polyclonal Antibody	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; REAL-TIME PCR; GREENING DISEASE; SWEET ORANGE; HUANGLONGBING DISEASE; TRANSMISSION; INFECTION; AMERICANUS; BACTERIUM; ORGANISM	'Candidatus Liberibacter asiaticus' (CaLas), a non-cultured member of the alpha-proteobacteria, is the causal agent of citrus Huanglongbing (HLB). Due to the difficulties of in vitro culture, antibodies against CaLas have not been widely used in studies of this pathogen. We have used an anti-OmpA polyclonal antibody based direct tissue blot immunoassay to localize CaLas in different citrus tissues and in periwinkle leaves. In citrus petioles, CaLas was unevenly distributed in the phloem sieve tubes, and tended to colonize in phloem sieve tubes on the underside of petioles in preference to the upper side of petioles. Both the leaf abscission zone and the junction of the petiole and leaf midrib had fewer CaLas bacteria compared to the main portions of the petiole and the midribs. Colonies of CaLas in phloem sieve tubes were more frequently found in stems with symptomatic leaves than in stems with asymptomatic leaves with an uneven distribution pattern. In serial sections taken from the receptacle to the peduncle, more CaLas were observed in the peduncle sections adjacent to the stem. In seed, CaLas was located in the seed coat. Many fewer CaLas were found in the roots, as compared to the seeds and petioles when samples were collected from trees with obvious foliar symptoms. The direct tissue blot immuno assay was adapted to whole periwinkle leaves infected by CaLas. The pathogen was distributed throughout the lateral veins and the results were correlated with results of qPCR. Our data provide direct spatial and anatomical information for CaLas in planta. This simple and scalable method may facilitate the future research on the interaction of CaLas and host plant.	[Ding, Fang; Paul, Cristina; Hartung, John S.] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA; [Ding, Fang] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Duan, Yongping] USDA ARS, Hort Res Lab, Ft Pierce, FL USA; [Brlansky, Ronald H.] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL USA	United States Department of Agriculture (USDA); Huazhong Agricultural University; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Hartung, JS (corresponding author), USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	John.Hartung@ars.usda.gov			Citrus Research and Development Foundation [551]; United States Department of Agriculture ARS [8042-22000-281-00D]; ARS [ARS-0422986] Funding Source: Federal RePORTER	Citrus Research and Development Foundation; United States Department of Agriculture ARS(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding provided by Grant #551 Citrus Research and Development Foundation, http://citrusrdf.org/ to JSH and Project 8042-22000-281-00D, United States Department of Agriculture ARS to JSH.	Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Amari K, 2001, ACTA HORTIC, P315, DOI 10.17660/ActaHortic.2001.550.45; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Beattie GAC, 2008, P INT RES C HUNGL DE, P2356; Bove JM, 2006, J PLANT PATHOL, V88, P7; Davis MJ, 2008, PLANT DIS, V92, P1547, DOI 10.1094/PDIS-92-11-1547; Ding F, 2005, J PLANT PATHOL, V87, P207; Duan YP, 2008, PLANT DIS, V92, P831, DOI 10.1094/PDIS-92-5-0831C; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Francischini FJB, 2007, PLANT DIS, V91, P631, DOI 10.1094/PDIS-91-5-0631B; Fujikawa T, 2012, MOL CELL PROBE, V26, P194, DOI 10.1016/j.mcp.2012.06.001; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; Garcia-Luis A, 2002, ANN BOT-LONDON, V90, P755, DOI 10.1093/aob/mcf257; GARNIER M, 1983, PHYTOPATHOLOGY, V73, P1358, DOI 10.1094/Phyto-73-1358; Garnier M, 1984, ANN MICROBIOL, V79, P90; Garnsey S M, 1993, P 12 C INT ORG CITR, P39; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; GOTTWALD TR, 1989, PHYTOPATHOLOGY, V79, P687, DOI 10.1094/Phyto-79-687; Gottwald TR, 2007, PLANT HLTH PROGR ONL; Hahn H, 2003, PLANT BREEDING, V122, P217, DOI 10.1046/j.1439-0523.2003.00855.x; Hartung JS, 2010, PHYTOPATHOLOGY, V100, P756, DOI 10.1094/PHYTO-100-8-0756; Hilf ME, 2013, PHYTOPATHOLOGY, V103, P545, DOI 10.1094/PHYTO-09-12-0226-R; Hoffman MT, 2013, PHYTOPATHOLOGY, V103, P15, DOI 10.1094/PHYTO-06-12-0138-R; Hu H, 2013, PLANT DIS, V97, P1158, DOI 10.1094/PDIS-09-12-0880-RE; HUSAIN MOHAMMAD AFZAL, 1927, MEM DEPT AGRIC INDIA ENT SER, V10, P5; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Johnson EG, 2014, PLANT PATHOL, V63, P290, DOI 10.1111/ppa.12109; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; KNAPP E, 1995, J VIROL METHODS, V55, P157, DOI 10.1016/0166-0934(95)00033-Q; Kunta M, 2014, SCI HORTIC-AMSTERDAM, V178, P23, DOI 10.1016/j.scienta.2014.07.041; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Lopes SA, 2009, PLANT DIS, V93, P257, DOI 10.1094/PDIS-93-3-0257; MCCLURE BA, 1989, PLANT MOL BIOL, V12, P517, DOI 10.1007/BF00036966; Melberg AR, 2009, BIOCHEM MOL BIOL EDU, V37, P92, DOI 10.1002/bmb.20246; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Neinchinov LG, 2007, PROTEIN EXPRES PURIF, V56, P153, DOI 10.1016/j.pep.2007.05.015; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Pagliai FA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004101; Pont-Lezica RF, 2009, METHODS MOL BIOL, V536, P75, DOI 10.1007/978-1-59745-542-8_10; Rigano LA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-86; Rouse B, 2013, PROC FL STATE HORTIC, V126, P51; S. P. CAPOOR, 1963, Decline of Citrus trees in India., P48; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Trivedi P, 2009, EUR J PLANT PATHOL, V124, P553, DOI 10.1007/s10658-009-9439-x; VARNER JE, 1994, FASEB J, V8, P378, DOI 10.1096/fasebj.8.6.8168688; VILLECHANOUX S, 1992, CURR MICROBIOL, V24, P89, DOI 10.1007/BF01570903; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wulff NA, 2014, MOL PLANT MICROBE IN, V27, P163, DOI 10.1094/MPMI-09-13-0292-R; Yan Q, 2013, MOL PLANT PATHOL, V14, P391, DOI 10.1111/mpp.12015; Zhao HW, 2013, MOL PLANT, V6, P301, DOI 10.1093/mp/sst002	58	30	36	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123939	10.1371/journal.pone.0123939	http://dx.doi.org/10.1371/journal.pone.0123939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946013	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700026
J	Kolderman, E; Bettampadi, D; Samarian, D; Dowd, SE; Foxman, B; Jakubovics, NS; Rickard, AH				Kolderman, Ethan; Bettampadi, Deepti; Samarian, Derek; Dowd, Scot E.; Foxman, Betsy; Jakubovics, Nicholas S.; Rickard, Alexander H.			L-Arginine Destabilizes Oral Multi-Species Biofilm Communities Developed in Human Saliva	PLOS ONE			English	Article							DENTAL PLAQUE; PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; STREPTOCOCCUS-MUTANS; BACTERIAL INTERACTIONS; ACTINOMYCES-VISCOSUS; COAGGREGATION; DIVERSITY; ADHESION; GROWTH	The amino acid L-arginine inhibits bacterial coaggregation, is involved in cell-cell signaling, and alters bacterial metabolism in a broad range of species present in the human oral cavity. Given the range of effects of L-arginine on bacteria, we hypothesized that L-arginine might alter multi-species oral biofilm development and cause developed multi-species biofilms to disassemble. Because of these potential biofilm-destabilizing effects, we also hypothesized that L-arginine might enhance the efficacy of antimicrobials that normally cannot rapidly penetrate biofilms. A static microplate biofilm system and a controlled-flow microfluidic system were used to develop multi-species oral biofilms derived from pooled unfiltered cell-containing saliva (CCS) in pooled filter-sterilized cell-free saliva (CFS) at 37 degrees C. The addition of pH neutral L-arginine monohydrochloride (LAHCl) to CFS was found to exert negligible antimicrobial effects but significantly altered biofilm architecture in a concentration-dependent manner. Under controlled flow, the biovolume of biofilms (mu m(3)/mu m(2)) developed in saliva containing 100-500 mM LAHCl were up to two orders of magnitude less than when developed without LAHCI. Culture-independent community analysis demonstrated that 500 mM LAHCl substantially altered biofilm species composition: the proportion of Streptococcus and Veillonella species increased and the proportion of Gram-negative bacteria such as Neisseria and Aggregatibacter species was reduced. Adding LAHCl to pre-formed biofilms also reduced biovolume, presumably by altering cell-cell interactions and causing cell detachment. Furthermore, supplementing 0.01% cetylpyridinium chloride (CPC), an antimicrobial commonly used for the treatment of dental plaque, with 500 mM LAHCl resulted in greater penetration of CPC into the biofilms and significantly greater killing compared to a non-supplemented 0.01% CPC solution. Collectively, this work demonstrates that LAHCl moderates multi-species oral biofilm development and community composition and enhances the activity of CPC. The incorporation of LAHCl into oral healthcare products may be useful for enhanced biofilm control.	[Kolderman, Ethan; Bettampadi, Deepti; Samarian, Derek; Foxman, Betsy; Rickard, Alexander H.] Univ Michigan, Dept Epidemiol, Ctr Mol & Clin Epidemiol Infect Dis, Ann Arbor, MI 48109 USA; [Dowd, Scot E.] Mol Res LP MR DNA, Shallowater, TX USA; [Jakubovics, Nicholas S.] Newcastle Univ, Ctr Oral Hlth Res, Sch Dent Sci, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England	University of Michigan System; University of Michigan; Newcastle University - UK	Rickard, AH (corresponding author), Univ Michigan, Dept Epidemiol, Ctr Mol & Clin Epidemiol Infect Dis, Ann Arbor, MI 48109 USA.	alexhr@umich.edu	Dowd, Scot E/M-5386-2017; Bettampadi, Deepti/W-5804-2019; Jakubovics, Nicholas S/B-1938-2010	Dowd, Scot E/0000-0002-6296-1427; Bettampadi, Deepti/0000-0002-4331-1568; Jakubovics, Nicholas S/0000-0001-6667-0515	AHR; Molecular Research LP	AHR; Molecular Research LP	The work described was supported by UM start-up funds provided to AHR. Co-author SED is the CEO of Molecular Research LP. SED and the company for which he works did not contribute financially to this work. Molecular Research LP provided support in the form of salary for author SED. Molecular Research LP did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; [Anonymous], 2011, ORAL HLTH PREVENTING; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bjorklund M, 2011, CURR MICROBIOL, V63, P46, DOI 10.1007/s00284-011-9937-x; Boneta ARE, 2013, J DENT, V41, pS34, DOI 10.1016/j.jdent.2012.11.004; Borriello G, 2006, ANTIMICROB AGENTS CH, V50, P382, DOI 10.1128/AAC.50.1.382-384.2006; Burne R A, 2012, Adv Dent Res, V24, P77, DOI 10.1177/0022034512449462; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; DEJONG MH, 1987, J DENT RES, V66, P498, DOI 10.1177/00220345870660021901; Edwards AM, 2007, ORAL MICROBIOL IMMUN, V22, P217, DOI 10.1111/j.1399-302X.2006.00343.x; ELLEN RP, 1992, ORAL MICROBIOL IMMUN, V7, P198, DOI 10.1111/j.1399-302X.1992.tb00025.x; EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V26, P473, DOI 10.1093/jac/26.4.473; Fu DJ, 2013, J DENT, V41, P619, DOI 10.1016/j.jdent.2013.04.013; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Gilbert P, 2002, J APPL MICROBIOL, V92, p98S, DOI 10.1046/j.1365-2672.92.5s1.5.x; Gilbert P, 2002, ADV MICROB PHYSIOL, V46, P203, DOI 10.1016/S0065-2911(02)46005-5; Gordan VV, 2010, CARIES RES, V44, P547, DOI 10.1159/000321139; GRENIER D, 1992, ORAL MICROBIOL IMMUN, V7, P280, DOI 10.1111/j.1399-302X.1992.tb00589.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Izano EA, 2007, J DENT RES, V86, P618, DOI 10.1177/154405910708600707; Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; Jakubovics NS, 2008, J BACTERIOL, V190, P3646, DOI 10.1128/JB.00088-08; Jakubovics NS, 2014, ADV APPL MICROBIOL, V87, P43, DOI 10.1016/B978-0-12-800261-2.00002-5; Kamaguchi A, 2001, MICROBIOL IMMUNOL, V45, P649, DOI 10.1111/j.1348-0421.2001.tb01298.x; Kasper SH, 2014, J APPL MICROBIOL, V117, P1472, DOI 10.1111/jam.12616; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Korber DR, 1996, APPL ENVIRON MICROB, V62, P3939, DOI 10.1128/AEM.62.11.3939-3947.1996; Levesque C, 2003, ORAL MICROBIOL IMMUN, V18, P333, DOI 10.1034/j.1399-302X.2003.00085.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756; Marsh PD, 2003, ORAL DIS, V9, P16, DOI 10.1034/j.1601-0825.9.s1.4.x; NAGATA H, 1990, J DENT RES, V69, P1476, DOI 10.1177/00220345900690080501; Nance WC, 2013, J ANTIMICROB CHEMOTH, V68, P2550, DOI 10.1093/jac/dkt211; Nascimento MM, 2014, MOL ORAL MICROBIOL, V29, P45, DOI 10.1111/omi.12044; Nascimento MM, 2013, J DENT RES, V92, P604, DOI 10.1177/0022034513487907; Nascimento MM, 2009, ORAL MICROBIOL IMMUN, V24, P89, DOI 10.1111/j.1399-302X.2008.00477.x; Petrou Irene, 2009, J Clin Dent, V20, P23; Pratten J, 1998, J APPL MICROBIOL, V84, P1149; RITZ HL, 1969, ARCH ORAL BIOL, V14, P1073, DOI 10.1016/0003-9969(69)90077-6; RITZ HL, 1967, ARCH ORAL BIOL, V12, P1561, DOI 10.1016/0003-9969(67)90190-2; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI 10.1586/ERI.10.106; ROGERS AH, 1987, MICROBIAL ECOL, V14, P193, DOI 10.1007/BF02012940; Sato T, 2014, J MICROBIOL IMMUNOL, V47, P182, DOI 10.1016/j.jmii.2012.09.005; Sharma S, 2014, MICROBIOL-SGM, V160, P1466, DOI 10.1099/mic.0.075267-0; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Sissons C H, 1997, Adv Dent Res, V11, P110; SOLOMONS CC, 1971, PEDIATRICS, V47, P384; TAKEMOTO T, 1993, J PERIODONTAL RES, V28, P21, DOI 10.1111/j.1600-0765.1993.tb01046.x; ten Cate J M, 2012, Adv Dent Res, V24, P108, DOI 10.1177/0022034512450028; Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513; Wong L, 2001, ARCH ORAL BIOL, V46, P477, DOI 10.1016/S0003-9969(01)00016-4; Wu CC, 2015, MOL ORAL MICROBIOL, V30, P16, DOI 10.1111/omi.12063; Xie H, 2007, MICROBIOL-SGM, V153, P3228, DOI 10.1099/mic.0.2007/009050-0; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	63	64	68	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0121835	10.1371/journal.pone.0121835	http://dx.doi.org/10.1371/journal.pone.0121835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946040	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700004
J	Li, GZ; Shao, FF; Zhang, H; Zou, CP; Li, HH; Jin, J				Li, Guo-Zheng; Shao, Feng-Feng; Zhang, Hao; Zou, Chun-Pu; Li, Hui-Hui; Jin, Jue			High Mean Water Vapour Pressure Promotes the Transmission of Bacillary Dysentery	PLOS ONE			English	Article							CLIMATE-CHANGE; SHIGELLA-FLEXNERI; HUMAN HEALTH; TEMPERATURE; DIARRHEA; DISEASE; CITIES; CHINA	Bacillary dysentery is an infectious disease caused by Shigella dysenteriae, which has a seasonal distribution. External environmental factors, including climate, play a significant role in its transmission. This paper identifies climate-related risk factors and their role in bacillary dysentery transmission. Harbin, in northeast China, with a temperate climate, and Quzhou, in southern China, with a subtropical climate, are chosen as the study locations. The least absolute shrinkage and selectionator operator is applied to select relevant climate factors involved in the transmission of bacillary dysentery. Based on the selected relevant climate factors and incidence rates, an AutoRegressive Integrated Moving Average (ARIMA) model is established successfully as a time series prediction model. The numerical results demonstrate that the mean water vapour pressure over the previous month results in a high relative risk for bacillary dysentery transmission in both cities, and the ARIMA model can successfully perform such a prediction. These results provide better explanations for the relationship between climate factors and bacillary dysentery transmission than those put forth in other studies that use only correlation coefficients or fitting models. The findings in this paper demonstrate that the mean water vapour pressure over the previous month is an important predictor for the transmission of bacillary dysentery.	[Li, Guo-Zheng] China Acad Chinese Med Sci, Data Ctr Tradit Chinese Med, Beijing, Peoples R China; [Shao, Feng-Feng; Li, Hui-Hui] Tongji Univ, Dept Control Sci & Engn, Shanghai 200092, Peoples R China; [Zhang, Hao; Zou, Chun-Pu; Jin, Jue] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Shanghai, Peoples R China	China Academy of Chinese Medical Sciences; Tongji University; Shanghai University of Traditional Chinese Medicine	Zou, CP (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Basic Med, Shanghai, Peoples R China.	chunpuzou@126.com	Li, Guo-Zheng/D-5744-2011	Li, Guo-Zheng/0000-0001-5568-0347	Natural Science Foundation of China [61105053, 61273305]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China under grant nos. 61105053 and 61273305. The funders had roles in data collection and preparation of the manuscript.	ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; Contreras J, 2003, IEEE T POWER SYST, V18, P1014, DOI 10.1109/TPWRS.2002.804943; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; Kolstad EW, 2011, ENVIRON HEALTH PERSP, V119, P299, DOI 10.1289/ehp.1002060; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Lama JR, 2004, J HEALTH POPUL NUTR, V22, P399; Ma WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062122; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Niyogi SK, 2005, J MICROBIOL, V43, P133; Onozuka D, 2010, EPIDEMIOL INFECT, V138, P236, DOI 10.1017/S0950268809990574; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Tam CC, 2006, EPIDEMIOL INFECT, V134, P119, DOI 10.1017/S0950268805004899; Tang F, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083487, DOI 10.1371/JOURNAL.PONE.0083487]; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhang Y, 2012, J ENVIRON MONITOR, V14, P510, DOI 10.1039/c1em10391a; Ziegel ER., 2012, TECHNOMETRICS, V36, P434, DOI [10.1080/00401706.1994.10485868, DOI 10.1080/00401706.1994.10485868]	20	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124478	10.1371/journal.pone.0124478	http://dx.doi.org/10.1371/journal.pone.0124478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946209	gold, Green Submitted, Green Published			2022-12-26	WOS:000354049700044
J	Mooij, P; Koopman, G; Mortier, D; van Heteren, M; Oostermeijer, H; Fagrouch, Z; de Laat, R; Kobinger, G; Li, Y; Remarque, EJ; Kondova, I; Verschoor, EJ; Bogers, WMJM				Mooij, Petra; Koopman, Gerrit; Mortier, Daniella; van Heteren, Melanie; Oostermeijer, Herman; Fagrouch, Zahra; de Laat, Rudy; Kobinger, Gary; Li, Yan; Remarque, Edmond J.; Kondova, Ivanela; Verschoor, Ernst J.; Bogers, Willy M. J. M.			Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets	PLOS ONE			English	Article							A VIRUS; PROTECTIVE IMMUNITY; ANIMAL-MODELS; MACAQUES; INFECTION; RESPONSES; PATHOGENESIS; EXPRESSION	The close immunological and physiological resemblance with humans makes non-human primates a valuable model for studying influenza virus pathogenesis and immunity and vaccine efficacy against infection. Although both cynomolgus and rhesus macaques are frequently used in influenza virus research, a direct comparison of susceptibility to infection and disease has not yet been performed. In the current study a head-to-head comparison was made between these species, by using a recently described swine-origin pandemic H1N1 strain, A/Mexico/InDRE4487/2009. In comparison to rhesus macaques, cynomolgus macaques developed significantly higher levels of virus replication in the upper airways and in the lungs, involving both peak level and duration of virus production, as well as higher increases in body temperature. In contrast, clinical symptoms, including respiratory distress, were more easily observed in rhesus macaques. Expression of sialyl-alpha-2,6-Gal saccharides, the main receptor for human influenza A viruses, was 50 to 73 times more abundant in trachea and bronchus of cynomolgus macaques relative to rhesus macaques. The study also shows that common marmosets, a New World non-human primate species, are susceptible to infection with pandemic H1N1. The study results favor the cynomolgus macaque as model for pandemic H1N1 influenza virus research because of the more uniform and high levels of virus replication, as well as temperature increases, which may be due to a more abundant expression of the main human influenza virus receptor in the trachea and bronchi.	[Mooij, Petra; Koopman, Gerrit; Mortier, Daniella; van Heteren, Melanie; Oostermeijer, Herman; Fagrouch, Zahra; de Laat, Rudy; Verschoor, Ernst J.; Bogers, Willy M. J. M.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Kobinger, Gary; Li, Yan] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kondova, Ivanela] Biomed Primate Res Ctr, Dept Anim Sci, Rijswijk, Netherlands	Public Health Agency of Canada	Koopman, G (corresponding author), Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands.	koopman@bprc.nl	Remarque, Ed/AAE-8643-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092843] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI092843] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004; BAUM LG, 1990, ACTA HISTOCHEM, P35; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Bontrop RE, 2001, IMMUNOL REV, V183, P5, DOI 10.1034/j.1600-065x.2001.1830101.x; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brining DL, 2010, COMPARATIVE MED, V60, P389; Cameron MJ, CYTOKINES CHEMOKINES; Carroll TD, 2011, VACCINE, V29, P931, DOI 10.1016/j.vaccine.2010.11.024; Chen YX, 2009, ARCH VIROL, V154, P227, DOI 10.1007/s00705-008-0277-5; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Henle W, 1943, J IMMUNOL, V46, P163; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Josset L, 2012, J VIROL, V86, P11115, DOI 10.1128/JVI.01571-12; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koopman G, 2012, VACCINE, V30, P2523, DOI 10.1016/j.vaccine.2012.01.082; Matsuoka Y, 2014, J VIROL, V88, P8139, DOI 10.1128/JVI.00425-14; Matzinger SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029255; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Poon LLM, 2009, CLIN CHEM, V55, P1555, DOI 10.1373/clinchem.2009.130229; Rimmelzwaan GF, 2001, VACCINE, V20, P158, DOI 10.1016/S0264-410X(01)00262-6; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com	31	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126132	10.1371/journal.pone.0126132	http://dx.doi.org/10.1371/journal.pone.0126132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946071	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700113
J	Liou, JM; Chang, CY; Chen, MJ; Chen, CC; Fang, YJ; Lee, JY; Wu, JY; Luo, JC; Liou, TC; Chang, WH; Tseng, CH; Wu, CY; Yang, TH; Chang, CC; Wang, HP; Sheu, BS; Lin, JT; Bair, MJ; Wu, MS				Liou, Jyh-Ming; Chang, Chi-Yang; Chen, Mei-Jyh; Chen, Chieh-Chang; Fang, Yu-Jen; Lee, Ji-Yuh; Wu, Jeng-Yih; Luo, Jiing-Chyuan; Liou, Tai-Cherng; Chang, Wen-Hsiung; Tseng, Cheng-Hao; Wu, Chun-Ying; Yang, Tsung-Hua; Chang, Chun-Chao; Wang, Hsiu-Po; Sheu, Bor-Shyang; Lin, Jaw-Town; Bair, Ming-Jong; Wu, Ming-Shiang		Taiwan Gastrointestinal Dis Helico	The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ERADICATION THERAPY; TRIPLE THERAPIES; PREVALENCE; INFECTION; TRIAL; MULTICENTER; EVOLUTION; 1ST-LINE; EFFICACY	Objective The Taiwan Government issued a policy to restrict antimicrobial usage since 2001. We aimed to assess the changes in the antibiotic consumption and the primary resistance of H. pylori after this policy and the impact of virulence factors on resistance. Methods The defined daily dose (DDD) of antibiotics was analyzed using the Taiwan National Health Insurance (NHI) research database. H. pylori strains isolated from treatment naive (N=1395) and failure from prior eradication therapies (N=360) from 9 hospitals between 2000 and 2012 were used for analysis. The minimum inhibitory concentration was determined by agar dilution test. Genotyping for CagA and VacA was determined by PCR method. Results The DDD per 1000 persons per day of macrolides reduced from 1.12 in 1997 to 0.19 in 2008, whereas that of fluoroquinolones increased from 0.12 in 1997 to 0.35 in 2008. The primary resistance of amoxicillin, clarithromycin, metronidazole, and tetracycline remained as low as 2.2%, 7.9%, 23.7%, and 1.9% respectively. However, the primary levofloxacin resistance rose from 4.9% in 2000-2007 to 8.3% in 2008-2010 and 13.4% in 2011-2012 (p=0.001). The primary resistance of metronidazole was higher in females than males (33.1% vs. 18.8%, p<0.001), which was probably attributed to the higher consumption of nitroimidazole. Neither CagA nor VacA was associated with antibiotic resistance. Conclusions The low primary clarithromycin and metronidazole resistance of H. pylori in Taiwan might be attributed to the reduced consumption of macrolides and nitroimidazole after the national policy to restrict antimicrobial usage. Yet, further strategies are needed to restrict the consumption of fluoroquinolones in the face of rising levofloxacin resistance.	[Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chieh-Chang; Wang, Hsiu-Po; Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chang, Chi-Yang; Tseng, Cheng-Hao] E DA Hosp, Dept Internal Med, Kaohsiung, Kaohsiung Count, Taiwan; [Chang, Chi-Yang; Tseng, Cheng-Hao] I Shou Univ, Kaohsiung, Kaohsiung Count, Taiwan; [Fang, Yu-Jen; Lee, Ji-Yuh; Yang, Tsung-Hua] Natl Taiwan Univ, Coll Med, Yun Lin Branch, Dept Internal Med,Natl Taiwan Univ Hosp, Yunlin, Taiwan; [Wu, Jeng-Yih] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Luo, Jiing-Chyuan] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Luo, Jiing-Chyuan] Taipei Vet Gen Hosp, Taipei, Taiwan; [Liou, Tai-Cherng; Chang, Wen-Hsiung] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Chun-Ying] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Wu, Chun-Ying] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Chang, Chun-Chao] Taipei Med Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Sheu, Bor-Shyang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Bair, Ming-Jong] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung Branch, Taitung, Taiwan; [Bair, Ming-Jong] Meiho Univ, Dept Nursing, Pingtung, Taiwan	National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Mackay Memorial Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Fu Jen Catholic University; Mackay Memorial Hospital	Bair, MJ (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung Branch, Taitung, Taiwan.	a5963@ttms.mmh.org.tw; mingshiang@ntu.edu.tw	Chen, Chieh-Chang/ABD-3228-2021; Wu, Chun-Ying/AAX-5077-2021	Wu, Chun-Ying/0000-0001-5053-1801; Chen, Mei-Jyh/0000-0003-3284-004X; LIOU, JYH-MING/0000-0002-7945-5408; Chen, Chieh-Chang/0000-0003-2953-210X; Wu, Ming-Shiang/0000-0002-1940-6428	National Clinical Trial Center of National Taiwan University Hospital [NTUH103 -002516]; National Science Council, Executive Yuan, ROC,Taiwan [NSC 100-2325-B-002-063, 101-2325-B-002-074, 102-2325-B-002-074]	National Clinical Trial Center of National Taiwan University Hospital; National Science Council, Executive Yuan, ROC,Taiwan	JML was funded by the National Clinical Trial Center of National Taiwan University Hospital (NTUH103 -002516) and MSW was funded by the National Science Council, Executive Yuan, ROC,Taiwan (NSC 100-2325-B-002-063, 101-2325-B-002-074, and 102-2325-B-002-074). All authors do not have conflicts of interests that are relevant to the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana LP, 2002, HELICOBACTER, V7, P306; Binh TT, 2013, J CLIN GASTROENTEROL, V47, P233, DOI 10.1097/MCG.0b013e3182676e2b; Camargo MC, 2014, AM J GASTROENTEROL, V109, P485, DOI 10.1038/ajg.2014.24; Chang SC, 2001, J FORMOS MED ASSOC, V100, P155; De Francesco V, 2006, J MICROBIOL, V44, P660; Deyi VYM, 2011, J CLIN MICROBIOL, V49, P2200, DOI 10.1128/JCM.02642-10; Gao W, 2010, HELICOBACTER, V15, P460, DOI 10.1111/j.1523-5378.2010.00788.x; Ho M, 2004, INT J ANTIMICROB AG, V23, P438, DOI 10.1016/j.ijantimicag.2003.10.013; Huang AH, 2000, J FORMOS MED ASSOC, V99, P704; Huang LY, 2013, EUR REV MED PHARMACO, V17, P410; Hung KH, 2009, HELICOBACTER, V14, P61, DOI 10.1111/j.1523-5378.2009.00655.x; Khan A, 2012, WORLD J GASTROENTERO, V18, P2245, DOI 10.3748/wjg.v18.i18.2245; Kostamo P, 2011, INT J ANTIMICROB AG, V37, P22, DOI 10.1016/j.ijantimicag.2010.09.013; Kupcinskas L, 2013, APMIS, V121, P431, DOI 10.1111/apm.12012; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Liou JM, 2013, J ANTIMICROB CHEMOTH, V68, P450, DOI 10.1093/jac/dks407; Liou JM, 2013, LANCET, V381, P205, DOI 10.1016/S0140-6736(12)61579-7; Liou JM, 2010, GUT, V59, P572, DOI 10.1136/gut.2009.198309; Loivukene K, 2002, CLIN MICROBIOL INFEC, V8, P598, DOI 10.1046/j.1469-0691.2002.00409.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; National Health Insurance Research Database, 2005, DAT SUBS LONG HLTH I; Niederman MS, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.07.008; Okamura T, 2014, HELICOBACTER, V19, P214, DOI 10.1111/hel.12124; Poon SK, 2002, ALIMENT PHARM THERAP, V16, P291, DOI 10.1046/j.1365-2036.2002.01184.x; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; Su P, 2013, HELICOBACTER, V18, P274, DOI 10.1111/hel.12046; Sun QJ, 2010, WORLD J GASTROENTERO, V16, P5118, DOI 10.3748/wjg.v16.i40.5118; Taneike I, 2009, ALIMENT PHARM THER, V30, P784, DOI 10.1111/j.1365-2036.2009.04095.x; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Vilaichone RK, 2013, DIAGN MICR INFEC DIS, V77, P346, DOI 10.1016/j.diagmicrobio.2013.08.010; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P5508, DOI 10.3748/wjg.v19.i33.5508; Wueppenhorst N, 2013, J ANTIMICROB CHEMOTH, V68, P1562, DOI 10.1093/jac/dkt061	33	62	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124199	10.1371/journal.pone.0124199	http://dx.doi.org/10.1371/journal.pone.0124199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942450	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400013
J	Mishra, A; Nizamuddin, S; Arekatla, G; Prakash, S; Dewangan, H; Dominic, A; Mishra, A; Sudhakar, DVS; Parine, NR; Tupperwar, NC; Thangaraj, K				Mishra, Anshuman; Nizamuddin, Sheikh; Arekatla, Geethika; Prakash, Satya; Dewangan, Hemlata; Dominic, Abishai; Mishra, Abhishek; Sudhakar, Digumarthi V. S.; Parine, Narasimha R.; Tupperwar, Nitin C.; Thangaraj, Kumarasamy			IL10 Variant g.5311A Is Associated with Visceral Leishmaniasis in Indian Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; PROMOTER POLYMORPHISMS; IL-10 PRODUCTION; INFECTIOUS-DISEASES; CYTOKINE RESPONSES; GENETIC-EVIDENCE; BEHCETS-DISEASE; MESSENGER-RNA; KALA-AZAR; INTERLEUKIN-10	Background Visceral leishmaniasis (VL) is a multifactorial disease, where the host genetics play a significant role in determining the disease outcome. The immunological role of anti-inflammatory cytokine, Interleukin 10 (IL10), has been well-documented in parasite infections and considered as a key regulatory cytokine for VL. Although VL patients in India display high level of IL10 in blood serum, no genetic study has been conducted to assess the VL susceptibility/resistance. Therefore, the aim of this study is to investigate the role of IL10 variations in Indian VL; and to estimate the distribution of disease associated allele in diverse Indian populations. Methodology All the exons and exon-intron boundaries of IL10 were sequenced in 184 VL patients along with 172 ethnically matched controls from VL endemic region of India. Result and Discussion Our analysis revealed four variations; rs1518111 (2195 A>G, intron), rs1554286 (2607 C>T, intron), rs3024496 (4976 T>C, 3' UTR) and rs3024498 (5311 A>G, 3' UTR). Of these, a variant g.5311A is significantly associated with VL (chi(2)= 18.87; p = 0.00001). In silico approaches have shown that a putative micro RNA binding site (miR-4321) is lost in rs3024498 mRNA. Further, analysis of the above four variations in 1138 individuals from 34 ethnic populations, representing different social and linguistic groups who are inhabited in different geographical regions of India, showed variable frequency. Interestingly, we have found, majority of the tribal populations have low frequency of VL ('A' of rs3024498); and high frequency of leprosy ('T' of rs1554286), and Behcet's ('A' of rs1518111) associated alleles, whereas these were vice versa in castes. Our findings suggest that majority of tribal populations of India carry the protected / less severe allele against VL, while risk / more severe allele for leprosy and Behcet's disease. This study has potential implications in counseling and management of VL and other infectious diseases.	[Mishra, Anshuman; Nizamuddin, Sheikh; Arekatla, Geethika; Prakash, Satya; Dewangan, Hemlata; Dominic, Abishai; Sudhakar, Digumarthi V. S.; Parine, Narasimha R.; Tupperwar, Nitin C.; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Mishra, Abhishek] Oriental Inst Sci & Technol, Bhopal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	thangs@ccmb.res.in	digumarthi, sudhakar/E-4885-2019; Parine, Narasimha Reddy/B-7975-2011	digumarthi, sudhakar/0000-0002-3373-8592; Parine, Narasimha Reddy/0000-0002-0765-9022; Mishra, Anshuman/0000-0002-9390-9971; Thangaraj, Kumarasamy/0000-0002-0075-0106; Tupperwar, Nitin/0000-0002-1223-1047; Nizamuddin, Sheikh/0000-0002-4586-5898	DBT-RA programme; Indian Council of Medical Research and Immunology foundation; ICMR-SRF programme; CSIR Network project [Genesis-BSC0121]; BBSRC, UK [BB/H009337]	DBT-RA programme; Indian Council of Medical Research and Immunology foundation; ICMR-SRF programme; CSIR Network project(Council of Scientific & Industrial Research (CSIR) - India); BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AM was supported by DBT-RA programme (Fellowship) and travel grant of Indian Council of Medical Research and Immunology foundation; SN was supported by ICMR-SRF programme; KT was supported by CSIR Network project (Genesis-BSC0121) and BBSRC, UK (BB/H009337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhimanyu, 2011, INFECT GENET EVOL, V11, P1015, DOI 10.1016/j.meegid.2011.03.017; Aggarwal S, 2011, J INFECT DIS, V204, P1264, DOI 10.1093/infdis/jir516; Agrawal M.C., 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/250868; Agrawal M. C., 2012, SCHISTOSOMES SCHISTO; Alamartine E, 2003, J INVEST DERMATOL, V120, P99, DOI 10.1046/j.1523-1747.2003.12016.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P389; [Anonymous], 2012, WHO GLOB TUB REP 201; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Bora D, 1999, NATL MED J INDIA, V12, P62; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Cummings HE, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/294389; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000859; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Farouk S, 2010, PUBLIC HEALTH GENOM, V13, P362, DOI 10.1159/000272457; Figueiredo CA, 2013, J ALLERGY CLIN IMMUN, V131, P1683, DOI 10.1016/j.jaci.2012.10.043; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Haanpaa M, 2002, SCAND J INFECT DIS, V34, P112, DOI 10.1080/00365540110077218; Hajilooi M, 2013, INFLAMMATION, V36, P1513, DOI 10.1007/s10753-013-9693-0; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Howell WM, 2001, GENES IMMUN, V2, P25, DOI 10.1038/sj.gene.6363726; ICMR, 2002, PROSP EL LYMPH FIL I; Jha AN, 2014, INFECT IMMUN, V82, P52, DOI 10.1128/IAI.01041-13; Jha AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048136; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lokossou AG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-215; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; Miyazoe S, 2002, AM J GASTROENTEROL, V97, P2086, DOI 10.1111/j.1572-0241.2002.05926.x; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Natividad A, 2008, HUM MOL GENET, V17, P323, DOI 10.1093/hmg/ddm310; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; O'Brien KM, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-12; Oleksyk TK, 2005, GENES IMMUN, V6, P347, DOI 10.1038/sj.gene.6364188; Powell MJ, 2000, J IMMUNOL, V165, P292, DOI 10.4049/jimmunol.165.1.292; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reuss E, 2002, GENES IMMUN, V3, P407, DOI 10.1038/sj.gene.6363920; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Salhi A, 2008, J IMMUNOL, V180, P6139, DOI 10.4049/jimmunol.180.9.6139; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Singh OP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001874; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Sundar Shyam, 2003, J Assoc Physicians India, V51, P195; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; Team RDC, 2009, R LANG ENV STAT COMP; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P156, DOI 10.1016/S0035-9203(00)90255-4; Thangaraj K, 2002, J ANDROL, V23, P815; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; WHO, NAT FIL CONTR PROGR; Wu ZY, 2014, HUM IMMUNOL, V75, P271, DOI 10.1016/j.humimm.2013.11.009; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019	67	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124559	10.1371/journal.pone.0124559	http://dx.doi.org/10.1371/journal.pone.0124559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25941808	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943400017
J	Wu, Y; Xue, L; Du, WM; Huang, B; Tang, CP; Liu, CQ; Qiu, HM; Jiang, QS				Wu, Yang; Xue, Lai; Du, Weimin; Huang, Bo; Tang, Cuiping; Liu, Changqing; Qiu, Hongmei; Jiang, Qingsong			Polydatin Restores Endothelium-Dependent Relaxation in Rat Aorta Rings Impaired by High Glucose: A Novel Insight into the PPAR beta-NO Signaling Pathway	PLOS ONE			English	Article							RED WINE; RESVERATROL; ACTIVATION; POLYPHENOLS; EXPRESSION	Polydatin, a natural component from Polygonum Cuspidatum, has important therapeutic effects on metabolic syndrome. A novel therapeutic strategy using polydatin to improve vascular function has recently been proposed to treat diabetes-related cardiovascular complications. However, the biological role and molecular basis of polydatin's action on vascular endothelial cells (VECs)-mediated vasodilatation under diabetes-related hyperglycemia condition remain elusive. The present study aimed to assess the contribution of polydatin in restoring endothelium-dependent relaxation and to determine the details of its underlying mechanism. By measuring endothelium-dependent relaxation, we found that acetylcholine-induced vasodilation was impaired by elevated glucose (55 mmol/L); however, polydatin (1, 3, 10 mu mol/L) could restore the relaxation in a dose-dependent manner. Polydatin could also improve the histological damage to endothelial cells in the thoracic aorta. Polydatin's effects were mediated via promoting the expression of endothelial NO synthase (eNOS), enhancing eNOS activity and decreasing the inducible NOS (iNOS) level, finally resulting in a beneficial increase in NO release, which probably, at least in part, through activation of the PPAR beta signaling pathway. The results provided a novel insight into polydatin action, via PPAR beta-NO signaling pathways, in restoring endothelial function in high glucose conditions. The results also indicated the potential utility of polydatin to treat diabetes related cardiovascular diseases.	[Wu, Yang; Xue, Lai; Du, Weimin; Huang, Bo; Tang, Cuiping; Qiu, Hongmei; Jiang, Qingsong] Chongqing Med Univ, Dept Pharmacol, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China; [Liu, Changqing] Fujiang Med Univ, Pharmaceut Coll, Fujian 350004, Peoples R China	Chongqing Medical University	Jiang, QS (corresponding author), Chongqing Med Univ, Dept Pharmacol, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	cqjiangqs@hotmail.com			Natural Science Foundation of China [81100905]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (No. 81100905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P7693, DOI 10.1021/jf901381x; Campos C, 2012, POSTGRAD MED, V124, P90, DOI 10.3810/pgm.2012.11.2615; Du QH, 2013, PHARM BIOL, V51, P1347, DOI 10.3109/13880209.2013.792849; Gao JAP, 2010, FITOTERAPIA, V81, P953, DOI 10.1016/j.fitote.2010.06.023; Giugliano D, 2008, AM J CLIN NUTR, V87, p217S, DOI 10.1093/ajcn/87.1.217S; Gray SP, 2014, J MOL MED, V92, P441, DOI 10.1007/s00109-014-1146-1; Indraccolo U, 2010, EUR J OBSTET GYN R B, V150, P76, DOI 10.1016/j.ejogrb.2010.01.008; Kerem Z, 2006, J AGR FOOD CHEM, V54, P1243, DOI 10.1021/jf052436+; Quintela AM, 2012, FREE RADICAL BIO MED, V53, P730, DOI 10.1016/j.freeradbiomed.2012.05.045; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Miao Q, 2011, PHYTOMEDICINE, V19, P8, DOI 10.1016/j.phymed.2011.06.023; Neels JG, 2014, PHYSIOL REV, V94, P795, DOI 10.1152/physrev.00027.2013; Nicholson SK, 2008, P NUTR SOC, V67, P42, DOI 10.1017/S0029665108006009; Qian LB, 2010, PHARMACOL RES, V61, P281, DOI 10.1016/j.phrs.2009.10.004; Rathel TR, 2007, J HYPERTENS, V25, P541, DOI 10.1097/HJH.0b013e328013e805; Takahashi S, 2009, BIOL PHARM BULL, V32, P1840, DOI 10.1248/bpb.32.1840; Tian XY, 2012, DIABETES, V61, P3285, DOI 10.2337/db12-0117; Verma S, 2006, CAN J CARDIOL, V22, p12B, DOI 10.1016/S0828-282X(06)70981-3; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Wang XW, 2012, AM J PHYSIOL-ENDOC M, V302, pE740, DOI 10.1152/ajpendo.00533.2011; Xie X, 2012, MOL CELL ENDOCRINOL, V362, P183, DOI 10.1016/j.mce.2012.06.008; Zhou CC, 2011, J LIPID RES, V52, P1483, DOI 10.1194/jlr.M014092	22	18	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126249	10.1371/journal.pone.0126249	http://dx.doi.org/10.1371/journal.pone.0126249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25941823	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943400064
J	Michalski, LJ; Norris, D; de Oliveira, TG; Michalski, F				Michalski, Lincoln Jose; Norris, Darren; de Oliveira, Tadeu Gomes; Michalski, Fernanda			Ecological Relationships of Meso-Scale Distribution in 25 Neotropical Vertebrate Species	PLOS ONE			English	Article							TROPICAL FORESTS; COMMUNITY STRUCTURE; CUNICULUS-PACA; CAMERA TRAP; TAYASSU-PECARI; LARGE MAMMALS; RAIN-FOREST; STATE-PARK; AMAZON; CONSERVATION	Vertebrates are a vital ecological component of Amazon forest biodiversity. Although vertebrates are a functionally important part of various ecosystem services they continue to be threatened by anthropogenic impacts throughout the Amazon. Here we use a standardized, regularly spaced arrangement of camera traps within 25km(2) to provide a baseline assessment of vertebrate species diversity in a sustainable use protected area in the eastern Brazilian Amazon. We examined seasonal differences in the per species encounter rates (number of photos per camera trap and number of cameras with photos). Generalized linear models (GLMs) were then used to examine the influence of five variables (altitude, canopy cover, basal area, distance to nearest river and distance to nearest large river) on the number of photos per species and on functional groups. GLMs were also used to examine the relationships between large predators [Jaguar (Panthera onca) and Puma (Puma concolor)] and their prey. A total of 649 independent photos of 25 species were obtained from 1,800 camera trap days (900 each during wet and dry seasons). Only ungulates and rodents showed significant seasonal differences in the number of photos per camera. The number of photos differed between seasons for only three species (Mazama americana, Dasyprocta leporina and Myoprocta acouchy) all of which were photographed more (3 to 10 fold increase) during the wet season. Mazama americana was the only species where a significant difference was found in occupancy, with more photos in more cameras during the wet season. For most groups and species variation in the number of photos per camera was only explained weakly by the GLMs (deviance explained ranging from 10.3 to 54.4%). Terrestrial birds (Crax alector, Psophia crepitans and Tinamus major) and rodents (Cuniculus paca, Dasyprocta leporina and M. acouchy) were the notable exceptions, with our GLMs significantly explaining variation in the distribution of all species (deviance explained ranging from 21.0 to 54.5%). The group and species GLMs showed some novel ecological information from this relatively pristine area. We found no association between large cats and their potential prey. We also found that rodent and bird species were more often recorded closer to streams. As hunters gain access via rivers this finding suggests that there is currently little anthropogenic impact on the species. Our findings provide a standardized baseline for comparison with other sites and with which planned management and extractive activities can be evaluated.	[Michalski, Lincoln Jose; Norris, Darren; Michalski, Fernanda] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Michalski, Lincoln Jose; Norris, Darren; Michalski, Fernanda] Univ Fed Amapa, Lab Ecol & Conservac Vertebrados, Macapa, Amapa, Brazil; [de Oliveira, Tadeu Gomes] Univ Estadual Maranhao, Dept Biol, Sao Luis, Maranhao, Brazil; [de Oliveira, Tadeu Gomes; Michalski, Fernanda] Inst Procarnivoros, Sao Paulo, Brazil; [Norris, Darren; Michalski, Fernanda] Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil	Institute Nacional de Pesquisas da Amazonia; Fundacao Universidade Federal do Amapa; Universidade Estadual do Maranhao; Fundacao Universidade Federal do Amapa	Michalski, F (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	fmichalski@gmail.com	Norris, Darren/J-5182-2012; Michalski, Fernanda/J-4691-2012; Oliveira, Tadeu/M-6095-2016	Norris, Darren/0000-0003-0015-8214; Michalski, Fernanda/0000-0002-8074-9964; Oliveira, Tadeu/0000-0002-8760-3159	Fundacao de Amparo a Pesquisa do Estado do Amazonas [019.549-9 A]; Federal Agency for Support and Evaluation of Graduate Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES) [PNPD20130074]; CNPq [477629/2011-3]	Fundacao de Amparo a Pesquisa do Estado do Amazonas; Federal Agency for Support and Evaluation of Graduate Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LJM received an MSc scholarship from the Fundacao de Amparo a Pesquisa do Estado do Amazonas - 019.549-9 A. DN received a post-doctoral scholarship from the Federal Agency for Support and Evaluation of Graduate Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES) - PNPD20130074. This research was partially supported by a research grant from CNPq (# 477629/2011-3).	Ahumada JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073707; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Alves TR, 2012, IHERINGIA SER ZOOL, V102, P150, DOI 10.1590/S0073-47212012000200006; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Beck H, 2013, BIOL CONSERV, V163, P115, DOI 10.1016/j.biocon.2013.03.012; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Bernard E, 2006, INVENTARIO RAPIDO MA; Bernard E., 2006, INVENTARIOS BIOL FLO; BODMER RE, 1990, J TROP ECOL, V6, P191, DOI 10.1017/S0266467400004314; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Clements JF, 2007, CLEMENTS CHECKLIST B; Martins SD, 2007, BIODIVERS CONSERV, V16, P857, DOI 10.1007/s10531-006-9094-x; DeFries R, 2010, FRONT ECOL ENVIRON, V8, P153, DOI 10.1890/080104; DUBOST G, 1988, J ZOOL, V214, P107, DOI 10.1111/j.1469-7998.1988.tb04990.x; Erard C, 2007, REV ECOL-TERRE VIE, V62, P323; Feer F, 1997, NEOTROPICAL RAINFORE; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Gallina S, 2012, REV BIOL TROP, V60, P1345; Gonthier DJ, 2013, TROP CONSERV SCI, V6, P584, DOI 10.1177/194008291300600409; Haugaasen T, 2005, BIOTROPICA, V37, P620, DOI 10.1111/j.1744-7429.2005.00079.x; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hollowell T, 2005, B BIOL SOC WASHINGTO, V13; Jiménez Carlos F., 2010, Rev. peru biol., V17, P191; Katayama N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093359; Kent R, 2014, ECOL EVOL, V4, P1963, DOI 10.1002/ece3.1072; Keuroghlian A, 2004, BIOL CONSERV, V120, P411, DOI 10.1016/j.biocon.2004.03.016; Khan H. H., 2014, Journal of Geographic Information System, V6, P345; Kindt R., 2005, WORLD; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Lemon P., 1956, FOREST SCI, V2, P314; Li S, 2012, DIVERS DISTRIB, V18, P1166, DOI 10.1111/j.1472-4642.2012.00907.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Magnusson W.E., 2005, BIOTA NEOTROP, V5, P1, DOI DOI 10.1590/S0101-81751996000200002; Magnusson WE, 2014, NAT CONSERV-BULGARIA, P77, DOI 10.3897/natureconservation.8.5929; Martins ACM, 2006, REV BRAS ZOOL, V23, P1175, DOI 10.1590/S0101-81752006000400026; MARTINS R., 2013, MAMMALIA, V74, P409, DOI [10.1515/mammalia-2012-0121, DOI 10.1515/MAMMALIA-2012-0121]; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Michalski F, 2006, MAMMALIA, V70, P52, DOI 10.1515/MAMM.2006.004; Michalski F, 2011, ZOOLOGIA-CURITIBA, V28, P701, DOI 10.1590/S1984-46702011000600002; Michalski F, 2010, ORYX, V44, P300, DOI 10.1017/S0030605309990871; Munari DP, 2011, MAMM BIOL, V76, P401, DOI 10.1016/j.mambio.2011.02.007; Negroes N, 2011, BIODIVERS CONSERV, V20, P505, DOI 10.1007/s10531-010-9961-3; Norris D, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0106150; Norris D, 2013, ZOOLOGIA-CURITIBA, V30, P482, DOI 10.1590/S1984-46702013000500003; Norris D, 2012, BIOTA NEOTROP, V12, P127, DOI 10.1590/S1676-06032012000200013; O'Brien TG, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P71, DOI 10.1007/978-4-431-99495-4_6; Oliveira L. L., 2010, TEMPO CLIMA RECURSOS, P83; Oliveira TG., 1994, NEOTROPICAL CATS ECO; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 1996, BIOL CONSERV, V77, P115, DOI 10.1016/0006-3207(96)00010-9; Peres CA, 1997, J TROP ECOL, V13, P381, DOI 10.1017/S0266467400010580; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Peres Carlos A., 2002, P407, DOI 10.1079/9780851995250.0407; Pickles RSA, 2011, BIOTA NEOTROP, V11, P237, DOI 10.1590/S1676-06032011000300021; Pontes ARM, 2007, J ZOOL, V273, P257, DOI 10.1111/j.1469-7998.2007.00323.x; Price B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074333; R Development Core Team, 2014, R 3 1 1 LANG ENV STA; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Reis N.L., 2006, MAMIFEROS BRASIL; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; SAGA (System for Automated Geoscientific Analyses), 2011, GIS SYST AUT GEOSC A; Sick H, 2001, ORNITOLOGIA BRASILEI; Sigrist T, 2009, GUIA CAMPO AVIS BRAS; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Stokstad E, 2010, SCIENCE, V329, P1272, DOI 10.1126/science.329.5997.1272; Stoner KE, 2007, BIOTROPICA, V39, P316, DOI 10.1111/j.1744-7429.2007.00292.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Togura CM, 2014, IHERINGIA SER ZOOL, V104, P81, DOI 10.1590/1678-4766201410418187; Valsecchi J, 2014, BRAZ J BIOL, V74, P560, DOI 10.1590/bjb.2014.0098; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x; Wilson WG, 2003, ECOL LETT, V6, P944, DOI 10.1046/j.1461-0248.2003.00521.x; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x	81	19	25	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126114	10.1371/journal.pone.0126114	http://dx.doi.org/10.1371/journal.pone.0126114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938582	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000139
J	Loughney, JW; Rustandi, RR; Wang, D; Troutman, MC; Dick, LW; Li, GH; Liu, Z; Li, FS; Freed, DC; Price, CE; Hoang, VM; Culp, TD; DePhillips, PA; Fu, TM; Ha, S				Loughney, John W.; Rustandi, Richard R.; Wang, Dai; Troutman, Matthew C.; Dick, Lawrence W., Jr.; Li, Guanghua; Liu, Zhong; Li, Fengsheng; Freed, Daniel C.; Price, Colleen E.; Hoang, Van M.; Culp, Timothy D.; DePhillips, Pete A.; Fu, Tong-Ming; Ha, Sha			Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; protein complex; protein purification; vaccine; virus entry; HCMV; gH; gL; pUL128-131; neutralizing epitope; pentameric complex	ENDOTHELIAL-CELLS; ANTIBODY-RESPONSE; RHESUS MACAQUES; VACCINE; TROPISM; GH/GL/UL128-131; INFECTION; GH; GL	Background: HCMV gH/gL/pUL128-131 pentameric complex is a main target for potent neutralizing antibody responses. Results: Soluble gH/gL/pUL128-131 inhibits viral entry and presents neutralizing epitopes. Conclusion: The biological activities of gH/gL/pUL128-131 confirm the critical role of the native complex as an immunogen. Significance: The functional differences between gH/gL and gH/gL/pUL128-131 must be considered when designing vaccines and assessing immune responses. Congenital infection of human cytomegalovirus (HCMV) is one of the leading causes of nongenetic birth defects, and development of a prophylactic vaccine against HCMV is of high priority for public health. The gH/gL/pUL128-131 pentameric complex mediates HCMV entry into endothelial and epithelial cells, and it is a major target for neutralizing antibody responses. To better understand the mechanism by which antibodies interact with the epitopes of the gH/gL/pUL128-131 pentameric complex resulting in viral neutralization, we expressed and purified soluble gH/gL/pUL128-131 pentameric complex and gH/gL from Chinese hamster ovary cells to >95% purity. The soluble gH/gL, which exists predominantly as (gH/gL)(2) homodimer with a molecular mass of 220 kDa in solution, has a stoichiometry of 1:1 and a pI of 6.0-6.5. The pentameric complex has a molecular mass of 160 kDa, a stoichiometry of 1:1:1:1:1, and a pI of 7.4-8.1. The soluble pentameric complex, but not gH/gL, adsorbs 76% of neutralizing activities in HCMV human hyperimmune globulin, consistent with earlier reports that the most potent neutralizing epitopes for blocking epithelial infection are unique to the pentameric complex. Functionally, the soluble pentameric complex, but not gH/gL, blocks viral entry to epithelial cells in culture. Our results highlight the importance of the gH/gL/pUL128-131 pentameric complex in HCMV vaccine design and emphasize the necessity to monitor the integrity of the pentameric complex during the vaccine manufacturing process.	[Loughney, John W.; Rustandi, Richard R.; Troutman, Matthew C.; Dick, Lawrence W., Jr.; Price, Colleen E.; Hoang, Van M.; Culp, Timothy D.; DePhillips, Pete A.; Ha, Sha] Merck Res Labs, Vaccine Bioproc Res & Dev, West Point, PA 19486 USA; [Wang, Dai; Li, Fengsheng; Freed, Daniel C.; Fu, Tong-Ming] Merck Res Labs, Vaccine Res, West Point, PA 19486 USA; [Li, Guanghua; Liu, Zhong] Merck Res Labs, Biol Bioproc Dev, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company	Ha, S (corresponding author), Merck Res Labs, Vaccine Bioproc Res & Dev, West Point, PA 19486 USA.	sha_ha@merck.com	Fu, Tong-Ming/GLU-4070-2022; Fu, Tong-Ming/AAF-7143-2022; Fu, Tong-Ming/AEV-7504-2022; LI, feng/HIR-1703-2022	Fu, Tong-Ming/0000-0003-1420-2271; Wang, Dai/0000-0001-5666-8622				Anderson CL, 2012, ELECTROPHORESIS, V33, P1538, DOI 10.1002/elps.201100611; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Ciferri C, 2015, P NATL ACAD SCI USA, V112, P1767, DOI 10.1073/pnas.1424818112; Dou P, 2008, J CHROMATOGR A, V1190, P372, DOI 10.1016/j.chroma.2008.03.001; Edward S, 2013, FIELDS VIROLOGY; ELEK SD, 1974, LANCET, V1, P1; Fouts AE, 2014, P NATL ACAD SCI USA, V111, P8209, DOI 10.1073/pnas.1404653111; Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12; Freed DC, 2013, P NATL ACAD SCI USA, V110, pE4997, DOI 10.1073/pnas.1316517110; Fu TM, 2012, VACCINE, V30, P7469, DOI 10.1016/j.vaccine.2012.10.053; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Institute of Medicine CtSPfV, 2001, VACC 21 CENT TOOL DE; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Loomis RJ, 2013, VACCINE, V31, P919, DOI 10.1016/j.vaccine.2012.12.009; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Michels DA, 2012, ANAL CHEM, V84, P5380, DOI 10.1021/ac3008847; NEFF BJ, 1979, P SOC EXP BIOL MED, V160, P32; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Ryckman BJ, 2010, J VIROL, V84, P2597, DOI 10.1128/JVI.02256-09; Saccoccio FM, 2011, VACCINE, V29, P2705, DOI 10.1016/j.vaccine.2011.01.079; Shytuhina A, 2014, J CHROMATOGR A, V1364, P192, DOI 10.1016/j.chroma.2014.05.087; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stampfer SD, 2013, CURR OPIN VIROL, V3, P13, DOI 10.1016/j.coviro.2012.10.005; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wang D, 2011, VACCINE, V29, P9075, DOI 10.1016/j.vaccine.2011.09.056; Wen YX, 2014, VACCINE, V32, P3796, DOI 10.1016/j.vaccine.2014.05.004; Wussow F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004524; Wussow F, 2013, J VIROL, V87, P1322, DOI 10.1128/JVI.01669-12; Zhou MM, 2013, J VIROL, V87, P9680, DOI 10.1128/JVI.01167-13	35	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15985	15995		10.1074/jbc.M115.652230	http://dx.doi.org/10.1074/jbc.M115.652230			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25947373	Green Published, hybrid			2022-12-26	WOS:000356930100008
J	Karaca, M; Liu, YB; Zhang, ZT; De Silva, D; Parker, JS; Earp, S; Whang, YE				Karaca, Mehmet; Liu, Yuanbo; Zhang, Zhentao; De Silva, Dinuka; Parker, Joel S.; Earp, Shelton; Whang, Young E.			Mutation of Androgen Receptor N-Terminal Phosphorylation Site Tyr-267 Leads to Inhibition of Nuclear Translocation and DNA Binding	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; INCREASED SURVIVAL; STEROID-BINDING; ACK1; GROWTH; GENE; AMPLIFICATION; ENZALUTAMIDE; TESTOSTERONE; PROGRESSION	Reactivation of androgen receptor (AR) may drive recurrent prostate cancer in castrate patients. Ack1 tyrosine kinase is overexpressed in prostate cancer and promotes castrate resistant xenograft tumor growth and enhances androgen target gene expression and AR recruitment to enhancers. Ack1 phosphorylates AR at Tyr-267 and possibly Tyr-363, both in the N-terminal transactivation domain. In this study, the role of these phosphorylation sites was investigated by characterizing the phosphorylation site mutants in the context of full length and truncated AR lacking the ligand-binding domain. Y267F and Y363F mutants showed decreased transactivation of reporters. Expression of wild type full length and truncated AR in LNCaP cells increased cell proliferation in androgen-depleted conditions and increased colony formation. However, the Y267F mutant of full length and truncated AR was defective in stimulating cell proliferation. The Y363F mutant was less severely affected than the Y267F mutant. The full length AR Y267F mutant was defective in nuclear translocation induced by androgen or Ack1 kinase. The truncated AR was constitutively localized to the nucleus. Chromatin immunoprecipitation analysis showed that it was recruited to the target enhancers without androgen. The truncated Y267F AR mutant did not exhibit constitutive nuclear localization and androgen enhancer binding activity. These results support the concept that phosphorylation of Tyr-267, and to a lesser extent Tyr-363, is required for AR nuclear translocation and recruitment and DNA binding and provide a rationale for development of novel approaches to inhibit AR activity.	[Karaca, Mehmet; De Silva, Dinuka; Whang, Young E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Liu, Yuanbo; Zhang, Zhentao; Parker, Joel S.; Earp, Shelton; Whang, Young E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Liu, Yuanbo] Capital Med Univ, Beijing Tiantan Hosp, Dept Hematol, Beijing 100050, Peoples R China; [Parker, Joel S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Earp, Shelton; Whang, Young E.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Earp, Shelton] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Capital Medical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Whang, YE (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	ywhang@med.unc.edu	Whang, Young/AAK-7435-2021; Parker, Joel/AAG-1108-2019	Whang, Young/0000-0002-1621-6661	NIH [R01CA120921, R01CA120304, T32ES007017, T32CA071341]; NATIONAL CANCER INSTITUTE [R01CA120304, T32CA071341, R01CA120921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from NIH R01CA120921 (YEW), R01CA120304 (HSE), T32ES007017 (MK), and T32CA071341 (DD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao B, 2014, ONCOTARGET; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SY, 2012, J BIOL CHEM, V287, P8571, DOI 10.1074/jbc.M111.325290; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Fu MF, 2004, J BIOL CHEM, V279, P29436, DOI 10.1074/jbc.M313466200; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Gregory CW, 2001, CANCER RES, V61, P4315; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Koivisto P, 1997, CANCER RES, V57, P314; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liu Y, 2010, ONCOGENE, V29, P3208, DOI 10.1038/onc.2010.103; Mahajan K, 2013, CANCER LETT, V338, P185, DOI 10.1016/j.canlet.2013.04.004; Mahajan K, 2012, J BIOL CHEM, V287, P22112, DOI 10.1074/jbc.M112.357384; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Rocha J, 2013, MOL CELL ENDOCRINOL, V381, P140, DOI 10.1016/j.mce.2013.07.017; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Titus MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030192; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; WONG CI, 1993, J BIOL CHEM, V268, P19004; Zuccarello D, 2008, CLIN ENDOCRINOL, V68, P580, DOI 10.1111/j.1365-2265.2007.03069.x	46	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126270	10.1371/journal.pone.0126270	http://dx.doi.org/10.1371/journal.pone.0126270			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950519	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400076
J	She, ZC; Li, L; Qi, HG; Song, K; Que, HY; Zhang, GF				She, Zhicai; Li, Li; Qi, Haigang; Song, Kai; Que, Huayong; Zhang, Guofan			Candidate Gene Polymorphisms and their Association with Glycogen Content in the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							LOCAL ADAPTATION; ADDUCTOR MUSCLE; MEAT QUALITY; PHOSPHORYLASE; SELECTION; PURIFICATION; METABOLISM; EXPRESSION; SYNTHASE; GROWTH	Background The Pacific oyster Crassostrea gigas is an important cultivated shellfish that is rich in nutrients. It contains high levels of glycogen, which is of high nutritional value. To investigate the genetic basis of this high glycogen content and its variation, we conducted a candidate gene association analysis using a wild population, and confirmed our results using an independent population, via targeted gene resequencing and mRNA expression analysis. Results We validated 295 SNPs in the 90 candidate genes surveyed for association with glycogen content, 86 of were ultimately genotyped in all 144 experimental individuals from Jiaonan (JN). In addition, 732 SNPs were genotyped via targeted gene resequencing. Two SNPs (Cg_SNP_TY202 and Cg_SNP_3021) in Cg_GD1 (glycogen debranching enzyme) and one SNP (Cg_SNP_4) in Cg_GP1 (glycogen phosphorylase) were identified as being associated with glycogen content. The glycogen content of individuals with genotypes TT and TC in Cg_SNP_TY202 was higher than that of individuals with genotype CC. The transcript abundance of both glycogen-associated genes was differentially expressed in high glycogen content and low glycogen content individuals. Conclusions This study identified three polymorphisms in two genes associated with oyster glycogen content, via candidate gene association analysis. The transcript abundance differences in Cg_GD1 and Cg_GP1 between low-and the high-glycogen content individuals suggests that it is possible that transcript regulation is mediated by variations of Cg_SNP_TY202, Cg_SNP_3021, and Cg_SNP_4. These findings will not only provide insights into the genetic basis of oyster quality, but also promote research into the molecular breeding of oysters.	[She, Zhicai; Li, Li; Qi, Haigang; Song, Kai; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Shandong, Peoples R China; [She, Zhicai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Shandong, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022		National Basic Research Program of China (973 Program) [2010CB126402]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholars Climbing Program of Shandong	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholars Climbing Program of Shandong	Funding: This research was supported by the National Basic Research Program of China (973 Program, No. 2010CB126402), the National High Technology Research and Development Program (863 program, No. 2012AA10A405), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48) and Taishan Scholars Climbing Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagesen AM, 2014, FOOD MICROBIOL, V38, P93, DOI 10.1016/j.fm.2013.08.008; AKASHIGE S, 1992, NIPPON SUISAN GAKK, V58, P1063; Akram M, 2011, J MED PLANTS RES, V5, P4980; Bacca H, 2005, COMP BIOCHEM PHYS B, V140, P635, DOI 10.1016/j.cbpc.2005.01.005; Berri C, 2005, BRIT POULTRY SCI, V46, P572, DOI 10.1080/00071660500303099; Bezborodkina NN, 2014, EXP TOXICOL PATHOL, V66, P147, DOI 10.1016/j.etp.2013.12.001; Bollig G, 2013, PEDIATR ANESTH, V23, P817, DOI 10.1111/pan.12164; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Chaosap C, 2011, J ANIM SCI, V89, P2231, DOI 10.2527/jas.2010-2953; Ciobanu D, 2001, GENETICS, V159, P1151; Diaz MT, 2014, MEAT SCI, V96, P653, DOI 10.1016/j.meatsci.2013.10.013; Dmitrzak-Weglarz M, 2005, EUR NEUROPSYCHOPHARM, V15, pS600; Du XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104960; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Frank-Lawale A, 2014, J SHELLFISH RES, V33, P153, DOI 10.2983/035.033.0115; Gionet C, 2012, AQUAC ASSOC CAN SPEC, P29; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HATA K, 1993, COMP BIOCHEM PHYS B, V105, P481, DOI 10.1016/0305-0491(93)90077-I; HATA K, 1987, COMP BIOCHEM PHYS B, V87, P747, DOI 10.1016/0305-0491(87)90383-X; Johansson H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1005; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kao WHL, 1999, AM J EPIDEMIOL, V149, pS3; Larsen PF, 2011, J FISH BIOL, V78, P1, DOI 10.1111/j.1095-8649.2010.02834.x; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Maguire GB, 1995, AQUACULTURE, V137, P357, DOI 10.1016/0044-8486(96)83594-0; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Park YJ, 2009, MOLECULES, V14, P4546, DOI 10.3390/molecules14114546; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Samain JF, 2011, AQUAT LIVING RESOUR, V24, P227, DOI 10.1051/alr/2011144; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Sun YF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-458; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Wang JF, 2014, MOLECULAR ECOLOGY RE, V11, P123; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244; Zhou XM, 2014, NAT GENET, V46, P1303, DOI 10.1038/ng.3137	48	13	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124401	10.1371/journal.pone.0124401	http://dx.doi.org/10.1371/journal.pone.0124401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951187	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400016
J	Stein, A; Engell, A; Lau, P; Wunderlich, R; Junghoefer, M; Wollbrink, A; Bruchmann, M; Rudack, C; Pantev, C				Stein, Alwina; Engell, Alva; Lau, Pia; Wunderlich, Robert; Junghoefer, Markus; Wollbrink, Andreas; Bruchmann, Maximilian; Rudack, Claudia; Pantev, Christo			Enhancing Inhibition-Induced Plasticity in Tinnitus - Spectral Energy Contrasts in Tailor-Made Notched Music Matter	PLOS ONE			English	Article							PHANTOM LIMB PAIN; AUDITORY-CORTEX; NEURAL ACTIVITY; CORTICAL PLASTICITY; LATERAL INHIBITION; HUMAN BRAIN; REORGANIZATION; NEUROSCIENCE; PERCEPTION; MODULATION	Chronic tinnitus seems to be caused by reduced inhibition among frequency selective neurons in the auditory cortex. One possibility to reduce tinnitus perception is to induce inhibition onto over-activated neurons representing the tinnitus frequency via tailor-made notched music (TMNM). Since lateral inhibition is modifiable by spectral energy contrasts, the question arises if the effects of inhibition-induced plasticity can be enhanced by introducing increased spectral energy contrasts (ISEC) in TMNM. Eighteen participants suffering from chronic tonal tinnitus, pseudo randomly assigned to either a classical TMNM or an ISEC-TMNM group, listened to notched music for three hours on three consecutive days. The music was filtered for both groups by introducing a notch filter centered at the individual tinnitus frequency. For the ISEC-TMNM group a frequency bandwidth of 3/8 octaves on each side of the notch was amplified, additionally, by about 20 dB. Before and after each music exposure, participants rated their subjectively perceived tinnitus loudness on a visual analog scale. During the magnetoencephalographic recordings, participants were stimulated with either a reference tone of 500 Hz or a test tone with a carrier frequency representing the individual tinnitus pitch. Perceived tinnitus loudness was significantly reduced after TMNM exposure, though TMNM type did not influence the loudness ratings. Tinnitus related neural activity in the N1m time window and in the so called tinnitus network comprising temporal, parietal and frontal regions was reduced after TMNM exposure. The ISEC-TMNM group revealed even enhanced inhibition-induced plasticity in a temporal and a frontal cortical area. Overall, inhibition of tinnitus related neural activity could be strengthened in people affected with tinnitus by increasing spectral energy contrast in TMNM, confirming the concepts of inhibition-induced plasticity via TMNM and spectral energy contrasts.	[Stein, Alwina; Engell, Alva; Lau, Pia; Wunderlich, Robert; Junghoefer, Markus; Wollbrink, Andreas; Bruchmann, Maximilian; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Rudack, Claudia] Univ Hosp, Dept Otolaryngol, Munster, Germany	University of Munster; University of Munster	Pantev, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	pantev@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986	Interdisziplinares Zentrum fuer Klinische Forschung (IZKF) [CRA05]; Deutsche Forschungsgemeinschaft (DFG) [PA 392/14-1]	Interdisziplinares Zentrum fuer Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by the Interdisziplinares Zentrum fuer Klinische Forschung (IZKF, CRA05) and Deutsche Forschungsgemeinschaft (DFG, PA 392/14-1).	Adamchic I, 2012, AM J AUDIOL, V21, P215, DOI 10.1044/1059-0889(2012/12-0010); Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Attal Y, 2013, PLOS ONE, V8; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Brockelmann AK, 2013, EUR J NEUROSCI, V37, P303, DOI 10.1111/ejn.12043; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Catz N, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00021; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Diesch E, 2010, NEUROIMAGE, V50, P1545, DOI 10.1016/j.neuroimage.2010.01.067; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Eggermont JJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00053; Fernandez F, 2007, TRENDS NEUROSCI, V30, P497, DOI 10.1016/j.tins.2007.07.005; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Guterman Y, 2007, CONSCIOUS COGN, V16, P400, DOI 10.1016/j.concog.2006.09.007; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Irvine DRF, 1997, ACTA OTO-LARYNGOL, P39; James W., 1890, PRINCIPLES PSYCHOL, V1, DOI [10.1037/10538-000, DOI 10.1037/10538-000]; Kolb B, 2003, CURR DIR PSYCHOL SCI, V12, P1, DOI 10.1111/1467-8721.01210; Kolb B, 2011, J CAN ACAD CHILD ADO, V20; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McCormack A, 2014, J PSYCHOSOM RES, V76, P56, DOI 10.1016/j.jpsychores.2013.08.018; MEIKLE MB, 1984, OTOLARYNG HEAD NECK, V92, P689, DOI 10.1177/019459988409200617; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nondahl DM, 2010, INT J AUDIOL, V49, P580, DOI 10.3109/14992021003753508; Norena A, 2000, HEARING RES, V149, P24, DOI 10.1016/S0378-5955(00)00158-1; Norena A, 1999, CLIN NEUROPHYSIOL, V110, P666, DOI 10.1016/S1388-2457(98)00034-0; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Okamoto H, 2005, EUR J NEUROSCI, V21, P1957, DOI 10.1111/j.1460-9568.2005.04022.x; Okamoto H, 2004, HEARING RES, V196, P77, DOI 10.1016/j.heares.2004.04.017; Okamoto H, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-33; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; Pantev C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00050; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2007, PROG BRAIN RES, V166, P487, DOI 10.1016/S0079-6123(07)66047-6; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Stein A, 2014, CLIN NEUROPHYSIOL; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080899; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; Teismann H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024685; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Willoch F, 2000, ANN NEUROL, V48, P842; Wunderlich R, 2014, J AM ACAD AUDIOL, V26	64	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126494	10.1371/journal.pone.0126494	http://dx.doi.org/10.1371/journal.pone.0126494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951605	Green Published, gold			2022-12-26	WOS:000354214400097
J	Arouri, A; Trojnar, J; Schmidt, S; Hansen, AH; Mollenhauer, J; Mouritsen, OG				Arouri, Ahmad; Trojnar, Jakub; Schmidt, Steffen; Hansen, Anders H.; Mollenhauer, Jan; Mouritsen, Ole G.			Development of a Cell-Based Bioassay for Phospholipase A(2)-Triggered Liposomal Drug Release	PLOS ONE			English	Article							GROUP-II PHOSPHOLIPASE-A2; SECRETORY PHOSPHOLIPASE-A2; CLINICAL DEVELOPMENT; FIREFLY LUCIFERASE; TARGETED DELIVERY; A(2) ENZYMES; FATTY-ACIDS; BIOLUMINESCENCE; EXPRESSION; PERMEABILITY	The feasibility of exploiting secretory phospholipase A(2) (sPLA(2)) enzymes, which are overexpressed in tumors, to activate drug release from liposomes precisely at the tumor site has been demonstrated before. Although the efficacy of the developed formulations was evaluated using in vitro and in vivo models, the pattern of sPLA(2)-assisted drug release is unknown due to the lack of a suitable bio-relevant model. We report here on the development of a novel bioluminescence living-cell-based luciferase assay for the monitoring of sPLA(2)-triggered release of luciferin from liposomes. To this end, we engineered breast cancer cells to produce both luciferase and sPLA(2) enzymes, where the latter is secreted to the extracellular medium. We report on setting up a robust and reproducible bioassay for testing sPLA(2)-sensitive, luciferin remote-loaded liposomal formulations, using 1,2-distearoyl-sn-glycero-3phosphatidylcholine/ 1,2-distearoyl-sn-glycero-3-phosphatidylglycerol (DSPC/DSPG) 7:3 and DSPC/DSPG/cholesterol 4:3:3 as initial test systems. Upon their addition to the cells, the liposomes were degraded almost instantaneously by sPLA(2) releasing the encapsulated luciferin, which provided readout from the luciferase-expressing cells. Cholesterol enhanced the integrity of the formulation without affecting its susceptibility to sPLA(2). PEGylation of the liposomes only moderately broadened the release profile of luciferin. The provided bioassay represents a useful tool for monitoring active drug release in situ in real time as well as for testing and optimizing of sPLA(2)-sensitive lipid formulations. In addition, the bioassay will pave the way for future in-depth in vitro and in vivo studies.	[Arouri, Ahmad; Hansen, Anders H.; Mouritsen, Ole G.] Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Arouri, Ahmad; Trojnar, Jakub; Schmidt, Steffen; Hansen, Anders H.; Mollenhauer, Jan; Mouritsen, Ole G.] Univ Southern Denmark, Inst Mol Med, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark; [Trojnar, Jakub; Schmidt, Steffen; Mollenhauer, Jan] Univ Southern Denmark, Inst Mol Med, Mol Oncol Grp, Odense, Denmark	University of Southern Denmark; Lundbeckfonden; University of Southern Denmark; University of Southern Denmark	Arouri, A (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.	arouri@memphys.sdu.dk	Højgaard Hansen, Anders/G-9662-2018; Mollenhauer, Jan/G-4452-2012	Højgaard Hansen, Anders/0000-0002-2572-9354; Mouritsen, Ole G./0000-0002-4258-8960	Lundbeckfonden (Center of Excellence NanoCAN grant); Danish Council for Independent Research|Technology and Production Sciences (DFF-FTP); DAWN-2020 project - Rektorspuljen SDU2020 program; MIO project of the OUH Frontlinjepuljen; Novo Nordisk Foundation	Lundbeckfonden (Center of Excellence NanoCAN grant); Danish Council for Independent Research|Technology and Production Sciences (DFF-FTP); DAWN-2020 project - Rektorspuljen SDU2020 program; MIO project of the OUH Frontlinjepuljen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by Lundbeckfonden (Center of Excellence NanoCAN grant), the Danish Council for Independent Research|Technology and Production Sciences (DFF-FTP), the DAWN-2020 project financed by Rektorspuljen SDU2020 program, the MIO project of the OUH Frontlinjepuljen, and a Scholarship from Novo Nordisk Foundation to AHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1997, INT J CANCER, V74, P245, DOI 10.1002/(SICI)1097-0215(19970620)74:3<245::AID-IJC2>3.0.CO;2-Z; Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001; Arechabala B, 1999, J APPL TOXICOL, V19, P163, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H; Arouri A, 2013, CURR OPIN COLLOID IN, V18, P419, DOI 10.1016/j.cocis.2013.06.001; Arouri A, 2013, PROG LIPID RES, V52, P130, DOI 10.1016/j.plipres.2012.09.002; Arouri A, 2012, EUR J PHARM SCI, V45, P408, DOI 10.1016/j.ejps.2011.09.013; Arouri A, 2011, J LIPOSOME RES, V21, P296, DOI 10.3109/08982104.2011.563365; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Belinsky GS, 2007, MOL CARCINOGEN, V46, P106, DOI 10.1002/mc.20271; Cai QC, 2012, FASEB J, V26, P3306, DOI 10.1096/fj.12-207597; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Cooper S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-10; da Silva LP, 2011, PHOTOCH PHOTOBIO SCI, V10, P1039, DOI 10.1039/c0pp00379d; Dabholkar RD, 2006, INT J PHARMACEUT, V315, P148, DOI 10.1016/j.ijpharm.2006.02.018; Davidsen J, 2002, BBA-BIOMEMBRANES, V1564, P256, DOI 10.1016/S0005-2736(02)00461-3; Davidsen J, 2001, INT J PHARMACEUT, V214, P67, DOI 10.1016/S0378-5173(00)00634-7; de Jonge MJA, 2010, EUR J CANCER, V46, P3016, DOI 10.1016/j.ejca.2010.07.015; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; GREGORIADIS G, 1974, LANCET, V1, P1313, DOI 10.1016/S0140-6736(74)90682-5; Hansen T, 2013, THESIS TU DENMARK LY; Hiyama M, 2013, PHOTOCHEM PHOTOBIOL, V89, P571, DOI 10.1111/php.12052; Hu Jia-jia, 2011, Clinical Oncology and Cancer Research, V8, P71, DOI 10.1007/s11805-011-0562-z; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Jensen SS, 2004, MOL CANCER THER, V3, P1451; Jorgensen K, 1999, PHARM RES-DORDR, V16, P1491, DOI 10.1023/A:1018931915924; Kheirolomoom A, 2010, J CONTROL RELEASE, V141, P128, DOI 10.1016/j.jconrel.2009.08.029; Kraske WV, 2001, BBA-BIOMEMBRANES, V1514, P159, DOI 10.1016/S0005-2736(01)00379-0; Leidy C, 2006, BIOPHYS J, V90, P3165, DOI 10.1529/biophysj.105.070987; Marques SM, 2009, IUBMB LIFE, V61, P6, DOI 10.1002/iub.134; Mayer LD, 2000, J LIPOSOME RES, V10, P99, DOI 10.3109/08982100009029381; MCELROY WD, 1951, J BIOL CHEM, V191, P547; Moghimi SM, 2014, NANOMED-NANOTECHNOL, V10, P1661, DOI 10.1016/j.nano.2014.04.011; MORTON RA, 1969, BIOCHEMISTRY-US, V8, P1598, DOI 10.1021/bi00832a041; Mouritsen OG, 2006, J PHYS-CONDENS MAT, V18, pS1293, DOI 10.1088/0953-8984/18/28/S12; MURATA K, 1993, BRIT J CANCER, V68, P103, DOI 10.1038/bjc.1993.294; Navizet I, 2011, CHEMPHYSCHEM, V12, P3064, DOI 10.1002/cphc.201100504; Park K, 2014, J CONTROL RELEASE, V178, P126, DOI 10.1016/j.jconrel.2014.02.018; Pedersen PJ, 2010, J MED CHEM, V53, P3782, DOI 10.1021/jm100190c; Pedersen PJ, 2009, J MED CHEM, V52, P3408, DOI 10.1021/jm900091h; Ribeiro C, 2008, PHOTOCH PHOTOBIO SCI, V7, P1085, DOI 10.1039/b809935a; Rosholm KR, 2012, LANGMUIR, V28, P2773, DOI 10.1021/la2039834; Rousseau J, 2010, CANCER GENE THER, V17, P387, DOI 10.1038/cgt.2009.89; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Tribler L, 2007, ANTICANCER RES, V27, P3179; Viviani VR, 2002, CELL MOL LIFE SCI, V59, P1833, DOI 10.1007/PL00012509; YAMASHITA SI, 1994, BRIT J CANCER, V69, P1166, DOI 10.1038/bjc.1994.229; Zhu GD, 2011, J PHARM SCI-US, V100, P3146, DOI 10.1002/jps.22530	49	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125508	10.1371/journal.pone.0125508	http://dx.doi.org/10.1371/journal.pone.0125508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945937	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700073
J	Kanakov, O; Kotelnikov, R; Alsaedi, A; Tsimring, L; Huerta, R; Zaikin, A; Ivanchenko, M				Kanakov, Oleg; Kotelnikov, Roman; Alsaedi, Ahmed; Tsimring, Lev; Huerta, Ramon; Zaikin, Alexey; Ivanchenko, Mikhail			Multi-Input Distributed Classifiers for Synthetic Genetic Circuits	PLOS ONE			English	Article							ESCHERICHIA-COLI; LOGIC GATES; EXPRESSION; PATTERN; ROBUST; CELLS	For practical construction of complex synthetic genetic networks able to perform elaborate functions it is important to have a pool of relatively simple modules with different functionality which can be compounded together. To complement engineering of very different existing synthetic genetic devices such as switches, oscillators or logical gates, we propose and develop here a design of synthetic multi-input classifier based on a recently introduced distributed classifier concept. A heterogeneous population of cells acts as a single classifier, whose output is obtained by summarizing the outputs of individual cells. The learning ability is achieved by pruning the population, instead of tuning parameters of an individual cell. The present paper is focused on evaluating two possible schemes of multi-input gene classifier circuits. We demonstrate their suitability for implementing a multi-input distributed classifier capable of separating data which are inseparable for single-input classifiers, and characterize performance of the classifiers by analytical and numerical results. The simpler scheme implements a linear classifier in a single cell and is targeted at separable classification problems with simple class borders. A hard learning strategy is used to train a distributed classifier by removing from the population any cell answering incorrectly to at least one training example. The other scheme implements a circuit with a bell-shaped response in a single cell to allow potentially arbitrary shape of the classification border in the input space of a distributed classifier. Inseparable classification problems are addressed using soft learning strategy, characterized by probabilistic decision to keep or discard a cell at each training iteration. We expect that our classifier design contributes to the development of robust and predictable synthetic biosensors, which have the potential to affect applications in a lot of fields, including that of medicine and industry.	[Kanakov, Oleg] Lobachevsky State Univ Nizhniy Novgorod, Oscillat Theory Dept, Nizhnii Novgorod, Russia; [Kotelnikov, Roman; Zaikin, Alexey; Ivanchenko, Mikhail] Lobachevsky State Univ Nizhniy Novgorod, Dept Bioinformat, Nizhnii Novgorod, Russia; [Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Jeddah 21413, Saudi Arabia; [Tsimring, Lev; Huerta, Ramon] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Zaikin, Alexey] UCL, Inst Womens Hlth, London, England; [Zaikin, Alexey] UCL, Dept Math, London, England	Lobachevsky State University of Nizhni Novgorod; Lobachevsky State University of Nizhni Novgorod; King Abdulaziz University; University of California System; University of California San Diego; University of London; University College London; University of London; University College London	Kanakov, O (corresponding author), Lobachevsky State Univ Nizhniy Novgorod, Oscillat Theory Dept, Nizhnii Novgorod, Russia.	okanakov@rf.unn.ru	Kanakov, Oleg/J-9418-2013; Ivanchenko, Mikhail V/J-7045-2013; Ivanchenko, Mikhail/AGE-5444-2022; Huerta, Ramon/J-4316-2012; Zaikin, Alexey/K-6581-2017; Zaikin, Alexey/T-7171-2019; Alsaedi, Ahmed/A-2094-2013	Ivanchenko, Mikhail V/0000-0002-1903-7423; Huerta, Ramon/0000-0003-3925-5169; Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Alsaedi, Ahmed/0000-0003-3452-8922; Tsimring, Lev/0000-0003-0709-3548	Ministry of education and science of the Russian Federation [3.820.2014/K, 02.B.49.21.0003]; Russian Foundation for Basic Research [14-02-01202, 13-02-00918]; King Abdulaziz University, Jeddah [20/34/Gr]; National Institutes of Health grant [RO1-GM069811]; Defense Advanced Research Projects Agency [W911NF-14-2-0032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	Ministry of education and science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); King Abdulaziz University, Jeddah; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors aknowledge support of this research from The Ministry of education and science of the Russian Federation (mon.gov.ru) within agreements No. 3.820.2014/K (OK) and No. 02.B.49.21.0003 (AZ and MI), from Russian Foundation for Basic Research (www.rfbr.ru) grants No. 14-02-01202 (RK and AZ) and No. 13-02-00918 (MI), from the Deanship of Scientifc Research, King Abdulaziz University, Jeddah (dsr.kau.edu.sa), grant No. 20/34/Gr (AA), from National Institutes of Health (nih.gov) grant RO1-GM069811 (LT), and from Defense Advanced Research Projects Agency (www.darpa.mil) contract W911NF-14-2-0032 (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Didovyk A, 2015, ACS SYNTH BIOL, V4, P72, DOI 10.1021/sb500235p; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fernando CT, 2009, J R SOC INTERFACE, V6, P463, DOI 10.1098/rsif.2008.0344; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Ptashne M., 1986, A GENETIC SWITCH; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schaerli Y, 2013, MOL BIOSYST, V9, P1559, DOI 10.1039/c2mb25483b; Shis DL, 2013, P NATL ACAD SCI USA, V110, P5028, DOI 10.1073/pnas.1220157110; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tewari A, 2007, J MACH LEARN RES, V8, P1007; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Weiss R, 2002, NAT COMPUT SER, P275; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151	37	8	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125144	10.1371/journal.pone.0125144	http://dx.doi.org/10.1371/journal.pone.0125144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946237	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700058
J	Liu, QQ; Zhang, FF; Wang, F; Qiu, JH; Luo, CH; Zhu, GY; Liu, YF				Liu, Qing-Qing; Zhang, Feng-Feng; Wang, Fang; Qiu, Jing-Hua; Luo, Chun-Hua; Zhu, Guo-Yong; Liu, Ying-Fu			TIPE2 Inhibits Lung Cancer Growth Attributing to Promotion of Apoptosis by Regulating Some Apoptotic Molecules Expression	PLOS ONE			English	Article							METASTASIS; OVEREXPRESSION; PATHWAY; SCC-S2	Recent studies found that TIPE2 was involved in cancer development. However, little is known about TIPE2 in lung cancer. Our study aims to clarify the role of TIPE2 in lung carcinogenesis. We examined the expression of TIPE2 in lung squamous cancer (LSC), small cell lung cancer and lung adenocarcinoma (AdC) tissues and found that TIPE2 expression was lost in small cell lung cancer, compared with adjacent non-tumor tissues. Overexpression of TIPE2 significantly inhibited the growth of lung cancer cell H446 in vitro and even suppressed tumor formation in vivo. Flow cytometry analysis found TIPE2 overexpression promoted apoptosis of H446. In TIPE2 over-expression cells, caspase-3, caspase-9, and Bax were significantly up-regulated while Bcl-2 was down-regulated. Moreover, coincident results were shown by immunohistochemistry in tumors from nude mice. TIPE2 inhibited the phosphorylation of Akt, while promoting the phosphorylation of P38, but had no effect on I kappa B alpha and ERK pathway. Taken together, TIPE2 promoted lung cancer cell apoptosis through affecting apoptosis-related molecules caspase-3, caspase-9, Bcl-2 and Bax, possibly via regulating P38 and Akt pathways, indicating that TIPE2 might be a novel marker for lung cancer diagnosis and therapy.	[Liu, Qing-Qing; Zhang, Feng-Feng; Qiu, Jing-Hua; Liu, Ying-Fu] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Luo, Chun-Hua] Tradit Chinese Med Hosp Xiamen, Dept Pathol, Xiamen, Fujian, Peoples R China; [Zhu, Guo-Yong] Xiamen Univ, Affiliated Hosp 1, Dept Thorac Surg, Xiamen, Fujian, Peoples R China; [Wang, Fang] NanYang Med Coll, Dept Basic Med Sci, Nanyang, Peoples R China	Xiamen University; Xiamen University; Nanyang Medical College	Liu, YF (corresponding author), Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China.	liuyingfu@126.com	liu, qingqing/HHD-0360-2022		National Natural Science Funds of China [81101764]; Natural Science Foundation of Fujian Province of China [2011J05099]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	Funding was provided by the National Natural Science Funds of China (81101764) http://www.nsfc.gov.cn/, the Natural Science Foundation of Fujian Province of China (2011J05099) http://www.fjkjt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Cui J, 2011, MOL IMMUNOL, V48, P1548, DOI 10.1016/j.molimm.2011.04.023; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Dong QZ, 2010, CANCER SCI, V101, P1562, DOI 10.1111/j.1349-7006.2010.01557.x; Fennell DA, 2005, CLIN CANCER RES, V11, P2097, DOI 10.1158/1078-0432.CCR-04-1482; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Houwen Li, 2003, Ann Thorac Cardiovasc Surg, V9, P147; Huang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098943; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Lauring J, 2013, J NATL COMPR CANC NE, V11, P670, DOI 10.6004/jnccn.2013.0086; Li D, 2009, CLIN IMMUNOL, V133, P422, DOI 10.1016/j.clim.2009.08.014; Li XM, 2014, CANCER BIOMARK, V14, P233, DOI 10.3233/CBM-140402; Little AG, 2007, LUNG CANCER, V57, P253, DOI 10.1016/j.lungcan.2007.03.012; Liu J, 2014, ASIAN PAC J CANCER P, V15, P4519, DOI 10.7314/APJCP.2014.15.11.4519; Liu YF, 2009, J PATHOL, V217, P54, DOI 10.1002/path.2429; Liu YF, 2011, CLIN EXP METASTAS, V28, P413, DOI 10.1007/s10585-011-9380-1; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Xi WJ, 2011, MOL IMMUNOL, V48, P1203, DOI 10.1016/j.molimm.2011.03.002; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020; Zhang GZ, 2010, MOL IMMUNOL, V47, P2435, DOI 10.1016/j.molimm.2010.06.016; Zhang L, 2011, MOL IMMUNOL, V48, P1209, DOI 10.1016/j.molimm.2011.03.001; Zhang X, 2009, NAT STRUCT MOL BIOL, V16, P89, DOI 10.1038/nsmb.1522; Zhang ZL, 2013, ONCOL LETT, V6, P571, DOI 10.3892/ol.2013.1388; Zhou YQ, 2014, CARCINOGENESIS, V35, P2660, DOI 10.1093/carcin/bgu186	26	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126176	10.1371/journal.pone.0126176	http://dx.doi.org/10.1371/journal.pone.0126176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946186	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700117
J	Morini, M; Pasquier, J; Dirks, R; van den Thillart, G; Tomkiewicz, J; Rousseau, K; Dufour, S; Lafont, AG				Morini, Marina; Pasquier, Jeremy; Dirks, Ron; van den Thillart, Guido; Tomkiewicz, Jonna; Rousseau, Karine; Dufour, Sylvie; Lafont, Anne-Gaelle			Duplicated Leptin Receptors in Two Species of Eel Bring New Insights into the Evolution of the Leptin System in Vertebrates	PLOS ONE			English	Article							OVERLAPPING TRANSCRIPT GENES; BASS DICENTRARCHUS-LABRAX; CARP CYPRINUS-CARPIO; MALE ATLANTIC SALMON; FOOD-INTAKE; MOLECULAR-CLONING; GENOMIC CHARACTERIZATION; TISSUE DISTRIBUTION; PLASMA LEPTIN; IN-VIVO	Since its discovery in mammals as a key-hormone in reproduction and metabolism, leptin has been identified in an increasing number of tetrapods and teleosts. Tetrapods possess only one leptin gene, while most teleosts possess two leptin genes, as a result of the teleost third whole genome duplication event (3R). Leptin acts through a specific receptor (LEPR). In the European and Japanese eels, we identified two leptin genes, and for the first time in vertebrates, two LEPR genes. Synteny analyses indicated that eel LEPRa and LEPRb result from teleost 3R. LEPRb seems to have been lost in the teleost lineage shortly after the elopomorph divergence. Quantitative PCRs revealed a wide distribution of leptins and LEPRs in the European eel, including tissues involved in metabolism and reproduction. Noticeably, leptin1 was expressed in fat tissue, while leptin2 in the liver, reflecting subfunctionalization. Four-month fasting had no impact on the expression of leptins and LEPRs in control European eels. This might be related to the remarkable adaptation of silver eel metabolism to long-term fasting throughout the reproductive oceanic migration. In contrast, sexual maturation induced differential increases in the expression of leptins and LEPRs in the BPG-liver axis. Leptin2 was strikingly upregulated in the liver, the central organ of the reproductive metabolic challenge in teleosts. LEPRs were differentially regulated during sexual maturation, which may have contributed to the conservation of the duplicated LEPRs in this species. This suggests an ancient and positive role of the leptin system in the vertebrate reproductive function. This study brings new insights on the evolutionary history of the leptin system in vertebrates. Among extant vertebrates, the eel represents a unique case of duplicated leptins and leptin receptors as a result of 3R.	[Morini, Marina; Pasquier, Jeremy; Rousseau, Karine; Dufour, Sylvie; Lafont, Anne-Gaelle] Univ Paris 04, Museum Natl Hist Nat, Res Unit BOREA Biol Aquat Organisms & Ecosyst, IRD207,UCBN,CNRS 7208, F-75230 Paris 05, France; [Dirks, Ron; van den Thillart, Guido] ZF Screens BV, Leiden, Netherlands; [van den Thillart, Guido] Leiden Univ, Inst Biol, Leiden, Netherlands; [Tomkiewicz, Jonna] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Leiden University; Leiden University - Excl LUMC; Technical University of Denmark	Lafont, AG (corresponding author), Univ Paris 04, Museum Natl Hist Nat, Res Unit BOREA Biol Aquat Organisms & Ecosyst, IRD207,UCBN,CNRS 7208, F-75230 Paris 05, France.	anne-gaelle.lafont@mnhn.fr	Tomkiewicz, Jonna/AAH-7526-2021; Morini, Marina/L-4088-2017	Tomkiewicz, Jonna/0000-0002-9695-2019; Morini, Marina/0000-0003-3313-3419	European Community, 7th Framework Programme, PRO-EEL [245257]; National Research Agency, PUBERTEEL [ANR-08-BLAN-0173]	European Community, 7th Framework Programme, PRO-EEL; National Research Agency, PUBERTEEL	This work was supported by grants from the European Community, 7th Framework Programme, PRO-EEL, number 245257 to AGL, SD, JT, RD, GT and from the National Research Agency, PUBERTEEL, number ANR-08-BLAN-0173 to SD, KR, MM, JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014; Angotzi AR, 2013, GEN COMP ENDOCR, V187, P48, DOI 10.1016/j.ygcen.2013.03.022; Aroua S, 2007, GEN COMP ENDOCR, V153, P333, DOI 10.1016/j.ygcen.2007.02.027; Tinoco AB, 2012, PEPTIDES, V34, P329, DOI 10.1016/j.peptides.2012.02.001; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Boswell T, 2006, GEN COMP ENDOCR, V146, P157, DOI 10.1016/j.ygcen.2005.08.001; Butts IAE, 2014, AQUACULTURE, V426, P9, DOI 10.1016/j.aquaculture.2014.01.020; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen JN, 2014, MOL PHYLOGENET EVOL, V70, P152, DOI 10.1016/j.ympev.2013.09.002; Chisada S, 2014, GEN COMP ENDOCR, V195, P9, DOI 10.1016/j.ygcen.2013.10.008; Cioffi JA, 1996, NAT MED, V2, P585, DOI 10.1038/nm0596-585; Copeland DL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00026; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; de Pedro N, 2006, J ENDOCRINOL, V188, P513, DOI 10.1677/joe.1.06349; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Fortuno A, 2003, J PHYSIOL BIOCHEM, V59, P51, DOI 10.1007/BF03179868; Friedman-Einat M, 2014, ENDOCRINOLOGY, V155, P3376, DOI 10.1210/en.2014-1273; Froiland E, 2010, GEN COMP ENDOCR, V165, P136, DOI 10.1016/j.ygcen.2009.06.010; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Fuentes EN, 2012, GEN COMP ENDOCR, V177, P120, DOI 10.1016/j.ygcen.2012.02.019; Gambardella C, 2012, AQUACULTURE, V354, P1, DOI 10.1016/j.aquaculture.2012.04.043; Gong Y, 2013, GEN COMP ENDOCR, V182, P1, DOI 10.1016/j.ygcen.2012.11.006; Gorissen M, 2009, J ENDOCRINOL, V201, P329, DOI 10.1677/JOE-09-0034; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Horev G, 2000, MOL CELL ENDOCRINOL, V162, P95, DOI 10.1016/S0303-7207(00)00205-7; Huang G, 2014, ENDOCRINOLOGY, V155, P3385, DOI 10.1210/en.2014-1084; Huising MO, 2006, ENDOCRINOLOGY, V147, P5786, DOI 10.1210/en.2006-0824; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Imagawa K, 1998, J BIOL CHEM, V273, P35245, DOI 10.1074/jbc.273.52.35245; ISSE N, 1995, J BIOL CHEM, V270, P27728, DOI 10.1074/jbc.270.46.27728; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johnson RM, 2000, J EXP ZOOL, V286, P718, DOI 10.1002/(SICI)1097-010X(20000601)286:7&lt;718::AID-JEZ6&gt;3.0.CO;2-I; Jorgensen EH, 2013, J EXP BIOL, V216, P3222, DOI 10.1242/jeb.088344; Karlsson C, 1997, J CLIN ENDOCR METAB, V82, P4144, DOI 10.1210/jc.82.12.4144; Karmazyn M, 2014, CURR PHARM DESIGN, V20, P646, DOI 10.2174/13816128113199990023; Kendall NR, 2004, REPRODUCTION, V128, P757, DOI 10.1530/rep.1.00256; Kukner A, 2006, ACTA OPHTHALMOL SCAN, V84, P54, DOI 10.1111/j.1600-0420.2005.00544.x; Kurokawa T, 2005, PEPTIDES, V26, P745, DOI 10.1016/j.peptides.2004.12.017; Kurokawa T, 2008, GEN COMP ENDOCR, V158, P108, DOI 10.1016/j.ygcen.2008.06.003; Kurokawa T, 2009, GEN COMP ENDOCR, V161, P229, DOI 10.1016/j.ygcen.2009.01.008; Li GG, 2010, GEN COMP ENDOCR, V166, P117, DOI 10.1016/j.ygcen.2009.10.009; Liu Q, 2010, GEN COMP ENDOCR, V166, P346, DOI 10.1016/j.ygcen.2009.11.015; Londraville RL, 2014, GEN COMP ENDOCR, V203, P146, DOI 10.1016/j.ygcen.2014.02.002; Lu RH, 2012, FISH PHYSIOL BIOCHEM, V38, P1759, DOI 10.1007/s10695-012-9673-6; Maberley D, 2006, EYE, V20, P801, DOI 10.1038/sj.eye.6702011; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Murashita K, 2008, COMP BIOCHEM PHYS B, V150, P377, DOI 10.1016/j.cbpb.2008.04.007; Murashita K, 2011, COMP BIOCHEM PHYS A, V158, P79, DOI 10.1016/j.cbpa.2010.09.001; Nieminen P, 2003, ZOOL SCI, V20, P1109, DOI 10.2108/zsj.20.1109; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Pasquier Jeremy, 2012, Front Endocrinol (Lausanne), V3, P173, DOI 10.3389/fendo.2012.00173; Pasquier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048931; Peyon P, 2003, GEN COMP ENDOCR, V132, P284, DOI 10.1016/S0016-6480(03)00097-2; Peyon P, 2001, BIOL REPROD, V65, P1573, DOI 10.1095/biolreprod65.5.1573; Pfundt B, 2009, ANAT HISTOL EMBRYOL, V38, P406, DOI 10.1111/j.1439-0264.2009.00951.x; Prokop JW, 2012, PEPTIDES, V38, P326, DOI 10.1016/j.peptides.2012.10.002; Prokop JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092751; Ronnestad I, 2010, GEN COMP ENDOCR, V168, P55, DOI 10.1016/j.ygcen.2010.04.010; Sbaihi M, 2009, J ENDOCRINOL, V201, P241, DOI 10.1677/JOE-08-0492; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; Shpilman M, 2014, GEN COMP ENDOCR, V207, P74, DOI 10.1016/j.ygcen.2014.05.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tang YK, 2013, COMP BIOCHEM PHYS B, V166, P133, DOI 10.1016/j.cbpb.2013.07.009; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Trombley S, 2013, FISH PHYSIOL BIOCHEM, V39, P103, DOI 10.1007/s10695-012-9731-0; Trombley S, 2014, GEN COMP ENDOCR, V204, P60, DOI 10.1016/j.ygcen.2014.04.033; Trombley S, 2012, GEN COMP ENDOCR, V175, P92, DOI 10.1016/j.ygcen.2011.10.001; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; WAHLI W, 1988, TRENDS GENET, V4, P227, DOI 10.1016/0168-9525(88)90155-2; Wang YS, 2006, J STEROID BIOCHEM, V100, P193, DOI 10.1016/j.jsbmb.2006.04.011; Watanobe H, 2002, J PHYSIOL-LONDON, V545, P255, DOI 10.1113/jphysiol.2002.023895; Weil C, 2003, GEN COMP ENDOCR, V130, P2, DOI 10.1016/S0016-6480(02)00504-X; Won E.T., 2013, FRONT ENDOCRINOL, V4, P74, DOI [DOI 10.3389/FEND0.2013.00074, DOI 10.3389/FENDO.2013.00074]; Won ET, 2012, GEN COMP ENDOCR, V178, P98, DOI 10.1016/j.ygcen.2012.04.019; Yu WH, 1997, P NATL ACAD SCI USA, V94, P1023, DOI 10.1073/pnas.94.3.1023; Yuan DY, 2014, GEN COMP ENDOCR, V204, P13, DOI 10.1016/j.ygcen.2014.05.013; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zhang HX, 2013, GEN COMP ENDOCR, V181, P295, DOI 10.1016/j.ygcen.2012.09.008; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zieba DA, 2005, DOMEST ANIM ENDOCRIN, V29, P166, DOI 10.1016/j.domaniend.2005.02.019	89	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126008	10.1371/journal.pone.0126008	http://dx.doi.org/10.1371/journal.pone.0126008			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946034	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700100
J	Pettersson, M; Bliman, D; Jacobsson, J; Nilsson, JR; Min, J; Iconaru, L; Guy, RK; Kriwacki, RW; Andreasson, J; Grotli, M				Pettersson, Mariell; Bliman, David; Jacobsson, Jimmy; Nilsson, Jesper R.; Min, Jaeki; Iconaru, Luigi; Guy, R. Kiplin; Kriwacki, Richard W.; Andreasson, Joakim; Grotli, Morten			8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PRINCIPLES; PEPTIDE; DESIGN; PURINE	Small molecule nonpeptidic mimics of alpha-helices are widely recognised as protein-protein interaction (PPIs) inhibitors. Protein-protein interactions mediate virtually all important regulatory pathways in a cell, and the ability to control and modulate PPIs is therefore of great significance to basic biology, where controlled disruption of protein networks is key to understanding network connectivity and function. We have designed and synthesised two series of 2,6,9-substituted 8-triazolylpurines as alpha-helix mimetics. The first series was designed based on low energy conformations but did not display any biological activity in a biochemical fluorescence polarisation assay targeting MDM2/p53. Although solution NMR conformation studies demonstrated that such molecules could mimic the topography of an alpha-helix, docking studies indicated that the same compounds were not optimal as inhibitors for the MDM2/p53 interaction. A new series of 8-triazolylpurines was designed based on a combination of docking studies and analysis of recently published inhibitors. The best compound displayed low micromolar inhibitory activity towards MDM2/p53 in a biochemical fluorescence polarisation assay. In order to evaluate the applicability of these compounds as biologically active and intrinsically fluorescent probes, their absorption/emission properties were measured. The compounds display fluorescent properties with quantum yields up to 50%.	[Pettersson, Mariell; Bliman, David; Jacobsson, Jimmy; Grotli, Morten] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Nilsson, Jesper R.; Andreasson, Joakim] Chalmers Univ Technol, Dept Chem & Biol Engn, Chem & Biochem, S-41296 Gothenburg, Sweden; [Min, Jaeki; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Iconaru, Luigi; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	University of Gothenburg; Chalmers University of Technology; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Grotli, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	grotli@chem.gu.se	Kriwacki, Richard/N-8154-2018; Grötli, Morten/A-8735-2010; Guy, Rodney/J-7107-2013; Andréasson, Joakim/A-2028-2011	Kriwacki, Richard/0000-0002-9798-6018; Grötli, Morten/0000-0003-3621-4222; Guy, Rodney/0000-0002-9638-2060; Andréasson, Joakim/0000-0003-4695-7943; Jakobsson, Erik Jimmy/0000-0002-5266-0591; Min, Jaeki/0000-0002-0083-3198	Swedish Research Council [62120083533]; American Lebanese Syrian Associated Charities (ALSAC); St Jude Children's Research Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St Jude Children's Research Hospital	This work was supported by the Swedish Research Council (project # 62120083533), the American Lebanese Syrian Associated Charities (ALSAC) and St Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeluri M, 2014, CHEM REV, V114, P4640, DOI 10.1021/cr4004049; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Bharatham N, 2014, J CHEM INF MODEL, V54, P648, DOI 10.1021/ci4004656; Bliman D, 2014, TETRAHEDRON LETT, V55, P2929, DOI 10.1016/j.tetlet.2014.03.084; Cechova L, 2011, TETRAHEDRON, V67, P866, DOI 10.1016/j.tet.2010.12.040; Chang YT, 1999, CHEM BIOL, V6, P361, DOI 10.1016/S1074-5521(99)80048-9; CICERO DO, 1995, J AM CHEM SOC, V117, P1027, DOI 10.1021/ja00108a019; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Danelius E, 2013, SYNLETT, V24, P2407, DOI 10.1055/s-0033-1339670; Davis MR, 2012, TETRAHEDRON, V68, P1029, DOI 10.1016/j.tet.2011.11.089; de Turiso FGL, 2013, J MED CHEM, V56, P4053, DOI 10.1021/jm400293z; Dierckx A, 2011, NUCLEIC ACIDS RES, V39, P4513, DOI 10.1093/nar/gkr010; Dyrager C, 2009, EUR J ORG CHEM, V2009, P1515, DOI 10.1002/ejoc.200900018; Fletcher S, 2010, TETRAHEDRON, V66, P4621, DOI 10.1016/j.tet.2010.03.118; Fletcher S, 2009, TETRAHEDRON LETT, V50, P4258, DOI 10.1016/j.tetlet.2009.04.137; Friden-Saxin M, 2012, TETRAHEDRON, V68, P7035, DOI 10.1016/j.tet.2012.06.077; Horne WS, 2004, J AM CHEM SOC, V126, P15366, DOI 10.1021/ja0450408; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Jochim AL, 2010, ACS CHEM BIOL, V5, P919, DOI 10.1021/cb1001747; Johansson JR, 2011, J ORG CHEM, V76, P2355, DOI 10.1021/jo200134a; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Koivisto JJ, 2010, ORG BIOMOL CHEM, V8, P2103, DOI 10.1039/b921794k; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Kwok SW, 2010, ORG LETT, V12, P4217, DOI 10.1021/ol101568d; Lee JH, 2011, J AM CHEM SOC, V133, P676, DOI 10.1021/ja108230s; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Michelsen K, 2012, J AM CHEM SOC, V134, P17059, DOI 10.1021/ja305839b; Orner BP, 2001, J AM CHEM SOC, V123, P5382, DOI 10.1021/ja0025548; Pedersen DS, 2011, EUR J ORG CHEM, V2011, P2399, DOI 10.1002/ejoc.201100157; Rew Y, 2012, J MED CHEM, V55, P4936, DOI 10.1021/jm300354j; Rosemeyer H, 2004, CHEM BIODIVERS, V1, P361, DOI 10.1002/cbdv.200490033; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yin H., 2005, ANGEW CHEM, V117, P2764; Zhang L, 2005, J AM CHEM SOC, V127, P15998, DOI 10.1021/ja054114s; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708	40	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124423	10.1371/journal.pone.0124423	http://dx.doi.org/10.1371/journal.pone.0124423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942498	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943400014
J	Gutierrez-Preciado, A; Torres, AG; Merino, E; Bonomi, HR; Goldbaum, FA; Garcia-Angulo, VA				Gutierrez-Preciado, Ana; Torres, Alfredo Gabriel; Merino, Enrique; Ruy Bonomi, Hernan; Alberto Goldbaum, Fernando; Antonio Garcia-Angulo, Victor			Extensive Identification of Bacterial Riboflavin Transporters and Their Distribution across Bacterial Species	PLOS ONE			English	Article							OCHROBACTRUM-ANTHROPI; GENE-EXPRESSION; CORYNEBACTERIUM-GLUTAMICUM; STREPTOMYCES-DAVAWENSIS; MICROBIAL COMMUNITIES; LACTOCOCCUS-LACTIS; ECF TRANSPORTER; FMN-RIBOSWITCH; BIOSYNTHESIS; BINDING	Riboflavin, the precursor for the cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide, is an essential metabolite in all organisms. While the functions for de novo riboflavin biosynthesis and riboflavin import may coexist in bacteria, the extent of this co-occurrence is undetermined. The RibM, RibN, RfuABCD and the energy-coupling factor-RibU bacterial riboflavin transporters have been experimentally characterized. In addition, ImpX, RfnT and RibXY are proposed as riboflavin transporters based on positional clustering with riboflavin biosynthetic pathway (RBP) genes or conservation of the FMN riboswitch regulatory element. Here, we searched for the FMN riboswitch in bacterial genomes to identify genes encoding riboflavin transporters and assessed their distribution among bacteria. Two new putative riboflavin transporters were identified: RibZ in Clostridium and RibV in Mesoplasma florum. Trans-complementation of an Escherichia coli riboflavin auxotroph strain confirmed the riboflavin transport activity of RibZ from Clostridium difficile, RibXY from Chloroflexus aurantiacus, ImpX from Fusobacterium nucleatum and RfnT from Ochrobactrum anthropi. The analysis of the genomic distribution of all known bacterial riboflavin transporters revealed that most occur in species possessing the RBP and that some bacteria may even encode functional riboflavin transporters from two different families. Our results indicate that some species possess ancestral riboflavin transporters, while others possess transporters that appear to have evolved recently. Moreover, our data suggest that unidentified riboflavin transporters also exist. The present study doubles the number of experimentally characterized riboflavin transporters and suggests a specific, non-accessory role for these proteins in riboflavin-prototrophic bacteria.	[Gutierrez-Preciado, Ana; Merino, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Torres, Alfredo Gabriel; Antonio Garcia-Angulo, Victor] Univ Texas Med Branch, Dept Microbiol & Immunol, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Torres, Alfredo Gabriel] Univ Texas Med Branch, Dept Pathol, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Ruy Bonomi, Hernan; Alberto Goldbaum, Fernando] IIBBA CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Antonio Garcia-Angulo, Victor] Univ Mayor, Ctr Genom & Bioinformat, Santiago, Chile	Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Universidad Mayor	Garcia-Angulo, VA (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.	v.garcia.angulo@gmail.com	Gutiérrez-Preciado, Ana/AAC-8161-2019; Bonomi, Hernán Ruy/D-8826-2019	Gutiérrez-Preciado, Ana/0000-0002-6032-466X; Bonomi, Hernán Ruy/0000-0002-1550-6181; Goldbaum, Fernando/0000-0001-6235-3002; Merino, Enrique/0000-0002-0374-0640; Torres, Alfredo/0000-0001-6450-0643	SECITI Postdoctoral Fellowship [029/2013]; CONICYT/FONDECYT [1150818]	SECITI Postdoctoral Fellowship; CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	A.G.P. was financially supported by a SECITI Postdoctoral Fellowship 029/2013. VAG is supported by CONICYT/FONDECYT Grant No 1150818 (Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Burgess CM, 2006, J BACTERIOL, V188, P2752, DOI 10.1128/JB.188.8.2752-2760.2006; Burke KE, 2014, GUT LIVER, V8, P1, DOI [10.5009/gn1.2014.8.1.1, 10.5009/gnl.2014.8.1.1]; Chen J, 2013, APPL ENVIRON MICROB, V79, P6140, DOI 10.1128/AEM.01953-13; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daxboeck F, 2002, AM J KIDNEY DIS, V40, DOI 10.1053/ajkd.2002.35759; De Colibus L, 2006, CURR OPIN STRUC BIOL, V16, P722, DOI 10.1016/j.sbi.2006.10.003; Deka RK, 2013, MBIO, V4, DOI 10.1128/mBio.00615-12; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Frigaard NU, 2004, ARCH MICROBIOL, V182, P265, DOI 10.1007/s00203-004-0718-9; Fujimura M, 2010, J NUTR, V140, P1722, DOI 10.3945/jn.110.128330; Angulo VAG, 2013, J BACTERIOL, V195, P4611, DOI 10.1128/JB.00644-13; Gopinath K, 2013, FUTURE MICROBIOL, V8, P1405, DOI 10.2217/fmb.13.113; Gopinath K, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120175; Grill S, 2007, ARCH MICROBIOL, V188, P377, DOI 10.1007/s00203-007-0258-1; Gutierrez-Preciado A, 2012, CLIN MICROBIOL INFEC, V18, P35, DOI 10.1111/j.1469-0691.2012.03864.x; Hemberger S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-119; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Jaehme M, 2015, BBA-GEN SUBJECTS, V1850, P565, DOI 10.1016/j.bbagen.2014.05.006; Kazanov MD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-347; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Mudshingkar SS, 2013, INDIAN J MED MICROBI, V31, P306, DOI 10.4103/0255-0857.115664; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ozdemir D, 2006, JPN J INFECT DIS, V59, P264; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Rodionova IA, 2015, ENV MICROBIOL REP, V7, P204, DOI 10.1111/1758-2229.12227; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Song JN, 2013, SCI REP-UK, V3, DOI 10.1038/srep03566; Sun EI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-597; Taboada B, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq254; Takai K, 1999, INT J SYST BACTERIOL, V49, P619, DOI 10.1099/00207713-49-2-619; Takemoto N, 2014, APPL MICROBIOL BIOT, V98, P4159, DOI 10.1007/s00253-014-5570-5; Vicens Q, 2011, NUCLEIC ACIDS RES, V39, P8586, DOI 10.1093/nar/gkr565; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yurgel SN, 2014, MOL PLANT MICROBE IN, V27, P437, DOI 10.1094/MPMI-11-13-0338-R; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	50	71	71	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126124	10.1371/journal.pone.0126124	http://dx.doi.org/10.1371/journal.pone.0126124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938806	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000142
J	Hughes, SF; Thomas-Wright, SJ; Banwell, J; Williams, R; Moyes, AJ; Mushtaq, S; Abdulmajed, M; Shergill, I				Hughes, Stephen Fon; Thomas-Wright, Samantha Jayne; Banwell, Joseph; Williams, Rachel; Moyes, Alyson Jayne; Mushtaq, Sohail; Abdulmajed, Mohamed; Shergill, Iqbal			A Pilot Study to Evaluate Haemostatic Function, following Shock Wave Lithotripsy (SWL) for the Treatment of Solitary Kidney Stones	PLOS ONE			English	Article							D-DIMER; COAGULATION; SURGERY; INJURY; DISEASE; MARKERS; DAMAGE	Purpose The number of patients undergoing shock wave lithotripsy (SWL) in the UK for solitary unilateral kidney stones is increasing annually. The development of postoperative complications such as haematuria and sepsis following SWL is likely to increase. Comparing a range of biological markers with the aim of monitoring or predicting postoperative complications following SWL has not been extensively researched. The main purpose of this pilot-study was to test the hypothesis that SWL results in changes to haemostatic function. Subsequently, this pilot-study would form a sound basis to undertake future investigations involving larger cohorts. Methods Twelve patients undergoing SWL for solitary unilateral kidney stones were recruited. From patients (8 male and 4 females) aged between 31-72 years (median-43 years), venous blood samples were collected pre-operatively (baseline), at 30, 120 and 240 minutes post-operatively. Specific haemostatic biomarkers [platelet counts, prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, D-dimer, von Willebrand Factor (vWF), sE-selectin and plasma viscosity (PV)] were measured. Results Platelet counts and fibrinogen concentration were significantly decreased following SWL (p = 0.027 and p = 0.014 respectively), while D-dimer and vWF levels significantly increased following SWL (p = 0.019 and p = 0.001 respectively). PT, APTT, sE-selectin and PV parameters were not significantly changed following SWL (p>0.05). Conclusions Changes to specific biomarkers such as plasma fibrinogen and vWF suggest that these represent a more clinically relevant assessment of the extent of haemostatic involvement following SWL. Analysis of such markers, in the future, may potentially provide valuable data on "normal" response after lithotripsy, and could be expanded to identify or predict those patients at risk of coagulopathy following SWL. The validation and reliability will be assessed through the assessment of larger cohorts.	[Hughes, Stephen Fon; Williams, Rachel; Moyes, Alyson Jayne] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Hughes, Stephen Fon; Moyes, Alyson Jayne; Mushtaq, Sohail; Abdulmajed, Mohamed; Shergill, Iqbal] Univ Chester, North Wales & North West Urol Res Ctr NW2URC, Chester, Cheshire, England; [Thomas-Wright, Samantha Jayne] BCUHB Wrexham Maelor Hosp, Dept Haematol, Wrexham, North Wales, Wales; [Banwell, Joseph] BCUHB Wrexham Maelor Hosp, Dept Clin Biochem, Wrexham, North Wales, Wales; [Mushtaq, Sohail] Univ Chester, Dept Clin Sci & Nutr, Chester, Cheshire, England; [Moyes, Alyson Jayne; Abdulmajed, Mohamed; Shergill, Iqbal] BCUHB Wrexham Maelor Hosp, Dept Urol, Wrexham, North Wales, Wales	University of Chester; University of Chester; University of Chester	Hughes, SF (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	stephen.hughes@chester.ac.uk		Mushtaq, Sohail/0000-0001-9980-8031	Institute of Biomedical Science (IBMS); University of Chester (Research & Knowledge Transfer Office)	Institute of Biomedical Science (IBMS); University of Chester (Research & Knowledge Transfer Office)	The authors would like to acknowledge the Institute of Biomedical Science (IBMS) and the University of Chester (Research & Knowledge Transfer Office) for their financial support.	Alessandro D, 2012, SCI WORLD J; Bates SM, 2012, SEMIN THROMB HEMOST, V38, P673, DOI 10.1055/s-0032-1326782; BLANN AD, 1994, EUR J VASCULAR SURG, V8, P10, DOI 10.1016/S0950-821X(05)80112-4; Blann AD, 1996, HAEMOSTASIS, V26, P72; de Moerloose P, 2001, THROMB HAEMOSTASIS, V85, P185; Dedej T, 2013, G CHIR, V34, P202, DOI 10.11138/gchir/2013.34.7.202; Foster W, 2009, RHEUMATOLOGY, V48, P285, DOI 10.1093/rheumatology/ken486; Handa RK, 2010, UROL RES, V38, P301, DOI 10.1007/s00240-010-0297-y; Handa RK, 2009, BJU INT, V103, P1270, DOI 10.1111/j.1464-410X.2008.08277.x; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Hughes SF, 2006, BRIT J BIOMED SCI, V63, P166, DOI 10.1080/09674845.2006.11732743; Hughes SF, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-40; Hughes SF, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-2; Lee YJ, 2007, RADIOL CLIN N AM, V45, P581, DOI 10.1016/j.rcl.2007.04.004; McAteer JA, 2008, SEMIN NEPHROL, V28, P200, DOI 10.1016/j.semnephrol.2008.01.003; Romero Victoriano, 2010, Rev Urol, V12, pe86; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Turney BW, 2012, BJU INT, V109, P1082, DOI 10.1111/j.1464-410X.2011.10495.x; UMEKAWA T, 1993, UROL INT, V50, P159, DOI 10.1159/000282475; Wyble CW, 1997, J SURG RES, V73, P107, DOI 10.1006/jsre.1997.5207; Yang L, 2013, J THROMB HAEMOST, V11, P1519, DOI 10.1111/jth.12304	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125840	10.1371/journal.pone.0125840	http://dx.doi.org/10.1371/journal.pone.0125840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938233	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000103
J	Liu, CC; Chen, ZC; Wang, T; Tang, DD; Hitchman, G; Sun, JZ; Zhao, XY; Wang, LJ; Chen, AT				Liu, Congcong; Chen, Zhencai; Wang, Ting; Tang, Dandan; Hitchman, Glenn; Sun, Jiangzhou; Zhao, Xiaoyue; Wang, Lijun; Chen, Antao			Predicting Stroop Effect from Spontaneous Neuronal Activity: A Study of Regional Homogeneity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL-CORTEX; RESTING STATE FMRI; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; RESPONSE-INHIBITION; NEURAL MECHANISMS; STOP SIGNAL; HUMAN BRAIN	The Stroop effect is one of the most robust and well-studied phenomena in cognitive psychology and cognitive neuroscience. However, little is known about the relationship between intrinsic brain activity and the individual differences of this effect. In the present study, we explored this issue by examining whether resting-state functional magnetic resonance imaging (rs-fMRI) signals could predict individual differences in the Stroop effect of healthy individuals. A partial correlation analysis was calculated to examine the relationship between regional homogeneity (ReHo) and Stroop effect size, while controlling for age, sex, and framewise displacement (FD). The results showed positive correlations in the left inferior frontal gyrus (LIFG), the left insula, the ventral anterior cingulate cortex (vACC), and the medial frontal gyrus (MFG), and negative correlation in the left precentral gyrus (LPG). These results indicate the possible influences of the LIFG, the left insula, and the LPG on the efficiency of cognitive control, and demonstrate that the key nodes of default mode network (DMN) may be important in goal-directed behavior and/or mental effort during cognitive control tasks.	[Liu, Congcong; Chen, Zhencai; Wang, Ting; Tang, Dandan; Hitchman, Glenn; Sun, Jiangzhou; Zhao, Xiaoyue; Wang, Lijun; Chen, Antao] Southwest Univ, Fac Psychol, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China; [Wang, Ting] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China	Southwest University - China; Chongqing University of Arts & Sciences	Chen, AT (corresponding author), Southwest Univ, Fac Psychol, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China.	xscat@swu.edu.cn	Chen, Zhencai/AAD-9136-2019; Hitchman, Glenn/F-6974-2014	Hitchman, Glenn/0000-0003-3268-5246	National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), New Century Excellent Talents in University (NCET-11-0698), and the Fundamental Research Funds for the Central Universities (SWU1009001).	Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Balota DA, 2010, PSYCHOL AGING, V25, P208, DOI 10.1037/a0017474; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chao HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072032; Chen ZC, 2013, NEUROIMAGE, V66, P577, DOI 10.1016/j.neuroimage.2012.10.028; Churchwell JC, 2013, DEV COGN NEUROS-NETH, V6, P80, DOI 10.1016/j.dcn.2013.07.001; Davidson DJ, 2003, AGING NEUROPSYCHOL C, V10, P85, DOI 10.1076/anec.10.2.85.14463; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Duchek JM, 2013, NEUROPSYCHOLOGY, V27, P516, DOI 10.1037/a0033402; DUM RP, 1991, J NEUROSCI, V11, P667; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; George M. S., 1997, J NEUROPSYCHIATRY CL; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; HE SQ, 1993, J NEUROSCI, V13, P952; Hlustik P, 2004, J CLIN NEUROPHYSIOL, V21, P180; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kalanthroff E, 2013, J EXP PSYCHOL HUMAN, V39, P579, DOI 10.1037/a0027429; Kendall M., 1990, DIV HODDER STOUGHTON, P29; Kornblum S, 1999, J EXP PSYCHOL HUMAN, V25, P688, DOI 10.1037/0096-1523.25.3.688; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Liu Xianglin, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P25, DOI 10.3969/j.issn.1672-7347.2010.01.004; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Melcher T, 2008, BRAIN RES REV, V59, P96, DOI 10.1016/j.brainresrev.2008.06.003; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; SOKOLOFF L, 1955, J CLIN INVEST, V34, P1101, DOI 10.1172/JCI103159; Steinhauser M, 2009, J EXP PSYCHOL HUMAN, V35, P1398, DOI 10.1037/a0016467; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Wang T, 2014, NEUROIMAGE, V90, P146, DOI 10.1016/j.neuroimage.2013.12.055; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yin Y, 2012, NEUROSCI BULL, V28, P541, DOI 10.1007/s12264-012-1261-3; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	80	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124405	10.1371/journal.pone.0124405	http://dx.doi.org/10.1371/journal.pone.0124405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938442	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000025
J	McMichael, L; Edson, D; McLaughlin, A; Mayer, D; Kopp, S; Meers, J; Field, H				McMichael, Lee; Edson, Daniel; McLaughlin, Amanda; Mayer, David; Kopp, Steven; Meers, Joanne; Field, Hume			Haematology and Plasma Biochemistry of Wild Black Flying-Foxes, (Pteropus alecto) in Queensland, Australia	PLOS ONE			English	Article							REFERENCE RANGES; HENDRA VIRUS; BATS; VALUES; ANESTHESIA; GIGANTEUS; INFECTION; RESERVOIR; STRESS; SERUM	This paper establishes reference ranges for hematologic and plasma biochemistry values in wild Black flying-foxes (Pteropus alecto) captured in South East Queensland, Australia. Values were found to be consistent with those of other Pteropus species. Four hundred and forty-seven animals were sampled over 12 months and significant differences were found between age, sex, reproductive and body condition cohorts in the sample population. Mean values for each cohort fell within the determined normal adult reference range, with the exception of elevated levels of alkaline phosphatase in juvenile animals. Hematologic and biochemistry parameters of injured animals showed little or no deviation from the normal reference values for minor injuries, while two animals with more severe injury or abscessation showed leucocytosis, anaemia, thrombocytosis, hyperglobulinemia and hypoalbuminemia.	[McMichael, Lee; Kopp, Steven; Meers, Joanne] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia; [McMichael, Lee; Edson, Daniel; McLaughlin, Amanda] Dept Agr Fisheries & Forestry, Biosecur Queensland, Brisbane, Qld 4108, Australia; [Mayer, David] Dept Agr Fisheries & Forestry, Brisbane, Qld 4103, Australia; [Field, Hume] EcoHlth Alliance, New York, NY 10001 USA	University of Queensland; Queensland Department of Agriculture & Fisheries; Queensland Department of Agriculture & Fisheries; EcoHealth Alliance	McMichael, L (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia.	lee.mcmichael@uqconnect.edu.au	McMichael, Lee UQ/C-7948-2018; Aktolun, Cumali/K-8514-2018; Mayer, David G/F-8616-2011; Kopp, Steven/G-8223-2014	McMichael, Lee UQ/0000-0002-7675-4859; Aktolun, Cumali/0000-0002-6245-9349; Mayer, David G/0000-0001-9564-9176; Kopp, Steven/0000-0001-7912-4556	Australian Biosecurity Co-operative Research Council; National Hendra virus research program	Australian Biosecurity Co-operative Research Council; National Hendra virus research program	LM received PhD scholarship funding from the now closed Australian Biosecurity Co-operative Research Council and the field work was carried out in collaboration with Queensland government funding through the National Hendra virus research program.	AGAR NS, 1992, COMP BIOCHEM PHYS B, V101, P9, DOI 10.1016/0305-0491(92)90150-P; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Breed AC, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0028816; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Churchill S, 2008, AUSTR BATS, V2nd; Clark P., 2004, HAEMATOLOGY AUSTR MA; Clarke J, 2013, J WILDLIFE DIS, V49, P831, DOI 10.7589/2011-12-345; Day RL, 2001, J ZOO WILDLIFE MED, V32, P206, DOI 10.1638/1042-7260(2001)032[0206:TEOTAW]2.0.CO;2; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; GASCOYNE SC, 1994, VET REC, V134, P7, DOI 10.1136/vr.134.1.7; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; GenStat, 2013, GENSTAT WIND REL 15; Hall J, 2014, J WILDLIFE DIS, V50, P447, DOI 10.7589/2013-09-245; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Heard DJ, 2006, J ZOO WILDLIFE MED, V37, P245, DOI 10.1638/02-064.1; Heard DJ, 1998, J ZOO WILDLIFE MED, V29, P14; Heard DJ, 1997, J ZOO WILDLIFE MED, V28, P464; Hossain MB, 2013, BANGL J VET MED, V11, P2308; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; McCullagh P, 1989, GEN LINEAR MODELS; McLaughlin AB, 2007, J ZOO WILDLIFE MED, V38, P446, DOI 10.1638/1042-7260(2007)38[446:PBAHVF]2.0.CO;2; McMichael LA, 2014, ECOHEALTH, V11, P400, DOI 10.1007/s10393-014-0954-7; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; O'Brien GM, 2001, AUSTR BAT SOC NEWSL, V16, P10; Olsson AR, 2002, THESIS J COOK U N QU; Pacioni C, 2013, J WILDLIFE DIS, V49, P816, DOI 10.7589/2011-09-275; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Ruykys L, 2012, AUST VET J, V90, P331, DOI 10.1111/j.1751-0813.2012.00956.x; Thrall M., 2004, VET HAEMATOLOGY CLIN; THRUSFIELD MT, 1997, VET EPIDEMIOLOGY; Webb NJ, 1996, P ROY SOC B-BIOL SCI, V263, P497, DOI 10.1098/rspb.1996.0075; Welbergen JA, 2011, OECOLOGIA, V165, P629, DOI 10.1007/s00442-010-1856-1; Wells RMG, 2000, COMP HAEMATOL INT, V10, P68, DOI 10.1007/s005800070010; WIGHTMAN J, 1987, COMP BIOCHEM PHYS B, V88, P305, DOI 10.1016/0305-0491(87)90119-2	38	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125741	10.1371/journal.pone.0125741	http://dx.doi.org/10.1371/journal.pone.0125741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938493	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000097
J	Qian, XQ; Sheng, XJ; Li, RP; Liu, HL; Kong, XJ; Duan, LJ; Qi, J				Qian, Xiaoqiang; Sheng, Xujun; Li, Ruipeng; Liu, Hailong; Kong, Xiangjie; Duan, Liujian; Qi, Jun			Which Stage of ADPKD Is More Appropriate for Decortication? A Retrospective Study of 137 Patients from a Single Clinic	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; TRANSPLANTATION; DECOMPRESSION; SURGERY	Objective To study retrospectively the efficacy of decortication in patients with different stages of ADPKD and to determine which stage for decortication is more appropriate. Materials and Methods We analyzed 137 patients with ADPKD from 2001 to 2010. All patients were divided into three stages. A total of 70 patients underwent decortication, and we studied intraoperative indicators and postoperative indicators at 1 and 3 years follow-up. Results In 70 patients who underwent decortication, significant differences were observed in operative duration and bleeding volume between patients with stage I and II ADPKD (P<0.05), but no significant differences were observed in intestinal recovery time, pain medication dose, and the days of postoperative hospitalization (P > 0.05). The total complication occurrence rate was significantly different between them (P < 0.05). The serum creatinine (Scr) levels in patients with stage I ADPKD were within normal limits 1 and 3 years postoperatively and did not differ significantly (P > 0.05). Scr levels were significantly decreased in patients with stage II ADPKD in the 1st postoperative year (P < 0.05), but these were not significant differences in the 3rd postoperative year (P > 0.05). In the 1st postoperative year, VAS value, blood pressure and renal volume significantly differed (P < 0.05). However, no significant differences were observed 3 years later (P > 0.05). Conclusions Decortication in patients with stage I ADPKD can alleviate back pain symptoms and decrease blood pressure within 1 year, but the long-term efficacy is not ideal. Scr levels can be maintained within normal limits, suggesting that decortication does not lead to deterioration of renal function. For patients with stage II ADPKD, decortication can significantly improve renal function over the short term. However, after 3 years, renal function returns to the preoperative level, and surgical difficulties and complications also increase.	[Qian, Xiaoqiang; Sheng, Xujun; Li, Ruipeng; Liu, Hailong; Kong, Xiangjie; Duan, Liujian; Qi, Jun] Shanghai Jiao Tong Univ, Dept Urol, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qi, J (corresponding author), Shanghai Jiao Tong Univ, Dept Urol, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	14235276@qq.com		Qi, Jun/0000-0003-0970-8462				Bricker NS, 1957, NEW ENGL J MED, P212; ELZINGA LW, 1992, J AM SOC NEPHROL, V2, P1219; Fleming TW, 1998, J UROLOGY, V159, P44, DOI 10.1016/S0022-5347(01)64007-2; Gigarel N, 2008, REPROD BIOMED ONLINE, V16, P152, DOI 10.1016/S1472-6483(10)60569-X; Goncalves S, 2009, TRANSPL P, V41, P887, DOI 10.1016/j.transproceed.2009.01.069; MILAM JH, 1963, J UROLOGY, V90, P144, DOI 10.1016/S0022-5347(17)64378-7; Powell CR, 2004, TRANSPL P, V36, P1288, DOI 10.1016/j.transproceed.2004.05.003; Resnick M, 2006, J UROLOGY, V175, P2274, DOI 10.1016/S0022-5347(06)00336-3; Sinibaldi D, 1996, AM J MED GENET, V65, P237; Tabibi A, 2005, TRANSPLANT P, V37, P2939, DOI 10.1016/j.transproceed.2005.07.053; TEICHMAN JMH, 1995, J UROLOGY, V153, P1105, DOI 10.1016/S0022-5347(01)67520-7	11	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0120696	10.1371/journal.pone.0120696	http://dx.doi.org/10.1371/journal.pone.0120696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25939015	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000001
J	El Hiani, Y; Linsdell, P				El Hiani, Yassine; Linsdell, Paul			Functional Architecture of the Cytoplasmic Entrance to the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; chloride channel; cystic fibrosis transmembrane conductance regulator (CFTR); electrophysiology; ion channel; cytoplasmic portals; electrostatic attraction; substituted cysteine accessibility mutagenesis; surface charge	WILD-TYPE; LOOP 3; DOMAIN; MUTATIONS; REGION; PHOSPHORYLATION; PYROPHOSPHATE; TUNNELS; PORTALS; ACCESS	As an ion channel, the cystic fibrosis transmembrane conductance regulator must form a continuous pathway for the movement of Cl- and other anions between the cytoplasm and the extracellular solution. Both the structure and the function of the membrane-spanning part of this pathway are well defined. In contrast, the structure of the pathway that connects the cytoplasm to the membrane-spanning regions is unknown, and functional roles for different parts of the protein forming this pathway have not been described. We used patch clamp recording and substituted cysteine accessibility mutagenesis to identify positively charged amino acid side chains that attract cytoplasmic Cl- ions to the inner mouth of the pore. Our results indicate that the side chains of Lys-190, Arg-248, Arg-303, Lys-370, Lys-1041, and Arg-1048, located in different intracellular loops of the protein, play important roles in the electrostatic attraction of Cl- ions. Mutation and covalent modification of these residues have charge-dependent effects on the rate of Cl- permeation, demonstrating their functional role in maximization of Cl- flux. Other nearby positively charged side chains were not involved in electrostatic interactions with Cl-. The location of these Cl--attractive residues suggests that cytoplasmic Cl- ions enter the pore via a lateral portal located between the cytoplasmic extensions to the fourth and sixth transmembrane helices; a secondary, functionally less relevant portal might exist between the extensions to the 10th and 12th transmembrane helices. These results define the cytoplasmic mouth of the pore and show how it attracts Cl- ions from the cytoplasm.	[El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		El Hiani, Yassine/0000-0002-1251-5066; Linsdell, Paul/0000-0001-6257-6273	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Billet A, 2013, J CYST FIBROS, V12, P737, DOI 10.1016/j.jcf.2013.02.002; Cant N, 2014, INT J BIOCHEM CELL B, V52, P15, DOI 10.1016/j.biocel.2014.02.004; Carland JE, 2013, J BIOL CHEM, V288, P31592, DOI 10.1074/jbc.M113.503300; CARSON MR, 1995, J BIOL CHEM, V270, P20466, DOI 10.1074/jbc.270.35.20466; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El Hiani Y, 2014, BIOCHEM CELL BIOL, V92, P481, DOI 10.1139/bcb-2014-0038; El Hiani Y, 2014, J BIOL CHEM, V289, P28149, DOI 10.1074/jbc.M114.593103; El Hiani Y, 2012, BIOCHEMISTRY-US, V51, P3971, DOI 10.1021/bi300065z; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Linsdell P, 2014, MOL MEMBR BIOL, V31, P1, DOI 10.3109/09687688.2013.868055; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Odolczyk N, 2014, INT J BIOCHEM CELL B, V52, P39, DOI 10.1016/j.biocel.2014.04.004; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Wang W, 2014, J BIOL CHEM, V289, P30364, DOI 10.1074/jbc.M114.595710; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Wang YT, 2014, INT J BIOCHEM CELL B, V52, P47, DOI 10.1016/j.biocel.2014.04.001; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	39	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15855	15865		10.1074/jbc.M115.656181	http://dx.doi.org/10.1074/jbc.M115.656181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944907	Green Published, hybrid			2022-12-26	WOS:000356527400044
J	Licursi, M; Carmona-Martinez, RA; Razavi, S; Hirasawa, K				Licursi, Maria; Carmona-Martinez, Ricardo A.; Razavi, Seyd; Hirasawa, Kensuke			Promotion of Viral IRES-Mediated Translation Initiation under Mild Hypothermia	PLOS ONE			English	Article							INTERNAL-RIBOSOME-ENTRY; TRACT-BINDING PROTEIN; C VIRUS-RNA; MESSENGER-RNA; HUMAN RHINOVIRUS; FUNCTIONAL REQUIREMENT; HCV REPLICATION; GENE-EXPRESSION; IN-VITRO; SITE	Internal ribosome entry site (IRES)-mediated translation is an essential replication step for certain viruses. As IRES-mediated translation is regulated differently from cap-dependent translation under various cellular conditions, we sought to investigate whether temperature influences efficiency of viral IRES-mediated translation initiation by using bicistronic reporter constructs containing an IRES element of encephalomyocarditis virus (EMCV), foot-and-mouth disease virus (FMDV), hepatitis C virus (HCV), human rhinovirus (HRV) or poliovirus (PV). Under mild hypothermic conditions (30 and 35 degrees C), we observed increases in the efficiency of translation initiation by HCV and HRV IRES elements compared to translation initiation at 37 degrees C. The promotion of HRV IRES activity was observed as early as 2 hours after exposure to mild hypothermia. We also confirmed the promotion of translation initiation by HRV IRES under mild hypothermia in multiple cell lines. The expression levels and locations of polypyrimidine tract-binding protein (PTB) and upstream of N-Ras (unr), the IRES trans-acting factors (ITAFs) of HCV and HRV IRES elements, were not modulated by the temperature shift from 37 degrees C to 30 degrees C. Taken together, this study demonstrates that efficiency of translation initiation by some viral IRES elements is temperature dependent.	[Licursi, Maria; Carmona-Martinez, Ricardo A.; Razavi, Seyd; Hirasawa, Kensuke] Mem Univ Newfoundland, Div Biomed Sci, Fac Med, St John, NF A1B 3V6, Canada	Memorial University Newfoundland	Hirasawa, K (corresponding author), Mem Univ Newfoundland, Div Biomed Sci, Fac Med, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada.	kensuke@mun.ca			 [311935-2011]		This work was supported by 311935-2011 (URL: www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995; Anwar A, 2000, J BIOL CHEM, V275, P34231, DOI 10.1074/jbc.M006343200; Back SH, 2002, J BIOL CHEM, V277, P27200, DOI 10.1074/jbc.M203887200; Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Chappell SA, 2001, J BIOL CHEM, V276, P36917, DOI 10.1074/jbc.M106008200; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Han W, 2014, BMB REP, V47, P233, DOI 10.5483/BMBRep.2014.47.4.140; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2003, ANN NY ACAD SCI, V1010, P249, DOI 10.1196/annals.1299.043; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437; Jahan N, 2011, J VIROL, V85, P7225, DOI 10.1128/JVI.01804-09; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Johansen LK, 2000, J VIROL, V74, P8335, DOI 10.1128/JVI.74.18.8335-8342.2000; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komatsu Y., 2014, ONCOGENE; Kozak M, 2003, GENE, V318, P1, DOI 10.1016/S0378-1119(03)00774-1; Lafuente E, 2002, J GEN VIROL, V83, P1113, DOI 10.1099/0022-1317-83-5-1113; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; Licursi M, 2012, J GEN VIROL, V93, P951, DOI 10.1099/vir.0.040386-0; LOMAX NB, 1989, J VIROL, V63, P2396, DOI 10.1128/JVI.63.5.2396-2399.1989; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Martinez-Salas E, 2001, J GEN VIROL, V82, P973, DOI 10.1099/0022-1317-82-5-973; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pilipenko EV, 2000, GENE DEV, V14, P2028; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; SHATKIN AJ, 1985, CELL, V40, P223, DOI 10.1016/0092-8674(85)90132-1; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Thieringer HA, 1997, NUCLEIC ACIDS RES, V25, P4764, DOI 10.1093/nar/25.23.4764; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Van Eden ME, 2004, RNA, V10, P469, DOI 10.1261/rna.5156804; Verbenko V. N., 2003, Genetika, V39, P748; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; YIN FH, 1983, J VIROL, V48, P410, DOI 10.1128/JVI.48.2.410-418.1983	52	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126174	10.1371/journal.pone.0126174	http://dx.doi.org/10.1371/journal.pone.0126174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951166	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000354214400071
J	Reiner, BC; Dunaevsky, A				Reiner, Benjamin C.; Dunaevsky, Anna			Deficit in Motor Training-Induced Clustering, but Not Stabilization, of New Dendritic Spines in fmr1 Knock-Out Mice	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MOUSE MODEL; MESSENGER-RNAS; CGG-REPEAT; AUTISM; CORTEX; IDENTIFICATION	Fragile X Syndrome is the most common inherited intellectual disability, and Fragile X Syndrome patients often exhibit motor and learning deficits. It was previously shown that the fmr1 knock-out mice, a common mouse model of Fragile X Syndrome, recapitulates this motor learning deficit and that the deficit is associated with altered plasticity of dendritic spines. Here, we investigated the motor learning-induced turnover, stabilization and clustering of dendritic spines in the fmr1 knock-out mouse using a single forelimb reaching task and in vivo multiphoton imaging. We report that fmr1 knock-out mice have deficits in motor learning-induced changes in dendritic spine turnover and new dendritic spine clustering, but not the motor learning-induced long-term stabilization of new dendritic spines. These results suggest that a failure to establish the proper synaptic connections in both number and location, but not the stabilization of the connections that are formed, contributes to the motor learning deficit seen in the fmr1 knock-out mouse.	[Reiner, Benjamin C.; Dunaevsky, Anna] Univ Nebraska, Med Ctr, Munroe Meyer Inst, Dept Dev Neurosci, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Dunaevsky, A (corresponding author), Univ Nebraska, Med Ctr, Munroe Meyer Inst, Dept Dev Neurosci, Omaha, NE 68182 USA.	adunaevsky@unmc.edu	Reiner, Benjamin/ABG-1618-2020	Reiner, Benjamin/0000-0001-7796-587X	National Institute of Child Health and Human Development [R01 HD67218]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067218] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institute of Child Health and Human Development R01 HD67218 to A.D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Budimirovic DB, 2011, DEV NEUROSCI-BASEL, V33, P379, DOI 10.1159/000330213; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Fu M, 2012, NATURE; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gernsbacher MA, 2008, J CHILD PSYCHOL PSYC, V49, P43, DOI 10.1111/j.1469-7610.2007.01820.x; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; Hodgson RA, 2005, NEUROBIOL LEARN MEM, V83, P22, DOI 10.1016/j.nlm.2004.07.001; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Larson J, 2005, J NEUROSCI, V25, P9460, DOI 10.1523/JNEUROSCI.2638-05.2005; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Maes B, 2000, MENT RETARD, V38, P207, DOI 10.1352/0047-6765(2000)038<0207:PCTSFF>2.0.CO;2; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Padmashri R, 2013, J NEUROSCI, V33, P19715, DOI 10.1523/JNEUROSCI.2514-13.2013; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Vanvuchelen M, 2007, AUTISM, V11, P225, DOI 10.1177/1362361307076846; Veloz MF, 2012, GENES BRAIN BEHAV; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xu ZH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-24; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126572	10.1371/journal.pone.0126572	http://dx.doi.org/10.1371/journal.pone.0126572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950728	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400101
J	Rosu, SA; Rimoldi, OJ; Prieto, ED; Curto, LM; Delfino, JM; Ramella, NA; Tricerri, MA				Rosu, Silvana A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Curto, Lucrecia M.; Delfino, Jose M.; Ramella, Nahuel A.; Alejandra Tricerri, M.			Amyloidogenic Propensity of a Natural Variant of Human Apolipoprotein A-I: Stability and Interaction with Ligands	PLOS ONE			English	Article							FIBRIL FORMATION; ALPHA-SYNUCLEIN; BUNDLE PROTEIN; TRANSTHYRETIN; AGGREGATION; PEPTIDE; BINDING; METABOLISM; PRESSURE; BIGLYCAN	A number of naturally occurring mutations of human apolipoprotein A-I (apoA-I) have been associated with hereditary amyloidoses. The molecular mechanisms involved in amyloid-associated pathology remain largely unknown. Here we examined the effects of the Arg173Pro point mutation in apoA-I on the structure, stability, and aggregation propensity, as well as on the ability to bind to putative ligands. Our results indicate that the mutation induces a drastic loss of stability, and a lower efficiency to bind to phospholipid vesicles at physiological pH, which could determine the observed higher tendency to aggregate as pro-amyloidogenic complexes. Incubation under acidic conditions does not seem to induce significant desestabilization or aggregation tendency, neither does it contribute to the binding of the mutant to sodium dodecyl sulfate. While the binding to this detergent is higher for the mutant as compared to wt apoA-I, the interaction of the Arg173Pro variant with heparin depends on pH, being lower at pH 5.0 and higher than wt under physiological pH conditions. We suggest that binding to ligands as heparin or other glycosaminoglycans could be key events tuning the fine details of the interaction of apoA-I variants with the micro-environment, and probably eliciting the toxicity of these variants in hereditary amyloidoses.	[Rosu, Silvana A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Ramella, Nahuel A.; Alejandra Tricerri, M.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina; [Rosu, Silvana A.; Rimoldi, Omar J.; Ramella, Nahuel A.; Alejandra Tricerri, M.] Univ Nacl La Plata, Fac Ciencias Med, RA-1900 La Plata, Buenos Aires, Argentina; [Prieto, Eduardo D.] Univ Nacl La Plata, CONICET, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, RA-1900 La Plata, Buenos Aires, Argentina; [Curto, Lucrecia M.; Delfino, Jose M.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Curto, Lucrecia M.; Delfino, Jose M.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Bioquim & Biofis, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; University of Buenos Aires; University of Buenos Aires	Tricerri, MA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	aletricerri@yahoo.com		Curto, Lucrecia/0000-0002-4335-5309; Ramella, Nahuel/0000-0002-6275-3193	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [2106-2008, 26228]; Universidad Nacional de La Plata [M158]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112 201101-00648]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Universidad Nacional de La Plata(National University of La Plata); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding: The work presented here was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, grants Number 2106-2008 to MAT and Number 26228 to Horacio Garda, Universidad Nacional de La Plata (grant Number M158 to MAT), Consejo Nacional de Investigaciones Cientificas y Tecnicas, (PIP 112 201101-00648 to MAT and HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 2014, FEBS LETT, V588, P389, DOI 10.1016/j.febslet.2013.11.031; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; [Anonymous], 1989, PROTEIN STRUCTURE PR; Arnulphi C, 2005, BIOPHYS J, V89, P285, DOI 10.1529/biophysj.104.047480; Asl KH, 1999, BIOCHEM BIOPH RES CO, V257, P584, DOI 10.1006/bbrc.1999.0518; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bellotti V, 1999, CELL MOL LIFE SCI, V55, P977, DOI 10.1007/s000180050348; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Prieto ED, 2012, PROTEIN J, V31, P681, DOI 10.1007/s10930-012-9448-z; Das M, 2014, FEBS J, V281, P2525, DOI 10.1111/febs.12809; Dember LM, 2006, J AM SOC NEPHROL, V17, P3458, DOI 10.1681/ASN.2006050460; Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Iannuzzi C, 2015, MOLECULES, V20, P2510, DOI 10.3390/molecules20022510; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; Mendoza-Espinosa P, 2014, MOL CELL BIOCHEM, V393, P99, DOI 10.1007/s11010-014-2050-2; Monsellier E, 2005, PROTEIN ENG DES SEL, V18, P445, DOI 10.1093/protein/gzi046; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Ramella NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Roman EA, 2010, PROTEINS, V78, P2757, DOI 10.1002/prot.22789; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; Shi Y, 2007, PROTEIN SCI, V16, P1165, DOI 10.1110/ps.062623707; Shirk RA, 2000, J BIOL CHEM, V275, P18085, DOI 10.1074/jbc.M001659200; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Rasente RY, 2012, CARBOHYD RES, V356, P233, DOI 10.1016/j.carres.2012.03.036	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124946	10.1371/journal.pone.0124946	http://dx.doi.org/10.1371/journal.pone.0124946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950566	gold, Green Published			2022-12-26	WOS:000354214400022
J	Fischer, ML; Hochkirch, A; Heddergott, M; Schulze, C; Anheyer-Behmenburg, HE; Lang, J; Michler, FU; Hohmann, U; Ansorge, H; Hoffmann, L; Klein, R; Frantz, AC				Fischer, Mari L.; Hochkirch, Axel; Heddergott, Mike; Schulze, Christoph; Anheyer-Behmenburg, Helena E.; Lang, Johannes; Michler, Frank-Uwe; Hohmann, Ulf; Ansorge, Hermann; Hoffmann, Lothar; Klein, Roland; Frantz, Alain C.			Historical Invasion Records Can Be Misleading: Genetic Evidence for Multiple Introductions of Invasive Raccoons (Procyon lotor) in Germany	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROSATELLITE LOCI; RE-IMPLEMENTATION; CENTRAL-EUROPE; N-E; SOFTWARE; INDIVIDUALS; EVOLUTION; PROGRAM; NUMBER	Biological invasions provide excellent study systems to understand evolutionary, genetic and ecological processes during range expansions. There is strong evidence for positive effects of high propagule pressure and the associated higher genetic diversity on invasion success, but some species have become invasive despite small founder numbers. The raccoon (Procyon lotor) is often considered as a typical example for such a successful invasion resulting from a small number of founders. The species' largest non-native population in Germany is commonly assumed to stem from a small number of founders and two separate founding events in the 1930s and 1940s. In the present study we analyzed 407 raccoons at 20 microsatellite loci sampled from the invasive range in Western Europe to test if these assumptions are correct. Contrary to the expectations, different genetic clustering methods detected evidence for at least four independent introduction events that gave rise to genetically differentiated subpopulations. Further smaller clusters were either artifacts or resulted from founder events at the range margin and recent release of captive individuals. We also found genetic evidence for on-going introductions of individuals. Furthermore a novel randomization process was used to determine the potential range of founder population size that would suffice to capture all the alleles present in a cluster. Our results falsify the assumption that this species has become widespread and abundant despite being genetically depauperate and show that historical records of species introductions may be misleading.	[Fischer, Mari L.; Hochkirch, Axel; Klein, Roland] Univ Trier, Dept Biogeog, Trier, Germany; [Heddergott, Mike; Frantz, Alain C.] Musee Natl Hist Nat, Luxembourg, Luxembourg; [Schulze, Christoph] Landeslabor Berlin Brandenburg, Frankfurt, Oder, Germany; [Anheyer-Behmenburg, Helena E.] Food & Vet Inst Braunschweig Hannover, Lower Saxony State Off Consumer Protect & Food Sa, Hannover, Germany; [Lang, Johannes] Inst Tierokol & Nat Bildung, Gonterskirchen, Germany; [Michler, Frank-Uwe] Tech Univ Dresden, Inst Forest Bot & Forest Zool, Tharandt, Germany; [Hohmann, Ulf] Res Inst Forest Ecol & Forestry Rhineland Palatin, Dept Wildlife Ecol, Trippstadt, Germany; [Ansorge, Hermann] Senckenberg Museum Nat Hist Gorlitz, Gorlitz, Germany; [Hoffmann, Lothar] Thuringer Landesamt Verbraucherschutz, Bad Langensalza, Germany	Universitat Trier; Technische Universitat Dresden; Senckenberg Gesellschaft fur Naturforschung (SGN)	Frantz, AC (corresponding author), Musee Natl Hist Nat, Luxembourg, Luxembourg.	alain.frantz@mnhn.lu	Hochkirch, Axel/A-4092-2008	Hochkirch, Axel/0000-0002-4475-0394; Lang, Johannes/0000-0002-7387-795X	German Science Foundation [GRK 1319]	German Science Foundation(German Research Foundation (DFG))	MH and the laboratory work was funded by the German Science Foundation (www.dfg.de, GRK 1319) as part of the interdisciplinary graduate school 'Cooperation of Science and Jurisprudence in Improving Development and Use of Standards for Environmental Protection - Strategies for Risk Assessment and Management'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda F, 2013, BIOL INVASIONS, V15, P687, DOI 10.1007/s10530-012-0318-6; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Anderson EC, 2007, EVOLUTION, V61, P972, DOI 10.1111/j.1558-5646.2007.00080.x; [Anonymous], 1996, 5000 CNRS UMR; Beltran-Beck B, 2012, EUR J WILDLIFE RES, V58, P5, DOI 10.1007/s10344-011-0600-4; Biedrzycka A, 2014, BIOL INVASIONS, V16, P1611, DOI 10.1007/s10530-013-0595-8; Bonhomme M, 2008, MOL ECOL, V17, P1009, DOI 10.1111/j.1365-294X.2007.03645.x; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cullingham CI, 2008, CAN J ZOOL, V86, P947, DOI 10.1139/Z08-072; Cullingham CI, 2006, MOL ECOL NOTES, V6, P1030, DOI 10.1111/j.1471-8286.2006.01418.x; Cullingham CI, 2009, MOL ECOL, V18, P43, DOI 10.1111/j.1365-294X.2008.03989.x; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dharmarajan G, 2009, CAN J ZOOL, V87, P814, DOI 10.1139/Z09-072; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fike JA, 2007, MOL ECOL NOTES, V7, P525, DOI 10.1111/j.1471-8286.2006.01643.x; Forsyth DM, 2004, CONSERV BIOL, V18, P557, DOI 10.1111/j.1523-1739.2004.00423.x; Forsyth DM, 2001, AM NAT, V157, P583, DOI 10.1086/320626; Frantz AC, 2013, EUR J WILDLIFE RES, V59, P665, DOI 10.1007/s10344-013-0719-6; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Frantz AC, 2005, EUR J WILDLIFE RES, V51, P126, DOI 10.1007/s10344-005-0091-2; Garcia JT, 2012, BIOL INVASIONS, V14, P1305, DOI 10.1007/s10530-011-0157-x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gramlich Susanne, 2011, Beitraege zur Jagd- und Wildforschung, V36, P521; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hertweck K, 2009, ATLAS SAUGETIERE SAC, P281, DOI DOI 10.2337/DC14-0835; Hohmann U., 2011, DER WASCHBAR; Hoopes M.F., 2013, INVASION ECOLOGY, V2nd; Ikeda Tohru, 2004, Global Environmental Research, V8, P125; Kalinowski ST, 2010, CONSERV GENET, V11, P2049, DOI 10.1007/s10592-009-0041-8; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LUTZ W, 1995, ANN ZOOL FENN, V32, P15; LUTZ W, 1984, Z JAGDWISS, V30, P218, DOI 10.1007/BF02241407; Manel S, 2002, CONSERV BIOL, V16, P650, DOI 10.1046/j.1523-1739.2002.00576.x; Michler Frank-Uwe Fritz, 2012, Beitraege zur Jagd- und Wildforschung, V37, P389; Michler FU, 2004, MAMMALIAN BIOL, V69, P26; MICHLER FU, 2004, BEITR JAGD WILDFORSC, V29, P257; Muller-Using D, 1959, Z JAGDWISS, V5, P108; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; R Development Core Team, 2006, R LANG ENV STAT COMP; Rasner CA, 2004, MOL ECOL, V13, P671, DOI 10.1046/j.1365-294X.2004.02104.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Santonastaso TT, 2012, J MAMMAL, V93, P447, DOI 10.1644/10-MAMM-A-410.1; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Schulte U, 2012, MOL ECOL, V21, P4313, DOI 10.1111/j.1365-294X.2012.05693.x; Siripunkaw C, 2008, MOL ECOL RESOUR, V8, P199, DOI 10.1111/j.1471-8286.2007.01922.x; Stubbe M., 1975, Hercynia N F, V12, P80; Stubbe M, 1990, BEITR JAGD WILDFORSC, V17, P180; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	64	33	33	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125441	10.1371/journal.pone.0125441	http://dx.doi.org/10.1371/journal.pone.0125441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946257	gold, Green Published			2022-12-26	WOS:000354049700070
J	Liu, SP; Li, J; Chen, MH; Liu, ZQ; Shi, WB				Liu, Shuiping; Li, Jing; Chen, Mei-Hua; Liu, Zhenqi; Shi, Weibin			Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; E GENE POLYMORPHISM; CARDIOVASCULAR-DISEASE; INBRED STRAINS; RISK-FACTOR; ATHEROSCLEROSIS SUSCEPTIBILITY; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; FASTING GLUCOSE; MICE	We recently have found that apolipoprotein E-deficient (Apoe(-/-)) mice with the C57BL/6 background develop type 2 diabetes when fed a Western diet for 12 weeks. In the present study we constructed multiple Apoe-/- mouse strains to find diabetes- related phenotyptic variations that might be linked to atherosclerosis development. Evaluation of both early and advanced lesion formation in aortic root revealed that C57BL/6, SWR/J, and SM/J Apoe(-/-) mice were susceptible to atherosclerosis and that C3H/HeJ and BALB/cJ Apoe(-/-) mice were relatively resistant. On a chow diet, fasting plasma glucose varied among strains with C3H/ HeJ having the highest (171.1 +/- 9.7 mg/dl) and BALB/cJ the lowest level (104.0 +/- 6.6 mg/ dl). On a Western diet, fasting plasma glucose rose significantly in all strains, with C57BL/6, C3H/HeJ and SWR/J exceeding 250 mg/dl. BALB/cJ and C3H/HeJ were more tolerant to glucose loading than the other 3 strains. C57BL/6 was sensitive to insulin while other strains were not. Non- fasting blood glucose was significantly lower in C3H/HeJ and BALB/cJ than C57BL/6, SM/J, and SWR/J. Glucose loading induced the 1st and the 2nd phase of insulin secretion in BALB/cJ, but the 2nd phase was not observed in other strains. Morphological analysis showed that BALB/cJ had the largest islet area (1,421,493 +/- 61,244 mu m(2)) and C57BL/6 had the smallest one (747,635 +/- 41,798 mu m(2)). This study has demonstrated strain-specific variations in the metabolic and atherosclerotic phenotypes, thus laying the basis for future genetic characterization.	[Liu, Shuiping; Li, Jing; Chen, Mei-Hua; Shi, Weibin] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA; [Liu, Zhenqi] Univ Virginia, Dept Med, Charlottesville, VA USA; [Shi, Weibin] Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Shi, WB (corresponding author), Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA.	ws4v@virginia.edu	, ws4v/L-4372-2019		National Institutes of Health [DK097120, HL112281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the National Institutes of Health grants DK097120 and HL112281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Bloomgarden ZT, 2008, DIABETES CARE, V31, P1260, DOI 10.2337/dc08-zb06; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; De Souza CT, 2005, DIABETOLOGIA, V48, P1860, DOI 10.1007/s00125-005-1866-4; DINNEEN S, 1992, NEW ENGL J MED, V327, P707, DOI 10.1056/NEJM199209033271007; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Erdogan M, 2009, J ENDOCRINOL INVEST, V32, P219, DOI 10.1007/BF03346455; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Hu DY, 2006, EUR HEART J, V27, P2573, DOI 10.1093/eurheartj/ehl207; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Kahle M, 2013, MOL METAB, V2, P435, DOI 10.1016/j.molmet.2013.07.009; Karagiannides I, 2008, FEBS J, V275, P4796, DOI 10.1111/j.1742-4658.2008.06619.x; KENDALL DM, 1990, NEW ENGL J MED, V322, P898, DOI 10.1056/NEJM199003293221305; Kontush A, 2008, CURR DIABETES REP, V8, P51, DOI 10.1007/s11892-008-0010-5; Li J, 2012, PHYSIOL GENOMICS, V44, P345, DOI 10.1152/physiolgenomics.00087.2011; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; NISHINA PM, 1993, LIPIDS, V28, P599, DOI 10.1007/BF02536053; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; ORAHILLY S, 1994, LANCET, V344, P585, DOI 10.1016/S0140-6736(94)91969-0; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rowlan JS, 2013, PHYSIOL GENOMICS, V45, P332, DOI 10.1152/physiolgenomics.00099.2012; RUDERMAN NB, 1984, PROG CARDIOVASC DIS, V26, P373, DOI 10.1016/0033-0620(84)90011-2; Satirapoj Bancha, 2013, Journal of the Medical Association of Thailand, V96, P1119; Shaw JE, 1999, DIABETOLOGIA, V42, P1050, DOI 10.1007/s001250051269; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; Silver L. M., 1995, MOUSE GENETICS; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Su ZG, 2006, HUM MOL GENET, V15, P1650, DOI 10.1093/hmg/ddl088; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Tian J, 2005, BIOCHEM BIOPH RES CO, V329, P1102, DOI 10.1016/j.bbrc.2005.02.090; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Verges B, 2009, FUND CLIN PHARMACOL, V23, P681, DOI 10.1111/j.1472-8206.2009.00739.x; Yin YW, 2014, METABOLISM, V63, P532, DOI 10.1016/j.metabol.2013.12.008; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649	48	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0120935	10.1371/journal.pone.0120935	http://dx.doi.org/10.1371/journal.pone.0120935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946019	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700003
J	Mettke-Hofmann, C; Hamel, PB; Hofmann, G; Zenzal, TJ; Pellegrini, A; Malpass, J; Garfinkel, M; Schiff, N; Greenberg, R				Mettke-Hofmann, Claudia; Hamel, Paul B.; Hofmann, Gerhard; Zenzal, Theodore J., Jr.; Pellegrini, Anne; Malpass, Jennifer; Garfinkel, Megan; Schiff, Nathan; Greenberg, Russell			Competition and Habitat Quality Influence Age and Sex Distribution in Wintering Rusty Blackbirds	PLOS ONE			English	Article							IDEAL FREE DISTRIBUTION; BODY CONDITION; MIGRATORY WARBLERS; RIPARIAN FORESTS; DIFFERENT WIDTHS; CLIMATE-CHANGE; SELECTION; BIRD; SEGREGATION; PASSERINES	Bird habitat quality is often inferred from species abundance measures during the breeding and non-breeding season and used for conservation management decisions. However, during the non-breeding season age and sex classes often occupy different habitats which suggest a need for more habitat-specific data. Rusty Blackbird (Euphagus carolinus) is a forested wetland specialist wintering in bottomland hardwood forests in the south-eastern U.S. and belongs to the most steeply declining songbirds in the U.S. Little information is available to support priority birds such as the Rusty Blackbird wintering in this threatened habitat. We assessed age and sex distribution and body condition of Rusty Blackbirds among the three major habitats used by this species in the Lower Mississippi Alluvial Valley and also measured food availability. Overall, pecan groves had the highest biomass mainly driven by the amount of nuts. Invertebrate biomass was highest in forests but contributed only a small percentage to overall biomass. Age and sex classes were unevenly distributed among habitats with adult males primarily occupying pecan groves containing the highest nut biomass, females being found in forests which had the lowest nut biomass and young males primarily staying in forest fragments along creeks which had intermediate nut biomass. Males were in better body condition than females and were in slightly better condition in pecan groves. The results suggest that adult males occupy the highest quality habitat and may competitively exclude the other age and sex classes.	[Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [Hamel, Paul B.; Schiff, Nathan] US Forest Serv, Stoneville, MS USA; [Hofmann, Gerhard] Tamar Grove, Moreton, Merseyside, England; [Zenzal, Theodore J., Jr.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Pellegrini, Anne] SWCA Environm Consultants, Flagstaff, AZ USA; [Malpass, Jennifer] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Garfinkel, Megan] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Mettke-Hofmann, Claudia; Greenberg, Russell] Smithsonian Inst, Natl Zool Pk, Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA	Liverpool John Moores University; United States Department of Agriculture (USDA); United States Forest Service; University of Southern Mississippi; Ohio State University; California State University System; California State Polytechnic University, Humboldt; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Mettke-Hofmann, C (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	C.C.Mettke-Hofmann@ljmu.ac.uk		Malpass, Jennifer/0000-0003-2176-992X; Garfinkel, Megan/0000-0002-9040-0555	U.S. Fish and Wildlife Service; Canadian Wildlife Service, Friends of the National Zoo, USA; Max Planck Institute for Ornithology, Andechs, Germany; German Ethological Society, Germany; Society for Tropical Ornithology, Germany; Arthur-von-Gwinner Foundation, Austria	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Canadian Wildlife Service, Friends of the National Zoo, USA; Max Planck Institute for Ornithology, Andechs, Germany; German Ethological Society, Germany; Society for Tropical Ornithology, Germany; Arthur-von-Gwinner Foundation, Austria	Assistants, travel and material were supported by the U.S. Fish and Wildlife Service (SMA grant, Quick Response Programme, Challenge Cost Share grant granted to the International Rusty Blackbird Technical Group). CM-H received support by the Canadian Wildlife Service, Friends of the National Zoo, USA, the Max Planck Institute for Ornithology, Andechs, Germany, the German Ethological Society, the Society for Tropical Ornithology, Germany, and the Arthur-von-Gwinner Foundation, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SWCA Environmental Consultants provided support in the form of salaries for authors AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JA, 1997, RESTOR ECOL, V5, P125, DOI 10.1046/j.1526-100X.1997.09715.x; Ardia DR, 1997, ANIM BEHAV, V53, P1305, DOI 10.1006/anbe.1996.0364; Avery Michael L., 1995, Birds of North America, V200, P1; Batema DL, 1985, 5 CENTR HARDW C U IL; Bauchinger U, 2011, J ORNITHOL, V152, P507, DOI 10.1007/s10336-010-0644-3; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brown DR, 2002, J WILDLIFE MANAGE, V66, P407, DOI 10.2307/3803173; Brzezinska J., 2012, FOL OECON, V269, P123; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Campos AR, 2011, ORNIS FENNICA, V88, P226; Corcoran RM, 2009, HYDROBIOLOGIA, V620, P77, DOI 10.1007/s10750-008-9616-5; DELNICKI D, 1986, J WILDLIFE MANAGE, V50, P43, DOI 10.2307/3801486; Edwards L.K., 1993, APPL ANAL VARIANCE B, P459; Flather CH, 1996, ECOLOGY, V77, P28, DOI 10.2307/2265651; Flaxman SM, 2006, J THEOR BIOL, V243, P587, DOI 10.1016/j.jtbi.2006.07.012; Fredrickson L.H., 1992, GREENTREE RESERVOIR; GOCHFELD M, 1984, BEHAVIOUR, V88, P227, DOI 10.1163/156853984X00335; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Greenberg R, 1999, CONSERV BIOL, V13, P553, DOI 10.1046/j.1523-1739.1999.97478.x; Greenberg R, 2011, STUD AVIAN BIOL, P107; Guilfoyle MP, 2001, EMRRP TECHNICAL NOTE; Hamel P.B., 2009, P 4 INT PARTN FLIGHT, P341; Heitmeyer ME, 2006, J WILDLIFE MANAGE, V70, P101, DOI 10.2193/0022-541X(2006)70[101:TIOWFT]2.0.CO;2; Hepp GR, 1995, BIRDS N AM; Hodges MF, 1996, WILSON BULL, V108, P496; Hoye BJ, 2012, J ANIM ECOL, V81, P657, DOI 10.1111/j.1365-2656.2011.01948.x; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Kaiser A, 1996, J ORNITHOL, V137, P141, DOI 10.1007/BF01653632; KELLER CME, 1993, WETLANDS, V13, P137, DOI 10.1007/BF03160874; KENNEDY HE, 1993, USDA SO FOR, V93, P49; Kilgo JC, 1996, WILSON BULL, V108, P53; King SL, 1998, FOREST ECOL MANAG, V112, P213, DOI 10.1016/S0378-1127(98)00344-2; Krivtsov V, 2006, ANIM BIOL, V56, P69, DOI 10.1163/157075606775904687; Latta SC, 2002, ECOLOGY, V83, P2502, DOI 10.1890/0012-9658(2002)083[2502:DAPROC]2.0.CO;2; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; McClure CJW, 2012, ECOL EVOL, V2, P370, DOI 10.1002/ece3.95; MORTON ES, 1990, AM NAT, V135, P319, DOI 10.1086/285048; Nicolai CA, 2014, ECOLOGY, V95, P1323, DOI 10.1890/13-0860.1; Niven D., 2004, AM BIRDS, V58, P10; ORNAT AL, 1990, AUK, V107, P539; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; Pyle P, 1997, IDENTIFICATION GUIDE; Sallabanks R., 1999, BIRDS N AM ONLINE; Sauer J. R., 2005, N AM BREEDING BIRD S; Schweitzer CJ, 1997, US FOR SERV T R NC, V188, P313; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Servello Frederick A., 2005, P554; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Stanturf JA, 2000, J FOREST, V98, P10; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1069; Strong AM, 2001, WILSON BULL, V113, P410, DOI 10.1676/0043-5643(2001)113[0410:BCOSSW]2.0.CO;2; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Townsend JM, 2012, AUK, V129, P683, DOI 10.1525/auk.2012.12043; Tronstad LM, 2005, FRESHWATER BIOL, V50, P646, DOI 10.1111/j.1365-2427.2005.01351.x; Twedt DJ, 2011, SOUTHEAST NAT, V10, P1, DOI 10.1656/058.010.0101; Twedt DJ, 1997, WILDLIFE SOC B, V25, P647; Twedt DJ, 2002, RESTOR ECOL, V10, P645, DOI 10.1046/j.1526-100X.2002.01045.x; Wan Y, 2013, INT J PRIMATOL, V34, P946, DOI 10.1007/s10764-013-9712-x; Wolfe JD, 2013, CONDOR, V115, P163, DOI 10.1525/cond.2012.120084; Zeller NS, 1995, WILSON BULL, V107, P698	64	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123775	10.1371/journal.pone.0123775	http://dx.doi.org/10.1371/journal.pone.0123775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946335	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000354049700021
J	Turtzo, LC; Budde, MD; Dean, DD; Gold, EM; Lewis, BK; Janes, L; Lescher, J; Coppola, T; Yarnell, A; Grunberg, NE; Frank, JA				Turtzo, L. Christine; Budde, Matthew D.; Dean, Dana D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Lescher, Jacob; Coppola, Tiziana; Yarnell, Angela; Grunberg, Neil E.; Frank, Joseph A.			Failure of Intravenous or Intracardiac Delivery of Mesenchymal Stromal Cells to Improve Outcomes after Focal Traumatic Brain Injury in the Female Rat	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; PROMOTES FUNCTIONAL RECOVERY; STEM-CELLS; DONOR GENDER; ADULT RATS; TRANSPLANTATION; THERAPY; SURVIVAL; INCREASES	Mesenchymal stromal cells secrete a variety of anti-inflammatory factors and may provide a regenerative medicine option for the treatment of traumatic brain injury. The present study investigates the efficacy of multiple intravenous or intracardiac administrations of rat mesenchymal stromal cells or human mesenchymal stromal cells in female rats after controlled cortical impact by in vivo MRI, neurobehavior, and histopathology evaluation. Neither intravenous nor intracardiac administration of mesenchymal stromal cells derived from either rats or humans improved MRI measures of lesion volume or neurobehavioral outcome compared to saline treatment. Few mesenchymal stromal cells (<0.0005% of injected dose) were found within 3 days of last dosage at the site of injury after either delivery route, with no mesenchymal stromal cells being detectable in brain at 30 or 56 days post-injury. These findings suggest that non-autologous mesenchymal stromal cells therapy via intravenous or intracardiac administration is not a promising treatment after focal contusion traumatic brain injury in this female rodent model.	[Turtzo, L. Christine; Gold, Eric M.; Janes, Lindsay; Lescher, Jacob] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Turtzo, L. Christine; Budde, Matthew D.; Dean, Dana D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Lescher, Jacob; Coppola, Tiziana; Frank, Joseph A.] NIH, Frank Lab, Bethesda, MD 20892 USA; [Yarnell, Angela; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Turtzo, LC (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	l.turtzo@nih.gov	Frank, Joseph/W-2021-2019		Center for Neuroscience and Regenerative Medicine [300604-8.01-60855, 305500-8.01-60855]; National Institutes of Health's Intramural Research Program; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	Center for Neuroscience and Regenerative Medicine(United States Department of Defense); National Institutes of Health's Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by funding from the the Center for Neuroscience and Regenerative Medicine (http://www.usuhs.mil/cnrm/) as administered by the Henry M. Jackson Foundation (http://www.hjf.org) (Henry M. Jackson Award #300604-8.01-60855 [JAF] and #305500-8.01-60855 [LCT]) and by the National Institutes of Health's Intramural Research Program (http://irp.nih.gov/) (JAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Bonilla C, 2012, J TRAUMA ACUTE CARE, V72, P1203, DOI 10.1097/TA.0b013e318248bdcf; Bonilla C, 2012, J NEUROTRAUM, V29, P394, DOI 10.1089/neu.2011.2101; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Britt JM, 2010, J NEUROPHYSIOL, V104, P695, DOI 10.1152/jn.01051.2009; Budde MD, 2009, J NUCL MED, V50, P171, DOI 10.2967/jnumed.108.053546; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CDC, RAT TBI REL EM DEP V; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Everaert BR, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-93; Fessart D, 2011, TRANSPL P, V43, P3899, DOI 10.1016/j.transproceed.2011.08.101; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gahrton G, 2005, BONE MARROW TRANSPL, V35, P609, DOI 10.1038/sj.bmt.1704861; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goldmacher GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060049; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Jiang JD, 2012, NEURAL REGEN RES, V7, P46, DOI 10.3969/j.issn.1673-5374.2012.01.008; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kerkela E, 2013, STEM CELL TRANSL MED, V2, P510, DOI 10.5966/sctm.2012-0187; Kim S, 2014, STEM CELLS DEV, V23, P530, DOI 10.1089/scd.2013.0297; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lundberg J, 2009, NEURORADIOLOGY, V51, P661, DOI 10.1007/s00234-009-0551-6; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Miller JD, 2010, AM J RESP CELL MOL, V43, P253, DOI 10.1165/rcmb.2010-0015RC; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Naumova AV, 2014, NAT BIOTECHNOL, V32, P804, DOI 10.1038/nbt.2993; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Rahman MA, 1997, PHARMACOL BIOCHEM BE, V56, P409, DOI 10.1016/S0091-3057(96)00222-5; Sabatino M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-23; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Schallert T, 2002, PHARM CEREBRAL ISCHE, P201; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; SCHRODER R, 1980, ACTA NEUROPATHOL, V52, P147, DOI 10.1007/BF00688013; Stroncek DF, 2014, TISSUE ENG PART B-RE, V20, P200, DOI [10.1089/ten.teb.2013.0529, 10.1089/ten.TEB.2013.0529]; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Walker PA, 2010, TISSUE ENG PART C-ME, V16, P989, DOI [10.1089/ten.tec.2009.0423, 10.1089/ten.TEC.2009.0423]; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Yang B, 2013, MESENCHYMAL STROMAL, P617; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69; Zhou JY, 2013, CLIN TRANSPLANT, V27, P764, DOI 10.1111/ctr.12191; Ziadloo A, 2012, STEM CELLS, V30, P1216, DOI 10.1002/stem.1099	69	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126551	10.1371/journal.pone.0126551	http://dx.doi.org/10.1371/journal.pone.0126551			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946089	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700137
J	Villanea, FA; Safi, KN; Busch, JW				Villanea, Fernando A.; Safi, Kristin N.; Busch, Jeremiah W.			A General Model of Negative Frequency Dependent Selection Explains Global Patterns of Human ABO Polymorphism	PLOS ONE			English	Article							BLOOD-GROUP FREQUENCIES; COLOR-VISION PHENOTYPE; WHITE-FACED CAPUCHINS; SELF-INCOMPATIBILITY; NATIVE-AMERICANS; BALANCING SELECTION; O-ALLELES; MOLECULAR CHARACTERIZATION; STATISTICAL EVALUATION; EVOLUTIONARY GENETICS	The ABO locus in humans is characterized by elevated heterozygosity and very similar allele frequencies among populations scattered across the globe. Using knowledge of ABO protein function, we generated a simple model of asymmetric negative frequency dependent selection and genetic drift to explain the maintenance of ABO polymorphism and its loss in human populations. In our models, regardless of the strength of selection, models with large effective population sizes result in ABO allele frequencies that closely match those observed in most continental populations. Populations must be moderately small to fall out of equilibrium and lose either the A or B allele (N-e <= 50) and much smaller (N-e <= 25) for the complete loss of diversity, which nearly always involved the fixation of the O allele. A pattern of low heterozygosity at the ABO locus where loss of polymorphism occurs in our model is consistent with small populations, such as Native American populations. This study provides a general evolutionary model to explain the observed global patterns of polymorphism at the ABO locus and the pattern of allele loss in small populations. Moreover, these results inform the range of population sizes associated with the recent human colonization of the Americas.	[Villanea, Fernando A.; Busch, Jeremiah W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Safi, Kristin N.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA	Washington State University; Washington State University	Villanea, FA (corresponding author), Washington State Univ, Sch Biol Sci, POB 644236, Pullman, WA 99164 USA.	fervillanea@gmail.com		Safi, Kristin/0000-0002-3587-5638	National Science Foundation [NSF DEB 1119000]	National Science Foundation(National Science Foundation (NSF))	We are especially grateful to Drew Kitchen, Omer Gokcumen, and Brian M. Kemp for useful discussions about the estimation of Native American effective population sizes from genetic data and to Nathan Layman for insightful discussion on modeling balancing selection and genetic drift. All authors declare we have no financial or professional interests that might bias our study efforts or presentation of results. Publication fees were covered by National Science Foundation grant number NSF DEB 1119000.	ADALSTEINSSON S, 1985, ANN HUM GENET, V49, P275, DOI 10.1111/j.1469-1809.1985.tb01703.x; Alcaide M, 2010, MOL ECOL, V19, P3842, DOI 10.1111/j.1365-294X.2010.04772.x; Augusto DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056755; Billiard S, 2007, GENETICS, V175, P1351, DOI 10.1534/genetics.105.055095; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Cavalli-Sforza LL, 1992, HIST GEOGRAPHY HUMAN; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Daniels G., 2002, HUMAN BLOOD GROUPS; Estrada-Mena B, 2010, AM J PHYS ANTHROPOL, V142, P85, DOI 10.1002/ajpa.21204; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Georges L, 2012, AM J PHYS ANTHROPOL, V149, P242, DOI 10.1002/ajpa.22115; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; Halverson MS, 2008, AM J PHYS ANTHROPOL, V137, P342, DOI 10.1002/ajpa.20887; HEDRICK PW, 1983, GENETICS, V104, P449; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hiscock SJ, 1996, TRENDS CELL BIOL, V6, P421, DOI 10.1016/S0962-8924(96)10037-4; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; Kemp B. M., 2010, HUMAN VARIATION AM I, P12; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; KOWYAMA Y, 1994, THEOR APPL GENET, V88, P859, DOI 10.1007/BF01253997; Lewis CM, 2010, AM J PHYS ANTHROPOL, V141, P281, DOI 10.1002/ajpa.21143; Llop E, 2006, AM J PHYS ANTHROPOL, V131, P535, DOI 10.1002/ajpa.20462; Malhi RS, 2007, J ARCHAEOL SCI, V34, P642, DOI 10.1016/j.jas.2006.07.004; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Molnar S, 2002, HUMAN VARIATION; Mourant A.E., 1983, BLOOD RELATIONS BLOO; Mourant AE., 1976, DISTRIBUTION HUMAN B; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Nettle D, 1999, P NATL ACAD SCI USA, V96, P3325, DOI 10.1073/pnas.96.6.3325; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Paixao-Cortes VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015656; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE; Reid ME, 2004, SEMIN HEMATOL, V41, P93, DOI 10.1053/j.seminhematol.2004.01.001; Richman AD, 2000, PLANT MOL BIOL, V42, P169, DOI 10.1023/A:1006336206637; Roubinet F, 2004, TRANSFUSION, V44, P707, DOI 10.1111/j.1537-2995.2004.03346.x; Saitou N, 1997, MOL BIOL EVOL, V14, P399, DOI 10.1093/oxfordjournals.molbev.a025776; Schierup MH, 2008, CURR OPIN PLANT BIOL, V11, P116, DOI 10.1016/j.pbi.2008.01.003; Schroeder KB, 2009, MOL BIOL EVOL, V26, P995, DOI 10.1093/molbev/msp024; Schroeder KB, 2007, BIOL LETT, V3; Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109; Seymour RM, 2004, P ROY SOC B-BIOL SCI, V271, P1065, DOI 10.1098/rspb.2004.2674; SHARON R, 1991, CYTOMETRY, V12, P545, DOI 10.1002/cyto.990120611; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Surridge AK, 2002, MOL ECOL, V11, P2157, DOI 10.1046/j.1365-294X.2002.01597.x; SWERDLOW DL, 1994, J INFECT DIS, V170, P468, DOI 10.1093/infdis/170.2.468; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; TORRONI A, 1993, AM J HUM GENET, V53, P563; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Urbanek S, 2009, R LANG ENV STAT COMP; Villanea FA, 2013, AM J PHYS A IN PRESS; Villanea FA, 2013, AM J PHYS ANTHROPOL, V151, P649, DOI 10.1002/ajpa.22292; Vogel ER, 2007, BEHAV ECOL, V18, P292, DOI 10.1093/beheco/arl082; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Westerdahl H, 2004, J EVOLUTION BIOL, V17, P485, DOI 10.1111/j.1420-9101.2004.00711.x; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; [No title captured]	68	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125003	10.1371/journal.pone.0125003	http://dx.doi.org/10.1371/journal.pone.0125003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946124	Green Submitted, gold, Green Published			2022-12-26	WOS:000354049700054
J	Feld, L; Hjelmso, MH; Nielsen, MS; Jacobsen, AD; Ronn, R; Ekelund, F; Krogh, PH; Strobel, BW; Jacobsen, CS				Feld, Louise; Hjelmso, Mathis Hjort; Nielsen, Morten Schostag; Jacobsen, Anne Dorthe; Ronn, Regin; Ekelund, Flemming; Krogh, Paul Henning; Strobel, Bjarne Westergaard; Jacobsen, Carsten Suhr			Pesticide Side Effects in an Agricultural Soil Ecosystem as Measured by amoA Expression Quantification and Bacterial Diversity Changes	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; METHYL ISOTHIOCYANATE; NITROSOMONAS-EUROPAEA; COMMUNITIES; NITROGEN; NITRIFICATION; ABUNDANCE; FUMIGANTS; RNA; MONOOXYGENASE	Background and Methods Assessing the effects of pesticide hazards on microbiological processes in the soil is currently based on analyses that provide limited insight into the ongoing processes. This study proposes a more comprehensive approach. The side effects of pesticides may appear as changes in the expression of specific microbial genes or as changes in diversity. To assess the impact of pesticides on gene expression, we focused on the amoA gene, which is involved in ammonia oxidation. We prepared soil microcosms and exposed them to dazomet, mancozeb or no pesticide. We hypothesized that the amount of amoA transcript decreases upon pesticide application, and to test this hypothesis, we used reverse-transcription qPCR. We also hypothesized that bacterial diversity is affected by pesticides. This hypothesis was investigated via 454 sequencing and diversity analysis of the 16S ribosomal RNA and RNA genes, representing the active and total soil bacterial communities, respectively. Results and Conclusion Treatment with dazomet reduced both the bacterial and archaeal amoA transcript numbers by more than two log units and produced long-term effects for more than 28 days. Mancozeb also inhibited the numbers of amoA transcripts, but only transiently. The bacterial and archaeal amoA transcripts were both sensitive bioindicators of pesticide side effects. Additionally, the numbers of bacterial amoA transcripts correlated with nitrate production in Namended microcosms. Dazomet reduced the total bacterial numbers by one log unit, but the population size was restored after twelve days. The diversity of the active soil bacteria also seemed to be re-established after twelve days. However, the total bacterial diversity as reflected in the 16S ribosomal RNA gene sequences was largely dominated by Firmicutes and Proteobacteria at day twelve, likely reflecting a halt in the growth of early opportunists and the re-establishment of a more diverse population. We observed no effects of mancozeb on diversity.	[Feld, Louise; Hjelmso, Mathis Hjort; Nielsen, Morten Schostag; Jacobsen, Anne Dorthe; Jacobsen, Carsten Suhr] Geol Survey Denmark & Greenland GEUS, Dept Geochem, Copenhagen, Denmark; [Ronn, Regin; Ekelund, Flemming] Univ Copenhagen, Dept Biol, Sect Terr Ecol, Copenhagen, Denmark; [Krogh, Paul Henning] Univ Aarhus, Dept Biosci, Sect Soil Fauna Ecol & Ecotoxicol, Silkeborg, Denmark; [Strobel, Bjarne Westergaard] Univ Copenhagen, Dept Plant & Environm Sci, Sect Environm Chem & Phys, Frederiksberg, Denmark	Geological Survey Of Denmark & Greenland; University of Copenhagen; Aarhus University; University of Copenhagen	Feld, L (corresponding author), Geol Survey Denmark & Greenland GEUS, Dept Geochem, Copenhagen, Denmark.	lfe@geus.dk	Strobel, Bjarne W./AAG-9434-2021; Schostag, Morten Dencker/G-9653-2018; Krogh, Paul Henning/B-3566-2009; Rønn, Regin/K-4460-2014	Strobel, Bjarne W./0000-0001-9680-1715; Schostag, Morten Dencker/0000-0001-9221-1398; Krogh, Paul Henning/0000-0003-2033-553X; Rønn, Regin/0000-0002-7486-1191; Jacobsen, Carsten Suhr/0000-0003-1041-0823; Hjelmso, Mathis Hjort/0000-0001-9716-624X; Feld, Louise/0000-0002-5533-5604	Danish EPA [667-00082]	Danish EPA	The study was funded by a public grant 667-00082 from the Danish EPA.	Baelum J, 2008, ISME J, V2, P677, DOI 10.1038/ismej.2008.21; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; BARTHA R, 1967, APPL MICROBIOL, V15, P67, DOI 10.1128/AEM.15.1.67-75.1967; Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bock E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P457, DOI 10.1007/0-387-30742-7_16; Bollmann A, 2005, APPL ENVIRON MICROB, V71, P1276, DOI 10.1128/AEM.71.3.1276-1282.2005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cernohlavkova J, 2009, ECOTOX ENVIRON SAFE, V72, P80, DOI 10.1016/j.ecoenv.2008.07.001; Chang YJ, 2001, ENVIRON TOXICOL CHEM, V20, P2462, DOI [10.1897/1551-5028(2001)020&lt;2462:IOHOTA&gt;2.0.CO;2, 10.1002/etc.5620201110]; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Floch C, 2011, EUR J SOIL BIOL, V47, P256, DOI 10.1016/j.ejsobi.2011.05.007; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He JZ, 2012, SOIL BIOL BIOCHEM, V55, P146, DOI 10.1016/j.soilbio.2012.06.006; Hernandez M, 2011, FEMS MICROBIOL ECOL, V78, P511, DOI 10.1111/j.1574-6941.2011.01180.x; Hjelmso MH, 2014, APPL ENVIRON MICROB, V80, P3568, DOI 10.1128/AEM.03923-13; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; Ibekwe AM, 2001, APPL ENVIRON MICROB, V67, P3245, DOI 10.1128/AEM.67.7.3245-3257.2001; Iizumi T, 1998, APPL ENVIRON MICROB, V64, P3656; Jacobsen CS, 2014, CURR OPIN BIOTECH, V27, P15, DOI 10.1016/j.copbio.2013.09.003; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; KIM JH, 1994, J AGR FOOD CHEM, V42, P2019, DOI 10.1021/jf00045a035; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LAM WW, 1993, J AGR FOOD CHEM, V41, P1497, DOI 10.1021/jf00033a027; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045306; Mao Y, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNALP0NE.0024750; Mertens J, 2006, ENVIRON MICROBIOL, V8, P2170, DOI 10.1111/j.1462-2920.2006.01100.x; Meyer A, 2014, MICROB ECOL, V67, P161, DOI 10.1007/s00248-013-0310-4; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nyberg KA, 2012, MICROB ECOL, V63, P701, DOI 10.1007/s00248-011-9970-0; OECD, 2000, TEST NO 106 AD DES U, DOI [10.1787/9789264069602-en, DOI 10.1787/9789264069602-EN]; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Pell M, 1998, AMBIO, V27, P24; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Ruzo LO, 2006, PEST MANAG SCI, V62, P99, DOI 10.1002/ps.1135; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Spyrou IM, 2009, MICROB ECOL, V58, P715, DOI 10.1007/s00248-009-9522-z; Stein LY, 1997, APPL ENVIRON MICROB, V63, P4588, DOI 10.1128/AEM.63.11.4588-4592.1997; Taylor AE, 2012, ISME J, V6, P2024, DOI 10.1038/ismej.2012.51; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Ufer A., 1995, Acta Horticulturae, P110; US EPA, 2005, RER EL DEC MANC; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; VONK JW, 1991, TOXICOL ENVIRON CHEM, V30, P241, DOI 10.1080/02772249109357662; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Wessen E, 2011, ECOL INDIC, V11, P1696, DOI 10.1016/j.ecolind.2011.04.018; Yang WJ, 2014, SOIL BIOL BIOCHEM, V69, P197, DOI 10.1016/j.soilbio.2013.10.030; Yu BB, 2014, APPL MICROBIOL BIOT, V98, P263, DOI 10.1007/s00253-013-5311-1	57	58	62	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126080	10.1371/journal.pone.0126080	http://dx.doi.org/10.1371/journal.pone.0126080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938467	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000136
J	Roh, SS; Smith, LE; Lee, JS; Via, LE; Barry, CE; Alland, D; Chakravorty, S				Roh, Sandy S.; Smith, Laura E.; Lee, Jong Seok; Via, Laura E.; Barry, Clifton E., III; Alland, David; Chakravorty, Soumitesh			Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance	PLOS ONE			English	Article							REAL-TIME PCR; DRUG-RESISTANCE; DIAGNOSTICS; GENES; SUSCEPTIBILITY; IDENTIFICATION; OFLOXACIN; SELECTION; REGIONS; CHINA	Several molecular assays to detect resistance to Rifampin, the Fluoroquinolones, and Aminoglycosides in Mycobacterium tuberculosis (M. tuberculosis) have been recently described. A systematic approach for comparing these assays in the laboratory is needed in order to determine the relative advantage of each assay and to decide which ones should be advanced to evaluation. We performed an analytic comparison of a Sloppy Molecular Beacon (SMB) melting temperature (Tm) assay and a Dual labeled probe (DLP) Tm assay. Both assays targeted the M. tuberculosis rpoB, gyrA, rrs genes and the eis promoter region. The sensitivity and specificity to detect mutations, analytic limit of detection (LOD) and the detection of heteroresistance were tested using a panel of 56 clinical DNA samples from drug resistant M. tuberculosis strains. Both SMB and DLP assays detected 29/29 (100%) samples with rpoB RRDR mutations and 3/3 (100%) samples with eis promoter mutations correctly. The SMB assay detected all 17/17 gyrA mutants and 22/22 rrs mutants, while the DLP assay detected 16/17 (94%) gyrA mutants and 12/22 (55%) rrs mutants. Both assays showed comparable LODs for detecting rpoB and eis mutations; however, the SMB assay LODs were at least two logs better for detecting wild type and mutants in gyrA and rrs targets. The SMB assay was also moderately better at detecting heteroresistance. In summary, both assays appeared to be promising methods to detect drug resistance associated mutations in M. tuberculosis; however, the relative advantage of each assay varied under each test condition.	[Roh, Sandy S.; Smith, Laura E.; Alland, David; Chakravorty, Soumitesh] Rutgers State Univ, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA; [Lee, Jong Seok] Int TB Res Ctr, Dept Microbiol, Chang Won, Gyeongsang, South Korea; [Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, LCID, NIH, Bethesda, MD 20892 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chakravorty, S (corresponding author), Rutgers State Univ, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA.	chakraso@njms.rutgers.edu	Barry, Clifton E/ABE-7992-2020; Via, Laura/AAD-3917-2021; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521; Barry, III, Clifton/0000-0002-2927-270X	U.S. National Institutes of Health (NIH) grant [AI080653]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080653, ZIAAI001067] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (NIH) grant AI080653 (DA, LES, SC and SSR). Partial funding for the clinical study in Masan, South Korea was provided by the intramural research program of NIAID, NIH (CEB and LEV).	Ajbani K, 2011, J CLIN MICROBIOL, V49, P2546, DOI 10.1128/JCM.02511-10; An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; Balasingham SV, 2009, MOL DIAGN THER, V13, P137, DOI 10.2165/01250444-200913030-00001; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2014, J CLIN MICROBIOL; Chakravorty S, 2012, J CLIN MICROBIOL, V50, P2194, DOI 10.1128/JCM.00143-12; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Cui ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-78; Dauendorffer JN, 2003, J CLIN MICROBIOL, V41, P1311, DOI 10.1128/JCM.41.3.1311-1315.2003; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055292; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Grimaldo ER, 2001, INT J TUBERC LUNG D, V5, P546; Heifets L, 2000, J CLIN MICROBIOL, V38, P1227, DOI 10.1128/JCM.38.3.1227-1230.2000; Hillery N, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-434; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Kalokhe AS, 2013, AM J MED SCI, V345, P143, DOI 10.1097/MAJ.0b013e31825d32c6; Khare R, 2014, J CLIN MICROBIOL, V52, P1711, DOI 10.1128/JCM.00358-14; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Liu QY, 2013, J ANTIMICROB CHEMOTH, V68, P1097, DOI 10.1093/jac/dks509; Luo T, 2011, J CLIN MICROBIOL, V49, P3132, DOI 10.1128/JCM.02046-10; Ma X, 2006, J CLIN MICROBIOL, V44, P3409, DOI 10.1128/JCM.00515-06; Marras Salvatore A. E., 2006, V335, P3; Nebenzahl-Guimaraes H, 2014, J ANTIMICROB CHEMOTH, V69, P331, DOI 10.1093/jac/dkt358; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Rice JE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks731; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; WHO, 2014, GLOBAL TUBERCULOSIS; Xu P, 2009, ANTIMICROB AGENTS CH, V53, P3170, DOI 10.1128/AAC.00177-09; Yadav R, 2012, J APPL MICROBIOL, V113, P856, DOI 10.1111/j.1365-2672.2012.05379.x; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zimenkov DV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-240	36	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126257	10.1371/journal.pone.0126257	http://dx.doi.org/10.1371/journal.pone.0126257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938476	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000156
J	Wang, ZQ; Wang, JL; Zhang, H; Mchugh, R; Sun, XY; Li, KC; Yang, QX				Wang, Zhiqun; Wang, Jianli; Zhang, Han; Mchugh, Robert; Sun, Xiaoyu; Li, Kuncheng; Yang, Qing X.			Interhemispheric Functional and Structural Disconnection in Alzheimer's Disease: A Combined Resting-State fMRI and DTI Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; BASAL FOREBRAIN ATROPHY; CORPUS-CALLOSUM; HUMAN BRAIN; BIMANUAL COORDINATION; ORBITOFRONTAL CORTEX; CINGULATE CORTEX; MOTOR CORTEX; IN-VIVO	Neuroimaging studies have demonstrated that patients with Alzheimer's disease presented disconnection syndrome. However, little is known about the alterations of interhemispheric functional interactions and underlying structural connectivity in the AD patients. In this study, we combined resting-state functional MRI and diffusion tensor imaging (DTI) to investigate interhemispheric functional and structural connectivity in 16 AD, 16 mild cognitive impairment (MCI), as well as 16 cognitive normal healthy subjects (CN). The pattern of the resting state interhemispheric functional connectivity was measured with a voxel-mirrored homotopic connectivity (VMHC) method. Decreased VMHC was observed in AD and MCI subjects in anterior brain regions including the prefrontal cortices and subcortical regions with a pattern of AD<MCI<CN. Increased VMHC was observed in MCI subjects in posterior brain regions with patterns of AD/CN < MCI (sensorimotor cortex) and AD < CN/MCI (occipital gyrus). DTI analysis showed the most significant difference among the three cohorts was the fractional anisotropy in the genu of corpus callosum, which was positively associated with the VMHC of prefrontal and subcortical regions. Across all the three cohorts, the diffusion parameters in the genu of corpus callosum and VMHC in the above brain regions had significant correlation with the cognitive performance. These results demonstrate that there are specific patterns of interhemispheric functional connectivity changes in the AD and MCI, which can be significantly correlated with the integrity changes in the midline white matter structures. These results suggest that VMHC can be used as a biomarker for the degeneration of the interhemispheric connectivity in AD.	[Wang, Zhiqun; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Wang, Jianli; Mchugh, Robert; Sun, Xiaoyu; Yang, Qing X.] Penn State Univ, Coll Med, Dept Radiol, Ctr NMR Res, Hershey, PA USA; [Zhang, Han] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Li, Kuncheng] Capital Med Univ, Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China; [Yang, Qing X.] Penn State Univ, George M Leader Fdn Alzheimers Lab, Dept Neurosurg, Coll Med, Hershey, PA USA	Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Hangzhou Normal University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Li, KC (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	likuncheng@xwh.ccmu.edu.cn; qyang@hmc.psu.edu	Yang, Heroine/GRY-2630-2022	Zhang, Han/0000-0002-6645-8810	NSF of China [81030028, 81000606, 81370037, 81225012, 81471649]; Beijing Natural Science Foundation [7153166]; NIH [RO1 AG027771]; NATIONAL INSTITUTE ON AGING [R01AG027771] Funding Source: NIH RePORTER	NSF of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NSF of China (Grant Nos. 81030028, 81000606, 81370037, 81225012, and 81471649), Beijing Natural Science Foundation ( Grant No 7153166), and a NIH RO1 AG027771. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bajo R, 2010, J ALZHEIMERS DIS, V22, P183, DOI 10.3233/JAD-2010-100177; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Bartzokis G, 2007, BIOL PSYCHIAT, V62, P1380, DOI 10.1016/j.biopsych.2007.03.024; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 2000, ANN NY ACAD SCI, V924, P53; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chaim TM, 2007, PSYCHIAT RES-NEUROIM, V154, P59, DOI 10.1016/j.pscychresns.2006.04.003; de Jong LW, 2011, J ALZHEIMERS DIS, V23, P49, DOI 10.3233/JAD-2010-101026; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gonzalez-Burgos I, 2008, PROG BRAIN RES, V172, P603, DOI 10.1016/S0079-6123(08)00928-X; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guo XJ, 2012, NEUROSCI LETT, V531, P136, DOI 10.1016/j.neulet.2012.10.038; Hall AM, 2008, ALZHEIMERS DEMENT, V4, P271, DOI 10.1016/j.jalz.2008.04.005; Heitger MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062133; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Koivunen J, 2008, BRAIN, V131, P1845, DOI 10.1093/brain/awn107; Lakmache Y, 1998, P NATL ACAD SCI USA, V95, P9042, DOI 10.1073/pnas.95.15.9042; Marigliano V, 2014, ALZ DIS ASSOC DIS, V28, P194, DOI 10.1097/WAD.0b013e31827bdb9f; Marion SD, 2003, DEV NEUROPSYCHOL, V23, P399, DOI 10.1207/S15326942DN2303_6; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856; Resnick SM, 2007, ANN NY ACAD SCI, V1121, P562, DOI 10.1196/annals.1401.027; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; SELDEN N, 1994, BRAIN RES, V648, P327, DOI 10.1016/0006-8993(94)91136-3; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Teipel SJ, 2005, BRAIN, V128, P2626, DOI 10.1093/brain/awh589; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060191; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wang ZQ, 2010, EUR J RADIOL, V75, P129, DOI 10.1016/j.ejrad.2009.04.041; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Xie CM, 2012, NEUROIMAGE, V63, P320, DOI 10.1016/j.neuroimage.2012.06.062; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou Y, 2013, AM J NEURORADIOL, V34, P1180, DOI 10.3174/ajnr.A3386; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	76	58	62	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126310	10.1371/journal.pone.0126310	http://dx.doi.org/10.1371/journal.pone.0126310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938561	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000158
J	Su, Y; Patra, A; Harp, JM; Egli, M; Guengerich, FP				Su, Yan; Patra, Amritraj; Harp, Joel M.; Egli, Martin; Guengerich, F. Peter			Roles of Residues Arg-61 and Gln-38 of Human DNA Polymerase in Bypass of Deoxyguanosine and 7,8-Dihydro-8-oxo-2-deoxyguanosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; kinetics; mutagenesis mechanism; pre-steady-state kinetics; site-directed mutagenesis; x-ray crystallography	IMMUNOGLOBULIN GENE HYPERMUTATION; Y-FAMILY; SOMATIC HYPERMUTATION; TRANSLESION SYNTHESIS; STRUCTURAL BASIS; ETA; REPLICATION; MECHANISM; MUTATIONS; RECOMBINATION	Background: Arg-61 and Gln-38 of human DNA polymerase (hpol) play important roles in the catalytic reaction. Results: Mutations R61M or Q38A/R61A dramatically disrupt the activity of hpol . Conclusion: Polarized water molecules can mimic and partially compensate for the missing side chains of Arg-61 and Gln-38 in the Q38A/R61A mutant. Significance: The positioning and positive charge of Arg-61 synergistically contribute to the activity of hpol , with additional effects of Gln-38. Like the other Y-family DNA polymerases, human DNA polymerase (hpol ) has relatively low fidelity and is able to tolerate damage during DNA synthesis, including 7,8-dihydro-8-oxo-2-deoxyguanosine (8-oxoG), one of the most abundant DNA lesions in the genome. Crystal structures show that Arg-61 and Gln-38 are located near the active site and may play important roles in the fidelity and efficiency of hpol . Site-directed mutagenesis was used to replace these side chains either alone or together, and the wild type or mutant proteins were purified and tested by replicating DNA past deoxyguanosine (G) or 8-oxoG. The catalytic activity of hpol was dramatically disrupted by the R61M and Q38A/R61A mutations, as opposed to the R61A and Q38A single mutants. Crystal structures of hpol mutant ternary complexes reveal that polarized water molecules can mimic and partially compensate for the missing side chains of Arg-61 and Gln-38 in the Q38A/R61A mutant. The combined data indicate that the positioning and positive charge of Arg-61 synergistically contribute to the nucleotidyl transfer reaction, with additional influence exerted by Gln-38. In addition, gel filtration chromatography separated multimeric and monomeric forms of wild type and mutant hpol , indicating the possibility that hpol forms multimers in vivo.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank P. S. Pallan for advice on some of the crystallography work and K. Trisler for assistance in preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source (Argonne, IL). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Bassett E, 2004, CANCER RES, V64, P6469, DOI 10.1158/0008-5472.CAN-04-1328; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Egli M, 2007, ACCOUNTS CHEM RES, V40, P197, DOI 10.1021/ar068174u; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Langer GG, 2013, ACTA CRYSTALLOGR D, V69, P635, DOI 10.1107/S0907444913000565; Lin HK, 2012, BIOCHEMISTRY-US, V51, P7367, DOI 10.1021/bi300956t; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Schorr S, 2010, P NATL ACAD SCI USA, V107, P20720, DOI 10.1073/pnas.1008894107; Silverstein TD, 2010, STRUCTURE, V18, P1463, DOI 10.1016/j.str.2010.08.019; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Suarez SC, 2013, MUTAT RES-FUND MOL M, V745, P46, DOI 10.1016/j.mrfmmm.2013.03.001; Tang KH, 2008, J CELL PHYSIOL, V216, P315, DOI 10.1002/jcp.21458; Tang KH, 2008, NUCLEIC ACIDS RES, V36, P849, DOI 10.1093/nar/gkm1101; Tereshko V, 2001, NUCLEIC ACIDS RES, V29, P1208, DOI 10.1093/nar/29.5.1208; Ummat A, 2012, J MOL BIOL, V415, P627, DOI 10.1016/j.jmb.2011.11.038; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Wouters J, 1998, PROTEIN SCI, V7, P2472, DOI 10.1002/pro.5560071127; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zahn KE, 2011, CURR OPIN STRUC BIOL, V21, P358, DOI 10.1016/j.sbi.2011.03.008; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P8146, DOI 10.1073/pnas.1303126110; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	57	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15921	15933		10.1074/jbc.M115.653691	http://dx.doi.org/10.1074/jbc.M115.653691			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25947374	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000356930100003
J	Beatson, R; Maurstad, G; Picco, G; Arulappu, A; Coleman, J; Wandell, HH; Clausen, H; Mandel, U; Taylor-Papadimitriou, J; Sletmoen, M; Burchell, JM				Beatson, Richard; Maurstad, Gjertrud; Picco, Gianfranco; Arulappu, Appitha; Coleman, Julia; Wandell, Hans H.; Clausen, Henrik; Mandel, Ulla; Taylor-Papadimitriou, Joyce; Sletmoen, Marit; Burchell, Joy M.			The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL	PLOS ONE			English	Article							O-GLYCOSYLATION; DENDRITIC CELLS; ANTIGEN; SIALYLTRANSFERASE; GLYCAN; METASTASIS; MIGRATION; RESPONSES; CHAPERONE; RECEPTOR	Aberrant glycosylation occurs in the majority of human cancers and changes in mucin-type O-glycosylation are key events that play a role in the induction of invasion and metastases. These changes generate novel cancer-specific glyco-antigens that can interact with cells of the immune system through carbohydrate binding lectins. Two glyco-epitopes that are found expressed by many carcinomas are Tn (GalNAc-Ser/Thr) and STn (NeuAc alpha 2,6GalNAc- Ser/Thr). These glycans can be carried on many mucin-type glycoproteins including MUC1. We show that the majority of breast cancers carry Tn within the same cell and in close proximity to extended glycan T (Gal beta 1,3GalNAc) the addition of Gal to the GalNAc being catalysed by the T synthase. The presence of active T synthase suggests that loss of the private chaperone for T synthase, COSMC, does not explain the expression of Tn and STn in breast cancer cells. We show that MUC1 carrying both Tn or STn can bind to the C-type lectin MGL and using atomic force microscopy show that they bind to MGL with a similar deadadhesion force. Tumour associated STn is associated with poor prognosis and resistance to chemotherapy in breast carcinomas, inhibition of DC maturation, DC apoptosis and inhibition of NK activity. As engagement of MGL in the absence of TLR triggering may lead to anergy, the binding of MUC1-STn to MGL may be in part responsible for some of the characteristics of STn expressing tumours.	[Beatson, Richard; Picco, Gianfranco; Arulappu, Appitha; Coleman, Julia; Taylor-Papadimitriou, Joyce; Burchell, Joy M.] Guys Hosp, Kings Coll London, Breast Canc Biol, London SE1 9RT, England; [Maurstad, Gjertrud; Sletmoen, Marit] Norwegian Univ Sci & Technol, Dept Phys, N-7491 Trondheim, Norway; [Wandell, Hans H.; Clausen, Henrik; Mandel, Ulla] Univ Copenhagen, Copenhagen Ctr Glyc, DK-2200 Copenhagen, Denmark	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Norwegian University of Science & Technology (NTNU); University of Copenhagen	Burchell, JM (corresponding author), Guys Hosp, Kings Coll London, Breast Canc Biol, London SE1 9RT, England.	joy.burchell@kcl.ac.uk	clausen, henrik/AAD-8016-2021; Sletmoen, Marit/H-8896-2016; Beatson, Richard/AAB-1029-2021; Beatson, Richard/AAB-8945-2021	Beatson, Richard/0000-0002-0411-932X; Mandel, Ulla/0000-0001-7012-9836; Burchell, Joy/0000-0003-0413-3823; Clausen, Henrik/0000-0002-0915-5055	Cancer Research UK; Breast Cancer Campaign [2010NovPR4, 2007MayPR18]; EU [HEALTH-F2-20077-201381]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's London; King's College Hospital NHS Foundation Trust; Cancer Research UK [16463] Funding Source: researchfish; Medical Research Council [1252897] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; EU(European Commission); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's London; King's College Hospital NHS Foundation Trust; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Cancer Research UK, Breast Cancer Campaign 2010NovPR4, 2007MayPR18, EU grant number HEALTH-F2-20077-201381. The authors also acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's London and King's College Hospital NHS Foundation Trust.	Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Carrascal MA, 2014, MOL ONCOL, V8, P753, DOI 10.1016/j.molonc.2014.02.008; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davicino RC, 2011, INT IMMUNOPHARMACOL, V11, P1457, DOI 10.1016/j.intimp.2011.05.002; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Ishida A, 2008, PROTEOMICS, V8, P3342, DOI 10.1002/pmic.200800039; Jegouzo SAF, 2013, GLYCOBIOLOGY, V23, P853, DOI 10.1093/glycob/cwt022; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Link T, 2004, J BIOTECHNOL, V110, P51, DOI 10.1016/j.jbiotec.2003.12.008; MILES DW, 1994, BRIT J CANCER, V70, P1272, DOI 10.1038/bjc.1994.486; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Murugaesu N, 2014, CANCER DISCOV, V4, P304, DOI 10.1158/2159-8290.CD-13-0287; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Napoletano C, 2012, EUR J IMMUNOL, V42, P936, DOI 10.1002/eji.201142086; OGATA S, 1992, CANCER RES, V52, P4741; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Sletmoen M, 2005, CARBOHYD RES, V340, P2782, DOI 10.1016/j.carres.2005.09.020; Sletmoen M, 2004, BIOMACROMOLECULES, V5, P1288, DOI 10.1021/bm0345211; Sletmoen M, 2012, SOFT MATTER, V8, P8413, DOI 10.1039/c2sm26256h; Sletmoen M, 2009, BIOPOLYMERS, V91, P719, DOI 10.1002/bip.21213; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Suzuki N, 1996, J IMMUNOL, V156, P128; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; van Vliet SJ, 2008, J IMMUNOL, V181, P3148, DOI 10.4049/jimmunol.181.5.3148; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2013, J BIOL CHEM, V288, P27519, DOI 10.1074/jbc.M113.471045; van Vliet SJ, 2013, J LEUKOCYTE BIOL, V94, P315, DOI 10.1189/jlb.1012520; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107	49	58	63	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125994	10.1371/journal.pone.0125994	http://dx.doi.org/10.1371/journal.pone.0125994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951175	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400060
J	Conson, M; Errico, D; Mazzarella, E; Giordano, M; Grossi, D; Trojano, L				Conson, Massimiliano; Errico, Domenico; Mazzarella, Elisabetta; Giordano, Marianna; Grossi, Dario; Trojano, Luigi			Transcranial Electrical Stimulation over Dorsolateral Prefrontal Cortex Modulates Processing of Social Cognitive and Affective Information	PLOS ONE			English	Article							SPATIAL PERSPECTIVE-TAKING; RECOGNITION; BEHAVIOR; FACE; NEUROSCIENCE; ACTIVATION; GENDER; MALES; RISK; SELF	Recent neurofunctional studies suggested that lateral prefrontal cortex is a domain-general cognitive control area modulating computation of social information. Neuropsychological evidence reported dissociations between cognitive and affective components of social cognition. Here, we tested whether performance on social cognitive and affective tasks can be modulated by transcranial direct current stimulation (tDCS) over dorsolateral prefrontal cortex (DLPFC). To this aim, we compared the effects of tDCS on explicit recognition of emotional facial expressions (affective task), and on one cognitive task assessing the ability to adopt another person's visual perspective. In a randomized, cross-over design, male and female healthy participants performed the two experimental tasks after bi-hemispheric tDCS (sham, left anodal/right cathodal, and right anodal/left cathodal) applied over DLPFC. Results showed that only in male participants explicit recognition of fearful facial expressions was significantly faster after anodal right/cathodal left stimulation with respect to anodal left/cathodal right and sham stimulations. In the visual perspective taking task, instead, anodal right/cathodal left stimulation negatively affected both male and female participants' tendency to adopt another's point of view. These findings demonstrated that concurrent facilitation of right and inhibition of left lateral prefrontal cortex can speed-up males' responses to threatening faces whereas it interferes with the ability to adopt another's viewpoint independently from gender. Thus, stimulation of cognitive control areas can lead to different effects on social cognitive skills depending on the affective vs. cognitive nature of the task, and on the gender-related differences in neural organization of emotion processing.	[Conson, Massimiliano; Errico, Domenico; Giordano, Marianna; Grossi, Dario; Trojano, Luigi] Univ Naples 2, Dept Psychol, Neuropsychol Lab, Caserta, Italy; [Mazzarella, Elisabetta] Sci Inst Fdn Santa Lucia, Dept Neuromotor Physiol, Rome, Italy	Universita della Campania Vanvitelli; IRCCS Santa Lucia	Conson, M (corresponding author), Univ Naples 2, Dept Psychol, Neuropsychol Lab, Caserta, Italy.	massimiliano.conson@unina2.it; luigi.trojano@unina2.it	Conson, Massimiliano/AAT-3300-2020; Trojano, Luigi/F-2396-2016	Conson, Massimiliano/0000-0002-4776-306X; Trojano, Luigi/0000-0002-0328-9642				Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Boggio PS, 2008, NEUROSCI LETT, V447, P101, DOI 10.1016/j.neulet.2008.10.009; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Campbell R, 2002, NEUROPSYCHOLOGIA, V40, P575, DOI 10.1016/S0028-3932(01)00164-6; Conson M, 2015, AUTISM RES, V8, P454, DOI 10.1002/aur.1460; Conson M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00382; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Ekman P., 1976, PICTURES FACIAL AFFE; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Feeser M, 2014, BRAIN STIMUL, V7, P105, DOI 10.1016/j.brs.2013.08.006; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fumagalli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008865; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Hoy KE, 2013, NEUROPSYCHOLOGIA, V51, P1777, DOI 10.1016/j.neuropsychologia.2013.05.018; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kessler K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0388; Kessler K, 2012, SPAT COGN COMPUT, V12, P133, DOI 10.1080/13875868.2011.634533; Lafontaine MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081721; Lapenta OM, 2012, NEUROSCI LETT, V527, P105, DOI 10.1016/j.neulet.2012.08.076; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Mathersul D, 2009, J CLIN EXP NEUROPSYC, V31, P278, DOI 10.1080/13803390802043619; Mazzarella E, 2012, Q J EXP PSYCHOL, V65, P2447, DOI 10.1080/17470218.2012.697905; McCleery JP, 2011, J NEUROSCI, V31, P12849, DOI 10.1523/JNEUROSCI.1392-11.2011; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Nakamura A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088628; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610, DOI 10.1152/jn.1999.82.3.1610; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ramsey R, 2013, J COGNITIVE NEUROSCI, V25, P670, DOI 10.1162/jocn_a_00345; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Russell M, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00104; Samson D, 2005, BRAIN, V128, P1102, DOI 10.1093/brain/awh464; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018; Shibata H, 2011, NEUROSCI LETT, V491, P187, DOI 10.1016/j.neulet.2011.01.033; Tversky B, 2009, COGNITION, V110, P124, DOI 10.1016/j.cognition.2008.10.008; van Honk J, 2002, BIOL PSYCHIAT, V52, P312, DOI 10.1016/S0006-3223(02)01346-X; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Vanderhasselt MA, 2013, BIOL PSYCHOL, V92, P433, DOI 10.1016/j.biopsycho.2012.03.005; Weisenbach SL, 2014, SOC COGN AFFECT NEUR, V9, P316, DOI 10.1093/scan/nss137; Weissman DH, 2008, NEUROIMAGE, V40, P955, DOI 10.1016/j.neuroimage.2007.12.021; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010; Zaki J, 2009, ANN NY ACAD SCI, V1167, P16, DOI 10.1111/j.1749-6632.2009.04601.x; Zar JH, 1999, BIOSTATISTICAL ANAL	54	34	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126448	10.1371/journal.pone.0126448	http://dx.doi.org/10.1371/journal.pone.0126448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951227	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400094
J	Gebert, D; Ketting, RF; Zischler, H; Rosenkranz, D				Gebert, Daniel; Ketting, Rene F.; Zischler, Hans; Rosenkranz, David			piRNAs from Pig Testis Provide Evidence for a Conserved Role of the Piwi Pathway in Post-Transcriptional Gene Regulation in Mammals	PLOS ONE			English	Article							NOVO DNA METHYLATION; TRANSFER-RNA; INTERACTING RNAS; PROTEIN; GERMLINE; DATABASE; CLEAVAGE; SIRNAS; IDENTIFICATION; TRANSLATION	Piwi-interacting (pi-) RNAs guide germline-expressed Piwi proteins in order to suppress the activity of transposable elements (TEs). But notably, the majority of pachytene piRNAs in mammalian testes is not related to TEs. This raises the question of whether the Piwi/piRNA pathway exerts functions beyond TE silencing. Although gene-derived piRNAs were described many times, a possible gene-regulatory function was doubted due to the absence of antisense piRNAs. Here we sequenced and analyzed piRNAs expressed in the adult testis of the pig, as this taxon possesses the full set of mammalian Piwi paralogs while their spermatozoa are marked by an extreme fitness due to selective breeding. We provide an exhaustive characterization of porcine piRNAs and genomic piRNA clusters. Moreover, we reveal that both sense and antisense piRNAs derive from protein-coding genes, while exhibiting features that clearly show that they originate from the Piwi/piRNA-mediated post-transcriptional silencing pathway, commonly referred to as ping-pong cycle. We further show that the majority of identified piRNA clusters in the porcine genome spans exonic sequences of protein-coding genes or pseudogenes, which reveals a mechanism by which primary antisense piRNAs directed against mRNA can be generated. Our data provide evidence that spliced mRNAs, derived from such loci, are not only targeted by piRNAs but are also subject to ping-pong cycle processing. Finally, we demonstrate that homologous genes are targeted and processed by piRNAs in pig, mouse and human. Altogether, this strongly suggests a conserved role for the mammalian Piwi/piRNA pathway in post-transcriptional regulation of protein-coding genes, which did not receive much attention so far.	[Gebert, Daniel; Zischler, Hans; Rosenkranz, David] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Ketting, Rene F.] Inst Mol Biol, Mainz, Germany	Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB)	Rosenkranz, D (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany.	rosenkranz@uni-mainz.de		Zischler, Hans/0000-0002-3440-8376; Gebert, Daniel/0000-0001-6159-3231; Ketting, Rene/0000-0001-6161-5621	MAIFOR (University Medical Center of the Johannes Gutenberg-University Mainz, Germany); International PhD Programme on the "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response" from the Institute of Molecular Biology gGmbH, (Mainz, Germany) by Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft DFG [247-594-1]; GeneRED (Gene Regulation in Evolution and Development)	MAIFOR (University Medical Center of the Johannes Gutenberg-University Mainz, Germany); International PhD Programme on the "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response" from the Institute of Molecular Biology gGmbH, (Mainz, Germany) by Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); GeneRED (Gene Regulation in Evolution and Development)	Funding: DR was supported by the research funding program MAIFOR (University Medical Center of the Johannes Gutenberg-University Mainz, Germany). DG holds a stipend from the International PhD Programme on the "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response" from the Institute of Molecular Biology gGmbH, (Mainz, Germany) funded by the Boehringer Ingelheim Foundation. This work was also supported by the Deutsche Forschungsgemeinschaft DFG (Grossgerateantrag GZ Inst. 247-594-1 FUGG Genome sequencer, Illumina) and is part of the research focus GeneRED (Gene Regulation in Evolution and Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewski C, 2014, METHODS MOL BIOL, V1173, P135, DOI 10.1007/978-1-4939-0931-5_12; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cora E, 2014, RNA, V20, P773, DOI 10.1261/rna.044701.114; Couvillion MT, 2010, GENE DEV, V24, P2742, DOI 10.1101/gad.1996210; Durdevic Z, 2013, CELL REP, V4, P931, DOI 10.1016/j.celrep.2013.07.046; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Farber C, 2000, GENOMICS, V65, P174, DOI 10.1006/geno.2000.6158; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Gerstl MP, 2013, J BIOTECHNOL, V166, P51, DOI 10.1016/j.jbiotec.2013.04.010; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kowalczykiewicz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113249; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034770; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Nagao A, 2010, RNA, V16, P2503, DOI 10.1261/rna.2270710; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Rosenkranz D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-5; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Vagin Vasily V, 2004, RNA Biol, V1, P54; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Xu MG, 2008, BIOL REPROD, V79, P51, DOI 10.1095/biolreprod.108.068072; Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.4, 10.1038/cr.2015.14]; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	68	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124860	10.1371/journal.pone.0124860	http://dx.doi.org/10.1371/journal.pone.0124860			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950437	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400021
J	Matsuba, R; Sakai, K; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Matsuba, Ren; Sakai, Kensuke; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENETIC ARCHITECTURE; RISK LOCI; METAANALYSIS; HOMEOSTASIS; VARIANTS; ALLELES; INSIGHT; GLUCOSE; KCNQ1	Aim We performed a replication study in a Japanese population to evaluate the association between type 2 diabetes and 7 susceptibility loci originally identified by European genome-wide association study (GWAS) in 2012: ZMIZ1, KLHDC5, TLE1, ANKRD55, CILP2, MC4R, and BCAR1. We also examined the association of 3 additional loci: CCND2 and GIPR, identified in sex-differentiated analyses, and LAMA1, which was shown to be associated with non-obese European type 2 diabetes. Methods We genotyped 6,972 Japanese participants (4,280 type 2 diabetes patients and 2,692 controls) for each of the 10 single nucleotide polymorphisms (SNPs): rs12571751 in ZMIZ1, rs10842994 near KLHDC5, rs2796441 near TLE1, rs459193 near ANKRD55, rs10401969 in CILP2, rs12970134 near MC4R, rs7202877 near BCAR1, rs11063069 near CCND2, rs8108269 near GIPR, and rs8090011 in LAMA1 using a multiplex polymerase chain reaction invader assay. The association of each SNP locus with the disease was evaluated using a logistic regression analysis. Results All SNPs examined in this study had the same direction of effect (odds ratio > 1.0, p = 9.77 x 10(-4), binomial test), as in the original reports. Among them, rs12571751 in ZMIZ1 was significantly associated with type 2 diabetes [p = 0.0041, odds ratio = 1.123, 95% confidence interval 1.037-1.215, adjusted for sex, age and body mass index (BMI)], but we did not observe significant association of the remaining 9 SNP loci with type 2 diabetes in the present Japanese population (p >= 0.005). A genetic risk score, constructed from the sum of risk alleles for the 7 SNP loci identified by un-stratified analyses in the European GWAS meta-analysis were associated with type 2 diabetes in the present Japanese population (p = 2.3 x 10(-4), adjusted for sex, age and BMI). Conclusions ZMIZ1 locus has a significant effect on conferring susceptibility to type 2 diabetes also in the Japanese population.	[Matsuba, Ren; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Sakai, Kensuke; Tanaka, Yasushi] St Marianna Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Iwata, Minoru] Toyama Univ, Community Med Support Unit, Fac Med, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan; [Maeda, Shiro] Univ Ryukyus, Dept Adv Genom & Lab Med, Grad Sch Med, Nishihara, Okinawa 90301, Japan	RIKEN; Saint Marianna University; University of Toyama; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University; University of the Ryukyus	Imamura, M (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan.	mimamura@src.riken.jp	Hirose, Hiroshi/F-8556-2014; Kashiwagi, Atsunori/H-8712-2019	Maegawa, Hiroshi/0000-0002-4611-8149; Watada, Hirotaka/0000-0001-5961-1816; Matsuba, Ren/0000-0001-5041-6344	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2012, HUM MOL GENET, V10, P1093; Imamura M, 2013, J CLIN ENDOCR METAB, V98, pE1667, DOI 10.1210/jc.2013-1642; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Omori S, 2009, DIABETOLOGIA, V52, P1554, DOI 10.1007/s00125-009-1397-5; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Sakai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076317; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126363	10.1371/journal.pone.0126363	http://dx.doi.org/10.1371/journal.pone.0126363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951451	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400085
J	Soderholm, M; Borne, Y; Hedblad, B; Persson, M; Engstrom, G				Soderholm, Martin; Borne, Yan; Hedblad, Bo; Persson, Margaretha; Engstrom, Gunnar			Red Cell Distribution Width in Relation to Incidence of Stroke and Carotid Atherosclerosis: A Population-Based Cohort Study	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; INTIMA-MEDIA THICKNESS; HEART-FAILURE; MALMO DIET; RISK; MORTALITY; CANCER; WOMEN; MEN; HYPERTENSION	Background Increased red cell distribution width (RDW) has been related to poor prognosis in patients with cardiovascular disease, and is a predictor of cardiovascular mortality in the general population. The purpose of the present study was to investigate if RDW is associated with increased incidence of stroke and its subtypes in individuals from the general population. Methods Red cell distribution width was measured in 26,879 participants (16,561 women and 10,318 men aged 45-73 years) without history of coronary events or stroke, from the population-based Malmo Diet and Cancer Study. Incidences of total stroke and stroke subtypes over a mean follow-up of 15.2 years were calculated in relation to sex-specific quartiles of RDW. The presence of carotid plaque and intima-media thickness, as assessed by ultrasound, was studied in relation to RDW in a randomly selected subcohort (n = 5,309). Results Incidences of total stroke (n = 1,869) and cerebral infarction (n = 1,544) were both increased in individuals with high RDW. Hazard ratios (HRs) in the highest compared to the lowest quartile were 1.31 for total stroke (95% confidence interval [CI]: 1.11-1.54, p for trend = 0.004) and 1.32 for cerebral infarction (95% CI: 1.10-1.58, p for trend = 0.004) after adjustment for stroke risk factors and hematological parameters. The adjusted HR for intracerebral hemorrhage (n = 230) was 1.44 (95% CI: 0.90-2.30) and the HR for subarachnoid hemorrhage (n = 75) was 0.94 (95% CI: 0.43-2.07), in the highest compared to the lowest quartile of RDW. Red cell distribution width was positively associated with intima-media thickness of the common carotid artery (p for trend = 0.011). Conclusions Red cell distribution width in the highest quartile was associated with increased incidence of total stroke and cerebral infarction. There was no significant association between RDW and incidence of intracerebral or subarachnoid hemorrhage.	[Soderholm, Martin; Borne, Yan; Hedblad, Bo; Persson, Margaretha; Engstrom, Gunnar] Lund Univ, Dept Clin Sci, Cardiovasc Epidemiol Res Grp, Malmo, Sweden	Lund University	Soderholm, M (corresponding author), Lund Univ, Dept Clin Sci, Cardiovasc Epidemiol Res Grp, Malmo, Sweden.	martin.soderholm@med.lu.se	b, y/AAG-3349-2019	Persson, Margaretha/0000-0001-8188-5792	Swedish Heart and Lung Foundation [20100244, 20130249]; Swedish Stroke Foundation; Ernhold Lundstrom Foundation; Swedish Research Council [2011-3891]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Stroke Foundation; Ernhold Lundstrom Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding: The authors were supported by grants from the Swedish Heart and Lung Foundation (grant number 20100244; 20130249), the Swedish Stroke Foundation, the Ernhold Lundstrom Foundation and the Swedish Research Council (grant number 2011-3891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsson Eryd S, 2013, J INTERN MED; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; [Anonymous], 2011, RDW SD RDW CV USING; Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Briggs C, 2009, INT J LAB HEMATOL, V31, P277, DOI 10.1111/j.1751-553X.2009.01160.x; Chae YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087813; Chatterjee S, 2006, REGRESSION ANAL EXAM, P233; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; D'Alessandro A, 2013, BLOOD TRANSFUS-ITALY, V11, P75, DOI 10.2450/2012.0164-11; DHERMY D, 1987, BIOCHIM BIOPHYS ACTA, V904, P201, DOI 10.1016/0005-2736(87)90369-5; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Engstrom G, 2014, J INTERN MED; Ericson U, 2010, J NUTR, V140, P1661, DOI 10.3945/jn.110.124313; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Kato H, 2005, FASEB J, V19, P2023, DOI 10.1096/fj.05-3820fje; Kaya A, 2013, CLIN APPL THROMB HEM; Kim J, 2012, THROMB HAEMOSTASIS, V108, P349, DOI 10.1160/TH12-03-0165; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Li C, 2009, EUR J CLIN NUTR, V63, P1448, DOI 10.1038/ejcn.2009.69; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Park HK, 2013, EXP THER MED, V5, P343, DOI 10.3892/etm.2012.790; Park TS, 2009, HAEMATOL-HEMATOL J, V94, P745, DOI 10.3324/haematol.2009.006965; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Remkova A, 2010, PHYSIOL RES, V59, P13, DOI 10.33549/physiolres.931525; Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; Sato S, 2006, STROKE, V37, P2488, DOI 10.1161/01.STR.0000242473.13884.8e; Soderholm M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-71; Sperrin M, 2013, STAT MED, V32, P99, DOI 10.1002/sim.5509; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Touboul PJ, 2005, STROKE, V36, P1741, DOI 10.1161/01.STR.0000174490.23495.57; Wen Y, 2010, EXP CLIN CARDIOL, V15, P37; WENDELHAG I, 1991, CLIN PHYSIOL, V11, P565, DOI 10.1111/j.1475-097X.1991.tb00676.x; Wirfalt E, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-3; Zia E, 2012, J INTERN MED, V272, P298, DOI 10.1111/j.1365-2796.2012.02526.x; Zoller B, 2014, THROMB RES, V133, P334, DOI 10.1016/j.thromres.2013.12.013; 1988, J CLIN EPIDEMIOL, V41, P105	46	72	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124957	10.1371/journal.pone.0124957	http://dx.doi.org/10.1371/journal.pone.0124957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950717	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400023
J	Abbott, KC; Karst, J; Biederman, LA; Borrett, SR; Hastings, A; Walsh, V; Bever, JD				Abbott, Karen C.; Karst, Justine; Biederman, Lori A.; Borrett, Stuart R.; Hastings, Alan; Walsh, Vonda; Bever, James D.			Spatial Heterogeneity in Soil Microbes Alters Outcomes of Plant Competition	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY STRUCTURE; DIVERSITY; PRODUCTIVITY; COEXISTENCE; POPULATION; SUCCESSION; CONTRIBUTE; DEPENDENCE; FEEDBACKS	Plant species vary greatly in their responsiveness to nutritional soil mutualists, such as mycorrhizal fungi and rhizobia, and this responsiveness is associated with a trade-off in allocation to root structures for resource uptake. As a result, the outcome of plant competition can change with the density of mutualists, with microbe-responsive plant species having high competitive ability when mutualists are abundant and non-responsive plants having high competitive ability with low densities of mutualists. When responsive plant species also allow mutualists to grow to greater densities, changes in mutualist density can generate a positive feedback, reinforcing an initial advantage to either plant type. We study a model of mutualist-mediated competition to understand outcomes of plant-plant interactions within a patchy environment. We find that a microbe-responsive plant can exclude a non-responsive plant from some initial conditions, but it must do so across the landscape including in the microbe- free areas where it is a poorer competitor. Otherwise, the non-responsive plant will persist in both mutualist-free and mutualist-rich regions. We apply our general findings to two different biological scenarios: invasion of a non-responsive plant into an established microbe- responsive native population, and successional replacement of non-responders by microbe-responsive species. We find that resistance to invasion is greatest when seed dispersal by the native plant is modest and dispersal by the invader is greater. Nonetheless, a native plant that relies on microbial mutualists for competitive dominance may be particularly vulnerable to invasion because any disturbance that temporarily reduces its density or that of the mutualist creates a window for a non-responsive invader to establish dominance. We further find that the positive feedbacks from associations with beneficial soil microbes create resistance to successional turnover. Our theoretical results constitute an important first step toward developing a general understanding of the interplay between mutualism and competition in patchy landscapes, and generate qualitative predictions that may be tested in future empirical studies.	[Abbott, Karen C.; Biederman, Lori A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Abbott, Karen C.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Karst, Justine] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Borrett, Stuart R.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Walsh, Vonda] Virginia Mil Inst, Dept Appl Math, Lexington, VA 24450 USA; [Bever, James D.] Indiana Univ, Dept Biol, Bloomington, IN USA	Iowa State University; Case Western Reserve University; University of Alberta; University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington	Abbott, KC (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	kcabbott@case.edu	Borrett, Stuart/E-6586-2010; Hastings, Alan/O-6864-2019	Borrett, Stuart/0000-0002-5759-3711; Hastings, Alan/0000-0002-0717-8026; Karst, Justine/0000-0003-0497-1552; Biederman, Lori/0000-0003-2171-7898; Abbott, Karen/0000-0001-5143-0690	National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]; University of Tennessee, Knoxville; James S. McDonnell Foundation Complex Systems Scholar grant; University of Alberta; NSF [DEB-1050237, DEB-1020944]; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award; University of Tennessee, Knoxville; James S. McDonnell Foundation Complex Systems Scholar grant; University of Alberta(University of Alberta); NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NIMBioS is sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award EF-0832858, with additional support from the University of Tennessee, Knoxville. KCA was supported by a James S. McDonnell Foundation Complex Systems Scholar grant, JDK was supported by an Izaak Walton Killam Memorial Fellowship from the University of Alberta, JDB was supported by NSF DEB-1050237, and SRB was supported by NSF DEB-1020944. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer JT, 2012, OECOLOGIA, V170, P1089, DOI 10.1007/s00442-012-2363-3; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Galvez L, 2001, PLANT SOIL, V228, P299, DOI 10.1023/A:1004810116854; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; JANOS DP, 1980, BIOTROPICA, V12, P56, DOI 10.2307/2388157; Kabir Z, 1997, PLANT SOIL, V192, P285, DOI 10.1023/A:1004205828485; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Koziol E, 2015, ECOLOGY IN PRESS; Lekberg Y, 2015, NEW PHYTOL, V205, P1399, DOI 10.1111/nph.13118; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Middleton EL, 2012, RESTOR ECOL, V20, P218, DOI 10.1111/j.1526-100X.2010.00752.x; Molofsky J, 2002, P ROY SOC B-BIOL SCI, V269, P2389, DOI 10.1098/rspb.2002.2164; Molofsky J, 2001, P ROY SOC B-BIOL SCI, V268, P273, DOI 10.1098/rspb.2000.1355; O'Connor PJ, 2002, NEW PHYTOL, V154, P209, DOI 10.1046/j.1469-8137.2002.00364.x; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Reinhart KO, 2012, ECOL LETT, V15, P689, DOI 10.1111/j.1461-0248.2012.01786.x; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Rodriguez-Echeverria S, 2009, BIOL INVASIONS, V11, P651, DOI 10.1007/s10530-008-9280-8; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; Seifert EK, 2009, ECOLOGY, V90, P1055, DOI 10.1890/08-0419.1; Souza-Alonso P, 2014, SOIL BIOL BIOCHEM, V79, P100, DOI 10.1016/j.soilbio.2014.09.008; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Stromberg MR., 2007, CALIFORNIA GRASSLAND; Umbanhowar J, 2005, ECOL LETT, V8, P247, DOI 10.1111/j.1461-0248.2004.00714.x; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2	38	22	22	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125788	10.1371/journal.pone.0125788	http://dx.doi.org/10.1371/journal.pone.0125788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946068	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700087
J	Fleischmann, J; Rocha, MA				Fleischmann, Jacob; Rocha, Miguel A.			Decrease in Ribosomal RNA in Candida albicans Induced by Serum Exposure	PLOS ONE			English	Article							HYPHAL FORMATION; POLYADENYLATION; DEGRADATION	Candida albicans is an important polymorphic human pathogen. It can switch from a unicellular yeast form to germinating hypha, which may play a role in making it the successful pathogen it is. This hyphal transformation can be triggered by various extracellular stimuli, the most potent one being serum from any source. We have previously reported that Candida albicans transiently polyadenylates portions of both the large and small subunits of ribosomal RNA, shortly after serum exposure. Northern blots at the same time suggested that serum might induce a decrease in total ribosomal RNA. We have carried out a number of experiments to carefully assess this possibility and now report that serum significantly reduces ribosomal RNA in Candida albicans. Fluorometric measurements, Northern blotting and quantitative RT-PCR, have all confirmed this decrease. Timed experiments show that serum induces this decrease rapidly, as it was seen in as early as five minutes. Cell mass is not decreased as total cellular protein content remains the same and metabolic activity does not appear to slow, as assessed by XTT assay, and by the observation that cells form hyphal structures robustly. Another hyphal inducer, N-acetylglucosamine, also caused RNA decrease, but to a lesser extent. We also observed it in non-germinating yeast, such as Candida glabrata. The reason for this decrease is unknown and overall our data suggests that decrease in rRNA does not play a causal role in hyphal transformation. Rapid and significant decrease in a molecule so central to the yeast's biology is of some importance, and further studies, such as its effect on protein metabolism, will be required to better understand its purpose.	[Fleischmann, Jacob] Greater Angeles VA Healthcare Syst, Dept Med, Los Angeles, CA 90073 USA; [Fleischmann, Jacob; Rocha, Miguel A.] Greater Angeles VA Healthcare Syst, Div Res, Los Angeles, CA USA; [Fleischmann, Jacob] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fleischmann, J (corresponding author), Greater Angeles VA Healthcare Syst, Dept Med, Los Angeles, CA 90073 USA.	jfl@ucla.edu			Elias; Genevieve; Georgianna Atol Charitable Trust	Elias; Genevieve; Georgianna Atol Charitable Trust	This work was financially supported by the Elias, Genevieve and Georgianna Atol Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Fleischmann J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-17; Fleischmann J, 2001, GENE, V265, P71, DOI 10.1016/S0378-1119(01)00362-6; Fleischmann J, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.th09b, DOI 10.5061/DRYAD.TH09B]; Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014; Kim D, 2002, YEAST, V19, P957, DOI 10.1002/yea.891; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; Messer SA, 2006, J CLIN MICROBIOL, V44, P1782, DOI 10.1128/JCM.44.5.1782-1787.2006; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124430	10.1371/journal.pone.0124430	http://dx.doi.org/10.1371/journal.pone.0124430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946110	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700041
J	Liu, ZH; Liu, CS; Guo, W; Li, SY; Bai, O				Liu, Zhihe; Liu, Chunshui; Guo, Wei; Li, Siyun; Bai, Ou			Clinical Analysis of 152 Cases of Multiple Primary Malignant Tumors in 15,398 Patients with Malignant Tumors	PLOS ONE			English	Article							BREAST-CANCER; COLORECTAL-CANCER; RISK-FACTORS; POPULATION; LEUKEMIA; PROGRAM	Objectives In this study, the etiology, clinical characteristics, and prognosis of multiple primary malignant tumors (MPMTs) were investigated. Furthermore, we analyzed the treatment factors associated with MPMTs. Methods From 15,398 patients with malignant tumors presenting to The First Hospital of Jilin University, China, between January 2010 and December 2013, we identified and analyzed patients with MPMTs. Data were obtained retrospectively from the hospital database. Results The prevalence of MPMTs in this study was 0.99% (152/15398): 51 cases were synchronous MPMTs, and 101 cases were metachronous MPMTs. The mean time between the first and second primary cancer was 43.1 months. In this population, MPMTs were observed more frequently in patients with head and neck tumors (5.65%) and urinary tumors (4.19%); the prevalence of MPMTs in these patients was over 4-fold greater than the prevalence of MPMTs in all patients (0.99%). There were no cases of MPMTs in 132 cases of nervous system tumors and 404 cases of multiple myeloma. Nearly 50% (45.4%) of patients with MPMTs did not receive chemotherapy or radiotherapy before the second primary cancer was diagnosed. Eighty-five patients with MPMTs were followed for more than 2 years, and the 2-year cumulative survival rate was 40.8%. Conclusions In this study, the prevalence of MPMTs was 0.99% (152/15398), which is consistent with the Chinese literature. Patients with head and neck tumors or urinary tumors are at greater risk of developing MPMTs. In addition to radiotherapy or chemotherapy, this study suggests that other factors may contribute to MPMTs.	[Liu, Zhihe; Liu, Chunshui; Guo, Wei; Bai, Ou] Jilin Univ, Hosp 1, Dept Oncol, Changchun 130023, Peoples R China; [Li, Siyun] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China	Jilin University; Jilin University	Bai, O (corresponding author), Jilin Univ, Hosp 1, Dept Oncol, Changchun 130023, Peoples R China.	oubai16@163.com	liu, zhihe/J-5319-2012	liu, zhihe/0000-0002-9264-094X; Li, Siyun/0000-0001-5527-9473	Science and Technology Department of Jilin Province [20130206024SF]	Science and Technology Department of Jilin Province	The authors received the following support: "The standard therapy and management of malignant lymphoma" (20130206024SF) from Science and Technology Department of Jilin Province.	Babacan NA, 2012, J BUON, V17, P770; CURTIS RE, 1990, CANCER RES, V50, P2741; Frodin JE, 1997, ACTA ONCOL, V36, P465; Gan SJ, 2013, CANCER-AM CANCER SOC, V119, P2593, DOI 10.1002/cncr.28107; HAAS JF, 1987, BRIT J CANCER, V55, P213, DOI 10.1038/bjc.1987.40; Harvey E B, 1985, Natl Cancer Inst Monogr, V68, P99; Lin BY, 1990, J PRACTITAL SURG, V7, P371; Liu F, 1979, CHINESE J ONCOL, V1, P113; MACDONALD EJ, 1960, ACTA UNION INT CONTR, V16, P1702; Morita M, 2003, J SURG ONCOL, V83, P216, DOI 10.1002/jso.10276; MURAKAMI R, 1987, JPN J CLIN ONCOL, V17, P293; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; NEUGUT AI, 1991, CANCER, V68, P2069, DOI 10.1002/1097-0142(19911101)68:9<2069::AID-CNCR2820680938>3.0.CO;2-M; Ries L MD, 2008, SEER CANC STAT REV 1; SCHATZKIN A, 1988, CANCER, V62, P1451, DOI 10.1002/1097-0142(19881001)62:7<1451::AID-CNCR2820620734>3.0.CO;2-Q; Warren S., 1932, AM J CANCER, V16, P1358; WU AH, 1987, BRIT J CANCER, V55, P687, DOI 10.1038/bjc.1987.140; Wu KN, 1990, J PRACT ONCOL, V4, P44; Zhu YR, 2006, J MED THEORY PRACTIC, V19, P1249	19	36	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125754	10.1371/journal.pone.0125754	http://dx.doi.org/10.1371/journal.pone.0125754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945938	gold, Green Submitted, Green Published			2022-12-26	WOS:000354049700085
J	Rosini, R; Campisi, E; De Chiara, M; Tettelin, H; Rinaudo, D; Toniolo, C; Metruccio, M; Guidotti, S; Sorensen, UBS; Kilian, M; Consortium, D; Ramirez, M; Janulczyk, R; Donati, C; Grandi, G; Margarit, I				Rosini, Roberto; Campisi, Edmondo; De Chiara, Matteo; Tettelin, Herve; Rinaudo, Daniela; Toniolo, Chiara; Metruccio, Matteo; Guidotti, Silvia; Sorensen, Uffe B. Skov; Kilian, Mogens; Consortium, Devani; Ramirez, Mario; Janulczyk, Robert; Donati, Claudio; Grandi, Guido; Margarit, Immaculada			Genomic Analysis Reveals the Molecular Basis for Capsule Loss in the Group B Streptococcus Population	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; POLYSACCHARIDE BIOSYNTHESIS; ANTIMICROBIAL RESISTANCE; SURFACE-PROTEINS; PREGNANT-WOMEN; AGALACTIAE; BOVINE; IDENTIFICATION; SEROTYPE; GENE	The human and bovine bacterial pathogen Streptococcus agalactiae (Group B Streptococcus, GBS) expresses a thick polysaccharide capsule that constitutes a major virulence factor and vaccine target. GBS can be classified into ten distinct serotypes differing in the chemical composition of their capsular polysaccharide. However, non-typeable strains that do not react with anti-capsular sera are frequently isolated from colonized and infected humans and cattle. To gain a comprehensive insight into the molecular basis for the loss of capsule expression in GBS, a collection of well-characterized non-typeable strains was investigated by genome sequencing. Genome based phylogenetic analysis extended to a wide population of sequenced strains confirmed the recently observed high clonality among GBS lineages mainly containing human strains, and revealed a much higher degree of diversity in the bovine population. Remarkably, non-typeable strains were equally distributed in all lineages. A number of distinct mutations in the cps operon were identified that were apparently responsible for inactivation of capsule synthesis. The most frequent genetic alterations were point mutations leading to stop codons in the cps genes, and the main target was found to be cpsE encoding the portal glycosyl trasferase of capsule biosynthesis. Complementation of strains carrying missense mutations in cpsE with a wild-type gene restored capsule expression allowing the identification of amino acid residues essential for enzyme activity.	[Rosini, Roberto; Campisi, Edmondo; De Chiara, Matteo; Rinaudo, Daniela; Toniolo, Chiara; Metruccio, Matteo; Guidotti, Silvia; Janulczyk, Robert; Grandi, Guido; Margarit, Immaculada] Novartis Vaccines & Diagnost Srl, Siena, Italy; [Tettelin, Herve] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Sorensen, Uffe B. Skov; Kilian, Mogens] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ramirez, Mario] Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal; [Donati, Claudio] Fdn Edmund Mach, Dept Computat Biol, Res & Innovat Ctr, San Michele All Adige, Italy	Novartis; University System of Maryland; University of Maryland Baltimore; Aarhus University; Universidade de Lisboa; Fondazione Edmund Mach	Margarit, I (corresponding author), Novartis Vaccines & Diagnost Srl, Siena, Italy.	immaculada.margarit_y_ros@novartis.com	Ramirez, Mario/B-4993-2008; Toniolo, Chiara/ABH-6697-2020; Campisi, Edmondo/AIE-8826-2022; Metruccio, Matteo/I-1467-2019; Baldassarri, Lucilla/B-1042-2013; Donati, Claudio/J-5180-2012; Donati, Claudio/AAF-1246-2020; Creti, Roberta/C-8813-2016; Berardi, Alberto/A-5889-2015	Ramirez, Mario/0000-0002-4084-6233; Toniolo, Chiara/0000-0002-2167-2936; Campisi, Edmondo/0000-0002-2250-3798; Metruccio, Matteo/0000-0002-2456-2652; Creti, Roberta/0000-0003-4290-9039; Sorensen, Uffe B. Skov/0000-0002-6777-054X; Grandi, Guido/0000-0001-9724-2185; Petrunov, Bogdan/0000-0001-8435-6175; Berardi, Alberto/0000-0002-3534-7499; De Chiara, Matteo/0000-0003-1014-350X; Melin, Pierrette/0000-0002-2159-5774; Donati, Claudio/0000-0001-8688-1651	Novartis Vaccines	Novartis Vaccines	The authors confirm that the Novartis Vaccines funder provided support in the form of salaries for authors RR DR SG RJ GG IM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; BAKER CJ, 1988, NEW ENGL J MED, V319, P1180, DOI 10.1056/NEJM198811033191802; Bergseng H, 2008, EUR J CLIN MICROBIOL, V27, P1193, DOI 10.1007/s10096-008-0565-8; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Broker G, 2004, INT J MED MICROBIOL, V294, P169, DOI 10.1016/j.ijmm.2004.06.018; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Creti R, 2012, EUR J CLIN MICROBIOL, V31, P233, DOI 10.1007/s10096-011-1298-7; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Dogan B, 2005, J CLIN MICROBIOL, V43, P5899, DOI 10.1128/JCM.43.12.5899-5906.2005; Flechard M, 2014, MICROBIOL-SGM, V160, P1298, DOI 10.1099/mic.0.077628-0; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gherardi G, 2007, J CLIN MICROBIOL, V45, P2909, DOI 10.1128/JCM.00999-07; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Kong F, 2008, J CLIN MICROBIOL, V46, P2745, DOI 10.1128/JCM.00189-08; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Martinez G, 2000, J CLIN MICROBIOL, V38, P71; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Martins ER, 2013, CLIN VACCINE IMMUNOL, V20, P313, DOI 10.1128/CVI.00529-12; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Rainard P, 2003, VET RES, V34, P647, DOI 10.1051/vetres:2003025; Ramaswamy SV, 2006, J MED MICROBIOL, V55, P775, DOI 10.1099/jmm.0.46253-0; Rato MG, 2013, VET MICROBIOL, V161, P286, DOI 10.1016/j.vetmic.2012.07.043; Richards VP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-920; Rodriguez-Granger J, 2012, EUR J CLIN MICROBIOL, V31, P2097, DOI 10.1007/s10096-012-1559-0; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; Sellin M, 2000, J CLIN MICROBIOL, V38, P3420, DOI 10.1128/JCM.38.9.3420-3428.2000; Sorensen UBS, 2010, MBIO, V1, DOI 10.1128/mBio.00178-10; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tazi A, 2011, CLIN MICROBIOL INFEC, V17, P1587, DOI 10.1111/j.1469-0691.2011.03628.x; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	47	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125985	10.1371/journal.pone.0125985	http://dx.doi.org/10.1371/journal.pone.0125985			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946017	Green Published, gold			2022-12-26	WOS:000354049700099
J	Fan, MY; Su, M; Tan, YY; Liu, QM; Ren, YJ; Li, LM; Lv, J				Fan, Mengyu; Su, Meng; Tan, Yayun; Liu, Qingmin; Ren, Yanjun; Li, Liming; Lv, Jun			Gender, Age, and Education Level Modify the Association between Body Mass Index and Physical Activity: A Cross-Sectional Study in Hangzhou, China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; WEIGHT-GAIN; TIME SPENT; OBESITY; ADULTS; ACCELEROMETER; RELIABILITY; PREVALENCE; SEDENTARY; MORTALITY	Introduction Numerous studies have reported a strong inverse association between BMI and physical activity in western populations. Recently, the association between BMI and physical activity has been considered bidirectional. This study aimed to examine the associations of body mass index (BMI) with physical activity and sedentary behavior and to explore whether those associations were modified by socio-demographic characteristics. Materials and Methods We conducted a multistage random sampling survey in three districts of Hangzhou, China, in 2012. The International Physical Activity Questionnaire long form was used to collect data regarding physical activity and sedentary behavior. A multilevel mixed-effects regression model was used to assess the associations of BMI with physical activity and sedentary behavior. Results A total of 1362 eligible people (624 men and 738 women, ages 23-59 years) completed the survey. People who are young or middle-aged and have the highest education level are the most inactive. Significant differences in the associations between physical activity and BMI across socio-demographic groups were identified (sex* BMI, P= 0.018; age* BMI, P< 0.001; education level* BMI, P= 0.030). Women or individuals older than 50 had a higher level of physical activity with increasing BMI. There was no statistically significant association between BMI and sedentary behavior (P= 0.450). Conclusions The associations between BMI and physical activity were modified by sex, age, and education level in Hangzhou, China.	[Fan, Mengyu; Su, Meng; Tan, Yayun; Li, Liming; Lv, Jun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Su, Meng] Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Su, Meng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Qingmin; Ren, Yanjun] Hangzhou Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control & Prevent, Hangzhou 310021, Zhejiang, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lv, J (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	lvjun@bjmu.edu.cn	刘庆敏, Liu qingmin/AAQ-9255-2020; Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870	National Natural Science Foundation of China [81072373]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China No. 81072373 (http://www.nsfc.gov.cn/) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2002, PREV MED, V35, P390, DOI 10.1006/pmed.2002.1079; Bak H, 2004, INT J OBESITY, V28, P99, DOI 10.1038/sj.ijo.0802525; Besson H, 2009, INT J OBESITY, V33, P497, DOI 10.1038/ijo.2009.25; Buchowski MS, 1999, OBES RES, V7, P23, DOI 10.1002/j.1550-8528.1999.tb00387.x; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Golubic R, 2013, INT J OBESITY, V37, P404, DOI 10.1038/ijo.2012.58; International Physical Activity Questionnaire(IPAQ), 2010, GUID DAT PROC AN INT; IPAQ Core Group, 2011, INT PHYS ACT QUEST; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Liang WC, 1999, AM J PREV MED, V17, P8, DOI 10.1016/S0749-3797(99)00040-9; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Lv SR, 2012, J PREVENTIVE MED, V23, P13; Macfarlane D, 2011, PUBLIC HEALTH NUTR, V14, P443, DOI 10.1017/S1368980010002806; May AM, 2010, AM J CLIN NUTR, V92, P491, DOI 10.3945/ajcn.2010.29404; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Nakamura K, 1999, J BIOSOC SCI, V31, P555, DOI 10.1017/S0021932099005556; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Peters TM, 2010, AM J PREV MED, V38, P583, DOI 10.1016/j.amepre.2010.02.012; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Ping Z, 2010, J CAPITAL I PHYS ED, V22, P89; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Su M, 2014, PREV MED, V66, P60, DOI 10.1016/j.ypmed.2014.06.001; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Tiggemann M., 2004, BODY IMAGE, V1, DOI https://doi.org/10.1016/S1740-1445(03)00002-0; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; von Lengerke T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-342; Xie YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107233; Yu J, 2004, J BEIJING SPORT U, V27, P1469; Yu J, 2004, J BEIJING SPORT U, V27, P1475; Zhao QL, 2008, J NURSING SCI, V23, P68; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	38	19	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125534	10.1371/journal.pone.0125534	http://dx.doi.org/10.1371/journal.pone.0125534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PT	25942446	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943400043
J	Zhou, WC; Tang, ZX; Hou, J; Hu, N; Yin, TM				Zhou, Wencai; Tang, Zaixiang; Hou, Jing; Hu, Nan; Yin, Tongming			Genetic Map Construction and Detection of Genetic Loci Underlying Segregation Distortion in an Intraspecific Cross of Populus deltoides	PLOS ONE			English	Article							TRANSMISSION RATIO DISTORTION; MARKER-ASSISTED SELECTION; LINKAGE MAPS; INBREEDING DEPRESSION; POSTZYGOTIC ISOLATION; INTERSPECIFIC CROSS; MOLECULAR-GENETICS; EUCALYPTUS-GRANDIS; MIMULUS-GUTTATUS; SEX-CHROMOSOME	Based on a two-way pseudo-testcross strategy, high density and complete coverage linkage maps were constructed for the maternal and paternal parents of an intraspecific F2 pedigree of Populus deltoides. A total of 1,107 testcross markers were obtained, and the mapping population consisted of 376 progeny. Among these markers, 597 were from the mother, and were assigned into 19 linkage groups, spanning a total genetic distance of 1,940.3 cM. The remaining 519 markers were from the father, and were also were mapped into 19 linkage groups, covering 2,496.3 cM. The genome coverage of both maps was estimated as greater than 99.9% at 20 cM per marker, and the numbers of linkage groups of both maps were in accordance with the 19 haploid chromosomes in Populus. Marker segregation distortion was observed in large contiguous blocks on some of the linkage groups. Subsequently, we mapped the segregation distortion loci in this mapping pedigree. Altogether, eight segregation distortion loci with significant logarithm of odds supports were detected. Segregation distortion indicated the uneven transmission of the alternate alleles from the mapping parents. The corresponding genome regions might contain deleterious genes or be associated with hybridization incompatibility. In addition to the detection of segregation distortion loci, the established genetic maps will serve as a basic resource for mapping genetic loci controlling traits of interest in future studies.	[Zhou, Wencai; Hou, Jing; Hu, Nan; Yin, Tongming] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Coll Forestry, Nanjing 210037, Jiangsu, Peoples R China; [Tang, Zaixiang] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Suzhou 215123, Peoples R China; [Zhou, Wencai] Jiangxi Acad Forestry, Nanchang 330032, Peoples R China	Nanjing Forestry University; Soochow University - China	Yin, TM (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Coll Forestry, Nanjing 210037, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			Key Forestry Public Welfare Project [201304102]; National Basic Research Project [2012CB114505]; Natural Science Foundation of China [31125008]	Key Forestry Public Welfare Project; National Basic Research Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Forestry Public Welfare Project (201304102, URL: http://www.forestry.gov.cn/), the National Basic Research Project (2012CB114505, URL: http://www.most.gov.cn/), and the Natural Science Foundation of China (31125008, URL: http://www.nsfc.gov.cn/). It was also enabled by the Program for Innovative Research Team of the Educational Department of China (URL: http://www.moe.gov.cn/), the Program for Innovative Research Team for Universities of Jiangsu Province (URL: http://www.jstd.gov.cn/), and the Priority Academic Program Development (PAPD) program of Jiangsu Province (URL: http://www.ec.js.edu.cn/). TY received the fundings, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2014, SCIENCE, V346, P646, DOI 10.1126/science.1257225; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Ballerini ES, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-91; BERRY ST, 1995, THEOR APPL GENET, V91, P195, DOI 10.1007/BF00220877; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P551, DOI 10.1007/BF00222447; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; Cervera MT, 2001, GENETICS, V158, P787; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Cheng R, 1998, THEOR APPL GENET, V97, P293, DOI 10.1007/s001220050898; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; DEVICENTE MC, 1991, THEOR APPL GENET, V83, P173, DOI 10.1007/BF00226248; ECHT CS, 1994, GENOME, V37, P61, DOI 10.1139/g94-008; Farmer R. E. Jr., 1964, Silvae Genetica, V13, P116; Fisher RA, 1958, GENETICAL THEOREM NA; Fishman L, 2001, GENETICS, V159, P1701; FU YB, 1994, THEOR APPL GENET, V88, P925, DOI 10.1007/BF00220798; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; GIBSON S, 1993, TRENDS BIOTECHNOL, V11, P306, DOI 10.1016/0167-7799(93)90019-6; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hall MC, 2005, GENETICS, V170, P375, DOI 10.1534/genetics.104.038653; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HARTL DL, 1974, GENETICS, V76, P477; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Hu Zhiqiu, 2009, Int J Plant Genomics, V2009, P141234, DOI 10.1155/2009/141234; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jiang CX, 2000, EVOLUTION, V54, P798, DOI 10.1111/j.0014-3820.2000.tb00081.x; Kim SC, 1999, GENETICS, V153, P965; Kuang H, 1999, THEOR APPL GENET, V98, P697, DOI 10.1007/s001220051123; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANGE K, 1982, AM J HUM GENET, V34, P842; Lashermes P, 2001, GENOME, V44, P589, DOI 10.1139/gen-44-4-589; Li SX, 2012, TREE GENET GENOMES, V8, P1371, DOI 10.1007/s11295-012-0524-5; Li SX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-37; LIU Z, 1993, J HERED, V84, P419, DOI 10.1093/oxfordjournals.jhered.a111365; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Luo L, 2005, HEREDITY, V94, P347, DOI 10.1038/sj.hdy.6800615; Luo L, 2003, HEREDITY, V90, P459, DOI 10.1038/sj.hdy.6800264; Maliepaard C, 1997, GENET RES, V70, P237, DOI 10.1017/S0016672397003005; MITCHELLOLDS T, 1995, GENETICS, V140, P1105; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Moyle LC, 2006, MOL BIOL EVOL, V23, P973, DOI 10.1093/molbev/msj112; Muchero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054468; Myburg AA, 2004, GENETICS, V166, P1405, DOI 10.1534/genetics.166.3.1405; Orr HA, 2001, EVOLUTION, V55, P1085; Pakull B, 2011, CAN J FOREST RES, V41, P245, DOI 10.1139/X10-206; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Paolucci I, 2010, TREE GENET GENOMES, V6, P863, DOI 10.1007/s11295-010-0297-7; Ranjan P, 2010, BIOENERG RES, V3, P172, DOI 10.1007/s12155-009-9060-z; Remington DL, 1999, THEOR APPL GENET, V98, P1279, DOI 10.1007/s001220051194; Rieseberg LH, 2000, PLANT MOL BIOL, V42, P205, DOI 10.1023/A:1006340407546; RITTER E, 1990, GENETICS, V125, P645; SANO Y, 1990, GENETICS, V125, P183; TANKSLEY SD, 1992, GENETICS, V132, P1141; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Vogl C, 2000, GENETICS, V155, P1439; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang YX, 2010, EUPHYTICA, V173, P193, DOI 10.1007/s10681-009-0085-3; Woolbright SA, 2008, HEREDITY, V100, P59, DOI 10.1038/sj.hdy.6801063; Wu RL, 2000, THEOR APPL GENET, V100, P1249, DOI 10.1007/s001220051431; Xu SZ, 2008, GENETICS, V180, P2201, DOI 10.1534/genetics.108.090688; Yin TM, 2009, NEW PHYTOL, V181, P498, DOI 10.1111/j.1469-8137.2008.02663.x; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin TM, 2001, GENOME, V44, P602, DOI 10.1139/gen-44-4-602; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zhang B, 2009, TREE GENET GENOMES, V5, P539, DOI 10.1007/s11295-009-0207-z; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7	73	17	19	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126077	10.1371/journal.pone.0126077	http://dx.doi.org/10.1371/journal.pone.0126077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942445	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400060
J	Qu, X; Ding, LF; Qin, ZQ; Wu, JG; Pan, ZS				Qu, Xiao; Ding, Longfei; Qin, Zhenqiao; Wu, Jianguo; Pan, Zishu			Additional Evidence That the Polymerase Subunits Contribute to the Viral Replication and the Virulence of H5N1 Avian Influenza Virus Isolates in Mice	PLOS ONE			English	Article							A VIRUS; HOST-RANGE; PB2 PROTEIN; GENES CONTRIBUTE; MOLECULAR-BASIS; PANDEMIC H1N1; AMINO-ACID; TRANSMISSION; DETERMINANT; MOUSE	Genetically similar H5N1 viruses circulating in the avian reservoir exhibit different levels of pathogenicity in mice. In this study, we characterized two highly pathogenic H5N1 avian isolates-A/Hunan/316/2005 (HN05), which is highly pathogenic in mice, and A/Hubei/489/2004 (HB04), which is nonpathogenic. In mammalian cells, HN05 replicates more efficiently than HB04, although both viruses have similar growth kinetics in avian cells. We used reverse genetics to generate recombinant H5N1 strains containing genes from HN05 and HB04 and examined their virulence. HN05 genes encoding the polymerase complex determine pathogenicity and viral replication ability both in vitro and in vivo. The PB2 subunit plays an important role in enhancing viral replication, and the PB1 and PA subunits contribute mainly to pathogenicity in mice. These results can be used to elucidate host-range expansion and the molecular basis of the high virulence of H5N1 viruses in mammalian species.	[Qu, Xiao; Ding, Longfei; Qin, Zhenqiao; Wu, Jianguo; Pan, Zishu] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Pan, ZS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zspan@whu.edu.cn		longfei, Ding/0000-0002-7660-0876; Wu, Jianguo/0000-0002-8326-2895	National Basic Research Program of China (973 Program) [2013CB911100, 2010CB534003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (2013CB911100 and 2010CB534003).	Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Czudai- Matwich V, 2014, J VIROL; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Fornek JL, 2009, J VIROL, V83, P11102, DOI 10.1128/JVI.00994-09; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hu J, 2013, J VIROL, V87, P2660, DOI 10.1128/JVI.02891-12; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jin H, 2007, VACCINE, V25, P8664, DOI 10.1016/j.vaccine.2007.10.032; Jin SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03799; Kashiwagi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114502; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; OIE (World Organization for Animal Health), 2014, MAN DIAGN TESTS VACC; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Schat KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030960; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093366; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; Uchida Y, 2012, J VIROL, V86, P2686, DOI 10.1128/JVI.06374-11; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wilker PR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3636; Xu C, 2012, J GEN VIROL, V93, P531, DOI 10.1099/vir.0.036434-0; Yao YX, 2001, J VIROL, V75, P5410, DOI 10.1128/JVI.75.11.5410-5415.2001; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	65	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124422	10.1371/journal.pone.0124422	http://dx.doi.org/10.1371/journal.pone.0124422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938456	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000026
J	Reuven, N; Adler, J; Porat, Z; Polonio-Vallon, T; Hofmann, TG; Shaul, Y				Reuven, Nina; Adler, Julia; Porat, Ziv; Polonio-Vallon, Tilman; Hofmann, Thomas G.; Shaul, Yosef			The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC RESPONSE; REGULATES P73; TISSUE-GROWTH; P53 ACTIVITY; DEGRADATION; PATHWAY; PHOSPHORYLATION; PROTEIN-KINASE-2; PML; ATM	The non-receptor tyrosine kinase c-Abl is activated in response to DNA damage and induces p73-dependent apoptosis. Here, we investigated c-Abl regulation of the homeodomain-interacting protein kinase 2 (HIPK2), an important regulator of p53-dependent apoptosis. c-Abl phosphorylated HIPK2 at several sites, and phosphorylation by c-Abl protected HIPK2 from degradation mediated by the ubiquitin E3 ligase Siah-1. c-Abl and HIPK2 synergized in activating p53 on apoptotic promoters in a reporter assay, and c-Abl was required for endogenous HIPK2 accumulation and phosphorylation of p53 at Ser(46) in response to DNA damage by gamma-and UV radiation. Accumulation of HIPK2 in nuclear speckles and association with promyelocytic leukemia protein (PML) in response to DNA damage were also dependent on c-Abl activity. At high cell density, the Hippo pathway inhibits DNA damage-induced c-Abl activation. Under this condition, DNA damage-induced HIPK2 accumulation, phosphorylation of p53 at Ser(46), and apoptosis were attenuated. These data demonstrate a new mechanism for the induction of DNA damage-induced apoptosis by c-Abl and illustrate network interactions between serine/threonine and tyrosine kinases that dictate cell fate.	[Reuven, Nina; Adler, Julia; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Porat, Ziv] Weizmann Inst Sci, Biol Serv Unit, IL-76100 Rehovot, Israel; [Polonio-Vallon, Tilman; Hofmann, Thomas G.] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum DKFZ, Cell & Tumor Biol Program, Cellular Senescence Grp, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ)	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Porat, Ziv/K-1672-2012; Reuven, Nina/AAM-8711-2020	Porat, Ziv/0000-0003-3059-181X; Reuven, Nina/0000-0003-1569-3818	Israel Science Foundation [551/11]; Israel Cancer Research Fund; Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST); Minerva Foundation; Federal German Ministry for Education and Research; Deutsche Forschungsgemeinschaft (DFG) [SFB 1036]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Israel Science Foundation (Grant 551/11), the Israel Cancer Research Fund, the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science and Technology (MOST), and the Minerva Foundation with funding from the Federal German Ministry for Education and Research. This work was also supported by the SFB 1036 from the Deutsche Forschungsgemeinschaft (DFG) (to T.G.H.).	Agami R, 1999, NATURE, V399, P809; Bar J, 2004, ONCOGENE, V23, P2128, DOI 10.1038/sj.onc.1207325; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chen J, 2012, CURR BIOL, V22, P1582, DOI 10.1016/j.cub.2012.06.074; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Gong JG, 1999, NATURE, V399, P806; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, J BIOL CHEM, V283, P27462, DOI 10.1074/jbc.M803941200; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Mancini F, 2009, EMBO J, V28, P1926, DOI 10.1038/emboj.2009.154; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Moller A, 2003, CANCER RES, V63, P4310; Okada N, 2011, J CELL SCI, V124, P57, DOI 10.1242/jcs.072918; Ortyn WE, 2007, CYTOM PART A, V71A, P215, DOI 10.1002/cyto.a.20370; Poon CLC, 2012, CURR BIOL, V22, P1587, DOI 10.1016/j.cub.2012.06.075; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Raina D, 2008, CANCER BIOL THER, V7, P1959, DOI 10.4161/cbt.7.12.6956; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	37	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16478	16488		10.1074/jbc.M114.628982	http://dx.doi.org/10.1074/jbc.M114.628982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25944899	Green Published, hybrid			2022-12-26	WOS:000357572800002
J	Fonseca, BD; Zakaria, C; Jia, JJ; Graber, TE; Svitkin, Y; Tahmasebi, S; Healy, D; Hoang, HD; Jensen, JM; Diao, IT; Lussier, A; Dajadian, C; Padmanabhan, N; Wang, W; Matta-Camacho, E; Hearnden, J; Smith, EM; Tsukumo, Y; Yanagiya, A; Morita, M; Petroulakis, E; Gonzalez, JL; Hernandez, G; Alain, T; Damgaard, CK				Fonseca, Bruno D.; Zakaria, Chadi; Jia, Jian-Jun; Graber, Tyson E.; Svitkin, Yuri; Tahmasebi, Soroush; Healy, Danielle; Hoang, Huy-Dung; Jensen, Jacob M.; Diao, Ilo T.; Lussier, Alexandre; Dajadian, Christopher; Padmanabhan, Niranjan; Wang, Walter; Matta-Camacho, Edna; Hearnden, Jaclyn; Smith, Ewan M.; Tsukumo, Yoshinori; Yanagiya, Akiko; Morita, Masahiro; Petroulakis, Emmanuel; Gonzalez, Jose L.; Hernandez, Greco; Alain, Tommy; Damgaard, Christian K.			La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; mammalian target of rapamycin (mTOR); protein synthesis; repressor protein; translation; 5'-terminal oligopyrimidine (5'TOP) motif; La-related protein 1 (LARP1); TOP mRNA translation; mTOR complex 1 (mTORC1); ribosome biogenesis	SENSITIVE PHOSPHOPROTEOME REVEALS; NUTRIENT-SENSING MECHANISMS; RICH AKT SUBSTRATE; 40 KDA PRAS40; MAMMALIAN TARGET; BINDING-PROTEIN; PYRIMIDINE SYNTHESIS; S6 KINASE; 5 UTR; RAPAMYCIN	Background: mTORC1 plays an important role in the regulation of TOP mRNA translation. Results: LARP1 is a target of mTORC1 that associates with TOP mRNAs via their 5TOP motif to repress their translation. Conclusion: LARP1 represses TOP mRNA translation downstream of mTORC1. Significance: We elucidate an important novel signaling pathway downstream of mTORC1 that controls the production of ribosomes and translation factors in eukaryotic cells. The mammalian target of rapamycin complex 1 (mTORC1) is a critical regulator of protein synthesis. The best studied targets of mTORC1 in translation are the eukaryotic initiation factor-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). In this study, we identify the La-related protein 1 (LARP1) as a key novel target of mTORC1 with a fundamental role in terminal oligopyrimidine (TOP) mRNA translation. Recent genome-wide studies indicate that TOP and TOP-like mRNAs compose a large portion of the mTORC1 translatome, but the mechanism by which mTORC1 controls TOP mRNA translation is incompletely understood. Here, we report that LARP1 functions as a key repressor of TOP mRNA translation downstream of mTORC1. Our data show the following: (i) LARP1 associates with mTORC1 via RAPTOR; (ii) LARP1 interacts with TOP mRNAs in an mTORC1-dependent manner; (iii) LARP1 binds the 5TOP motif to repress TOP mRNA translation; and (iv) LARP1 competes with the eukaryotic initiation factor (eIF) 4G for TOP mRNA binding. Importantly, from a drug resistance standpoint, our data also show that reducing LARP1 protein levels by RNA interference attenuates the inhibitory effect of rapamycin, Torin1, and amino acid deprivation on TOP mRNA translation. Collectively, our findings demonstrate that LARP1 functions as an important repressor of TOP mRNA translation downstream of mTORC1.	[Fonseca, Bruno D.; Jia, Jian-Jun; Graber, Tyson E.; Healy, Danielle; Hoang, Huy-Dung; Alain, Tommy] Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada; [Zakaria, Chadi; Graber, Tyson E.; Svitkin, Yuri; Tahmasebi, Soroush; Lussier, Alexandre; Dajadian, Christopher; Padmanabhan, Niranjan; Wang, Walter; Matta-Camacho, Edna; Hearnden, Jaclyn; Tsukumo, Yoshinori; Yanagiya, Akiko; Morita, Masahiro; Petroulakis, Emmanuel] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Jensen, Jacob M.; Diao, Ilo T.; Damgaard, Christian K.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Smith, Ewan M.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Petroulakis, Emmanuel] Pfizer Canada Inc, Kirkland, PQ H9J 2M5, Canada; [Gonzalez, Jose L.; Hernandez, Greco] Natl Canc Inst, Div Basic Sci, Mexico City 14080, DF, Mexico	University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; Aarhus University; University of Leicester; Pfizer	Fonseca, BD (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada.	brunodfonseca@gmail.com; tommy@arc.cheo.ca; ckd@mbg.au.dk	Damgaard, Christian/AAR-4075-2020; Hoang, Huy-Dung/HDO-6126-2022; Graber, Tyson/K-9385-2019; Morita, Masahiro/ABC-1150-2020; Damgaard, Christian/AAP-3147-2021; Damgaard, Christian K/G-7360-2015	Graber, Tyson/0000-0002-5337-3404; Damgaard, Christian/0000-0003-4940-0868; Lussier, Alexandre/0000-0002-1179-0621; Hoang, Huy-Dung/0000-0001-8793-1673; Gonzalez Montoya, Jose Luis/0000-0002-1807-9410; Smith, Ewan/0000-0002-3992-3748; Yanagiya, Akiko/0000-0002-5553-0311; Svitkin, Yuri/0000-0003-3819-2143; Morita, Masahiro/0000-0002-8627-084X	United States Department of Defense prostate cancer research fellow grant award; Novo Nordisk Fonden [NNF13OC0007719] Funding Source: researchfish	United States Department of Defense prostate cancer research fellow grant award(United States Department of Defense); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by a United States Department of Defense prostate cancer research fellow grant award. To whom correspondence may be addressed. E-mail: brunodfonseca@gmail.com.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aoki K, 2013, FEBS LETT, V587, P2173, DOI 10.1016/j.febslet.2013.05.035; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Biberman Y, 1999, FEBS LETT, V456, P357, DOI 10.1016/S0014-5793(99)00983-7; Biberman Y, 1997, FEBS LETT, V405, P333, DOI 10.1016/S0014-5793(97)00234-2; Blagden SP, 2009, DEV BIOL, V334, P186, DOI 10.1016/j.ydbio.2009.07.016; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Burrows C, 2010, NUCLEIC ACIDS RES, V38, P5542, DOI 10.1093/nar/gkq294; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coffman K, 2014, J BIOL CHEM, V289, P4723, DOI 10.1074/jbc.M113.482067; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Deragon JM, 2015, WIRES RNA, V6, P399, DOI 10.1002/wrna.1282; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ginalski K, 2004, TRENDS BIOCHEM SCI, V29, P522, DOI 10.1016/j.tibs.2004.08.006; Gingras AC, 2001, GENE DEV, V15, P2852; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harthill JE, 2002, BIOCHEM J, V368, P565, DOI 10.1042/BJ20020838; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hornstein E, 1999, FEBS LETT, V457, P209, DOI 10.1016/S0014-5793(99)01039-X; Hornstein E, 1999, J BIOL CHEM, V274, P1708, DOI 10.1074/jbc.274.3.1708; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kakegawa T, 2007, ARCH BIOCHEM BIOPHYS, V465, P274, DOI 10.1016/j.abb.2007.06.001; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee VHY, 2008, FEBS J, V275, P2185, DOI 10.1111/j.1742-4658.2008.06372.x; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Merret R, 2013, RNA, V19, P36, DOI 10.1261/rna.035469.112; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Meyuhas O, 2014, BIOCHIM BIOPHYS ACTA, DOI [DOI 10.1016/J.BBAGRM.2014.08.015, 10.1016/j.bbagrm.2014.08.015]; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Mori H, 2000, FEBS LETT, V467, P61, DOI 10.1016/S0014-5793(00)01126-1; Mura M, 2015, ONCOGENE, V34, P5025, DOI 10.1038/onc.2014.428; Nakashima A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-24; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; NOLAN RD, 1969, EUR J BIOCHEM, V9, P445, DOI 10.1111/j.1432-1033.1969.tb00629.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Patursky-Polischuk I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109410; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pellizzoni L, 1996, J MOL BIOL, V259, P904, DOI 10.1006/jmbi.1996.0368; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schultze FC, 2010, CELL PROLIFERAT, V43, P396, DOI 10.1111/j.1365-2184.2010.00690.x; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; van Gorp AGM, 2009, ONCOGENE, V28, P95, DOI 10.1038/onc.2008.367; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Xie JW, 2014, BBA-GENE REGUL MECH, V1839, P1062, DOI 10.1016/j.bbagrm.2014.08.001; Yang RQ, 2011, MOL CELL BIOL, V31, P542, DOI 10.1128/MCB.01162-10; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	100	139	142	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15996	16020		10.1074/jbc.M114.621730	http://dx.doi.org/10.1074/jbc.M114.621730			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25940091	Green Published, hybrid			2022-12-26	WOS:000356930100009
J	Li, Z; Liu, XW; Chi, ZC; Sun, BS; Cheng, Y; Cheng, LW				Li, Ze; Liu, Xue-Wei; Chi, Zhao-Cheng; Sun, Bao-Sheng; Cheng, Ying; Cheng, Long-Wei			Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							KRAS MUTATIONS; COLON-CANCER; CETUXIMAB; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; SURVIVAL; BRAF	Epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors are useful in treating different advanced human cancers; however, their clinical efficacy varies. This study detected K-ras mutations to predict the efficacy of EGFR-TK inhibitor cetuximab treatment on Chinese patients with metastatic colorectal cancer (mCRC). A total of 87 patients with metastatic colorectal cancer were treated with cetuximab for 2-16 months, in combination with chemotherapy between August 2008 and July 2012, and tissue samples were used to detect K-ras mutations. The data showed that K-ras mutation occurred in 27/87 (31%). The objective response rates and disease control rate in K-ras wild type and mutant patients were 42% (25/60) versus 11% (3/27) (p<0.05) and 60% (36/60) versus 26% (7/27) (p<0.05), respectively. Patients with the wild-type K-ras had significantly higher median survival times and progression-free survival, than patients with mutated K-ras (21 months versus 17 months, p= 0.017; 10 months versus 6 months, p= 0.6). These findings suggest that a high frequency of K-ras mutations occurs in Chinese mCRC patients and that K-ras mutation is required to select patients for eligibility for cetuximab therapy. Further prospective studies using a large sample size are needed to confirm these preliminary findings.	[Li, Ze; Liu, Xue-Wei; Chi, Zhao-Cheng; Sun, Bao-Sheng; Cheng, Ying; Cheng, Long-Wei] Canc Hosp Jilin Prov, Dept Gastrointestinal Surg, Changchun, Jilin, Peoples R China		Cheng, Y (corresponding author), Canc Hosp Jilin Prov, Dept Gastrointestinal Surg, Changchun, Jilin, Peoples R China.	18844151881@163.com; chenglongwei0509@163.com						Alberts SR, 2008, ONCOLOGIST, V13, P1063, DOI 10.1634/theoncologist.2008-0142; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; Cao Ka-Jia, 2009, Ai Zheng, V28, P441; CAPELLA G, 1991, ENVIRON HEALTH PERSP, V93, P125, DOI 10.2307/3431180; Chiu BCH, 2003, CANCER EPIDEM BIOMAR, V12, P201; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Gao J, 2011, CHINESE J CANCER RES, V23, P271, DOI 10.1007/s11670-011-0271-4; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Li Z, 2012, J INT MED RES, V40, P1589, DOI 10.1177/147323001204000439; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; NCCN, 2011, COLON CANCER, P3; Park JH, 2011, CANCER CHEMOTH PHARM, V68, P1045, DOI 10.1007/s00280-011-1586-z; PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896; Prewett M, 1996, J IMMUNOTHER, V19, P419, DOI 10.1097/00002371-199611000-00006; Ramos FJ, 2008, BIOMARK MED, V2, P97, DOI 10.2217/17520363.2.2.97; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Soulieres D, 2010, CURR ONCOL, V17, pS31; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Zuo YX, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-34	23	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0101019	10.1371/journal.pone.0101019	http://dx.doi.org/10.1371/journal.pone.0101019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950441	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400001
J	Arora, T; Velagapudi, V; Pournaras, DJ; Welbourn, R; le Roux, CW; Oresic, M; Backhed, F				Arora, Tulika; Velagapudi, Vidya; Pournaras, Dimitri J.; Welbourn, Richard; le Roux, Carel W.; Oresic, Matej; Backhed, Fredrik			Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission	PLOS ONE			English	Article							BARIATRIC SURGERY; BRANCHED-CHAIN; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; OBESE; METABOANALYST; PREVENTION; SERVER	Roux-en-Y gastric bypass (RYGB) is an effective method to attain sustained weight loss and diabetes remission. We aimed to elucidate early changes in the plasma metabolome and lipidome after RYGB. Plasma samples from 16 insulin-resistant morbidly obese subjects, of whom 14 had diabetes, were subjected to global metabolomics and lipidomics analysis at pre-surgery and 4 and 42 days after RYGB. Metabolites and lipid species were compared between time points and between subjects who were in remission and not in remission from diabetes 2 years after surgery. We found that the variables that were most discriminatory between time points were decanoic acid and octanoic acid, which were elevated 42 days after surgery, and sphingomyelins (18:1/21:0 and 18:1/23:3), which were at their lowest level 42 days after surgery. Insulin levels were lower at 4 and 42 days after surgery compared with pre-surgery levels. At 4 days after surgery, insulin levels correlated positively with metabolites of branched chain and aromatic amino acid metabolism and negatively with triglycerides with long-chain fatty acids. Of the 14 subjects with diabetes prior to surgery, 7 were in remission 2 years after surgery. The subjects in remission displayed higher pre-surgery levels of tricarboxylic acid cycle intermediates and triglycerides with long-chain fatty acids compared with subjects not in remission. Thus, metabolic alterations are induced soon after surgery and subjects with diabetes remission differ in the metabolic profiles at pre- and early post-surgery time points compared to patients not in remission.	[Arora, Tulika; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Arora, Tulika; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden; [Velagapudi, Vidya; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Velagapudi, Vidya] Inst Mol Med Finland FIMM, Metabol Unit, Helsinki, Finland; [Pournaras, Dimitri J.; Welbourn, Richard] Musgrove Pk Hosp, Dept Bariatr Surg, Taunton, Somerset, England; [le Roux, Carel W.] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Diabet Complicat Res Ctr, Dublin 2, Ireland; [le Roux, Carel W.] Univ Gothenburg, Sahlgrenska Acad, Gastrosurg Lab, Gothenburg, Sweden; [Oresic, Matej] Steno Diabet Ctr AS, Gentofte, Denmark; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; VTT Technical Research Center Finland; Musgrove Park Hospital; University College Dublin; University of Gothenburg; Steno Diabetes Center; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden.	Fredrik.Backhed@wlab.gu.se	Oresic, Matej/AAV-3978-2020; Velagapudi, Vidya/L-7278-2015; Backhed, Fredrik/ABE-6613-2020; Oresic, Matej/K-7673-2016	Velagapudi, Vidya/0000-0002-8261-7164; Backhed, Fredrik/0000-0002-4871-8818; Oresic, Matej/0000-0002-2856-9165; Arora, Tulika/0000-0001-8821-8191; Le Roux, Carel/0000-0001-5521-5445	Human Frontier of Science Program [RGY64/2008]; Swedish Research Council; Swedish Diabetes Foundation; Swedish Foundation for Strategic Research; Swedish Heart Lung Foundation; EU [FP7-KBBE-222639]; Vastra Gotalandsregionen; Novo Nordisk Fonden [NNF13OC0008163] Funding Source: researchfish	Human Frontier of Science Program(Human Frontier Science Program); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); EU(European Commission); Vastra Gotalandsregionen; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Human Frontier of Science Program (RGY64/2008), Swedish Research Council, Swedish Diabetes Foundation, Swedish Foundation for Strategic Research, Swedish Heart Lung Foundation, the EU-funded project ETHERPATHS (FP7-KBBE-222639, www.etherpaths.org), Torsten Soderberg's, Ragnar Soderberg's, and NovoNordisk Foundations, and LUA-ALF grants from Vastra Gotalandsregionen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2014, CURR OPIN BIOTECH, V28, P165, DOI 10.1016/j.copbio.2014.05.007; Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b; Gaster M, 2012, ARCH PHYSIOL BIOCHEM, V118, P156, DOI 10.3109/13813455.2012.656653; Graessler J, 2014, PHARMACOGENOMICS J, V14, P201, DOI 10.1038/tpj.2013.42; Gupta A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084803; Heneghan HM, 2013, SURG OBES RELAT DIS, V9, P100, DOI 10.1016/j.soard.2011.11.018; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Hyotylainen T, 2014, PROG LIPID RES, V55, P43, DOI 10.1016/j.plipres.2014.06.001; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Jeppesen PB, 1998, GUT, V43, P478, DOI 10.1136/gut.43.4.478; Jorgensen NB, 2012, AM J PHYSIOL-ENDOC M, V303, pE122, DOI 10.1152/ajpendo.00073.2012; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Magkos F, 2013, DIABETES, V62, P2757, DOI 10.2337/db13-0185; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pournaras DJ, 2012, BRIT J SURG, V99, P100, DOI 10.1002/bjs.7704; Pournaras DJ, 2010, ANN SURG, V252, P966, DOI 10.1097/SLA.0b013e3181efc49a; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; St-Onge MP, 2002, J NUTR, V132, P329; Umeda LM, 2011, OBES SURG, V21, P896, DOI 10.1007/s11695-011-0412-3; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	30	40	40	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126401	10.1371/journal.pone.0126401	http://dx.doi.org/10.1371/journal.pone.0126401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946120	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700126
J	Toro, R; Cordova, A; Canales, M; Morales, RGE; Mardones, P; Leiva, MA				Toro A., Richard; Cordova J., Alicia; Canales, Mauricio; Morales S., Raul G. E.; Mardones P., Pedro; Leiva G., Manuel A.			Trends and threshold exceedances analysis of airborne pollen concentrations in Metropolitan Santiago Chile	PLOS ONE			English	Article							ALLERGIC RHINITIS; IMMUNOGLOBULIN-E; CIUDAD REAL; ASTHMA; SEASON; URBAN; CITY; DETERMINANTS; AEROALLERGEN; GUIDELINES	Pollen is one of the primary causes of allergic rhinoconjunctivitis in urban centers. In the present study, the concentrations of 39 different pollens in the Santiago de Chile metropolitan area over the period 2009-2013 are characterized. The pollen was monitored daily using Burkard volumetric equipment. The contribution of each type of pollen and the corresponding time trends are evaluated. The concentrations of the pollens are compared with the established threshold levels for the protection of human health. The results show that the total amount of pollen grains originating from trees, grasses, weeds and indeterminate sources throughout the period of the study was 258,496 grains m-3, with an annual average of 51,699 +/- 3,906 grains m-3 year-1. The primary source of pollen is Platanus orientalis, which produces 61.8% of the analyzed pollen. Grass pollen is the third primary component of the analyzed pollen, with a contribution of 5.82%. Among the weeds, the presence of Urticacea (3.74%) is remarkable. The pollination pattern of the trees is monophasic, and the grasses have a biphasic pattern. The trends indicate that the total pollen and tree pollen do not present a time trend that is statistically significant throughout the period of the study, whereas the grass pollen and weed pollen concentrations in the environment present a statistically significant decreasing trend. The cause of this decrease is unclear. The pollen load has doubled over the past decade. When the observed concentrations of the pollens were compared with the corresponding threshold levels, the results indicated that over the period of the study, the pollen concentrations were at moderate, high and very high levels for an average of 293 days per year. Systematic counts of the pollen grains are an essential method for diagnosing and treating patients with pollinosis and for developing forestation and urban planning strategies.	[Toro A., Richard; Canales, Mauricio; Morales S., Raul G. E.; Leiva G., Manuel A.] Univ Chile, Ctr Ciencias Ambient, Santiago, Chile; [Toro A., Richard; Canales, Mauricio; Morales S., Raul G. E.; Leiva G., Manuel A.] Univ Chile, Dept Quim, Fac Ciencias, Santiago, Chile; [Cordova J., Alicia; Mardones P., Pedro] Clin Enfermedades Resp & Alerg Miguel Servet, Santiago, Chile; [Cordova J., Alicia; Mardones P., Pedro] Fdn Aerobiol Medio Ambiente & Salud, Santiago, Chile	Universidad de Chile; Universidad de Chile	Mardones, P (corresponding author), Clin Enfermedades Resp & Alerg Miguel Servet, Almirante Pastene 150-118, Santiago, Chile.	pemardo@gmail.com; manleiva@uchile.cl	Toro Araya, Richard E./J-7586-2018; Leiva, Manuel/AAV-7772-2020; Leiva, Manuel/E-7069-2012	Toro Araya, Richard E./0000-0002-4741-0504; Leiva, Manuel/0000-0001-8891-0399; Leiva, Manuel/0000-0001-8891-0399	Centro de Ciencias Ambientales, Facultad de Ciencias, Universidad de Chile; Fundacion de Aerobiologia, Medio Ambiente y Salud	Centro de Ciencias Ambientales, Facultad de Ciencias, Universidad de Chile; Fundacion de Aerobiologia, Medio Ambiente y Salud	The authors acknowledged the partial financial support of the Centro de Ciencias Ambientales, Facultad de Ciencias, Universidad de Chile and Fundacion de Aerobiologia, Medio Ambiente y Salud. PMP thank to Clinica Servet. The authors declare no financial relationships with any organisations that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work.	AAAAI, 2014, NAB POLL MOLD SPOR L; Alcazar P, 2009, AEROBIOLOGIA, V25, P55, DOI 10.1007/s10453-009-9109-7; ALJARO ME, 1979, REV MED CHILE, V107, P588; Allergen and Botanic Reference Library, 2012, TREE PLANT ALL INF R; Banzhaf E, 2013, HABITAT INT, V39, P179, DOI 10.1016/j.habitatint.2012.11.005; Bilisik A, 2008, EKOLOJI, V17, P8; Bilisik A, 2008, FRESEN ENVIRON BULL, V17, P640; Braido F, 2014, CURR OPIN ALLERGY CL, V14, P168, DOI 10.1097/ACI.0000000000000043; Brito FF, 2007, ALLERGY, V62, P1152, DOI 10.1111/j.1398-9995.2007.01438.x; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; Carinanos P, 2002, J ENVIRON MONITOR, V4, P734, DOI 10.1039/b205595c; Carinanos P, 2014, LANDSCAPE URBAN PLAN, V123, P134, DOI 10.1016/j.landurbplan.2013.12.009; Carinanos P, 2011, LANDSCAPE URBAN PLAN, V101, P205, DOI 10.1016/j.landurbplan.2011.03.006; Carslaw DC, 2012, ENVIRON MODELL SOFTW, V27-28, P9; Carslaw DC, 2013, OP MAN OP SOURC TOOL; Charpin D, 2005, ALLERGY, V60, P293, DOI 10.1111/j.1398-9995.2005.00731.x; Chini L, PAEDIAT RESP REV; Chiriac AM, 2013, PRESSE MED, V42, P395, DOI 10.1016/j.lpm.2012.06.005; Cui L, 2013, J ALLERGY CLIN IMMUN, V131, pAB162, DOI 10.1016/j.jaci.2012.12.1239; Cuinica LG, 2014, ENVIRON POLLUT, V186, P50, DOI 10.1016/j.envpol.2013.12.001; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; de la Maza Carmen Luz, 2002, Arboricultural Journal, V26, P347; Donoso G, 2008, ALLERGY, V63, P397; Douladiris N, 2013, INT ARCH ALLERGY IMM, V162, P65, DOI 10.1159/000353113; Durham SR, 2008, ABC OF ALLERGIES; Brito FF, 2010, J INVEST ALLERG CLIN, V20, P295; Fili L, 2013, J ALLERGY CLIN IMMUN, V132, P84, DOI 10.1016/j.jaci.2013.01.030; Fireman P, 2005, ATLAS ALLERGIES CLIN; Gentile D, 2013, J ALLER CL IMM-PRACT, V1, P214, DOI 10.1016/j.jaip.2013.03.012; Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035; Gonzalo-Garijo MA, 2006, J INVEST ALLERG CLIN, V16, P37; Haberle SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097925; Hoffmann A, 1976, REV MED CHILE, V104, P3; Hoffmann A, 1983, ARBOL URBANO CHILE E; HOFFMANN AJ, 1978, REV MED CHILE, V106, P595; Iglesias I, 2007, J INVEST ALLERG CLIN, V17, P145; Jiang L, 2014, ANN ALLERGY ASTHMA I; Kuchelmeister G., 1998, APFSOSWP44 FAO; Lacey ME, 2006, USING BURKARD TRAP A, P49; Laforest L, 2005, INT ARCH ALLERGY IMM, V136, P281, DOI 10.1159/000083955; Lippincott Williams & Wilkins, 2003, HDB ALLERGIC DISORDE; Lorenzoni-Chiesura F., 2000, AEROBIOLOGIA, V16, P313, DOI DOI 10.1023/A:1007652602113; Mardones P, 2013, AEROBIOLOGIA, V29, P449, DOI 10.1007/s10453-013-9292-4; Mardones P, 2013, ALLERGOL IMMUNOPATH, V41, P233, DOI 10.1016/j.aller.2012.06.001; MARDONES P PEDRO, 2011, Rev. chil. enferm. respir., V27, P7; MMA, 2011, AV GREEN AR OFF ENV; Murray MG, 2010, AEROBIOLOGIA, V26, P195, DOI 10.1007/s10453-010-9156-0; Piontelli E, 1974, REV MED CHILE, V102, P4; Plotz SG, 2004, J ALLERGY CLIN IMMUN, V113, P1152, DOI 10.1016/j.jaci.2004.03.011; Pomes A, 2002, ALLERGY, V57, P673, DOI 10.1034/j.1398-9995.2002.02160.x; Packe SR, 2010, EURE, V36, P89; RStudio Desktop, 2014, RSTUDIO INT DEV ENV; Sen PK, 1968, J AM STAT ASSOC, V63, P10; Simons FER, 2012, CURR OPIN ALLERGY CL, V12, P389, DOI 10.1097/ACI.0b013e328355b7e4; SINCA, 2013, AIR QUAL INF NAT SYS; SUBIZA J, 1995, J ALLERGY CLIN IMMUN, V96, P15, DOI 10.1016/S0091-6749(95)70028-5; Team RDC, LANG ENV STAT COMP R; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Theil H., 1950, RANK INVARIANT METHO, V53, P386, DOI DOI 10.1007/978-94-011-2546-8_20; Theil H., 1950, P KONINKLIJKE NEDERL, V53, P1397; Theil H., 1950, MATH SCI A, V53, P145; Tosca MA, 2014, ALLERGOL IMMUNOPATH, V42, P362, DOI 10.1016/j.aller.2013.02.006; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; van Cauwenberge P, 2005, B-ENT, P45; Varela S, 1997, J ALLERGY CLIN IMMUN, V100, P748, DOI 10.1016/S0091-6749(97)70268-9; Villalta D, 2010, J INVEST ALLERG CLIN, V20, P591; Villegas GR, 2001, GRANA, V40, P126, DOI 10.1080/00173130152625860; WAO, 2013, AER MON STAND AS PAC; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076	69	7	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123077	10.1371/journal.pone.0123077	http://dx.doi.org/10.1371/journal.pone.0123077			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946339	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700010
J	Bjorck, L; Capewell, S; O'Flaherty, M; Lappas, G; Bennett, K; Rosengren, A				Bjorck, Lena; Capewell, Simon; O'Flaherty, Martin; Lappas, Georgios; Bennett, Kathleen; Rosengren, Annika			Decline in Coronary Mortality in Sweden between 1986 and 2002: Comparing Contributions from Primary and Secondary Prevention	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; INDIVIDUALS; SENSITIVITY; PREVALENCE; COUNTRIES; DECREASE; DEATHS	Background The relative importance of risk factor reduction in healthy people (primary prevention) versus that in patients with coronary heart disease (secondary prevention) has been debated. We aimed to quantify the contribution of the two. Methodology We used the previously validated IMPACT model to estimate contributions from primary prevention (reducing risk factors in the population, particularly smoking, cholesterol and systolic blood pressure) and from secondary prevention (reducing risk factors in coronary heart disease patients) in the Swedish population. Principal Findings Between 1986 and 2002, about 8,690 fewer deaths were related to changes in the three major risk factors. Population cholesterol fell by 0.64 mmol/L, with approximately 5,210 fewer deaths attributable to diet changes (4,470 in healthy people740 in patients.) plus 810 to statin treatment (200 in healthy people, 610 in patients). Overall smoking prevalence decreased by 10.3%, resulting in 1,195 fewer deaths, attributable to smoking cessation (595 in healthy people, 600 in patients). Mean population systolic blood pressure fell by 2.6 mmHg, resulting in 900 fewer deaths (865 in healthy people, 35 in patients), plus 575 fewer deaths attributable to antihypertensive medication in healthy people. The majority of falls in deaths attributable to risk factors occurred in people without known heart disease: 6,705 fewer deaths compared with 1,985 fewer deaths in patients (secondary prevention), emphasizing the importance of promoting health interventions in the general population. Conclusions The largest effects on mortality came from primary prevention, giving markedly larger mortality reductions than secondary prevention.	[Bjorck, Lena; Lappas, Georgios; Rosengren, Annika] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Bjorck, Lena] Gothenburg Univ, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden; [Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Bennett, Kathleen] St James Hosp, Dept Pharmacol & Therapeut, Trinity Ctr Hlth Sci, Dublin 8, Ireland	University of Gothenburg; University of Gothenburg; University of Liverpool; Trinity College Dublin	Bjorck, L (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden.	lena.bjorck@gu.se		Bjorck, Lena/0000-0002-4827-4559; O'Flaherty, Martin/0000-0001-8944-4131; Rosengren, Annika/0000-0002-5409-6605; Bennett, Kathleen/0000-0002-2861-7665	Hjart-Lungfonden [20120463]; Swedish Research Council [2013-5187, 2013-423]; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	Hjart-Lungfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is supported by Hjart-Lungfonden 20120463 (LB) (http://www.hjartlungfonden.se/) and the Swedish Research Council 2013-5187 and 2013-423 (GL) (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-9; Bjorck L, EUR HEART J; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Cooney MT, 2013, EUR J PREV CARDIOL, V20, P686, DOI 10.1177/2047487312445562; Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Kabir Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-117; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lindblad U, 2012, SCAND J PRIM HEALTH, V30, P88, DOI 10.3109/02813432.2012.684207; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Nichol MB, 1999, ANN PHARMACOTHER, V33, P531, DOI 10.1345/aph.18233; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; The Swedish Council of Technology Assessment in Health Care (SBU Statens beredning for medicinsk utvardering), 2004, MODERATELY ELEVATED; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilhelmsen L, 1997, J INTERN MED, V242, P199, DOI 10.1046/j.1365-2796.1997.00163.x; Young F, 2010, AM J PREV MED, V39, P228, DOI 10.1016/j.amepre.2010.05.009; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	27	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124769	10.1371/journal.pone.0124769	http://dx.doi.org/10.1371/journal.pone.0124769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942424	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400021
J	Fernandez-Bertolin, L; Mullol, J; Fuentes-Prado, M; Roca-Ferrer, J; Alobid, I; Picado, C; Pujols, L				Fernandez-Bertolin, Laura; Mullol, Joaquim; Fuentes-Prado, Mireya; Roca-Ferrer, Jordi; Alobid, Isam; Picado, Cesar; Pujols, Laura			Effect of Lipopolysaccharide on Glucocorticoid Receptor Function in Control Nasal Mucosa Fibroblasts and in Fibroblasts from Patients with Chronic Rhinosinusitis with Nasal Polyps and Asthma	PLOS ONE			English	Article							INDUCED LEUCINE-ZIPPER; STEROID RESPONSIVENESS; STAPHYLOCOCCUS-AUREUS; EXPRESSION; MICROBIOME; INFECTION; LUNG; PHOSPHORYLATION; PROLIFERATION; INFLAMMATION	Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the upper airways frequently associated with asthma. Bacterial infection is a feature of CRSwNP that can aggravate the disease and the response to glucocorticoid treatment. Objective We examined whether the bacterial product lipopolysaccharide (LPS) reduces glucocorticoid receptor (GR) function in control nasal mucosa (NM) fibroblasts and in nasal polyp (NP) fibroblasts from patients with CRSwNP and asthma. Methods NP (n = 12) and NM fibroblasts (n = 10) were in vitro pre-incubated with LPS (24 hours) prior to the addition of dexamethasone. Cytokine/chemokine secretion was measured by ELISA and Cytometric Bead Array. GR alpha, GR beta, mitogen-activated protein-kinase phosphatase-1 (MKP-1) and glucocorticoid-induced leucine zipper (GILZ) expression was measured by RT-PCR and immunoblotting, GRa nuclear translocation by immunocytochemistry, and GR beta localization by immunoblotting. The role of MKP-1 and GILZ on dexamethasone-mediated cytokine inhibition was analyzed by small interfering RNA silencing. Results Pre-incubation of nasal fibroblasts with LPS enhanced the secretion of IL-6, CXCL8, RANTES, and GM-CSF induced by FBS. FBS-induced CXCL8 secretion was higher in NP than in NM fibroblasts. LPS effects on IL-6 and CXCL8 were mediated via activation of p38 alpha/beta MAPK and IKK/NF-kappa B pathways. Additionally, LPS pre-incubation: 1) reduced dexamethasone's capacity to inhibit FBS-induced IL-6, CXCL8 and RANTES, 2) reduced dexamethasone-induced GR alpha nuclear translocation (only in NM fibroblasts), 3) did not alter GR alpha/GR beta expression, 4) decreased GILZ expression, and 5) did not affect dexamethasone's capacity to induce MKP-1 and GILZ expression. MKP-1 knockdown reduced dexamethasone's capacity to suppress FBS-induced CXCL8 release. Conclusion The bacterial product LPS negatively affects GR function in control NM and NP fibroblasts by interfering with the capacity of the activated receptor to inhibit the production of pro-inflammatory mediators. This study contributes to the understanding of how bacterial infection of the upper airways may limit the efficacy of glucocorticoid treatment.	[Fernandez-Bertolin, Laura; Mullol, Joaquim; Fuentes-Prado, Mireya; Roca-Ferrer, Jordi; Alobid, Isam; Picado, Cesar; Pujols, Laura] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Ctr Recerca Biomed CELLEX, Clin & Expt Resp Immunoallergy, Barcelona, Spain; [Fernandez-Bertolin, Laura; Mullol, Joaquim; Fuentes-Prado, Mireya; Roca-Ferrer, Jordi; Alobid, Isam; Picado, Cesar; Pujols, Laura] Ctr Invest Biomed Red Enfermedades Resp CIBERes, Barcelona, Spain; [Mullol, Joaquim; Alobid, Isam] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Spain; [Mullol, Joaquim; Alobid, Isam] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Spain; [Picado, Cesar] Univ Barcelona, Pneumol & Allergy Dept, Allergy Unit, Hosp Clin, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Pujols, L (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Ctr Recerca Biomed CELLEX, Clin & Expt Resp Immunoallergy, Barcelona, Spain.	lpujols@clinic.ub.es	Fuentes, Mireya/J-5901-2017; Pujols, Laura/G-8920-2015; /AFX-9519-2022; /AAL-7347-2021; Roca-Ferrer, Jordi/AFQ-4652-2022	Fuentes, Mireya/0000-0002-1381-5589; Pujols, Laura/0000-0003-3708-5098; Roca-Ferrer, Jordi/0000-0002-9527-2273	Fondo de Investigacion Sanitaria (FIS); MINECO (Ministerio de Economia y Competitividad; Fundacio Catalana de Pneumologia [FUCAP-09]; FEDER, Spain; IDIBAPS; European Respiratory Society Fellowship [STRTF 221-2010]; FIS-ISCIII; Instituto de Salud Carlos III (ISCIII);  [PI080419]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); MINECO (Ministerio de Economia y Competitividad(Spanish Government); Fundacio Catalana de Pneumologia; FEDER, Spain(European CommissionSpanish Government); IDIBAPS; European Respiratory Society Fellowship; FIS-ISCIII(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); 	This study was funded by research grants from Fondo de Investigacion Sanitaria (FIS), Instituto de Salud Carlos III (ISCIII) (http://www.isciii.es/), MINECO (Ministerio de Economia y Competitividad, http://www.idi.mineco.gob.es/portal/site/MICINN/) (PI080419), Fundacio Catalana de Pneumologia (FUCAP-09), and co-funded by FEDER (http://ec.europa.eu/regional_policy/thefunds/regional/index_en.cfm), Spain. L.F.-B. was the recipient of a predoctoral fellowship grant from IDIBAPS and a European Respiratory Society Fellowship (STRTF 221-2010). The research activity of L.P. was supported by FIS-ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bachert C, 2010, CURR ALLERGY ASTHM R, V10, P194, DOI 10.1007/s11882-010-0096-0; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Boase S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-210; Cho YS, 2005, CLIN EXP ALLERGY, V35, P1625, DOI 10.1111/j.1365-2222.2005.02391.x; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Cleland EJ, 2013, INT FORUM ALLERGY RH, V3, P642, DOI 10.1002/alr.21159; Callejas FD, 2013, AM J RHINOL ALLERGY, V27, pE69, DOI 10.2500/ajra.2013.27.3908; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Fernandez-Bertolin L, 2013, J ALLERGY CLIN IMMUN, V132, P1243, DOI 10.1016/j.jaci.2013.07.010; Fernandez-Bertolin L, 2011, RHINOLOGY, V49, P562, DOI 10.4193/Rhino11.036; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Global Initiative for asthma, 2012, GINA REP GLOB STRAT; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Hamdi H, 2007, HEPATOLOGY, V46, P1986, DOI 10.1002/hep.21880; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hinzey A, 2011, ENDOCRINOLOGY, V152, P483, DOI 10.1210/en.2010-0774; Hirotsu M, 2011, ACTA OTO-LARYNGOL, V131, P997, DOI 10.3109/00016489.2011.576430; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Issa R, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-30; Komlosi ZI, 2006, CLIN EXP ALLERGY, V36, P951, DOI 10.1111/j.1365-2222.2006.02514.x; Liu QH, 2014, ACTA OTO-LARYNGOL, V134, P1251, DOI 10.3109/00016489.2013.879737; Marketon JIW, 2010, TOXINS, V2, P1357, DOI 10.3390/toxins2061357; McSharry C, 2014, J ALLERGY CLIN IMMUN, V134, P1068, DOI 10.1016/j.jaci.2014.08.022; Nonaka M, 2004, CLIN EXP ALLERGY, V34, P804, DOI 10.1111/j.1365-2222.2004.1954.x; Nonaka M, 1999, INT ARCH ALLERGY IMM, V119, P314, DOI 10.1159/000024209; Ocampo CJ, 2013, ALLERGY ASTHMA PROC, V34, P132, DOI 10.2500/aap.2013.34.3636; Papi A, 2013, J ALLERGY CLIN IMMUN, V132, P1075, DOI 10.1016/j.jaci.2013.05.028; Park CS, 2012, J MED MICROBIOL, V61, P705, DOI 10.1099/jmm.0.036624-0; Perros F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-125; Pujols L, 2008, ALLERGY, V63, P1377, DOI 10.1111/j.1398-9995.2008.01745.x; Pujols L, 2012, J PHARMACOL EXP THER, V343, P184, DOI 10.1124/jpet.111.190710; Pujols L, 2011, RESP MED, V105, P218, DOI 10.1016/j.rmed.2010.08.001; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; XING Z, 1993, AM J RESP CELL MOL, V9, P255, DOI 10.1165/ajrcmb/9.3.255; Yamada K, 2002, J ALLERGY CLIN IMMUN, V109, P35, DOI 10.1067/mai.2002.120525	42	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125443	10.1371/journal.pone.0125443	http://dx.doi.org/10.1371/journal.pone.0125443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25943109	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400036
J	Johnson, LNL; McLeod, BA; Burns, LE; Arseneault, K; Frasier, TR; Broders, HG				Johnson, Laura N. L.; McLeod, Brenna A.; Burns, Lynne E.; Arseneault, Krista; Frasier, Timothy R.; Broders, Hugh G.			Population Genetic Structure Within and among Seasonal Site Types in the Little Brown Bat (Myotis lucifugus) and the Northern Long-Eared Bat (M-septentrionalis)	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; WHITE-NOSE SYNDROME; SWARMING SITES; MITOCHONDRIAL-DNA; MICROSATELLITE LOCI; COMPUTER-PROGRAM; NATAL PHILOPATRY; NATTERERS BATS; INDIANA BATS; FEMALE	During late summer and early autumn, temperate bats migrate from their summering sites to swarming sites, where mating likely occurs. However, the extent to which individuals of a single summering site migrate to the same swarming site, and vice versa, is not known. We examined the migratory connectivity between summering and swarming sites in two temperate, North American, bat species, the little brown bat (Myotis lucifugus) and the northern long-eared bat (Myotis septentrionalis). Using mitochondrial and microsatellite DNA markers, we examined population structuring within and among summering and swarming sites. Both species exhibited moderate degrees of mitochondrial DNA differentiation (little brown bat: F-ST(SWARMING) = 0.093, F-ST(SWARMING) = 0.052; northern long-eared bat: F-ST(SWARMING) = 0.117, F-ST(SWARMING) = 0.043) and little microsatellite DNA differentiation among summering and among swarming sites. Haplotype diversity was significantly higher at swarming sites than summering sites, supporting the idea that swarming sites are comprised of individuals from various summering sites. Further, pairwise analyses suggest that swarming sites are not necessarily comprised of only individuals from the most proximal summering colonies.	[Johnson, Laura N. L.; McLeod, Brenna A.; Arseneault, Krista; Frasier, Timothy R.; Broders, Hugh G.] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [McLeod, Brenna A.] Nova Scotia Museum Nat Hist, Halifax, NS, Canada; [Burns, Lynne E.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Saint Marys University - Canada; Dalhousie University	Broders, HG (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	hugh.broders@smu.ca		Broders, Hugh/0000-0002-6151-8079; Burns, Lynne/0000-0002-7286-6431	Canadian Wildlife Federation; Nova Scotia Power; Eon Wind Electric; Shear Wind Inc.; New Brunswick Museum; New Brunswick Wildlife Trust Fund; Bat Conservation International; Natural Sciences and Engineering Research Council [283217-2010, CRDG 418936-11]	Canadian Wildlife Federation; Nova Scotia Power; Eon Wind Electric; Shear Wind Inc.; New Brunswick Museum; New Brunswick Wildlife Trust Fund; Bat Conservation International; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by The Canadian Wildlife Federation, Nova Scotia Power, Eon Wind Electric, Shear Wind Inc., The New Brunswick Museum, New Brunswick Wildlife Trust Fund, Bat Conservation International, and the Natural Sciences and Engineering Research Council (Discovery Grant 283217-2010; CRDG 418936-11) Canadian Wildlife Federation: http://www.cwf-fcf.org/en/. Nova Scotia Power: https://www.nspower.ca/en/home/default.aspx. Eon Wind Electric: http://www.eonwind.com. Shear Wind Inc.: http://www.shearwind.com. The New Brunswick Museum: http://www.nbmmnb.ca. New Brunswick Wildlife Trust Fund: http://www.nbwtf.ca/eindex.asp. Bat Conservation International: http://www.batcon.org. Natural Sciences and Engineering Research Council (Discovery Grant 283217-2010; CRDG 418936-11): http://www.nserccrsng.gc.ca/index_eng.asp. Note: each industrial funder has agreed to the publishing of this paper.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Anthony ELP, 1988, ECOLOGICAL BEHAV MET; Arnett EB, 2013, BAT EVOLUTION ECOLOG, DOI 10.1007/978-1-4614-7397-8; Arnold BD, 2007, AM MIDL NAT, V157, P374, DOI 10.1674/0003-0031(2007)157[374:PSASDI]2.0.CO;2; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Barbour R.W., 1969, BATS AM; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bogdanowicz W, 2012, J MAMMAL, V93, P799, DOI 10.1644/11-MAMM-A-180.3; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Broders HG, 2004, J WILDLIFE MANAGE, V68, P602, DOI 10.2193/0022-541X(2004)068[0602:IAIVIR]2.0.CO;2; Burland TM, 2001, MOL ECOL, V10, P1309, DOI 10.1046/j.1365-294X.2001.01273.x; Burns LE, 2014, ECOL EVOL, V4, P4130, DOI 10.1002/ece3.1266; Burns LE, 2012, CONSERV GENET RESOUR, V4, P653, DOI 10.1007/s12686-012-9615-8; Caceres M.C., 2000, MAMMAL SPECIES, V634, P1; Carter TC, 2005, FOREST ECOL MANAG, V219, P259, DOI 10.1016/j.foreco.2005.08.049; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Croteau EK, 2012, CONSERV GENET, V13, P1637, DOI 10.1007/s10592-012-0416-0; D'Intino Anna M., 2013, Journal of Cetacean Research and Management, V13, P97; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Demboski JR, 2001, MOL ECOL, V10, P1227, DOI 10.1046/j.1365-294X.2001.01260.x; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Entwistle AC, 2000, J ZOOL, V252, P11, DOI 10.1017/S095283690000902X; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; Frasier TR, 2008, MOL ECOL RESOUR, V8, P1263, DOI 10.1111/j.1755-0998.2008.02358.x; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Gladden JGB, 1999, MOL ECOL, V8, P347, DOI 10.1046/j.1365-294X.1998.00559.x; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Humphrey SR, 1976, INDIANA N CENTRAL KE; Janmaat KRL, 2009, INT J PRIMATOL, V30, P443, DOI 10.1007/s10764-009-9352-3; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson Gregory D., 2005, Bat Research News, V46, P45; Johnson JB, 2014, ACTA THERIOL, V59, P223, DOI 10.1007/s13364-013-0163-8; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P203, DOI 10.1007/s00265-002-0499-6; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Kerth G, 2001, OECOLOGIA, V126, P1, DOI 10.1007/s004420000489; Kunz T.H., 1982, P1; Kurta A, 2002, J MAMMAL, V83, P585, DOI 10.1644/1545-1542(2002)083<0585:PAMOBI>2.0.CO;2; Lecomte N, 2009, MOL ECOL, V18, P593, DOI 10.1111/j.1365-294X.2008.04067.x; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Miller-Butterworth CM, 2014, J HERED, V105, P354, DOI 10.1093/jhered/esu012; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; Moussy C, 2013, MAMMAL REV, V43, P183, DOI 10.1111/j.1365-2907.2012.00218.x; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Olson CR, 2013, CAN J ZOOL, V91, P149, DOI 10.1139/cjz-2012-0267; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Petit E, 1999, EVOLUTION, V53, P1247, DOI 10.1111/j.1558-5646.1999.tb04537.x; Pierson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067248; Pierson JC, 2010, EVOL APPL, V3, P263, DOI 10.1111/j.1752-4571.2009.00111.x; Pritchard JK, 2000, GENETICS, V155, P945; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Reynolds HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086437; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Rousset F, 1997, GENETICS, V145, P1219; ROUSSET F, 1995, GENETICS, V140, P1413; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sachteleben J, 1991, NYCTALUS, V4, P51; SAMBROOK J, 2000, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Siegel S, 1956, MANN WHITNEY U TEST; Solick DI, 2006, CAN J ZOOL, V84, P589, DOI 10.1139/Z06-028; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vonhof MJ, 2008, J MAMMAL, V89, P1411, DOI 10.1644/08-MAMM-S-062.1; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; [No title captured]	90	11	12	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126309	10.1371/journal.pone.0126309	http://dx.doi.org/10.1371/journal.pone.0126309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942425	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400068
J	Osman, AEF; Hassan, AN; Ali, AE; Abdoel, TH; Smits, HL				Osman, Amira E. F.; Hassan, Abdullahi N.; Ali, Ali E.; Abdoel, Theresia H.; Smits, Henk L.			Brucella melitensis Biovar 1 and Brucella abortus S19 Vaccine Strain Infections in Milkers Working at Cattle Farms in the Khartoum Area, Sudan	PLOS ONE			English	Article							FLOW ASSAYS; DIAGNOSIS; SERODIAGNOSIS; CULTURE; SHEEP; KENYA	Background Human brucellosis is a preventable zoonoses that may become persistent, causing, if left untreated, severe localized disease. Occupational exposure to infected animals or animal products and consumption of fresh contaminated dairy are main risk factors. Methods One hundred farmworkers employed at two cattle farms one in Khartoum North and one in Omdurman were screened for the presence of specific antibodies and seropositive workers were invited to donate a blood sample for blood culture. Molecular typing was used to characterize Brucella isolates. Results Ten percent of farmworkers tested seropositive and while Brucella melitensis biovar 1 was isolated from the blood of three individuals, an isolate identical to the B. abortus S19 vaccine strain was isolated from a fourth person. All four bacteremic individuals were employed as milkers and did not have obvious disease. Conclusions The isolation of the highly infectious pathogen B. melitensis from seropositive workers is consistent with the notion that the pathogen may persist in the blood without causing overt disease. While vaccination with strain S19 is essential for the control of bovine brucellosis the vaccine strain may be transmitted to the human population and protective measures remain important to prevent exposure also in view of the presence of B. melitensis. To create awareness for this potentially severe disease more information on the prevalence of the pathogen in different risk groups and in livestock in the Sudan is needed.	[Osman, Amira E. F.; Hassan, Abdullahi N.; Ali, Ali E.] Univ Alzaiem Alazhari, Khartoum, Sudan; [Abdoel, Theresia H.; Smits, Henk L.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands		Smits, HL (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	h.smits@kit.nl						Agab H, 1994, Rev Elev Med Vet Pays Trop, V47, P361; Al-Attas RA, 2000, ANN SAUDI MED, V20, P224, DOI 10.5144/0256-4947.2000.224; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Celebi G, 2007, SCAND J INFECT DIS, V39, P205, DOI 10.1080/00365540600978898; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; CORBEL MJ, 1988, INT J SYST BACTERIOL, V38, P450, DOI 10.1099/00207713-38-4-450; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; El-Ansary EHH, 2001, SAUDI MED J, V22, P577; Espinosa BJ, 2009, AM J TROP MED HYG, V80, P625, DOI 10.4269/ajtmh.2009.80.625; Ferreira AC, 2003, VET RES, V34, P297, DOI 10.1051/vetres:2003005; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; del Pozo JSG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032090; Garin-Bastuji B, 1998, VET RES, V29, P255; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Gwida M, 2011, PREV VET MED, V102, P118, DOI [10.1016/j.prevetmed.2011.04.007, DOI 10.1016/J.PREVETMED.2011.04.007]; HELLMANN E, 1984, TROPENMED PARASITOL, V35, P123; Irmak H, 2004, AM J TROP MED HYG, V70, P688, DOI 10.4269/ajtmh.2004.70.688; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Matope Gift, 2009, BMC Res Notes, V2, P261, DOI 10.1186/1756-0500-2-261; Mendoza-Nunez M, 2008, AM J TROP MED HYG, V78, P595, DOI 10.4269/ajtmh.2008.78.595; Muendo EN, 2012, TROP ANIM HEALTH PRO, V44, P17, DOI 10.1007/s11250-011-9899-9; MUSA MT, 1990, J COMP PATHOL, V103, P467, DOI 10.1016/S0021-9975(08)80034-5; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; Omer MM, 2010, REV SCI TECH OIE, V29, P663, DOI 10.20506/rst.29.3.2003; PALING RW, 1988, J WILDLIFE DIS, V24, P308, DOI 10.7589/0090-3558-24.2.308; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Smits HL, 2003, CLIN DIAGN LAB IMMUN, V10, P1141, DOI 10.1128/CDLI.10.6.1141-1146.2003; SPINK WW, 1950, J LAB CLIN MED, V35, P440; THOMAS EL, 1981, VET REC, V108, P90, DOI 10.1136/vr.108.5.90; Wallach JC, 2008, CLIN MICROBIOL INFEC, V14, P805, DOI 10.1111/j.1469-0691.2008.02029.x; Young E. J., 1990, Advances in brucellosis research., P465; Zhen Q, 2013, CLIN MICROBIOL INFEC, V19, pE395, DOI 10.1111/1469-0691.12250	38	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123374	10.1371/journal.pone.0123374	http://dx.doi.org/10.1371/journal.pone.0123374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938483	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000007
J	Yoon, SJ; Kwon, WS; Rahman, MS; Lee, JS; Pang, MG				Yoon, Sung-Jae; Kwon, Woo-Sung; Rahman, Md Saidur; Lee, June-Sub; Pang, Myung-Geol			A Novel Approach to Identifying Physical Markers of Cryo-Damage in Bull Spermatozoa	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; 2 DIFFERENT EXTENDERS; COLD SHOCK INJURY; SPERM CRYOPRESERVATION; BOVINE SPERM; POSTTHAW MOTILITY; OXIDATIVE STRESS; MALE-FERTILITY; PROTEINS; CAPACITATION	Cryopreservation is an efficient way to store spermatozoa and plays a critical role in the livestock industry as well as in clinical practice. During cryopreservation, cryo-stress causes substantial damage to spermatozoa. In present study, the effects of cryo-stress at various cryopreservation steps, such as dilution / cooling, adding cryoprtectant, and freezing were studied in spermatozoa collected from 9 individual bull testes. The motility (%), motion kinematics, capacitation status, mitochondrial activity, and viability of bovine spermatozoa at each step of the cryopreservation process were assessed using computer-assisted sperm analysis, Hoechst 33258/chlortetracycline fluorescence, rhodamine 123 staining, and hypo-osmotic swelling test, respectively. The results demonstrate that the cryopreservation steps reduced motility (%), rapid speed (%), and mitochondrial activity, whereas medium/slow speed (%), and the acrosome reaction were increased (P < 0.05). Differences (Delta) of the acrosome reaction were higher in dilution/cooling step (P < 0.05), whereas differences (Delta) of motility, rapid speed, and non-progressive motility were higher in cryoprotectant and freezing as compared to dilution/cooling (P < 0.05). On the other hand, differences (Delta) of mitochondrial activity, viability, and progressive motility were higher in freezing step ( P < 0.05) while the difference (Delta) of the acrosome reaction was higher in dilution/cooling ( P < 0.05). Based on these results, we propose that freezing / thawing steps are the most critical in cryopreservation and may provide a logical ground of understanding on the cryo-damage. Moreover, these sperm parameters might be used as physical markers of sperm cryo-damage.	[Yoon, Sung-Jae; Kwon, Woo-Sung; Rahman, Md Saidur; Lee, June-Sub; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Pang, Myung-Geol/AAV-2014-2021; Rahman, Md Saidur/AAT-2972-2020; Rahman, Mohammad Sohelur/AAJ-7376-2020; Rahman, Saidur/J-7855-2012	Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Saifur/0000-0002-9887-4456; Pang, Myung-Geol/0000-0003-2019-3789; Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, Saidur/0000-0003-4583-8731	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2014R1A2A2A01002706]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (no. NRF-2014R1A2A2A01002706).	Ahmad M, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.972; Alapati R, 2009, CRYOBIOLOGY, V59, P164, DOI 10.1016/j.cryobiol.2009.06.009; Ardon F, 2013, REPRODUCTION, V146, P111, DOI 10.1530/REP-12-0468; Awad MM, 2004, ANIM REPROD SCI, V84, P83, DOI 10.1016/j.anireprosci.2003.12.001; Ball B, 2001, TLS-TIMES LIT SUPPL, P22; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Brugnon F, 2013, HUM REPROD, V28, P2045, DOI 10.1093/humrep/det253; Celeghini ECC, 2008, ANIM REPROD SCI, V104, P119, DOI 10.1016/j.anireprosci.2007.02.001; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; DELAMIRANDE E, 1992, J ANDROL, V13, P368; DELEEUW FE, 1990, CRYOBIOLOGY, V27, P171, DOI 10.1016/0011-2240(90)90009-S; Dona G, 2013, MAR DRUGS, V11, P1909, DOI 10.3390/md11061909; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Ebertz SL, 2002, CRYOBIOLOGY, V45, P109, DOI 10.1016/S0011-2240(02)00116-5; Garcia-Herreros M, 2015, ANIMAL, V9, P1016, DOI 10.1017/S1751731115000129; Gilmore JA, 1996, J REPROD FERTIL, V107, P87, DOI 10.1530/jrf.0.1070087; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; HINTON BT, 1979, J REPROD FERTIL, V55, P167, DOI 10.1530/jrf.0.0550167; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Kutluyer F, 2014, CRYOBIOLOGY, V69, P462, DOI 10.1016/j.cryobiol.2014.10.005; Kwon WS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-897; Kwon WS, 2014, J PROTEOME RES, V13, P4505, DOI 10.1021/pr500524p; Kwon WS, 2013, FERTIL STERIL, V99, P354, DOI 10.1016/j.fertnstert.2012.09.021; Lessard C, 2000, J ANDROL, V21, P700; Li JJ, 2006, ACTA PHARMACOL SIN, V27, P1078, DOI 10.1111/j.1745-7254.2006.00345.x; Liu QH, 2015, FISH PHYSIOL BIOCHEM, V41, P413, DOI 10.1007/s10695-014-9993-9; Liu ZS, 1998, CRYOBIOLOGY, V37, P207, DOI 10.1006/cryo.1998.2116; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Martins MIM, 2012, REPROD DOMEST ANIM, V47, P293, DOI 10.1111/rda.12042; Melville DF, 2012, CRYOBIOLOGY, V65, P224, DOI 10.1016/j.cryobiol.2012.06.007; Miller RR, 2004, CRYOBIOLOGY, V49, P137, DOI 10.1016/j.cryobiol.2004.06.002; Mostafapor Somayeh, 2014, Vet Res Forum, V5, P101; Mota AC, 2014, CRYOBIOLOGY, V69, P17, DOI 10.1016/j.cryobiol.2014.04.013; Olaciregui M, 2014, CRYOBIOLOGY, V68, P91, DOI 10.1016/j.cryobiol.2013.12.009; Peris SI, 2007, MOL REPROD DEV, V74, P878, DOI 10.1002/mrd.20686; PHOLPRAMOOL C, 1985, J REPROD FERTIL, V75, P413, DOI 10.1530/jrf.0.0750413; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; Prathalingam NS, 2006, THERIOGENOLOGY, V66, P1894, DOI 10.1016/j.theriogenology.2006.04.041; Rahman MS, 2014, ANDROLOGY-US, V2, P899, DOI 10.1111/j.2047-2927.2014.00273.x; Rahman MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/360986; RAMON M, 2013, PLOS ONE, V0008; Sariozkan S, 2009, CRYOBIOLOGY, V58, P134, DOI 10.1016/j.cryobiol.2008.11.006; SHABANOWITZ RB, 1987, BIOL REPROD, V36, P753, DOI 10.1095/biolreprod36.3.753; Sorrenti G, 2014, CRYOBIOLOGY, V68, P43, DOI 10.1016/j.cryobiol.2013.11.005; SPUNGIN B, 1995, J CELL SCI, V108, P2525; Viveiros ATM, 2012, THERIOGENOLOGY, V78, P803, DOI 10.1016/j.theriogenology.2012.03.028; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Wang SQ, 2014, PROTEOMICS, V14, P298, DOI 10.1002/pmic.201300225; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; WHITE IG, 1993, REPROD FERT DEVELOP, V5, P639, DOI 10.1071/RD9930639; Xu X, 2012, J BIOTECHNOL, V162, P224, DOI 10.1016/j.jbiotec.2012.09.004; 김영희, 2010, Reproductive & Developmental biology, V34, P241; ZANEVELD LJD, 1991, HUM REPROD, V6, P1265, DOI 10.1093/oxfordjournals.humrep.a137524	54	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126232	10.1371/journal.pone.0126232	http://dx.doi.org/10.1371/journal.pone.0126232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938413	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000154
J	Zhao, YJ; Chen, X; Zhang, M; Su, P; Liu, YJ; Tong, YR; Wang, XJ; Huang, LQ; Gao, W				Zhao, Yu-Jun; Chen, Xin; Zhang, Meng; Su, Ping; Liu, Yu-Jia; Tong, Yu-Ru; Wang, Xiu-Juan; Huang, Lu-Qi; Gao, Wei			Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii	PLOS ONE			English	Article							DIPHOSPHATE SYNTHASE; ISOPRENOID BIOSYNTHESIS; SQUALENE SYNTHETASE; UP-REGULATION; GENE; EXPRESSION; INDUCTION; CULTURES; LOCALIZATION; TRIPTOLIDE	Farnesylpyrophosphate synthase (FPS) catalyzes the biosynthesis of farnesyl pyrophosphate (FPP), which is an important precursor of sesquiterpenoids such as artemisinin and wilfordine. In the present study, we report the molecular cloning and characterization of two full-length cDNAs encoding FPSs from Tripterygium wilfordii (TwFPSs). TwFPSs maintained their capability to synthesise FPP in vitro when purified as recombinant proteins from E. coli. Consistent with the endogenous role of FPS in FPP biosynthesis, TwFPSs were highly expressed in Tripterygium wilfordii roots, and were up-regulated upon methyl jasmonate (MeJA) treatment. The global gene expression profiles suggested that the TwFPSs might play an important regulatory role interpenoid biosynthesis in Tripterygium wilfordii, laying the groundwork for the future study of the synthetic biology of natural terpene products.	[Zhao, Yu-Jun; Chen, Xin; Zhang, Meng; Su, Ping; Liu, Yu-Jia; Tong, Yu-Ru; Wang, Xiu-Juan; Gao, Wei] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China; [Huang, Lu-Qi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China	Capital Medical University; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Chen, X (corresponding author), Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China.	chenxin4283@126.com; huangluqi01@126.com; weigao@ccmu.edu.cn	Zhao, Yujun/HGU-7295-2022	Zhao, Yujun/0000-0001-6687-6652	National Natural Science Foundation of China [81422053, 81373906, 81325023]; National Excellent Doctoral Dissertation of China [201188]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by the National Natural Science Foundation of China (81422053 and 81373906 to WG, and 81325023 to LH) and the Author of National Excellent Doctoral Dissertation of China (201188) and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD201304174) to WG.	Alcaino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096626; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Banyai W, 2010, PLANT CELL TISS ORG, V103, P255, DOI 10.1007/s11240-010-9775-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Cervantes-Cervantes M, 2006, PLANT PHYSIOL, V141, P220, DOI 10.1104/pp.106.077008; CHAPPELL J, 1995, ANNU REV PLANT PHYS, V46, P521, DOI 10.1146/annurev.pp.46.060195.002513; CHAPPELL J, 1987, PLANT PHYSIOL, V85, P469, DOI 10.1104/pp.85.2.469; CHEN AJ, 1994, PROTEIN SCI, V3, P600; Chen DH, 2000, PLANT SCI, V155, P179, DOI 10.1016/S0168-9452(00)00217-X; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Closa M, 2010, PLANT J, V63, P512, DOI 10.1111/j.1365-313X.2010.04253.x; CORNISH K, 1993, EUR J BIOCHEM, V218, P267, DOI 10.1111/j.1432-1033.1993.tb18374.x; Cunillera N, 2000, PLANT MOL BIOL, V44, P747, DOI 10.1023/A:1026588708849; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Devarenne TP, 1998, ARCH BIOCHEM BIOPHYS, V349, P205, DOI 10.1006/abbi.1997.0463; Gaffe J, 2000, PLANT PHYSIOL, V123, P1351, DOI 10.1104/pp.123.4.1351; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Han JL, 2006, J INTEGR PLANT BIOL, V48, P482, DOI 10.1111/j.1744-7909.2006.00208.x; Jones CG, 2011, J BIOL CHEM, V286, P17445, DOI 10.1074/jbc.M111.231787; Kim OT, 2010, BIOL PLANTARUM, V54, P47, DOI 10.1007/s10535-010-0007-1; Kim OT, 2010, PLANT CELL REP, V29, P403, DOI 10.1007/s00299-010-0831-y; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lambert E, 2011, APPL BIOCHEM BIOTECH, V164, P220, DOI 10.1007/s12010-010-9129-3; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li CP, 1996, GENE, V171, P193, DOI 10.1016/0378-1119(95)00880-2; Liao ZH, 2006, J INTEGR PLANT BIOL, V48, P692, DOI 10.1111/j.1744-7909.2006.00243.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manzo SG, 2012, CANCER RES, V72, P5363, DOI 10.1158/0008-5472.CAN-12-1006; Matsushita Y, 1996, GENE, V172, P207, DOI 10.1016/0378-1119(96)00054-6; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Moco S, 2007, J EXP BOT, V58, P4131, DOI 10.1093/jxb/erm271; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Nkembo KM, 2005, CHEM PHARM BULL, V53, P780, DOI 10.1248/cpb.53.780; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Thabet I, 2011, J PLANT PHYSIOL, V168, P2110, DOI 10.1016/j.jplph.2011.06.017; THRELFALL DR, 1988, PHYTOCHEMISTRY, V27, P2567, DOI 10.1016/0031-9422(88)87028-6; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vervacke JS, 2013, CURR MED CHEM, V20, P1585; VOGELI U, 1988, PLANT PHYSIOL, V88, P1291, DOI 10.1104/pp.88.4.1291; Wang JJ, 2014, MAR DRUGS, V12, P4274, DOI 10.3390/md12084274; Wang P, 2004, MOL CELLS, V18, P150; Wang Y, 2007, PLANT CELL REP, V26, P1073, DOI 10.1007/s00299-006-0295-2; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yin T, 2011, ACTA PHYSIOL PLANT, V33, P137, DOI 10.1007/s11738-010-0529-3	49	27	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125415	10.1371/journal.pone.0125415	http://dx.doi.org/10.1371/journal.pone.0125415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938487	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000067
J	Mei, ZC; Zhang, DW; Hu, B; Wang, J; Shen, X; Xiao, WH				Mei, Zhichao; Zhang, Dawei; Hu, Bo; Wang, Jing; Shen, Xian; Xiao, Wuhan			FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; muscle atrophy; Myc (c-Myc); oncogene; ubiquitylation (ubiquitination); FBXO32; proteasomal degradation	TRANSCRIPTIONAL ACTIVITY; DEPENDENT DEGRADATION; UBIQUITIN LIGASES; TUMOR-SUPPRESSOR; PROTEIN; EXPRESSION; GENE; PHOSPHORYLATION; IDENTIFICATION; ATROPHY	Background: FBXO32 is an E3 ubiquitin ligase that plays important roles in tumorigenesis and muscle atrophy. Results: c-Myc was found to be a target of FBXO32 for proteasomal degradation. Conclusion: FBXO32 targets Lys-326 of c-Myc to form polyubiquitin chains, resulting in inhibition of cell proliferation. Significance: FBXO32 may mediate c-Myc proteasomal degradation. FBXO32 (MAFbx/Atrogin-1) is an E3 ubiquitin ligase that is markedly up-regulated in muscle atrophy. Although some data indicate that FBXO32 may play an important role in tumorigenesis, the molecular mechanism of FBXO32 in tumorigenesis has been poorly understood. Here, we present evidence that FBXO32 targets the oncogenic protein c-Myc for ubiquitination and degradation through the proteasome pathway. Phosphorylation of c-Myc at Thr-58 and Ser-62 is dispensable for FBXO32 to induce c-Myc degradation. Mutation of the lysine 326 in c-Myc reduces c-Myc ubiquitination and prevents the c-Myc degradation induced by FBXO32. Furthermore, overexpression of FBXO32 suppresses c-Myc activity and inhibits cell growth, but knockdown of FBXO32 enhances c-Myc activity and promotes cell growth. Finally, we show that FBXO32 is a direct downstream target of c-Myc, highlighting a negative feedback regulation loop between c-Myc and FBXO32. Thus, FBXO32 may function by targeting c-Myc. This work explains the function of FBXO32 and highlights its mechanisms in tumorigenesis.	[Mei, Zhichao; Zhang, Dawei; Hu, Bo; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Shen, Xian] Wenzhou Med Univ, Hosp 1, Wenzhou 325000, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Wenzhou Medical University	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022; hu, bo/ABC-3810-2021	hu, bo/0000-0001-5656-9632	CAS Major Scientific and Technological Project [XDA08010208]; NSFC [31461163003, 31071212, 91019008]; Natural Science Foundation of Zhejiang Province [2012C37080]	CAS Major Scientific and Technological Project; NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by CAS Major Scientific and Technological Project XDA08010208; NSFC Grants 31461163003, 31071212, and 91019008 (to W. X.); and the Natural Science Foundation of Zhejiang Province Grant 2012C37080 (to X. S.). The authors declare that they have no conflicts of interest with the contents of this article.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Baltgalvis KA, 2009, PFLUG ARCH EUR J PHY, V457, P989, DOI 10.1007/s00424-008-0574-6; Barsyte-Lovejoy D, 2004, ONCOGENE, V23, P3481, DOI 10.1038/sj.onc.1207487; Bartholomeusz G, 2007, CANCER RES, V67, P3912, DOI 10.1158/0008-5472.CAN-06-4464; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; Ciarapica R, 2014, ONCOGENE, V33, P4173, DOI 10.1038/onc.2013.471; DEAN M, 1986, J BIOL CHEM, V261, P9161; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guo W, 2014, CANCER-AM CANCER SOC, V120, P2412, DOI 10.1002/cncr.28764; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Julie LC, 2012, FEBS LETT, V586, P362, DOI 10.1016/j.febslet.2011.12.031; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lobo VJSA, 2013, ONCOGENE, V32, P5261, DOI 10.1038/onc.2012.621; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; PERSSON H, 1986, MOL CELL BIOL, V6, P942, DOI 10.1128/MCB.6.3.942; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tansey W.P., 2014, NEW J SCI, V2014, P1; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; WATERS CM, 1991, ONCOGENE, V6, P797; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	48	39	47	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16202	16214		10.1074/jbc.M115.645978	http://dx.doi.org/10.1074/jbc.M115.645978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944903	Green Published, hybrid			2022-12-26	WOS:000356930100024
J	Maiorino, L; Farke, AA; Kotsakis, T; Piras, P				Maiorino, Leonardo; Farke, Andrew A.; Kotsakis, Tassos; Piras, Paolo			Males Resemble Females: Re-Evaluating Sexual Dimorphism in Protoceratops andrewsi (Neoceratopsia, Protoceratopsidae)	PLOS ONE			English	Article							DINOSAUR PARK FORMATION; GEOMETRIC MORPHOMETRICS; SIZE DIMORPHISM; EVOLUTION; ORNITHISCHIA; MORPHOLOGY; SKULL; CERATOPSIDAE; SELECTION; BEHAVIOR	Background Protoceratops andrewsi(Neoceratopsia, Protoceratopsidae) is a well-known dinosaur from the Upper Cretaceous of Mongolia. Some previous workers hypothesized sexual dimorphism in the cranial shape of this taxon, using qualitative and quantitative observations. In particular, width and height of the frill as well as the development of a nasal horn have been hypothesized as potentially sexually dimorphic. Methodology/Principal Findings Here, we reassess potential sexual dimorphism in skulls of Protoceratops andrewsiby applying two-dimensional geometric morphometrics to 29 skulls in lateral and dorsal views. Principal Component Analyses and nonparametric MANOVAs recover no clear separation between hypothetical "males" and "females" within the overall morphospace. Males and females thus possess similar overall cranial morphologies. No differences in size between "males" and "females" are recovered using nonparametric ANOVAs. Conclusions/Significance Sexual dimorphism within Protoceratops andrewsiis not strongly supported by our results, as previously proposed by several authors. Anatomical traits such as height and width of the frill, and skull size thus may not be sexually dimorphic. Based on PCA for a data set focusing on the rostrum and associated ANOVA results, nasal horn height is the only feature with potential dimorphism. As a whole, most purported dimorphic variation is probably primarily the result of ontogenetic cranial shape changes as well as intraspecific cranial variation independent of sex.	[Maiorino, Leonardo; Kotsakis, Tassos; Piras, Paolo] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Maiorino, Leonardo; Kotsakis, Tassos; Piras, Paolo] Ctr Evolutionary Ecol, Rome, Italy; [Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA	Roma Tre University	Maiorino, L (corresponding author), Univ Roma Tre, Dipartimento Sci, Rome, Italy.	leonardo.maiorino@uniroma3.it		Piras, Paolo/0000-0001-9832-2742; Farke, Andrew/0000-0002-6930-2002				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-72; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Baab KL, 2012, EVOL ANTHROPOL, V21, P151, DOI 10.1002/evan.21320; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Barden HE, 2011, J VERTEBR PALEONTOL, V31, P641, DOI 10.1080/02724634.2011.557112; BERRY JF, 1980, OECOLOGIA, V44, P185, DOI 10.1007/BF00572678; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 2002, NEUROIMAGE, V15, P233, DOI 10.1006/nimg.2001.0977; BOOKSTEIN FL, 1986, STAT SCI, V1, P181, DOI [10.1214/ss/1177013696, DOI 10.1214/SS/1177013696]; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Butler MA, 2007, NATURE, V447, P202, DOI 10.1038/nature05774; Chapman R.E., 1990, P21, DOI 10.1017/CBO9780511608377.005; Chapman Ralph E., 1997, P83; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS; Dodson P., 1990, P231, DOI 10.1017/CBO9780511608377.020; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; DODSON P, 1976, J PALEONTOL, V50, P929; Dodson P., 1996, THE HORNED DINOSAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Erickson GM, 2005, ZOOLOGY, V108, P277, DOI 10.1016/j.zool.2005.08.001; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; Figueirido B, 2011, PALEOBIOLOGY, V37, P490, DOI 10.1666/09062.1; Foth C, 2015, ACTA ZOOL-STOCKHOLM, V96, P1, DOI 10.1111/azo.12045; Foth C, 2013, ACTA PALAEONTOL POL, V58, P1, DOI 10.4202/app.2011.0145; Frederickson J., 2011, GEOL S AM S, V43S, P119; Frederickson JA, 2014, PEERJ, V2, DOI 10.7717/peerj.252; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Gregory W. K., 1925, American Museum Novitates, V156, P1; Handa N, 2012, PALEONTOL RES, V16, P179, DOI 10.2517/1342-8144-16.3.179; Happ JW, 1996, J VERTEBR PALEONTOL, V16, p40A; Heckert KE, 2002, NM MUS NAT HIST SCI, V21, P179; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Isles TE, 2009, HIST BIOL, V21, P139, DOI 10.1080/08912960903450505; Kurzanov S. M., 1972, PALAEONT J, V1, P91; Lambert Olivier, 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V71 Supplement, P5; Lehman T.M., 1990, P211, DOI 10.1017/CBO9780511608377.019; Lehman Thomas M., 2007, P259; Ljubisavljevic K, 2010, ZOOLOGY, V113, P168, DOI 10.1016/j.zool.2009.09.003; Maiorino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081608; Makovicky P, 2007, J VERTEBR PALEONTOL, V27, p109A; Mallon JC, 2006, CAN FIELD NAT, V120, P403, DOI 10.22621/cfn.v120i4.347; Mallon JC, 2011, J VERTEBR PALEONTOL, V31, P1047, DOI 10.1080/02724634.2011.601484; Marcus Leslie F., 2000, Hystrix, V11, P27; Mead AJ, 2000, PALEOBIOLOGY, V26, P689, DOI 10.1666/0094-8373(2000)026<0689:SDAPIT>2.0.CO;2; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mullin SK, 2002, COMPUT BIOL MED, V32, P455, DOI 10.1016/S0010-4825(02)00037-9; Oksanen J., 2016, R PACKAG; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; Piras P, 2010, EVOL ECOL RES, V12, P897; Prevosti FJ, 2010, AMEGHINIANA, V47, P239, DOI 10.5710/AMGH.v47i2.9; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, P603, DOI 10.1671/0272-4634(2007)27[603:NEOPSA]2.0.CO;2; Rehg JA, 1999, AM J PHYS ANTHROPOL, V110, P95, DOI 10.1002/(SICI)1096-8644(199909)110:1<95::AID-AJPA8>3.0.CO;2-J; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2013, TPSDIG2; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson Scott D., 2001, P263; Sampson Scott D., 1999, Historical Biology, V13, P173; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Schlager S, 2013, MORPHO CALCULATIONS; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Sicuro FL, 2011, BIOL J LINN SOC, V103, P176, DOI 10.1111/j.1095-8312.2011.01636.x; Tereschenko VS, 2008, PALEONTOL J+, V42, P273, DOI 10.1134/S003103010803009X; Tereshchenko V.S., 2001, Paleontologicheskii Zhurnal, V4, P79; Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; [No title captured]	79	14	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126464	10.1371/journal.pone.0126464	http://dx.doi.org/10.1371/journal.pone.0126464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951329	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400095
J	Singh, S; Arcaroli, J; Chen, Y; Thompson, DC; Messersmith, W; Jimeno, A; Vasiliou, V				Singh, Surendra; Arcaroli, John; Chen, Ying; Thompson, David C.; Messersmith, Wells; Jimeno, Antonio; Vasiliou, Vasilis			ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/beta-Catenin, Notch and PI3K/Akt Signaling Pathways	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1A1; CANCER STEM-CELLS; COLORECTAL-CANCER; BETA-CATENIN; C-MYC; WNT; EXPRESSION; PROLIFERATION; TRANSCRIPTION; ACTIVATION	In the normal human colon, aldehyde dehydrogenase 1B1 (ALDH1B1) is expressed only at the crypt base, along with stem cells. It is also highly expressed in the human colonic adenocarcinomas. This pattern of expression corresponds closely to that observed for Wnt/acatenin signaling activity. The present study examines the role of ALDH1B1 in colon tumorigenesis and signalling pathways mediating its effects. In a 3-dimensional spheroid growth model and a nude mouse xenograft tumor model, shRNA-induced suppression of ALDH1B1 expression decreased the number and size of spheroids formed in vitro and the size of xenograft tumors formed in vivo by SW 480 cells. Six binding elements for Wnt/acatenin signalling transcription factor binding elements (T-cell factor/lymphoid enhancing factor) were identified in the human ALDH1B1 gene promoter (3 kb) but shown by dual luciferase reporter assay to not be necessary for ALDH1B1 mRNA expression in colon adenocarcinoma cell lines. We examined Wnt-reporter activity and protein/mRNA expression for Wnt, Notch and PI3K/Akt signaling pathways. Wnt/beta-catenin, Notch and PI3K/Akt-signaling pathways were down-regulated in SW480 cells in which ALDH1B1 expression had been suppressed. In summary, our data demonstrate that ALDH1B1 may promote colon cancer tumorigenesis by modulating the Wnt/beta-catenin, Notch and PI3K/Akt signaling pathways. Selective targeting of ALDH1B1 may represent a novel means to prevent or treat colon cancer.	[Singh, Surendra; Chen, Ying; Vasiliou, Vasilis] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Arcaroli, John; Messersmith, Wells; Jimeno, Antonio] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO USA; [Chen, Ying; Vasiliou, Vasilis] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA; [Thompson, David C.] Univ Colorado, Dept Clin Pharm, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus	Vasiliou, V (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	vasilis.vasiliou@yale.edu		vasiliou, vasilis/0000-0003-2552-3118	National Institutes of Health [5R24AA022057, 1U01AA021724]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022057, U01AA021724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported by the following: National Institutes of Health 5R24AA022057 (VV); and National Institutes of Health 1U01AA021724 (VV).	Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bartley AN, 2013, CANCER PREV RES, V6, P1162, DOI 10.1158/1940-6207.CAPR-13-0113; Chen C, 2013, BIOCHEM BIOPH RES CO, V430, P505, DOI 10.1016/j.bbrc.2012.12.006; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; ERISMAN MD, 1988, ONCOGENE, V2, P367; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Girish V, 2004, Indian J Cancer, V41, P47; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Hao XP, 2001, CANCER RES, V61, P419; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jackson BC, 2014, PHARM RES; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Johnson SM, 2010, J AM COLL SURGEONS, V210, P767, DOI 10.1016/j.jamcollsurg.2009.12.008; Koshiyama A, 2013, BIOMED CHROMATOGR, V27, P440, DOI 10.1002/bmc.2811; Li X, 2012, J THORAC ONCOL, V7, P1235, DOI 10.1097/JTO.0b013e318257cc6d; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mao CD, 2011, CRIT REV EUKAR GENE, V21, P207, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.10; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Miyamoto S, 2011, CANCER SCI, V102, P1938, DOI 10.1111/j.1349-7006.2011.02049.x; Modak C, 2010, WORLD J GASTROENTERO, V16, P2195, DOI 10.3748/wjg.v16.i18.2195; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Qian J, 2013, MOL MED REP, V8, P1055, DOI 10.3892/mmr.2013.1604; Qiao L, 2009, CARCINOGENESIS, V30, P1979, DOI 10.1093/carcin/bgp236; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Rubinfeld B, 1997, CANCER RES, V57, P4624; Sanders MA, 2011, FRONT BIOSCI-LANDMRK, V16, P1651, DOI 10.2741/3811; Schewe DM, 2003, CLIN CANCER RES, V9, P2267; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Song LJ, 2012, J MOL MED, V90, P707, DOI 10.1007/s00109-011-0851-2; Stagos D, 2010, DRUG METAB DISPOS, V38, P1679, DOI 10.1124/dmd.110.034678; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUZUKI H, 1995, P NATL ACAD SCI USA, V92, P4442, DOI 10.1073/pnas.92.10.4442; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yang L, 2013, MODERN PATHOL, P1; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102; Zhang HX, 2008, CANCER BIOTHER RADIO, V23, P229, DOI 10.1089/cbr.2007.0441	59	40	42	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0121648	10.1371/journal.pone.0121648	http://dx.doi.org/10.1371/journal.pone.0121648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950950	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400004
J	Gierczyk, B; Ceglowski, M; Zalas, M				Gierczyk, Blazej; Ceglowski, Michal; Zalas, Maciej			New Gel-Like Polymers As Selective Weak-Base Anion Exchangers	PLOS ONE			English	Article							ADSORPTION-ISOTHERMS; REMOVAL; SORPTION; CHITOSAN; WATER; ARSENIC(V); ARSENATE; RECOVERY	A group of new anion exchangers, based on polyamine podands and of excellent ion-binding capacity, were synthesized. The materials were obtained in reactions between various poly(ethyleneamines) with glycidyl derivatives of cyclotetrasiloxane. The final polymeric, strongly cross-linked materials form gel-like solids. Their structures and interactions with anions adsorbed were studied by spectroscopic methods (CP-MAS NMR, FR-IR, UV-Vis). The sorption isotherms and kinetic parameters were determined for 29 anions. Materials studied show high ion capacity and selectivity towards some important anions, e.g., selenate(VI) or perrhenate.	[Gierczyk, Blazej; Ceglowski, Michal; Zalas, Maciej] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland	Adam Mickiewicz University	Gierczyk, B (corresponding author), Adam Mickiewicz Univ, Fac Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	hanuman@amu.edu.pl	Gierczyk, Błażej/M-4521-2018; Zalas, Maciej/AAY-3801-2020	Gierczyk, Błażej/0000-0003-3376-5467; Zalas, Maciej/0000-0002-0702-1213; Ceglowski, Michal/0000-0002-8257-642X	Polish National Science Centre (Narodowe Centrum Nauki-NCN) [N N204 155840]	Polish National Science Centre (Narodowe Centrum Nauki-NCN)	Support was provided to BG: grant no. N N204 155840: Polish National Science Centre (Narodowe Centrum Nauki-NCN), (www.ncn.gov.pl).	Awual MR, 2013, ENVIRON SCI POLLUT R, V20, P421, DOI 10.1007/s11356-012-0936-7; Awual MR, 2008, WATER RES, V42, P689, DOI 10.1016/j.watres.2007.08.020; Awual MR, 2014, MICROPOR MESOPOR MAT, V197, P331, DOI 10.1016/j.micromeso.2014.07.005; Awual MR, 2011, DESALINATION, V281, P111, DOI 10.1016/j.desal.2011.07.047; Awual MR, 2011, J HAZARD MATER, V188, P164, DOI 10.1016/j.jhazmat.2011.01.092; Awual MR, 2009, WATER RES, V43, P1229, DOI 10.1016/j.watres.2008.12.018; Barbaro P, 2009, CHEM REV, V109, P515, DOI 10.1021/cr800404j; Boddu VM, 2008, WATER RES, V42, P633, DOI 10.1016/j.watres.2007.08.014; Chassary P, 2004, REACT FUNCT POLYM, V60, P137, DOI 10.1016/j.reactfunctpolym.2004.02.018; CHICZ RM, 1986, J CHROMATOGR, V359, P121, DOI 10.1016/0021-9673(86)80067-X; Dbrowski A, 1996, ADSORPTION NEW MODIF; Deng SB, 2008, LANGMUIR, V24, P10961, DOI 10.1021/la8023138; Depecker G, 2009, REACT FUNCT POLYM, V69, P877, DOI 10.1016/j.reactfunctpolym.2009.09.002; FOGG AG, 1971, ANALYST, V96, P854, DOI 10.1039/an9719600854; Gerente C, 2010, CHEM ENG J, V158, P593, DOI 10.1016/j.cej.2010.02.005; Gierczyk B, 2011, REACT FUNCT POLYM, V71, P463, DOI 10.1016/j.reactfunctpolym.2011.01.007; Guibal E, 1998, IND ENG CHEM RES, V37, P1454, DOI 10.1021/ie9703954; Guibal E, 1999, POLYM INT, V48, P671; Guimaraes D, 2014, J HAZARD MATER, V280, P209, DOI 10.1016/j.jhazmat.2014.07.071; Hibino T, 2014, APPL CLAY SCI, V87, P150, DOI 10.1016/j.clay.2013.10.024; Hickner MA, 2013, J POLYM SCI POL PHYS, V51, P1727, DOI 10.1002/polb.23395; Kailasam V, 2012, HYDROMETALLURGY, V129, P97, DOI 10.1016/j.hydromet.2012.08.010; Kim EM, 2004, J KOREAN MED SCI, V19, P647, DOI 10.3346/jkms.2004.19.5.647; Kumar KV, 2006, J HAZARD MATER, V134, P277, DOI 10.1016/j.jhazmat.2005.11.003; LEYDEN DE, 1976, ANAL CHEM, V48, P67, DOI 10.1021/ac60365a015; Liu Y, 2006, COLLOID SURFACE A, V274, P34, DOI 10.1016/j.colsurfa.2005.08.029; Loganathan P, 2013, J ENVIRON MANAGE, V131, P363, DOI 10.1016/j.jenvman.2013.09.034; MISAK NZ, 1995, COLLOID SURFACE A, V97, P129, DOI 10.1016/0927-7757(94)03073-9; Misak NZ, 2000, REACT FUNCT POLYM, V43, P153, DOI 10.1016/S1381-5148(99)00046-2; Mustafa S, 2010, WATER AIR SOIL POLL, V210, P43, DOI 10.1007/s11270-009-0221-7; Nishimura T, 2007, SEPAR SCI TECHNOL, V42, P3155, DOI 10.1080/01496390701513107; Pande SV, 2011, ION EXCHANGE RESINS; Pillewan P, 2014, ENVIRON PROG SUSTAIN, V33, P1274, DOI 10.1002/ep.11933; Roundhill DM, 2002, CHEM SOC REV, V31, P60, DOI 10.1039/b003141k; Srikanth MV, 2010, ION EXCHANGE RESINS; Walcarius A, 2010, J MATER CHEM, V20, P4478, DOI 10.1039/b924316j; Zhu LL, 2010, J MATER CHEM, V20, P1553, DOI 10.1039/b912345h	37	7	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0122891	10.1371/journal.pone.0122891	http://dx.doi.org/10.1371/journal.pone.0122891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946220	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700009
J	Harb, R; Taulor, JR				Harb, Roa; Taulor, Jane R.			The Fragrant Power of Collective Fear	PLOS ONE			English	Article							CONDITIONED FEAR; MECHANISMS; INHIBITION; EXTINCTION; EXPRESSION; AMYGDALA; MEMORY; SYSTEM	Fear is a well-characterized biological response to threatening or stressful situations in humans and other social animals. Importantly, fearful stimuli in the natural environment are likely to be encountered concurrently by a group of animals. The modulation of fear acquisition and fear memory by a group as opposed to an individual experience, however, remains largely unknown. Here, we demonstrate a robust reduction in fear memory to an aversive event undertaken in a group despite similar fear learning between individually- and group-conditioned rats. This reduction persists outside the group confines, appears to be a direct outcome of group cognizance and is counteracted by loss of olfactory signaling among the group members. These results show that a group experience of fear can be protective and suggest that distinct neural pathways from those classically studied in individuals modulate collective fear memories.	[Harb, Roa] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Taulor, Jane R.] Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat, New Haven, CT 06520 USA	Yale University; Yale University	Taulor, JR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat, New Haven, CT 06520 USA.	jane.taylor@yale.edu			Interdisciplinary Research Consortium [RL-AA017537]; Brian Smith; National Institute of Health; National Institute on Drug Abuse [RO1 DA015222];  [UL1-DE19586];  [2 T32 HL007974-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015222] Funding Source: NIH RePORTER	Interdisciplinary Research Consortium; Brian Smith; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work received support from the following sources: UL1-DE19586, Rajita Sinha (Director), Interdisciplinary Research Consortium RL-AA017537, PI: RH, co-PI: JRT; 2 T32 HL007974-11, Brian Smith (PI), National Institute of Health, Trainee/Postdoctoral fellow: RH; and RO1 DA015222, National Institute on Drug Abuse, PI: JRT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anagnostaras SG, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00158; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Bredy TW, 2009, LEARN MEMORY, V16, P12, DOI 10.1101/lm.1226009; Bruchey AK, 2010, BEHAV BRAIN RES, V214, P80, DOI 10.1016/j.bbr.2010.04.047; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Guzman YF, 2009, BEHAV BRAIN RES, V201, P173, DOI 10.1016/j.bbr.2009.02.024; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Kiyokawa Y, 2014, BEHAV BRAIN RES, V267, P189, DOI 10.1016/j.bbr.2014.03.043; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kollack-Walker S, 1999, J NEUROENDOCRINOL, V11, P547; Langford DJ, 2010, SOC NEUROSCI-UK, V5, P163, DOI 10.1080/17470910903216609; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Masini CV, 2010, BEHAV BRAIN RES, V207, P70, DOI 10.1016/j.bbr.2009.09.038; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Sanders J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074609; Santiago PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059236; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123908	10.1371/journal.pone.0123908	http://dx.doi.org/10.1371/journal.pone.0123908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25945800	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700024
J	Wang, Z; Ke, Q; Kim, MD; Kim, SH; Ji, CY; Jeong, JC; Lee, HS; Park, WS; Ahn, MJ; Li, HB; Xu, BC; Deng, XP; Lee, SH; Lim, YP; Kwak, SS				Wang, Zhi; Ke, Qingbo; Kim, Myoung Duck; Kim, Sun Ha; Ji, Chang Yoon; Jeong, Jae Cheol; Lee, Haeng-Soon; Park, Woo Sung; Ahn, Mi-Jeong; Li, Hongbing; Xu, Bingcheng; Deng, Xiping; Lee, Sang-Hoon; Lim, Yong Pyo; Kwak, Sang-Soo			Transgenic Alfalfa Plants Expressing the Sweetpotato Orange Gene Exhibit Enhanced Abiotic Stress Tolerance	PLOS ONE			English	Article							SALT-STRESS; CAROTENOID ACCUMULATION; TOBACCO PLANTS; BETA-CAROTENE; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION; LIPID-PEROXIDATION; DROUGHT; GROWTH; PROLINE	Alfalfa (Medicago sativa L.), a perennial forage crop with high nutritional content, is widely distributed in various environments worldwide. We recently demonstrated that the sweetpotato Orange gene (IbOr) is involved in increasing carotenoid accumulation and enhancing resistance to multiple abiotic stresses. In this study, in an effort to improve the nutritional quality and environmental stress tolerance of alfalfa, we transferred the IbOr gene into alfalfa (cv. Xinjiang Daye) under the control of an oxidative stress-inducible peroxidase (SWPA2) promoter through Agrobacterium tumefaciens-mediated transformation. Among the 11 transgenic alfalfa lines (referred to as SOR plants), three lines (SOR2, SOR3, and SOR8) selected based on their IbOr transcript levels were examined for their tolerance to methyl viologen (MV)-induced oxidative stress in a leaf disc assay. The SOR plants exhibited less damage in response to MV-mediated oxidative stress and salt stress than non-transgenic plants. The SOR plants also exhibited enhanced tolerance to drought stress, along with higher total carotenoid levels. The results suggest that SOR alfalfa plants would be useful as forage crops with improved nutritional value and increased tolerance to multiple abiotic stresses, which would enhance the development of sustainable agriculture on marginal lands.	[Wang, Zhi; Ke, Qingbo; Kim, Myoung Duck; Kim, Sun Ha; Ji, Chang Yoon; Jeong, Jae Cheol; Lee, Haeng-Soon; Kwak, Sang-Soo] KRIBB, Plant Syst Engn Res Ctr, Taejon 3054432, South Korea; [Wang, Zhi; Lim, Yong Pyo] Chungnam Natl Univ, Dept Hort, Taejon, South Korea; [Wang, Zhi; Li, Hongbing; Xu, Bingcheng; Deng, Xiping] Chinese Acad Sci, State Key Lab Soil Eros & Dryland Farming Loess P, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Wang, Zhi; Li, Hongbing; Xu, Bingcheng; Deng, Xiping] Northwest A&F Univ, Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Lee, Sang-Hoon] Natl Inst Anim Sci, Rural Dev Adm, Grassland & Forages Div, Cheonan, South Korea; [Park, Woo Sung; Ahn, Mi-Jeong] Gyeongsang Natl Univ, Coll Pharm, Jinju, South Korea; [Park, Woo Sung; Ahn, Mi-Jeong] Gyeongsang Natl Univ, Pharmaceut Sci Res Inst, Jinju, South Korea; [Ke, Qingbo; Ji, Chang Yoon; Jeong, Jae Cheol; Lee, Haeng-Soon; Kwak, Sang-Soo] Korea Univ Sci & Technol, Dept Green Chem & Environm Biotechnol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Gyeongsang National University; Gyeongsang National University	Kwak, SS (corresponding author), KRIBB, Plant Syst Engn Res Ctr, Taejon 3054432, South Korea.	sskwak@kribb.re.kr		Xu, Bingcheng/0000-0002-1702-491X; Park, Woo Sung/0000-0001-6854-1688; deng, xi ping/0000-0003-4577-9217	KRIBB Initiative program; Korea-China International Collaboration Project; National Research Foundation of Korea (NRF); National Natural Science Foundation of China, China [51479189]; 111 project of the Ministry of Education, China [B12007]	KRIBB Initiative program; Korea-China International Collaboration Project; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); 111 project of the Ministry of Education, China	This work was supported by grants from the KRIBB Initiative program, the Korea-China International Collaboration Project, National Research Foundation of Korea (NRF), the National Natural Science Foundation of China (No. 51479189), China and the 111 project of the Ministry of Education, China (No. B12007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2008, PLANT CELL REP, V27, P687, DOI 10.1007/s00299-007-0479-4; Ahn YJ, 2006, PLANT CELL ENVIRON, V29, P95, DOI 10.1111/j.1365-3040.2005.01403.x; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; AUER T, 1995, TRANSPL P, V27, P2749; Bai C, 2014, PLANT J, V77, P464, DOI 10.1111/tpj.12384; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; CHADWICK CA, 1995, J PHOTOCH PHOTOBIO B, V28, P163, DOI 10.1016/1011-1344(94)07096-7; Chao YH, 2009, MOL BIOL REP, V36, P2315, DOI 10.1007/s11033-009-9450-5; Chen TT, 2012, MOL BIOL REP, V39, P6067, DOI 10.1007/s11033-011-1421-y; Cuevas HE, 2009, THEOR APPL GENET, V119, P741, DOI 10.1007/s00122-009-1085-3; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Goo YM, 2015, CR BIOL, V338, P12, DOI 10.1016/j.crvi.2014.10.006; Gotz T, 2002, PLANT MOL BIOL, V50, P129, DOI 10.1023/A:1016072218801; Han HP, 2008, BIOTECHNOL LETT, V30, P1501, DOI 10.1007/s10529-008-9705-6; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Kim GB, 2013, J PLANT PHYSIOL, V170, P291, DOI 10.1016/j.jplph.2012.10.004; Kim KY, 2003, PLANT MOL BIOL, V51, P831, DOI 10.1023/A:1023045218815; Kim SH, 2005, BIOTECHNOL LETT, V27, P1841, DOI 10.1007/s10529-005-3891-2; Kim SH, 2013, PLANT PHYSIOL BIOCH, V70, P445, DOI 10.1016/j.plaphy.2013.06.011; Kim SH, 2013, PHYSIOL PLANTARUM, V147, P432, DOI 10.1111/j.1399-3054.2012.01688.x; Kim SH, 2012, PHYTOCHEMISTRY, V74, P69, DOI 10.1016/j.phytochem.2011.11.003; Kim YH, 2011, PLANT BIOTECHNOL J, V9, P334, DOI 10.1111/j.1467-7652.2010.00551.x; Kwon SY, 2002, PLANT CELL ENVIRON, V25, P873, DOI 10.1046/j.1365-3040.2002.00870.x; Li L, 2013, ARCH BIOCHEM BIOPHYS, V539, P102, DOI 10.1016/j.abb.2013.07.002; Li L, 2012, MOL PLANT, V5, P339, DOI 10.1093/mp/ssr099; Liu HY, 2007, CELL RES, V17, P638, DOI 10.1038/cr.2007.34; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Ma QQ, 2006, J PLANT PHYSIOL, V163, P165, DOI 10.1016/j.jplph.2005.04.023; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Park SC, 2015, PLANT PHYSIOL BIOCH, V86, P82, DOI 10.1016/j.plaphy.2014.11.017; Radovic J., 2009, Biotechnology in Animal Husbandry, V25, P465; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wang Z, 2014, PLANT PHYSIOL BIOCH, V84, P67, DOI 10.1016/j.plaphy.2014.08.025; Wise AA, 2006, METH MOL B, V343, P43; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	47	41	46	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126050	10.1371/journal.pone.0126050	http://dx.doi.org/10.1371/journal.pone.0126050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946429	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700106
J	Wu, L; Clamp, JC; Yi, ZZ; Li, JQ; Lin, XF				Wu, Lei; Clamp, John C.; Yi, Zhenzhen; Li, Jiqiu; Lin, Xiaofeng			Phylogenetic and Taxonomic Revision of an Enigmatic Group of Haptorian Ciliates, with Establishment of the Kentrophyllidae fam. n. (Protozoa, Ciliophora, Litostomatea, Pleurostomatida)	PLOS ONE			English	Article							NOV SPEC. CILIOPHORA; MOLECULAR PHYLOGENY; MARINE; MORPHOLOGY; CHINA; CLASSIFICATION; EMPHASIS; GENUS; SEA	Haptorian ciliates in the closely similar genera Kentrophyllum and Epiphyllum possess a unique pattern of ciliature and are distinguished from one another only by the presence or absence of cytoplasmic spines projecting from the margin of the cell. Phylogenetic analyses based on SSU rDNA sequences of three new samples from coastal habitats in China revealed that species in the two genera clustered together indiscriminately (i.e. forms of neither genus clustered into an independent clade) as a maximally supported, monophyletic clade that branches basally to all other clades in the order Pleurostomatida and is strongly divergent from other members of the family in which the genera have been placed. As a result, we propose that Epiphyllum be synonymized with Kentrophyllum and that a new family Kentrophyllidae fam. n. be established for the genus. We hypothesize that the two-sutures of Kentrophyllum is a plesiomorphy within the Pleurostomatida and the unique peripheral kinety might represent an autapomorphy of Kentrophyllum. In addition, we provide a taxonomic revision of Kentrophyllum including description of three new species (K. bispinum sp. n., K. strumosum sp. n., and K. qingdaoensesp. n.), redescription of K. verrucosum (Stokes, 1893) Petz et al., 1995, and three new combinations (K. soliforme(Faure-Fremiet, 1908) comb. n., K. hohuensis(Wang and Nie, 1933) comb. n. and K. shenzhenense(Pan et al., 2010) comb. n.). The surface ultrastructure of the genus Kentrophyllum is recorded for the first time. And a key to all known species of Kentrophyllum was also suggested.	[Wu, Lei; Yi, Zhenzhen; Li, Jiqiu; Lin, Xiaofeng] S China Normal Univ, Lab Protozool, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou 510631, Guangdong, Peoples R China; [Clamp, John C.] N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA	South China Normal University; University of North Carolina; North Carolina Central University	Lin, XF (corresponding author), S China Normal Univ, Lab Protozool, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou 510631, Guangdong, Peoples R China.	xlin@scnu.edu.cn	Wu, Lei/E-2202-2013	Wu, Lei/0000-0002-0036-4141	National Natural Science Foundation of China [31222050, 31172060, 31430077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China (projects numbers: 31222050, 31172060, 31430077) (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheid KAS, 1997, ARAB GULF J SCI RES, V15, P733; Carey P.G, 1992, MARINE INTERSTITIAL; Corliss J.O., 1979, CILIATED PROTOZOA CH, V2nd, DOI [10.1016/C2013-0-02659-X, DOI 10.1016/C2013-0-02659-X]; CZAPIK A, 1976, ACTA PROTOZOOL, V15, P423; DRAGESCO J, 1965, CAH BIOL MAR, V6, P357; Dragesco J, 1954, B SOC ZOOL FR, V79; Dragesco J., 1960, TRAV STAT BIOL ROSCO, V12; Faure-Fremiet E, 1908, B SOC ZOOL FR, V33, P13; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foissner W., 1995, Informationsberichte des Bayerischen Landesamtes fuer Wasserwirtschaft, V1, P1; FOISSNER W, 1995, J EUKARYOT MICROBIOL, V42, P476, DOI 10.1111/j.1550-7408.1995.tb05894.x; Foissner W, 1992, PROTOCOLS PROTOZOOLO; Gao S, 2008, J EUKARYOT MICROBIOL, V55, P562, DOI 10.1111/j.1550-7408.2008.00360.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jones EE., 1974, U S ALABAMA MONOGR, V1, P1; Kahl A., 1933, Grimpe's Tierwelt der Nord-und Ostsee Leipzig Lfg, V23, P29; Kahl A, 1931, TIERWELT DTL, V21, P1931; Kwon CB, 2014, J EUKARYOT MICROBIOL, V61, P278, DOI 10.1111/jeu.12105; Lin XF, 2005, EUR J PROTISTOL, V41, P163, DOI 10.1016/j.ejop.2005.01.002; Lin XF, 2005, ACTA PROTOZOOL, V44, P147; Lin XF, 2005, ACTA PROTOZOOL, V44, P129; Lin XF, 2004, J EUKARYOT MICROBIOL, V51, P618, DOI 10.1111/j.1550-7408.2004.tb00595.x; Lin XF, 2008, J EUKARYOT MICROBIOL, V55, P331, DOI 10.1111/j.1550-7408.2008.00332.x; Lin XF, 2007, EUR J PROTISTOL, V43, P131, DOI 10.1016/j.ejop.2006.12.004; Lin XF, 2007, EUR J PROTISTOL, V43, P77, DOI 10.1016/j.ejop.2006.10.002; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Nylander J. A. A., 2004, MRMODELTEST V2 DISTR; Pan HB, 2014, J EUKARYOT MICROBIOL, V61, P644, DOI 10.1111/jeu.12146; Pan HB, 2013, J EUKARYOT MICROBIOL, V60, P44, DOI 10.1111/jeu.12005; Pan HB, 2010, J EUKARYOT MICROBIOL, V57, P421, DOI 10.1111/j.1550-7408.2010.00492.x; Petran A., 1963, Stud Oercet Biol Acad RPR Ser Biol Anitn, V15, P187; Petz Wolfgang, 1995, Stapfia, V40, P1; Quennerstedt A., 1867, ACTA U LUND, V4, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAUERBREY ERNESTINE, 1928, ARCH PROTISTENK, V62, P355; SHIGEMATSU AKIYO, 1953, JOUR SCL HIROSHIMA U SER B DIV 1 ZOOL, V14, P47; Song WB., 1989, LAUTERBORNIA, V3, P2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stokes AC., 1893, J R MICR SOC, V1, P298; Struder-Kypke MC, 2006, PROTIST, V157, P261, DOI 10.1016/j.protis.2006.03.003; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vd'acny P, 2014, PROTIST, V165, P93, DOI 10.1016/j.protis.2013.11.001; Vd'acny P, 2011, EUR J PROTISTOL, V47, P295, DOI 10.1016/j.ejop.2011.04.006; Vd'acny P, 2011, MOL PHYLOGENET EVOL, V59, P510, DOI 10.1016/j.ympev.2011.02.016; Vdacny P, 2013, ZOOL SCR, V42, P529, DOI 10.1111/zsc.12023; WANG CHIA CHI, 1932, CONTR BIOL LAB SCI SOC CHINA ZOOL SER, V8, P285; WANG ChIA CHI, 1933, CONTR BIOL LAB SCI SOC CHINA ZOOL SER, V10, P1; Wilbert N, 2005, J NAT HIST, V39, P935, DOI 10.1080/00222930400001509; WILBERT N, 1975, Mikrokosmos, V64, P171; Wu L, 2014, J EUKARYOT MICROBIOL, V61, P115, DOI 10.1111/jeu.12089; Wu L, 2013, J EUKARYOT MICROBIOL, V60, P267, DOI 10.1111/jeu.12032; Yagiu R., 1943, J SCI HIROSHIMA U B, V10, P21; Zhang QQ, 2012, P ROY SOC B-BIOL SCI, V279, P2625, DOI 10.1098/rspb.2011.2688	53	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123720	10.1371/journal.pone.0123720	http://dx.doi.org/10.1371/journal.pone.0123720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946216	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700020
J	Cheng, QY; Seltzer, Z; Sima, C; Lakschevitz, FS; Glogauer, M				Cheng, Quyen; Seltzer, Ze'ev; Sima, Corneliu; Lakschevitz, Flavia S.; Glogauer, Michael			Quantitative Trait Loci and Candidate Genes for Neutrophil Recruitment in Sterile Inflammation Mapped in AXB-BXA Recombinant Inbred Mice	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RESOLUTION; MIGRATION; ARTHRITIS; INFILTRATION; SITES; HIF-1	Neutrophil recruitment (NR) to sites of sterile inflammation plays a key role in tissue damage and healing potential of lesions characteristic to non-infectious inflammatory diseases. Previous studies suggested significant genetic control of neutrophil survival, function, and migration in inflammatory responses to endogenous and exogenous stimuli. We have mapped the murine genome for quantitative trait loci (QTLs) harbouring genetic determinants that regulate NR in SI using a murine model of chemically-induced peritonitis. NR was quantified in 16 AXB-BXA recombinant inbred strains and their progenitors, A/J (A) and C57BL/6J (B). A continuous distribution of NR was found among the strains, with parent B showing higher NR and parent A showing lower NR (3.0-fold difference, p=0.05). Within the progeny strains, a 5.5-fold difference in NR was observed between the lowest, BXA1, and the highest responders AXB19 (p<0.001). This data was analyzed using GeneNetwork, which linked NR to one significant QTL on chromosome 12 (Peritoneal Neutrophil Recruitment 1, PNR1) and two suggestive QTLs (PNR2, PNR3) on chromosomes 12 and 16 respectively. Sixty-four candidate genes within PNR1 were cross-referenced with currently published data, mRNA expression from two NR microarrays, and single nucleotide polymorphism analysis. The present study brings new light into the genetics of NR in response to cell injury and highlights potential candidate genes Hif1 alpha, Fntb, and Prkch and their products for further studies on neutrophil infiltration and inflammation resolution in sterile inflammation.	[Cheng, Quyen; Sima, Corneliu; Lakschevitz, Flavia S.; Glogauer, Michael] Univ Toronto, Fac Dent, Dept Periodontol, Toronto, ON, Canada; [Cheng, Quyen; Sima, Corneliu; Lakschevitz, Flavia S.; Glogauer, Michael] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada; [Seltzer, Ze'ev] Univ Toronto, Fac Dent, Ctr Study Pain, Toronto, ON, Canada; [Seltzer, Ze'ev] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto	Glogauer, M (corresponding author), Univ Toronto, Fac Dent, Dept Periodontol, Toronto, ON, Canada.	michael.glogauer@utoronto.ca	Glogauer, Michael/D-2504-2011	Sima, Corneliu/0000-0003-3526-4850	Canadian Institutes of Health Research grant [TBO-122068]; Alpha Omega postdoctoral education research grant	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Alpha Omega postdoctoral education research grant	This work was supported by Canadian Institutes of Health Research grant TBO-122068 (to M.G.); Alpha Omega postdoctoral education research grant (to Q.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Borrego-Pinto J, 2012, J CELL SCI, V125, P1099, DOI 10.1242/jcs.087049; Brandao KE, 2012, J COMP NEUROL, V520, P81, DOI 10.1002/cne.22692; Chan J, 1998, BLOOD, V92, P1423, DOI 10.1182/blood.V92.4.1423.416k31_1423_1431; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; DOWNEY GP, 1993, J CELL PHYSIOL, V155, P505, DOI 10.1002/jcp.1041550309; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Esworthy RS, 2005, J NUTR, V135, P740, DOI 10.1093/jn/135.4.740; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gallagher RCJ, 2010, VOX SANG, V98, pe290, DOI 10.1111/j.1423-0410.2009.01299.x; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jiang N, 2005, J LEUKOCYTE BIOL, V77, P296, DOI 10.1189/jlb.0704411; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Laragione T, 2007, GENES IMMUN, V8, P147, DOI 10.1038/sj.gene.6364371; Laragione T, 2007, J IMMUNOL, V178, P2344, DOI 10.4049/jimmunol.178.4.2344; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; MARSHALL JD, 1992, MAMM GENOME, V3, P669, DOI 10.1007/BF00444361; Matesic LE, 2000, FASEB J, V14, P2247, DOI 10.1096/fj.99-1051com; METCALF D, 1995, BLOOD, V85, P2364, DOI 10.1182/blood.V85.9.2364.bloodjournal8592364; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sparkenbaugh EM, 2011, J PHARMACOL EXP THER, V338, P492, DOI 10.1124/jpet.111.180521; Takata Y, 2007, ARTHRITIS RHEUM-US, V56, P30, DOI 10.1002/art.22262; Talishinsky A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044236; Visscher PM, 1996, GENETICS, V143, P1013; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wang WB, 2009, MOL BIOTECHNOL, V43, P221, DOI 10.1007/s12033-009-9199-z; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zhang SG, 2012, INFECT IMMUN, V80, P3952, DOI 10.1128/IAI.00696-12	43	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124117	10.1371/journal.pone.0124117	http://dx.doi.org/10.1371/journal.pone.0124117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942439	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400012
J	Chinzei, N; Hayashi, S; Ueha, T; Fujishiro, T; Kanzaki, N; Hashimoto, S; Sakata, S; Kihara, S; Haneda, M; Sakai, Y; Kuroda, R; Kurosaka, M				Chinzei, Nobuaki; Hayashi, Shinya; Ueha, Takeshi; Fujishiro, Takaaki; Kanzaki, Noriyuki; Hashimoto, Shingo; Sakata, Shuhei; Kihara, Shinsuke; Haneda, Masahiko; Sakai, Yoshitada; Kuroda, Ryosuke; Kurosaka, Masahiro			P21 Deficiency Delays Regeneration of Skeletal Muscular Tissue	PLOS ONE			English	Article							MUSCLE INJURIES; EXPRESSION; DIFFERENTIATION; RECOVERY; LAMININ; P21(CIP1/WAF1); REPLICATION; PREVENTION; DYSTROPHIN; REPAIR	The potential relationship between cell cycle checkpoint control and tissue regeneration has been indicated. Despite considerable research being focused on the relationship between p21 and myogenesis, p21 function in skeletal muscle regeneration remains unclear. To clarify this, muscle injury model was recreated by intramuscular injection of bupivacaine hydrochloride in the soleus of p21 knockout (KO) mice and wild type (WT) mice. The mice were sacrificed at 3, 14, and 28 days post-operation. The results of hematoxylin-eosin staining and immunofluorescence of muscle membrane indicated that muscle regeneration was delayed in p21 KO mice. Cyclin D1 mRNA expression and both Ki-67 and PCNA immunohistochemistry suggested that p21 deficiency increased cell cycle and muscle cell proliferation. F4/80 immunohistochemistry also suggested the increase of immune response in p21 KO mice. On the other hand, both the mRNA expression and western blot analysis of MyoD, myogenin, and Pax7 indicated that muscular differentiation was delayed in p21KO mice. Considering these results, we confirmed that muscle injury causes an increase in cell proliferation. However, muscle differentiation in p21 KO mice was inhibited due to the low expression of muscular synthesis genes, leading to a delay in the muscular regeneration. Thus, we conclude that p21 plays an important role in the in vivo healing process in muscular injury.	[Chinzei, Nobuaki; Hayashi, Shinya; Fujishiro, Takaaki; Kanzaki, Noriyuki; Hashimoto, Shingo; Sakata, Shuhei; Kihara, Shinsuke; Haneda, Masahiko; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthoped Surg, Kobe, Hyogo 657, Japan; [Ueha, Takeshi; Sakai, Yoshitada] Kobe Univ, Grad Sch Med, Div Rehabil Med, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Hayashi, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Orthoped Surg, Kobe, Hyogo 657, Japan.	shayashi@med.kobe-u.ac.jp		Kihara, Shinsuke/0000-0002-5901-6627				Agley CC, 2012, J HISTOCHEM CYTOCHEM, V60, P428, DOI 10.1369/0022155412442897; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Apponi LH, 2011, TRENDS PHARMACOL SCI, V32, P652, DOI 10.1016/j.tips.2011.06.004; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Baple EL, 2014, J CLIN INVEST, V124, P3137, DOI 10.1172/JCI74593; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Chan YS, 2005, AM J SPORT MED, V33, P43, DOI 10.1177/0363546504265190; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; de Souza J, 2013, J ELECTROMYOGR KINES, V23, P1253, DOI 10.1016/j.jelekin.2013.07.009; DICKSON G, 1992, J CELL SCI, V103, P1223; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Figliola R, 2004, J CELL PHYSIOL, V200, P468, DOI 10.1002/jcp.20044; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALLCRAGGS ECB, 1975, EXP NEUROL, V46, P345, DOI 10.1016/0014-4886(75)90140-5; Horie M, 2014, J APPL PHYSIOL, V116, P149, DOI 10.1152/japplphysiol.00235.2013; Imtiyaz S, 2014, J CLIN DIAGN RES, V8, P133, DOI 10.7860/JCDR/2014/7294.3971; ISHIURA S, 1986, J CELL SCI, V83, P197; Iwata A, 2010, MUSCLE NERVE, V41, P694, DOI 10.1002/mus.21567; Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004; Jarvinen Tero Ah, 2013, Muscles Ligaments Tendons J, V3, P337; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kuribayashi K, 2008, ADV EXP MED BIOL, V615, P201, DOI 10.1007/978-1-4020-6554-5_10; Ma JF, 2012, AGEING RES REV, V11, P432, DOI 10.1016/j.arr.2012.05.004; Markovic G, 2014, BRIT J SPORT MED, V48, P633; Mavers M, 2012, ARTHRITIS RHEUM-US, V64, P141, DOI 10.1002/art.33311; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Oe K, 2011, BIOCHEM BIOPH RES CO, V407, P148, DOI 10.1016/j.bbrc.2011.02.128; Olive M, 2008, J CLIN INVEST, V118, P2050, DOI 10.1172/JCI31244; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Yokoi Y, 2014, J PHYS THER SCI, V26, P455, DOI 10.1589/jpts.26.455	40	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125765	10.1371/journal.pone.0125765	http://dx.doi.org/10.1371/journal.pone.0125765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942471	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400052
J	Sini, M; Kipson, S; Linares, C; Koutsoubas, D; Garrabou, J				Sini, Maria; Kipson, Silvija; Linares, Cristina; Koutsoubas, Drosos; Garrabou, Joaquim			The Yellow Gorgonian Eunicella cavolini: Demography and Disturbance Levels across the Mediterranean Sea	PLOS ONE			English	Article							SHALLOW-WATER OCTOCORALLIA; ROCKY BENTHIC COMMUNITIES; MASS MORTALITY EVENT; POPULATION-STRUCTURE; PARAMURICEA-CLAVATA; LIFE-HISTORY; HABITAT SUITABILITY; COLONY SIZE; AEGEAN SEA; CORAL	The yellow octocoral Eunicella cavolini is one of the most common gorgonians thriving in Mediterranean hard-bottom communities. However, information regarding its distribution and ecology in several parts of the Mediterranean is lacking, while population trends and conservation status remain largely unknown. We investigated 19 populations of E. cavolini over three representative geographic regions: the NW Mediterranean, CE Adriatic, and N Aegean. Focusing on the upper bathymetric range of the species (<40 m), data were collected on the populations' upper depth limit, density, colony height, and extent of injury. A three-level hierarchical sampling design was applied to assess the existence of spatial patterns, using: a) regions (located thousands of km apart), b) localities within regions (tens to hundreds of km apart), and c) sites within localities (hundreds of m to a few km apart). In the NW Mediterranean and CE Adriatic, the upper distribution limit was at depths <= 15 m, whereas in the N Aegean most populations were found deeper than 30 m. Population density ranged between 4.46-62 colonies per m(2), while mean colony height was 15.6 +/- 8.9 SD cm with a maximum of 62 cm. The NW Mediterranean sites were characterized by dense populations dominated by small colonies (<20 cm), periodic recruitment, and low proportion of large gorgonians (>30 cm). The CE Adriatic displayed intermediate densities, with well-structured populations, and continuous recruitment. In the N Aegean, most populations presented low densities, high proportion of large colonies, but low number of small colonies, signifying limited recruitment. Disturbance levels, as a function of extent and type of injury, are discussed in relation to past or present human-induced threats. This work represents geographically the most wide ranging demographic study of a Mediterranean octocoral to date. The quantitative information obtained provides a basis for future monitoring at a Mediterranean scale.	[Sini, Maria; Koutsoubas, Drosos] Univ Aegean, Fac Environm, Dept Marine Sci, Mitilini, Lesvos, Greece; [Kipson, Silvija] Univ Zagreb, Fac Sci, Dept Biol, Zagreb 41000, Croatia; [Linares, Cristina] Univ Barcelona, Dept Ecol, Barcelona, Catalonia, Spain; [Garrabou, Joaquim] CSIC, Inst Ciencies Mar, Barcelona, Catalonia, Spain; [Garrabou, Joaquim] Univ Sud Toulon Var, Aix Marseille Univ, CNRS INSU, IRD,MIO, Marseille, France	University of Aegean; University of Zagreb; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Sini, M (corresponding author), Univ Aegean, Fac Environm, Dept Marine Sci, Mitilini, Lesvos, Greece.	mariasini@marine.aegean.gr	Linares, Cristina/A-5244-2018	Linares, Cristina/0000-0003-3855-2743; SINI, MARIA/0000-0002-9608-3503	European Union (European Social Fund ESF); Greek national funds (Ministry of Education and Religious Affairs managing authority) through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; Croatian Ministry of Culture; Croatian Ministry of Science and Education [119-0362975-1226]	European Union (European Social Fund ESF)(European Social Fund (ESF)European Commission); Greek national funds (Ministry of Education and Religious Affairs managing authority) through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; Croatian Ministry of Culture; Croatian Ministry of Science and Education(Ministry of Science, Education and Sports, Republic of Croatia)	MS research activity has been co-financed by the European Union (European Social Fund ESF) and Greek national funds (Ministry of Education and Religious Affairs managing authority) through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. SK received funding provided by the Croatian Ministry of Culture through the grant allocated to Marine Explorers Society -"20,000 leagues" in 2009 and by the Croatian Ministry of Science and Education (project 119-0362975-1226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bak RPM, 1999, AM ZOOL, V39, P56; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; Ballesteros, 1989, SCI MAR, V53, P3; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G., 1988, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V52, P295; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Bianchi Carlo Nike, 2010, Travaux Scientifiques du Parc National de Port-Cros, V24, P39; Bo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049870; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Cebrian E, 2012, BIOL INVASIONS, V14, P2647, DOI 10.1007/s10530-012-0261-6; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Cigliano M., 2007, Biologia Marina Mediterranea, V14, P292; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Cupido R, 2008, AQUAT CONSERV, V18, P984, DOI 10.1002/aqc.904; Cupido R, 2012, MAR ECOL PROG SER, V469, P25, DOI 10.3354/meps09976; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; Dounas C, 2009, NOAA TECHNICAL MEMOR, P106; Gambi M.C., 2012, Biologia Marina Mediterranea, V19, P174; Gambi M.C., 2010, Biologia Marina Mediterranea, V17, P126; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; GILI J-M, 1989, Scientia Marina, V53, P19; Gilmour JP, 2004, CORAL REEFS, V23, P493, DOI 10.1007/s00338-004-0427-5; Gori A, 2012, MAR BIOL, V159, P1485, DOI 10.1007/s00227-012-1928-3; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Gorley C.K., 2006, GETTING STARTED PRIM; GRIGG RW, 1975, AM NAT, V109, P647, DOI 10.1086/283035; GRIGG RW, 1977, ECOLOGY, V58, P278, DOI 10.2307/1935603; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; Harmelin JG, 2005, SCI REP PORT CROS NA, V21, P175; Ignatiades L, 2005, J SEA RES, V54, P51, DOI 10.1016/j.seares.2005.02.010; Ioannou E, 2009, STEROIDS, V74, P73, DOI 10.1016/j.steroids.2008.09.007; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kipson S, 2014, MAR ECOL, DOI [10.1111/maec.12195, DOI 10.1111/MAEC.12195]; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Linares Cristina, 2010, Travaux Scientifiques du Parc National de Port-Cros, V24, P161; Linares C, 2010, MAR ECOL PROG SER, V402, P69, DOI 10.3354/meps08436; Alvarado-Chacon EM, 2009, B MAR SCI, V85, P61; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; RUSSO AR, 1985, MAR ECOL PROG SER, V24, P155, DOI 10.3354/meps024155; Salomidi M, 2009, P 1 MED S CONS COR O, P242; Sebens KP, 2002, INTEGR COMP BIOL, V42, P853, DOI 10.1093/icb/42.4.853; Sini M, 2014, P 2 MED S CONS COR O, P235; Skoufas G, 2006, MAR BIOL, V149, P1365, DOI 10.1007/s00227-006-0314-4; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Spatharis S, 2007, ESTUAR COAST SHELF S, V73, P807, DOI 10.1016/j.ecss.2007.03.016; Spatharis S, 2009, HARMFUL ALGAE, V8, P736, DOI 10.1016/j.hal.2009.03.002; Topcu EN, 2013, J BLACK SEA MEDITERR, V19, P46; Torrents O, 2005, BIOL CONSERV, V121, P391, DOI 10.1016/j.biocon.2004.05.010; True MA, 1970, B I OCEANOGR MONACO, V60, P1; Tsounis G, 2006, MAR BIOL, V149, P1059, DOI 10.1007/s00227-006-0302-8; VELIMIROV B, 1973, HELGOLAND WISS MEER, V24, P163, DOI 10.1007/BF01609509; VELIMIROV B, 1975, OECOLOGIA, V19, P259, DOI 10.1007/BF00345309; VELIMIROV B, 1976, J EXP MAR BIOL ECOL, V21, P109, DOI 10.1016/0022-0981(76)90032-0; Watremez P., 2012, MEDITERRANEAN SUBMAR, P105; WEINBAUER MG, 1995, MAR ECOL PROG SER, V121, P211, DOI 10.3354/meps121211; WEINBAUER MG, 1995, B MAR SCI, V56, P283; Weinbauer MG, 1996, B MAR SCI, V58, P786; Weinbauer MG, 1996, ESTUAR COAST SHELF S, V42, P583, DOI 10.1006/ecss.1996.0038; WEINBERG S, 1979, BIJDR DIERKD, V49, P1; WEINBERG S, 1980, BIJDR DIERKD, V50, P73; Yoshioka PM, 1998, REV BIOL TROP, V46, P137; YOSHIOKA PM, 1994, J EXP MAR BIOL ECOL, V184, P111, DOI 10.1016/0022-0981(94)90169-4; Zavodnik Dusan, 2005, Acta Adriatica, V46, P3	80	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126253	10.1371/journal.pone.0126253	http://dx.doi.org/10.1371/journal.pone.0126253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942319	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943400066
J	Barrabes, JA; Inserte, J; Agullo, L; Rodriguez-Sinovas, A; Alburquerque-Bejar, JJ; Garcia-Dorado, D				Barrabes, Jose A.; Inserte, Javier; Agullo, Luis; Rodriguez-Sinovas, Antonio; Alburquerque-Bejar, Juan J.; Garcia-Dorado, David			Effects of the Selective Stretch-Activated Channel Blocker GsMtx4 on Stretch-Induced Changes in Refractoriness in Isolated Rat Hearts and on Ventricular Premature Beats and Arrhythmias after Coronary Occlusion in Swine	PLOS ONE			English	Article							ACUTE REGIONAL ISCHEMIA; ISOLATED RABBIT HEART; ATRIAL-FIBRILLATION; MECHANOELECTRIC FEEDBACK; MYOCARDIAL-ISCHEMIA; CANINE HEARTS; SPIDER VENOM; IN-SITU; GADOLINIUM; REPERFUSION	Mechanical factors may contribute to ischemic ventricular arrhythmias. GsMtx4 peptide, a selective stretch-activated channel blocker, inhibits stretch-induced atrial arrhythmias. We aimed to assess whether GsMtx4 protects against ventricular ectopy and arrhythmias following coronary occlusion in swine. First, the effects of 170-nM GsMtx4 on the changes in the effective refractory period (ERP) induced by left ventricular (LV) dilatation were assessed in 8 isolated rat hearts. Then, 44 anesthetized, open-chest pigs subjected to 50-min left anterior descending artery occlusion and 2-h reperfusion were blindly allocated to GsMtx4 (57 mu g/kg iv. bolus and 3.8 mu g/kg/min infusion, calculated to attain the above concentration in plasma) or saline, starting 5-min before occlusion and continuing until after reflow. In rat hearts, LV distension induced progressive reductions in ERP (35 +/- 2, 32 +/- 2, and 29 +/- 2 ms at 0, 20, and 40 mmHg of LV end-diastolic pressure, respectively, P<0.001) that were prevented by GsMTx4 (33 +/- 2, 33 +/- 2, and 32 +/- 2 ms, respectively, P=0.002 for the interaction with LV end-diastolic pressure). Pigs receiving GsMtx4 had similar number of ventricular premature beats during the ischemic period as control pigs (110 +/- 28 vs. 103 +/- 21, respectively, P=0.842). There were not significant differences among treated and untreated animals in the incidence of ventricular fibrillation (13.6 vs. 22.7%, respectively, P=0.696) or tachycardia (36.4 vs. 50.0%, P=0.361) or in the number of ventricular tachycardia episodes during the occlusion period (1.8 +/- 0.7 vs. 5.5 +/- 2.6, P=0.323). Thus, GsMtx4 administered under these conditions does not suppress ventricular ectopy following coronary occlusion in swine. Whether it might protect against malignant arrhythmias should be tested in studies powered for these outcomes.	[Barrabes, Jose A.; Inserte, Javier; Agullo, Luis; Rodriguez-Sinovas, Antonio; Alburquerque-Bejar, Juan J.; Garcia-Dorado, David] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, Serv Cardiol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Barrabes, JA (corresponding author), Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, Serv Cardiol, E-08193 Barcelona, Spain.	jabarrabes@vhebron.net	Alburquerque-Bejar, Juan/AAA-7666-2020; Inserte, Javier/S-6061-2019; Agulló, Luis/A-2747-2009; Rodriguez-Sinovas, Antonio/A-8259-2010	Inserte, Javier/0000-0002-4736-5010; Agulló, Luis/0000-0002-8578-4902; Rodriguez-Sinovas, Antonio/0000-0003-2930-8773; Alburquerque Bejar, Juan Jose/0000-0002-9022-124X	Spanish Government [FIS PI12/01844, SAF 2008-3067]; Redes Tematicas de Investigacion Cardiovascular (RECAVA)	Spanish Government(Spanish GovernmentEuropean Commission); Redes Tematicas de Investigacion Cardiovascular (RECAVA)	This study was funded by grants from the Spanish Government (FIS PI12/01844 and SAF 2008-3067), and Redes Tematicas de Investigacion Cardiovascular (RECAVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrabes JA, 1998, AM J PHYSIOL-HEART C, V274, pH1767, DOI 10.1152/ajpheart.1998.274.5.H1767; Barrabes JA, 1996, PFLUG ARCH EUR J PHY, V431, P519, DOI 10.1007/BF02191898; Barrabes JA, 2002, BASIC RES CARDIOL, V97, P445, DOI 10.1007/s003950200051; Barrabes JA, 2006, AM J PHYSIOL-HEART C, V290, pH2344, DOI 10.1152/ajpheart.00917.2005; Barrabes JA, 2013, REV ESP CARDIOL, V66, P171, DOI 10.1016/j.rec.2012.08.006; Barrabes JA, 2010, THROMB HAEMOSTASIS, V104, P128, DOI 10.1160/TH09-07-0440; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Bode F, 2000, CIRCULATION, V101, P2200, DOI 10.1161/01.CIR.101.18.2200; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; CALKINS H, 1989, AM J PHYSIOL, V256, pH1697, DOI 10.1152/ajpheart.1989.256.6.H1697; Calvo D, 2013, REV ESP CARDIOL, V66, P168, DOI 10.1016/j.rec.2012.09.017; Chorro FJ, 2009, AM J PHYSIOL-HEART C, V297, pH1860, DOI 10.1152/ajpheart.00144.2009; Coronel R, 2002, J AM COLL CARDIOL, V39, P166, DOI 10.1016/S0735-1097(01)01686-2; Di Diego JM, 2011, HEART RHYTHM, V8, P1963, DOI 10.1016/j.hrthm.2011.06.036; HANSEN DE, 1991, CIRC RES, V69, P820, DOI 10.1161/01.RES.69.3.820; HANSEN DE, 1990, CIRCULATION, V81, P1094, DOI 10.1161/01.CIR.81.3.1094; HORNER SM, 1994, CARDIOVASC RES, V28, P528, DOI 10.1093/cvr/28.4.528; Hu YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060287; Inserte J, 2009, CARDIOVASC RES, V83, P169, DOI 10.1093/cvr/cvp109; JALAL S, 1992, AM J PHYSIOL, V263, pH1306, DOI 10.1152/ajpheart.1992.263.4.H1306; JANSE MJ, 1980, CIRC RES, V47, P151, DOI 10.1161/01.RES.47.2.151; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; KAPLINSKY E, 1979, CIRCULATION, V60, P397, DOI 10.1161/01.CIR.60.2.397; Kiseleva I, 2000, CARDIOVASC RES, V45, P370, DOI 10.1016/S0008-6363(99)00361-2; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109313; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Ravelli F, 2003, PROG BIOPHYS MOL BIO, V82, P137, DOI 10.1016/S0079-6107(03)00011-7; REITER MJ, 1988, CIRC RES, V62, P554, DOI 10.1161/01.RES.62.3.554; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Trayanova NA, 2011, AM J PHYSIOL-HEART C, V301, pH279, DOI 10.1152/ajpheart.00324.2011; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zaitsev AV, 2003, CIRC RES, V92, P546, DOI 10.1161/01.RES.0000061917.23107.F7; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548	34	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125753	10.1371/journal.pone.0125753	http://dx.doi.org/10.1371/journal.pone.0125753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938516	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000098
J	Basu, S; Majumder, S; Bhowal, A; Ghosh, A; Naskar, S; Nandy, S; Mukherjee, S; Sinha, RK; Basu, K; Karmakar, D; Banerjee, S; Sengupta, S				Basu, Sanmitra; Majumder, Subhadipa; Bhowal, Ankur; Ghosh, Alip; Naskar, Sukla; Nandy, Sumit; Mukherjee, Subhabrata; Sinha, Rajan Kumar; Basu, Keya; Karmakar, Dilip; Banerjee, Soma; Sengupta, Sanghamitra			A Study of Molecular Signals Deregulating Mismatch Repair Genes in Prostate Cancer Compared to Benign Prostatic Hyperplasia	PLOS ONE			English	Article							DNA METHYLATION; CPG-ISLAND; RADICAL PROSTATECTOMY; ESTROGEN-RECEPTOR; RISK; HYPOXIA; EXPRESSION; AGE; VARIANTS; TRENDS	Prostate cancer is one of the leading causes of mortality among aging males. There is an unmet requirement of clinically useful biomarkers for early detection of prostate cancer to reduce the liabilities of overtreatment and accompanying morbidity. The present population-based study investigates the factors disrupting expression of multiple functionally related genes of DNA mismatch repair pathway in prostate cancer patients to identify molecular attributes distinguishing adenocarcinoma from benign hyperplasia of prostate. Gene expression was compared between tissue samples from prostate cancer and benign prostatic hyperplasia using real-time-PCR, western blot and immunohistochemistry. Assessment of genotypes of seven single-nucleotide-polymorphisms of three MMR genes was conducted using PCR-coupled RFLP and sequencing. Promoter methylation was interrogated by methylation-specific-PCR and bisulfite-sequencing. Interaction between microRNAs and MMR genes was verified by 3'UTR-based dual luciferase assays. Concurrent reduction of three MMR genes namely hMLH1, hMSH6 and hMSH2 (34-85%, P<0.05) was observed in prostate cancer tissues. hMSH6 polymorphism rs1800932(Pro92Pro) conferred a borderline protection in cancer patients (OR = 0.33, 95% CI = 0.15-0.75). Relative transcript level of hMLH1 was inversely related (r = -0.59, P<0.05) with methylation quotient of its promoter which showed a significantly higher methylation density (P = 0.008, Z = -2.649) in cancer patients. hsa-miR-155, hsa-miR-141 and hsa-miR-21 gene expressions were significantly elevated (66-85%, P<0.05) in tumor specimens and negatively correlated (r = -0.602 to -0.527, P<0.05) with that of MMR genes. hsa-miR-155 & hsa-miR-141 and hsa-miR-155 & hsa-miR-21 were demonstrated to bind to their putative seed sequences in hMLH1 and hMSH6 3'UTRs respectively. Relatively higher expression of DNA methyl-transferases (DNMT1 and DNMT3b) and HIF-1 alpha genes (34-50%, P<0.05) were also detected in tumor tissues. This study provides statistical evidence that MMR deficiency is correlated with hypermethylation of hMLH1 promoter and upregulation of hsa-miR-155, hsa-miR-141 and hsa-miR-21 in prostate cancer. This comparative study reflects that microRNA expression level, particularly hsa-miR-155, exhibits predictive signature of prostate adenocarcinoma.	[Basu, Sanmitra; Majumder, Subhadipa; Bhowal, Ankur; Sengupta, Sanghamitra] Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India; [Naskar, Sukla; Nandy, Sumit; Basu, Keya] Calcutta Natl Med Coll & Hosp, Dept Pathol, Kolkata, W Bengal, India; [Mukherjee, Subhabrata; Sinha, Rajan Kumar; Karmakar, Dilip] Calcutta Natl Med Coll & Hosp, Dept Urol, Kolkata, W Bengal, India; [Ghosh, Alip; Banerjee, Soma] Postgrad Inst Med Educ & Res, Liver Res Ctr, Kolkata, W Bengal, India	University of Calcutta; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Sengupta, S (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India.	sanghamitrasg@yahoo.com	Sengupta, Sanghamitra/AAW-4300-2021	Basu, Prof.(Dr.) Keya/0000-0001-5268-7551	Council of Scientific and Industrial Research, New Delhi, India [27/(0206)/09/EMR-II]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi, India, Grant No. 27/(0206)/09/EMR-II (www.csirhrdg.res.in). SS received the funding.	Ahuja N, 1998, CANCER RES, V58, P5489; [Anonymous], IARC SCIENTIFIC PUBL, VVIII; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickers B, 2009, ANTICANCER RES, V29, P3289; BOSTWICK DG, 1992, CANCER, V70, P291, DOI 10.1002/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Chokkalingam AP, 2003, CANCER, V98, P1727, DOI 10.1002/cncr.11710; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dahiya R, 1997, INT J CANCER, V72, P762, DOI 10.1002/(SICI)1097-0215(19970904)72:5<762::AID-IJC10>3.0.CO;2-B; Dean M, 2013, ASIAN J ANDROL, V15, P309, DOI 10.1038/aja.2013.29; Deng GR, 1999, CANCER RES, V59, P2029; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; Dluzniewski PJ, 2015, CANCER EPIDEM BIOMAR, V24, P88, DOI 10.1158/1055-9965.EPI-14-0863; Eifler JB, 2013, BJU INT, V111, P22, DOI 10.1111/j.1464-410X.2012.11324.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao X, 1997, ADV EXP MED BIOL, V407, P41; Gerstenberger JP, 2015, PROSTATE, V75, P60, DOI 10.1002/pros.22892; Han Y, 2015, INT J CANCER, V136, P1210, DOI 10.1002/ijc.29066; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Hsing AW, 2001, EPIDEMIOL REV, V23, P3, DOI 10.1093/oxfordjournals.epirev.a000792; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jain S, 2014, META GENE, V2, P596, DOI 10.1016/j.mgene.2014.07.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Jing LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097522; Johnson KC, 2014, EPIGENETICS-US, V9, P268, DOI 10.4161/epi.27015; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karan D, 2003, INT J CANCER, V103, P285, DOI 10.1002/ijc.10813; Karyadi DM, 2015, INT J CANCER, V136, P2166, DOI 10.1002/ijc.29241; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lalitha K, 2012, ASIAN PAC J CANCER P, V13, P6245, DOI 10.7314/APJCP.2012.13.12.6245; Langeberg WJ, 2010, CANCER EPIDEM BIOMAR, V19, P258, DOI 10.1158/1055-9965.EPI-09-0800; Lawrie CH, 2009, J CELL MOL MED, V13, P1248, DOI 10.1111/j.1582-4934.2008.00628.x; Li LC, 2000, CANCER RES, V60, P702; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Mace TA, 2013, J SURG RES, V184, P855, DOI 10.1016/j.jss.2013.04.061; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Miah S, 2014, INDIAN J UROL, V30, P214, DOI 10.4103/0970-1591.126909; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Miller GJ, 2001, EPIDEMIOL REV, V23, P14, DOI 10.1093/oxfordjournals.epirev.a000780; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nojima D, 2001, CANCER, V92, P2076, DOI 10.1002/1097-0142(20011015)92:8<2076::AID-CNCR1548>3.0.CO;2-A; Panagiotou OA, 2015, EUR UROL, V67, P649, DOI 10.1016/j.eururo.2014.09.020; Park HJ, 2013, WORLD J MENS HEALTH, V31, P193, DOI 10.5534/wjmh.2013.31.3.193; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Perry JRB, 2014, HUM MOL GENET, V23, P2490, DOI 10.1093/hmg/ddt620; Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Pinto M, 2000, LAB INVEST, V80, P1915, DOI 10.1038/labinvest.3780201; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Reyes-Hernandez OD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099974; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Ryan S, 2014, CANCER EPIDEM BIOMAR, V23, P437, DOI 10.1158/1055-9965.EPI-13-1165; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sinha R, 2003, J Postgrad Med, V49, P222; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Smith TR, 2011, CARCINOGENESIS, V32, P1354, DOI 10.1093/carcin/bgr117; Soni A, 2011, OMICS, V15, P319, DOI 10.1089/omi.2010.0110; Srivastava K, 2010, CANCER-AM CANCER SOC, V116, P3160, DOI 10.1002/cncr.25063; Stangelberger Anton, 2008, Rev Urol, V10, P111; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Yang XR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097460; Yeole BB, 2008, ASIAN PAC J CANCER P, V9, P141; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	81	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125560	10.1371/journal.pone.0125560	http://dx.doi.org/10.1371/journal.pone.0125560			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938433	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000075
J	Brachet, E; Beneut, C; Serrentino, ME; Borde, V				Brachet, Elsa; Beneut, Claire; Serrentino, Maria-Elisabetta; Borde, Valerie			The CAF-1 and Hir Histone Chaperones Associate with Sites of Meiotic Double-Strand Breaks in Budding Yeast	PLOS ONE			English	Article							ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; CROSSOVER RECOMBINATION; CROSSING-OVER; CHROMATIN; GENE; MEIOSIS; REPAIR	In the meiotic prophase, programmed DNA double-strand breaks (DSB) are introduced along chromosomes to promote homolog pairing and recombination. Although meiotic DSBs usually occur in nucleosome-depleted, accessible regions of chromatin, their repair by homologous recombination takes place in a nucleosomal environment. Nucleosomes may represent an obstacle for the recombination machinery and their timely eviction and re-incorporation into chromatin may influence the outcome of recombination, for instance by stabilizing recombination intermediates. Here we show in budding yeast that nucleosomes flanking a meiotic DSB are transiently lost during recombination, and that specific histone H3 chaperones, CAF-1 and Hir, are mobilized at meiotic DSBs. However, the absence of these chaperones has no effect on meiotic recombination, suggesting that timely histone re-incorporation following their eviction has no influence on the recombination outcome, or that redundant pathways are activated. This study is the first example of the involvement of histone H3 chaperones at naturally occurring, developmentally programmed DNA double-strand breaks.	[Brachet, Elsa; Beneut, Claire; Serrentino, Maria-Elisabetta; Borde, Valerie] Ctr Rech, Inst Curie, Paris, France; [Brachet, Elsa; Beneut, Claire; Serrentino, Maria-Elisabetta; Borde, Valerie] CNRS, UMR 3664, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Borde, V (corresponding author), Ctr Rech, Inst Curie, Paris, France.	valerie.borde@curie.fr			Association pour la Recherche sur le Cancer; la Ligue contre le Cancer; la Fondation pour la Recherche Medicale; Electricite de France; Agence Nationale pour la Recherche [ANR-11-LABX-0044_DEEP]; University Pierre Marie Curie	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); la Ligue contre le Cancer(Ligue nationale contre le cancer); la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Electricite de France; Agence Nationale pour la Recherche(French National Research Agency (ANR)); University Pierre Marie Curie	This work was funded by the Association pour la Recherche sur le Cancer, la Ligue contre le Cancer, la Fondation pour la Recherche Medicale, Electricite de France and Agence Nationale pour la Recherche (ANR-11-LABX-0044_DEEP). E. B. was a recipient of a predoctoral fellowship from University Pierre & Marie Curie and from Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; Crismani W, 2012, SCIENCE, V336, P1588, DOI 10.1126/science.1220381; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; de los Santos T, 2003, GENETICS, V164, P81; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Fukuda T, 2003, GENES CELLS, V8, P587, DOI 10.1046/j.1365-2443.2003.00659.x; Fukuda T, 2008, NUCLEIC ACIDS RES, V36, P984, DOI 10.1093/nar/gkm1082; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Haber JE, 2013, CELL REP, V3, P2168, DOI 10.1016/j.celrep.2013.05.007; Hoek M, 2011, J BIOL CHEM, V286, P10876, DOI 10.1074/jbc.M110.217075; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Ishii S, 2008, FEBS J, V275, P2032, DOI 10.1111/j.1742-4658.2008.06357.x; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Kim JA, 2009, P NATL ACAD SCI USA, V106, P1151, DOI 10.1073/pnas.0812578106; Knoll A, 2012, PLANT CELL, V24, P1448, DOI 10.1105/tpc.112.096644; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz A, 2012, SCIENCE, V336, P1585, DOI 10.1126/science.1220111; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pietrobon V, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001968; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Scherthan H, 2008, DIFFERENTIATION, V76, P91, DOI 10.1111/j.1432-0436.2007.00212.x; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Shinohara M, 1997, GENETICS, V147, P1545; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Thacker D, 2011, GENETICS, V189, P423, DOI 10.1534/genetics.111.131326; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tsukuda T, 2009, DNA REPAIR, V8, P360, DOI 10.1016/j.dnarep.2008.11.014; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yamada S, 2013, NUCLEIC ACIDS RES, V41, P3504, DOI 10.1093/nar/gkt049; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032	65	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125965	10.1371/journal.pone.0125965	http://dx.doi.org/10.1371/journal.pone.0125965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938567	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000120
J	Craig, D; Mazilu, M; Dholakia, K				Craig, Derek; Mazilu, Michael; Dholakia, Kishan			Quantitative Detection of Pharmaceuticals Using a Combination of Paper Microfluidics and Wavelength Modulated Raman Spectroscopy	PLOS ONE			English	Article							FLUORESCENCE SUPPRESSION; CELLS; INSTRUMENTATION; DIAGNOSTICS; EXCITATION; SCATTERING; ALGORITHM; PLATFORM; DEVICE; SPACE	Raman spectroscopy has proven to be an indispensable technique for the identification of various types of analytes due to the fingerprint vibration spectrum obtained. Paper microfluidics has also emerged as a low cost, easy to fabricate and portable approach for point of care testing. However, due to inherent background fluorescence, combining Raman spectroscopy with paper microfluidics is to date an unmet challenge in the absence of using surface enhanced mechanisms. We describe the first use of wavelength modulated Raman spectroscopy (WMRS) for analysis on a paper microfluidics platform. This study demonstrates the ability to suppress the background fluorescence of the paper using WMRS and the subsequent implementation of this technique for pharmaceutical analysis. The results of this study demonstrate that it is possible to discriminate between both paracetamol and ibuprofen, whilst, also being able to detect the presence of each analyte quantitatively at nanomolar concentrations.	[Craig, Derek; Mazilu, Michael; Dholakia, Kishan] Univ St Andrews, Dept Phys & Astron, St Andrews, Fife, Scotland	University of St Andrews	Dholakia, K (corresponding author), Univ St Andrews, Dept Phys & Astron, St Andrews, Fife, Scotland.	kd1@st-andrews.ac.uk	Mazilu, Michael/B-1852-2009	Mazilu, Michael/0000-0002-4758-3528; Dholakia, Kishan/0000-0001-6534-9009	UK Engineering and Physical Sciences Research Council [EP/J01771X/1, EP/M000869/1]; Engineering and Physical Sciences Research Council [EP/M000869/1, EP/J01771X/1] Funding Source: researchfish; EPSRC [EP/J01771X/1, EP/M000869/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	All authors acknowledge the support of the UK Engineering and Physical Sciences Research Council through grant numbers EP/J01771X/1 and EP/M000869/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2010, DANCING TIMES, V100, P55; Betz JF, 2014, PHYS CHEM CHEM PHYS, V16, P2224, DOI 10.1039/c3cp53560f; Cai LF, 2013, J CHEM EDUC, V90, P232, DOI 10.1021/ed300385j; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Chen YY, 2013, ANALYST, V138, P2624, DOI 10.1039/c3an36647b; Cialla D, 2012, ANAL BIOANAL CHEM, V403, P27, DOI 10.1007/s00216-011-5631-x; Clarke SJ, 2005, ANALYST, V130, P1019, DOI 10.1039/b502540k; Cooper JB, 2013, APPL SPECTROSC, V67, P973, DOI 10.1366/12-06852; De Luca AC, 2010, ANAL CHEM, V82, P738, DOI 10.1021/ac9026737; Dochow S, 2013, ANAL METHODS-UK, V5, P4608, DOI 10.1039/c3ay40193f; Dungchai W, 2009, ANAL CHEM, V81, P5821, DOI 10.1021/ac9007573; Hu J, 2014, BIOSENS BIOELECTRON, V54, P585, DOI 10.1016/j.bios.2013.10.075; Jarvis RM, 2006, FARADAY DISCUSS, V132, P281, DOI 10.1039/b506413a; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Lee CH, 2011, ANAL CHEM, V83, P8953, DOI 10.1021/ac2016882; Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398; Liu Z, 2010, NANO RES, V3, P222, DOI 10.1007/s12274-010-1025-1; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Mazilu M, 2010, OPT EXPRESS, V18, P11382, DOI 10.1364/OE.18.011382; McAughtrie S, 2013, CHEM SCI, V4, P3566, DOI 10.1039/c3sc51437d; Moore DS, 2004, REV SCI INSTRUM, V75, P2499, DOI 10.1063/1.1771493; Ni J, 1999, ANAL CHEM, V71, P4903, DOI 10.1021/ac990616a; Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a; Praveen BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067211; Praveen BB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077006; Sundarajoo S, 2013, J RAMAN SPECTROSC, V44, P949, DOI 10.1002/jrs.4313; Thom NK, 2014, RSC ADV, V4, P1334, DOI 10.1039/c3ra44717k; Tian LM, 2012, ANAL CHEM, V84, P9928, DOI 10.1021/ac302332g; Ying Hui N, 2013, J COLLOID INTERF SCI, V409, P59, DOI [10.1016/j.jcis.2013.07.051PMID:23978290, DOI 10.1016/J.JCIS.2013.07.051]; Yu WW, 2013, ANALYST, V138, P1020, DOI 10.1039/c2an36116g; Yu WW, 2010, ANAL CHEM, V82, P9626, DOI 10.1021/ac102475k; Zavaleta CL, 2013, P NATL ACAD SCI USA, V110, pE2288, DOI 10.1073/pnas.1211309110; Zhang R, 2012, CHEM COMMUN, V48, P5913, DOI 10.1039/c2cc31604h	33	12	12	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123334	10.1371/journal.pone.0123334	http://dx.doi.org/10.1371/journal.pone.0123334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938464	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000006
J	Ellingjord-Dale, M; dos-Santos-Silva, I; Grotmol, T; Sakhi, AK; Hofvind, S; Qureshi, S; Markussen, MS; Couto, E; Vos, L; Ursin, G				Ellingjord-Dale, Merete; dos-Santos-Silva, Isabel; Grotmol, Tom; Sakhi, Amrit Kaur; Hofvind, Solveig; Qureshi, Samera; Markussen, Marianne Skov; Couto, Elisabeth; Vos, Linda; Ursin, Giske			Vitamin D Intake, Month the Mammogram Was Taken and Mammographic Density in Norwegian Women Aged 50-69	PLOS ONE			English	Article							BREAST-CANCER RISK; FOOD FREQUENCY QUESTIONNAIRE; CALCIUM SUPPLEMENTATION; DIETARY-INTAKE; PREVENTION; EXPOSURE; ASSOCIATION; HEALTH; 25-HYDROXYVITAMIN-D; PREMENOPAUSAL	Background The role of vitamin D in breast cancer etiology is unclear. There is some, but inconsistent, evidence that vitamin D is associated with both breast cancer risk and mammographic density (MD). We evaluated the associations of MD with month the mammogram was taken, and with vitamin D intake, in a population of women from Norway-a country with limited sunlight exposure for a large part of the year. Methods 3114 women aged 50-69, who participated in the Norwegian Breast Cancer Screening Program (NBCSP) in 2004 or 2006/07, completed risk factor and food frequency (FFQ) questionnaires. Dietary and total (dietary plus supplements) vitamin D, calcium and energy intakes were estimated by the FFQ. Month when the mammogram was taken was recorded on the mammogram. Percent MD was assessed using a computer assisted method (Madena, University of Southern California) after digitization of the films. Linear regression models were used to investigate percent MD associations with month the mammogram was taken, and vitamin D and calcium intakes, adjusting for age, body mass index (BMI), study year, estrogen and progestin therapy (EPT), education, parity, calcium intakes and energy intakes. Results There was no statistical significant association between the month the mammogram was taken and percent MD. Overall, there was no association between percent MD and quartiles of total or dietary vitamin D intakes, or of calcium intake. However, analysis restricted to women aged < 55 years revealed a suggestive inverse association between total vitamin D intake and percent MD ( p for trend = 0.03). Conclusion Overall, we found no strong evidence that month the mammogram was taken was associated with percent MD. We found no inverse association between vitamin D intake and percent MD overall, but observed a suggestive inverse association between dietary vitamin D and MD for women less than 55 years old.	[Ellingjord-Dale, Merete; Markussen, Marianne Skov; Ursin, Giske] Univ Oslo, Oslo, Norway; [dos-Santos-Silva, Isabel] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Grotmol, Tom; Hofvind, Solveig; Vos, Linda; Ursin, Giske] Canc Registry Norway, Oslo, Norway; [Ursin, Giske] Univ So Calif, Los Angeles, CA USA; [Sakhi, Amrit Kaur] Norwegian Inst Publ Hlth, Oslo, Norway; [Couto, Elisabeth] Norwegian Knowledge Ctr Hlth Serv, Hlth Econ & Drug Unit, Oslo, Norway; [Qureshi, Samera] Norwegian Ctr Minor Hlth Res, Oslo, Norway	University of Oslo; University of London; London School of Hygiene & Tropical Medicine; University of Oslo; University of Southern California; Norwegian Institute of Public Health (NIPH); Norwegian Knowledge Centre for Health Services	Ursin, G (corresponding author), Univ Oslo, Oslo, Norway.	Giske.Ursin@kreftregisteret.no	Ursin, Giske/U-6637-2017	Ursin, Giske/0000-0002-0835-9507; dos Santos Silva, Isabel/0000-0002-6596-8798	Norwegian Cancer Society [171743 - PR-2009-0210]; Norwegian Research Council [196999]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by grants from the Norwegian Cancer Society (171743 - PR-2009-0210) and the Norwegian Research Council (196999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2007, NUTR CANCER, V59, P54, DOI 10.1080/01635580701390223; Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921; Anderson LN, 2010, AM J CLIN NUTR, V91, P1699, DOI 10.3945/ajcn.2009.28869; Berstad P, 2007, AM J CLIN NUTR, V85, P1598, DOI 10.1093/ajcn/85.6.1598; Bertone-Johnson ER, 2012, CANCER EPIDEM BIOMAR, V21, P462, DOI 10.1158/1055-9965.EPI-11-1009; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Berube S, 2005, CANCER EPIDEM BIOMAR, V14, P1653, DOI 10.1158/1055-9965.EPI-05-0068; Berube S, 2004, CANCER EPIDEM BIOMAR, V13, P1466; Boyd Norman F, 2006, J Br Menopause Soc, V12, P186, DOI 10.1258/136218006779160436; BRISSON J, 1989, AM J EPIDEMIOL, V130, P14, DOI 10.1093/oxfordjournals.aje.a115305; Brisson J, 2007, CANCER EPIDEM BIOMAR, V16, P929, DOI 10.1158/1055-9965.EPI-06-0746; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Cauley JA, 2013, J WOMENS HEALTH, V22, P915, DOI 10.1089/jwh.2013.4270; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chlebowski RT, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2846; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Colston KW, 1998, J MOL ENDOCRINOL, V20, P157, DOI 10.1677/jme.0.0200157; Couto E, 2011, BREAST CANC RES TREA; Couto E, 2012, BREAST CANCER RES TR, V132, P297, DOI 10.1007/s10549-011-1810-x; Crew Katherine D, 2013, ISRN Oncol, V2013, P483687, DOI 10.1155/2013/483687; Cui Y, 2006, CANCER EPIDEM BIOMAR, V15, P1427, DOI 10.1158/1055-9965.EPI-06-0075; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Diorio C, 2006, CANCER RES, V66, P588, DOI 10.1158/0008-5472.CAN-05-1959; Edvardsen K, 2011, INT J CANCER, V128, P1425, DOI 10.1002/ijc.25463; Ellingjord-Dale M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3337; Engel P, 2011, CANCER EPIDEM BIOMAR, V20, P187, DOI 10.1158/1055-9965.EPI-10-1039; Engel P, 2010, CANCER EPIDEM BIOMAR, V19, P2341, DOI 10.1158/1055-9965.EPI-10-0264; Engelsen O, 2005, PHOTOCHEM PHOTOBIOL, V81, P1287, DOI 10.1562/2004-11-19-RN-375; Freedman DM, 2008, CANCER EPIDEM BIOMAR, V17, P889, DOI 10.1158/1055-9965.EPI-07-2594; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Gonzalez CA, 2010, EUR J CANCER, V46, P2555, DOI 10.1016/j.ejca.2010.07.025; Green AK, 2010, INT J CANCER, V127, P667, DOI 10.1002/ijc.25075; Kawase T, 2010, CANCER SCI, V101, P1234, DOI 10.1111/j.1349-7006.2010.01496.x; Khan QJ, 2010, CURR ONCOL REP, V12, P136, DOI 10.1007/s11912-010-0081-8; Knight JA, 2007, CANCER EPIDEM BIOMAR, V16, P422, DOI 10.1158/1055-9965.EPI-06-0865; Knight JA, 2006, CANCER EPIDEM BIOMAR, V15, P1988, DOI 10.1158/1055-9965.EPI-06-0241; Kuper H, 2009, CANCER EPIDEM BIOMAR, V18, P2558, DOI 10.1158/1055-9965.EPI-09-0449; Lee MS, 2011, J EPIDEMIOL, V21, P87, DOI 10.2188/jea.JE20100088; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; McCullough ML, 2005, CANCER EPIDEM BIOMAR, V14, P2898, DOI 10.1158/1055-9965.EPI-05-0611; Mishra G, 2008, BRIT J CANCER, V99, P1539, DOI 10.1038/sj.bjc.6604697; National Nutrition Council NFCA IfNRU, 2001, STOR MATV; NES M, 1992, EUR J CLIN NUTR, V46, P809; PELLER S, 1946, NEW YORK STATE J MED, V46, P1355; Qureshi SA, 2011, BREAST CANC RES TREA; Qureshi SA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-45; Qureshi SA, 2012, BREAST CANCER RES TR, V131, P993, DOI 10.1007/s10549-011-1812-8; Qureshi SA, 2011, NUTR CANCER, V63, P1011, DOI 10.1080/01635581.2011.605983; Shin MH, 2002, JNCI-J NATL CANCER I, V94, P1301, DOI 10.1093/jnci/94.17.1301; Skeie G, 2009, INT J CANCER, V125, P1155, DOI 10.1002/ijc.24422; Thomson CA, 2007, MENOPAUSE, V14, P243, DOI 10.1097/01.gme.0000235362.72899.7b; Tseng M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1781; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2000, CANCER EPIDEM BIOMAR, V9, P151; Welsh J, 2011, MOL CELL ENDOCRINOL, V347, P55, DOI 10.1016/j.mce.2011.05.020; Work Meghan E, 2014, Int J Cancer, V135, P1740, DOI 10.1002/ijc.28825	60	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123754	10.1371/journal.pone.0123754	http://dx.doi.org/10.1371/journal.pone.0123754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938768	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000353943000012
J	Khan, HAA; Akram, W; Iqbal, J; Naeem-Ullah, U				Khan, Hafiz Azhar Ali; Akram, Waseem; Iqbal, Javaid; Naeem-Ullah, Unsar			Thiamethoxam Resistance in the House Fly, Musca domestica L.: Current Status, Resistance Selection, Cross-Resistance Potential and Possible Biochemical Mechanisms	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; DIPTERA MUSCIDAE; INSECTICIDE RESISTANCE; ALEYRODIDAE; POPULATIONS; PAKISTAN; SPINOSAD; DAIRIES; FLIES	The house fly, Musca domestica L., is an important ectoparasite with the ability to develop resistance to insecticides used for their control. Thiamethoxam, a neonicotinoid, is a relatively new insecticide and effectively used against house flies with a few reports of resistance around the globe. To understand the status of resistance to thiamethoxam, eight adult house fly strains were evaluated under laboratory conditions. In addition, to assess the risks of resistance development, cross-resistance potential and possible biochemical mechanisms, a field strain of house flies was selected with thiamethoxam in the laboratory. The results revealed that the field strains showed varying level of resistance to thiamethoxam with resistance ratios (RR) at LC50 ranged from 7.66-20.13 folds. Continuous selection of the field strain (Thia-SEL) for five generations increased the RR from initial 7.66 fold to 33.59 fold. However, resistance declined significantly when the Thia-SEL strain reared for the next five generations without exposure to thiamethoxam. Compared to the laboratory susceptible reference strain (Lab-susceptible), the Thia-SEL strain showed cross-resistance to imidacloprid. Synergism tests revealed that S,S,S-tributylphosphorotrithioate (DEF) and piperonyl butoxide (PBO) produced synergism of thiamethoxam effects in the Thia-SEL strain (2.94 and 5.00 fold, respectively). In addition, biochemical analyses revealed that the activities of carboxylesterase (CarE) and mixed function oxidase (MFO) in the Thia-SEL strain were significantly higher than the Lab-susceptible strain. It seems that metabolic detoxification by CarE and MFO was a major mechanism for thiamethoxam resistance in the Thia-SEL strain of house flies. The results could be helpful in the future to develop an improved control strategy against house flies.	[Khan, Hafiz Azhar Ali] Univ Punjab, Inst Agr Sci, Lahore, Pakistan; [Akram, Waseem] Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan; [Iqbal, Javaid] Islamia Univ Bahawalpur, Univ Coll Agr & Environm Sci, Bahawalpur, Pakistan; [Naeem-Ullah, Unsar] Punjab Govt, Farm Water Management Off, Multan, Pakistan	University of Punjab; University of Agriculture Faisalabad; Islamia University of Bahawalpur	Khan, HAA (corresponding author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.	azhar_naturalist@yahoo.com	Iqbal, Javaid/X-1554-2018; Khan, Hafiz Azhar Ali/AAI-7476-2021	Iqbal, Javaid/0000-0002-8298-129X; Khan, Hafiz Azhar Ali/0000-0002-7209-4750				Abbas N, 2014, ECOTOXICOLOGY, V23, P791, DOI 10.1007/s10646-014-1217-7; [Anonymous], P 10 IUPAC INT C CHE; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Finney D.J., 1971, PROBIT ANAL; Gao CF, 2014, PESTIC BIOCHEM PHYS, V114, P90, DOI 10.1016/j.pestbp.2014.06.009; Horowitz AR, 2004, J ECON ENTOMOL, V97, P2051, DOI 10.1603/0022-0493-97.6.2051; Kaufman PE, 2001, PEST MANAG SCI, V57, P514, DOI 10.1002/ps.319; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Khan HAA, 2015, THESIS B Z U MULTAN; Khan HAA, 2014, ACTA TROP, V130, P148, DOI 10.1016/j.actatropica.2013.11.006; Khan HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077225; Khan HAA, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-18; Khan HAA, 2013, ECOTOXICOLOGY, V22, P522, DOI 10.1007/s10646-013-1044-2; Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146; Kristensen M, 2005, J ECON ENTOMOL, V98, P1341, DOI 10.1603/0022-0493-98.4.1341; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Li J, 2012, PESTIC BIOCHEM PHYS, V102, P109, DOI 10.1016/j.pestbp.2011.10.012; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Liu NN, 2000, J ECON ENTOMOL, V93, P1269, DOI 10.1603/0022-0493-93.4.1269; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; Naveed M, 2010, PAK J ZOOL, V42, P559; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Yang Y, 2004, INSECT BIOCHEM MOLEC, V34, P763, DOI 10.1016/j.ibmb.2004.04.001	26	23	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125850	10.1371/journal.pone.0125850	http://dx.doi.org/10.1371/journal.pone.0125850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938578	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000109
J	Xu, JH; Teng, IT; Zhang, LQ; Delgado, S; Champanhac, C; Cansiz, S; Wu, CC; Shan, H; Tan, WH				Xu, Jiehua; Teng, I-Ting; Zhang, Liqin; Delgado, Stefanie; Champanhac, Carole; Cansiz, Sena; Wu, Cuichen; Shan, Hong; Tan, Weihong			Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; IN-VITRO SELECTION; DRUG; STABILITY; DIAGNOSIS; DELIVERY; LIGANDS; PROBES; HER2	Most clinical cases of liver cancer cannot be diagnosed until they have evolved to an advanced stage, thus resulting in high mortality. It is well recognized that the implementation of early detection methods and the development of targeted therapies for liver cancer are essential to reducing the high mortality rates associated with this disease. To achieve these goals, molecular probes capable of recognizing liver cancer cell-specific targets are needed. Here we describe a panel of aptamers able to distinguish hepatocarcinoma from normal liver cells. The aptamers, which were selected by cell-based SELEX (Systematic Evolution of Ligands by Exponential Enrichment), have Kd values in the range of 64-349 nM toward the target human hepatoma cell HepG2, and also recognize ovarian cancer cells and lung adenocarcinoma. The proteinase treatment experiment indicated that all aptamers could recognize target HepG2 cells through surface proteins. This outcome suggested that these aptamers could be used as potential probes for further research in cancer studies, such as developing early detection assays, targeted therapies, and imaging agents, as well as for the investigation of common membrane proteins in these distinguishable cancers.	[Xu, Jiehua] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Jiehua; Teng, I-Ting; Zhang, Liqin; Delgado, Stefanie; Champanhac, Carole; Cansiz, Sena; Wu, Cuichen; Tan, Weihong] Univ Florida, Dept Chem, Dept Biochem & Mol Biol, Gainesville, FL 32611 USA; [Xu, Jiehua; Teng, I-Ting; Zhang, Liqin; Delgado, Stefanie; Champanhac, Carole; Cansiz, Sena; Wu, Cuichen; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Ctr Res Bio Nano Interface, Hlth Canc Ctr,UF Genet Inst, Gainesville, FL USA; [Xu, Jiehua; Teng, I-Ting; Zhang, Liqin; Delgado, Stefanie; Champanhac, Carole; Cansiz, Sena; Wu, Cuichen; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Shan, Hong] Sun Yat Sen Univ, Intervent Radiol Inst, Dept Radiol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sun Yat Sen University	Tan, WH (corresponding author), Univ Florida, Dept Chem, Dept Biochem & Mol Biol, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Tan, Weihong/A-5412-2008; Tan, Weihong/AAA-4536-2020	Tan, Weihong/0000-0002-8066-1524; 	National Institutes of Health [GM079359, CA133086]; State Scholarship Fund; National Natural Science Foundation of China [81101866, 81430041]; Fundamental Research Funds for the Central Universities [11ykpy41]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State Scholarship Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health GM079359 and National Institutes of Health CA133086; State Scholarship Fund, PI = Jiehua Xu; National Natural Science Foundation of China 81101866, PI = Jiehua Xu; National Natural Science Foundation of China 81430041, PI = Jiehua Xu; and Fundamental Research Funds for the Central Universities 11ykpy41, PI = Jiehua Xu. The funders had no role in study degign, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan S, 2008, ANAL CHEM, V80, P9630, DOI 10.1021/ac8009559; Banerjee J, 2013, J MOL MED, V91, P1333, DOI 10.1007/s00109-013-1085-2; Chang YM, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/817350; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Cho S, 2004, ELECTROPHORESIS, V25, P3730, DOI 10.1002/elps.200406103; Dastjerdi K, 2011, BIOTECHNOL APPL BIOC, V58, P226, DOI 10.1002/bab.36; Donovan MJ, 2011, METHODS MOL BIOL, V764, P141, DOI 10.1007/978-1-61779-188-8_9; Dua P, 2013, CANCER RES, V73, P1934, DOI 10.1158/0008-5472.CAN-12-3682; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Hu K, 2013, BIOSENS BIOELECTRON, V42, P598, DOI 10.1016/j.bios.2012.11.025; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Jelic S, 2010, ANN ONCOL, V21, pv59, DOI 10.1093/annonc/mdq166; Jimenez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046222; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085; LEE YTM, 1987, J SURG ONCOL, V36, P26, DOI 10.1002/jso.2930360107; Li H, 2010, NUCLEIC ACIDS RES, V38, pD658, DOI 10.1093/nar/gkp933; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Li X, 2013, J CONTROL RELEASE, V171, P152, DOI 10.1016/j.jconrel.2013.06.006; Liu H, 2012, ANGEW CHEM INT EDIT, V51, P6925, DOI 10.1002/anie.201202929; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Mairal T, 2014, BIOSENS BIOELECTRON, V54, P207, DOI 10.1016/j.bios.2013.10.070; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Medley CD, 2011, ANAL CHEM, V83, P727, DOI 10.1021/ac102263v; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Schoukroun-Barnes LR, 2014, ANAL CHEM, V86, P1131, DOI 10.1021/ac4029054; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Sefah K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014269; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070476; Shigdar S, 2013, SENSORS-BASEL, V13, P13624, DOI 10.3390/s131013624; Shigdar S, 2013, CANCER LETT, V330, P84, DOI 10.1016/j.canlet.2012.11.032; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Simaeys D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013770; Verslype C, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds225; Wang RE, 2011, CURR MED CHEM, V18, P4126; Xiao SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053935; Xing H, 2012, CURR OPIN CHEM BIOL, V16, P429, DOI 10.1016/j.cbpa.2012.03.016; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01583; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zhou WZ, 2014, ANALYST, V139, P2627, DOI 10.1039/c4an00132j	48	54	55	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125863	10.1371/journal.pone.0125863	http://dx.doi.org/10.1371/journal.pone.0125863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938802	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000112
J	Cameron, K; Weinstein, JY; Zhivin, O; Bule, P; Fleishman, SJ; Alves, VD; Gilbert, HJ; Ferreira, LMA; Fontes, CMGA; Bayer, EA; Najmudin, S				Cameron, Kate; Weinstein, Jonathan Y.; Zhivin, Olga; Bule, Pedro; Fleishman, Sarel J.; Alves, Victor D.; Gilbert, Harry J.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Bayer, Edward A.; Najmudin, Shabir			Combined Crystal Structure of a Type I Cohesin MUTATION AND AFFINITY BINDING STUDIES REVEAL STRUCTURAL DETERMINANTS OF COHESIN-DOCKERIN SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulase; cellulose; cellulosome; computational biology; computer modeling; protein-protein interaction	BACTEROIDES-CELLULOSOLVENS CELLULOSOME; CLOSTRIDIUM-THERMOCELLUM; DOCKERIN COMPLEX; PROTEIN; MODULES; SURFACE; RECOGNITION; SCAFFOLDIN; CELLULASE; FAMILIES	Background: Cellulosomal cohesin-dockerin types are reversed in Bacteroides cellulosolvens. Results: Combined crystallographic and computational approaches of a lone cohesin yielded a structural model of the cohesin-dockerin complex that was verified experimentally. Conclusion: The dockerin dual-binding mode is not exclusive to enzyme integration into cellulosomes; it also characterizes cell-surface attachment. Significance: This combined approach provides a platform for generating testable hypotheses of the high affinity cohesin-dockerin interaction. Cohesin-dockerin interactions orchestrate the assembly of one of nature's most elaborate multienzyme complexes, the cellulosome. Cellulosomes are produced exclusively by anaerobic microbes and mediate highly efficient hydrolysis of plant structural polysaccharides, such as cellulose and hemicellulose. In the canonical model of cellulosome assembly, type I dockerin modules of the enzymes bind to reiterated type I cohesin modules of a primary scaffoldin. Each type I dockerin contains two highly conserved cohesin-binding sites, which confer quaternary flexibility to the multienzyme complex. The scaffoldin also bears a type II dockerin that anchors the entire complex to the cell surface by binding type II cohesins of anchoring scaffoldins. In Bacteroides cellulosolvens, however, the organization of the cohesin-dockerin types is reversed, whereby type II cohesin-dockerin pairs integrate the enzymes into the primary scaffoldin, and type I modules mediate cellulosome attachment to an anchoring scaffoldin. Here, we report the crystal structure of a type I cohesin from B. cellulosolvens anchoring scaffoldin ScaB to 1.84-angstrom resolution. The structure resembles other type I cohesins, and the putative dockerin-binding site, centered at -strands 3, 5, and 6, is likely to be conserved in other B. cellulosolvens type I cohesins. Combined computational modeling, mutagenesis, and affinity-based binding studies revealed similar hydrogen-bonding networks between putative Ser/Asp recognition residues in the dockerin at positions 11/12 and 45/46, suggesting that a dual-binding mode is not exclusive to the integration of enzymes into primary cellulosomes but can also characterize polycellulosome assembly and cell-surface attachment. This general approach may provide valuable structural information of the cohesin-dockerin interface, in lieu of a definitive crystal structure.	[Cameron, Kate; Bule, Pedro; Alves, Victor D.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Lisbon, Fac Med Vet, CIISA, P-1300477 Lisbon, Portugal; [Weinstein, Jonathan Y.; Zhivin, Olga; Fleishman, Sarel J.; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Weizmann Institute of Science; Newcastle University - UK	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Ed.Bayer@weizmann.ac.il	Bule, Pedro/W-6838-2019	Bule, Pedro/0000-0003-2531-9926; Najmudin, Shabir/0000-0002-0429-5454; Fontes, Carlos/0000-0002-1219-9753; Alves, Victor Diogo/0000-0002-8430-4380; Fleishman, Sarel/0000-0003-3177-7560	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012]; European Union Seventh Framework Programme FP7 under the WallTraC Project [263916]; European Union Seventh Framework Programme FP7 under BioStruct-X [283570]; Israel Science Foundation [1349/13]; European Research Council Starter's Grant; European Union [NMP.2013.1.1-2, 604530]; ERA-IB Consortium [EIB.12.022]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Union Seventh Framework Programme FP7 under the WallTraC Project; European Union Seventh Framework Programme FP7 under BioStruct-X; Israel Science Foundation(Israel Science Foundation); European Research Council Starter's Grant; European Union(European Commission); ERA-IB Consortium	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) Grants PTDC/BIA-PRO/103980/2008 and EXPL/BIA-MIC/1176/2012, European Union Seventh Framework Programme FP7 2007-2013 under the WallTraC Project Grant 263916 and under BioStruct-X Grant 283570; Israel Science Foundation and a European Research Council Starter's Grant (to the Fleishman laboratory); Israel Science Foundation Grant 1349/13, European Union, Area NMP.2013.1.1-2 "Self-assembly of Naturally Occuring Nanosystems," CellulosomePlus Project 604530, and an ERA-IB Consortium Grant EIB.12.022 (acronym FiberFuel) (to the Bayer laboratory). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Alber O, 2009, PROTEINS, V77, P699, DOI 10.1002/prot.22483; Artzi L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-100; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Carvalho AL, 2005, J MOL BIOL, V349, P909, DOI 10.1016/j.jmb.2005.04.037; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GIULIANO C, 1984, APPL ENVIRON MICROB, V48, P446, DOI 10.1128/AEM.48.2.446-448.1984; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Horino H, 2014, INT J SYST EVOL MICR, V64, P1296, DOI 10.1099/ijs.0.059378-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MURRAY WD, 1984, INT J SYST BACTERIOL, V34, P185, DOI 10.1099/00207713-34-2-185; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Najmudin S, 2010, J STRUCT BIOL, V172, P353, DOI 10.1016/j.jsb.2010.07.009; Nakar D, 2004, J BIOL CHEM, V279, P42881, DOI 10.1074/jbc.M407350200; Noach I, 2005, J MOL BIOL, V348, P1, DOI 10.1016/j.jmb.2005.02.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Pinheiro BA, 2012, BIOCATAL BIOTRANSFOR, V30, P309, DOI 10.3109/10242422.2012.681854; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2004, J BACTERIOL, V186, P968, DOI 10.1128/JB.186.4.968-977.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003	39	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16215	16225		10.1074/jbc.M115.653303	http://dx.doi.org/10.1074/jbc.M115.653303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25934389	Green Published, hybrid			2022-12-26	WOS:000356930100025
J	Wang, W; Runkle, KB; Terkowski, SM; Ekaireb, RI; Witze, ES				Wang, Wei; Runkle, Kristin B.; Terkowski, Samantha M.; Ekaireb, Rachel I.; Witze, Eric S.			Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell polarity; cell signaling; protein palmitoylation; Wnt signaling	NITRIC-OXIDE SYNTHASE; RAS LOCALIZATION; PALMITOYLATION; MELANOMA; MIGRATION; INVASION; REVEALS; GROWTH; EXPRESSION; PATHWAY	Background: Wnt5a signaling induces asymmetric localization of the melanoma cell adhesion molecules (MCAM). Results: Wnt5a promotes MCAM depalmitoylation and point mutations in MCAM that block palmitoylation are sufficient to cause asymmetric MCAM localization. Conclusion: Wnt5a induces polarized MCAM localization by promoting MCAM depalmitoylation. Significance: These results reveal a mechanism for Wnt5a-induced polarized cell behavior. Wnt5a signaling regulates polarized cell behavior, but the downstream signaling events that promote cell polarity are not well understood. Our results show that Wnt5a promotes depalmitoylation of the melanoma cell adhesion molecule (MCAM) at cysteine 590. Mutation of Cys-590 to glycine is sufficient to polarize MCAM localization, similar to what is observed with Wnt5a stimulation. Inhibition of the depalmitoylating enzyme APT1 blocks Wnt5a-induced depalmitoylation, asymmetric MCAM localization, and cell invasion. Directly altering expression of the basal protein palmitoylation machinery is sufficient to promote cell invasion. Additionally, cancer mutations in palmitoyltransferases decrease MCAM palmitoylation and have impaired ability to suppress cell invasion. Our results provide evidence that Wnt5a induces protein depalmitoylation, which promotes polarized protein localization and cell invasion.	[Wang, Wei; Runkle, Kristin B.; Terkowski, Samantha M.; Ekaireb, Rachel I.; Witze, Eric S.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Witze, Eric S.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Witze, ES (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	ewitze@exchange.upenn.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-CA-181633-01A1, 2-T32-CA-557726-07]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [T32CA115299, R01CA181633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA-181633-01A1 and the Melanoma Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by National Institutes of Health Grant 2-T32-CA-557726-07.	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Bakker ERM, 2013, CARCINOGENESIS, V34, P2629, DOI 10.1093/carcin/bgt215; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Draper JM, 2010, MOL MEMBR BIOL, V27, P123, DOI 10.3109/09687681003616854; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; GUO YJ, 1994, INT IMMUNOL, V6, P213, DOI 10.1093/intimm/6.2.213; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kong E, 2013, J BIOL CHEM, V288, P9112, DOI 10.1074/jbc.M112.421073; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohno Y., 2006, BIOCHIM BIOPHYS ACTA, V176, P1474; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Saitoh T, 2002, INT J MOL MED, V9, P515; Satyamoorthy K, 2001, ONCOGENE, V20, P4676, DOI 10.1038/sj.onc.1204616; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	42	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15707	15716		10.1074/jbc.M115.639609	http://dx.doi.org/10.1074/jbc.M115.639609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944911	hybrid, Green Published			2022-12-26	WOS:000356527400033
J	Naito, T; Takatsu, H; Miyano, R; Takada, N; Nakayama, K; Shin, HW				Naito, Tomoki; Takatsu, Hiroyuki; Miyano, Rie; Takada, Naoto; Nakayama, Kazuhisa; Shin, Hye-Won			Phospholipid Flippase ATP10A Translocates Phosphatidylcholine and Is Involved in Plasma Membrane Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; RECYCLING ENDOSOMES; CDC50 PROTEINS; PHOSPHATIDYLSERINE; TRANSPORT; YEAST; DEFICIENCY; ASYMMETRY	We showed previously that ATP11A and ATP11C have flippase activity toward aminophospholipids (phosphatidylserine (PS) and phosphatidylethanolamine (PE)) and ATP8B1 and that ATP8B2 have flippase activity toward phosphatidylcholine (PC) (Takatsu, H., Tanaka, G., Segawa, K., Suzuki, J., Nagata, S., Nakayama, K., and Shin, H. W. (2014) J. Biol. Chem. 289, 33543-33556). Here, we show that the localization of class 5 P4-ATPases to the plasma membrane (ATP10A and ATP10D) and late endosomes (ATP10B) requires an interaction with CDC50A. Moreover, exogenous expression of ATP10A, but not its ATPase-deficient mutant ATP10A(E203Q), dramatically increased PC flipping but not flipping of PS or PE. Depletion of CDC50A caused ATP10A to be retained at the endoplasmic reticulum instead of being delivered to the plasma membrane and abrogated the increased PC flipping activity observed by expression of ATP10A. These results demonstrate that ATP10A is delivered to the plasma membrane via its interaction with CDC50A and, specifically, flips PC at the plasma membrane. Importantly, expression of ATP10A, but not ATP10A(E203Q), dramatically altered the cell shape and decreased cell size. In addition, expression of ATP10A, but not ATP10A(E203Q), delayed cell adhesion and cell spreading onto the extracellular matrix. These results suggest that enhanced PC flipping activity due to exogenous ATP10A expression alters the lipid composition at the plasma membrane, which may in turn cause a delay in cell spreading and a change in cell morphology.	[Naito, Tomoki; Takatsu, Hiroyuki; Miyano, Rie; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch, Sakyo Ku, Kyoto 6068501, Japan; [Takada, Naoto] Kyoto Univ, Fac Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Shin, HW (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	shin@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Naito, Tomoki/0000-0002-8393-3601; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K14456, 15H01320, 15H04370] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Takeda Science Foundation.	Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Folmer DE, 2009, HEPATOLOGY, V50, P1597, DOI 10.1002/hep.23158; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Hurst SE, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/152902; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Morita S, 2007, HEPATOLOGY, V46, P188, DOI 10.1002/hep.21591; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SCHRIER SL, 1992, BLOOD, V79, P782; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	44	46	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15004	15017		10.1074/jbc.M115.655191	http://dx.doi.org/10.1074/jbc.M115.655191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25947375	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000356177300017
J	Cusack, JJ; Dickman, AJ; Rowcliffe, JM; Carbone, C; Macdonald, DW; Coulson, T				Cusack, Jeremy J.; Dickman, Amy J.; Rowcliffe, J. Marcus; Carbone, Chris; Macdonald, David W.; Coulson, Tim			Random versus Game Trail-Based Camera Trap Placement Strategy for Monitoring Terrestrial Mammal Communities	PLOS ONE			English	Article							PHOTOGRAPHIC RATES; ESTIMATE DENSITIES; ANIMAL DENSITY; FOREST MAMMALS; TIGERS; EXTRAPOLATION; POPULATIONS; DIVERSITY; ABUNDANCE; LOCATION	Camera trap surveys exclusively targeting features of the landscape that increase the probability of photographing one or several focal species are commonly used to draw inferences on the richness, composition and structure of entire mammal communities. However, these studies ignore expected biases in species detection arising from sampling only a limited set of potential habitat features. In this study, we test the influence of camera trap placement strategy on community-level inferences by carrying out two spatially and temporally concurrent surveys of medium to large terrestrial mammal species within Tanzania's Ruaha National Park, employing either strictly game trail-based or strictly random camera placements. We compared the richness, composition and structure of the two observed communities, and evaluated what makes a species significantly more likely to be caught at trail placements. Observed communities differed marginally in their richness and composition, although differences were more noticeable during the wet season and for low levels of sampling effort. Lognormal models provided the best fit to rank abundance distributions describing the structure of all observed communities, regardless of survey type or season. Despite this, carnivore species were more likely to be detected at trail placements relative to random ones during the dry season, as were larger bodied species during the wet season. Our findings suggest that, given adequate sampling effort (> 1400 camera trap nights), placement strategy is unlikely to affect inferences made at the community level. However, surveys should consider more carefully their choice of placement strategy when targeting specific taxonomic or trophic groups.	[Cusack, Jeremy J.; Coulson, Tim] Univ Oxford, Dept Zool, Oxford, England; [Cusack, Jeremy J.; Rowcliffe, J. Marcus; Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England; [Dickman, Amy J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford, England	University of Oxford; Zoological Society of London; University of Oxford	Cusack, JJ (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	jeremy.cusack@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021; Rowcliffe, Marcus/G-3713-2018	Coulson, Tim/0000-0001-9371-9003; Rowcliffe, Marcus/0000-0002-4286-6887	UK Natural Environment Research Council [NE/J016527/1]; Recanati-Kaplan Foundation; Riverbanks Zoo and Garden; SeaWorld Busch Gardens; St Louis WildCare Insitute; Natural Environment Research Council [1221700, NE/H007148/2, NE/E015921/1, NE/G004390/1, NE/I023791/2, 1136795, NE/H007148/1, NE/I023783/2, NE/I023791/1, NE/G004390/2, NE/K014218/1, NE/I023783/1] Funding Source: researchfish; NERC [NE/I023783/1, NE/K014218/1, NE/E015921/1, NE/I023791/1, NE/I023783/2, NE/G004390/1, NE/G004390/2, NE/I023791/2, NE/H007148/2] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Recanati-Kaplan Foundation; Riverbanks Zoo and Garden; SeaWorld Busch Gardens; St Louis WildCare Insitute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a UK Natural Environment Research Council (www.nerc.ac.uk/) grant NE/J016527/1 to TC, and by grants from the Recanati-Kaplan Foundation, Riverbanks Zoo and Garden (www.riverbanks.org/), SeaWorld Busch Gardens (seaworldparks.com/en/buschgardenstampa/) and St Louis WildCare Insitute (www.stlzoo.org/conservation/) to AJD. The Zoological Society of London, represented by JMR and CC, contributed towards fieldwork living expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; Ahumada JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073707; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Blake John G, 2014, Mastozool. neotrop., V21, P17; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Can OE, 2009, ORYX, V43, P427, DOI 10.1017/S0030605308000628; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Collins SL, 2008, ECOLOGY, V89, P3534, DOI 10.1890/07-1646.1; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jennelle CS, 2002, ANIM CONSERV, V5, P119, DOI 10.1017/S1367943002002160; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Kays Roland, 2011, International Journal of Research and Reviews in Wireless Sensor Networks, V1, P19; Kays R, 2009, C LOCAL COMPUT NETW, P811, DOI 10.1109/LCN.2009.5355046; Kingdon J, 2013, KINGDON FIELD GUIDE; Kissling WD, 2014, ECOL EVOL, V4, P2913, DOI 10.1002/ece3.1136; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Meek P, 2012, INTRO CAMERA TRAPPIN; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Melo GL, 2012, IHERINGIA SER ZOOL, V102, P88, DOI 10.1590/S0073-47212012000100012; Mugerwa B, 2013, AFR J ECOL, V51, P21, DOI 10.1111/aje.12004; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Oksanen J., 2017, COMMUNITY ECOLOGY PA; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Srbek-Araujo AC, 2005, J TROP ECOL, V21, P121, DOI 10.1017/S0266467404001956; Stolberger S, 2012, RUAHA NATL PARK INTI; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Walsh M, 2000, DEV COMMUNITY WILDLI; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896	49	109	112	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126373	10.1371/journal.pone.0126373	http://dx.doi.org/10.1371/journal.pone.0126373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950183	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400086
J	Demirovic, D; Nizard, C; Rattan, SIS				Demirovic, Dino; Nizard, Carine; Rattan, Suresh I. S.			Basal Level of Autophagy Is Increased in Aging Human Skin Fibroblasts In Vitro, but Not in Old Skin	PLOS ONE			English	Article							REMOVAL; STRESS	Intracellular autophagy (AP) is a stress response that is enhanced under conditions of limitation of amino acids, growth factors and other nutrients, and also when macromolecules become damaged, aggregated and fibrillated. Aging is generally accompanied by an increase in intracellular stress due to all the above factors. Therefore, we have compared the basal levels of AP in serially passaged human facial skin fibroblasts undergoing aging and replicative senescence in vitro, and ex vivo in the skin biopsies from the photo-protected and photo-exposed area of the arms of 20 healthy persons of young and old ages. Immunofluorescence microscopy, employing antibodies against a specific intracellular microtubule-associated protein-1 light chain-3 (LC3) as a well established marker of AP, showed a 5-fold increase in the basal level of LC3 in near senescent human skin fibroblasts. However, no such age-related increase in LC3 fluorescence and AP could be detected in full thickness skin sections from the biopsies obtained from 10 healthy young (age 25 to 30 yr) and 10 old (age 60 to 65 yr) donors. Furthermore, there was no difference in the basal level of LC3 in the skin sections from photo-protected and photo-exposed areas of the arm. Thus, in normal conditions, the aging phenotype of the skin cells in culture and in the body appears to be different in the case of AP.	[Demirovic, Dino; Rattan, Suresh I. S.] Aarhus Univ, Dept Mol Biol & Genet, Lab Cellular Ageing, Aarhus, Denmark; [Nizard, Carine] LVMH Res, St Jean de Braye, France	Aarhus University	Rattan, SIS (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Lab Cellular Ageing, Aarhus, Denmark.	rattan@mbg.au.dk		Rattan, Suresh I.S./0000-0002-3478-1381	LVMH Research, France	LVMH Research, France	The Laboratory of Cellular Ageing received a PhD fellowship grant from LVMH Research, France. The funder provided support in the form of salary for author CN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Demirovic D, 2014, J CELL COMMUN SIGNAL, V8, P333, DOI 10.1007/s12079-014-0244-8; Demirovic D, 2013, EXP GERONTOL, V48, P94, DOI 10.1016/j.exger.2012.02.005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Farage MA, 2010, TXB AGING SKIN; Gilchrest B., 2006, SKIN AGING; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Musiwaro P, 2013, AUTOPHAGY, V9, P1407, DOI 10.4161/auto.25455; Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124; RATTAN SIS, 2008, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0002567.PUB2; Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303; Rattan SIS, 2012, BIOGERONTOLOGY, V13, P83, DOI 10.1007/s10522-011-9354-3; Rattan SIS, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P233, DOI 10.1007/978-90-481-8556-6_13; Rattan SIS, 2010, ANN NY ACAD SCI, V1197, P28, DOI 10.1111/j.1749-6632.2010.05193.x; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rello-Varona S, 2012, CELL CYCLE, V11, P170, DOI 10.4161/cc.11.1.18564; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Shen HM, 2014, TRENDS BIOCHEM SCI, V39, P61, DOI 10.1016/j.tibs.2013.12.001; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002	22	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126546	10.1371/journal.pone.0126546	http://dx.doi.org/10.1371/journal.pone.0126546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950597	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400100
J	Hui, TCY; Gryba, R; Gregr, EJ; Trites, AW				Hui, Tabitha C. Y.; Gryba, Rowenna; Gregr, Edward J.; Trites, Andrew W.			Assessment of Competition between Fisheries and Steller Sea Lions in Alaska Based on Estimated Prey Biomass, Fisheries Removals and Predator Foraging Behaviour	PLOS ONE			English	Article							MACKEREL PLEUROGRAMMUS-MONOPTERYGIUS; POLLOCK THERAGRA-CHALCOGRAMMA; EASTERN ALEUTIAN ISLANDS; NORTH PACIFIC-OCEAN; EUMETOPIAS-JUBATUS; WALLEYE POLLOCK; ATTENDANCE PATTERNS; BERING-SEA; WANDERING ALBATROSSES; COMMERCIAL FISHERIES	A leading hypothesis to explain the dramatic decline of Steller sea lions (Eumetopias jubatus) in western Alaska during the latter part of the 20th century is a change in prey availability due to commercial fisheries. We tested this hypothesis by exploring the relationships between sea lion population trends, fishery catches, and the prey biomass accessible to sea lions around 33 rookeries between 2000 and 2008. We focused on three commercially important species that have dominated the sea lion diet during the population decline: walleye pollock, Pacific cod and Atka mackerel. We estimated available prey biomass by removing fishery catches from predicted prey biomass distributions in the Aleutian Islands, Bering Sea and Gulf of Alaska; and modelled the likelihood of sea lions foraging at different distances from rookeries (accessibility) using satellite telemetry locations of tracked animals. We combined this accessibility model with the prey distributions to estimate the prey biomass accessible to sea lions by rookery. For each rookery, we compared sea lion population change to accessible prey biomass. Of 304 comparisons, we found 3 statistically significant relationships, all suggesting that sea lion populations increased with increasing prey accessibility. Given that the majority of comparisons showed no significant effect, it seems unlikely that the availability of pollock, cod or Atka mackerel was limiting sea lion populations in the 2000s.	[Hui, Tabitha C. Y.; Gryba, Rowenna; Gregr, Edward J.; Trites, Andrew W.] Univ British Columbia, Marine Mammal Res Unit, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hui, TCY (corresponding author), Natl Biodivers Ctr, Natl Pk Board, Singapore, Singapore.	tabitha.hui@gmail.com		Gryba, Rowenna/0000-0002-0426-8034; Trites, Andrew/0000-0003-0342-5322	National Oceanic and Atmospheric Administration (NOAA); NOAA	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Financial support was provided by National Oceanic and Atmospheric Administration (NOAA) to the North Pacific Universities Marine Mammal Research Consortium through the North Pacific Marine Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Brian Fadely for the sea lion telemetry data, Gina K. Himes Boor for the Platform of Opportunity sightings analysis, Ruth Joy for help with statistical analysis and Edward Richardson, Bill Wilson, Jeannie Heltzel, Phil Dang and Todd Loomis for catch information. Financial support was provided by NOAA to the North Pacific Universities Marine Mammal Research Consortium through the North Pacific Marine Science Foundation.	ALVERSON DL, 1992, REV AQUAT SCI, V6, P203; ALVERSON DL, 1991, COMMERCIAL FISHERIES; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; [Anonymous], 2000, MAR FISH REV; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Ban S, 2007, MAR MAMMAL SCI, V23, P496, DOI 10.1111/j.1748-7692.2007.00130.x; BARAFF LS, 2000, MAR FISH REV, V62, P1; Begon M., 2009, ECOLOGY INDIVIDUALS; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bernard DR, 2011, ALASKA DEP FISH GAME, P136; BOWEN WD, 2001, REV NOVEMBER 2000 BI; BRAHAM HW, 1980, J WILDLIFE MANAGE, V44, P25, DOI 10.2307/3808347; Brandon EAA, 2000, THESIS; Calkins D.G., 1998, BIOSPH CONSERV NAT W, V1, P33, DOI DOI 10.20798/BI0SPHEREC0NS.1.1_; Calkins DG, 2008, FIXED GEAR MARINE MA; Call KA, 2005, FISH OCEANOGR, V14, P212, DOI 10.1111/j.1365-2419.2005.00370.x; Conn PB, 2013, ALASKA REGIONA UNPUB; Conners ME, 2008, FISH B-NOAA, V106, P281; Cornick LA, 2006, ECOL MODEL, V199, P107, DOI 10.1016/j.ecolmodel.2006.07.003; Dillingham PW, 2006, CAN J FISH AQUAT SCI, V63, P107, DOI 10.1139/F05-208; Eastman JR, 2001, IDRISI RELEASE 2 GID, DOI [10.1056/NEJMoa1300955, DOI 10.1056/NEJMOA1300955]; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Fadely BS, 2005, FISH OCEANOGR, V14, P243, DOI 10.1111/j.1365-2419.2005.00379.x; FERRERO R, 1994, NMFSAFSC43 NOAA US D; Gregr EJ, 2008, MAR ECOL PROG SER, V365, P247, DOI 10.3354/meps07513; Gryba R, 2014, 201429 U BRIT COL FI; Guenette S, 2006, CAN J FISH AQUAT SCI, V63, P2495, DOI 10.1139/F06-136; Hanna S, 2000, SETTING FISHERY MANA; Hennen D, 2006, ECOL APPL, V16, P704, DOI 10.1890/1051-0761(2006)016[0704:ABTASS]2.0.CO;2; Hunt GL, 2005, FISH OCEANOGR, V14, P292, DOI 10.1111/j.1365-2419.2005.00378.x; Kane A, 2015, ANIMAL CONSERVATION; Karpouzi VS, 2007, MAR ECOL PROG SER, V343, P87, DOI 10.3354/meps06860; Kitts DD, 2004, CAN J ZOOL, V82, P1408, DOI 10.1139/Z04-116; Ladd C, 2005, FISH OCEANOGR, V14, P22, DOI 10.1111/j.1365-2419.2005.00373.x; Lander ME, 2013, MAR BIOL, V160, P195, DOI 10.1007/s00227-012-2077-4; Lander ME, 2009, ECOL APPL, V19, P1645, DOI 10.1890/08-0159.1; Litzow MA, 2014, PROG OCEANOGR, V120, P110, DOI 10.1016/j.pocean.2013.08.003; LIVINGSTON PA, 1993, MAR ECOL PROG SER, V102, P205, DOI 10.3354/meps102205; Logerwell EA, 2005, FISH OCEANOGR, V14, P93, DOI 10.1111/j.1365-2419.2005.00366.x; Loughlin T.R., 1989, P INT S BIOL MAN WAL; Loughlin TR, 2003, FISH B-NOAA, V101, P566; Lowry LF, 1986, FISHERY B, V84, P192; Lowry LF, 1982, 47 N AM WILD C BER S; Marcotte ML, 2006, THESIS; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Maschner HDG, 2014, FISH FISH, V15, P634, DOI 10.1111/faf.12038; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; McDermott SF, 2005, FISH OCEANOGR, V14, P113, DOI 10.1111/j.1365-2419.2005.00380.x; MEGREY B A, 1990, North American Journal of Fisheries Management, V10, P125, DOI 10.1577/1548-8675(1990)010<0125:AGRYOM>2.3.CO;2; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; MERRICK RL, 1987, FISH B-NOAA, V85, P351; MERRICK RL, 1994, POLAR RES, V13, P105, DOI 10.1111/j.1751-8369.1994.tb00441.x; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; Mueter FJ, 2002, FISH B-NOAA, V100, P559; National Research Council (NRC), 2003, DEC STELL SEA LION A; NMFS, 2009, STOCK ASS FISH EV RE; NMFS, 2008, PERC OBS COV BER SEA; Orensanz JML, 1998, REV FISH BIOL FISHER, V8, P117, DOI 10.1023/A:1008891412756; Orians G.H., 1979, P155; Pinheiro J, 2001, MIXED EFFECTS MODELS; PITCHER KW, 1981, FISH B-NOAA, V79, P467; R Core Team, 2020, R LANG ENV STAT COMP; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Rea LD, 1998, COMP BIOCHEM PHYS A, V120, P617, DOI 10.1016/S1095-6433(98)10074-0; Rehberg MJ, 2008, CAN J ZOOL, V86, P539, DOI 10.1139/Z08-018; Rehberg MJ, 2009, MAR MAMMAL SCI, V25, P588, DOI 10.1111/j.1748-7692.2008.00278.x; Sampson DB, 1995, ANAL GROUNDFISH FISH, P40; SEASE JL, 2001, NMFSAFSC122 NOAA US; Shima M, 2002, FISH B-NOAA, V100, P307; SHIMADA AM, 1994, FISH B-NOAA, V92, P800; Sigler MF, 2007, FISH RES, V83, P319, DOI 10.1016/j.fishres.2006.10.007; Sigler MF, 2009, MAR ECOL PROG SER, V388, P243, DOI 10.3354/meps08144; Sinclair E. H, 2013, NMFSAFSC248 NOAA US; Sinclair EH, 2002, J MAMMAL, V83, P973, DOI 10.1644/1545-1542(2002)083<0973:SASDID>2.0.CO;2; Sinclair EH, 2005, FISH OCEANOGR, V14, P223, DOI 10.1111/j.1365-2419.2005.00375.x; SMITH RL, 1990, J FISH BIOL, V36, P307, DOI 10.1111/j.1095-8649.1990.tb05611.x; Springer A.M., 1992, Fisheries Oceanography, V1, P80, DOI 10.1111/j.1365-2419.1992.tb00026.x; Trites AW, 2007, FISH OCEANOGR, V16, P46, DOI 10.1111/j.1365-2419.2006.00408.x; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Trites AW, 2002, J ZOOL, V256, P547, DOI 10.1017/S0952836902000596; Trites AW, 1999, DECLINE STELLE UNPUB; TRITES AW, 1992, STATUS STELLER SEA L; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Winship AJ, 2003, FISH B-NOAA, V101, P147; Winship AJ, 2006, MAR MAMMAL SCI, V22, P124, DOI 10.1111/j.1748-7692.2006.00009.x; Winship AJ, 2002, MAR ECOL PROG SER, V229, P291, DOI 10.3354/meps229291; Winter Andreas, 2009, Aquatic Mammals, V35, P145, DOI 10.1578/AM.35.2.2009.145; Womble JN, 2006, MAR ECOL PROG SER, V325, P281, DOI 10.3354/meps325281; Zeppelin TK, 2004, FISH B-NOAA, V102, P509	93	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0123786	10.1371/journal.pone.0123786	http://dx.doi.org/10.1371/journal.pone.0123786			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4RU	25950178	Green Published, gold, Green Submitted			2022-12-26	WOS:000367788800003
J	Ma, H; Liu, J; Bian, ZH; Cui, YQ; Zhou, XY; Zhou, XF; Zhang, B; Adesanya, TMA; Yi, F; Park, KH; Tan, T; Chen, ZS; Zhu, H				Ma, Hanley; Liu, Jason; Bian, Zehua; Cui, Yuqi; Zhou, Xinyu; Zhou, Xuefeng; Zhang, Bo; Adesanya, T. M. Ayodele; Yi, Frank; Park, Ki Ho; Tan, Tao; Chen, Zhishui; Zhu, Hua			Effect of Metabolic Syndrome on Mitsugumin 53 Expression and Function	PLOS ONE			English	Article							INSULIN-RESISTANCE; MEMBRANE REPAIR; MG53; DISRUPTION; INJURY; CARDIOPROTECTION; MICE	Metabolic syndrome is a cluster of risk factors, such as obesity, insulin resistance, and hyperlipidemia that increases the individual's likelihood of developing cardiovascular diseases. Patients inflicted with metabolic disorders also suffer from tissue repair defect. Mitsugumin 53 (MG53) is a protein essential to cellular membrane repair. It facilitates the nucleation of intracellular vesicles to sites of membrane disruption to create repair patches, contributing to the regenerative capacity of skeletal and cardiac muscle tissues upon injury. Since individuals suffering from metabolic syndrome possess tissue regeneration deficiency and MG53 plays a crucial role in restoring membrane integrity, we studied MG53 activity in mice models exhibiting metabolic disorders induced by a 6 month high-fat diet (HFD) feeding. Western blotting showed that MG53 expression is not altered within the skeletal and cardiac muscles of mice with metabolic syndrome. Rather, we found that MG53 levels in blood circulation were actually reduced. This data directly contradicts findings presented by Song et. al that indict MG53 as a causative factor for metabolic syndrome (Nature 494, 375-379). The diminished MG53 serum level observed may contribute to the inadequate tissue repair aptitude exhibited by diabetic patients. Furthermore, immunohistochemical analyses reveal that skeletal muscle fibers of mice with metabolic disorders experience localization of subcellular MG53 around mitochondria. This clustering may represent an adaptive response to oxidative stress resulting from HFD feeding and may implicate MG53 as a guardian to protect damaged mitochondria. Therapeutic approaches that elevate MG53 expression in serum circulation may be a novel method to treat the degenerative tissue repair function of diabetic patients.	[Ma, Hanley; Liu, Jason; Bian, Zehua; Cui, Yuqi; Zhou, Xinyu; Zhou, Xuefeng; Zhang, Bo; Adesanya, T. M. Ayodele; Yi, Frank; Park, Ki Ho; Tan, Tao; Zhu, Hua] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA; [Ma, Hanley] Olentangy Liberty High Sch, Powell, OH USA; [Liu, Jason] Dublin Jerome High Sch, Dublin, OH USA; [Zhang, Bo; Chen, Zhishui] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Organ Transplantat, Wuhan 430074, Hubei, Peoples R China	University System of Ohio; Ohio State University; Huazhong University of Science & Technology	Zhu, H (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA.	Hua.Zhu@osumc.edu	Park, Ki Ho/N-8153-2017; Cui, Yuqi/U-5914-2017; Zhu, Hua/G-4409-2010	Park, Ki Ho/0000-0002-6193-9826; Zhu, Hua/0000-0001-7136-7326	American Heart Association [12SDG12070174]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124122] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: The work was supported by American Heart Association (12SDG12070174 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; He B, 2012, MOL THER, V20, P727, DOI 10.1038/mt.2012.5; Howard AC, 2011, DIABETES, V60, P3034, DOI 10.2337/db11-0851; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; Ma LL, 2013, INT J CARDIOL, V168, P3671, DOI 10.1016/j.ijcard.2013.06.037; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076652; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Yuan HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053887; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	26	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124128	10.1371/journal.pone.0124128	http://dx.doi.org/10.1371/journal.pone.0124128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950605	gold, Green Published			2022-12-26	WOS:000354214400011
J	Osorio-Paz, I; Uribe-Carvajal, S; Salceda, R				Osorio-Paz, Ixchel; Uribe-Carvajal, Salvador; Salceda, Rocio			In the Early Stages of Diabetes, Rat Retinal Mitochondria Undergo Mild Uncoupling due to UCP2 Activity	PLOS ONE			English	Article							BETA-PINENE; GLUCOSE; METABOLISM; MEMBRANE; BRAIN; RETINOPATHY; ACTIVATION; MORPHOLOGY; MECHANISM; GLUTAMINE	In order to maintain high transmembrane ionic gradients, retinal tissues require a large amount of energy probably provided by a high rate of both, glycolysis and oxidative phosphorylation. However, little information exists on retinal mitochondrial efficiency. We analyzed the retinal mitochondrial activity in ex vivo retinas and in isolated mitochondria from normal rat retina and from short-term streptozotocin-diabetic rats. In normal ex vivo retinas, increasing glucose concentrations from 5.6mM to 30mM caused a four-fold increase in glucose accumulation and CO2 production. Retina from diabetic rats accumulated similar amounts of glucose. However, CO2 production was not as high. Isolated mitochondria from normal rat retina exhibited a resting rate of oxygen consumption of 14.6 +/- 1.1 natgO (min. mg prot)(-1) and a respiratory control of 4.0. Mitochondria from 7, 20 and 45 days diabetic rats increased the resting rate of oxygen consumption and the activity of the electron transport complexes; under these conditions the mitochondrial transmembrane potential decreased. In spite of this, the ATP synthesis was not modified. GDP, an UCP2 inhibitor, increased mitochondrial membrane potential and superoxide production in controls and at 45 days of diabetes. The role of UCP2 is discussed. The results suggest that at the early stage of diabetes we studied, retinal mitochondria undergo adaptations leading to maintain energetic requirements and prevent oxidative stress.	[Osorio-Paz, Ixchel; Salceda, Rocio] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Salceda, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico.	rsalceda@ifc.unam.mx		Osorio-Paz, Ixchel/0000-0002-3754-7304; Uribe-Carvajal, Salvador/0000-0002-7028-8121	Direccion General de Asuntos del Personal Academico/Programa de Apoyo de Investigacon e Innovacion Tecnologica UNAM/DGAPA/PAPIIT [IN202813]; Biochemistry PhD Program at UNAM [263808/221053]	Direccion General de Asuntos del Personal Academico/Programa de Apoyo de Investigacon e Innovacion Tecnologica UNAM/DGAPA/PAPIIT; Biochemistry PhD Program at UNAM	This work by supported by grant from Direccion General de Asuntos del Personal Academico/Programa de Apoyo de Investigacon e Innovacion Tecnologica UNAM/DGAPA/PAPIIT IN202813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ixchel Osorio Paz is a CONACYT fellow (263808/221053) enrolled in the Biochemistry PhD Program at UNAM.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; [Anonymous], 1997, Invest Ophthalmol Vis Sci, V38, pS1; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Cardoso S, 2013, J BIOENERG BIOMEMBR, V45, P397, DOI 10.1007/s10863-013-9503-2; Coffe V, 2006, NEUROCHEM RES, V31, P103, DOI 10.1007/s11064-005-9236-7; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; GRAYMORE CN, 1970, BRIT MED BULL, V26, P130, DOI 10.1093/oxfordjournals.bmb.a070763; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowluru RA, 2003, INVEST OPHTH VIS SCI, V44, P5327, DOI 10.1167/iovs.03-0353; Kowluru RA, 2014, DIABETOLOGIA, V57, P1047, DOI 10.1007/s00125-014-3194-z; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; Kukat A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004385; Liu RH, 2009, IND ENG CHEM RES, V48, P9331, DOI 10.1021/ie9007826; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; McKenna MC, 1996, DEV NEUROSCI-BASEL, V18, P380, DOI 10.1159/000111431; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Osorio-Paz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030822; Perkins GA, 2003, MOL VIS, V9, P60; Salceda R, 1998, NEUROCHEM RES, V23, P893, DOI 10.1023/A:1022467230259; Sanchez-Chavez G, 2008, NEUROCHEM RES, V33, P1301, DOI 10.1007/s11064-007-9583-7; Santos JM, 2012, FREE RADICAL BIO MED, V53, P1729, DOI 10.1016/j.freeradbiomed.2012.08.588; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Tewari S, 2012, ANTIOXID REDOX SIGN, V17, P492, DOI 10.1089/ars.2011.4333; Trautschold IL, 1988, BERGMEYER ENZYMATIC, VVII, P346; Trudeau K, 2011, INVEST OPHTH VIS SCI, V52, P8657, DOI 10.1167/iovs.11-7934; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; URIBE S, 1984, PESTIC BIOCHEM PHYS, V22, P43, DOI 10.1016/0048-3575(84)90008-7; URIBE S, 1985, J BACTERIOL, V161, P1195, DOI 10.1128/JB.161.3.1195-1200.1985; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Winkler BS, 1997, INVEST OPHTH VIS SCI, V38, P1569; Winkler BS, 1997, INVEST OPHTH VIS SCI, V38, P62; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Wong-Riley M, 2010, EYE BRAIN, V2, P99	38	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0122727	10.1371/journal.pone.0122727	http://dx.doi.org/10.1371/journal.pone.0122727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951172	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400005
J	Herbert, BA; Valerio, MS; Gaestel, M; Kirkwood, KL				Herbert, Bethany A.; Valerio, Michael S.; Gaestel, Matthias; Kirkwood, Keith L.			Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations	PLOS ONE			English	Article							NF-KAPPA-B; STIMULATORY TRANSMEMBRANE PROTEIN; P38 MAPK; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; RECEPTOR ACTIVATOR; GENE-EXPRESSION; TRABECULAR BONE; NUCLEAR EXPORT; NFATC1	Osteoclasts (OCs) are bone-resorptive cells critical for maintaining skeletal integrity through coupled bone turnover. OC differentiation and activation requires receptor activator of NFkB ligand (RANKL) signaling through the p38 MAPK pathway. However the role of the p38 MAPK substrate, MAPK-activated protein kinase 2 (MK2), is not clearly delineated. Within the bone marrow exists a specific subpopulation of defined osteoclast progenitor cells (dOCPs) with surface expression of B220(-)Gr1(-)CD11b(lo/-)CD115(+)(dOCP(lo/-)). In this study, we isolated dOCPs from male and female mice to determine sex-specific effects of MK2 signaling in osteoclastogenesis (OCgen). Male Mk2(-/-) mice display an increase in the dOCP(lo) cell population when compared to Mk(2+/+) mice, while female Mk2(-/-) and Mk2(+/+) mice exhibit no difference. Defined OCPs from male and female Mk2(+/+) and Mk2(-/-) bone marrow were treated with macrophage colony stimulation factor (M-CSF) and RANKL cytokines to promote OCgen. RANKL treatment of dOCPlo cells stimulated p38 and MK2 phosphorylation. Tartrate-resistant acid phosphatase (TRAP) assays were used to quantify OC number, size, and TRAP enzyme activity post-RANKL stimulation. MK2 signaling was critical for male dOCP(lo) OCgen, yet MK2 signaling regulated OCgen from female dOCP(-) and CD11b(hi) sub-populations as well. The functional gene, Ctsk, was attenuated in both male and female Mk2(-/-) dOCP(lo)-derived OCs. Conversely, MK2 signaling was only critical for gene expression of pre-OC fusion genes, Oc-stamp and Tm7sf4, in male OCgen. Therefore, these data suggest there is a sexual dimorphism in MK2 signaling of OCP subpopulations.	[Herbert, Bethany A.; Valerio, Michael S.; Kirkwood, Keith L.] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Herbert, Bethany A.; Valerio, Michael S.; Kirkwood, Keith L.] Med Univ S Carolina, Ctr Oral Hlth Res, Charleston, SC 29425 USA; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany	Medical University of South Carolina; Medical University of South Carolina; Hannover Medical School	Kirkwood, KL (corresponding author), Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA.	klkirk@musc.edu	Gaestel, Matthias/A-6560-2013; Kirkwood, Keith L/L-4728-2018	Gaestel, Matthias/0000-0002-4944-4652; Kirkwood, Keith/0000-0003-4519-8973	National Institutes of Health [5R01DE021423, P30GM103331, P30CA138313, C06RR015455, F30DE024368, T32DE017551-05]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021423, F30DE024368, T32DE017551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the National Institutes of Health: 5R01DE021423, P30GM103331, P30CA138313, C06RR015455, F30DE024368 and T32DE017551-05. The supporting agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barf T, 2011, BIOORG MED CHEM LETT, V21, P3818, DOI 10.1016/j.bmcl.2011.04.018; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; Braun T, 2013, J BONE MINER RES, V28, P936, DOI 10.1002/jbmr.1816; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chambers TJ, 2000, J PATHOL, V192, P4; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Geusens P, 2012, THER ADV MUSCULOSKEL, V4, P225, DOI 10.1177/1759720X12438080; Grossi S G, 1998, Compend Contin Educ Dent Suppl, pS30; Hayman AR, 1996, DEVELOPMENT, V122, P3151; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Li QY, 2011, J PHARMACOL EXP THER, V336, P633, DOI 10.1124/jpet.110.172395; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Lorenzo J., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P273; Lorenzo J., 2003, J MUSCULOSKEL NEURON, V3, P92; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; MOSEKILDE L, 1989, BONE, V10, P425, DOI 10.1016/8756-3282(89)90074-4; Pang M, 2007, GENE, V403, P151, DOI 10.1016/j.gene.2007.08.007; PARFITT AM, 1982, METAB BONE DIS RELAT, V4, P1, DOI 10.1016/0221-8747(82)90002-9; Ronkina N, 2011, NUCLEIC ACIDS RES, V39, P2503, DOI 10.1093/nar/gkq1178; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Schwermann J, 2009, EMBO J, V28, P1392, DOI 10.1038/emboj.2009.100; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381, DOI 10.1002/jlb.61.4.381; Valerio MS, 2014, BONE, V60, P16, DOI 10.1016/j.bone.2013.11.012; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	51	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125387	10.1371/journal.pone.0125387	http://dx.doi.org/10.1371/journal.pone.0125387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946081	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700064
J	Hussain, MA; Noorani, S; Khan, A; Asad, H; Rehan, A; Kazi, A; Baig, MZ; Noor, A; Aqil, A; Bham, NS; Khan, MA; Hassan, IN; Kadir, MM				Hussain, Mohammad Ahraz; Noorani, Sandal; Khan, Amna; Asad, Hafsa; Rehan, Anam; Kazi, Aamir; Baig, Mirza Zain; Noor, Arish; Aqil, Amash; Bham, Nida Shahab; Khan, Mohammad Ali; Hassan, Irfan Nazir; Kadir, M. Masood			The Role of Neighborhood Environment in Promoting Risk Factors of Cardiovascular Disease among Young Adults: Data from Middle to High Income Population in an Asian Megacity	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; UNITED-STATES; SOUTH ASIANS; SMOKING; BEHAVIORS; COMMUNITY; ATTITUDES; EXPOSURE; MEDIA	Background Modifiable risk factors of cardiovascular diseases (CVD) have their triggers in the neighborhood environments of communities. Studying the environmental triggers for CVD risk factors is important to understand the situation in a broader perspective. Young adults are influenced the most by the environment profile around them hence it is important to study this subset of the population. Methods This was a descriptive study conducted using the EPOCH research tool designed by the authors of the PURE study. The study population consisted of young adults aged 18-25 in two areas of Karachi. The study setting was busy shopping malls frequented by young adults in the particular community being studied. Results Our total sample size was 120 individuals, who consented to be interviewed by our interviewers. Less than 50% of the population recognized some form of restriction regarding smoking in their communities. The largest contributor to tobacco advertising was actors smoking in movies and TV shows with 89% responses from both communities. Only 11.9% of the individuals disapproved of smoking cigarettes among men with wide acceptance of 'sheesha' across all age groups. Advertising for smoking and junk food was more frequent as compared to smoking cessation, healthy diet and exercise in both the areas.Unhealthy food items were more easily available in contrast to healthier options. The cost of healthy snack food options including vegetables and fruits was higher than sugary drinks and foods. Conclusion This assessment showed that both communities were exposed to environments that promote risk factors for cardiovascular diseases.	[Hussain, Mohammad Ahraz; Noorani, Sandal; Khan, Amna; Asad, Hafsa; Rehan, Anam; Kazi, Aamir; Baig, Mirza Zain; Noor, Arish; Aqil, Amash; Bham, Nida Shahab; Khan, Mohammad Ali; Hassan, Irfan Nazir] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Kadir, M. Masood] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Hussain, MA (corresponding author), Aga Khan Univ, Coll Med, Stadium Rd,POB 3500, Karachi, Pakistan.	ahrazhussain89@gmail.com						Aboaziza E, 2014, TOB CONTROL; Adams J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-368; Alkerwi Aa, BMC PUBLIC HLTH, V10, P698; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Barnhart JM, 2009, AM J HEALTH PROMOT, V23, P339, DOI 10.4278/ajhp.07072574; Carson NJ, 2005, PREV MED, V41, P511, DOI 10.1016/j.ypmed.2005.01.002; Choi SE, 2014, TOB CONTROL; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Coon K A, 2002, Minerva Pediatr, V54, P423; Corsi DJ, 2012, PUBLIC HEALTH NUTR, V7, DOI [10.1371/ journal. pone. 0044410, DOI 10.1371/J0URNAL.P0NE.0044410]; Day K, 2006, AM J PREV MED, V30, P144, DOI 10.1016/j.amepre.2005.09.017; Dodani S, 2004, J PUBLIC HEALTH-UK, V26, P245, DOI 10.1093/pubmed/fdh154; Eriksen M P, 1999, Nicotine Tob Res, V1 Suppl 1, pS79; Farooqi A, 2000, FAM PRACT, V17, P293, DOI 10.1093/fampra/17.4.293; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Gilmore AB, 2014, J PUBLIC HLTH OXFORD; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Khan FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056008; Krauss MJ, 2014, ALCOHOL CLIN EXP RES, V38, P2630, DOI 10.1111/acer.12533; Lovato C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003439.pub2; Neergaard J, 2007, NICOTINE TOB RES, V9, P987, DOI 10.1080/14622200701591591; Pawar PS, 2014, INDIAN J CANCER, V51, P83, DOI 10.4103/0019-509X.147479; Plunkett SW, 2007, HISPANIC J BEHAV SCI, V29, P19, DOI 10.1177/0739986306295038; Rankin J, 2001, PUBLIC HEALTH, V115, P253; Rasool Ahsan, 2011, J Ayub Med Coll Abbottabad, V23, P94; Reddy P, 1996, S AFR MED J, V86, P1389; Rehman ZU, 2013, EXPOSING KARACHI AFG; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Saelens BE, 2003, J INFORM, V93; Sargent JD, 2009, ADDICTION, V104, P815, DOI 10.1111/j.1360-0443.2009.02542.x; Smedslund G, 2004, TOB CONTROL, V13, P197, DOI 10.1136/tc.2002.002915; Steyn NP, PUBLIC HLTH NUTR, P1; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thomson G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-64; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124827	10.1371/journal.pone.0124827	http://dx.doi.org/10.1371/journal.pone.0124827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946006	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700050
J	Sheludchenko, MS; Huygens, F; Stratton, H; Hargreaves, M				Sheludchenko, Maxim S.; Huygens, Flavia; Stratton, Helen; Hargreaves, Megan			CRISPR Diversity in E-coli Isolates from Australian Animals, Humans and Environmental Waters	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; GENOME SEQUENCE; E. COLI; IMMUNITY; REPEATS; DNA; PROKARYOTES; EVOLUTION; BACTERIA; ELEMENTS	Seventy four SNP genotypes and 54 E. coli genomes from kangaroo, Tasmanian devil, reptile, cattle, dog, horse, duck, bird, fish, rodent, human and environmental water sources were screened for the presence of the CRISPR 2.1 loci flanked by cas2 and iap genes. CRISPR 2.1 regions were found in 49% of the strains analysed. The majority of human E. coli isolates lacked the CRISPR 2.1 locus. We described 76 CRISPR 2.1 positive isolates originating from Australian animals and humans, which contained a total of 764 spacer sequences. CRISPR arrays demonstrated a long history of phage attacks especially in isolates from birds (up to 40 spacers). The most prevalent spacer (1.6%) was an ancient spacer found mainly in human, horse, duck, rodent, reptile and environmental water sources. The sequence of this spacer matched the intestinal P7 phage and the pO111 plasmid of E. coli.	[Sheludchenko, Maxim S.; Stratton, Helen] Griffith Univ, Smart Water Res Ctr, Southport, Qld 4215, Australia; [Sheludchenko, Maxim S.] Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia; [Huygens, Flavia; Hargreaves, Megan] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Griffith University; University of the Sunshine Coast; Queensland University of Technology (QUT)	Huygens, F (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	f.huygens@qut.edu.au	Stratton, Helen M/E-5820-2010	Stratton, Helen M/0000-0002-5871-292X; Huygens, Flavia/0000-0002-2737-2264	Institute of Sustainable Resources, Queensland University of Technology; Institute of Molecular Biosciences, University of Queensland	Institute of Sustainable Resources, Queensland University of Technology; Institute of Molecular Biosciences, University of Queensland	We thank S. Mureev and K. Alexandrov from Institute of Molecular Biosciences, University of Queensland, who provided technical and financial support for cloning and sequencing of CRISPR loci. Also I would like to thank F. Mojica and R. Nilsson for critical review of the manuscript. M. S. S. was in receipt of a postgraduate studentship from the Institute of Sustainable Resources, Queensland University of Technology. Note: The GenBank accession number for the CRISPR sequences are KF707494-KF707538. Laboratory work was conducted at Queensland University of Technology.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Carroll D, 2012, MOL THER, V20, P1658, DOI 10.1038/mt.2012.171; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2010, MOL MICROBIOL, V77, P1341, DOI 10.1111/j.1365-2958.2010.07326.x; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.200700035; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Sambrook J., 2001, MOL CLONING LAB MANU; Sheludchenko MS, 2011, ENVIRON SCI TECHNOL, V45, P10331, DOI 10.1021/es201599u; Sheludchenko MS, 2010, APPL ENVIRON MICROB, V76, P4337, DOI 10.1128/AEM.00128-10; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Dang TND, 2013, INFECT GENET EVOL, V19, P212, DOI 10.1016/j.meegid.2013.07.017; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Waldminghaus T., 2009, CHROMOSOMAL DNA ISOL; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	40	10	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124090	10.1371/journal.pone.0124090	http://dx.doi.org/10.1371/journal.pone.0124090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946192	Green Published, gold			2022-12-26	WOS:000354049700032
J	de Assis, NRG; de Morais, SB; Figueiredo, BCP; Ricci, ND; de Almeida, LA; Pinheiro, CD; Martins, VD; Oliveira, SC				Goncalves de Assis, Natan Raimundo; de Morais, Suellen Batistoni; Pimentel Figueiredo, Barbara Castro; Ricci, Natasha Delaqua; de Almeida, Leonardo Augusto; Pinheiro, Carina da Silva; Martins, Vicente de Paulo; Oliveira, Sergio Costa			DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection	PLOS ONE			English	Article							IMMUNE-RESPONSE; PROTEIN SM29; B-CELL; IMMUNIZATION; ANTIGEN; TEGUMENT; PROGRESS; SURFACE; FUTURE; MICE	Schistosomiasis is an important parasitic disease worldwide that affects more than 207 million people in 76 countries and causes approximately 250,000 deaths per year. The best long-term strategy to control schistosomiasis is through immunization combined with drug treatment. Due to the ability of DNA vaccines to generate humoral and cellular immune responses, such vaccines are considered a promising approach against schistosomiasis. Sm29 and tetraspanin-2 (Sm-TSP2) are two proteins that are located in the S. mansoni tegument of adult worms and schistosomula and induce high levels of protection through recombinant protein immunization. In this study, we transfected BHK-21 cells with plasmids encoding Sm29, Sm-TSP2 or a chimera containing both genes. Using RT-PCR analysis and western blot, we confirmed that the DNA vaccine constructs were transcribed and translated, respectively, in BHK-21 cells. After immunization of mice, we evaluated the reduction in worm burden. We observed worm burden reductions of 17-22%, 22%, 31-32% and 24-32% in animals immunized with the pUMVC3/Sm29, pUMVC3/SmTSP-2, pUMVC3/Chimera and pUMVC3/Sm29 + pUMVC3/SmTSP-2 plasmids, respectively. We evaluated the humoral response elicited by DNA vaccines, and animals immunized with pUMVC3/Sm29 and pUMVC3/Sm29 + pUMVC3/SmTSP-2 showed higher titers of anti-Sm29 antibodies. The cytokine profile produced by the spleen cells of immunized mice was then evaluated. We observed higher production of Th1 cytokines, such as TNF-alpha and IFN-gamma, in vaccinated mice and no significant production of IL-4 and IL-5. The DNA vaccines tested in this study showed the ability to generate a protective immune response against schistosomiasis, probably through the production of Th1 cytokines. However, future strategies aiming to optimize the protective response induced by a chimeric DNA construct need to be developed.	[Goncalves de Assis, Natan Raimundo; de Morais, Suellen Batistoni; Pimentel Figueiredo, Barbara Castro; Ricci, Natasha Delaqua; de Almeida, Leonardo Augusto; Oliveira, Sergio Costa] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil; [Goncalves de Assis, Natan Raimundo; de Morais, Suellen Batistoni; Pimentel Figueiredo, Barbara Castro; Ricci, Natasha Delaqua; Oliveira, Sergio Costa] CNPq MCT, Inst Nacl Ciencia & Tecnol Doencas Tropicais, BR-31270901 Belo Horizonte, MG, Brazil; [Pinheiro, Carina da Silva] Univ Fed Bahia, Inst Ciencias Saude, Dept Biointeracao, BR-40110100 Salvador, BA, Brazil; [Martins, Vicente de Paulo] Univ Brasilia, Fac Ceilandia, BR-70910900 Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Universidade Federal da Bahia; Universidade de Brasilia	Oliveira, SC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.	scozeus@icb.ufmg.br	DA SILVA PINHEIRO, CARINA/AAY-5395-2020; de Almeida, Leonardo A/G-2482-2012; Pinheiro, Carina S/J-4473-2015; Martins, Vicente P/F-8395-2012; Ricci, Natasha Delaqua/M-3847-2015; Oliveira, Sergio Costa/AAG-5408-2021; de paulo martins, vicente/H-7182-2019	DA SILVA PINHEIRO, CARINA/0000-0001-5623-1308; de Almeida, Leonardo A/0000-0003-1886-5080; Martins, Vicente P/0000-0001-7611-861X; Oliveira, Sergio Costa/0000-0003-4062-5577; de paulo martins, vicente/0000-0001-7611-861X; Assis, Natan/0000-0002-8905-1159	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Insituto Nacional de Ciencia e Tecnologia em Doencas Tropicais	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Insituto Nacional de Ciencia e Tecnologia em Doencas Tropicais	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (SCO), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (SCO), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (SCO), and Insituto Nacional de Ciencia e Tecnologia em Doencas Tropicais (SCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad G, 2009, PARASITE IMMUNOL, V31, P156, DOI 10.1111/j.1365-3024.2008.01091.x; Bergquist NR, 2005, TRENDS PARASITOL, V21, P112, DOI 10.1016/j.pt.2005.01.001; Bergquist NR, 1998, MEM I OSWALDO CRUZ, V93, P95, DOI 10.1590/S0074-02761998000700013; Cardoso FC, 2006, CLIN EXP IMMUNOL, V144, P382, DOI 10.1111/j.1365-2249.2006.03081.x; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1; Castro-Borges W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000993; Chan MS, 1997, VACCINE, V15, P1545, DOI 10.1016/S0264-410X(97)00071-6; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Farias LP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000597; Fioretti D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/174378; Fonseca CT, 2006, MICROBES INFECT, V8, P2509, DOI 10.1016/j.micinf.2006.06.008; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Harder A, 2002, PARASITOL RES, V88, P395, DOI 10.1007/s00436-001-0588-x; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Jankovic D, 1999, J IMMUNOL, V162, P345; Jia XY, 2014, J BIOL CHEM, V289, P7151, DOI 10.1074/jbc.M113.531558; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Liu MA, 2003, J INTERN MED, V253, P402, DOI 10.1046/j.1365-2796.2003.01140.x; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; MACPHERSON I, 1962, VIROLOGY, V16, P147, DOI 10.1016/0042-6822(62)90290-8; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Oliveira SC, 2008, ACTA TROP, V108, P256, DOI 10.1016/j.actatropica.2008.05.023; Pacifico LGG, 2006, IMMUNOBIOLOGY, V211, P97, DOI 10.1016/j.imbio.2005.06.004; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pearson MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001564; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pinheiro CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/503068; Pinheiro CS, 2014, PARASITE IMMUNOL; Rezende CMF, 2011, IMMUNOL LETT, V141, P123, DOI 10.1016/j.imlet.2011.09.003; Romeih MH, 2008, ACTA BIOCH BIOPH SIN, V40, P327, DOI 10.1111/j.1745-7270.2008.00404.x; Shalaby KA, 2003, VACCINE, V22, P130, DOI 10.1016/s0264-410X(03)00535-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wilson RA, 1996, IMMUNOLOGY, V87, P275, DOI 10.1046/j.1365-2567.1996.465550.x; WYNN TA, 1995, CURR OPIN IMMUNOL, V7, P505, DOI 10.1016/0952-7915(95)80095-6; Zhang L, 2007, ACTA BIOCH BIOPH SIN, V39, P770, DOI 10.1111/j.1745-7270.2007.00340.x; Zhang W, 2010, PARASITE IMMUNOL, V32, P252, DOI 10.1111/j.1365-3024.2009.01181.x	42	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125075	10.1371/journal.pone.0125075	http://dx.doi.org/10.1371/journal.pone.0125075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942636	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400025
J	Ballantyne, LL; Sin, YY; Amand, TS; Si, J; Goossens, S; Haenebalcke, L; Haigh, JJ; Kyriakopoulou, L; Schulze, A; Funk, CD				Ballantyne, Laurel L.; Sin, Yuan Yan; Amand, Tim St.; Si, Joshua; Goossens, Steven; Haenebalcke, Lieven; Haigh, Jody J.; Kyriakopoulou, Lianna; Schulze, Andreas; Funk, Colin D.			Strategies to Rescue the Consequences of Inducible Arginase-1 Deficiency in Mice	PLOS ONE			English	Article							UREA CYCLE DISORDERS; GENE-THERAPY; MOUSE; EXPRESSION; HYPERARGININEMIA; MUTATIONS; PHENOTYPE; VECTORS; MODEL	Arginase-1 catalyzes the conversion of arginine to ornithine and urea, which is the final step of the urea cycle used to remove excess ammonia from the body. Arginase-1 deficiency leads to hyperargininemia in mice and man with severe lethal consequences in the former and progressive neurological impairment to varying degrees in the latter. In a tamoxifen-induced arginase-1 deficient mouse model, mice succumb to the enzyme deficiency within 2 weeks after inducing the knockout and retain <2 % enzyme in the liver. Standard clinical care regimens for arginase-1 deficiency (low-protein diet, the nitrogen-scavenging drug sodium phenylbutyrate, ornithine supplementation) either failed to extend lifespan (ornithine) or only minimally prolonged lifespan (maximum 8 days with low-protein diet and drug). A conditional, tamoxifen-inducible arginase-1 transgenic mouse strain expressing the enzyme from the Rosa26 locus modestly extended lifespan of neonatal mice, but not that of 4-week old mice, when crossed to the inducible arginase-1 knockout mouse strain. Delivery of an arginase-1/enhanced green fluorescent fusion construct by adeno-associated viral delivery (rh10 serotype with a strong cytomegalovirus-chicken beta-actin hybrid promoter) rescued about 30% of male mice with lifespan prolongation to at least 6 months, extensive hepatic expression and restoration of significant enzyme activity in liver. In contrast, a vector of the AAV8 serotype driven by the thyroxine-binding globulin promoter led to weaker liver expression and did not rescue arginase-1 deficient mice to any great extent. Since the induced arginase-1 deficient mouse model displays a much more severe phenotype when compared to human arginase-1 deficiency, these studies reveal that it may be feasible with gene therapy strategies to correct the various manifestations of the disorder and they provide optimism for future clinical studies.	[Ballantyne, Laurel L.; Sin, Yuan Yan; Amand, Tim St.; Si, Joshua; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Goossens, Steven; Haenebalcke, Lieven; Haigh, Jody J.] VIB, Inflammat Res Ctr, Vasc Cell Biol Unit, Ghent, Belgium; [Goossens, Steven; Haenebalcke, Lieven; Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Goossens, Steven; Haigh, Jody J.] Monash Univ, Mammalian Funct Genet Lab, Div Blood Canc, Australian Ctr Blood Dis,Dept Clin Haematol, Melbourne, Vic 3004, Australia; [Goossens, Steven; Haigh, Jody J.] Alfred Hlth Ctr, Melbourne, Vic, Australia; [Kyriakopoulou, Lianna] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Schulze, Andreas] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Kyriakopoulou, Lianna] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Schulze, Andreas] Hosp Sick Children, Genet & Genome Biol Program, Res Inst, Toronto, ON M5G 1X8, Canada	Queens University - Canada; Flanders Institute for Biotechnology (VIB); Ghent University; Monash University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Schulze, Andreas/I-5706-2019	Schulze, Andreas/0000-0001-8491-1095; Funk, Colin/0000-0001-7029-4233; Sin, Yuan Yan/0000-0001-6537-5266; Goossens, Steven/0000-0002-5693-8570; haigh, jody/0000-0002-7319-8922				Cohen YH, 2012, JIMD REP, V5, P83, DOI 10.1007/8904_2011_101; Davidoff AM, 2003, BLOOD, V102, P480, DOI 10.1182/blood-2002-09-2889; Deignan JL, 2008, MOL GENET METAB, V93, P7, DOI 10.1016/j.ymgme.2007.08.123; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gau CL, 2009, MOL THER, V17, P1155, DOI 10.1038/mt.2009.65; Hu C, 2015, GENE THER, V22, P111, DOI 10.1038/gt.2014.106; Hu CH, 2014, MOL THER, V22, P1792, DOI 10.1038/mt.2014.99; Hu CH, 2010, J GENE MED, V12, P766, DOI 10.1002/jgm.1496; Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; Kasten J, 2013, MOL GENET METAB, V110, P222, DOI 10.1016/j.ymgme.2013.06.020; Lee EK, 2013, GENE THER, V20, P785, DOI 10.1038/gt.2012.99; Lee EK, 2012, MOL THER, V20, P1844, DOI 10.1038/mt.2012.129; Monteleone JPR, 2013, J CLIN PHARMACOL, V53, P699, DOI 10.1002/jcph.92; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Sin YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tsang JPK, 2012, PEDIATR NEUROL, V47, P263, DOI 10.1016/j.pediatrneurol.2012.06.012; Vockley JG, 1996, BIOCHEM MOL MED, V59, P44, DOI 10.1006/bmme.1996.0063; Wang L, 2012, GENE THER, V19, P404, DOI 10.1038/gt.2011.111; Wu TF, 2013, PEDIATR NEUROL, V49, P119, DOI 10.1016/j.pediatrneurol.2013.04.026	22	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125967	10.1371/journal.pone.0125967	http://dx.doi.org/10.1371/journal.pone.0125967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938595	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000353943000121
J	Casseau, V; De Croon, G; Izzo, D; Pandolfi, C				Casseau, Vincent; De Croon, Guido; Izzo, Dario; Pandolfi, Camilla			Morphologic and Aerodynamic Considerations Regarding the Plumed Seeds of Tragopogon pratensis and Their Implications for Seed Dispersal	PLOS ONE			English	Article							WIND-DISPERSAL; ASTERACEAE; SIZE; MASS; EMERGENCE; ACHENES; DUBIUS; PLANT	Tragopogon pratensis is a small herbaceous plant that uses wind as the dispersal vector for its seeds. The seeds are attached to parachutes that increase the aerodynamic drag force and increase the total distance travelled. Our hypothesis is that evolution has carefully tuned the air permeability of the seeds to operate in the most convenient fluid dynamic regime. To achieve final permeability, the primary and secondary fibres of the pappus have evolved with complex weaving; this maximises the drag force (i.e., the drag coefficient), and the pappus operates in an "optimal" state. We used computational fluid dynamics (CFD) simulations to compute the seed drag coefficient and compare it with data obtained from drop experiments. The permeability of the parachute was estimated from microscope images. Our simulations reveal three flow regimes in which the parachute can operate according to its permeability. These flow regimes impact the stability of the parachute and its drag coefficient. From the permeability measurements and drop experiments, we show how the seeds operate very close to the optimal case. The porosity of the textile appears to be an appropriate solution to achieve a lightweight structure that allows a low terminal velocity, a stable flight and a very efficient parachute for the velocity at which it operates.	[Casseau, Vincent; De Croon, Guido; Izzo, Dario; Pandolfi, Camilla] European Space Agcy, European Space Res & Technol Ctr, Adv Concepts Team, NL-2200 AG Noordwijk, Netherlands; [De Croon, Guido] Delft Univ Technol, Micro Air Vehicle Lab, Delft, Netherlands; [Pandolfi, Camilla] Univ Florence, Dept Agrifood Prod & Environm Sci, Florence, Italy	European Space Agency; Delft University of Technology; University of Florence	Pandolfi, C (corresponding author), European Space Agcy, European Space Res & Technol Ctr, Adv Concepts Team, NL-2200 AG Noordwijk, Netherlands.	camilla.pandolfi@unifi.it	de Croon, Guido/AAG-5098-2020	de Croon, Guido/0000-0001-8265-1496; Izzo, Dario/0000-0002-9846-8423				ANDERSEN MC, 1993, AM J BOT, V80, P487, DOI 10.2307/2445362; AUGSPURGER CK, 1987, ECOLOGY, V68, P27, DOI 10.2307/1938802; BRUSCHKE MV, 1993, J RHEOL, V37, P479, DOI 10.1122/1.550455; Carman P. C., 1937, CHEM ENG RES DES, V15, P150; De Clavijo ER, 2001, WEED RES, V41, P275, DOI 10.1046/j.1365-3180.2001.00237.x; Epps HH, 1996, J TEST EVAL, V24, P26; Fahn A, 1972, SEED BIOL, V1, P155; Greene DF, 2011, FUNCT ECOL, V25, P468, DOI 10.1111/j.1365-2435.2010.01788.x; GREENE DF, 1990, FUNCT ECOL, V4, P117, DOI 10.2307/2389661; Hartley R., 2004, ROBOTICA; HENDRIX SD, 1992, AM J BOT, V79, P365, DOI 10.2307/2445148; Imbert E, 1997, OIKOS, V79, P325, DOI 10.2307/3546016; Jakobsson A, 2003, EVOL ECOL, V17, P233, DOI 10.1023/A:1025526903281; Knauf G.H., 1986, IPC TECHNICAL PAPER, V183; KOZENY J., 1927, STIZUNGSBER AKAD WIS, V136, P271; MATLACK GR, 1987, AM J BOT, V74, P1150, DOI 10.2307/2444151; MAXWELL CD, 1994, CAN J BOT, V72, P1282, DOI 10.1139/b94-156; MCGINLEY MA, 1989, FUNCT ECOL, V3, P489, DOI 10.2307/2389623; Minami S, 2003, J THEOR BIOL, V225, P1, DOI 10.1016/S0022-5193(03)00216-9; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Parciak W, 2002, ECOLOGY, V83, P780, DOI 10.1890/0012-9658(2002)083[0780:EVISNS]2.0.CO;2; Rhodes M., 2008, INTRO PARTICLE TECHN, P155; Scheidegger A. E., 1974, PHYS FLOW POROUS MED; STRYKOWSKI PJ, 1990, J FLUID MECH, V218, P71, DOI 10.1017/S0022112090000933; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Van Molken T, 2005, AM J BOT, V92, P432, DOI 10.3732/ajb.92.3.432; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; WINN AA, 1985, J ECOL, V73, P831, DOI 10.2307/2260150	28	24	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125040	10.1371/journal.pone.0125040	http://dx.doi.org/10.1371/journal.pone.0125040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938765	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000041
J	Chan, SM; Lee, MS; Lu, CH; Cherng, CH; Huang, YS; Yeh, CC; Kuo, CY; Wu, ZF				Chan, Shun-Ming; Lee, Meei-Shyuan; Lu, Chueng-He; Cherng, Chen-Hwan; Huang, Yuan-Shiou; Yeh, Chun-Chang; Kuo, Chan-Yang; Wu, Zhi-Fu			Confounding Factors to Predict the Awakening Effect-Site Concentration of Propofol in Target-Controlled Infusion Based on Propofol and Fentanyl Anesthesia	PLOS ONE			English	Article							MANUALLY CONTROLLED INFUSION; GENERAL-ANESTHESIA; CONSCIOUSNESS; REMIFENTANIL; SUFENTANIL; PHARMACODYNAMICS; PHARMACOKINETICS; SURGERY; AGE; ALFENTANIL	We conducted a large retrospective study to investigate the confounding factors that predict Ce ROC under propofol-based TIVA with TCI. We recorded sex, age, height, weight, Ce LOC, Ce ROC, total propofol and fentanyl consumption dose, and anesthetic time. Simple linear regression models were used to identify potential predictors of Ce ROC, and multiple linear regression models were used to identify the confounding predictors of Ce ROC. We found that Ce ROC correlated with age, sex, Ce LOC, and both total fentanyl and propofol consumption dose. The prediction formula was: Ce ROC = 0.87 - 0.06 x age + 0.18 x Ce LOC + 0.04 (if fentanyl consumption > 150 mu g; if not, ignore this value) + 0.07 x (1 or 2, according to the total propofol consumption dose, 1 for a propofol amount 1000-2000 mg and 2 for a propofol amount > 2000 mg). We simplified the formula further as Ce ROC = 0.87 - 0.06 x age + 0.18 x Ce LOC. In conclusion, Ce ROC can be predicted under TCI with propofol- and fentanyl-based TIVA. The confounding factors that predicted propofol Ce ROC are age, sex, Ce LOC, and total consumption dose of propofol and fentanyl.	[Chan, Shun-Ming; Lu, Chueng-He; Cherng, Chen-Hwan; Huang, Yuan-Shiou; Yeh, Chun-Chang; Kuo, Chan-Yang; Wu, Zhi-Fu] Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chan, Shun-Ming; Lu, Chueng-He; Cherng, Chen-Hwan; Huang, Yuan-Shiou; Yeh, Chun-Chang; Kuo, Chan-Yang; Wu, Zhi-Fu] Natl Def Med Ctr, Taipei, Taiwan; [Lee, Meei-Shyuan] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chan, Shun-Ming; Wu, Zhi-Fu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Wu, ZF (corresponding author), Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	aneswu@gmail.com	Yeh, Chun-Chang/AFS-9309-2022; Wu, Zhi-Fu/ABE-6379-2020					Aceto P, 2007, NEUROREPORT, V18, P823, DOI 10.1097/WNR.0b013e3280e129f5; [Anonymous], 1979, ASA Newsl, V43, P3; BRODY H, 1992, ACTA NEUROL SCAND, V85, P40, DOI 10.1111/j.1600-0404.1992.tb05037.x; Chan S.M., 2009, MED SCI, V29, P75; Chen J.L., 2013, MED SCI, V33, P205; Chiang MH, 2013, ENDOSCOPY, V45, P907, DOI 10.1055/s-0033-1344645; De Cosmo G, 2005, CURR DRUG TARGETS, V6, P741; De Cosmo G, 2005, NEUROL RES, V27, P433, DOI 10.1179/016164105X21724; Gan TJ, 1999, ANESTHESIOLOGY, V90, P1283, DOI 10.1097/00000542-199905000-00010; Glass PS, 2009, MILLERS ANESTHESIA, P997; Hentgen E, 2002, ANESTH ANALG, V95, P597, DOI 10.1097/00000539-200209000-00019; Horng Huei-Chi, 2007, Acta Anaesthesiol Taiwan, V45, P205; Hoymork SC, 2005, BRIT J ANAESTH, V95, P627, DOI 10.1093/bja/aei245; Iwakiri H, 2005, ANESTH ANALG, V100, P107, DOI 10.1213/01.ANE.0000139358.15909.EA; Jung SM, 2011, ACTA ANAESTH SCAND, V55, P110, DOI 10.1111/j.1399-6576.2010.02327.x; Kreuer S, 2005, EUR J ANAESTH, V22, P123, DOI 10.1017/S0265021505000232; Lentschener C, 2003, ACTA ANAESTH SCAND, V47, P84, DOI 10.1034/j.1399-6576.2003.470115.x; Lin BF, 2012, J NEUROSURG ANESTH, V24, P127, DOI 10.1097/ANA.0b013e31823c4a24; Lu Chueng-He, 2014, Acta Anaesthesiol Taiwan, V52, P6, DOI 10.1016/j.aat.2014.05.004; Lysakowski C, 2001, BRIT J ANAESTH, V86, P523, DOI 10.1093/bja/86.4.523; Nunes CS, 2009, J CLIN ANESTH, V21, P3, DOI 10.1016/j.jclinane.2008.06.011; Nunes CS, 2005, J NEUROSURG ANESTH, V17, P110, DOI 10.1097/01.ana.0000163198.02742.9d; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; Schuttler J, 1988, Anaesthesia, V43 Suppl, P2, DOI 10.1111/j.1365-2044.1988.tb09059.x; SHAFER A, 1988, ANESTHESIOLOGY, V69, P348, DOI 10.1097/00000542-198809000-00011; VUYK J, 1992, ANESTHESIOLOGY, V77, P3, DOI 10.1097/00000542-199207000-00002; Vuyk J, 1999, Minerva Anestesiol, V65, P215; Vuyk J, 2001, BRIT J ANAESTH, V86, P183, DOI 10.1093/bja/86.2.183; Wu ZF, 2014, ANESTH ANALG, V119, P1393, DOI 10.1213/ANE.0000000000000435; Yeganeh Naser, 2010, Middle East Journal of Anesthesiology, V20, P785	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124343	10.1371/journal.pone.0124343	http://dx.doi.org/10.1371/journal.pone.0124343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938415	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000024
J	Cui, FC; Yang, KC; Li, YQ				Cui, Fengchao; Yang, Kecheng; Li, Yunqi			Investigate the Binding of Catechins to Trypsin Using Docking and Molecular Dynamics Simulation	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THERMOCHEMISTRY; GREEN TEA POLYPHENOLS; ALPHA-AMYLASE; LUNG-CANCER; INHIBITORS; PROTEIN; ENERGY; CELLS; (-)-EPIGALLOCATECHIN-3-GALLATE; CONSUMPTION	To explore the inhibitory mechanism of catechins for digestive enzymes, we investigated the binding mode of catechins to a typical digestive enzyme-trypsin and analyzed the structure- activity relationship of catechins, using an integration of molecular docking, molecular dynamics simulation and binding free energy calculation. We found that catechins with different structures bound to a conservative pocket S1 of trypsin, which is comprised of residues 189-195, 214-220 and 225-228. In the trypsin-catechin complexes, Asp189 by forming strong hydrogen bonding, and Gln192, Trp215 and Gly216 through hydrophobic interactions, all significantly contribute to the binding of catechins. The number and the position of hydroxyl and aromatic groups, the structure of stereoisomers, and the orientation of catechins in the binding pocket S1 of trypsin all affect the binding affinity. The binding affinity is in the order of Epigallocatechin gallate (EGCG) > Epicatechin gallate (ECG) > Epicatechin (EC) > Epigallocatechin (EGC), and 2R-3R EGCG shows the strongest binding affinity out of other stereoisomers. Meanwhile, the synergic conformational changes of residues and catechins were also analyzed. These findings will be helpful in understanding the knowledge of interactions between catechins and trypsin and referable for the design of novel polyphenol based functional food and nutriceutical formulas.	[Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China; Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.	yunqi@ciac.ac.cn	Yang, kecheng/Y-8236-2018; Li, Yunqi/C-8372-2016	Li, Yunqi/0000-0002-5190-3037	National Natural Science Foundation of China [21374117]; 100 Talents Program of Chinese Academy of Sciences; China Postdoctoral Science Foundation [2014M561310]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (21374117) (http://www.nsfc.gov.cn/publish/portal1/) to YQL, the 100 Talents Program of Chinese Academy of Sciences to YQL, and the China Postdoctoral Science Foundation (2014M561310) to FCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217; Afaq F, 2003, ONCOGENE, V22, P9254, DOI 10.1038/sj.onc.1207035; BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397; BECKE AD, 1992, J CHEM PHYS, V96, P2155, DOI 10.1063/1.462066; BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertoldi M, 2001, BIOCHEM BIOPH RES CO, V284, P90, DOI 10.1006/bbrc.2001.4945; Blum C, 2008, STUD COMPUT INTELL, V114, P1, DOI 10.1007/978-3-540-78295-7; Case D.A., 2012, AMBER; Chen JZ, 2013, J COMPUT AID MOL DES, V27, P965, DOI 10.1007/s10822-013-9693-z; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fisher SJ, 2012, ACTA CRYSTALLOGR D, V68, P800, DOI 10.1107/S0907444912012589; Frazier RA, 2006, J PHARMACEUT BIOMED, V41, P1602, DOI 10.1016/j.jpba.2006.02.004; Ghosh KS, 2004, BIOCHEM BIOPH RES CO, V325, P807, DOI 10.1016/j.bbrc.2004.10.116; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; Grater F, 2005, J PHYS CHEM B, V109, P10474, DOI 10.1021/jp044185y; HARA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1939, DOI 10.1080/00021369.1990.10870239; He Q, 2007, FOOD CHEM, V101, P1178, DOI 10.1016/j.foodchem.2006.03.020; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Hou TJ, 2011, BIOINFORMATICS, V27, P1814, DOI 10.1093/bioinformatics/btr294; Huang HH, 2004, J SCI FOOD AGR, V84, P121, DOI 10.1002/jsfa.1610; Huang HH, 2008, EUR FOOD RES TECHNOL, V227, P361, DOI 10.1007/s00217-007-0729-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishii T, 2010, MOL NUTR FOOD RES, V54, P816, DOI 10.1002/mnfr.200900071; Jia XD, 2002, CANCER EPIDEM BIOMAR, V11, P1663; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472.CAN-05-1949; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kato Y, 1998, EUR J CANCER, V34, P1117, DOI 10.1016/S0959-8049(98)00077-X; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee JY, 2011, B KOREAN CHEM SOC, V32, P2222, DOI 10.5012/bkcs.2011.32.7.2222; Li DF, 2014, APPL NUMER MATH, V82, P1, DOI 10.1016/j.apnum.2014.01.008; Li YQ, 2014, J PHYS CHEM B, V118, P10362, DOI 10.1021/jp5048503; Liebschner D, 2013, ACTA CRYSTALLOGR D, V69, P1447, DOI 10.1107/S0907444913009050; Ma WZ, 2005, BIOPHYS J, V89, P1183, DOI 10.1529/biophysj.104.057158; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Maurya PK, 2009, NAT PROD RES, V23, P1072, DOI 10.1080/14786410802267643; Mendilaharsu M, 1998, LUNG CANCER-J IASLC, V19, P101, DOI 10.1016/S0169-5002(97)00075-5; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Nyberg P, 2006, EXP CELL RES, V312, P1219, DOI 10.1016/j.yexcr.2005.12.024; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Pascal C, 2007, J AGR FOOD CHEM, V55, P4895, DOI 10.1021/jf0704108; Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahoo BR, 2014, MOL BIOSYST, V10, P1104, DOI 10.1039/c3mb70600a; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scalmani G., 2016, GAUSSIAN 09; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sueoka N, 2001, ANN NY ACAD SCI, V928, P274; Suganuma M, 2001, J CANCER RES CLIN, V127, P69, DOI 10.1007/s004320000189; Tao Y, 2010, J BIOMOL STRUCT DYN, V28, P143, DOI 10.1080/073911010010524953; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Ruiz-Perez MV, 2012, J CHEM INF MODEL, V52, P113, DOI 10.1021/ci200221z; WALTER J, 1982, ACTA CRYSTALLOGR B, V38, P1462, DOI 10.1107/S0567740882006153; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang XW, 2014, MOL BIOSYST, V10, P1196, DOI 10.1039/c4mb00013g; Wang YP, 2012, LUNG CANCER, V78, P169, DOI 10.1016/j.lungcan.2012.08.009; Weinbach Y, 2005, J COMPUT PHYS, V209, P193, DOI 10.1016/j.jcp.2005.03.015; Wu XL, 2013, INT J FOOD SCI TECH, V48, P2340, DOI 10.1111/ijfs.12223; Xiao JB, 2011, MOL NUTR FOOD RES, V55, P310, DOI 10.1002/mnfr.201000208; Yen S G PYB, 1995, J KOREAN SOC FOOD NU, V24, P154; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhu QZ, 2014, J PHARM INNOV, V9, P331, DOI 10.1007/s12247-014-9202-5	79	60	61	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125848	10.1371/journal.pone.0125848	http://dx.doi.org/10.1371/journal.pone.0125848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938485	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000107
J	Gao, J; Munch, SB				Gao, Jin; Munch, Stephan B.			Does Reproductive Investment Decrease Telomere Length in Menidia menidia?	PLOS ONE			English	Article							NATURAL-SELECTION; QUANTITATIVE PCR; LIFE-HISTORIES; AGE; EVOLUTION; GROWTH; FISH; EXPRESSION; LONGEVITY; DYNAMICS	Given finite resources, intense investment in one life history trait is expected to reduce investment in others. Although telomere length appears to be strongly tied to age in many taxa, telomere maintenance requires energy. We therefore hypothesize that telomere maintenance may trade off against other life history characters. We used natural variation in laboratory populations of Atlantic silversides (Menidia menidia) to study the relationship between growth, fecundity, life expectancy, and relative telomere length. In keeping with several other studies on fishes, we found no clear dependence of telomere length on age. However, we did find that more fecund fish tended to have both reduced life expectancy and shorter telomeres. This result is consistent with the hypothesis that there is a trade-off between telomere maintenance and reproductive output.	[Gao, Jin] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Munch, Stephan B.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gao, J (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan.	jingao84@gmail.com; Steve.Munch@noaa.gov						ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Almroth BC, 2012, BIOL OPEN, V1, P922, DOI 10.1242/bio.20121446; Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955; Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005; Bidder. Senesence, 1932, BR MED J, V2, P583; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Bronikowski AM, 2008, AGE, V30, P169, DOI 10.1007/s11357-008-9060-5; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chanov EL, 1973, INT J AVIAN SCI, V116, P217; CONOVER DO, 1982, ESTUARIES, V5, P275, DOI 10.2307/1351750; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Downs KP, 2012, COMP BIOCHEM PHYS C, V155, P89, DOI 10.1016/j.cbpc.2011.05.005; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; Foote CG, 2011, J ZOOL, V283, P203, DOI 10.1111/j.1469-7998.2010.00774.x; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Gopalakrishnan S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-78; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Hatase H, 2008, GENES GENET SYST, V83, P423, DOI 10.1266/ggs.83.423; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Horn T, 2008, AUST J ZOOL, V56, P207, DOI 10.1071/ZO08046; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; Izzo C, 2014, COPEIA, P87, DOI 10.1643/CI-11-162; JOHNSON MS, 1974, EVOLUTION, V28, P607, DOI 10.1111/j.1558-5646.1974.tb00793.x; Kim YJ, 2011, ASIAN AUSTRAL J ANIM, V24, P603, DOI 10.5713/ajas.2011.10187; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Lopez de Abechuco E, 2013, REV INVESTIG MAR, V20, P30; Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Munch SB, 2003, EVOLUTION, V57, P2119, DOI 10.1554/02-711; Nakagawa S, 2004, MOL ECOL, V13, P2523, DOI 10.1111/j.1365-294X.2004.02291.x; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Rollings N, 2014, NATURWISSENSCHAFTEN, V101, P241, DOI 10.1007/s00114-014-1142-x; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; SCHAFFER WM, 1974, ECOLOGY, V55, P291, DOI 10.2307/1935217; Scott NM, 2006, SOUTHEAST NAT, V5, P685, DOI 10.1656/1528-7092(2006)5[685:TLSWBL]2.0.CO;2; Selz Y, 2007, GENE, V401, P114, DOI 10.1016/j.gene.2007.07.005; Setiamarga DHE, 2008, MOL PHYLOGENET EVOL, V49, P598, DOI 10.1016/j.ympev.2008.08.008; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zeichner SL, 1999, BLOOD, V93, P2824	50	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125674	10.1371/journal.pone.0125674	http://dx.doi.org/10.1371/journal.pone.0125674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938489	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000088
J	Hu, YB; Yan, C; Mu, L; Huang, KY; Li, XL; Tao, DD; Wu, YQ; Qin, JC				Hu, Yibing; Yan, Chang; Mu, Lei; Huang, Kaiyu; Li, Xiaolan; Tao, Deding; Wu, Yaqun; Qin, Jichao			Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer	PLOS ONE			English	Article							DRUG-RESISTANCE; BETA-CATENIN; ACTIVATION PROTEIN; TUMOR-GROWTH; CHEMOTHERAPY; POPULATION; EXPRESSION; PHENOTYPE; MECHANISM; EXCHANGE	Chemotherapy resistance observed in patients with colorectal cancer (CRC) may be related to the presence of cancer stem cells (CSCs), but the underlying mechanism(s) remain unclear. Carcinoma-associated fibroblasts (CAFs) are intimately involved in tumor recurrence, and targeting them increases chemo-sensitivity. We investigated whether fibroblasts might increase CSCs thus mediating chemotherapy resistance. CSCs were isolated from either patient-derived xenografts or CRC cell lines based on expression of CD133. First, CSCs were found to be inherently resistant to cell death induced by chemotherapy. In addition, fibroblast-derived conditioned medium (CM) promoted percentage, clonogenicity and tumor growth of CSCs (i.e., CD133+ and TOP-GFP+) upon treatment with 5-fluorouracil (5-Fu) or oxaliplatin (OXA). Further investigations exhibited that exosomes, isolated from CM, similarly took the above effects. Inhibition of exosome secretion decreased the percentage, clonogenicity and tumor growth of CSCs. Altogether, our findings suggest that, besides targeting CSCs, new therapeutic strategies blocking CAFs secretion even before chemotherapy shall be developed to gain better clinical benefits in advanced CRCs.	[Hu, Yibing; Yan, Chang; Mu, Lei; Huang, Kaiyu; Wu, Yaqun; Qin, Jichao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Surg, Wuhan 430074, Peoples R China; [Hu, Yibing; Yan, Chang; Mu, Lei; Huang, Kaiyu; Li, Xiaolan; Tao, Deding; Qin, Jichao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Mol Med Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Qin, JC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Surg, Wuhan 430074, Peoples R China.	jcqin@tjh.tjmu.edu.cn		Qin, Jichao/0000-0002-2961-7624	National Natural Science Foundation of China [81172065, 81272660]; Program for New Century Excellent Talents in University [NCET-12-0208]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [JYBHG201002]; Fundamental Research Funds for the Central Universities (HUST) [01-18-540005]; Tongji Hospital Funds for the Returned Overseas Scientists and Outstanding Young Scientists [2012yq004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities (HUST)(Fundamental Research Funds for the Central Universities); Tongji Hospital Funds for the Returned Overseas Scientists and Outstanding Young Scientists	This study was supported by grants from the National Natural Science Foundation of China (Nos. 81172065, 81272660), Program for New Century Excellent Talents in University (No. NCET-12-0208), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (No. JYBHG201002), the Fundamental Research Funds for the Central Universities (HUST, No. 01-18-540005), Tongji Hospital Funds for the Returned Overseas Scientists and Outstanding Young Scientists (2012yq004) (all to JCQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fan F, 2015, BRIT J CANCER, V112, P539, DOI 10.1038/bjc.2014.620; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hu XP, 2014, MOL MED REP, V9, P793, DOI 10.3892/mmr.2014.1907; Iliou MS, 2014, ONCOGENE, V33, P4003, DOI 10.1038/onc.2013.398; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kinugasa Y, 2014, STEM CELLS, V32, P145, DOI 10.1002/stem.1556; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mertens JC, 2013, CANCER RES, V73, P897, DOI 10.1158/0008-5472.CAN-12-2130; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	43	233	239	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125625	10.1371/journal.pone.0125625	http://dx.doi.org/10.1371/journal.pone.0125625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938772	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000082
J	Murthy, SRK; Sherrin, T; Jansen, C; Nijholt, I; Robles, M; Dolga, AM; Andreotti, N; Sabatier, JM; Knaus, HG; Penner, R; Todorovic, C; Blank, T				Murthy, Saravana R. K.; Sherrin, Tessi; Jansen, Chad; Nijholt, Ingrid; Robles, Michael; Dolga, Amalia M.; Andreotti, Nicolas; Sabatier, Jean-Marc; Knaus, Hans-Guenther; Penner, Reinhold; Todorovic, Cedomir; Blank, Thomas			Small-Conductance Ca2+-Activated Potassium Type 2 Channels Regulate the Formation of Contextual Fear Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; K+ CHANNELS; SYNAPTIC PLASTICITY; CONJUNCTIVE REPRESENTATIONS; SK2 CHANNELS; C-TERMINUS; HIPPOCAMPUS; BRAIN; RECEPTORS; EXPRESSION	Small-conductance, Ca2+ activated K+ channels (SK channels) are expressed at high levels in brain regions responsible for learning and memory. In the current study we characterized the contribution of SK2 channels to synaptic plasticity and to different phases of hippocampal memory formation. Selective SK2 antisense-treatment facilitated basal synaptic transmission and theta-burst induced LTP in hippocampal brain slices. Using the selective SK2 antagonist Lei-Dab(7) or SK2 antisense probes, we found that hippocampal SK2 channels are critical during two different time windows: 1) blockade of SK2 channels before the training impaired fear memory, whereas, 2) blockade of SK2 channels immediately after the training enhanced contextual fear memory. We provided the evidence that the post-training cleavage of the SK2 channels was responsible for the observed bidirectional effect of SK2 channel blockade on memory consolidation. Thus, Lei-Dab(7)-injection before training impaired the C-terminal cleavage of SK2 channels, while Lei-Dab(7) given immediately after training facilitated the C-terminal cleavage. Application of the synthetic peptide comprising a leucine-zipper domain of the C-terminal fragment to Jurkat cells impaired SK2 channel-mediated currents, indicating that the endogenously cleaved fragment might exert its effects on memory formation by blocking SK2 channel-mediated currents. Our present findings suggest that SK2 channel proteins contribute to synaptic plasticity and memory not only as ion channels but also by additionally generating a SK2 C-terminal fragment, involved in both processes. The modulation of fear memory by down-regulating SK2 C-terminal cleavage might have applicability in the treatment of anxiety disorders in which fear conditioning is enhanced.	[Murthy, Saravana R. K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, Program Dev Neurosci, Bethesda, MD USA; [Sherrin, Tessi; Jansen, Chad; Robles, Michael; Penner, Reinhold; Todorovic, Cedomir; Blank, Thomas] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Jansen, Chad; Penner, Reinhold] Queens Med Ctr, Lab Cell & Mol Signaling, Honolulu, HI USA; [Nijholt, Ingrid] Isala Acad, Isala Clin, Zwolle, Netherlands; [Dolga, Amalia M.] Univ Marburg, Dept Pharmacol & Toxicol, Marburg, Germany; [Andreotti, Nicolas; Sabatier, Jean-Marc] Lab INSERM UMR1097, Marseille 09, France; [Knaus, Hans-Guenther] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Blank, Thomas] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Hawaii System; The Queen's Medical Center; Isala Clinics; Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; University of Freiburg	Todorovic, C (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	cedomir@hawaii.edu	Dolga, Amalia/C-9664-2018; Nijholt, Ingrid/AAB-8740-2021	Nijholt, Ingrid/0000-0003-4820-7505; Penner, Reinhold/0000-0002-5366-1537; Dolga, Amalia/0000-0001-5400-5614; Robles, Michael/0000-0002-5112-3882; SABATIER, Jean-Marc/0000-0002-9040-5647	National Institutes of Health [G12MD007601, U54MD008149, MH086733]; Angus Foundation [115054959]; Hawaiian Community Foundation [13ADVC-60319]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086733] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008149, G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angus Foundation; Hawaiian Community Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health grants G12MD007601, U54MD008149 and MH086733. Additional funding was provided by grants from the Angus Foundation (115054959) and the Hawaiian Community Foundation (13ADVC-60319).	Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Blank T, 2003, NAT NEUROSCI, V6, P911, DOI 10.1038/nn1101; Blank T, 2002, J NEUROSCI, V22, P3788; Desai R, 2000, J BIOL CHEM, V275, P39954, DOI 10.1074/jbc.M001562200; Fakira AK, 2014, BIOL PSYCHIAT, V75, P105, DOI 10.1016/j.biopsych.2013.04.026; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Garcia-Negredo G, 2014, J NEUROSCI, V34, P14793, DOI 10.1523/JNEUROSCI.2038-14.2014; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kim JY, 2008, PROTEINS, V70, P568, DOI 10.1002/prot.21634; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Lee AL, 2003, J NEUROCHEM, V86, P1079, DOI 10.1046/j.1471-4159.2003.01880.x; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKay BM, 2012, J NEUROPHYSIOL, V108, P863, DOI 10.1152/jn.00025.2012; Mpari Bedel, 2005, Journal of Integrative Neuroscience, V4, P381, DOI 10.1142/S0219635205000884; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Rudy JW, 2001, COGN AFFECT BEHAV NE, V1, P66, DOI 10.3758/CABN.1.1.66; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Shah M, 2000, BRIT J PHARMACOL, V129, P627, DOI 10.1038/sj.bjp.0703111; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Sherrin T, 2010, J NEUROSCI, V30, P13348, DOI 10.1523/JNEUROSCI.3492-10.2010; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Stackman RW, 2008, LEARN MEMORY, V15, P208, DOI 10.1101/lm.906808; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Vick KA, 2010, NEUROPHARMACOLOGY, V58, P650, DOI 10.1016/j.neuropharm.2009.11.008; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0127264	10.1371/journal.pone.0127264	http://dx.doi.org/10.1371/journal.pone.0127264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938421	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000164
J	Raymond, WW; Xu, X; Nimishakavi, S; Le, C; McDonald, DM; Caughey, GH				Raymond, Wilfred W.; Xu, Xiang; Nimishakavi, Shilpa; Le, Catherine; McDonald, Donald M.; Caughey, George H.			Regulation of Hepatocyte Growth Factor in Mice with Pneumonia by Peptidases and Trans-Alveolar Flux	PLOS ONE			English	Article							ACUTE LUNG INJURY; C-MET RECEPTOR; MAST-CELL; SCATTER FACTOR; MYCOPLASMA-PNEUMONIA; TUMOR-GROWTH; INFLAMMATION; METASTASIS; ANTAGONIST; MODEL	Hepatocyte growth factor (HGF) promotes lung epithelial repair after injury. Because prior studies established that human neutrophil proteases inactivate HGF in vitro, we predicted that HGF levels decrease in lungs infiltrated with neutrophils and that injury is less severe in lungs lacking HGF-inactivating proteases. After establishing that mouse neutrophil elastase cleaves mouse HGF in vitro, we tested our predictions in vivo by examining lung pathology and HGF in mice infected with Mycoplasma pulmonis, which causes neutrophilic tracheobronchitis and pneumonia. Unexpectedly, pneumonia severity was similar in wild type and dipeptidylpeptidase I-deficient (Dppi(-/-)) mice lacking neutrophil serine protease activity. To assess how this finding related to our prediction that Dppi-activated proteases regulate HGF levels, we measured HGF in serum, bronchoalveolar lavage fluid, and lung tissue from Dppi(+/+) and Dppi(-/-) mice. Contrary to prediction, HGF levels were higher in lavage fluid from infected mice. However, serum and tissue concentrations were not different in infected and uninfected mice, and HGF lung transcript levels did not change. Increased HGF correlated with increased albumin in lavage fluid from infected mice, and immunostaining failed to detect increased lung tissue expression of HGF in infected mice. These findings are consistent with trans-alveolar flux rather than local production as the source of increased HGF in lavage fluid. However, levels of intact HGF from infected mice, normalized for albumin concentration, were two-fold higher in Dppi(-/-) versus Dppi(+/+) lavage fluid, suggesting regulation by Dppi-activated proteases. Consistent with the presence of active HGF, increased expression of activated receptor c-Met was observed in infected tissues. These data suggest that HGF entering alveoli from the bloodstream during pneumonia compensates for destruction by Dppi-activated inflammatory proteases to allow HGF to contribute to epithelial repair.	[Raymond, Wilfred W.; Nimishakavi, Shilpa; McDonald, Donald M.; Caughey, George H.] Univ Calif San Francisco, Sch Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Xu, Xiang; Caughey, George H.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Le, Catherine; McDonald, Donald M.] Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA USA; [Caughey, George H.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northern California Institute for Research & Education; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caughey, GH (corresponding author), Univ Calif San Francisco, Sch Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	George.Caughey@ucsf.edu		Le, Catherine/0000-0002-0175-570X	National Institutes of Health [P01 HL024136, R01 HL059157]; AngelWorks Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136, R01HL127402, P01HL024075, R01HL096511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AngelWorks Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (nih.gov) P01 HL024136 (WWR XX SN DMM GHC); National Institutes of Health (nih.gov) R01 HL059157 (DMM); AngelWorks Foundation (www.angelworksfoundation.com) (DMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Aurora AB, 2005, J IMMUNOL, V175, P6319, DOI 10.4049/jimmunol.175.10.6319; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; CHAN AML, 1991, SCIENCE, V254, P1382, DOI 10.1126/science.1720571; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; Codolo G, 2008, CELL MICROBIOL, V10, P2355, DOI 10.1111/j.1462-5822.2008.01217.x; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Dohi M, 2000, AM J RESP CRIT CARE, V162, P2302, DOI 10.1164/ajrccm.162.6.9908097; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Ito W, 2008, INT ARCH ALLERGY IMM, V145, P324, DOI 10.1159/000110891; Kishi Y, 2009, CANCER SCI, V100, P1351, DOI 10.1111/j.1349-7006.2009.01184.x; Kuba K, 2000, CANCER RES, V60, P6737; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Ohmichi H, 1998, DEVELOPMENT, V125, P1315; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Okunishi K, 2009, INT ARCH ALLERGY IMM, V149, P14, DOI 10.1159/000210648; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; Raymond WW, 2009, J IMMUNOL, V182, P5770, DOI 10.4049/jimmunol.0900127; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Sakai K, 2009, J BIOL CHEM, V284, P22491, DOI 10.1074/jbc.M109.025148; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; TASHIRO K, 1990, P NATL ACAD SCI USA, V87, P3200, DOI 10.1073/pnas.87.8.3200; Tolbert WD, 2010, P NATL ACAD SCI USA, V107, P13264, DOI 10.1073/pnas.1005183107; Tomioka D, 2001, CANCER RES, V61, P7518; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Verghese GM, 1998, AM J RESP CRIT CARE, V158, P386, DOI 10.1164/ajrccm.158.2.9711111; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Xu X, 2006, AM J RESP CRIT CARE, V173, P219, DOI 10.1164/rccm.200507-1034OC; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232; Yaekashiwa M, 1997, AM J RESP CRIT CARE, V156, P1937, DOI 10.1164/ajrccm.156.6.9611057; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; YANAGITA K, 1993, J BIOL CHEM, V268, P21212	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125797	10.1371/journal.pone.0125797	http://dx.doi.org/10.1371/journal.pone.0125797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938594	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000100
J	Bos-Touwen, I; Schuurmans, M; Monninkhof, EM; Korpershoek, Y; Spruit-Bentvelzen, L; Ertugrul-van der Graaf, I; de Wit, N; Trappenburg, J				Bos-Touwen, Irene; Schuurmans, Marieke; Monninkhof, Evelyn M.; Korpershoek, Yvonne; Spruit-Bentvelzen, Lotte; Ertugrul-van der Graaf, Inge; de Wit, Niek; Trappenburg, Jaap			Patient and Disease Characteristics Associated with Activation for Self-Management in Patients with Diabetes, Chronic Obstructive Pulmonary Disease, Chronic Heart Failure and Chronic Renal Disease: A Cross-Sectional Survey Study	PLOS ONE			English	Article							PERCEIVED SOCIAL SUPPORT; DUTCH LANGUAGE VERSION; HEALTH SURVEY; MULTIDIMENSIONAL SCALE; DEPRESSION SCALE; HOSPITAL ANXIETY; SHORT-FORM; VALIDATION; POPULATION; IMPUTATION	A substantial proportion of chronic disease patients do not respond to self-management interventions, which suggests that one size interventions do not fit all, demanding more tailored interventions. To compose more individualized strategies, we aim to increase our understanding of characteristics associated with patient activation for self-management and to evaluate whether these are disease-transcending. A cross-sectional survey study was conducted in primary and secondary care in patients with type-2 Diabetes Mellitus (DM-II), Chronic Obstructive Pulmonary Disease (COPD), Chronic Heart Failure (CHF) and Chronic Renal Disease (CRD). Using multiple linear regression analysis, we analyzed associations between self-management activation (13-item Patient Activation Measure; PAM13) and a wide range of socio-demographic, clinical, and psychosocial determinants. Furthermore, we assessed whether the associations between the determinants and the PAM were disease-transcending by testing whether disease was an effect modifier. In addition, we identified determinants associated with low activation for self-management using logistic regression analysis. We included 1154 patients (53% response rate); 422 DM-II patients, 290 COPD patients, 223 HF patients and 219 CRD patients. Mean age was 69.6 +/- 10.9. Multiple linear regression analysis revealed 9 explanatory determinants of activation for self-management: age, BMI, educational level, financial distress, physical health status, depression, illness perception, social support and underlying disease, explaining a variance of 16.3%. All associations, except for social support, were disease transcending. This study explored factors associated with varying levels of activation for self-management. These results are a first step in supporting clinicians and researchers to identify subpopulations of chronic disease patients less likely to be engaged in self-management. Increased scientific efforts are needed to explain the greater part of the factors that contribute to the complex nature of patient activation for self-management.	[Bos-Touwen, Irene; Schuurmans, Marieke; Korpershoek, Yvonne; Spruit-Bentvelzen, Lotte; Ertugrul-van der Graaf, Inge; Trappenburg, Jaap] Univ Med Ctr Utrecht, Dept Rehabil Nursing Sci & Sports, Utrecht, Netherlands; [Monninkhof, Evelyn M.; de Wit, Niek] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bos-Touwen, I (corresponding author), Univ Med Ctr Utrecht, Dept Rehabil Nursing Sci & Sports, Utrecht, Netherlands.	I.D.Touwen-3@umcutrecht.nl		Trappenburg, Jaap/0000-0003-0489-7401	ZonMw, The Netherlands Organization for Health Research and Development [520001002]	ZonMw, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This project was funded by ZonMw, The Netherlands Organization for Health Research and Development, Grant 520001002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Cameron J, 2009, HEART LUNG, V38, P410, DOI 10.1016/j.hrtlng.2008.11.004; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Connelly C E, 1993, Clin Nurse Spec, V7, P247; de Raaij EJ, 2012, MANUAL THER, V17, P330, DOI 10.1016/j.math.2012.03.001; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Disler RT, 2012, INT J NURS STUD, V49, P230, DOI 10.1016/j.ijnurstu.2011.11.005; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Feil DG, 2012, J BEHAV MED, V35, P190, DOI 10.1007/s10865-011-9344-6; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Harel O, 2008, THE ESTIMATION OF R2; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x; IBM Corp, 2011, RELEASED 2011 IBM SP; Insignia Health, 2011, PATIENT ACTIVATION M; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002; Nici Linda, 2014, Ann Am Thorac Soc, V11, P101, DOI 10.1513/AnnalsATS.201306-150FR; Pedersen SS, 2009, PSYCHOSOMATICS, V50, P461, DOI 10.1176/appi.psy.50.5.461; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rademakers J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-577; Rask KJ, 2009, DIABETES EDUCATOR, V35, P622, DOI 10.1177/0145721709335004; Rockwell JM, 2001, HEART LUNG, V30, P18, DOI 10.1067/mhl.2001.112503; Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35; Siabani S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-320; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Trappenburg J, 2013, PATIENT EDUC COUNS, V92, P134, DOI 10.1016/j.pec.2013.02.009; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	43	124	130	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126400	10.1371/journal.pone.0126400	http://dx.doi.org/10.1371/journal.pone.0126400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH7KF	25950517	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400088
J	Cabre, EJ; Monterroso, B; Alfonso, C; Sanchez-Gorostiaga, A; Reija, B; Jimenez, M; Vicente, M; Zorrilla, S; Rivas, G				Cabre, Elisa J.; Monterroso, Begona; Alfonso, Carlos; Sanchez-Gorostiaga, Alicia; Reija, Belen; Jimenez, Mercedes; Vicente, Miguel; Zorrilla, Silvia; Rivas, German			The Nucleoid Occlusion SlmA Protein Accelerates the Disassembly of the FtsZ Protein Polymers without Affecting Their GTPase Activity	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; STATIC LIGHT-SCATTERING; ESCHERICHIA-COLI; Z-RING; QUANTITATIVE CHARACTERIZATION; BACTERIAL CYTOKINESIS; FILAMENT DYNAMICS; SIZE-DISTRIBUTION; MINCDE SYSTEM; IN-VITRO	Division site selection is achieved in bacteria by different mechanisms, one of them being nucleoid occlusion, which prevents Z-ring assembly nearby the chromosome. Nucleoid occlusion in E. coli is mediated by SlmA, a sequence specific DNA binding protein that antagonizes FtsZ assembly. Here we show that, when bound to its specific target DNA sequences (SBS), SlmA reduces the lifetime of the FtsZ protofilaments in solution and of the FtsZ bundles when located inside permeable giant vesicles. This effect appears to be essentially uncoupled from the GTPase activity of the FtsZ protofilaments, which is insensitive to the presence of SlmA.SBS. The interaction of SlmA.SBS with either FtsZ protofilaments containing GTP or FtsZ oligomers containing GDP results in the disassembly of FtsZ polymers. We propose that SlmA.SBS complexes control the polymerization state of FtsZ by accelerating the disassembly of the FtsZ polymers leading to their fragmentation into shorter species that are still able to hydrolyze GTP at the same rate. SlmA defines therefore a new class of inhibitors of the FtsZ ring different from the SOS response regulator SulA and from the moonlighting enzyme OpgH, inhibitors of the GTPase activity. SlmA also shows differences compared with MinC, the inhibitor of the division site selection Min system, which shortens FtsZ protofilaments by interacting with the GDP form of FtsZ.	[Cabre, Elisa J.; Monterroso, Begona; Alfonso, Carlos; Jimenez, Mercedes; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid, Spain; [Sanchez-Gorostiaga, Alicia; Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Zorrilla, S (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	silvia@cib.csic.es; grivas@cib.csic.es	Sánchez-Gorostiaga, Alicia/K-6049-2014; Alfonso, Carlos/K-1316-2014; Rivas, German/AAG-7458-2022; Sánchez-Gorostiaga, Alicia/AFV-4900-2022; Rivas, German/AFL-7528-2022; Monterroso, Begoña/J-9748-2014; Zorrilla, Silvia/J-9771-2014; Jimenez Sarmiento, Mercedes/K-2691-2014	Sánchez-Gorostiaga, Alicia/0000-0002-2719-5659; Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; Sánchez-Gorostiaga, Alicia/0000-0002-2719-5659; Rivas, German/0000-0003-3450-7478; Monterroso, Begoña/0000-0003-2538-084X; Zorrilla, Silvia/0000-0002-6309-9058; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Jimenez-Cabre, Elisa/0000-0002-0493-6477	Spanish government [BIO2011-28941-C03]; European Commission [HEALTH-F3-2009-223432 DIVINOCELL]; Human Frontier Science Program [RGP0050/2010-C102]	Spanish government(Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Spanish government (http://www.idi.mineco.gob.es) through grants BIO2011-28941-C03 (to MV, GR and SZ); by the European Commission (http://cordis.europa.eu) through contract HEALTH-F3-2009-223432 DIVINOCELL (to MV and GR), and by Human Frontier Science Program (http://www.hfsp.org/) through grant RGP0050/2010-C102 (to MV and GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Attri AK, 2005, ANAL BIOCHEM, V346, P132, DOI 10.1016/j.ab.2005.08.013; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Cabre EJ, 2013, J BIOL CHEM, V288, P26625, DOI 10.1074/jbc.M113.491688; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Cho H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003304; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cisse I, 2007, P NATL ACAD SCI USA, V104, P12646, DOI 10.1073/pnas.0610673104; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kameyama K, 2006, BIOPHYS J, V90, P2164, DOI 10.1529/biophysj.105.074310; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mateos-Gil P, 2012, P NATL ACAD SCI USA, V109, P8133, DOI 10.1073/pnas.1204844109; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mukherjee A, 1998, P NATL ACAD SCI USA, V95, P2885, DOI 10.1073/pnas.95.6.2885; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Okuno T, 2009, BIOL PHARM BULL, V32, P1473, DOI 10.1248/bpb.32.1473; Pazos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091984; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; ROYER CA, 1990, ANAL BIOCHEM, V191, P287, DOI 10.1016/0003-2697(90)90221-T; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; Trusca D, 1998, J BACTERIOL, V180, P3946, DOI 10.1128/JB.180.15.3946-3953.1998; Turner DJ, 2012, BIOPHYS J, V102, P731, DOI 10.1016/j.bpj.2012.01.015; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	63	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126434	10.1371/journal.pone.0126434	http://dx.doi.org/10.1371/journal.pone.0126434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950808	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400090
J	Marafini, I; Monteleone, I; Di Fusco, D; Cupi, ML; Paoluzi, OA; Colantoni, A; Ortenzi, A; Izzo, R; Vita, S; De Luca, E; Sica, G; Pallone, F; Monteleone, G				Marafini, Irene; Monteleone, Ivan; Di Fusco, Davide; Cupi, Maria Laura; Paoluzi, Omero Alessandro; Colantoni, Alfredo; Ortenzi, Angela; Izzo, Roberta; Vita, Simone; De Luca, Elisabetta; Sica, Giuseppe; Pallone, Francesco; Monteleone, Giovanni			TNF-alpha Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice	PLOS ONE			English	Article							T-CELLS; INFLAMMATION; RESPONSES	Innate lymphoid cells (ILCs) are an emerging family of innate hematopoietic cells producing inflammatory cytokines and involved in the pathogenesis of several immune-mediated diseases. The aim of this study was to characterize the tissue distribution of ILCs in celiac disease (CD), a gluten-driven enteropathy, and analyze their role in gut tissue damage. ILC subpopulations were analyzed in lamina propria mononuclear cells (LPMCs) isolated from duodenal biopsies of CD patients and healthy controls (CTR) and jejunal specimens of patients undergoing gastro-intestinal bypass by flow cytometry. Cytokines and Toll-like receptors (TLR) were assessed in ILCs either freshly isolated or following incubation of control LPMC with peptidoglycan, poly I:C, or CpG, the agonists of TLR2, TLR3, or TLR9 respectively, by flow cytometry. The role of ILCs in gut tissue damage was evaluated in a mouse model of poly I:C-driven small intestine atrophy. Although the percentage of total ILCs did not differ between CD patients and CTR, ILCs producing TNF-alpha and IFN-gamma were more abundant in CD mucosa compared to controls. ILCs expressed TLR2, TLR3 and TLR9 but neither TLR7 nor TLR4. Stimulation of LPMC with poly I:C but not PGN or CpG increased TNF alpha and IFN-gamma in ILCs. RAG1-deficient mice given poly I:C exhibited increased frequency of TNF-alpha but not IFN-gamma/IL17A-producing ILCs in the gut and depletion of ILCs prevented the poly I:C-driven intestinal damage. Our data indicate that CD-related inflammation is marked by accumulation of ILCs producing TNF-alpha and IFN-gamma in the mucosa. Moreover, ILCs express TLR3 and are functionally able to respond to poly I:C with increased synthesis of TNF-alpha thus contributing to small intestinal atrophy.	[Marafini, Irene; Monteleone, Ivan; Di Fusco, Davide; Cupi, Maria Laura; Paoluzi, Omero Alessandro; Colantoni, Alfredo; Ortenzi, Angela; Izzo, Roberta; Pallone, Francesco; Monteleone, Giovanni] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Vita, Simone] San Pietro Fatebenefratelli Hosp, Dept Surg, Rome, Italy; [De Luca, Elisabetta; Sica, Giuseppe] Univ Roma Tor Vergata, Dept Surg, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Monteleone, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	Gi.Monteleone@Med.uniroma2.it	Monteleone, Giovanni/AAE-1418-2021; Monteleone, Ivan/AEW-2892-2022; marafini, irene/AHD-5205-2022	Di Fusco, Davide/0000-0002-8908-9237; paoluzi, omero alessandro/0000-0002-5393-5796; Monteleone, Ivan/0000-0002-3212-832X				Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Constantinides MG, 2014, NATURE; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; GARSIDE P, 1993, IMMUNOLOGY, V78, P335; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; KAGNOFF MF, 1984, J EXP MED, V160, P1544, DOI 10.1084/jem.160.5.1544; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Monteleone G, 2001, GUT, V48, P425, DOI 10.1136/gut.48.3.425; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Nistal E, 2012, INFLAMM BOWEL DIS, V18, P649, DOI 10.1002/ibd.21830; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sonnenberg Gregory F, 2013, Immunity, V39, P622, DOI 10.1016/j.immuni.2013.08.021; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	33	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126291	10.1371/journal.pone.0126291	http://dx.doi.org/10.1371/journal.pone.0126291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950701	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400077
J	Alfonso-Morales, A; Rios, L; Martinez-Perez, O; Dolz, R; Valle, R; Perera, CL; Bertran, K; Frias, MT; Ganges, L; de Arce, HD; Majo, N; Nunez, JI; Perez, LJ				Alfonso-Morales, Abdulahi; Rios, Liliam; Martinez-Perez, Orlando; Dolz, Roser; Valle, Rosa; Perera, Carmen L.; Bertran, Kateri; Frias, Maria T.; Ganges, Llilianne; de Arce, Heidy Diaz; Majo, Natalia; Nunez, Jose I.; Perez, Lester J.			Evaluation of a Phylogenetic Marker Based on Genomic Segment B of Infectious Bursal Disease Virus: Facilitating a Feasible Incorporation of this Segment to the Molecular Epidemiology Studies for this Viral Agent	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; RECOMBINATION; PATHOGENICITY; REASSORTMENT; POLYMERASE; CONTRIBUTE; INFERENCE; ALGORITHM; SELECTION; REVEALS	Background Infectious bursal disease (IBD) is a highly contagious and acute viral disease, which has caused high mortality rates in birds and considerable economic losses in different parts of the world for more than two decades and it still represents a considerable threat to poultry. The current study was designed to rigorously measure the reliability of a phylogenetic marker included into segment B. This marker can facilitate molecular epidemiology studies, incorporating this segment of the viral genome, to better explain the links between emergence, spreading and maintenance of the very virulent IBD virus (vvIBDV) strains worldwide. Methodology/Principal Findings Sequences of the segment B gene from IBDV strains isolated from diverse geographic locations were obtained from the GenBank Database; Cuban sequences were obtained in the current work. A phylogenetic marker named B-marker was assessed by different phylogenetic principles such as saturation of substitution, phylogenetic noise and high consistency. This last parameter is based on the ability of B-marker to reconstruct the same topology as the complete segment B of the viral genome. From the results obtained from B-marker, demographic history for both main lineages of IBDV regarding segment B was performed by Bayesian skyline plot analysis. Phylogenetic analysis for both segments of IBDV genome was also performed, revealing the presence of a natural reassortant strain with segment A from vvIBDV strains and segment B from non-vvIBDV strains within Cuban IBDV population. Conclusions/Significance This study contributes to a better understanding of the emergence of vvIBDV strains, describing molecular epidemiology of IBDV using the state-of-the-art methodology concerning phylogenetic reconstruction. This study also revealed the presence of a novel natural reassorted strain as possible manifest of change in the genetic structure and stability of the vvIBDV strains. Therefore, it highlights the need to obtain information about both genome segments of IBDV for molecular epidemiology studies.	[Alfonso-Morales, Abdulahi; Rios, Liliam; Perera, Carmen L.; Frias, Maria T.; Perez, Lester J.] Ctr Nacl Sanidad Agr CENSA, Havana, Cuba; [Martinez-Perez, Orlando] Univ Ciencias Informat, Havana, Cuba; [Dolz, Roser; Valle, Rosa; Bertran, Kateri; Ganges, Llilianne; Majo, Natalia; Nunez, Jose I.] UAB IRTA, Ctr Recerca Sanitat Anim, Barcelona 08193, Spain; [de Arce, Heidy Diaz] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; Hospital Italiano de Buenos Aires; University of Buenos Aires; Autonomous University of Barcelona	Perez, LJ (corresponding author), Ctr Nacl Sanidad Agr CENSA, Havana, Cuba.	lesterjosue@gmail.com	Bertran, Kateri/H-3458-2019; Perez, Lester J./A-1339-2016; Ganges, Llilianne/O-7342-2017; Masferrer, Natàlia Majó/AAV-3696-2021; Nuñez, Jose I/M-7141-2018; Rios, Liliam/J-2272-2019	Bertran, Kateri/0000-0002-6920-4154; Perez, Lester J./0000-0002-5717-5181; Ganges, Llilianne/0000-0002-8644-3560; Nuñez, Jose I/0000-0001-9890-7695; Rios, Liliam/0000-0002-2763-5431; Alfonso, Abdulahi/0000-0002-8710-6099; Perera, Carmen Laura/0000-0002-8032-0412; Majo, Natalia/0000-0003-0189-9751	MAEC-AECID program of the Spanish government; program of the Cuban government for the development of molecular differential diagnosis of exotic diseases	MAEC-AECID program of the Spanish government; program of the Cuban government for the development of molecular differential diagnosis of exotic diseases	The work was supported by a 2011/12 scholarship from the MAEC-AECID program of the Spanish government and by the program of the Cuban government for the development of molecular differential diagnosis of exotic diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Morales A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065999; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Banda A, 2004, AVIAN DIS, V48, P540, DOI 10.1637/7157-12304R; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Capella-Gutierrez S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku071; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Cortey M, 2012, AVIAN PATHOL, V41, P277, DOI 10.1080/03079457.2012.682562; Cui P, 2013, ARCH VIROL, V158, P1973, DOI 10.1007/s00705-013-1682-y; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Escaffre O, 2013, J VIROL, V87, P2767, DOI 10.1128/JVI.02360-12; Eterradossi N, 2004, DIS POULTRY, P185; Gao L, 2014, J GEN VIROL, V95, P888, DOI 10.1099/vir.0.060194-0; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gray RR, 2010, MOL PHYLOGENET EVOL, V56, P195, DOI 10.1016/j.ympev.2010.01.019; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He XM, 2014, ARCH VIROL, V159, P3279, DOI 10.1007/s00705-014-2195-z; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hon CC, 2006, J VIROL, V80, P8503, DOI 10.1128/JVI.00585-06; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; ISMAIL NM, 1991, AVIAN DIS, V35, P460, DOI 10.2307/1591208; ISMAIL NM, 1988, AVIAN DIS, V32, P757, DOI 10.2307/1590995; Jackwood DJ, 2007, VIROLOGY, V365, P369, DOI 10.1016/j.virol.2007.03.046; Jeon WJ, 2008, VIRUS RES, V137, P153, DOI 10.1016/j.virusres.2008.06.013; Perez LJ, 2012, INFECT GENET EVOL, V12, P1405, DOI 10.1016/j.meegid.2012.04.030; Kasanga CJ, 2013, ARCH VIROL, V158, P685, DOI 10.1007/s00705-012-1531-4; KIBENGE FSB, 1988, J GEN VIROL, V69, P1757, DOI 10.1099/0022-1317-69-8-1757; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Lasher HN, 1997, AVIAN DIS, V41, P11, DOI 10.2307/1592439; Le Nouen C, 2006, J GEN VIROL, V87, P209, DOI 10.1099/vir.0.81184-0; Lojkic I, 2008, AVIAN DIS, V52, P513, DOI 10.1637/8272-022808-Reg.1; Mahmood MS, 2007, VACCINE, V25, P7629, DOI 10.1016/j.vaccine.2007.08.059; Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martinez N, 2012, INFECT GENET EVOL, V12, P1870, DOI 10.1016/j.meegid.2012.05.007; MCFERRAN JB, 1980, AVIAN PATHOL, V9, P395, DOI 10.1080/03079458008418423; Moscoso H, 2006, AVIAN DIS, V50, P391, DOI 10.1637/7505-011306R.1; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Noda J., 2003, Revista Cubana de Ciencia Avicola, V27, P139; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Qi XiaoLe, 2011, Agricultural Science & Technology - Hunan, V12, P1946; Rambaut A., 2008, FIGTREE V112; Rinaldi A, 1974, Avian Pathol, V3, P51, DOI 10.1080/03079457409353815; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safari M, 2014, CURR OPIN VIROL, V9, P39, DOI 10.1016/j.coviro.2014.09.004; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silva FMF, 2013, INFECT GENET EVOL, V13, P18, DOI 10.1016/j.meegid.2012.09.005; SMITH JM, 1992, J MOL EVOL, V34, P126; Straub SCK, 2014, MOL PHYLOGENET EVOL, V80, P169, DOI 10.1016/j.ympev.2014.07.020; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Thornton D H, 1976, Dev Biol Stand, V33, P343; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; van den Berg TP, 2000, AVIAN PATHOL, V29, P175, DOI 10.1080/03079450050045431; Van den Berg TP, 2004, AVIAN PATHOL, V1, P1; VANDENBERG TP, 1991, AVIAN PATHOL, V20, P409, DOI 10.1080/03079459108418779; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081106; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu F, 2010, VIRUS GENES, V41, P246, DOI 10.1007/s11262-010-0499-y; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003	76	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125853	10.1371/journal.pone.0125853	http://dx.doi.org/10.1371/journal.pone.0125853			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946336	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700093
J	Beversdorf, LJ; Chaston, SD; Miller, TR; McMahon, KD				Beversdorf, Lucas J.; Chaston, Sheena D.; Miller, Todd R.; McMahon, Katherine D.			Microcystin mcyA and mcyE Gene Abundances Are Not Appropriate Indicators of Microcystin Concentrations in Lakes	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS; ENVIRONMENTAL-FACTORS; TOXIC MICROCYSTIS; DRINKING-WATER; LR SYNTHESIS; AERUGINOSA; BIOSYNTHESIS; DIVERSITY; BLOOMS; PCR	Cyanobacterial harmful algal blooms (cyanoHABs) are a primary source of water quality degradation in eutrophic lakes. The occurrence of cyanoHABs is ubiquitous and expected to increase with current climate and land use change scenarios. However, it is currently unknown what environmental parameters are important for indicating the presence of cyano-HAB toxins making them difficult to predict or even monitor on time-scales relevant to protecting public health. Using qPCR, we aimed to quantify genes within the microcystin operon (mcy) to determine which cyanobacterial taxa, and what percentage of the total cyanobacterial community, were responsible for microcystin production in four eutrophic lakes. We targeted Microcystis-16S, mcyA, and Microcystis, Planktothrix, and Anabaena-specific mcyE genes. We also measured microcystins and several biological, chemical, and physical parameters-such as temperature, lake stability, nutrients, pigments and cyanobacterial community composition (CCC)-to search for possible correlations to gene copy abundance and MC production. All four lakes contained Microcystis-mcyE genes and high percentages of toxic Microcystis, suggesting Microcystis was the dominant microcystin producer. However, all genes were highly variable temporally, and in few cases, correlated with increased temperature and nutrients as the summer progressed. Interestingly, toxin gene abundances (and biomass indicators) were anti-correlated with microcystin in all lakes except the largest lake, Lake Mendota. Similarly, gene abundance and microcystins differentially correlated to CCC in all lakes. Thus, we conclude that the presence of microcystin genes are not a useful tool for eliciting an ecological role for toxins in the environment, nor are microcystin genes (e.g. DNA) a good indicator of toxins in the environment.	[Beversdorf, Lucas J.; McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Chaston, Sheena D.; Miller, Todd R.; McMahon, Katherine D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Beversdorf, LJ (corresponding author), Univ Wisconsin, Zilber Sch Publ Hlth, 3209 North Maryland Ave, Milwaukee, WI 53211 USA.	lucasb@uwm.edu	Miller, Todd/Y-3612-2019	Miller, Todd/0000-0002-2113-1662; McMahon, Katherine D./0000-0002-7038-026X	Wisconsin SeaGrant [R/BT-24]; National Science Foundation (CAREER) [CBET-0644949, MCB-0702395, NTL-LTER DEB-0822700]; UW-Madison Biotechnology Training Program (BTP); National Institutes of Health [NIH 5 T32 GM08349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	Wisconsin SeaGrant; National Science Foundation (CAREER)(National Science Foundation (NSF)); UW-Madison Biotechnology Training Program (BTP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by Wisconsin SeaGrant (R/BT-24; http://www.seagrant.wisc.edu/home/), the National Science Foundation (CAREER CBET-0644949; NTL-Microbial Observatory MCB-0702395; NTL-LTER DEB-0822700; http://www.nsf.gov/), and the UW-Madison Biotechnology Training Program (BTP), a National Institutes of Health training grant (NIH 5 T32 GM08349; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxa DV, 2010, HARMFUL ALGAE, V9, P342, DOI 10.1016/j.hal.2010.01.001; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Brock T.D., 1985, EUTROPHIC LAKE LAKE; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; Conradie KR, 2012, HARMFUL ALGAE, V20, P1, DOI 10.1016/j.hal.2012.03.006; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; DEMARSAC NT, 1988, METHOD ENZYMOL, V167, P318; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Downing TG, 2005, ENVIRON TOXICOL, V20, P257, DOI 10.1002/tox.20106; Eaglesham GK, 1999, ENVIRON TOXICOL, V14, P151, DOI 10.1002/(SICI)1522-7278(199902)14:1<151::AID-TOX19>3.3.CO;2-4; Flowers JJ, 2009, ENV MICROBIOL REP, V1, P583, DOI 10.1111/j.1758-2229.2009.00090.x; Fortin N, 2010, APPL ENVIRON MICROB, V76, P5105, DOI 10.1128/AEM.00183-10; Ginn HP, 2010, APPL ENVIRON MICROB, V76, P4362, DOI 10.1128/AEM.01862-09; Greenberg A.E., 1992, STANDARD METHODS EXA, V18; Ha JH, 2009, ENVIRON SCI TECHNOL, V43, P812, DOI 10.1021/es801265f; HARADA KI, 1988, J CHROMATOGR, V448, P275, DOI 10.1016/S0021-9673(01)84589-1; Heldman CJ, 2008, J ENVIRON QUAL, V37, P1817, DOI 10.2134/jeq2007.0368; Hisbergues M, 2003, ARCH MICROBIOL, V180, P402, DOI 10.1007/s00203-003-0605-9; Jahnichen S, 2011, HARMFUL ALGAE, V12, P95, DOI 10.1016/j.hal.2011.09.002; Kaebernick M, 2002, APPL ENVIRON MICROB, V68, P449, DOI 10.1128/AEM.68.2.449-455.2002; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kotak BG, 1996, CAN J FISH AQUAT SCI, V53, P1974, DOI 10.1139/cjfas-53-9-1974; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Kurmayer R, 2004, ENVIRON MICROBIOL, V6, P831, DOI 10.1111/j.1462-2920.2004.00626.x; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; Lathrop RC, 2007, LAKE RESERV MANAGE, V23, P345, DOI 10.1080/07438140709354023; Legendre P., 1998, DEV ENV MODELLING, P20; Li Y, 2011, ENVIRON HEALTH PERSP, V119, P1483, DOI 10.1289/ehp.1002412; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Meriluoto JAO, 2008, ADV EXP MED BIOL, V619, P483, DOI 10.1007/978-0-387-75865-7_21; Miller TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074933; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; Neilan BA, 1997, INT J SYST BACTERIOL, V47, P693, DOI 10.1099/00207713-47-3-693; Neilan BA, 2013, ENVIRON MICROBIOL, V15, P1239, DOI 10.1111/j.1462-2920.2012.02729.x; Nishizawa T, 2000, J BIOCHEM, V127, P779, DOI 10.1093/oxfordjournals.jbchem.a022670; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; Oh HM, 2001, APPL ENVIRON MICROB, V67, P1484, DOI 10.1128/AEM.67.4.1484-1489.2001; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pattanaik B, 2010, HARMFUL ALGAE, V10, P30, DOI 10.1016/j.hal.2010.06.001; POOLE H. H., 1929, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V16, P297; R Core Team, 2014, LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Rantala A, 2006, APPL ENVIRON MICROB, V72, P6101, DOI 10.1128/AEM.01058-06; Read JS, 2011, ENVIRON MODELL SOFTW, V26, P1325, DOI 10.1016/j.envsoft.2011.05.006; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rouhiainen L, 2004, APPL ENVIRON MICROB, V70, P686, DOI 10.1128/AEM.70.2.686-692.2004; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Sevilla E, 2010, ECOTOXICOLOGY, V19, P1167, DOI 10.1007/s10646-010-0500-5; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; TETT P, 1975, LIMNOL OCEANOGR, V20, P887, DOI 10.4319/lo.1975.20.5.0887; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; Weirich CA, 2014, CURR PROB PEDIATR AD, V44, P2, DOI 10.1016/j.cppeds.2013.10.007; Welker M, 2003, ARCH HYDROBIOL, V157, P227, DOI 10.1127/0003-9136/2003/0157-0227; White A, 2010, LIBR J, V135, P101; WICKS RJ, 1990, ENVIRON SCI TECHNOL, V24, P1413, DOI 10.1021/es00079a017; Zhou L, 2002, BIOMED ENVIRON SCI, V15, P166; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	68	40	42	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125353	10.1371/journal.pone.0125353	http://dx.doi.org/10.1371/journal.pone.0125353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945933	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700061
J	Chang, CC; Jou, SH; Lin, TT; Lai, TJ; Liu, CS				Chang, Cheng-Chen; Jou, Shaw-Hwa; Lin, Ta-Tsung; Lai, Te-Jen; Liu, Chin-San			Mitochondria DNA Change and Oxidative Damage in Clinically Stable Patients with Major Depressive Disorder	PLOS ONE			English	Article							BIPOLAR DISORDER; COPY NUMBER; DYSFUNCTION; DELETION; STRESS; GENE; SCHIZOPHRENIA; EXPRESSION; TISSUES; BLOOD	Background To compare alterations of mitochondria DNA (mtDNA) copy number, single nucleotide polymorphisms (SNPs), and oxidative damage of mtDNA in clinically stable patients with major depressive disorder (MDD). Methods Patients met DSM-IV diagnostic criteria for MDD were recruited from the psychiatric outpatient clinic at Changhua Christian Hospital, Taiwan. They were clinically stable and their medications had not changed for at least the preceding two months. Exclusion criteria were substance-induced psychotic disorder, eating disorder, anxiety disorder or illicit substance abuse. Comparison subjects did not have any major psychiatric disorder and they were medically healthy. Peripheral blood leukocytes were analyzed to compare copy number, SNPs and oxidative damage of mtDNA between the two groups. Results 40 MDD patients and 70 comparison subjects were collected. The median age of the subjects was 42 years and 38 years in MDD and comparison groups, respectively. Leukocyte mtDNA copy number of MDD patients was significantly lower than that of the comparison group (p = 0.037). MDD patients had significantly higher mitochondrial oxidative damage than the comparison group (6.44 vs. 3.90, p < 0.001). After generalized linear model adjusted for age, sex, smoking, family history, and psychotropic use, mtDNA copy number was still significantly lower in the MDD group (p < 0.001). MtDNA oxidative damage was positively correlated with age (p < 0.001) and MDD (p < 0.001). Antipsychotic use was negatively associated with mtDNA copy number (p = 0.036). Limitations The study is cross-sectional with no longitudinal follow up. The cohort is clinically stable and generalizability of our result to other cohort should be considered. Conclusions Our study suggests that oxidative stress and mitochondria may play a role in the pathophysiology of MDD. More large-scale studies are warranted to assess the interplay between oxidative stress, mitochondria dysfunction and MDD.	[Chang, Cheng-Chen; Lai, Te-Jen] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan; [Chang, Cheng-Chen] Changhua Christian Hosp, Dept Psychiat, Changhua, Taiwan; [Jou, Shaw-Hwa] Taichung Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Psychiat, Taichung, Taiwan; [Jou, Shaw-Hwa] Buddhist Tzu Chi Univ, Dept Med, Hualien, Taiwan; [Jou, Shaw-Hwa] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Ta-Tsung; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Res Ctr, Changhua, Taiwan; [Liu, Chin-San] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Lai, Te-Jen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung 40201, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Tzu Chi University; National Chung Hsing University; Changhua Christian Hospital; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, TJ (corresponding author), Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.	tejenlai@hotmail.com; liu48111@gmail.com						Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Chang CC, 2014, PSYCHIAT CLIN NEUROS, V68, P551, DOI 10.1111/pcn.12163; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; GATTERMANN N, 1995, LEUKEMIA, V9, P1704; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096869; Hosnijeh FS, 2014, BLOOD, V124, P530, DOI 10.1182/blood-2013-10-532085; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kato T, 2000, AM J MED GENET, V96, P182, DOI 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.3.CO;2-H; Kim MY, 2011, ARCH GERONTOL GERIAT, V53, pE218, DOI 10.1016/j.archger.2010.11.019; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Leuner K, 2012, MOL NEUROBIOL, V46, P194, DOI 10.1007/s12035-012-8300-y; Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Madrigal JLM, 2001, NEUROPSYCHOPHARMACOL, V24, P420, DOI 10.1016/S0893-133X(00)00208-6; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Milaneschi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065406; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Rodrigues T, 2002, BRIT J PHARMACOL, V136, P136, DOI 10.1038/sj.bjp.0704672; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103; Shanske AL, 2001, ARCH PEDIAT ADOL MED, V155, P1210; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002	36	52	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125855	10.1371/journal.pone.0125855	http://dx.doi.org/10.1371/journal.pone.0125855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946463	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700094
J	Cottee-Jones, HEW; Matthews, TJ; Bregman, TP; Barua, M; Tamuly, J; Whittaker, RJ				Cottee-Jones, H. Eden W.; Matthews, Thomas J.; Bregman, Tom P.; Barua, Maan; Tamuly, Jatin; Whittaker, Robert J.			Are Protected Areas Required to Maintain Functional Diversity in Human-Modified Landscapes?	PLOS ONE			English	Article							RAIN-FOREST; CONTINENTAL RADIATION; BIRD ASSEMBLAGES; TREES; RICHNESS; BIODIVERSITY; COMPONENTS; ABUNDANCE; FICUS	The conversion of forest to agriculture across the world's tropics, and the limited space for protected areas, has increased the need to identify effective conservation strategies in human-modified landscapes. Isolated trees are believed to conserve elements of ecological structure, providing micro-sites for conservation in matrix landscapes, and facilitating seed dispersal and forest restoration. Here we investigate the role of isolated Ficus trees, which are of critical importance to tropical forest ecosystems, in conserving frugivore composition and function in a human-modified landscape in Assam, India. We surveyed the frugivorous birds feeding at 122 isolated Ficus trees, 33 fruit trees, and 31 other large trees across a range of 32 km from the nearest intact forest. We found that Ficus trees attracted richer and more abundant assemblages of frugivores than the other tree categories. However, incidence function estimates revealed that forest specialist species decreased dramatically within the first kilometre of the forest edge. Despite this, species richness and functional diversity remained consistent across the human-modified landscape, as habitat generalists replaced forest-dependent frugivores, and accounted for most of the ecological function found in Ficus trees near the forest edge. We recommend that isolated Ficus trees are awarded greater conservation status, and suggest that their conservation can support ecologically functional networks of frugivorous bird communities.	[Cottee-Jones, H. Eden W.; Matthews, Thomas J.; Barua, Maan; Whittaker, Robert J.] Univ Oxford, Ctr Environm, Sch Geog & Environm, Conservat Biogeog & Macroecol Grp, Oxford, England; [Matthews, Thomas J.] Univ Azores, Dept Ciencias Agr, CITA A, ABG, PT-9700042 Pico Da Urze, Angra Do Herois, Portugal; [Matthews, Thomas J.] Univ Azores, Dept Ciencias Agr, Portuguese Platform Enhancing Ecol Res & Sustaina, PT-9700042 Pico Da Urze, Angra Do Herois, Portugal; [Bregman, Tom P.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford, England; [Tamuly, Jatin] Wild Grass EcoLodge, Kaziranga, Assam, India; [Whittaker, Robert J.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, Copenhagen, Denmark	University of Oxford; Universidade dos Acores; Universidade dos Acores; University of Oxford; University of Copenhagen	Cottee-Jones, HEW (corresponding author), Univ Oxford, Ctr Environm, Sch Geog & Environm, Conservat Biogeog & Macroecol Grp, Oxford, England.	henry.cottee-jones@seh.ox.ac.uk	Whittaker, Robert J/H-1548-2015	Whittaker, Robert J/0000-0001-7775-3383; Matthews, Thomas/0000-0002-7624-244X	St Edmund Hall Writing-up Grant; University of Oxford Clarendon Fund award; EPA Cephalosporin Trust; Richard Stapley Trust; Sidney Perry Foundation; Rufford Small Grants fund	St Edmund Hall Writing-up Grant; University of Oxford Clarendon Fund award; EPA Cephalosporin Trust; Richard Stapley Trust; Sidney Perry Foundation; Rufford Small Grants fund	Funding was provided by a St Edmund Hall Writing-up Grant (awarded to HEWCJ), a University of Oxford Clarendon Fund award (MB), the EPA Cephalosporin Trust, Richard Stapley Trust, and the Sidney Perry Foundation (TJM). A portion of the data were collected with funds from the Rufford Small Grants fund (awarded to MB and JT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua M., 1999, Forktail, V15, P47; Barua M, 2011, CONSERVATION FIGS FR; Breitbach N, 2010, OECOLOGIA, V162, P965, DOI 10.1007/s00442-009-1547-y; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Caughlin TT, 2012, CURR SCI INDIA, V102, P918; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2010, PROGRAM USERS GUIDE; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Claramunt S, 2012, P ROY SOC B-BIOL SCI, V279, P1567, DOI 10.1098/rspb.2011.1922; CLARK GA, 1979, CONDOR, V81, P193, DOI 10.2307/1367288; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; del Hoyo J., 1992, P1; del Hoyo J., 2003, HDB BIRDS WORLD, V8; Derryberry EP, 2011, EVOLUTION, V65, P2973, DOI 10.1111/j.1558-5646.2011.01374.x; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards FA, 2013, IBIS, V155, P313, DOI 10.1111/ibi.12027; Eshiamwata GW, 2006, J TROP ECOL, V22, P723, DOI 10.1017/S0266467406003646; ESRI, 2011, ARCGIS DESKT REL 10; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gotelli NJ, 2000, ECOSIM NULL MODELS S; Grimmett R., 1998, BIRDS INDIAN SUBCONT, DOI DOI 10.3732/ajb.1000230; Guevara S, 2004, BIOTROPICA, V36, P99, DOI 10.1646/02111; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; INDIA POFMPIN, 2011, CENS IND 2011 PROV P; Kinnaird Margaret F., 1999, Tropical Biodiversity, V6, P5; Kinnaird MF, 1996, AUK, V113, P431, DOI 10.2307/4088909; Koenker R., 2013, QUANTREG QUANTILE RE; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Laliberte E, 2013, FD PACKAGE MEASURING; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; LAMBERT FR, 1991, J ECOL, V79, P793, DOI 10.2307/2260668; Luck GW, 2003, ECOL APPL, V13, P235, DOI 10.1890/1051-0761(2003)013[0235:TCBARC]2.0.CO;2; Manning AD, 2004, OIKOS, V104, P621, DOI 10.1111/j.0030-1299.2004.12813.x; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; Mawdsley NA, 1998, CONSERV BIOL, V12, P1416, DOI 10.1046/j.1523-1739.1998.97243.x; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Mendenhall CD, 2014, ECOLOGY, V95, P856, DOI 10.1890/12-2017.1; Miklos I, 2004, ECOLOGY, V85, P86, DOI 10.1890/03-0101; O'Brien TG, 1998, NATURE, V392, P668, DOI 10.1038/33580; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paradis E, 2014, PACKAGE APE ANAL PHY; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Core Team, 2021, R LANGUAGE ENV STAT; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Terborgh J., 1986, CONSERVATION BIOL SC, P330; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Vidal MM, 2013, BIOL CONSERV, V163, P42, DOI 10.1016/j.biocon.2013.03.025; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005	60	10	10	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123952	10.1371/journal.pone.0123952	http://dx.doi.org/10.1371/journal.pone.0123952			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946032	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700027
J	Downs, ME; Buch, A; Sierra, C; Karakatsani, ME; Chen, SS; Konofagou, EE; Ferrera, VP				Downs, Matthew E.; Buch, Amanda; Sierra, Carlos; Karakatsani, Maria Eleni; Chen, Shangshang; Konofagou, Elisa E.; Ferrera, Vincent P.			Long-Term Safety of Repeated Blood-Brain Barrier Opening via Focused Ultrasound with Microbubbles in Non-Human Primates Performing a Cognitive Task	PLOS ONE			English	Article							BASAL GANGLIA; MAGNETIC-RESONANCE; RAT-BRAIN; DELIVERY; CAUDATE; MRI; PERMEABILITY; DOPAMINE; ACCURACY; NUCLEUS	Focused Ultrasound (FUS) coupled with intravenous administration of microbubbles (MB) is a non-invasive technique that has been shown to reliably open (increase the permeability of) the blood-brain barrier (BBB) in multiple in vivo models including non-human primates (NHP). This procedure has shown promise for clinical and basic science applications, yet the safety and potential neurological effects of long term application in NHP requires further investigation under parameters shown to be efficacious in that species (500kHz, 200-400 kPa, 4-5 mu m MB, 2 minute sonication). In this study, we repeatedly opened the BBB in the caudate and putamen regions of the basal ganglia of 4 NHP using FUS with systemicallyadministered MB over 4-20 months. We assessed the safety of the FUS with MB procedure using MRI to detect edema or hemorrhaging in the brain. Contrast enhanced T1-weighted MRI sequences showed a 98% success rate for openings in the targeted regions. T2weighted and SWI sequences indicated a lack edema in the majority of the cases. We investigated potential neurological effects of the FUS with MB procedure through quantitative cognitive testing of' visual, cognitive, motivational, and motor function using a random dot motion task with reward magnitude bias presented on a touchpanel display. Reaction times during the task significantly increased on the day of the FUS with MB procedure. This increase returned to baseline within 4-5 days after the procedure. Visual motion discrimination thresholds were unaffected. Our results indicate FUS with MB can be a safe method for repeated opening of the BBB at the basal ganglia in NHP for up to 20 months without any long-term negative physiological or neurological effects with the parameters used.	[Downs, Matthew E.; Buch, Amanda; Sierra, Carlos; Karakatsani, Maria Eleni; Konofagou, Elisa E.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Konofagou, Elisa E.] Columbia Univ, Dept Radiol, New York, NY USA; [Chen, Shangshang; Ferrera, Vincent P.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; Columbia University	Downs, ME (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	med2173@columbia.edu		Downs, Matthew/0000-0001-6115-3156; Ferrera, Vincent/0000-0002-6599-7740; Teichert, Tobias/0000-0001-6500-9573	National Institute of Health [R01AG038961, R01EB009041]; Wallace H. Coulter Foundation; FUS Foundation; Kavli Foundation; Alfonso Martin Escuerdo Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038961] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wallace H. Coulter Foundation; FUS Foundation; Kavli Foundation; Alfonso Martin Escuerdo Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	EK received funding from the National Institute of Health R01AG038961 and R01EB009041; http://grants.nih.gov/grants/funding/r01.htm. EK received funding from the Wallace H. Coulter Foundation; http://www.whcf.org/. EK received funding from the FUS Foundation; http://www.fusfoundation.org/. EK received funding from the Kavli Foundation; http://www.kavlifoundation.org/. CS received funding from the Alfonso Martin Escuerdo Foundation; http://www.fundame.org/?lang = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Alam MI, 2010, EUR J PHARM SCI, V40, P385, DOI 10.1016/j.ejps.2010.05.003; Alonso A, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.64; Authier S, 2006, J AM ASSOC LAB ANIM, V45, P73; Baseri B, 2012, PHYS MED BIOL, V57, pN65, DOI 10.1088/0031-9155/57/7/N65; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; DRAGO F, 1986, PHARMACOL BIOCHEM BE, V24, P1185, DOI 10.1016/0091-3057(86)90168-1; Etame AB, 2012, NANOMED-NANOTECHNOL, V8, P1133, DOI 10.1016/j.nano.2012.02.003; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hom GJ, 1999, CONTEMP TOP LAB ANIM, V38, P60; Howles GP, 2010, MAGN RESON MED, V64, P995, DOI 10.1002/mrm.22411; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; Marquet F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084310; Maurer TS, 2005, DRUG METAB DISPOS, V33, P175, DOI 10.1124/dmd.104.001222; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; NYBERG P, 1983, NEUROCHEM PATH, V1, P193; Olumolade O, 2012, 3 INT S FOC ULTR BET; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pardridge WM, 2007, PHARM RES, V24, P1733, DOI 10.1007/s11095-007-9324-2; Pardridge William M, 2005, NeuroRx, V2, P3; Pratt PW, 1998, PRINCIPLES PRACTICE; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; Shen YC, 2005, J MOTOR BEHAV, V37, P3, DOI 10.3200/JMBR.37.1.3-9; SMITH AS, 1985, AM J ROENTGENOL, V145, P949, DOI 10.2214/ajr.145.5.949; Sun T, 2014, IEEE INT ULTR S CHIC; Tagliabue M, 2009, NEUROSCIENCE, V158, P1206, DOI 10.1016/j.neuroscience.2008.12.007; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Wenzlaff H, 2011, J NEUROSCI, V31, P1254, DOI 10.1523/JNEUROSCI.4000-10.2011; WHISHAW IQ, 1986, BRAIN, V109, P805, DOI 10.1093/brain/109.5.805; Wu SY, 2014, IEEE T ULTRASON FERR, V61, P966, DOI 10.1109/TUFFC.2014.2992; Xie F, 2008, ULTRASOUND MED BIOL, V34, P2028, DOI 10.1016/j.ultrasmedbio.2008.05.004	48	108	112	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125911	10.1371/journal.pone.0125911	http://dx.doi.org/10.1371/journal.pone.0125911			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945493	Green Submitted, gold, Green Published			2022-12-26	WOS:000354049700095
J	Sonego, M; Oberoi, M; Stoddart, J; Gajendra, S; Hendricusdottir, R; Oozeer, F; Worth, DC; Hobbs, C; Eickholt, BJ; Gordon-Weeks, PR; Doherty, P; Lalli, G				Sonego, Martina; Oberoi, Michelle; Stoddart, Jake; Gajendra, Sangeetha; Hendricusdottir, Rita; Oozeer, Fazal; Worth, Daniel C.; Hobbs, Carl; Eickholt, Britta J.; Gordon-Weeks, Phillip R.; Doherty, Patrick; Lalli, Giovanna			Drebrin Regulates Neuroblast Migration in the Postnatal Mammalian Brain	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; ZONE-DERIVED NEUROBLASTS; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; F-ACTIN; ADULT NEUROGENESIS; BUNDLING ACTIVITY; DENDRITIC SPINES; CELL MOTILITY; EXPRESSION	After birth, stem cells in the subventricular zone (SVZ) generate neuroblasts that migrate along the rostral migratory stream (RMS) to become interneurons in the olfactory bulb (OB). This migration is crucial for the proper integration of newborn neurons in a pre-existing synaptic network and is believed to play a key role in infant human brain development. Many regulators of neuroblast migration have been identified; however, still very little is known about the intracellular molecular mechanisms controlling this process. Here, we have investigated the function of drebrin, an actin-binding protein highly expressed in the RMS of the postnatal mammalian brain. Neuroblast migration was monitored both in culture and in brain slices obtained from electroporated mice by time-lapse spinning disk confocal microscopy. Depletion of drebrin using distinct RNAi approaches in early postnatal mice affects neuroblast morphology and impairs neuroblast migration and orientation in vitro and in vivo. Overexpression of drebrin also impairs migration along the RMS and affects the distribution of neuroblasts at their final destination, the OB. Drebrin phosphorylation on Ser142 by Cyclin-dependent kinase 5 (Cdk5) has been recently shown to regulate F-actin-microtubule coupling in neuronal growth cones. We also investigated the functional significance of this phosphorylation in RMS neuroblasts using in vivo postnatal electroporation of phosphomimetic (S142D) or non-phosphorylatable (S142A) drebrin in the SVZ of mouse pups. Preventing or mimicking phosphorylation of S142 in vivo caused similar effects on neuroblast dynamics, leading to aberrant neuroblast branching. We conclude that drebrin is necessary for efficient migration of SVZ-derived neuroblasts and propose that regulated phosphorylation of drebrin on S142 maintains leading process stability for polarized migration along the RMS, thus ensuring proper neurogenesis.	[Sonego, Martina; Stoddart, Jake; Hobbs, Carl; Doherty, Patrick; Lalli, Giovanna] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Oberoi, Michelle] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Gajendra, Sangeetha; Hendricusdottir, Rita; Oozeer, Fazal; Worth, Daniel C.; Gordon-Weeks, Phillip R.] Kings Coll London, MRC, Ctr Dev Neurobiol, London, England; [Eickholt, Britta J.] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Eickholt, Britta J.] Charite, Inst Biochem, D-13353 Berlin, Germany	University of London; King's College London; University of California System; University of California Irvine; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lalli, G (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	giovanna.lalli@kcl.ac.uk	Gordon-Weeks, Phillip R./C-5328-2009; Doherty, Patrick/A-8752-2008	Gordon-Weeks, Phillip R./0000-0002-4738-4246; Doherty, Patrick/0000-0002-0407-5689; Oozeer, Fazal/0000-0002-8106-588X; Oberoi, Michelle/0000-0003-0993-489X; Eickholt, Britta/0000-0001-7873-8687	King's College PhD studentship; Minority Health and Health Disparities International Research Training (MHIRT) Program; NIH [MD-01485]; British Society for Cell Biology (BSCB) studentship; CASE BBSRC PhD studentship [D527118/1]; Age UK PhD studentship; Wellcome Trust [0892326/Z/09/Z]; BBSRC; MRC; Biotechnology and Biological Sciences Research Council [BB/H010963/1] Funding Source: researchfish; BBSRC [BB/H010963/1] Funding Source: UKRI; National Institute on Minority Health and Health Disparities [T37MD001485] Funding Source: NIH RePORTER	King's College PhD studentship; Minority Health and Health Disparities International Research Training (MHIRT) Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Society for Cell Biology (BSCB) studentship; CASE BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Age UK PhD studentship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	M.S. was supported by a King's College PhD studentship, M.O. by a Minority Health and Health Disparities International Research Training (MHIRT) Program, NIH Grant MD-01485, J.S. by a British Society for Cell Biology (BSCB) studentship, S.G. by a CASE BBSRC PhD studentship awarded to P.D. (D527118/1), R.H. by an Age UK PhD studentship awarded to B.J.E. This work was supported by the Wellcome Trust (G.L. and P.D., 0892326/Z/09/Z). P.G-W. is supported by BBSRC and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Bron R, 2004, DEV DYNAM, V230, P299, DOI 10.1002/dvdy.20043; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Chew CS, 2005, AM J PHYSIOL-GASTR L, V289, pG320, DOI 10.1152/ajpgi.00002.2005; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Curtis MA, 2007, CLIN EXP PHARMACOL P, V34, P528, DOI 10.1111/j.1440-1681.2007.04609.x; Das A, 2014, J CELL SCI, V127, P686, DOI 10.1242/jcs.145037; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Dun XP, 2012, MOL CELL NEUROSCI, V49, P341, DOI 10.1016/j.mcn.2012.01.006; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Falenta K, 2013, JOVE-J VIS EXP, DOI 10.3791/50989; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Hirota Y, 2007, J NEUROSCI, V27, P12829, DOI 10.1523/JNEUROSCI.1014-07.2007; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Keon BH, 2000, J CELL SCI, V113, P325; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; KOJIMA N, 1988, MOL BRAIN RES, V4, P207, DOI 10.1016/0169-328X(88)90027-7; Lalli G, 2014, ADV EXP MED BIOL, V800, P149, DOI 10.1007/978-94-007-7687-6_9; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mercer JC, 2010, INT J BIOCHEM CELL B, V42, P337, DOI 10.1016/j.biocel.2009.11.019; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Peitsch WK, 2006, EXP CELL RES, V312, P2605, DOI 10.1016/j.yexcr.2006.04.017; Peitsch WK, 2005, J INVEST DERMATOL, V125, P761, DOI 10.1111/j.0022-202X.2005.23793.x; Peitsch WK, 1999, EUR J CELL BIOL, V78, P767, DOI 10.1016/S0171-9335(99)80027-2; Rehm K, 2013, J CELL SCI, V126, P3756, DOI 10.1242/jcs.129437; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; SHIRAO T, 1988, MOL BRAIN RES, V4, P71, DOI 10.1016/0169-328X(88)90020-4; Shirao T, 1990, Neurosci Res Suppl, V13, pS106, DOI 10.1016/0921-8696(90)90039-6; SHIRAO T, 1994, EXP CELL RES, V215, P145, DOI 10.1006/excr.1994.1326; Sonego M, 2013, JOVE-J VIS EXP, DOI 10.3791/50905; Sonego M, 2013, J NEUROSCI, V33, P12171, DOI 10.1523/JNEUROSCI.0653-13.2013; Song M, 2008, NEUROSCIENCE, V152, P670, DOI 10.1016/j.neuroscience.2007.10.068; Tanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092291; Terakawa Y, 2013, EXP CELL RES, V319, P517, DOI 10.1016/j.yexcr.2012.11.008; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	56	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126478	10.1371/journal.pone.0126478	http://dx.doi.org/10.1371/journal.pone.0126478			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945928	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700133
J	Dalsgaard, EM; Skriver, MV; Sandbaek, A; Vestergaard, M				Dalsgaard, Else-Marie; Skriver, Mette V.; Sandbaek, Annelli; Vestergaard, Mogens			Socioeconomic Position, Type 2 Diabetes and Long-Term Risk of Death	PLOS ONE			English	Article							EDUCATIONAL-LEVEL; FOLLOW-UP; MORTALITY; PEOPLE; REGISTER; HEALTH; MELLITUS; EPIDEMIOLOGY; INEQUALITIES; DEPRIVATION	Background Both socioeconomic position (SEP) and type 2 diabetes have previously been found to be associated with mortality; however, little is known about the association between SEP, type 2 diabetes and long-term mortality when comorbidity is taken into account. Methods We conducted a population-based cohort study of all Danish citizens aged 40-69 years with no history of diabetes during 2001-2006 (N= 2,330,206). The cohort was identified using nationwide registers, and it was followed for up to 11 years (mean follow-up was 9.5 years (SD:2.6)). We estimated the age-standardised mortality rate (MR) and performed Poisson regression to estimate the mortality-rate-ratio (MRR) by educational level, income and cohabiting status among people with and without type 2 diabetes. Results We followed 2,330,206 people for 22,971,026 person-years at risk and identified 139,681 individuals with type 2 diabetes. In total, 195,661 people died during the study period; 19,959 of these had type 2 diabetes. The age-standardised MR increased with decreasing SEP both for people with and without diabetes. Type 2 diabetes and SEP both had a strong impact on the overall mortality; the combined effect of type 2 diabetes and SEP on mortality was additive rather than multiplicative. Compared to women without diabetes and in the highest income quintile, the MRR's were 2.8 (95% CI 2.6, 3.0) higher for women with type 2 diabetes in the lowest income quintile, while diabetes alone increased the risk of mortality 2.0 (95% CI 1.9, 2.2) times and being in the lowest income quintile without diabetes 1.8 (95% CI 1.7,1.9) times after adjusting for comorbidity. For men, the MRR's were 2.7 (95%-CI 2.5,2.9), 1.9 (95% CI 1.8,2.0) and 1.8 (95% CI 1.8,1.9), respectively. Conclusion Both Type 2 diabetes and SEP were associated with the overall mortality. The relation between type 2 diabetes, SEP, and all-cause mortality was only partly explained by comorbidity.	[Dalsgaard, Else-Marie; Sandbaek, Annelli] Aarhus Univ, Sect Gen Practice, Dept Publ Hlth, DK-8000 Aarhus C, Denmark; [Skriver, Mette V.] Aarhus Univ, Dept Publ Hlth, Sect Hlth Promot & Hlth Serv, DK-8000 Aarhus C, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, DK-8000 Aarhus C, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Dalsgaard, EM (corresponding author), Aarhus Univ, Sect Gen Practice, Dept Publ Hlth, DK-8000 Aarhus C, Denmark.	emdl@ph.au.dk	Vestergaard, Mogens/M-9333-2014	Vestergaard, Mogens/0000-0001-8830-2174; Skriver, Mette/0000-0002-7017-8221; Dalsgaard, Else-Marie/0000-0003-2115-7480	Danish Council for Strategic Research; Lundbeck Foundation; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Council for Strategic Research. MV is supported by an unrestricted grant from the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], WHAT AR EQ SCAL ADJ; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P175, DOI 10.1177/1403494811404279; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dalsgaard EM, 2014, PRIM CARE DIABETES, V8, P322, DOI 10.1016/j.pcd.2014.01.006; Dray-Spira R, 2010, DIABETES CARE, V33, P1200, DOI 10.2337/dc09-2094; Espelt A, 2008, DIABETOLOGIA, V51, P1971, DOI 10.1007/s00125-008-1146-1; Espelt A, 2013, GAC SANIT, V27, P494, DOI 10.1016/j.gaceta.2013.03.002; Forssas E, 2012, EUR J PUBLIC HEALTH, V22, P305, DOI 10.1093/eurpub/ckr044; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Gnavi R, 2011, DIABETES RES CLIN PR, V92, P205, DOI 10.1016/j.diabres.2011.02.011; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Koskinen SVP, 1996, BRIT MED J, V313, P975, DOI 10.1136/bmj.313.7063.975; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nilsson PM, 1998, DIABETIC MED, V15, P213, DOI 10.1002/(SICI)1096-9136(199803)15:3<213::AID-DIA569>3.3.CO;2-R; O'Kane MJ, 2010, PRIM CARE DIABETES, V4, P241, DOI 10.1016/j.pcd.2010.08.004; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; ROBINSON N, 1984, DIABETES METAB, V10, P245; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Saydah SH, 2013, DIABETES CARE, V36, P49, DOI 10.2337/dc11-1864; Statistics Denmark, 1991, IDA INT DAT ARB HOV; UNESCO, 2011, INT STANDARD CLASSIF, DOI 10.15220/978-92-9189-123-8-en; VanderWeele T. J., 2014, EPIDEMIOLOGIC METHOD, V3, DOI [10.1515/em-2013-0005, DOI 10.1515/EM-2013-0005]; Walker JJ, 2011, DIABETES CARE, V34, P1127, DOI 10.2337/dc10-1862; Wild S, 2008, DIABETIC MED, V25, P194, DOI 10.1111/j.1464-5491.2008.02382.x	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124829	10.1371/journal.pone.0124829	http://dx.doi.org/10.1371/journal.pone.0124829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942435	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400022
J	Gong, YM; Liu, J; Jiang, ML; Liang, Z; Jin, H; Hu, XJ; Wan, X; Hu, CJ				Gong, Yangmin; Liu, Jiao; Jiang, Mulan; Liang, Zhuo; Jin, Hu; Hu, Xiaojia; Wan, Xia; Hu, Chuanjiong			Improvement of Omega-3 Docosahexaenoic Acid Production by Marine Dinoflagellate Crypthecodinium cohnii Using Rapeseed Meal Hydrolysate and Waste Molasses as Feedstock	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; CANOLA-MEAL; XYLANASE PRODUCTION; BEET MOLASSES; PHYTIC ACID; BIODIESEL; MICROALGAE; SUBSTRATE; NITROGEN; STRAIN	Rapeseed meal and waste molasses are two important agro-industrial by-products which are produced in large quantities. In this study, solid state fermentation and fungal autolysis were performed to produce rapeseed meal hydrolysate (RMH) using fungal strains of Aspergillus oryzae, Penicillium oxalicum and Neurospora crassa. The hydrolysate was used as fermentation feedstock for heterotrophic growth of microalga Crypthecodinium cohnii that produce docosahexaenoic acid (DHA). The addition of waste molasses as a supplementary carbon source greatly increased the biomass and DHA yield. In the batch fermentations using media composed of diluted RMH (7%) and 1-9% waste molasses, the highest biomass concentration and DHA yield reached 3.43 g/L and 8.72 mg/L, respectively. The algal biomass produced from RMH and molasses medium also had a high percentage of DHA (22-34%) in total fatty acids similar to that of commercial algal biomass. RMH was shown to be rich in nitrogen supply comparable to the commercial nitrogen feedstock like yeast extract. Using RMH as sole nitrogen source, waste molasses excelled other carbon sources and produced the highest concentration of biomass. This study suggests that DHA production of the marine dinoflagellate C. cohnii could be greatly improved by concomitantly using the cheap by-products rapeseed meal hydrolysate and molasses as alternative feedstock.	[Gong, Yangmin; Liu, Jiao; Jiang, Mulan; Liang, Zhuo; Hu, Xiaojia; Wan, Xia; Hu, Chuanjiong] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China; [Jin, Hu] Chinese Acad Agr Sci, Oil Crops Res Inst, Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Wan, X (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China.	wanxia@oilcrops.cn; cjhu@oilcrops.cn			National Hi-Tech Program of China [2011AA100904]; Oil Crops Research Institute [1610172013005]	National Hi-Tech Program of China; Oil Crops Research Institute	Support was provided by: the National Hi-Tech Program of China Grant (2011AA100904) to YG; the Director Fund of Oil Crops Research Institute (1610172013005) to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Athalye SK, 2009, J AGR FOOD CHEM, V57, P2739, DOI 10.1021/jf803922w; Bozbas K, 2008, RENEW SUST ENERG REV, V12, P542, DOI 10.1016/j.rser.2005.06.001; Chen KQ, 2011, ENZYME MICROB TECH, V48, P339, DOI 10.1016/j.enzmictec.2010.12.009; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Damude HG, 2008, PLANT PHYSIOL, V147, P962, DOI 10.1104/pp.108.121681; de Swaaf ME, 2001, APPL MICROBIOL BIOT, V57, P395; Ebune A, 1995, BIORESOURCE TECHNOL, V54, P241, DOI 10.1016/0960-8524(95)00133-6; EVANS CT, 1984, J GEN MICROBIOL, V130, P1705; Fakas S, 2008, BIORESOURCE TECHNOL, V99, P5986, DOI 10.1016/j.biortech.2007.10.016; Gao CF, 2010, APPL ENERG, V87, P756, DOI 10.1016/j.apenergy.2009.09.006; GATTINGER LD, 1990, APPL MICROBIOL BIOT, V33, P21, DOI 10.1007/BF00170563; Gong YM, 2014, PROG LIPID RES, V56, P19, DOI 10.1016/j.plipres.2014.07.001; Gong YM, 2013, J BASIC MICROB, V53, P29, DOI 10.1002/jobm.201100487; Graham IA, 2007, CURR OPIN BIOTECH, V18, P142, DOI 10.1016/j.copbio.2007.01.014; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; Gupta Adarsha, 2012, Biotechnol Adv, V30, P1733, DOI 10.1016/j.biotechadv.2012.02.014; HARLAND BF, 1980, CEREAL CHEM, V57, P226; He JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103931; Hristov AN, 2011, J DAIRY SCI, V94, P4057, DOI 10.3168/jds.2011-4283; Ikram-ul-Haq, 2003, BIORESOURCE TECHNOL, V87, P57, DOI 10.1016/S0960-8524(02)00198-0; Index Mundi, 2014, COMM; Jacobs A, 2010, BIORESOURCES, V5, P1232; Kiran EU, 2012, ENZYME MICROB TECH, V50, P337, DOI 10.1016/j.enzmictec.2012.03.004; Kota KP, 1999, PROCESS BIOCHEM, V34, P325; Kotzamanidis C, 2002, WORLD J MICROB BIOT, V18, P441, DOI 10.1023/A:1015523126741; Lacki K, 1999, BIOTECHNOL BIOENG, V62, P422, DOI 10.1002/(SICI)1097-0290(19990220)62:4<422::AID-BIT5>3.0.CO;2-N; LIE S, 1973, J I BREWING, V79, P37, DOI 10.1002/j.2050-0416.1973.tb03495.x; Litchman E, 2009, P NATL ACAD SCI USA, V106, P2665, DOI 10.1073/pnas.0810891106; Liu J, 2012, BIORESOURCE TECHNOL, V107, P393, DOI 10.1016/j.biortech.2011.12.047; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Lu Y, 2010, J APPL PHYCOL, V22, P573, DOI 10.1007/s10811-009-9496-8; Martins DA, 2013, MAR DRUGS, V11, P2259, DOI 10.3390/md11072259; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Najafpour GD, 2003, BIORESOURCE TECHNOL, V86, P91, DOI 10.1016/S0960-8524(02)00103-7; Pustjens AM, 2012, J AGR FOOD CHEM, V60, P8257, DOI 10.1021/jf301160m; Rajoka MI, 2005, WORLD J MICROB BIOT, V21, P869, DOI 10.1007/s11274-004-6030-7; Roukas T, 1998, PROCESS BIOCHEM, V33, P805, DOI 10.1016/S0032-9592(98)00048-X; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Sarada I, 1998, PROCESS BIOCHEM, V33, P317, DOI 10.1016/S0032-9592(97)00086-1; Sircar A, 1998, PROCESS BIOCHEM, V33, P283, DOI 10.1016/S0032-9592(97)00058-7; Somashekar D, 2003, PROCESS BIOCHEM, V38, P1719, DOI 10.1016/S0032-9592(02)00258-3; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; THOMAS KC, 1980, J BACTERIOL, V141, P10, DOI 10.1128/JB.141.1.10-19.1980; Vig AP, 2001, BIORESOURCE TECHNOL, V78, P309, DOI 10.1016/S0960-8524(01)00030-X; Wang JL, 2000, BIORESOURCE TECHNOL, V75, P231, DOI 10.1016/S0960-8524(00)00067-5; Wang RH, 2010, ENZYME MICROB TECH, V47, P77, DOI 10.1016/j.enzmictec.2010.05.005; WILLISON JHM, 1985, CAN J MICROBIOL, V31, P109, DOI 10.1139/m85-022; Yan D, 2011, BIORESOURCE TECHNOL, V102, P6487, DOI 10.1016/j.biortech.2011.03.036; Yao DH, 2012, WORLD J MICROB BIOT, V28, P985, DOI 10.1007/s11274-011-0896-y; YEOMAN KH, 1994, J APPL BACTERIOL, V77, P264, DOI 10.1111/j.1365-2672.1994.tb03073.x; Zuchowski J, 2013, APPL BIOCHEM BIOTECH, V171, P2075, DOI 10.1007/s12010-013-0506-6	52	17	21	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125368	10.1371/journal.pone.0125368	http://dx.doi.org/10.1371/journal.pone.0125368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942565	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943400033
J	Ohta, N; Ishiguro, S; Kawabata, A; Uppalapati, D; Pyle, M; Troyer, D; De, S; Zhang, YQ; Becker, KG; Tamura, M				Ohta, Naomi; Ishiguro, Susumu; Kawabata, Atsushi; Uppalapati, Deepthi; Pyle, Marla; Troyer, Deryl; De, Supriyo; Zhang, Yongqing; Becker, Kevin G.; Tamura, Masaaki			Human Umbilical Cord Matrix Mesenchymal Stem Cells Suppress the Growth of Breast Cancer by Expression of Tumor Suppressor Genes	PLOS ONE			English	Article							LUNG ADENOCARCINOMA; IN-VITRO; METASTASIS; SURVIVAL; MICE; TRANSPLANTATION; PROLIFERATION; TUMORIGENESIS; SERPINE2; THERAPY	Human and rat umbilical cord matrix mesenchymal stem cells (UCMSC) possess the ability to control the growth of breast carcinoma cells. Comparative analyses of two types of UCMSC suggest that rat UCMSC-dependent growth regulation is significantly stronger than that of human UCMSC. Their different tumoricidal abilities were clarified by analyzing gene expression profiles in the two types of UCMSC. Microarray analysis revealed differential gene expression between untreated naive UCMSC and those co-cultured with species-matched breast carcinoma cells. The analyses screened 17 differentially expressed genes that are commonly detected in both human and rat UCMSC. The comparison between the two sets of gene expression profiles identified two tumor suppressor genes, adipose-differentiation related protein (ADRP) and follistatin (FST), that were specifically up-regulated in rat UCMSC, but down-regulated in human UCMSC when they were co-cultured with the corresponding species' breast carcinoma cells. Over-expression of FST, but not ADRP, in human UCMSC enhanced their ability to suppress the growth of MDA-231 cells. The growth of MDA-231 cells was also significantly lower when they were cultured in medium conditioned with FST, but not ADRP over-expressing human UCMSC. In the breast carcinoma lung metastasis model generated with MDA-231 cells, systemic treatment with FST-over-expressing human UCMSC significantly attenuated the tumor burden. These results suggest that FST may play an important role in exhibiting stronger tumoricidal ability in rat UCMSC than human UCMSC and also implies that human UCMSC can be transformed into stronger tumoricidal cells by enhancing tumor suppressor gene expression.	[Ohta, Naomi; Ishiguro, Susumu; Kawabata, Atsushi; Uppalapati, Deepthi; Pyle, Marla; Troyer, Deryl; Tamura, Masaaki] Kansas State Univ, Dept Anat & Physiol, Coll Vet Med, Manhattan, KS 66506 USA; [De, Supriyo; Zhang, Yongqing; Becker, Kevin G.] NIA, Gene Express & Genom Unit, NIH Biomed Res Ctr, NIH, Baltimore, MD 21224 USA	Kansas State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tamura, M (corresponding author), Kansas State Univ, Dept Anat & Physiol, Coll Vet Med, Manhattan, KS 66506 USA.	mtamura@vet.ksu.edu	De, Supriyo/Y-2492-2019	De, Supriyo/0000-0002-2075-7655; Ohta, Naomi/0000-0001-5790-3137; Ishiguro, Susumu/0000-0002-3268-7754; Tamura, Masaaki/0000-0003-4863-3379	Intramural Research Program of the National Institutes of Health, National Institute on Aging; Kansas State University Johnson Cancer Research Center; National Institutes of Health [P20 RR017686, P20 RR015563, P20 GM103418]; Kansas State University Targeted Excellence Research Grant; Kansas State Legislature; Kansas State University College of Veterinary Medicine Dean's Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686, P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kansas State University Johnson Cancer Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University Targeted Excellence Research Grant; Kansas State Legislature; Kansas State University College of Veterinary Medicine Dean's Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging, Kansas State University Johnson Cancer Research Center, Kansas State University College of Veterinary Medicine Dean's Fund, National Institutes of Health P20 RR017686, P20 RR015563, P20 GM103418, Kansas State University Targeted Excellence Research Grant, and the Kansas State Legislature. MT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger B, 2013, ONCOTARGET, V4, P378, DOI 10.18632/oncotarget.937; Ayuzawa R, 2009, CANCER LETT, V280, P31, DOI 10.1016/j.canlet.2009.02.011; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chao KC, 2012, J CELL MOL MED, V16, P1803, DOI 10.1111/j.1582-4934.2011.01459.x; Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Doi C, 2010, CYTOTHERAPY, V12, P408, DOI 10.3109/14653240903548194; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Ganta C, 2009, CANCER RES, V69, P1815, DOI 10.1158/0008-5472.CAN-08-2750; Ghorbel MT, 2005, PHYSIOL GENOMICS, V22, P93, DOI 10.1152/physiolgenomics.00202.2004; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Ji WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023274; Kawabata A, 2013, CYTOTHERAPY, V15, P586, DOI 10.1016/j.jcyt.2013.01.006; Kretschmer C, 2011, CELL ONCOL, V34, P419, DOI 10.1007/s13402-011-0023-y; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Matsuzuka T, 2010, LUNG CANCER, V70, P28, DOI 10.1016/j.lungcan.2010.01.003; Mauel S, 2007, APMIS, V115, P687, DOI 10.1111/j.1600-0463.2007.apm_453.x; Maurya DK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-590; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Pickel L, 2010, CANCER BIOL THER, V9, P277, DOI 10.4161/cbt.9.4.10643; Rachakatla RS, 2007, CANCER GENE THER, V14, P828, DOI 10.1038/sj.cgt.7701077; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Seshareddy K, 2008, METHOD CELL BIOL, V86, P101, DOI 10.1016/S0091-679X(08)00006-X; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; Venkatesan JK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt113; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Wu GJ, 2007, CANCER RES, V67, P4123, DOI 10.1158/0008-5472.CAN-07-0012; Yao M, 2007, CLIN CANCER RES, V13, P152, DOI 10.1158/1078-0432.CCR-06-1877; Ying SY, 1996, BREAST CANCER RES TR, V37, P151, DOI 10.1007/BF01806496	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0123756	10.1371/journal.pone.0123756	http://dx.doi.org/10.1371/journal.pone.0123756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942583	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400007
J	Chen, XN; Li, J; Zeng, L; Zhang, XB; Lu, XH; Zuo, MX; Zhang, XW; Zeng, SJ				Chen, XiaoNing; Li, Jia; Zeng, Lei; Zhang, XueBo; Lu, XiaoHua; Zuo, MingXue; Zhang, XinWen; Zeng, ShaoJu			Sexual Differences in Cell Loss during the Post-Hatch Development of Song Control Nuclei in the Bengalese Finch	PLOS ONE			English	Article							VOCAL CONTROL NEURONS; FEMALE ZEBRA FINCHES; NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; CYTOCHROME-C; IN-SITU; POSTNATAL-DEVELOPMENT; DNA FRAGMENTATION; FOREBRAIN NUCLEUS; BCL-2 FAMILY	Birdsongs and the regions of their brain that control song exhibit obvious sexual differences. However, the mechanisms underlying these sexual dimorphisms remain unknown. To address this issue, we first examined apoptotic cells labeled with caspase-3 or TUNEL in Bengalese finch song control nuclei - the robust nucleus of the archopallium (RA), the lateral magnocellular nucleus of the anterior nidopallium (LMAN), the high vocal center (HVC) and Area X from post-hatch day (P) 15 to 120. Next, we investigated the expression dynamics of pro-apoptotic (Bid, Bad and Bax) and anti-apoptotic (Bcl-2 and Bcl-xL) genes in the aforementioned nuclei. Our results revealed that the female RA at P45 exhibited marked cell apoptosis, confirmed by low densities of Bcl-xL and Bcl-2. Both the male and female LMAN exhibited apoptotic peaks at P35 and P45, respectively, and the observed cell loss was more extensive in males. A corresponding sharp decrease in the density of Bcl-2 after P35 was observed in both sexes, and a greater density of Bid was noted at P45 in males. In addition, we observed that RA volume and the total number of BDNF-expressing cells decreased significantly after unilateral lesion of the LMAN or HVC (two areas that innervate the RA) and that greater numbers of RA-projecting cells were immunoreactive for BDNF in the LMAN than in the HVC. We reasoned that a decrease in the amount of BDNF transported via HVC afferent fibers might result in an increase in cell apoptosis in the female RA. Our data indicate that cell apoptosis resulting from different pro-and anti-apoptotic agents is involved in generating the differences between male and female song control nuclei.	[Chen, XiaoNing; Li, Jia; Zeng, Lei; Zhang, XueBo; Lu, XiaoHua; Zuo, MingXue; Zeng, ShaoJu] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zhang, XueBo; Zhang, XinWen] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China	Beijing Normal University; Hainan Normal University	Zhang, XW (corresponding author), Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China.	zhangxw2844@sina.com; sjzeng@bnu.edu.cn			National Natural Science Foundation of China [31172082, 31372200, 31160205, 31360517, 31360243, 37212310]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China to SJ Zeng (No: 31172082 and 31372200), XW Zhang (No: 31160205 and 31360517), XB Zhang (No: 31360243), and MX Zuo (No: 37212310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; Alvarez-Borda B, 2004, P NATL ACAD SCI USA, V101, P3957, DOI 10.1073/pnas.0308118101; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; BOTTJER SW, 1989, J NEUROBIOL, V20, P609, DOI 10.1002/neu.480200702; BOTTJER SW, 1986, NEUROSCI LETT, V67, P263, DOI 10.1016/0304-3940(86)90319-8; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; BUREK MJ, 1995, DEV BRAIN RES, V85, P220, DOI 10.1016/0165-3806(94)00215-L; BUREK MJ, 1994, DEV BRAIN RES, V78, P57, DOI 10.1016/0165-3806(94)90009-4; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097403; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gibbons A, 2005, INT J DEV NEUROSCI, V23, P389, DOI 10.1016/j.ijdevneu.2004.10.003; GILLARDON F, 1995, J NEUROSCI RES, V41, P708, DOI 10.1002/jnr.490410517; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hou JL, 2011, CURR NEUROVASC RES, V8, P220, DOI 10.2174/156720211796558069; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jeon BS, 1999, J NEUROCHEM, V73, P322, DOI 10.1046/j.1471-4159.1999.0730322.x; Johnson F, 1997, J NEUROSCI, V17, P2101; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KIRN JR, 1989, J NEUROSCI, V9, P3176; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koh PO, 2011, NEUROSCI LETT, V498, P105, DOI 10.1016/j.neulet.2011.05.003; KONISHI M, 1990, P NATL ACAD SCI USA, V87, P3538, DOI 10.1073/pnas.87.9.3538; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Kraupp BG, 1995, HEPATOLOGY, V21, P1465, DOI DOI 10.1002/HEP.1840210534; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; MARTINOU JC, 1994, J PHYSIOLOGY-PARIS, V88, P209, DOI 10.1016/0928-4257(94)90007-8; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Negoescu A, 1998, BIOMED PHARMACOTHER, V52, P252, DOI 10.1016/S0753-3322(98)80010-3; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Oomman S, 2004, J COMP NEUROL, V476, P154, DOI 10.1002/cne.20223; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Raemy E, 2014, CHEM PHYS LIPIDS, V179, P70, DOI 10.1016/j.chemphyslip.2013.12.002; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Srinivasan A, 1996, J NEUROSCI, V16, P5654; Tobari Y, 2005, ZOOL SCI, V22, P1089, DOI 10.2108/zsj.22.1089; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Vekrellis K, 1997, DEVELOPMENT, V124, P1239; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zeng S, 2001, J NEUROANAT, V17, P166; Zeng SJ, 2007, NEUROSCI RES, V58, P207, DOI 10.1016/j.neures.2007.02.001; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhu N, 2008, BRAIN RES BULL, V76, P551, DOI 10.1016/j.brainresbull.2008.04.011	66	0	0	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125802	10.1371/journal.pone.0125802	http://dx.doi.org/10.1371/journal.pone.0125802			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938674	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000101
J	Coleman, DT; Soung, YH; Surh, YJ; Cardelli, JA; Chung, J				Coleman, David T.; Soung, Young Hwa; Surh, Young-Joon; Cardelli, James A.; Chung, Jun			Curcumin Prevents Palmitoylation of Integrin beta 4 in Breast Cancer Cells	PLOS ONE			English	Article							PROTEIN PALMITOYLATION; S-ACYLTRANSFERASES; PHOSPHORYLATION; ALPHA-6-BETA-4; TETRAHYDROCURCUMIN; HEMIDESMOSOMES; MOBILIZATION; PROGRESSION; MECHANISM; INVASION	Curcumin has been shown to mitigate cancer phenotypes such as invasive migration, proliferation, and survival by disrupting numerous signaling pathways. Our previous studies showed that curcumin inhibits integrin beta 4 (ITG beta 4)-dependent migration by blocking interaction of this integrin with growth factor receptors in lipid rafts. In the current study, we investigated the possibility that curcumin inhibits ITG beta 4 palmitoylation, a post-translational modification required for its lipid raft localization and signaling activity. We found that the levels of ITG beta 4 palmitoylation correlated with the invasive potential of breast cancer cells, and that curcumin effectively reduced the levels of ITG beta 4 palmitoylation in invasive breast cancer cells. Through studies of ITG beta 4 palmitoylation kinetics, we concluded curcumin suppressed palmitoylation independent of growth factor-induced phosphorylation of key ITG beta 4 Ser and Tyr residues. Rather, curcumin blocked autoacylation of the palmitoyl acyltransferase DHHC3 that is responsible for ITG beta 4 palmitoylation. Moreover, these data reveal that curcumin is able to prevent the palmitoylation of a subset of proteins, but not indiscriminately bind to and block all cysteines from modifications. Our studies reveal a novel paradigm for curcumin to account for much of its biological activity, and specifically, how it is able to suppress the signaling function of ITG beta 4 in breast cancer cells.	[Soung, Young Hwa; Chung, Jun] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Soung, Young Hwa; Chung, Jun] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA; [Coleman, David T.; Soung, Young Hwa; Cardelli, James A.; Chung, Jun] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, Shreveport, LA 71105 USA; [Coleman, David T.; Soung, Young Hwa; Cardelli, James A.; Chung, Jun] Louisiana State Univ, Hlth Sci Ctr, FeistWeiller Canc Ctr, Shreveport, LA 71105 USA; [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Seoul National University (SNU)	Chung, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.	Jun-Chung@ouhsc.edu			American Cancer Society [RSG-09-091-01-CSM]; National Institutes of Health-National Cancer Institute [R01CA163657-01A1]; NATIONAL CANCER INSTITUTE [R01CA163657] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by American Cancer Society (RSG-09-091-01-CSM: JC) and National Institutes of Health-National Cancer Institute (R01CA163657-01A1: JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Fuchs JR, 2009, BIOORG MED CHEM LETT, V19, P2065, DOI 10.1016/j.bmcl.2009.01.104; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kim HI, 2008, CANCER PREV RES, V1, P385, DOI 10.1158/1940-6207.CAPR-08-0087; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Niu MS, 2013, TRAFFIC, V14, P1042, DOI 10.1111/tra.12090; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Sharma C, 2012, CELL MOL LIFE SCI, V69, P2233, DOI 10.1007/s00018-012-0924-6; Soung YH, 2011, MOL CANCER THER, V10, P883, DOI 10.1158/1535-7163.MCT-10-1053; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Sugiyama Y, 1996, BIOCHEM PHARMACOL, V52, P519, DOI 10.1016/0006-2952(96)00302-4; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100	28	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125399	10.1371/journal.pone.0125399	http://dx.doi.org/10.1371/journal.pone.0125399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938910	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000062
J	Dotsey, EY; Gorlani, A; Ingale, S; Achenbach, CJ; Forthal, DN; Felgner, PL; Gach, JS				Dotsey, Emmanuel Y.; Gorlani, Andrea; Ingale, Sampat; Achenbach, Chad J.; Forthal, Donald N.; Felgner, Philip L.; Gach, Johannes S.			A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEPENDENT CELLULAR CYTOTOXICITY; PROXIMAL EXTERNAL REGION; CD4 BINDING-SITE; NEUTRALIZING ANTIBODIES; VACCINE; GP41; EPITOPE; BROAD; RECOGNIZES	In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has been applied to greatly advance our understanding of the specificity, and functional activity of antibodies against HIV. Thousands of antibodies have been generated and screened in functional neutralization assays, and antibodies associated with cross-strain neutralization and passive protection in primates, have been identified. To facilitate this type of discovery, a high throughput-screening tool is needed to accurately classify mAbs, and their antigen targets. In this study, we analyzed and evaluated a prototype microarray chip comprised of the HIV-1 recombinant proteins gp140, gp120, gp41, and several membrane proximal external region peptides. The protein microarray analysis of 11 HIV-1 envelope-specific mAbs revealed diverse binding affinities and specificities across clades. Half maximal effective concentrations, generated by our chip analysis, correlated significantly (P<0.0001) with concentrations from ELISA binding measurements. Polyclonal immune responses in plasma samples from HIV-1 infected subjects exhibited different binding patterns, and reactivity against printed proteins. Examining the totality of the specificity of the humoral response in this way reveals the exquisite diversity, and specificity of the humoral response to HIV.	[Dotsey, Emmanuel Y.; Gorlani, Andrea; Forthal, Donald N.; Felgner, Philip L.; Gach, Johannes S.] Univ Calif Irvine, Div Infect Dis, Irvine, CA 92697 USA; [Ingale, Sampat] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Achenbach, Chad J.] Northwestern Univ, Div Infect Dis, Chicago, IL 60611 USA	University of California System; University of California Irvine; Scripps Research Institute; Northwestern University	Felgner, PL (corresponding author), Univ Calif Irvine, Div Infect Dis, Irvine, CA 92697 USA.	pfelgner@uci.edu; jgach@uci.edu	Achenbach, Chad/AAQ-4035-2020	Achenbach, Chad/0000-0003-4847-7249; Gach, Johannes/0000-0002-5043-5710	US National Institute of Health [R01AI095916, U54AI065359, U01AI078213]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078213, U54AI065359, R01AI095916] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by US National Institute of Health grants R01AI095916 (PLF), U54AI065359 (PLF), and U01AI078213 (PLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2010, J INFECT DIS, V202, pS315, DOI 10.1086/655654; Baum E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082246; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Gach JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085371; Gach JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072054; Gach JS, 2011, CURR TOP MED CHEM, V11, P2997; Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776; Hope TJ, 2011, NAT MED, V17, P1195, DOI 10.1038/nm.2528; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Ingale S, 2010, J PEPT SCI, V16, P716, DOI 10.1002/psc.1325; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Stanfield RL, 2011, J MOL BIOL, V414, P460, DOI 10.1016/j.jmb.2011.10.014; Tudor D, 2011, AIDS, V25, P751, DOI 10.1097/QAD.0b013e32834507bd; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WANG YH, 1995, VIROLOGY, V208, P142, DOI 10.1006/viro.1995.1137; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	52	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125581	10.1371/journal.pone.0125581	http://dx.doi.org/10.1371/journal.pone.0125581			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938510	Green Published, gold			2022-12-26	WOS:000353943000078
J	Jensen, LM; Wallis, IR; Foley, WJ				Jensen, Lora M.; Wallis, Ian R.; Foley, William J.			The Relative Concentrations of Nutrients and Toxins Dictate Feeding by a Vertebrate Browser, the Greater Glider Petauroides volans	PLOS ONE			English	Article							PLANT SECONDARY METABOLITES; FOOD SELECTION; FOLIVOROUS MARSUPIALS; BRUSHTAIL POSSUM; LEAF CHEMISTRY; TREE USE; EUCALYPTUS; PROTEIN; HERBIVORES; AVAILABILITY	Although ecologists believe that vertebrate herbivores must select a diet that allows them to meet their nutritional requirements, while avoiding intoxication by plant secondary metabolites, this is remarkably difficult to show. A long series of field and laboratory experiments means that we have a good understanding of the factors that affect feeding by leaf-eating marsupials. This knowledge and the natural intraspecific variation in Eucalyptus chemistry allowed us to test the hypothesis that the feeding decisions of greater gliders (Petauroides volans) depend on the concentrations of available nitrogen (incorporating total nitrogen, dry matter digestibility and tannins) and of formylated phloroglucinol compounds (FPCs), potent antifeedants unique to Eucalyptus. We offered captive greater gliders foliage from two species of Eucalyptus, E. viminalisand E. melliodora, which vary naturally in their concentrations of available nitrogen and FPCs. We then measured the amount of foliage eaten by each glider and compared this with our laboratory analyses of foliar total nitrogen, available nitrogen and FPCs for each tree offered. The concentration of FPCs was the main factor that determined how much gliders ate of E. viminalis and E. melliodora, but in gliders fed E. viminalis the concentration of available nitrogen was also a significant influence. In other words, greater gliders ate E. viminalis leaves with a particular combination of FPCs and available nitrogen that maximised the nutritional gain but minimised their ingestion of toxins. In contrast, the concentration of total nitrogen was not correlated with feeding. This study is among the first to empirically show that browsing herbivores select a diet that balances the potential gain (available nutrients) and the potential costs (plant secondary chemicals) of eating leaves. The major implication of the study is that it is essential to identify the limiting nutrients and relevant toxins in a system in order to understand feeding behaviour.	[Jensen, Lora M.; Wallis, Ian R.; Foley, William J.] Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet, Canberra, ACT 0200, Australia	Australian National University	Jensen, LM (corresponding author), Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet, Canberra, ACT 0200, Australia.	Lora.Jensen@anu.edu.au	Foley, William J/C-8069-2009	Foley, William J/0000-0001-8587-1814	Australian Research Council [DP0986142]	Australian Research Council(Australian Research Council)	The work was supported by an Australian Research Council Discovery Grant (DP0986142) to IRW and WJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barthelmess EL, 2001, ETHOL ECOL EVOL, V13, P115; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Comport SS, 1996, WILDLIFE RES, V23, P401, DOI 10.1071/WR9960401; Cork SJ, 1996, FOREST ECOL MANAG, V85, P163, DOI 10.1016/S0378-1127(96)03757-7; CORK SJ, 1984, POSSUMS GLIDERS, P269; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; DEGABRIELE R, 1981, AUST J ECOL, V6, P139, DOI 10.1111/j.1442-9993.1981.tb01284.x; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; FOLEY WJ, 1990, AUST J ZOOL, V38, P1, DOI 10.1071/ZO9900001; FOLEY WJ, 1987, PHYSIOL ZOOL, V60, P103, DOI 10.1086/physzool.60.1.30158632; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Ganzhorn JU, 2002, OECOLOGIA, V131, P427, DOI 10.1007/s00442-002-0891-y; Gogarten JF, 2012, TROP CONSERV SCI, V5, P381, DOI 10.1177/194008291200500311; Harris Jamie M., 2010, Mammalian Species, P207, DOI 10.1644/866.1; Iason GR, 2006, J CHEM ECOL, V32, P1115, DOI 10.1007/s10886-006-9075-2; Jensen LM, 2014, OECOLOGIA, V176, P251, DOI 10.1007/s00442-014-2997-4; KAVANAGH RP, 1990, AUST WILDLIFE RES, V17, P285; KOOL KM, 1992, OECOLOGIA, V90, P527, DOI 10.1007/BF01875446; Lawler IR, 1998, OECOLOGIA, V116, P160, DOI 10.1007/s004420050575; Lawler IR, 2000, ECOLOGY, V81, P1327, DOI 10.1890/0012-9658(2000)081[1327:FCOAST]2.0.CO;2; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McLean S, 2006, J CHEM ECOL, V32, P1213, DOI 10.1007/s10886-006-9081-4; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; MOORE BD, 2004, CONSERVATION AUSTR F; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Pass DM, 1998, J CHEM ECOL, V24, P1513, DOI 10.1023/A:1020911800847; Pryor L. D., 1959, Monographiae Biologicae, V8, P461; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Wallis IR, 2012, OECOLOGIA, V169, P281, DOI 10.1007/s00442-011-2212-9; Wallis IR, 2010, FOREST ECOL MANAG, V260, P814, DOI 10.1016/j.foreco.2010.05.040; Wallis IR, 2005, PHYTOCHEM ANALYSIS, V16, P49, DOI 10.1002/pca.810; Wallis IR, 2002, AUST J ZOOL, V50, P507, DOI 10.1071/ZO02029; WATERMAN PG, 1988, BIOL J LINN SOC, V34, P1, DOI 10.1111/j.1095-8312.1988.tb01946.x; White T. C. R., 1993, INADEQUATE ENV NITRO; Youngentob KN, 2011, J CHEM ECOL, V37, P71, DOI 10.1007/s10886-010-9889-9; [No title captured]	45	15	15	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0121584	10.1371/journal.pone.0121584	http://dx.doi.org/10.1371/journal.pone.0121584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938422	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000004
J	Palacin-Arce, A; Monteagudo, C; Beas-Jimenez, JD; Olea-Serrano, F; Mariscal-Arcas, M				Palacin-Arce, Alba; Monteagudo, Celia; de Dios Beas-Jimenez, Juan; Olea-Serrano, Fatima; Mariscal-Arcas, Miguel			Proposal of a Nutritional Quality Index (NQI) to Evaluate the Nutritional Supplementation of Sportspeople	PLOS ONE			English	Article							DIETARY-SUPPLEMENTS; MEDITERRANEAN DIET; QUESTIONNAIRES; VALIDATION; ADHERENCE; HABITS; PEOPLE	Background Numerous supplements are used by sportspeople. They are not always appropriate for the individual or the sports activity and may do more harm than good. Vitamin and mineral supplements are unnecessary if the energy intake is sufficient to maintain body weight and derives from a diet with an adequate variety of foods. The study objectives were to evaluate the main nutrients used as supplements in sports and to propose a nutritional quality index (NQI) that enables sportspeople to optimize their use of supplements and detect and remedy possible nutritional deficits. Material and Methods A nutritional study was performed in 485 sportspeople recruited from Centros Andaluces de Medicina del Deporte, (CAMD). All completed socio-demographic, food frequency, and lifestyle questionnaires. The nutritional quality of their diet and need for supplementation were evaluated by scoring their dietary intake with and without supplementation, yielding two NQI scores (scales of 0-21 points) for each participant. Results A superior mean NQI score was obtained when the supplements taken by participants were not included (16. 28 (SD of 3.52)) than when they were included (15.47 (SD: 3.08)), attributable to an excessive intake of some nutrients through supplementation. Conclusions These results indicate that sportspeople with a varied and balanced diet do not need supplements, which appear to offer no performance benefits and may pose a health risk.	[Palacin-Arce, Alba; Monteagudo, Celia; Olea-Serrano, Fatima; Mariscal-Arcas, Miguel] Univ Granada, Dept Nutr & Food Sci, Diet & Risk Assessment AGR255, Res Grp Nutr, Granada, Spain; [de Dios Beas-Jimenez, Juan; Mariscal-Arcas, Miguel] Andalusian Ctr Sport Med CAMD, Junta De Andalucia, Spain; [Mariscal-Arcas, Miguel] Univ Murcia, Dept Nutr & Food Sci, Food Technol, Murcia, Spain	University of Granada; University of Murcia	Olea-Serrano, F (corresponding author), Univ Granada, Dept Nutr & Food Sci, Diet & Risk Assessment AGR255, Res Grp Nutr, Granada, Spain.	folea@ugr.es	Olea-Serrano, Fatima/I-4584-2017; Mariscal, Miguel/N-6543-2019; Mariscal-Arcas, Miguel/K-4150-2017; Sánchez, Celia Monteagudo/M-1460-2014; Mariscal-Arcas, Miguel/R-3406-2019	Mariscal-Arcas, Miguel/0000-0001-9852-4950; Sánchez, Celia Monteagudo/0000-0003-0529-379X; Mariscal-Arcas, Miguel/0000-0001-9852-4950; Beas-Jimenez, Juan de Dios/0000-0001-9805-029X	Junta de Andalucia [FMD2010SC0071]	Junta de Andalucia(Junta de Andalucia)	The authors are grateful to the High Performance Centre of Sierra Nevada and the Sports Medicine Centres of Andalusia for their collaboration in this study and thank Richard Davies for his assistance with the English version. Furthermore, the authors are grateful to the Junta de Andalucia, Spain (Research Group AGR-255"Nutrition. Diet and Risk Assessment"), a collaboration agreement with the Andalusian Centres of Sports Medicine (Junta de Andalucia) and the FPU program of the Spanish Ministry of Education and Science. Study participants were recruited through the project "Nutritional and diet assessment methodologies applied to the Andalusian sportsperson in Andalusian Sports centres", Research project FMD2010SC0071 of the Junta de Andalucia.	[Anonymous], 2009, J AM DIET ASSOC, V109, P330, DOI 10.1016/j.jada.2008.11.041; [Anonymous], 2005, JOINT FAO OMS TECHN; [Anonymous], 2002, DIET REF INT EN CARB; Bountziouka V, 2010, CURR PHARM DESIGN, V16, P3770, DOI 10.2174/138161210794455102; Brennan B, 2014, BRIT J SPORT MED, V48, P343, DOI 10.1136/bjsports-2013-092956; EFSA, 2011, PUBL CONS DRAFT SCI; Gabarra AG, 2006, NUTR HOSP, V21, P437; Gabarra AG, 2006, NUTR HOSP, V21, P291; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Guallar E, 2013, ANN INTERN MED, V159, P850, DOI 10.7326/0003-4819-159-12-201312170-00011; Hamdan M, 2013, PUBLIC HEALTH NUTR, V16, P1; Hanekamp JC, 2007, CRIT REV FOOD SCI, V47, P267, DOI 10.1080/10408390600737748; Hansen BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053044; Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010; Huang SH, 2006, CLIN J SPORT MED, V16, P27, DOI 10.1097/01.jsm.0000194766.35443.9c; IoM United Kingdom Department of Health, 1991, DIET REF VAL FOOD EN; Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x; Marisca-Arcas M, 2011, J NUTR HEALTH AGING, V15, P739, DOI 10.1007/s12603-011-0136-z; Mariscal-Arcas M, 2010, NUTR HOSP, V25, P1006, DOI 10.3305/nh.2010.25.6.4889; Maughan RJ, 2011, J SPORT SCI, V29, pS57, DOI 10.1080/02640414.2011.587446; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Maughan RJ, 2012, P NUTR SOC, V71, P112, DOI 10.1017/S0029665111003211; Munro IC, 2006, J NUTR, V136, p490S, DOI 10.1093/jn/136.2.490S; National Statistic Office of Spain, NAT SURV SPORTS HAB; Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842; Nikolaidis MG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/707941; Ortega Anta RM, 2008, DIAL V 1 19, V1.19; Panel on Dietetic Products Nutrition and Allergies (NDA), PUBL CONS DRAFT SCI; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Richardson D. P., 2007, Food Science and Technology Bulletin: Functional Foods, V4, P51, DOI 10.1616/1476-2137.14996; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rivas A, 2009, NUTR HOSP, V24, P521, DOI 10.3305/nh.2009.24.5.4462; Rodek J, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-51; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Suedekum Natalie A, 2005, Curr Sports Med Rep, V4, P199, DOI 10.1097/01.CSMR.0000306207.79809.7f; WHO, 2007, WHO TECH REP SER, V935, P1; WHO, 2000, OB PREV MAN GLOB EP; Willett W., 2012, NUTR EPIDEMIOLOGY	38	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125630	10.1371/journal.pone.0125630	http://dx.doi.org/10.1371/journal.pone.0125630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938239	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000083
J	Poitou, C; Perret, C; Mathieu, F; Truong, V; Blum, Y; Durand, H; Alili, R; Chelghoum, N; Pelloux, V; Aron-Wisnewsky, J; Torcivia, A; Bouillot, JL; Parks, BW; Ninio, E; Clement, K; Tiret, L				Poitou, Christine; Perret, Claire; Mathieu, Francois; Truong, Vinh; Blum, Yuna; Durand, Herve; Alili, Rohia; Chelghoum, Nadjim; Pelloux, Veronique; Aron-Wisnewsky, Judith; Torcivia, Adriana; Bouillot, Jean-Luc; Parks, Brian W.; Ninio, Ewa; Clement, Karine; Tiret, Laurence			Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; EXTRACELLULAR-MATRIX; PROTEINS; OBESITY; SIGNATURE; PACKAGE; MARKER; DIET	Background Bariatric surgery is associated to improvements in obesity-associated comorbidities thought to be mediated by a decrease of adipose inflammation. However, the molecular mechanisms behind these beneficial effects are poorly understood. Methodology/Principal Findings We analyzed RNA-seq expression profiles in adipose tissue from 22 obese women before and 3 months after surgery. Of 15,972 detected genes, 1214 were differentially expressed after surgery at a 5% false discovery rate. Upregulated genes were mostly involved in the basal cellular machinery. Downregulated genes were enriched in metabolic functions of adipose tissue. At baseline, 26 modules of coexpressed genes were identified. The four most stable modules reflected the innate and adaptive immune responses of adipose tissue. A first module reflecting a non-specific signature of innate immune cells, mainly macrophages, was highly conserved after surgery with the exception of DUSP2 and CD300C. A second module reflected the adaptive immune response elicited by T lymphocytes; after surgery, a disconnection was observed between genes involved in T-cell signaling and mediators of the signal transduction such as CXCR1, CXCR2, GPR97, CCR7 and IL7R. A third module reflected neutrophil-mediated inflammation; after surgery, several genes were dissociated from the module, including S100A8, S100A12, CD300E, VNN2, TUBB1 and FAM65B. We also identified a dense network of 19 genes involved in the interferon-signaling pathway which was strongly preserved after surgery, with the exception of DDX60, an antiviral factor involved in RIG-I-mediated interferon signaling. A similar loss of connection was observed in lean mice compared to their obese counterparts. Conclusions/Significance These results suggest that improvements of the inflammatory state following surgery might be explained by a disruption of immuno-inflammatory cascades involving a few crucial molecules which could serve as potential therapeutic targets.	[Poitou, Christine; Perret, Claire; Mathieu, Francois; Truong, Vinh; Durand, Herve; Alili, Rohia; Pelloux, Veronique; Aron-Wisnewsky, Judith; Ninio, Ewa; Clement, Karine; Tiret, Laurence] Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr ICAN, Dept Nutr, F-75013 Paris, France; [Poitou, Christine; Alili, Rohia; Pelloux, Veronique; Aron-Wisnewsky, Judith; Clement, Karine] Univ Paris 06, Sorbonne Univ, INSERM, Nutri Team,UMR S 1166, F-75005 Paris, France; [Perret, Claire; Mathieu, Francois; Truong, Vinh; Durand, Herve; Ninio, Ewa; Tiret, Laurence] Univ Paris 06, Sorbonne Univ, INSERM, Genom & Pathophysiol Cardiovasc Dis Team,UMR S 11, F-75005 Paris, France; [Blum, Yuna; Parks, Brian W.] Univ Calif Los Angeles, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Chelghoum, Nadjim] Univ Paris 06, Sorbonne Univ, Post Genom Platform Pitie Salpetriere P3S, F-75013 Paris, France; [Torcivia, Adriana] Hop La Pitie Salpetriere, AP HP, Dept Visceral Surg, F-75013 Paris, France; [Bouillot, Jean-Luc] Ambroise Pare Hosp, AP HP, Dept Gen Digest & Metab Surg, F-92100 Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Los Angeles; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Tiret, L (corresponding author), Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr ICAN, Dept Nutr, F-75013 Paris, France.	laurence.tiret@upmc.fr	Blum, Yuna/W-7343-2019; ARON-WISNEWSKY, judith/AAH-7608-2020; Clément, karine/R-1120-2017; Poitou, Christine/GVT-6117-2022	Poitou, Christine/0000-0001-7769-6331; Durand, Herve/0000-0002-8167-4693; Blum, Yuna/0000-0002-4716-8017	Fondation pour la Recherche Medicale (FRM) [ING20121226269]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (PHRC MICROBARIA)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (PHRC MICROBARIA)	The research was supported by the Fondation pour la Recherche Medicale (FRM ING20121226269) (F.M.), the Agence Nationale de la Recherche, France (ANR 09 GENO 106 01) (V.T.), the Assistance Publique-Hopitaux de Paris (APHP) and the Direction of Clinical Research (PHRC MICROBARIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Chiellini C, 2008, BIOCHEM BIOPH RES CO, V374, P64, DOI 10.1016/j.bbrc.2008.06.121; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Cimino D, 2008, INT J CANCER, V123, P1327, DOI 10.1002/ijc.23660; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; el Bouazzaoui F, 2014, INT J OBESITY, V38, P746, DOI 10.1038/ijo.2013.175; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Jeon H, 2010, J BIOMOL SCREEN, V15, P949, DOI 10.1177/1087057110376090; Jing ZZ, 2010, J IMMUNOL, V185, P6719, DOI 10.4049/jimmunol.0903869; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kessel C, 2013, CLIN IMMUNOL, V147, P229, DOI 10.1016/j.clim.2012.11.008; Kirschner LS, 2000, BIOCHEM BIOPH RES CO, V270, P1106, DOI 10.1006/bbrc.2000.2568; Kolehmainen M, 2008, INT J OBESITY, V32, P292, DOI 10.1038/sj.ijo.0803718; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Longhese MP, 2012, FRONT BIOSCI-LANDMRK, V17, P1715, DOI 10.2741/4014; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Ronnegard L, 2010, R J, V2, P20; Rougerie P, 2013, J IMMUNOL, V190, P748, DOI 10.4049/jimmunol.1201174; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Sobczak A, 2011, BBA-MOL CELL RES, V1813, P1025, DOI 10.1016/j.bbamcr.2010.12.023; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang IM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.24; Wang XA, 2013, AM J PHYSIOL-ENDOC M, V305, pE485, DOI 10.1152/ajpendo.00505.2012; Wei SJ, 2013, CELL MOL LIFE SCI, V70, P4569, DOI 10.1007/s00018-013-1395-0; Wei W, 2013, GENES IMMUN, V14, P1, DOI 10.1038/gene.2012.54; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang HR, 2011, ARTERIOSCL THROM VAS, V31, P2063, DOI 10.1161/ATVBAHA.111.225870	57	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125718	10.1371/journal.pone.0125718	http://dx.doi.org/10.1371/journal.pone.0125718			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938420	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000094
J	Zhang, HW; Xu, RN; Xie, CX; Huang, CL; Liao, H; Xu, YB; Wang, JX; Li, WX				Zhang, Hongwei; Xu, Ruineng; Xie, Chuanxiao; Huang, Changling; Liao, Hong; Xu, Yunbi; Wang, Jinxiang; Li, Wen-Xue			Large-Scale Evaluation of Maize Germplasm for Low-Phosphorus Tolerance	PLOS ONE			English	Article							ZEA-MAYS L.; ROOT; ACQUISITION; EFFICIENCY; INCREASE; GROWTH; LINES; GRAIN	Low-phosphorus (LP) stress is a global problem for maize production and has been exacerbated by breeding activities that have reduced the genetic diversity of maize. Although LP tolerance in maize has been previously evaluated, the evaluations were generally performed with only a small number of accessions or with samples collected from a limited area. In this research, 826 maize accessions (including 580 tropical/subtropical accessions and 246 temperate accessions) were evaluated for LP tolerance under field conditions in 2011 and 2012. Plant height (PH) and leaf number were measured at three growth stages. The normalized difference vegetation index (NDVI) and fresh ear weight (FEW) were also measured. Genetic correlation analysis revealed that FEW and NDVI were strongly correlated with PH, especially at later stages. LP-tolerant and -sensitive accessions were selected based on the relative trait values of all traits using principal component analysis, and all the 14 traits of the tolerant maize accessions showed less reduction than the sensitive accessions under LP conditions. LP tolerance was strongly correlated with agronomic performance under LP stress conditions, and both criteria could be used for genetic analysis and breeding of LP tolerance. Temperate accessions showed slightly better LP tolerance than tropical/subtropical ones, although more tolerant accessions were identified from tropical/subtropical accessions, which could be contributed by their larger sample size. This large-scale evaluation provides useful information, LP-tolerant germplasm resources and evaluation protocol for genetic analysis and developing maize varieties for LP tolerance.	[Zhang, Hongwei; Xie, Chuanxiao; Huang, Changling; Xu, Yunbi; Li, Wen-Xue] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Xu, Ruineng; Liao, Hong; Wang, Jinxiang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Xu, Ruineng; Liao, Hong; Wang, Jinxiang] South China Agr Univ, Coll Agron, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China; [Xu, Yunbi] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Texcoco, Mexico	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; South China Agricultural University; South China Agricultural University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Wang, JX (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	jinxwang@scau.edu.cn; liwenxue@caas.cn	Wang, Jinxiang/I-2684-2016	Wang, Jinxiang/0000-0002-4523-4359; Zhang, Hongwei/0000-0002-5737-6151	National High-Tech R D Program [2012AA101104, 2012AA10A306]; National International Science and Technology Collaboration Program of China [2012DFA32290]; Agricultural Science and Technology Innovation Program of CAAS; Core Research Budget of the Non-profit Governmental Research Institution [2014001]	National High-Tech R D Program; National International Science and Technology Collaboration Program of China; Agricultural Science and Technology Innovation Program of CAAS; Core Research Budget of the Non-profit Governmental Research Institution	This work was supported by National High-Tech R & D Program (2012AA101104) and National International Science and Technology Collaboration Program of China (2012DFA32290) to YX, and the National High-Tech R & D Program (2012AA10A306), the Agricultural Science and Technology Innovation Program of CAAS, and the Core Research Budget of the Non-profit Governmental Research Institution (2014001) to W-XL.	Bayuelo-Jimenez JS, 2011, FIELD CROP RES, V121, P350, DOI 10.1016/j.fcr.2011.01.001; Cai HG, 2012, MOL BREEDING, V30, P251, DOI 10.1007/s11032-011-9615-5; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Camus-Kulandaivelu L, 2008, GENETICS, V180, P1107, DOI 10.1534/genetics.108.088849; Chen HongMei, 2011, Acta Agronomica Sinica, V37, P1785, DOI 10.3724/SP.J.1006.2011.01785; Chen JY, 2008, PLANT SOIL, V313, P251, DOI 10.1007/s11104-008-9698-x; Colomb B, 2000, AGRON J, V92, P428, DOI 10.2134/agronj2000.923428x; DASILVA AE, 1992, PLANT SOIL, V146, P181, DOI 10.1007/BF00012011; Gaume A, 2001, PLANT SOIL, V228, P253, DOI 10.1023/A:1004824019289; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Holland JB, 2002, PL BRED RE, V22, P9; Li JZ, 2009, J GENET GENOMICS, V36, P173, DOI 10.1016/S1673-8527(08)60104-6; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Lu YL, 2011, FIELD CROP RES, V124, P37, DOI 10.1016/j.fcr.2011.06.003; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Pollak LM, 2003, ADV AGRON, V78, P45, DOI 10.1016/S0065-2113(02)78002-4; SAS Institute Inc, 1985, US GUID STAT; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Trachsel S, 2010, MAYDICA, V55, P101; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Wissuwa M, 2001, PLANT SOIL, V237, P275, DOI 10.1023/A:1013385620875; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang T, 2010, J HYDROL, V380, P386, DOI 10.1016/j.jhydrol.2009.11.013; Zhang HW, 2014, J INTEGR PLANT BIOL, V56, P262, DOI 10.1111/jipb.12168; [张吉海 ZHANG Jihai], 2006, [玉米科学, Maize Science], V14, P20; Zhang LT, 2014, EUPHYTICA, V197, P435, DOI 10.1007/s10681-014-1079-3; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	32	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124212	10.1371/journal.pone.0124212	http://dx.doi.org/10.1371/journal.pone.0124212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938641	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000021
J	Lee, S; Jia, B; Liu, JL; Pham, BP; Kwak, JM; Xuan, YH; Cheong, GW				Lee, Sangmin; Jia, Baolei; Liu, Jinliang; Bang Phuong Pham; Kwak, Jae Myeong; Xuan, Yuan Hu; Cheong, Gang-Won			A 1-Cys Peroxiredoxin from a Thermophilic Archaeon Moonlights as a Molecular Chaperone to Protect Protein and DNA against Stress-Induced Damage	PLOS ONE			English	Article							THIOL-SPECIFIC ANTIOXIDANT; THERMOCOCCUS-KODAKARAENSIS KOD1; OXIDATIVE STRESS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RING STRUCTURE; NADH OXIDASE; ENZYMES; PEROXIDASE	Peroxiredoxins (Prxs) act against hydrogen peroxide (H2O2), organic peroxides, and peroxynitrite. Thermococcus kodakaraensis KOD1, an anaerobic archaeon, contains many antioxidant proteins, including three Prxs (Tk0537, Tk0815, and Tk1055). Only Tk0537 has been found to be induced in response to heat, osmotic, and oxidative stress. Tk0537 was found to belong to a 1-Cys Prx6 subfamily based on sequence analysis and was named 1-Cys TkPrx. Using gel filtration chromatography, electron microscopy, and blue-native polyacrylamide gel electrophoresis, we observed that 1-Cys TkPrx exhibits oligomeric forms with reduced peroxide reductase activity as well as decameric and dodecameric forms that can act as molecular chaperones by protecting both proteins and DNA from oxidative stress. Mutational analysis showed that a cysteine residue at the N-terminus (Cys(46)) was responsible for the peroxide reductase activity, and cysteine residues at the C-terminus (Cys(205) and Cys(211)) were important for oligomerization. Based on our results, we propose that interconversion between different oligomers is important for regulating the different functions of 1-Cys TkPrx.	[Lee, Sangmin; Jia, Baolei; Bang Phuong Pham; Kwak, Jae Myeong; Cheong, Gang-Won] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Lee, Sangmin; Jia, Baolei; Bang Phuong Pham; Kwak, Jae Myeong; Cheong, Gang-Won] Gyeongsang Natl Univ, Res Inst Nat Sci, Jinju, South Korea; [Lee, Sangmin] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea; [Jia, Baolei] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Liu, Jinliang] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Xuan, Yuan Hu] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou, Peoples R China	Gyeongsang National University; Gyeongsang National University; Korea Basic Science Institute (KBSI); Chung Ang University; Jilin University; Wenzhou Medical University	Cheong, GW (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea.	gwcheong@gnu.ac.kr	Jia, Baolei/AIF-1053-2022	, Yuanhu/0000-0002-4704-8090; Jia, Baolei/0000-0001-6434-5604	Fund of Research Promotion Program (Gyeongsang National University); Natural Science Foundation of China [31201485]	Fund of Research Promotion Program (Gyeongsang National University); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of Research Promotion Program (Gyeongsang National University, 2012) and Natural Science Foundation of China (31201485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Hicks LD, 2010, J BACTERIOL, V192, P2077, DOI 10.1128/JB.01324-09; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Jeon SJ, 2003, J BIOL CHEM, V278, P24174, DOI 10.1074/jbc.M300618200; Jia B, 2008, FEBS J, V275, P5355, DOI 10.1111/j.1742-4658.2008.06665.x; Jia BL, 2013, EXTREMOPHILES, V17, P193, DOI 10.1007/s00792-012-0509-1; Jia BL, 2011, EXTREMOPHILES, V15, P337, DOI 10.1007/s00792-011-0365-4; Jia B, 2010, MOL CELLS, V29, P363, DOI 10.1007/s10059-010-0045-8; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Konig J, 2013, J EXP BOT, V64, P3483, DOI 10.1093/jxb/ert184; Kohda J, 2006, J BIOSCI BIOENG, V101, P131, DOI 10.1263/jbb.101.131; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Nelson KJ, 2011, CURR PROTOC TOXICOL, V7, DOI [10.1002/0471140856.tx0709s49, DOI 10.1002/0471140856.TX0709S49]; Noguera-Mazon V, 2006, PHOTOSYNTH RES, V89, P277, DOI 10.1007/s11120-006-9106-4; Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Saccoccia F, 2012, STRUCTURE, V20, P429, DOI 10.1016/j.str.2012.01.004; SAURI H, 1995, BIOCHEM BIOPH RES CO, V208, P964, DOI 10.1006/bbrc.1995.1428; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wang Q, 2008, COMP BIOCHEM PHYS B, V149, P176, DOI 10.1016/j.cbpb.2007.09.005; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	37	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125325	10.1371/journal.pone.0125325	http://dx.doi.org/10.1371/journal.pone.0125325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933432	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100098
J	Lopez-Uribe, MM; Morreale, SJ; Santiago, CK; Danforth, BN				Lopez-Uribe, Margarita M.; Morreale, Stephen J.; Santiago, Christine K.; Danforth, Bryan N.			Nest Suitability, Fine-Scale Population Structure and Male-Mediated Dispersal of a Solitary Ground Nesting Bee in an Urban Landscape	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; GENETIC-STRUCTURE; MATING SYSTEMS; PAIRWISE RELATEDNESS; ECOSYSTEM SERVICES; RE-IMPLEMENTATION; EFFECTIVE NUMBER; COMMUNAL BEE; DESERT BEE; SWEAT BEE	Bees are the primary pollinators of flowering plants in almost all ecosystems. Worldwide declines in bee populations have raised awareness about the importance of their ecological role in maintaining ecosystem functioning. The naturally strong philopatric behavior that some bee species show can be detrimental to population viability through increased probability of inbreeding. Furthermore, bee populations found in human-altered landscapes, such as urban areas, can experience lower levels of gene flow and effective population sizes, increasing potential for inbreeding depression in wild bee populations. In this study, we investigated the fine-scale population structure of the solitary bee Colletes inaequalis in an urbanized landscape. First, we developed a predictive spatial model to detect suitable nesting habitat for this ground nesting bee and to inform our field search for nests. We genotyped 18 microsatellites in 548 female individuals collected from nest aggregations throughout the study area. Genetic relatedness estimates revealed that genetic similarity among individuals was slightly greater within nest aggregations than among randomly chosen individuals. However, genetic structure among nest aggregations was low (Nei's G(ST) = 0.011). Reconstruction of parental genotypes revealed greater genetic relatedness among females than among males within nest aggregations, suggesting male-mediated dispersal as a potentially important mechanism of population connectivity and inbreeding avoidance. Size of nesting patch was positively correlated with effective population size, but not with other estimators of genetic diversity. We detected a positive trend between geographic distance and genetic differentiation between nest aggregations. Our landscape genetic models suggest that increased urbanization is likely associated with higher levels of inbreeding. Overall, these findings emphasize the importance of density and distribution of suitable nesting patches for enhancing bee population abundance and connectivity in human dominated habitats and highlights the critical contribution of landscape genetic studies for enhanced conservation and management of native pollinators.	[Lopez-Uribe, Margarita M.; Santiago, Christine K.; Danforth, Bryan N.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Morreale, Stephen J.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University; Cornell University	Lopez-Uribe, MM (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	mmlopezu@ncsu.edu	Lopez-Uribe, Margarita/I-7112-2015	Danforth, Bryan/0000-0002-6495-428X	Andrew W. Mellon Foundation at Cornell University; Sarah Bradley Fellowship; Cornell Biology Research Fellowship Program; National Science Foundation [DEB-0814544, DEB-0742998]	Andrew W. Mellon Foundation at Cornell University; Sarah Bradley Fellowship; Cornell Biology Research Fellowship Program; National Science Foundation(National Science Foundation (NSF))	Funding: Funding was provided by grants from the Andrew W. Mellon Foundation at Cornell University (MMLU), the Sarah Bradley Fellowship (MMLU), the Cornell Biology Research Fellowship Program (CKS), and awards from the National Science Foundation (DEB-0814544 and DEB-0742998 to BND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATRA S W T, 1980, Journal of the Kansas Entomological Society, V53, P509; Batra SWT, 1997, ACTA HORTIC, P71, DOI 10.17660/ActaHortic.1997.446.9; Beveridge M, 2006, MOL ECOL, V15, P951, DOI 10.1111/j.1365-294X.2006.02846.x; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Beyer HL, HAWTHS ANALYSIS TOOL; Bilde T, 2005, EVOLUTION, V59, P160, DOI 10.1111/j.0014-3820.2005.tb00903.x; Boff S, 2014, CONSERV GENET, V15, P1123, DOI 10.1007/s10592-014-0605-0; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Buchalski MR, 2014, MOL ECOL, V23, P464, DOI 10.1111/mec.12593; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; CANE JH, 1991, J KANSAS ENTOMOL SOC, V64, P406; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Clark RW, 2008, MOL ECOL, V17, P719; Costanza R, 1998, ECOL ECON, V25, P3, DOI 10.1016/S0921-8009(98)00020-2; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Danforth BN, 2003, J KANSAS ENTOMOL SOC, V76, P221; Darvill B, 2006, MOL ECOL, V15, P601, DOI 10.1111/j.1365-294X.2006.02797.x; Davis ES, 2010, MOL ECOL, V19, P4922, DOI 10.1111/j.1365-294X.2010.04868.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Exeler N, 2008, CONSERV GENET, V9, P1233, DOI 10.1007/s10592-007-9450-8; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Frankham R, 2010, CONSERV GENET, V11, P661, DOI 10.1007/s10592-009-0010-2; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 2006, TRENDS ECOL EVOL, V21, P55, DOI 10.1016/j.tree.2005.11.014; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Jha S, 2013, MOL ECOL, V22, P2483, DOI 10.1111/mec.12275; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Lane A, 2011, MOL ECOL, V20, P1870, DOI 10.1111/j.1365-294X.2011.05059.x; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; Lopez-Uribe MM, 2013, APIDOLOGIE, V44, P163, DOI 10.1007/s13592-012-0168-3; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Lozier JD, 2011, MOL ECOL, V20, P4870, DOI 10.1111/j.1365-294X.2011.05314.x; Lynch M, 1999, GENETICS, V152, P1753; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller MP, 2013, CONSERV GENET, V14, P333, DOI 10.1007/s10592-012-0420-4; Cerantola NDM, 2011, APIDOLOGIE, V42, P214, DOI 10.1051/apido/2010055; Muralidhar P, 2014, MOL ECOL, V23, P453, DOI 10.1111/mec.12592; Nomura T, 2008, EVOL APPL, V1, P462, DOI 10.1111/j.1752-4571.2008.00015.x; Oi CA, 2013, J INSECT CONSERV, V17, P1071, DOI 10.1007/s10841-013-9582-8; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; Paxton RJ, 1999, ETHOL ECOL EVOL, V11, P371, DOI 10.1080/08927014.1999.9522820; Paxton RJ, 2005, APIDOLOGIE, V36, P145, DOI 10.1051/apido:2005007; Peakall R, 2004, BEHAV ECOL SOCIOBIOL, V56, P579, DOI 10.1007/s00265-004-0816-3; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Pokorny T, 2015, APIDOLOGIE, V46, P224, DOI 10.1007/s13592-014-0317-y; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SMITH BE, 1993, B TORREY BOT CLUB, V120, P229, DOI 10.2307/2996988; SMITH BH, 1983, P NATL ACAD SCI-BIOL, V80, P4551, DOI 10.1073/pnas.80.14.4551; Stelkens RB, 2012, MOL ECOL, V21, P2896, DOI 10.1111/j.1365-294X.2012.05581.x; Suni SS, 2014, BIOTROPICA, V46, P202, DOI 10.1111/btp.12084; Tarpy DR, 2002, BEHAV ECOL SOCIOBIOL, V52, P143, DOI 10.1007/s00265-002-0498-7; Ulrich Y, 2009, MOL ECOL, V18, P1791, DOI 10.1111/j.1365-294X.2009.04154.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vangestel C, 2011, MOL ECOL, V20, P4643, DOI 10.1111/j.1365-294X.2011.05316.x; VANNOORDWIJK AJ, 1981, EVOLUTION, V35, P674, DOI 10.1111/j.1558-5646.1981.tb04929.x; Vereecken NJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P811, DOI 10.1007/s00265-006-0312-z; Wang J, 2009, PHILOS TRANS R SOC L, V360, P1395; Wang JL, 2006, THEOR POPUL BIOL, V70, P300, DOI 10.1016/j.tpb.2005.11.003; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2002, GENETICS, V160, P1203; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WCISLO WT, 1987, BEHAV ECOL SOCIOBIOL, V20, P179, DOI 10.1007/BF00299731; WCISLO WT, 1992, BEHAV ECOL SOCIOBIOL, V31, P139, DOI 10.1007/BF00166347; Zayed A, 2002, INSECT SOC, V49, P282, DOI 10.1007/s00040-002-8315-x; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zhdanova OL, 2008, J HERED, V99, P694, DOI 10.1093/jhered/esn061	92	39	39	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125719	10.1371/journal.pone.0125719	http://dx.doi.org/10.1371/journal.pone.0125719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950429	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400043
J	Virk, SM; Gibson, RM; Quinones-Mateu, ME; Barnholtz-Sloan, JS				Virk, Selene M.; Gibson, Richard M.; Quinones-Mateu, Miguel E.; Barnholtz-Sloan, Jill S.			Identification of Variants in Primary and Recurrent Glioblastoma Using a Cancer-Specific Gene Panel and Whole Exome Sequencing	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; LANDSCAPE; VALIDATION	Glioblastoma (GBM) is an aggressive, malignant brain tumor typically resulting in death of the patient within one year following diagnosis; and those who survive beyond this point usually present with tumor recurrence within two years (5-year survival is 5%). The genetic heterogeneity of GBM has made the molecular characterization of these tumors an area of great interest and has led to identification of molecular subtypes in GBM. The availability of sequencing platforms that are both fast and economical can further the adoption of tumor sequencing in the clinical environment, potentially leading to identification of clinically actionable genetic targets. In this pilot study, comprised of triplet samples of normal blood, primary tumor, and recurrent tumor samples from three patients; we compared the ability of Illumina whole exome sequencing (ExomeSeq) and the Ion AmpliSeq Comprehensive Cancer Panel (CCP) to identify somatic variants in patient-paired primary and recurrent tumor samples. Thirteen genes were found to harbor variants, the majority of which were exclusive to the ExomeSeq data. Surprisingly, only two variants were identified by both platforms and they were located within the PTCH1 and NF1 genes. Although preliminary in nature, this work highlights major differences in variant identification in data generated from the two platforms. Additional studies with larger samples sizes are needed to further explore the differences between these technologies and to enhance our understanding of the clinical utility of panel based platforms in genomic profiling of brain tumors.	[Virk, Selene M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Gibson, Richard M.; Quinones-Mateu, Miguel E.] Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH 44106 USA; [Quinones-Mateu, Miguel E.; Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Quinones-Mateu, Miguel E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University	Quinones-Mateu, ME (corresponding author), Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH 44106 USA.	meq@case.edu; jsb42@case.edu	Quinones-Mateu, Miguel/H-3846-2019; Barnholtz-Sloan, Jill/A-4817-2011	Barnholtz-Sloan, Jill/0000-0001-6190-9304; Quinones-Mateu, Miguel/0000-0001-9170-5601	National Institutes of Health [5R25CA094186, HHSN261201000057C]; NIH/NCI [2P30 CA043703-23]; NATIONAL CANCER INSTITUTE [R25CA094186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by National Institutes of Health (www.nih.gov) 5R25CA094186 SMV, National Institutes of Health HHSN261201000057C, and NIH/NCI 2P30 CA043703-23 JSB.	American Cancer Society, 2014, CANCER FACTS FIGURES; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gibson RM, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0401-5; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Nickel GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035262; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Riehmer V, 2014, GENE CHROMOSOME CANC, V53, P589, DOI 10.1002/gcc.22169; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126	25	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124178	10.1371/journal.pone.0124178	http://dx.doi.org/10.1371/journal.pone.0124178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950952	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400014
J	Xu, JF; Lan, YH				Xu, Jianfeng; Lan, Yueheng			Hierarchical Feedback Modules and Reaction Hubs in Cell Signaling Networks	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SYSTEMS; COMPLEXITY; PATHWAYS; PHOSPHORYLATION; TRANSDUCTION; ACTIVATION; MECHANISM; DYNAMICS; SPACE	Despite much effort, identification of modular structures and study of their organizing and functional roles remain a formidable challenge in molecular systems biology, which, however, is essential in reaching a systematic understanding of large-scale cell regulation networks and hence gaining capacity of exerting effective interference to cell activity. Combining graph theoretic methods with available dynamics information, we successfully retrieved multiple feedback modules of three important signaling networks. These feedbacks are structurally arranged in a hierarchical way and dynamically produce layered temporal profiles of output signals. We found that global and local feedbacks act in very different ways and on distinct features of the information flow conveyed by signal transduction but work highly coordinately to implement specific biological functions. The redundancy embodied with multiple signal-relaying channels and feedback controls bestow great robustness and the reaction hubs seated at junctions of different paths announce their paramount importance through exquisite parameter management. The current investigation reveals intriguing general features of the organization of cell signaling networks and their relevance to biological function, which may find interesting applications in analysis, design and control of bio-networks.	[Xu, Jianfeng; Lan, Yueheng] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Xu, Jianfeng; Lan, Yueheng] Collaborat Innovat Ctr Quantum Matter, Beijing 100084, Peoples R China	Tsinghua University	Lan, YH (corresponding author), Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China.	lanyh@mail.tsinghua.edu.cn	Lan, Yue-heng/AAI-4419-2020		National Natural Science Foundation of China [11375093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (grant no. 11375093); the URL of the funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arkin AP, 2001, CURR OPIN BIOTECH, V12, P638, DOI 10.1016/S0958-1669(01)00273-7; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Chen L, 2010, MODELING BIOMOLECULAR NETWORKS IN CELLS: STRUCTURES AND DYNAMICS, P1, DOI 10.1007/978-1-84996-214-8; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Even S., 2011, GRAPH ALGORITHMS; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harrison DA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011205; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heinrich Reinhart, 1996, REGULATION CELLULAR; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Hynes NE, 2013, NAT REV MOL CELL BIO, V14, P393, DOI 10.1038/nrm3581; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lan YH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-37; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Ma HW, 2004, BIOINFORMATICS, V20, P1870, DOI 10.1093/bioinformatics/bth167; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; Mezic I, 2004, IEEE DECIS CONTR P, P1778, DOI 10.1109/CDC.2004.1430303; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Pavlopoulos GA, BIODATA MINING; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wellstead P, 2008, ANNU REV CONTROL, V32, P33, DOI 10.1016/j.arcontrol.2008.02.001; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-6; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125886	10.1371/journal.pone.0125886	http://dx.doi.org/10.1371/journal.pone.0125886			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4RU	25951347	gold, Green Submitted, Green Published			2022-12-26	WOS:000367788800007
J	Armitage, AR; Highfield, WE; Brody, SD; Louchouarn, P				Armitage, Anna R.; Highfield, Wesley E.; Brody, Samuel D.; Louchouarn, Patrick			The Contribution of Mangrove Expansion to Salt Marsh Loss on the Texas Gulf Coast	PLOS ONE			English	Article							FRESH-WATER INFLOW; SEA-LEVEL RISE; CLIMATE-CHANGE; BLACK MANGROVE; LAND-COVER; OF-MEXICO; AVICENNIA-GERMINANS; AERIAL-PHOTOGRAPHY; THEMATIC MAPPER; NORTHERN GULF	Landscape-level shifts in plant species distribution and abundance can fundamentally change the ecology of an ecosystem. Such shifts are occurring within mangrove-marsh ecotones, where over the last few decades, relatively mild winters have led to mangrove expansion into areas previously occupied by salt marsh plants. On the Texas (USA) coast of the western Gulf of Mexico, most cases of mangrove expansion have been documented within specific bays or watersheds. Based on this body of relatively small-scale work and broader global patterns of mangrove expansion, we hypothesized that there has been a recent regional-level displacement of salt marshes by mangroves. We classified Landsat-5 Thematic Mapper images using artificial neural networks to quantify black mangrove (Avicennia germinans) expansion and salt marsh (Spartina alterniflora and other grass and forb species) loss over 20 years across the entire Texas coast. Between 1990 and 2010, mangrove area grew by 16.1 km(2), a 74% increase. Concurrently, salt marsh area decreased by 77.8 km(2), a 24% net loss. Only 6% of that loss was attributable to mangrove expansion; most salt marsh was lost due to conversion to tidal flats or water, likely a result of relative sea level rise. Our research confirmed that mangroves are expanding and, in some instances, displacing salt marshes at certain locations. However, this shift is not widespread when analyzed at a larger, regional level. Rather, local, relative sea level rise was indirectly implicated as another important driver causing regional-level salt marsh loss. Climate change is expected to accelerate both sea level rise and mangrove expansion; these mechanisms are likely to interact synergistically and contribute to salt marsh loss.	[Armitage, Anna R.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Highfield, Wesley E.; Brody, Samuel D.; Louchouarn, Patrick] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Brody, Samuel D.] Texas A&M Univ, Dept Landscape Architecture & Urban Planning, College Stn, TX USA; [Louchouarn, Patrick] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Armitage, AR (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	armitaga@tamug.edu	Armitage, Anna/X-2773-2019; Highfield, Wesley/AHB-4536-2022	Armitage, Anna/0000-0003-1563-8026; 	National Aeronautics and Space Administration; United States Department of Agriculture [4200407091]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work supported by National Aeronautics and Space Administration and United States Department of Agriculture grant No. 4200407091 from the Research Opportunities in Space and Earth Sciences (ROSES): Carbon Cycle Science program (http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={2EBEDEA0-817D-D318-55C3-BC5086A4AB70}&path=open). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2002, ESTUARIES, V25, P1246, DOI 10.1007/BF02692222; [Anonymous], 1976, LARS S; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Berlanga-Robles CA, 2002, J COASTAL RES, V18, P514; Bianchi TS, 2013, ESTUAR COAST SHELF S, V119, P7, DOI 10.1016/j.ecss.2012.12.007; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Butera MK., 1979, TP1553 NASA; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; CRIST EP, 1986, PHOTOGRAMM ENG REM S, V52, P81; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; Doyle TW, 2010, FOREST ECOL MANAG, V259, P770, DOI 10.1016/j.foreco.2009.10.023; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Engle VD, 2011, WETLANDS, V31, P179, DOI 10.1007/s13157-010-0132-9; Everitt JH, 2010, J COASTAL RES, V26, P649, DOI 10.2112/JCOASTRES-D-09-00133.1; Everitt JH, 1996, J COASTAL RES, V12, P64; Fensham RJ, 2005, J ECOL, V93, P596, DOI 10.1111/j.1365-2745.2005.00998.x; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Fuhlendorf S.D., 2008, ECOL STU AN, P219; Gao J, 1999, INT J REMOTE SENS, V20, P2823, DOI 10.1080/014311699211813; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Giri C, 2011, J COASTAL RES, V27, P1059, DOI 10.2112/JCOASTRES-D-11-00028.1; Giri CP, 2014, P NATL ACAD SCI USA, V111, pE1447, DOI 10.1073/pnas.1400687111; Green BC, 2012, MAR ECOL PROG SER, V466, P177, DOI 10.3354/meps09791; Green EP, 1998, INT J REMOTE SENS, V19, P935, DOI 10.1080/014311698215801; HARDISKY MA, 1986, BIOSCIENCE, V36, P453, DOI 10.2307/1310341; Harvey KR, 2001, INT J REMOTE SENS, V22, P2911, DOI 10.1080/01431160119174; HINSON JM, 1994, MAR TECHNOL SOC J, V28, P4; JENSEN JR, 1993, PHOTOGRAMM ENG REM S, V59, P1039; Juman RA, 2013, J COAST CONSERV, V17, P133, DOI 10.1007/s11852-012-0225-0; Keim BD, 2011, PHYS GEOGR, V32, P561, DOI 10.2747/0272-3646.32.6.561; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kim HC, 2014, J COASTAL RES, P65, DOI 10.2112/SI68-009.1; Krauss KW, 2011, J COAST CONSERV, V15, P629, DOI 10.1007/s11852-011-0153-4; LONARD RI, 1991, SOUTHWEST NAT, V36, P213, DOI 10.2307/3671923; Lovelock CE, 2011, ECOSYSTEMS, V14, P745, DOI 10.1007/s10021-011-9443-9; Madrid EN, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00503; Mas JF, 2008, INT J REMOTE SENS, V29, P617, DOI 10.1080/01431160701352154; Montagna PA, 2002, ESTUARIES, V25, P1243, DOI 10.1007/BF02692221; Montagna PA, 2011, THE IMPACT OF GLOBAL; Osland MJ, 2014, ECOLOGY, V95, P2789, DOI 10.1890/13-1269.1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Palmer TA, 2011, HYDROBIOLOGIA, V667, P49, DOI 10.1007/s10750-011-0637-0; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; PICKENS CN, 2011, WOS, V824, P14, DOI DOI 10.1007/S12237-010-9358-2; Plourde L, 2003, PHOTOGRAMM ENG REM S, V69, P289, DOI 10.14358/PERS.69.3.289; Raabe EA, 2012, ESTUAR COAST, V35, P1145, DOI 10.1007/s12237-012-9503-1; Ramsey EW, 1997, J COASTAL RES, V13, P281; Rogers K, 2013, ECOL MODEL, V264, P27, DOI 10.1016/j.ecolmodel.2013.04.016; Saintilan N, 2013, ESTUAR COAST SHELF S, V128, P84, DOI 10.1016/j.ecss.2013.05.010; Saintilan N., 2009, COASTAL WETLANDS INT, P855; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Saintilan N, 2013, MAR FRESHWATER RES, V64, P66, DOI 10.1071/MF12212; Semeniuk V, 2013, HYDROBIOLOGIA, V708, P23, DOI 10.1007/s10750-012-1159-0; Sharp BR, 2003, J BIOGEOGR, V30, P783, DOI 10.1046/j.1365-2699.2003.00840.x; SHERROD CL, 1981, CONTRIB MAR SCI, V24, P115; Smith TJ, 2013, FIRE ECOL, V9, P66, DOI 10.4996/fireecology.0901066; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Sulong I., 2002, Environment Development and Sustainability, V4, P135, DOI 10.1023/A:1020844620215; Tolan JM, 2007, ESTUAR COAST SHELF S, V72, P247, DOI 10.1016/j.ecss.2006.10.018; Torio DD, 2013, J COASTAL RES, V29, P1049, DOI 10.2112/JCOASTRES-D-12-00162.1; TURNER RE, 1991, ESTUARIES, V14, P139, DOI 10.2307/1351687; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Walsh JE, 2001, J CLIMATE, V14, P2642, DOI 10.1175/1520-0442(2001)014<2642:ECOITU>2.0.CO;2; WEBB JW, 1989, WETLANDS, V9, P61, DOI 10.1007/BF03160768; Williamson GJ, 2011, REG ENVIRON CHANGE, V11, P19, DOI 10.1007/s10113-010-0109-5	71	103	104	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125404	10.1371/journal.pone.0125404	http://dx.doi.org/10.1371/journal.pone.0125404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946132	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700066
J	Kleczko, EK; Kim, J; Keysar, SB; Heasley, LR; Eagles, JR; Simon, M; Marshall, ME; Singleton, KR; Jimeno, A; Tan, AC; Heasley, LE				Kleczko, Emily K.; Kim, Jihye; Keysar, Stephen B.; Heasley, Lydia R.; Eagles, Justin R.; Simon, Matthew; Marshall, Marianne E.; Singleton, Katherine R.; Jimeno, Antonio; Tan, Aik-Choon; Heasley, Lynn E.			An Inducible TGF-beta 2-TGF beta R Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TGF-BETA; GEFITINIB RESISTANCE; PHASE-II; HEAD; CANCER; CARCINOMA; EGFR; MUTATIONS; THROMBOSPONDIN	The epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of head and neck squamous cell carcinomas (HNSCC), and molecularly targeted therapy against the EGFR with the monoclonal antibody cetuximab modestly increases overall survival in head and neck cancer patients. We hypothesize that co-signaling through additional pathways limits the efficacy of cetuximab and EGFR-specific tyrosine kinase inhibitors (TKIs) in the clinical treatment of HNSCC. Analysis of gene expression changes in HNSCC cell lines treated 4 days with TKIs targeting EGFR and/or fibroblast growth factor receptors (FGFRs) identified transforming growth factor beta 2 (TGF-beta 2) induction in the three cell lines tested. Measurement of TGF-beta 2 mRNA validated this observation and extended it to additional cell lines. Moreover, TGF-beta 2 mRNA was increased in primary patient HNSCC xenografts treated for 4 weeks with cetuximab, demonstrating in vivo relevance of these findings. Functional genomics analyses with shRNA libraries identified TGF-beta 2 and TGF-beta receptors (TGF beta Rs) as synthetic lethal genes in the context of TKI treatment. Further, direct RNAi-mediated silencing of TGF-beta 2 inhibited cell growth, both alone and in combination with TKIs. Also, a pharmacological TGF beta RI inhibitor similarly inhibited basal growth and enhanced TKI efficacy. In summary, the studies support a TGF-beta 2-TGF beta R pathway as a TKI-inducible growth pathway in HNSCC that limits efficacy of EGFR-specific inhibitors.	[Kleczko, Emily K.; Heasley, Lydia R.; Simon, Matthew; Marshall, Marianne E.; Singleton, Katherine R.; Heasley, Lynn E.] Univ Colorado, Dept Craniofacial Biol, Aurora, CO 80045 USA; [Kim, Jihye; Keysar, Stephen B.; Eagles, Justin R.; Jimeno, Antonio; Tan, Aik-Choon] Univ Colorado, Dept Med, Aurora, CO USA; [Heasley, Lynn E.] Vet Affairs Eastern Colorado Healthcare Syst, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Kleczko, EK (corresponding author), Univ Colorado, Dept Craniofacial Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	emily.kleczko@ucdenver.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Kleczko, Emily/0000-0003-4254-5415	U.S. Veteran's Affairs Merit Award [1BX001994-01]; University of Colorado Cancer Center [P30 CA046934]; National Institutes of Health [R21DE019712]; NATIONAL CANCER INSTITUTE [P50CA058187, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001994] Funding Source: NIH RePORTER	U.S. Veteran's Affairs Merit Award; University of Colorado Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	U.S. Veteran's Affairs Merit Award 1BX001994-01 was awarded to LEH. Funding was also provided by University of Colorado Cancer Center Support Grant P30 CA046934. National Institutes of Health R21DE019712 was awarded to AJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Baba Y, 2012, J ONCOL, V2012, DOI 10.1155/2012/986725; Barlaam B, 2013, ACS MED CHEM LETT, V4, P742, DOI 10.1021/ml400146c; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; Chin D, 2004, BRIT J PLAST SURG, V57, P595, DOI 10.1016/j.bjps.2004.06.010; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; Keysar SB, 2013, MOL ONCOL, V7, P776, DOI 10.1016/j.molonc.2013.03.004; Kim J, 2012, METHODS MOL BIOL, V802, P389, DOI 10.1007/978-1-61779-400-1_26; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Lee JW, 2005, CLIN CANCER RES, V11, P2879, DOI 10.1158/1078-0432.CCR-04-2029; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Loeffler-Ragy J, 2006, EUR J CANCER, V42, P109, DOI 10.1016/j.ejca.2005.08.034; Marshall ME, 2011, CLIN CANCER RES, V17, P5016, DOI 10.1158/1078-0432.CCR-11-0050; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Murray S, 2010, J ONCOL, V2010, DOI 10.1155/2010/709678; Osthus AA, 2011, ORAL ONCOL, V47, P974, DOI 10.1016/j.oraloncology.2011.07.010; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Ricci C, 2002, CANCER RES, V62, P5995; ROBERTS AB, 1991, CIBA F SYMP, V157, P7; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singleton KR, 2013, MOL PHARMACOL, V83, P882, DOI 10.1124/mol.112.084111; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Stransky N, 2011, SCIENCE; Tada H, 1998, NEPHRON, V79, P38, DOI 10.1159/000044989; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Willmore-Payne C, 2006, MODERN PATHOL, V19, P634, DOI 10.1038/modpathol.3800552; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123600	10.1371/journal.pone.0123600	http://dx.doi.org/10.1371/journal.pone.0123600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946135	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700017
J	Kornete, M; Mason, ES; Girouard, J; Lafferty, EI; Qureshi, S; Piccirillo, CA				Kornete, Mara; Mason, Edward S.; Girouard, Julien; Lafferty, Erin I.; Qureshi, Salman; Piccirillo, Ciriaco A.			Th1-Like ICOS+ Foxp3(+) T-reg Cells Preferentially Express CXCR3 and Home to beta-Islets during Pre-Diabetes in BDC2.5 NOD Mice	PLOS ONE			English	Article							RECEPTOR; DIFFERENTIATION; HOMEOSTASIS; DISEASE; ONSET	Type 1 diabetes (T1D) occurs through a breakdown of self-tolerance resulting in the autoimmune destruction of the insulin producing beta-islets of the pancreas. A numerical and functional waning of CD4(+)Foxp3(+) regulatory T (T-reg) cells, prompted by a pancreatic IL-2 deficiency, accompanies Th1 autoimmunity and T1D progression in non-obese diabetic (NOD) mice. Recently, we identified a dominant subset of intra-islet T-reg cells that expresses the ICOS costimulatory receptor and promotes self-tolerance delaying the onset of T1D. ICOS co-stimulation potently enhances IL-2 induced survival and proliferation, and suppressive activity of T-reg cells in situ. Here, we propose an ICOS-dependent mechanism of T-reg cell homing to the beta-islets during pre-diabetes in the NOD model via upregulation of the CXCR3 chemokine receptor. The islet-specific ICOS+ T-reg cell subset preferentially expresses CXCR3 in the pancreatic lymph nodes (pLN) in response to Teff cell-mediated pancreatic inflammation, an expression correlating with the onset and magnitude of IFN-gamma production by Teff cells in pancreatic sites. We also reveal that intra-pancreatic APC populations and insulin-producing beta, but not a nor d, islet cells secrete the CXCR3 chemokines, CXCL9, 10 and 11, and selectively promote ICOS(+)CXCR3(+) T-reg cell chemotaxis in vitro. Strikingly, islet-derived T-reg cells also produce these chemokines suggesting an auto-regulation of homing by this subset. Unlike ICOS-cells, ICOS+ T-reg cells adopt a Th1-like T-reg phenotype while maintaining their suppressive capacity, characterized by expression of Tbet and CXCR3 and production of IFN-gamma in the draining pLNs. Finally, in vivo neutralization of IFN-gamma blocked T-reg cell CXCR3 upregulation evincing its role in regulating expression of this chemokine receptor by T-reg cells. Thus, CXCR3-mediated trafficking of T-reg cells could represent a mechanism of homeostatic immunoregulation during diabetogeneesis.	[Kornete, Mara; Mason, Edward S.; Girouard, Julien; Piccirillo, Ciriaco A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Qureshi, Salman] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ H3A 2B4, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Ctr Hlth, Res Inst, FOCIS Ctr Excellence Translat Immunol, Montreal, PQ H3A 2B4, Canada; [Lafferty, Erin I.] McGill Univ, Div Expt Med, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Piccirillo, CA (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	Ciro.piccirillo@mcgill.ca			CIHR [MOP67211, MOP-102494]; Fonds de la recherche en sante du Quebec (FRSQ)	CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported from the grants of CIHR (CAP: MOP67211; SQ: MOP-102494). C.A.P. holds the Canada Research Chair. MK has received a doctoral fellowship from the Fonds de la recherche en sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Beaudoin L, 2014, EUR J IMMUNOL, V44, P1454, DOI 10.1002/eji.201343910; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Himmel ME, 2011, EUR J IMMUNOL, V41, P306, DOI 10.1002/eji.201040459; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kornete M, 2013, AUTOIMMUNITY, V46, P259, DOI 10.3109/08916934.2012.752462; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Redjimi N, 2012, CANCER RES, V72, P4351, DOI 10.1158/0008-5472.CAN-12-0579; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Sgouroudis E, 2008, J IMMUNOL, V181, P6283, DOI 10.4049/jimmunol.181.9.6283; Sgouroudis E, 2011, AUTOIMMUNITY, V44, P406, DOI 10.3109/08916934.2010.536795; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yamada Y, 2012, DIABETOLOGIA, V55, P2238, DOI 10.1007/s00125-012-2547-8; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	34	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126311	10.1371/journal.pone.0126311	http://dx.doi.org/10.1371/journal.pone.0126311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946021	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700123
J	Shibano, T; Mamada, H; Hakuno, F; Takahashi, SI; Taira, M				Shibano, Takashi; Mamada, Hiroshi; Hakuno, Fumihiko; Takahashi, Shin-Ichiro; Taira, Masanori			The Inner Nuclear Membrane Protein Nemp1 Is a New Type of RanGTP-Binding Protein in Eukaryotes	PLOS ONE			English	Article							CELL-CYCLE; XENOPUS-EMBRYOS; QUANTITATIVE PHOSPHOPROTEOMICS; IMPORTIN-BETA; IN-VITRO; ENVELOPE; PHOSPHORYLATION; TRANSPORT; KINASE; EXPRESSION	The inner nuclear membrane (INM) protein Nemp1/TMEM194A has previously been suggested to be involved in eye development in Xenopus, and contains two evolutionarily conserved sequences in the transmembrane domains (TMs) and the C-terminal region, named region A and region B, respectively. To elucidate the molecular nature of Nemp1, we analyzed its interacting proteins through those conserved regions. First, we found that Nemp1 interacts with itself and lamin through the TMs and region A, respectively. Colocalization of Nemp1 and lamin at the INM suggests that the interaction with lamin participates in the INM localization of Nemp1. Secondly, through yeast two-hybrid screening using region B as bait, we identified the small GTPase Ran as a probable Nemp1-binding partner. GST pulldown and co-immunoprecipitation assays using region B and Ran mutants revealed that region B binds directly to the GTP-bound Ran through its effector domain. Immunostaining experiments using transfected COS-7 cells revealed that full-length Nemp1 recruits Ran near the nuclear envelope, suggesting a role for Nemp1 in the accumulation of RanGTP at the nuclear periphery. At the neurula-to-tailbud stages of Xenopusembryos, nemp1expression overlapped with ranin several regions including the eye vesicles. Co-knockdown using antisense morpholino oligos for nemp1 and ran caused reduction of cell densities and severe eye defects more strongly than either single knockdown alone, suggesting their functional interaction. Finally we show that Arabidopsis thalianaNemp1-orthologous proteins interact with A. thalianaRan, suggesting their evolutionally conserved physical and functional interactions possibly in basic cellular functions including nuclear transportation. Taken together, we conclude that Nemp1 represents a new type of RanGTP-binding protein.	[Shibano, Takashi; Mamada, Hiroshi; Taira, Masanori] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shibano, Takashi; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Shibano, Takashi; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Taira, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	m_taira@bs.s.u-tokyo.ac.jp	柴野, 卓志/AHB-7015-2022	Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ellis JA, 1998, J CELL SCI, V111, P781; FELDHERR CM, 1994, EXP CELL RES, V215, P206, DOI 10.1006/excr.1994.1333; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hahn S, 2011, BIOCHEM BIOPH RES CO, V406, P383, DOI 10.1016/j.bbrc.2011.02.051; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hiratani I, 2003, DEVELOPMENT, V130, P4161, DOI 10.1242/dev.00621; HOCEVAR BA, 1993, J BIOL CHEM, V268, P7545; Huang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025123; Hughes M, 1998, J CELL SCI, V111, P3017; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Korfali N, 2012, NUCLEUS-PHILA, V3, P552, DOI 10.4161/nucl.22257; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Ma L, 2007, PLANT CELL REP, V26, P1373, DOI 10.1007/s00299-007-0367-y; Mamada H, 2009, DEV BIOL, V327, P497, DOI 10.1016/j.ydbio.2008.12.038; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Merkle T, 2011, PLANT CELL REP, V30, P153, DOI 10.1007/s00299-010-0928-3; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Murphy GA, 1997, MOL BIOL CELL, V8, P2591, DOI 10.1091/mbc.8.12.2591; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Onuma Y, 2000, DEV GENES EVOL, V210, P325, DOI 10.1007/s004270050320; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shibano T, 2007, FEBS LETT, V581, P4333, DOI 10.1016/j.febslet.2007.08.004; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tseng LC, 2011, MOL BIOL CELL, V22, P3306, DOI 10.1091/mbc.E11-03-0199; Vernon AE, 2003, GENE EXPR PATTERNS, V3, P179, DOI 10.1016/S1567-133X(03)00006-1; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Wu W, 2002, J CELL SCI, V115, P1361; Zuleger N, 2011, NUCLEUS-PHILA, V2, P339, DOI 10.4161/nucl.2.5.17846	40	11	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0127271	10.1371/journal.pone.0127271	http://dx.doi.org/10.1371/journal.pone.0127271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946333	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700142
J	Feng, WW; Zhao, T; Mao, GH; Wang, W; Feng, Y; Li, F; Zheng, DH; Wu, HY; Jin, D; Yang, LQ; Wu, XY				Feng, Weiwei; Zhao, Ting; Mao, Guanghua; Wang, Wei; Feng, Yun; Li, Fang; Zheng, Daheng; Wu, Huiyu; Jin, Dun; Yang, Liuqing; Wu, Xiangyang			Type 2 Diabetic Rats on Diet Supplemented With Chromium Malate Show Improved Glycometabolism, Glycometabolism-Related Enzyme Levels and Lipid Metabolism	PLOS ONE			English	Article							HIGH-FAT DIET; PROPIONATE COMPLEX; STEM BARK; PICOLINATE; GLUCOSE; MEMORY; CARBOHYDRATE; ANTIOXIDANT; HEALTH; DAMAGE	Our previous study showed that chromium malate improved the regulation of blood glucose in mice with alloxan-induced diabetes. The present study was designed to evaluate the effect of chromium malate on glycometabolism, glycometabolism-related enzymes and lipid metabolism in type 2 diabetic rats. Our results showed that fasting blood glucose, serum insulin level, insulin resistance index and C-peptide level in the high dose group had a significant downward trend when compared with the model group, chromium picolinate group and chromium trichloride group. The hepatic glycogen, glucose-6-phosphate dehydrogenase, glucokinase, Glut4, phosphor-AMPK beta 1 and Akt levels in the high dose group were significantly higher than those of the model, chromium picolinate and chromium trichloride groups. Chromium malate in a high dose group can significantly increase high density lipoprotein cholesterol level while decreasing the total cholesterol, low density lipoprotein cholesterol and triglyceride levels when compared with chromium picolinate and chromium trichloride. The serum chromium content in chromium malate and chromium picolinate group is significantly higher than that of the chromium trichloride group. The results indicated that the curative effects of chromium malate on glycometabolism, glycometabolism-related enzymes and lipid metabolism changes are better than those of chromium picolinate and chromium trichloride. Chromium malate contributes to glucose uptake and transport in order to improved glycometabolism and glycometabolism-related enzymes.	[Feng, Weiwei; Wang, Wei; Zheng, Daheng] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Zhao, Ting; Jin, Dun; Yang, Liuqing] Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang, Jiangsu, Peoples R China; [Mao, Guanghua; Wu, Xiangyang] Jiangsu Univ, Sch Environm & Safety Engn, Zhenjiang, Jiangsu, Peoples R China; [Feng, Yun; Li, Fang] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Wu, Huiyu] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University	Yang, LQ (corresponding author), Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang, Jiangsu, Peoples R China.	yangliuqing@ujs.edu.cn; wuxy@ujs.edu.cn			Specialized Research Fund for the Natural Science Foundation of China [31271850]; Graduate innovative projects in Jiangsu University [CXLX13_685]	Specialized Research Fund for the Natural Science Foundation of China; Graduate innovative projects in Jiangsu University	This work was supported financially by Specialized Research Fund for the Natural Science Foundation of China (31271850), Graduate innovative projects in Jiangsu University (CXLX13_685).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anekwe TD, 2014, AM J PUBLIC HEALTH, V104, P678, DOI 10.2105/AJPH.2013.301661; Bordbar AK, 2009, J INORG BIOCHEM, V103, P643, DOI 10.1016/j.jinorgbio.2008.10.009; de Vries ST, 2014, J PSYCHOSOM RES, V76, P134, DOI 10.1016/j.jpsychores.2013.11.003; Enomoto T, 2008, BEHAV BRAIN RES, V186, P197, DOI 10.1016/j.bbr.2007.08.012; Fang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103194; Finegold SM, 2011, ANAEROBE, V17, P367, DOI 10.1016/j.anaerobe.2011.03.007; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Hasanein P, 2010, NEUROBIOL LEARN MEM, V93, P472, DOI 10.1016/j.nlm.2010.01.004; He YH, 2009, NUTRITION, V25, P1143, DOI 10.1016/j.nut.2009.04.003; Hepburn DDD, 2003, POLYHEDRON, V22, P455, DOI 10.1016/S0277-5387(02)01369-4; Ibrahim MA, 2014, J ETHNOPHARMACOL, V153, P392, DOI 10.1016/j.jep.2014.02.042; Izbicki JA, 2008, APPL GEOCHEM, V23, P1325, DOI 10.1016/j.apgeochem.2007.11.015; Jain SK, 2007, FREE RADICAL BIO MED, V43, P1124, DOI 10.1016/j.freeradbiomed.2007.05.019; Jangale Nivedita M, 2013, Food Chem, V141, P187, DOI 10.1016/j.foodchem.2013.03.001; Kim DS, 2003, J TRACE ELEM MED BIO, V17, P243, DOI 10.1016/S0946-672X(04)80025-7; Krol E, 2011, FOOD CHEM TOXICOL, V49, P3217, DOI 10.1016/j.fct.2011.09.006; Krol E, 2010, FOOD CHEM TOXICOL, V48, P2791, DOI 10.1016/j.fct.2010.07.008; Kuznetsov L, 2014, DIABETES RES CLIN PR, V104, P281, DOI 10.1016/j.diabres.2013.12.029; Li F, 2012, FOOD CHEM TOXICOL, V50, P1623, DOI 10.1016/j.fct.2012.02.012; Manygoats KR, 2002, J BIOL INORG CHEM, V7, P791, DOI 10.1007/s00775-002-0357-z; Michelle CE, 2014, CANADIAN J DIABETES, P1; Nah WH, 2012, FOOD CHEM, V134, P173, DOI 10.1016/j.foodchem.2012.02.085; Qiu CY, 2011, TOXICOLOGY, V289, P83, DOI 10.1016/j.tox.2011.07.012; Rahigude A, 2012, NEUROSCIENCE, V226, P62, DOI 10.1016/j.neuroscience.2012.09.026; Sahin K, 2007, METABOLISM, V56, P1233, DOI 10.1016/j.metabol.2007.04.021; Salido EM, 2012, EXP NEUROL, V236, P151, DOI 10.1016/j.expneurol.2012.04.010; Sereshti H, 2011, TALANTA, V83, P885, DOI 10.1016/j.talanta.2010.10.052; Sharma S, 2011, J TRACE ELEM MED BIO, V25, P149, DOI 10.1016/j.jtemb.2011.03.003; Song NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105174; Staniek H, 2010, FOOD CHEM TOXICOL, V48, P859, DOI 10.1016/j.fct.2009.12.022; Suge R, 2012, BRAIN RES, V1481, P97, DOI 10.1016/j.brainres.2012.08.056; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Veerapur VP, 2012, FOOD CHEM, V132, P186, DOI 10.1016/j.foodchem.2011.10.052; Vincent JB, 2004, P NUTR SOC, V63, P41, DOI 10.1079/PNS2003315; Whittaker P, 2005, FOOD CHEM TOXICOL, V43, P1619, DOI 10.1016/j.fct.2005.05.003; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Wu XY, 2011, BIOL TRACE ELEM RES, V143, P1031, DOI 10.1007/s12011-010-8916-6; Xu J, 2014, J ETHNOPHARMACOL, V153, P368, DOI 10.1016/j.jep.2014.02.020; Yang XP, 2005, FEBS LETT, V579, P1458, DOI 10.1016/j.febslet.2005.01.049; YOUSEFIDAREDOR H, 2014, ASIAN PAC J TROP DIS, V4, P412, DOI DOI 10.1016/S2222-1808(14)60598-3	41	29	31	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125952	10.1371/journal.pone.0125952	http://dx.doi.org/10.1371/journal.pone.0125952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942313	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400057
J	Chiu, CT; Liao, CK; Shen, CC; Tang, TK; Jow, GM; Wang, HS; Wu, JC				Chiu, Chi-Ting; Liao, Chih-Kai; Shen, Chien-Chang; Tang, Tswen-Kei; Jow, Guey-Mei; Wang, Hwai-Shi; Wu, Jiahn-Chun			HYS-32-Induced Microtubule Catastrophes in Rat Astrocytes Involves the PI3K-GSK3beta Signaling Pathway	PLOS ONE			English	Article							PLUS-END; CELL-MIGRATION; NEURONAL POLARITY; AXON GROWTH; EB1; DYNAMICS; EXPRESSION; PHOSPHORYLATION; GSK-3-BETA; ASSOCIATION	HYS-32 is a novel derivative of combretastatin-A4 (CA-4) previously shown to induce microtubule coiling in rat primary astrocytes. In this study, we further investigated the signaling mechanism and EB1, a microtubule-associated end binding protein, involved in HYS-32-induced microtubule catastrophes. Confocal microscopy with double immunofluorescence staining revealed that EB1 accumulates at the growing microtubule plus ends, where they exhibit a bright comet-like staining pattern in control astrocytes. HYS-32 induced microtubule catastrophes in both a dose-and time-dependent manner and dramatically increased the distances between microtubule tips and the cell border. Treatment of HYS-32 (5 mu M) eliminated EB1 localization at the microtubule plus ends and resulted in an extensive redistribution of EB1 to the microtubule lattice without affecting the beta-tubulin or EB1 protein expression. Time-lapse experiments with immunoprecipitation further displayed that the association between EB-1 and beta-tubulin was significantly decreased following a short-term treatment (2 h), but gradually increased in a prolonged treatment (6-24 h) with HYS-32. Further, HYS-32 treatment induced GSK3 beta phosphorylation at Y216 and S9, where the ratio of GSK3 beta-pY216 to GSK3 beta-pS9 was first elevated followed by a decrease over time. Co-treatment of astrocytes with HYS-32 and GSK3 beta inhibitor SB415286 attenuated the HYS-32-induced microtubule catastrophes and partially prevented EB1 dissociation from the plus end of microtubules. Furthermore, co-treatment with PI3K inhibitor LY294002 inhibited HYS-32-induced GSK3 beta-pS9 and partially restored EB1 distribution from the microtubule lattice to plus ends. Together these findings suggest that HYS-32 induces microtubule catastrophes by preventing EB1 from targeting to microtubule plus ends through the GSK3 beta signaling pathway.	[Chiu, Chi-Ting; Wang, Hwai-Shi; Wu, Jiahn-Chun] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 11221, Taiwan; [Liao, Chih-Kai] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10051, Taiwan; [Shen, Chien-Chang] Natl Res Inst Chinese Med, Div Med Chem, Taipei 11221, Taiwan; [Tang, Tswen-Kei] Natl Quemoy Univ, Dept Nursing, Coll Nursing & Hlth, Kinmen 89250, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Research Institute of Chinese Medicine; Fu Jen Catholic University	Wu, JC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 11221, Taiwan.	jcwu2@ym.edu.tw			MOST grant [Ministry of Science and Technology, Taiwan] [MOST-103-2320-B010-013]	MOST grant [Ministry of Science and Technology, Taiwan]	JCW was supported by a MOST grant [Ministry of Science and Technology, Taiwan, grant number: MOST-103-2320-B010-013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Behrens J, 2010, EUR J CELL BIOL, V89, P828, DOI 10.1016/j.ejcb.2010.06.003; Camand E, 2012, J CELL SCI, V125, P844, DOI 10.1242/jcs.087668; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Liao CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079350; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; Lin PC, 2013, NEUROCHEM INT, V62, P881, DOI 10.1016/j.neuint.2013.02.027; Liu CM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00003; Matsunaga W, 2002, NEUROSCIENCE, V111, P151, DOI 10.1016/S0306-4522(01)00607-8; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Pagano A, 2012, BIOCHEM PHARMACOL, V84, P432, DOI 10.1016/j.bcp.2012.05.010; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; SANCHEZMARGALET V, 1994, ROLE PHOSPHATIDYLINO, V204, P446; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; SHAIN W, 1992, GLIA, V5, P223, DOI 10.1002/glia.440050308; SHEN C-L, 1984, Proceedings of the National Science Council Republic of China Part B Life Sciences, V8, P324; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126217	10.1371/journal.pone.0126217	http://dx.doi.org/10.1371/journal.pone.0126217			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938237	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000153
J	Cooper, S; Guo, H; Friedman, AD				Cooper, Stacy; Guo, Hong; Friedman, Alan D.			The+37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBP alpha, PU.1, and Additional Ets Factors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GRANULOCYTIC DIFFERENTIATION; C-MYB; CELLS; PROMOTER; LEUKEMIA; INHIBITION	The murine Cebpa gene contains an evolutionarily conserved 453 bp enhancer located at +37 kb that, together with its promoter, directs expression to myeloid progenitors and to long-term hematopoietic stem cells in transgenic mice. In human acute myeloid leukemia cases, the enhancer lacks point mutations but binds the RUNX1-ETO oncoprotein. The enhancer contains the H3K4me1 and H3K27Ac histone modifications, denoting an active enhancer, at progressively increasing levels as long-term hematopoietic stem cells transition to granulocyte-monocyte progenitors. We previously identified four enhancer sites that bind RUNX1 and demonstrated that their integrity is required for maximal enhancer activity in 32Dcl3 myeloid cells. The +37 kb Cebpa enhancer also contains C/EBP, Ets factor, Myb, GATA, and E-box consensus sites conserved in the human +42 kb CEBPA enhancer. Mutation of the two C/EBP, seven Ets, one Myb, two GATA, or two E-box sites reduces activity of an enhancer-promoter reporter in 32Dcl3 cells. In 293T gel shift assays, exogenous C/EBP alpha binds both C/EBP sites, c-Myb binds the Myb site, PU.1 binds the second Ets site, PU.1, Fli-1, ERG, and Ets1 bind the sixth Ets site, GATA2 binds both GATA sites, and SCL binds the second E-box. Endogenous hematopoietic RUNX1, PU.1, Fli-1, ERG, C/EBP alpha, GATA2, and SCL were previously shown to bind the enhancer, and we find that endogenous PU.1 binds the second Ets site in 32Dcl3 cells. Using CRISPR/Cas9, we developed 32Dcl3 lines in which the wild-type enhancer alleles are replaced with a variant mutant in the seven Ets sites. These lines have 20-fold reduced Cebpa mRNA when cultured in IL-3 or G-CSF, demonstrating a critical requirement for enhancer integrity for optimal Cebpa expression. In addition, these results indicate that the +37 kb Cebpa enhancer is the focus of multiple regulatory transcriptional pathways that impact its expression during normal hematopoiesis and potentially during myeloid transformation.	[Cooper, Stacy; Guo, Hong; Friedman, Alan D.] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University	Friedman, AD (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21205 USA.	afriedm2@jhmi.edu			National Institutes of Health [U01 HL099775, T32 CA60441]; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [T32CA060441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants U01 HL099775 and T32 CA60441, www.nih.gov. The U01 grant includes funds designated for Dr. Friedman's laboratory and personnel support. The T32 grant is a training grant which helps fund Dr. Cooper's salary. The Giant Food Children's Cancer Research Fund, no grant number, www.giantfood.com. Giant foods makes an annual charitable donation to our Pediatric Oncology division and the monies are used in part for maintaining laboratory equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberich-Jorda M, 2012, J CLIN INVEST, V122, P4490, DOI 10.1172/JCI65102; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; BritosBray M, 1997, MOL CELL BIOL, V17, P5127, DOI 10.1128/MCB.17.9.5127; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Guo H, 2014, J LEUKOCYTE BIOL, V96, P419, DOI 10.1189/jlb.2AB0314-145R; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Helboe L, 2003, EUR J NEUROSCI, V18, P2227, DOI 10.1046/j.1460-9568.2003.02966.x; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ma O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095784; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; SCOTT LM, 1992, BLOOD, V80, P1725; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; SUZOW J, 1993, MOL CELL BIOL, V13, P2141, DOI 10.1128/MCB.13.4.2141; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024	30	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126385	10.1371/journal.pone.0126385	http://dx.doi.org/10.1371/journal.pone.0126385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938608	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000159
J	Di Nardo, F; Cogo, CE; Faelli, E; Morettini, M; Burattini, L; Ruggeri, P				Di Nardo, Francesco; Cogo, Carla E.; Faelli, Emanuela; Morettini, Micaela; Burattini, Laura; Ruggeri, Piero			C-Peptide-Based Assessment of Insulin Secretion in the Zucker Fatty Rat: A Modelistic Study	PLOS ONE			English	Article							BETA-CELL FUNCTION; HEPATIC EXTRACTION; GLUCOSE-TOLERANCE; MINIMAL MODEL; SENSITIVITY; RESISTANCE; HUMANS; MECHANISMS; KINETICS	A C-peptide-based assessment of beta-cell function was performed here in the Zucker fatty rat, a suitable animal model of human metabolic syndrome. To this aim, a 90-min intravenous glucose tolerance test (IVGTT) was performed in seven Zucker fatty rats (ZFR), 7-to-9week-old, and seven age-matched Zucker lean rats (ZLR). The minimal model of Cpeptide (CPMM), originally introduced for humans, was adapted to Zucker rats and then applied to interpret IVGTT data. For a comprehensive evaluation of glucose tolerance in ZFR, CPMM was applied in combination with the minimal model of glucose kinetics (GKMM). Our results showed that the present CPMM-based interpretation of data is able to: 1) provide a suitable fit of C-Peptide data; 2) achieve a satisfactory estimation of parameters of interest 3) quantify both insulin secretion by estimating the time course of pre-hepatic secretion rate, SR(t), and total insulin secretion, TIS, and pancreatic sensitivity by means of three specific indexes of beta-cell responsiveness to glucose stimulus (first-phase,phi(1), second-phase,phi(2), and steady-state,phi(ss), never assessed in Zucker rats before; 4) detect the significant enhancement of insulin secretion in the ZFR, in face of a severe insulin-resistant state, previously observed only using a purely experimental approach. Thus, the methodology presented here represents a reliable tool to assess beta-cell function in the Zucker rat, and opens new possibilities for the quantification of further processes involved in glucose homeostasis such as the hepatic insulin degradation.	[Di Nardo, Francesco; Morettini, Micaela; Burattini, Laura] Univ Politecn Marche, Dept Informat Engn, Ancona, Italy; [Cogo, Carla E.; Faelli, Emanuela; Ruggeri, Piero] Univ Genoa, Dept Expt Med, Genoa, Italy	Marche Polytechnic University; University of Genoa	Di Nardo, F (corresponding author), Univ Politecn Marche, Dept Informat Engn, Ancona, Italy.	f.dinardo@univpm.it	Di Nardo, Francesco/AAD-1680-2019; Morettini, Micaela/K-3097-2018; Burattini, Laura/I-7962-2012; faelli, emanuela/AAF-3607-2021	Di Nardo, Francesco/0000-0002-5362-3776; Morettini, Micaela/0000-0002-8327-8379; Burattini, Laura/0000-0002-9474-7046; ruggeri, piero/0000-0001-5939-1489; FAELLI, EMANUELA LUISA/0000-0002-9093-8021				Ahren B, 2005, DIABETOLOGIA, V48, P2140, DOI 10.1007/s00125-005-1915-z; Anderwald CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077326; Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BRAY GA, 1977, FED PROC, V36, P148; Burattini L, 2006, COMPUTERS IN CARDIOL, V33, P85; Carson ER, 1983, THE MATHEMATICAL MOD; Chentouf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022954; COBELLI C, 1988, DIABETES, V37, P223, DOI 10.2337/diabetes.37.2.223; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Di Nardo F, 2009, EXP PHYSIOL, V94, P162, DOI 10.1113/expphysiol.2008.044529; Di Nardo F, 2013, COMPUT METH PROG BIO, V110, P215, DOI 10.1016/j.cmpb.2012.10.007; Di Nardo Francesco, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P449; Di Nardo F, 2010, COMPUT METH PROG BIO, V97, P189, DOI 10.1016/j.cmpb.2009.08.007; EATON RP, 1980, J CLIN ENDOCR METAB, V51, P520, DOI 10.1210/jcem-51-3-520; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrannini E, 2004, DIABETOLOGIA, V47, P943, DOI 10.1007/s00125-004-1381-z; Filipsson K, 1998, AM J PHYSIOL-ENDOC M, V274, pE834, DOI 10.1152/ajpendo.1998.274.5.E834; Goh TT, 2007, AM J PHYSIOL-ENDOC M, V292, pE549, DOI 10.1152/ajpendo.00255.2006; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; KURTZ TW, 1989, HYPERTENSION, V13, P896, DOI 10.1161/01.HYP.13.6.896; Liu RH, 2002, INT J OBESITY, V26, P318, DOI 10.1038/sj.ijo.0801924; Natalucci S, 2000, EXP PHYSIOL, V85, P775; PACINI G, 1990, COMPUT METH PROG BIO, V32, P241, DOI 10.1016/0169-2607(90)90106-J; Pacini G, 2001, AM J PHYSIOL-ENDOC M, V281, pE693, DOI 10.1152/ajpendo.2001.281.4.E693; POLONSKY KS, 1986, J CLIN INVEST, V77, P98, DOI 10.1172/JCI112308; Ruggeri P, 1999, PFLUGERS ARCHIV, V438, pR15; Ruggeri P, 2006, AM J PHYSIOL-REG I, V291, pR376, DOI 10.1152/ajpregu.00644.2005; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Toffolo G, 2006, AM J PHYSIOL-ENDOC M, V290, pE169, DOI 10.1152/ajpendo.00473.2004; TOFFOLO G, 1995, DIABETES, V44, P845, DOI 10.2337/diabetes.44.7.845; Wasserman L, 2004, ALL OF STATISTICS A; Watanabe RM, 2000, DIABETES, V49, P373, DOI 10.2337/diabetes.49.3.373	35	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125252	10.1371/journal.pone.0125252	http://dx.doi.org/10.1371/journal.pone.0125252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938808	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000052
J	Kanke, M; Macdonald, PM				Kanke, Matt; Macdonald, Paul M.			Translational Activation of Oskar mRNA: Reevaluation of the Role and Importance of a 5 ' Regulatory Element	PLOS ONE			English	Article							DROSOPHILA OOCYTE; BINDING-PROTEIN; POSTERIOR POLE; BICAUDAL-C; LOCALIZATION; EXPRESSION; OOGENESIS; BRUNO; ORGANIZATION; REPRESSION	Local translation of oskar (osk) mRNA at the posterior pole of the Drosophila oocyte is essential for axial patterning of the embryo, and is achieved by a program of translational repression, mRNA localization, and translational activation. Multiple forms of repression are used to prevent Oskar protein from accumulating at sites other than the oocyte posterior. Activation is mediated by several types of cis-acting elements, which presumably control different forms of activation. We characterize a 5' element, positioned in the coding region for the Long Osk isoform and in the extended 5' UTR for translation of the Short Osk isoform. This element was previously thought to be essential for osk mRNA translation, with a role in posterior-specific release from repression. From our work, which includes assays which separate the effects of mutations on RNA regulatory elements and protein coding capacity, we find that the element is not essential, and conclude that there is no evidence supporting a role for the element only at the posterior of the oocyte. The 5' element has a redundant role, and is only required when Long Osk is not translated from the same mRNA. Mutations in the element do disrupt the anchoring function of Long Osk protein through their effects on the amino acid sequence, a confounding influence on interpretation of previous experiments.	[Kanke, Matt; Macdonald, Paul M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Macdonald, PM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	pmac@utexas.edu			National Institutes of Health (USA) [GM54409]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054409] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from the National Institutes of Health (USA) grant GM54409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit P, 2008, DEVELOPMENT, V135, P1969, DOI 10.1242/dev.021444; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kim G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004992; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Lasko P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012294; Lasko P, 2011, WIRES RNA, V2, P408, DOI 10.1002/wrna.70; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Reveal B, 2010, DEV CELL, V18, P496, DOI 10.1016/j.devcel.2009.12.021; Saffman EE, 1998, MOL CELL BIOL, V18, P4855, DOI 10.1128/MCB.18.8.4855; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Snee MJ, 2007, DIFFERENTIATION, V75, P246, DOI 10.1111/j.1432-0436.2006.00136.x; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; Wieschaus E., 1986, P199; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Zimyanin V, 2007, CURR BIOL, V17, P353, DOI 10.1016/j.cub.2006.12.044	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125849	10.1371/journal.pone.0125849	http://dx.doi.org/10.1371/journal.pone.0125849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938537	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000108
J	Liu, ZK; Liu, YH; Shan, HK; Cai, BP; Huang, Q				Liu, Zengkai; Liu, Yonghong; Shan, Hongkai; Cai, Baoping; Huang, Qing			A Fault Diagnosis Methodology for Gear Pump Based on EEMD and Bayesian Network	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; ALGORITHM; VIBRATION; FAILURE	This paper proposes a fault diagnosis methodology for a gear pump based on the ensemble empirical mode decomposition (EEMD) method and the Bayesian network. Essentially, the presented scheme is a multi-source information fusion based methodology. Compared with the conventional fault diagnosis with only EEMD, the proposed method is able to take advantage of all useful information besides sensor signals. The presented diagnostic Bayesian network consists of a fault layer, a fault feature layer and a multi-source information layer. Vibration signals from sensor measurement are decomposed by the EEMD method and the energy of intrinsic mode functions (IMFs) are calculated as fault features. These features are added into the fault feature layer in the Bayesian network. The other sources of useful information are added to the information layer. The generalized three-layer Bayesian network can be developed by fully incorporating faults and fault symptoms as well as other useful information such as naked eye inspection and maintenance records. Therefore, diagnostic accuracy and capacity can be improved. The proposed methodology is applied to the fault diagnosis of a gear pump and the structure and parameters of the Bayesian network is established. Compared with artificial neural network and support vector machine classification algorithms, the proposed model has the best diagnostic performance when sensor data is used only. A case study has demonstrated that some information from human observation or system repair records is very helpful to the fault diagnosis. It is effective and efficient in diagnosing faults based on uncertain, incomplete information.	[Liu, Zengkai; Liu, Yonghong; Cai, Baoping] China Univ Petr, Coll Mech & Elect Engn, Qingdao 266580, Peoples R China; [Shan, Hongkai] Xi An Jiao Tong Univ, Dept Mech Engn, Xian 710049, Peoples R China; [Huang, Qing] China Beijing Petrochem Engn Co Ltd, Beijing 100107, Peoples R China	China University of Petroleum; Xi'an Jiaotong University	Liu, YH (corresponding author), China Univ Petr, Coll Mech & Elect Engn, Qingdao 266580, Peoples R China.	liuyhup@163.com		Liu, Yonghong/0000-0002-4339-6389; Liu, Zengkai/0000-0001-6475-7481	Open Fund of Key Laboratory of Oil & Gas Equipment, Ministry of Education (Southwest Petroleum University) [OGE20140324]; National Natural Science Foundation of China [51309240]; Specialized Research Fund for the Doctoral Program of Higher Education [20130133120007]; Applied Basic Research Programs of Qingdao [14-2-4-68-jch]; Science and Technology Project of Huangdao District [2014-1-48]; Fundamental Research Funds for the Central Universities [13CX02077A]; National High-Technology Research and Development Program of China [2013AA09A220]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1086]; Incubation Program of Excellent Doctoral Dissertation of China University of Petroleum [2013-4]	Open Fund of Key Laboratory of Oil & Gas Equipment, Ministry of Education (Southwest Petroleum University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Applied Basic Research Programs of Qingdao; Science and Technology Project of Huangdao District; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High-Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Incubation Program of Excellent Doctoral Dissertation of China University of Petroleum	The authors wish to acknowledge the financial support of Open Fund of Key Laboratory of Oil & Gas Equipment, Ministry of Education (Southwest Petroleum University) (No. OGE20140324), National Natural Science Foundation of China (No. 51309240), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130133120007), Applied Basic Research Programs of Qingdao (No. 14-2-4-68-jch), Science and Technology Project of Huangdao District (No. 2014-1-48), Fundamental Research Funds for the Central Universities (No. 13CX02077A), National High-Technology Research and Development Program of China (No. 2013AA09A220), Program for Changjiang Scholars and Innovative Research Team in University (IRT1086), and Incubation Program of Excellent Doctoral Dissertation of China University of Petroleum (No. 2013-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Badour F, 2011, MECH SYST SIGNAL PR, V25, P2083, DOI 10.1016/j.ymssp.2011.01.017; Amarnath M, 2014, MEASUREMENT, V58, P154, DOI 10.1016/j.measurement.2014.08.015; Amarnath M, 2013, TRIBOL INT, V61, P224, DOI 10.1016/j.triboint.2013.01.001; Amirat Y, 2013, MECH SYST SIGNAL PR, V41, P667, DOI 10.1016/j.ymssp.2013.06.012; Barco R, 2009, EXPERT SYST APPL, V36, P489, DOI 10.1016/j.eswa.2007.09.030; Ben Ali J, 2015, APPL ACOUST, V89, P16, DOI 10.1016/j.apacoust.2014.08.016; Caesarendra W, 2013, J MECH SCI TECHNOL, V27, P2253, DOI 10.1007/s12206-013-0608-7; Cai BP, 2014, APPL ENERG, V114, P1, DOI 10.1016/j.apenergy.2013.09.043; Ehrhardt MJ, 2012, COMPUT GEOSCI-UK, V45, P4, DOI 10.1016/j.cageo.2012.03.022; Feng G, 2014, PATTERN RECOGN, V47, P2057, DOI 10.1016/j.patcog.2013.12.005; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jing JP, 2009, MECH MACH THEORY, V44, P697, DOI 10.1016/j.mechmachtheory.2008.05.002; Kariv G, 2011, COMPUT METH PROG BIO, V104, P135, DOI 10.1016/j.cmpb.2010.06.018; Lei YG, 2008, MECH SYST SIGNAL PR, V22, P419, DOI 10.1016/j.ymssp.2007.07.013; Lei YG, 2009, MECH SYST SIGNAL PR, V23, P1327, DOI 10.1016/j.ymssp.2008.11.005; Maglogiannis I, 2006, J BIOMED INFORM, V39, P637, DOI 10.1016/j.jbi.2005.10.003; Mahgoun H, 2012, MECH IND, V13, P33, DOI 10.1051/meca/2011150; Muralidharan V, 2013, MEASUREMENT, V46, P353, DOI 10.1016/j.measurement.2012.07.007; Onisko A, 2001, INT J APPROX REASON, V27, P165, DOI 10.1016/S0888-613X(01)00039-1; Oukhellou L, 2008, TRANSPORT RES C-EMER, V16, P755, DOI 10.1016/j.trc.2008.04.001; Paya BA, 1997, MECH SYST SIGNAL PR, V11, P751, DOI 10.1006/mssp.1997.0090; Peng FQ, 2011, MECH SYST SIGNAL PR, V25, P549, DOI 10.1016/j.ymssp.2010.06.004; Sahin F, 2007, PARALLEL COMPUT, V33, P124, DOI 10.1016/j.parco.2006.11.005; Samanta B, 2004, MECH SYST SIGNAL PR, V18, P625, DOI 10.1016/S0888-3270(03)00020-7; Samanta B, 2003, MECH SYST SIGNAL PR, V17, P317, DOI 10.1006/mssp.2001.1462; Sun Y, 2011, EXPERT SYST APPL, V38, P442, DOI 10.1016/j.eswa.2010.06.084; Van M, 2014, IET SCI MEAS TECHNOL, V8, P571, DOI 10.1049/iet-smt.2014.0023; Wang X, 2013, MECH SYST SIGNAL PR, V41, P581, DOI 10.1016/j.ymssp.2013.07.009; Weber P, 2012, ENG APPL ARTIF INTEL, V25, P671, DOI 10.1016/j.engappai.2010.06.002; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xiao F, 2014, AUTOMAT CONSTR, V41, P106, DOI 10.1016/j.autcon.2013.10.019; Xu BG, 2012, EXPERT SYST APPL, V39, P816, DOI 10.1016/j.eswa.2011.07.079; Zagorecki A, 2013, IEEE T SYST MAN CY-S, V43, P186, DOI 10.1109/TSMCA.2012.2189880; Zhao Y, 2013, ENERG BUILDINGS, V57, P278, DOI 10.1016/j.enbuild.2012.11.007	34	21	26	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125703	10.1371/journal.pone.0125703	http://dx.doi.org/10.1371/journal.pone.0125703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938760	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000092
J	Milligan, GN; Sarathy, VV; Infante, E; Li, L; Campbell, GA; Beatty, PR; Harris, E; Barrett, ADT; Bourne, N				Milligan, Gregg N.; Sarathy, Vanessa V.; Infante, Ernesto; Li, Li; Campbell, Gerald A.; Beatty, P. Robert; Harris, Eva; Barrett, Alan D. T.; Bourne, Nigel			A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice	PLOS ONE			English	Article							INTERFERON RECEPTOR; NONHUMAN-PRIMATES; MOUSE MODEL; DEFICIENT; DISEASE; STRAIN; PATHOGENESIS; ENHANCEMENT; PROTECTION; INHIBITOR	Dengue is a mosquito-borne disease of global public health significance that is caused by four serologically and genetically related viruses (DENV-1 to DENV-4). Most human DENV infections are asymptomatic, but clinical cases can range in severity from a relatively mild self-limiting illness to a severe life-threatening disease. Infection with one serotype of DENV results in life-long homotypic immunity but only short term heterotypic protection. There are no licensed vaccines or antivirals for dengue due in part to difficulty in developing small animal models that mimic the systemic disease seen in humans. Consequently, an important advance was the description of models of DENV-2 infection in AG129 mice (deficient in interferon alpha/beta and gamma receptor signaling) that resemble human disease. However, the need for well characterized models of disease due to DENV-1, -3, and -4 still remains. Here we describe a new AG129 mouse model utilizing a non-mouse-adapted Thai human DENV-4 strain 703-4. Following intraperitoneal challenge, animals experience a rapidly progressive lethal infection without developing neurologic clinical signs of disease. High virus titers are seen in multiple visceral tissues including the liver, spleen and large intestine, and the infected animals develop vascular leakage and thrombocytopenia, hallmarks of human dengue. Taken together, our studies demonstrate that this model is an important addition to the field of dengue research particularly in understanding similarities and differences in the pathologic basis of the disease caused by different DENV serotypes and in determining comparative efficacy of putative vaccines and antivirals.	[Milligan, Gregg N.; Infante, Ernesto; Bourne, Nigel] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Milligan, Gregg N.; Sarathy, Vanessa V.; Barrett, Alan D. T.; Bourne, Nigel] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Milligan, Gregg N.; Bourne, Nigel] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sarathy, Vanessa V.; Li, Li; Campbell, Gerald A.; Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Beatty, P. Robert] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Harris, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bourne, N (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	nibourne@utmb.edu	Sarathy, Vanessa V./U-7803-2019	Sarathy, Vanessa V./0000-0002-1262-2101; Campbell, Gerald/0000-0002-7123-6884	National Institute of Allergy and Infectious Diseases [N01 AI 30065]; National Institute of Allergy and Infectious Diseases T32 postdoctoral fellowship [AI 07536]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007536] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases T32 postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov/) contract N01 AI 30065 (ADTB, NB). VVS was supported by National Institute of Allergy and Infectious Diseases T32 postdoctoral fellowship AI 07536. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cassetti MC, 2014, VACCINE, V32, P3115, DOI 10.1016/j.vaccine.2014.04.017; Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045; Chang JH, 2011, ANTIVIR RES, V92, P369, DOI 10.1016/j.antiviral.2011.08.003; Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305; Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990; Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Tan GKX, 2011, ANN ACAD MED SINGAP, V40, P523; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2019, DENG SEV DENG; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	30	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125476	10.1371/journal.pone.0125476	http://dx.doi.org/10.1371/journal.pone.0125476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938762	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000071
J	Schneider, M; Schumacher, V; Lischke, T; Lucke, K; Meyer-Schwesinger, C; Velden, J; Koch-Nolte, F; Mittrucker, HW				Schneider, Michael; Schumacher, Valea; Lischke, Timo; Luecke, Karsten; Meyer-Schwesinger, Catherine; Velden, Joachim; Koch-Nolte, Friedrich; Mittruecker, Hans-Willi			CD38 Is Expressed on Inflammatory Cells of the Intestine and Promotes Intestinal Inflammation	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; INNATE IMMUNE-RESPONSE; T-CELLS; RETINOIC ACID; EXTRACELLULAR NAD(+); MICE; SURFACE; GLYCOHYDROLASE; CYCLASE; ENZYME	The enzyme CD38 is expressed on a variety of hematopoietic and non-hematopoietic cells and is involved in diverse processes such as generation of calcium-mobilizing metabolites, cell activation, and chemotaxis. Here, we show that under homeostatic conditions CD38 is highly expressed on immune cells of the colon mucosa of C57BL/6 mice. Myeloid cells recruited to this tissue upon inflammation also express enhanced levels of CD38. To determine the role of CD38 in intestinal inflammation, we applied the dextran sulfate sodium (DSS) colitis model. Whereas wild-type mice developed severe colitis, CD38(-/-) mice had only mild disease following DSS-treatment. Histologic examination of the colon mucosa revealed pronounced inflammatory damage with dense infiltrates containing numerous granulocytes and macrophages in wild-type animals, while these findings were significantly attenuated in CD38(-/-) mice. Despite attenuated histological findings, the mRNA expression of inflammatory cytokines and chemokines was only marginally lower in the colons of CD38(-/-) mice as compared to wild-type mice. In conclusion, our results identify a function for CD38 in the control of inflammatory processes in the colon.	[Schneider, Michael; Schumacher, Valea; Lischke, Timo; Luecke, Karsten; Koch-Nolte, Friedrich; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Meyer-Schwesinger, Catherine] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Nephrol, Hamburg, Germany; [Velden, Joachim] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mittrucker, HW (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	h.mittruecker@uke.de		Lischke, Timo/0000-0003-0413-4252; Yan, Karsten/0000-0002-7343-2205; Koch-Nolte, Friedrich/0000-0003-1730-6674	Deutsche Forschungsgemeinschaft [MI476/3-1, SFB841, GRK841, PAK362, SFB877, KF228]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the following: Deutsche Forschungsgemeinschaft MI476/3-1, SFB841, HWM; Deutsche Forschungsgemeinschaft GRK841, MS; Deutsche Forschungsgemeinschaft PAK362, SFB877, FKN; and Deutsche Forschungsgemeinschaft KF228, CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriouch S, 2012, MICROBES INFECT, V14, P1284, DOI 10.1016/j.micinf.2012.05.011; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Cervantes-Sandoval I, 2008, PARASITOL INT, V57, P307, DOI 10.1016/j.parint.2008.01.006; Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Chen YG, 2006, J IMMUNOL, V177, P2939, DOI 10.4049/jimmunol.177.5.2939; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; COOPER HS, 1993, LAB INVEST, V69, P238; Deaglio S, 2001, FASEB J, V15, P580; DRACH J, 1993, BIOCHEM BIOPH RES CO, V195, P545, DOI 10.1006/bbrc.1993.2080; du Pre MF, 2011, AM J GASTROENTEROL, V106, P1147, DOI 10.1038/ajg.2011.24; Ernst IMA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00259; Estrada-Figueroa LA, 2011, PARASITE IMMUNOL, V33, P661, DOI 10.1111/j.1365-3024.2011.01333.x; Gally F, 2009, AM J RESP CELL MOL, V40, P433, DOI 10.1165/rcmb.2007-0392OC; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Hussain AMM, 1998, PROTEIN EXPRES PURIF, V12, P133, DOI 10.1006/prep.1997.0811; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kahl S, 2000, J IMMUNOL, V165, P4463, DOI 10.4049/jimmunol.165.8.4463; KONTANI K, 1993, J BIOL CHEM, V268, P16895; Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13; Lischke T, 2013, EUR J IMMUNOL, V43, P1828, DOI 10.1002/eji.201243231; Lo Buono N, 2014, FRONT BIOSCI-LANDMRK, V19, P366, DOI 10.2741/4213; Longhi MS, 2013, J MOL MED, V91, P165, DOI 10.1007/s00109-012-0991-z; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MCNAGNY KM, 1988, J IMMUNOL, V141, P2551; Meyer-Schwesinger C, 2011, J IMMUNOL, V187, P3218, DOI 10.4049/jimmunol.1003451; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Partida-Sanchez S, 2003, MICROBES INFECT, V5, P49, DOI 10.1016/S1286-4579(02)00055-2; Postigo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033534; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Viegas MS, 2007, MICROBES INFECT, V9, P847, DOI 10.1016/j.micinf.2007.03.003; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	43	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126007	10.1371/journal.pone.0126007	http://dx.doi.org/10.1371/journal.pone.0126007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938500	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000128
J	Strecker, T; Barnard, RL; Niklaus, PA; Scherer-Lorenzen, M; Weigelt, A; Scheu, S; Eisenhauer, N				Strecker, Tanja; Barnard, Romain L.; Niklaus, Pascal A.; Scherer-Lorenzen, Michael; Weigelt, Alexandra; Scheu, Stefan; Eisenhauer, Nico			Effects of Plant Diversity, Functional Group Composition, and Fertilization on Soil Microbial Properties in Experimental Grassland	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; ELEVATED CO2; TERRESTRIAL ECOSYSTEMS; PRIMARY PRODUCTIVITY; NITROGEN ADDITIONS; BIODIVERSITY LOSS; FOOD WEBS; BIOMASS; CARBON; MICROORGANISMS	Background Loss of biodiversity and increased nutrient inputs are two of the most crucial anthropogenic factors driving ecosystem change. Although both received considerable attention in previous studies, information on their interactive effects on ecosystem functioning is scarce. In particular, little is known on how soil biota and their functions are affected by combined changes in plant diversity and fertilization. Methodology/Principal Findings We investigated the effects of plant diversity, functional community composition, and fertilization on the biomass and respiration of soil microbial communities in a long-term biodiversity experiment in semi-natural grassland (Jena Experiment). Plant species richness enhanced microbial basal respiration and microbial biomass, but did not significantly affect microbial specific respiration. In contrast, the presence of legumes and fertilization significantly decreased microbial specific respiration, without altering microbial biomass. The effect of legumes was superimposed by fertilization as indicated by a significant interaction between the presence of legumes and fertilization. Further, changes in microbial stoichiometry (C-to-N ratio) and specific respiration suggest the presence of legumes to reduce N limitation of soil microorganisms and to modify microbial C use efficiency. Conclusions/Significance Our study highlights the role of plant species and functional group diversity as well as interactions between plant community composition and fertilizer application for soil microbial functions. Our results suggest soil microbial stoichiometry to be a powerful indicator of microbial functioning under N limited conditions. Although our results support the notion that plant diversity and fertilizer application independently affect microbial functioning, legume effects on microbial N limitation were superimposed by fertilization, indicating significant interactions between the functional composition of plant communities and nutrient inputs for soil processes.	[Strecker, Tanja; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Barnard, Romain L.] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Barnard, Romain L.; Niklaus, Pascal A.] ETH, Zurich, Switzerland; [Niklaus, Pascal A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, Chair Geobot, D-79106 Freiburg, Germany; [Weigelt, Alexandra; Eisenhauer, Nico] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Weigelt, Alexandra; Eisenhauer, Nico] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	University of Gottingen; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Freiburg; Leipzig University	Strecker, T (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	Tanja-Strecker@gmx.de	Barnard, Romain L./G-8190-2011; Niklaus, Pascal A/G-5786-2010; Eisenhauer, Nico/I-3191-2019; Scheu, Stefan/H-7049-2015; Scherer-Lorenzen, Michael/AGB-4140-2022; Eisenhauer, Nico/I-5932-2012	Barnard, Romain L./0000-0002-6440-1159; Niklaus, Pascal A/0000-0002-2360-1357; Eisenhauer, Nico/0000-0002-0371-6720; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Eisenhauer, Nico/0000-0002-0371-6720	German Science Foundation (DFG) [FOR 456]; ETH Zurich (from N. Buchmann research group)	German Science Foundation (DFG)(German Research Foundation (DFG)); ETH Zurich (from N. Buchmann research group)	The Jena Experiment is funded by the German Science Foundation (DFG; FOR 456) with additional support from ETH Zurich (funds from N. Buchmann research group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; ANDERSON TH, 1985, BIOL FERT SOILS, V1, P81, DOI 10.1007/BF00255134; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Biederbeck VO, 2005, SOIL BIOL BIOCHEM, V37, P1775, DOI 10.1016/j.soilbio.2005.02.011; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Brum OB, 2009, REV BRAS ZOOTECN, V38, P596, DOI 10.1590/S1516-35982009000400002; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chaudhary MI, 2008, ACTA PHYSIOL PLANT, V30, P537, DOI 10.1007/s11738-008-0152-8; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; Dijkstra FA, 2005, PLANT SOIL, V272, P41, DOI 10.1007/s11104-004-3848-6; Donnison LM, 2000, SOIL BIOL BIOCHEM, V32, P253, DOI 10.1016/S0038-0717(99)00159-5; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2013, P NATL ACAD SCI USA, V110, P6889, DOI 10.1073/pnas.1217382110; Eisenhauer N, 2012, GLOBAL CHANGE BIOL, V18, P435, DOI 10.1111/j.1365-2486.2011.02555.x; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; Eisenhauer N, 2009, EUR J SOIL BIOL, V45, P455, DOI 10.1016/j.ejsobi.2009.06.001; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P2430, DOI 10.1016/j.soilbio.2009.09.001; Farrell M, 2014, SOIL BIOL BIOCHEM, V77, P261, DOI 10.1016/j.soilbio.2014.07.003; Fenn M. E., 2006, Journal of Forest Science (Prague), V52, P3; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Hartman WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057127; He JS, 2002, OIKOS, V97, P337, DOI 10.1034/j.1600-0706.2002.970304.x; Hobbie JE, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00324; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P167, DOI 10.1016/0038-0717(76)90001-8; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Joffre R, 2003, ANN FOREST SCI, V60, P519, DOI 10.1051/forest:2003045; Johnson D, 2008, BIOL LETTERS, V4, P345, DOI 10.1098/rsbl.2008.0121; JOHNSON DW, 1990, P ROY SOC EDINB B, V97, P81, DOI 10.1017/S0269727000005303; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Lange M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096182; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; MARTENS R, 1990, SOIL BIOL BIOCHEM, V22, P141, DOI 10.1016/0038-0717(90)90078-E; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Oelmann Y, 2007, J ENVIRON QUAL, V36, P396, DOI 10.2134/jeq2006.0217; Paterson E, 2003, EUR J SOIL SCI, V54, P741, DOI 10.1046/j.1351-0754.2003.0557.x; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Phillips RP, 2007, NEW PHYTOL, V176, P655, DOI 10.1111/j.1469-8137.2007.02204.x; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ravenek JM, 2014, OIKOS, V4; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Schimel DS, 1997, P NATL ACAD SCI USA, V94, P8280, DOI 10.1073/pnas.94.16.8280; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Van der Krift TAJ, 2001, PLANT SOIL, V228, P191, DOI 10.1023/A:1004834128220; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031042; Wardle D, 1992, BIOL REV; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Weigelt A, 2008, ECOL LETT, V11, P338, DOI 10.1111/j.1461-0248.2007.01145.x; Wilman D, 1996, GRASS FORAGE SCI, V51, P52, DOI 10.1111/j.1365-2494.1996.tb02037.x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	87	25	29	9	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125678	10.1371/journal.pone.0125678	http://dx.doi.org/10.1371/journal.pone.0125678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938580	Green Accepted, gold, Green Published			2022-12-26	WOS:000353943000090
J	Yoon, HS; Yang, JJ; Song, M; Lee, HW; Han, S; Lee, SA; Choi, JY; Lee, JK; Kang, D				Yoon, Hyung-Suk; Yang, Jae Jeong; Song, Minkyo; Lee, Hwi-Won; Han, Sohee; Lee, Sang-Ah; Choi, Ji-Yeob; Lee, Jong-koo; Kang, Daehee			Correlates of Self-Reported Sleep Duration in Middle-Aged and Elderly Koreans: from the Health Examinees Study	PLOS ONE			English	Article							METABOLIC CONSEQUENCES; LONG-SLEEP; SOCIOECONOMIC-STATUS; UNIVERSITY-STUDENTS; UNITED-STATES; WHITEHALL II; QUALITY; ASSOCIATION; HYPERTENSION; MORTALITY	Though various factors related to fluctuations in sleep duration have been identified, information remains limited regarding the correlates of short and long sleep duration among the Korean population. Thus, we investigated characteristics that could be associated with short and/or long sleep duration among middle-aged and elderly Koreans. A total of 84,094 subjects (27,717 men and 56,377 women) who participated in the Health Examinees Study were analyzed by using multinomial logistic regression models. To evaluate whether sociodemographic factors, lifestyle factors, psychological conditions, anthropometry results, and health conditions were associated with short and/or long sleep duration, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated with sleep duration of 6-7 hours as the reference group, accounting for putative covariates. Regardless of sexual differences, we found that adverse behaviors and lifestyle factors including low educational attainment, unemployment, being unmarried, current smoking status, lack of exercise, having irregular meals, poor psychosocial well-being, frequent stress events, and poor self-rated health were significantly associated with abnormal sleep duration. Similarly, diabetes mellitus and depression showed positive associations with abnormal sleep duration in both men and women. Our findings suggest that low sociodemographic characteristics, adverse lifestyle factors, poor psychological conditions, and certain disease morbidities could be associated with abnormal sleep duration in middle-aged and elderly Koreans.	[Yoon, Hyung-Suk; Song, Minkyo; Lee, Hwi-Won; Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Yoon, Hyung-Suk; Yang, Jae Jeong; Song, Minkyo; Lee, Hwi-Won; Han, Sohee; Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yoon, Hyung-Suk; Yang, Jae Jeong; Song, Minkyo; Han, Sohee; Kang, Daehee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Lee, Sang-Ah] Kangwon Natl Univ, Dept Prevent Med, Kangwon Do, South Korea; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, D (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.	dhkang@snu.ac.kr	Yoon, Alex/ADQ-5328-2022; Song, Minkyo/AAE-9095-2020	Yoon, Alex/0000-0001-6368-2684; Song, Minkyo/0000-0002-9412-2871; Kang, Daehee/0000-0003-4031-5878	National Genome Research Institute, Korea Center for Disease Control and Prevention	National Genome Research Institute, Korea Center for Disease Control and Prevention	This study was supported by the National Genome Research Institute, Korea Center for Disease Control and Prevention. We would like to thank the participants and all members of the HEXA Study Group.	Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; Arora T, 2011, DIABETES CARE, V34, P2317, DOI 10.2337/dc11-0647; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Ban DJ, 2001, J KOREAN MED SCI, V16, P475, DOI 10.3346/jkms.2001.16.4.475; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Campbell SS, 2007, J SLEEP RES, V16, P24, DOI 10.1111/j.1365-2869.2007.00567.x; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chang S-J, 2000, DEVELOPING THE PSYCH, P92; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Dinas PC, 2011, IRISH J MED SCI, V180, P319, DOI 10.1007/s11845-010-0633-9; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Fang J, 2012, AM J HYPERTENS, V25, P335, DOI 10.1038/ajh.2011.201; Franco OH, 2012, EUR J EPIDEMIOL, V27, P255, DOI 10.1007/s10654-012-9664-z; Geiger SD, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/518263; Goldfarb AH, 1997, SPORTS MED, V24, P8, DOI 10.2165/00007256-199724010-00002; Gu DN, 2010, SLEEP, V33, P601, DOI 10.1093/sleep/33.5.601; Haseli-Mashhadi N, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-130, 10.1186/1471-2458-9-368]; Hayashino Y, 2010, SLEEP MED, V11, P366, DOI 10.1016/j.sleep.2009.05.021; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Hori H, 2011, J PSYCHIATR RES, V45, P1257, DOI 10.1016/j.jpsychires.2011.04.001; Kalleinen Nea, 2008, Menopause Int, V14, P97, DOI 10.1258/mi.2008.008013; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kim S, 2011, PUBLIC HEALTH NUTR, V14, P889, DOI 10.1017/S136898001000296X; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kravitz HM, 2003, MENOPAUSE, V10, P19, DOI 10.1097/01.GME.0000030707.35686.5A; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kronholm E, 2006, J SLEEP RES, V15, P276, DOI 10.1111/j.1365-2869.2006.00543.x; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lemma S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-237; Leproult R, 1997, SLEEP, V20, P865; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Moore PJ, 2002, PSYCHOSOM MED, V64, P337, DOI 10.1097/00006842-200203000-00018; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakata A, 2008, INT J BEHAV MED, V15, P81, DOI 10.1080/10705500801929577; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Park SE, 2009, OBESITY, V17, P767, DOI 10.1038/oby.2008.586; Patel SR, 2007, SLEEP, V30, P1077, DOI 10.1093/sleep/30.9.1077; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patel SR, 2012, SLEEP, V35, P641, DOI 10.5665/sleep.1822; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Polo-Kantola P, 2011, MATURITAS, V68, P224, DOI 10.1016/j.maturitas.2010.12.009; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Sabanayagam C, 2011, SLEEP MED, V12, P7, DOI 10.1016/j.sleep.2010.09.002; Stamatakis KA, 2007, ANN EPIDEMIOL, V17, P948, DOI 10.1016/j.annepidem.2007.07.096; Stefani KM, 2013, DIABETES RES CLIN PR, V102, P250, DOI 10.1016/j.diabres.2013.10.003; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Tamakoshi A, 2004, SLEEP, V27, P51; Troxel WM, 2010, J PSYCHOSOM RES, V69, P459, DOI 10.1016/j.jpsychores.2010.04.003; Tu XD, 2012, SLEEP MED, V13, P1138, DOI 10.1016/j.sleep.2012.06.014; Van Cauter E, 1999, ANN NY ACAD SCI, V896, P254, DOI 10.1111/j.1749-6632.1999.tb08120.x; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Yeo Yohwan, 2013, J Prev Med Public Health, V46, P271, DOI 10.3961/jpmph.2013.46.5.271; Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231	62	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123510	10.1371/journal.pone.0123510	http://dx.doi.org/10.1371/journal.pone.0123510			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933418	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100021
J	VanSchouwen, B; Akimoto, M; Sayadi, M; Fogolari, F; Melacini, G				VanSchouwen, Bryan; Akimoto, Madoka; Sayadi, Maryam; Fogolari, Federico; Melacini, Giuseppe			Role of Dynamics in the Autoinhibition and Activation of the Hyperpolarization-activated Cyclic Nucleotide-modulated (HCN) Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CAMP-DEPENDENT ACTIVATION; EMPIRICAL FORCE-FIELD; NMR CHEMICAL-SHIFTS; MOLECULAR-DYNAMICS; PACEMAKER CHANNELS; STRUCTURAL BASIS; COVARIANCE ANALYSIS; REGULATORY SUBUNIT; TERMINAL REGION	The hyperpolarization-activated cyclic nucleotide-modulated (HCN) ion channels control rhythmicity in neurons and cardiomyocytes. Cyclic AMP allosterically modulates HCN through the cAMP-dependent formation of a tetrameric gating ring spanning the intracellular region (IR) of HCN, to which cAMP binds. Although the apo versus holo conformational changes of the cAMP-binding domain (CBD) have been previously mapped, only limited information is currently available on the HCN IR dynamics, which have been hypothesized to play a critical role in the cAMP-dependent gating of HCN. Here, using molecular dynamics simulations validated and complemented by experimental NMR and CD data, we comparatively analyze HCN IR dynamics in the four states of the thermodynamic cycle arising from the coupling between cAMP binding and tetramerization equilibria. This extensive set of molecular dynamics trajectories captures the active-to-inactive transition that had remained elusive for other CBDs, and it provides unprecedented insight on the role of IR dynamics in HCN autoinhibition and its release by cAMP. Specifically, the IR tetramerization domain becomes more flexible in the monomeric states, removing steric clashes that the apo-CDB structure would otherwise impose. Furthermore, the simulations reveal that the active/inactive structural transition for the apo-monomeric CBD occurs through a manifold of pathways that are more divergent than previously anticipated. Upon cAMP binding, these pathways become disallowed, pre-confining the CBD conformational ensemble to a tetramer-compatible state. This conformational confinement primes the IR for tetramerization and thus provides a model of how cAMP controls HCN channel gating.	[VanSchouwen, Bryan; Akimoto, Madoka; Sayadi, Maryam; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Fogolari, Federico] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy	McMaster University; McMaster University; University of Udine	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St West, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca		Fogolari, Federico/0000-0001-9862-250X	Canadian Institutes of Health Research [MOP-68897]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant (MOP-68897) from the Canadian Institutes of Health Research (to G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Akimoto M, 2014, BIOCHEM SOC T, V42, P139, DOI 10.1042/BST20130257; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Berrera M, 2006, BIOPHYS J, V90, P3428, DOI 10.1529/biophysj.105.071621; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blyuss KB, 2012, J THEOR BIOL, V308, P45, DOI 10.1016/j.jtbi.2012.05.019; Bois P, 2011, ION CHANNELS AND THEIR INHIBITORS, P33, DOI 10.1007/978-3-642-19922-6_2; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; De S, 2012, BIOCHEMISTRY-US, V51, P8583, DOI 10.1021/bi3008214; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Qu Y, 2008, J PHYSIOL-LONDON, V586, P701, DOI 10.1113/jphysiol.2007.144329; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rosenbaum T, 2004, NEURON, V42, P193, DOI 10.1016/S0896-6273(04)00199-0; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Veglia G, 2013, FEBS J, V280, P5608, DOI 10.1111/febs.12462; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	62	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17642	17654		10.1074/jbc.M115.651877	http://dx.doi.org/10.1074/jbc.M115.651877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25944904	hybrid, Green Published			2022-12-26	WOS:000358511700001
J	Moore, CE; Nget, P; Saroeun, M; Kuong, S; Chanthou, S; Kumar, V; Bousfield, R; Nader, J; Bailey, JW; Beeching, NJ; Day, NP; Parry, CM				Moore, Catrin E.; Nget, Phot; Saroeun, Mao; Kuong, Suy; Chanthou, Seng; Kumar, Varun; Bousfield, Rachel; Nader, Johanna; Bailey, J. Wendi; Beeching, Nicholas J.; Day, Nicholas P.; Parry, Christopher M.			Intestinal Parasite Infections in Symptomatic Children Attending Hospital in Siem Reap, Cambodia	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; STRONGYLOIDES-STERCORALIS; RISK-FACTORS; LABORATORY DIAGNOSIS; HELMINTH INFECTIONS; TIME PCR; HOOKWORM; STOOL; EFFICACY; PROVINCE	Background Infections with helminths and other intestinal parasites are an important but neglected problem in children in developing countries. Accurate surveys of intestinal parasites in children inform empirical treatment regimens and can assess the impact of school based drug treatment programmes. There is limited information on this topic in Cambodia. Methods In a prospective study of intestinal parasites in symptomatic children attending Angkor Hospital for Children, Siem Reap, Cambodia, April-June 2012, samples were examined by microscopy of a direct and concentrated fecal sample. Two culture methods for hookworm and Strongyloides stercoralis were employed when sufficient sample was received. Demographic, clinical and epidemiological data were collected. Principal Findings We studied 970 samples from 865 children. The median (inter-quartile range) age of the children was 5.4 (1.9-9.2) years, 54% were male. The proportion of children with abdominal pain was 66.8%, diarrhea 34.9%, anemia 12.7% and malnutrition 7.4%. 458 parasitic infections were detected in 340 (39.3%) children. The most common parasites using all methods of detection were hookworm (14.3%), Strongyloides stercoralis (11.6%) and Giardia lamblia (11.2%). Giardia lamblia was most common in children aged 1-5 years, hookworm and Strongyloides stercoralis were more common with increasing age. Hookworm, Strongloides stercoralis and Giardia lamblia were more common in children living outside of Siem Reap town. In a multivariate logistic regression increasing age was associated with all three infections, defecating in the forest for hookworm infection, the presence of cattle for S. stercoralis and not using soap for handwashing for G. lamblia. Conclusions/Significance This study confirms the importance of intestinal parasitic infections in symptomatic Cambodian children and the need for adequate facilities for laboratory diagnosis together with education to improve personal hygiene and sanitation.	[Moore, Catrin E.; Bousfield, Rachel; Day, Nicholas P.; Parry, Christopher M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Moore, Catrin E.; Bousfield, Rachel; Day, Nicholas P.; Parry, Christopher M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England; [Nget, Phot; Saroeun, Mao; Kuong, Suy; Chanthou, Seng; Kumar, Varun] Angkor Hosp Children, Svay Dangkum, Siem Reap, Cambodia; [Bousfield, Rachel] Addenbrookes Hosp, Dept Clin Med, Cambridge CB2 0QQ, England; [Nader, Johanna; Bailey, J. Wendi; Beeching, Nicholas J.; Parry, Christopher M.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Liverpool School of Tropical Medicine	Moore, CE (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	catrin.moore@ndm.ox.ac.uk	Beeching, Nicholas J/L-5363-2017; Moore, Catrin/K-1980-2017	Moore, Catrin/0000-0002-8639-9846; , Varun/0000-0003-4976-6229	University of Oxford Li Ka Shing Global Health Foundation; Wellcome Trust of Great Britain	University of Oxford Li Ka Shing Global Health Foundation; Wellcome Trust of Great Britain(Wellcome Trust)	This study was supported by the University of Oxford Li Ka Shing Global Health Foundation and the Wellcome Trust of Great Britain. The study sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency HP, 2013, UK STANDARDS MICRO B, VB 31; Ahmadi NA, 2009, PARASITOL RES, V104, P553, DOI 10.1007/s00436-008-1229-4; CASEMORE DP, 1985, J CLIN PATHOL, V38, P1337, DOI 10.1136/jcp.38.12.1337; Chesnaye N, 2011, ACTA TROP, V118, P21, DOI 10.1016/j.actatropica.2010.12.013; Chhakda Tep, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P859; DANCESCU P, 1968, T ROY SOC TROP MED H, V62, P490, DOI 10.1016/0035-9203(68)90131-4; DEKAMINSKY RG, 1993, J PARASITOL, V79, P277, DOI 10.2307/3283519; Dorny P, 2011, VET PARASITOL, V175, P293, DOI 10.1016/j.vetpar.2010.10.023; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Humphries D, 2012, CURR OPIN INFECT DIS, V25, P584, DOI 10.1097/QCO.0b013e328357e4cf; Ines ED, 2011, ACTA TROP, V120, P206, DOI 10.1016/j.actatropica.2011.08.010; Jeon HK, 2011, KOREAN J PARASITOL, V49, P195, DOI 10.3347/kjp.2011.49.2.195; Jiraanankul V, 2011, AM J TROP MED HYG, V84, P594, DOI 10.4269/ajtmh.2011.10-0189; Khieu V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002035; Khieu V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002854; Khieu V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-221; KOGA K, 1991, AM J TROP MED HYG, V45, P518, DOI 10.4269/ajtmh.1991.45.518; Lee JW, 2004, 3 GLOB M PARTN PAR C; Lee Kyu-Jae, 2002, Korean Journal of Parasitology, V40, P153, DOI 10.3347/kjp.2002.40.3.153; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Marmot MG, 2008, SOCIAL DETERMINANTS; Miyamoto K, 2014, PARASITOL INT, V63, P366, DOI 10.1016/j.parint.2013.12.003; Moges F, 2010, ETHIOP J HEALTH DEV, V24, P148; Moore CE, 2012, J TROP PEDIAT; NTF, 2004, NAT POL GUID HELM CO; Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013; Parija SC, 2003, TROP DOCT, V33, P163, DOI 10.1177/004947550303300315; Park Seung Kyu, 2004, Korean Journal of Parasitology, V42, P201, DOI 10.3347/kjp.2004.42.4.201; Prevention and control of intestinal parasitic infections, 1987, WHO TECH REP SER, V749, P1; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Sayasone S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001037; Schar F, 2013, ACTA TROP, V126, P89, DOI 10.1016/j.actatropica.2012.12.012; Sinuon M, 2005, T ROY SOC TROP MED H, V99, P664, DOI 10.1016/j.trstmh.2004.12.004; Smits HL, 2009, EXPERT REV ANTI-INFE, V7, P37, DOI 10.1586/14787210.7.1.37; Sohn WM, 2011, EMERG INFECT DIS, V17, P1302, DOI 10.3201/eid1707.102071; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Suputtamongkol Y, 2006, CLIN INFECT DIS, V43, P793, DOI 10.1086/507103; UNICEF, 2009, UNICEF STAT CAMB; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; Verweij JJ, 2009, T ROY SOC TROP MED H, V103, P342, DOI 10.1016/j.trstmh.2008.12.001; WHO, 2002, WHO TECH REP SER, V912, P1; Wirkom V, 2007, INTERNET J TROP MED, V5	45	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0123719	10.1371/journal.pone.0123719	http://dx.doi.org/10.1371/journal.pone.0123719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951607	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000354214400009
J	Salari, S; Ghasemi, M; Fahanik-Babaei, J; Saghiri, R; Sauve, R; Eliassi, A				Salari, Sajjad; Ghasemi, Maedeh; Fahanik-Babaei, Javad; Saghiri, Reza; Sauve, Remy; Eliassi, Afsaneh			Evidence for a K-ATP Channel in Rough Endoplasmic Reticulum (rerK(ATP) Channel) of Rat Hepatocytes	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; VOLTAGE-DEPENDENT BEHAVIORS; SULFONYLUREAS; TRAFFICKING; EXPRESSION; MEMBRANE; BLOCKADE; FAMILY; CELLS	We report in a previous study the presence of a large conductance K+ channel in the membrane of rough endoplasmic reticulum (RER) from rat hepatocytes incorporated into lipid bilayers. Channel activity in this case was found to decrease in presence of ATP 100 mu M on the cytoplasmic side and was totally inhibited at ATP concentrations greater than 0.25 mM. Although such features would be compatible with the presence of a K-ATP channel in the RER, recent data obtained from a brain mitochondrial inner membrane preparation have provided evidence for a Maxi-K channel which could also be blocked by ATP within the mM concentration range. A series of channel incorporation experiments was thus undertaken to determine if the ATP-sensitive channel originally observed in the RER corresponds to K-ATP channel. Our results indicate that the gating and permeation properties of this channel are unaffected by the addition of 800 nM charybdotoxin and 1 mu M iberiotoxin, but appeared sensitive to 10 mM TEA and 2.5 mM ATP. Furthermore, adding 100 mu M glibenclamide at positive potentials and 400 mu M tolbutamide at negative or positive voltages caused a strong inhibition of channel activity. Finally Western blot analyses provided evidence for Kir6.2, SUR1 and/or SUR2B, and SUR2A expression in our RER fractions. It was concluded on the basis of these observations that the channel previously characterized in RER membranes corresponds to K-ATP, suggesting that opening of this channel may enhance Ca2+ releases, alter the dynamics of the Ca2+ transient and prevent accumulation of Ca2+ in the ER during Ca2+ overload.	[Salari, Sajjad; Eliassi, Afsaneh] Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Tehran, Iran; [Salari, Sajjad; Ghasemi, Maedeh; Eliassi, Afsaneh] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Salari, Sajjad; Fahanik-Babaei, Javad] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Saghiri, Reza] Pasteur Inst Iran, Dept Biochem, Tehran, Iran; [Sauve, Remy] Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ H3C 3J7, Canada; [Sauve, Remy] Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Universite de Montreal; Universite de Montreal	Eliassi, A (corresponding author), Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Tehran, Iran.	af.eliassi@sbmu.ac.ir	Ghasemi, Maedeh/Y-8120-2019; Ghasemi, Maedeh/AAB-1545-2021; Eliassi, Afsaneh/V-5370-2019	Ghasemi, Maedeh/0000-0002-5414-9594; Eliassi, Afsaneh/0000-0002-4899-3430; Salari, Sajjad/0000-0001-6892-2544	Neuroscience Research Centre of Shahid Beheshti University of Medical Sciences [1202-87/12/12]	Neuroscience Research Centre of Shahid Beheshti University of Medical Sciences	Funding: This work was supported by the grant 1202-87/12/12 from the Neuroscience Research Centre of Shahid Beheshti University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashcroft FM, 2000, J DIABETES COMPLICAT, V14, P192, DOI 10.1016/S1056-8727(00)00081-7; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Ashrafpour M, 2008, ARCH BIOCHEM BIOPHYS, V471, P50, DOI 10.1016/j.abb.2007.12.012; Averaimo S, 2010, FEBS LETT, V584, P2076, DOI 10.1016/j.febslet.2010.02.073; Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; BENZ I, 1994, J MEMBRANE BIOL, V142, P309; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Brady PA, 1996, AM J PHYSIOL-HEART C, V271, pH2710, DOI 10.1152/ajpheart.1996.271.6.H2710; Decrouy A, 1996, J MOL CELL CARDIOL, V28, P767, DOI 10.1006/jmcc.1996.0071; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; EDWARDS G, 1993, ANNU REV PHARMACOL, V33, P597, DOI 10.1146/annurev.pa.33.040193.003121; Edwards JC, 2010, FEBS LETT, V584, P2102, DOI 10.1016/j.febslet.2010.01.037; Eliassi A, 1997, J MEMBRANE BIOL, V159, P219, DOI 10.1007/s002329900285; Fahanik-Babaei J, 2011, NEUROSCIENCE, V199, P125, DOI 10.1016/j.neuroscience.2011.09.055; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; Grell W, 1998, J MED CHEM, V41, P5219, DOI 10.1021/jm9810349; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Hirano J, 2001, JPN J PHYSIOL, V51, P481, DOI 10.2170/jjphysiol.51.481; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; KAN FWK, 1992, BIOCHIM BIOPHYS ACTA, V1107, P331, DOI 10.1016/0005-2736(92)90420-Q; Kim YC, 2007, J KOREAN MED SCI, V22, P57, DOI 10.3346/jkms.2007.22.1.57; Kuniyasu A, 2003, FEBS LETT, V552, P259, DOI 10.1016/S0014-5793(03)00936-0; Kutluay E, 2005, BIOPHYS J, V88, P1018, DOI 10.1529/biophysj.104.052043; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Ma DH, 2007, FEBS LETT, V581, P1000, DOI 10.1016/j.febslet.2007.01.077; Malaisse WJ, 1995, PHARM RES, V32, P111; Malinska D, 2010, FEBS LETT, V584, P2043, DOI 10.1016/j.febslet.2010.01.013; MARUYAMA Y, 1995, PFLUG ARCH EUR J PHY, V430, P148, DOI 10.1007/BF00373851; Mayorga-Wark O, 1996, AM J PHYSL 1, V271, P1122; Nagashima K, 2004, DIABETES RES CLIN PR, V66, pS75, DOI 10.1016/j.diabres.2003.12.011; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Picard L, 2002, J MOL CELL CARDIOL, V34, P1163, DOI 10.1006/jmcc.2002.2041; Picher M, 1997, BBA-BIOMEMBRANES, V1328, P243, DOI 10.1016/S0005-2736(97)00104-1; Picher M, 1996, BBA-BIOMEMBRANES, V1279, P93, DOI 10.1016/0005-2736(95)00239-1; Sepehri H, 2007, ARCH BIOCHEM BIOPHYS, V457, P35, DOI 10.1016/j.abb.2006.10.012; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; SINGLETON WS, 1965, J AM OIL CHEM SOC, V42, P53, DOI 10.1007/BF02558256; Song X, 2010, NEUROSCIENCE, V169, P1548, DOI 10.1016/j.neuroscience.2010.06.026; Su WT, 2010, NEUROSCI LETT, V471, P1, DOI 10.1016/j.neulet.2009.12.058; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; WANG JX, 1994, J PHYSIOL-LONDON, V477, P279, DOI 10.1113/jphysiol.1994.sp020190; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Wheeler A, 2008, MOL PHARMACOL, V74, P1333, DOI 10.1124/mol.108.048355; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zhou M, 2005, J HISTOCHEM CYTOCHEM, V53, P1491, DOI 10.1369/jhc.5A6736.2005	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125798	10.1371/journal.pone.0125798	http://dx.doi.org/10.1371/journal.pone.0125798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950903	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400047
J	Dorr, C; Wu, BL; Guan, WH; Muthusamy, A; Sanghavi, K; Schladt, DP; Maltzman, JS; Scherer, SE; Brott, MJ; Matas, AJ; Jacobson, PA; Oetting, WS; Israni, AK				Dorr, Casey; Wu, Baolin; Guan, Weihua; Muthusamy, Amutha; Sanghavi, Kinjal; Schladt, David P.; Maltzman, Jonathan S.; Scherer, Steven E.; Brott, Marcia J.; Matas, Arthur J.; Jacobson, Pamala A.; Oetting, William S.; Israni, Ajay K.			Differentially Expressed Gene Transcripts Using RNA Sequencing from the Blood of Immunosuppressed Kidney Allograft Recipients	PLOS ONE			English	Article							PERIPHERAL-BLOOD; TRANSPLANT REJECTION; T-CELLS; THERAPY; INJURY; TOPHAT	We performed RNA sequencing (RNAseq) on peripheral blood mononuclear cells (PBMCs) to identify differentially expressed gene transcripts (DEGs) after kidney transplantation and after the start of immunosuppressive drugs. RNAseq is superior to microarray to determine DEGs because it's not limited to available probes, has increased sensitivity, and detects alternative and previously unknown transcripts. DEGs were determined in 32 adult kidney recipients, without clinical acute rejection (AR), treated with antibody induction, calcineurin inhibitor, mycophenolate, with and without steroids. Blood was obtained pre-transplant (baseline), week 1, months 3 and 6 post-transplant. PBMCs were isolated, RNA extracted and gene expression measured using RNAseq. Principal components (PCs) were computed using a surrogate variable approach. DEGs post-transplant were identified by controlling false discovery rate (FDR) at < 0.01 with at least a 2 fold change in expression from pre-transplant. The top 5 DEGs with higher levels of transcripts in blood at week 1 were TOMM40L, TMEM205, OLFM4, MMP8, and OSBPL9 compared to baseline. The top 5 DEGs with lower levels at week 1 post-transplant were IL7R, KLRC3, CD3E, CD3D, and KLRC2 (Striking Image) compared to baseline. The top pathways from genes with lower levels at 1 week post-transplant compared to baseline, were T cell receptor signaling and iCOS-iCOSL signaling while the top pathways from genes with higher levels than baseline were axonal guidance signaling and LXR/RXR activation. Gene expression signatures at month 3 were similar to week 1. DEGs at 6 months post-transplant create a different gene signature than week 1 or month 3 post-transplant. RNAseq analysis identified more DEGs with lower than higher levels in blood compared to baseline at week 1 and month 3. The number of DEGs decreased with time post-transplant. Further investigations to determine the specific lymphocyte(s) responsible for differential gene expression may be important in selecting and personalizing immune suppressant drugs and may lead to targeted therapies.	[Dorr, Casey; Muthusamy, Amutha; Schladt, David P.; Israni, Ajay K.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA; [Dorr, Casey; Israni, Ajay K.] Univ Minnesota, Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA; [Wu, Baolin; Guan, Weihua] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Sanghavi, Kinjal; Brott, Marcia J.; Jacobson, Pamala A.; Oetting, William S.] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA; [Maltzman, Jonathan S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scherer, Steven E.] Baylor Coll Med, Dept Mol & Human Genet, Dallas, TX USA; [Matas, Arthur J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Israni, Ajay K.] Univ Minnesota, Sch Med, Dept Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	Minneapolis Medical Research Foundation; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Israni, AK (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA.	isran001@umn.edu	matas, arthur/ABE-1018-2021	Dorr, Casey/0000-0002-6108-280X; WU, BAOLIN/0000-0001-6676-0422; Maltzman, Jonathan/0000-0001-5722-269X	National Institute for General Medical Sciences' Pharmacogenomics Research Network; Baylor College of Medicine Human Genome Sequencing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070119] Funding Source: NIH RePORTER	National Institute for General Medical Sciences' Pharmacogenomics Research Network; Baylor College of Medicine Human Genome Sequencing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institute for General Medical Sciences' Pharmacogenomics Research Network for the project titled "Precision Immune Suppression. The PRECISE Study. Genomics of Transplantation" that was awarded to Pamala A. Jacobson and Baylor College of Medicine Human Genome Sequencing Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Chen WB, 2014, MOL MED REP, V10, P2210, DOI 10.3892/mmr.2014.2420; Dominguez J, 2011, TRANSPL P, V43, P2300, DOI 10.1016/j.transproceed.2011.06.006; Famulski KS, 2010, AM J TRANSPLANT, V10, P810, DOI 10.1111/j.1600-6143.2009.03007.x; Famulski KS, 2012, J AM SOC NEPHROL, V23, P948, DOI 10.1681/ASN.2011090887; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Ganji MR, 2012, IRAN J KIDNEY DIS, V6, P88; Garcia GG, 2012, AM J NEPHROL, V35, P259, DOI 10.1159/000336371; Haller M, 2011, NEPHROL DIAL TRANSPL, V26, P2988, DOI 10.1093/ndt/gfq780; Hidalgo LG, 2008, AM J TRANSPLANT, V8, P637, DOI 10.1111/j.1600-6143.2007.02129.x; Hidalgo LG, 2012, AM J TRANSPLANT, V12, P1180, DOI 10.1111/j.1600-6143.2011.03970.x; Israni AK, 2013, CLIN TRANSPLANT, V27, P348, DOI 10.1111/ctr.12074; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurian SM, 2014, AM J TRANSPLANT, V14, P1164, DOI 10.1111/ajt.12671; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Leventhal JR, 2013, J AM SOC NEPHROL, V24, P1376, DOI 10.1681/ASN.2013010068; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082153; Perkins D, 2011, SEMIN IMMUNOPATHOL, V33, P211, DOI 10.1007/s00281-011-0243-2; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roedder S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001759; Roedder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056657; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vitalone MJ, 2014, AM J TRANSPLANT, V14, P1912, DOI 10.1111/ajt.12746; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	31	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125045	10.1371/journal.pone.0125045	http://dx.doi.org/10.1371/journal.pone.0125045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946140	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700055
J	Jonges, M; van Leuken, J; Wouters, I; Koch, G; Meijer, A; Koopmans, M				Jonges, Marcel; van Leuken, Jeroen; Wouters, Inge; Koch, Guus; Meijer, Adam; Koopmans, Marion			Wind-Mediated Spread of Low-Pathogenic Avian Influenza Virus into the Environment during Outbreaks at Commercial Poultry Farms	PLOS ONE			English	Article							COXIELLA-BURNETII DNA; AIRBORNE INFLUENZA; TRANSMISSION; NETHERLANDS; QUANTIFICATION; POLIOVIRUS; CHICKENS; EPIDEMIC; AMMONIUM; TENACITY	Avian influenza virus-infected poultry can release a large amount of virus-contaminated droppings that serve as sources of infection for susceptible birds. Much research so far has focused on virus spread within flocks. However, as fecal material or manure is a major constituent of airborne poultry dust, virus-contaminated particulate matter from infected flocks may be dispersed into the environment. We collected samples of suspended particulate matter, or the inhalable dust fraction, inside, upwind and downwind of buildings holding poultry infected with low-pathogenic avian influenza virus, and tested them for the presence of endotoxins and influenza virus to characterize the potential impact of airborne influenza virus transmission during outbreaks at commercial poultry farms. Influenza viruses were detected by RT-PCR in filter-rinse fluids collected up to 60 meters downwind from the barns, but virus isolation did not yield any isolates. Viral loads in the air samples were low and beyond the limit of RT-PCR quantification except for one in-barn measurement showing a virus concentration of 8.48x10(4) genome copies/m(3). Air samples taken outside poultry barns had endotoxin concentrations of similar to 50 EU/m(3) that declined with increasing distance from the barn. Atmospheric dispersion modeling of particulate matter, using location-specific meteorological data for the sampling days, demonstrated a positive correlation between endotoxin measurements and modeled particulate matter concentrations, with an R-2 varying from 0.59 to 0.88. Our data suggest that areas at high risk for human or animal exposure to airborne influenza viruses can be modeled during an outbreak to allow directed interventions following targeted surveillance.	[Jonges, Marcel; van Leuken, Jeroen; Meijer, Adam; Koopmans, Marion] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Jonges, Marcel; Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Leuken, Jeroen; Wouters, Inge] Univ Utrecht, Fac Vet Sci, Inst Risk Assessment Sci, Utrecht, Netherlands; [Koch, Guus] Wageningen Univ & Res Ctr, Cent Vet Inst, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Wageningen University & Research	Jonges, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	marcel.jonges@rivm.nl	Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312; Wouters, Inge M./0000-0001-7834-9390	Dutch Ministry of Economic Affairs, Castellum Project	Dutch Ministry of Economic Affairs, Castellum Project	This work was supported by the Dutch Ministry of Economic Affairs, Castellum Project (MJ MK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A, 2009, AGR TECHN CHANG CLIM; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Beest DET, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-81; Benson E, 2007, POULTRY SCI, V86, P219, DOI 10.1093/ps/86.2.219; Bowes VA, 2007, AVIAN DIS, V51, P313, DOI 10.1637/7627-042706R.1; Cafarchia C, 2014, J MED MICROBIOL, V63, P464, DOI 10.1099/jmm.0.065946-0; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; Cao G, 2011, J ENVIRON MONITOR, V13, P3321, DOI 10.1039/c1em10607d; Chen PS, 2009, AEROSOL SCI TECH, V43, P290, DOI 10.1080/02786820802621232; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Burton NC, 2007, ANN OCCUP HYG, V51, P143, DOI 10.1093/annhyg/mel073; Corzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071444; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; DOUWES J, 1995, APPL ENVIRON MICROB, V61, P1763, DOI 10.1128/AEM.61.5.1763-1769.1995; Engelhart S, 2007, INT J HYG ENVIR HEAL, V210, P733, DOI 10.1016/j.ijheh.2006.10.001; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; FAO, 2012, HIGHL PATH AV INFL M; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gerritzen MA, 2006, VET REC, V159, P39, DOI 10.1136/vr.159.2.39; Heederik DJJI, 2011, MOGELIJKE EFFECTEN V; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; Horm SV, 2012, INFLUENZA OTHER RESP, V6, P442, DOI 10.1111/j.1750-2659.2012.00338.x; Jaarsveld JAV, 2004, OPERATIONAL PRIORITY; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; KNMI, UURG WEER NED BILT R; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Lu H, 2003, AVIAN DIS, V47, P1015, DOI 10.1637/0005-2086-47.s3.1015; Lv J, 2011, ARCH VIROL, V156, P1795, DOI 10.1007/s00705-011-1054-4; Mandal J., 2011, Open Environmental & Biological Monitoring Journal, V4, P83, DOI 10.2174/1875040001104010083; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Reis A, 2012, POULTRY SCI, V91, P1745, DOI 10.3382/ps.2011-01625; Sorensen JH, 2001, PHYS CHEM EARTH PT B, V26, P93, DOI 10.1016/S1464-1909(00)00223-9; Spekreijse D, 2013, INFLUENZA OTHER RESP, V7, P132, DOI 10.1111/j.1750-2659.2012.00362.x; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031114; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stull R. B., 2000, METEOROLOGY SCI ENG; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Tuladhar E, 2012, J HOSP INFECT, V80, P110, DOI 10.1016/j.jhin.2011.10.012; Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P2456, DOI 10.1128/AEM.07738-11; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; van der Swaluw E, 2011, ATMOS ENVIRON, V45, P3819, DOI 10.1016/j.atmosenv.2011.04.017; van Jaarsveld JA, 2011, INT J ENVIRON POLLUT, V44, P217, DOI 10.1504/IJEP.2011.038421; VANWEZEL AI, 1984, REV INFECT DIS, V6, pS335; Wallensten A., 2010, EURO SURVEILL, P15; Wang X, 2014, CLIN INFECT DIS, V59, pE76, DOI 10.1093/cid/ciu399; Ypma RJF, 2013, J INFECT DIS, V207, P730, DOI 10.1093/infdis/jis757; Zhao Y, 2014, CRIT REV ENV SCI TEC, V44, P1071, DOI 10.1080/10643389.2012.746064	51	49	49	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125401	10.1371/journal.pone.0125401	http://dx.doi.org/10.1371/journal.pone.0125401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946115	Green Published, gold			2022-12-26	WOS:000354049700065
J	Chen, Y; Tang, Y; Zhang, YC; Huang, XH; Xie, YQ; Xiang, Y				Chen, Yu; Tang, Yong; Zhang, Ya-Chen; Huang, Xiao-Hong; Xie, Yu-Quan; Xiang, Yin			A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment	PLOS ONE			English	Article							ADRIAMYCIN-INDUCED CARDIOMYOPATHY; OXIDATIVE STRESS; HEART-FAILURE; INDUCED CARDIOTOXICITY; CENTELLA-ASIATICA; SYSTEMS BIOLOGY; DISEASE; AMPK; MOUSE; CARDIOPROTECTION	Doxorubicin-induced cardiomyopathy (DOX-CM) is a severe complication of doxorubicin (DOX) chemotherapy. Characterized by cumulative and irreversible myocardial damage, its pathogenesis has not been fully elucidated. Shengmai Injection (SMI), a Traditional Chinese Medicine, may alleviate myocardial injury and improve heart function in the setting of DOX-CM. As a result of its multi-component and multi-target nature and comprehensive regulation, the pharmacological mechanisms underlying SMI's effects remain obscure. The emerging field of metabolomics provides a potential approach with which to explore the pathogenesis of DOX-CM and the benefits of SMI treatment. DOX-CM was induced in rats via intraperitoneal injections of DOX. Cardiac metabolic profiling was performed via gas chromatography/mass spectrometry and ultra-performance liquid chromatography/tandem mass spectrometry. A bioinformatics analysis was conducted via Ingenuity Pathway Analysis (IPA). Eight weeks following DOX treatment, significant cardiac remodeling, dysfunction and metabolic perturbations were observed in the rats with DOX-CM. The metabolic disturbances primarily involved lipids, amino acids, vitamins and energy metabolism, and may have been indicative of both an energy metabolism disorder and oxidative stress secondary to DOX chemotherapy. However, SMI improved cardiac structure and function, as well as the metabolism of the rats with DOX-CM. The metabolic alterations induced via SMI, including the promotion of glycogenolysis, glycolysis, amino acid utilization and antioxidation, suggested that SMI exerts cardioprotective effects by improving energy metabolism and attenuating oxidative stress. Moreover, the IPA revealed that important signaling molecules and enzymes interacted with the altered metabolites. These findings have provided us with new insights into the pathogenesis of DOX-CM and the effects of SMI, and suggest that the combination of metabolomic analysis and IPA may represent a promising tool with which to explore and better understand both heart disease and TCM therapy.	[Chen, Yu; Tang, Yong; Zhang, Ya-Chen; Huang, Xiao-Hong; Xie, Yu-Quan; Xiang, Yin] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Div Cardiol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University	Zhang, YC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Div Cardiol, Shanghai 200092, Peoples R China.	zhangyachen1965@126.com			National Natural Science Foundation of China [81170125, 81270209]; Shanghai Committee of Science and Technology of China [12JC1406400]; Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201224]; Shanghai Municipality for further acceleration of the development of Chinese Medicine [ZY3-CCCX-3-3040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology of China; Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine; Shanghai Municipality for further acceleration of the development of Chinese Medicine	This work was supported by the National Natural Science Foundation of China (No. 81170125, 81270209), the Shanghai Committee of Science and Technology of China (No. 12JC1406400), the Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine (No. BXJ201224) and the 3-year Action Plan (2014-2016) of Shanghai Municipality for further acceleration of the development of Chinese Medicine (No. ZY3-CCCX-3-3040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordoni A, 1999, BBA-MOL CELL BIOL L, V1440, P100, DOI 10.1016/S1388-1981(99)00113-4; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Carvalho RA, 2010, TOXICOLOGY, V270, P92, DOI 10.1016/j.tox.2010.01.019; Chartoumpekis D, 2010, BIOCHEM BIOPH RES CO, V396, P463, DOI 10.1016/j.bbrc.2010.04.117; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen Lei, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P2036; Cheng PW, 2014, BRIT J PHARMACOL, V171, P2739, DOI 10.1111/bph.12648; Choi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081773; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Cox MJ, 2002, AM J PHYSIOL-HEART C, V282, pH1197, DOI 10.1152/ajpheart.00483.2001; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Firdous Alikunjhi P, 2012, J Exp Ther Oncol, V10, P101; Ge MK, 2015, LASER MED SCI, V30, P1609, DOI 10.1007/s10103-014-1538-z; Gnanapragasam A, 2007, MOL CELL BIOCHEM, V294, P55, DOI 10.1007/s11010-006-9245-0; Gnanapragasam A, 2004, LIFE SCI, V76, P585, DOI 10.1016/j.lfs.2004.09.009; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hai J., 2006, LISHIZHEN MED MAT ME, V17, P329; Hong YM, 2002, PEDIATR RES, V51, P249, DOI 10.1203/00006450-200202000-00020; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jang YM, 2004, FEBS LETT, V577, P483, DOI 10.1016/j.febslet.2004.10.053; Jones SP, 2004, AM J PHYSIOL-HEART C, V286, pH276, DOI 10.1152/ajpheart.00129.2003; Katare R, 2013, CARDIOVASC RES, V97, P55, DOI 10.1093/cvr/cvs291; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li LH, 2006, MODERN J INTEGRATED, V15, P595; Lovric-Bencic M, 2004, J PHARMACOL SCI, V95, P19, DOI 10.1254/jphs.95.19; MACK CP, 1995, BIOCHEM BIOPH RES CO, V212, P35, DOI 10.1006/bbrc.1995.1932; McNulty PH, 2000, METABOLISM, V49, P1365, DOI 10.1053/meta.2000.9510; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1075, DOI 10.1038/aps.2010.139; Simunek T, 2009, PHARMACOL REP, V61, P154; SIVESKIILISKOVIC N, 1994, CIRCULATION, V89, P2829, DOI 10.1161/01.CIR.89.6.2829; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Subashini R, 2007, PHARMAZIE, V62, P382, DOI 10.1691/ph.2007.5.6678; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tan GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027683; Thomas Sterling, 2010, Human Genomics, V4, P353; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Wang XJ, 2011, J PHARMACEUT BIOMED, V55, P859, DOI 10.1016/j.jpba.2011.01.042; Wei R, 2011, CURR DRUG METAB, V12, P345, DOI 10.2174/138920011795202947; Xiang P, 2009, CANCER CHEMOTH PHARM, V63, P343, DOI 10.1007/s00280-008-0744-4; Yang X. D., 2008, CENTRAL S PHARM, V6, P162; Yang XL., 2008, GUIDE CHIN MED CHIN, V6, P203, DOI [10.3736/jcim20080220, DOI 10.3736/JCIM20080220]; Yao HT, 2008, J ETHNOPHARMACOL, V116, P49, DOI 10.1016/j.jep.2007.10.043; Yin XH, 1998, BIOCHEM PHARMACOL, V56, P87, DOI 10.1016/S0006-2952(98)00099-9; Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/402159; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhang Ya-chen, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P277; Zhang YK, 2007, J EMERGENCY TRADITIO, V16, P1082; Zhou Q, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005052.pub5	61	24	27	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125209	10.1371/journal.pone.0125209	http://dx.doi.org/10.1371/journal.pone.0125209			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938766	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000051
J	Luo, W; Nguyen, T; Nichols, M; Tran, T; Rana, S; Gupta, S; Phung, D; Venkatesh, S; Allender, S				Luo, Wei; Thin Nguyen; Nichols, Melanie; Truyen Tran; Rana, Santu; Gupta, Sunil; Dinh Phung; Venkatesh, Svetha; Allender, Steve			Is Demography Destiny? Application of Machine Learning Techniques to Accurately Predict Population Health Outcomes from a Minimal Demographic Dataset	PLOS ONE			English	Article							SELECTION	For years, we have relied on population surveys to keep track of regional public health statistics, including the prevalence of non-communicable diseases. Because of the cost and limitations of such surveys, we often do not have the up-to-date data on health outcomes of a region. In this paper, we examined the feasibility of inferring regional health outcomes from socio-demographic data that are widely available and timely updated through national censuses and community surveys. Using data for 50 American states (excluding Washington DC) from 2007 to 2012, we constructed a machine-learning model to predict the prevalence of six non-communicable disease (NCD) outcomes (four NCDs and two major clinical risk factors), based on population socio-demographic characteristics from the American Community Survey. We found that regional prevalence estimates for non-communicable diseases can be reasonably predicted. The predictions were highly correlated with the observed data, in both the states included in the derivation model (median correlation 0.88) and those excluded from the development for use as a completely separated validation sample (median correlation 0.85), demonstrating that the model had sufficient external validity to make good predictions, based on demographics alone, for areas not included in the model development. This highlights both the utility of this sophisticated approach to model development, and the vital importance of simple socio-demographic characteristics as both indicators and determinants of chronic disease.	[Luo, Wei; Thin Nguyen; Truyen Tran; Rana, Santu; Gupta, Sunil; Dinh Phung; Venkatesh, Svetha] Deakin Univ, Sch Informat Technol, Ctr Pattern Recognit & Data Analyt, Geelong, Vic 3217, Australia; [Nichols, Melanie; Allender, Steve] Deakin Univ, World Hlth Org Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia	Deakin University; Deakin University; World Health Organization	Luo, W (corresponding author), Deakin Univ, Sch Informat Technol, Ctr Pattern Recognit & Data Analyt, Geelong, Vic 3217, Australia.	wei.luo@deakin.edu.au	Allender, Steven/G-9881-2011; Rana, Santu/R-2992-2019; Luo, Wei/A-6043-2011	Rana, Santu/0000-0003-2247-850X; Luo, Wei/0000-0002-4711-7543; venkatesh, svetha/0000-0001-8675-6631; Tran, Truyen/0000-0001-6531-8907; Phung, Dinh/0000-0002-9977-8247; Nichols, Melanie/0000-0002-7834-5899; Nguyen, Thin/0000-0003-3467-8963; Allender, Steven/0000-0002-4842-3294; gupta, sunil/0000-0002-4669-9940	Australian National Health and Medical Research Council/National Heart Foundation of Australia Career Development Fellowship [APP1045836]; US National Institutes of Health [1R01HL115485-01A1]; National Heart Foundation of Australia; Deakin University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council/National Heart Foundation of Australia Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Foundation of Australia(National Heart Foundation of Australia); Deakin University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SA is supported by funding from an Australian National Health and Medical Research Council/National Heart Foundation of Australia Career Development Fellowship (APP1045836). Allender is a researcher on the US National Institutes of Health grant titled Systems Science to Guide Whole-of-Community Childhood Obesity Interventions (1R01HL115485-01A1). Allender is a researcher within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020). MN is supported by funding from the National Heart Foundation of Australia and Deakin University for the Australian Heart Disease Statistics Project (HeartStats); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Centers for Disease Control and Prevention, 2012, BEH RISK FACT SURV S; Delen D, 2010, ARTIF INTELL MED, V49, P33, DOI 10.1016/j.artmed.2010.01.002; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gupta S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004007; Link BG, 1996, AM J PUBLIC HEALTH, V86, P471, DOI 10.2105/AJPH.86.4.471; Metzler Marilyn, 2007, Prev Chronic Dis, V4, pA85; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Rana S, 2014, AUST HEALTH REV, V38, P377, DOI 10.1071/AH14059; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Schuessler AA, 1999, P NATL ACAD SCI USA, V96, P10578, DOI 10.1073/pnas.96.19.10578; Tam Cho WK, 2008, OXFORD HDB POLITICAL; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Hooijdonk C, 2007, SOC SCI MED, V64, P1326, DOI 10.1016/j.socscimed.2006.10.041; Venables WN., 2002, MODERN APPL STAT S 4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Yamada M, 2014, NEURAL COMPUT, V26, P185, DOI 10.1162/NECO_a_00537	18	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125602	10.1371/journal.pone.0125602	http://dx.doi.org/10.1371/journal.pone.0125602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938675	Green Published, gold			2022-12-26	WOS:000353943000081
J	Mangels, J; Bluthgen, N; Frank, K; Grassein, F; Hilpert, A; Mody, K				Mangels, Jule; Bluethgen, Nico; Frank, Kevin; Grassein, Fabrice; Hilpert, Andrea; Mody, Karsten			Tree Species Composition and Harvest Intensity Affect Herbivore Density and Leaf Damage on Beech, Fagus sylvatica, in Different Landscape Contexts	PLOS ONE			English	Article							FOREST MANAGEMENT INTENSITY; ASSOCIATIONAL SUSCEPTIBILITY; VEGETATIONAL DIVERSITY; COMMUNITY STRUCTURE; INSECT HERBIVORY; PLANT DEFENSES; NORTH-AMERICA; GLOBAL CHANGE; BIODIVERSITY; RESISTANCE	Most forests are exposed to anthropogenic management activities that affect tree species composition and natural ecosystem processes. Changes in ecosystem processes such as herbivory depend on management intensity, and on regional environmental conditions and species pools. Whereas influences of specific forest management measures have already been addressed for different herbivore taxa on a local scale, studies considering effects of different aspects of forest management across different regions are rare. We assessed the influence of tree species composition and intensity of harvesting activities on arthropod herbivores and herbivore-related damage to beech trees, Fagus sylvatica, in 48 forest plots in three regions of Germany. We found that herbivore abundance and damage to beech trees differed between regions and that - despite the regional differences - density of tree-associated arthropod taxa and herbivore damage were consistently affected by tree species composition and harvest intensity. Specifically, overall herbivore damage to beech trees increased with increasing dominance of beech trees - suggesting the action of associational resistance processes - and decreased with harvest intensity. The density of leaf chewers and mines was positively related to leaf damage, and several arthropod groups responded to beech dominance and harvest intensity. The distribution of damage patterns was consistent with a vertical shift of herbivores to higher crown layers during the season and with higher beech dominance. By linking quantitative data on arthropod herbivore abundance and herbivory with tree species composition and harvesting activity in a wide variety of beech forests, our study helps to better understand the influence of forest management on interactions between a naturally dominant deciduous forest tree and arthropod herbivores.	[Mangels, Jule; Bluethgen, Nico; Frank, Kevin; Hilpert, Andrea; Mody, Karsten] Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany; [Grassein, Fabrice] Univ Bern, Inst Plant Sci, Bern, Switzerland	Technical University of Darmstadt; University of Bern	Mody, K (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany.	mody@bio.tu-darmstadt.de	Blüthgen, Nico/F-5983-2010		DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [BL 960/2-1]	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (BL 960/2-1) to NB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2009, BIOL INVASIONS, V11, P1005, DOI 10.1007/s10530-008-9312-4; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Banfield-Zanin JA, 2015, AGR FOREST ENTOMOL, V17, P48, DOI 10.1111/afe.12079; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Bouget C, 2012, CAN J FOREST RES, V42, P1421, DOI [10.1139/X2012-078, 10.1139/x2012-078]; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; BROWN BJ, 1987, ECOLOGY, V68, P108, DOI 10.2307/1938810; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Dodd LE, 2012, FOREST ECOL MANAG, V267, P262, DOI 10.1016/j.foreco.2011.12.016; Elderd BD, 2013, P NATL ACAD SCI USA, V110, P14978, DOI 10.1073/pnas.1300759110; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; FAO, 2010, GLOBAL FOREST RESOUR; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Forkner RE, 2006, CONSERV BIOL, V20, P429, DOI 10.1111/j.1523-1739.2006.00346.x; Forkner RE, 2004, FOREST ECOL MANAG, V199, P21, DOI 10.1016/j.foreco.2004.03.044; Franklin AJ, 2003, ECOL ENTOMOL, V28, P278, DOI 10.1046/j.1365-2311.2003.00516.x; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gandhi KJK, 2008, FOREST ECOL MANAG, V256, P1104, DOI 10.1016/j.foreco.2008.06.011; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Gaylord ML, 2013, NEW PHYTOL, V198, P567, DOI 10.1111/nph.12174; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gossner MM, 2014, BASIC APPL ECOL, V15, P347, DOI 10.1016/j.baae.2014.03.003; Gossner MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104876; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Gutbrodt B, 2012, ARTHROPOD-PLANT INTE, V6, P171, DOI 10.1007/s11829-011-9173-0; Hartley MK, 2010, ARTHROPOD-PLANT INTE, V4, P237, DOI 10.1007/s11829-010-9105-4; Heiermann J, 2008, FOREST ECOL MANAG, V255, P1161, DOI 10.1016/j.foreco.2007.10.020; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Hochuli DF, 2001, AUSTRAL ECOL, V26, P563, DOI 10.1046/j.1442-9993.2001.01135.x; Hunter M.L., 1999, J WILDLIFE MANAGE; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Jactel H, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009054; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Kareiva P., 1983, P259; KEMP WP, 1979, ENVIRON ENTOMOL, V8, P993, DOI 10.1093/ee/8.6.993; KENNEDY CEJ, 1984, J ANIM ECOL, V53, P455, DOI 10.2307/4528; Koricheva J, 2006, CAN J FOREST RES, V36, P324, DOI 10.1139/x05-172; Lange M, 2014, FOREST ECOL MANAG, V329, P166, DOI 10.1016/j.foreco.2014.06.012; Lavandero B, 2009, BASIC APPL ECOL, V10, P10, DOI 10.1016/j.baae.2007.11.009; Leksono AS, 2005, ENTOMOL SCI, V8, P235, DOI 10.1111/j.1479-8298.2005.00122.x; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Milad M, 2011, FOREST ECOL MANAG, V261, P829, DOI 10.1016/j.foreco.2010.10.038; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Moreau G, 2006, J ANIM ECOL, V75, P853, DOI 10.1111/j.1365-2656.2006.01109.x; NIELSEN BO, 1978, ECOL ENTOMOL, V3, P193, DOI 10.1111/j.1365-2311.1978.tb00919.x; Nixon AE, 2012, ECOL ENTOMOL, V37, P13, DOI 10.1111/j.1365-2311.2011.01330.x; NUMMELIN M, 1992, AFR J ECOL, V30, P213, DOI 10.1111/j.1365-2028.1992.tb00496.x; Packham JR, 2012, J ECOL, V100, P1557, DOI 10.1111/j.1365-2745.2012.02017.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Paquette A, 2006, ECOL APPL, V16, P1575, DOI 10.1890/1051-0761(2006)016[1575:SAGOUT]2.0.CO;2; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Pere C, 2011, BIODIVERS CONSERV, V20, P3003, DOI 10.1007/s10531-011-0134-9; PERRIN RM, 1978, ENTOMOL EXP APPL, V24, P585, DOI 10.1007/BF02385112; Peter F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095551; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; PHILLIPSON J, 1983, ECOL ENTOMOL, V8, P315, DOI 10.1111/j.1365-2311.1983.tb00512.x; Pinheiro J., 2014, NLME LINEAR AND NONL; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; Poelman EH, 2009, ECOLOGY, V90, P1863, DOI 10.1890/08-0977.1; Poveda K, 2008, REV COLOMB ENTOMOL, V34, P131; Powers RF, 1999, NEW FOREST, V17, P263, DOI 10.1023/A:1006555219130; Pretzsch H, 2013, PLANT BIOLOGY, V15, P483, DOI 10.1111/j.1438-8677.2012.00670.x; Rasband W, 1997, IMAGEJ 1 46R; Rheinheimer J, 2010, RUSSELKAFER BADEN WU; Riedel J, 2013, FOREST ECOL MANAG, V297, P49, DOI 10.1016/j.foreco.2013.02.003; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Ruhnke H, 2009, BASIC APPL ECOL, V10, P726, DOI 10.1016/j.baae.2009.06.006; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Savilaakso S, 2009, BIODIVERS CONSERV, V18, P3931, DOI 10.1007/s10531-009-9689-0; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Schmitz OJ, 2014, BIOL CONTROL, V75, P87, DOI 10.1016/j.biocontrol.2013.10.001; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Schowalter T. D., 1999, ECOSYSTEMS DISTURBED, V16, P253; Schowalter T.D, 2006, INSECT ECOLOGY ECOSY, P347, DOI [10.1016/B978-012088772-9/50038-8, DOI 10.1016/B978-012088772-9/50038-8]; SCHOWALTER TD, 1995, FOREST ECOL MANAG, V78, P115, DOI 10.1016/0378-1127(95)03592-4; SCHOWALTER TD, 1986, ANNU REV ENTOMOL, V31, P177, DOI 10.1146/annurev.en.31.010186.001141; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; SHEEHAN W, 1986, ENVIRON ENTOMOL, V15, P456, DOI 10.1093/ee/15.3.456; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Speight M. R., 1989, ECOLOGY MANAGEMENT F; Stoeckli S, 2008, TREE GENET GENOMES, V4, P833, DOI 10.1007/s11295-008-0156-y; Su JC, 2001, ENVIRON ENTOMOL, V30, P400, DOI 10.1603/0046-225X-30.2.400; Summerville KS, 2008, CAN ENTOMOL, V140, P475, DOI 10.4039/N07-Ls06; Summerville KS, 2011, ECOL APPL, V21, P806, DOI 10.1890/10-0715.1; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Truxa C, 2012, INSECT CONSERV DIVER, V5, P389, DOI 10.1111/j.1752-4598.2011.00177.x; Ulyshen MD, 2011, FOREST ECOL MANAG, V261, P1479, DOI 10.1016/j.foreco.2011.01.033; Vandermeer J., 1989, The ecology of intercropping.; Vehvilainen H, 2006, BASIC APPL ECOL, V7, P1, DOI 10.1016/j.baae.2005.05.003; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Watt A.D., 1992, Special Publication of the British Ecological Society, P267; Way MJ, 1977, ORIGINS PEST PARASIT, P127; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; WILSON E O, 1992; Yela JL, 1997, ENTOMOL EXP APPL, V85, P275, DOI 10.1023/A:1003125930772	119	6	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126140	10.1371/journal.pone.0126140	http://dx.doi.org/10.1371/journal.pone.0126140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938417	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000144
J	Moniaux, N; Darnaud, M; Garbin, K; Dos Santos, A; Guettier, C; Samuel, D; Amouyal, G; Amouyal, P; Brechot, C; Faivre, J				Moniaux, Nicolas; Darnaud, Marion; Garbin, Kevin; Dos Santos, Alexandre; Guettier, Catherine; Samuel, Didier; Amouyal, Gilles; Amouyal, Paul; Brechot, Christian; Faivre, Jamila			The Reg3 alpha (HIP/PAP) Lectin Suppresses Extracellular Oxidative Stress in a Murine Model of Acute Liver Failure	PLOS ONE			English	Article							INTRAVENOUS N-ACETYLCYSTEINE; CELL INJURY; NEUROTROPHIC FACTOR; FIBRIN DEPOSITION; REACTIVE OXYGEN; REGENERATION; MATRIX; ACTIVATION; MECHANISMS; SURVIVAL	Background and Aims Acute liver failure (ALF) is a rapidly progressive heterogeneous illness with high mortality rate and no widely accessible cure. A promising drug candidate according to previous preclinical studies is the Reg3 alpha (or HIP/PAP) lectin, which alleviates ALF through its free-radical scavenging activity. Here we study the therapeutic targets of Reg3 alpha in order to gain information on the nature of the oxidative stress associated with ALF. Methods Primary hepatocytes stressed with the reactive oxygen species (ROS) inducers TNF alpha and H2O2 were incubated with a recombinant Reg3 alpha protein. ALF was induced in C57BL/6J mice by an anti-CD95 antibody. Livers and primary hepatocytes were harvested for deoxycholate separation of cellular and extracellular fractions, immunostaining, immunoprecipitation and malondialdehyde assays. Fibrin deposition was studied by immunofluorescence in frozen liver explants from patients with ALF. Results Fibrin deposition occurs during experimental and clinical acute liver injuries. Reg3 alpha bound the resulting transient fibrin network, accumulated in the inflammatory extracellular matrix (ECM), greatly reduced extracellular ROS levels, and improved cell viability. Hepatocyte treatment with ligands of death receptors, e.g. TNF alpha and Fas, resulted in a twofold increase of malondialdehyde (MDA) level in the deoxycholate-insoluble fractions. Reg3 alpha treatment maintained MDA at a level similar to control cells and thereby increased hepatocyte survival by 35%. No antioxidant effect of Reg3 alpha was noted in the deoxycholate-soluble fractions. Preventing fibrin network formation with heparin suppressed the prosurvival effect of Reg3 alpha. Conclusions Reg3 alpha is an ECM-targeted ROS scavenger that binds the fibrin scaffold resulting from hepatocyte death during ALF. ECM alteration is an important pathogenic factor of ALF and a relevant target for pharmacotherapy.	[Moniaux, Nicolas; Darnaud, Marion; Garbin, Kevin; Dos Santos, Alexandre; Guettier, Catherine; Samuel, Didier; Brechot, Christian; Faivre, Jamila] INSERM, Ctr Hepatobiliaire, U1193, F-94800 Villejuif, France; [Moniaux, Nicolas; Darnaud, Marion; Garbin, Kevin; Dos Santos, Alexandre; Guettier, Catherine; Samuel, Didier; Brechot, Christian; Faivre, Jamila] Univ Paris 11, Fac Med, F-94800 Villejuif, France; [Guettier, Catherine; Samuel, Didier; Faivre, Jamila] Hop Univ Paul Brousse, AP HP, F-94800 Villejuif, France; [Amouyal, Gilles; Amouyal, Paul] Alfact Innovat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Moniaux, N (corresponding author), INSERM, Ctr Hepatobiliaire, U1193, F-94800 Villejuif, France.	nicolas.moniaux@inserm.fr; jamila.faivre@inserm.fr	Moniaux, Nicolas/Y-3243-2018; Dos Santos, Alexandre/S-1933-2018	Moniaux, Nicolas/0000-0001-9718-1386; 	French National Research Agency ANR [RIB 00801, Tecsan 01502]; European Commission (project "MODHEP"); French National Cancer Institute (INCa) [2009-PAIR-INCa]; Alfact Innovation	French National Research Agency ANR(French National Research Agency (ANR)); European Commission (project "MODHEP"); French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); Alfact Innovation	This work was supported by the French National Research Agency ANR (Programs RIB 00801 and Tecsan 01502 to J. Faivre), the European Commission (project "MODHEP" to J. Faivre), the French National Cancer Institute (INCa Grant 2009-PAIR-INCa to J. Faivre). The authors P. Amouyal and G. Amouyal received salary from Alfact Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chung Raymond T, 2012, Gastroenterology, V143, pe1, DOI 10.1053/j.gastro.2012.07.011; Copple BL, 2002, TOXICOL SCI, V65, P309, DOI 10.1093/toxsci/65.2.309; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Ganey PE, 2007, HEPATOLOGY, V46, P1177, DOI 10.1002/hep.21779; Giri RK, 2003, EXP CELL RES, V291, P451, DOI 10.1016/S0014-4827(03)00405-1; Gironella M, 2007, GUT, V56, P1091, DOI 10.1136/gut.2006.116087; HAMLYN AN, 1978, POSTGRAD MED J, V54, P400, DOI 10.1136/pgmj.54.632.400; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Huxley-Jones J, 2008, DRUG DISCOV TODAY, V13, P685, DOI 10.1016/j.drudis.2008.05.005; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kennett EC, 2011, BIOCHEM SOC T, V39, P1279, DOI 10.1042/BST0391279; Kheradpezhouh E, 2014, P NATL ACAD SCI USA, V111, P3176, DOI 10.1073/pnas.1322657111; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Leu JI, 2003, J CLIN INVEST, V111, P129, DOI 10.1172/JCI200316712; Lieu HT, 2006, HEPATOLOGY, V44, P1452, DOI 10.1002/hep.21434; Lieu HT, 2005, HEPATOLOGY, V42, P618, DOI 10.1002/hep.20845; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Masubuchi Y, 2011, BIOL PHARM BULL, V34, P366, DOI 10.1248/bpb.34.366; Miyazaki M, 2012, WORLD J GASTROENTERO, V18, P1884, DOI 10.3748/wjg.v18.i16.1884; Molnar Z, 1999, CRIT CARE MED, V27, P1100, DOI 10.1097/00003246-199906000-00028; Moniaux N, 2011, HEPATOLOGY, V53, P618, DOI 10.1002/hep.24087; Moriya K, 2012, HEPATOLOGY, V56, P311, DOI 10.1002/hep.25624; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Nissim O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049611; O'Grady J, 2014, J HEPATOL, V60, P663, DOI 10.1016/j.jhep.2013.10.024; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; PRESCOTT LF, 1983, ANNU REV PHARMACOL, V23, P87, DOI 10.1146/annurev.pa.23.040183.000511; Rank N, 2000, CRIT CARE MED, V28, P3799, DOI 10.1097/00003246-200012000-00006; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Saliba F, 2013, J HEPATOL, V59, P6, DOI 10.1016/j.jhep.2013.04.001; Samuel D, 2013, HEPATOLOGY, V58, p1390A; Sato T, 2011, HEPATOL RES, V41, P660, DOI 10.1111/j.1872-034X.2011.00821.x; Schattenberg JM, 2012, FREE RADICAL BIO MED, V52, P1911, DOI 10.1016/j.freeradbiomed.2012.02.049; SCHNITT SJ, 1993, CIRC RES, V72, P914, DOI 10.1161/01.RES.72.4.914; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Simon MT, 2003, FASEB J, V17, P1441, DOI 10.1096/fj.02-1013com; Singh S, 2013, DIGEST DIS SCI, V58, P1397, DOI 10.1007/s10620-012-2512-x; Squires RH, 2013, HEPATOLOGY, V57, P1542, DOI 10.1002/hep.26001; STAMATOGLOU SC, 1987, J CELL BIOL, V105, P2417, DOI 10.1083/jcb.105.5.2417; Stravitz RT, 2013, LIVER INT, V33, P1324, DOI 10.1111/liv.12214; Stravitz RT, 2009, NAT REV GASTRO HEPAT, V6, P542, DOI 10.1038/nrgastro.2009.127; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; Tell G, 2013, J HEPATOL, V58, P365, DOI 10.1016/j.jhep.2012.09.018; Weerasinghe SVW, 2011, HEPATOLOGY, V53, P1323, DOI 10.1002/hep.24203; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	60	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125584	10.1371/journal.pone.0125584	http://dx.doi.org/10.1371/journal.pone.0125584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938566	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000079
J	Redaniel, MT; Martin, RM; Ridd, MJ; Wade, J; Jeffreys, M				Redaniel, Maria Theresa; Martin, Richard M.; Ridd, Matthew J.; Wade, Julia; Jeffreys, Mona			Diagnostic Intervals and Its Association with Breast, Prostate, Lung and Colorectal Cancer Survival in England: Historical Cohort Study Using the Clinical Practice Research Datalink	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; PRIMARY-CARE; DELAYS; STAGE; RISK; TIME	Rapid diagnostic pathways for cancer have been implemented, but evidence whether shorter diagnostic intervals (time from primary care presentation to diagnosis) improves survival is lacking. Using the Clinical Practice Research Datalink, we identified patients diagnosed with female breast (8,639), colorectal (5,912), lung (5,737) and prostate (1,763) cancers between 1998 and 2009, and aged >15 years. Presenting symptoms were classified as alert or non-alert, according to National Institute for Health and Care Excellence guidance. We used relative survival and excess risk modeling to determine associations between diagnostic intervals and five-year survival. The survival of patients with colorectal, lung and prostate cancer was greater in those with alert, compared with non-alert, symptoms, but findings were opposite for breast cancer. Longer diagnostic intervals were associated with lower mortality for colorectal and lung cancer patients with non-alert symptoms, (colorectal cancer: Excess Hazards Ratio, EHR >6 months vs <1 month: 0.85; 95% CI: 0.72-1.00; Lung cancer: EHR 3-6 months vs <1 month: 0.87; 95% CI: 0.80-0.95; EHR >6 months vs <1 month: 0.81; 95% CI: 0.74-0.89). Prostate cancer mortality was lower in patients with longer diagnostic intervals, regardless of type of presenting symptom. The association between diagnostic intervals and cancer survival is complex, and should take into account cancer site, tumour biology and clinical practice. Nevertheless, unnecessary delay causes patient anxiety and general practitioners should continue to refer patients with alert symptoms via the cancer pathways, and actively follow-up patients with non-alert symptoms in the community.	[Redaniel, Maria Theresa] Univ Bristol, NIHR CLAHRC West, Bristol, Avon, England; [Redaniel, Maria Theresa; Martin, Richard M.; Ridd, Matthew J.; Wade, Julia; Jeffreys, Mona] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol; University of Bristol	Redaniel, MT (corresponding author), Univ Bristol, NIHR CLAHRC West, Bristol, Avon, England.	theresa.redaniel@bristol.ac.uk	Jeffreys, Mona/W-3425-2019; Ridd, Matthew/E-5656-2016	Martin, Richard/0000-0002-7992-7719; Redaniel, Theresa/0000-0002-0668-0874; Jeffreys, Mona/0000-0002-2617-0361; Ridd, Matthew/0000-0002-7954-8823	Cancer Research UK [C41354/A13273]; National Institute for Health Research (NIHR); Care West at University Hospitals Bristol NHS Foundation Trust; Cancer Research UK [13273] Funding Source: researchfish; National Institute for Health Research [CTF-01-12-06] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Care West at University Hospitals Bristol NHS Foundation Trust; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is funded by Cancer Research UK (Grant Ref: C41354/A13273). MTR was supported in part by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funding agency had no role in the study design, in the collection, analysis and interpretation of the data, in the writing of the report and in the decision to submit the article for publication.	Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Bosman FT, 2010, TUMOURS DIGESTIVE SY; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Cancer Research UK Cancer Survival Group, 2009, LIFE TABLES FOR ENGL; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; CPRD, 2012, CANCER REGISTRY DATA; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Department of Health, 2005, PRACT GUID ETHN MON; Department of Health, 2000, THE NHS CANCER PLAN; Department of Health, 2007, CANCER REFORM STRATE; Department of Health Public Health England NHS England, 2013, IMPROVING OUTCOMES A; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Dregan A, 2012, CANCER EPIDEMIOL; Dregan A, 2013, BRIT J GEN PRACT, V63, pE807, DOI 10.3399/bjgp13X675197; Droste JSTS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-332; Eble J, 2004, PATHOLOGY AND GENETI; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; European Network of Cancer Registries, 1997, ENCR DEFINITIONS FOR; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hamilton W, 2010, BRIT J GEN PRACT, V60, P121, DOI 10.3399/bjgp10X483175; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Holmberg L, 2012, CANCER EPIDEMIOL, V36, pE7, DOI 10.1016/j.canep.2011.08.001; Hospital Episode Statistics, 2009, HOW GOOD IS HES ETHN; Gonzalez-Barcala FJ, 2010, CLIN TRANSL ONCOL, V12, P836, DOI 10.1007/s12094-010-0606-5; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Korsgaard M, 2006, COLORECTAL DIS, V8, P688, DOI 10.1111/j.1463-1318.2006.01014.x; Murchie P, 2014, BRIT J CANCER, V111, P461, DOI 10.1038/bjc.2014.352; Myrdal G, 2004, THORAX, V59, P45; National Institute for Health and Clinical Excellence, 2014, REFERRAL GUIDELINES; National Institute for Health and Clinical Excellence, 2005, REFERRAL GUIDELINES; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Neal RD, 2009, BRIT J CANCER, V101, pS9, DOI 10.1038/sj.bjc.6605384; Neal RD, 2005, BRIT J CANCER, V92, P1971, DOI 10.1038/sj.bjc.6602623; Neal RD, 2015, BR J CANCER; Noble M, 2008, THE ENGLISH INDICES; Nur U, 2010, INT J EPIDEMIOL, V39, P118, DOI 10.1093/ije/dyp309; Office of the Deputy Prime Minister, 2004, THE ENGLISH INDICES; OS M, 1985, THEORETICAL EPIDEMIO; PORTA M, 1991, J EPIDEMIOL COMMUN H, V45, P225, DOI 10.1136/jech.45.3.225; Pruitt SL, 2013, CANCER CAUSE CONTROL, V24, P961, DOI 10.1007/s10552-013-0172-6; Radzikowska E, 2013, ADV EXP MED BIOL, V788, P355, DOI 10.1007/978-94-007-6627-3_48; Rai S, 2007, COLORECTAL DIS, V9, P195, DOI 10.1111/j.1463-1318.2006.01107.x; Ramos M, 2007, EUR J CANCER, V43, P2467, DOI 10.1016/j.ejca.2007.08.023; Redaniel MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-642; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Richards MA, 1999, BRIT J CANCER, V79, P858, DOI 10.1038/sj.bjc.6690137; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rupassara KS, 2006, COLORECTAL DIS, V8, P423, DOI 10.1111/j.1463-1318.2006.00958.x; Salisbury C, 2013, BRIT J GEN PRACT, V63, pE751, DOI 10.3399/bjgp13X674431; StataCorp, 2011, STATA STATISTICAL SO; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tavassoli FA, 2003, PATHOLOGY AND GENETI; Torring ML, 2012, J CLIN EPIDEMIOL, V65, P669, DOI 10.1016/j.jclinepi.2011.12.006; Torring ML, 2013, EUR J CANCER; Travis WD, 2004, PATHOLOGY AND GENETI; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	59	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126608	10.1371/journal.pone.0126608	http://dx.doi.org/10.1371/journal.pone.0126608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933397	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100154
J	Sun, HY; Kim, N; Hwang, CS; Yoo, JY				Sun, Hwa-Young; Kim, Nari; Hwang, Cheol-Sang; Yoo, Joo-Yeon			Protein Degradation of RNA Polymerase II-Association Factor 1(PAF1) Is Controlled by CNOT4 and 26S Proteasome	PLOS ONE			English	Article							PAF1 COMPLEX; CCR4-NOT COMPLEX; GENE-EXPRESSION; EUKARYOTIC CELLS; TRANSCRIPTION; CHROMATIN; METHYLATION; UBIQUITINATION; RECRUITMENT; ELONGATION	The PAF complex (PAFc) participates in various steps of the transcriptional process, from initiation to termination, by interacting with and recruiting various proteins to the proper locus for each step. PAFc is an evolutionarily conserved, multi-protein complex comprising PAF1, CDC73, CTR9, LEO1, yRTF1 and, in humans, hSKI8. These components of PAFc work together, and their protein levels are closely interrelated. In the present study, we investigated the mechanism of PAF1 protein degradation. We found that PAF1 protein levels are negatively regulated by the expression of CNOT4, an ortholog of yNOT4 and a member of the CCR4-NOT complex. CNOT4 specifically controls PAF1 but not other components of PAFc at the protein level by regulating the polyubiquitination of PAF1 and its subsequent degradation by the 26S proteasome. The degradation of PAF1 was found to require nuclear localization, as no PAF1 degradation by CNOT4 and the 26S proteasome was observed with NLS (nucleus localization signal)-deficient PAF1 mutants. However, chromatin binding by PAF1 was not necessary for 26S proteasome- or CNOT4-mediated degradation. Our results suggest that CNOT4 controls the degradation of chromatin-unbound PAF1 via the 26S proteasome.	[Sun, Hwa-Young; Kim, Nari; Hwang, Cheol-Sang; Yoo, Joo-Yeon] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea	Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	jyoo@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Kim, Nari/0000-0003-4837-9278	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012R1A2A2A01007525, NRF-2012R1A4 A1028200]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF; http://www.nrf.re.kr/) grant funded by the Korea government (MSIP) (NO. NRF-2012R1A2A2A01007525, NRF-2012R1A4 A1028200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrich CG, 2012, J BIOL CHEM, V287, P10863, DOI 10.1074/jbc.M111.325647; Carrera I, 2008, CURR OPIN GENET DEV, V18, P397, DOI 10.1016/j.gde.2008.07.007; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Collart MA, 2013, CELL SIGNAL, V25, P743, DOI 10.1016/j.cellsig.2012.12.018; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Finkbeiner MG, 2008, CELL CYCLE, V7, P3908, DOI 10.4161/cc.7.24.7354; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim N, 2013, NUCLEIC ACIDS RES, V41, P4495, DOI 10.1093/nar/gkt156; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lin L, 2008, P NATL ACAD SCI USA, V105, P17420, DOI 10.1073/pnas.0710725105; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Ulrich HD, 2014, NAT STRUCT MOL BIOL, V21, P317, DOI 10.1038/nsmb.2805; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200	32	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125599	10.1371/journal.pone.0125599	http://dx.doi.org/10.1371/journal.pone.0125599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933433	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100119
J	Burgardt, NI; Schmidt, A; Manns, A; Schutkowski, A; Jahreis, G; Lin, YJ; Schulze, B; Masch, A; Lucke, C; Weiwad, M				Ines Burgardt, Noelia; Schmidt, Andreas; Manns, Annika; Schutkowski, Alexandra; Jahreis, Guenther; Lin, Yi-Jan; Schulze, Bianca; Masch, Antonia; Luecke, Christian; Weiwad, Matthias			Parvulin 17-catalyzed Tubulin Polymerization Is Regulated by Calmodulin in a Calcium-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL CIS/TRANS ISOMERASE; MICROTUBULE-ASSOCIATED PROTEIN-2; STABLE MICROTUBULES; TARGET RECOGNITION; BINDING-SITE; STOP PROTEIN; AMINO-ACIDS; DOMAIN; PIN1; PHOSPHORYLATION	Recently we have shown that the peptidyl-prolyl cis/trans isomerase parvulin 17 (Par17) interacts with tubulin in a GTP-dependent manner, thereby promoting the formation of microtubules. Microtubule assembly is regulated by Ca2+-loaded calmodulin (Ca2+/CaM) both in the intact cell and under in vitro conditions via direct interaction with microtubule-associated proteins. Here we provide the first evidence that Ca2+/CaM interacts also with Par17 in a physiologically relevant way, thus preventing Par17-promoted microtubule assembly. In contrast, parvulin 14 (Par14), which lacks only the first 25 N-terminal residues of the Par17 sequence, does not interact with Ca2+/CaM, indicating that this interaction is exclusive for Par17. Pull-down experiments and chemical shift perturbation analysis with N-15-labeled Par17 furthermore confirmed that calmodulin (CaM) interacts in a Ca2+-dependent manner with the Par17 N terminus. The reverse experiment with N-15-labeled Ca2+/CaM demonstrated that the N-terminal Par17 segment binds to both CaM lobes simultaneously, indicating that Ca2+/CaM undergoes a conformational change to form a binding channel between its two lobes, apparently similar to the structure of the CaM-smMLCK(796-815) complex. In vitro tubulin polymerization assays furthermore showed that Ca2+/CaM completely suppresses Par17-promoted microtubule assembly. The results imply that Ca2+/CaM binding to the N-terminal segment of Par17 causes steric hindrance of the Par17 active site, thus interfering with the Par17/tubulin interaction. This Ca2+/CaM-mediated control of Par17-assisted microtubule assembly may provide a mechanism that couples Ca2+ signaling with microtubule function.	[Ines Burgardt, Noelia] Univ Buenos Aires, Sch Pharm & Biochem, Inst Biochem & Biophys IQUIFIB, Buenos Aires, DF, Argentina; [Ines Burgardt, Noelia; Schmidt, Andreas; Manns, Annika; Schutkowski, Alexandra; Jahreis, Guenther; Schulze, Bianca; Luecke, Christian; Weiwad, Matthias] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Saale, Germany; [Lin, Yi-Jan] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Ctr Excellence Environm Med, Grad Inst Nat Prod, Kaohsiung 807, Taiwan; [Masch, Antonia; Weiwad, Matthias] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Enzymol, D-06099 Halle, Saale, Germany	University of Buenos Aires; Max Planck Society; Kaohsiung Medical University; Martin Luther University Halle Wittenberg	Burgardt, NI (corresponding author), Inst Quim & Fis Quim Biol Prof Alejandro C Paladi, Junin 956,C1113AAD, Buenos Aires, DF, Argentina.	burgardt@qb.ffyb.uba.ar		Schutkowski, Alexandra/0000-0002-9387-7869	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Recipient of the Partial Funding Program for Short Stays Abroad of Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAGCHI IC, 1992, J BIOL CHEM, V267, P3024; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BARTON JS, 1980, BIOCHIM BIOPHYS ACTA, V630, P392, DOI 10.1016/0304-4165(80)90288-3; Burgardt NI, 2012, BIOMOL NMR ASSIGN, V6, P185, DOI 10.1007/s12104-011-9352-z; Cohen P, 1988, CALMODULIN; COX JA, 1985, J BIOL CHEM, V260, P2527; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Hasezawa S, 1997, PROTOPLASMA, V198, P202, DOI 10.1007/BF01287569; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jaremko L, 2011, J BIOL CHEM, V286, P6554, DOI 10.1074/jbc.M110.160713; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; KINDLER S, 1990, J BIOL CHEM, V265, P19679; Kurek I, 2002, PLANT MOL BIOL, V48, P369, DOI 10.1023/A:1014023329807; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LEE YC, 1984, J BIOL CHEM, V259, P1226; Lefevre J, 2013, J BIOL CHEM, V288, P24910, DOI 10.1074/jbc.M113.457267; Lin YJ, 2013, BIOMOL NMR ASSIGN, V7, P325, DOI 10.1007/s12104-012-9438-2; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Maestre-Martinez M, 2010, BIOL CHEM, V391, P1157, DOI 10.1515/BC.2010.122; MARGOLIS RL, 1990, EMBO J, V9, P4095, DOI 10.1002/j.1460-2075.1990.tb07631.x; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Mueller JW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-9; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PADILLA R, 1990, MOL CELL BIOCHEM, V97, P35; Pemberton TJ, 2005, COMP FUNCT GENOM, V6, P277, DOI 10.1002/cfg.482; PIROLLET F, 1992, BIOCHEMISTRY-US, V31, P8849, DOI 10.1021/bi00152a022; POTTER JD, 1983, METHOD ENZYMOL, V102, P135; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Reimer T, 2003, J MOL BIOL, V330, P955, DOI 10.1016/S0022-2836(03)00713-7; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; SHIN RW, 1991, LAB INVEST, V64, P693; SOBUE K, 1981, FEBS LETT, V132, P137, DOI 10.1016/0014-5793(81)80447-4; Surmacz TA, 2002, J MOL BIOL, V321, P235, DOI 10.1016/S0022-2836(02)00615-0; Terada T, 2001, J MOL BIOL, V305, P917, DOI 10.1006/jmbi.2000.4293; Thiele A, 2011, J MOL BIOL, V411, P896, DOI 10.1016/j.jmb.2011.06.040; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065266; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242	65	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16708	16722		10.1074/jbc.M114.593228	http://dx.doi.org/10.1074/jbc.M114.593228			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25940090	Green Published, hybrid			2022-12-26	WOS:000357572800020
J	Cabana, J; Holleran, B; Leduc, R; Escher, E; Guillemette, G; Lavigne, P				Cabana, Jerome; Holleran, Brian; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan; Lavigne, Pierre			Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the G(q/11) Protein Pathway and the -Arrestin Pathway Using Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; G protein-coupled receptor (GPCR); molecular dynamics; protein conformation; receptor structure-function; AT1 receptor; AT1R; activation mechanism; biased signaling; functional selectivity	SIGNAL-REGULATED KINASE-1; AMYLOID BETA-PEPTIDE; CONSERVED DRY MOTIF; AT(1) RECEPTOR; CRYSTAL-STRUCTURE; COUPLED-RECEPTOR; FUNCTIONAL SELECTIVITY; ACTIVATION MECHANISM; LIPID-BILAYER; BETA(2)-ADRENERGIC RECEPTOR	Biased signaling represents the ability of G protein-coupled receptors to engage distinct pathways with various efficacies depending on the ligand used or on mutations in the receptor. The angiotensin-II type 1 (AT(1)) receptor, a prototypical class A G protein-coupled receptor, can activate various effectors upon stimulation with the endogenous ligand angiotensin-II (AngII), including the G(q/11) protein and -arrestins. It is believed that the activation of those two pathways can be associated with distinct conformations of the AT(1) receptor. To verify this hypothesis, microseconds of molecular dynamics simulations were computed to explore the conformational landscape sampled by the WT-AT(1) receptor, the N111G-AT(1) receptor (constitutively active and biased for the G(q/11) pathway), and the D74N-AT(1) receptor (biased for the -arrestin1 and -2 pathways) in their apo-forms and in complex with AngII. The molecular dynamics simulations of the AngII-WT-AT(1), N111G-AT(1), and AngII-N111G-AT(1) receptors revealed specific structural rearrangements compared with the initial and ground state of the receptor. Simulations of the D74N-AT(1) receptor revealed that the mutation stabilizes the receptor in the initial ground state. The presence of AngII further stabilized the ground state of the D74N-AT(1) receptor. The biased agonist [Sar(1),Ile(8)]AngII also showed a preference for the ground state of the WT-AT(1) receptor compared with AngII. These results suggest that activation of the G(q/11) pathway is associated with a specific conformational transition stabilized by the agonist, whereas the activation of the -arrestin pathway is linked to the stabilization of the ground state of the receptor.	[Cabana, Jerome; Holleran, Brian; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Lavigne, Pierre] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Hlth Sci, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada; [Cabana, Jerome; Lavigne, Pierre] Univ Laval, PROTEO Quebec Network Prot Struct Funct & Engn, Quebec City, PQ G1V 0A6, Canada	University of Sherbrooke; University of Sherbrooke; Laval University	Lavigne, P (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Hlth Sci, Dept Biochem, 3001 12th Ave North, Sherbrooke, PQ J1H 5N4, Canada.	Pierre.Lavigne@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Aplin M, 2009, J MOL CELL CARDIOL, V46, P15, DOI 10.1016/j.yjmcc.2008.09.123; Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BERWEGER CD, 1995, CHEM PHYS LETT, V232, P429, DOI 10.1016/0009-2614(94)01391-8; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; BOSSE R, 1990, J CARDIOVASC PHARM, V16, pS50, DOI 10.1097/00005344-199016004-00011; Cabana J, 2013, J BIOL CHEM, V288, P2593, DOI 10.1074/jbc.M112.395939; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2006, J RECEPT SIG TRANSD, V26, P417, DOI 10.1080/10799890600923195; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Vries AH, 2004, J PHYS CHEM B, V108, P2454, DOI 10.1021/jp0366926; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Domazet I, 2015, MOL PHARMACOL, V87, P982, DOI 10.1124/mol.114.097337; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Fillion D, 2013, J BIOL CHEM, V288, P8187, DOI 10.1074/jbc.M112.442053; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLCK M, 1989, BIOCHEM BIOPH RES CO, V160, P1350, DOI 10.1016/S0006-291X(89)80152-4; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hunyady L, 1999, J AM SOC NEPHROL, V10, pS47; HUNYADY L, 1995, J BIOL CHEM, V270, P16602, DOI 10.1074/jbc.270.28.16602; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; KHOSLA MC, 1973, J MED CHEM, V16, P829, DOI 10.1021/jm00265a018; KHOSLA MC, 1972, J MED CHEM, V15, P792, DOI 10.1021/jm00278a003; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Laporte SA, 1996, MOL PHARMACOL, V49, P89; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CW, 2008, J BIOL CHEM, V283, P21612, DOI 10.1074/jbc.M803062200; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Lemkul JA, 2008, ARCH BIOCHEM BIOPHYS, V470, P54, DOI 10.1016/j.abb.2007.11.004; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; MacCallum JL, 2006, J AM CHEM SOC, V128, P125, DOI 10.1021/ja0535099; Matsoukas MT, 2013, J CHEM INF MODEL, V53, P2798, DOI 10.1021/ci4003014; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Nikiforovich GV, 2006, CHEM BIOL DRUG DES, V68, P239, DOI 10.1111/j.1747-0285.2006.00444.x; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Ohyama K, 2002, BIOCHEM BIOPH RES CO, V292, P362, DOI 10.1006/bbrc.2002.6670; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thomas WG, 2003, TRENDS ENDOCRIN MET, V14, P130, DOI 10.1016/S1043-2760(03)00023-7; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Tieleman D. Peter, 2004, BMC Biochemistry, V5, P10, DOI 10.1186/1471-2091-5-10; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D, 2011, WIRES COMPUT MOL SCI, V1, P710, DOI 10.1002/wcms.50; Vauquelin G, 2001, J RENIN-ANGIO-ALDO S, V2, pS32, DOI 10.1177/14703203010020010501; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Werner T, 2012, ADV DRUG DELIVER REV, V64, P323, DOI 10.1016/j.addr.2011.11.011; Wilson PC, 2013, J BIOL CHEM, V288, P18872, DOI 10.1074/jbc.M113.472381; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Zhang XJC, 2013, PROTEIN CELL, V4, P747, DOI 10.1007/s13238-013-3073-2; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	84	26	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15835	15854		10.1074/jbc.M114.627356	http://dx.doi.org/10.1074/jbc.M114.627356			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25934394	Green Published, hybrid			2022-12-26	WOS:000356527400043
J	August, F; Pembe, AB; Mpembeni, R; Axemo, P; Darj, E				August, Furaha; Pembe, Andrea B.; Mpembeni, Rose; Axemo, Pia; Darj, Elisabeth			Men's Knowledge of Obstetric Danger Signs, Birth Preparedness and Complication Readiness in Rural Tanzania	PLOS ONE			English	Article							MATERNAL MORTALITY; SKILLED CARE; DELIVERY; SERVICES; NEPAL	Background Men's involvement in reproductive health is recommended. Their involvement in antenatal care service is identified as important in maternal health. Awareness of obstetric danger signs facilitates men in making a joint decision with their partners regarding accessing antenatal and delivery care. This study aims to assess the level of knowledge of obstetric complications among men in a rural community in Tanzania, and to determine their involvement in birth preparedness and complication readiness. Methods A cross-sectional survey was conducted where 756 recent fathers were invited through a two-stage cluster sampling procedure. A structured questionnaire was used to collect socio-demographic characteristics, knowledge of danger signs and steps taken on birth preparedness and complication readiness. Data were analyzed using bivariate and multivariable logistic regression to determine factors associated with being prepared, with statistically significant level at p<0.05. Results Among the invited men, 95.9% agreed to participate in the community survey. Fifty-three percent could mention at least one danger sign during pregnancy, 43.9% during delivery and 34.6% during the postpartum period. Regarding birth preparedness and complication readiness, 54.3% had bought birth kit, 47.2% saved money, 10.2% identified transport, 0.8% identified skilled attendant. In general, only 12% of men were prepared. Birth preparedness was associated with knowledge of danger signs during pregnancy (AOR = 1.4, 95% CI: 1.8-2.6). It was less likely for men living in the rural area to be prepared (AOR=0.6, 95% CI; 0.5-0.8). Conclusion There was a low level of knowledge of obstetric danger signs among men in a rural district in Tanzania. A very small proportion of men had prepared for childbirth and complication readiness. There was no effect of knowledge of danger signs during childbirth and postpartum period on being prepared. Innovative strategies that increase awareness of danger signs as well as birth preparedness and complication readiness among men are required. Strengthening counseling during antenatal care services that involve men together with partners is recommended.	[August, Furaha; Pembe, Andrea B.] Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania; [August, Furaha; Pembe, Andrea B.; Axemo, Pia; Darj, Elisabeth] Uppsala Univ, Dept Womens & Childrens Hlth Int Maternal & Child, Uppsala, Sweden; [Mpembeni, Rose] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Darj, Elisabeth] Norwegian Univ Sci & Technol, Inst Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	Muhimbili University of Health & Allied Sciences; Uppsala University; Muhimbili University of Health & Allied Sciences; Norwegian University of Science & Technology (NTNU)	August, F (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania.	drfuraha@gmail.com	PEMBE, ANDREA BARNABAS/GLV-2523-2022; August, Furaha/L-4147-2019	PEMBE, ANDREA BARNABAS/0000-0002-8090-3298; August, Furaha/0000-0002-1145-5153	Swedish International Development Agency (SIDA/SAREC) through Muhimbili University of Health and Allied Sciences	Swedish International Development Agency (SIDA/SAREC) through Muhimbili University of Health and Allied Sciences	Swedish International Development Agency (SIDA/SAREC) provided financial support through Muhimbili University of Health and Allied Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio P, 2013, HEALTH CARE WOMEN IN, V34, P419, DOI 10.1080/07399332.2012.755982; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Brazier E, 2014, HEALTH CARE WOMEN IN, V35, P878, DOI 10.1080/07399332.2014.916293; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Dunn A, 2011, PAN AFR MED J, V10; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097194; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Hailu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083459; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hiluf M, 2007, ETHIOP J HEALTH DEV, V22, P14; JHPIEGO, 2004, MON BIRTH PREP COMPL; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Kululanga Lucy I, 2012, Afr J Reprod Health, V16, P145; Kululanga LI, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-36; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Magoma M, 2013, TROP MED INT HEALTH, V18, P435, DOI 10.1111/tmi.12069; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mekonnen Y, 2003, J HEALTH POPUL NUTR, V21, P374; MoHSW, 2008, NAT ROAD MAP STRAT P; MOHSW, 2002, FOC ANT CAR MAL SYPH; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Mutiso S M, 2008, East Afr Med J, V85, P275; NBS, 2013, POP HOUS CENS DAR SA; NBS, 2013, BAS FACTS FIG HUM SE; Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tura G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-60; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; Urassa DP, 2012, TANZANIA J HLTH RES, V14, P1; WHO U UNFPA and The World Bank, 2012, TRENDS MAT MORT 1990	40	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125978	10.1371/journal.pone.0125978	http://dx.doi.org/10.1371/journal.pone.0125978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH7KF	25950814	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400057
J	Gonzalez-Delgado, AM; Ashigh, J; Shukla, MK; Perkins, R				Gonzalez-Delgado, Amir M.; Ashigh, Jamshid; Shukla, Manoj K.; Perkins, Russ			Mobility of Indaziflam Influenced by Soil Properties in a Semi-Arid Area	PLOS ONE			English	Article							HYBRID BERMUDAGRASS INJURY; FIELD DISSIPATION; LONG-TERM; PESTICIDES; BIODEGRADATION; DEGRADATION; VARIABILITY; TRANSPORT; ATRAZINE; TILLAGE	Indaziflam, a broad-spectrum, pre-emergence herbicide was the focus of a field investigation conducted after the identification of sporadic injury symptoms on the pecan trees a few months after the application. The study was conducted in two pecan orchards located in southern New Mexico, USA, and southeastern Arizona, USA. The objectives of this study were to evaluate the occurrence and distribution of indaziflam in the soil profile of areas where pecan trees were injured (impacted) and areas where no injury symptoms were observed (unimpacted), and to determine the relationship between indaziflam concentrations and soil properties in those locations. Soil samples were collected, one year after applications, from six depth representing 0-7, 7-15, 15-30, 30-60, 60-90 and 90-120 cm depth to determine the concentration of indaziflam in impacted and unimpacted areas of the two orchards. Soil samples were analyzed to determine texture, bulk density, organic matter content, cation exchange capacity, pH, nitrate, chloride and calcium concentrations. The detection frequency of indaziflam was higher in Arizona than in New Mexico, likely due to the differences between the tillage practices and sand contents of the orchards. No significant correlations were observed between indaziflam and soil properties, however indaziflam was mostly detected in areas where pecan trees were unimpacted probably as result of greater organic matter content and soil porosity. More research is needed to understand the causes of injury to pecan trees by indaziflam application.	[Gonzalez-Delgado, Amir M.; Shukla, Manoj K.] New Mexico State Univ, Plant & Environm Sci Dept, Las Cruces, NM 88003 USA; [Ashigh, Jamshid] New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA; [Perkins, Russ] Bayer CropSci LP, Field Dev Southern, Idalou, TX 79329 USA	New Mexico State University; New Mexico State University; Bayer AG; Bayer CropScience	Gonzalez-Delgado, AM (corresponding author), New Mexico State Univ, Plant & Environm Sci Dept, POB 30003 MSC 3Q Skeen Hall Room N 127, Las Cruces, NM 88003 USA.	amir.gonzalez@gmail.com			Bayer CropScience; New Mexico State University Agricultural Experiment Station	Bayer CropScience(Bayer AG); New Mexico State University Agricultural Experiment Station	This work was supported by grants from Bayer CropScience and New Mexico State University Agricultural Experiment Station. Co-author Russ Perkins is employed by Bayer CropScience LP. Bayer CropScience provided support in the form of salary for co-author Russ Perkins that was involved in analytical data and decision to publish, but did not have any additional role in the study design. The specific roles of this author is articulated in the 'author contributions' section.	Alonso DG, 2011, J AGR FOOD CHEM, V59, P13096, DOI 10.1021/jf203014g; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Azlan A., 2012, J APPL SCI ENV MANAG, V16, P346; Bates TE, 1993, SOIL SAMPLING METHOD, P19; Bernoux M, 1998, SOIL SCI SOC AM J, V62, P743, DOI 10.2136/sssaj1998.03615995006200030029x; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Chaudhari P.R., 2013, INT J SCI RES PUBLIC, V3, P1; Cox L, 1994, BRIGHT CROP PROT C P; CURTIS ROBERT O., 1964, SOIL SCI SOC AMER PROC, V28, P285; Das A. C., 2012, Journal of Crop and Weed, V8, P129; Durovic R., 2009, Pesticidi i Fitomedicina, V24, P51; El-Ghamry A. M., 2000, Journal of Environmental Sciences (China), V12, P138; Foth HD, 1991, FUNDAMENTALS SOIL SC; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gonzalez-Delgado AM, 2011, SOIL SCI, V176, P346, DOI 10.1097/SS.0b013e31821f48f2; HARRISON GW, 1976, WEED SCI, V24, P120, DOI 10.1017/S0043174500065528; Janaki P, 2013, J ENVIRON SCI HEAL B, V48, P941, DOI 10.1080/03601234.2013.816599; Jhala AJ, 2012, WEED TECHNOL, V26, P602, DOI 10.1614/WT-D-11-00161.1; Jhala AJ, 2012, B ENVIRON CONTAM TOX, V88, P326, DOI 10.1007/s00128-011-0514-6; Jones PA, 2013, CROP SCI, V53, P660, DOI 10.2135/cropsci2012.08.0475; Jones PA, 2013, WEED TECHNOL, V27, P547, DOI 10.1614/WT-D-13-00001.1; Kaapro J., 2012, Pakistan Journal of Weed Science Research, V18, P267; Kah M, 2007, J AGR FOOD CHEM, V55, P4487, DOI 10.1021/jf0635356; Koskinen WC, 2006, PEST MANAG SCI, V62, P598, DOI 10.1002/ps.1196; Li LF, 2004, J ENVIRON SCI-CHINA, V16, P678; Mao M, 2004, GROUND WATER, V42, P500, DOI 10.1111/j.1745-6584.2004.tb02618.x; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MOORMAN T B, 1989, Journal of Production Agriculture, V2, P14; Nemeth-Konda L, 2002, CHEMOSPHERE, V48, P545, DOI 10.1016/S0045-6535(02)00106-6; Oorts K, 2003, AGR ECOSYST ENVIRON, V100, P161, DOI 10.1016/S0167-8809(03)00190-7; Radivojevic L., 2011, Pesticidi i Fitomedicina, V26, P135; Rodriguez-Cruz MS, 2006, SOIL BIOL BIOCHEM, V38, P2910, DOI 10.1016/j.soilbio.2006.04.051; ROGER PA, 1994, AUST J EXP AGR, V34, P1057, DOI 10.1071/EA9941057; Rouchaud J, 1997, ARCH ENVIRON CON TOX, V33, P247, DOI 10.1007/s002449900250; SAARI LL, 1990, PLANT PHYSIOL, V93, P55, DOI 10.1104/pp.93.1.55; Sakin E, 2011, AFR J AGR RES, V6, P1750; Shaner DL, 2012, WEED TECHNOL, V26, P633, DOI 10.1614/WT-D-12-00037.1; Shukla MK, 2005, SOIL SCI, V170, P445, DOI 10.1097/01.ss.0000171667.60883.f2; Soil Survey of Dona Ana County Area New Mexico, 1980, SOIL SURV DON AN COU; Tebrugge F, 1999, SOIL TILL RES, V53, P15, DOI 10.1016/S0167-1987(99)00073-2; U.S. EPA, 2000, ASS VAL NOND NONQ PE, P1; Umrit G., 1999, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P24; United States Dpeartment of Agriculture, 1976, SOIL SURV WILLC AR; US EPA, 2010, PROV PEER REV TOX VA, P1; VandenBygaart AJ, 2004, SOIL SCI SOC AM J, V68, P1394, DOI 10.2136/sssaj2004.1394; Vervoort RW, 2001, SOIL SCI SOC AM J, V65, P1227, DOI 10.2136/sssaj2001.6541227x; Vischetti C, 1997, PESTIC SCI, V50, P175, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;175::AID-PS577&gt;3.0.CO;2-2; Wauchope RD, 2002, PEST MANAG SCI, V58, P419, DOI 10.1002/ps.489; Xu RK, 2003, PLANT SOIL, V250, P113, DOI 10.1023/A:1022882408133	49	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126100	10.1371/journal.pone.0126100	http://dx.doi.org/10.1371/journal.pone.0126100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950921	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400069
J	Hou, YN; Ernst, SA; Stuenkel, EL; Lentz, SI; Williams, JA				Hou, Yanan; Ernst, Stephen A.; Stuenkel, Edward L.; Lentz, Stephen I.; Williams, John A.			Rab27A Is Present in Mouse Pancreatic Acinar Cells and Is Required for Digestive Enzyme Secretion	PLOS ONE			English	Article							CORE VESICLE EXOCYTOSIS; MYOSIN-VA; MELANOSOME TRANSPORT; GRANULE EXOCYTOSIS; GRISCELLI-SYNDROME; LINKS RAB27A; PC12 CELLS; F-ACTIN; PROTEINS; INSULIN	The small G-protein Rab27A has been shown to regulate the intracellular trafficking of secretory granules in various cell types. However, the presence, subcellular localization and functional impact of Rab27A on digestive enzyme secretion by mouse pancreatic acinar cells are poorly understood. Ashen mice, which lack the expression of Rab27A due to a spontaneous mutation, were used to investigate the function of Rab27A in pancreatic acinar cells. Isolated pancreatic acini were prepared from wild-type or ashen mouse pancreas by collagenase digestion, and CCK-or carbachol-induced amylase secretion was measured. Secretion occurring through the major-regulated secretory pathway, which is characterized by zymogen granules secretion, was visualized by Dextran-Texas Red labeling of exocytotic granules. The minor-regulated secretory pathway, which operates through the endosomal/lysosomal pathway, was characterized by luminal cell surface labeling of lysosomal associated membrane protein 1 (LAMP1). Compared to wild-type, expression of Rab27B was slightly increased in ashen mouse acini, while Rab3D and digestive enzymes (amylase, lipase, chymotrypsin and elastase) were not affected. Localization of Rab27B, Rab3D and amylase by immunofluorescence was similar in both wild-type and ashen acinar cells. The GTP-bound states of Rab27B and Rab3D in wild-type and ashen mouse acini also remained similar in amount. In contrast, acini from ashen mice showed decreased amylase release induced by CCK-or carbachol. Rab27A deficiency reduced the apical cell surface labeling of LAMP1, but did not affect that of Dextran-Texas Red incorporation into the fusion pockets at luminal surface. These results show that Rab27A is present in mouse pancreatic acinar cells and mainly regulates secretion through the minor-regulated pathway.	[Hou, Yanan; Stuenkel, Edward L.; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Lentz, Stephen I.; Williams, John A.] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Williams, JA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	jawillms@umich.edu		Stuenkel, Edward/0000-0001-8225-5725; Lentz, Stephen/0000-0003-1686-7998	National Institute of Health [R37DK041122, R01DK077050]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK34933, P30DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041122, P30DK020572, R01DK077050, P30DK034933] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Support was provided by the National Institute of Health grants R37DK041122 to JAW and R01DK077050 to ELS; National Institute of Diabetes and Digestive and Kidney Diseases grants P30DK34933 to JAW and SAE, P30DK020572 to JAW and SIL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PANCREAPEDIA EXOCRIN, DOI DOI 10.3998/PANC.2010.18; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Castle AM, 2002, J CELL SCI, V115, P2963; Castle JD, 1996, J CELL SCI, V109, P2591; Cazares VA, 2014, TRAFFIC, V15, P997, DOI 10.1111/tra.12182; Chen X, 2010, PANCREAPEDIA EXOCRIN, DOI [10.3998/panc.2010.3, DOI 10.3998/PANC.2010.3]; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Crozier SJ, 2009, GASTROENTEROLOGY, V137, P1093, DOI 10.1053/j.gastro.2009.04.058; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Flikweert ER, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-135; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Hou Y, 2010, PANCREAPEDIA EXOCRIN, DOI [10.3998/panc.2010.14, DOI 10.3998/PANC.2010.14]; Hou YA, 2013, J BIOL CHEM, V288, P19548, DOI 10.1074/jbc.M113.472134; Huang AY, 2001, J BIOL CHEM, V276, P22296, DOI 10.1074/jbc.M100211200; Johnson JL, 2009, TRAFFIC; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kimura T, 2008, J CELL SCI, V121, P3092, DOI 10.1242/jcs.030544; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kimura T, 2011, ENDOCR J, V58, P1, DOI 10.1507/endocrj.K10E-391; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Messenger SW, 2013, AM J PHYSIOL-GASTR L, V305, pG439, DOI 10.1152/ajpgi.00143.2013; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Turvey MR, 2004, PFLUG ARCH EUR J PHY, V448, P552, DOI 10.1007/s00424-004-1288-z; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125596	10.1371/journal.pone.0125596	http://dx.doi.org/10.1371/journal.pone.0125596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951179	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400038
J	Yang, ZY; Chen, W; Xia, ZD; Liu, YJ; Peggrem, S; Geng, T; Yang, ZX; Li, H; Xu, B; Zhang, C; Triffitt, JT; Zhang, YZ				Yang, Zongyou; Chen, Wei; Xia, Zhidao; Liu, Yueju; Peggrem, Shaun; Geng, Tao; Yang, Zhaoxu; Li, Han; Xu, Bin; Zhang, Chi; Triffitt, James T.; Zhang, Yingze			Local Application of Ibandronate/Gelatin Sponge Improves Osteotomy Healing in Rabbits	PLOS ONE			English	Article							ZOLEDRONIC ACID; CATABOLIC RESPONSES; SKELETAL COMPLICATIONS; MULTIPLE-MYELOMA; BONE-RESORPTION; BISPHOSPHONATE; ALENDRONATE; NONUNION; OSTEONECROSIS; STRENGTH	Delayed healing or non-union of skeletal fractures are common clinical complications. Ibandronate is a highly potent anti-catabolic reagent used for treatment of osteopenia and fracture prevention. We hypothesized that local application of ibandronate after fracture fixation may improve and sustain callus formation and therefore prevent delayed healing or nonunion. This study tested the effect of local application of an ibandronate/gelatin sponge composite on osteotomy healing. A right-side distal-femoral osteotomy was created surgically, with fixation using a k-wire, in forty adult male rabbits. The animals were divided into four groups of ten animals and treated by: (i) intravenous injection of normal saline (Control); (ii) local implantation of absorbable gelatin sponge (GS); (iii) local implantation of absorbable GS containing ibandronate (IB+ GS), and (iv) intravenous injection of ibandronate (IB i. v.). At two and four weeks the affected femora were harvested for X-ray photography, computed tomography (CT), biomechanical testing and histopathology. At both time-points the results showed that the calluses in both the ibandronate-treated groups, but especially in the IB+ GS group, were significantly larger than in the control and GS groups. At four weeks the cross sectional area (CSA) and mechanical test results of ultimate load and energy in the IB+ GS group were significantly higher than in other groups. Histological procedures showed a significant reduction in osteoclast numbers in the IB+ GS and IB i. v. groups at day 14. The results indicate that local application of an ibandronate/gelatin sponge biomaterial improved early osteotomy healing after surgical fixation and suggest that such treatment may be a valuable local therapy to enhance fracture repair and potentially prevent delayed or non-union.	[Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China; [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang 050051, Peoples R China; [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Xia, Zhidao; Peggrem, Shaun] Swansea Univ, Ctr Nanohlth, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Yang, Zhaoxu] Hebei Gen Hosp, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China; [Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	Hebei Medical University; Swansea University; Nuffield Orthopaedic Centre; University of Oxford	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.	yzling_liu@163.com	Xia, Zhidao/AAA-5192-2019; Chen, Wei/GRX-2231-2022	Zhang, YIngze/0000-0001-8042-6105; Xia, Zhidao/0000-0002-2047-7282				Amanat N, 2005, J ORTHOP RES, V23, P1029, DOI 10.1016/j.orthres.2005.03.004; Amanat N, 2007, J BONE MINER RES, V22, P867, DOI 10.1359/JBMR.070318; Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74; AZUMA Y, 1995, BONE, V16, P235, DOI 10.1016/8756-3282(94)00035-X; Bergner R, 2007, J CLIN PHARMACOL, V47, P942, DOI 10.1177/0091270007301801; Bobba RS, 2006, DRUG SAFETY, V29, P1133, DOI 10.2165/00002018-200629120-00005; Chennuru S, 2008, INTERN MED J, V38, P635, DOI 10.1111/j.1445-5994.2007.01580.x; Copuroglu C, 2013, INJURY, V44, P1379, DOI 10.1016/j.injury.2013.08.003; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Diel IJ, 2009, SUPPORT CARE CANCER, V17, P719, DOI 10.1007/s00520-008-0553-7; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Goodship A E, 1994, Ann Oncol, V5 Suppl 7, pS53; Grazio S, 2008, CLIN RHEUMATOL, V27, P651, DOI 10.1007/s10067-007-0827-3; Guyver P, 2012, INJURY, V43, P1187, DOI 10.1016/j.injury.2012.03.035; Hardeman F, 2012, INJURY, V43, P153, DOI 10.1016/j.injury.2011.04.003; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; Lipton A, 2002, CANCER INVEST, V20, P45, DOI 10.1081/CNV-120014886; Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301; Little DG, 2005, J BONE MINER RES, V20, P2044, DOI 10.1359/JBMR.050712; Maalouf Naim M, 2006, Endocr Pract, V12, P48; Manabe T, 2012, CALCIFIED TISSUE INT, V90, P193, DOI 10.1007/s00223-011-9563-4; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Mills LA, 2013, BMJ OPEN, P3; Miura N, 2009, CLIN EXP NEPHROL, V13, P85, DOI 10.1007/s10157-008-0078-x; Olson Karin, 2007, J Oncol Pharm Pract, V13, P223, DOI 10.1177/1078155207080806; Peter CP, 1996, J ORTHOP RES, V14, P74, DOI 10.1002/jor.1100140113; Ralston SH, 2004, CALCIFIED TISSUE INT, V74, P1, DOI 10.1007/s00223-001-1135-6; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Rozental TD, 2009, J HAND SURG-AM, V34A, P595, DOI 10.1016/j.jhsa.2008.12.011; Ruggiero SL, 2006, ORAL SURG ORAL MED O, V102, P433, DOI 10.1016/j.tripleo.2006.06.004; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Song F, 2007, HEALTH TECHNOL ASSES, V11, piii; Stakkestad JA, 2008, CLIN RHEUMATOL, V27, P955, DOI 10.1007/s10067-007-0824-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; VANBEEK E, 1994, J BONE MINER RES, V9, P1875, DOI 10.1002/jbmr.5650091206; Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P110, DOI 10.1007/s00223-009-9323-x; Yu NYC, 2013, EUR CELLS MATER, V25, P190, DOI 10.22203/eCM.v025a14; Yu Nicole Y C, 2012, Front Biosci (Elite Ed), V4, P2647	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125807	10.1371/journal.pone.0125807	http://dx.doi.org/10.1371/journal.pone.0125807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951178	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400050
J	da Silva, T; Albertin, W; Dillmann, C; Bely, M; la Guerche, S; Giraud, C; Huet, S; Sicard, D; Masneuf-Pomarede, I; de Vienne, D; Marullo, P				da Silva, Telma; Albertin, Warren; Dillmann, Christine; Bely, Marina; la Guerche, Stephane; Giraud, Christophe; Huet, Sylvie; Sicard, Delphine; Masneuf-Pomarede, Isabelle; de Vienne, Dominique; Marullo, Philippe			Hybridization within Saccharomyces Genus Results in Homoeostasis and Phenotypic Novelty in Winemaking Conditions	PLOS ONE			English	Article							BAYANUS VAR. UVARUM; NATURAL HYBRIDS; FERMENTATION TEMPERATURE; CEREVISIAE STRAINS; ESTER SYNTHESIS; WINE-MAKING; KUDRIAVZEVII; ALCOHOL; REVEALS; TRAITS	Despite its biotechnological interest, hybridization, which can result in hybrid vigor, has not commonly been studied or exploited in the yeast genus. From a diallel design including 55 intra-and interspecific hybrids between Saccharomyces cerevisiae and S. uvarum grown at two temperatures in enological conditions, we analyzed as many as 35 fermentation traits with original statistical and modeling tools. We first showed that, depending on the types of trait - kinetics parameters, life-history traits, enological parameters and aromas -, the sources of variation (strain, temperature and strain * temperature effects) differed in a large extent. Then we compared globally three groups of hybrids and their parents at two growth temperatures: intraspecific hybrids S. cerevisiae * S. cerevisiae, intraspecific hybrids S. uvarum * S. uvarum and interspecific hybrids S. cerevisiae * S. uvarum. We found that hybridization could generate multi-trait phenotypes with improved oenological performances and better homeostasis with respect to temperature. These results could explain why interspecific hybridization is so common in natural and domesticated yeast, and open the way to applications for wine-making.	[da Silva, Telma] INRA, Genet Vegetale, UMR 0320, UMR 8120, Gif Sur Yvette, France; [Albertin, Warren] ENSCBP Bordeaux INP, Pessac, France; [Albertin, Warren; Bely, Marina; Masneuf-Pomarede, Isabelle; Marullo, Philippe] Univ Bordeaux, ISVV, Unite Rech Oenol, EA 4577, Villenave Dornon, France; [Dillmann, Christine; Sicard, Delphine; de Vienne, Dominique] Univ Paris 11, Genet Vegetale, UMR 0320, UMR 8120, Gif Sur Yvette, France; [la Guerche, Stephane] SARCO, Bordeaux, France; [Giraud, Christophe] Ecole Polytech, CMAP, Palaiseau, France; [Huet, Sylvie] INRA, MIA, Jouy En Josas, France; [Masneuf-Pomarede, Isabelle] Bordeaux Sci Agro, Gradignan, France; [Marullo, Philippe] Biolaffort, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Institut Polytechnique de Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marullo, P (corresponding author), Univ Bordeaux, ISVV, Unite Rech Oenol, EA 4577, Villenave Dornon, France.	philippe.marullo@u-bordeaux.fr		Marullo, Philippe/0000-0002-3594-5173; Masneuf-Pomarede, Isabelle/0000-0002-8806-8944; Sicard, Delphine/0000-0002-6570-3212; Albertin, Warren/0000-0002-7385-9882; Dillmann, Christine/0000-0002-9025-341X	SARCO; BIOLAFFORT	SARCO; BIOLAFFORT	SARCO and BIOLAFFORT provided support in the form of salaries for authors (PM, SIG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADAMS MW, 1959, GENETICS, V44, P777; Aguera E, 2010, AM J ENOL VITICULT, V61, P53; Albertin W, 2009, J EVOLUTION BIOL, V22, P2157, DOI 10.1111/j.1420-9101.2009.01828.x; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Albertin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075121; Albertin W, 2011, APPL ENVIRON MICROB, V77, P2772, DOI 10.1128/AEM.02547-10; Almeida P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5044; Antonelli A, 1999, J AGR FOOD CHEM, V47, P1139, DOI 10.1021/jf9807317; Antunovics Z, 2005, J APPL MICROBIOL, V98, P971, DOI 10.1111/j.1365-2672.2005.02543.x; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Beltran G, 2008, INT J FOOD MICROBIOL, V121, P169, DOI 10.1016/j.ijfoodmicro.2007.11.030; Bely M, 2013, 1 INT S 2013 6 SEPT; Blein-Nicolas M, 2013, MOL BIOL EVOL, V30, P1368, DOI 10.1093/molbev/mst050; Bon E, 2000, FEBS LETT, V487, P37, DOI 10.1016/S0014-5793(00)02276-6; Borneman AR, 2012, FEMS YEAST RES, V12, P88, DOI 10.1111/j.1567-1364.2011.00773.x; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Caridi A, 2002, FOLIA MICROBIOL, V47, P407, DOI 10.1007/BF02818698; CASTELLARI L, 1994, VITIS, V33, P49; Coque M, 2008, MAYDICA, V53; CRUSIO WE, 1984, BEHAV GENET, V14, P81, DOI 10.1007/BF01066070; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dufour M, 2013, APPL MICROBIOL BIOT, V97, P5893, DOI 10.1007/s00253-013-4739-7; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Erny C, 2012, APPL ENVIRON MICROB, V78, P3256, DOI 10.1128/AEM.06752-11; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; Fukuda K, 1998, APPL ENVIRON MICROB, V64, P4076; Gamero A, 2013, J APPL MICROBIOL, V114, P1405, DOI 10.1111/jam.12126; Gamero A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097626; Gao X, 2008, J STAT PLAN INFER, V138, P2574, DOI 10.1016/j.jspi.2007.10.015; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; He Y, 2014, J I BREWING, V120, P119, DOI 10.1002/jib.120; Nguyen HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025821; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Le Jeune C, 2007, FEMS YEAST RES, V7, P540, DOI 10.1111/j.1567-1364.2007.00207.x; LEAMY L, 1984, BIOL J LINN SOC, V22, P233, DOI 10.1111/j.1095-8312.1984.tb01678.x; Lerner IM, 1954, GENETIC HOMEOSTASIS; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopandic K, 2008, FEMS YEAST RES, V8, P1063, DOI 10.1111/j.1567-1364.2008.00385.x; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Lopez-Malo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060135; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2004, FEMS YEAST RES, V4, P711, DOI 10.1016/j.femsyr.2004.01.006; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Masneuf I, 2002, J INT SCI VIGNE VIN, V36, P205; Masneuf-Pomarede I, 2007, SYST APPL MICROBIOL, V30, P75, DOI 10.1016/j.syapm.2006.02.006; Masneuf-Pomarede I, 2010, INT J FOOD MICROBIOL, V139, P79, DOI 10.1016/j.ijfoodmicro.2010.01.038; Mason AB, 2000, YEAST, V16, P1287, DOI 10.1002/1097-0061(200010)16:14<1287::AID-YEA613>3.0.CO;2-I; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Miranda JB., 1981, QUANTITATIVE GENETIC; Morales L, 2012, MICROBIOL MOL BIOL R, V76, P721, DOI 10.1128/MMBR.00022-12; Naumov G. I., 2000, Mikrobiologiya, V69, P410; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Naumov GI, 2002, APPL MICROBIOL BIOT, V59, P727, DOI 10.1007/s00253-002-1077-6; Newman HH, 1917, BIOL BULL-US, V32, P306, DOI 10.2307/1536313; Nguyen HV, 2000, SYST APPL MICROBIOL, V23, P71, DOI 10.1016/S0723-2020(00)80048-X; Arroyo-Lopez FN, 2009, INT J FOOD MICROBIOL, V131, P120, DOI 10.1016/j.ijfoodmicro.2009.01.035; PATE JB, 1962, ANAL CHEM, V34, P1660, DOI 10.1021/ac60192a001; Peris D, 2011, YEAST, V29, P81, DOI [10.1002/cbf.1722, DOI 10.1002/CBF.1722]; Peris D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-407; Picazo C, 2015, LETT APPL MICROBIOL, V60, P217, DOI 10.1111/lam.12369; Piotrowski JS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-46; Plech M, 2014, G3-GENES GENOM GENET, V4, P315, DOI 10.1534/g3.113.009381; Rainieri S, 1998, AM J ENOL VITICULT, V49, P319; Rainieri S, 1999, FEMS MICROBIOL LETT, V177, P177, DOI 10.1111/j.1574-6968.1999.tb13729.x; Richards KD, 2009, ANTON LEEUW INT J G, V96, P355, DOI 10.1007/s10482-009-9346-3; Roncoroni M, 2011, FOOD MICROBIOL, V28, P926, DOI 10.1016/j.fm.2011.01.002; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; SARKISSIAN IV, 1964, P NATL ACAD SCI USA, V51, P212, DOI 10.1073/pnas.51.2.212; Schmidtke LM, 2012, J FOOD SCI, V77, pR25, DOI 10.1111/j.1750-3841.2011.02448.x; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Shapira R, 2014, HEREDITY EDINB; Sipiczki M, 2008, FEMS YEAST RES; Solieri L, 2008, YEAST, V25, P485, DOI 10.1002/yea.1600; Spor A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001579; Sprague G. F., 1983, Heterosis. Reappraisal of theory and practice, P47; Sumby KM, 2010, FOOD CHEM, V121, P1, DOI 10.1016/j.foodchem.2009.12.004; Tilloy V, 2014, APPL ENVIRON MICROB, V80, P2623, DOI 10.1128/AEM.03710-13; Timberlake WE, 2011, YEAST, V28, P63, DOI 10.1002/yea.1821; Tominaga T, 1998, FLAVOUR FRAG J, V13, P159, DOI 10.1002/(SICI)1099-1026(199805/06)13:3<159::AID-FFJ709>3.3.CO;2-Z; Torija MJ, 2003, INT J FOOD MICROBIOL, V85, P127, DOI 10.1016/S0168-1605(02)00506-8; Torriani S, 1999, ANTON LEEUW INT J G, V75, P207, DOI 10.1023/A:1001773916407; Tosi E, 2009, J APPL MICROBIOL, V107, P210, DOI 10.1111/j.1365-2672.2009.04196.x; Tronchoni J, 2009, INT J FOOD MICROBIOL, V134, P237, DOI 10.1016/j.ijfoodmicro.2009.07.004; Vilela-Moura A, 2008, APPL MICROBIOL BIOT, V80, P881, DOI 10.1007/s00253-008-1616-x; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Weldegergis BT, 2007, J AGR FOOD CHEM, V55, P8696, DOI 10.1021/jf071554p; Zorgo E, 2012, MOL BIOL EVOL, V29, P1781, DOI 10.1093/molbev/mss019	95	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123834	10.1371/journal.pone.0123834	http://dx.doi.org/10.1371/journal.pone.0123834			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946464	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700022
J	Riccio, A; Gogliettino, M; Palmieri, G; Balestrieri, M; Facchiano, A; Rossi, M; Palumbo, S; Monti, G; Cocca, E				Riccio, Alessia; Gogliettino, Marta; Palmieri, Gianna; Balestrieri, Marco; Facchiano, Angelo; Rossi, Mose; Palumbo, Stefania; Monti, Giuseppe; Cocca, Ennio			A New APEH Cluster with Antioxidant Functions in the Antarctic Hemoglobinless Icefish Chionodraco hamatus	PLOS ONE			English	Article							ACYLPEPTIDE HYDROLASE; OXIDIZED PROTEIN; SERINE-PROTEASE; DEFENSE SYSTEMS; ADAPTATION; ERYTHROCYTE; STRESS; COLD; FISH; TEMPERATURE	Acylpeptide hydrolase (APEH) is a ubiquitous cytosolic protease that plays an important role in the detoxification of oxidised proteins. In this work, to further explore the physiological role of this enzyme, two apeh cDNAs were isolated from the Chionodraco hamatus icefish, which lives in the highly oxygenated Antarctic marine environment. The encoded proteins (APEH-1(Ch) and APEH-2(Ch)) were characterised in comparison with the uniquely expressed isoform from the temperate fish Dicentrarchus labrax (APEH-1(Dl)) and the two APEHs from the red-blooded Antarctic fish Trematomus bernacchii (APEH-1(Tb) and APEH-2(Tb)). Homology modelling and kinetic characterisation of the APEH isoforms provided new insights into their structure/function properties. APEH-2 isoforms were the only ones capable of hydrolysing oxidised proteins, with APEH-2(Ch) being more efficient than APEH-2(Tb) at this specific function. Therefore, this ability of APEH-2 isoforms is the result of an evolutionary adaptation due to the pressure of a richly oxygenated environment. The lack of expression of APEH-2 in the tissues of the temperate fish used as the controls further supported this hypothesis. In addition, analysis of gene expression showed a significant discrepancy between the levels of transcripts and those of proteins, especially for apeh-2 genes, which suggests the presence of post-transcriptional regulation mechanisms, triggered by cold-induced oxidative stress, that produce high basal levels of APEH-2 mRNA as a reserve that is ready to use in case of the accumulation of oxidised proteins.	[Riccio, Alessia; Gogliettino, Marta; Palmieri, Gianna; Balestrieri, Marco; Rossi, Mose; Palumbo, Stefania; Cocca, Ennio] CNR, Inst Biosci & BioResources CNR IBBR, I-80125 Naples, Italy; [Facchiano, Angelo] CNR, Inst Food Sci CNR ISA, Avellino, Italy; [Monti, Giuseppe] Ittica Literno Srl, Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Palmieri, G (corresponding author), CNR, Inst Biosci & BioResources CNR IBBR, I-80125 Naples, Italy.	g.palmieri@ibp.cnr.it	Palmieri, Gianna/AAW-6176-2020; Facchiano, Angelo/K-3375-2012; Cocca, Ennio/AAY-3817-2020; Palmieri, Gianna/S-4872-2017; Balestrieri, Marco/G-1847-2011; BALESTRIERI, MARCO/AAA-1869-2021	Palmieri, Gianna/0000-0002-9007-4075; Facchiano, Angelo/0000-0002-7077-4912; Cocca, Ennio/0000-0003-2432-9663; BALESTRIERI, MARCO/0000-0003-4343-2148; Palumbo, Stefania/0000-0002-8084-9818	Italian Antarctic Research Program (PNRA) project "Role of the Oxygen in the Evolution-Genes and proteins of polar marine organisms" [2010/A1.08]; FLAGSHIP 'Interomics' project - Italian MIUR [PB.P05]; CNR; FIRB-MERIT [RBNE08NKH7_008]; Ittica Literno srl	Italian Antarctic Research Program (PNRA) project "Role of the Oxygen in the Evolution-Genes and proteins of polar marine organisms"; FLAGSHIP 'Interomics' project - Italian MIUR; CNR(Consiglio Nazionale delle Ricerche (CNR)); FIRB-MERIT(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ittica Literno srl	EC was supported by Italian Antarctic Research Program (PNRA) project 2010/A1.08 "Role of the Oxygen in the Evolution-Genes and proteins of polar marine organisms". AF was supported by FLAGSHIP 'Interomics' project (PB.P05), funded by the Italian MIUR and CNR organizations. GP was supported by FIRB-MERIT RBNE08NKH7_008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ittica Literno srl provided support in the form of salaries for authors (GM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Benedetti M, 2010, CHEM ECOL, V26, P305, DOI 10.1080/02757541003789066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunialti EAS, 2011, BIOCHIMIE, V93, P1543, DOI 10.1016/j.biochi.2011.05.010; Camus L, 2005, POLAR RES, V24, P111, DOI 10.1111/j.1751-8369.2005.tb00144.x; Chow JM, 2008, TOXICOL LETT, V177, P97, DOI 10.1016/j.toxlet.2008.01.004; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coppe A, 2013, GENOME BIOL EVOL, V5, P45, DOI 10.1093/gbe/evs108; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Fujino T, 2000, J BIOCHEM, V127, P1087, DOI 10.1093/oxfordjournals.jbchem.a022702; Fujino T, 1998, BBA-BIOMEMBRANES, V1374, P47, DOI 10.1016/S0005-2736(98)00131-X; Fujino T, 1998, J BIOCHEM-TOKYO, V124, P1077, DOI 10.1093/oxfordjournals.jbchem.a022224; GLOMSKI CA, 1992, HISTOL HISTOPATHOL, V7, P501; Gogliettino M, 2014, FEBS J, V281, P401, DOI 10.1111/febs.12610; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Jaeschke H, 2010, COMPREHENSIVE TOXICOLOGY, VOL 9: HEPATIC TOXICOLOGY, 2ND EDITION, P319; JONES WM, 1994, METHOD ENZYMOL, V244, P227; Kehrer JP, 2010, COMPREHENSIVE TOXICOLOGY, VOL 1: GENERAL PRINCIPLES , 2ND EDITION, P277; Kock KH, 2005, POLAR BIOL, V28, P897, DOI [10.1007/s00300-005-0019-z, 10.1007/s00300-005-0020-6]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lockwood BL, 2012, MOL BIOL EVOL, V29, P3061, DOI 10.1093/molbev/mss111; Marabotti A, 2004, BIOCHEM J, V380, P677, DOI 10.1042/BJ20031876; Marabotti A, 2005, J MED CHEM, V48, P773, DOI 10.1021/jm049731q; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mueller IA, 2012, J EXP BIOL, V215, P3655, DOI 10.1242/jeb.071811; Nakai A, 2012, PLANTA, V236, P427, DOI 10.1007/s00425-012-1614-1; O'Brien KM, 2010, INTEGR COMP BIOL, V50, P993, DOI 10.1093/icb/icq038; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Palmieri G, 2010, MOL BIOSYST, V6, P2498, DOI 10.1039/c005293k; Parravicini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056254; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Petricorena ZLC, 2007, COMP BIOCHEM PHYS A, V147, P799, DOI 10.1016/j.cbpa.2006.09.028; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Shin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043762; Sidell BD, 2006, J EXP BIOL, V209, P1791, DOI 10.1242/jeb.02091; Snyder GK, 1999, AM ZOOL, V39, P189; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhang ZW, 2011, IUBMB LIFE, V63, P560, DOI 10.1002/iub.490	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125594	10.1371/journal.pone.0125594	http://dx.doi.org/10.1371/journal.pone.0125594			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946123	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700077
J	Yao, R; Cao, Y; He, YR; Lau, WB; Zeng, Z; Liang, ZA				Yao, Rong; Cao, Yu; He, Ya-rong; Lau, Wayne Bond; Zeng, Zhi; Liang, Zong-an			Adiponectin Attenuates Lung Fibroblasts Activation and Pulmonary Fibrosis Induced by Paraquat	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TGF-BETA; MYOFIBROBLAST; INFLAMMATION	Pulmonary fibrosis is one of the most common complications of paraquat (PQ) poisoning, which demands for more effective therapies. Accumulating evidence suggests adiponectin (APN) may be a promising therapy against fibrotic diseases. In the current study, we determine whether the exogenous globular APN isoform protects against pulmonary fibrosis in PQ-treated mice and human lung fibroblasts, and dissect the responsible underlying mechanisms. BALB/C mice were divided into control group, PQ group, PQ + low-dose APN group, and PQ + high-dose APN group. Mice were sacrificed 3, 7, 14, and 21 days after PQ treatment. We compared pulmonary histopathological changes among different groups on the basis of fibrosis scores, TGF-beta(1), CTGF and alpha-SMA pulmonary content via Western blot and real-time quantitative fluorescence-PCR (RT-PCR). Blood levels of MMP-9 and TIMP-1 were determined by ELISA. Human lung fibroblasts WI-38 were divided into control group, PQ group, APN group, and APN receptor (AdipoR) 1 small-interfering RNA (siRNA) group. Fibroblasts were collected 24, 48, and 72 hours after PQ exposure for assay. Cell viability and apoptosis were determined via Kit-8 (CCK-8) and fluorescein Annexin V-FITC/PI double labeling. The protein and mRNA expression level of collagen type III, AdipoR1, and AdipoR2 were measured by Western blot and RT-PCR. APN treatment significantly decreased the lung fibrosis scores, protein and mRNA expression of pulmonary TGF-beta(1), CTGF and alpha-SMA content, and blood MMP-9 and TIMP-1 in a dose-dependent manner (p<0.05). Pre-treatment with APN significantly attenuated the reduced cell viability and up-regulated collagen type III expression induced by PQ in lung fibroblasts, (p<0.05). APN pretreatment up-regulated AdipoR1, but not AdipoR2, expression in WI-38 fibroblasts. AdipoR1 siRNA abrogated APN-mediated protective effects in PQ-exposed fibroblasts. Taken together, our data suggests APN protects against PQ-induced pulmonary fibrosis in a dose-dependent manner, via suppression of lung fibroblast activation. Functional AdipoR1 are expressed by human WI-38 lung fibroblasts, suggesting potential future clinical applicability of APN against pulmonary fibrosis.	[Yao, Rong; Cao, Yu; He, Ya-rong; Zeng, Zhi] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu 610041, Sichuan, Peoples R China; [Lau, Wayne Bond] Thomas Jefferson Univ Hosp, Dept Emergency Med, Philadelphia, PA 19107 USA; [Liang, Zong-an] Sichuan Univ, West China Hosp, Resp Dept, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Jefferson University; Sichuan University	Zeng, Z (corresponding author), Sichuan Univ, West China Hosp, Dept Emergency Med, 37 Guoxue Rd, Chengdu 610041, Sichuan, Peoples R China.	530291451@qq.com; 1362960346@qq.com		Lau, Wayne Bond/0000-0002-8064-8290	National Natural Science Foundation of China [30900493, 81471836]; Science and Technology Department Foundation of Sichuan Province [2013JY0011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department Foundation of Sichuan Province	This work was supported by the National Natural Science Foundation of China (No. 30900493 and No. 81471836) and the Science and Technology Department Foundation of Sichuan Province (No. 2013JY0011).	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Brigstock DR, 2009, J CELL COMMUN SIGNAL, V3, P5, DOI 10.1007/s12079-009-0043-9; Bronnum H, 2013, GROWTH FACTORS, V31, P81, DOI 10.3109/08977194.2013.787994; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; HOET PHM, 1994, BIOCHEM PHARMACOL, V48, P517, DOI 10.1016/0006-2952(94)90281-X; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Keeley EC, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-2; Krenning G, 2009, CIRC RES, V104, P1029, DOI 10.1161/CIRCRESAHA.109.198044; Lai CK, 2006, SEMIN RESP CRIT CARE, V27, P613, DOI 10.1055/s-2006-957333; Lim DH, 2006, AM J PHYSIOL-LUNG C, V291, pL265, DOI 10.1152/ajplung.00305.2005; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Yamashita M, 2000, HUM EXP TOXICOL, V19, P99, DOI 10.1191/096032700678815729; Yokoi H, 2004, J AM SOC NEPHROL, V15, P1430, DOI 10.1097/01.ASN.0000130565.69170.85	29	39	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125169	10.1371/journal.pone.0125169	http://dx.doi.org/10.1371/journal.pone.0125169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945502	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700059
J	Bao, WL; Wang, YF; Fu, YT; Jia, XY; Li, JX; Vangan, N; Bao, LL; Hao, HF; Wang, ZG				Bao, Wenlei; Wang, Yanfeng; Fu, Yuting; Jia, Xiaoyang; Li, Jiaxin; Vangan, Nyamtsengel; Bao, Lili; Hao, Huifang; Wang, Zhigang			mTORC1 Regulates Flagellin-Induced Inflammatory Response in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; PROINFLAMMATORY GENE-EXPRESSION; MAMMALIAN TARGET; BACTERIAL FLAGELLIN; CUTTING EDGE; CANCER-CELLS; ACTIVATION; PATHWAY; 3-KINASE; PROLIFERATION	Bacterial flagellin triggers inflammatory responses. Phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) regulate the production of pro-and anti-inflammatory cytokines that are induced by extrinsic antigens, but the function of mTORC1 in flagellin-induced inflammatory response is unknown. The purpose of this study was to examine the role and the mechanism of PI3K/Akt/mTOR pathway in flagellin-induced cytokine expression in mouse macrophages. We observed that flagellin upregulated TNF-alpha time-and dose-dependently. Flagellin stimulated rapid (<15 min) PI3K/Akt/mTOR phosphorylation that was mediated by TLR5. Inhibition of PI3K with LY294002 and wortmannin, and of mTORC1 with rapamycin decreased flagellin-induced TNF-a and IL-6 expression and cell proliferation. The activation of NF-kappa B p65 and STAT3 was regulated by mTORC1 via degradation of I kappa B alpha and phosphorylation of STAT3 in response to flagellin, respectively. Thus, the PI3K/Akt/mTORC1 pathway regulates the innate immune response to bacterial flagellin. Rapamycin is potential therapy that can regulate host defense against pathogenic infections.	[Bao, Wenlei; Wang, Yanfeng; Fu, Yuting; Jia, Xiaoyang; Li, Jiaxin; Vangan, Nyamtsengel; Bao, Lili; Hao, Huifang; Wang, Zhigang] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China; [Bao, Lili] Inner Mongolia Med Univ, Coll Basic Med Sci, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia Medical University	Wang, ZG (corresponding author), Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China.	lswzg@imu.edu.cn		Hao, Huifang/0000-0002-9680-8308; Wang, Yanfeng/0000-0003-0859-3472; Wang, Zhigang/0000-0002-6818-2205; Yuting, Fu/0000-0002-8667-8298	Natural Sciences Foundation of China [31160469, 31360561]; graduate student research project of Inner Mongolia University; Major Projects for New Varieties of Genetically Modified Organisms [2014ZX08008-002]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); graduate student research project of Inner Mongolia University; Major Projects for New Varieties of Genetically Modified Organisms	This work was supported by a grant from the Natural Sciences Foundation of China (No. 31160469, 31360561), a graduate student research project of Inner Mongolia University, and the Major Projects for New Varieties of Genetically Modified Organisms (No. 2014ZX08008-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/678627; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Cheekatla SS, 2012, MED MICROBIOL IMMUN, V201, P37, DOI 10.1007/s00430-011-0202-5; Cho HY, 2014, CELL IMMUNOL, V289, P27, DOI 10.1016/j.cellimm.2014.03.003; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirano T, 1998, Int Rev Immunol, V16, P249; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Jhang J.-J., 2014, CELL MOL IMMUNOL; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035; Lee PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014399; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Park Y, 2002, J IMMUNOL, V168, P5, DOI 10.4049/jimmunol.168.1.5; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schaeffer V, 2011, J SURG RES, V171, P769, DOI 10.1016/j.jss.2010.05.035; Semba S, 2002, CLIN CANCER RES, V8, P1957; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	47	22	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125910	10.1371/journal.pone.0125910	http://dx.doi.org/10.1371/journal.pone.0125910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942007	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400056
J	Guo, X; Zhang, R; Liu, J; Li, M; Song, CH; Dovat, S; Li, JY; Ge, Z				Guo, Xing; Zhang, Run; Liu, Juan; Li, Min; Song, Chunhua; Dovat, Sinisa; Li, Jianyong; Ge, Zheng			Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ENHANCER-BINDING FACTOR-1; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; FACTOR-I LEF1; T-CELL; TRANSCRIPTION FACTORS; PROGNOSTIC-FACTOR; STEM-CELLS; LYMPHOMA; FBXW7	Aberrant activation of the Wnt pathway plays a pathogenetic role in tumors and has been associated with adverse outcome in acute lymphoblastic leukemia (ALL). Lymphoid enhancer binding factor 1 (LEF1), a key mediator of Wnt signaling, has been linked to leukemic transformation, and LEF1 mutations have been identified in T-ALL. Here we found LEF1 is highly expressed in 25.0% adult ALL patients and LEF1 high expression was associated with high-risk leukemia factors (high WBC, Philadelphia chromosome positive, complex karyotype), shorter event-free survival (EFS), and high relapse rates in patients with B-ALL. LEF1 high expression is also associated with high mutation rate of Notch1 and JAK1 in T-ALL. We identified 2 novel LEF1 mutations (K86E and P106L) in 4 of 131 patients with ALL, and those patients with high-risk ALL (high WBC, complex karyotype). These results suggest a role for LEF1 mutations in leukemogenesis. We further explored the effect of the mutations on cell proliferation and found both mutations significantly promoted the proliferation of ALL cells. We also observed the effect of LEF1 and its mutations on the transcription of its targets, c-MYC and Cyclin D1. We found LEF1 increased the promoter activity of its targets c-MYC and Cyclin D1, and LEF1 K86E and P106L mutants further significantly enhanced this effect. We also observed that the c-MYC and Cyclin D1 mRNA levels were significantly increased in patients with LEF1 high expression compared with those with low expression. Taken together, our findings indicate high LEF1 expression and mutation are associated with high-risk leukemia and our results also revealed that LEF1 high expression and/or gain-of-function mutations are involved in leukemogenesis of ALL.	[Guo, Xing; Zhang, Run; Liu, Juan; Li, Min; Li, Jianyong; Ge, Zheng] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Song, Chunhua; Dovat, Sinisa; Ge, Zheng] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA	Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ge, Z (corresponding author), Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.	Janege879@hotmail.com	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022; song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Dovat, Sinisa/0000-0003-3906-6165; song, chunhua/0000-0002-4081-2543	National Natural Science Foundation of China [81270613, 30973376]; Jiangsu Province Key Medical Talents [RC2011077]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (39th); China Postdoctoral Science Foundation [20090461134, 201003598]; Six Great Talent Peak Plan of Jiangsu [2010-WS-024]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Nanjing Municipal Bureau of Personnel; Four Diamonds Fund of the Pennsylvania State University, College of Medicine; John Wawrynovic Leukemia Research Scholar Endowment, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095120] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Key Medical Talents; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (39th); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Six Great Talent Peak Plan of Jiangsu; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Nanjing Municipal Bureau of Personnel(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Four Diamonds Fund of the Pennsylvania State University, College of Medicine; John Wawrynovic Leukemia Research Scholar Endowment, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The following funding supported this study design, experiments, data collection and analysis, and preparation of the manuscript: The National Natural Science Foundation of China (81270613,30973376); Jiangsu Province Key Medical Talents (RC2011077); The Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (39th); China Postdoctoral Science Foundation (20090461134); Special grade of the financial support from China Postdoctoral Science Foundation (201003598); The Six Great Talent Peak Plan of Jiangsu (2010-WS-024); The Scientific Research Foundation for the Returned Overseas Chinese Scholars, Nanjing Municipal Bureau of Personnel (2009); also supported partially by the Four Diamonds Fund of the Pennsylvania State University, College of Medicine, and the John Wawrynovic Leukemia Research Scholar Endowment, USA (to S.D. and C.S.).	Albano F, 2014, ONCOTARGET, V5, P649, DOI 10.18632/oncotarget.1619; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Dosen G, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-13; Erdfelder F, 2010, HEMATOL REP, V2, P24, DOI 10.4081/hr.2010.e3; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Fu Y, 2014, LEUKEMIA LYMPHOMA, V55, P371, DOI 10.3109/10428194.2013.805759; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kuhnl A, 2011, BLOOD, V118, P6362, DOI 10.1182/blood-2011-04-350850; Lin Zhong-Kun, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1403, DOI 10.7534/j.issn.1009-2137.2013.06.008; Liu Juan, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P1212, DOI 10.7534/j.issn.1009-2137.2014.05.004; Liu P, 2012, ANN HEMATOL, V91, P1039, DOI 10.1007/s00277-012-1415-4; Menter T, 2015, J CLIN PATHOL; Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827; Park MJ, 2009, BRIT J HAEMATOL, V145, P198, DOI 10.1111/j.1365-2141.2009.07607.x; Pellagatti A, 2009, BRIT J HAEMATOL, V146, P86, DOI 10.1111/j.1365-2141.2009.07720.x; Pereira-Fernandes A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084816; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 1999, COLD SPRING HARB SYM, V64, P133, DOI 10.1101/sqb.1999.64.133; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Song JH, 2008, LEUKEMIA RES, V32, P1751, DOI 10.1016/j.leukres.2008.03.040; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Tandon B, 2011, MODERN PATHOL, V24, P1433, DOI 10.1038/modpathol.2011.103; Tsai BP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140180; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483; Zuurbier L, 2010, LEUKEMIA, V24, P2014, DOI 10.1038/leu.2010.204; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	34	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125429	10.1371/journal.pone.0125429	http://dx.doi.org/10.1371/journal.pone.0125429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942645	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400034
J	Pan, DZ; Lin, Y; Wu, WM; Song, JJ; Zhang, EJ; Wu, CC; Chen, XW; Hu, KH; Yang, DL; Xu, Y; Lu, MJ				Pan, Danzhen; Lin, Yong; Wu, Weimin; Song, Jingjiao; Zhang, Ejuan; Wu, Chunchen; Chen, Xinwen; Hu, Kanghong; Yang, Dongliang; Xu, Yang; Lu, Mengji			Persistence of the Recombinant Genomes of Woodchuck Hepatitis Virus in the Mouse Model	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; IMMUNE-RESPONSES; T-CELL; VIRAL PERSISTENCE; SURFACE-ANTIGEN; DNA; REPLICATION; INFECTION; HEPATOMA; ANTIBODY	Hydrodynamic injection (HI) with a replication competent hepatitis B virus (HBV) genome may lead to transient or prolonged HBV replication in mice. However, the prolonged HBV persistence after HI depends on the specific backbone of the vector carrying HBV genome and the genetic background of the mouse strain. We asked whether a genetically closely related hepadnavirus, woodchuck hepatitis virus (WHV), may maintain the gene expression and replication in the mouse liver after HI. Interestingly, we found that HI of pBS-WHV1.3 containing a 1.3 fold overlength WHV genome in BALB/c mouse led to the long presence of WHV DNA and WHV proteins expression in the mouse liver. Thus, we asked whether WHV genome carrying foreign DNA sequences could maintain the long term gene expression and persistence. For this purpose, the coding region of HBV surface antigen (HBsAg) was inserted into the WHV genome to replace the corresponding region. Three recombinant WHV-HBV genomes were constructed with the replacement with HBsAg a-determinant, major HBsAg, and middle HBsAg. Serum HBsAg, viral DNA, hepatic WHV protein expression, and viral replication intermediates were detected in mice after HI with recombinant genomes. Similarly, the recombinant genomes could persist for a prolonged period of time up to 45 weeks in mice. WHV and recombinant WHV-HBV genomes did not trigger effective antibody and T-cell responses to viral proteins. The ability of recombinant WHV constructs to persist in mice is an interesting aspect for the future investigation and may be explored for in vivo gene transfer.	[Pan, Danzhen; Lin, Yong; Wu, Weimin; Xu, Yang; Lu, Mengji] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Microbiol, Wuhan 430074, Peoples R China; [Zhang, Ejuan; Wu, Chunchen; Chen, Xinwen; Hu, Kanghong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China; [Yang, Dongliang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430074, Peoples R China; [Lu, Mengji] Univ Hosp Essen, Inst Virol, Essen, Germany; [Song, Jingjiao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Clin Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Huazhong University of Science & Technology; University of Duisburg Essen; Huazhong University of Science & Technology	Xu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Microbiol, Wuhan 430074, Peoples R China.	xuyang@hust.edu.cn; mengji.lu@uni-due.de	Lu, Mengji/ABF-9410-2020; Hu, Kanghong/AAL-3011-2020		National Natural Science Foundation of China [81201290, 81461130019]; Health Department of Hubei Province [JX6B46]; National Major Science and Technology Special Project for Infectious Diseases of China [2008ZX10002-011, 2012ZX10004503]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft (Transregio) [GRK1045/2, TRR60]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Hubei Province; National Major Science and Technology Special Project for Infectious Diseases of China; International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft (Transregio)(German Research Foundation (DFG))	This work was supported by the National Natural Science Foundation of China (81201290, 81461130019, http://www.nsfc.gov.cn), the Funds of the Health Department of Hubei Province (JX6B46, http://www.hbwsjs.gov.cn) to YX; the National Major Science and Technology Special Project for Infectious Diseases of China (2008ZX10002-011, 2012ZX10004503, http://www.moh.gov.cn), the International Science & Technology Cooperation Program of China (2011DFA31030, http://www.most.gov.cn) to DY; and grants of Deutsche Forschungsgemeinschaft (GRK1045/2 and Transregio TRR60, http://www.dfg.de) to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Cao L, 2014, J VIROL, V88, P8656, DOI 10.1128/JVI.01123-14; FERRARI C, 1990, J IMMUNOL, V145, P3442; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; GALIBERT F, 1982, J VIROL, V41, P51, DOI 10.1128/JVI.41.1.51-65.1982; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Hong R, 2013, J VIROL, V87, P6615, DOI 10.1128/JVI.03328-12; Hourioux C, 2002, INTERVIROLOGY, V45, P233, DOI 10.1159/000067913; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; JUNG MC, 1991, J HEPATOL, V13, P310, DOI 10.1016/0168-8278(91)90074-L; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Lu MJ, 2007, EXPERT OPIN INV DRUG, V16, P787, DOI 10.1517/13543784.16.6.787; Meng ZJ, 2014, J VIROL, V88, P1573, DOI 10.1128/JVI.02086-13; Menne S, 2007, WORLD J GASTROENTERO, V13, P104, DOI 10.3748/wjg.v13.i1.104; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; OKAMOTO H, 1990, J GEN VIROL, V71, P959, DOI 10.1099/0022-1317-71-4-959; Qi ZH, 2014, J VIROL, V88, P8045, DOI 10.1128/JVI.01024-14; Qin B, 2013, ANTIVIR RES, V97, P93, DOI 10.1016/j.antiviral.2012.12.007; Raney AK, 2001, J VIROL, V75, P2900, DOI 10.1128/JVI.75.6.2900-2911.2001; Schirmbeck R, 2001, J IMMUNOL, V166, P1405, DOI 10.4049/jimmunol.166.2.1405; Song JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090977; SUMMERS J, 1978, P NATL ACAD SCI USA, V75, P4533, DOI 10.1073/pnas.75.9.4533; Tian YJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002159; Wang BJ, 2011, J GEN VIROL, V92, P681, DOI 10.1099/vir.0.025023-0; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zhang EJ, 2015, VIROLOGY, V475, P56, DOI 10.1016/j.virol.2014.11.004; Zheng X, 2002, VIROLOGY, V294, P342, DOI 10.1006/viro.2001.1338	31	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125658	10.1371/journal.pone.0125658	http://dx.doi.org/10.1371/journal.pone.0125658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942393	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400049
J	Qi, X; Yuan, YH; Xu, K; Zhong, HS; Zhang, Z; Zhai, H; Guan, GF; Yu, GB				Qi, Xun; Yuan, Yonghui; Xu, Ke; Zhong, Hongshan; Zhang, Zhen; Zhai, Huan; Guan, Gefei; Yu, Guibo			(2-Hydroxypropyl)-beta-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; NITRIC-OXIDE; ENDOTHELIAL-CELL; GENE-THERAPY; BLOOD-FLOW; STEM-CELL; IN-VITRO; PROLIFERATION; PDGF; ANGIOPOIETIN-1	Background Peripheral artery disease (PAD), which is caused by atherosclerosis, results in progressive narrowing and occlusion of the peripheral arteries and inhibits blood flow to the lower extremities. Therapeutic angiogenesis is a promising strategy for treating ischemia caused by PAD. Nitric oxide (NO) has been shown to be a key mediator of angiogenesis. It has been demonstrated that beta-cyclodextrincan stimulate vessel growth in rabbit corneas. In this study, we assessed the mechanism of action and therapeutic potential of a new angiogenic molecule, (2-hydroxypropyl)-beta-cyclodextrin (2HP-beta-CD). Methods and Results 2HP-beta-CD significantly increased vascular endothelial growth factor A (VEGF-A) and platelet- derived growth factor BB (PDGF-BB) peptides in human umbilical vein endothelial cells (HUVECs) and also increased basic fibroblast growth factor (bFGF) peptide in human aortic smooth muscle cells (HASMCs). 2HP-beta-CD stimulated both proliferation and migration of HUVECs in an endothelial nitric oxide synthase (eNOS)/NO-dependent manner, whereas NO was found to be involved in proliferation, but not migration, of HASMCs. In a unilateral hindlimb ischemia model in mice, 2HP-beta-CD injections not only promoted blood flow recovery and increased microvessel densities in ischemic muscle, but also promoted coverage of the vessels with smooth muscle cells, thus stabilizing the vessels. Administration of 2HP-beta CD increased the expression of several angiogenic factors, including VEGF-A, PDGF-BB and transforming growth factor beta-1 (TGF-beta 1) in ischemic muscle. Injections of 2HP-beta CD also stimulated protein kinase B and extracellular regulated protein kinases (ERK), leading to an increase in phosphorylation of eNOS in ischemic muscle. Treatment with the NOS inhibitor, N omega-nitro-L-arginine methyl ester (L-NAME), showed that stimulation of blood flow induced by 2HP-beta-CD was partially dependent on NO. Conclusions Therapeutic angiogenesis by 2HP-beta-CD may be beneficial to patients with PAD.	[Qi, Xun; Xu, Ke; Zhong, Hongshan; Zhai, Huan; Yu, Guibo] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Peoples R China; [Qi, Xun; Xu, Ke; Zhong, Hongshan; Zhai, Huan; Yu, Guibo] China Med Univ, Affiliated Hosp 1, Key Lab Diagnost Imaging & Intervent Radiol Liaon, Shenyang 110001, Peoples R China; [Yuan, Yonghui] Liaoning Canc Hosp & Inst, Hosp Infect Management Off, Shenyang, Peoples R China; [Zhang, Zhen] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang 110001, Peoples R China; [Guan, Gefei] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang 110001, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Xu, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Peoples R China.	kexu@vip.sina.com; zhonghongshan@hotmail.com			National Natural Science Foundations of China [81201168, 81171443, 81471809]; Science and Technology Plan Project of Liaoning Province [2013225086]; General Scientific Research Project from Education Department of Liaoning Province [L2012282]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Project of Liaoning Province; General Scientific Research Project from Education Department of Liaoning Province	This work was supported by the National Natural Science Foundations of China (Grant No. 81201168, 81171443 and 81471809) http://www.nsfc.gov.cn/, Science and Technology Plan Project of Liaoning Province (Grant No. 2013225086) http://www.lninfo.gov.cn/ and General Scientific Research Project from Education Department of Liaoning Province (Grant No. L2012282) http://www.lnen.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Bouloumie A, 1999, CARDIOVASC RES, V41, P773, DOI 10.1016/S0008-6363(98)00228-4; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; ENENSTEIN J, 1992, EXP CELL RES, V203, P499, DOI 10.1016/0014-4827(92)90028-7; Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0; Fernandes DJ, 2004, BRIT J PHARMACOL, V142, P1182, DOI 10.1038/sj.bjp.0705809; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1989, SCIENCE, V243, P1490, DOI 10.1126/science.2467380; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Lawall H, 2010, THROMB HAEMOSTASIS, V103, P696, DOI 10.1160/TH09-10-0688; Lee M, 2008, TISSUE ENG PT A, V14, P1395, DOI 10.1089/ten.tea.2007.0232; Liddell Robert P, 2004, Tech Vasc Interv Radiol, V7, P40, DOI 10.1053/j.tvir.2004.01.002; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Ma FX, 2005, HISTOL HISTOPATHOL, V20, P275, DOI 10.14670/HH-20.275; Meijer WT, 1998, ARTERIOSCL THROM VAS, V18, P185, DOI 10.1161/01.ATV.18.2.185; Michel JB, 1998, PATHOL BIOL, V46, P181; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nishishita T, 2004, J CELL BIOCHEM, V91, P584, DOI 10.1002/jcb.10718; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; Obst M, 2004, J HYPERTENS, V22, P1889, DOI 10.1097/00004872-200410000-00010; Ouma GO, 2013, ANGIOLOGY, V64, P466, DOI 10.1177/0003319712464514; Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038; Rissanen TT, 2001, EUR J CLIN INVEST, V31, P651, DOI 10.1046/j.1365-2362.2001.00864.x; Rosen EM, 1997, CIBA F SYMP, V212, P215; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Saddar S, 2013, CIRC RES, V112, P140, DOI 10.1161/CIRCRESAHA.112.280081; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Strauss Laura, 2002, Pathology and Oncology Research, V8, P47; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Urano T, 2008, ARTERIOSCL THROM VAS, V28, P827, DOI 10.1161/ATVBAHA.107.149674; Vinals F, 2001, MOL CELL BIOL, V21, P7218, DOI 10.1128/MCB.21.21.7218-7230.2001; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zabner J, 1997, ADV DRUG DELIVER REV, V27, P17, DOI 10.1016/S0169-409X(97)00019-7; Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451	51	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125323	10.1371/journal.pone.0125323	http://dx.doi.org/10.1371/journal.pone.0125323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25944736	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400029
J	da Silva, PG; Hernandez, MIM				da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel			Spatial Patterns of Movement of Dung Beetle Species in a Tropical Forest Suggest a New Trap Spacing for Dung Beetle Biodiversity Studies	PLOS ONE			English	Article							SCARABAEINAE COLEOPTERA SCARABAEIDAE; CANTHON-CYANELLUS-CYANELLUS; ATLANTIC FOREST; BETA DIVERSITY; BODY-SIZE; COMMUNITY; FRAGMENTATION; DISPERSAL; RICHNESS; BEHAVIOR	A primary goal of community ecologists is to understand the processes underlying the spatiotemporal patterns of species distribution. Understanding the dispersal process is of great interest in ecology because it is related to several mechanisms driving community structure. We investigated the mobility of dung beetles using mark-release-recapture technique, and tested the usefulness of the current recommendation for interaction distance between baited pitfall traps in the Brazilian Atlantic Forest. We found differences in mean movement rate between Scarabaeinae species, and between species with different sets of ecological traits. Large-diurnal-tunneler species showed greater mobility than did both large-nocturnal tunneler and roller species. Our results suggest that, based on the analyses of the whole community or the species with the highest number of recaptured individuals, the minimum distance of 50 m between pairs of baited pitfall traps proposed roughly 10 years ago is inadequate. Dung beetle species with different sets of ecological traits may differ in their dispersal ability, so we suggest a new minimum distance of 100 m between pairs of traps to minimize interference between baited pitfall traps for sampling copronecrophagous Scarabaeinae dung beetles.	[da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel] Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	da Silva, PG (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	pedrogiovanidasilva@yahoo.com.br	Hernandez, Malva I. M./E-3485-2013; da Silva, Pedro Giovâni/F-7605-2014	Hernandez, Malva I. M./0000-0002-6820-5980; da Silva, Pedro Giovâni/0000-0002-0702-9186	Coordenacao de Pessoal de Nivel Superior [001/2010 MEC/CAPES/PNPD]; Coordenacao de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303800/2010-0]	Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is part of the Project "Biodiversidade de artropodes terrestres e aquaticos em diferentes gradientes ambientais da Mata Atlantica do estado de Santa Catarina", and was supported by Coordenacao de Pessoal de Nivel Superior (Proc. 001/2010 MEC/CAPES/PNPD). PGS received a post-graduate fellowship from Coordenacao de Pessoal de Nivel Superior. MIMH received a research grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Research Productivity/PQ/2010, Proc. 303800/2010-0, Project "Comportamento de besouros Scarabaeinae e sua funcao no ciclo de decomposicao da materia organica"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarte VM, 2014, HYDROBIOLOGIA, V722, P279, DOI 10.1007/s10750-013-1711-6; [Anonymous], 2014, R LANG ENV STAT COMP; Arellano L, 2008, LANDSCAPE ECOL, V23, P69, DOI 10.1007/s10980-007-9165-8; Noriega JA, 2011, J TROP ECOL, V27, P111, DOI 10.1017/S0266467410000581; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Barlow J, 2010, J APPL ECOL, V47, P779, DOI 10.1111/j.1365-2664.2010.01825.x; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Byrne M, 2009, 16 C ENT SOC SO AFR; Byrne Marcus, 2011, P177; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cambefort Y., 1991, P36; Campos RC, 2015, ECOL INDIC, V49, P216, DOI 10.1016/j.ecolind.2014.09.043; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Chown Steven L., 2011, P200; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; da Silva PG, 2013, AN ACAD BRAS CIENC, V85, P679, DOI 10.1590/S0001-37652013005000033; da Silva PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123030; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; da Silva PG, 2012, ZOOL STUD, V51, P429; Dacke M, 2013, CURR BIOL, V23, P298, DOI 10.1016/j.cub.2012.12.034; Diaz A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8101; Diaz-Rojas A, 2003, EFECTO FRAGMENTACION, P226; Doube B.M., 1991, P133; DOUBE BM, 1990, B ENTOMOL RES, V80, P259, DOI 10.1017/S0007485300050458; Edmonds W.D., 2010, Insecta Mundi, V0129, P1; FAVILA ME, 1993, ETHOL ECOL EVOL, V5, P319, DOI 10.1080/08927014.1993.9523019; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Filgueiras BKC, 2009, REV BRAS ENTOMOL, V53, P422, DOI 10.1590/S0085-56262009000300017; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gill B.D., 1991, P211; Halffter G., 1982, NESTING BEHAV DUNG B; Halffter Gonzalo, 1993, Biology International, V27, P15; Hanski I., 1991, P305; Hanski I., 1991, P366; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Hernandez MIM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0113; Hernández Malva Isabel Medina, 2002, Rev. Bras. entomol., V46, P597, DOI 10.1590/S0085-56262002000400015; HOWDEN H F, 1975, Biotropica, V7, P77, DOI 10.2307/2989750; HOWDEN HF, 1978, BIOTROPICA, V10, P43, DOI 10.2307/2388104; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Lopes J, 2011, ZOOLOGIA-CURITIBA, V28, P72, DOI 10.1590/S1984-46702011000100011; Marsh CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073147; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Hernandez MIM, 2009, REV BRAS ENTOMOL, V53, P607, DOI 10.1590/S0085-56262009000400010; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2013, ECOLOGY, V94, P180, DOI 10.1890/12-0251.1; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Philips T. Keith, 2011, P21; Puker A, 2013, ENVIRON ENTOMOL, V42, P1218, DOI 10.1603/EN13100; Ramage BS, 2013, CONSERV BIOL, V27, P364, DOI 10.1111/cobi.12004; Roslin T, 2000, OIKOS, V91, P323, DOI 10.1034/j.1600-0706.2000.910213.x; Roslin Tomas, 2011, P220; Sanchez Pinero F., 2007, Zoologica Baetica, V18, P69; Simmons LW, 2011, ECOLOGY EVOLUTION DU, P1, DOI DOI 10.1002/9781444342000; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2013, ECOLOGY, V94, P1519, DOI 10.1890/12-1366.1; Spector S, 2003, BIOTROPICA, V35, P394; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Stevens VM, 2010, BIOL REV, V85, P625, DOI 10.1111/j.1469-185X.2009.00119.x; Vaz-De-Mello FZ, 2008, ZOOTAXA, P1; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Veloso HP, 1991, CLASSIFICACAO VEGETA, DOI [10.5681/joddd.2014.003, DOI 10.5681/J0DDD.2014.003]; Verdu JR, 2006, J INSECT PHYSIOL, V52, P854, DOI 10.1016/j.jinsphys.2006.05.005; Viegas G, 2014, ECOL INDIC, V36, P703, DOI 10.1016/j.ecolind.2013.09.036; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WILLE A, 1974, Revista de Biologia Tropical, V22, P129; Young OP, 2011, COLEOPTS BULL, V65, P227, DOI 10.1649/072.065.0303	79	110	111	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126112	10.1371/journal.pone.0126112	http://dx.doi.org/10.1371/journal.pone.0126112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938506	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000138
J	Verinaud, L; Lopes, SCP; Prado, ICN; Zanucoli, F; da Costa, TA; Di Gangi, R; Issayama, LK; Carvalho, AC; Bonfanti, AP; Niederauer, GF; Duran, N; Costa, FTM; Oliveira, ALR; Hofling, MAD; Machado, DRS; Thome, R				Verinaud, Liana; Pinto Lopes, Stefanie Costa; Naranjo Prado, Isabel Cristina; Zanucoli, Fabio; da Costa, Thiago Alves; Di Gangi, Rosaria; Issayama, Luidy Kazuo; Carvalho, Ana Carolina; Bonfanti, Amanda Pires; Niederauer, Guilherme Francio; Duran, Nelson; Maranhao Costa, Fabio Trindade; Rodrigues Oliveira, Alexandre Leite; da Cruz Hoefling, Maria Alice; Stach Machado, Dagmar Ruth; Thome, Rodolfo			Violacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; DENDRITIC CELLS; CHROMOBACTERIUM-VIOLACEUM; IN-VITRO; CHLOROQUINE; TOLERANCE; SECRETION; DISEASE; IL-17; TREG	Inflammation is a necessary process to control infection. However, exacerbated inflammation, acute or chronic, promotes deleterious effects in the organism. Violacein (viola), a quorum sensing metabolite from the Gram-negative bacterium Chromobacterium violaceum, has been shown to protect mice from malaria and to have beneficial effects on tumors. However, it is not known whether this drug possesses anti-inflammatory activity. In this study, we investigated whether viola administration is able to reduce acute and chronic autoimmune inflammation. For that purpose, C57BL/6 mice were intraperitoneally injected with 1 mu g of LPS and were treated with viola (3.5mg/kg) via i.p. at the same time-point. Three hours later, the levels of inflammatory cytokines in the sera and phenotypical characterization of leukocytes were determined. Mice treated with viola presented a significant reduction in the production of inflammatory cytokines compared with untreated mice. Interestingly, although viola is a compound derived from bacteria, it did not induce inflammation upon administration to naive mice. To test whether viola would protect mice from an autoimmune inflammation, Experimental Autoimmune Encephalomyelitis (EAE)-inflicted mice were given viola i.p. at disease onset, at the 10th day from immunization. Viola-treated mice developed mild EAE disease in contrast with placebo-treated mice. The frequencies of dendritic cells and macrophages were unaltered in EAE mice treated with viola. However, the sole administration of viola augmented the levels of splenic regulatory T cells (CD4+ Foxp3+). We also found that adoptive transfer of viola-elicited regulatory T cells significantly reduced EAE. Our study shows, for the first time, that violacein is able to modulate acute and chronic inflammation. Amelioration relied in suppression of cytokine production (in acute inflammation) and stimulation of regulatory T cells (in chronic inflammation). New studies must be conducted in order to assess the possible use of viola in therapeutic approaches in human autoimmune diseases.	[Verinaud, Liana; Zanucoli, Fabio; da Costa, Thiago Alves; Di Gangi, Rosaria; Issayama, Luidy Kazuo; Carvalho, Ana Carolina; Bonfanti, Amanda Pires; Niederauer, Guilherme Francio; Rodrigues Oliveira, Alexandre Leite; Stach Machado, Dagmar Ruth; Thome, Rodolfo] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Pinto Lopes, Stefanie Costa; Naranjo Prado, Isabel Cristina; Maranhao Costa, Fabio Trindade] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil; [Duran, Nelson] Univ Estadual Campinas, Inst Chem, Biol Chem Lab, Campinas, SP, Brazil; [Duran, Nelson] Univ Estadual Campinas, Inst Chem, Lab Nanostruct Synth & Biosyst Interact NanoBioss, Campinas, SP, Brazil; [da Cruz Hoefling, Maria Alice] Univ Estadual Campinas, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Thome, R (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.	rodolfo.thome@gmail.com	Lopes, Stefanie/A-8314-2012; Oliveira, Alexandre L. R./C-4436-2012; da Costa, Thiago Alves/F-8187-2016; Oliveira, Alexandre/AAI-6815-2020; de Carvalho, Ana Carolina/B-1825-2019; Bonfanti, Amanda/AAS-4286-2021; Thome, Rodolfo/C-1564-2012; Costa, Fabio/E-1181-2012	Oliveira, Alexandre L. R./0000-0003-4224-4575; Oliveira, Alexandre/0000-0003-4224-4575; de Carvalho, Ana Carolina/0000-0001-7996-6497; Thome, Rodolfo/0000-0001-7627-4137; Costa, Fabio/0000-0001-9969-7300; Lopes, Stefanie/0000-0002-6981-2192; Issayama, Luidy/0000-0003-1701-0101; Alves da Costa, Thiago/0000-0001-9591-331X; Niederauer, Guilherme Francio/0000-0002-3032-778X; Duran, Nelson/0000-0001-8372-5143; Bonfanti, Amanda/0000-0003-0896-0105	Sao Paulo Research Foundation (FAPESP) [2011/17965-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471066/2012-5]; FAPESP scholarship [2014/02631-0, 2011/23664-6, 2012/01892-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #2011/17965-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant 471066/2012-5). FTMC and LV are CNPq researcher fellows. RT, SCPL and ICNP received FAPESP scholarships (#2014/02631-0, #2011/23664-6 and #2012/01892-0, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2003, J PHARMACOL EXP THER, V304, P156, DOI 10.1124/jpet.102.042523; Alarcon GS, 2007, ANN RHEUM DIS, V66, P1168, DOI 10.1136/ard.2006.068676; Apostolidis SA, 2011, LUPUS, V20, P120, DOI 10.1177/0961203310389100; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bromberg N, 2010, CHEM-BIOL INTERACT, V186, P43, DOI 10.1016/j.cbi.2010.04.016; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Duran M, 2010, FOLIA MICROBIOL, V55, P535, DOI 10.1007/s12223-010-0088-4; Duran M, 2012, MED CHEM RES, V21, P1524, DOI 10.1007/s00044-011-9654-9; Duran N, 2007, BIOTECHNOL APPL BIOC, V48, P127, DOI 10.1042/BA20070115; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Zorzella-Pezavento SFG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/519627; Grifka-Walk HM, 2013, EUR J IMMUNOL, V43, P2824, DOI 10.1002/eji.201343723; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Lee JH, 2006, IMMUNOLOGY, V117, P280, DOI 10.1111/j.1365-2567.2005.02306.x; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lopes SCP, 2009, ANTIMICROB AGENTS CH, V53, P2149, DOI 10.1128/AAC.00693-08; Mangalam AK, 2014, J IMMUNOL, V193, P4859, DOI 10.4049/jimmunol.1302008; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Palafox D, 2010, TRANSPLANT REV-ORLAN, V24, P160, DOI 10.1016/j.trre.2010.04.003; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Pena C, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/296031; Platt D, 2014, BIOCHEM BIOPH RES CO, V455, P107, DOI 10.1016/j.bbrc.2014.10.124; Queiroz KCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045362; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Subramaniam S, 2014, PHARM BIOL, V52, P86, DOI 10.3109/13880209.2013.815634; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Thome R, 2014, PLOS ONE IN PRESS; Thome R, 2013, IMMUNOLOGY LETTERS; Thome R, 2014, IMMUNOLOGY, V143, P164, DOI 10.1111/imm.12298; Thome R, 2014, IMMUNOL CELL BIOL, V92, P124, DOI 10.1038/icb.2013.73; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Thome R, 2012, CELL IMMUNOL, V280, P113, DOI 10.1016/j.cellimm.2012.11.017; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Verinaud L, 2014, CELLULAR AND MOLECUL; Wakasa-Morimoto C, 2008, INT IMMUNOL, V20, P1331, DOI 10.1093/intimm/dxn091; Zanucoli F, 2014, CNS NEUROSCI THER, V20, P1061, DOI 10.1111/cns.12357; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919; Zozulya AL, 2009, J NEUROSCI, V29, P140, DOI 10.1523/JNEUROSCI.2199-08.2009	45	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125409	10.1371/journal.pone.0125409	http://dx.doi.org/10.1371/journal.pone.0125409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938431	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000065
J	Lu, XW; Megchelenbrink, W; Notebaart, RA; Huynen, MA				Lu, Xiaowen; Megchelenbrink, Wout; Notebaart, Richard A.; Huynen, Martijn A.			Predicting Human Genetic Interactions from Cancer Genome Evolution	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MISSING HERITABILITY; NETWORKS; HETEROGENEITY; TRANSCRIPTION; CELLS	Synthetic Lethal (SL) genetic interactions play a key role in various types of biological research, ranging from understanding genotype-phenotype relationships to identifying drug-targets against cancer. Despite recent advances in empirical measuring SL interactions in human cells, the human genetic interaction map is far from complete. Here, we present a novel approach to predict this map by exploiting patterns in cancer genome evolution. First, we show that empirically determined SL interactions are reflected in various gene presence, absence, and duplication patterns in hundreds of cancer genomes. The most evident pattern that we discovered is that when one member of an SL interaction gene pair is lost, the other gene tends not to be lost, i.e. the absence of co-loss. This observation is in line with expectation, because the loss of an SL interacting pair will be lethal to the cancer cell. SL interactions are also reflected in gene expression profiles, such as an under representation of cases where the genes in an SL pair are both under expressed, and an over representation of cases where one gene of an SL pair is under expressed, while the other one is over expressed. We integrated the various previously unknown cancer genome patterns and the gene expression patterns into a computational model to identify SL pairs. This simple, genome-wide model achieves a high prediction power (AUC = 0.75) for known genetic interactions. It allows us to present for the first time a comprehensive genome-wide list of SL interactions with a high estimated prediction precision, covering up to 591,000 gene pairs. This unique list can potentially be used in various application areas ranging from biotechnology to medical genetics.	[Lu, Xiaowen; Megchelenbrink, Wout; Notebaart, Richard A.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Dept Bioinformat, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Megchelenbrink, Wout] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands; [Notebaart, Richard A.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Syst Biol & Bioenerget, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Notebaart, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Bioinformat, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	Richard.Notebaart@radboudumc.nl; Martijn.Huijnen@radboudumc.nl	Huynen, Martijn A/A-1530-2014; Notebaart, Richard/A-1459-2014	Huynen, Martijn A/0000-0001-6189-5491; 	Netherlands Organisation for Scientific Research (NWO) [CSBR09/013V]; European Union [HEALTH-241995]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	This work was supported by Netherlands Organisation for Scientific Research (NWO), No: CSBR09/013V, (WM); and European Union's FP7 large scale integrated network Gencodys, http://www.gencodys.eu, HEALTH-241995, (XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R J, V6, P82; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broad Institute TCGA Genome Data Analysis Center, 2014, AN OV 16 MARCH 2014; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cohen W W, 1995, P 12 INT C MACH LEAR, V95, P115, DOI DOI 10.1016/B978-1-55860-377-6.50023-2; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Deshpande R, 2013, CANCER RES, V73, P6128, DOI 10.1158/0008-5472.CAN-12-3956; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jerby-Arnon L, 2014, CELL, V158, P1199, DOI 10.1016/j.cell.2014.07.027; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Lu XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3124; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; Menardi G, 2014, DATA MIN KNOWL DISC, V28, P92, DOI 10.1007/s10618-012-0295-5; Nakatomi M, 2010, DEV BIOL, V340, P438, DOI 10.1016/j.ydbio.2010.01.031; Pandey G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000928; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	50	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125795	10.1371/journal.pone.0125795	http://dx.doi.org/10.1371/journal.pone.0125795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933428	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100133
J	Seitz, F; Luderwald, S; Rosenfeldt, RR; Schulz, R; Bundschuh, M				Seitz, Frank; Luederwald, Simon; Rosenfeldt, Ricki R.; Schulz, Ralf; Bundschuh, Mirco			Aging of TiO2 Nanoparticles Transiently Increases Their Toxicity to the Pelagic Microcrustacean Daphnia magna	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; HUMIC-ACID; AGGREGATION; SURFACE; ADSORPTION; FRESH; SIZE; PH	During their aquatic life cycle, nanoparticles are subject to environmentally driven surface modifications (e.g. agglomeration or coating) associated with aging. Although the ecotoxicological potential of nanoparticles might be affected by these processes, only limited information about the potential impact of aging is available. In this context, the present study investigated acute (96 h) and chronic (21 d) implications of systematically aged titanium dioxide nanoparticles (nTiO(2); similar to 90 nm) on the standard test species Daphnia magna by following the respective test guidelines. The nTiO(2) were aged for 0, 1, 3 and 6 d in media with varying ionic strengths (Milli-Q water: approx. 0.00 mmol/L and ASTM: 9.25 mmol/L) in the presence or absence of natural organic matter (NOM). Irrespective of the other parameters, aging in Milli-Q did not change the acute toxicity relative to an unaged control. In contrast, 6 d aged nTiO(2) in ASTM without NOM caused a fourfold decreased acute toxicity. Relative to the 0 d aged particles, nTiO(2) aged for 1 and 3 d in ASTM with NOM, which is the most environmentally-relevant setup used here, significantly increased acute toxicity (by approximately 30%), while a toxicity reduction (60%) was observed for 6 d aged nTiO(2). Comparable patterns were observed during the chronic experiments. A likely explanation for this phenomenon is that the aging of nTiO(2) increases the particle size at the start of the experiment or the time of the water exchange from <100 nm to approximately 500 nm, which is the optimal size range to be taken up by filter feeding D. magna. If subjected to further agglomeration, larger nTiO(2) particles, however, cannot be retained by the daphnids' filter apparatus ultimately reducing their ecotoxicological potential. This nonlinear pattern of increasing and decreasing nTiO(2) related toxicity over the aging duration, highlights the knowledge gap regarding the underlying mechanisms and processes. This understanding seems, however, fundamental to predict the risks of nanoparticles in the field.	[Seitz, Frank; Luederwald, Simon; Rosenfeldt, Ricki R.; Schulz, Ralf; Bundschuh, Mirco] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Bundschuh, Mirco] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	University of Koblenz & Landau; Swedish University of Agricultural Sciences	Bundschuh, M (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	mirco.bundschuh@slu.se	Schulz, Ralf/ABI-4526-2020; Schulz, Ralf/G-3674-2011; Bundschuh, Mirco/H-4559-2014	Schulz, Ralf/0000-0002-6348-6971; Schulz, Ralf/0000-0002-6348-6971; Bundschuh, Mirco/0000-0003-4876-220X; Seitz, Frank/0000-0002-3181-0140	DFG [SCHU2271/5-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant#SCHU2271/5-1. (http://www.dfg.de/en/research funding/programmes/list/projectdetails/index.jsp? id=172114680) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2000, STATISTICS WITH CONF; [Anonymous], 2007, ASTM STANDARD E729; Bergman TU, 2011, ENVIRON SCI POLLUT R, V18, P655, DOI 10.1007/s11356-010-0413-0; Bouchnak R, 2010, LIMNOLOGICA, V40, P86, DOI 10.1016/j.limno.2009.11.010; Brame J, 2014, WATER RES, V60, P259, DOI 10.1016/j.watres.2014.05.005; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Cupi D, 2015, ENVIRON TOXICOL CHEM, V34, P497, DOI 10.1002/etc.2855; D'Agata A, 2014, NANOTOXICOLOGY, V8, P549, DOI 10.3109/17435390.2013.807446; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Dalai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062970; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; Erhayem M, 2014, SCI TOTAL ENVIRON, V470, P92, DOI 10.1016/j.scitotenv.2013.09.063; Erhayem M, 2014, SCI TOTAL ENVIRON, V468, P249, DOI 10.1016/j.scitotenv.2013.08.038; European Comission, 2015, PAPER ASSESSES NANOT; Fouqueray M, 2012, ENVIRON POLLUT, V163, P55, DOI 10.1016/j.envpol.2011.11.035; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; GELLER W, 1981, OECOLOGIA, V49, P316, DOI 10.1007/BF00347591; GLAZIER DS, 1992, OECOLOGIA, V90, P540, DOI 10.1007/BF01875448; Hall S, 2009, NANOTOXICOLOGY, V3, P91, DOI 10.1080/17435390902788078; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Kwon D, 2015, J NANOSCI NANOTECHNO, V15, P4229, DOI 10.1166/jnn.2015.9695; Lemon J, 2010, R NEWS, V6, P8; Lin DH, 2012, WATER RES, V46, P4477, DOI 10.1016/j.watres.2012.05.035; Loosli F, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2863-2; Loureiro C, 2011, ECOTOXICOLOGY, V20, P139, DOI 10.1007/s10646-010-0565-1; Ma HB, 2012, ENVIRON TOXICOL CHEM, V31, P1621, DOI 10.1002/etc.1858; Noss C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080960; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P195, DOI 10.1021/es801955n; R Development Core Team R, 2013, R A LANGUAGE AND ENV, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ritz C, 2005, J STATIST SOFTWARE, V12; Rosenfeldt RR, 2015, ENVIRON SCI TECHNOL, V49, P1815, DOI 10.1021/es506243d; Rosenfeldt RR, 2014, ENVIRON SCI TECHNOL, V48, P6965, DOI 10.1021/es405396a; Rosenkranz P, 2009, ENVIRON TOXICOL CHEM, V28, P2142, DOI 10.1897/08-559.1; Scheringer M, 2008, NAT NANOTECHNOL, V3, P322, DOI 10.1038/nnano.2008.145; Seitz F, 2015, ECOTOX ENVIRON SAFE, V111, P263, DOI 10.1016/j.ecoenv.2014.09.031; Seitz F, 2014, SCI TOTAL ENVIRON, V493, P891, DOI 10.1016/j.scitotenv.2014.06.092; Seitz F, 2013, AQUAT TOXICOL, V126, P163, DOI 10.1016/j.aquatox.2012.10.015; Seitz F, 2012, ENVIRON TOXICOL CHEM, V31, P518, DOI 10.1002/etc.1715; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P1485, DOI 10.1080/10934520903263231; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Zhao CM, 2012, ENVIRON SCI TECHNOL, V46, P11345, DOI 10.1021/es3014375; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	45	30	30	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126021	10.1371/journal.pone.0126021	http://dx.doi.org/10.1371/journal.pone.0126021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933435	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100147
J	Maszczak-Seneczko, D; Sosicka, P; Kaczmarek, B; Majkowski, M; Luzarowski, M; Olczak, T; Olczak, M				Maszczak-Seneczko, Dorota; Sosicka, Paulina; Kaczmarek, Beata; Majkowski, Michal; Luzarowski, Marcin; Olczak, Teresa; Olczak, Mariusz			UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); glycosylation; glycosyltransferase; Golgi; protein complex; sugar transport; UDP-N-acetylglucosamine transporter; UDP-galactose transporter; mannoside acetylglucosaminyltransferase; proximity ligation assay	NUCLEOTIDE SUGAR TRANSPORTERS; MEDIAL GOLGI ENZYMES; CELL-LINE; GLYCOSYLTRANSFERASE COMPLEXES; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; KIN RECOGNITION; GAL TRANSPORTER; HELA-CELLS	Background: UDP-galactose (UGT) and UDP-N-acetylglucosamine (NGT) transporters and mannoside acetylglucosaminyltransferases (Mgats) are important mediators of N-linked protein glycosylation. Results: UGT and NGT are in close proximity to Mgats. Conclusion: UGT, NGT and Mgats may form multiprotein complexes mediating biosynthesis of N-glycans. Significance: Protein-protein interactions between Golgi-resident nucleotide sugar transporters and glycosyltransferases appears to be an inherent feature of N-linked glycosylation. UDP-galactose transporter (UGT; SLC35A2) and UDP-N-acetylglucosamine transporter (NGT; SLC35A3) form heterologous complexes in the Golgi membrane. NGT occurs in close proximity to mannosyl (-1,6-)-glycoprotein -1,6-N-acetylglucosaminyltransferase (Mgat5). In this study we analyzed whether NGT and both splice variants of UGT (UGT1 and UGT2) are able to interact with four different mannoside acetylglucosaminyltransferases (Mgat1, Mgat2, Mgat4B, and Mgat5). Using an in situ proximity ligation assay, we found that all examined glycosyltransferases are in the vicinity of these UDP-sugar transporters both at the endogenous level and upon overexpression. This observation was confirmed via the FLIM-FRET approach for both NGT and UGT1 complexes with Mgats. This study reports for the first time close proximity between endogenous nucleotide sugar transporters and glycosyltransferases. We also observed that among all analyzed Mgats, only Mgat4B occurs in close proximity to UGT2, whereas the other three Mgats are more distant from UGT2, and it was only possible to visualize their vicinity using proximity ligation assay. This strongly suggests that the distance between these protein pairs is longer than 10 nm but at the same time shorter than 40 nm. This study adds to the understanding of glycosylation, one of the most important post-translational modifications, which affects the majority of macromolecules. Our research shows that complex formation between nucleotide sugar transporters and glycosyltransferases might be a more common phenomenon than previously thought.	[Maszczak-Seneczko, Dorota; Sosicka, Paulina; Kaczmarek, Beata; Luzarowski, Marcin; Olczak, Teresa; Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50383 Wroclaw, Poland; [Majkowski, Michal] Univ Wroclaw, Fac Biotechnol, Lab Cytobiochem, PL-50383 Wroclaw, Poland	University of Wroclaw; University of Wroclaw	Olczak, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Biochem Lab, 14A F Joliot Curie St, PL-50383 Wroclaw, Poland.	Mariusz.Olczak@biotech.uni.wroc.pl			National Science Center (Krakow, Poland) [2011/03/B/NZ1/02084]; Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW)	National Science Center (Krakow, Poland); Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW)	This work was supported by Grant 2011/03/B/NZ1/02084 from the National Science Center (Krakow, Poland). Publication costs were supported by Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW) for 2014-2018.	Abe M, 1999, FEBS LETT, V458, P309, DOI 10.1016/S0014-5793(99)01177-1; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; COATES SW, 1980, J BIOL CHEM, V255, P9225; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Ferrari ML, 2012, NEUROCHEM RES, V37, P1325, DOI 10.1007/s11064-012-0741-1; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 1996, J BIOCHEM, V120, P1074; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Oguri S, 1997, J BIOL CHEM, V272, P22721, DOI 10.1074/jbc.272.36.22721; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Oikawa A, 2013, TRENDS PLANT SCI, V18, P49, DOI 10.1016/j.tplants.2012.07.002; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; SCHACHTER H, 1994, MOL GLYCOBIOLOGY, P88; Schoberer J, 2013, PLANT PHYSIOL, V161, P1737, DOI 10.1104/pp.112.210757; SLUSAREWICZ P, 1994, J CELL BIOL, V124, P405, DOI 10.1083/jcb.124.4.405; Sosicka P, 2014, BIOCHEM BIOPH RES CO, V454, P486, DOI 10.1016/j.bbrc.2014.10.098; Spessott W, 2012, FEBS LETT, V586, P2346, DOI 10.1016/j.febslet.2012.05.041; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; VANDENEIJNDEN DH, 1993, CURR OPIN STRUC BIOL, V3, P711, DOI 10.1016/0959-440X(93)90054-O; Yoshioka S, 1997, J BIOCHEM, V122, P691	49	30	30	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15475	15486		10.1074/jbc.M115.636670	http://dx.doi.org/10.1074/jbc.M115.636670			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944901	hybrid, Green Published			2022-12-26	WOS:000356527400014
J	Drenos, F; Grossi, E; Buscema, M; Humphries, SE				Drenos, Fotios; Grossi, Enzo; Buscema, Massimo; Humphries, Steve E.			Networks in Coronary Heart Disease Genetics As a Step towards Systems Epidemiology	PLOS ONE			English	Article							HEPATIC LIPASE; ASSOCIATION; POLYMORPHISM; PREDICTION; EXPERIENCE; DISCOVERY; PROMOTER	We present the use of innovative machine learning techniques in the understanding of Coronary Heart Disease (CHD) through intermediate traits, as an example of the use of this class of methods as a first step towards a systems epidemiology approach of complex diseases genetics. Using a sample of 252 middle-aged men, of which 102 had a CHD event in 10 years follow-up, we applied machine learning algorithms for the selection of CHD intermediate phenotypes, established markers, risk factors, and their previously associated genetic polymorphisms, and constructed a map of relationships between the selected variables. Of the 52 variables considered, 42 were retained after selection of the most informative variables for CHD. The constructed map suggests that most selected variables were related to CHD in a context dependent manner while only a small number of variables were related to a specific outcome. We also observed that loss of complexity in the network was linked to a future CHD event. We propose that novel, non-linear, and integrative epidemiological approaches are required to combine all available information, in order to truly translate the new advances in medical sciences to gains in preventive measures and patients care.	[Drenos, Fotios; Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London, England; [Drenos, Fotios] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Grossi, Enzo] Bracco Pharmaceut, Dept Med, San Donato Milanese, Italy; [Grossi, Enzo; Buscema, Massimo] Seme Res Ctr Sci Commun, Rome, Italy; [Buscema, Massimo] Univ Colorado, Dept Math & Stat Sci, Denver, CO 80202 USA	University of London; University College London; University of Bristol; Bracco; University of Colorado System; University of Colorado Denver	Drenos, F (corresponding author), UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London, England.	f.drenos@bristol.ac.uk	Grossi, Enzo/AAF-7765-2020	Humphries, Stephen E/0000-0002-8221-6547; Buscema, Paolo Massimo/0000-0003-4356-0510; Drenos, Fotios/0000-0003-2469-5516	British Heart Foundation [PG/2008/008]; European Commission [QLG1-CT-2002-00896]; British Medical Research Council; US National Institutes of Health [NHLBI 33014]; Du Pont Pharma, Wilmington, Delaware; Bracco Pharmaceuticals; MRC [MC_UU_12013/5] Funding Source: UKRI; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish; Medical Research Council [MC_UU_12013/5] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Du Pont Pharma, Wilmington, Delaware; Bracco Pharmaceuticals; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Heart Foundation [grant number PG/2008/008 to SE], the European Commission [grant number QLG1-CT-2002-00896 to SE EG and MB]. NPHS-II was supported by the British Medical Research Council, the US National Institutes of Health [grant number NHLBI 33014], and Du Pont Pharma, Wilmington, Delaware. Bracco Pharmaceuticals provided support in the form of salaries for authors EG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bensadoun A, 1996, CURR OPIN LIPIDOL, V7, P77, DOI 10.1097/00041433-199604000-00005; Brunzell JD, 2012, BBA-MOL CELL BIOL L, V1821, P365, DOI 10.1016/j.bbalip.2011.09.008; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Buscema M, 2005, ARTIF INTELL MED, V34, P279, DOI 10.1016/j.artmed.2004.12.001; Buscema M, 2004, EXPERT SYST, V21, P63, DOI 10.1111/j.1468-0394.2004.00264.x; Buscema M, 2012, NEUROLOGY RESEARCH I, V2012, P13; Buscema M., 2009, ARTIFICIAL ADAPTIVE; Buscema M, 2008, CURR ALZHEIMER RES, V5, P481, DOI 10.2174/156720508785908928; Buscema M, 2007, IEEE SYS MAN CYBERN, P1495; Buscema M, 2010, APPLICATIONS OF MATHEMATICS IN MODELS, ARTIFICIAL NEURAL NETWORKS AND ARTS: MATHEMATICS AND SOCIETY, P227, DOI 10.1007/978-90-481-8581-8_11; Buscema M, 2009, PHYSICA A, V388, P4736, DOI 10.1016/j.physa.2009.07.034; Buscema M, 2008, INT J DATA MIN BIOIN, V2, P362, DOI 10.1504/IJDMB.2008.022159; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; COMSTOCK KE, 1993, J BIOL CHEM, V268, P16958; Cooper JA, 2000, CIRCULATION, V102, P2816; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102459; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dhamrait SS, 2012, J APPL PHYSIOL, V112, P1122, DOI 10.1152/japplphysiol.00766.2011; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Fredman ML, 1990, TRANS DICHOTOMOUS AL, V712, P719; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Gomez-Gallego F, 2009, EUR J APPL PHYSIOL, V107, P565, DOI 10.1007/s00421-009-1166-7; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Grossi Enzo, 2010, Immun Ageing, V7 Suppl 1, pS3, DOI 10.1186/1742-4933-7-S1-S3; HUNT KJ, 1992, AUTOMATICA, V28, P1083, DOI 10.1016/0005-1098(92)90053-I; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kraus V, 2014, INFORM SCIENCES, V288, P220, DOI 10.1016/j.ins.2014.07.018; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Lawson HA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002256; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lok CAR, 2009, AM J REPROD IMMUNOL, V61, P346, DOI 10.1111/j.1600-0897.2009.00701.x; Matsunaga T, 2009, J HYPERTENS, V27, P305, DOI 10.1097/HJH.0b013e32831ac967; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Ordovas JM, 2002, CIRCULATION, V106, P2315, DOI 10.1161/01.CIR.0000036597.52291.C9; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Smith AJP, 2010, HUM MOL GENET, V19, P3936, DOI 10.1093/hmg/ddq308; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swami M, 2009, NAT REV GENET, V10, P219, DOI 10.1038/nrg2566; Tastle W.J., 2013, DATA MINING APPL USI; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125876	10.1371/journal.pone.0125876	http://dx.doi.org/10.1371/journal.pone.0125876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951190	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400051
J	Herman, A; Gruden, K; Blejec, A; Podpecan, V; Motaln, H; Rozman, P; Hren, M; Zupancic, K; Veber, M; Verbovsek, U; Turnsek, TL; Porcnik, A; Korsic, M; Knezevic, M; Jeras, M				Herman, Ana; Gruden, Kristina; Blejec, Andrej; Podpecan, Vid; Motaln, Helena; Rozman, Primoz; Hren, Matjaz; Zupancic, Klemen; Veber, Matija; Verbovsek, Urska; Turnsek, Tamara Lah; Porcnik, Andrej; Korsic, Marjan; Knezevic, Miomir; Jeras, Matjaz			Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin	PLOS ONE			English	Article							CIRCULATING MICRORNAS; SERUM MICRORNAS; CANCER; MIRNAS; RNA; EXPRESSION; PROTEIN; GLIOMA; BLOOD; CLASSIFICATION	Background Glioblastoma multiforme (GBM) is among the most aggressive cancers with a poor prognosis in spite of a plethora of established diagnostic and prognostic biomarkers and treatment modalities. Therefore, the current goal is the detection of novel biomarkers, possibly detectable in the blood of GBM patients that may enable an early diagnosis and are potential therapeutic targets, leading to more efficient interventions. Experimental Procedures MicroRNA profiling of 734 human and human-associated viral miRNAs was performed on blood plasma samples from 16 healthy individuals and 16 patients with GBM, using the nCounter miRNA Expression Assay Kits. Results We identified 19 miRNAs with significantly different plasma levels in GBM patients, compared to the healthy individuals group with the difference limited by a factor of 2. Additionally, 11 viral miRNAs were found differentially expressed in plasma of GBM patients and 24 miRNA levels significantly correlated with the patients' survival. Moreover, the overlap between the group of candidate miRNAs for diagnostic biomarkers and the group of miRNAs associated with survival, consisted of ten miRNAs, showing both diagnostic and prognostic potential. Among them, hsa miR 592 and hsa miR 514a 3p have not been previously described in GBM and represent novel candidates for selective biomarkers. The possible signalling, induced by the revealed miRNAs is discussed, including those of viral origin, and in particular those related to the impaired immune response in the progression of GBM. Conclusion The GBM burden is reflected in the alteration of the plasma miRNAs pattern, including viral miRNAs, representing the potential for future clinical application. Therefore proposed biomarker candidate miRNAs should be validated in a larger study of an independent cohort of patients.	[Herman, Ana; Rozman, Primoz] Ctr Blood Transfus, Ljubljana, Slovenia; [Gruden, Kristina; Blejec, Andrej; Motaln, Helena; Verbovsek, Urska; Turnsek, Tamara Lah] Natl Inst Biol, Ljubljana, Slovenia; [Podpecan, Vid] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia; [Hren, Matjaz; Zupancic, Klemen] Raziskave Razvoj Doo, BioSistemika, Ljubljana, Slovenia; [Veber, Matija; Knezevic, Miomir] Educell Ltd, Trzin, Slovenia; [Porcnik, Andrej; Korsic, Marjan] Univ Ljubljana, Med Ctr, Dept Neurosurg, Ljubljana, Slovenia; [Turnsek, Tamara Lah] Univ Ljubljana, Fac Chem & Chem Engn, Ljubljana, Slovenia; [Jeras, Matjaz] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Jeras, Matjaz] Celica Doo, Ljubljana, Slovenia	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana; University of Ljubljana	Gruden, K (corresponding author), Natl Inst Biol, Ljubljana, Slovenia.	kristina.gruden@nib.si; matjaz.jeras@ffa.uni-lj.si	Motaln, Helena/AAD-1507-2022; Gruden, kristina/AAI-6439-2020; Blejec, Andrej/M-5215-2019; Rozman, Primoz/ABD-4051-2020; Motaln, Helena/AAF-3489-2019	Motaln, Helena/0000-0002-0646-7934; Blejec, Andrej/0000-0001-7484-6031; gruden, kristina/0000-0001-5906-8569	BioSistemika; Educell Ltd; Celica	BioSistemika; Educell Ltd; Celica	Funding: BioSistemika, Educell Ltd and Celica provided support in the form of salaries for authors MH, KZ, MV and MJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abreu MM, 2010, EXP CELL RES, V316, P3227, DOI 10.1016/j.yexcr.2010.07.021; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Bozdag S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062982; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Dhuruvasan K, 2011, VIRUS RES, V157, P180, DOI 10.1016/j.virusres.2010.10.011; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eronen L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-119; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gruden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028761; He ZW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0557-0; Henriksen M, 2014, MOL NEUROBIOL, V50, P896, DOI 10.1007/s12035-014-8668-y; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ilhan-Mutlu A, 2012, CANCER INVEST, V30, P615, DOI 10.3109/07357907.2012.708071; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karsy Michael, 2012, Genes Cancer, V3, P3, DOI 10.1177/1947601912448068; Kunder R, 2013, NEURO-ONCOLOGY, V15, P1644, DOI 10.1093/neuonc/not123; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Lagana Alessandro, 2010, J RNAi Gene Silencing, V6, P379; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lang MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036248; Lin Z, 2011, CANCER LETT, V305, P186, DOI 10.1016/j.canlet.2010.08.018; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nikaki A, 2012, EXPERT OPIN INV DRUG, V21, P1475, DOI 10.1517/13543784.2012.710199; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pfeffer S, 2006, ONCOGENE, V25, P6211, DOI 10.1038/sj.onc.1209915; Podpecan V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-416; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Ramalingam D, 2012, VIRUSES-BASEL, V4, P1687, DOI 10.3390/v4091687; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rogler A, 2013, INT J CLIN EXP PATHO, V6, P1984; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Shen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088531; Shi L, 2015, CELL MOL NEUROBIOL, V35, P217, DOI 10.1007/s10571-014-0114-1; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sokilde R, 2014, J MOL DIAGN, V16, P106, DOI 10.1016/j.jmoldx.2013.10.001; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tiso N, 1996, BIOCHEM BIOPH RES CO, V225, P983, DOI 10.1006/bbrc.1996.1282; Trajkovski I, 2008, J BIOMED INFORM, V41, P588, DOI 10.1016/j.jbi.2007.12.001; Tunca B, 2012, J CANCER RES CLIN, V138, P1831, DOI 10.1007/s00432-012-1261-8; Turner JD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09207; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang L, 2012, FEBS LETT, V586, P1312, DOI 10.1016/j.febslet.2012.03.035; Wang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-97; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014	74	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125791	10.1371/journal.pone.0125791	http://dx.doi.org/10.1371/journal.pone.0125791			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950799	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400046
J	Kim, SH; Wu, SY; Baek, JI; Choi, SY; Su, Y; Flynn, CR; Gamse, JT; Ess, KC; Hardiman, G; Lipschutz, JH; Abumrad, NN; Rockey, DC				Kim, Seok-Hyung; Wu, Shu-Yu; Baek, Jeong-In; Choi, Soo Young; Su, Yanhui; Flynn, Charles R.; Gamse, Joshua T.; Ess, Kevin C.; Hardiman, Gary; Lipschutz, Joshua H.; Abumrad, Naji N.; Rockey, Don C.			A Post-Developmental Genetic Screen for Zebrafish Models of Inherited Liver Disease	PLOS ONE			English	Article							ANIMAL-MODELS; HEPATIC STEATOSIS; LEADS; IDENTIFICATION; STRESS	Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease such as simple steatosis, nonalcoholic steatohepatitis (NASH), cirrhosis and fibrosis. However, the molecular pathogenesis and genetic variations causing NAFLD are poorly understood. The high prevalence and incidence of NAFLD suggests that genetic variations on a large number of genes might be involved in NAFLD. To identify genetic variants causing inherited liver disease, we used zebrafish as a model system for a large-scale mutant screen, and adopted a whole genome sequencing approach for rapid identification of mutated genes found in our screen. Here, we report on a forward genetic screen of ENU mutagenized zebrafish. From 250 F2 lines of ENU mutagenized zebrafish during post-developmental stages (5 to 8 days post fertilization), we identified 19 unique mutant zebrafish lines displaying visual evidence of hepatomegaly and/or steatosis with no developmental defects. Histological analysis of mutants revealed several specific phenotypes, including common steatosis, micro/macrovesicular steatosis, hepatomegaly, ballooning, and acute hepatocellular necrosis. This work has identified multiple post-developmental mutants and establishes zebrafish as a novel animal model for post-developmental inherited liver disease.	[Kim, Seok-Hyung; Baek, Jeong-In; Choi, Soo Young; Su, Yanhui; Hardiman, Gary; Lipschutz, Joshua H.; Rockey, Don C.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Wu, Shu-Yu; Gamse, Joshua T.] Vanderbilt Univ, Dept Biol, Nashville, TN 37232 USA; [Flynn, Charles R.; Abumrad, Naji N.] Vanderbilt Univ, Dept Surg, Nashville, TN 37232 USA; [Ess, Kevin C.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA	Medical University of South Carolina; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kim, SH (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.	kims@musc.edu	Flynn, Charles/M-3895-2015	Flynn, Charles/0000-0002-3749-0598; Hardiman, Gary/0000-0003-4558-0400	Norman S. Coplon Extramural Research Grant; Metabolic Technologies, Inc.;  [W81XWH-10-1-0854];  [DK069909];  [DK070980];  [DK057830];  [DK098819];  [DK091748];  [DK096527];  [P30 DK020593];  [P30 DK058404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098819, R21DK070980, P30DK020593, R24DK096527, R01DK057830, R01DK069909, P30DK058404, R01DK091748] Funding Source: NIH RePORTER	Norman S. Coplon Extramural Research Grant; Metabolic Technologies, Inc.; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the following grants: W81XWH-10-1-0854 (to KCE) (http://www.defense.gov/); Merit Award (to JHL) (http://www.va.gov/); Norman S. Coplon Extramural Research Grant (to JHL) (http://www.satellitehealth.com/); DK069909 and DK070980 (to JHL), DK057830 and DK098819 (to DCR), DK091748 and DK096527 (to NNA), P30 DK020593 and P30 DK058404 (to CRF) (http://www.nih.gov/); Metabolic Technologies, Inc. (to NNA) (http://www.mettechinc.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes H, 2013, LANCET, V382, P1514, DOI 10.1016/S0140-6736(13)60020-3; Chen JN, 1996, DEVELOPMENT, V123, P293; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Gu QL, 2014, HEPATOLOGY, V60, P1929, DOI 10.1002/hep.27356; Guo L, 2012, CANCER SCI, V103, P2110, DOI 10.1111/cas.12025; Haffter P, 1996, DEVELOPMENT, V123, P1; Huang MB, 2014, HEPATOLOGY, V60, P1753, DOI 10.1002/hep.27285; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Kim SH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003563; Kohli R, 2011, J HEPATOL, V55, P941, DOI 10.1016/j.jhep.2011.04.010; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lavallard VJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/120179; Leshchiner I, 2012, GENOME RES, V22, P1541, DOI 10.1101/gr.135541.111; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Sapp V, 2014, HEPATOLOGY, V60, P1581, DOI 10.1002/hep.27284; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Thakur PC, 2011, HEPATOLOGY, V54, P452, DOI 10.1002/hep.24349; van der Velden YU, 2011, P NATL ACAD SCI USA, V108, P4358, DOI 10.1073/pnas.1010210108; Westbroek W, 2007, J INVEST DERMATOL, V127, P2674, DOI 10.1038/sj.jid.5700899	23	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125980	10.1371/journal.pone.0125980	http://dx.doi.org/10.1371/journal.pone.0125980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950913	Green Submitted, gold, Green Published			2022-12-26	WOS:000354214400058
J	Xu, L; Pan, LQ; Jin, SL; Liu, HB; Yin, GS				Xu, Li; Pan, Liqiang; Jin, Shuilin; Liu, Haibo; Yin, Guisheng			A Reliability-Based Track Fusion Algorithm	PLOS ONE			English	Article							VISUAL TRACKING; MULTIPLE	The common track fusion algorithms in multi-sensor systems have some defects, such as serious imbalances between accuracy and computational cost, the same treatment of all the sensor information regardless of their quality, high fusion errors at inflection points. To address these defects, a track fusion algorithm based on the reliability (TFR) is presented in multi-sensor and multi-target environments. To improve the information quality, outliers in the local tracks are eliminated at first. Then the reliability of local tracks is calculated, and the local tracks with high reliability are chosen for the state estimation fusion. In contrast to the existing methods, TFR reduces high fusion errors at the inflection points of system tracks, and obtains a high accuracy with less computational cost. Simulation results verify the effectiveness and the superiority of the algorithm in dense sensor environments.	[Xu, Li; Liu, Haibo; Yin, Guisheng] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Pan, Liqiang] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Jin, Shuilin] Harbin Inst Technol, Dept Math, Harbin 150006, Heilongjiang, Peoples R China	Harbin Engineering University; Harbin Institute of Technology; Harbin Institute of Technology	Yin, GS (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	yinguisheng@hrbeu.edu.cn			National Natural Science Foundation of China [61201084, 11301110, 61100030]; China Postdoctoral Science Foundation [2013M541346]; Heilongjiang Postdoctoral Special Fund (Postdoctoral Youth Talent Program) [LBH-TZ0504]; Heilongjiang Postdoctoral Fund [LBH-Z13058]; Fundamental Research Funds for the Central Universities [HEUCF100604]; Program for Innovation Research of Science in Harbin Institute of Technology [A201401]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology; Postdoctoral Science-research Developmental Foundation of Heilongjiang Province [LBH-Q13072]; Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University [93K172014K08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Special Fund (Postdoctoral Youth Talent Program); Heilongjiang Postdoctoral Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Innovation Research of Science in Harbin Institute of Technology; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology); Postdoctoral Science-research Developmental Foundation of Heilongjiang Province; Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University	The work described in this paper is supported by the National Natural Science Foundation of China under Grant No. 61201084, No. 11301110, and No. 61100030; the China Postdoctoral Science Foundation under Grant No. 2013M541346; Heilongjiang Postdoctoral Special Fund (Postdoctoral Youth Talent Program) under Grant No. LBH-TZ0504; Heilongjiang Postdoctoral Fund under Grant No. LBH-Z13058; the Fundamental Research Funds for the Central Universities under Grant No. HEUCF100604; the Program for Innovation Research of Science in Harbin Institute of Technology under Grant No. A201401; the Natural Scientific Research Innovation Foundation in Harbin Institute of Technology, Postdoctoral Science-research Developmental Foundation of Heilongjiang Province under Grant No. LBH-Q13072; and the Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University under Grant No. 93K172014K08.	Aeberhard M, 2012, IEEE T INTELL TRANSP, V13, P1717, DOI 10.1109/TITS.2012.2202229; Aziz AM, 2014, INFORM FUSION, V18, P175, DOI 10.1016/j.inffus.2013.09.002; BARSHALOM Y, 1986, IEEE T AERO ELEC SYS, V22, P803, DOI 10.1109/TAES.1986.310815; Beugnon C., 2000, P ISIF, P24; Chen H.M., 2007, P 10 INT C INF FUS F, P1; Chen HM, 2007, P 46 IEEE C DEC CONT, P2675, DOI DOI 10.1109/CDC.2007.4434638; Duan ZS, 2011, IEEE T SIGNAL PROCES, V59, P362, DOI 10.1109/TSP.2010.2084574; Duraisamy B, 2013, INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, IMAGE PROCESSING AND PATTERN RECOGNITION (ICSIPR 2013), P179, DOI 10.1109/ICSIPR.2013.6497983; Hall DL, 1997, P IEEE, V85, P6, DOI 10.1109/5.554205; Hao L, 2013, 16 INT IEEE C INT TR; Hu YY, 2010, IEEE T AERO ELEC SYS, V46, P2090, DOI 10.1109/TAES.2010.5595618; Jin SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088519; Li Hui, 2006, Chinese Journal of Computers, V29, P2232; Li XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051199; Quaranta C, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.4.046401; SINGER RA, 1970, IEEE T AERO ELEC SYS, VAES6, P473, DOI 10.1109/TAES.1970.310128; Stienne G, 2014, INFORM FUSION, V18, P86, DOI 10.1016/j.inffus.2013.05.012; Sun QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106911; Watson GA, 2000, P SOC PHOTO-OPT INS, V4052, P2, DOI 10.1117/12.391672; Willner D., 1978, P IEEE C DEC CONTR S, P570; Yoon JH, 2012, LECT NOTES COMPUT SC, V7575, P28, DOI 10.1007/978-3-642-33765-9_3; Yuan Q, 2009, EXPERT SYST APPL, V36, P111, DOI 10.1016/j.eswa.2007.09.026; Zhang JM, 2014, LECT NOTES COMPUT SC, V8694, P188, DOI 10.1007/978-3-319-10599-4_13; Zhao X., 2012, PLOS ONE, V10; Zhong B, 2014, PATTERN RECOGN, V47, P1395, DOI 10.1016/j.patcog.2013.10.002; Zhu HY, 2014, INFORM FUSION, V18, P187, DOI 10.1016/j.inffus.2013.09.003	27	0	0	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126227	10.1371/journal.pone.0126227	http://dx.doi.org/10.1371/journal.pone.0126227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950174	Green Submitted, gold, Green Published			2022-12-26	WOS:000354214400074
J	Zhang, H; Zhang, LM; Zhu, KK; Shi, BW; Yin, YS; Zhu, JF; Yue, DS; Zhang, B; Wang, CL				Zhang, Hua; Zhang, Lianmin; Zhu, Kaikai; Shi, Bowen; Yin, Yuesong; Zhu, Jinfang; Yue, Dongsheng; Zhang, Bin; Wang, Changli			Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study	PLOS ONE			English	Article							COLORECTAL-CANCER; POSTOPERATIVE SURVIVAL; USEFUL PREDICTOR; GASTRIC-CANCER; INFLAMMATION; ADENOCARCINOMA; THROMBOCYTOSIS; METASTASIS; MECHANISM	Introduction The aim of this study was to investigate the prognostic significance of the combination of the preoperative platelet count and neutrophil-lymphocyte ratio (COP-NLR) for predicting postoperative survival of patients undergoing complete resection for non-small cell lung cancer (NSCLC). Methods The preoperative COP-NLR was calculated on the basis of data obtained. Patients with both an increased platelet count (>30.0x10(4) mm(-3)) and an elevated NLR (>2.3) were assigned a score of 2, and patients with one or neither were assigned as a score of 1 or 0, respectively. Results A total of 1238 NSCLC patients were enrolled in this analysis. Multivariate analysis using the 15 clinicolaboratory variables selected by univariate analyses demonstrated that the preoperative COP-NLR was an independent prognostic factor for DFS (HR: 1.834, 95%CI: 1.536 to 2.200, P<0.001) and OS (HR: 1.810, 95% CI: 1.587 to 2.056, P<0.001). In sub-analyses by tumor stage (I, II, IIIA), a significant association was found between DFS and OS and level of COP-NLR in each subgroup (P<0.001, P=0.002, P<0.001 for DFS, respectively; P<0.001, P=0.001, P<0.001 for OS). When the subgroup of patients with high-risk COP-NLR (score of 2) was analyzed, no benefit of adjuvant chemotherapy could be found (P=0.237 for DFS and P=0.165 for OS). Conclusions NSCLCThe preoperative COP-NLR is able to predict the prognosis of patients with NSCLC and divide these patients into three independent groups before surgery. Our results also demonstrate that high-risk patients based on the COP-NLR do not benefit from adjuvant chemotherapy. Independent validation of our findings is warranted.	[Zhang, Hua; Zhang, Lianmin; Shi, Bowen; Yin, Yuesong; Zhu, Jinfang; Yue, Dongsheng; Zhang, Bin; Wang, Changli] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Lung Canc, Tianjin, Peoples R China; [Zhang, Hua; Zhang, Lianmin; Shi, Bowen; Yin, Yuesong; Zhu, Jinfang; Yue, Dongsheng; Zhang, Bin; Wang, Changli] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Hua; Zhang, Lianmin; Shi, Bowen; Yin, Yuesong; Zhu, Jinfang; Yue, Dongsheng; Zhang, Bin; Wang, Changli] Tianjin Lung Canc Ctr, Tianjin, Peoples R China; [Zhu, Kaikai] Tianjin Med Univ, Gen Hosp, Dept Pediat, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, CL (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Lung Canc, Tianjin, Peoples R China.	only_zh@yeah.net			National Natural Science Foundation of China [81470137]; Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission [12ZCDZSY15400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission	This work was supported by the National Natural Science Foundation of China (81470137 to CL Wang, http://www.nsfc.gov.cn) and Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission (12ZCDZSY15400 to CL Wang, [http://www.tstc.gov.cn/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe K, 2004, RESPIRATION, V71, P170, DOI 10.1159/000076679; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Gaetano G, 2001, HAEMATOLOGICA, V86, P349; DEBUYZERE M, 1993, AM J HEMATOL, V43, P91, DOI 10.1002/ajh.2830430204; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guo F, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-19; Guthrie GJK, 2013, CANCER TREAT REV, V39, P89, DOI 10.1016/j.ctrv.2012.07.003; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Ishizuka M, 2014, J SURG ONCOL, V110, P935, DOI 10.1002/jso.23753; Jaiswal M, 2000, CANCER RES, V60, P184; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Maraz A, 2013, ANTICANCER RES, V33, P1725; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Tomita M, 2011, ANTICANCER RES, V31, P2995; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147	34	67	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126496	10.1371/journal.pone.0126496	http://dx.doi.org/10.1371/journal.pone.0126496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950176	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400098
J	Chen, CJ; Cheng, FC; Su, HL; Sheu, ML; Lu, ZH; Chiang, CY; Yang, DY; Sheehan, J; Pan, HC				Chen, Chun-Jung; Cheng, Fu-Chou; Su, Hong-Lin; Sheu, Meei-Ling; Lu, Zong-Han; Chiang, Chien-Yi; Yang, Dar-Yu; Sheehan, Jason; Pan, Hung-Chuan			Improved Neurological Outcome by Intramuscular Injection of Human Amniotic Fluid Derived Stem Cells in a Muscle Denervation Model	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; SKELETAL-MUSCLE; SCIATIC-NERVE; CYTOCHROME-C; REGENERATION; INJURY; RECEPTORS; RAT; EXPRESSION; THERAPY	Purpose The skeletal muscle develops various degrees of atrophy and metabolic dysfunction following nerve injury. Neurotrophic factors are essential for muscle regeneration. Human amniotic fluid derived stem cells (AFS) have the potential to secrete various neurotrophic factors necessary for nerve regeneration. In the present study, we assess the outcome of neurological function by intramuscular injection of AFS in a muscle denervation and nerve anastomosis model. Materials and Methods Seventy two Sprague-Dawley rats weighing 200-250 gm were enrolled in this study. Muscle denervation model was conducted by transverse resection of a sciatic nerve with the proximal end sutured into the gluteal muscle. The nerve anastomosis model was performed by transverse resection of the sciatic nerve followed by four stitches reconnection. These animals were allocated to three groups: control, electrical muscle stimulation, and AFS groups. Results NT-3 (Neurotrophin 3), BDNF (Brain derived neurotrophic factor), CNTF (Ciliary neurotrophic factor), and GDNF (Glia cell line derived neurotrophic factor) were highly expressed in AFS cells and supernatant of culture medium. Intra-muscular injection of AFS exerted significant expression of several neurotrophic factors over the distal end of nerve and denervated muscle. AFS caused high expression of Bcl-2 in denervated muscle with a reciprocal decrease of Bad and Bax. AFS preserved the muscle morphology with high expression of desmin and acetylcholine receptors. Up to two months, AFS produced significant improvement in electrophysiological study and neurological functions such as SFI (sciatic nerve function index) and Catwalk gait analysis. There was also significant preservation of the number of anterior horn cells and increased nerve myelination as well as muscle morphology. Conclusion Intramuscular injection of AFS can protect muscle apoptosis and likely does so through the secretion of various neurotrophic factors. This protection furthermore improves the nerve regeneration in a long term nerve anastomosis model.	[Chen, Chun-Jung; Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Su, Hong-Lin] Natl Chung Hsing Univ, Inst Life Sci, Taichung 40227, Taiwan; [Sheu, Meei-Ling; Lu, Zong-Han; Chiang, Chien-Yi] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Yang, Dar-Yu] Chang Bing Show Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan; [Sheehan, Jason] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Pan, Hung-Chuan] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Chang Bing Show Chwan Memorial Hospital; University of Virginia; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Pan, HC (corresponding author), Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan.	hcpan2003@yahoo.com.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282	Chung-Hsing University [TCVGH-NCHU9976071]; Taichung Veterans General Hospital [TCVGH-1014905C]; National Science Council, Taiwan [NSC-99-2314-B-075A-001-MY2]; Taichung Veterans General Hospital	Chung-Hsing University; Taichung Veterans General Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital	This study was supported from the grants from Taichung Veterans General Hospital, Chung-Hsing University (TCVGH-NCHU9976071), Taichung Veterans General Hospital (TCVGH-1014905C) and the National Science Council (NSC-99-2314-B-075A-001-MY2), Taiwan.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; Cheng FC, 2010, J NEUROSURG, V112, P868, DOI 10.3171/2009.8.JNS09850; Clow C, 2010, MOL BIOL CELL, V21, P2182, DOI 10.1091/mbc.E10-02-0154; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; De B. C, 2003, J CELL BIOL, V160, P909; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Grounds MD, 2007, NEUROMUSCULAR DISORD, V17, P206, DOI 10.1016/j.nmd.2007.01.007; Gu ZZ, 1997, NEUROCHEM INT, V30, P417, DOI 10.1016/S0197-0186(96)00077-0; Ip FCF, 2001, NEUROSCI LETT, V301, P107, DOI 10.1016/S0304-3940(01)01603-2; Jin HM, 2001, J TRAUMA, V50, P31, DOI 10.1097/00005373-200101000-00005; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Pan HC, 2006, J CLIN NEUROSCI, V13, P570, DOI 10.1016/j.jocn.2005.06.007; Pan HC, 2009, NEUROCHEM RES, V34, P1304, DOI 10.1007/s11064-008-9910-7; Pan HC, 2009, NEUROCHEM RES, V34, P518, DOI 10.1007/s11064-008-9815-5; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pitts EV, 2006, INT ANESTHESIOL CLIN, V44, P21, DOI 10.1097/00004311-200604420-00004; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sheard PW, 2002, INT J DEV BIOL, V46, P569; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; SLATER CR, 1985, J PHYSIOL-PARIS, V80, P238; Sun L, 2010, BIOCHEM BIOPH RES CO, V399, P391, DOI 10.1016/j.bbrc.2010.07.084; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Yang DY, 2012, J NEUROSURG, V116, P1357, DOI 10.3171/2012.2.JNS111360	35	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124624	10.1371/journal.pone.0124624	http://dx.doi.org/10.1371/journal.pone.0124624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945496	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700047
J	Corona-Santiago, DK; Doadrio, I; Dominguez-Dominguez, O				Corona-Santiago, Diushi Keri; Doadrio, Ignacio; Dominguez-Dominguez, Omar			Evolutionary History of the Live-Bearing Endemic Allotoca diazi Species Complex (Actinopterygii, Goodeinae): Evidence of Founder Effect Events in the Mexican Pre-Hispanic Period	PLOS ONE			English	Article							LAKE PATZCUARO BASIN; GREAT-TAILED GRACKLE; FRESH-WATER FISHES; POPULATION-STRUCTURE; MAXIMUM-LIKELIHOOD; GENETIC-STRUCTURE; MICHOACAN; MUTATION; CLIMATE; PHYLOGEOGRAPHY	The evolutionary history of Mexican ichthyofauna has been strongly linked to natural events, and the impact of pre-Hispanic cultures is little known. The live-bearing fish species Allotoca diazi, Allotoca meeki and Allotoca catarinae occur in areas of biological, cultural and economic importance in central Mexico: Patzcuaro basin, Zirahuen basin, and the Cupatitzio River, respectively. The species are closely related genetically and morphologically, and hypotheses have attempted to explain their systematics and biogeography. Mitochondrial DNA and microsatellite markers were used to investigate the evolutionary history of the complex. The species complex shows minimal genetic differentiation. The separation of A. diazi and A. meeki was dated to 400-7000 years ago, explained by geological and climate events. A bottleneck and reduction of genetic diversity in Allotoca diazi was detected, attributed to recent climate fluctuations and anthropogenic activity. The isolation of A. catarinae occurred similar to 1900 years ago. No geological events are documented in the area during this period, but the date is contemporary with P'urhepecha culture settlements. This founder effect represents the first evidence of fish species translocation by a pre-Hispanic culture of Mexico. The response of the complex to climate fluctuation, geological changes and human activity in the past and the future according to the ecological niches predictions indicates areas of vulnerability and important information for conservation. The new genetic information showed that the Allotoca diazi complex consist of two genetic groups with an incomplete lineage sorting pattern: Patzcuaro and Zirahuen lakes, and an introduced population in the Cupatitzio River.	[Corona-Santiago, Diushi Keri] Univ Michoacana, Fac Biol, Programa Inst Maestria Ciencias Biol, Morelia, Michoacan, Mexico; [Corona-Santiago, Diushi Keri; Dominguez-Dominguez, Omar] Univ Michoacana, Fac Biol, Lab Biol Acuat, Morelia, Michoacan, Mexico; [Doadrio, Ignacio] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad Biol & Evolut, E-28006 Madrid, Spain	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Corona-Santiago, DK (corresponding author), Univ Michoacana, Fac Biol, Programa Inst Maestria Ciencias Biol, Morelia, Michoacan, Mexico.	diushi.keri.c@gmail.com	Doadrio, Ignacio/F-8448-2016	Doadrio, Ignacio/0000-0003-4863-9711	CONACyT [313653]; Programa Integral de Fortalecimiento Institucional (PIFI-UMSNH); Chester Zoo Garden, Fish Aqualab Conservation Project; Programa de Mejoramiento del Profesorado grant	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa Integral de Fortalecimiento Institucional (PIFI-UMSNH); Chester Zoo Garden, Fish Aqualab Conservation Project; Programa de Mejoramiento del Profesorado grant	ODD is grateful to Chester Zoo Garden, Fish Aqualab Conservation Project and to the Programa de Mejoramiento del Profesorado grant 2009 for its financial support. DKCS is grateful to CONACyT for a Master of Sciences scholarship ( No. 313653) and to the Programa Integral de Fortalecimiento Institucional (PIFI-UMSNH 2010-2011) for the grant provided for this project.	alvarez Del Villar V. J., 1972, ANALES ESCUELA NACL, V19, P155; ALVAREZ J., 1959, CIENCIA [MEXICO], V19, P13; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bloom DD, 2009, COPEIA, P408, DOI 10.1643/CI-07-151; Boto L, 2003, MOL ECOL NOTES, V3, P70, DOI 10.1046/j.1471-8286.2003.00353.x; Bradbury JP, 2000, PALAEOGEOGR PALAEOCL, V163, P69; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Bravo- Espinosa M., 2009, INVESTIGACIONES GEOG, V68, P73; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Buen F. de, 1943, Revista de la Sociedad Mexicana de Historia Natural, V4, P211; Christensen AF, 2000, GLOBAL ECOL BIOGEOGR, V9, P415, DOI 10.1046/j.1365-2699.2000.00190.x; Cornuet JM, 1996, GENETICS, V144, P2001; Corona-Santiago DK, 2013, CONTRIBUTIONS BIOL C, P681; Cutter AD, 2005, WORMBOOK ONLINE REV; Daneels A., 2012, OXFORD HDB MESOAMERI, DOI [10.1093/oxfordhb/9780195390933.013.0025, DOI 10.1093/OXFORDHB/9780195390933.013.0025]; De Alcala FJ, 2000, FONDO, V1540, P88; De Buen F, 1942, ANALES I BIOL, V13, P342, DOI [10.1039/b902763g, DOI 10.1039/B902763G]; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Doadrio I, 2004, MOL PHYLOGENET EVOL, V31, P416, DOI 10.1016/j.ympev.2003.08.022; Doadrio I, 1996, ENVIRON BIOL FISH, V45, P259, DOI 10.1007/BF00003094; Domingues VS, 2006, MOL PHYLOGENET EVOL, V40, P139, DOI 10.1016/j.ympev.2006.02.009; Dominguez-Dominguez O, 2010, VIVIPAROUS FISHES, P13; Dominguez-Dominguez O, 2008, THESIS UNAM MEXICO; Dominguez-Dominguez O, 2006, J BIOGEOGR, V33, P1437, DOI 10.1111/j.1365-2699.2006.01526.x; Dominguez-Dominguez O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-161; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fisher CT, 2005, AM ANTHROPOL, V107, P87, DOI 10.1525/aa.2005.107.1.087; Fisher CT, 2003, P NATL ACAD SCI USA, V100, P4957, DOI 10.1073/pnas.0630493100; Fu YX, 1997, GENETICS, V147, P915; Fujino J., 2006, ENERGY J; Goggin JM, 1943, AM ANTIQUITY, V9, P44, DOI 10.2307/275451; Gomez-Tuena A, 2005, BOL SOC GEOL MEX, V57, P227, DOI [10.18268/BSGM2005v57n3a2, DOI 10.18268/BSGM2005V57N3A2]; Guzman A. F., 2001, ARCHAEOFAUNA, V10, P149; Haasl RJ, 2010, MOL BIOL EVOL, V27, P2702, DOI 10.1093/molbev/msq164; Haemig Paul D., 2014, NeoBiota, V22, P59; Hamill RM, 2007, J FISH BIOL, V70, P16, DOI 10.1111/j.1095-8649.2006.01288.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hieronimus H, 1995, POECILIA NIEUWS, V2, P22; Hubbs CL, 1939, STUDIES FISHERS ORDE; Hubbs CL, 1932, STUDIES FISHES ORDER, P1; Hubbs CL, 1926, STUDIES FISHES ORDER, VVI, P3; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUDSON RR, 1987, GENETICS, V116, P153; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Garduno-Monroy VH, 2011, GEOFIS INT, V50, P147; Garduno-Monroy VH, 2009, REV MEX CIENC GEOL, V26, P623; Israde Alcántara Isabel, 2002, Hidrobiológica, V12, P61; Israde-Alcantara I, 2005, QUATERN INT, V135, P35, DOI 10.1016/j.quaint.2004.10.022; Israde-Alcantara I, 1999, PALAEOGEOGR PALAEOCL, V151, P209, DOI 10.1016/S0031-0182(99)00024-3; Israde-Alcantara I., 2008, ESTRATIGRAFIA ENCUAD; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Ramos E., 1981, REV MEX CIENC GEOL, V5, P158; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lyons J, 1998, FISHERIES, V23, P10, DOI 10.1577/1548-8446(1998)023<0010:DOFFAF>2.0.CO;2; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Meek S. E., 1902, Field Museum Zool, Viii, P63; Meyer MK, 2001, ANN NATURHISTORISC B, V103 B, P453; Morelli S, 2010, J VOLCANOL GEOTH RES, V193, P93, DOI 10.1016/j.jvolgeores.2010.03.008; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Near TJ, 2004, EVOLUTION, V58, P2798; NORRIS S. M., 2005, FRESHWATER FISHES ME; OHARA SL, 1993, GEOGR J, V159, P51, DOI 10.2307/3451489; OHara SL, 1995, HOLOCENE, V5, P485, DOI 10.1177/095968369500500412; OHARA SL, 1994, CHEMOSPHERE, V29, P965, DOI 10.1016/0045-6535(94)90163-5; Ortega B, 2010, J PALEOLIMNOL, V44, P745, DOI 10.1007/s10933-010-9449-x; Ownby S, 2007, J VOLCANOL GEOTH RES, V161, P1, DOI 10.1016/j.jvolgeores.2006.10.009; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Peer BD, 2011, ARDEOLA, V58, P405, DOI 10.13157/arla.58.2.2011.405; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Perez-Rodriguez R, 2009, REV MEX BIODIVERS, V80, P483; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; POSADA D, 2003, PHYLOGENETIC HDB PRA, P256; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 5; Ramirez-Herrejon JP, 2014, LAT AM J AQUAT RES, V42, P137, DOI 10.3856/vol42-issue1-fulltext-11; Regan C.T., 1906, pUnpaginated; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ritchie MG, 2007, J EVOLUTION BIOL, V20, P2048, DOI 10.1111/j.1420-9101.2007.01357.x; Robles-Camacho J, 2010, REV MEX CIENC GEOL, V27, P530; Rosenfeld JA, 2012, MOL PHYLOGENET EVOL, V64, P12, DOI 10.1016/j.ympev.2012.02.029; Roskamp H, 1998, HIST INDIGENA MICHOA; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seyfert AL, 2008, GENETICS, V178, P2113, DOI 10.1534/genetics.107.081927; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STREETPERROTT FA, 1989, AM ANTIQUITY, V54, P759, DOI 10.2307/280680; TAJIMA F, 1989, GENETICS, V123, P585; Tamayo LT, 1964, HDB MIDDLE AM INDIAN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tella JL, 2011, ARDEOLA, V58, P399, DOI 10.13157/arla.58.2.2011.399; Vázquez Gabriel, 2010, Bol. Soc. Geol. Mex, V62, P325; Villasenor-Gomez LE, 2005, BIODIVERSIDAD MICHOA; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weigand PC, 1996, CUENCAS OCCIDENTE ME, P456; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Yue GH, 2007, GENETICA, V129, P329, DOI 10.1007/s10709-006-0003-8; Zambrano L, 2011, ESTUDIO ECOSISTEMICO, P133; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545	115	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124138	10.1371/journal.pone.0124138	http://dx.doi.org/10.1371/journal.pone.0124138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946217	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700033
J	Glenthoj, A; Nickles, K; Cowland, J; Borregaard, N				Glenthoj, Andreas; Nickles, Katrin; Cowland, Jack; Borregaard, Niels			Processing of Neutrophil alpha-Defensins Does Not Rely on Serine Proteases In Vivo	PLOS ONE			English	Article							PAPILLON-LEFEVRE-SYNDROME; CATHEPSIN-C; ELASTASE; GRANULES; ACTIVATION; LOCALIZATION; SERGLYCIN; PROTEINS; SIVELESTAT; MUTATIONS	The alpha-defensins, human neutrophil peptides (HNPs) are the predominant antimicrobial peptides of neutrophil granules. They are synthesized in promyelocytes and myelocytes as proHNPs, but only processed in promyelocytes and stored as mature HNPs in azurophil granules. Despite decades of search, the mechanisms underlying the posttranslational processing of neutrophil defensins remain unidentified. Thus, neither the enzyme that processes proHNPs nor the localization of processing has been identified. It has been hypothesized that proHNPs are processed by the serine proteases highly expressed in promyelocytes: Neutrophil elastase (NE), cathepsin G (CG), and proteinase 3 (PR3), all of which are able to process recombinant proHNP into HNP in vitro. We investigated whether serine proteases are in fact responsible for processing of proHNP in human bone marrow cells and in human and murine myeloid cell lines. Subcellular fractionation of the human promyelocytic cell line PLB-985 demonstrated proHNP processing to commence in fractions containing endoplasmic reticulum. Processing of S-35-proHNP was insensitive to serine protease inhibitors. Simultaneous knockdown of NE, CG, and PR3 did not decrease proHNP processing in primary human bone marrow cells. Furthermore, introduction of NE, CG, and PR3 into murine promyelocytic cells did not enhance the proHNP processing capability. Finally, two patients suffering from Papillon-Lefevre syndrome, who lack active neutrophil serine proteases, demonstrated normal levels of fully processed HNP in peripheral neutrophils. Contradicting earlier assumptions, our study found serine proteases dispensable for processing of proHNPs in vivo. This calls for study of other protease classes in the search for the proHNP processing protease(s).	[Glenthoj, Andreas; Cowland, Jack; Borregaard, Niels] Univ Copenhagen, Rigshosp, Dept Hematol, Granulocyte Res Lab, DK-1168 Copenhagen, Denmark; [Nickles, Katrin] Goethe Univ Frankfurt, Zentrum Zahn Mund & Kieferheilkunde Carolinum, Poliklin Parodontol, D-60054 Frankfurt, Germany	Rigshospitalet; University of Copenhagen; Goethe University Frankfurt	Glenthoj, A (corresponding author), Univ Copenhagen, Rigshosp, Dept Hematol, Granulocyte Res Lab, DK-1168 Copenhagen, Denmark.	angl@rh.dk	Glenthøj, Andreas/ABD-5948-2021	Glenthøj, Andreas/0000-0003-2082-0738; Cowland, Jack Bernard/0000-0002-7429-5388	Danish Medical Research Council; National University Hospital	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National University Hospital	This work was supported by grants from The Danish Medical Research Council (NB) and The National University Hospital (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Arnljots K, 1998, LEUKEMIA, V12, P1789, DOI 10.1038/sj.leu.2401202; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; CAPUTO A, 1993, J BIOL CHEM, V268, P17672; CARMASSI F, 1994, INT J TISSUE REACT, V16, P89; de Haar Susanne F, 2004, Hum Mutat, V23, P524, DOI 10.1002/humu.9243; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Dunlevy FK, 2012, J CYST FIBROS, V11, P300, DOI 10.1016/j.jcf.2012.02.003; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Emmertsen F, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.11; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Faurschou M, 2005, J LEUKOCYTE BIOL, V78, P785, DOI 10.1189/jlb.1104688; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; Gaines Peter, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22f05s67; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1993, BLOOD, V82, P641; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Glenthoj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092471; Glenthoj A, 2013, EUR J CLIN INVEST, V43, P836, DOI 10.1111/eci.12114; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Hayakawa M, 2010, SHOCK, V33, P14, DOI 10.1097/SHK.0b013e3181aa95c4; Henriksen PA, 2014, CURR OPIN HEMATOL, V21, P23, DOI 10.1097/MOH.0000000000000001; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; JENNE DE, 1988, IMMUNOL REV, V103, P53, DOI 10.1111/j.1600-065X.1988.tb00749.x; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Kohira S, 2013, ARTIF ORGANS, V37, P1027, DOI 10.1111/aor.12103; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Mastroianni JR, 2012, J BIOL CHEM, V287, P11205, DOI 10.1074/jbc.M111.333559; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; Noack B, 2004, J DENT RES, V83, P368, DOI 10.1177/154405910408300503; Noack B, 2008, J CLIN PERIODONTOL, V35, P311, DOI 10.1111/j.1600-051X.2008.01201.x; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; RICE WG, 1987, BLOOD, V70, P757; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Rorvig S, 2009, J LEUKOCYTE BIOL, V86, P1439, DOI 10.1189/jlb.1008606; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Stockley R, 2013, RESP MED, V107, P524, DOI 10.1016/j.rmed.2012.12.009; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Tongaonkar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032469; VALORE EV, 1992, BLOOD, V79, P1538; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yap VL, 2015, CURR OPIN INFECT DIS, V28, P171, DOI 10.1097/QCO.0000000000000147	53	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125483	10.1371/journal.pone.0125483	http://dx.doi.org/10.1371/journal.pone.0125483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945506	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700071
J	Nishitani, WS; Alencar, AM; Wang, YX				Nishitani, Wagner Shin; Alencar, Adriano Mesquita; Wang, Yingxiao			Rapid and Localized Mechanical Stimulation and Adhesion Assay: TRPM7 Involvement in Calcium Signaling and Cell Adhesion	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; MECHANOSENSITIVE CHANNELS; FLUORESCENT INDICATORS; PLASMA-MEMBRANE; STRETCH; MECHANOTRANSDUCTION; GRADIENTS; STRESS; FORCE; SHEAR	A cell mechanical stimulation equipment, based on cell substrate deformation, and a more sensitive method for measuring adhesion of cells were developed. A probe, precisely positioned close to the cell, was capable of a vertical localized mechanical stimulation with a temporal frequency of 207 Hz, and strain magnitude of 50%. This setup was characterized and used to probe the response of Human Umbilical Endothelial Vein Cells (HUVECs) in terms of calcium signaling. The intracellular calcium ion concentration was measured by the genetically encoded Cameleon biosensor, with the Transient Receptor Potential cation channel, subfamily M, member 7 (TRPM7) expression inhibited. As TRPM7 expression also regulates adhesion, a relatively simple method for measuring adhesion of cells was also developed, tested and used to study the effect of adhesion alone. Three adhesion conditions of HUVECs on polyacrylamide gel dishes were compared. In the first condition, the substrate is fully treated with Sulfo-SANPAH crosslinking and fibronectin. The other two conditions had increasingly reduced adhesion: partially treated (only coated with fibronectin, with no use of Sulfo-SANPAH, at 5% of the normal amount) and non-treated polyacrylamide gels. The cells showed adhesion and calcium response to the mechanical stimulation correlated to the degree of gel treatment: highest for fully treated gels and lowest for non-treated ones. TRPM7 inhibition by siRNA on HUVECs caused an increase in adhesion relative to control (no siRNA treatment) and non-targeting siRNA, but a decrease to 80% of calcium response relative to non-targeting siRNA which confirms the important role of TRPM7 in mechanotransduction despite the increase in adhesion.	[Nishitani, Wagner Shin; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Nishitani, Wagner Shin; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Biophys & Computat Biol, Inst Genom Biol, Urbana, IL 61801 USA; [Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Dept Mech Sci & Engn Integrat & Mol Physiol, Inst Genom Biol, Urbana, IL 61801 USA; [Nishitani, Wagner Shin; Alencar, Adriano Mesquita] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, SP, Brazil; [Wang, Yingxiao] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wang, Yingxiao] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Universidade de Sao Paulo; University of California System; University of California San Diego; University of California System; University of California San Diego	Nishitani, WS (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	wagnersn@if.usp.br; yiw015@eng.ucsd.edu	Alencar, Adriano M/L-5071-2013	Alencar, Adriano M/0000-0001-9324-2698	National Institutes of Health [HL098472, HL109142, GM106403, NS063405]; National Science Foundation [CBET0846429]; Beckman Laser Institute, Inc.; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Fulbright [2340/05-4]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/07907-9]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL109142, R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM106403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Beckman Laser Institute, Inc.; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Fulbright; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants from National Institutes of Health (http://www.nih.gov/) HL098472, HL109142, GM106403, NS063405, The National Science Foundation (http://www.nsf.gov/) CBET0846429, Beckman Laser Institute, Inc. (http://beckman.illinois.edu/) (YW), and fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Fulbright (http://www.capes.gov.br/) 2340/05-4 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://fapesp.br/) 2012/07907-9 (WSN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feneberg W, 2004, BIOPHYS J, V87, P1338, DOI 10.1529/biophysj.103.037044; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hong D, 2006, AM J PHYSIOL-HEART C, V290, pH2498, DOI 10.1152/ajpheart.00828.2005; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Marini JJ, 2003, CRIT CARE, V7, P435, DOI 10.1186/cc2392; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Sung HJ, 2007, AM J PHYSIOL-CELL PH, V293, pC87, DOI 10.1152/ajpcell.00585.2006; Tang X, 2010, BIOPHYS J, V99, P2460, DOI 10.1016/j.bpj.2010.08.034; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; Visser D, 2013, CELL CALCIUM, V54, P404, DOI 10.1016/j.ceca.2013.09.003; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; White CR, 2005, AM J PHYSIOL-HEART C, V289, pH2350, DOI 10.1152/ajpheart.01229.2004; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053	36	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126440	10.1371/journal.pone.0126440	http://dx.doi.org/10.1371/journal.pone.0126440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946314	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700130
J	Wojta-Stremayr, D; Neunkirchner, A; Srinivasan, B; Trapin, D; Schmetterer, KG; Pickl, WF				Wojta-Stremayr, Daniela; Neunkirchner, Alina; Srinivasan, Bharani; Trapin, Doris; Schmetterer, Klaus G.; Pickl, Winfried F.			CD8(+) T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2	PLOS ONE			English	Article							LIPID RAFTS; RECEPTOR; EFFECTOR; LYMPHOCYTES; ACTIVATION; GAMMA; TOLERANCE; SUBSETS; SIGNAL; GENE	A variety of adjuvants fostering humoral immunity are known as of today. However, there is a lack of adjuvants or adjuvant strategies, which directly target T cellular effector functions and memory. We here determined whether systemically toxic cytokines such as IL-2 can be restricted to the site of antigen presentation and used as 'natural adjuvants'. Therefore, we devised antigen-presenting virus-like nanoparticles (VNP) co-expressing IL-2 attached to different membrane-anchors and assessed their potency to modulate CD8(+) T cell responses in vitro and in vivo. Efficient targeting of IL-2 to lipid rafts and ultimately VNP was achieved by fusing IL-2 at its C-terminus to a minimal glycosylphosphatidylinositol (GPI)-anchor acceptor sequence. To identify optimal membrane-anchor dimensions we inserted one (1Ig), two (2Ig) or four (4Ig) immunoglobulin(Ig)-like domains of CD16b between IL-2 and the minimal GPI-anchor acceptor sequence of CD16b (GPI). We found that the 2IgGPI version was superior to all other evaluated IL-2 variants (IL-2v) in terms of its i) degree of targeting to lipid rafts and to the VNP surface, ii) biological activity, iii) co-stimulation of cognate T cells in the absence of bystander activation and iv) potency to induce differentiation and acquisition of CD8(+) T cell effector functions in vitro and in vivo. In contrast, the GPI version rather favored memory precursor cell formation. These results exemplify novel beneficial features of membrane-bound IL-2, which in addition to its mere T cell stimulatory capacity include the induction of differential effector and memory functions in CD8(+) T lymphocytes.	[Wojta-Stremayr, Daniela; Neunkirchner, Alina; Srinivasan, Bharani; Trapin, Doris; Schmetterer, Klaus G.; Pickl, Winfried F.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Wojta-Stremayr, Daniela; Neunkirchner, Alina; Pickl, Winfried F.] Christian Doppler Lab Immunomodulat, Vienna, Austria	Medical University of Vienna	Pickl, WF (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria.	winfried.pickl@meduniwien.ac.at	Srinivasan, Bharani/O-5593-2019; Srinivasan, Bharani/N-5689-2019	Srinivasan, Bharani/0000-0002-8260-4603; Pickl, Winfried F./0000-0003-0430-4952	Christian Doppler Society; Austrian Science Fund (FWF) [SFB 4609-B19]; Biomay AG	Christian Doppler Society; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biomay AG	The research was funded by the Christian Doppler Society, the Austrian Science Fund (FWF): SFB 4609-B19 & Biomay AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Atkins MB, 1997, CLIN CANCER RES, V3, P409; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boulet S, 2014, J IMMUNOL, V193, P1847, DOI 10.4049/jimmunol.1302365; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; DEPPER JM, 1984, J IMMUNOL, V133, P3054; Derdak SV, 2006, P NATL ACAD SCI USA, V103, P13144, DOI 10.1073/pnas.0602283103; Feau S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1948; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; FOXWELL BMJ, 1992, INT IMMUNOL, V4, P277, DOI 10.1093/intimm/4.2.277; Hammerbeck CD, 2008, J IMMUNOL, V180, P2107, DOI 10.4049/jimmunol.180.4.2107; HIBBS ML, 1994, J IMMUNOL, V152, P4466; HORAK I, 1995, CLIN IMMUNOL IMMUNOP, V76, pS172, DOI 10.1016/S0090-1229(95)90126-4; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kamimura D, 2007, J EXP MED, V204, P1803, DOI 10.1084/jem.20070543; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; KRAMER S, 1994, EUR J IMMUNOL, V24, P2317, DOI 10.1002/eji.1830241009; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kueng HJ, 2007, J VIROL, V81, P8666, DOI 10.1128/JVI.00682-07; Kueng HJ, 2011, INT ARCH ALLERGY IMM, V154, P89, DOI 10.1159/000320224; Kueng HJ, 2010, FASEB J, V24, P1572, DOI 10.1096/fj.09-137281; Leb VM, 2009, J ALLERGY CLIN IMMUN, V124, P121, DOI 10.1016/j.jaci.2009.04.008; Letvin NL, 1998, SCIENCE, V280, P1875, DOI 10.1126/science.280.5371.1875; LOLLINI PL, 1995, INT J CANCER, V61, P425, DOI 10.1002/ijc.2910610325; Mach N, 2000, CURR OPIN IMMUNOL, V12, P571, DOI 10.1016/S0952-7915(00)00144-8; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; MEUER SC, 1989, LANCET, V1, P15; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; OGNIBENE FP, 1988, CHEST, V94, P750, DOI 10.1378/chest.94.4.750; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PALIARD X, 1988, J IMMUNOL, V141, P849; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RISSO A, 1989, EUR J IMMUNOL, V19, P323, DOI 10.1002/eji.1830190216; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samlowski WE, 2011, J IMMUNOTHER, V34, P419, DOI 10.1097/CJI.0b013e31821dcb50; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SIMMONS D, 1988, NATURE, V333, P568, DOI 10.1038/333568a0; TABI Z, 1988, CELL IMMUNOL, V113, P268, DOI 10.1016/0008-8749(88)90026-3; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WALUNAS TL, 1995, J IMMUNOL, V155, P1873; WANG A, 1984, SCIENCE, V224, P1431, DOI 10.1126/science.6427925; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wojta-Stremayr D, 2013, SENSORS-BASEL, V13, P8722, DOI 10.3390/s130708722; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126034	10.1371/journal.pone.0126034	http://dx.doi.org/10.1371/journal.pone.0126034			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946103	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700102
J	Dinh, TH; Delaney, KP; Goga, A; Jackson, D; Lombard, C; Woldesenbet, S; Mogashoa, M; Pillay, Y; Shaffer, N				Dinh, Thu-Ha; Delaney, Kevin P.; Goga, Ameena; Jackson, Debra; Lombard, Carl; Woldesenbet, Selamawit; Mogashoa, Mary; Pillay, Yogan; Shaffer, Nathan			Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation	PLOS ONE			English	Article							INCIDENT HIV; INFECTION; VIRUS; PREVENTION; THERAPY; UGANDA; RAKAI; WOMEN; TRIAL	Background Mother-to-child transmission of HIV (MTCT) depends on the timing of HIV infection. We estimated HIV-seroconversion during pregnancy (HSP) after having a HIV-negative result antenatally, and its contribution to early MTCT in South Africa (SA). Methods and Findings Between August 2011 and March 2012, we recruited a nationally representative sample of mother-infant pairs with infants aged 4-to-8 weeks from 578 health facilities. Data collection included mother interviews, child health-card reviews, and infant dried-blood-spots sample (iDBS). iDBS were tested for HIV antibodies and HIV-deoxyribonucleic-acid (HIV-DNA). HSP was defined as maternal self-report of an HIV-negative test during this pregnancy, no documented use of antiretroviral drugs and a matched HIV sero-positive iDBS. We used 20 imputations from a uniform distribution for time from reported antenatal HIV-negative result to delivery to estimate time of HSP. Early MTCT was defined based on detection of HIV-DNA in iDBS. Estimates were adjusted for clustering, nonresponse, and weighted by SA's 2011 live-births. Results Of 9802 mother-infant pairs, 2738 iDBS were HIV sero-positive, including 212 HSP, resulting in a nationally weighted estimate of 3.3% HSP (95% Confidence Interval: 2.8%-3.8%). Median time of HIV-seroconversion was 32.8weeks gestation; 28.3% (19.7%-36.9%) estimated to be >36 weeks. Early MTCT was 10.7% for HSP (6.2%-16.8%) vs. 2.2% (1.7%2.8%) for mothers with known HIV-positive status. Although they represent 2.2% of all mothers and 6.7% of HIV-infected mothers, HSP accounted for 26% of early MTCT. Multivariable analysis indicated the highest risk for HSP was among women who knew the baby's father was HIV-infected (adjusted-hazard ratio (aHR) 4.71; 1.49-14.99), or who had been screened for tuberculosis (aHR 1.82; 1.43-2.32). Conclusions HSP risk is high and contributes significantly to early MTCT. Identification of HSP by repeat-testing at 32 weeks gestation, during labor, 6 weeks postpartum, in tuberculosis-exposed women, and in discordant couples might reduce MTCT.	[Dinh, Thu-Ha] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Delaney, Kevin P.] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Goga, Ameena] MRC, Pretoria, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat & Child Hlth, Kalafong Hosp, ZA-0002 Pretoria, South Africa; [Jackson, Debra] MRC, Cape Town, South Africa; [Lombard, Carl; Woldesenbet, Selamawit] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Mogashoa, Mary] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Pretoria, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Shaffer, Nathan] WHO, CH-1211 Geneva, Switzerland; [Jackson, Debra] United Nations Childrens Fund, New York, NY USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Pretoria; University of the Western Cape; World Health Organization; UNICEF	Dinh, TH (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA 30333 USA.	dvt1@cdc.gov	Delaney, Kevin/HHS-1060-2022	Lombard, Carl/0000-0002-2136-6533; Jackson, Debra/0000-0003-3307-632X	Centers for Disease Control and Prevention (CDC) [1U2GPS001137-02, 1U2GPS001137-03]; MRC [1U2GPS001137-02, 1U2GPS001137-03]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This evaluation was primarily supported by the President's Emergency Plan for AIDS Relief (PEPFAR) under a Cooperative Agreement between Centers for Disease Control and Prevention (CDC) and MRC (1U2GPS001137-02 and 1U2GPS001137-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, STAT S AFR REP; [Anonymous], 2001, ROAD HLTH CHART GUID; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; CLARK SJ, 1991, NEW ENGL J MED, V324, P954, DOI 10.1056/NEJM199104043241404; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Herringa SG WB, 2010, BERGLUND PA APPL SUR; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kinuthia J, 2010, CURR HIV RES, V8, P510, DOI 10.2174/157016210793499213; Lehtonen R., 2004, PRACTICAL METHODS DE, V2; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; *NAT DEP HLTH S AF, 2010, CLIN GUID PMTCT PREV; National Department of Health of South Africa, 2013, DISTR HLTH BARR 2012; National Department of Health of South Africa, 2011, PROGR HIV INC EST ME, V1; PAREKH BS, 1993, AIDS RES HUM RETROV, V9, P907, DOI 10.1089/aid.1993.9.907; PIZZO PA, 1991, NEW ENGL J MED, V325, P652, DOI 10.1056/NEJM199108293250909; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P221; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; SCHMID BC, 1991, AM J PUBLIC HEALTH, V81, P805, DOI 10.2105/AJPH.81.6.805; SCHUPBACH J, 1989, AIDS, V3, P583, DOI 10.1097/00002030-198909000-00005; Shaffer N, 1999, J INFECT DIS, V179, P590, DOI 10.1086/314641; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51	30	66	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125525	10.1371/journal.pone.0125525	http://dx.doi.org/10.1371/journal.pone.0125525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942423	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400041
J	Mcgowan, I; Cranston, RD; Duffill, K; Siegel, A; Engstrom, JC; Nikiforov, A; Jacobson, C; Rehman, KK; Elliott, J; Khanukhova, E; Abebe, K; Mauck, C; Spiegel, HML; Dezzutti, CS; Rohan, LC; Marzinke, MA; Hiruy, H; Hendrix, CW; Richardson-Harman, N; Anton, PA				Mcgowan, Ian; Cranston, Ross D.; Duffill, Kathryn; Siegel, Aaron; Engstrom, Jarret C.; Nikiforov, Alexyi; Jacobson, Cindy; Rehman, Khaja K.; Elliott, Julie; Khanukhova, Elena; Abebe, Kaleab; Mauck, Christine; Spiegel, Hans M. L.; Dezzutti, Charlene S.; Rohan, Lisa C.; Marzinke, Mark A.; Hiruy, Hiwot; Hendrix, Craig W.; Richardson-Harman, Nicola; Anton, Peter A.			A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; ORAL TENOFOVIR; HIV-INFECTION; TISSUE; INFLAMMATION	Objectives The CHARM-01 study characterized the safety, acceptability, pharmacokinetics (PK), and pharmacodynamics (PD) of three tenofovir (TFV) gels for rectal application. The vaginal formulation (VF) gel was previously used in the CAPRISA 004 and VOICE vaginal microbicide Phase 2B trials and the RMP-02/MTN-006 Phase 1 rectal safety study. The reduced glycerin VF (RGVF) gel was used in the MTN-007 Phase 1 rectal microbicide trial and is currently being evaluated in the MTN-017 Phase 2 rectal microbicide trial. A third rectal specific formulation (RF) gel was also evaluated in the CHARM-01 study. Methods Participants received 4 mL of the three TFV gels in a blinded, crossover design: seven daily doses of RGVF, seven daily doses of RF, and six daily doses of placebo followed by one dose of VF, in a randomized sequence. Safety, acceptability, compartmental PK, and explant PD were monitored throughout the trial. Results All three gels were found to be safe and acceptable. RF and RGVF PK were not significantly different. Median mucosal mononuclear cell (MMC) TFV-DP trended toward higher values for RF compared to RGVF (1136 and 320 fmol/10(6) cells respectively). Use of each gel in vivo was associated with significant inhibition of ex vivo colorectal tissue HIV infection. There was also a significant negative correlation between the tissue levels of TFV, tissue TFV-DP, MMC TFV-DP, rectal fluid TFV, and explant HIV-1 infection. Conclusions All three formulations were found to be safe and acceptable. However, the safety profile of the VF gel was only based on exposure to one dose whereas participants received seven doses of the RGVF and RF gels. There was a trend towards higher tissue MMC levels of TFV-DP associated with use of the RF gel. Use of all gels was associated with significant inhibition of ex vivo tissue HIV infection.	[Mcgowan, Ian; Cranston, Ross D.; Abebe, Kaleab; Dezzutti, Charlene S.; Rohan, Lisa C.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Mcgowan, Ian; Duffill, Kathryn; Siegel, Aaron; Engstrom, Jarret C.; Nikiforov, Alexyi; Jacobson, Cindy; Rehman, Khaja K.; Dezzutti, Charlene S.; Rohan, Lisa C.] Magee Womens Res Inst, Pittsburgh, PA USA; [Elliott, Julie; Khanukhova, Elena; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mauck, Christine] CONRAD, Arlington, VA USA; [Spiegel, Hans M. L.] NIAID, HJF DAIDS, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Marzinke, Mark A.; Hiruy, Hiwot; Hendrix, Craig W.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Richardson-Harman, Nicola] Alpha StatConsult LLC, Damascus, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University	Mcgowan, I (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	imcgowan@pitt.edu	M, i/HCI-9242-2022; Hendrix, Craig W/G-4182-2014; Spiegel, Hans/AAC-4220-2020; Abebe, Kaleab/K-4400-2019; M, Ian/AAP-1032-2021	Hendrix, Craig W/0000-0002-5696-8665; Abebe, Kaleab/0000-0002-3644-8419; M, Ian/0000-0002-6470-8476; Cranston, Ross/0000-0002-2687-6217; Dezzutti, Charlene/0000-0001-5902-5841	U19 grant under the Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [AI082637]; NIH/NIAID/DAIDS [HHSN272201000001C]; Alpha StatConsult, LLC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, U19AI082637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066691] Funding Source: NIH RePORTER	U19 grant under the Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); NIH/NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alpha StatConsult, LLC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by a U19 grant under the Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) (AI082637). The CHARM-01 study was registered at http://www.ClinicalTrials.gov (NCT01575405). The PK/PD analysis of CHARM-01 data was supported through a NIH/NIAID/DAIDS contract (HHSN272201000001C) to Advanced BioScience Laboratories, Inc., Rockville, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Nicola Richardson-Harman is employed by Alpha StatConsult, LLC. Alpha StatConsult, LLC provided support in the form of salary for author NR-H, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The coauthor NR-H, as a statistical consultant, analyzed data and contributed to the statistical sections of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Dezzutti CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102585; Dezzutti CS, 2013, CURR HIV-AIDS REP, V10, P12, DOI 10.1007/s11904-012-0148-2; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Doleans-Jordheim A, 2011, EUR J CLIN MICROBIOL, V30, P1249, DOI 10.1007/s10096-011-1220-3; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McGowan I, 2013, CURR TOP MICROBIOL I; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Nuttall J, 2012, ANTIMICROB AGENTS CH, V56, P103, DOI 10.1128/AAC.00597-11; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Richardson-Harman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111507; Richardson-Harman N, 2012, AIDS RES HUM RETROV, V28, P1422, DOI [10.1089/aid.2012.0073, 10.1089/AID.2012.0073]; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Schwartz JL, 2007, CONTRACEPTION, V75, P136, DOI 10.1016/j.contraception.2006.09.003; Severy LJ, 2005, J SOC ISSUES, V61, P45, DOI 10.1111/j.0022-4537.2005.00393.x; Stoner KA, 2008, J CLIN MICROBIOL, V46, P2739, DOI 10.1128/JCM.00161-08; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2013, AIDS BEHAV, V17, P640, DOI 10.1007/s10461-012-0330-y	32	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125363	10.1371/journal.pone.0125363	http://dx.doi.org/10.1371/journal.pone.0125363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942472	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000353943400032
J	Meng, FR; Joshi, B; Nabi, IR				Meng, Fanrui; Joshi, Bharat; Nabi, Ivan Robert			Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration	PLOS ONE			English	Article							FOCAL ADHESION DYNAMICS; INTEGRIN-MEDIATED ADHESION; TRANSCRIPT RELEASE FACTOR; PHOSPHORYLATED CAVEOLIN-1; EXPRESSION; INHIBITION; KINASE; CAVIN; TRANSFORMATION; METASTASIS	Expression of Caveolin-1 (Cav1), a key component of cell surface caveolae, is elevated in prostate cancer (PCa) and associated with PCa metastasis and a poor prognosis for PCa patients. Polymerase I and Transcript Release Factor (PTRF)/cavin-1 is a cytoplasmic protein required for Cav1-dependent formation of caveolae. Expression of PTRF reduces the motility of PC3 cells, a metastatic prostate cancer cell line that endogenously expresses abundant Cav1 but no PTRF and no caveolae, suggesting a role for non-caveolar Cav1 domains, or Cav1 scaffolds, in PCa cell migration. Tyrosine phosphorylated Cav1 (pCav1) functions in concert with Galectin-3 (Gal3) and the galectin lattice to stabilize focal adhesion kinase (FAK) within focal adhesions (FAs) and promote cancer cell motility. However, whether PTRF regulation of Cav1 function in PCa cell migration is related to Gal3 expression and functionality has yet to be determined. Here we show that PTRF expression in PC3 cells reduces FAK stabilization in focal adhesions and reduces cell motility without affecting pCav1 levels. Exogenous Gal3 stabilized FAK in focal adhesions of PTRF-expressing cells and restored cell motility of PTRF-expressing PC3 cells to levels of PC3 cells in a dose-dependent manner, with an optimal concentration of 2 mu g/ml. Exogenous Gal3 stabilized FAK in focal adhesions of Gal3 knockdown PC3 cells but not in Cav1 knockdown PC3 cells. Cav1 knockdown also prevented Gal3 rescue of FA-associated FAK stabilization in PTRF-expressing PC3 cells. Our data support a role for PTRF/cavin-1, through caveolae formation, as an attenuator of the non-caveolar functionality of Cav1 in Gal3-Cav1 signalling and regulation of focal adhesion dynamics and cancer cell migration.	[Meng, Fanrui; Joshi, Bharat; Nabi, Ivan Robert] Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada		Nabi, IR (corresponding author), Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@mail.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513	Prostate Cancer Canada; Canadian Institutes for Health Research [MOP-126029]; China Scholarship Council-UBC doctoral scholarship	Prostate Cancer Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); China Scholarship Council-UBC doctoral scholarship	This work was supported by Prostate Cancer Canada, Canadian Institutes for Health Research (MOP-126029), China Scholarship Council-UBC doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Glinskii OV, 2012, NEOPLASIA, V14, P65, DOI 10.1593/neo.111544; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gould ML, 2010, PROSTATE, V70, P1609, DOI 10.1002/pros.21195; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Granovsky M, 2000, NAT MED, V6, P306; Guha P, 2013, P NATL ACAD SCI USA, V110, P5052, DOI 10.1073/pnas.1202653110; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2009, J CELL MOL MED, V13, P3218, DOI 10.1111/j.1582-4934.2009.00732.x; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li LK, 2001, CANCER RES, V61, P4386; Li SW, 1996, J BIOL CHEM, V271, P3863; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Moon H, 2014, ONCOGENE, V33, P3561, DOI 10.1038/onc.2013.315; Nassar ZD, 2013, ONCOTARGET, V4, P1844, DOI 10.18632/oncotarget.1300; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Shankar J, 2012, J PATHOL, V228, P56, DOI 10.1002/path.4041; Wallner M, 2004, METHODS, V32, P219, DOI 10.1016/j.ymeth.2003.08.004; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.277; Wang Y, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.79; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yang G, 1999, CANCER RES, V59, P5719; Yang G, 1998, CLIN CANCER RES, V4, P1873; Zheng YZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007146	54	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126056	10.1371/journal.pone.0126056	http://dx.doi.org/10.1371/journal.pone.0126056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942420	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400059
J	Talactac, MR; Chowdhury, MYE; Park, ME; Weeratunga, P; Kim, TH; Cho, WK; Kim, CJ; Ma, JY; Lee, JS				Talactac, Melbourne R.; Chowdhury, Mohammed Y. E.; Park, Min-Eun; Weeratunga, Prasanna; Kim, Tae-Hwan; Cho, Won-Kyung; Kim, Chul-Joong; Ma, Jin Yeul; Lee, Jong-Soo			Antiviral Effects of Novel Herbal Medicine KIOM-C, on Diverse Viruses	PLOS ONE			English	Article							HETEROLOGOUS STRAINS; IFN-ALPHA/BETA; RIG-I; INTERFERON; INFECTION; MICE; GLYCYRRHIZIN; ACTIVATION; INDUCTION; RECEPTOR	In order to identify new potential antiviral agents, recent studies have advocated thorough testing of herbal medicines or natural substances that are traditionally used to prevent viral infections. Antiviral activities and the mechanism of action of the total aqueous extract preparation of KIOM-C, a novel herbal medicine, against diverse types of viruses were investigated. In vitro antiviral activity against A/Puerto Rico/8/34 (H1N1) (PR8), vesicular stomatitis virus (VSV), and Newcastle disease virus (NDV) through the induction of type-I interferon related protein phosphorylation and up-regulation of pro-inflammatory cytokines in murine macrophage cells (RAW264.7) were determined. In vivo, KIOM-C-treated BALB/c mice showed higher survivability and lower lung viral titers when challenged with A/Aquatic bird/Korea/W81/2005 (H5N2), A/PR/8/34(H1N1), A/Aquatic bird/Korea/W44/2005(H7N3) or A/Chicken/Korea/116/2004(H9N2) influenza subtypes in contrast with the non-treated group. The present study revealed that total aqueous extract preparation of KIOM-C stimulates an antiviral state in murine macrophage cells and in mice leading to inhibition of viral infection and protection against lethal challenges.	[Talactac, Melbourne R.; Chowdhury, Mohammed Y. E.; Park, Min-Eun; Weeratunga, Prasanna; Kim, Tae-Hwan; Kim, Chul-Joong; Lee, Jong-Soo] Chungnam Natl Univ, Coll Vet Med, Taejon, South Korea; [Talactac, Melbourne R.] Cavite State Univ, Coll Vet Med & Biomed Sci, Cavite, Philippines; [Chowdhury, Mohammed Y. E.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Chittagong, Bangladesh; [Cho, Won-Kyung; Ma, Jin Yeul] Korea Inst Oriental Med, Korean Med KM Based Herbal Drug Dev Grp, Taejon, South Korea	Chungnam National University; Cavite State University; Korea Institute of Oriental Medicine (KIOM)	Lee, JS (corresponding author), Korea Inst Oriental Med, Korean Med KM Based Herbal Drug Dev Grp, Taejon, South Korea.	jyma@kiom.re.kr; jongsool@cnu.ac.kr	Weeratunga, Prasanna/GWZ-5169-2022	Weeratunga, Prasanna/0000-0001-6366-7628; Kim, Chul-Joong/0000-0001-8827-6332; Chowdhury, Mohammed/0000-0003-0935-705X; Lee, Jong-Soo/0000-0001-5119-0711; Weeratunga, Prasanna/0000-0002-4258-6025	Ministry of Education, Science and Technology (MEST), Republic of Korea [K12050]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the grant K12050 awarded to the Korea Institute of Oriental Medicine (KIOM) from the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Balasubramanian P., 2010, Journal of Basic and Clinical Pharmacy (JBCP), V1, P37; Calixto JB, 2000, BRAZ J MED BIOL RES, V33, P179, DOI 10.1590/S0100-879X2000000200004; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chung TaeHo, 2012, Journal of Medicinal Plants Research, V6, P4456, DOI 10.5897/JMPR10.691; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Dou J, 2011, ARCH VIROL, V156, P793, DOI 10.1007/s00705-011-0917-z; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Harada S, 2005, BIOCHEM J, V392, P191, DOI 10.1042/BJ20051069; Haruyama T, 2013, J NAT MED-TOKYO, V67, P636, DOI 10.1007/s11418-012-0725-0; He W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-538; Hu G, 2012, J INTEGR AGR, V11, P646, DOI 10.1016/S2095-3119(12)60052-5; Huang H, 2010, PLANTA MED, V76, P76, DOI 10.1055/s-0029-1185943; Hwang SY, 2011, NUCL ACIDS, V40, P2724; Javed T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-26; Karoline D, 2007, ANTIVIR RES, V76, P1, DOI 10.1016/j.antiviral.2007.04.001; Kim A, 2014, ONCOL REP, V31, P287, DOI 10.3892/or.2013.2822; Kim EH, 2013, ANTIVIR RES, V98, P386, DOI 10.1016/j.antiviral.2013.04.006; Kim MC, 2012, IMMUNOPHARM IMMUNOT, V34, P66, DOI 10.3109/08923973.2011.576254; Konopka JL, 2009, J VIROL, V83, P12432, DOI 10.1128/JVI.00564-09; Kurokawa M, 2010, OPEN ANTIMICROBIAL A, V2, P49; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li RM, 2014, J IMMUNOL, V193, P4515, DOI 10.4049/jimmunol.1301930; Magadula J. J., 2010, Tanzania Journal of Health Research, V12, punpaginated; Makau JN, 2013, DRUG DISCOV THER, V7, P189, DOI 10.5582/ddt.2013.v7.5.189; Maneewatch S, 2009, ANTIVIR THER, V14, P221; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Moon HJ, 2012, ANTIVIR RES, V94, P98, DOI 10.1016/j.antiviral.2012.02.010; Pant M., 2012, INDIAN J SCI TECHNOL, V5, P1, DOI [DOI 10.17485/IJST/2012/V5I5.20, 10.17485/ijst/2012/v5i5.20]; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pleschka S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-197; Puig-Saus C, 2012, MOL THER, V20, P54, DOI 10.1038/mt.2011.159; Qin Lin, 2002, Zhongguo Zhongyao Zazhi, V27, P541; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shin Seulmee, 2010, Immune Netw, V10, P55, DOI 10.4110/in.2010.10.2.55; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Strober W., 2001, CURR PROTOC IMMUNOL, V64, p9 2 1, DOI DOI 10.1002/0471142735.IMA03BS21; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Wilden H, 2011, INT J ONCOL, V39, P493, DOI 10.3892/ijo.2011.1033; Wilden H, 2009, INT J ONCOL, V34, P971, DOI 10.3892/ijo_00000223; Xu L, 2014, VIRUSES-BASEL, V6, P2778, DOI 10.3390/v6072778; Xu XJ, 2015, BIOORG MED CHEM LETT, V25, P241, DOI 10.1016/j.bmcl.2014.11.065; Yu CH, 2010, J ETHNOPHARMACOL, V127, P280, DOI 10.1016/j.jep.2009.11.008	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125357	10.1371/journal.pone.0125357	http://dx.doi.org/10.1371/journal.pone.0125357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942440	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943400031
J	Akbar, U; He, Y; Dai, Y; Hack, N; Malaty, I; McFarland, NR; Hess, C; Schmidt, P; Wu, S; Okun, MS				Akbar, Umer; He, Ying; Dai, Yunfeng; Hack, Nawaz; Malaty, Irene; McFarland, Nikolaus R.; Hess, Christopher; Schmidt, Peter; Wu, Samuel; Okun, Michael S.			Weight Loss and Impact on Quality of Life in Parkinson's Disease	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; MANAGEMENT; DIAGNOSIS; DOPAMINE	Introduction Weight loss is common in Parkinson's Disease (PD) and sometimes may precede the diagnosis. Weight loss is associated with multiple factors but its impact on health-related quality of life (HRQL) in PD remains unknown. We sought to investigate the factors associated with weight change and to quantify its effect on HRQL. Methods The National Parkinson Foundation Quality Improvement Initiative (NPF-QII) data was used to analyze PD patients longitudinally between two visits, separated by 12 +/- 6 months. Multiple linear regression analyses were used to assess the associations between baseline covariates and body weight change per month, and to evaluate whether, and to what degree, Parkinson's Disease Questionnaire (PDQ-39) scores were affected. Results A higher Hoehn & Yahr stage, higher number of comorbidities, older age, lower MOCA estimate, and higher rate of levodopa usage were observed in patients who lost weight. Multivariate regression analysis indicated that age and levodopa usage were significantly associated with weight loss. Furthermore, monthly body weight loss was significantly associated with HRQL decline in PD patients. Loss of 1 lb (0.45 kg) per month was associated with a decline in QOL: an increase of 0.5% in PDQ-39 Summary Index score (p=0.004), and 1.1% and 1.5% increases in the mobility and ADL dimensions, respectively. Conclusion Weight loss in PD is common and seems to correlate with worsened HRQL. Awareness of factors associated with weight loss and its relation to HRQL may help practitioners improve patient management and expectations.	[Akbar, Umer] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [He, Ying] Clarkson Univ, Dept Math, Potsdam, NY USA; [Dai, Yunfeng; Wu, Samuel] Univ Florida, Dept Biostat, Gainesville, FL USA; [Hack, Nawaz; Malaty, Irene; McFarland, Nikolaus R.; Hess, Christopher; Okun, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Schmidt, Peter] Natl Parkinson Fdn, Miami, FL USA	Brown University; Clarkson University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Akbar, U (corresponding author), Brown Univ, Dept Neurol, Providence, RI 02912 USA.	umerakbar@yahoo.com	McFarland, Nikolaus R/I-4209-2017; Malaty, Irene/AAE-2553-2020; Hack, Nawaz/AAH-4509-2020	McFarland, Nikolaus R/0000-0002-8699-8857; Hess, Christopher/0000-0002-7317-8999; Okun, Michael/0000-0002-6247-9358	NIH; NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation	Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, Smashwords, and Cambridge (movement disorders books). This does not alter the authors' adherence to PLOS policy on sharing data and materials.	ABBOTT RA, 1992, EUR J CLIN NUTR, V46, P879; Bachmann CG, 2006, MOVEMENT DISORD, V21, P1824, DOI 10.1002/mds.21068; Barichella M, 2009, MOVEMENT DISORD, V24, P1881, DOI 10.1002/mds.22705; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Cersosimo MG, 2008, MOVEMENT DISORD, V23, P1065, DOI 10.1002/mds.22051; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Delikanaki-Skaribas E, 2009, MOVEMENT DISORD, V24, P667, DOI 10.1002/mds.22372; Keller HH, 2003, J AM GERIATR SOC, V51, P945, DOI 10.1046/j.1365-2389.2003.51307.x; LEVI S, 1990, BRIT MED J, V301, P1256, DOI 10.1136/bmj.301.6763.1256; Loewdalt B, 2006, GERONTOLOGY, V52, P160, DOI 10.1159/000091825; Lorefalt B, 2004, ACTA NEUROL SCAND, V110, P180, DOI 10.1111/j.1600-0404.2004.00307.x; MARKUS HS, 1993, J NEURAL TRANSM-PARK, V5, P117, DOI 10.1007/BF02251202; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; Toth MJ, 1997, NEUROLOGY, V48, P88, DOI 10.1212/WNL.48.1.88; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837	21	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124541	10.1371/journal.pone.0124541	http://dx.doi.org/10.1371/journal.pone.0124541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938478	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000027
J	Brown, PM; Kennedy, DJ; Morton, RE; Febbraio, M				Brown, Paul M.; Kennedy, David J.; Morton, Richard E.; Febbraio, Maria			CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; FOAM CELL-FORMATION; PERIODONTAL-DISEASE; LIPOPOLYSACCHARIDE PREPARATION; OXIDIZED PHOSPHOLIPIDS; LESION DEVELOPMENT; ORAL INFECTION; ACTIVATION; INFLAMMASOME; LIPOPROTEIN	There is strong epidemiological association between periodontal disease and cardiovascular disease but underlying mechanisms remain ill-defined. Because the human periodontal disease pathogen, Porphyromonas gingivalis (Pg), interacts with innate immune receptors Toll-like Receptor (TLR) 2 and CD36/scavenger receptor-B2 (SR-B2), we studied how CD36/SR-B2 and TLR pathways promote Pg-mediated atherosclerosis. Western diet fed low density lipoprotein receptor knockout (Ldlr degrees) mice infected orally with Pg had a significant increase in lesion burden compared with uninfected controls. This increase was entirely CD36/SR-B2-dependent, as there was no significant change in lesion burden between infected and uninfected Ldlr degrees mice. Western diet feeding promoted enhanced CD36/SR-B2-dependent IL1 beta generation and foam cell formation as a result of Pg lipopolysaccharide (PgLPS) exposure. CD36/SR-B2 and TLR2 were necessary for inflammasome activation and optimal IL1 beta generation, but also resulted in LPS induced lethality (pyroptosis). Modified forms of LDL inhibited Pg-mediated IL1 beta generation in a CD36/SR-B2-dependent manner and prevented pyroptosis, but promoted foam cell formation. Our data show that Pg infection in the oral cavity can lead to significant TLR2-CD36/SR-B2 dependent IL1 beta release. In the vessel wall, macrophages encountering systemic release of IL1 beta, PgLPS and modified LDL have increased lipid uptake, foam cell formation, and release of IL1 beta, but because pyroptosis is inhibited, this enables macrophage survival and promotes increased plaque development. These studies may explain increased lesion burden as a result of periodontal disease, and suggest strategies for development of therapeutics.	[Brown, Paul M.] Cleveland Clin, Lerner Res Inst, Pediat Res Ctr, Cleveland, OH 44106 USA; [Kennedy, David J.; Morton, Richard E.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Kennedy, David J.; Morton, Richard E.] Case Western Reserve Univ, Coll Med, Cleveland Clin Lerner, Dept Mol Med, Cleveland, OH 44106 USA; [Febbraio, Maria] Univ Alberta, Dept Dent, Edmonton, AB, Canada	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of Alberta	Febbraio, M (corresponding author), Univ Alberta, Dept Dent, Edmonton, AB, Canada.	febbraio@ualberta.ca			National Institutes of Health [HL094879, T32 HL7914]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094879, T32HL007914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from the National Institutes of Health, HL094879 (MF), National Institutes of Health, T32 HL7914 (PMB) and the American Heart Association Grant in Aid (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Andrukhov O, 2011, J PERIODONTOL, V82, P885, DOI 10.1902/jop.2010.100425; Aquino ARL, 2011, J PERIODONTAL RES, V46, P303, DOI 10.1111/j.1600-0765.2010.01343.x; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Azarpazhooh Amir, 2012, J Can Dent Assoc, V78, pc25; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bodet C, 2006, CLIN EXP IMMUNOL, V143, P50, DOI 10.1111/j.1365-2249.2005.02956.x; Breyne K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105680; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Cai Y, 2014, ARCH ORAL BIOL, V59, P1183, DOI 10.1016/j.archoralbio.2014.07.012; Cassel SL, 2014, P NATL ACAD SCI USA, V111, P1072, DOI 10.1073/pnas.1318685111; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chen G, 2010, SENSORS-BASEL, V10, P97, DOI 10.3390/s100100097; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Garber DW, 2000, J LIPID RES, V41, P1020; Giacona MB, 2004, FEMS MICROBIOL LETT, V241, P95, DOI 10.1016/j.femsle.2004.10.009; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gotto Antonio M Jr, 2011, Trans Am Clin Climatol Assoc, V122, P256; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guy E, 2007, ATHEROSCLEROSIS, V192, P123, DOI 10.1016/j.atherosclerosis.2006.07.015; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Hayashi Chie, 2010, J Innate Immun, V2, P334, DOI 10.1159/000314686; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hou LT, 2003, J PERIODONTAL RES, V38, P247, DOI 10.1034/j.1600-0765.2003.02601.x; Huber J, 2006, J LIPID RES, V47, P1054, DOI 10.1194/jlr.M500555-JLR200; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leone CW, 2006, INFECT IMMUN, V74, P2286, DOI 10.1128/IAI.74.4.2286-2292.2006; Li CH, 2007, J PERIODONTOL, V78, P1120, DOI 10.1902/jop.2007.060320; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Miyakawa H, 2004, J PERIODONTAL RES, V39, P1, DOI 10.1111/j.1600-0765.2004.00697.x; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pace CC, 2010, DYSPHAGIA, V25, P307, DOI 10.1007/s00455-010-9298-9; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rivaldo EG, 2005, J PERIODONTOL, V76, P1966, DOI 10.1902/jop.2005.76.11.1966; Schenkein Harvey A, 2013, J Clin Periodontol, V40 Suppl 14, pS51, DOI [10.1902/jop.2013.134006, 10.1111/jcpe.12060]; Schillinger T, 2006, STROKE, V37, P2271, DOI 10.1161/01.STR.0000236495.82545.2e; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Skeggs JW, 2002, J LIPID RES, V43, P1264, DOI 10.1194/jlr.M100431-JLR200; Stashenko P, 2007, AM J PATHOL, V170, P203, DOI 10.2353/ajpath.2007.060597; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Toyofuku T, 2011, SURG TODAY, V41, P1395, DOI 10.1007/s00595-010-4496-5; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Turunen SP, 2015, INNATE IMMUN-LONDON, V21, P370, DOI 10.1177/1753425914542444; VANNIER E, 1993, J CLIN INVEST, V92, P281, DOI 10.1172/JCI116562; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	84	32	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125126	10.1371/journal.pone.0125126	http://dx.doi.org/10.1371/journal.pone.0125126			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938460	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000046
J	Lu, X; Zhang, XX; Wang, Z; Huang, KL; Wang, Y; Liang, WG; Tan, YF; Liu, B; Tang, JY				Lu, Xin; Zhang, Xu-Xiang; Wang, Zhu; Huang, Kailong; Wang, Yuan; Liang, Weigang; Tan, Yunfei; Liu, Bo; Tang, Junying			Bacterial Pathogens and Community Composition in Advanced Sewage Treatment Systems Revealed by Metagenomics Analysis Based on High-Throughput Sequencing	PLOS ONE			English	Article							WATER TREATMENT PLANTS; ACTIVATED-SLUDGE; ANTIBIOTIC-RESISTANCE; AEROMONAS-HYDROPHILA; MICROBIAL PATHOGENS; VIRULENCE; INDICATORS; REMOVAL; RESIN; PCR	This study used 454 pyrosequencing, Illumina high-throughput sequencing and metagenomic analysis to investigate bacterial pathogens and their potential virulence in a sewage treatment plant (STP) applying both conventional and advanced treatment processes. Pyrosequencing and Illumina sequencing consistently demonstrated that Arcobacter genus occupied over 43.42% of total abundance of potential pathogens in the STP. At species level, potential pathogens Arcobacter butzleri, Aeromonas hydrophila and Klebsiella pneumonia dominated in raw sewage, which was also confirmed by quantitative real time PCR. Illumina sequencing also revealed prevalence of various types of pathogenicity islands and virulence proteins in the STP. Most of the potential pathogens and virulence factors were eliminated in the STP, and the removal efficiency mainly depended on oxidation ditch. Compared with sand filtration, magnetic resin seemed to have higher removals in most of the potential pathogens and virulence factors. However, presence of the residual Arcobacter butzleri in the final effluent still deserves more concerns. The findings indicate that sewage acts as an important source of environmental pathogens, but STPs can effectively control their spread in the environment. Joint use of the high-throughput sequencing technologies is considered a reliable method for deep and comprehensive overview of environmental bacterial virulence.	[Lu, Xin; Zhang, Xu-Xiang; Wang, Zhu; Huang, Kailong; Liu, Bo; Tang, Junying] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Yuan] Environm Sci Res Inst Jiangsu, Nanjing, Jiangsu, Peoples R China; [Liang, Weigang; Tan, Yunfei] Zhengzhou Sewage Purificat Co, Zhengzhou, Peoples R China; [Liu, Bo] Nanjing Univ Lianyungang, Res Inst, Lianyungang, Peoples R China	Nanjing University	Zhang, XX (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; yongboliu@163.com	zhang, xian/GYA-0290-2022; Zhu, Wang/AAT-1740-2021; 王, 铸/I-3824-2016; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022	王, 铸/0000-0002-6763-8194; 	National Science and Technology Major Project of China [2012ZX07204-001, 2012ZX07101-002]; Environmental Protection Research Foundation of Jiangsu Province (China) [2012044, 2012045]	National Science and Technology Major Project of China; Environmental Protection Research Foundation of Jiangsu Province (China)	This study was financially supported by National Science and Technology Major Project of China (No. 2012ZX07204-001, PI: BL; No. 2012ZX07101-002, PI: XXZ; URL: http://www.nmp.gov.cn/) and Environmental Protection Research Foundation of Jiangsu Province (China) (No. 2012044 and 2012045; PI: XXZ; URL: http://www.jshb.gov.cn/jshbw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaqi K, 2007, J CLIN MICROBIOL, V45, P3015, DOI 10.1128/JCM.00256-07; Ahmed W, 2008, APPL ENVIRON MICROB, V74, P5490, DOI 10.1128/AEM.00331-08; [Anonymous], 2012, EMERGING ORGANIC CON; Atia AA, 2008, SEP PURIF TECHNOL, V61, P348, DOI 10.1016/j.seppur.2007.11.008; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Cai L, 2013, ENVIRON SCI TECHNOL, V47, P5433, DOI 10.1021/es400275r; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cheng HWA, 2012, J WATER HEALTH, V10, P380, DOI 10.2166/wh.2012.138; Collado L, 2008, ENVIRON MICROBIOL, V10, P1635, DOI 10.1111/j.1462-2920.2007.01555.x; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Elmund GK, 1999, WATER ENVIRON RES, V71, P332, DOI 10.2175/106143098X121752; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fu CY, 2010, WATER SCI TECHNOL, V61, P1589, DOI 10.2166/wst.2010.757; George T, 2003, WASTEWATER ENG TREAT; Godfree A, 2005, J ENVIRON QUAL, V34, P105, DOI 10.2134/jeq2005.0105; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Lee DY, 2006, J MICROBIOL METH, V65, P453, DOI 10.1016/j.mimet.2005.09.008; Lucena F, 2004, J APPL MICROBIOL, V97, P1069, DOI 10.1111/j.1365-2672.2004.02397.x; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Ma LP, 2013, J ENVIRON BIOL, V34, P391; Ma LP, 2011, ECOTOXICOLOGY, V20, P968, DOI 10.1007/s10646-011-0652-y; MONFORT P, 1990, APPL ENVIRON MICROB, V56, P1999, DOI 10.1128/AEM.56.7.1999-2006.1990; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Okoh AI, 2007, AFR J BIOTECHNOL, V6, P2932; Olsen JS, 2010, ENVIRON SCI TECHNOL, V44, P8712, DOI 10.1021/es1007774; Pillar CM, 2004, FRONT BIOSCI-LANDMRK, V9, P2335, DOI 10.2741/1400; POFFE R, 1991, J APPL BACTERIOL, V71, P366, DOI 10.1111/j.1365-2672.1991.tb03802.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Sonune A, 2004, DESALINATION, V167, P55, DOI 10.1016/j.desal.2004.06.113; Srinivasan S, 2011, WATER RES, V45, P2561, DOI 10.1016/j.watres.2011.02.010; Sun FL, 2010, FOOD CONTROL, V21, P487, DOI 10.1016/j.foodcont.2009.07.014; Toze S, 1999, WATER RES, V33, P3545, DOI 10.1016/S0043-1354(99)00071-8; Varela AR, 2013, ENVIRON SCI POLLUT R, V20, P3550, DOI 10.1007/s11356-013-1594-0; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Wen QX, 2009, J ENVIRON MANAGE, V90, P1442, DOI 10.1016/j.jenvman.2008.09.002; Wert EC, 2005, OZONE-SCI ENG, V27, P371, DOI 10.1080/01919510500250754; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e; Zhang R, 2006, DESALINATION, V192, P296, DOI 10.1016/j.desal.2005.07.040; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	54	43	45	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125549	10.1371/journal.pone.0125549	http://dx.doi.org/10.1371/journal.pone.0125549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938416	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000074
J	Toh, LS; Lai, PSM; Wu, DBC; Wong, KT; Low, BY; Anderson, C				Toh, Li Shean; Lai, Pauline Siew Mei; Wu, David Bin-Chia; Wong, Kok Thong; Low, Bee Yean; Anderson, Claire			The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; WOMENS KNOWLEDGE; QUESTIONNAIRE; EDUCATION; VALIDITY	Objectives To develop and validate Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia. Methods The OPAAT was modified from the Malaysian Osteoporosis Knowledge Tool and developed from an exploratory study on patients. Face and content validity was established by an expert panel. The OPAAT consists of 30 items, categorized into three domains. A higher score indicates higher knowledge level. English speaking non-osteoporotic postmenopausal women >= 50 years of age and pharmacists were included in the study. Results A total of 203 patients and 31 pharmacists were recruited. Factor analysis extracted three domains. Flesch reading ease was 59.2. The mean +/- SD accuracy rate was 0.60 +/- 0.22 (range: 0.26-0.94). The Cronbach's alpha for each domain ranged from 0.286-0.748. All items were highly correlated (Spearman's rho: 0.761-0.990, p<0.05), with no significant change in the overall test-retest scores, indicating that OPAAT has achieved stable reliability. Pharmacists had higher knowledge score than patients (80.9 +/- 8.7vs63.6 +/- 17.4, p<0.001), indicating that the OPAAT was able to discriminate between the knowledge levels of pharmacists and patients. Conclusion The OPAAT was found to be a valid and reliable instrument for assessing patient's knowledge about osteoporosis and its prevention in Malaysia. The OPAAT can be used to identify individuals in need of osteoporosis educational intervention.	[Toh, Li Shean; Wong, Kok Thong; Low, Bee Yean] Univ Nottingham, Fac Sci, Sch Pharm, Semenyih, Selangor, Malaysia; [Lai, Pauline Siew Mei] Univ Malaya, Fac Med, Dept Primary Care Med, Primary Care Res Grp, Kuala Lumpur, Wilayah Perseku, Malaysia; [Wu, David Bin-Chia] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Selangor, Malaysia; [Anderson, Claire] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2RD, England	University of Nottingham Malaysia; Universiti Malaya; Monash University; Monash University Sunway; University of Nottingham	Anderson, C (corresponding author), Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2RD, England.	claire.anderson@nottingham.ac.uk	Low, Bee Yean/L-9195-2017; Toh, Li Shean/F-2167-2016; Wu, David Bin-Chia/H-3267-2019; Lai, Pauline Siew Mei/B-1031-2012	Low, Bee Yean/0000-0002-1841-0169; Toh, Li Shean/0000-0002-9228-6266; Lai, Pauline Siew Mei/0000-0002-9940-9644; Anderson, Claire/0000-0002-5406-2296	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [06-02-12 SF0183]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This project was funded by the 06-02-12 SF0183 Ministry of Science, Technology and Innovation (MOSTI), Malaysia. The URL: http://ernd.mosti.gov.my/eScience/frmLogin.aspx. The authors receiving the funding are LST, PSML, CA, KTW, LBY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulameer SA, 2013, J COMMUN HEALTH, V38, P95, DOI 10.1007/s10900-012-9586-4; Ailinger R L, 1998, Orthop Nurs, V17, P66; Ailinger RL, 2003, NURS RES, V52, P198, DOI 10.1097/00006199-200305000-00010; Ailinger RL, 1998, APPL NURS RES, V11, P111, DOI 10.1016/S0897-1897(98)80102-X; Alexandraki KI, 2008, MATURITAS, V59, P38, DOI 10.1016/j.maturitas.2007.10.008; Andersen RM, 1995, J HLTH SOCIAL BEHAV, P36; [Anonymous], 2001, HLTH SCI RES HDB QUA; Baheiraei A, 2005, MATURITAS, V50, P134, DOI 10.1016/j.maturitas.2004.05.001; Beaton DE, 2012, QUAL HEALTH RES, V22, P1647, DOI 10.1177/1049732312457467; Bruin J, 2006, NEWTEST COMMAND COMP; Burke-Doe Annie, 2008, J Geriatr Phys Ther, V31, P11; Cadarette SM, 2007, OSTEOPOROSIS INT, V18, P981, DOI 10.1007/s00198-007-0326-z; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cranney A, 2008, OSTEOPOROSIS INT, V19, P1733, DOI 10.1007/s00198-008-0669-0; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Curry LC, 2001, J WOMEN AGING, V13; Davis JC, 2007, J GERONTOL A-BIOL, V62, P888, DOI 10.1093/gerona/62.8.888; [Department of statistics Malaysia Malaysia Dos], 2013, SALARIES WAGES SURVE; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Etemadifar MR, 2013, WORLD J ORTHOP, V4, P139, DOI 10.5312/wjo.v4.i3.139; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Gaines JM, 2011, MATURITAS, V68, P5, DOI 10.1016/j.maturitas.2010.08.013; Gemalmaz A, 2008, CLIN RHEUMATOL, V27, P723, DOI 10.1007/s10067-007-0777-9; George D, 2003, SPSS WINDOWS STEP ST, V4th, DOI DOI 10.1080/13803395.2011.614598; Gorsuch R.L., 1983, FACTOR ANAL, V2nd ed.; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; Harman H.H., 1976, MODERN FACTOR ANAL; Harrington D., 2009, CONFIRMATORY FACTOR, DOI DOI 10.1093/ACPROF:OSO/9780195339888.001.0001; Jensen AL, 2014, OSTEOPOROSIS INT, V25, P1209, DOI 10.1007/s00198-013-2573-5; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kasper M J, 1994, Arch Fam Med, V3, P696, DOI 10.1001/archfami.3.8.696; Khan YH, 2014, TROP J PHARM RES, V13, P155, DOI 10.4314/tjpr.v13i1.22; Kim J, 1978, FACTOR ANAL STAT MET; Kim K., 1991, OSTEOPOROSIS KNOWLED; Lai PSM, 2008, MATURITAS, V60, P122, DOI 10.1016/j.maturitas.2008.04.006; Lai Psm, 2013, Malays Fam Physician, V8, P2; Liza H, 2009, MALAYS ORTHOP J, V3, P28; Lundy K. S., 2009, COMMUNITY HLTH NURSI; Magnus JH, 1996, OSTEOPOROSIS INT, V6, P31, DOI 10.1007/BF01626535; [Ministry of Health Malaysia Health Mo], 2012, CLIN GUIDELINE MANAG; Nielsen D, 2008, SCAND J PUBLIC HEALT, V36, P346, DOI 10.1177/1403494808089558; Pande KC, 2000, MATURITAS, V37, P75, DOI 10.1016/S0378-5122(00)00165-1; Richy F, 2004, J BONE MINER RES, V19, P1955, DOI 10.1359/JBMR.040903; Saw SM, 2003, OSTEOPOROSIS INT, V14, P595, DOI 10.1007/s00198-003-1403-6; Schutt, 2012, RES METHODS ED, P159; Smith F, 2002, RES METHODS PHARM PR; Terrio K, 2002, J COMMUN HEALTH, V27, P307, DOI 10.1023/A:1019840709367; Toh LS, 2012, OSTEOPOROSIS INT, V23, pS777; Ungan M, 2001, FAM PRACT, V18, P199, DOI 10.1093/fampra/18.2.199; University Testing Services ASU, GUID INT IT AN REP; Winzenberg TM, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-17; Yeap SS, 2010, ASIA-PAC J PUBLIC HE, V22, P233, DOI 10.1177/1010539509343948; Yuksel N, 2010, OSTEOPOROSIS INT, V21, P391, DOI 10.1007/s00198-009-0977-z	54	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124553	10.1371/journal.pone.0124553	http://dx.doi.org/10.1371/journal.pone.0124553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938494	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000028
J	Yang, YQ; Chen, FY; Karasawa, T; Ma, KT; Guan, BC; Shi, XR; Li, HZ; Steyger, PS; Nuttall, AL; Jiang, ZG				Yang, Yuqin; Chen, Fangyi; Karasawa, Takatoshi; Ma, Ke-Tao; Guan, Bing-Cai; Shi, Xiao-Rui; Li, Hongzhe; Steyger, Peter S.; Nuttall, Alfred L.; Jiang, Zhi-Gen			Diverse Kir Expression Contributes to Distinct Bimodal Distribution of Resting Potentials and Vasotone Responses of Arterioles	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RECTIFIER POTASSIUM CHANNEL; SPIRAL MODIOLAR ARTERY; COCHLEAR BLOOD-FLOW; AGE-RELATED-CHANGES; GUINEA-PIG; K+ CHANNELS; ENDOTHELIAL-CELLS; PATCH-CLAMP; FUNCTIONAL EXPRESSION	The resting membrane potential (RP) of vascular smooth muscle cells (VSMCs) is a major determinant of cytosolic calcium concentration and vascular tone. The heterogeneity of RPs and its underlying mechanism among different vascular beds remain poorly understood. We compared the RPs and vasomotion properties between the guinea pig spiral modiolar artery (SMA), brain arterioles (BA) and mesenteric arteries (MA). We found: 1) RPs showed a robust bimodal distribution peaked at -76 and -40 mV evenly in the SMA, unevenly at -77 and -51 mV in the BA and similar to-71 and -52 mV in the MA. Ba2+ 0.1 mM eliminated their high RP peaks similar to-75 mV. 2) Cells with low RP (similar to-45 mV) hyperpolarized in response to 10 mM extracellular K+, while cells with a high RP depolarized, and cells with intermediate RP (similar to-58 mV) displayed an initial hyperpolarization followed by prolonged depolarization. Moderate high K+ typically induced dilation, constriction and a dilation followed by constriction in the SMA, MA and BA, respectively. 3) Boltzmann-fit analysis of the Ba2+-sensitive inward rectifier K+ (Kir) whole-cell current showed that the maximum Kir conductance density significantly differed among the vessels, and the half-activation voltage was significantly more negative in the MA. 4) Corresponding to the whole-cell data, computational modeling simulated the three RP distribution patterns and the dynamics of RP changes obtained experimentally, including the regenerative swift shifts between the two RP levels after reaching a threshold. 5) Molecular works revealed strong Kir2.1 and Kir2.2 transcripts and Kir2.1 immunolabeling in all 3 vessels, while Kir2.3 and Kir2.4 transcript levels varied. We conclude that a dense expression of functional Kir2. X channels underlies the more negative RPs in endothelial cells and a subset of VSMC in these arterioles, and the heterogeneous Kir function is primarily responsible for the distinct bimodal RPs among these arterioles. The fast Kir-based regenerative shifts between two RP states could form a critical mechanism for conduction/spread of vasomotion along the arteriole axis.	[Yang, Yuqin; Chen, Fangyi; Karasawa, Takatoshi; Ma, Ke-Tao; Guan, Bing-Cai; Shi, Xiao-Rui; Li, Hongzhe; Steyger, Peter S.; Nuttall, Alfred L.; Jiang, Zhi-Gen] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Chen, Fangyi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [Ma, Ke-Tao] Shihezi Univ, Coll Med, Dept Physiol, Shihezi, Peoples R China; [Guan, Bing-Cai] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China	Oregon Health & Science University; Southern University of Science & Technology; Shihezi University; Hebei Medical University	Jiang, ZG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	Jiangz@ohsu.edu	Steyger, Peter S./B-9147-2011; Chen, Fangyi/I-3497-2018	Steyger, Peter S./0000-0002-6103-5237; Chen, Fangyi/0000-0002-5024-6215	Hearing Health Foundation; Oregon Medical Research Fund; NIH NIDCD [R01 DC004716, R03DC011622, DC010844, DC R21DC1239801, DC004555, DC00105]; NIH [P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC004555, P30DC005983, R01DC012588, R01DC004555, K23DC000105, R01DC010844, R21DC012398] Funding Source: NIH RePORTER	Hearing Health Foundation; Oregon Medical Research Fund; NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from Hearing Health Foundation, Oregon Medical Research Fund, NIH NIDCD R01 DC004716 (ZGJ), and by NIH NIDCD R03DC011622 (HL), DC010844 (XS), DC R21DC1239801 (XS), DC004555 (PSS), DC00105 (ALN) and NIH P30 DC005983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON PI, 1988, J PHYSIOL-LONDON, V405, P57, DOI 10.1113/jphysiol.1988.sp017321; Albert AP, 2006, J PHYSIOL-LONDON, V570, P45, DOI 10.1113/jphysiol.2005.096875; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; AXELSSON A, 1988, AM J OTOLARYNG, V9, P278, DOI 10.1016/S0196-0709(88)80036-X; Bae YM, 1999, J PHYSIOL-LONDON, V514, P747, DOI 10.1111/j.1469-7793.1999.747ad.x; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; BROWN JN, 1995, HEARING RES, V86, P189, DOI 10.1016/0378-5955(95)00070-K; Casella G., 2021, STAT INFERENCE; Crane GJ, 2003, J VASC RES, V40, P159, DOI 10.1159/000070713; DIETRICH HH, 1994, J NEUROSURG, V81, P437, DOI 10.3171/jns.1994.81.3.0437; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; EDWARDS FR, 1989, BRIT J PHARMACOL, V96, P785, DOI 10.1111/j.1476-5381.1989.tb11884.x; Emerson GG, 2000, CIRC RES, V87, P474; Emerson GG, 2001, AM J PHYSIOL-HEART C, V280, pH160; Emerson GG, 2000, CIRC RES, V86, P94, DOI 10.1161/01.RES.86.1.94; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; Faraci FM, 1998, J CEREBR BLOOD F MET, V18, P1047, DOI 10.1097/00004647-199810000-00001; Feletou M, 1999, J PHYSIOL PHARMACOL, V50, P525; Figueroa XF, 2004, PHYSIOLOGY, V19, P277, DOI 10.1152/physiol.00008.2004; Guan BC, 2007, BRIT J PHARMACOL, V151, P1049, DOI 10.1038/sj.bjp.0707244; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Hill CE, 2008, J PHYSIOL-LONDON, V586, P1465, DOI 10.1113/jphysiol.2008.151308; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; HULTCRANTZ E, 1988, AM J OTOLARYNG, V9, P317, DOI 10.1016/S0196-0709(88)80039-5; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Jernigan NL, 2005, AM J PHYSIOL-RENAL, V289, pF891, DOI 10.1152/ajprenal.00019.2005; Jiang ZG, 2004, HEARING RES, V189, P92, DOI 10.1016/S0378-5955(03)00398-8; Jiang ZG, 2001, J PHYSIOL-LONDON, V537, P829; Jiang ZG, 1999, HEARING RES, V138, P171, DOI 10.1016/S0378-5955(99)00166-5; Jiang ZG, 2005, J PHYSIOL-LONDON, V564, P475, DOI 10.1113/jphysiol.2004.080960; Jiang ZG, 2007, J PHARMACOL EXP THER, V320, P544, DOI 10.1124/jpet.106.115212; Jiang ZG, 2010, FASEB J, V24; KIMURA RS, 1986, AM J OTOLARYNG, V7, P130, DOI 10.1016/S0196-0709(86)80042-4; KLIEBER HG, 1994, CARDIOVASC RES, V28, P823, DOI 10.1093/cvr/28.6.823; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; KONISHI T, 1961, J ACOUST SOC AM, V33, P349, DOI 10.1121/1.1908659; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Ma KT, 2011, AM J PHYSIOL-HEART C, V300, pH335, DOI 10.1152/ajpheart.00737.2010; Nakahata K, 2006, ANESTH ANALG, V102, P571, DOI 10.1213/01.ane.0000194303.00844.5e; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn K, 2000, AM J PHYSIOL-HEART C, V279, pH351, DOI 10.1152/ajpheart.2000.279.1.H351; Quinn K, 1998, PFLUG ARCH EUR J PHY, V435, P564, DOI 10.1007/s004240050553; QUIRK WS, 1991, HEARING RES, V52, P217, DOI 10.1016/0378-5955(91)90201-J; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; SCHEIBE F, 1993, EUR ARCH OTO-RHINO-L, V250, P281; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; Schram G, 2002, J PHYSIOL-LONDON, V544, P337, DOI 10.1113/jphysiol.2002.026047; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SCHUKNECHT HF, 1982, AM J OTOLARYNG, V3, P349, DOI 10.1016/S0196-0709(82)80009-4; Si JQ, 2002, HEARING RES, V171, P167, DOI 10.1016/S0378-5955(02)00497-5; Suzuki T, 1998, ANN OTO RHINOL LARYN, V107, P648, DOI 10.1177/000348949810700803; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tennant BP, 2006, J MEMBRANE BIOL, V213, P19, DOI 10.1007/s00232-006-0037-y; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; Wangemann P, 1998, HEARING RES, V115, P113, DOI 10.1016/S0378-5955(97)00184-6; Welsh DG, 1998, AM J PHYSIOL-HEART C, V274, pH178, DOI 10.1152/ajpheart.1998.274.1.H178; Xu XP, 1999, PFLUG ARCH EUR J PHY, V438, P187, DOI 10.1007/s004240050897; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	65	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125266	10.1371/journal.pone.0125266	http://dx.doi.org/10.1371/journal.pone.0125266			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938437	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000055
J	Yang, ZY; Zhang, YS; Dong, LM; Yang, C; Gou, SM; Yin, T; Wu, HS; Wang, CY				Yang, Zhiyong; Zhang, Yushun; Dong, Liming; Yang, Chong; Gou, Shanmiao; Yin, Tao; Wu, Heshui; Wang, Chunyou			The Reduction of Peripheral Blood CD4(+) T Cell Indicates Persistent Organ Failure in Acute Pancreatitis	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; LYMPHOCYTE SUBSETS; DYSFUNCTION; SEVERITY; INTERLEUKIN-6; DEATH; RISK; MICE	Objective Few data are available on the potential role of inflammatory mediators and T lymphocytes in persistent organ failure (POF) in acute pancreatitis (AP). We conducted a retrospective study to characterize their role in the progression of POF in AP. Methods A total of 69 AP patients presented within 24 hours from symptom onset developing organ failure (OF) on admission were included in our study. There were 39 patients suffering from POF and 30 from transient OF (TOF). On the 1st, 3rd and 7th days after admission, blood samples were collected for biochemical concentration monitoring including serum IL-1 beta, IL-6, TNF-alpha and high-sensitivity C-reactive protein (hs-CRP). The proportions of peripheral CD4(+) and CD8(+) T lymphocytes were assessed based on flow cytometry simultaneously. Results Patients with POF showed a significantly higher value of IL-1 beta and hs-CRP on day 7 compared with the group of TOF (P < 0.05). Proportions of CD4(+) T cells on days 1, 3, 7 and CD4(+)/CD8(+) ratio on day 1 were statistically lower in the group of POF patients (P < 0.05). A CD4(+) T cell proportion of 30.34% on day 1 predicted POF with an area under the curve (AUC) of 0.798, a sensitivity with 61.54% and specificity with 90.00%, respectively. Conclusions The reduction of peripheral blood CD4(+) T lymphocytes is associated with POF in AP, and may act as a potential predictor.	[Yang, Zhiyong; Zhang, Yushun; Dong, Liming; Yang, Chong; Gou, Shanmiao; Yin, Tao; Wu, Heshui; Wang, Chunyou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan, Hubei Province, Peoples R China.	heshuiwu@163.com; chunyouwang52@126.com			National Natural Science Foundation of China [81171840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81171840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Aoun E, 2009, PANCREATOLOGY, V9, P777, DOI 10.1159/000214191; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; CURLEY PJ, 1993, BRIT J SURG, V80, P1312, DOI 10.1002/bjs.1800801031; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Group of Pancreas Surgery Chinese Society of Surgery Chinese Medical Association, 2007, Zhonghua Wai Ke Za Zhi, V45, P727; Halonen KI, 2002, CRIT CARE MED, V30, P1274, DOI 10.1097/00003246-200206000-00019; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Johnson CD, 2001, GUT, V48, P62, DOI 10.1136/gut.48.1.62; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kylanpaa ML, 2010, WORLD J GASTROENTERO, V16, P2867, DOI 10.3748/wjg.v16.i23.2867; Lytras D, 2008, PANCREAS, V36, P249, DOI 10.1097/MPA.0b013e31815acb2c; Mayer J, 2000, GUT, V47, P546, DOI 10.1136/gut.47.4.546; Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290; Nakayama S, 2014, PANCREAS, V43, P28, DOI 10.1097/MPA.0b013e3182a7c76b; Nawaz H, 2013, AM J GASTROENTEROL, V108, P1911, DOI 10.1038/ajg.2013.348; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Papachristou GI, 2007, GASTROENTEROL CLIN N, V36, P277, DOI 10.1016/j.gtc.2007.03.003; PEZZILLI R, 1995, PANCREAS, V11, P95, DOI 10.1097/00006676-199507000-00010; Pietruczuk M, 2006, WORLD J GASTROENTERO, V12, P5344, DOI 10.3748/wjg.v12.i33.5344; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sweeney KJ, 2003, BRIT J SURG, V90, P313, DOI 10.1002/bjs.4080; Takeyama Y, 2000, J GASTROINTEST SURG, V4, P379, DOI 10.1016/S1091-255X(00)80016-5; Tompkins RG, 1997, ANN SURG, V225, P243, DOI 10.1097/00000658-199703000-00001; Uehara S, 2003, J GASTROEN HEPATOL, V18, P363, DOI 10.1046/j.1440-1746.2003.02979.x; Wilson PG, 1998, J ANTIMICROB CHEMOTH, V41, P51, DOI 10.1093/jac/41.suppl_1.51	30	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125529	10.1371/journal.pone.0125529	http://dx.doi.org/10.1371/journal.pone.0125529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938229	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000073
J	Ohkawa, Y; Momota, H; Kato, A; Hashimoto, N; Tsuda, Y; Kotani, N; Honke, K; Suzumura, A; Furukawa, K; Ohmi, Y; Natsume, A; Wakabayashi, T; Furukawa, K				Ohkawa, Yuki; Momota, Hiroyuki; Kato, Akira; Hashimoto, Noboru; Tsuda, Yusuke; Kotani, Norihiro; Honke, Koichi; Suzumura, Akio; Furukawa, Keiko; Ohmi, Yuhsuke; Natsume, Atsushi; Wakabayashi, Toshihiko; Furukawa, Koichi			Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor and Yes Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cell invasion; ganglioside; glioblastoma; invasion; lipid raft	NF-KAPPA-B; SYNTHASE GENE; MALIGNANT PROPERTIES; REACTIVE ASTROCYTES; NEURAL PROGENITORS; ANTITUMOR-ACTIVITY; GENOMIC ANALYSIS; CELL-MIGRATION; MELANOMA-CELLS; T-CELLS	Background: Roles of GD3 in gliomas are not well understood. Results: PDGF receptor was identified as a GD3-associated molecule by enzyme-mediated activation of radical sources and mass spectrometry, and its association with GD3 and Yes leads to increased invasiveness. Conclusion: GD3 enhances invasiveness by forming a molecular complex. Significance: GD3/PDGF receptor <bold>Yes complex is a potential target for glioma therapy</bold>. There have been a few studies on the ganglioside expression in human glioma tissues. However, the role of these gangliosides such as GD3 and GD2 has not been well understood. In this study we employed a genetically engineered mouse model of glioma to clarify the functions of GD3 in gliomas. Forced expression of platelet-derived growth factor B in cultured astrocytes derived from p53-deficient mice resulted in the expression of GD3 and GD2. GD3-positive astrocytes exhibited increased cell growth and invasion activities along with elevated phosphorylation of Akt and Yes kinase. By enzyme-mediated activation of radical sources reaction and mass spectrometry, we identified PDGF receptor (PDGFR) as a GD3-associated molecule. GD3-positive astrocytes showed a significant amount of PDGFR in glycolipid-enriched microdomains/rafts compared with GD3-negative cells. Src kinase family Yes was co-precipitated with PDGFR, and its pivotal role in the increased cell invasion of GD3-positive astrocytes was demonstrated by silencing with anti-Yes siRNA. Direct association between PDGFR and GD3 was also shown, suggesting that GD3 forms ternary complex with PDGFR and Yes. The fact that GD3, PDGFR, and activated Yes were colocalized in lamellipodia and the edge of tumors in cultured cells and glioma tissues, respectively, suggests that GD3 induced by platelet-derived growth factor B enhances PDGF signals in glycolipid-enriched microdomain/rafts, leading to the promotion of malignant phenotypes such as cell proliferation and invasion in gliomas.	[Ohkawa, Yuki; Hashimoto, Noboru; Tsuda, Yusuke; Furukawa, Keiko; Ohmi, Yuhsuke; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan; [Ohkawa, Yuki; Momota, Hiroyuki; Kato, Akira; Natsume, Atsushi; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4660065, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Fac Med, Moroyama, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan; [Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ohkawa, Yuki; Furukawa, Keiko; Furukawa, Koichi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Nagoya University; Saitama Medical University; Kochi University; Nagoya University; Chubu University	Furukawa, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Natsume, Atsushi/I-7364-2014; Wakabayashi, Toshihiko/I-3526-2012; OHMI, Yuhsuke/I-7302-2014	Natsume, Atsushi/0000-0002-9113-0470; Wakabayashi, Toshihiko/0000-0001-5254-2088; Kotani, Norihiro/0000-0003-3739-6478	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22117511, 23590371, 24390078];  [24.8954]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) Grants 22117511, 23590371, and 24390078 and Grant-in-aid for Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellows 24.8954.	Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Furukawa K, 2014, CANCER SCI, V105, P52, DOI 10.1111/cas.12310; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Furukawa K, 2012, J BIOCHEM, V151, P573, DOI 10.1093/jb/mvs043; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2011, J BIOL CHEM, V286, P18526, DOI 10.1074/jbc.M110.164798; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Jung J, 2011, CELL CYCLE, V10, P1502, DOI 10.4161/cc.10.9.15495; Kang NY, 2007, BBA-GENE STRUCT EXPR, V1769, P622, DOI 10.1016/j.bbaexp.2007.08.001; KAWAI K, 1994, NEUROSCI LETT, V174, P225, DOI 10.1016/0304-3940(94)90027-2; Kawai K, 1999, PSYCHIAT CLIN NEUROS, V53, P79, DOI 10.1046/j.1440-1819.1999.00475.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Lee DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057489; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Miyata M, 2014, BIOCHEM BIOPH RES CO, V445, P504, DOI 10.1016/j.bbrc.2014.02.038; Momota H, 2010, BRAIN TUMOR PATHOL, V27, P95, DOI 10.1007/s10014-010-0272-x; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Okada M, 1996, CANCER RES, V56, P2844; Park S, 2009, CANCER RES, V69, P2809, DOI 10.1158/0008-5472.CAN-08-4079; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sato A, 2012, ONCOL REP, V28, P1889, DOI 10.3892/or.2012.2010; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Suzumura A, 1996, BRAIN RES, V713, P192, DOI 10.1016/0006-8993(95)01535-3; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vajn K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075720; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vukelic Z, 2007, GLYCOBIOLOGY, V17, P504, DOI 10.1093/glycob/cwm012; Wagener R, 1999, ACTA NEUROCHIR, V141, P1339, DOI 10.1007/s007010050439; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251; Yang RK, 2010, DRUG FUTURE, V35, P665, DOI 10.1358/dof.2010.035.08.1513490; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao JM, 1999, J BIOL CHEM, V274, P13744, DOI 10.1074/jbc.274.20.13744; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	58	48	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16043	16058		10.1074/jbc.M114.635755	http://dx.doi.org/10.1074/jbc.M114.635755			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25940087	Green Published, hybrid			2022-12-26	WOS:000356930100012
J	Nakhaei-Rad, S; Nakhaeizadeh, H; Kordes, C; Cirstea, IC; Schmick, M; Dvorsky, R; Bastiaens, PIH; Haussinger, D; Ahmadian, MR				Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Kordes, Claus; Cirstea, Ion C.; Schmick, Malte; Dvorsky, Radovan; Bastiaens, Philippe I. H.; Haeussinger, Dieter; Ahmadian, Mohammad Reza			The Function of Embryonic Stem Cell-expressed RAS (E-RAS), a Unique RAS Family Member, Correlates with Its Additional Motifs and Its Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositide 3-kinase (PI 3-kinase); phosphatidylinositol kinase (PI kinase); Raf kinase; RAS protein; small GTPase; E-RAS; effector selection; H-RAS; embryonic stem cell-expressed RAS; specificity determining residues	PHOSPHOLIPASE-C; H-RAS; K-RAS; PLASMA-MEMBRANE; GOLGI-COMPLEX; LIPID RAFTS; PROTEINS; ACTIVATION; EFFECTOR; ERAS	E-RAS is a member of the RAS family specifically expressed in embryonic stem cells, gastric tumors, and hepatic stellate cells. Unlike classical RAS isoforms (H-, N-, and K-RAS4B), E-RAS has, in addition to striking and remarkable sequence deviations, an extended 38-amino acid-long unique N-terminal region with still unknown functions. We investigated the molecular mechanism of E-RAS regulation and function with respect to its sequence and structural features. We found that N-terminal extension of E-RAS is important for E-RAS signaling activity. E-RAS protein most remarkably revealed a different mode of effector interaction as compared with H-RAS, which correlates with deviations in the effector-binding site of E-RAS. Of all these residues, tryptophan 79 (arginine 41 in H-RAS), in the interswitch region, modulates the effector selectivity of RAS proteins from H-RAS to E-RAS features.	[Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Cirstea, Ion C.; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40255 Dusseldorf, Germany; [Kordes, Claus; Haeussinger, Dieter] Univ Dusseldorf, Fak Med, Clin Gastroenterol Hepatol & Infect Dis, D-40255 Dusseldorf, Germany; [Cirstea, Ion C.] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Schmick, Malte; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Nakhaeirad, Saeideh/AAV-1771-2020; Dvorsky, Radovan/ABE-3042-2020; Kordes, Claus/AFM-1775-2022; Cirstea, Ion Cristian/AAQ-7670-2020	Nakhaeirad, Saeideh/0000-0001-8966-8960; Kordes, Claus/0000-0003-0782-1998; Cirstea, Ion Cristian/0000-0003-3204-1598	German Research Foundation through Collaborative Research Center 974 [SFB 974]	German Research Foundation through Collaborative Research Center 974	This work was supported in part by the German Research Foundation through Collaborative Research Center 974 (Grant SFB 974), Communication and Systems Relevance during Liver Injury and Regeneration. The authors declare that they have no conflicts of interest with the contents of this article.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian Mohammad Reza, 2002, EMBO Reports, V3, P214, DOI 10.1093/embo-reports/kvf057; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aoyama M, 2010, INT J ONCOL, V37, P1011, DOI 10.3892/ijo_00000752; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dillon L. M., 2014, ONCOGENE, V6, P328; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaumot M, 2002, J BIOL CHEM, V277, P272, DOI 10.1074/jbc.M108423200; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kaizaki R, 2009, ANTICANCER RES, V29, P2189; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kubota E, 2010, AM J PATHOL, V177, P955, DOI 10.2353/ajpath.2010.091056; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Nakamura K, 2008, ONCOGENE, V27, P2961, DOI 10.1038/sj.onc.1210956; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, J CELL SCI, V114, P1603; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qamra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072473; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 2001, STRUCTURE, V9, P1043, DOI 10.1016/S0969-2126(01)00674-8; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schmidt G, 1996, ONCOGENE, V12, P87; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka Y, 2009, CELL TRANSPLANT, V18, P381, DOI 10.3727/096368909788809794; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yu Y, 2014, STEM CELLS, V32, P349, DOI 10.1002/stem.1447	82	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15892	15903		10.1074/jbc.M115.640607	http://dx.doi.org/10.1074/jbc.M115.640607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25940089	Green Published, hybrid			2022-12-26	WOS:000356527400047
J	Martins-Duarte, ES; Dubar, F; Lawton, P; da Silva, CF; Soeiro, MDC; de Souza, W; Biot, C; Vommaro, RC				Martins-Duarte, Erica S.; Dubar, Faustine; Lawton, Philippe; da Silva, Cristiane Franca; Soeiro, Maria de Nazare C.; de Souza, Wanderley; Biot, Christophe; Vommaro, Rossiane C.			Ciprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondii	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IN-VITRO; CRYPTOSPORIDIUM-PARVUM; APICOMPLEXAN PARASITES; OCULAR TOXOPLASMOSIS; DRUG TARGET; APICOPLAST; PYRIMETHAMINE; ORGANELLE; SULFADIAZINE	Toxoplasmosis, caused by the protozoan Toxoplasma gondii, is a worldwide disease whose clinical manifestations include encephalitis and congenital malformations in newborns. Previously, we described the synthesis of new ethyl-ester derivatives of the antibiotic ciprofloxacin with similar to 40-fold increased activity against T. gondii in vitro, compared with the original compound. Cipro derivatives are expected to target the parasite's DNA gyrase complex in the apicoplast. The activity of these compounds in vivo, as well as their mode of action, remained thus far uncharacterized. Here, we examined the activity of the Cipro derivatives in vivo, in a model of acute murine toxoplasmosis. In addition, we investigated the cellular effects T. gondii tachyzoites in vitro, by immunofluorescence and transmission electron microscopy (TEM). When compared with Cipro treatment, 7-day treatments with Cipro derivatives increased mouse survival significantly, with 13-25% of mice surviving for up to 60 days post-infection (vs. complete lethality 10 days post-infection, with Cipro treatment). Light microscopy examination early (6 and 24h) post-infection revealed that 6-h treatments with Cipro derivatives inhibited the initial event of parasite cell division inside host cells, in an irreversible manner. By TEM and immunofluorescence, the main cellular effects observed after treatment with Cipro derivatives and Cipro were cell scission inhibition with the appearance of 'tethered' parasites -malformation of the inner membrane complex, and apicoplast enlargement and missegregation. Interestingly, tethered daughter cells resulting from Cipro derivatives, and also Cipro, treatment did not show MORN1 cap or centrocone localization. The biological activity of Cipro derivatives against C. parvum, an apicomplexan species that lacks the apicoplast, is, approximately, 50 fold lower than that in T. gondii tachyzoites, supporting that these compounds targets the apicoplast. Our results show that Cipro derivatives improved the survival of mice acutely infected with T. gondii and inhibited parasite replication early in the first cycle of infection in vitro, highlighting their therapeutic potential for the treatment of toxoplasmosis.	[Martins-Duarte, Erica S.; de Souza, Wanderley; Vommaro, Rossiane C.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Martins-Duarte, Erica S.; de Souza, Wanderley; Vommaro, Rossiane C.] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Dubar, Faustine; Biot, Christophe] Univ Lille 1, UGSF, F-59650 Villeneuve Dascq, France; [Dubar, Faustine] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Lawton, Philippe] Univ Lyon 1, ISPB, Fac Pharm, F-69365 Lyon, France; [da Silva, Cristiane Franca; Soeiro, Maria de Nazare C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Celular, BR-21045900 Rio De Janeiro, Brazil; [de Souza, Wanderley] Inst Nacl Metrol Qualidade & Tecnol Inmetro, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Fundacao Oswaldo Cruz; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	Vommaro, RC (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	vommaro@biof.ufrj.br	de Nazaré Correia Soeiro, Maria/S-1894-2019; vommaro, Rossiane/AAD-7193-2021; Biot, Christophe/ABG-3796-2020; Lawton, Philippe/A-6656-2009; Martins-Duarte, Erica S./A-9878-2017	de Nazaré Correia Soeiro, Maria/0000-0003-0078-6106; Biot, Christophe/0000-0002-7396-1959; Lawton, Philippe/0000-0003-1661-8705; Martins-Duarte, Erica S./0000-0003-0925-6953; Dubar, Faustine/0000-0002-0233-7067	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro); Programa de Nucleos de Excelencia-Pronex-FAPERJ-CNPq; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq; FAPERJ	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia-Pronex-FAPERJ-CNPq; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding: The work was supported by grants from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro), Programa de Nucleos de Excelencia-Pronex-FAPERJ-CNPq, and fellowships from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), CNPq and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo J Fernando, 2010, Int Ophthalmol Clin, V50, P57, DOI 10.1097/IIO.0b013e3181d26bf4; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Charron AJ, 2002, J CELL SCI, V115, P3049; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; da Silva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030356; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dar MA, 2007, EUKARYOT CELL, V6, P398, DOI 10.1128/EC.00357-06; DEROUIN F, 1992, ANTIMICROB AGENTS CH, V36, P997, DOI 10.1128/AAC.36.5.997; Dubar F, 2011, MEDCHEMCOMM, V2, P430, DOI 10.1039/c1md00022e; Dubar F, 2009, J MED CHEM, V52, P7954, DOI 10.1021/jm901357n; FICHERA ME, 1995, ANTIMICROB AGENTS CH, V39, P1530, DOI 10.1128/AAC.39.7.1530; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Fleige T, 2008, CURR DRUG TARGETS, V9, P948, DOI 10.2174/138945008786786073; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Goodman CD, 2013, EXPERT OPIN THER TAR, V17, P167, DOI 10.1517/14728222.2013.739158; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Gouvea LR, 2013, BIOMETALS, V26, P813, DOI 10.1007/s10534-013-9661-z; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; Iaccheri B, 2008, CLIN THER, V30, P2069, DOI 10.1016/j.clinthera.2008.10.021; Johannes CB, 2007, DRUG SAFETY, V30, P705, DOI 10.2165/00002018-200730080-00007; Khan AA, 1996, ANTIMICROB AGENTS CH, V40, P1855, DOI 10.1128/AAC.40.8.1855; Khan AA, 2001, ANTIMICROB AGENTS CH, V45, P48, DOI 10.1128/AAC.45.1.48-51.2001; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lawton P, 1997, J EUKARYOT MICROBIOL, V44, p66S, DOI 10.1111/j.1550-7408.1997.tb05783.x; Lawton P, 2003, FEMS MICROBIOL LETT, V226, P39, DOI 10.1016/S0378-1097(03)00555-X; Lorestani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012302; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Martins-Duarte ED, 2008, FEMS MICROBIOL LETT, V282, P290, DOI 10.1111/j.1574-6968.2008.01130.x; Martins-Duarte ES, 2013, EXP PARASITOL, V133, P294, DOI 10.1016/j.exppara.2012.12.011; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 1997, J CELL SCI, V110, P35; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Ouologuem DT, 2014, J CELL SCI, V127, P3320, DOI 10.1242/jcs.147736; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; PFEFFERKORN ER, 1994, ANTIMICROB AGENTS CH, V38, P31, DOI 10.1128/AAC.38.1.31; Ram EVSR, 2007, MOL BIOCHEM PARASIT, V154, P30, DOI 10.1016/j.molbiopara.2007.04.001; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; ROMAND S, 1993, ANTIMICROB AGENTS CH, V37, P2371, DOI 10.1128/AAC.37.11.2371; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; Weissig V, 1997, DNA CELL BIOL, V16, P1483, DOI 10.1089/dna.1997.16.1483; Wiesner J, 2008, CURR PHARM DESIGN, V14, P855, DOI 10.2174/138161208784041105; Woods KM, 1996, ANN TROP MED PARASIT, V90, P603, DOI 10.1080/00034983.1996.11813090; Zhu G, 2000, MICROBIOL-SGM, V146, P315, DOI 10.1099/00221287-146-2-315	56	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125705	10.1371/journal.pone.0125705	http://dx.doi.org/10.1371/journal.pone.0125705			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950173	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400042
J	SanGiovanni, JP; Chen, J; Gupta, AS; Smith, LEH; Sapieha, P; Lee, PH				SanGiovanni, John Paul; Chen, Jing; Gupta, Ankur S.; Smith, Lois E. H.; Sapieha, Przemyslaw; Lee, Phil H.			Netrin-1-DCC Signaling Systems and Age-Related Macular Degeneration	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANGIOGENESIS; HYPOXIA; DISEASE; GROWTH	We conducted a nested candidate gene study and pathway-based enrichment analysis on data from a multi-national 77,000-person project on the molecular genetics of age-related macular degeneration (AMD) to identify AMD-associated DNA-sequence variants in genes encoding constituents of a netrin-1 (NTN1)-based signaling pathway that converges on DNA-binding transcription complexes through a 3'-5'-cyclic adenosine monophosphate-calcineurin (cAMP-CN)-dependent axis. AMD-associated single nucleotide polymorphisms (SNPs) existed in 9 linkage disequilibrium-independent genomic regions; these included loci overlapping NTN1 (rs9899630, P <= 9.48 x 10(-5)), DCC (Deleted in Colorectal Cancer)-the gene encoding a primary NTN1 receptor (rs8097127, P <= 3.03 x 10(-5)), and 6 other netrin-related genes. Analysis of the NTN1-DCC pathway with exact methods demonstrated robust enrichment with AMD-associated SNPs (corrected P-value = 0.038), supporting the idea that processes driven by NTN1-DCC signaling systems operate in advanced AMD. The NTN1-DCC pathway contains targets of FDA-approved drugs and may offer promise for guiding applied clinical research on preventive and therapeutic interventions for AMD.	[SanGiovanni, John Paul] NIAAA, Sect Nutr Neurosci, NIH, Bethesda, MD 20892 USA; [Chen, Jing; Smith, Lois E. H.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA USA; [Gupta, Ankur S.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Sapieha, Przemyslaw] Univ Montreal, Dept Ophthalmol, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Lee, Phil H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Analyt & Translat Genet Unit,Ctr Human Genet Res, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Harvard University; Boston Children's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital	SanGiovanni, JP (corresponding author), NIAAA, Sect Nutr Neurosci, NIH, Bethesda, MD 20892 USA.	jpsangio@post.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020		Canadian Institutes of Health Research [221478]; Foundation Fighting Blindness; U.S. National Institute of Mental Health (NIMH) grant [K99MH101367]; U.S. National Eye Institute [NEI EY022274, EY017017, PO1 HD18655, R01 EY024963]; Lowey Medical Research Institute; European Commission FP7 Project [305485]; NIH Intramural Research Program; Bright Focus Foundation; NATIONAL EYE INSTITUTE [R01EY017017, R01EY024963] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness(European Commission); U.S. National Institute of Mental Health (NIMH) grant; U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lowey Medical Research Institute; European Commission FP7 Project; NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bright Focus Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	PS holds a Canada Research Chair in Retinal Cell Biology and is supported by operating grants from the Canadian Institutes of Health Research (221478) and the Foundation Fighting Blindness. PHL is supported by U.S. National Institute of Mental Health (NIMH) grant K99MH101367. LEHS was supported by grants from the U.S. National Eye Institute (NEI EY022274, EY017017, PO1 HD18655), The Lowey Medical Research Institute, European Commission FP7 Project 305485 PREVENT-ROP. JPSG was supported by the NIH Intramural Research Program. JC was supported by the Bright Focus Foundation and a grant from the U.S. National Eye Institute (R01 EY024963). None of these funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Extant GWA study findings were published by Fritsche et al.[12] The data used for the original genetic analyses were obtained from the NEI Study of Age-Related Macular Degeneration (NEI-AMD) Database found at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id = phs000182.v2.p1 (dbGaP Study Accession: phs000182.v2.p1). We thank NEI-AMD and AGC participants and the NEI-AMD and AGC Research Groups for their valuable contributions to this research project. JPSG was supported by the NIH Intramural Research Program. PS holds a Canada Research Chair in Retinal Cell Biology and is supported by operating grants from the Canadian Institutes of Health Research (221478) and the Foundation Fighting Blindness.	Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; Bretz CA, 2013, INVEST OPHTH VIS SCI, V54, P7020, DOI 10.1167/iovs.13-12183; Cho YG, 2011, LAB INVEST, V91, P519, DOI 10.1038/labinvest.2010.184; de Frutos S, 2010, AM J PHYSIOL-HEART C, V299, pH356, DOI 10.1152/ajpheart.00341.2010; Edwards AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003813; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gomez MF, 2003, J BIOL CHEM, V278, P46847, DOI 10.1074/jbc.M304765200; Gorin MB, 2012, MOL ASPECTS MED, V33, P467, DOI 10.1016/j.mam.2012.04.004; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Riveros C, 2015, METHODS MOL BIOL, V1253, P217, DOI 10.1007/978-1-4939-2155-3_12; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; SanGiovanni JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071239; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125548	10.1371/journal.pone.0125548	http://dx.doi.org/10.1371/journal.pone.0125548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4RU	25950802	Green Submitted, Green Published, gold			2022-12-26	WOS:000367788800006
J	Wang, L; Xing, J; Cheng, R; Shao, Y; Li, P; Zhu, ST; Zhang, ST				Wang, Li; Xing, Jie; Cheng, Rui; Shao, Ying; Li, Peng; Zhu, Shengtao; Zhang, Shutian			Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ETS FAMILY; EXPRESSION; CANCER	Esophageal cancer is one of the most common malignant cancers worldwide. The molecular mechanism of esophageal squamous cell carcinoma (ESCC) is still poorly understood. ESE3 is a member of the Ets transcription family, which is only expressed in epithelial tissues and acts as a tumor suppressor gene in prostate cancer. Our study aim was to confirm whether ESE3 is involved in the carcinogenesis of ESCC. Immunohistochemical analysis revealed that ESE3 was mainly located in cell nuclei of normal tissues and the cytoplasm in ESCC tissues. Immunofluorescence and western blot analyses of the normal esophageal cell line HEEpiC and ESCC cell lines EC9706 TE-1, KYSE150, and KYSE410 confirmed these results. pEGFP-ESE3 and pcDNA3.1-V5/HisA-ESE3 plasmids were constructed for overexpression of ESE3 in EC9706 and KYSE150 cells. The stably transfected cells showed restoration of the nuclear localization of ESE3. EC9706 cells with re-localization of ESE3 to the nucleus showed inhibition of proliferation, colony formation, migration, and invasion. To explore the possible mechanism of the differences in localization of ESE3 in normal esophageal cells and ESCC cells, ESCC cell lines were treated with the nuclear export inhibitor leptomycin B, transcription inhibitor actinomycin D, PKC inhibitor sphinganine, P38 MAPK inhibitor SB202190, and CK II inhibitor TBCA. These reagents were chosen according to the well-known mechanisms of protein translocation. However, the localization of ESE3 was unchanged after these treatments. The sequence of ESE3 cDNA in ESCC cells was identical to the standard sequence of ESE3 in the NCBI Genebank database, indicating that there was no mutation in the coding region of ESE3 in ESCC. Taken together, our study suggests that ESE3 plays an important role in the carcinogenesis of ESCC through changes in subcellular localization and may act as a tumor suppressor gene in ESCC, although the mechanisms require further study.	[Wang, Li; Xing, Jie; Cheng, Rui; Shao, Ying; Li, Peng; Zhu, Shengtao; Zhang, Shutian] Capital Med Univ, Natl Clin Res Ctr Digest Dis, Beijing Key Lab Precancerous Les Digest Dis,Beiji, Dept Gastroenterol & Hepatol,Beijing Digest Dis C, Beijing, Peoples R China	Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Natl Clin Res Ctr Digest Dis, Beijing Key Lab Precancerous Les Digest Dis,Beiji, Dept Gastroenterol & Hepatol,Beijing Digest Dis C, Beijing, Peoples R China.	zhangst0612@126.com			Natural Science Foundation of China [81272447]; National Key Basic Research Program of China [2012CB526601]; Beijing National Science Foundation Program; Science Research Key Program of Beijing Municipal Commission of Education [KZ201410025024]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Beijing National Science Foundation Program; Science Research Key Program of Beijing Municipal Commission of Education	This study was supported by Natural Science Foundation of China (81272447), and the National Key Basic Research Program of China (2012CB526601), and Beijing National Science Foundation Program and Science Research Key Program of Beijing Municipal Commission of Education (KZ201410025024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Chen XC, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-40; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kleinbaum LA, 1999, BIOCHEM BIOPH RES CO, V264, P119, DOI 10.1006/bbrc.1999.1493; Lehrbach Dárcio Matenhauer, 2003, Arq. Gastroenterol., V40, P256, DOI 10.1590/S0004-28032003000400011; Neary CL, 2010, BIOCHEM BIOPH RES CO, V394, P1075, DOI 10.1016/j.bbrc.2010.03.129; Oh HM, 2012, J BIOL CHEM, V287, P30436, DOI 10.1074/jbc.M112.359661; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Souissi I, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-14; Sprater F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049577; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223	17	8	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126319	10.1371/journal.pone.0126319	http://dx.doi.org/10.1371/journal.pone.0126319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950810	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400078
J	Wang, Q; Mao, DQ; Mu, QH; Luo, Y				Wang, Qing; Mao, Daqing; Mu, Quanhua; Luo, Yi			Enhanced Horizontal Transfer of Antibiotic Resistance Genes in Freshwater Microcosms Induced by an Ionic Liquid	PLOS ONE			English	Article							ACTIVATED-SLUDGE; ESCHERICHIA-COLI; OUTER-MEMBRANE; PLASMID RP4; IN-SITU; ANTIMICROBIAL ACTIVITY; BACTERIAL; SOIL; IMIDAZOLIUM; CONJUGATION	The spread and propagation of antibiotic resistance genes (ARGs) is a worldwide public health concern. Ionic liquids (ILs), considered as "environmentally friendly" replacements for industrial organic solvents, have been widely applied in modern industry. However, few data have been collected regarding the potential ecological and environmental risks of ILs, which are important for preparing for their potential discharge into the environment. In this paper, the IL 1-butyl-3-methylimidazolium hexafluorophosphate ([BMIm][PF6]) (0.001-5.0 g/L) was tested for its effects on facilitating ARGs horizontal transfer mediated by plasmid RP4 in freshwater microcosms. In the horizontal transfer microcosms, the transfer frequency of plasmid RP4 was significantly enhanced (60-fold higher than untreated groups) by the IL [BMIm][PF6] (1.0 g/L). Meanwhile, two strains of opportunistic pathogen Acinetobacter spp. and Salmonella spp. were isolated among the transconjugants, illustrating plasmid RP4 mediated horizontal transfer of ARGs occurred in pathogen. This could increase the risk of ARGs dissemination to human pathogens and pose great threat to public health. The cause that [BMIm[PF6] enhanced the transfer frequency of plasmid RP4 was proposed by suppressed cell membrane barrier and enhanced cell membrane permeability, which was evidenced by flow cytometry (FCM). This is the first report that some ILs facilitate horizontal transfer of plasmid RP4 which is widely distributed in the environment and thus add the adverse effects of the environmental risk of ILs.	[Wang, Qing; Mu, Quanhua; Luo, Yi] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China; [Mao, Daqing] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China	Nankai University; Tianjin University	Mao, DQ (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.	mao@tju.edu.cn; luoy@nankai.edu.cn	Luo, Yi/C-2451-2018		Ministry of Education, People's Republic of China [IRT13024]; National Natural Science Foundation of China [21277075, 31270542]; Ministry of Education program for New Century Excellent Talents [NCET-11-0254]	Ministry of Education, People's Republic of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education program for New Century Excellent Talents	This work was supported by the Ministry of Education, People's Republic of China as an innovative research team project (grant No. IRT13024), National Natural Science Foundation of China (Grants 21277075 and 31270542) (http://www.nsfc.gov.cn/), and the Ministry of Education program for New Century Excellent Talents (NCET-11-0254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; Agerso Y, 2007, J ANTIMICROB CHEMOTH, V59, P23, DOI 10.1093/jac/dkl419; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Berglund B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108151; Burch TR, 2014, ENVIRON SCI TECHNOL, V48, P5620, DOI 10.1021/es501098g; Chen B, 2014, ENVIRON SCI TECHNOL, V7, P12753; Cheng WX, 2013, ENVIRON INT, V61, P1, DOI 10.1016/j.envint.2013.08.023; Colomer-Lluch M, 2014, ENVIRON INT, V73, P167, DOI 10.1016/j.envint.2014.07.003; Daane LL, 1997, APPL ENVIRON MICROB, V63, P679, DOI 10.1128/AEM.63.2.679-686.1997; de Maria PD, 2011, CURR OPIN CHEM BIOL, V15, P220, DOI 10.1016/j.cbpa.2010.11.008; Docherty KM, 2005, GREEN CHEM, V7, P185, DOI 10.1039/b419172b; Dodd MC, 2012, J ENVIRON MONITOR, V14, P1754, DOI 10.1039/c2em00006g; Earle MJ, 2000, PURE APPL CHEM, V72, P1391, DOI 10.1351/pac200072071391; Ganske F, 2006, BIOTECHNOL LETT, V28, P465, DOI 10.1007/s10529-006-0006-7; Geisenberger O, 1999, FEMS MICROBIOL LETT, V174, P9, DOI 10.1111/j.1574-6968.1999.tb13543.x; Guglielmini J, 2014, NUCLEIC ACIDS RES, V42, P5715, DOI 10.1093/nar/gku194; Hausner M, 1999, APPL ENVIRON MICROB, V65, P3710; HENSCHKE RB, 1990, CURR MICROBIOL, V20, P105, DOI 10.1007/BF02092881; Inoue D, 2005, J BIOSCI BIOENG, V100, P600, DOI 10.1263/jbb.100.600; Kelman D, 2001, AQUAT MICROB ECOL, V24, P9, DOI 10.3354/ame024009; Khudyakov JI, 2012, P NATL ACAD SCI USA, V109, pE2173, DOI 10.1073/pnas.1112750109; Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300; Kubisa P, 2005, J POLYM SCI POL CHEM, V43, P4675, DOI 10.1002/pola.20971; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lavigne JP, 2012, CLIN MICROBIOL INFEC, V18, P539, DOI 10.1111/j.1469-0691.2011.03607.x; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li GJ, 1998, J APPL POLYM SCI, V67, P1761, DOI 10.1002/(SICI)1097-4628(19980307)67:10<1761::AID-APP9>3.0.CO;2-H; Li ZH, 2008, CURR OPIN SOLID ST M, V12, P1, DOI 10.1016/j.cossms.2009.01.002; Liu JF, 2005, TRAC-TREND ANAL CHEM, V24, P20, DOI 10.1016/j.trac.2004.09.005; Lu JM, 2009, PROG POLYM SCI, V34, P431, DOI 10.1016/j.progpolymsci.2008.12.001; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; MANCEAU C, 1986, CAN J MICROBIOL, V32, P835, DOI 10.1139/m86-154; Markiewicz M, 2013, ENVIRON SCI TECHNOL, V47, P6951, DOI 10.1021/es304568w; Marti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078906; Mispagel H, 2005, WATER ENVIRON RES, V77, P2996, DOI 10.2175/106143005X73875; Nancharaiah YV, 2012, BIOFOULING, V28, P1141, DOI 10.1080/08927014.2012.736966; NIKAIDO H, 1988, J ANTIMICROB CHEMOTH, V22, P17, DOI 10.1093/jac/22.Supplement_A.17; OECD, 2002, AER AN TRANSF AQ SED; Olivier H, 1999, J MOL CATAL A-CHEM, V146, P285, DOI 10.1016/S1381-1169(99)00114-4; OSBORN MJ, 1980, ANNU REV MICROBIOL, V34, P369, DOI 10.1146/annurev.mi.34.100180.002101; Ozkanca R, 2002, J APPL MICROBIOL, V92, P1097, DOI 10.1046/j.1365-2672.2002.01642.x; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pernak J, 2003, GREEN CHEM, V5, P52, DOI 10.1039/b207543c; Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Qiu ZG, 2012, P NATL ACAD SCI USA, V109, P4944, DOI 10.1073/pnas.1107254109; Ranke J, 2004, ECOTOX ENVIRON SAFE, V58, P396, DOI 10.1016/S0147-6513(03)00105-2; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Romero A, 2008, J HAZARD MATER, V151, P268, DOI 10.1016/j.jhazmat.2007.10.079; Roosen C, 2008, APPL MICROBIOL BIOT, V81, P607, DOI 10.1007/s00253-008-1730-9; Soda S, 2008, J BIOSCI BIOENG, V106, P292, DOI 10.1263/jbb.106.292; Sorensen S J, 1993, Microb Releases, V2, P135; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorensen SJ, 1999, APPL SOIL ECOL, V11, P79; Stepnowski P, 2005, ANAL BIOANAL CHEM, V381, P189, DOI 10.1007/s00216-004-2932-3; Su JQ, 2014, ENVIRON INT, V65, P9, DOI 10.1016/j.envint.2013.12.010; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Van Meervenne E, 2012, BIOMED RES INT, V2012, P1; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Wishart JF, 2009, ENERG ENVIRON SCI, V2, P956, DOI 10.1039/b906273d; Xue Z, 2012, ENVIRON SCI TECHNOL, V46, P13212, DOI 10.1021/es3031165; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	72	17	19	6	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126784	10.1371/journal.pone.0126784	http://dx.doi.org/10.1371/journal.pone.0126784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951456	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400109
J	Dai, X; Jiang, Y; Tan, C				Dai, Xin; Jiang, Ying; Tan, Chalet			Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; PANCREATIC-CANCER CELLS; III BETA-TUBULIN; LUNG-CANCER; RIBONUCLEOTIDE REDUCTASE; EXPRESSION; RESISTANCE; ADENOCARCINOMA; GEMCITABINE; HMGA2	KRAS is the most commonly mutated oncogene in human cancers and is associated with poor prognosis and drug resistance. Let-7 is a family of tumor suppressor microRNAs that are frequently suppressed in solid tumors, where KRAS mutations are highly prevalent. In this study, we investigated the potential use of let-7 as a chemosensitizer. We found that let-7b repletion selectively sensitized KRAS mutant tumor cells to the cytotoxicity of paclitaxel and gemcitabine. Transfection of let-7b mimic downregulated the expression of mutant but not wild-type KRAS. Combination of let-7b mimic with paclitaxel or gemcitabine diminished MEK/ERK and PI3K/AKT signaling concurrently, triggered the onset of apoptosis, and reverted the epithelial-mesenchymal transition in KRAS mutant tumor cells. In addition, let-7b repletion downregulated the expression of beta-tubulin III and ribonucleotide reductase subunit M2, two proteins known to mediate tumor resistance to paclitaxel and gemcitabine, respectively. Let-7 may represent a new class of chemosensitizer for the treatment of KRAS mutant tumors.	[Dai, Xin; Jiang, Ying; Tan, Chalet] Mercer Univ, Dept Pharmaceut Sci, Atlanta, GA 30341 USA	Mercer University	Tan, C (corresponding author), Mercer Univ, Dept Pharmaceut Sci, Atlanta, GA 30341 USA.	tan_c@mercer.edu			National Institutes of Health [R15CA152860]; NATIONAL CANCER INSTITUTE [R15CA152860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant R15CA152860 (CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, BRIT J CANCER, V89, P2104, DOI 10.1038/sj.bjc.6601391; Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bunn PA, 1998, CLIN CANCER RES, V4, P1087; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Cihalova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083467; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Collins MA, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00407; Cui SY, 2013, MOL CANCER RES, V11, P699, DOI 10.1158/1541-7786.MCR-13-0019-T; Dumontet Charles, 2005, Bull Cancer, V92, pE25; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; ERIKSSON S, 1981, J BIOL CHEM, V256, P9436; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Goan YG, 1999, CANCER RES, V59, P4204; Guo Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-41; Han L, 2013, INT J CLIN EXP PATHO, V6, P2357; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Lee KM, 2007, HISTOPATHOLOGY, V51, P539, DOI 10.1111/j.1365-2559.2007.02792.x; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Levallet G, 2012, MOL CANCER THER, V11, P1203, DOI 10.1158/1535-7163.MCT-11-0899; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Maeda S, 2011, INT J CLIN ONCOL, V16, P539, DOI 10.1007/s10147-011-0220-8; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Moqadam FA, 2013, LEUKEMIA, V27, P16, DOI 10.1038/leu.2012.179; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Su HT, 2013, MOL CANCER RES, V11, P768, DOI 10.1158/1541-7786.MCR-12-0511; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yuan TL, 2014, CANCER DISCOV, V4, P1182, DOI 10.1158/2159-8290.CD-13-0900	55	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126653	10.1371/journal.pone.0126653	http://dx.doi.org/10.1371/journal.pone.0126653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946136	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700138
J	Dutta, T; Sharma, S; Maldonado, JE; Panwar, HS; Seidensticker, J				Dutta, Trishna; Sharma, Sandeep; Maldonado, Jesus E.; Panwar, Hemendra Singh; Seidensticker, John			Genetic Variation, Structure, and Gene Flow in a Sloth Bear (Melursus ursinus) Meta-Population in the Satpura-Maikal Landscape of Central India	PLOS ONE			English	Article							COMPUTER-PROGRAM; MADHYA-PRADESH; BLACK BEAR; INDIVIDUAL IDENTIFICATION; RECENT MIGRATION; PANTHERA-PARDUS; BROWN BEARS; FRAGMENTATION; DNA; CONSERVATION	Sloth bears (Melursus ursinus) are endemic to the Indian subcontinent. As a result of continued habitat loss and degradation over the past century, sloth bear populations have been in steady decline and now exist only in isolated or fragmented habitat across the entire range. We investigated the genetic connectivity of the sloth bear meta-population in five tiger reserves in the Satpura-Maikal landscape of central India. We used noninvasively collected fecal and hair samples to obtain genotypic information using a panel of seven polymorphic loci. Out of 194 field collected samples, we identified 55 individuals in this meta-population. We found that thismeta-population has moderate genetic variation, and is subdivided into two genetic clusters. Further, we identified five first-generationmigrants and signatures of contemporary gene flow. We found evidence of sloth bears in the corridor between the Kanha and Pench Tiger Reserves, and our results suggest that habitat connectivity and corridors play an important role inmaintaining gene flow in this meta-population. These corridors face several anthropogenic and infrastructure development threats that have the potential to sever ongoing gene flow, if policies to protect them are not put into action immediately.	[Dutta, Trishna; Sharma, Sandeep; Maldonado, Jesus E.; Seidensticker, John] Smithsonian Conservat Biol Inst, Washington, DC 20560 USA; [Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DC 20560 USA; [Panwar, Hemendra Singh] Peace Inst Charitable Trust, Delhi, India	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History	Dutta, T (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20560 USA.	trishnad@gmail.com	Maldonado, Jesus/AIE-8664-2022; Sharma, Sandeep/C-2892-2012	Maldonado, Jesus/0000-0002-4282-1072; Dutta, Trishna/0000-0002-5236-2658	International Bear Association (IBA); Smithsonian Conservation Biology Institute (SCBI); Friends of the National Zoo (FONZ); Kathryn Fuller Science for Nature Fund of the World Wildlife Fund (WWF)	International Bear Association (IBA); Smithsonian Conservation Biology Institute (SCBI); Friends of the National Zoo (FONZ); Kathryn Fuller Science for Nature Fund of the World Wildlife Fund (WWF)	This project was funded by the International Bear Association (IBA), Smithsonian Conservation Biology Institute (SCBI), Friends of the National Zoo (FONZ), and Kathryn Fuller Science for Nature Fund of the World Wildlife Fund (WWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2004, URSUS, V15, P203, DOI 10.2192/1537-6176(2004)015<0203:SBHUID>2.0.CO;2; Areendran G, 2012, ASIAN J GEOINFORMATI, V12; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Bargali HS, 2004, URSUS, V15, P212, DOI 10.2192/1537-6176(2004)015<0212:FEOSBI>2.0.CO;2; BEEHLER BM, 1987, IBIS, V129, P197, DOI 10.1111/j.1474-919X.1987.tb03201.x; Bellemain E, 2007, BIOL CONSERV, V134, P537, DOI 10.1016/j.biocon.2006.09.004; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Cronin MA, 2006, CAN J ZOOL, V84, P655, DOI 10.1139/Z06-039; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Dixon JD, 2007, CONSERV GENET, V8, P455, DOI 10.1007/s10592-006-9184-z; Dutta T, 2013, EVOL APPL, V6, P949, DOI 10.1111/eva.12078; Dutta T, 2013, DIVERS DISTRIB, V19, P760, DOI 10.1111/ddi.12024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; GOPAL R, 1991, Indian Forester, V117, P915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harris L.D., 1984, FRAGMENTED FOREST IS; Harris Larry D., 1992, P197; Jena J., 2011, LIFELINE TIGERS STAT; Jhala Y. V., 2011, STATUS TIGERS COPRED; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kaczensky P, 2003, BIOL CONSERV, V111, P191, DOI 10.1016/S0006-3207(02)00273-2; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Krishnan M., 1972, J BOMBAY NATURAL HIS, V69, P47; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Larkin JL, 2004, ANIM CONSERV, V7, P23, DOI 10.1017/S1367943003001100; Lloyd MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063981; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peyton B., 1999, BEARS STATUS SURVEY; Piggott MP, 2004, CONSERV GENET, V5, P417, DOI 10.1023/B:COGE.0000031138.67958.44; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pragatheesh A., 2013, Oecologia Australis, V17, P20; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Rajpurohit KS, 2000, WILDLIFE SOC B, V28, P393; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ratnayeke S, 2007, URSUS, V18, P189, DOI 10.2192/1537-6176(2007)18[189:LCOSBR]2.0.CO;2; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rutledge LY, 2009, J WILDLIFE MANAGE, V73, P1430, DOI 10.2193/2008-492; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Sathyakumar S., 2012, NATL BEAR CONSERVATI; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sawaya MA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1705; Seidensticker John, 2011, P217; SENGUPTA M., 1993, ENV IMPACTS MINING M; Sharma S, 2013, URSUS, V24, P164, DOI 10.2192/URSUS-D-13-00001.1; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tallmon DA, 2004, J WILDLIFE MANAGE, V68, P960, DOI 10.2193/0022-541X(2004)068[0960:GMOSBB]2.0.CO;2; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wilson GA, 2003, GENETICS, V163, P1177; Yoganand K., 2006, Journal of the Bombay Natural History Society, V103, P172; [No title captured]	72	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123384	10.1371/journal.pone.0123384	http://dx.doi.org/10.1371/journal.pone.0123384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945939	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700013
J	Flaquer, A; Rospleszcz, S; Reischl, E; Zeilinger, S; Prokisch, H; Meitinger, T; Meisinger, C; Peters, A; Waldenberger, M; Grallert, H; Strauch, K				Flaquer, Antonia; Rospleszcz, Susanne; Reischl, Eva; Zeilinger, Sonja; Prokisch, Holger; Meitinger, Thomas; Meisinger, Christa; Peters, Annette; Waldenberger, Melanie; Grallert, Harald; Strauch, Konstantin			Mitochondrial GWA Analysis of Lipid Profile Identifies Genetic Variants to Be Associated with HDL Cholesterol and Triglyceride Levels	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; GENDER-DIFFERENCES; ENDOTHELIAL-CELLS; DYSFUNCTION; LOCI; ACCUMULATION; MUTATIONS	It has been suggested that mitochondrial dysfunction has an influence on lipid metabolism. The fact that mitochondrial defects can be accumulated over time as a normal part of aging may explain why cholesterol levels often are altered with age. To test the hypothesis whether mitochondrial variants are associated with lipid profile (total cholesterol, LDL, HDL, and triglycerides) we analyzed a total number of 978 mitochondrial single nucleotide polymorphisms (mtSNPs) in a sample of 2,815 individuals participating in the population-based KORA F4 study. To assess mtSNP association while taking the presence of heteroplasmy into account we used the raw signal intensity values measured on the microarray and applied linear regression. Ten mtSNPs (mt3285, mt3336, mt5285, mt6591, mt6671, mt9163, mt13855, mt13958, mt14000, and mt14580) were significantly associated with HDL cholesterol and one mtSNP (mt15074) with triglycerides levels. These results highlight the importance of the mitochondrial genome among the factors that contribute to the regulation of lipid levels. Focusing on mitochondrial variants may lead to further insights regarding the underlying physiological mechanisms, or even to the development of innovative treatments. Since this is the first mitochondrial genome-wide association analysis (mtGWAS) for lipid profile, further analyses are needed to follow up on the present findings.	[Flaquer, Antonia; Rospleszcz, Susanne; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Flaquer, Antonia; Rospleszcz, Susanne; Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Reischl, Eva; Zeilinger, Sonja; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Prokisch, Holger; Meitinger, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Reischl, Eva; Zeilinger, Sonja; Meisinger, Christa; Peters, Annette; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Flaquer, A (corresponding author), Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany.	antonia.flaquer@lmu.de	Waldenberger, Melanie/B-5355-2014; Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014; Grallert, Harald/B-3424-2013; Reischl, Eva/B-9311-2013; Rospleszcz, Susanne/AGF-1630-2022; Meitinger, Thomas/O-1318-2015	Waldenberger, Melanie/0000-0003-0583-5093; Peters, Annette/0000-0001-6645-0985; Reischl, Eva/0000-0003-4055-8060; Rospleszcz, Susanne/0000-0002-4788-2341; Meitinger, Thomas/0000-0002-8838-8403; Prokisch, Holger/0000-0003-2379-6286; Kunze, Sonja/0000-0002-9685-2675; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen - German Research Center for Environmental Health; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, LMUinnovativ	Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, LMUinnovativ	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is founded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260; Acarturk E, 2004, CLIN CHIM ACTA, V339, P123, DOI 10.1016/j.cccn.2003.10.001; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Chang JC, 2010, WORLD J CARDIOL, V2, P150, DOI 10.4330/wjc.v2.i6.150; Chistiakov DA, 2012, WORLD J CARDIOL, V4, P148, DOI 10.4330/wjc.v4.i5.148; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; Davis CE, 1996, AM J EPIDEMIOL, V143, P1100; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Ferrara A, 1997, CIRCULATION, V96, P37; Flaquer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105116; Flaquer A, 2014, MITOCHONDRION, V14, P49, DOI 10.1016/j.mito.2013.11.002; Garcia-Ruiz C, 2009, HISTOL HISTOPATHOL, V24, P117, DOI 10.14670/HH-24.117; Gesquiere L, 1999, FREE RADICAL BIO MED, V27, P134, DOI 10.1016/S0891-5849(99)00055-6; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Giorgio V, 2010, J BIOENERG BIOMEMBR, V42, P117, DOI 10.1007/s10863-010-9270-2; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Pirola CJ, 2013, GUT, V62, P1356, DOI 10.1136/gutjnl-2012-302962; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Kokaze A, 2001, HUM GENET, V109, P521, DOI 10.1007/s004390100602; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee CM, 2005, ATHEROSCLEROSIS, V183, P251, DOI 10.1016/j.atherosclerosis.2005.03.029; Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lluis JM, 2003, GASTROENTEROLOGY, V124, P708, DOI 10.1053/gast.2003.50089; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mangiacapra F, 2012, J CARDIOVASC MED, V13, P439, DOI 10.2459/JCM.0b013e328351725a; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Mascitelli Luca, 2006, Am J Med, V119, pe17, DOI 10.1016/j.amjmed.2005.10.044; MCNAMARA JR, 1987, ARTERIOSCLEROSIS, V7, P483, DOI 10.1161/01.ATV.7.5.483; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; National Institutes of Health MP, 2014, USMARCH, DOI [10.1155/2014/109263, DOI 10.1155/2014/109263]; Puddu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-112; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ravnskov U, 2002, QJM-INT J MED, V95, P397, DOI 10.1093/qjmed/95.6.397; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Robbesyn F, 2003, FASEB J, V17, P743, DOI 10.1096/fj.02-0240fje; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; ROUSLIN W, 1982, AM J PHYSIOL, V242, pH254, DOI 10.1152/ajpheart.1982.242.2.H254; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151; SEIDELL JC, 1991, ATHEROSCLEROSIS, V87, P203, DOI 10.1016/0021-9150(91)90022-U; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sobenin IA, 2013, WORLD J CARDIOL, V5, P132, DOI 10.4330/wjc.v5.i5.132; Sobenin IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046573; Suc I, 1997, ARTERIOSCL THROM VAS, V17, P2158, DOI 10.1161/01.ATV.17.10.2158; Sugano M, 2000, BIOCHEM BIOPH RES CO, V272, P872, DOI 10.1006/bbrc.2000.2877; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Toth PP, 2005, CIRCULATION, V111, pE89, DOI 10.1161/01.CIR.0000154555.07002.CA; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wallace DC, 2013, COLD SPRING HARB PER, V3; Weijenberg MP, 1996, AM J PUBLIC HEALTH, V86, P798, DOI 10.2105/AJPH.86.6.798; West R, 2008, AM J GERIAT PSYCHIAT, V16, P781, DOI 10.1097/JGP.0b013e3181812790; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200	77	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126294	10.1371/journal.pone.0126294	http://dx.doi.org/10.1371/journal.pone.0126294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945934	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700121
J	Houehanou, YCN; Lacroix, P; Mizehoun, GC; Preux, PM; Marin, B; Houinato, DS				Houehanou, Yessito Corine Nadege; Lacroix, Philippe; Mizehoun, Gbedecon Carmelle; Preux, Pierre-Marie; Marin, Benoit; Houinato, Dismand Stephan			Magnitude of Cardiovascular Risk Factors in Rural and Urban Areas in Benin: Findings from a Nationwide Steps Survey	PLOS ONE			English	Article							BLOOD-PRESSURE; PHYSICAL INACTIVITY; PREVALENCE; HYPERTENSION; POPULATION; OBESITY; DISEASE; COMMUNITIES; AWARENESS; ALCOHOL	Data on variations in the frequency of cardiovascular risk factors (CVRF) in sub-Saharan populations are limited, particularly with regard to Benin. Objective To describe and compare the prevalences of CVRF in urban and rural populations of Benin. Methods Subjects were drawn from participants in the Benin Steps survey, a nationwide cross-sectional study conducted in 2008 using the World Health Organisation (WHO) stepwise approach to surveillance of chronic disease risk factors. Subjects aged above 24 and below 65 years were recruited using a five-stage random sampling process within households. Sociodemographic data, behavioral data along with medical history of high blood pressure and diabetes mellitus were collected in Step 1. Anthropometric parameters and blood pressure were measured in Step 2. Blood glucose and cholesterol levels were measured in Step 3. CVRF were defined according to WHO criteria. The prevalences of CVRF were assessed and the relationships between each CVRF and the area of residence (urban or rural), were evaluated using multivariable logistic regression models. Results Of the 6762 subjects included in the study, 2271 were from urban areas and 4491 were from rural areas. High blood pressure was more prevalent in urban than in rural areas, 29.9% (95% confidence intervals (95% CI): 27.4, 32.5) and 27.5% (95% CI: 25.6, 29.5) respectively, p = 0.001 (p-value after adjustment for age and gender). Obesity was more prevalent in urban than in rural areas, 16.4%(95% CI: 14.4, 18.4) and 5.9% (95% CI: 5.1, 6.7), p<0.001. Diabetes was more prevalent in urban than in rural areas, 3.3% (95% CI: 2.1, 4.5) and 1.8% (95% CI: 1.2, 2.4), p = 0.004. Conversely, daily tobacco smoking was more prevalent in rural than in urban areas, 9.3% (95% CI: 8.1, 10.4) and 4.3% (95% CI: 3.1, 5.6), p<0.001. No differences in raised blood cholesterol were noted between the two groups. Conclusion According to our data, CVRF are prevalent among adults in Benin, and variations between rural and urban populations are significant. It may be useful to take account of the heterogeneity in the prevalence of CVRF when planning and implementing preventive interventions.	[Houehanou, Yessito Corine Nadege; Lacroix, Philippe; Mizehoun, Gbedecon Carmelle; Preux, Pierre-Marie; Marin, Benoit; Houinato, Dismand Stephan] INSERM UMR 1094, Trop Neuroepidemiol, Limoges, France; [Houehanou, Yessito Corine Nadege; Houinato, Dismand Stephan] Hlth Minist Benin, Natl Noncommunicable Dis Control Program, Porto Novo, Benin; [Lacroix, Philippe] Univ Hosp Limoges France, Dept Vasc Med, Limoges, France; [Lacroix, Philippe; Preux, Pierre-Marie; Marin, Benoit] Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, CNRS FR GEIST 3503, Limoges, France; [Preux, Pierre-Marie; Marin, Benoit] Univ Hosp Limoges France, Funct Unit Clin Res & Biostat, Limoges, France; [Houehanou, Yessito Corine Nadege; Mizehoun, Gbedecon Carmelle; Houinato, Dismand Stephan] Fac Hlth Sci Cotonou Benin, Lab Noncommunicable & Neurol Dis Epidemiol, Cotonou, Benin	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Limoges; Universite de Franche-Comte; Universite de Limoges; CHU Limoges	Houinato, DS (corresponding author), INSERM UMR 1094, Trop Neuroepidemiol, Limoges, France.	dshouinato@gmail.com	MARIN, Benoit/HHZ-4976-2022; PREUX, Pierre-Marie/B-8393-2014; Preux, Pierre-Marie/N-3538-2019; MARIN, Benoit/E-2356-2015	MARIN, Benoit/0000-0001-8857-0910; PREUX, Pierre-Marie/0000-0002-2171-2977; Preux, Pierre-Marie/0000-0002-2171-2977; MARIN, Benoit/0000-0001-8857-0910	French Ministry of Higher Education; Benin Health Ministry; WHO (World Health Organisation)	French Ministry of Higher Education; Benin Health Ministry; WHO (World Health Organisation)	The first author is a doctoral student at the University of Limoges thanks to a scholarship funded by the French Ministry of Higher Education. Benin steps survey, the database used for this work, was funded by the Benin Health Ministry and the WHO (World Health Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Abubakari AR, 2008, PUBLIC HEALTH, V122, P173, DOI 10.1016/j.puhe.2007.06.012; Adebayo RA, 2013, INT J GEN MED, V6, P863, DOI 10.2147/IJGM.S51906; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Akoha E, 2007, THESIS; Almeida L, 2012, INT J ENV RES PUB HE, V9, P2520, DOI 10.3390/ijerph9072520; [Anonymous], WHO STEPS COUNTR REP; [Anonymous], 2005, PREV CHRON DIS VIT I; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Baragou S, 2012, CARDIOVASC J AFR, V23, P308, DOI 10.5830/CVJA-2011-071; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berthier C, 1998, INSEE SERIE METH STA; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cossi MJ, 2012, CEREBROVASC DIS, V33, P166, DOI 10.1159/000334195; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Fezeu L, 2010, J EPIDEMIOL COMMUN H, V64, P360, DOI 10.1136/jech.2008.086355; Houinato DS, 2012, REV EPIDEMIOL SANTE, V60, P95, DOI 10.1016/j.respe.2011.09.010; Institut national de la statistique et de l'analyse economique du Benin, 2013, RES PROV 4 REC GEN P; Institut national de la statistique et de l'analyse economique (INSAE), 2011, ENQ MOD INT COND VIE; Kasiam Lasi On'kin J B, 2007, Cardiovasc J Afr, V18, P300; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Mensah GA, 2008, HEART, V94, P836, DOI 10.1136/hrt.2007.136523; Ministere de la sante du Benin, 2011, ANN STAT 2010; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Mukamal KJ, 2001, ALCOHOL RES HEALTH, V25, P255; Mumford EA, 2006, TOB CONTROL, V15, P166, DOI 10.1136/tc.2005.012807; Nair P., 1994, Central African Journal of Medicine, V40, P278; Ngoungou EB, 2012, ARCH CARDIOVASC DIS, V105, P77, DOI 10.1016/j.acvd.2011.12.005; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Organisation mondiale de la Sante, 2005, MAN SURV STEPS OMS A; Pessinaba S, 2013, CARDIOVASC J AFR, V24, P180, DOI 10.5830/CVJA-2013-030; Pletcher MJ, 2005, AM J EPIDEMIOL, V161, P423, DOI 10.1093/aje/kwi062; Rouillier P, 2005, ALCOHOL CLIN EXP RES, V29, P84, DOI 10.1097/01.ALC.0000150005.52605.FA; Sobngwi E, 2002, INT J OBESITY, V26, P1009, DOI 10.1038/sj.ijo.0802008; Vander Weg MW, 2011, ADDICT BEHAV, V36, P231, DOI 10.1016/j.addbeh.2010.11.005; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; World Health Organization, 2012, WORLD HLTH STAT 2012	44	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126441	10.1371/journal.pone.0126441	http://dx.doi.org/10.1371/journal.pone.0126441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25945498	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700131
J	Li, R; Knight, JF; Park, M; Pendergast, AM				Li, Ran; Knight, Jennifer F.; Park, Morag; Pendergast, Ann Marie			Abl Kinases Regulate HGF/Met Signaling Required for Epithelial Cell Scattering, Tubulogenesis and Motility	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; BREAST-CANCER CELLS; SRC FAMILY KINASES; C-MET; BCR-ABL; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; DRUG-RESISTANCE; DENDRITIC SPINE	Tight regulation of receptor tyrosine kinases (RTKs) is crucial for normal development and homeostasis. Dysregulation of RTKs signaling is associated with diverse pathological conditions including cancer. The Met RTK is the receptor for hepatocyte growth factor (HGF) and is dysregulated in numerous human tumors. Here we show that Abl family of non-receptor tyrosine kinases, comprised of Abl (ABL1) and Arg (ABL2), are activated downstream of the Met receptor, and that inhibition of Abl kinases dramatically suppresses HGF-induced cell scattering and tubulogenesis. We uncover a critical role for Abl kinases in the regulation of HGF/Met-dependent RhoA activation and RhoA-mediated actomyosin contractility and actin cytoskeleton remodeling in epithelial cells. Moreover, treatment of breast cancer cells with Abl inhibitors markedly decreases Met-driven cell migration and invasion. Notably, expression of a transforming mutant of the Met receptor in the mouse mammary epithelium results in hyper-activation of both Abl and Arg kinases. Together these data demonstrate that Abl kinases link Met activation to Rho signaling and Abl kinases are required for Met-dependent cell scattering, tubulogenesis, migration, and invasion. Thus, inhibition of Abl kinases might be exploited for the treatment of cancers driven by hyperactivation of HGF/Met signaling.	[Li, Ran; Pendergast, Ann Marie] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Knight, Jennifer F.; Park, Morag] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ, Canada	Duke University; McGill University; McGill University; McGill University	Pendergast, AM (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	ann.pendergast@duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	National Institutes of Health Grant [R01 CA155160, R01 CA070940]; Terry Fox New Frontier Grant; Canadian Institutes for Health Research [224954]; Susan G. Komen for the Cure Postdoctoral Fellowship [KG101445]; Department of Defense Breast Cancer Pre-doctoral Grant [W81XWH-06-1- 0399]; NATIONAL CANCER INSTITUTE [R01CA155160, R01CA070940] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox New Frontier Grant; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Susan G. Komen for the Cure Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Department of Defense Breast Cancer Pre-doctoral Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (www.nih.gov) Grants R01 CA155160 and R01 CA070940 (to A.M.P.), a Terry Fox New Frontier Grant and funds from the Canadian Institutes for Health Research (224954) (to M.P.), Susan G. Komen for the Cure Postdoctoral Fellowship KG101445 (to J.F.K.), and Department of Defense Breast Cancer Pre-doctoral Grant W81XWH-06-1- 0399 (to R.L.).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chislock EM, 2013, P NATL ACAD SCI USA, V110, P12432, DOI 10.1073/pnas.1304188110; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Cipres A, 2007, CELL SIGNAL, V19, P1662, DOI 10.1016/j.cellsig.2007.02.011; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dempke WCM, 2009, EUR J CANCER, V45, P1117, DOI 10.1016/j.ejca.2008.11.038; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frasca F, 2001, ONCOGENE, V20, P3845, DOI 10.1038/sj.onc.1204531; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gelsomino F, 2014, CRIT REV ONCOL HEMAT, V89, P284, DOI 10.1016/j.critrevonc.2013.11.006; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Graveel CR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009209; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gu JJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002632; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; HOULDSWORTH J, 1990, CANCER RES, V50, P6417; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kadono Y, 1998, BIOCHEM BIOPH RES CO, V251, P681, DOI 10.1006/bbrc.1998.9531; Kerrisk ME, 2013, INT J BIOCHEM CELL B, V45, P2496, DOI 10.1016/j.biocel.2013.07.018; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Lai AZ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004839; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; Lin YC, 2013, J NEUROSCI, V33, P1846, DOI 10.1523/JNEUROSCI.4284-12.2013; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Park WS, 1999, CANCER RES, V59, P307; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rajadurai CV, 2012, J CELL SCI, V125, P2940, DOI 10.1242/jcs.100834; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Simpson MA, 2015, J BIOL CHEM, V290, P8360, DOI 10.1074/jbc.M115.638874; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Sourbier C, 2014, CANCER CELL, V26, P840, DOI 10.1016/j.ccell.2014.10.005; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Tong CYK, 2004, J NEUROSURG, V100, P187, DOI 10.3171/ped.2004.100.2.0187; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Ueki T, 1997, HEPATOLOGY, V25, P619, DOI 10.1002/hep.510250321; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wells CM, 2005, CELL MOTIL CYTOSKEL, V62, P180, DOI 10.1002/cm.20095; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Yamamoto N, 2006, J CELL SCI, V119, P4623, DOI 10.1242/jcs.03236; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; ZHU H, 1994, J BIOL CHEM, V269, P29943	84	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124960	10.1371/journal.pone.0124960	http://dx.doi.org/10.1371/journal.pone.0124960			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946048	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700052
J	You, ZH; Chan, KCC; Hu, PW				You, Zhu-Hong; Chan, Keith C. C.; Hu, Pengwei			Predicting Protein-Protein Interactions from Primary Protein Sequences Using a Novel Multi-Scale Local Feature Representation Scheme and the Random Forest	PLOS ONE			English	Article							INTERACTION NETWORKS; IDENTIFICATION; HYPERPLANES; COMPLEXES	The study of protein-protein interactions (PPIs) can be very important for the understanding of biological cellular functions. However, detecting PPIs in the laboratories are both timeconsuming and expensive. For this reason, there has been much recent effort to develop techniques for computational prediction of PPIs as this can complement laboratory procedures and provide an inexpensive way of predicting the most likely set of interactions at the entire proteome scale. Although much progress has already been achieved in this direction, the problem is still far from being solved. More effective approaches are still required to overcome the limitations of the current ones. In this study, a novel Multi-scale Local Descriptor (MLD) feature representation scheme is proposed to extract features from a protein sequence. This scheme can capture multi-scale local information by varying the length of protein-sequence segments. Based on the MLD, an ensemble learning method, the Random Forest (RF) method, is used as classifier. The MLD feature representation scheme facilitates the mining of interaction information from multi-scale continuous amino acid segments, making it easier to capture multiple overlapping continuous binding patterns within a protein sequence. When the proposed method is tested with the PPI data of Saccharomyces cerevisiae, it achieves a prediction accuracy of 94.72% with 94.34% sensitivity at the precision of 98.91%. Extensive experiments are performed to compare our method with existing sequence-based method. Experimental results show that the performance of our predictor is better than several other state-of-the-art predictors also with the H. pylori dataset. The reason why such good results are achieved can largely be credited to the learning capabilities of the RF model and the novel MLD feature representation scheme. The experiment results show that the proposed approach can be very promising for predicting PPIs and can be a useful tool for future proteomic studies.	[You, Zhu-Hong; Chan, Keith C. C.; Hu, Pengwei] Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China; [You, Zhu-Hong] Tongji Univ, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China	Hong Kong Polytechnic University; Tongji University	Chan, KCC (corresponding author), Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China.	keith.chan@polyu.edu.hk	You, Zhu-Hong/A-4056-2011; You, Zhu-Hong/AAI-6862-2020	You, Zhu-Hong/0000-0003-1266-2696; CHAN, Keith C.C./0000-0001-7962-6564	National Science Foundation of China [61102119, 61373086, 61401385, 61202347]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Foundation of China, under grants 61102119, 61373086, 61401385, and 61202347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autore F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063633; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Bock JR, 2003, BIOINFORMATICS, V19, P125, DOI 10.1093/bioinformatics/19.1.125; Browne F, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-2; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Fernandes LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012083; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang DS, 2013, IEEE ACM T COMPUT BI, V10, P457, DOI 10.1109/TCBB.2013.10; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam WWM, 2012, IEEE T BIO-MED ENG, V59, P899, DOI 10.1109/TBME.2010.2093524; Lei YK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S3; Lu HC, 2013, EXPERT REV PROTEOMIC, V10, P511, DOI 10.1586/14789450.2013.856764; Luo X, 2015, SCI REP-UK, V5, DOI 10.1038/srep07702; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mei SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110488; Nanni L, 2006, BIOINFORMATICS, V22, P1207, DOI 10.1093/bioinformatics/btl055; Nanni L, 2005, NEUROCOMPUTING, V69, P257, DOI 10.1016/j.neucom.2005.05.007; Pan XY, 2010, J PROTEOME RES, V9, P4992, DOI 10.1021/pr100618t; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Pitre S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00239; Qi YJ, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P531; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shi MG, 2010, AMINO ACIDS, V38, P891, DOI 10.1007/s00726-009-0295-y; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Smialowski P, 2010, NUCLEIC ACIDS RES, V38, pD540, DOI 10.1093/nar/gkp1026; Veres DV, 2015, NUCLEIC ACIDS RES, V43, pD485, DOI 10.1093/nar/gku1007; Wang H, 2013, J COMPUT BIOL, V20, P344, DOI 10.1089/cmb.2012.0273; Xia JF, 2010, AMINO ACIDS, V39, P1595, DOI 10.1007/s00726-010-0588-1; Xia JF, 2010, PROTEIN PEPTIDE LETT, V17, P137, DOI 10.2174/092986610789909403; Yang L, 2010, PROTEIN PEPTIDE LETT, V17, P1085, DOI 10.2174/092986610791760306; You ZH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S10; You ZH, 2010, BIOINFORMATICS, V26, P2744, DOI 10.1093/bioinformatics/btq510; You ZH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-343; Yu HJ, 2013, IEEE J BIOMED HEALTH, V17, P503, DOI 10.1109/TITB.2012.2227146; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhang YN, 2011, J THEOR BIOL, V283, P44, DOI 10.1016/j.jtbi.2011.05.023; Zhao XM, 2008, PROTEINS, V70, P1125, DOI 10.1002/prot.21870; Zhao XM, 2010, PROTEINS, V78, P1243, DOI 10.1002/prot.22643; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002; Zhou Fengfeng, 2009, Genomics Proteomics & Bioinformatics, V7, P194, DOI 10.1016/S1672-0229(08)60049-2; Zhou YZ, 2011, COMM COM INF SC, V202, P254	48	94	95	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125811	10.1371/journal.pone.0125811	http://dx.doi.org/10.1371/journal.pone.0125811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946106	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700088
J	Avsar, T; Durasi, IM; Uygunoglu, U; Tutuncu, M; Demirci, NO; Saip, S; Sezerman, OU; Siva, A; Turanli, ET				Avsar, Timucin; Durasi, Ilknur Melis; Uygunoglu, Ugur; Tutuncu, Melih; Demirci, Nuri Onat; Saip, Sabahattin; Sezerman, O. Ugur; Siva, Aksel; Turanli, Eda Tahir			CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SNP-TARGETED PATHWAYS; VITAMIN-D; CEREBROSPINAL-FLUID; EXPERIMENTAL-DESIGN; AUTOIMMUNE-DISEASE; NATURAL-HISTORY; T-CELLS; PATHOGENESIS; SUSCEPTIBILITY	Multiple sclerosis (MS) is an immune-mediated, neuro-inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) with a heterogeneous clinical presentation and course. There is a remarkable phenotypic heterogeneity in MS, and the molecular mechanisms underlying it remain unknown. We aimed to investigate further the etiopathogenesis related molecular pathways in subclinical types of MS using proteomic and bioinformatics approaches in cerebrospinal fluids of patients with clinically isolated syndrome, relapsing remitting MS and progressive MS (n=179). Comparison of disease groups with controls revealed a total of 151 proteins that are differentially expressed in clinically different MS subtypes. KEGG analysis using PANOGA tool revealed the disease related pathways including aldosterone-regulated sodium reabsorption (p=8.02x10(-5)) which is important in the immune cell migration, renin-angiotensin (p=6.88x10(-5)) system that induces Th17 dependent immunity, notch signaling (p=1.83x10(-10)) pathway indicating the activated remyelination and vitamin digestion and absorption pathways (p=1.73x10(-5)). An emerging theme from our studies is that whilst all MS clinical forms share common biological pathways, there are also clinical subtypes specific and pathophysiology related pathways which may have further therapeutic implications.	[Avsar, Timucin; Turanli, Eda Tahir] Istanbul Tech Univ, Dr Orhan Ocalgiray Mol Biol Biotechnol & Genet Re, TR-80626 Istanbul, Turkey; [Durasi, Ilknur Melis] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn, Istanbul, Turkey; [Uygunoglu, Ugur; Tutuncu, Melih; Demirci, Nuri Onat; Saip, Sabahattin; Siva, Aksel] Istanbul Univ, Cerrahpasa Med Sch, Dept Neurol, Istanbul, Turkey; [Turanli, Eda Tahir] Istanbul Tech Univ, Sci & Letter Fac, Mol Biol & Genet Dept, TR-80626 Istanbul, Turkey; [Sezerman, O. Ugur] Acibadem Univ, Dept Med Informat, Istanbul, Turkey	Istanbul Technical University; Sabanci University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul Technical University; Acibadem University	Turanli, ET (corresponding author), Istanbul Tech Univ, Dr Orhan Ocalgiray Mol Biol Biotechnol & Genet Re, TR-80626 Istanbul, Turkey.	turanlie@itu.edu.tr	DURASI, ILKNUR MELIS/AAE-8729-2021; AVSAR, TIMUCIN/W-2624-2019; Tütüncü, Melih/AAF-1702-2021; Tahir Turanli, Eda/D-4989-2009; SEZERMAN, OSMAN U/X-6441-2018; Siva, Aksel/A-5132-2016; Uygunoglu, Ugur/S-9141-2016; SAİP, SABAHATTİN/AAE-2410-2021; Turanli, Eda Tahir/AAF-6837-2020; Tahir Turanli, Eda/GNP-2451-2022	AVSAR, TIMUCIN/0000-0001-8841-4811; Tütüncü, Melih/0000-0002-9851-7002; Siva, Aksel/0000-0002-8340-6641; Uygunoglu, Ugur/0000-0003-2866-4004; Tahir Turanli, Eda/0000-0002-0789-0398	Scientific and Technological Research Council of Turkey (TUBITAK) [109S070]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by the The Scientific and Technological Research Council of Turkey (TUBITAK) project number 109S070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Bakir-Gungor B, 2013, EPILEPSY RES, V105, P92, DOI 10.1016/j.eplepsyres.2013.02.008; Bakir-Gungor B, 2012, NATURE PROTOCOL EXCH, V10, DOI [10.1038/protex.2012.019, DOI 10.1038/PR0TEX.2012.019]; Bakir-Gungor B, 2014, BIOINFORMATICS, V30, P1287, DOI 10.1093/bioinformatics/btt743; Bakir-Gungor B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057022; Bakir-Gungor B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026277; Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hunt SMN, 2005, J PROTEOME RES, V4, P809, DOI 10.1021/pr049758y; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Kantarci O, 2006, CURR OPIN NEUROL, V19, P248, DOI 10.1097/01.wco.0000227033.47458.82; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; MARTIN R, 1995, CRIT REV CL LAB SCI, V32, P121, DOI 10.3109/10408369509084683; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Ontaneda D, 2012, ANNU REV MED, V63, P389, DOI 10.1146/annurev-med-042910-135833; Ottervald J, 2010, J PROTEOMICS, V73, P1117, DOI 10.1016/j.jprot.2010.01.004; Paling D, 2013, BRAIN, V136, P2305, DOI 10.1093/brain/awt149; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ponsonby A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1267, DOI 10.1562/2005-02-15-IR-441; Rajalahti T, 2010, J PROTEOME RES, V9, P3608, DOI 10.1021/pr100142m; Satoh JI, 2009, MULT SCLER J, V15, P531, DOI 10.1177/1352458508101943; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Selter RC, 2013, IMMUNOTARGETS THER, V2, P21, DOI 10.2147/ITT.S31813; Siva A, 2006, CLIN NEUROL NEUROSUR, V108, P333, DOI 10.1016/j.clineuro.2005.11.010; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; VanAmerongen BM, 2004, EUR J CLIN NUTR, V58, P1095, DOI 10.1038/sj.ejcn.1601952; Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14; Weber MS, 2011, BBA-MOL BASIS DIS, V1812, P239, DOI 10.1016/j.bbadis.2010.06.009; Weiss HA, 2007, J NEUROIMMUNOL, V191, P79, DOI 10.1016/j.jneuroim.2007.09.011; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	54	11	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0122045	10.1371/journal.pone.0122045	http://dx.doi.org/10.1371/journal.pone.0122045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942430	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400004
J	Gilra, A; Bhalla, US				Gilra, Aditya; Bhalla, Upinder S.			Bulbar Microcircuit Model Predicts Connectivity and Roles of Interneurons in Odor Coding	PLOS ONE			English	Article							MAIN OLFACTORY-BULB; BACKPROPAGATING ACTION-POTENTIALS; CELL LATERAL DENDRITES; EXTERNAL TUFTED CELLS; MITRAL CELLS; DENDRODENDRITIC INHIBITION; INTRAGLOMERULAR INHIBITION; GRANULE CELLS; AIR-FLOW; PRESYNAPTIC INHIBITION	Stimulus encoding by primary sensory brain areas provides a data-rich context for understanding their circuit mechanisms. The vertebrate olfactory bulb is an input area having unusual two-layer dendro-dendritic connections whose roles in odor coding are unclear. To clarify these roles, we built a detailed compartmental model of the rat olfactory bulb that synthesizes a much wider range of experimental observations on bulbar physiology and response dynamics than has hitherto been modeled. We predict that superficial-layer inhibitory interneurons (periglomerular cells) linearize the input-output transformation of the principal neurons (mitral cells), unlike previous models of contrast enhancement. The linearization is required to replicate observed linear summation of mitral odor responses. Further, in our model, action-potentials back-propagate along lateral dendrites of mitral cells and activate deep-layer inhibitory interneurons (granule cells). Using this, we propose sparse, long-range inhibition between mitral cells, mediated by granule cells, to explain how the respiratory phases of odor responses of sister mitral cells can be sometimes decorrelated as observed, despite receiving similar receptor input. We also rule out some alternative mechanisms. In our mechanism, we predict that a few distant mitral cells receiving input from different receptors, inhibit sister mitral cells differentially, by activating disjoint subsets of granule cells. This differential inhibition is strong enough to decorrelate their firing rate phases, and not merely modulate their spike timing. Thus our well-constrained model suggests novel computational roles for the two most numerous classes of interneurons in the bulb.	[Gilra, Aditya; Bhalla, Upinder S.] NCBS, TIFR, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Bhalla, US (corresponding author), NCBS, TIFR, Bangalore 560065, Karnataka, India.	bhalla@ncbs.res.in	Gilra, Aditya/AAW-1842-2021	Gilra, Aditya/0000-0002-8628-1864; Bhalla, Upinder/0000-0003-1722-5188	Department of Biotechnology, India [DBT: BT/01/CEIB/09/III/03]; National Centre for Biological Sciences, India; NIGMS/SBCNY, Systems Biology Center of New York [5P50 GM071158-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071158] Funding Source: NIH RePORTER	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences, India; NIGMS/SBCNY, Systems Biology Center of New York; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by 1) Department of Biotechnology, India (DBT: BT/01/CEIB/09/III/03), http://www.dbtindia.nic.in/; 2) National Centre for Biological Sciences, India (Institutional funding), ncbs.res.in; 3) NIGMS/SBCNY, Systems Biology Center of New York (5P50 GM071158-03), sbcny.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Arruda D, 2009, BMC NEUROSCI, V10, pP43, DOI [10.1186/1471-2202-10-S1-P43, DOI 10.1186/1471-2202-10-S1-P43]; Arruda D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056148; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BENSON TE, 1984, J NEUROSCI, V4, P638; BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Christie JM, 2003, J NEUROPHYSIOL, V89, P2466, DOI 10.1152/jn.00997.2002; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cleland TA, 2005, CHEM SENSES, V30, P801, DOI 10.1093/chemse/bji072; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Cleland TA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00005; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Davison AP, 2001, NEUROCOMPUTING, V38, P515, DOI 10.1016/S0925-2312(01)00391-5; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; de Almeida L, 2013, J NEUROPHYSIOL, V109, P1360, DOI 10.1152/jn.00577.2012; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Destexhe A, 1996, J NEUROSCI, V16, P169; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008; Dong HW, 2007, J NEUROSCI, V27, P5654, DOI 10.1523/JNEUROSCI.5495-06.2007; Duchamp-Viret P, 2005, J NEUROBIOL, V65, P97, DOI 10.1002/neu.20177; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Egger V, 2003, J NEUROSCI, V23, P7551; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Ennis M., 2007, HDB NEUROCHEMISTRY M, P137, DOI [DOI 10.1007/978-0-387-30374-1_6, 10.1007/978-0-387-30374-1_6]; Esclassan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040927; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Fletcher ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029360; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Fukunaga I, 2012, NEURON, V75, P320, DOI 10.1016/j.neuron.2012.05.017; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Gire DH, 2013, NEURON, V78, P416, DOI 10.1016/j.neuron.2013.04.033; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Grossman KJ, 2008, EUR J NEUROSCI, V27, P2676, DOI 10.1111/j.1460-9568.2008.06213.x; Gupta P, 2015, NAT NEUROSCI, V18, P272, DOI 10.1038/nn.3913; Gutierrez-Osuna R, 2002, IEEE SENS J, V2, P189, DOI 10.1109/JSEN.2002.800688; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Huang LW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00032; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Jan DD, 2007, J NEUROSCI, V27, P132, DOI 10.1523/JNEUROSCI.2439-06.2007; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kato HK, 2013, NEURON, V80, P1218, DOI 10.1016/j.neuron.2013.08.036; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Kikuta S, 2013, NEURON, V77, P1122, DOI 10.1016/j.neuron.2013.01.022; Kim DH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00005; Kimbell JS, 1997, TOXICOL APPL PHARM, V145, P388, DOI 10.1006/taap.1997.8206; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kosaka T, 2005, NEUROSCIENCE, V131, P611, DOI 10.1016/j.neuroscience.2004.11.050; Krosnowski K, 2012, NEUROSCIENCE, V213, P161, DOI 10.1016/j.neuroscience.2012.04.024; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Li GS, 2013, J NEUROSCI, V33, P3037, DOI 10.1523/JNEUROSCI.2831-12.2013; Linster C, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00157; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; Lowe G, 2002, J NEUROPHYSIOL, V88, P64, DOI 10.1152/jn.2002.88.1.64; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Matsumoto H, 2009, J NEUROPHYSIOL, V101, P1890, DOI 10.1152/jn.91019.2008; McGann JP, 2013, CHEM SENSES, V38, P459, DOI 10.1093/chemse/bjt018; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; McTavish TS, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00003; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Migliore M, 2008, J COMPUT NEUROSCI, V24, P207, DOI 10.1007/s10827-007-0051-9; Migliore M, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.012.2007, 10.3389/neuro.07/012.2007]; Migliore M, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00122; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Oka Y, 2009, J NEUROSCI, V29, P12070, DOI 10.1523/JNEUROSCI.1415-09.2009; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; PRICE JL, 1970, J CELL SCI, V7, P631; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Ray Subhasis, 2008, Front Neuroinform, V2, P6, DOI 10.3389/neuro.11.006.2008; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schaefer AT, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00030; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Sethupathy P, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00049; Shao Z, 2009, J NEUROPHYSIOL, V101, P1988, DOI 10.1152/jn.91116.2008; Shao ZY, 2012, J NEUROPHYSIOL, V108, P782, DOI 10.1152/jn.00119.2012; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Shipley MT, 1996, J NEUROBIOL, V30, P123; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Spors H, 2012, J NEUROSCI, V32, P14102, DOI 10.1523/JNEUROSCI.3328-12.2012; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; Wen H, 2013, ELIFE, V2, DOI 10.7554/eLife.01206; Whitesell JD, 2013, J NEUROSCI, V33, P1552, DOI 10.1523/JNEUROSCI.3410-12.2013; Wiechert MT, 2010, NAT NEUROSCI, V13, P1003, DOI 10.1038/nn.2591; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; WOOLF TB, 1991, SYNAPSE, V7, P181, DOI 10.1002/syn.890070303; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; Yu YG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003014; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008; Zhu PX, 2013, NAT NEUROSCI, V16, P1678, DOI 10.1038/nn.3528	128	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0098045	10.1371/journal.pone.0098045	http://dx.doi.org/10.1371/journal.pone.0098045			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942312	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400001
J	Chen, CW; Wu, MS; Huang, YJ; Cheng, CA; Chang, CY				Chen, Chien-Wen; Wu, Ming-Shan; Huang, Yi-Jen; Cheng, Chao-An; Chang, Chi-Yao			Recognition of Linear B-Cell Epitope of Betanodavirus Coat Protein by RG-M18 Neutralizing mAB Inhibits Giant Grouper Nervous Necrosis Virus (GGNNV) Infection	PLOS ONE			English	Article							EPINEPHELUS-AWOARA TEMMINCK; YELLOW GROUPER; GENOMIC CLASSIFICATION; PHYLOGENETIC ANALYSIS; VIRAL ENCEPHALOPATHY; HOST-SPECIFICITY; FISH; RETINOPATHY; SCHLEGEL; YGNNV	Betanodavirus is a causative agent of viral nervous necrosis syndrome in many important aquaculture marine fish larvae, resulting in high global mortality. The coat protein of Betanodavirus is the sole structural protein, and it can assemble the virion particle by itself. In this study, we used a high-titer neutralizing mAB, RG-M18, to identify the linear B-cell epitope on the viral coat protein. By mapping a series of recombinant proteins generated using the E. coli PET expression system, we demonstrated that the linear epitope recognized by RG-M18 is located at the C-terminus of the coat protein, between amino acid residues 195 and 338. To define the minimal epitope region, a set of overlapping peptides were synthesized and evaluated for RG-M18 binding. Such analysis identified the 195VNVSVLCR202 motif as the minimal epitope. Comparative analysis of Alanine scanning mutagenesis with dot-blotting and ELISA revealed that Valine(197), Valine(199), and Cysteine(201) are critical for antibody binding. Substitution of Leucine(200) in the RGNNV, BFNNV, and TPNNV genotypes with Methionine(200) (thereby simulating the SJNNV genotype) did not affect binding affinity, implying that RG-M18 can recognize all genotypes of Betanodaviruses. In competition experiments, synthetic multiple antigen peptides of this epitope dramatically suppressed giant grouper nervous necrosis virus (GGNNV) propagation in grouper brain cells. The data provide new insights into the protective mechanism of this neutralizing mAB, with broader implications for Betanodavirus vaccinology and antiviral peptide drug development.	[Chen, Chien-Wen; Wu, Ming-Shan; Huang, Yi-Jen; Chang, Chi-Yao] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Chien-Wen; Chang, Chi-Yao] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Cheng, Chao-An] Natl Quemoy Univ, Dept Food Sci, Kinmen, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chang, CY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	cychang@gate.sinica.edu.tw			Institute of Cellular and Organismic Biology, Academia Sinica	Institute of Cellular and Organismic Biology, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the Institute of Cellular and Organismic Biology, Academia Sinica.	Chang C.-Y., 2008, AQUACULTURE GROUPERS, P207; Costa JZ, 2007, J FISH DIS, V30, P419, DOI 10.1111/j.1365-2761.2007.00824.x; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; DIMMOCK NJ, 1987, TRENDS BIOCHEM SCI, V12, P70, DOI 10.1016/0968-0004(87)90034-X; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Ito Y, 2008, DIS AQUAT ORGAN, V79, P199, DOI 10.3354/dao01906; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Iwamoto T, 2004, J VIROL, V78, P1256, DOI 10.1128/JVI.78.3.1256-1262.2004; Johansen R, 2004, J FISH DIS, V27, P591, DOI 10.1111/j.1365-2761.2004.00581.x; Lai YS, 2002, VACCINE, V20, P3221, DOI 10.1016/S0264-410X(02)00239-6; Lai YS, 2001, J FISH DIS, V24, P299, DOI 10.1046/j.1365-2761.2001.00303.x; Lai YS, 2001, J FISH DIS, V24, P237, DOI 10.1046/j.1365-2761.2001.00293.x; Lin CH, 2006, BIOCHEM BIOPH RES CO, V351, P534, DOI 10.1016/j.bbrc.2006.10.063; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; MUNDAY BL, 1992, AQUACULTURE, V103, P197, DOI 10.1016/0044-8486(92)90166-I; Nishizawa T, 1997, APPL ENVIRON MICROB, V63, P1633, DOI 10.1128/AEM.63.4.1633-1636.1997; Nishizawa T, 1999, J GEN VIROL, V80, P3023, DOI 10.1099/0022-1317-80-11-3023; Okinaka Y, 2008, DIS AQUAT ORGAN, V80, P113, DOI 10.3354/dao01914; Olveira JG, 2009, J GEN VIROL, V90, P2940, DOI 10.1099/vir.0.013912-0; Panzarin V, 2012, INFECT GENET EVOL, V12, P63, DOI 10.1016/j.meegid.2011.10.007; REED L. J., 1938, AMER JOUR HYG, V27, P493; Thiery R, 2004, J GEN VIROL, V85, P3079, DOI 10.1099/vir.0.80264-0; Vendramin N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-20; Wang CH, 2010, VIRUS GENES, V41, P73, DOI 10.1007/s11262-010-0488-1; YOSHIKOSHI K, 1990, J FISH DIS, V13, P69, DOI 10.1111/j.1365-2761.1990.tb00758.x	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126121	10.1371/journal.pone.0126121	http://dx.doi.org/10.1371/journal.pone.0126121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938761	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000141
J	Hartin, SN; Hudson, ML; Yingling, C; Ackley, BD				Hartin, Samantha N.; Hudson, Martin L.; Yingling, Curtis; Ackley, Brian D.			A Synthetic Lethal Screen Identifies a Role for Lin-44/Wnt in C-elegans Embryogenesis	PLOS ONE			English	Article							VAB-1 EPH RECEPTOR; PROTEIN-TYROSINE-PHOSPHATASES; POSTERIOR NEUROBLAST MIGRATION; ASYMMETRIC CELL DIVISIONS; FIBROBLAST-GROWTH-FACTOR; CAENORHABDITIS-ELEGANS; AXON GUIDANCE; NERVOUS-SYSTEM; PTP-SIGMA; EMBRYONIC MORPHOGENESIS	Background The C. elegans proteins PTP-3/LAR-RPTP and SDN-1/Syndecan are conserved cell adhesion molecules. Loss-of-function (LOF) mutations in either ptp-3 or sdn-1 result in low penetrance embryonic developmental defects. Work from other systems has shown that syndecans can function as ligands for LAR receptors in vivo. We used double mutant analysis to test whether ptp-3 and sdn-1 function in a linear genetic pathway during C. elegans embryogenesis. Results We found animals with LOF in both sdn-1 and ptp-3 exhibited a highly penetrant synthetic lethality (SynLet), with only a small percentage of animals surviving to adulthood. Analysis of the survivors demonstrated that these animals had a synergistic increase in the penetrance of embryonic developmental defects. Together, these data strongly suggested PTP-3 and SDN-1 function in parallel during embryogenesis. We subsequently used RNAi to knockdown similar to 3,600 genes predicted to encode secreted and/or transmembrane molecules to identify genes that interacted with ptp-3 or sdn-1. We found that the Wnt ligand, lin-44, was SynLet with sdn-1, but not ptp-3. We used 4-dimensional time-lapse analysis to characterize the interaction between lin-44 and sdn-1. We found evidence that loss of lin-44 caused defects in the polarization and migration of endodermal precursors during gastrulation, a previously undescribed role for lin-44 that is strongly enhanced by the loss of sdn-1. Conclusions PTP-3 and SDN-1 function in compensatory pathways during C. elegans embryonic and larval development, as simultaneous loss of both genes has dire consequences for organismal survival. The Wnt ligand lin-44 contributes to the early stages of gastrulation in parallel to sdn-1, but in a genetic pathway with ptp-3. Overall, the SynLet phenotype provides a robust platform to identify ptp-3 and sdn-1 interacting genes, as well as other genes that function in development, yet might be missed in traditional forward genetic screens.	[Hartin, Samantha N.; Yingling, Curtis; Ackley, Brian D.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Hudson, Martin L.] Kennesaw State Univ, Dept Biol & Phys, Kennesaw, GA USA	University of Kansas; University System of Georgia; Kennesaw State University	Ackley, BD (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	bdackley@ku.edu		Hudson, Martin/0000-0002-2628-035X	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103418]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638, P20GM103418] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a Major Starter Award (PI Brian D. Ackley) through the Kansas Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103418, K-INBRE PI Dr. Douglas Wright. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; BRAUKER JH, 1991, DEV BIOL, V147, P285, DOI 10.1016/0012-1606(91)90286-C; BRENNER S, 1974, GENETICS, V77, P71; Carmona-Fontaine C, 2008, CELL ADHES MIGR, V2, P240, DOI 10.4161/cam.2.4.6747; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Chin-Sang ID, 2002, DEVELOPMENT, V129, P5499, DOI 10.1242/dev.00122; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Coutts JC, 1995, IMMUNOL CELL BIOL, V73, P584, DOI 10.1038/icb.1995.92; Dani N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003031; Davies AG, 1999, GENETICS, V153, P117; Dejima K, 2014, DEVELOPMENT, V141, P4354, DOI 10.1242/dev.113266; Escobedo N, 2013, DEVELOPMENT, V140, P3008, DOI 10.1242/dev.091173; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Ghenea S, 2005, DEVELOPMENT, V132, P3679, DOI 10.1242/dev.01947; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Gonzalez-Brito MR, 2009, MOL CELL NEUROSCI, V42, P458, DOI 10.1016/j.mcn.2009.09.009; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Harrington RJ, 2002, DEVELOPMENT, V129, P2141; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hudson ML, 2006, DEV BIOL, V294, P352, DOI 10.1016/j.ydbio.2006.02.036; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kirszenblat L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001157; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kramer James M, 2005, WormBook, P1; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Li X, 2012, CELL DEATH DIFFER, V19, P1080, DOI 10.1038/cdd.2011.192; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; LUNDQUIST EA, 1994, GENETICS, V138, P83; Mani K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000510; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; Minniti AN, 2004, J CELL SCI, V117, P5179, DOI 10.1242/jcs.01394; Mohamed AM, 2011, DEV BIOL, V354, P55, DOI 10.1016/j.ydbio.2011.03.019; Morck C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-55; Morton DG, 2012, GENETICS, V192, P929, DOI 10.1534/genetics.112.143727; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Nance J, 2002, DEVELOPMENT, V129, P387; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Park EC, 2012, EMBO J, V31, P1379, DOI 10.1038/emboj.2011.499; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Sajnani G, 2005, J NEUROBIOL, V65, P59, DOI 10.1002/neu.20175; SALMIVIRTA M, 1995, EXPERIENTIA, V51, P863, DOI 10.1007/BF01921737; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schaapveld RQJ, 1997, DEV BIOL, V188, P134, DOI 10.1006/dbio.1997.8630; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwabiuk M, 2009, DEV BIOL, V334, P235, DOI 10.1016/j.ydbio.2009.07.020; Shao ZY, 2009, GENETICS, V183, P821, DOI 10.1534/genetics.109.107284; Shen P, 1999, BRAIN RES, V826, P157, DOI 10.1016/S0006-8993(99)01179-8; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sommer L, 1997, DEV DYNAM, V208, P48, DOI 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun Q, 2000, DEVELOPMENT, V127, P801; Sundararajan L, 2014, DEV BIOL, V392, P141, DOI 10.1016/j.ydbio.2014.06.009; Sundararajan L, 2012, GENETICS, V192, P1373, DOI 10.1534/genetics.112.145706; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Tucker M, 2008, DEV BIOL, V318, P215, DOI 10.1016/j.ydbio.2008.02.062; van Haaften G, 2004, P NATL ACAD SCI USA, V101, P12992, DOI 10.1073/pnas.0403131101; Wang F, 2012, CURR BIOL, V22, P373, DOI 10.1016/j.cub.2012.01.040; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wu MF, 2007, DEV BIOL, V303, P650, DOI 10.1016/j.ydbio.2006.12.002	77	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0121397	10.1371/journal.pone.0121397	http://dx.doi.org/10.1371/journal.pone.0121397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938228	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000003
J	Olasz, EB; Seline, LN; Schock, AM; Duncan, NE; Lopez, A; Lazar, J; Flister, MJ; Lu, Y; Liu, PY; Sokumbi, O; Harwood, CA; Proby, CM; Neuburg, M; Lazarova, Z				Olasz, Edit B.; Seline, Lauren N.; Schock, Ashley M.; Duncan, Nathan E.; Lopez, Argelia; Lazar, Jozef; Flister, Michael J.; Lu, Yan; Liu, Pengyuan; Sokumbi, Olayemi; Harwood, Catherine A.; Proby, Charlotte M.; Neuburg, Marcy; Lazarova, Zelmira			MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; COLORECTAL-CANCER; FEZ1/LZTS1 GENE; DOWN-REGULATION; CHROMOSOME 8P22; EXPRESSION; SKIN; PROGRESSION; METASTASIS; INVASION	Cutaneous squamous cell carcinoma (cSCC) is the second most common skin malignancy and it presents a therapeutic challenge in organ transplant recipient patients. Despite the need, there are only a few targeted drug treatment options. Recent studies have revealed a pivotal role played by microRNAs (miRNAs) in multiple cancers, but only a few studies tested their function in cSCC. Here, we analyzed differential expression of 88 cancer related miRNAs in 43 study participants with cSCC; 32 immunocompetent, 11 OTR patients, and 15 non-lesional skin samples by microarray analysis. Of the examined miRNAs, miR-135b was the most upregulated (13.3-fold, 21.5-fold; p=0.0001) in both patient groups. Similarly, the miR-135b expression was also upregulated in three cSCC cell lines when evaluated by quantitative real-time PCR. In functional studies, inhibition of miR-135b by specific anti-miR oligonucleotides resulted in upregulation of its target gene LZTS1 mRNA and protein levels and led to decreased cell motility and invasion of both primary and metastatic cSCC cell lines. In contrast, miR-135b overexpression by synthetic miR-135b mimic induced further down-regulation of LZTS1 mRNA in vitro and increased cancer cell motility and invasiveness. Immunohistochemical evaluation of 67 cSCC tumor tissues demonstrated that miR-135b expression inversely correlated with LZTS1 staining intensity and the tumor grade. These results indicate that miR-135b functions as an oncogene in cSCC and provide new understanding into its pathological role in cSCC progression and invasiveness.	[Olasz, Edit B.; Seline, Lauren N.; Schock, Ashley M.; Duncan, Nathan E.; Lopez, Argelia; Lazar, Jozef; Sokumbi, Olayemi; Neuburg, Marcy; Lazarova, Zelmira] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Flister, Michael J.; Lu, Yan; Liu, Pengyuan] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Harwood, Catherine A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England; [Proby, Charlotte M.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Dundee DD1 9SY, Scotland	Medical College of Wisconsin; Medical College of Wisconsin; University of London; Queen Mary University London; University of Dundee	Lazarova, Z (corresponding author), Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA.	zlazarov@mcw.edu		Harwood, Catherine/0000-0002-1375-0965; Sokumbi, Olayemi/0000-0001-8060-4311	Froedtert Hospital Foundation Skin Cancer Center grant; Medical College of Wisconsin, Milwaukee; Cancer Research UK [13044] Funding Source: researchfish	Froedtert Hospital Foundation Skin Cancer Center grant; Medical College of Wisconsin, Milwaukee; Cancer Research UK(Cancer Research UK)	This work was funded by Froedtert Hospital Foundation Skin Cancer Center grant (ZL and EO) through the generosity of the Szymanczyk Family, and Medical College of Wisconsin, Milwaukee.	Anglicheau D, 2010, TRANSPLANTATION, V90, P105, DOI 10.1097/TP.0b013e3181e913c2; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bruegger C, 2013, EXP DERMATOL, V22, P426, DOI 10.1111/exd.12153; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P4169, DOI 10.1038/sj.onc.1204539; Cooper JZ, 2006, ARCH DERMATOL, V142, P755, DOI 10.1001/archderm.142.6.755; EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gastaldi C, 2014, CARCINOGENESIS; Hameetman L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-58; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Jourdan MM, 2011, RADIAT RES, V176, P636, DOI 10.1667/RR2422.1; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102621; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Ono K, 2003, INT J ONCOL, V23, P297; Petracco R, 2011, J CLIN ENDOCR METAB, V96, pE1925, DOI 10.1210/jc.2011-1231; Popp S, 2000, J INVEST DERMATOL, V115, P1095, DOI 10.1046/j.1523-1747.2000.00173.x; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Rajabi H, 2012, PROSTATE, V72, P1659, DOI 10.1002/pros.22519; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Sanchez-Diaz PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061622; Sand M, 2012, J DERMATOL SCI, V68, P119, DOI 10.1016/j.jdermsci.2012.09.004; Sarma NJ, 2012, EXP MOL PATHOL, V93, P378, DOI 10.1016/j.yexmp.2012.09.020; Toyooka S, 2002, CLIN CANCER RES, V8, P2292; Vecchione A, 2002, AM J PATHOL, V160, P1345, DOI 10.1016/S0002-9440(10)62561-8; Vecchione A, 2001, CLIN CANCER RES, V7, P1546; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Vecchione Andrea, 2004, BMC Urol, V4, P11, DOI 10.1186/1471-2490-4-11; Vecchione A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-24; Wang XX, 2011, HUM PATHOL, V42, P1410, DOI 10.1016/j.humpath.2010.12.007; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wells JL, 2012, AM J CLIN ONCOL-CANC, V35, P498, DOI 10.1097/COC.0b013e318201a3ef; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu WY, 2014, MOL CELL BIOCHEM, V388, P249, DOI 10.1007/s11010-013-1916-z; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yamane K, 2013, J MOL MED, V91, P69, DOI 10.1007/s00109-012-0935-7; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	43	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125412	10.1371/journal.pone.0125412	http://dx.doi.org/10.1371/journal.pone.0125412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938461	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000066
J	Zahl, PH; Maehlen, J				Zahl, Per-Henrik; Maehlen, Jan			Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; SCREENING MAMMOGRAPHY; REPLACEMENT THERAPY; NORWAY; SWEDEN; COHORT	Background During the period 1985-2000 the breast cancer incidence rates increased 50% in the age group invited to mammography screening in Norway and Sweden. Simultaneously, use of hormone replacement treatment therapy (HT) increased 5 times. Several influential observational studies showed that HT was associated with 50% to 100% increased risk of breast cancer and most for those using combined (estrogen plus progestin) hormone replacement therapy (CHT). In contrast, the randomized WHI trial reported that CHT increased the risk by 10% for those not having previously used hormones and 24% when including previous users in the analyses. In another randomized trial, estrogen use only was not associated with any increased risk at all. After the WHI trial was published in 2003, use of HT dropped 70% within 5 years in Norway and Sweden while breast cancer rates were essentially unchanged. After 2008, HT use has dropped further and breast cancer incidence rates have started increasing again. The study objective is to calculate and to explain potential bias in the observational study design. Methods and Findings Here we use data from the randomized WHI trial and analyze these data as done in the observational studies to calculate the magnitude of the potential biases in the observational study design. Time varying effect of hormones and categorization of the follow-up time may increase the hazard ratio for long-term users from 1.10 to 1.48. Selective retrospective reporting of hormone use may further increase the hazard ratio to 1.68. Conclusions We suggest that the mechanism causing higher hazard ratio of breast cancer (compared to the observational studies) is the time-varying effect of CHT on the breast cancer risk and selective retrospective reporting of hormone use. Other risk factors for the increase in breast cancer risk in the age group 50-69 years should be considered, for example, overdiagnosis.	[Zahl, Per-Henrik] Norwegian Inst Publ Hlth, Oslo, Norway; [Maehlen, Jan] Ullevaal Univ Hosp, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo	Zahl, PH (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	per-henrik.zahl@fhi.no						Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2004, BMJ-BRIT MED J, V329, P477, DOI 10.1136/bmj.329.7464.477; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Cancer Registry of Norway, 2014, CANC NORW 2012; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Hofvind S, 2006, INT J CANCER, V118, P3112, DOI 10.1002/ijc.21742; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; National Board of Health and Welfare (Socialstyrelsen), 2013, CANC SWED 2011; Parkin DM, 2009, EUR J CANCER, V45, P1649, DOI 10.1016/j.ejca.2009.01.016; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rothmann KJ, 2008, MODERN EPIDEMIOLOGY; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Suhrke P, 2012, BREAST J, V18, P549, DOI 10.1111/tbj.12001; Zahl Per-Henrik, 2012, Tidsskr Nor Laegeforen, V132, P414, DOI 10.4045/tidsskr.11.0195; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124076	10.1371/journal.pone.0124076	http://dx.doi.org/10.1371/journal.pone.0124076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938446	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000016
J	Bai, LJ; Liang, RY; Yang, YL; Hou, XH; Wang, ZS; Zhu, SY; Wang, CD; Tang, ZL; Li, K				Bai, Lijing; Liang, Ruyi; Yang, Yalan; Hou, Xinhua; Wang, Zishuai; Zhu, Shiyun; Wang, Chuduan; Tang, Zhonglin; Li, Kui			MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGF beta I during Muscle Development in Pigs	PLOS ONE			English	Article							SKELETAL-MUSCLE; CELL-PROLIFERATION; EXPRESSION; PROTEIN; DIFFERENTIATION; GROWTH; SUPPRESSES; MIR-378; MIR-126; MIR-21	MicroRNAs (miRNAs), which are short (22-24 base pairs), non-coding RNAs, play critical roles in myogenesis. Using Solexa deep sequencing, we detected the expression levels of 229 and 209 miRNAs in swine skeletal muscle at 90 days post-coitus (E90) and 100 days postnatal (D100), respectively. A total of 138 miRNAs were up-regulated on E90, and 31 were up-regulated on D100. Of these, 9 miRNAs were selected for the validation of the small RNA libraries by quantitative RT-PCR (RT-qPCR). We found that miRNA-21 was down-regulated by 17-fold on D100 (P<0.001). Bioinformatics analysis suggested that the transforming growth factor beta-induced (TGFaI) gene was a potential target of miRNA-21. Both dual luciferase reporter assays and western blotting demonstrated that the TGFbI gene was regulated by miRNA-21. Co-expression analysis revealed that the mRNA expression levels of miRNA-21 and TGFaI were negatively correlated (r = -0.421, P = 0.026) in skeletal muscle during the 28 developmental stages. Our results revealed that more miRNAs are expressed in prenatal than in postnatal skeletal muscle. The miRNA-21 is a novel myogenic miRNA that is involved in skeletal muscle development and regulates PI3K/Akt/mTOR signaling by targeting the TGFaI gene.	[Bai, Lijing; Liang, Ruyi; Yang, Yalan; Hou, Xinhua; Wang, Zishuai; Zhu, Shiyun; Tang, Zhonglin; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, State Key Lab Anim Nut,Key Lab Farm Anim Genet Re, Beijing 100193, Peoples R China; [Bai, Lijing; Tang, Zhonglin] Chinese Acad Agr Sci, Agr Genome Inst Shenzhen, Shenzhen, Peoples R China; [Wang, Chuduan] China Agr Univ, Dept Anim Breeding & Genet, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Key Lab Agr Anim Gene, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; China Agricultural University	Tang, ZL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, State Key Lab Anim Nut,Key Lab Farm Anim Genet Re, Beijing 100193, Peoples R China.	tangzhonglin@caas.cn	Liang, Ruyi/GQH-7241-2022	Tang, Zhonglin/0000-0002-4538-4349; WANG, Zishuai/0000-0002-4496-8430	National Natural Science Foundation of China [31171192, 31330074]; National Basic Research Program of China [2012CB124706-6]; National Key Project [2014ZX08009-001]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key Project; Agricultural Science and Technology Innovation Program	This study was supported by the National Natural Science Foundation of China (31171192, 31330074), the National Basic Research Program of China (2012CB124706-6), the National Key Project (2014ZX08009-001), and the Agricultural Science and Technology Innovation Program (ASTIP-IAS05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex S F, 2007, NAT GENET, V39, P259; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bismuth K, 2010, EXP CELL RES, V316, P3081, DOI 10.1016/j.yexcr.2010.08.018; Blumensatt M, 2013, CARDIOVASC RES, V100, P201, DOI 10.1093/cvr/cvt173; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Carvajal JJ, 2010, EXP CELL RES, V316, P3014, DOI 10.1016/j.yexcr.2010.07.005; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen L, 2014, CURR MOL MED, V14, P370, DOI 10.2174/1566524014666140228100250; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; CUSELLADEANGELIS MG, 1994, DEVELOPMENT, V120, P925; Dirk Pette, 1997, INT REV CYTOL, V170, P143; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; F Jill W, 2003, MECH DEVELOP, V120, P851; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052123; K Hak K, 2006, J CELL BIOL, V174, P677, DOI DOI 10.1083/JCB.200603008; Katharina Wystub, 2013, PLOS GENET, V9, DOI [10.1371/journal.pgen. 1003793, DOI 10.1371/JOURNAL.PGEN.1003793]; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Li TS, 2008, BIOCHEM BIOPH RES CO, V366, P1074, DOI 10.1016/j.bbrc.2007.12.095; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Ronald E A, 1987, J CELLULAR PHYSL, V133, P567; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; Su Ryu Hyun, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017343, DOI 10.1371/JOURNAL.PONE.0017343]; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tyesha B N, 2011, BURKS COHN SKELETAL, V1, DOI [10.1186/2044-5040-1-19, DOI 10.1186/2044-5040-1-19]; Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wen GY, 2011, INT J ONCOL, V39, P1001, DOI 10.3892/ijo.2011.1097; WIGMORE PMC, 1983, J ANAT, V137, P235; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yang YL, 2014, J INTEGR AGR, V13, P1331, DOI 10.1016/S2095-3119(13)60419-0; Yin J, 2014, CHINESE J CANCER RES, V26, P95, DOI 10.3978/j.issn.1000-9604.2014.02.07; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041478; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhang KL, 2014, CANCER LETT, V342, P139, DOI 10.1016/j.canlet.2013.08.043; Zhao SP, 2012, INT J BIOL SCI, V8, P459, DOI 10.7150/ijbs.3821; Zhou L, 2012, J BIOL CHEM, V287, P25255, DOI 10.1074/jbc.M112.357053; Zhou TB, 2014, J RECEPT SIG TRANSD, V34, P335, DOI 10.3109/10799893.2014.896382	51	49	55	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0119396	10.1371/journal.pone.0119396	http://dx.doi.org/10.1371/journal.pone.0119396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950587	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400002
J	Chiu, LY; Hu, ME; Yang, TY; Hsin, IL; Ko, JL; Tsai, KJ; Sheu, GT				Chiu, Ling-Yen; Hu, Ming-E; Yang, Tsung-Ying; Hsin, I-Lun; Ko, Jiunn-Liang; Tsai, Kan-Jen; Sheu, Gwo-Tarng			Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CALCIUM; APOPTOSIS; DEATH; A549; GMI; THAPSIGARGIN; EXPRESSION; PRINCIPLES; DOCETAXEL	Chemoresistance in cancer therapy is an unfavorable prognostic factor in non-small cell lung cancer (NSCLC). Elevation of intracellular calcium level in multidrug resistant (MDR) sublines leads to sensitization of MDR sublines to cell death. We demonstrated that a fungal protein from Ganoderma microsporum, GMI, elevates the intracellular calcium level and reduces the growth of MDR subline via autophagy and apoptosis, regardless of p-glycoprotein (P-gp) overexpression, in mice xenograft tumors. In addition, we examined the roles of autophagy in the death of MDR A549 lung cancer sublines by GMI, thapsigargin (TG) and tunicamycin (TM) in vitro. Cytotoxicity of TG was inhibited by overexpressed P-gp. However, TM-induced death of MDR sublines was independent of P-gp level. Combinations of TG and TM with either docetaxel or vincristine showed no additional cytotoxic effects on MDR sublines. TG-and TM-mediated apoptosis of MDR sublines was demonstrated on AnnexinV assay and Western blot and repressed by pan-caspase inhibitor (Z-VAD-FMK). Treatment of MDR sublines with TG and TM also augmented autophagy with accumulation of LC3-II proteins, breakdown of p62 and formation of acidic vesicular organelles (AVOs). Inhibition of ATG5 by shRNA silencing significantly reduced autophagy and cell death but not apoptosis following TG or TM treatment. GMI treatment inhibited the phosphorylation of Akt/S473 and p70S6K/T389. Interestingly, the phosphorylation of ERK was not associated with GMI-induced autophagy. We conclude that autophagy plays a pro-death role in acquired MDR and upregulation of autophagy by GMI via Akt/mTOR inhibition provides a potential strategy for overcoming MDR in the treatment of lung cancers.	[Chiu, Ling-Yen; Hsin, I-Lun; Ko, Jiunn-Liang; Sheu, Gwo-Tarng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hu, Ming-E] Chung Shan Med Univ, Dept Anat, Sch Med, Taichung, Taiwan; [Yang, Tsung-Ying] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Ko, Jiunn-Liang; Sheu, Gwo-Tarng] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung 40201, Taiwan; [Tsai, Kan-Jen] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Sheu, GT (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	gtsheu@csmu.edu.tw	Sheu, Gwo-Tarng/H-8855-2019	Sheu, Gwo-Tarng/0000-0002-1299-3375; Hsin, I-Lun/0000-0003-4711-3582; Ko, Jiunn-Liang/0000-0001-6855-9239	National Science Council, Taiwan [NSC-100-2320-B-040-005]; Ministry of Science and Technology, Taiwan [MOST-103-2320-B-040-015]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC-100-2320-B-040-005) and the Ministry of Science and Technology, Taiwan (MOST-103-2320-B-040-015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Baird RD, 2003, EUR J CANCER, V39, P2450, DOI 10.1016/S0959-8049(03)00619-1; Bialik S, 2010, TRENDS BIOCHEM SCI, V35, P556, DOI 10.1016/j.tibs.2010.04.008; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Chai Stella, 2010, Chin Med, V5, P26, DOI 10.1186/1749-8546-5-26; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Chiu LY, 2010, TOXICOL LETT, V192, P408, DOI 10.1016/j.toxlet.2009.11.018; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Davies AM, 2003, EXPERT OPIN PHARMACO, V4, P553, DOI 10.1517/14656566.4.4.553; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; GHOSH TK, 1991, J BIOL CHEM, V266, P24690; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hsieh MJ, 2014, TOXICOL SCI, V137, P65, DOI 10.1093/toxsci/kft238; Hsin IL, 2012, BRIT J PHARMACOL, V167, P1287, DOI 10.1111/j.1476-5381.2012.02073.x; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kunjachan S, 2013, ADV DRUG DELIVER REV, V65, P1852, DOI 10.1016/j.addr.2013.09.018; Lin CH, 2010, J AGR FOOD CHEM, V58, P12014, DOI 10.1021/jf103068w; Lin CH, 2010, PROCESS BIOCHEM, V45, P1537, DOI 10.1016/j.procbio.2010.06.006; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McCormick TS, 1997, J BIOL CHEM, V272, P6087, DOI 10.1074/jbc.272.9.6087; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Padar S, 2004, BRIT J PHARMACOL, V142, P305, DOI 10.1038/sj.bjp.0705755; Platini F, 2010, CURR PHARM DESIGN, V16, P101, DOI 10.2174/138161210789941810; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Saleem A, 2012, PROSTATE, V72, P1374, DOI 10.1002/pros.22487; Schleicher SM, 2010, DRUG RESIST UPDATE, V13, P79, DOI 10.1016/j.drup.2010.04.002; Shimoke K, 2004, J BIOCHEM, V135, P439, DOI 10.1093/jb/mvh053; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8	43	42	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125774	10.1371/journal.pone.0125774	http://dx.doi.org/10.1371/journal.pone.0125774			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946033	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700086
J	Couvigny, B; de Wouters, T; Kaci, G; Jacouton, E; Delorme, C; Dore, J; Renault, P; Blottiere, HM; Guedon, E; Lapaque, N				Couvigny, Benoit; de Wouters, Tomas; Kaci, Ghalia; Jacouton, Elsa; Delorme, Christine; Dore, Joel; Renault, Pierre; Blottiere, Herve M.; Guedon, Eric; Lapaque, Nicolas			Commensal Streptococcus salivarius Modulates PPAR gamma Transcriptional Activity in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; GUT MICROBIOTA; MOLECULAR ANALYSIS; ADIPOSE-TISSUE; ORAL-CAVITY; EXPRESSION; BINDING; PROTEIN; COLONIZATION; INFLAMMATION	The impact of commensal bacteria in eukaryotic transcriptional regulation has increasingly been demonstrated over the last decades. A multitude of studies have shown direct effects of commensal bacteria from local transcriptional activity to systemic impact. The commensal bacterium Streptococcus salivarius is one of the early bacteria colonizing the oral and gut mucosal surfaces. It has been shown to down-regulate nuclear transcription factor (NF kappa B) in human intestinal cells, a central regulator of the host mucosal immune system response to the microbiota. In order to evaluate its impact on a further important transcription factor shown to link metabolism and inflammation in the intestine, namely PPAR gamma (peroxisome proliferator-activated receptor), we used human intestinal epithelial cell-lines engineered to monitor PPAR gamma transcriptional activity in response to a wide range of S. salivarius strains. We demonstrated that different strains from this bacterial group share the property to inhibit PPAR gamma activation independently of the ligand used. First attempts to identify the nature of the active compounds showed that it is a low-molecular-weight, DNase-, proteases-and heat-resistant metabolite secreted by S. salivarius strains. Among PPAR gamma-targeted metabolic genes, I-FABP and Angptl4 expression levels were dramatically reduced in intestinal epithelial cells exposed to S. salivarius supernatant. Both gene products modulate lipid accumulation in cells and down-regulating their expression might consequently affect host health. Our study shows that species belonging to the salivarius group of streptococci impact both host inflammatory and metabolic regulation suggesting a possible role in the host homeostasis and health.	[Couvigny, Benoit; de Wouters, Tomas; Kaci, Ghalia; Jacouton, Elsa; Delorme, Christine; Dore, Joel; Renault, Pierre; Blottiere, Herve M.; Guedon, Eric; Lapaque, Nicolas] INRA, UMR 1319, MICALIS, Jouy En Josas, France; [Couvigny, Benoit; de Wouters, Tomas; Kaci, Ghalia; Jacouton, Elsa; Delorme, Christine; Dore, Joel; Renault, Pierre; Blottiere, Herve M.; Guedon, Eric; Lapaque, Nicolas] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Dore, Joel; Blottiere, Herve M.] INRA, US MetaGenoPolis 1367, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guedon, E (corresponding author), INRA, UMR 1319, MICALIS, Jouy En Josas, France.	eric.guedon@jouy.inra.fr; nicolas.lapaque@jouy.inra.fr	Delorme, Christine/AHA-7246-2022; Guedon, Eric/S-5635-2016; Guédon, Eric/AAP-4143-2021; Lapaque, Nicolas/AAB-4530-2021; GUEDON, Eric/N-8624-2019; BLOTTIERE, Hervé M/C-6120-2011; Dore, Joel/ABA-8921-2020	Delorme, Christine/0000-0002-5208-7238; Guedon, Eric/0000-0002-0901-4447; Lapaque, Nicolas/0000-0003-0824-0108; GUEDON, Eric/0000-0002-0901-4447; BLOTTIERE, Hervé M/0000-0002-8390-0607; 	Institut National de la Recherche Agronomique; European Community [HEALTH-F4-2007-201052]; ANR [ANR-11-DPBS-0001]; ANR; ministere de la Recherche et de l'Education Nationale [ED425]	Institut National de la Recherche Agronomique; European Community(European Commission); ANR(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ministere de la Recherche et de l'Education Nationale	This work was supported by Institut National de la Recherche Agronomique and financed by grants from the European Community's Seventh Framework Program (FP7/2007-2013), MetaHIT, grant agreement HEALTH-F4-2007-201052, the ANR project MetaGenoPolis (ANR-11-DPBS-0001) and the ANR Blanc FunMetaGen. BC was a recipient of a grant from the ministere de la Recherche et de l'Education Nationale (ED425).	Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Atarashi K, 2011, CURR OPIN IMMUNOL, V23, P761, DOI 10.1016/j.coi.2011.11.002; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; Berger JP, 2005, INT J OBESITY, V29, pS3, DOI 10.1038/sj.ijo.0802904; Chassaing B, 2014, TOXICOL PATHOL, V42, P49, DOI 10.1177/0192623313508481; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; de Wouters T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105598; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; El Aidy S, 2013, BIOESSAYS, V35, P913, DOI 10.1002/bies.201300073; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hakalehto Elias, 2011, ISRN Gastroenterol, V2011, P109183, DOI 10.5402/2011/109183; Hansen CHF, 2014, J IMMUNOL, V193, P1213, DOI 10.4049/jimmunol.1400085; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Kaci G, 2014, APPL ENVIRON MICROB, V80, P928, DOI 10.1128/AEM.03133-13; Kaci G, 2011, APPL ENVIRON MICROB, V77, P4681, DOI 10.1128/AEM.03021-10; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelly D, 2012, NUTR REV, V70, pS18, DOI 10.1111/j.1753-4887.2012.00498.x; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Kundu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003887; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Nakajima Takuya, 2013, Ulster Med J, V82, P164; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishio J, 2012, CELL MOL LIFE SCI, V69, P3635, DOI 10.1007/s00018-012-0993-6; Park HK, 2005, J MICROBIOL, V43, P345; PEARCE C, 1995, J MED MICROBIOL, V42, P67, DOI 10.1099/00222615-42-1-67; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Tezera LB, 2011, CELL MICROBIOL, V13, P554, DOI 10.1111/j.1462-5822.2010.01554.x; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Van den Bogert B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083418; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Wahli W, 1999, ADV EXP MED BIOL, V447, P199; Wang SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097523; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	57	36	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125371	10.1371/journal.pone.0125371	http://dx.doi.org/10.1371/journal.pone.0125371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946041	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700063
J	Jung, IL; Ryu, M; Cho, SK; Shah, P; Lee, JH; Bae, H; Kim, IG; Yang, SW				Jung, Il Lae; Ryu, Moonyoung; Cho, Seok Keun; Shah, Pratik; Lee, Ju Hye; Bae, Hansol; Kim, In Gyu; Yang, Seong Wook			Cesium Toxicity Alters MicroRNA Processing and AGO1 Expressions in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; TARGETS REVEALS; ACCUMULATION; PLANTS; GENE; POTASSIUM; RESPONSES; GROWTH; HOMEOSTASIS; AUXIN	MicroRNAs (miRNAs) are short RNA fragments that play important roles in controlled gene silencing, thus regulating many biological processes in plants. Recent studies have indicated that plants modulate miRNAs to sustain their survival in response to a variety of environmental stimuli, such as biotic stresses, cold, drought, nutritional starvation, and toxic heavy metals. Cesium and radio-cesium contaminations have arisen as serious problems that both impede plant growth and enter the food chain through contaminated plants. Many studies have been performed to define plant responses against cesium intoxication. However, the complete profile of miRNAs in plants during cesium intoxication has not been established. Here we show the differential expression of the miRNAs that are mostly downregulated during cesium intoxication. Furthermore, we found that cesium toxicity disrupts both the processing of pri-miRNAs and AGONOUTE 1 (AGO1)-mediated gene silencing. AGO 1 seems to be especially destabilized by cesium toxicity, possibly through a proteolytic regulatory pathway. Our study presents a comprehensive profile of cesium-responsive miRNAs, which is distinct from that of potassium, and suggests two possible mechanisms underlying the cesium toxicity on miRNA metabolism.	[Jung, Il Lae; Lee, Ju Hye; Kim, In Gyu] Korea Atom Energy Res Inst, Environm Radiat Res Grp, Dept Radiat Biol, Taejon 305353, South Korea; [Ryu, Moonyoung; Cho, Seok Keun; Shah, Pratik; Bae, Hansol; Yang, Seong Wook] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Copenhagen, Denmark	Korea Atomic Energy Research Institute (KAERI); University of Copenhagen	Jung, IL (corresponding author), Korea Atom Energy Res Inst, Environm Radiat Res Grp, Dept Radiat Biol, Taejon 305353, South Korea.	ex-jil7147@kaeri.re.kr; swyang@plen.ku.dk	Shah, Pratik/J-3557-2015; Shah, Pratik/N-2542-2019	Shah, Pratik/0000-0003-4755-1267; Shah, Pratik/0000-0003-4755-1267; Bae, Hansol/0000-0002-6737-5865	Center for Synthetic Biology - UNIK research initiative of the Danish Ministry of Science, Technology and Innovation [09-065274]; Korea Atomic Energy Research Institute [698241-14]	Center for Synthetic Biology - UNIK research initiative of the Danish Ministry of Science, Technology and Innovation; Korea Atomic Energy Research Institute	This work was supported by the Center for Synthetic Biology, funded by the UNIK research initiative of the Danish Ministry of Science, Technology and Innovation (Grant 09-065274) and was supported by funds from the Korea Atomic Energy Research Institute (Grant 698241-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2013, INT J MOL SCI, V14, P4545, DOI 10.3390/ijms14034545; AVERY SV, 1995, J IND MICROBIOL, V14, P76, DOI 10.1007/BF01569888; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben Chaabane S, 2013, NUCLEIC ACIDS RES, V41, P1984, DOI 10.1093/nar/gks1309; Broadley MR, 2001, J EXP BOT, V52, P839, DOI 10.1093/jexbot/52.357.839; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; CLINE JF, 1960, PLANT PHYSIOL, V35, P826, DOI 10.1104/pp.35.6.826; Cuypers A, 2011, J PLANT PHYSIOL, V168, P309, DOI 10.1016/j.jplph.2010.07.010; Derrien B, 2012, P NATL ACAD SCI USA, V109, P15942, DOI 10.1073/pnas.1209487109; Draxl S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3092; Eckardt NA, 2005, PLANT CELL, V17, P1335, DOI 10.1105/tpc.105.033159; Frazier TP, 2014, FUNCT INTEGR GENOMIC, V14, P75, DOI 10.1007/s10142-013-0341-4; Gao W, 2015, NUCLEIC ACIDS RES, V43, P607, DOI 10.1093/nar/gku1325; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gupta OP, 2014, PLANT MOL BIOL, V84, P1, DOI 10.1007/s11103-013-0120-6; Hampton CR, 2004, PLANT PHYSIOL, V136, P3824, DOI 10.1104/pp.104.046672; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim EJ, 1998, PLANT CELL, V10, P51, DOI 10.1105/tpc.10.1.51; Kong WW, 2010, PLANT PHYSIOL BIOCH, V48, P153, DOI 10.1016/j.plaphy.2009.12.008; KORDAN HA, 1987, NEW PHYTOL, V107, P395, DOI 10.1111/j.1469-8137.1987.tb00191.x; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; LEIGH RA, 1984, NEW PHYTOL, V97, P1, DOI 10.1111/j.1469-8137.1984.tb04103.x; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048951; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Muraro D, 2014, P NATL ACAD SCI USA, V111, P857, DOI 10.1073/pnas.1221766111; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Outola I, 2003, SCI TOTAL ENVIRON, V303, P221, DOI 10.1016/S0048-9697(02)00402-3; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Remy E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004375; Sahr T, 2005, NEW PHYTOL, V165, P747, DOI 10.1111/j.1469-8137.2004.01282.x; Saito T, 2014, J ENVIRON RADIOACTIV, V138, P11, DOI 10.1016/j.jenvrad.2014.07.025; SHEAHAN JJ, 1993, PLANT J, V3, P647, DOI 10.1111/j.1365-313X.1993.00647.x; Srivastava S, 2013, J EXP BOT, V64, P303, DOI 10.1093/jxb/ers333; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Valdes-Lopez O, 2010, NEW PHYTOL, V187, P805, DOI 10.1111/j.1469-8137.2010.03320.x; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; White PJ, 2000, NEW PHYTOL, V147, P241, DOI 10.1046/j.1469-8137.2000.00704.x; White PJ, 2003, PLANT SOIL, V249, P177, DOI 10.1023/A:1022593307224; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-66; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Yang ZM, 2013, METALLOMICS, V5, P1184, DOI 10.1039/c3mt00022b; Zhang LW, 2013, J HAZARD MATER, V250, P204, DOI 10.1016/j.jhazmat.2013.01.053; Zhang Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0271-x; Zhao YY, 2012, RNA BIOL, V9, P1218, DOI 10.4161/rna.22034; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	61	12	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125514	10.1371/journal.pone.0125514	http://dx.doi.org/10.1371/journal.pone.0125514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946015	gold, Green Submitted, Green Published			2022-12-26	WOS:000354049700074
J	Tram, K; Xia, JJ; Gysbers, R; Li, YF				Kha Tram; Xia, Jiaji; Gysbers, Rachel; Li, Yingfu			An Efficient Catalytic DNA that Cleaves L-RNA	PLOS ONE			English	Article							IN-VITRO SELECTION; GOLD NANOPARTICLES; DNAZYME; ENZYMES; DEOXYRIBOZYMES; MOLECULES; SEQUENCE; HYDROLYSIS; BIOSENSOR; ADENOSINE	Many DNAzymes have been isolated from synthetic DNA pools to cleave natural RNA (D-RNA) substrates and some have been utilized for the design of aptazyme biosensors for bioanalytical applications. Even though these biosensors perform well in simple sample matrices, they do not function effectively in complex biological samples due to ubiquitous RNases that can efficiently cleave D-RNA substrates. To overcome this issue, we set out to develop DNAzymes that cleave L-RNA, the enantiomer of D-RNA, which is known to be completely resistant to RNases. Through in vitro selection we isolated three L-RNA-cleaving DNAzymes from a random-sequence DNA pool. The most active DNAzyme exhibits a catalytic rate constant similar to 3 min(-1) and has a structure that contains a kissing loop, a structural motif that has never been observed with D-RNA-cleaving DNAzymes. Furthermore we have used this DNAzyme and a well-known ATP-binding DNA aptamer to construct an aptazyme sensor and demonstrated that this biosensor can achieve ATP detection in biological samples that contain RNases. The current work lays the foundation for exploring RNA-cleaving DNAzymes for engineering biosensors that are compatible with complex biological samples.	[Kha Tram] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Xia, Jiaji; Gysbers, Rachel] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Gysbers, Rachel; Li, Yingfu] McMaster Univ, Origins Inst, Hamilton, ON, Canada; [Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Dept Chem & Chem Biol, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Li, YF (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Dept Chem & Chem Biol, Hamilton, ON L8N 3Z5, Canada.	liying@mcmaster.ca			Natural Sciences and EngineeringResearch Council of Canada [227594-2009]; Sentinel Bioactive Paper Network	Natural Sciences and EngineeringResearch Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sentinel Bioactive Paper Network	The research work was supported by the Natural Sciences and EngineeringResearch Council of Canada Discovery Grant (227594-2009) and by a research grant to YL from the Sentinel Bioactive Paper Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JC, 2005, BIOCHEMISTRY-US, V44, P3765, DOI 10.1021/bi0483054; Ali MM, 2011, ANGEW CHEM INT EDIT, V50, P3751, DOI 10.1002/anie.201100477; ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; Baum DA, 2008, CELL MOL LIFE SCI, V65, P2156, DOI 10.1007/s00018-008-8029-y; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Brandsen BM, 2014, ANGEW CHEM INT EDIT, V53, P9045, DOI 10.1002/anie.201404622; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; BREAKER RR, 1995, CHEM BIOL, V2, P655, DOI 10.1016/1074-5521(95)90028-4; Chandra M, 2009, NAT CHEM BIOL, V5, P718, DOI 10.1038/nchembio.201; Chandrasekar J, 2013, P NATL ACAD SCI USA, V110, P5315, DOI 10.1073/pnas.1221946110; Chiuman W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001224; CHOW LT, 1977, CELL, V11, P819, DOI 10.1016/0092-8674(77)90294-X; Cruz RPG, 2004, CHEM BIOL, V11, P57, DOI 10.1016/j.chembiol.2003.12.012; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; He SN, 2015, ANAL CHEM, V87, P569, DOI 10.1021/ac5031557; Huang PJJ, 2014, ANAL CHEM, V86, P9993, DOI 10.1021/ac5029962; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Li J, 2000, J AM CHEM SOC, V122, P10466, DOI 10.1021/ja0021316; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Liu J, 2005, J AM CHEM SOC, V127, P12677, DOI 10.1021/ja053567u; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; Liu JW, 2003, J AM CHEM SOC, V125, P6642, DOI 10.1021/ja034775u; Liu ZJ, 2003, J AM CHEM SOC, V125, P7539, DOI 10.1021/ja035208+; Lu LM, 2011, J AM CHEM SOC, V133, P11686, DOI 10.1021/ja203693b; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; Ordoukhanian P, 2002, J AM CHEM SOC, V124, P12499, DOI 10.1021/ja027467p; Parker DJ, 2013, J AM CHEM SOC, V135, P8472, DOI 10.1021/ja4032488; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2008, NUCLEIC ACIDS RES, V36, P4768, DOI 10.1093/nar/gkn396; Schlosser K, 2010, CHEMBIOCHEM, V11, P866, DOI 10.1002/cbic.200900786; Schlosser K, 2009, CHEM BIOL, V16, P311, DOI 10.1016/j.chembiol.2009.01.008; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Tang J, 1998, NUCLEIC ACIDS RES, V26, P4214, DOI 10.1093/nar/26.18.4214; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Tram K, 2014, ANGEW CHEM INT EDIT, V53, P12799, DOI 10.1002/anie.201407021; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang DY, 2002, J MOL BIOL, V318, P33, DOI 10.1016/S0022-2836(02)00046-3; Wang W, 2002, CHEM BIOL, V9, P507, DOI 10.1016/S1074-5521(02)00127-8; Wong OY, 2011, ANGEW CHEM INT EDIT, V50, P11679, DOI 10.1002/anie.201104976; Xiao Y, 2007, J AM CHEM SOC, V129, P11896, DOI 10.1021/ja074218y; Xiao Y, 2011, CHEM COMMUN, V47, P1749, DOI 10.1039/c0cc04575f; Yang XR, 2010, CHEM COMMUN, V46, P3107, DOI 10.1039/c002137g; Zhang XB, 2011, ANNU REV ANAL CHEM, V4, P105, DOI 10.1146/annurev.anchem.111808.073617; Zhao WA, 2008, SMALL, V4, P810, DOI 10.1002/smll.200700757	49	16	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126402	10.1371/journal.pone.0126402	http://dx.doi.org/10.1371/journal.pone.0126402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946137	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700127
J	Luo, M; Embree, J; Ramdahin, S; Bielawny, T; Laycock, T; Tuff, J; Haber, D; Plummer, M; Plummer, FA				Luo, Ma; Embree, Joanne; Ramdahin, Suzie; Bielawny, Thomas; Laycock, Tyler; Tuff, Jeffrey; Haber, Darren; Plummer, Mariel; Plummer, Francis A.			HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR HISTOCOMPATIBILITY COMPLEX; MARROW-TRANSPLANTATION; ALLELE ASSIGNMENT; REDUCED RISK; EXON-2 DNA; RESISTANCE; INFECTION; SUSCEPTIBILITY; EXPRESSION	HLA class II antigens are central in initiating antigen-specific CD4+ T cell responses to HIV-1. Specific alleles have been associated with differential responses to HIV-1 infection and disease among adults. This study aims to determine the influence of HLA class II genes and their interactive effect on mother-child perinatal transmission in a drug naive, Mother-Child HIV transmission cohort established in Kenya, Africa in 1986. Our study showed that DRB concordance between mother and child increased risk of perinatal HIV transmission by three fold (P = 0.00035/Pc = 0.0014, OR: 3.09, 95%CI, 1.64-5.83). Whereas, DPA1, DPB1 and DQB1 concordance between mother and child had no significant influence on perinatal HIV transmission. In addition, stratified analysis showed that DRB1*15:03+ phenotype (mother or child) significantly increases the risk of perinatal HIV-1 transmission. Without DRB1*15:03, DRB1 discordance between mother and child provided 5 fold protection (P = 0.00008, OR:0.186, 95%CI: 0.081-0.427). However, the protective effect of DRB discordance was diminished if either the mother or the child was DRB1*15:03+ phenotype (P = 0.49-0.98, OR: 0.7-0.99, 95% CI: 0.246-2.956). DRB3+ children were less likely to be infected perinatally (P = 0.0006, Pc = 0.014; OR:0.343, 95% CI:0.183-0.642). However, there is a 4 fold increase in risk of being infected at birth if DRB3+ children were born to DRB1*15: 03+ mother compared to those with DRB1*15:03- mother. Our study showed that DRB concordance/discordance, DRB1*15:03, children's DRB3 phenotype and their interactions play an important role in perinatal HIV transmission. Identification of genetic factors associated with protection or increased risk in perinatal transmission will help develop alternative prevention and treatment methods in the event of increases in drug resistance of ARV.	[Luo, Ma; Embree, Joanne; Ramdahin, Suzie; Laycock, Tyler; Haber, Darren; Plummer, Mariel; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Luo, Ma; Bielawny, Thomas; Tuff, Jeffrey; Plummer, Francis A.] Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca			Canadian Institutes of Health Research; National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was founded by grants from the Canadian Institutes of Health Research and National Institutes of Health to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikhionbare Felix O, 2006, AIDS Res Ther, V3, P28; Aikhionbare FO, 2001, AIDS, V15, P2196, DOI 10.1097/00002030-200111090-00019; Alcaide-Loridan C, 1999, MICROBES INFECT, V1, P929, DOI 10.1016/S1286-4579(99)00224-5; Blanck G, 1999, MICROBES INFECT, V1, P913, DOI 10.1016/S1286-4579(99)00226-9; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; Debaz H, 1998, HUM IMMUNOL, V59, P287, DOI 10.1016/S0198-8859(98)00017-2; Fawzi W, 2001, AIDS, V15, P1157, DOI 10.1097/00002030-200106150-00011; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Gould SJ, 2004, Q REV BIOL, V79, P359, DOI 10.1086/426088; Hader SL, 2002, J INFECT DIS, V185, P1729, DOI 10.1086/340648; Hardie RA, 2008, AIDS, V22, P2038, DOI 10.1097/QAD.0b013e328311d1a0; Hardie RA, 2008, AIDS, V22, P807, DOI 10.1097/QAD.0b013e3282f51b71; Ho B. C. H., 2000, Annals Academy of Medicine Singapore, V29, P708; Kannangai R, 2001, CLIN DIAGN LAB IMMUN, V8, P1286, DOI 10.1128/CDLI.8.6.1286-1288.2001; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Luzuriaga Katherine, 2002, AIDS Reviews, V4, P21; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; MacDonald KS, 2001, J INFECT DIS, V183, P503, DOI 10.1086/318092; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528; Petersdorf EW, 2001, BLOOD, V98, P2922, DOI 10.1182/blood.V98.10.2922; Petersdorf EW, 1998, BLOOD, V92, P3515, DOI 10.1182/blood.V92.10.3515.422k49_3515_3520; Polycarpou A, 2002, AIDS RES HUM RETROV, V18, P741, DOI 10.1089/08892220260139477; Prat E, 2005, J NEUROIMMUNOL, V167, P108, DOI 10.1016/j.jneuroim.2005.04.027; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Robinson J, 2000, Rev Immunogenet, V2, P518; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; Robinson J, 2000, TISSUE ANTIGENS, V55, P280, DOI 10.1034/j.1399-0039.2000.550314.x; Robinson J, 2006, HUM MUTAT, V27, P1192, DOI 10.1002/humu.20406; Sampathkumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101475; SANTAMARIA, 1994, BLOOD, V83, P3834; Scarlatti G, 2004, AIDS REV, V6, P67; Selvaraj P, 2006, JAIDS-J ACQ IMM DEF, V43, P497, DOI 10.1097/01.qai.0000233312.36226.76; Tang JM, 2004, J INFECT DIS, V189, P1696, DOI 10.1086/383280	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126068	10.1371/journal.pone.0126068	http://dx.doi.org/10.1371/journal.pone.0126068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945792	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700108
J	Quaedflieg, CWEM; van de Ven, V; Meyer, T; Siep, N; Merckelbach, H; Smeets, T				Quaedflieg, C. W. E. M.; van de Ven, V.; Meyer, T.; Siep, N.; Merckelbach, H.; Smeets, T.			Temporal Dynamics of Stress-Induced Alternations of Intrinsic Amygdala Connectivity and Neuroendocrine Levels	PLOS ONE			English	Article							ANTI-CORRELATED NETWORKS; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PSYCHOSOCIAL STRESS; NEURAL BASIS; HUMAN BRAIN; STATE; EMOTION; FLUCTUATIONS; CORTISOL	Stress-induced changes in functional brain connectivity have been linked to the etiology of stress-related disorders. Resting state functional connectivity (rsFC) is especially informative in characterizing the temporal trajectory of glucocorticoids during stress adaptation. Using the imaging Maastricht Acute Stress Test (iMAST), we induced acute stress in 39 healthy volunteers and monitored the neuroendocrine stress levels during three runs of resting state functional magnetic resonance imaging (rs-fMRI): before (run 1), immediately following (run 2), and 30min after acute stress (run 3). The iMAST resulted in strong increases in cortisol levels. Whole-brain analysis revealed that acute stress (run 2-1) was characterized by changes in connectivity of the amygdala with the ventrolateral prefrontal cortex (vlPFC), ventral posterior cingulate cortex (PCC), cuneus, parahippocampal gyrus, and culmen. Additionally, cortisol responders were characterized by enhanced amygdala-medial prefrontal cortex (mPFC) connectivity. Stress recovery (run 3-2) was characterized by altered amygdala connectivity with the dorsolateral prefrontal cortex (dlPFC), ventral and dorsal anterior cingulate cortex (ACC), anterior hippocampal complex, cuneus, and presupplementary motor area (preSMA). Opposite to non-responders, cortisol responders were characterized by enhanced amygdala connectivity with the anterior hippocampal complex and parahippocampal gyrus, and reduced connectivity with left dlPFC, dACC, and culmen during early recovery. Acute stress responding and recovery are thus associated with changes in the functional connectivity of the amygdala network. Our findings show that these changes may be regulated via stress-induced neuroendocrine levels. Defining stress-induced neuronal network changes is pertinent to developing treatments that target abnormal neuronal activity.	[Quaedflieg, C. W. E. M.; van de Ven, V.; Meyer, T.; Siep, N.; Merckelbach, H.; Smeets, T.] Maastricht Univ, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands	Maastricht University	Quaedflieg, CWEM (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands.	conny.quaedflieg@maastrichtuniversity.nl	van de Ven, Vincent/D-3003-2009; Smeets, Tom/H-1212-2011	van de Ven, Vincent/0000-0001-8735-3711; Smeets, Tom/0000-0002-3773-0264; Siep, Nicolette/0000-0002-0326-2933; Meyer, Thomas/0000-0001-7228-5365	Netherlands Organization for Scientific Research (NWO) [451-08-005, 056-25-011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by grants 451-08-005 and 056-25-011 from the Netherlands Organization for Scientific Research (NWO) to TS. NWO had no further role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carbonell F, 2014, NEUROIMAGE, V86, P343, DOI 10.1016/j.neuroimage.2013.10.013; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Clewett D, 2013, COGN AFFECT BEHAV NE, V13, P501, DOI 10.3758/s13415-013-0162-x; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Dedovic K, 2009, CAN J PSYCHIAT, V54, P6, DOI 10.1177/070674370905400104; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; Etkin A, 2006, NEURON, V52, P1121, DOI 10.1016/j.neuron.2006.12.003; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Henckens MJAG, 2012, HUM BRAIN MAPP, V33, P2885, DOI 10.1002/hbm.21409; Henckens MJAG, 2011, P NATL ACAD SCI USA, V108, P5801, DOI 10.1073/pnas.1019128108; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Hermans EJ, 2014, TRENDS NEUROSCI, V37, P304, DOI 10.1016/j.tins.2014.03.006; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lang P.J., 2008, A8 U FLOR; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li HJ, 2014, NEUROIMAGE, V92, P1, DOI 10.1016/j.neuroimage.2014.01.044; Lovallo WR, 2010, PSYCHONEUROENDOCRINO, V35, P15, DOI 10.1016/j.psyneuen.2009.09.010; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McRae K, 2008, NEUROIMAGE, V41, P648, DOI 10.1016/j.neuroimage.2008.02.030; Miller R, 2013, PSYCHOSOM MED, V75, P832, DOI 10.1097/PSY.0000000000000002; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Quaedflieg CWEM, 2013, PSYCHOPHYSIOLOGY, V50, P758, DOI 10.1111/psyp.12058; Quaedflieg CWEM, 2014, BIOL PSYCHO IN PRESS; Robinson JL, 2010, HUM BRAIN MAPP, V31, P173, DOI 10.1002/hbm.20854; Roozendaal B, 2003, PROG NEURO-PSYCHOPH, V27, P1213, DOI 10.1016/j.pnpbp.2003.09.015; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Smeets T, 2012, PSYCHONEUROENDOCRINO, V37, P1998, DOI 10.1016/j.psyneuen.2012.04.012; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Strelzyk F, 2012, J NEUROSCI, V32, P616, DOI 10.1523/JNEUROSCI.2384-11.2012; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Vaisvaser S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00313; van de Ven V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068355; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	70	66	66	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124141	10.1371/journal.pone.0124141	http://dx.doi.org/10.1371/journal.pone.0124141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946334	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700034
J	Rullo, M; Presaghi, F; Livi, S				Rullo, Marika; Presaghi, Fabio; Livi, Stefano			Reactions to Ingroup and Outgroup Deviants: An Experimental Group Paradigm for Black Sheep Effect	PLOS ONE			English	Article							SUBJECTIVE GROUP-DYNAMICS; IN-GROUP DEVIANTS; PHYSIOLOGICAL AROUSAL; AGGRESSIVE-BEHAVIOR; PROSOCIAL BEHAVIOR; SOCIAL IDENTITY; MEMBERS; IDENTIFICATION; EXTREMITY; JUDGMENTS	In the classic black sheep effect (BSE) an ingroup deviant member is usually evaluated more negatively than the corresponding outgroup deviant. This effect is usually obtained by using scenarios and asking people to imagine the situation as vividly as possible. The present study proposes a new method to investigate the BSE by considering the behavioral and physiological reactions to unfair behavior (aggressive game behavior) in a realistic experimental group-setting. The study involved 52 university students in a minimal group setting who performed a modified version of the competitive reaction time (CRT) task adapted to be played in groups of four people. The classic BSE was replicated for evaluation but not for the behavioral reactions (retaliate to aggression) to deviants. More interestingly, a negative relationship emerged in the ingroup deviant condition between the level of behavioral derogation and the systolic blood pressure level.	[Rullo, Marika; Presaghi, Fabio; Livi, Stefano] Univ Roma La Sapienza, Dipartimento Psicol Proc Sviluppo & Socializzaz, I-00185 Rome, Italy	Sapienza University Rome	Rullo, M (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol Proc Sviluppo & Socializzaz, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marika.rullo@uniroma1.it	Presaghi, Fabio/P-3845-2015; Livi, Stefano/H-5348-2012; Presaghi, Fabio/N-1590-2019	Presaghi, Fabio/0000-0001-7880-6715; Presaghi, Fabio/0000-0001-7880-6715; rullo, marika/0000-0003-0642-5985				Abrams D, 2000, J PERS SOC PSYCHOL, V78, P906, DOI 10.1037/0022-3514.78.5.906; Abrams D., 2002, GR PROCESS INTERGR R, V5, P163, DOI [10.1177/1368430202005002922, DOI 10.1177/1368430202005002922]; Abrams D, 2007, DEV PSYCHOL, V43, P134, DOI 10.1037/0012-1649.43.1.134; Aiken L. S., 1991, MULTIPLE REGRESSION; Anderson CA, 2001, PSYCHOL SCI, V12, P353, DOI 10.1111/1467-9280.00366; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; BAKER JW, 1969, J PERS SOC PSYCHOL, V12, P80, DOI 10.1037/h0027345; Begue L, 2001, J SOC PSYCHOL, V141, P640, DOI 10.1080/00224540109600577; Blascovich J., 2002, PREJUDICE INTERGROUP, P89; Branscombe N.R., 1999, SOCIAL IDENTITY CONT, P35, DOI DOI 10.4135/9781446200919.N23; BRANSCOMBE NR, 1993, PERS SOC PSYCHOL B, V19, P381, DOI 10.1177/0146167293194003; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Castano E, 2002, BRIT J SOC PSYCHOL, V41, P365, DOI 10.1348/014466602760344269; Coull Alastair., 2001, GROUP PROCESSES INTE, V4, P327, DOI [10.1177/1368430201004004003, DOI 10.1177/1368430201004004003]; CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037/0033-295X.96.4.608; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frings D, 2012, GROUP DYN-THEOR RES, V16, P105, DOI 10.1037/a0027504; Frings D, 2010, GROUP DYN-THEOR RES, V14, P281, DOI 10.1037/a0019162; Frings D, 2010, GROUP DYN-THEOR RES, V14, P80, DOI 10.1037/a0016092; Harter S., 1986, PROCESSES UNDERLYING, VVolume 3, P137; HENSLEY V, 1976, J PERS SOC PSYCHOL, V34, P159, DOI 10.1037/0022-3514.34.2.159; Hogg MA, 2007, ADV EXP SOC PSYCHOL, V39, P69, DOI 10.1016/S0065-2601(06)39002-8; HOKANSON JE, 1962, J ABNORM PSYCHOL, V65, P232, DOI 10.1037/h0043800; HOKANSON JE, 1961, J ABNORM SOC PSYCH, V63, P446, DOI 10.1037/h0046864; Jetten J, 2014, ANNU REV PSYCHOL, V65, P461, DOI 10.1146/annurev-psych-010213-115151; Khan S, 1998, BASIC APPL SOC PSYCH, V20, P263, DOI 10.1207/s15324834basp2004_3; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; Mannetti L, 2010, SOC COGNITION, V28, P447, DOI 10.1521/soco.2010.28.3.447; Marques J.M., 1994, EUR REV SOC PSYCHOL, V5, P37, DOI [10.1080/14792779543000011, DOI 10.1080/14792779543000011]; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; Marques JM, 2001, J PERS SOC PSYCHOL, V81, P436, DOI 10.1037//0022-3514.81.3.436; Marques JM, 1998, J PERS SOC PSYCHOL, V75, P976, DOI 10.1037/0022-3514.75.4.976; MARQUES JM, 1992, EUR J SOC PSYCHOL, V22, P331, DOI 10.1002/ejsp.2420220403; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P287, DOI 10.1002/ejsp.2420180308; Marques JM, 1998, SOCIAL IDENTITY INTR; Marques JM, 1990, SOCIAL IDENTITY THEO; Papillo J., 1990, PRINCIPLES PSYCHOPHY, P456; Pfattheicher S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085691; Piliavin J.A., 1981, EMERGENCY INTERVENTI; Pinto IR, 2010, J PERS SOC PSYCHOL, V99, P107, DOI 10.1037/a0018187; Reese G, 2013, SOC COGNITION, V31, P482; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; SCHACHTER S, 1951, J ABNORM SOC PSYCH, V46, P190, DOI 10.1037/h0062326; Schmitt MT, 2001, J EXP SOC PSYCHOL, V37, P510, DOI 10.1006/jesp.2001.1476; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tajfel H., 1978, DIFFERENTIATION SOCI, P77; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x	50	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125605	10.1371/journal.pone.0125605	http://dx.doi.org/10.1371/journal.pone.0125605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946148	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700078
J	Zhang, M; Luo, H; Xi, ZR; Rogaeva, E				Zhang, Ming; Luo, Heng; Xi, Zhengrui; Rogaeva, Ekaterina			Drug Repositioning for Diabetes Based on 'Omics' Data Mining	PLOS ONE			English	Article							INSULIN-RESISTANCE; RECEPTORS; LIVER; ACID	Drug repositioning has shorter developmental time, lower cost and less safety risk than traditional drug development process. The current study aims to repurpose marketed drugs and clinical candidates for new indications in diabetes treatment by mining clinical 'omics' data. We analyzed data from genome wide association studies (GWAS), proteomics and metabolomics studies and revealed a total of 992 proteins as potential anti-diabetic targets in human. Information on the drugs that target these 992 proteins was retrieved from the Therapeutic Target Database (TTD) and 108 of these proteins are drug targets with drug projects information. Research and preclinical drug targets were excluded and 35 of the 108 proteins were selected as druggable proteins. Among them, five proteins were known targets for treating diabetes. Based on the pathogenesis knowledge gathered from the OMIM and PubMed databases, 12 protein targets of 58 drugs were found to have a new indication for treating diabetes. CMap (connectivity map) was used to compare the gene expression patterns of cells treated by these 58 drugs and that of cells treated by known antidiabetic drugs or diabetes risk causing compounds. As a result, 9 drugs were found to have the potential to treat diabetes. Among the 9 drugs, 4 drugs (diflunisal, nabumetone, niflumic acid and valdecoxib) targeting COX2 (prostaglandin G/H synthase 2) were repurposed for treating type 1 diabetes, and 2 drugs (phenoxybenzamine and idazoxan) targeting ADRA2A (Alpha-2A adrenergic receptor) had a new indication for treating type 2 diabetes. These findings indicated that 'omics' data mining based drug repositioning is a potentially powerful tool to discover novel anti-diabetic indications from marketed drugs and clinical candidates. Furthermore, the results of our study could be related to other disorders, such as Alzheimer's disease.	[Zhang, Ming; Xi, Zhengrui; Rogaeva, Ekaterina] Univ Toronto, Dept Med, Div Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Luo, Heng] Univ Arkansas, Med Sci Bioinformat Grad Program, Little Rock, AR 72204 USA	University of Toronto; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Zhang, M (corresponding author), Univ Toronto, Dept Med, Div Neurol, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard St, Toronto, ON M5T 2S8, Canada.	lifeming@gmail.com	Luo, Heng/D-3616-2016	Luo, Heng/0000-0001-5192-8878	Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the grant from the Canadian Institutes of Health Research (ER).	Andronis C, 2011, BRIEF BIOINFORM, V12, P357, DOI 10.1093/bib/bbr005; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Burgess TA, 2011, ARCH SURG-CHICAGO, V146, P556, DOI 10.1001/archsurg.2011.100; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; Jones PM, 2004, DIABETES, V53, pS172, DOI 10.2337/diabetes.53.2007.S172; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Lam CKL, 2010, J BIOL CHEM, V285, P21913, DOI 10.1074/jbc.M109.087338; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Ma LN, 2015, CLIN CHIM ACTA, V444, P18, DOI 10.1016/j.cca.2015.01.027; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Robertson DG, 2013, CLIN PHARMACOL THER, V94, P559, DOI 10.1038/clpt.2013.120; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Sanseau P, 2013, NAT BIOTECHNOL, V31, P1082, DOI 10.1038/nbt.2769; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schafer J, 2010, J PHARMACOL EXP THER, V333, P621, DOI 10.1124/jpet.109.164509; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Ueno N, 2002, DIABETOLOGIA, V45, P792, DOI 10.1007/s00125-002-0835-4; Wang KJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003315; Wang ZY, 2013, NAT BIOTECHNOL, V31, P1080, DOI 10.1038/nbt.2758; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016	33	44	47	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126082	10.1371/journal.pone.0126082	http://dx.doi.org/10.1371/journal.pone.0126082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946000	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700110
J	Brocke, HJ; Polerecky, L; de Beer, D; Weber, M; Claudet, J; Nugues, MM				Brocke, Hannah J.; Polerecky, Lubos; de Beer, Dirk; Weber, Miriam; Claudet, Joachim; Nugues, Maggy M.			Organic Matter Degradation Drives Benthic Cyanobacterial Mat Abundance on Caribbean Coral Reefs	PLOS ONE			English	Article							LYNGBYA-MAJUSCULA; NUTRIENT ENRICHMENT; TROPICAL LAGOON; MICROBIAL MATS; LIMITING NUTRIENT; NITROGEN-FIXATION; SPATIAL-PATTERNS; FLORIDA-KEYS; MORETON BAY; PHOSPHORUS	Benthic cyanobacterial mats (BCMs) are impacting coral reefs worldwide. However, the factors and mechanisms driving their proliferation are unclear. We conducted a multi-year survey around the Caribbean island of Curacao, which revealed highest BCM abundance on sheltered reefs close to urbanised areas. Reefs with high BCM abundance were also characterised by high benthic cover of macroalgae and low cover of corals. Nutrient concentrations in the water-column were consistently low, but markedly increased just above substrata (both sandy and hard) covered with BCMs. This was true for sites with both high and low BCM coverage, suggesting that BCM growth is stimulated by a localised, substrate-linked release of nutrients from the microbial degradation of organic matter. This hypothesis was supported by a higher organic content in sediments on reefs with high BCM coverage, and by an in situ experiment which showed that BCMs grew within days on sediments enriched with organic matter (Spirulina). We propose that nutrient runoff from urbanised areas stimulates phototrophic blooms and enhances organic matter concentrations on the reef. This organic matter is transported by currents and settles on the seabed at sites with low hydrodynamics. Subsequently, nutrients released from the organic matter degradation fuel the growth of BCMs. Improved management of nutrients generated on land should lower organic loading of sediments and other benthos (e.g. turf and macroalgae) to reduce BCM proliferation on coral reefs.	[Brocke, Hannah J.; Polerecky, Lubos; de Beer, Dirk; Weber, Miriam] Max Planck Inst Marine Microbiol MPI Bremen, Dept Biogeochem, Bremen, Germany; [Brocke, Hannah J.] Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany; [Brocke, Hannah J.; Claudet, Joachim; Nugues, Maggy M.] EPHE CNRS UPVD, CRIOBE USR 3278, Lab Excellence Corail, Perpignan, France; [Polerecky, Lubos] Univ Utrecht, Fac Geosci, Geochem, Utrecht, Netherlands; [Weber, Miriam] HYDRA Inst Marine Sci, Elba Field Stn, Campo Nellelba, Italy; [Nugues, Maggy M.] Caribbean Res & Management Biodivers CARMABI Fdn, Willemstad, Curacao, Netherlands	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Utrecht University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Brocke, HJ (corresponding author), Max Planck Inst Marine Microbiol MPI Bremen, Dept Biogeochem, Bremen, Germany.	hbrocke@mpi-bremen.de	Nugues, Maggy M/O-4314-2015; de Beer, Dirk/L-4840-2013; Claudet, Joachim/C-6335-2008; Polerecky, Lubos/E-1134-2014	Nugues, Maggy M/0000-0002-1399-9787; de Beer, Dirk/0000-0001-5274-1781; Claudet, Joachim/0000-0001-6295-1061; Polerecky, Lubos/0000-0003-4425-585X	European Union 7th Framework programme (P7) [244161]	European Union 7th Framework programme (P7)	The research leading to these results has received funding from the European Union 7th Framework programme (P7/2007-2013) under grant agreement No. 244161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern KS, 2008, HARMFUL ALGAE, V7, P389, DOI 10.1016/j.hal.2007.08.006; Ahern KS, 2006, MAR FRESHWATER RES, V57, P167, DOI 10.1071/MF05022; Ahern KS, 2006, MAR FRESHWATER RES, V57, P177, DOI 10.1071/MF05115; Albert S, 2005, MAR POLLUT BULL, V51, P428, DOI 10.1016/j.marpolbul.2004.10.016; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1986, AGRONOMY-BASEL, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C28; Armitage AR, 2004, OECOLOGIA, V139, P560, DOI 10.1007/s00442-004-1530-6; Arthur KE, 2009, MAR ECOL PROG SER, V394, P101, DOI 10.3354/meps08311; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Becerro MA, 2006, CORAL REEFS, V25, P193, DOI 10.1007/s00338-005-0080-7; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Charpy L., 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/259571; Charpy L, 2010, MICROB ECOL, V59, P174, DOI 10.1007/s00248-009-9576-y; Chipman L, 2010, LIMNOL OCEANOGR, V55, P857, DOI 10.4319/lo.2009.55.2.0857; Clavier J, 1999, MAR ECOL PROG SER, V191, P79, DOI 10.3354/meps191079; d'Elia C.F., 1990, P49; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DELIA CF, 1981, B MAR SCI, V31, P903; Elmetri I, 2004, MAR ECOL PROG SER, V281, P27, DOI 10.3354/meps281027; FONG P, 1993, LIMNOL OCEANOGR, V38, P906; Gast GJ, 1999, B MAR SCI, V65, P523; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Hallock P, 2005, SEDIMENT GEOL, V175, P19, DOI 10.1016/j.sedgeo.2004.12.027; Hippolyte JC, 2011, MAR PETROL GEOL, V28, P259, DOI 10.1016/j.marpetgeo.2009.06.010; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; HUETTEL M, 2010, GEOCHIM COSM SUPPL, V74, pA435; JENSEN HS, 1995, LIMNOL OCEANOGR, V40, P908, DOI 10.4319/lo.1995.40.5.0908; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; Kelly LW, 2012, ISME J, V6, P638, DOI 10.1038/ismej.2011.114; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Koroleff F, 1972, NEW BALTIC MANUAL A, P44; Kuffner IB, 2001, MAR ECOL PROG SER, V222, P63, DOI 10.3354/meps222063; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V308, P23, DOI 10.1016/j.jembe.2004.01.019; LARKUM AWD, 1988, MAR BIOL, V98, P143, DOI 10.1007/BF00392669; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; Lin HJ, 2004, MAR BIOL, V144, P653, DOI 10.1007/s00227-003-1231-4; McDole T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043233; Miller MW, 1999, LIMNOL OCEANOGR, V44, P1847, DOI 10.4319/lo.1999.44.8.1847; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; Nagle DG, 1999, J PHYCOL, V35, P1412; Nagle DG, 1998, J EXP MAR BIOL ECOL, V225, P29, DOI 10.1016/S0022-0981(97)00205-0; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Paerl HW, 2008, MAR ECOL PROG SER, V371, P143, DOI 10.3354/meps07681; Palinska KA, 2012, FOTTEA, V12, P127, DOI 10.5507/fot.2012.010; Paul VJ, 2005, CORAL REEFS, V24, P693, DOI 10.1007/s00338-005-0061-x; Pringault O, 2005, MICROB ECOL, V49, P604, DOI 10.1007/s00248-004-0102-y; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Schaffelke B, 1999, J PHYCOL, V35, P1150, DOI 10.1046/j.1529-8817.1999.3561150.x; Szmant AM, 1996, CORAL REEFS, V15, P21, DOI 10.1007/BF01626075; Thacker RW, 2001, B MAR SCI, V69, P497; van Duyl F.C., 1985, Uitgaven Natuurwetenschappelijke Studiekring voor Suriname en de Nederlandse Antillen, P1; van Duyl FC, 2002, CORAL REEFS, V21, P293, DOI 10.1007/s00338-002-0248-3; van Sambeek MHG, 2000, GEOL MIJNBOUW-N J G, V79, P459; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Watkinson AJ, 2005, HARMFUL ALGAE, V4, P697, DOI 10.1016/j.hal.2004.09.001; Weber M, 2007, ENVIRON SCI TECHNOL, V41, P6210, DOI 10.1021/es070200b; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Werner U, 2006, MAR ECOL PROG SER, V309, P93, DOI 10.3354/meps309093; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344	68	35	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125445	10.1371/journal.pone.0125445	http://dx.doi.org/10.1371/journal.pone.0125445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25941812	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400037
J	Gao, W; Nan, TG; Tan, GY; Zhao, HW; Tan, WM; Meng, FY; Li, ZH; Li, QX; Wang, BM				Gao, Wei; Nan, Tiegui; Tan, Guiyu; Zhao, Hongwei; Tan, Weiming; Meng, Fanyun; Li, Zhaohu; Li, Qing X.; Wang, Baomin			Cellular and Subcellular Immunohistochemical Localization and Quantification of Cadmium Ions in Wheat (Triticum aestivum)	PLOS ONE			English	Article							HYPERACCUMULATING ECOTYPE; THLASPI-CAERULESCENS; ACCUMULATION; LEAVES; ARABIDOPSIS; ROOTS; CELLS; ZINC; TOLERANCE; SOIL	The distribution of metallic ions in plant tissues is associated with their toxicity and is important for understanding mechanisms of toxicity tolerance. A quantitative histochemical method can help advance knowledge of cellular and subcellular localization and distribution of heavy metals in plant tissues. An immunohistochemical (IHC) imaging method for cadmium ions (Cd2+) was developed for the first time for the wheat Triticum aestivum grown in Cd2+-fortified soils. Also, 1-(4-Isothiocyanobenzyl)-ethylenediamine-N, N, N, N-tetraacetic acid (ITCB-EDTA) was used to chelate the mobile Cd2+. The ITCB-EDTA/Cd2+ complex was fixed with proteins in situ via the isothiocyano group. A new Cd2+-EDTA specific monoclonal antibody, 4F3B6D9A1, was used to locate the Cd2+-EDTA protein complex. After staining, the fluorescence intensities of sections of Cd2+-positive roots were compared with those of Cd2+-negative roots under a laser confocal scanning microscope, and the location of colloidal gold particles was determined with a transmission electron microscope. The results enable quantification of the Cd2+ content in plant tissues and illustrate Cd2+ translocation and cellular and subcellular responses of T. aestivum to Cd2+ stress. Compared to the conventional metal-S coprecipitation histochemical method, this new IHC method is quantitative, more specific and has less background interference. The subcellular location of Cd2+ was also confirmed with energy-dispersive X-ray microanalysis. The IHC method is suitable for locating and quantifying Cd2+ in plant tissues and can be extended to other heavy metallic ions.	[Gao, Wei; Nan, Tiegui; Tan, Guiyu; Zhao, Hongwei; Tan, Weiming; Li, Zhaohu; Wang, Baomin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Gao, Wei] Henan Agr Univ, Coll Resources & Environm Sci, Zhengzhou, Peoples R China; [Zhao, Hongwei; Li, Qing X.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Meng, Fanyun] Beijing Normal Univ, Inst Nat Med & Chinese Med Resources, Beijing 100875, Peoples R China	China Agricultural University; Henan Agricultural University; University of Hawaii System; University of Hawaii Manoa; Beijing Normal University	Li, QX (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	qingl@hawaii.edu; wbaomin@263.net	Li, Qing/AAO-3938-2020; li, zh/HII-5698-2022	ZHAO, HONGWEI/0000-0003-2334-9793	national high technology research and development program ("863" Program) of China [2008AA10Z426, 009ZX09502-026]; National Center for Research Resources [5 G12 RR003061-26]; National Institute on Minority Health and Health Disparities [8 G12 MD007601-26]; National Institute of Occupational Safety and Health of the U.S. Department of Health and Human Services [2U54OH007550-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH007550] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	national high technology research and development program ("863" Program) of China(National High Technology Research and Development Program of China); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Occupational Safety and Health of the U.S. Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported in part by the national high technology research and development program ("863" Program) of China (2008AA10Z426 and 009ZX09502-026), the National Center for Research Resources (5 G12 RR003061-26), the National Institute on Minority Health and Health Disparities (8 G12 MD007601-26) and the National Institute of Occupational Safety and Health (2U54OH007550-11) of the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NYR, 2007, ANAL CHEM, V79, P7416, DOI 10.1021/ac071460e; Astruc T, 2007, J AGR FOOD CHEM, V55, P9554, DOI 10.1021/jf0717586; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Bose S, 2008, CHEMOSPHERE, V70, P1264, DOI 10.1016/j.chemosphere.2007.07.062; Collins RN, 2010, ENVIRON SCI TECHNOL, V44, P2904, DOI 10.1021/es903485h; Cosio C, 2005, J EXP BOT, V56, P765, DOI 10.1093/jxb/eri062; Dinh NT, 2015, ENVIRON EXP BOT, V110, P85, DOI 10.1016/j.envexpbot.2014.10.001; Gao W, 2012, FOOD AGR IMMUNOL, V23, P27, DOI 10.1080/09540105.2011.589045; Garg N, 2011, J PLANT GROWTH REGUL, V30, P286, DOI 10.1007/s00344-010-9191-7; Griesen D, 2004, PLANT PHYSIOL, V134, P726, DOI 10.1104/pp.103.032359; Han YL, 2007, ECOTOXICOLOGY, V16, P557, DOI 10.1007/s10646-007-0162-0; Hao HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076660; Heumann HG, 2002, J PLANT PHYSIOL, V159, P191, DOI 10.1078/0176-1617-00553; Hou ZX, 2005, PLANTA, V222, P678, DOI 10.1007/s00425-005-0014-1; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; KHAN DH, 1984, J PLANT PHYSIOL, V115, P19, DOI 10.1016/S0176-1617(84)80047-4; Leitenmaier B, 2011, PLANT CELL ENVIRON, V34, P208, DOI 10.1111/j.1365-3040.2010.02236.x; Lu LL, 2008, J EXP BOT, V59, P3203, DOI 10.1093/jxb/ern174; Ma JF, 2005, PLANTA, V220, P731, DOI 10.1007/s00425-004-1392-5; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Peng YB, 2006, NEW PHYTOL, V170, P459, DOI 10.1111/j.1469-8137.2006.01683.x; Puschenreiter M, 2005, PLANT SOIL ENVIRON, V51, P1, DOI 10.17221/3549-PSE; Solis-Dominguez FA, 2007, J HAZARD MATER, V141, P630, DOI 10.1016/j.jhazmat.2006.07.014; Sridhar BBM, 2005, ENVIRON EXP BOT, V54, P131, DOI 10.1016/j.envexpbot.2004.06.011; Ueki S, 2005, P NATL ACAD SCI USA, V102, P12089, DOI 10.1073/pnas.0505927102; Van Belleghem F, 2007, NEW PHYTOL, V173, P495, DOI 10.1111/j.1469-8137.2006.01940.x; Vassilev A, 2002, J CENTRAL EURO AGR, V4, P66; VAZQUEZ MD, 1992, J PLANT PHYSIOL, V140, P350, DOI 10.1016/S0176-1617(11)81091-6; Vazquez S, 2007, J PLANT PHYSIOL, V164, P1235, DOI 10.1016/j.jplph.2006.11.011; Vogel-Mikus K, 2008, NEW PHYTOL, V179, P712, DOI 10.1111/j.1469-8137.2008.02519.x; Vollenweider P, 2006, ENVIRON EXP BOT, V58, P25, DOI [10.1016/j.envexpbot.2005.06.012, 10.1016/j.envexpbot.2005.06.017]; Wang ZW, 2011, J SCI FOOD AGR, V91, P377, DOI 10.1002/jsfa.4196; Wojcik M, 2005, BIOL PLANTARUM, V49, P237, DOI 10.1007/s10535-005-7245-7; Wojcik M, 2005, ENVIRON EXP BOT, V53, P163, DOI 10.1016/j.envexpbot.2004.03.011; Xu RY, 2007, PLANT GROWTH REGUL, V52, P1, DOI 10.1007/s10725-007-9168-0; Zeng FR, 2011, J PLANT NUTR SOIL SC, V174, P249, DOI 10.1002/jpln.200900309; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhao YF, 2015, FOOD CHEM, V168, P48, DOI 10.1016/j.foodchem.2014.07.054; Zhou YQ, 2010, ECOTOXICOLOGY, V19, P69, DOI 10.1007/s10646-009-0389-z	39	5	7	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0123779	10.1371/journal.pone.0123779	http://dx.doi.org/10.1371/journal.pone.0123779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25941807	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400008
J	Howlett, JR; Paulus, MP				Howlett, Jonathon R.; Paulus, Martin P.			The Neural Basis of Testable and Non-Testable Beliefs	PLOS ONE			English	Article							PREFRONTAL CORTEX; CINGULATE CORTEX; HUMAN BRAIN; FMRI; SYSTEMS; ANXIETY; SELF; INTEROCEPTION; METAANALYSIS; UNCERTAINTY	Beliefs about the state of the world are an important influence on both normal behavior and psychopathology. However, understanding of the neural basis of belief processing remains incomplete, and several aspects of belief processing have only recently been explored. Specifically, different types of beliefs may involve fundamentally different inferential processes and thus recruit distinct brain regions. Additionally, neural processing of truth and falsity may differ from processing of certainty and uncertainty. The purpose of this study was to investigate the neural underpinnings of assessment of testable and non-testable propositions in terms of truth or falsity and the level of certainty in a belief. Functional magnetic resonance imaging (fMRI) was used to study 14 adults while they rated propositions as true or false and also rated the level of certainty in their judgments. Each proposition was classified as testable or non-testable. Testable propositions activated the DLPFC and posterior cingulate cortex, while non-testable statements activated areas including inferior frontal gyrus, superior temporal gyrus, and an anterior region of the superior frontal gyrus. No areas were more active when a proposition was accepted, while the dorsal anterior cingulate was activated when a proposition was rejected. Regardless of whether a proposition was testable or not, certainty that the proposition was true or false activated a common network of regions including the medial prefrontal cortex, caudate, posterior cingulate, and a region of middle temporal gyrus near the temporo-parietal junction. Certainty in the truth or falsity of a non-testable proposition (a strong belief without empirical evidence) activated the insula. The results suggest that different brain regions contribute to the assessment of propositions based on the type of content, while a common network may mediate the influence of beliefs on motivation and behavior based on the level of certainty in the belief.	[Howlett, Jonathon R.; Paulus, Martin P.] Univ Calif San Diego, Lab Biol Dynam & Theoret Med, La Jolla, CA 92093 USA; [Howlett, Jonathon R.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Paulus, Martin P.] Laureate Inst Brain Res, Tulsa, OK USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Laureate Institute for Brain Research, Inc.	Howlett, JR (corresponding author), Univ Calif San Diego, Lab Biol Dynam & Theoret Med, La Jolla, CA 92093 USA.	jhowlett@ucsd.edu	Howlett, Jonathon/AAY-2390-2021	Paulus, Martin/0000-0002-0825-3606	National Institutes of Health [5T32MH018399 - 28]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support was provided by National Institutes of Health grant number 5T32MH018399 - 28. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bann CM, 2004, DEPRESS ANXIETY, V20, P114, DOI 10.1002/da.20036; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Blackburn S., 2008, OXFORD DICT PHILOS, Vrevised; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bystritsky A, 2005, GEN HOSP PSYCHIAT, V27, P313, DOI 10.1016/j.genhosppsych.2005.05.005; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Eddy WF, 1996, MAGNET RESON MED, V36, P923, DOI 10.1002/mrm.1910360615; ELLIOTT R, 1995, BRIT J SOC PSYCHOL, V34, P161, DOI 10.1111/j.2044-8309.1995.tb01055.x; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; Gopnik A., 1994, SELF AWARENESS ANIMA, P166; Grupe DW, 2011, EMOTION, V11, P413, DOI 10.1037/a0022583; Happe F, 2003, ANN NY ACAD SCI, V1001, P134, DOI 10.1196/annals.1279.008; Harris S, 2008, ANN NEUROL, V63, P141, DOI 10.1002/ana.21301; Harris S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007272; Haxby JV, 2000, NEUROIMAGE, V11, P145, DOI 10.1006/nimg.1999.0527; JONES EE, 1978, PERS SOC PSYCHOL B, V4, P200, DOI 10.1177/014616727800400205; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; Ma N, 2012, SOC COGN AFFECT NEUR, V7, P937, DOI 10.1093/scan/nsr064; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; NELSON RE, 1977, J CONSULT CLIN PSYCH, V45, P1190, DOI 10.1037/0022-006X.45.6.1190; O'Reilly RC, 2010, TRENDS NEUROSCI, V33, P355, DOI 10.1016/j.tins.2010.05.002; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Roese NJ, 2009, J SOC CLIN PSYCHOL, V28, P671, DOI 10.1521/jscp.2009.28.6.671; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Van Overwalle F, 2011, NEUROIMAGE, V54, P1589, DOI 10.1016/j.neuroimage.2010.09.043; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Young L, 2010, NEUROPSYCHOLOGIA, V48, P2658, DOI 10.1016/j.neuropsychologia.2010.05.012; Zeelenberg M, 2004, ORGAN BEHAV HUM DEC, V93, P155, DOI 10.1016/j.obhdp.2003.10.001	53	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124596	10.1371/journal.pone.0124596	http://dx.doi.org/10.1371/journal.pone.0124596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942019	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400018
J	Ahram, DF; Grozdanic, SD; Kecova, H; Henkes, A; Collin, RWJ; Kuehn, MH				Ahram, Dina F.; Grozdanic, Sinisa D.; Kecova, Helga; Henkes, Arjen; Collin, Rob W. J.; Kuehn, Markus H.			Variants in Nebulin (NEB) Are Linked to the Development of Familial Primary Angle Closure Glaucoma in Basset Hounds	PLOS ONE			English	Article							ANTERIOR-CHAMBER-DEPTH; NEMALINE MYOPATHY; FILAMENT LENGTH; RISK-FACTOR; MUTATIONS; MUSCLE; ACTIN; GENE; ASSOCIATION; IDENTIFICATION	Several dog breeds are susceptible to developing primary angle closure glaucoma (PACG), which suggests a genetic basis for the disease. We have identified a four-generation Basset Hound pedigree with characteristic autosomal recessive PACG that closely recapitulates PACG in humans. Our aim is to utilize gene mapping and whole exome sequencing approaches to identify PACG-causing sequence variants in the Basset. Extensive clinical phenotyping of all pedigree members was conducted. SNP-chip genotyping was carried out in 9 affected and 15 unaffected pedigree members. Two-point and multipoint linkage analyses of genome-wide SNP data were performed using Superlink-Online SNP-1.1 and a locus was mapped to chromosome 19q with a maximum LOD score of 3.24. The locus contains 12 Ensemble predicted canine genes and is syntenic to a region on chromosome 2 in the human genome. Using exome-sequencing analysis, a possibly damaging, non-synonymous variant in the gene Nebulin (NEB) was found to segregate with PACG which alters a phylogenetically conserved Lysine residue. The association of this variants with PACG was confirmed in a secondary cohort of unrelated Basset Hounds (p = 3.4 x 10(-4), OR = 15.3 for homozygosity). Nebulin, a protein that promotes the contractile function of sarcomeres, was found to be prominently expressed in the ciliary muscles of the anterior segment. Our findings may provide insight into the molecular mechanisms that underlie PACG. The phenotypic similarities of disease presentation in dogs and humans may enable the translation of findings made in this study to patients with PACG.	[Ahram, Dina F.; Kuehn, Markus H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Grozdanic, Sinisa D.; Kecova, Helga] Anim Eye Consultants Iowa, North Liberty, IA USA; [Henkes, Arjen; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	University of Iowa; Radboud University Nijmegen; Radboud University Nijmegen	Kuehn, MH (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	markus-kuehn@uiowa.edu	Collin, Rob/N-3575-2014; Fiumefreddo, Andrea/T-2977-2019	Kuehn, Markus/0000-0003-3940-198X	American Kennel Club - AKC Canine Health Foundation [CHF01594]; Stichting A.F Deutman Researchfonds Oogheelknde Nijmegen; Landelijke Stichting voor Blinden en Slechtzienden	American Kennel Club - AKC Canine Health Foundation; Stichting A.F Deutman Researchfonds Oogheelknde Nijmegen; Landelijke Stichting voor Blinden en Slechtzienden	Markus Kuehn received funding for this work from the American Kennel Club - AKC Canine Health Foundation (CHF01594). Rob W.J. Collin received funding for this work from the Stichting A.F Deutman Researchfonds Oogheelknde Nijmegen and from the Landelijke Stichting voor Blinden en Slechtzienden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahonen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070903; Ahram DF, 2014, MOL VIS, V20, P497; Anderson SL, 2004, HUM GENET, V115, P185, DOI 10.1007/s00439-004-1140-8; Aptel F, 2010, OPHTHALMOLOGY, V117, pc, DOI 10.1016/j.ophtha.2009.10.030; Aung T, 2005, ARCH OPHTHALMOL-CHIC, V123, P527, DOI 10.1001/archopht.123.4.527; Awadalla MS, 2011, MOL VIS, V17, P2248; Ayub H, 2010, MOL VIS, V16, P18; BEDFORD PGC, 1975, J SMALL ANIM PRACT, V16, P217, DOI 10.1111/j.1748-5827.1975.tb05739.x; Bonomi L, 2000, OPHTHALMOLOGY, V107, P998, DOI 10.1016/S0161-6420(00)00022-1; Coleman AL, 1999, LANCET, V354, P1803, DOI 10.1016/S0140-6736(99)04240-3; Dai Xiaohua, 2008, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V25, P493; Drance S, 2001, ACTA OPHTHALMOL SCAN, V79, P545, DOI 10.1034/j.1600-0420.2001.790601.x; Eid TM, 2000, GLAUCOMAS CONCEPTS F; Fan BJ, 2010, J CLIN INVEST, V120, P3064, DOI 10.1172/JCI43085; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Gelatt KN, 1998, J GLAUCOMA, V7, P187; Gelatt KN, 2004, VET OPHTHALMOL, V7, P97, DOI 10.1111/j.1463-5224.2004.04006.x; GROSVENOR T, 1988, AM J OPTOM PHYS OPT, V65, P689; Grozdanic SD, 2010, INVEST OPHTH VIS SCI, V51, P255, DOI 10.1167/iovs.09-4081; Gurgel-Giannetti J, 2001, NEUROMUSCULAR DISORD, V11, P154, DOI 10.1016/S0960-8966(00)00177-2; He M, 2006, EYE, V20, P3, DOI 10.1038/sj.eye.6701797; JIN JP, 1991, FEBS LETT, V281, P93, DOI 10.1016/0014-5793(91)80366-B; JOHNSON MC, 1983, INVEST OPHTH VIS SCI, V24, P320; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lehtokari VL, 2014, HUM MUTAT, V35, P1418, DOI 10.1002/humu.22693; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; LOWE R F, 1964, Br J Ophthalmol, V48, P544, DOI 10.1136/bjo.48.10.544; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; Morrison JC, 2005, J GLAUCOMA, V14, P315, DOI 10.1097/01.ijg.0000169410.09258.bf; O'Neill EC, 2011, OPHTHALMOLOGY, V118, P964, DOI 10.1016/j.ophtha.2010.09.002; OH YG, 1994, EYE, V8, P104, DOI 10.1038/eye.1994.20; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Pelin K, 2002, NEUROMUSCULAR DISORD, V12, P680, DOI 10.1016/S0960-8966(02)00066-4; PFUHL M, 1994, EMBO J, V13, P1782, DOI 10.1002/j.1460-2075.1994.tb06446.x; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Sampaolesi R, 2013, THE GLAUCOMAS; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sihota R, 2008, EYE, V22, P521, DOI 10.1038/sj.eye.6702687; Silberstein M, 2013, BIOINFORMATICS, V29, P197, DOI 10.1093/bioinformatics/bts658; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wallgren-Pettersson C, 1999, NEUROMUSCULAR DISORD, V9, P564, DOI 10.1016/S0960-8966(99)00061-9; Wallgren-Pettersson C, 2002, NEUROMUSCULAR DISORD, V12, P674, DOI 10.1016/S0960-8966(02)00065-2; Wang K, 1996, J BIOL CHEM, V271, P4304; Yoo YJ, 2008, ANN HUM GENET, V72, P566, DOI 10.1111/j.1469-1809.2008.00442.x	55	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126660	10.1371/journal.pone.0126660	http://dx.doi.org/10.1371/journal.pone.0126660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938837	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000162
J	Chadha, MS; Potdar, VA; Saha, S; Koul, PA; Broor, S; Dar, L; Chawla-Sarkar, M; Biswas, D; Gunasekaran, P; Abraham, AM; Shrikhande, S; Jain, A; Anukumar, B; Lal, RB; Mishra, AC				Chadha, Mandeep S.; Potdar, Varsha A.; Saha, Siddhartha; Koul, Parvaiz A.; Broor, Shobha; Dar, Lalit; Chawla-Sarkar, Mamta; Biswas, Dipankar; Gunasekaran, Palani; Abraham, Asha Mary; Shrikhande, Sunanda; Jain, Amita; Anukumar, Balakrishnan; Lal, Renu B.; Mishra, Akhilesh C.			Dynamics of Influenza Seasonality at Sub-Regional Levels in India and Implications for Vaccination Timing	PLOS ONE			English	Article							PATTERNS; TRANSMISSION	Background Influenza surveillance is an important tool to identify emerging/reemerging strains, and defining seasonality. We describe the distinct patterns of circulating strains of the virus in different areas in India from 2009 to 2013. Methods Patients in ten cities presenting with influenza like illness in out-patient departments of dispensaries/hospitals and hospitalized patients with severe acute respiratory infections were enrolled. Nasopharangeal swabs were tested for influenza viruses by real-time RT-PCR, and subtyping; antigenic and genetic analysis were carried out using standard assays. Results Of the 44,127 ILI/SARI cases, 6,193 (14.0%) were positive for influenza virus. Peaks of influenza were observed during July-September coinciding with monsoon in cities Delhi and Lucknow (north), Pune (west), Allaphuza (southwest), Nagpur (central), Kolkata (east) and Dibrugarh (northeast), whereas Chennai and Vellore (southeast) revealed peaks in October- November, coinciding with the monsoon months in these cities. In Srinagar (Northern most city at 34 degrees N latitude) influenza circulation peaked in January-March in winter months. The patterns of circulating strains varied over the years: whereas A/H1N1pdm09 and type B co-circulated in 2009 and 2010, H3N2 was the predominant circulating strain in 2011, followed by circulation of A/H1N1pdm09 and influenza B in 2012 and return of A/H3N2 in 2013. Antigenic analysis revealed that most circulating viruses were close to vaccine selected viral strains. Conclusions Our data shows that India, though physically located in northern hemisphere, has distinct seasonality that might be related to latitude and environmental factors. While cities with temperate seasonality will benefit from vaccination in September-October, cities with peaks in the monsoon season in July-September will benefit from vaccination in April-May. Continued surveillance is critical to understand regional differences in influenza seasonality at regional and sub-regional level, especially in countries with large latitude span.	[Chadha, Mandeep S.; Potdar, Varsha A.; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India; [Saha, Siddhartha; Lal, Renu B.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Koul, Parvaiz A.] Sheri Kashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India; [Broor, Shobha; Dar, Lalit] All India Inst Med Sci, New Delhi, India; [Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Biswas, Dipankar] Reg Med Res Ctr, Dibrugarh, Assam, India; [Gunasekaran, Palani] King Inst Prevent Med & Res, Madras, Tamil Nadu, India; [Abraham, Asha Mary] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Shrikhande, Sunanda] Indira Gandhi Med Coll, Nagpur, Maharashtra, India; [Jain, Amita] King George Med Univ, Lucknow, Uttar Pradesh, India; [Anukumar, Balakrishnan] Natl Inst Virol, Alappuzha, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Centers for Disease Control & Prevention - USA; Sher-i-Kashmir Institute of Medical Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Christian Medical College & Hospital (CMCH) Vellore; King George's Medical University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Chadha, MS (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	mscniv@gmail.com	jain, amita/ABA-9223-2020; Broor, Shobha/AAX-4163-2021; Koul, Parvaiz/B-1666-2017; Potdar, Varsha/ABA-3799-2021	Broor, Shobha/0000-0001-9679-4180; Koul, Parvaiz/0000-0002-1700-9285; Potdar, Varsha/0000-0002-7535-7878; Abraham, Asha/0000-0002-0736-1445; Saha, Siddhartha/0000-0002-7494-267X	Department of Health and Human Services-Centers for Disease Control and Prevention (DHHS-CDC) Cooperative [1U51000333]; Indian Council of Medical Research, New Delhi	Department of Health and Human Services-Centers for Disease Control and Prevention (DHHS-CDC) Cooperative(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This study was funded by Department of Health and Human Services-Centers for Disease Control and Prevention (DHHS-CDC) Cooperative agreement number 1U51000333 and Indian Council of Medical Research, New Delhi. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; Centers for Disease Control and Prevention, 2009, CDC PROT REALT RTPCR; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Mathews JD, 2009, INFLUENZA OTHER RESP, V3, P143, DOI 10.1111/j.1750-2659.2009.00089.x; *MEMB W PAC REG GL, 2012, PLOS ONE, V0007; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WHO, REC COMP INFL VIR VA; World Health Organization, 2012, WHO GLOB DIS RESP AL; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	23	72	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124122	10.1371/journal.pone.0124122	http://dx.doi.org/10.1371/journal.pone.0124122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938466	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000017
J	Gibbs, JEM				Gibbs, Jane E. M.			Eucalyptus Pollen Allergy and Asthma in Children: A Cross-Sectional Study in South-East Queensland, Australia	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; OLEA-EUROPAEA; MONOTERPENE; EMISSIONS; OIL; IDENTIFICATION; MELALEUCA; ISOPRENE; REACTIVITY; LINALOOL	Objectives To investigate Eucalyptus (gum tree) pollen allergy in children in relation to geography, particularly vegetation, and its relationship to asthma. Methods Males (n = 180) and females (n = 200) aged 9 to 14 participated. Some were healthy (asymptomatic), some had asthma, and some had other symptoms associated with atopy. School students were from three urban coastal schools and one school from a nearby semirural elevated area (range) near Brisbane, Australia. Coastal and range locations featured different distributions of Myrtaceae family vegetation (including Eucalyptus, Melaleuca, Leptospermum species). Skin prick test (SPT) responses to 15 commercial allergens were compared. As well, responses from coast versus range groups, and 'asthma' (n = 97) versus 'healthy' status (n = 107) groups, were compared. Results SPT responses (>= 3mm wheal diameter) indicate that children with asthma are 31.1 times more likely to be allergic to Eucalyptus pollen extract (OR: 31.1; 95% CI 4.1-235.7) compared to healthy children. Dust mite (p = .018), Eucalyptus (p = .046) and cockroach (p = .047) allergen SPT responses (wheals >= 3mm) were significantly greater in participants located on the coast versus range as determined by Fisher's Exact Test (alpha.05). For each location, percentage of positive responses (wheals >= 3mm) was greatest for 'dust mite' (30.9%-46%), 'cockroach' (18.1% -35%) and 'Bermuda grass' (10.6%-19.4%). Conclusions The results support the hypothesis that proximity to Myrtaceae vegetation is related to positive SPT response and that Eucalyptus is an important allergen for children with asthma. Substantial response to olive allergen, in the absence of olive trees, suggests that the response may be driven by substances in other plants, perhaps Melaleuca quinquenervia, which abounds in coastal areas.	Griffith Univ, Sch Med, Southport, Qld 4215, Australia	Griffith University	Gibbs, JEM (corresponding author), Griffith Univ, Sch Med, Southport, Qld 4215, Australia.	janegibbs.plos@gmail.com		GIBBS, JANE E.M./0000-0002-7042-6272	South East Queensland Regional Organization of Councils (SEQROC); ENTOX	South East Queensland Regional Organization of Councils (SEQROC); ENTOX	The South East Queensland Regional Organization of Councils (SEQROC) funded the project. The National Research Centre for Environmental Toxicology (now ENTOX) provided a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, CONSERVATION ATLAS P; [Anonymous], 2004, GLOBAL BURDEN ASTHMA; Arruda LK, 1997, J BIOL CHEM, V272, P20907, DOI 10.1074/jbc.272.33.20907; Australian Centre for Asthma Monitoring, 2011, ASTHM AUSTR 2011; Barata EN, 2000, J CHEM ECOL, V26, P1877, DOI 10.1023/A:1005548824429; Behrendt H, 2001, INT ARCH ALLERGY IMM, V124, P121, DOI 10.1159/000053688; Blanch JS, 2011, J ENVIRON BIOL, V32, P1; Boland DJ, 1991, EUCALYPTUS LEAF OILS; Cseke L, 1998, MOL BIOL EVOL, V15, P1491, DOI 10.1093/oxfordjournals.molbev.a025876; DERRICK EH, 1972, AUST NZ J MED, V2, P235, DOI 10.1111/j.1445-5994.1972.tb03068.x; Dormont L, 1998, PHYTOCHEMISTRY, V49, P1269, DOI 10.1016/S0031-9422(98)00105-8; Fischbach RJ, 2000, PHYTOCHEMISTRY, V54, P257, DOI 10.1016/S0031-9422(00)00119-9; Flamini G, 2003, J AGR FOOD CHEM, V51, P1382, DOI 10.1021/jf020854y; Gonzalez EM, 2000, ALLERGY, V55, P658, DOI 10.1034/j.1398-9995.2000.00406.x; Harrison D, 2001, ATMOS ENVIRON, V35, P4687, DOI 10.1016/S1352-2310(01)00092-9; He CR, 2000, ATMOS ENVIRON, V34, P645, DOI 10.1016/S1352-2310(99)00219-8; HE ZD, 1994, PHYTOCHEMISTRY, V36, P709, DOI 10.1016/S0031-9422(00)89802-7; Hirschwehr R, 1998, J ALLERGY CLIN IMMUN, V101, P196, DOI 10.1016/S0091-6749(98)70384-7; Hoelscher DJ, 2003, PHYTOCHEMISTRY, V62, P1081, DOI 10.1016/S0031-9422(02)00674-X; Ireland BF, 2002, BIOCHEM SYST ECOL, V30, P457, DOI 10.1016/S0305-1978(01)00112-0; Lewis WH VP, 1983, AIRBORNE ALLERGENIC; Matura M, 2002, J AM ACAD DERMATOL, V47, P709, DOI 10.1067/mjd.2002.124817; NSW AFo, 2013, ASTHM FRIENDL GARD; Pajaron MJ, 1997, ALLERGY, V52, P829, DOI 10.1111/j.1398-9995.1997.tb02154.x; Peat JK, 1998, CLIN EXP ALLERGY, V28, P261; Petroeschevsky A, 2001, ARCH ENVIRON HEALTH, V56, P37, DOI 10.1080/00039890109604053; Pio CA, 2005, ATMOS ENVIRON, V39, P1817, DOI 10.1016/j.atmosenv.2004.11.018; Rutherford S, 2000, J OCCUP ENVIRON MED, V42, P882, DOI 10.1097/00043764-200009000-00006; Skold M, 2004, CHEM RES TOXICOL, V17, P1697, DOI 10.1021/tx049831z; Skold M, 2008, CONTACT DERMATITIS, V58, P9, DOI 10.1111/j.1600-0536.2008.01380.x; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; Stablein JJ, 2002, ANN ALLERG ASTHMA IM, V89, P523, DOI 10.1016/S1081-1206(10)62092-3; Street RA, 1997, J GEOPHYS RES-ATMOS, V102, P15875, DOI 10.1029/97JD00010; SWEENEY M, 1994, INT ARCH ALLERGY IMM, V105, P289, DOI 10.1159/000236771; Tollsten L, 1996, PHYTOCHEMISTRY, V43, P759, DOI 10.1016/0031-9422(96)00272-5; Wrigley J, 2012, EUCALYPTS CELEBRATIO; Yates A, 1987, YATES GARDEN GUIDE C	37	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126506	10.1371/journal.pone.0126506	http://dx.doi.org/10.1371/journal.pone.0126506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938684	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000160
J	Lee, J; Kim, SK; Youm, HW; Kim, HJ; Lee, JR; Suh, CS; Kim, SH				Lee, Jaewang; Kim, Seul Ki; Youm, Hye Won; Kim, Hak Jun; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun			Effects of Three Different Types of Antifreeze Proteins on Mouse Ovarian Tissue Cryopreservation and Transplantation	PLOS ONE			English	Article							ICE-BINDING PROTEIN; TRANSGENIC MICE; POLYPEPTIDE; INHIBITION; MECHANISMS; EXPRESSION; RESISTANCE; FOLLICLES; APOPTOSIS; PROMOTES	Background Ovarian tissue (OT) cryopreservation is effective in preserving fertility in cancer patients who have concerns about fertility loss due to cancer treatment. However, the damage incurred at different steps during the cryopreservation procedure may cause follicular depletion; hence, preventing chilling injury would help maintain ovarian function. Objective This study was designed to investigate the beneficial effects of different antifreeze proteins (AFPs) on mouse ovarian tissue cryopreservation and transplantation. Methodology Ovaries were obtained from 5-week-old B6D2F1 mice, and each ovary was cryopreserved using two-step vitrification and four-step warming procedures. In Experiment I, ovaries were randomly allocated into fresh, vitrification control, and nine experimental groups according to the AFP type (FfIBP, LeIBP, type III) and concentration (0.1, 1, 10 mg/mL) used. After vitrification and warming, 5,790 ovarian follicles were evaluated using histology and TUNEL assays, and immunofluorescence for tau H2AX and Rad51 was used to detect DNA double-strand breaks (DSBs) and repair (DDR), respectively. In Experiment II, 20 mice were randomly divided into two groups: one where the vitrification and warming media were supplemented with 10 mg/mL LeIBP, and the other where media alone were used (control). Ovaries were then autotransplanted under both kidney capsules 7 days after vitrification together with the addition of 10 mg/mL LeIBP in the vitrification-warming media. After transplantation, the ovarian follicles, the percentage of apoptotic follicles, the extent of the CD31-positive area, and the serum FSH levels of the transplanted groups were compared. Principal Findings In Experiment I, the percentage of total grade 1 follicles was significantly higher in the 10 mg/mL LeIBP group than in the vitrification control, while all AFP-treated groups had significantly improved grade 1 primordial follicle numbers compared with those of the vitrification control. The number of apoptotic (TUNEL-positive) follicles was significantly decreased in the groups treated with 1 and 10 mg/mL LeIBP. The proportion of tau H2AX-positive follicles was significantly reduced in all AFP-treated groups, while the proportion of Rad51-positive follicles was significantly decreased in only the FfIBP- and LeIBP-treated groups. In Experiment II, after autotransplantation of OT vitrified with 10 mg/mL of LeIBP, the percentage of total grade 1 and primordial grade 1 follicles, and the extent of the CD31-positive area, were increased significantly. Moreover, the levels of serum FSH and the percentage of TUNEL-positive follicles were significantly lower in the LeIBP-treated than in the control group. Conclusion A supplementation with high concentrations of AFPs had protective effects on follicle preservation during OT vitrification-warming procedures. The group treated with LeIBP was protected most effectively. The beneficial effects of LeIBP were also observed after autotransplantation of vitrified-warmed OT. Further studies are necessary to determine the exact mechanism of these protective effects.	[Lee, Jaewang; Kim, Seul Ki; Youm, Hye Won; Lee, Jung Ryeol; Suh, Chang Suk] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, Gyeonggi Do, South Korea; [Lee, Jaewang; Kim, Seul Ki; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Hak Jun] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea; [Kim, Hak Jun] Pukyong Natl Univ, Dept Chem, Busan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Pukyong National University	Lee, JR (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, Gyeonggi Do, South Korea.	leejrmd@snu.ac.kr		Lee, Jung Ryeol/0000-0003-3743-2934; Kim, Seul Ki/0000-0002-1647-6711; Lee, Jaewang/0000-0001-6801-7149	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055).	Arav A, 2012, REPROD DOMEST ANIM, V47, P193, DOI 10.1111/j.1439-0531.2012.02075.x; Bagis H, 2008, J EXP ZOOL PART A, V309A, P255, DOI 10.1002/jez.455; Bagis H, 2008, MOL REPROD DEV, V75, P608, DOI 10.1002/mrd.20799; Bagis H, 2006, MOL REPROD DEV, V73, P1404, DOI 10.1002/mrd.20601; Bos-Mikich A, 2012, J ASSIST REPROD GEN, V29, P1267, DOI 10.1007/s10815-012-9867-y; Brown ET, 2009, MOL CARCINOGEN, V48, P105, DOI 10.1002/mc.20463; Campbell BK, 2004, ENDOCRINOLOGY, V145, P1870, DOI 10.1210/en.2003-1138; DeLuca CI, 1998, BIOPHYS J, V74, P1502, DOI 10.1016/S0006-3495(98)77862-2; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Do H, 2012, ACTA CRYSTALLOGR F, V68, P806, DOI 10.1107/S1744309112020465; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115; Gandolfi F, 2006, FERTIL STERIL, V85, P1150, DOI 10.1016/j.fertnstert.2005.08.062; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Hemadi M, 2009, EUR J PHARMACOL, V618, P84, DOI 10.1016/j.ejphar.2009.07.018; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Jo JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037043; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Kamijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073643; Kawahara H, 2009, BIOCONTROL SCI, V14, P49, DOI 10.4265/bio.14.49; Kim GA, 2011, THERIOGENOLOGY, V75, P1045, DOI 10.1016/j.theriogenology.2010.11.012; KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X; Kristiansen E, 2012, J INSECT PHYSIOL, V58, P1502, DOI 10.1016/j.jinsphys.2012.09.004; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Lee JR, 2015, YONSEI MED J, V56, P778, DOI 10.3349/ymj.2015.56.3.778; Lee SG, 2012, APPL BIOCHEM BIOTECH, V167, P824, DOI 10.1007/s12010-012-9739-z; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Newton H, 1996, HUM REPROD, V11, P1487; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pfeifer S, 2013, FERTIL STERIL, V100, P1214, DOI 10.1016/j.fertnstert.2013.08.012; Prathalingam NS, 2006, THERIOGENOLOGY, V66, P1894, DOI 10.1016/j.theriogenology.2006.04.041; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Rubinsky L, 2010, NEUROSCI RES, V67, P256, DOI 10.1016/j.neures.2010.04.004; Sak A, 2005, BRIT J CANCER, V92, P1089, DOI 10.1038/sj.bjc.6602457; Salvay AG, 2010, BIOPHYS J, V99, P609, DOI 10.1016/j.bpj.2010.04.030; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; WEN DY, 1992, J BIOL CHEM, V267, P14102; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Youm HW, 2014, HUM REPROD, V29, P720, DOI 10.1093/humrep/det449; Yu SO, 2010, CRYOBIOLOGY, V61, P327, DOI 10.1016/j.cryobiol.2010.10.158	47	34	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126252	10.1371/journal.pone.0126252	http://dx.doi.org/10.1371/journal.pone.0126252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938445	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000155
J	Patil, KR; Mohapatra, P; Patel, HM; Goyal, SN; Ojha, S; Kundu, CN; Patil, CR				Patil, Kalpesh R.; Mohapatra, Purusottam; Patel, Harun M.; Goyal, Sameer N.; Ojha, Shreesh; Kundu, Chanakya N.; Patil, Chandragouda R.			Pentacyclic Triterpenoids Inhibit IKK beta Mediated Activation of NF-kappa B Pathway: In Silico and In Vitro Evidences	PLOS ONE			English	Article							INDUCED INFLAMMATORY RESPONSES; COMPUTER-AIDED PREDICTION; DRUG DISCOVERY; PHARMACOLOGICAL-ACTIVITIES; CRYSTAL-STRUCTURE; GENE-EXPRESSION; CANCER CELLS; KINASE IKK; ACID; IDENTIFICATION	Pentacyclic Triterpenoids (PTs) and their analogues as well as derivatives are emerging as important drug leads for various diseases. They act through a variety of mechanisms and a majority of them inhibit the nuclear factor kappa-beta (NF-kappa B) signaling pathway. In this study, we examined the effects of the naturally occurring PTs on I kappa B kinase-beta (IKK beta), which has great scientific relevance in the NF-kappa B signaling pathway. On virtual screening, 109 PTs were screened through the PASS (prediction of activity spectra of substances) software for prediction of NF-kappa B inhibitory activity followed by docking on the NEMO/IKK beta association complex (PDB: 3BRV) and testing for compliance with the softened Lipinski's Rule of Five using Schrodinger (LLC, New York, USA). Out of the projected 45 druggable PTs, Corosolic Acid (CA), Asiatic Acid (AA) and Ursolic Acid (UA) were assayed for IKK beta kinase activity in the cell free medium. The UA exhibited a potent IKK beta inhibitory effect on the hot-spot kinase assay with IC50 of 69 mu M. Whereas, CA at 50 mu M concentration markedly reduced the NF-kappa B luciferase activity and phospho-IKK beta protein expressions. The PTs tested, attenuated the expression of the NF-kappa B cascade proteins in the LPS-stimulated RAW 264.7 cells, prevented the phosphorylation of the IKK alpha/beta and blocked the activation of the Interferon-gamma (IFN-gamma). The results suggest that the IKK beta inhibition is the major mechanism of the PTs-induced NF-kappa B inhibition. PASS predictions along with in-silico docking against the NEMO/IKK beta can be successfully applied in the selection of the prospective NF-kappa B inhibitory downregulators of IKK beta phosphorylation.	[Patil, Kalpesh R.] HR Patel Inst Pharmaceut Educ & Res, Dept Pharmacol, Dist Dhule, Maharashtra, India; [Mohapatra, Purusottam; Kundu, Chanakya N.] KIIT Univ, KIIT Sch Biotechnol, Canc Biol Lab, Bhubaneswar, Orissa, India; [Patel, Harun M.] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Dist Dhule, Maharashtra, India; [Goyal, Sameer N.; Patil, Chandragouda R.] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmacol, Dist Dhule, Maharashtra, India; [Ojha, Shreesh] United Arab Emirates Univ, Dept Pharmacol & Therapeut, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	Kalinga Institute of Industrial Technology (KIIT); United Arab Emirates University	Kundu, CN (corresponding author), KIIT Univ, KIIT Sch Biotechnol, Canc Biol Lab, Bhubaneswar, Orissa, India.	kalpeshpharma20@gmail.com; cnkundu@gmail.com; pchandragouda@yahoo.com	Patel, Harun/P-1434-2019; Patil, Kalpesh R./H-4173-2019; Patil, Chandragouda Raosaheb/E-3510-2019; Patel, Harun Miyalal/L-7942-2019	Patil, Chandragouda Raosaheb/0000-0001-7712-7227; Patel, Harun Miyalal/0000-0003-0920-1266; Goyal, sameer/0000-0002-5241-7049; Mohapatra, Purusottam/0000-0001-8059-4141; Kundu, Chanakya/0000-0003-0297-1030; Patil, Chandragouda/0000-0001-8401-1978; OJHA, SHREESH/0000-0001-7801-2966; Patil, Kalpesh/0000-0003-2397-4687				Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Alqahtani A, 2013, CURR MED CHEM, V20, P908; An HJ, 2011, INT IMMUNOPHARMACOL, V11, P504, DOI 10.1016/j.intimp.2011.01.002; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; [Anonymous], 2009, QIKPROP VERSION 9 0; [Anonymous], 2009, LIGPREP VERSION 2 3; [Anonymous], 2009, GLIDE VERSION 5 5; Bamborough P, 2009, CURR TOP MED CHEM, V9, P623, DOI 10.2174/156802609789007336; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Cao W, 2010, INT IMMUNOPHARMACOL, V10, P723, DOI 10.1016/j.intimp.2010.03.015; Cha DS, 2011, J ETHNOPHARMACOL, V134, P305, DOI 10.1016/j.jep.2010.12.017; Chakraborty P, 2014, TOXICOL APPL PHARM, V277, P95, DOI 10.1016/j.taap.2014.03.011; Checker R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031318; Chen HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038261; Chen H, 2012, CIRC J, V76, P995, DOI 10.1253/circj.CJ-11-0344; Chen RJY, 2010, ACTA PHARMACOL SIN, V31, P696, DOI 10.1038/aps.2010.61; Choi RJ, 2014, INT IMMUNOPHARMACOL, V18, P182, DOI 10.1016/j.intimp.2013.11.022; Cuoi YH, 2011, BIOL PHARM BULL, V34, P959, DOI 10.1248/bpb.34.959; de las Heras B., 2009, Inflammation & Allergy Drug Targets, V8, P28; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Filimonov DA, 2014, CHEM HETEROCYCL COM+, V50, P444, DOI 10.1007/s10593-014-1496-1; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Goel RK, 2011, MED CHEM RES, V20, P1509, DOI 10.1007/s00044-010-9398-y; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang JJ, 2013, EUR J MED CHEM, V63, P269, DOI 10.1016/j.ejmech.2013.01.045; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Jung YS, 2014, TOXICOL APPL PHARM, V277, P67, DOI 10.1016/j.taap.2014.03.001; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kim IT, 2012, J CELL BIOCHEM, V113, P1936, DOI 10.1002/jcb.24062; Kim JH, 2009, EUR J PHARMACOL, V602, P422, DOI 10.1016/j.ejphar.2008.10.062; Klimpel GR., 1996, MED MICROBIOLOGY; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kryzhanovskii SA, 2012, PHARM CHEM J+, V45, P605; Kwon OK, 2010, J ETHNOPHARMACOL, V130, P28, DOI 10.1016/j.jep.2010.04.002; Lagunin A, 2010, CURR PHARM DESIGN, V16, P1703, DOI 10.2174/138161210791164063; Lagunin A, 2009, QSAR COMB SCI, V28, P806, DOI 10.1002/qsar.200860192; Lagunin AA, 2014, NAT PROD REP, V31, P1585, DOI 10.1039/c4np00068d; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lee SH, 2012, MBIO, V3, DOI 10.1128/mBio.00411-12; Leung CH, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-3; Li FY, 2012, INFLAMMATION, V35, P1669, DOI 10.1007/s10753-012-9483-0; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; MOOLA ZB, 1994, BIOCHEM J, V302, P921, DOI 10.1042/bj3020921; Moura LIF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/941764; Nagarajan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S7-S15, 10.1186/1471-2105-11-S7-515]; Nam KY, 2011, B KOREAN CHEM SOC, V32, P4397, DOI 10.5012/bkcs.2011.32.12.4397; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Novoselova EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/724838; Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P52, DOI 10.4103/0976-500X.77119; Petit J, 2012, BIOORGAN MED CHEM, V20, P5343, DOI 10.1016/j.bmc.2011.11.064; Piccagli L, 2010, BIOORGAN MED CHEM, V18, P8341, DOI 10.1016/j.bmc.2010.09.063; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Preet R, 2012, INT J CANCER, V130, P1660, DOI 10.1002/ijc.26158; Rios JL, 2010, J ETHNOPHARMACOL, V128, P1, DOI 10.1016/j.jep.2009.12.045; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Satapathy SR, 2013, NANOMEDICINE-UK, V8, P1307, DOI [10.2217/NNM.12.176, 10.2217/nnm.12.176]; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shah BA, 2009, NAT PROD REP, V26, P72, DOI 10.1039/b809437n; Sporn MB, 2007, DRUG DEVELOP RES, V68, P174, DOI 10.1002/ddr.20179; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tarasova OA, 2008, SAR QSAR ENVIRON RES, V19, P81, DOI 10.1080/10629360701844183; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tolliday N, 2006, CANCER RES, V66, P8935, DOI 10.1158/0008-5472.CAN-06-2552; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wen DY, 2006, J PHARMACOL EXP THER, V317, P989, DOI 10.1124/jpet.105.097584; WEST MA, 1995, SURGERY, V118, P220, DOI 10.1016/S0039-6060(05)80327-7; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zhang MQ, 2007, CURR OPIN BIOTECH, V18, P478, DOI 10.1016/j.copbio.2007.10.005	91	38	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125709	10.1371/journal.pone.0125709	http://dx.doi.org/10.1371/journal.pone.0125709			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938234	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000093
J	Zhang, GY; Liu, RR; Zhang, CQ; Tang, KX; Sun, MF; Yan, GH; Liu, QQ				Zhang, Gui-Yun; Liu, Ru-Ru; Zhang, Chang-Quan; Tang, Ke-Xuan; Sun, Ming-Fa; Yan, Guo-Hong; Liu, Qiao-Quan			Manipulation of the Rice L-Galactose Pathway: Evaluation of the Effects of Transgene Overexpression on Ascorbate Accumulation and Abiotic Stress Tolerance	PLOS ONE			English	Article							GALACTURONIC ACID REDUCTASE; VITAMIN-C; BIOSYNTHETIC-PATHWAY; CHILLING STRESS; PLANTS; GENE; ARABIDOPSIS; PHOSPHORYLASE; CHLOROPLASTS; LEAVES	Ascorbic acid (AsA) is the most abundant water-soluble antioxidant in plants, and it plays a crucial role in plant growth, development and abiotic stress tolerance. In the present study, six key Arabidopsis or rapeseed genes involved in AsA biosynthesis were constitutively overexpressed in an elite Japonica rice cultivar. These genes encoded the GDP-mannose pyrophosphorylase (GMP), GDP-mannose-3', 5'-epimerase (GME), GDP-L-galactose phosphorylase (GGP), L-galactose-1-phosphate phosphatase (GPP), L-galactose dehydrogenase (GDH), and L-galactono-1,4-lactone dehydrogenase (GalLDH). The effects of transgene expression on rice leaf AsA accumulation were carefully evaluated. In homozygous transgenic seedlings, AtGGP transgenic lines had the highest AsA contents (2.55-fold greater than the empty vector transgenic control), followed by the AtGME and AtGDH transgenic lines. Moreover, with the exception of the AtGPP lines, the increased AsA content also provoked an increase in the redox state (AsA/DHA ratio). To evaluate salt tolerance, AtGGP and AtGME transgenic seedlings were exposed to salt stress for one week. The relative plant height, root length and fresh weight growth rates were significantly higher for the transgenic lines compared with the control plants. Altogether, our results suggest that GGP may be a key rate-limiting step in rice AsA biosynthesis, and the plants with elevated AsA contents demonstrated enhanced tolerance for salt stress.	[Zhang, Gui-Yun; Liu, Ru-Ru; Zhang, Chang-Quan; Liu, Qiao-Quan] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Gui-Yun; Sun, Ming-Fa; Yan, Guo-Hong] Agr Sci Inst Coastal Reg Jiangsu, Yancheng 224002, Jiangsu, Peoples R China; [Tang, Ke-Xuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200240, Peoples R China	Yangzhou University; Jiangsu Academy of Agricultural Sciences; Shanghai Jiao Tong University	Liu, QQ (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China.	qqliu@yzu.edu.cn	Tang, Kexuan/E-3555-2013	Tang, Kexuan/0000-0002-8748-9624	National Key Basic Research Projects [2012CB944803]; National Major Special Project for the Development of Transgenic Organisms [2014ZX08001006-005]; National Science Foundation of China [31471459]; Independent Innovation Fund of Jiangsu Province, China [CX (13) 5084]	National Key Basic Research Projects(National Basic Research Program of China); National Major Special Project for the Development of Transgenic Organisms; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Fund of Jiangsu Province, China	This study was supported by the National Key Basic Research Projects (2012CB944803), the National Major Special Project for the Development of Transgenic Organisms (2014ZX08001006-005), the National Science Foundation of China (31471459) to QQL, and the Independent Innovation Fund of Jiangsu Province (CX (13) 5084), China to GYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Badejo AA, 2008, PLANT CELL PHYSIOL, V49, P126, DOI 10.1093/pcp/pcm164; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Chao YY, 2010, PLANT PHYSIOL BIOCH, V48, P374, DOI 10.1016/j.plaphy.2010.01.009; Cronje C, 2012, PLANTA, V235, P553, DOI 10.1007/s00425-011-1525-6; De Tullio MC, 2004, CELL MOL LIFE SCI, V61, P209, DOI 10.1007/s00018-003-3203-8; Debolt S, 2007, ANN BOT-LONDON, V99, P3, DOI 10.1093/aob/mcl236; Eltayeb AE, 2011, BREEDING SCI, V61, P3, DOI 10.1270/jsbbs.61.3; Feng ZZ, 2010, ENVIRON POLLUT, V158, P3539, DOI 10.1016/j.envpol.2010.08.019; Frei M, 2012, PLANT PHYSIOL BIOCH, V59, P63, DOI 10.1016/j.plaphy.2012.02.015; Fukunaga K, 2010, BIOSCI BIOTECH BIOCH, V74, P888, DOI 10.1271/bbb.90929; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Guo ZF, 2005, PLANT PHYSIOL BIOCH, V43, P955, DOI 10.1016/j.plaphy.2005.08.007; Hemavathi, 2011, MOL BREEDING, V28, P105, DOI 10.1007/s11032-010-9465-6; Hemavathi, 2009, PLANT SCI, V177, P659, DOI 10.1016/j.plantsci.2009.08.004; Holler S, 2014, PLANTA, V239, P367, DOI 10.1007/s00425-013-1978-x; Imai T, 2012, PLANT CELL TISS ORG, V111, P1, DOI 10.1007/s11240-012-0165-2; Jain AK, 2000, MOL BREEDING, V6, P73, DOI 10.1023/A:1009680818138; Kwon SY, 2003, J PLANT PHYSIOL, V160, P347, DOI 10.1078/0176-1617-00926; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lim MY, 2012, IN VITRO CELL DEV-PL, V48, P453, DOI 10.1007/s11627-012-9461-0; Lisko KA, 2013, IN VITRO CELL DEV-PL, V49, P643, DOI 10.1007/s11627-013-9568-y; Liu W, 2013, ACTA PHYSIOL PLANT, V35, P1617, DOI 10.1007/s11738-012-1204-7; Liu YH, 2011, ACTA PHYSIOL PLANT, V33, P1353, DOI 10.1007/s11738-010-0669-5; Lopez-Carbonell M, 2006, J PLANT GROWTH REGUL, V25, P137, DOI 10.1007/s00344-005-0119-6; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Talla S, 2011, J BIOSCIENCES, V36, P163, DOI 10.1007/s12038-011-9000-x; Venkatesh J, 2012, HORTIC ENVIRON BIOTE, V53, P320, DOI 10.1007/s13580-012-0035-1; Wang HS, 2011, PLANT CELL REP, V30, P1029, DOI 10.1007/s00299-011-1009-y; Wang LY, 2013, J PLANT PHYSIOL, V170, P303, DOI 10.1016/j.jplph.2012.10.015; Wang LY, 2014, PLANT CELL REP, V33, P1441, DOI 10.1007/s00299-014-1627-2; Wang ZN, 2010, J INTEGR PLANT BIOL, V52, P400, DOI 10.1111/j.1744-7909.2010.00921.x; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yamane K, 2004, PLANT PROD SCI, V7, P292, DOI 10.1626/pps.7.292; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang GY, 2013, TRANSGENIC RES, V22, P89, DOI 10.1007/s11248-012-9630-2; Zhou Y, 2012, BIOL PLANTARUM, V56, P451, DOI 10.1007/s10535-012-0119-x	44	42	46	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125870	10.1371/journal.pone.0125870	http://dx.doi.org/10.1371/journal.pone.0125870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938231	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000113
J	Cohan, CH; Neumann, JT; Dave, KR; Alekseyenko, A; Binkert, M; Stransky, K; Lin, HW; Barnes, CA; Wright, CB; Perez-Pinzon, MA				Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Binkert, Marc; Stransky, Kenneth; Lin, Hung Wen; Barnes, Carol A.; Wright, Clinton B.; Perez-Pinzon, Miguel A.			Effect of Cardiac Arrest on Cognitive Impairment and Hippocampal Plasticity in Middle-Aged Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MEMORY IMPAIRMENT; NEURONAL DAMAGE; FOREBRAIN ISCHEMIA; WORKING-MEMORY; BRAIN-DAMAGE; BARNES MAZE; WATER MAZE; CA1; DEFICITS	Cardiopulmonary arrest is a leading cause of death and disability in the United States that usually occurs in the aged population. Cardiac arrest (CA) induces global ischemia, disrupting global cerebral circulation that results in ischemic brain injury and leads to cognitive impairments in survivors. Ischemia-induced neuronal damage in the hippocampus following CA can result in the impairment of cognitive function including spatial memory. In the present study, we used a model of asphyxial CA (ACA) in nine month old male Fischer 344 rats to investigate cognitive and synaptic deficits following mild global cerebral ischemia. These experiments were performed with the goals of 1) establishing a model of CA in nine month old middle-aged rats; and 2) to test the hypothesis that learning and memory deficits develop following mild global cerebral ischemia in middle-aged rats. To test this hypothesis, spatial memory assays (Barnes circular platform maze and contextual fear conditioning) and field recordings (long-term potentiation and paired-pulse facilitation) were performed. We show that following ACA in nine month old middle-aged rats, there is significant impairment in spatial memory formation, paired-pulse facilitation n dysfunction, and a reduction in the number of non-compromised hippocampal Cornu Ammonis 1 and subiculum neurons. In conclusion, nine month old animals undergoing cardiac arrest have impaired survival, deficits in spatial memory formation, and synaptic dysfunction.	[Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Binkert, Marc; Stransky, Kenneth; Lin, Hung Wen; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA; [Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Lin, Hung Wen; Wright, Clinton B.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Evelyn F McKnight Brain Inst, Miami, FL USA; [Cohan, Charles H.; Neumann, Jake T.; Dave, Kunjan R.; Alekseyenko, Aleksey; Binkert, Marc; Stransky, Kenneth; Lin, Hung Wen; Wright, Clinton B.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Dept Neurol, Miami, FL USA; [Cohan, Charles H.; Dave, Kunjan R.; Wright, Clinton B.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Neurosci Program, Miami, FL USA; [Barnes, Carol A.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Barnes, Carol A.] Univ Arizona, ARL Div Neural Syst Memory & Aging, Tucson, AZ USA; [Barnes, Carol A.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Barnes, Carol A.] Univ Arizona, Dept Neurol & Neurosci, Tucson, AZ 85721 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Arizona; University of Arizona; University of Arizona; University of Arizona	Perez-Pinzon, MA (corresponding author), Univ Miami, Leonard M Miller Sch Med, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA.	Perezpinzon@med.miami.edu			National Institutes of Health [NS45676, NS054147, NS34773, NS073779]; American Heart Association [13POST16720001]; Evelyn F. McKnight Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034773, R01NS073779, R55NS034773, R01NS045676, R01NS034773, R01NS054147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Evelyn F. McKnight Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, Grant Numbers: NS45676, NS054147, NS34773, and NS073779 (http://www.nih.gov); the American Heart Association, 13POST16720001 (http://www.heart.org); and the Evelyn F. McKnight Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 2011, J INT NEUROPSYCH SOC, V17, P364, DOI 10.1017/S1355617710001633; AUER RN, 1989, J NEUROSCI, V9, P1641; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Bizon JL, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00019; Block F, 1997, PHARMACOL BIOCHEM BE, V56, P755, DOI 10.1016/S0091-3057(96)00484-4; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Calabresi P, 2003, LANCET NEUROL, V2, P622, DOI 10.1016/S1474-4422(03)00532-5; CALLE PA, 1989, J PHARMACOL METHOD, V22, P185, DOI 10.1016/0160-5402(89)90013-2; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Dai XN, 2007, NEUROPHARMACOLOGY, V52, P1124, DOI 10.1016/j.neuropharm.2006.11.012; Dave KR, 2004, BRAIN RES, V1024, P89, DOI 10.1016/j.brainres.2004.07.050; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; DAVIS HP, 1986, PHYSIOL BEHAV, V37, P387, DOI 10.1016/0031-9384(86)90195-2; de la Tremblaye PB, 2011, BEHAV BRAIN RES, V219, P227, DOI 10.1016/j.bbr.2011.01.009; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; GLOBUS MYT, 1992, STROKE, V23, P1595, DOI 10.1161/01.STR.23.11.1595; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grubb NR, 2000, STROKE, V31, P1509, DOI 10.1161/01.STR.31.7.1509; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hickey RW, 1996, PEDIATR RES, V39, P77, DOI 10.1203/00006450-199601000-00011; Hicks SD, 2000, J CEREBR BLOOD F MET, V20, P520, DOI 10.1097/00004647-200003000-00011; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kiryk A, 2011, BEHAV BRAIN RES, V219, P1, DOI 10.1016/j.bbr.2010.12.004; KIYOTA Y, 1991, BRAIN RES, V538, P295, DOI 10.1016/0006-8993(91)90443-Y; Kurinami H, 2014, STROKE, V45, P1131, DOI 10.1161/STROKEAHA.113.003577; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lin HW, 2014, J CEREBR BLOOD F MET, V34, P613, DOI 10.1038/jcbfm.2013.232; Lin HW, 2014, TRANSL STROKE RES, V5, P109, DOI 10.1007/s12975-013-0276-z; McNally B, 2011, MMWR SURVEILL SUMM, V60, P1; Moyer JR, VISUALLY GUIDED PATC, P169; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; ORDY JM, 1988, NEUROBIOL AGING, V9, P667, DOI 10.1016/S0197-4580(88)80131-3; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Rea TD, 2010, CIRCULATION, V121, P1134, DOI 10.1161/CIRCULATIONAHA.109.899799; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Sama DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038170; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Verkhratsky A, 1998, TRENDS NEUROSCI, V21, P2, DOI 10.1016/S0166-2236(97)01156-9; VOLPE BT, 1992, BEHAV NEUROSCI, V106, P457, DOI 10.1037/0735-7044.106.3.457; VOLPE BT, 1989, STROKE, V20, P1700, DOI 10.1161/01.STR.20.12.1700; Wadowska M, 2014, NEUROPATHOLOGY APPL; Wang RM, 2013, HIPPOCAMPUS, V23, P634, DOI 10.1002/hipo.22126; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; WU LG, 1994, J NEUROSCI, V14, P645; Xu K, 2007, ADV EXP MED BIOL, V599, P199; Xu K, 2010, BRAIN RES, V1328, P181, DOI 10.1016/j.brainres.2010.02.080	69	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124918	10.1371/journal.pone.0124918	http://dx.doi.org/10.1371/journal.pone.0124918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933411	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100063
J	Liu, Y; Mi, N; Zhou, YM; An, P; Bai, YY; Guo, YF; Hong, CM; Ji, ZX; Ye, P; Wu, CE				Liu, Yuan; Mi, Ning; Zhou, Yiming; An, Peng; Bai, Yongyi; Guo, Yifang; Hong, Changming; Ji, Zhixin; Ye, Ping; Wu, Caie			Transverse False Tendons in the Left Ventricular Cavity Are Associated with Early Repolarization	PLOS ONE			English	Article							PREVALENCE; SUBSTRATE; AUTOPSY; HEART; BAND	Background Left ventricular false tendons (LVFTs) are related to precordial murmurs, ventricular arrhythmias and some repolarization abnormalities. Early repolarization (ER) is a specific type of repolarization abnormality. Objective The aim of the present study was to investigate the relationship between LVFTs and ER. Methods This study retrospectively included 99 consecutive healthy subjects and 33 patients with ER. Early repolarization was defined as an elevation of the QRS-ST junction of >0.1 mV from baseline in at least 2 inferior or lateral leads, manifested as QRS slurring or notching. Each participant was examined using echocardiography with second harmonic imaging, and the attachments of the LVFTs were recorded. Results A total of 93 LVFTs were present in 82 (83%) of the 99 healthy subjects. Of these 93 LVFTs, the majority (79/93, or 84.9%) were longitudinal-type LVFTs, which originated from the basal interventricular septum (IVS) and progressed toward the apical segment of the left ventricular free wall. There were significant differences in the positioning of the LVFTs between the ER patients and control (P < 0.0001). LVFTs between mid-IVS to the middle of the LV free wall were found more common in patients with ER compared with control subjects (47.5% vs. 6.5%, P < 0.0001). In the ER group, LVFTs between the basal IVS to the apical segment of LV free wall were only identified in 21% of the LVFTs, compared to a value of 84.9% for the control group (P < 0.0001). The distribution of LVFT trends in the ER group was also significantly different from that in the control group (P < 0.05). Conclusions LVFTs are commonly visualized using echocardiography. An LVFT from the basal IVS to the apical segment of the left ventricular free wall may be a normal anatomical structure in the left ventricular cavity. On the contrary, transverse false tendons in the left ventricular cavity may be associated with ER.	[Liu, Yuan; Bai, Yongyi; Hong, Changming; Ye, Ping; Wu, Caie] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Mi, Ning] Bethune Med Profess Sergeant Sch, Dept Clin Med, Shijiazhuang, Peoples R China; [Zhou, Yiming] Beijing Gen Hosp, Beijing Mil Command, Dept Liver Dis, Beijing, Peoples R China; [An, Peng] First Peoples Hosp Qujing, Dept Internal Med, Qujing, Peoples R China; [Guo, Yifang] Hebei Prov Peoples Hosp, Dept Geriatr Cardiol, Shijiazhuang, Hebei Province, Peoples R China; [Ji, Zhixin] Chinese Peoples Liberat Army Gen Hosp, Med Adm, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Seventh Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Wu, CE (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China.	linyiling301@sina.com			Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Nature Science Foundation of China [81270941, 81100878]; Beijing Nova Program [Z121107002513124]	Key National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and Nature Science Foundation of China (81270941) to PY, and the Nature Science Foundation of China (81100878) and the Beijing Nova Program (Z121107002513124) to YB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA AK, 1990, CHEST, V98, P129, DOI 10.1378/chest.98.1.129; Barnes AR, 1943, AM HEART J, V25, P528, DOI 10.1016/S0002-8703(43)90492-2; Boineau JP, 2007, J ELECTROCARDIOL, V40, P392, DOI 10.1016/j.jelectrocard.2007.07.012; BOYD MT, 1987, J AM COLL CARDIOL, V9, P323, DOI 10.1016/S0735-1097(87)80383-2; CASTA A, 1986, AM HEART J, V111, P321, DOI 10.1016/0002-8703(86)90147-X; Eckardt L, 2001, BASIC RES CARDIOL, V96, P369, DOI 10.1007/s003950170045; FORSGREN S, 1988, ANAT EMBRYOL, V177, P437, DOI 10.1007/BF00304741; Ho ML, 2009, J THORAC IMAG, V24, P119, DOI 10.1097/RTI.0b013e318192d4c1; Kenchaiah S, 2009, J AM SOC ECHOCARDIOG, V22, P739, DOI 10.1016/j.echo.2009.03.008; Kervancioglu M, 2003, CLIN ANAT, V16, P389, DOI 10.1002/ca.10152; LEPESCHKIN E, 1952, AM HEART J, V44, P80, DOI 10.1016/0002-8703(52)90174-9; Lin FC, 1996, CIRCULATION, V93, P525, DOI 10.1161/01.CIR.93.3.525; Lotkowski D, 1997, Folia Morphol (Warsz), V56, P31; Loukas M, 2007, CLIN ANAT, V20, P163, DOI 10.1002/ca.20347; LUETMER PH, 1986, J AM COLL CARDIOL, V8, P179, DOI 10.1016/S0735-1097(86)80110-3; MALOUF J, 1986, BRIT HEART J, V55, P587; Miyazaki S, 2010, CIRC J, V74, P2039, DOI 10.1253/circj.CJ-10-0753; Mobilia G, 1991, Minerva Cardioangiol, V39, P149; NISHIMURA T, 1981, AM J CARDIOL, V48, P177; Philip S, 2011, PEDIATR NEONATOL, V52, P279, DOI 10.1016/j.pedneo.2011.06.007; Pueyo E, 2009, PHILOS T R SOC A, V367, P213, DOI 10.1098/rsta.2008.0230; Salazar J, 1997, PEDIATR CARDIOL, V18, P434, DOI 10.1007/s002469900223; SUTTON MGS, 1994, BRIT HEART J, V71, P187; SUWA M, 1988, J AM COLL CARDIOL, V12, P910, DOI 10.1016/0735-1097(88)90453-6; Tereshchenko LG, 2012, HEART RHYTHM, V9, P1594, DOI 10.1016/j.hrthm.2012.06.036; Thakur RK, 1996, CIRCULATION, V93, P497, DOI 10.1161/01.CIR.93.3.497; Turner W., 1986, J ANAT PHYSL, V30, P568; van Noord C, 2010, EUR J EPIDEMIOL, V25, P21, DOI 10.1007/s10654-009-9406-z; VERED Z, 1984, AM J CARDIOL, V53, P330, DOI 10.1016/0002-9149(84)90450-8	29	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125173	10.1371/journal.pone.0125173	http://dx.doi.org/10.1371/journal.pone.0125173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933440	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100084
J	Tan, B; Dong, SC; Shepard, RL; Kays, L; Roth, KD; Geeganage, S; Kuo, MS; Zhao, GS				Tan, Bo; Dong, Sucai; Shepard, Robert L.; Kays, Lisa; Roth, Kenneth D.; Geeganage, Sandaruwan; Kuo, Ming-Shang; Zhao, Genshi			Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD(+) Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; glucose metabolism; glycolysis; nicotinamide adenine dinucleotide (NAD); pharmacology	PHARMACOLOGICAL INHIBITION; COLORECTAL-CANCER; GASTRIC-CANCER; ALDOLASE-B; CARCINOMA; APOPTOSIS; STRESS; DEATH; OVEREXPRESSION; KETOHEXOKINASE	Nicotinamide phosphoribosyltransferase (NAMPT) has been extensively studied due to its essential role in NAD(+) biosynthesis in cancer cells and the prospect of developing novel therapeutics. To understand how NAMPT regulates cellular metabolism, we have shown that the treatment with FK866, a specific NAMPT inhibitor, leads to attenuation of glycolysis by blocking the glyceraldehyde 3-phosphate dehydrogenase step (Tan, B., Young, D. A., Lu, Z. H., Wang, T., Meier, T. I., Shepard, R. L., Roth, K., Zhai, Y., Huss, K., Kuo, M. S., Gillig, J., Parthasarathy, S., Burkholder, T. P., Smith, M. C., Geeganage, S., and Zhao, G. (2013) Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD(+) biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J. Biol. Chem. 288, 3500-3511). Due to technical limitations, we failed to separate isotopomers of phosphorylated sugars. In this study, we developed an enabling LC-MS methodology. Using this, we confirmed the previous findings and also showed that NAMPT inhibition led to accumulation of fructose 1-phosphate and sedoheptulose 1-phosphate but not glucose 6-phosphate, fructose 6-phosphate, and sedoheptulose 7-phosphate as previously thought. To investigate the metabolic basis of the metabolite formation, we carried out biochemical and cellular studies and established the following. First, glucose-labeling studies indicated that fructose 1-phosphate was derived from dihydroxyacetone phosphate and glyceraldehyde, and sedoheptulose 1-phosphate was derived from dihydroxyacetone phosphate and erythrose via an aldolase reaction. Second, biochemical studies showed that aldolase indeed catalyzed these reactions. Third, glyceraldehyde- and erythrose-labeling studies showed increased incorporation of corresponding labels into fructose 1-phosphate and sedoheptulose 1-phosphate in FK866-treated cells. Fourth, NAMPT inhibition led to increased glyceraldehyde and erythrose levels in the cell. Finally, glucose-labeling studies showed accumulated fructose 1,6-bisphosphate in FK866-treated cells mainly derived from dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. Taken together, this study shows that NAMPT inhibition leads to attenuation of glycolysis, resulting in further perturbation of carbohydrate metabolism in cancer cells. The potential clinical implications of these findings are also discussed.	[Dong, Sucai; Shepard, Robert L.; Kays, Lisa; Geeganage, Sandaruwan; Kuo, Ming-Shang; Zhao, Genshi] Eli Lilly & Co, Lilly Res Labs, Canc Res, Indianapolis, IN 46285 USA; [Tan, Bo; Roth, Kenneth D.; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Discovery Chem, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Kuo, MS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Canc Res, DC0434, Indianapolis, IN 46285 USA.	Kuo_Ming-Shang@Lilly.com; Zhao_Genshi@Lilly.com			Eli Lilly and Co.	Eli Lilly and Co.(Eli Lilly)	This work was supported by Eli Lilly and Co. The authors declare that they have no conflicts of interest with the contents of this article.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; Beck T, 2013, BIOCHEMISTRY-US, V52, P6232, DOI 10.1021/bi400838t; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Catchpole G, 2011, J CELL MOL MED, V15, P109, DOI 10.1111/j.1582-4934.2009.00939.x; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Giannetti AM, 2014, J MED CHEM, V57, P770, DOI 10.1021/jm4015108; Hasmann M, 2003, CANCER RES, V63, P7436; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Hwa JS, 2006, PROTEOMICS, V6, P1077, DOI 10.1002/pmic.200401345; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kardon T, 2008, FEBS LETT, V582, P3330, DOI 10.1016/j.febslet.2008.08.024; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; KITAJIMA Y, 1990, J BIOL CHEM, V265, P17493; KUSAKABE T, 1994, J BIOCHEM-TOKYO, V115, P1172, DOI 10.1093/oxfordjournals.jbchem.a124475; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rellos P, 2000, J BIOL CHEM, V275, P1145, DOI 10.1074/jbc.275.2.1145; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zheng XZ, 2013, J MED CHEM, V56, P6413, DOI 10.1021/jm4008664	39	32	34	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15812	15824		10.1074/jbc.M114.632141	http://dx.doi.org/10.1074/jbc.M114.632141			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944913	Green Published, hybrid			2022-12-26	WOS:000356527400041
J	Zhang, RS; Wright, JD; Pless, SA; Nunez, JJ; Kim, RY; Li, JBW; Yang, RY; Ahern, CA; Kurata, HT				Zhang, Roger S.; Wright, Jordan D.; Pless, Stephan A.; Nunez, John-Jose; Kim, Robin Y.; Li, Jenny B. W.; Yang, Runying; Ahern, Christopher A.; Kurata, Harley T.			A Conserved Residue Cluster That Governs Kinetics of ATP-dependent Gating of Kir6.2 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; gating; ion channel; kinetics; potassium channel; KATP channel; PIP2; ligand-dependent gating	CATION-PI INTERACTIONS; ACTIVATING MUTATIONS; CRYSTAL-STRUCTURE; AMINO-ACIDS; K+ CHANNEL; INHIBITION; MECHANISM; TRYPTOPHAN; STOICHIOMETRY; DETERMINANTS	Background: Kir6.2 potassium channels are regulated by ATP. Results: We measured Kir6.2 gating kinetics in response to rapid ATP concentration jumps. Mutations to Trp-68 and Lys-170 dramatically decelerate gating. Conclusion: Trp-68 and Lys-170 interact to form a cluster that enables rapid gating transitions. Significance: The Trp-68/Lys-170 cluster is highly conserved and may play a similar role in other Kir channels. ATP-sensitive potassium (K-ATP) channels are heteromultimeric complexes of an inwardly rectifying Kir channel (Kir6.x) and sulfonylurea receptors. Their regulation by intracellular ATP and ADP generates electrical signals in response to changes in cellular metabolism. We investigated channel elements that control the kinetics of ATP-dependent regulation of K-ATP (Kir6.2 + SUR1) channels using rapid concentration jumps. WT Kir6.2 channels re-open after rapid washout of ATP with a time constant of approximate to 60 ms. Extending similar kinetic measurements to numerous mutants revealed fairly modest effects on gating kinetics despite significant changes in ATP sensitivity and open probability. However, we identified a pair of highly conserved neighboring amino acids (Trp-68 and Lys-170) that control the rate of channel opening and inhibition in response to ATP. Paradoxically, mutations of Trp-68 or Lys-170 markedly slow the kinetics of channel opening (500 and 700 ms for W68L and K170N, respectively), while increasing channel open probability. Examining the functional effects of these residues using phi value analysis revealed a steep negative slope. This finding implies that these residues play a role in lowering the transition state energy barrier between open and closed channel states. Using unnatural amino acid incorporation, we demonstrate the requirement for a planar amino acid at Kir6.2 position 68 for normal channel gating, which is potentially necessary to localize the E-amine of Lys-170 in the phosphatidylinositol 4,5-bisphosphate-binding site. Overall, our findings identify a discrete pair of highly conserved residues with an essential role for controlling gating kinetics of Kir channels.	[Zhang, Roger S.; Wright, Jordan D.; Nunez, John-Jose; Kim, Robin Y.; Li, Jenny B. W.; Yang, Runying; Kurata, Harley T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Pless, Stephan A.] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Ahern, Christopher A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52246 USA	University of British Columbia; University of Copenhagen; University of Iowa	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Ahern, Christopher/0000-0002-7975-2744; Pless, Stephan/0000-0001-6654-114X; Kurata, Harley/0000-0003-4357-4189	National Institutes of Health from NIGMS [GM106569, GM087519]; Canadian Institutes of Health Research [MOP-97988]; Human Frontiers in Science Program Young Investigator award; University of British Columbia Work Study; Canadian Institutes of Health Research Banting; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research CGS-M award; Michael Smith Foundation; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research awards; Faculty of Medicine; Novo Nordisk Fonden [NNF14OC0011767] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106569, U54GM087519] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontiers in Science Program Young Investigator award; University of British Columbia Work Study; Canadian Institutes of Health Research Banting(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research CGS-M award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research awards; Faculty of Medicine; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM106569 from NIGMS (to C. A. A.). This work was also supported by Canadian Institutes of Health Research MOP-97988 and a Human Frontiers in Science Program Young Investigator award (to H. T. K.).; Recipient of summer student research awards from the University of British Columbia Work Study and Faculty of Medicine.; Recipient of Canadian Institutes of Health Research Banting and Michael Smith Foundation for Health Research awards.; Supported by Natural Sciences and Engineering Research Council of Canada undergraduate research award.; Supported by a Canadian Institutes of Health Research CGS-M award.; Member of the Membrane Protein Structural Dynamics Consortium, which is funded by National Institutes of Health Grant GM087519 from NIGMS.; Received salary support as a Michael Smith Foundation for Health Research Scholar and a Canadian Institutes of Health Research New Investigator. To whom correspondence should be addressed. Tel.: 604-827-3634; E-mail: harley.kurata@ubc.ca.	Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Belokon YN, 2004, ARKIVOC, P132, DOI 10.3998/ark.5550190.0005.313; CANNELL MB, 1991, BIOPHYS J, V60, P1156, DOI 10.1016/S0006-3495(91)82151-8; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2014, CHEMBIOCHEM, V15, P1710, DOI 10.1002/cbic.201402080; Drain P, 2004, BIOPHYS J, V86, P2101, DOI 10.1016/S0006-3495(04)74269-1; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; FERSHT AR, 1991, PHILOS T ROY SOC B, V332, P171, DOI 10.1098/rstb.1991.0046; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kim MS, 2007, J KOREAN MED SCI, V22, P616, DOI 10.3346/jkms.2007.22.4.616; Koeppe RE, 2007, J GEN PHYSIOL, V130, P223, DOI 10.1085/jgp.200709829; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; Lacroix JJ, 2012, J GEN PHYSIOL, V140, P635, DOI 10.1085/jgp.201210827; Li JBW, 2013, J BIOL CHEM, V288, P23038, DOI 10.1074/jbc.M113.485789; Li LH, 2002, J GEN PHYSIOL, V119, P105, DOI 10.1085/jgp.119.1.105; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Mannikko R, 2011, J PHYSIOL-LONDON, V589, P3071, DOI 10.1113/jphysiol.2011.209700; Massa O, 2005, HUM MUTAT, V25, P22, DOI 10.1002/humu.20124; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Ozkan SB, 2001, NAT STRUCT BIOL, V8, P765, DOI 10.1038/nsb0901-765; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Pless SA, 2013, ELIFE, V2, DOI 10.7554/eLife.01289; Pless SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2761; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Shimomura K, 2007, NEUROLOGY, V69, P1342, DOI 10.1212/01.wnl.0000268488.51776.53; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046	54	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15450	15461		10.1074/jbc.M114.631960	http://dx.doi.org/10.1074/jbc.M114.631960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25934393	Green Published, hybrid			2022-12-26	WOS:000356527400012
J	Han, ME; Baek, SJ; Kim, SY; Kang, CD; Oh, SO				Han, Myoung-Eun; Baek, Su-Jin; Kim, Seon-Young; Kang, Chi-Dug; Oh, Sae-Ock			ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; C/EBP-ALPHA; PROLIFERATION; HATH1; IDENTIFICATION; THERAPY; MATH1	Cancer stem cells (CSCs) have been shown to mediate tumorigenicity, chemo-resistance, radio-resistance and metastasis, which suggest they be considered therapeutic targets. Because their differentiated daughter cells are no longer tumorigenic, to induce the differentiation of CSCs can be one of strategies which can eradicate CSCs. Here we show that ATOH1 can induce the differentiation of gastric cancer stem cells (GCSCs). Real time PCR and western blot analysis showed that ATOH1 was induced during the differentiation of GCSCs. Furthermore, the lentivirus-induced overexpression of ATOH1 in GCSCs and in gastric cancer cell lines significantly induced differentiation, reduced proliferation and sphere formation, and reduced in vivo tumor formation in the subcutaneous injection and liver metastasis xenograft models. These results suggest ATOH1 be considered for the development of a differentiation therapy for gastric cancer.	[Han, Myoung-Eun; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Pusan 609735, South Korea; [Kim, Seon-Young; Kang, Chi-Dug] Pusan Natl Univ, Sch Med, Dept Biochem, Pusan 609735, South Korea; [Han, Myoung-Eun] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Pusan 609735, South Korea; [Baek, Su-Jin] KRIBB, Med Genom Res Ctr, Taejon, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Oh, SO (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Pusan 609735, South Korea.	hedgehog@pusan.ac.kr			Bio and Medical Technology Development Program [2012M3A9C6050213]; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST) [2012R1A1A3010521]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	Bio and Medical Technology Development Program; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Bio and Medical Technology Development Program (2012M3A9C6050213) and Basic Science Research Foundation (2012R1A1A3010521) of the National Research Foundation (NRF) funded by the Korean government (MEST) and, a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (0920050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114; Choe Gheeyong, 1997, Journal of Korean Medical Science, V12, P433; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Forget A, 2014, DEV CELL, V29, P649, DOI 10.1016/j.devcel.2014.05.014; Halmos B, 2002, CANCER RES, V62, P528; Han ME, 2011, CELL MOL LIFE SCI, V68, P3589, DOI 10.1007/s00018-011-0672-z; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Lai HC, 2011, J NEUROSCI, V31, P10859, DOI 10.1523/JNEUROSCI.0445-11.2011; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Mutoh H, 2006, DIFFERENTIATION, V74, P313, DOI 10.1111/j.1432-0436.2006.00074.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Park ET, 2006, CLIN CANCER RES, V12, P5403, DOI 10.1158/1078-0432.CCR-06-0573; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Scopelliti A, 2009, EXPERT OPIN BIOL TH, V9, P1005, DOI 10.1517/14712590903066687; Sekine A, 2006, BIOCHEM BIOPH RES CO, V344, P1166, DOI 10.1016/j.bbrc.2006.03.238; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Truong BTH, 2003, BLOOD, V101, P1141, DOI 10.1182/blood-2002-05-1374; Vaillant C, 2009, CEREBELLUM, V8, P291, DOI 10.1007/s12311-009-0094-8; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vincent A, 2012, BBA-REV CANCER, V1826, P83, DOI 10.1016/j.bbcan.2012.03.009; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Wang Y, 2014, CANCER RES; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang X, 2010, J GASTROINTEST SURG, V14, P1220, DOI 10.1007/s11605-010-1246-3	41	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126085	10.1371/journal.pone.0126085	http://dx.doi.org/10.1371/journal.pone.0126085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950549	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400066
J	Park, JW; Park, CW; Lee, SH; Hwang, J				Park, Ji-Woon; Park, Chul Woo; Lee, Sung Hwa; Hwang, Jungho			Fast Monitoring of Indoor Bioaerosol Concentrations with ATP Bioluminescence Assay Using an Electrostatic Rod-Type Sampler	PLOS ONE			English	Article							SUPERHYDROPHOBIC SURFACE; AIRBORNE MICROORGANISMS; BACTERIA; ENUMERATION; PRECIPITATOR; PERFORMANCE; COLLECTION; PARTICLES; DESIGN; SPORES	A culture-based colony counting method is the most widely used analytical technique for monitoring bioaerosols in both indoor and outdoor environments. However, this method requires several days for colony formation. In this study, our goal was fast monitoring (Sampling: 3 min, Detection: < 1 min) of indoor bioaerosol concentrations with ATP bioluminescence assay using a bioaerosol sampler. For this purpose, a novel hand-held electrostatic rod-type sampler (110 mm wide, 115 mm long, and 200 mm tall) was developed and used with a commercial luminometer, which employs the Adenosine triphosphate (ATP) bioluminescence method. The sampler consisted of a wire-rod type charger and a cylindrical collector, and was operated with an applied voltage of 4.5 kV and a sampling flow rate of 150.7 lpm. Its performance was tested using Staphylococcus epidermidis which was aerosolized with an atomizer. Bioaerosol concentrations were measured using ATP bioluminescence method with our sampler and compared with the culture-based method using Andersen cascade impactor under controlled laboratory conditions. Indoor bioaerosol concentrations were also measured using both methods in various indoor environments. A linear correlation was obtained between both methods in lab-tests and field-tests. Our proposed sampler with ATP bioluminescence method may be effective for fast monitoring of indoor bioaerosol concentrations.	[Park, Ji-Woon; Hwang, Jungho] Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea; [Park, Chul Woo; Lee, Sung Hwa] LG Elect, HAE Res & Dev Ctr, Seoul, South Korea	Yonsei University; LG Electronics	Hwang, J (corresponding author), Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea.	hwangjh@yonsei.ac.kr			BioNano Health-Guard Research Center - Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project [H-GUARD_2013M3A6B2078959]	BioNano Health-Guard Research Center - Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project	Funding: This work was supported by BioNano Health-Guard Research Center funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project (Grant Number H-GUARD_2013M3A6B2078959) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranovski V, 2003, J AEROSOL SCI, V34, P1711, DOI 10.1016/S0021-8502(03)00191-5; ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Auty MAE, 2001, APPL ENVIRON MICROB, V67, P420, DOI 10.1128/AEM.67.1.420-425.2001; BEUMER RR, 1992, INT J FOOD MICROBIOL, V15, P153, DOI 10.1016/0168-1605(92)90144-R; Blatny JM, 2008, ENVIRON SCI TECHNOL, V42, P7360, DOI 10.1021/es800306m; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Byeon JH, 2008, BIORESOURCE TECHNOL, V99, P5150, DOI 10.1016/j.biortech.2007.09.014; Dong SF, 2010, ENVIRON MONIT ASSESS, V170, P331, DOI 10.1007/s10661-009-1236-7; Han T, 2011, INDOOR AIR, V21, P110, DOI 10.1111/j.1600-0668.2010.00685.x; Han T, 2010, AEROSOL SCI TECH, V44, P339, DOI 10.1080/02786821003649352; Han T, 2008, J AEROSOL SCI, V39, P1066, DOI 10.1016/j.jaerosci.2008.07.009; Hentz NG, 2013, ENCYCLOPEDIA OF INDU, P757, DOI [10.1002/9780470054581.EIB655, DOI 10.1002/9780470054581.EIB655]; KARL DM, 1980, MICROBIOL REV, V44, P739, DOI 10.1128/MMBR.44.4.739-796.1980; Lee AKY, 2004, ATMOS ENVIRON, V38, P6307, DOI 10.1016/j.atmosenv.2004.08.013; Lee SJ, 2008, SENSOR ACTUAT B-CHEM, V132, P443, DOI 10.1016/j.snb.2007.10.035; Lee T, 2006, INDOOR AIR, V16, P37, DOI 10.1111/j.1600-0668.2005.00396.x; Mainelis G, 2002, J AEROSOL SCI, V33, P1417, DOI 10.1016/S0021-8502(02)00091-5; Mandal J., 2011, Open Environmental & Biological Monitoring Journal, V4, P83, DOI 10.2174/1875040001104010083; Miller A, 2010, AEROSOL SCI TECH, V44, P417, DOI 10.1080/02786821003692063; Park CW, 2014, BIOSENS BIOELECTRON, V52, P379, DOI 10.1016/j.bios.2013.09.015; Pasanen AL, 1997, INDOOR AIR, V7, P121, DOI 10.1111/j.1600-0668.1997.t01-2-00006.x; Rakotonirainy MS, 2003, LUMINESCENCE, V18, P113, DOI 10.1002/bio.710; Roux JM, 2013, AEROSOL SCI TECH, V47, P463, DOI 10.1080/02786826.2013.763896; Rule AM, 2007, ENVIRON SCI TECHNOL, V41, P2467, DOI 10.1021/es062394l; Russell SC, 2005, ANAL CHEM, V77, P4734, DOI 10.1021/ac048202r; Seshadri S, 2009, J AEROSOL SCI, V40, P113, DOI 10.1016/j.jaerosci.2008.10.002; Snyder AP, 2001, FIELD ANAL CHEM TECH, V5, P190, DOI 10.1002/fact.1021; Srivastava A, 2005, ANAL CHEM, V77, P3315, DOI 10.1021/ac048298p; Stewart IW, 1997, J AEROSOL SCI, V28, P511, DOI 10.1016/S0021-8502(96)00452-1; Tan MM, 2011, AEROSOL SCI TECH, V45, P1154, DOI 10.1080/02786826.2011.582193; Terzieva S, 1996, APPL ENVIRON MICROB, V62, P2264, DOI 10.1128/AEM.62.7.2264-2272.1996; THORE A, 1975, J CLIN MICROBIOL, V1, P1; Tong YY, 1999, AEROSOL SCI TECH, V30, P246, DOI 10.1080/027868299304822; Yoon KY, 2010, ENVIRON SCI TECHNOL, V44, P1742, DOI 10.1021/es903437z	34	17	20	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125251	10.1371/journal.pone.0125251	http://dx.doi.org/10.1371/journal.pone.0125251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950929	Green Submitted, gold, Green Published			2022-12-26	WOS:000354214400025
J	Sastre, E; Blanco-Rivero, J; Caracuel, L; Callejo, M; Balfagon, G				Sastre, Esther; Blanco-Rivero, Javier; Caracuel, Laura; Callejo, Maria; Balfagon, Gloria			Alterations in Perivascular Sympathetic and Nitrergic Innervation Function Induced by Late Pregnancy in Rat Mesenteric Arteries	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; NEURONAL NITRIC-OXIDE; ELECTRICAL-FIELD STIMULATION; CALCITONIN-GENE; VASOCONSTRICTOR RESPONSE; MEDIATED RESPONSES; INDUCED RELAXATION; ENDOTHELIUM; EXPRESSION; INCREASES	Background and Purpose We investigated whether pregnancy was associated with changed function in components of perivascular mesenteric innervation and the mechanism/s involved. Experimental Approach We used superior mesenteric arteries from female Sprague-Dawley rats divided into two groups: control rats (in oestrous phase) and pregnant rats (20 days of pregnancy). Modifications in the vasoconstrictor response to electrical field stimulation (EFS) were analysed in the presence/absence of phentolamine (alpha-adrenoceptor antagonist) or L-NAME (nitric oxide synthase-NOS-non-specific inhibitor). Vasomotor responses to noradrenaline (NA), and to NO donor DEA-NO were studied, NA and NO release measured and neuronal NOS (nNOS) expression/activation analysed. Key Results EFS induced a lower frequency-dependent contraction in pregnant than in control rats. Phentolamine decreased EFS-induced vasoconstriction in segments from both experimental groups, but to a greater extent in control rats. EFS-induced vasoconstriction was increased by L-NAME in arteries from both experimental groups. This increase was greater in segments from pregnant rats. Pregnancy decreased NA release while increasing NO release. nNOS expression was not modified but nNOS activation was increased by pregnancy. Pregnancy decreased NA-induced vasoconstriction response and did not modify DEA-NO-induced vasodilation response. Conclusions and Implications Neural control of mesenteric vasomotor tone was altered by pregnancy. Diminished sympathetic and enhanced nitrergic components both contributed to the decreased vasoconstriction response to EFS during pregnancy. All these changes indicate the selective participation of sympathetic and nitrergic innervations in vascular adaptations produced during pregnancy.	[Sastre, Esther; Blanco-Rivero, Javier; Caracuel, Laura; Callejo, Maria; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Sastre, Esther; Blanco-Rivero, Javier; Caracuel, Laura; Balfagon, Gloria] Inst Invest Sanitaria IdiPAZ, Madrid, Spain	Autonomous University of Madrid	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	gloria.balfagon@uam.es	Blanco Rivero, Javier/J-6118-2014	Blanco Rivero, Javier/0000-0001-7232-2314; Balfagon Calvo, Gloria/0000-0001-9477-7950	Ministerio de Economia y Competitividad [SAF2012-38530]; Red RIC [RD12/0042/0024]; Fundacion MAPFRE; Alianza 4 Universidades Program	Ministerio de Economia y Competitividad(Spanish Government); Red RIC; Fundacion MAPFRE; Alianza 4 Universidades Program	This study was supported by Ministerio de Economia y Competitividad (SAF2012-38530), Red RIC (RD12/0042/0024), and Fundacion MAPFRE. E. Sastre received a FPI-UAM fellowship. L. Caracuel received a fellowship from Alianza 4 Universidades Program.	Aukes AM, 2008, REPROD SCI, V15, P411, DOI 10.1177/1933719107314067; Balfagon G, 2004, REGUL PEPTIDES, V120, P253, DOI 10.1016/j.regpep.2004.03.016; Blanco-Rivero J, 2013, J HYPERTENS, V31, P916, DOI 10.1097/HJH.0b013e32835f749c; Blanco-Rivero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053802; Blanco-Rivero J, 2011, CLIN SCI, V121, P331, DOI 10.1042/CS20110072; Blanco-Rivero J, 2011, EXP PHYSIOL, V96, P275, DOI 10.1113/expphysiol.2010.055822; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Carbillon L, 2000, OBSTET GYNECOL SURV, V55, P574, DOI 10.1097/00006254-200009000-00023; Coelho EB, 1997, HYPERTENSION, V30, P585, DOI 10.1161/01.HYP.30.3.585; Cunningham MW, 2013, AM J PHYSIOL-REG I, V304, pR443, DOI 10.1152/ajpregu.00496.2012; DANGELO G, 1993, AM J PHYSIOL, V264, pH78, DOI 10.1152/ajpheart.1993.264.1.H78; de Arellano MLB, 2013, FERTIL STERIL, V100, P801, DOI 10.1016/j.fertnstert.2013.05.013; del Campo L, 2011, EUR J PHARMACOL, V666, P142, DOI 10.1016/j.ejphar.2011.03.056; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; Donald JA, 2005, COMP BIOCHEM PHYS A, V142, P188, DOI 10.1016/j.cbpa.2005.07.015; Ferrer M, 2003, J VASC RES, V40, P509, DOI 10.1159/000075183; Gangula PRR, 2000, BIOL REPROD, V62, P1033, DOI 10.1095/biolreprod62.4.1033; Gangula PRR, 2004, BIOL REPROD, V71, P1739, DOI 10.1095/biolreprod.104.031369; Gerber RT, 1998, BRIT J PHARMACOL, V125, P455, DOI 10.1038/sj.bjp.0702099; GOETZ RM, 1994, BIOCHEM BIOPH RES CO, V205, P905, DOI 10.1006/bbrc.1994.2750; HOHMANN M, 1992, Z GEBURTSH PERINATOL, V196, P33; JANSAKUL C, 1990, J AUTON PHARMACOL, V10, P353, DOI 10.1111/j.1474-8673.1990.tb00035.x; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Lanlua P, 2002, BIOL REPROD, V67, P1430, DOI 10.1095/biolreprod.102.006437; Learmont JG, 1996, AM J OBSTET GYNECOL, V174, P1631, DOI 10.1016/S0002-9378(96)70620-8; Lekontseva O, 2011, J PHARMACOL EXP THER, V339, P367, DOI 10.1124/jpet.111.183798; LI YJ, 1992, EUR J PHARMACOL, V210, P23, DOI 10.1016/0014-2999(92)90647-M; Loesch A, 2002, HISTOL HISTOPATHOL, V17, P591, DOI 10.14670/HH-17.591; Lopez-Sanchez P, 2009, PHARMACOLOGY, V84, P367, DOI 10.1159/000258655; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; Martini M, 2011, BRAIN RES, V1404, P1, DOI 10.1016/j.brainres.2011.06.017; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; NELSON SH, 1995, AM J PHYSIOL-HEART C, V268, pH1694, DOI 10.1152/ajpheart.1995.268.4.H1694; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; PARENT A, 1990, AM J OBSTET GYNECOL, V163, P229, DOI 10.1016/S0002-9378(11)90703-0; Ralevic V, 1996, BRIT J PHARMACOL, V117, P1463, DOI 10.1111/j.1476-5381.1996.tb15307.x; SAGGESE G, 1990, HORM RES, V34, P240, DOI 10.1159/000181833; Sastre E, 2012, PLOS ONE, V8; Sastre E, 2012, CLIN SCI, V122, P337, DOI 10.1042/CS20110303; Sastre E, 2010, REV NEUROLOGIA, V50, P727, DOI 10.33588/rn.5012.2010334; Smith PG, 2009, UROLOGY, V73, P1392, DOI 10.1016/j.urology.2008.11.052; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; van Drongelen J, 2012, AM J PHYSIOL-HEART C, V303, pH639, DOI 10.1152/ajpheart.00617.2011; van Eijndhoven HWF, 2003, J VASC RES, V40, P344, DOI 10.1159/000072698; VANHOUTTE PM, 1985, CIRCULATION, V72, P728, DOI 10.1161/01.CIR.72.4.728; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; Xu DL, 1996, AM J PHYSIOL-REG I, V271, pR1739, DOI 10.1152/ajpregu.1996.271.6.R1739; Yallampalli C, 2002, TRENDS ENDOCRIN MET, V13, P263, DOI 10.1016/S1043-2760(02)00563-5; Zancheta D, 2015, LIFE SCI, V122, P78, DOI 10.1016/j.lfs.2014.12.014; Zhang HY, 2006, AM J PHYSIOL-HEART C, V291, pH2282, DOI 10.1152/ajpheart.00321.2006	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126017	10.1371/journal.pone.0126017	http://dx.doi.org/10.1371/journal.pone.0126017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951331	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400061
J	De Santo, LS; Torella, M; Romano, G; Maiello, C; Buonocore, M; Bancone, C; Della Corte, A; Galdieri, N; Nappi, G; Amarelli, C				De Santo, Luca Salvatore; Torella, Michele; Romano, Gianpaolo; Maiello, Ciro; Buonocore, Marianna; Bancone, Ciro; Della Corte, Alessandro; Galdieri, Nicola; Nappi, Gianantonio; Amarelli, Cristiano			Perioperative Myocardial Injury after Adult Heart Transplant: Determinants and Prognostic Value	PLOS ONE			English	Article							LONG-TERM SURVIVAL; TROPONIN-I; CREATINE-KINASE; CARDIAC-SURGERY; GRAFT FAILURE; ISCHEMIC TIME; DONOR HEARTS; PRESERVATION; PATIENT; RISK	Background and Aim of the Study Implications of Cardiac troponin (cTnI) release after cardiac transplantation are still unclear. This study disclosed risk factors and prognostic implication of cTnI early levels in a single centre cohort operated on between January 1999 and December 2010. Methods Data on 362 consecutive recipients (mean age: 47.8 +/- 13.7, 20.2% female, 18.2% diabetics, 22.1% with previous cardiac operations, 27.6% hospitalized, 84.9 +/- 29.4 ml/min preoperative glomerular filtration rate) were analyzed using multivariable logistic regression modeling. Target outcomes were determinants of troponin release, early graft failure (EGF), acute kidney injury (AKI) and operative death. Results Mean cTnI release measured 24 hours after transplant was 10.9 +/- 11.6 mu g/L. Overall hospital mortality was 10.8%, EGF 10.5%, and AKI was 12.2%. cTnI release>10 mu g/L proved an independent predictor of EGF (OR 2.2; 95% CI, 1.06-4.6) and AKI (OR 1.031; 95% CI, 1.001-1.064). EGF, in turn, proved a determinant of hospital mortality. Risk factors for cTnI>10 mu g/L release were: status 2B (OR 0.35; 95% CI, 0.18-0.69, protective), duration of the ischemic period (OR 1.006; 95% CI, 1.001-1.011), previous cardiac operation (OR 2.9; 95% CI, 1.67-5.0), and left ventricular hypertrophy (OR 3.3; 95% CI, 1.9-5.6). Conclusions Myocardial enzyme leakage clearly emerged as an epiphenomenon of more complicated clinical course. The complex interplay between surgical procedure features, graft characteristics and recipient end-organ function highlights cTnI release as a risk marker of graft failure and acute kidney injury. The search for optimal myocardial preservation is still an issue.	[Romano, Gianpaolo; Maiello, Ciro; Galdieri, Nicola; Amarelli, Cristiano] Univ Foggia, Dept Surg & Med Sci, Chair Cardiac Surg, Foggia, Italy; [Romano, Gianpaolo; Maiello, Ciro; Galdieri, Nicola; Amarelli, Cristiano] V Monaldi Hosp, Dept Cardiovasc Surg & Transplants, Naples, Italy; [Torella, Michele; Buonocore, Marianna; Bancone, Ciro; Della Corte, Alessandro; Nappi, Gianantonio] Univ Naples 2, Dept Cardiothorac Sci, Naples, Italy	University of Foggia; Universita della Campania Vanvitelli	Torella, M (corresponding author), Univ Naples 2, Dept Cardiothorac Sci, Naples, Italy.	michele.torella@unina2.it	Della Corte, Alessandro/K-9383-2016; De+Santo, Luca/AAJ-2231-2020; Amarelli, Cristiano/U-6804-2017; Bancone, Ciro/K-9762-2016	Della Corte, Alessandro/0000-0002-4636-3339; Amarelli, Cristiano/0000-0002-7949-7771; Bancone, Ciro/0000-0003-0235-5860; torella, michele/0000-0003-3853-3171; DE SANTO, LUCA SALVATORE/0000-0002-8958-9063; Maiello, Ciro/0000-0003-1604-4756				Amarelli C, 2012, INTERACT CARDIOV TH, V15, P57, DOI 10.1093/icvts/ivs113; Banner NR, 2008, TRANSPLANTATION, V86, P542, DOI 10.1097/TP.0b013e31818149b9; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Beyersdorf F, 2009, CARDIOVASC RES, V83, P262, DOI 10.1093/cvr/cvp110; Braga JR, 2012, CLIN TRANSPLANT, V26, pE111, DOI 10.1111/j.1399-0012.2011.01565.x; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Buse GAL, 2010, EUR J CARDIO-THORAC, V37, P399, DOI 10.1016/j.ejcts.2009.05.054; CARRIER M, 1994, J HEART LUNG TRANSPL, V13, P696; De Santo LS, 2006, HEART VESSELS, V21, P89, DOI 10.1007/s00380-005-0867-z; De Santo LS, 2004, TRANSPL P, V36, P627, DOI 10.1016/j.transproceed.2004.02.052; de Santo LS, 2008, EUR J CARDIO-THORAC, V33, P666, DOI 10.1016/j.ejcts.2007.12.046; De Santo LS, 2011, EUR J CARDIO-THORAC, V40, P1355, DOI 10.1016/j.ejcts.2011.02.068; Erbel C, 2013, TRANSPL INT, V26, P267, DOI 10.1111/tri.12024; Fiocchi R, 2000, Transpl Int, V13 Suppl 1, pS240; Fiocchi R, 1997, J HEART LUNG TRANSPL, V16, P969; Frangieh AH, 2015, EUR HEART J, V36, DOI 10.1093/eurheartj/ehu310; Galassi AR, 2014, EUR HEART J, V35, P2009, DOI 10.1093/eurheartj/ehu070; George TJ, 2011, J HEART LUNG TRANSPL, V30, P1033, DOI 10.1016/j.healun.2011.05.005; Jokinen JJ, 2010, J HEART LUNG TRANSPL, V29, P633, DOI 10.1016/j.healun.2010.01.004; Kuppahally SS, 2007, AM J TRANSPLANT, V7, P2388, DOI 10.1111/j.1600-6143.2007.01930.x; Labarrere CA, 2000, JAMA-J AM MED ASSOC, V284, P457, DOI 10.1001/jama.284.4.457; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marasco SF, 2007, CLIN TRANSPLANT, V21, P321, DOI 10.1111/j.1399-0012.2007.00644.x; McIlroy DR, 2010, J CARDIOTHOR VASC AN, V24, P939, DOI 10.1053/j.jvca.2010.05.008; Minami K, 2003, J HEART LUNG TRANSPL, V22, P192, DOI 10.1016/S1053-2498(02)00568-5; Patel ND, 2008, CIRCULATION, V118, pS83, DOI 10.1161/CIRCULATIONAHA.107.756866; Patel PC, 2014, CIRC-HEART FAIL, V7, P463, DOI 10.1161/CIRCHEARTFAILURE.113.000697; Pinzon OW, 2011, AM J TRANSPLANT, V11, P2755, DOI 10.1111/j.1600-6143.2011.03744.x; Ryan JB, 2003, EUR J CARDIO-THORAC, V23, P898, DOI 10.1016/S1010-7940(03)00114-3; Rylski B, 2010, INTERACT CARDIOV TH, V10, P945, DOI 10.1510/icvts.2009.223719; Subramaniam K, 2012, INT ANESTHESIOL CLIN, V50, P202, DOI 10.1097/AIA.0b013e3182603ead; Weisel RD, 2012, EUR J CARDIO-THORAC, V41, pE53, DOI 10.1093/ejcts/ezs058	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0120813	10.1371/journal.pone.0120813	http://dx.doi.org/10.1371/journal.pone.0120813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942400	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400002
J	Gu, XC; Zhang, YN; Kang, K; Dong, SL; Zhang, LW				Gu, Xiao-Cui; Zhang, Ya-Nan; Kang, Ke; Dong, Shuang-Lin; Zhang, Long-Wa			Antennal Transcriptome Analysis of Odorant Reception Genes in the Red Turpentine Beetle (RTB), Dendroctonus valens	PLOS ONE			English	Article							PHEROMONE-DEGRADING ENZYME; NEURON MEMBRANE-PROTEINS; ANTHERAEA-POLYPHEMUS; SEX-PHEROMONE; SPODOPTERA-LITTORALIS; FUNCTIONAL-CHARACTERIZATION; CURCULIONIDAE SCOLYTINAE; DIFFERENTIAL EXPRESSION; DROSOPHILA-MELANOGASTER; TEMNOCHILA-CHLORODIA	Background The red turpentine beetle (RTB), Dendroctonus valens LeConte (Coleoptera: Curculionidae, Scolytinae), is a destructive invasive pest of conifers which has become the second most important forest pest nationwide in China. Dendroctonus valens is known to use host odors and aggregation pheromones, as well as non-host volatiles, in host location and mass-attack modulation, and thus antennal olfaction is of the utmost importance for the beetles' survival and fitness. However, information on the genes underlying olfaction has been lacking in D. valens. Here, we report the antennal transcriptome of D. valens from next-generation sequencing, with the goal of identifying the olfaction gene repertoire that is involved in D. valens odor-processing. Results We obtained 51 million reads that were assembled into 61,889 genes, including 39,831 contigs and 22,058 unigenes. In total, we identified 68 novel putative odorant reception genes, including 21 transcripts encoding for putative odorant binding proteins (OBP), six chemosensory proteins (CSP), four sensory neuron membrane proteins (SNMP), 22 odorant receptors (OR), four gustatory receptors (GR), three ionotropic receptors (IR), and eight ionotropic glutamate receptors. We also identified 155 odorant/xenobiotic degradation enzymes from the antennal transcriptome, putatively identified to be involved in olfaction processes including cytochrome P450s, glutathione-S-transferases, and aldehyde dehydrogenase. Predicted protein sequences were compared with counterparts in Tribolium castaneum, Megacyllene caryae, Ips typographus, Dendroctonus ponderosae, and Agrilus planipennis. Conclusion The antennal transcriptome described here represents the first study of the repertoire of odor processing genes in D. valens. The genes reported here provide a significant addition to the pool of identified olfactory genes in Coleoptera, which might represent novel targets for insect management. The results from our study also will assist with evolutionary analyses of coleopteran olfaction.	[Gu, Xiao-Cui; Kang, Ke; Zhang, Long-Wa] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Anhui Prov Key Lab Microbial Control, Hefei, Peoples R China; [Dong, Shuang-Lin] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Zhang, Ya-Nan] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China	Anhui Agricultural University; Nanjing Agricultural University; Huaibei Normal University	Dong, SL (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn; zhanglw@ahau.edu.cn			National Natural Science Foundation of China [31170616, 31000304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (31170616, 31000304). L-WZ received the funding and the founders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Allen JE, 2011, INSECT BIOCHEM MOLEC, V41, P141, DOI 10.1016/j.ibmb.2010.10.005; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Briscoe AD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003620; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chandler J.C., 2014, GEN COMP ENDOCRINOL; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Chertemps T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-56; Choo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067794; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Erbilgin N, 2007, J CHEM ECOL, V33, P131, DOI 10.1007/s10886-006-9200-2; Fettig CJ, 2005, CAN ENTOMOL, V137, P748; Fettig CJ, 2004, J ENTOMOL SCI, V39, P490, DOI 10.18474/0749-8004-39.4.490; FETTIG CJ, 2007, CAN ENTOMOL, V139, P141; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gress JC, 2013, INSECT MOL BIOL, V22, P659, DOI 10.1111/imb.12053; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; He P, 2014, INSECT MOL BIOL, V23, P475, DOI 10.1111/imb.12095; He P, 2014, GENOME, V57, P201, DOI 10.1139/gen-2014-0041; He P, 2014, ARCH INSECT BIOCHEM, V86, P85, DOI 10.1002/arch.21164; Hobson Kenneth R., 1993, Bulletin of the Ecological Society of America, V74, P278; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Keeling CI, 2013, INSECT BIOCHEM MOLEC, V43, P1142, DOI 10.1016/j.ibmb.2013.10.001; Koch SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081518; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li J.S., 2001, FOREST PEST DIS, V4, P41; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu CC, 2014, ARCH INSECT BIOCHEM, V85, P114, DOI 10.1002/arch.21150; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Liu ZD, 2013, CHEM SENSES, V38, P485, DOI 10.1093/chemse/bjt019; Lopez MF, 2013, INSECT BIOCHEM MOLEC, V43, P417, DOI 10.1016/j.ibmb.2013.02.004; LYON R. L., 1958, CANADIAN ENT, V90, P582; MAIDA R, 1995, NEUROREPORT, V6, P822, DOI 10.1097/00001756-199503270-00029; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; Menuz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004810; Merlin C, 2007, INSECT MOL BIOL, V16, P73, DOI [10.1111/j.1365-2583.2006.00702.x, 10.1111/1365-2583.2006.00702.x]; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Miao Zhen-Wang, 2004, Acta Entomologica Sinica, V47, P360; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pottier MA, 2012, INSECT MOL BIOL, V21, P568, DOI 10.1111/j.1365-2583.2012.01160.x; Rappaport NG, 2001, ENVIRON ENTOMOL, V30, P837, DOI 10.1603/0046-225X-30.5.837; Rogers ME, 1999, J EXP BIOL, V202, P1625; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Sun JH, 2003, CAN ENTOMOL, V135, P721; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; Taerum SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078126; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu W, 2012, J CHEM ECOL, V38, P1513, DOI 10.1007/s10886-012-0221-8; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; Yin Hui-Fen, 2000, Acta Zootaxonomica Sinica, V25, P43; Younus F, 2014, INSECT BIOCHEM MOLEC, V53, P30, DOI 10.1016/j.ibmb.2014.07.003; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024111; Zhang LW, 2007, ANN FOREST SCI, V64, P267, DOI 10.1051/forest:2007004; Zhang Long-Wa, 2007, Chinese Bulletin of Entomology, V44, P171; Zhang LW, 2006, ENVIRON ENTOMOL, V35, P655, DOI 10.1603/0046-225X-35.3.655; Zhang LW, 2006, ENVIRON ENTOMOL, V35, P1232, DOI 10.1603/0046-225X(2006)35[1232:EABROD]2.0.CO;2; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715	95	60	73	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125159	10.1371/journal.pone.0125159	http://dx.doi.org/10.1371/journal.pone.0125159			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938508	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000048
J	Houlden, A; Hayes, KS; Bancroft, AJ; Worthington, JJ; Wang, P; Grencis, RK; Roberts, IS				Houlden, Ashley; Hayes, Kelly S.; Bancroft, Allison J.; Worthington, John J.; Wang, Ping; Grencis, Richard K.; Roberts, Ian S.			Chronic Trichuris muris Infection in C57BL/6 Mice Causes Significant Changes in Host Microbiota and Metabolome: Effects Reversed by Pathogen Clearance	PLOS ONE			English	Article							COMMENSAL BACTERIA; GUT MICROBIOTA; MICROFLORA; RESISTANCE; IMMUNITY; MODEL; TIME; DIET	Trichuris species are a globally important and prevalent group of intestinal helminth parasites, in which Trichuris muris (mouse whipworm) is an ideal model for this disease. This paper describes the first ever highly controlled and comprehensive investigation into the effects of T. muris infection on the faecal microbiota of mice and the effects on the microbiota following successful clearance of the infection. Communities were profiled using DGGE, 454 pyrosequencing, and metabolomics. Changes in microbial composition occurred between 14 and 28 days post infection, resulting in significant changes in a and beta-diversity. This impact was dominated by a reduction in the diversity and abundance of Bacteroidetes, specifically Prevotella and Parabacteroides. Metabolomic analysis of stool samples of infected mice at day 41 showed significant differences to uninfected controls with a significant increase in the levels of a number of essential amino acids and a reduction in breakdown of dietary plant derived carbohydrates. The significant reduction in weight gain by infected mice probably reflects these metabolic changes and the incomplete digestion of dietary polysaccharides. Following clearance of infection the intestinal microbiota underwent additional changes gradually transitioning by day 91 towards a microbiota of an uninfected animal. These data indicate that the changes in microbiota as a consequence of infection were transitory requiring the presence of the pathogen for maintenance. Interestingly this was not observed for all of the key immune cell populations associated with chronic T. muris infection. This reflects the highly regulated chronic response and potential lasting immunological consequences of dysbiosis in the microbiota. Thus infection of T. muris causes a significant and substantial impact on intestinal microbiota and digestive function of mice with affects in long term immune regulation.	[Houlden, Ashley; Hayes, Kelly S.; Bancroft, Allison J.; Worthington, John J.; Wang, Ping; Grencis, Richard K.; Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Grencis, RK (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	Richard.k.grencis@manchester.ac.uk; i.s.roberts@manchester.ac.uk	hayes, kelly/GVT-8455-2022	Houlden, Ashley/0000-0002-1526-5963; Worthington, John Joseph/0000-0002-1429-5669	Medical Research Council [G1100076]; Welcome Trust [WT 100290MA]; MRC [G1100076] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council Grant G1100076 (http://www.mrc.ac.uk) Awarded to ISR and RKG. The Welcome Trust grant WT 100290MA (http://www.wellcome.ac.uk) awarded to RKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Artis D, 1999, EXP PARASITOL, V92, P144, DOI 10.1006/expr.1999.4407; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bancroft AJ, 2012, TRENDS PARASITOL, V28, P93, DOI 10.1016/j.pt.2011.12.001; BEER RJS, 1973, PARASITOLOGY, V67, P263, DOI 10.1017/S0031182000046503; Begley P, 2009, ANAL CHEM, V81, P7038, DOI 10.1021/ac9011599; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cantacessi C, 2014, J INFECT DIS, V210, P1431, DOI 10.1093/infdis/jiu256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hepworth MR, 2010, EUR J IMMUNOL, V40, P406, DOI 10.1002/eji.200939589; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ooi M, 2011, INFLAMM RES, V60, P831, DOI 10.1007/s00011-011-0340-7; PANESAR TS, 1980, INT J PARASITOL, V10, P261, DOI 10.1016/0020-7519(80)90006-5; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Yau YK, 2013, J GASTROEN HEPATOL, V28, P1076, DOI 10.1111/jgh.12193	55	122	124	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125945	10.1371/journal.pone.0125945	http://dx.doi.org/10.1371/journal.pone.0125945			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938477	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000353943000117
J	Munoz-Gonzalez, S; Ruggli, N; Rosell, R; Perez, LJ; Frias-Leuporeau, MT; Fraile, L; Montoya, M; Cordoba, L; Domingo, M; Ehrensperger, F; Summerfield, A; Ganges, L				Munoz-Gonzalez, Sara; Ruggli, Nicolas; Rosell, Rosa; Josue Perez, Lester; Teresa Frias-Leuporeau, Maria; Fraile, Lorenzo; Montoya, Maria; Cordoba, Lorena; Domingo, Mariano; Ehrensperger, Felix; Summerfield, Artur; Ganges, Llilianne			Postnatal Persistent Infection with Classical Swine Fever Virus and Its Immunological Implications	PLOS ONE			English	Article							CONVENTIONAL DENDRITIC CELLS; HOG-CHOLERA VIRUS; T-CELLS; IMMUNE-RESPONSE; BLOOD; PIGS; VACCINATION; ANTIBODIES; PIGLETS; STRAIN	It is well established that trans-placental transmission of classical swine fever virus (CSFV) during mid-gestation can lead to persistently infected offspring. The aim of the present study was to evaluate the ability of CSFV to induce viral persistence upon early postnatal infection. Two litters of 10 piglets each were infected intranasally on the day of birth with low and moderate virulence CSFV isolates, respectively. During six weeks after postnatal infection, most of the piglets remained clinically healthy, despite persistent high virus titres in the serum. Importantly, these animals were unable to mount any detectable humoral and cellular immune response. At necropsy, the most prominent gross pathological lesion was a severe thymus atrophy. Four weeks after infection, PBMCs from the persistently infected seronegative piglets were unresponsive to both, specific CSFV and non-specific PHA stimulation in terms of IFN-gamma-producing cells. These results suggested the development of a state of immunosuppression in these postnatally persistently infected pigs. However, IL-10 was undetectable in the sera of the persistently infected animals. Interestingly, CSFV-stimulated PBMCs from the persistently infected piglets produced IL-10. Nevertheless, despite the addition of the anti-IL-10 antibody in the PBMC culture from persistently infected piglets, the response of the IFN-gamma producing cells was not restored. Therefore, other factors than IL-10 may be involved in the general suppression of the T-cell responses upon CSFV and mitogen activation. Interestingly, bone marrow immature granulocytes were increased and targeted by the virus in persistently infected piglets. Taken together, we provided the first data demonstrating the feasibility of CSFV in generating a postnatal persistent disease, which has not been shown for other members of the Pestivirus genus yet. Since serological methods are routinely used in CSFV surveillance, persistently infected pigs might go unnoticed. In addition to the epidemiological and economic significance of persistent CSFV infection, this model could be useful for understanding the mechanisms of viral persistence.	[Munoz-Gonzalez, Sara; Rosell, Rosa; Montoya, Maria; Cordoba, Lorena; Domingo, Mariano; Ganges, Llilianne] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, IRTA, E-08193 Barcelona, Spain; [Ruggli, Nicolas; Summerfield, Artur] Inst Immunol & Virol, Mittelhausem, Switzerland; [Rosell, Rosa] DAAM, Dept Agr Ramaderia Pesca Alimentacio Medi Nat, Generalitat De Catalunya, Spain; [Josue Perez, Lester; Teresa Frias-Leuporeau, Maria] Ctr Nacl Sanidad Agr CENSA, Havana, Cuba; [Fraile, Lorenzo] Univ Lleida, ETSEA, Dept Anim Prod, Lleida, Spain; [Montoya, Maria] Inst Recerca Tecnol Agroalimentaria, Barcelona, Spain; [Domingo, Mariano] UAB, Fac Vet, Dept Sanitat Anat Anim, Bellaterra, Spain; [Ehrensperger, Felix] Univ Zurich, Inst Vet Pathol, Div Immunopathol, Zurich, Switzerland	Autonomous University of Barcelona; IRTA; Universitat de Lleida; IRTA; Autonomous University of Barcelona; University of Zurich	Ganges, L (corresponding author), Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus UAB, E-08193 Barcelona, Spain.	llilianne.ganges@cresa.uab.es	Montoya, Maria/G-3430-2015; Summerfield, Artur/H-6025-2019; Ganges, Llilianne/O-7342-2017; Summerfield, Artur/K-2105-2016; Fraile, Lorenzo/A-1142-2009; Perez, Lester J./A-1339-2016; Fraile, Lorenzo/AGE-2172-2022; Fraile, Lorenzo/GQQ-8989-2022; Domingo, Mariano/A-1015-2009	Montoya, Maria/0000-0002-5703-7360; Summerfield, Artur/0000-0001-8292-4634; Ganges, Llilianne/0000-0002-8644-3560; Summerfield, Artur/0000-0001-8292-4634; Fraile, Lorenzo/0000-0002-8980-5862; Perez, Lester J./0000-0002-5717-5181; Fraile, Lorenzo/0000-0002-8980-5862; Fraile, Lorenzo/0000-0002-8980-5862; Domingo, Mariano/0000-0002-9623-4826; Ruggli, Nicolas/0000-0002-7679-6290; Rosell, Rosa/0000-0002-8294-1159; Munoz-Gonzalez, Sara/0000-0002-7846-7001	Spanish government [AGL2012-38343]; AGAUR, Generalitat de Catalunya [FI-DGR 2014]	Spanish government(Spanish GovernmentEuropean Commission); AGAUR, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This research was supported by grant AGL2012-38343 from Spanish government. Author who received the funding: Llilianne Ganges (LG). S. Munoz-Gonzalez received predoctoral fellowship FI-DGR 2014 from AGAUR, Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allepuz A, 2007, VET REC, V160, P398, DOI 10.1136/vr.160.12.398; Aynaud J. M., 1977, Agricultural research seminar on hog cholera/classical swine fever and African swine fever, held at the Tierarztliche Hochschule, Hannover, September 6-11, 1976., P273; BAKER JA, 1960, P SOC EXP BIOL MED, V105, P675, DOI 10.3181/00379727-105-26214; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Campos T, 2013, P 7 EPIZONE ANN M NO; Carbrey EA, 1977, COMMISSION EUROPEAN, V5904, P214; Carrasco CP, 2004, J GEN VIROL, V85, P1633, DOI 10.1099/vir.0.19716-0; de Arce HD, 2005, VIRUS RES, V112, P123, DOI 10.1016/j.virusres.2005.03.018; de Arce HD, 1999, VIRUS RES, V64, P61, DOI 10.1016/S0168-1702(99)00077-5; DEARCE HD, 1992, VET IMMUNOL IMMUNOP, V30, P319, DOI 10.1016/0165-2427(92)90102-V; Eble PL, 2014, VET MICROBIOL, V174, P27, DOI 10.1016/j.vetmic.2014.08.030; Ehrensperger F., 1988, Classical swine fever and related viral infections, P143; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Everett HE, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0281-9; Fan YF, 2008, VIRUS GENES, V36, P531, DOI 10.1007/s11262-008-0229-x; Floegel-Niesmann G, 2009, VET MICROBIOL, V139, P165, DOI 10.1016/j.vetmic.2009.05.008; FREY HR, 1980, ZBL VET MED B, V27, P154; Frias-Lepoureau MT, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P165; Ganges L, 2005, VACCINE, V23, P3741, DOI 10.1016/j.vaccine.2005.01.153; Ganges L, 2008, VET J, V177, P169, DOI 10.1016/j.tvjl.2007.01.030; Guzylack-Piriou L, 2004, IMMUNOLOGY, V112, P28, DOI 10.1111/j.1365-2567.2004.01856.x; Harding JCS, 2008, J VET DIAGN INVEST, V20, P274, DOI 10.1177/104063870802000303; He YL, 2012, VET MICROBIOL, V160, P455, DOI 10.1016/j.vetmic.2012.05.040; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Jamin A, 2008, VET RES, V39, DOI 10.1051/vetres:2007045; Ji W, 2014, INFECT GENET EVOL, V25, P69, DOI 10.1016/j.meegid.2014.04.008; Perez LJ, 2012, INFECT GENET EVOL, V12, P1405, DOI 10.1016/j.meegid.2012.04.030; Kaden V, 2005, J VET MED B, V52, P161, DOI 10.1111/j.1439-0450.2005.00838.x; Kakumu S, 1997, CLIN EXP IMMUNOL, V108, P138, DOI 10.1046/j.1365-2249.1997.d01-987.x; Kane M, 2010, J VIROL, V84, P4116, DOI 10.1128/JVI.01905-09; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Leifer I, 2013, VIROLOGY, V438, P51, DOI 10.1016/j.virol.2013.01.013; LIESS B, 1984, PREV VET MED, V2, P109, DOI 10.1016/0167-5877(84)90054-0; Liu B, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.323; Mussa T, 2011, VIROLOGY, V420, P125, DOI 10.1016/j.virol.2011.09.001; NOWACKI W, 1993, RES IMMUNOL, V144, P111, DOI 10.1016/0923-2494(93)80066-8; Parchariyanon S, 2000, J VIROL METHODS, V87, P145, DOI 10.1016/S0166-0934(00)00162-2; Perez C, 2007, DEV COMP IMMUNOL, V31, P296, DOI 10.1016/j.dci.2006.06.002; Python S, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003412, 10.1371/annotation/4290dfee-64fd-4157-89e3-8edbba912420]; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ruemenapf Till, 2008, P39; Ruggli N, 2009, J VIROL, V83, P817, DOI 10.1128/JVI.01509-08; Sanchez-Cordon PJ, 2002, J COMP PATHOL, V127, P239, DOI 10.1053/jcpa.2002.0587; Selvarajah S, 2012, J GEN VIROL, V93, P1673, DOI 10.1099/vir.0.041277-0; Shen H, 2011, VIRUS GENES, V43, P234, DOI 10.1007/s11262-011-0625-5; Summerfield A, 2006, J INTERF CYTOK RES, V26, P248, DOI 10.1089/jir.2006.26.248; Summerfield A, 1998, VET IMMUNOL IMMUNOP, V63, P289, DOI 10.1016/S0165-2427(98)00108-1; Summerfield A, 1998, J VIROL, V72, P1853, DOI 10.1128/JVI.72.3.1853-1861.1998; Summerfield A, 2001, VET IMMUNOL IMMUNOP, V78, P3, DOI 10.1016/S0165-2427(00)00248-8; Suradhat S, 2003, VET MICROBIOL, V92, P187, DOI 10.1016/S0378-1135(02)00357-7; Tamura T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-47; Taoufik Y, 1997, BLOOD, V89, P2842, DOI 10.1182/blood.V89.8.2842; Tarradas J, 2010, VET MICROBIOL, V142, P51, DOI 10.1016/j.vetmic.2009.09.043; Tarradas J, 2014, VIRUS RES, V185, P82, DOI 10.1016/j.virusres.2014.03.004; TERPSTRA C, 1984, VET MICROBIOL, V9, P113, DOI 10.1016/0378-1135(84)90026-9; Terpstra C, 2000, VET MICROBIOL, V77, P3, DOI 10.1016/S0378-1135(00)00252-2; Thiel H-J, 2005, VIRUS TAXONOMY, P981; Trautwein G., 1988, Classical swine fever and related viral infections, P27; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008; Van Oirschot JT, 1979, VET MICROBIOL, V4; Vandeputte J, 2001, AM J VET RES, V62, P1805, DOI 10.2460/ajvr.2001.62.1805; VANNIER P, 1981, AM J VET RES, V42, P135; VANOIRSCHOT JT, 1977, VET MICROBIOL, V2, P133, DOI 10.1016/0378-1135(77)90004-9; VANOIRSCHOT JT, 1977, VET MICROBIOL, V2, P121, DOI 10.1016/0378-1135(77)90003-7; VANOIRSCHOT JT, 1983, VET MICROBIOL, V8, P81, DOI 10.1016/0378-1135(83)90021-4; VANOIRSCHOT JT, 1979, VET MICROBIOL, V4, P117, DOI 10.1016/0378-1135(79)90048-8; von Rosen T, 2013, RES VET SCI, V95, P1262, DOI 10.1016/j.rvsc.2013.09.011; Wang G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-2; Wang Z, 2008, TRANSBOUND EMERG DIS, V55, P369, DOI 10.1111/j.1865-1682.2008.01049.x; Weesendorp E, 2011, VET MICROBIOL, V147, P262, DOI 10.1016/j.vetmic.2010.06.032; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6	71	40	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125692	10.1371/journal.pone.0125692	http://dx.doi.org/10.1371/journal.pone.0125692			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938664	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000091
J	Hsu, HE; Liu, TN; Yeh, CS; Chang, TH; Lo, YC; Kao, CF				Hsu, Hsiang-En; Liu, Tzu-Ning; Yeh, Chung-Shu; Chang, Tien-Hsien; Lo, Yi-Chen; Kao, Cheng-Fu			Feedback Control of Snf1 Protein and Its Phosphorylation Is Necessary for Adaptation to Environmental Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; GLOBAL ANALYSIS; HISTONE H2B; BUDDING YEAST; KINASE; UBIQUITYLATION; PHOSPHATASE; GROWTH	Snf1, a member of the AMP-activated protein kinase family, plays a critical role in metabolic energy control in yeast cells. Snf1 activity is activated by phosphorylation of Thr-210 on the activation loop of its catalytic subunit; following activation, Snf1 regulates stress-responsive transcription factors. Here, we report that the level of Snf1 protein is dramatically decreased in a UBP8-and UBP10-deleted yeast mutant (ubp8 Delta ubp10 Delta), and this is independent of transcriptional regulation and proteasome-mediated degradation. Surprisingly, most Snf1-mediated functions, including glucose limitation regulation, utilization of alternative carbon sources, stress responses, and aging, are unaffected in this strain. Snf1 phosphorylation in ubp8 Delta ubp10 Delta cells is hyperactivated upon stress, which may compensate for the loss of the Snf1 protein and protect cells against stress and aging. Furthermore, artificial elevation of Snf1 phosphorylation (accomplished through deletion of REG1, which encodes a protein that regulates Snf1 dephosphorylation) restored Snf1 protein levels and the regulation of Snf1 activity in ubp8 Delta ubp10 Delta cells. Our results reveal the existence of a feedback loop that controls Snf1 protein level and its phosphorylation, which is masked by Ubp8 and Ubp10 through an unknown mechanism. We propose that this dynamic modulation of Snf1 phosphorylation and its protein level may be important for adaptation to environmental stress.	[Hsu, Hsiang-En; Kao, Cheng-Fu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Liu, Tzu-Ning; Lo, Yi-Chen] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Food Sci & Technol, Taipei 10617, Taiwan; [Yeh, Chung-Shu; Chang, Tien-Hsien] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Yeh, Chung-Shu; Chang, Tien-Hsien] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Hsu, Hsiang-En; Kao, Cheng-Fu] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan	National Defense Medical Center; National Taiwan University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Lo, YC (corresponding author), Inst Food Sci & Technol, Roosevelt Rd,Sect 4, Taipei, Taiwan.	loyichen@ntu.edu.tw; ckao@gate.sinica.edu.tw	Kao, Cheng-Fu/AAE-8400-2022	Kao, Cheng-Fu/0000-0002-8875-8152	Ministry of Science and Technology, Taiwan [101-2311-B-001-005, 102-2311-B-001-029, 102-2313-B-002-057-MY3, 103-2320-B-001-015, 102-2320-B-001-020]; Thematic Projects (Academia Sinica) [AS-99-TP-B20, AS-103-TP-B12, AS-103-TP-B02]; Academia Sinica; College of Bioresources and Agriculture, National Taiwan University	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Thematic Projects (Academia Sinica); Academia Sinica(Academia Sinica - Taiwan); College of Bioresources and Agriculture, National Taiwan University	Supported by the Ministry of Science and Technology, Taiwan, Grants 101-2311-B-001-005 and 102-2311-B-001-029, Thematic Projects (Academia Sinica) Grants AS-99-TP-B20 and AS-103-TP-B12, and Academia Sinica.; Supported by Ministry of Science and Technology, Taiwan, Grant 102-2313-B-002-057-MY3 and the College of Bioresources and Agriculture, National Taiwan University.; Supported by the Ministry of Science and Technology, Taiwan, Grants 103-2320-B-001-015 and 102-2320-B-001-020, Thematic Projects (Academia Sinica) Grants AS-99-TP-B20 and AS-103-TP-B02, and Academia Sinica.	Ashrafi K, 2000, GENE DEV, V14, P1872; BALZI E, 1994, J BIOL CHEM, V269, P2206; Braun KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005000; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lee WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-440; Madia F, 2008, J CELL BIOL, V180, P67, DOI 10.1083/jcb.200707154; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rhie BH, 2013, BIOCHEM BIOPH RES CO, V439, P570, DOI 10.1016/j.bbrc.2013.09.017; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Ruiz A, 2013, J BIOL CHEM, V288, P31052, DOI 10.1074/jbc.M113.503763; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Simpson-Lavy KJ, 2013, P NATL ACAD SCI USA, V110, P17432, DOI 10.1073/pnas.1304839110; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; TU JL, 1994, MOL CELL BIOL, V14, P6789, DOI 10.1128/MCB.14.10.6789; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Woods R. A., 2001, METH MOL B, V177, P85; Wright DE, 2012, FRONT BIOSCI-LANDMRK, V17, P1051, DOI 10.2741/3973	48	16	16	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16786	16796		10.1074/jbc.M115.639443	http://dx.doi.org/10.1074/jbc.M115.639443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25947383	Green Published, hybrid			2022-12-26	WOS:000357572800025
J	Srivastava, J; Robertson, CL; Gredler, R; Siddiq, A; Rajasekaran, D; Akiel, MA; Emdad, L; Mas, V; Mukhopadhyay, ND; Fisher, PB; Sarkar, D				Srivastava, Jyoti; Robertson, Chadia L.; Gredler, Rachel; Siddiq, Ayesha; Rajasekaran, Devaraja; Akiel, Maaged A.; Emdad, Luni; Mas, Valeria; Mukhopadhyay, Nitai D.; Fisher, Paul B.; Sarkar, Devanand			Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocellular carcinoma; liver; NF-kappa B; thyroid hormone; transcriptional coactivator; AEG-1; non-thyroidal illness syndrome	THYROID-HORMONE ACTIONS; RETINOID-X-RECEPTOR; NF-KAPPA-B; LIVER-CANCER; HEPATOCARCINOGENESIS; INFLAMMATION; PROGRESSION; METASTASIS; ACTIVATION; RESISTANCE	Background: Astrocyte elevated gene-1 (AEG-1) inhibits retinoid X receptor (RXR) function and is overexpressed in human hepatocellular carcinoma (HCC), which is associated with non-thyroidal illness syndrome (NTIS). Results: AEG-1 inhibits thyroid hormone (T-3) function by down-regulating type I 5-deiodinase (DIO1) thus contributing to NTIS. Conclusion: A novel role of AEG-1 is identified regulating cancer-associated NTIS. Significance: AEG-1 inhibition might alleviate cancer-associated debilitating disorders. Non-thyroidal illness syndrome (NTIS), characterized by low serum 3,5,3-triiodothyronine (T-3) with normal l-thyroxine (T-4) levels, is associated with malignancy. Decreased activity of type I 5-deiodinase (DIO1), which converts T-4 to T-3, contributes to NTIS. T-3 binds to thyroid hormone receptor, which heterodimerizes with retinoid X receptor (RXR) and regulates transcription of target genes, such as DIO1. NF-B activation by inflammatory cytokines inhibits DIO1 expression. The oncogene astrocyte elevated gene-1 (AEG-1) inhibits RXR-dependent transcription and activates NF-B. Here, we interrogated the role of AEG-1 in NTIS in the context of hepatocellular carcinoma (HCC). T-3-mediated gene regulation was analyzed in human HCC cells, with overexpression or knockdown of AEG-1, and primary hepatocytes from AEG-1 transgenic (Alb/AEG-1) and AEG-1 knock-out (AEG-1KO) mice. Serum T-3 and T-4 levels were checked in Alb/AEG-1 mice and human HCC patients. AEG-1 and DIO1 levels in human HCC samples were analyzed by immunohistochemistry. AEG-1 inhibited T-3-mediated gene regulation in human HCC cells and mouse hepatocytes. AEG-1 overexpression repressed and AEG-1 knockdown induced DIO1 expression. An inverse correlation was observed between AEG-1 and DIO1 levels in human HCC patients. Low T-3 with normal T-4 was observed in the sera of HCC patients and Alb/AEG-1 mice. Inhibition of co-activator recruitment to RXR and activation of NF-B were identified to play a role in AEG-1-mediated down-regulation of DIO1. AEG-1 thus might play a role in NTIS associated with HCC and other cancers.	[Srivastava, Jyoti; Robertson, Chadia L.; Gredler, Rachel; Siddiq, Ayesha; Rajasekaran, Devaraja; Akiel, Maaged A.; Emdad, Luni; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Mukhopadhyay, Nitai D.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA 23298 USA; [Mas, Valeria] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Srivastava, Jyoti/AAD-7610-2022; Regan, Clinton/E-6250-2012; Akiel, Maaged/B-5109-2014	Akiel, Maaged/0000-0002-0211-2837	National Institutes of Health from NCI [R01 CA138540, R21 CA183954]; National Institutes of Health [R01 CA134721]; James S. McDonnell Foundation; National Institutes of Health from NIDDK [T32DK007150]; NATIONAL CANCER INSTITUTE [R01CA134721, R21CA183954, R01CA138540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Institutes of Health from NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA138540 and R21 CA183954 from NCI (to D. S.) and National Institutes of Health Grant R01 CA134721 (to P. B. F.). This work was also supported by the James S. McDonnell Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant T32DK007150 from NIDDK.	Alexia C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004496; Arnaldi LAT, 2005, THYROID, V15, P210, DOI 10.1089/thy.2005.15.210; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Darras VM, 2012, J ENDOCRINOL, V215, P189, DOI 10.1530/JOE-12-0204; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Frau C, 2015, HEPATOLOGY, V61, P249, DOI 10.1002/hep.27399; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Nagaya T, 2000, J CLIN INVEST, V106, P393, DOI 10.1172/JCI7771; Ortiga-Carvalho TM, 2014, NAT REV ENDOCRINOL, V10, P582, DOI 10.1038/nrendo.2014.143; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Sarkar D, 2004, CANCER RES, V64, P7473, DOI 10.1158/0008-5472.CAN-04-1772; Sarkar D, 2000, ENDOCR J, V47, P63, DOI 10.1507/endocrj.47.63; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2013, ADV CANCER RES, V120, P193, DOI 10.1016/B978-0-12-401676-7.00007-3; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Srivastava J, 2015, HEPATOLOGY, V61, P915, DOI 10.1002/hep.27339; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Wu SM, 2013, CELL MOL LIFE SCI, V70, P1915, DOI 10.1007/s00018-012-1146-7; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Zhu K, 2011, CLIN CANCER RES, V17, P7294, DOI 10.1158/1078-0432.CCR-11-1327	33	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15549	15558		10.1074/jbc.M115.649707	http://dx.doi.org/10.1074/jbc.M115.649707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944909	Green Published, hybrid			2022-12-26	WOS:000356527400020
J	Anguille, S; Van Acker, HH; Van den Bergh, J; Willemen, Y; Goossens, H; Van Tendeloo, VF; Smits, EL; Berneman, ZN; Lion, E				Anguille, Sebastien; Van Acker, Heleen H.; Van den Bergh, Johan; Willemen, Yannick; Goossens, Herman; Van Tendeloo, Viggo F.; Smits, Evelien L.; Berneman, Zwi N.; Lion, Eva			Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; IFN-GAMMA; DISTINCT ROLES; BOUND IL-15; CROSS-TALK; ACTIVATION; DC; INNATE; CANCER	The contribution of natural killer (NK) cells to the treatment efficacy of dendritic cell (DC)based cancer vaccines is being increasingly recognized. Much current efforts to optimize this form of immunotherapy are therefore geared towards harnessing the NK cell-stimulatory ability of DCs. In this study, we investigated whether generation of human monocyte-derived DCs with interleukin (IL)-15 followed by activation with a Toll-like receptor stimulus endows these DCs, commonly referred to as "IL-15 DCs", with the capacity to stimulate NK cells. In a head-to-head comparison with "IL-4 DCs" used routinely for clinical studies, IL-15 DCs were found to induce a more activated, cytotoxic effector phenotype in NK cells, in particular in the CD56bright NK cell subset. With the exception of GM-CSF, no significant enhancement of cytokine/chemokine secretion was observed following co-culture of NK cells with IL-15 DCs. IL-15 DCs, but not IL-4 DCs, promoted NK cell tumoricidal activity towards both NK-sensitive and NK-resistant targets. This effect was found to require cell-to-cell contact and to be mediated by DC surface-bound IL-15. This study shows that DCs can express a membrane-bound form of IL-15 through which they enhance NK cell cytotoxic function. The observed lack of membrane-bound IL-15 on "gold-standard" IL-4 DCs and their consequent inability to effectively promote NK cell cytotoxicity may have important implications for the future design of DC-based cancer vaccine studies.	[Anguille, Sebastien; Van Acker, Heleen H.; Van den Bergh, Johan; Willemen, Yannick; Goossens, Herman; Van Tendeloo, Viggo F.; Berneman, Zwi N.; Lion, Eva] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol Tumor,Immunol Grp TIGR, B-2020 Antwerp, Belgium; [Anguille, Sebastien; Smits, Evelien L.; Berneman, Zwi N.] Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, Edegem, Belgium; [Smits, Evelien L.] Univ Antwerp, Fac Med & Hlth Sci, Oncol Res Ctr, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Anguille, S (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol Tumor,Immunol Grp TIGR, B-2020 Antwerp, Belgium.	sebastien.anguille@uantwerp.be	Van Tendeloo, Viggo FI/A-1233-2010; Smits, Evelien/A-3520-2014	Van Tendeloo, Viggo FI/0000-0003-3217-9917; Smits, Evelien/0000-0001-9255-3435; Lion, Eva/0000-0002-2420-0301; Berneman, Zwi/0000-0002-9133-4588	Research Foundation Flanders (FWO Vlaanderen) [G039914N]; Belgian Foundation against Cancer; Belgian public utility foundation VOCATIO; Belgian Hercules Foundation; Flemish League against Cancer; Institute for the Promotion of Innovation through Science and Technology (IWT)	Research Foundation Flanders (FWO Vlaanderen)(FWO); Belgian Foundation against Cancer; Belgian public utility foundation VOCATIO; Belgian Hercules Foundation; Flemish League against Cancer; Institute for the Promotion of Innovation through Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants of the Research Foundation Flanders (FWO Vlaanderen, www.fwo.be, grant number G039914N), the Belgian Foundation against Cancer (Stichting tegen Kanker, www.kanker.be), the Belgian public utility foundation VOCATIO (www.vocatio.be) and the Belgian Hercules Foundation (www.herculesstichting.be). SA is a former PhD fellow of the Research Foundation Flanders and a former holder of an Emmanuel van der Schueren Fellowship granted by the Flemish League against Cancer (Vlaamse Liga tegen Kanker, www.tegenkanker.be). HHVA and YW are supported by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology (IWT, www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Anguille S, 2014, LANCET ONCOL, V15, pE257, DOI 10.1016/S1470-2045(13)70585-0; Anguille S, 2013, HUM VACC IMMUNOTHER, V9, P1956, DOI 10.4161/hv.25373; Anguille S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051851; Anguille S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-109; Bontkes HJ, 2008, CLIN IMMUNOL, V127, P375, DOI 10.1016/j.clim.2008.02.001; Boudreau JE, 2009, MOL THER, V17, P1465, DOI 10.1038/mt.2009.95; Bouwer AL, 2014, J IMMUNOL, V192, P2514, DOI 10.4049/jimmunol.1202797; Burt BM, 2008, HUM IMMUNOL, V69, P469, DOI 10.1016/j.humimm.2008.06.009; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; Chijioke O, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00365; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; ELLIS TM, 1989, J IMMUNOL, V142, P2949; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Ferlazzo G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00159; Fernandez NC, 2002, EUR CYTOKINE NETW, V13, P17; Guo ZH, 2014, P NATL ACAD SCI USA, V111, P14199, DOI 10.1073/pnas.1414780111; Harris KM, 2011, J LEUKOCYTE BIOL, V90, P727, DOI 10.1189/jlb.0311132; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Homberg N, 2014, INT J CANCER, V135, P2825, DOI 10.1002/ijc.28932; Karimi K, 2008, MOL THER, V16, P411, DOI 10.1038/sj.mt.6300347; Kirkwood JM, 2012, CA-CANCER J CLIN, V62, P309, DOI 10.3322/caac.20132; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Lion E, 2012, LEUKEMIA, V26, P2019, DOI 10.1038/leu.2012.87; Lion E, 2009, J IMMUNOL METHODS, V350, P89, DOI 10.1016/j.jim.2009.08.014; Lion E, 2012, ONCOLOGIST, V17, P1256, DOI 10.1634/theoncologist.2011-0122; Lion E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020952; Lion E, 2009, LEUKEMIA RES, V33, P539, DOI 10.1016/j.leukres.2008.08.020; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Massa C, 2013, J IMMUNOL, V190, P3328, DOI 10.4049/jimmunol.1202024; Messaoudene M, 2014, CANCER RES, V74, P81, DOI 10.1158/0008-5472.CAN-13-1303; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Morandi B, 2009, INT IMMUNOL, V21, P599, DOI 10.1093/intimm/dxp029; Moretta L, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00087; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Munz C, 2005, BLOOD, V105, P266, DOI 10.1182/blood-2004-06-2492; Musso T, 1999, BLOOD, V93, P3531; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Neely GG, 2004, J IMMUNOL, V172, P4225, DOI 10.4049/jimmunol.172.7.4225; Okada S, 2015, IMMUNOL CELL BIOL, V93, P461, DOI 10.1038/icb.2014.103; Osada T, 2006, CANCER IMMUNOL IMMUN, V55, P1122, DOI 10.1007/s00262-005-0089-3; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Pellegatta S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23401; ROBERTSON MJ, 1990, J IMMUNOL, V145, P3194; ROBERTSON MJ, 1992, J EXP MED, V175, P779, DOI 10.1084/jem.175.3.779; Romee R, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2283.2283; Roothans D, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23037; Shimizu K, 2009, EUR J IMMUNOL, V39, P457, DOI 10.1002/eji.200838794; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Tel J, 2014, TRENDS IMMUNOL, V35, P38, DOI 10.1016/j.it.2013.10.007; van Beek JJP, 2014, CRIT REV IMMUNOL, V34, P517, DOI 10.1615/CritRevImmunol.2014012204; Van den Bergh JMJ, 2014, J CELL MOL MED, V18, P1372, DOI 10.1111/jcmm.12284; van den Broeke LT, 2003, J IMMUNOL, V171, P5842, DOI 10.4049/jimmunol.171.11.5842; Van Elssen CHMJ, 2014, CLIN CANCER RES, V20, P1095, DOI 10.1158/1078-0432.CCR-13-2302; Van Elssen CHMJ, 2011, BLOOD, V118, P2473, DOI 10.1182/blood-2010-09-307835; Van Elssen CHMJ, 2010, EUR J IMMUNOL, V40, P3138, DOI 10.1002/eji.201040496; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Zanoni I, 2013, CELL REP, V4, P1235, DOI 10.1016/j.celrep.2013.08.021; Zhang H, 2011, J IMMUNOTHER, V34, P187, DOI 10.1097/CJI.0b013e31820d2a21	68	41	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0123340	10.1371/journal.pone.0123340	http://dx.doi.org/10.1371/journal.pone.0123340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951230	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400006
J	Ferradini, N; Iannacone, R; Capomaccio, S; Metelli, A; Armentano, N; Semeraro, L; Cellini, F; Veronesi, F; Rosellini, D				Ferradini, Nicoletta; Iannacone, Rina; Capomaccio, Stefano; Metelli, Alessandra; Armentano, Nadia; Semeraro, Lucia; Cellini, Francesco; Veronesi, Fabio; Rosellini, Daniele			Assessment of Heat Shock Protein 70 Induction by Heat in Alfalfa Varieties and Constitutive Overexpression in Transgenic Plants	PLOS ONE			English	Article							SHOCK PROTEINS; IMMUNE-RESPONSES; ARABIDOPSIS-THALIANA; ALTERED EXPRESSION; HSP70; TUMOR; TRANSFORMATION; FAMILY; CONSEQUENCES; ANTIBODIES	Heat shock proteins (HSPs) are molecular chaperones involved in many cellular functions. It has been shown that mammalian cytosolic HSP70 binds antigenic peptides mediating the activation of the immune system, and that it plays a determining role in tumour immunogenicity. This suggests that HSP70 may be used for the production of conjugated vaccines. Human and plant HSPs share high sequence similarity and some important biological functions in vitro. In addition, plant HSPs have no endotoxic side effects. Extraction of HSP70 from plants for use as vaccine adjuvant requires enhancing its concentration in plant tissues. In this work, we explored the possibility to produce HSP70 in both transgenic and non-transgenic plants, using alfalfa as a model species. First, a transcriptional analysis of a constitutive and an inducible HSP70 genes was conducted in Arabidopsis thaliana. Then the coding sequence of the inducible form was cloned and introduced into alfalfa by Agro-bacterium- mediated transformation, and the accumulation of the protein in leaf tissue of transgenic plants was demonstrated. We also tested diverse alfalfa varieties for heat-inducible expression of endogenous HSP70, revealing variety-specific responses to heat shock.	[Ferradini, Nicoletta; Capomaccio, Stefano; Metelli, Alessandra; Veronesi, Fabio; Rosellini, Daniele] Univ Perugia, Dept Agr Food & Environm Sci, I-06100 Perugia, Italy; [Iannacone, Rina; Armentano, Nadia; Semeraro, Lucia; Cellini, Francesco] ALSIA Res Ctr Metapontum Agrobios, I-75012 Metaponto, Italy	University of Perugia	Rosellini, D (corresponding author), Univ Perugia, Dept Agr Food & Environm Sci, I-06100 Perugia, Italy.	daniele.rosellini@unipg.it	Rosellini, Daniele/H-8252-2019; Capomaccio, Stefano/K-6042-2015; Iannacone, Rina/AAJ-7709-2021	Rosellini, Daniele/0000-0002-8473-7012; Capomaccio, Stefano/0000-0002-0004-9272; Veronesi, Fabio/0000-0001-7884-6987	Regione Basilicata [L- 598/94]	Regione Basilicata(Regione Basilicata)	Grant No. L- 598/94 Regione Basilicata (http://www.regione.basilicata.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone P, 2008, PLANT CELL REP, V27, P893, DOI 10.1007/s00299-008-0517-x; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BINGHAM ET, 1991, CROP SCI, V31, P1098, DOI 10.2135/cropsci1991.0011183X003100040075x; BLUM P, 1992, J BACTERIOL, V174, P7436, DOI 10.1128/jb.174.22.7436-7444.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buriani G, 2012, PLANT BIOTECHNOL J, V10, P363, DOI 10.1111/j.1467-7652.2011.00673.x; Buriani G, 2011, TRANSGENIC RES, V20, P331, DOI 10.1007/s11248-010-9418-1; Cazale AC, 2009, J EXP BOT, V60, P2653, DOI 10.1093/jxb/erp109; Farzanehpour M, 2013, EUR REV MED PHARMACO, V17, P228; Ferradini N, 2011, PLANT CELL REP, V30, P1991, DOI 10.1007/s00299-011-1107-x; Gehrmann M, 2008, CELL STRESS CHAPERON, V13, P1, DOI 10.1007/s12192-007-0006-0; Gong JL, 2010, J IMMUNOL, V184, P488, DOI 10.4049/jimmunol.0902255; Grabowski GA, 2014, MOL GENET METAB, V112, P1, DOI 10.1016/j.ymgme.2014.02.011; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kiang JG, 2004, CELL RES, V14, P450, DOI 10.1038/sj.cr.7290247; Ko K, 2009, CURR TOP MICROBIOL, V332, P55, DOI 10.1007/978-3-540-70868-1_4; Kumaraguru U, 2003, CELL STRESS CHAPERON, V8, P134, DOI 10.1379/1466-1268(2003)008<0134:APCTPD>2.0.CO;2; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; Menoret A, 2001, IMMUNOL MED, V30, P157; Nimura K, 2001, J BACTERIOL, V183, P1320, DOI 10.1128/JB.183.4.1320-1328.2001; Paul M, 2011, HUM VACCINES, V7, P375, DOI 10.4161/HV.7.3.14456; Poli M, 2007, ERBA MED LISTE VARIE, P80; Ren WH, 2004, CANCER RES, V64, P6645, DOI 10.1158/0008-5472.CAN-04-1084; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rosellini D, 2004, PLANT CELL REP, V22, P774, DOI 10.1007/s00299-004-0757-3; Rosellini D, 2007, PLANT CELL REP, V26, P1035, DOI 10.1007/s00299-007-0321-z; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Srivastava Pramod K, 2005, Curr Oncol Rep, V7, P104, DOI 10.1007/s11912-005-0035-8; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Twyman RM, 2013, CURR PHARM DESIGN, V19, P5486, DOI 10.2174/1381612811319310004; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006	38	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126051	10.1371/journal.pone.0126051	http://dx.doi.org/10.1371/journal.pone.0126051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951604	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400062
J	Galbany, J; Tung, J; Altmann, J; Alberts, SC				Galbany, Jordi; Tung, Jenny; Altmann, Jeanne; Alberts, Susan C.			Canine Length in Wild Male Baboons: Maturation, Aging and Social Dominance Rank	PLOS ONE			English	Article							MALE SAVANNA BABOONS; FREE-RANGING BABOONS; PAPIO-CYNOCEPHALUS; LIFE-HISTORY; HYBRIDIZATION PATTERNS; SEXUAL-DIMORPHISM; AMBOSELI BABOONS; TOOTH BREAKAGE; CHACMA BABOONS; AGE	Canines represent an essential component of the dentition for any heterodont mammal. In primates, like many other mammals, canines are frequently used as weapons. Hence, tooth size and wear may have significant implications for fighting ability, and consequently for social dominance rank, reproductive success, and fitness. We evaluated sources of variance in canine growth and length in a well-studied wild primate population because of the potential importance of canines for male reproductive success in many primates. Specifically, we measured maxillary canine length in 80 wild male baboons (aged 5.04-20.45 years) from the Amboseli ecosystem in southern Kenya, and examined its relationship with maturation, age, and social dominance rank. In our analysis of maturation, we compared food-enhanced baboons (those that fed part time at a refuse pit associated with a tourist lodge) with wild-feeding males, and found that food-enhanced males achieved long canines earlier than wild-feeding males. Among adult males, canine length decreased with age because of tooth wear. We found some evidence that, after controlling for age, longer canines were associated with higher adult dominance rank (accounting for 9% of the variance in rank), but only among relatively high-ranking males. This result supports the idea that social rank, and thus reproductive success and fitness, may depend in part on fighting ability mediated by canine size.	[Galbany, Jordi] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Tung, Jenny] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Tung, Jenny] Duke Univ, Duke Populat Res Inst, Durham, NC USA; [Tung, Jenny; Altmann, Jeanne; Alberts, Susan C.] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Tung, Jenny; Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC USA; [Altmann, Jeanne] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	George Washington University; Duke University; Duke University; Duke University; Princeton University	Galbany, J (corresponding author), George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA.	jgalbany@gwu.edu	Galbany, Jordi/K-8609-2017	Galbany, Jordi/0000-0001-6724-3451	National Science Foundation [IOS 1053461, IBN 9985910, IBN 0322613, IBN 0322781, BCS 0323553, BCS 0323596, DEB 0846286, DEB 0846532, IOS 0919200]; National Institute on Aging [R01AG034513, P01AG031719]; Princeton Center for the Demography of Aging [P30AG024361]; Spanish project [CGL2007-60802]; "Departament d'Educacio i Universitats de la Generalitat de Catalunya - Beatriu de Pinos" [2006BPA10118]; Beca Floquet de Neu, Barcelona de Serveis Municipals S.A. (Divisio Parc Zoologic de Barcelona); Duke University; Princeton University; Max Planck Institute for Demography; NATIONAL INSTITUTE ON AGING [R01AG034513, P30AG024361, P01AG031719] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Princeton Center for the Demography of Aging; Spanish project(Spanish Government); "Departament d'Educacio i Universitats de la Generalitat de Catalunya - Beatriu de Pinos"; Beca Floquet de Neu, Barcelona de Serveis Municipals S.A. (Divisio Parc Zoologic de Barcelona); Duke University; Princeton University(Princeton University); Max Planck Institute for Demography; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Science Foundation IOS 1053461, IBN 9985910, IBN 0322613, IBN 0322781, BCS 0323553, BCS 0323596, DEB 0846286, DEB 0846532, and IOS 0919200. This study was also funded by the National Institute on Aging R01AG034513 and P01AG031719, and the Princeton Center for the Demography of Aging P30AG024361. The authors also acknowledge support of the Spanish CGL2007-60802 project, the "Departament d'Educacio i Universitats de la Generalitat de Catalunya - Beatriu de Pinos 2006BPA10118" and Beca Floquet de Neu 2007-2008, Barcelona de Serveis Municipals S.A. (Divisio Parc Zoologic de Barcelona). We also thank Duke University, Princeton University, and the Max Planck Institute for Demography for support at various times over the years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2003, ANIM BEHAV, V65, P821, DOI 10.1006/anbe.2003.2106; Alberts SC, 2001, AM J PRIMATOL, V53, P139, DOI 10.1002/ajp.1; ALBERTS SC, 1995, BEHAV ECOL SOCIOBIOL, V36, P397, DOI 10.1007/BF00177335; Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Alberts SC, 2005, CAM S BIO EVOL ANTHR, V44, P157, DOI 10.1017/CBO9780511542343.007; Alberts Susan C., 2012, P412; Alberts Susan C., 2012, P261; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Altmann J, 2002, AFR J ECOL, V40, P248, DOI 10.1046/j.1365-2028.2002.00366.x; Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; Altmann J, 2010, ANN NY ACAD SCI, V1204, P127, DOI 10.1111/j.1749-6632.2010.05531.x; Archie EA, 2012, P NATL ACAD SCI USA, V109, P9017, DOI 10.1073/pnas.1206391109; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; BERCOVITCH FB, 1993, BEHAV ECOL SOCIOBIOL, V33, P313; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; BULGER JB, 1993, BEHAVIOUR, V127, P67, DOI 10.1163/156853993X00434; Charpentier MJE, 2008, MOL ECOL, V17, P2026, DOI 10.1111/j.1365-294X.2008.03724.x; Cuozzo FP, 2006, J HUM EVOL, V51, P490, DOI 10.1016/j.jhevol.2006.07.001; Darlington RB, 2001, ANIM BEHAV, V62, P599, DOI 10.1006/anbe.2001.1806; Deane AS, 2012, J HUM EVOL, V62, P707, DOI 10.1016/j.jhevol.2012.03.004; Derocher AE, 2010, BEHAV ECOL SOCIOBIOL, V64, P939, DOI 10.1007/s00265-010-0909-0; Fa JE, 1988, ECOLOGY BEHAV FOOD E; Fairbanks B, 2012, INTERACTIONS HOST SO, P440; Fenton MB, 1998, J ZOOL, V246, P83, DOI 10.1017/S0952836998009108; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Galbany J, 2006, MICROSC RES TECHNIQ, V69, P246, DOI 10.1002/jemt.20296; Galbany J., 2004, ANTHROPOLOGIE, V42, P5; Galbany J, 2008, AM J PHYS ANTHROPOL, V135, P100; Galbany J, 2011, FOLIA PRIMATOL, V81, P348, DOI 10.1159/000323588; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; GREENFIELD LO, 1991, AM J PHYS ANTHROPOL, V84, P17, DOI 10.1002/ajpa.1330840103; Hausfater G., 1975, CONTRIBUTIONS PRIMAT, V7; Johnson SE, 2003, AM J PHYS ANTHROPOL, V120, P83, DOI 10.1002/ajpa.10139; KAY RF, 1988, AM J PHYS ANTHROPOL, V77, P385, DOI 10.1002/ajpa.1330770311; Kemnitz JW, 2002, AM J PRIMATOL, V57, P13, DOI 10.1002/ajp.1083; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; Lee Phyllis C., 1999, P111, DOI 10.1017/CBO9780511542466.008; Leigh SR, 2008, J HUM EVOL, V55, P75, DOI 10.1016/j.jhevol.2008.01.001; McGraw WS, 2011, AM J PHYS ANTHROPOL, V144, P140, DOI 10.1002/ajpa.21402; MORI A, 1979, Primates, V20, P371, DOI 10.1007/BF02373390; PACKER C, 1979, ANIM BEHAV, V27, P1, DOI 10.1016/0003-3472(79)90126-X; Packer C, 2000, PHILOS T ROY SOC B, V355, P1627, DOI 10.1098/rstb.2000.0725; PALOMBIT RA, 1993, AM J PRIMATOL, V31, P311, DOI 10.1002/ajp.1350310407; PHILLIPSCONROY JE, 1993, AM J PHYS ANTHROPOL, V90, P359, DOI 10.1002/ajpa.1330900310; PHILLIPSCONROY JE, 1988, AM J PRIMATOL, V15, P17, DOI 10.1002/ajp.1350150104; Plavcan JM, 2008, AM J PHYS ANTHROPOL, V136, P65, DOI 10.1002/ajpa.20779; Plavcan J. Michael, 1994, Evolutionary Anthropology, V2, P208, DOI 10.1002/evan.1360020606; PLAVCAN JM, 1992, AM J PHYS ANTHROPOL, V87, P461, DOI 10.1002/ajpa.1330870407; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; REED OM, 1973, AM J PHYS ANTHROPOL, V38, P309, DOI 10.1002/ajpa.1330380226; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; STRUM SC, 1991, AM J PRIMATOL, V25, P219, DOI 10.1002/ajp.1350250403; SUGIYAMA Y, 1982, FOLIA PRIMATOL, V39, P238, DOI 10.1159/000156080; Sussman Robert W., 2012, P45; Tung J, 2008, MOL ECOL, V17, P1998, DOI 10.1111/j.1365-294X.2008.03723.x; Tung J, 2009, NATURE, V460, P388, DOI 10.1038/nature08149; VANVALKENBURGH B, 1988, AM NAT, V131, P291, DOI 10.1086/284790; WALKER A, 1984, AM J PHYS ANTHROPOL, V65, P47, DOI 10.1002/ajpa.1330650108; Weingrill T, 2000, ETHOLOGY, V106, P1033, DOI 10.1046/j.1439-0310.2000.00616.x; ZINGESER MR, 1969, AM J PHYS ANTHROPOL, V31, P205, DOI 10.1002/ajpa.1330310210	62	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126415	10.1371/journal.pone.0126415	http://dx.doi.org/10.1371/journal.pone.0126415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950700	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400089
J	Keniya, MV; Fleischer, E; Klinger, A; Cannon, RD; Monk, BC				Keniya, Mikhail V.; Fleischer, Edmond; Klinger, Anette; Cannon, Richard D.; Monk, Brian C.			Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance	PLOS ONE			English	Article							AZOLE RESISTANCE; ANTIFUNGAL RESISTANCE; MOLECULAR-MECHANISMS; EFFLUX PUMPS; DRUG EFFLUX; OVEREXPRESSION; GENE; ABC; SUSCEPTIBILITY; MUTATIONS	Objective To identify a novel class of inhibitors of fungal transporters involved in drug resistance. Methods A series of structurally-related low molecular mass compounds was synthesized using combinatorial chemistry of a cyclobutene-dione (squarile) core. These compounds were screened for their inhibition of plasma membrane Major Facilitator Superfamily (MFS) and ATP-binding cassette (ABC) transporters responsible for efflux pump-mediated drug resistance in the fungal pathogen Candida albicans. Strains of Saccharomyces cerevisiae that specifically overexpress the MFS pump CaMdr1p or the ABC transporter CaCdr1p were used in primary screens and counterscreens, respectively, and to detect inhibition of glucose-dependent Nile Red efflux. Efflux pump inhibition, activity as pump substrates and antifungal activity against yeast and clinical isolates expressing efflux pumps were determined using agarose diffusion susceptibility assays and checkerboard liquid chemosensitization assays with fluconazole. Results The screen identified five structurally-related compounds which inhibited CaMdr1p. Two compounds, A and B, specifically chemosensitized AD/CaMDR1 to FLC in a pH-dependent fashion and acted synergistically with FLC in checkerboard liquid MIC assays but compound B had limited solubility. Compound A chemosensitized to FLC the azole-resistant C. albicans strain FR2, which over-expresses CaMdr1p, inhibited Nile Red efflux mediated by CaMdr1p but not CaCdr1p and was not toxic to cultured human cells. A minor growth-inhibitory effect of B on AD/CaMDR1, but not on AD/CaCDR1 and AD/CaCDR2, indicated that compound B may be a substrate of these transporters. The related compound F was found to have antifungal activity against the three pump over-expressing strains used in the study. Conclusions Compound A is a 'first in class' small molecule inhibitor of MFS efflux pump CaMdr1p.	[Keniya, Mikhail V.; Cannon, Richard D.; Monk, Brian C.] Univ Otago, Sch Dent, Sir John Walsh Res Inst, Dunedin, New Zealand; [Fleischer, Edmond; Klinger, Anette] MicroCombiChem eK, Wiesbaden, Germany	University of Otago	Keniya, MV (corresponding author), Univ Otago, Sch Dent, Sir John Walsh Res Inst, Dunedin, New Zealand.	mikhail.keniya@otago.ac.nz		Keniya, Mikhail/0000-0001-5193-6982; Cannon, Richard/0000-0002-5398-2066; Monk, Brian/0000-0003-2264-3480	National Institutes of Health [R01DE016885]; New Zealand Marsden Fund [UOO1004]; Health Research Council of New Zealand [13/263]; MicroCombiChem e.K.; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); MicroCombiChem e.K.; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this work came from National Institutes of Health grant R01DE016885 to RDC, New Zealand Marsden Fund grant UOO1004 to BCM and MVK, and Health Research Council of New Zealand grant 13/263 to BCM. MicroCombiChem e.K. provided support in the form of salaries for authors AK and EF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835; BECKER JM, 1995, INFECT IMMUN, V63, P4515, DOI 10.1128/IAI.63.11.4515-4518.1995; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chamilos G, 2007, ANTIMICROB AGENTS CH, V51, P2257, DOI 10.1128/AAC.00095-07; Cheng SJ, 2007, ANTIMICROB AGENTS CH, V51, P1855, DOI 10.1128/AAC.00182-07; Diwischek F, 2009, ARCH PHARM, V342, P150, DOI 10.1002/ardp.200800160; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; FLING ME, 1991, MOL GEN GENET, V227, P318, DOI 10.1007/BF00259685; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Hayama K, 2012, FEMS MICROBIOL LETT, V328, P130, DOI 10.1111/j.1574-6968.2011.02490.x; Hiller D, 2006, ANTIMICROB AGENTS CH, V50, P1365, DOI 10.1128/AAC.50.4.1365-1371.2006; Holmes AR, 2012, ANTIMICROB AGENTS CH, V56, P1508, DOI 10.1128/AAC.05706-11; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; KELLY R, 1987, MOL CELL BIOL, V7, P199, DOI 10.1128/MCB.7.1.199; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Lohberger A, 2014, EUKARYOT CELL, V13, P127, DOI 10.1128/EC.00245-13; Lopez-Ribot JL, 1998, ANTIMICROB AGENTS CH, V42, P2932, DOI 10.1128/AAC.42.11.2932; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Marr KA, 2001, ANTIMICROB AGENTS CH, V45, P52, DOI 10.1128/AAC.45.1.52-59.2001; Maurya IK, 2013, J BIOL CHEM, V288, P16775, DOI 10.1074/jbc.M113.467159; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Milewski S, 2001, ANTIMICROB AGENTS CH, V45, P223, DOI 10.1128/AAC.45.1.223-228.2001; Monk BC, 2005, ANTIMICROB AGENTS CH, V49, P57, DOI 10.1128/AAC.49.1.57-70.2005; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Niimi K, 2004, ANTIMICROB AGENTS CH, V48, P1256, DOI 10.1128/AAC.48.4.1256-1271.2004; Niimi K, 2012, MOL MICROBIOL, V85, P747, DOI 10.1111/j.1365-2958.2012.08140.x; Niimi M, 2004, J ANTIMICROB CHEMOTH, V54, P999, DOI 10.1093/jac/dkh456; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Perea S, 2001, ANTIMICROB AGENTS CH, V45, P2676, DOI 10.1128/AAC.45.10.2676-2684.2001; Ricardo E, 2009, FEMS YEAST RES, V9, P618, DOI 10.1111/j.1567-1364.2009.00504.x; Richards TS, 2008, J ANTIMICROB CHEMOTH, V62, P349, DOI 10.1093/jac/dkn156; Schuetzer-Muehlbauer M, 2003, INT J ANTIMICROB AG, V22, P291, DOI 10.1016/S0924-8579(03)00213-9; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482	37	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126350	10.1371/journal.pone.0126350	http://dx.doi.org/10.1371/journal.pone.0126350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951180	gold, Green Submitted, Green Published			2022-12-26	WOS:000354214400082
J	Bellini, GP; Giraudo, AR; Arzamendia, V; Etchepare, EG				Bellini, Gisela P.; Giraudo, Alejandro R.; Arzamendia, Vanesa; Etchepare, Eduardo G.			Temperate Snake Community in South America: Is Diet Determined by Phylogeny or Ecology?	PLOS ONE			English	Article							NICHE CONSERVATISM; SERPENTES; COLUBRIDAE; HISTORY; LIZARDS; CLASSIFICATION; PITVIPERS; PREY	Communities are complex and dynamic systems that change with time. The first attempts to explain how they were structured involve contemporary phenomena like ecological interactions between species (e.g., competition and predation) and led to the competition-predation hypothesis. Recently, the deep history hypothesis has emerged, which suggests that profound differences in the evolutionary history of organisms resulted in a number of ecological features that remain largely on species that are part of existing communities. Nevertheless, both phylogenetic structure and ecological interactions can act together to determine the structure of a community. Because diet is one of the main niche axes, in this study we evaluated, for the first time, the impact of ecological and phylogenetic factors on the diet of Neotropical snakes from the subtropical-temperate region of South America. Additionally, we studied their relationship with morphological and environmental aspects to understand the natural history and ecology of this community. A canonical phylogenetical ordination analysis showed that phylogeny explained most of the variation in diet, whereas ecological characters explained very little of this variation. Furthermore, some snakes that shared the habitat showed some degree of diet convergence, in accordance with the competition-predation hypothesis, although phylogeny remained the major determinant in structuring this community. The clade with the greatest variability was the subfamily Dipsadinae, whose members had a very different type of diet, based on soft-bodied invertebrates. Our results are consistent with the deep history hypothesis, and we suggest that the community under study has a deep phylogenetic effect that explains most of the variation in the diet.	[Bellini, Gisela P.; Giraudo, Alejandro R.; Arzamendia, Vanesa] Inst Nacl Limnol CONICET UNL, Santa Fe, Argentina; [Giraudo, Alejandro R.; Arzamendia, Vanesa] Univ Nacl Litoral, Fac Humanidades & Ciencias, Santa Fe, Argentina; [Etchepare, Eduardo G.] Univ Nacl Nordeste, Fac Ciencias Exactas & Nat Agrimensura, Corrientes, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; National University of the Littoral	Bellini, GP (corresponding author), Inst Nacl Limnol CONICET UNL, Santa Fe, Argentina.	giselabellini@yahoo.com.ar			Fondo para la Investigacion Cientifica y Tecnologica, Biogeografia y conservacion de las serpientes de la Cuenca del Plata [PICT-2011-1526]; PIP-Consejo Nacional de Investigaciones Cientificas y Tecnicas Biogeografia y conservacion de la cuenca del Plata usando grupos indicadores (serpientes y aves): aplicando enfoques historicos y ecologicos [0355]; Universidad Nacional del Litoral, Biogeografia de la conservacion en humedales de la cuenca del Plata usando reptiles y aves como indicadores [CAID-2011-524]; Fondo para la Investigacion Cientifica y Tecnologica, Biogeografia de la conservacion y modelos de optimizacion para detectar areas prioritarias para su proteccion en la Cuenca del Plata [PICT-2013-2203]	Fondo para la Investigacion Cientifica y Tecnologica, Biogeografia y conservacion de las serpientes de la Cuenca del Plata; PIP-Consejo Nacional de Investigaciones Cientificas y Tecnicas Biogeografia y conservacion de la cuenca del Plata usando grupos indicadores (serpientes y aves): aplicando enfoques historicos y ecologicos; Universidad Nacional del Litoral, Biogeografia de la conservacion en humedales de la cuenca del Plata usando reptiles y aves como indicadores; Fondo para la Investigacion Cientifica y Tecnologica, Biogeografia de la conservacion y modelos de optimizacion para detectar areas prioritarias para su proteccion en la Cuenca del Plata	The work was supported by the following: PICT-2011-1526, Fondo para la Investigacion Cientifica y Tecnologica, Biogeografia y conservacion de las serpientes de la Cuenca del Plata, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt; PIP-Consejo Nacional de Investigaciones Cientificas y Tecnicas-0355 (2011-2013) Biogeografia y conservacion de la cuenca del Plata usando grupos indicadores (serpientes y aves): aplicando enfoques historicos y ecologicos, http://web.conicet.gov.ar/web/conicet.trabajar.investigacion/proyectos-ejecuccion; CAID-2011-524-Universidad Nacional del Litoral, Biogeografia de la conservacion en humedales de la cuenca del Plata usando reptiles y aves como indicadores, http://www.unl.edu.ar/categories/view/proyectos_de_investigacion#.VAcwhMV5NIE; and PICT-2013-2203, Fondo para la Investigacion Cientifica y Tecnologica, Biogeografia de la conservacion y modelos de optimizacion para detectar areas prioritarias para su proteccion en la Cuenca del Plata, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzamendia V, 2009, J BIOGEOGR, V36, P1739, DOI 10.1111/j.1365-2699.2009.02116.x; Balestrin RL, 2007, HERPETOL J, V17, P62; Bellini GP, 2014, HERPETOL J, V24, P87; Bellini GP, 2013, HERPETOLOGICA, V69, P67, DOI 10.1655/HERPETOLOGICA-D-12-00027; BURGHARD.GM, 1969, BEHAVIOUR, V33, P77, DOI 10.1163/156853969X00332; Burghardt GM, 2000, PSYCHOL SCI, V11, P69, DOI 10.1111/1467-9280.00217; Cabrera A, 1994, ENCICLOPEDIA ARGENTI, VII; CADLE JE, 1985, SYST ZOOL, V34, P1, DOI 10.2307/2413341; Cadle John E., 1993, P281; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Carreira-Vidal S, 2002, ASOCIACION HERPETOLO, V6, P1; Castoe TA, 2007, ZOOL J LINN SOC-LOND, V151, P809, DOI 10.1111/j.1096-3642.2007.00350.x; Colston TJ, 2010, BIOL J LINN SOC, V101, P476, DOI 10.1111/j.1095-8312.2010.01502.x; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; de Queiroz A, 2006, AM NAT, V167, P684, DOI 10.1086/503118; Di Rienzo J. A., 2005, INFOSTAT SOFTWARE ES; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Ford Neil B., 1993, P117; Franca FGR, 2008, COPEIA, P23, DOI 10.1643/CH-05-034; Giannini NP, 2003, SYST BIOL, V52, P684, DOI 10.1080/10635150390238888; Giraudo A.R., 2001, DIVERSIDAD SERPIENTE; Giraudo AR, 2014, REV MEX BIODIVERS, V85, P1206, DOI 10.7550/rmb.43765; Giraudo Alejandro R., 2012, Cuad. herpetol., V26, P303; Giraudo Alejandro R., 2007, P341, DOI 10.1007/978-3-540-70624-3_14; Grazziotin FG, 2012, CLADISTICS, V28, P437, DOI 10.1111/j.1096-0031.2012.00393.x; GREENE HW, 2001, SNAKES EVOLUTION MYS; HENDERSON R W, 1979, Milwaukee Public Museum Contributions in Biology and Geology, P1; Iglesias de Cuello A, 1982, ATLAS FISICO REPUBLI; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Leps J, 1999, MULTIVARIATE ANAL EC; Lopez M. S., 2003, HERPETOLOGICAL REV, V34, P68; Lopez MS, 2008, J HERPETOL, V42, P474, DOI 10.1670/07-087.1; Lopez MS, 2004, AMPHIBIA-REPTILIA, V25, P178, DOI 10.1163/1568538041231148; Lopez SM, 2009, REV CHIL HIST NAT, V82, P233; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Luiselli L, 2006, OIKOS, V114, P193, DOI 10.1111/j.2006.0030-1299.14064.x; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; Paoli C., 2000, RIO PARANA TRAMO MED, P27; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Saviola AJ, 2012, ACTA HERPETOL, V7, P91; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shine R, 2005, OECOLOGIA, V144, P492, DOI 10.1007/s00442-005-0074-8; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Vitt L.J., 1984, Amphibia-Reptilia, V4, P273; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Vitt LJ, 2005, P NATL ACAD SCI USA, V102, P7877, DOI 10.1073/pnas.0501104102; Vitt LJ, 1999, OIKOS, V87, P286, DOI 10.2307/3546743; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; WINEMILLER KO, 1990, ECOL MONOGR, V60, P27, DOI 10.2307/1943025; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115	54	17	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123237	10.1371/journal.pone.0123237	http://dx.doi.org/10.1371/journal.pone.0123237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945501	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700011
J	Brown, M; Moore, L; McMahon, B; Powell, D; LaBute, M; Hyman, JM; Rivas, A; Jankowski, M; Berendzen, J; Loeppky, J; Manore, C; Fair, J				Brown, Mac; Moore, Leslie; McMahon, Benjamin; Powell, Dennis; LaBute, Montiago; Hyman, James M.; Rivas, Ariel; Jankowski, Mark; Berendzen, Joel; Loeppky, Jason; Manore, Carrie; Fair, Jeanne			Constructing Rigorous and Broad Biosurveillance Networks for Detecting Emerging Zoonotic Outbreaks	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; A H5N1 VIRUS; RISK-FACTORS; POULTRY FLOCKS; NIGERIA; EPIDEMIC; SPREAD; FARMS; IDENTIFICATION; SURVEILLANCE	Determining optimal surveillance networks for an emerging pathogen is difficult since it is not known beforehand what the characteristics of a pathogen will be or where it will emerge. The resources for surveillance of infectious diseases in animals and wildlife are often limited and mathematical modeling can play a supporting role in examining a wide range of scenarios of pathogen spread. We demonstrate how a hierarchy of mathematical and statistical tools can be used in surveillance planning help guide successful surveillance and mitigation policies for a wide range of zoonotic pathogens. The model forecasts can help clarify the complexities of potential scenarios, and optimize biosurveillance programs for rapidly detecting infectious diseases. Using the highly pathogenic zoonotic H5N1 avian influenza 2006-2007 epidemic in Nigeria as an example, we determined the risk for infection for localized areas in an outbreak and designed biosurveillance stations that are effective for different pathogen strains and a range of possible outbreak locations. We created a general multi-scale, multi-host stochastic SEIR epidemiological network model, with both short and long-range movement, to simulate the spread of an infectious disease through Nigerian human, poultry, backyard duck, and wild bird populations. We chose parameter ranges specific to avian influenza (but not to a particular strain) and used a Latin hypercube sample experimental design to investigate epidemic predictions in a thousand simulations. We ranked the risk of local regions by the number of times they became infected in the ensemble of simulations. These spatial statistics were then complied into a potential risk map of infection. Finally, we validated the results with a known outbreak, using spatial analysis of all the simulation runs to show the progression matched closely with the observed location of the farms infected in the 2006-2007 epidemic.	[Brown, Mac] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93111 USA; [Moore, Leslie] Los Alamos Natl Lab, Stat Sci, Los Alamos, NM 87545 USA; [McMahon, Benjamin] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA; [Powell, Dennis] Los Alamos Natl Lab, Energy & Infrastruct Anal, Los Alamos, NM 87545 USA; [LaBute, Montiago] Lawrence Livermore Natl Lab, Computat Engn Div, Appl Stat Group, Livermore, CA 94550 USA; [Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Rivas, Ariel] Univ New Mexico, Hlth Sci Ctr, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Jankowski, Mark] Minnesota Pollut Control Agcy, Environm Anal & Outcomes Div, St Paul, MN 55155 USA; [Berendzen, Joel] Los Alamos Natl Lab, Appl Modern Phys, Los Alamos, NM 87545 USA; [Loeppky, Jason] Univ British Columbia, Kelowna, BC V1V 1V7, Canada; [Manore, Carrie] Tulane Univ, Ctr Computat Sci, New Orleans, LA 70118 USA; [Fair, Jeanne] Los Alamos Natl Lab, Environm Stewardship, Los Alamos, NM 87545 USA	University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Tulane University; University of New Mexico; University of New Mexico's Health Sciences Center; United States Department of Energy (DOE); Los Alamos National Laboratory; University of British Columbia; Tulane University; United States Department of Energy (DOE); Los Alamos National Laboratory	Fair, J (corresponding author), Los Alamos Natl Lab, Environm Stewardship, K404, Los Alamos, NM 87545 USA.	jmfair@lanl.gov	Hyman, James M/AAF-7389-2020	Hyman, James M/0000-0001-5247-5794; Fair, Jeanne/0000-0002-3377-6134; Mcmahon, Benjamin/0000-0002-8226-1276; Berendzen, Joel/0000-0002-9454-9074	US Department of Energy [DE-AC52-06NA25396]; Los Alamos National Security, LLC	US Department of Energy(United States Department of Energy (DOE)); Los Alamos National Security, LLC(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was performed in part by Defense Threat Reduction Agency (DTRA) CBT-09-IST- 05-1-0092. All other funding was through Los Alamos National Security, LLC, operator of the Los Alamos National Laboratory (LANL) under Contract No. DE-AC52-06NA25396 with the US Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adene DF, 2008, STRUCTURE IMPORTANCE; Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bavinck V, 2009, PREV VET MED, V88, P247, DOI 10.1016/j.prevetmed.2008.10.007; Bian L, 2013, T GIS, V17, P1, DOI 10.1111/j.1467-9671.2012.01329.x; Briand S, 2010, INFLUENZA OTHER RESP, V4, P31; Cannon RM, 2005, PREV VET MED, V92, P163; Cecchi G, 2008, GEOSPATIAL HEALTH, V3, P7, DOI 10.4081/gh.2008.227; Childs JE, 2009, MT SINAI J MED, V76, P421, DOI 10.1002/msj.20133; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ekong PS, 2012, PREV VET MED, V103, P170, DOI 10.1016/j.prevetmed.2011.10.001; Fair JM, 2012, INT J RISK ASSESSMEN; Fasina FO, 2008, ONDERSTEPOORT J VET, V75, P39; Fasina FO, 2011, PREV VET MED, V98, P204, DOI 10.1016/j.prevetmed.2010.11.007; GAO, 2011, NONF CAP SHOULD BE C; Henning J, 2012, INCIDENCE HIGHLY PAT; Joannis T, 2006, VET REC, V158, P309, DOI 10.1136/vr.158.9.309-b; JOHNSON ME, 1990, J STAT PLAN INFER, V26, P131, DOI 10.1016/0378-3758(90)90122-B; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; Manore C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-55; Martin V, 2008, REV SCI TECH OIE, V27, P413, DOI 10.20506/rst.27.2.1802; McKay M.D, 1995, EVALUATING PREDICTIO; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; McKay MD, 1996, VARIANCE BASED METHO; McNabb SJN, 2010, BMC PUBLIC HEALTH, P10; Metras R, 2013, TRANSBOUND EMERG DIS, V60, P87, DOI 10.1111/j.1865-1682.2012.01322.x; Minh PQ, 2011, SPAT SPATIO-TEMPORAL, V2, P49, DOI 10.1016/j.sste.2010.11.001; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Morris MD, 2008, TECHNOMETRICS, V50, P205, DOI 10.1198/004017008000000208; Nguyen AM, 2013, PLOS ONE, V8; Nishiguchi A, 2007, ZOONOSES PUBLIC HLTH, V54, P337, DOI 10.1111/j.1863-2378.2007.01074.x; OIE, 2009, LAUNCH GLOB EARL WAR; Okoye J, 2013, J MED VIROL, V85, P670, DOI 10.1002/jmv.23520; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Paul M, 2013, ACTA TROP, V126, P43, DOI 10.1016/j.actatropica.2013.01.008; Pelletier STK, 2012, TROP ANIM HEALTH PRO, V44, P1681, DOI 10.1007/s11250-012-0124-2; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Pritchett J.G., 2005, INT FOOD AGRIBUS MAN, V8, P23, DOI [10.22004/ag.econ.8177, DOI 10.22004/AG.ECON.8177]; Rich KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082019; Rivas AL, 2010, EPIDEMIOL INFECT, V138, P192, DOI 10.1017/S0950268809990495; Rivas AL, 2012, PLOS ONE IN PRESS; Santner T. J, 2003, DESIGN ANAL COMPUTER; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; TANG B, 1993, J AM STAT ASSOC, V88, P1392, DOI 10.2307/2291282; Thompson PN, 2008, PREV VET MED, V86, P139, DOI 10.1016/j.prevetmed.2008.03.011; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Van Kerkhove MD, 2013, VIRUSES, V7, P872, DOI DOI 10.1111/IRV.12074; Warns-Petit E, 2009, B ACAD VET FRANCE, V162, P205; Wint W., 2007, GRIDDED LIVESTOCK WO; Wu C.J., 2011, EXPT PLANNING ANAL O; Zhong L, 2014, VET MICROBIOL, V171, P23, DOI 10.1016/j.vetmic.2014.02.033	53	6	7	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124037	10.1371/journal.pone.0124037	http://dx.doi.org/10.1371/journal.pone.0124037			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946164	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700031
J	Danese, E; Minicozzi, AM; Benati, M; Montagnana, M; Paviati, E; Salvagno, GL; Lima-Oliveira, G; Gusella, M; Pasini, F; Lippi, G; Guidi, GC				Danese, Elisa; Minicozzi, Anna Maria; Benati, Marco; Montagnana, Martina; Paviati, Elisa; Salvagno, Gian Luca; Lima-Oliveira, Gabriel; Gusella, Milena; Pasini, Felice; Lippi, Giuseppe; Guidi, Gian Cesare			Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal Cancer	PLOS ONE			English	Article							CELL-FREE DNA; KRAS MUTATIONS; PERIPHERAL-BLOOD; BRAF MUTATIONS; METHYLATION; CETUXIMAB; EVOLUTION; THERAPY; BIOPSY; SERUM	Background Although recent advances in circulating DNA analysis allow the prediction of tumor genomes by noninvasive means, some challenges remain, which limit the widespread introduction of cfDNA in cancer diagnostics. We analyzed the status of the two best characterized colorectal cancer (CRC) genetic and epigenetic alterations in a cohort of CRC patients, and then compared the degree to which the two patterns move from tissue to plasma in order to improve our understanding of biology modulating the concordance between tissues and plasma methylation and mutation profiles. Methods Plasma and tumor tissues were collected from 85 patients (69 +/- 14 years, 56 males). KRAS and SEPT9 status was assessed by allele refractory mutation system quantitative PCR and quantitative methylation-specific PCR, respectively. Six of the most common point mutations at codon 12 and 13 were investigated for KRAS analysis. Results KRAS mutations and SEPT9 promoter methylation were present in 34% (29/85) and in 82% (70/85) of primary tumor tissue samples. Both genetic and epigenetic analyses of cfDNA revealed a high overall concordance and specificity compared with tumor-tissue analyses. Patients presenting with both genetic and epigenetic alterations in tissue specimens (31.8%, 27/85) were considered for further analyses. The median methylation rates in tumour tissues and plasma samples were 64.5%(12.2-99.8%) and 14.5%(0-45.5%), respectively. The median KRAS mutation load (for matched mutations) was 33.6% (1.886.3%) in tissues and 2.9% (0-17.3) in plasma samples. The plasma/tissue (p/t) ratio of SEPT9 methylation rate was significantly higher than the p/t ratio of KRAS mutation load, especially in early stage cancers (p=0.0108). Conclusion The results of this study show a discrepant rate of epigenetic vs. genetic alterations moving from tissue to plasma. Many factors could affect mutation cfDNA analysis, including both presence of tumor clonal heterogeneity and strict compartmentalization of KRAS mutation profile. The present study highlights the importance of considering the nature of the alteration when analyzing tumor-derived cfDNA.	[Danese, Elisa; Benati, Marco; Montagnana, Martina; Paviati, Elisa; Salvagno, Gian Luca; Lima-Oliveira, Gabriel; Guidi, Gian Cesare] Univ Hosp Verona, Dept Life & Reprod Sci, Lab Clin Biochem, Verona, Italy; [Minicozzi, Anna Maria] Queen Mary Univ London, Barts & London NHS Trust, Acad Surg Unit, NCBRSI, London, England; [Gusella, Milena] Rovigo Gen Hosp, Lab Pharmacol & Mol Biol, Dept Oncol, Rovigo, Italy; [Pasini, Felice] Rovigo Hosp, Dept Med Oncol, Rovigo, Italy; [Lippi, Giuseppe] Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Barts Health NHS Trust; University of London; Queen Mary University London; ULSS 5 Polesana; Ospedale di Rovigo; ULSS 5 Polesana; Ospedale di Rovigo; University of Parma; University Hospital of Parma	Danese, E (corresponding author), Univ Hosp Verona, Dept Life & Reprod Sci, Lab Clin Biochem, Verona, Italy.	elisa.danese@univr.it	Lippi, Giuseppe/X-7198-2018; Guidi, Gian Cesare/AAG-8463-2019; Danese, Elisa/N-2848-2016; Salvagno, Gian Luca/R-3857-2016; Benati, Marco/F-1406-2019	Lippi, Giuseppe/0000-0001-9523-9054; Guidi, Gian Cesare/0000-0002-4682-7834; Danese, Elisa/0000-0002-2454-0410; Benati, Marco/0000-0002-0140-3640; Lima-Oliveira, Gabriel/0000-0002-5937-9137; gusella, milena/0000-0002-6257-0282; SALVAGNO, GIAN LUCA/0000-0003-0487-9051				Abba M, 2012, CANCER GENOM PROTEOM, V9, P15; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andersen RF, 2015, CLIN CHIM ACTA, V439, P97, DOI 10.1016/j.cca.2014.10.011; Baloglu H, 2011, CANCER LETT, V308, P118, DOI 10.1016/j.canlet.2011.04.021; Danese E, 2013, BRIT J CANCER, V109, P807, DOI 10.1038/bjc.2013.351; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Deschoolmeester V, 2010, BRIT J CANCER, V103, P1627, DOI 10.1038/sj.bjc.6605959; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ellison G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-132; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; He QO, 2010, CANCER GENET CYTOGEN, V202, P1, DOI 10.1016/j.cancergencyto.2010.05.018; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Ignatiadis M, 2014, ANN ONCOL, V25, P2304, DOI 10.1093/annonc/mdu480; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; LEON SA, 1977, CANCER RES, V37, P646; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Mouliere F, 2014, MOL ONCOLOG IN PRESS; Mouliere F, 2013, TRANSL ONCOL, V6, P319, DOI 10.1593/tlo.12445; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Redshaw N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1174; Ryan BM, 2003, GUT, V52, P101, DOI 10.1136/gut.52.1.101; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Trevisiol C, 2006, INT J BIOL MARKER, V21, P223, DOI 10.1177/172460080602100405; Visani M, 2013, INT J SURG PATHOL, V21, P546, DOI 10.1177/1066896912475073; Wasserkort R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-398; Yanus GA, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0686-5; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yen LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179	33	36	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126417	10.1371/journal.pone.0126417	http://dx.doi.org/10.1371/journal.pone.0126417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946211	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700129
J	Fung, ICH; Hao, Y; Cai, JX; Ying, YC; Schaible, BJ; Yu, CM; Tse, ZTH; Fu, KW				Fung, Isaac Chun-Hai; Hao, Yi; Cai, Jingxian; Ying, Yuchen; Schaible, Braydon James; Yu, Cynthia Mengxi; Tse, Zion Tsz Ho; Fu, King-Wa			Chinese Social Media Reaction to Information about 42 Notifiable Infectious Diseases	PLOS ONE			English	Article							LOCAL HEALTH DEPARTMENTS; INFLUENZA; TWITTER; SURVEILLANCE; LIMITATIONS; MICROBLOGS; ADOPTION; SYSTEMS	This study aimed to identify what information triggered social media users' responses regarding infectious diseases. Chinese microblogs in 2012 regarding 42 infectious diseases were obtained through a keyword search in the Weiboscope database. Qualitative content analysis was performed for the posts pertinent to each keyword of the day of the year with the highest daily count. Similar posts were grouped and coded. We identified five categories of information that increased microblog traffic pertaining to infectious diseases: news of an outbreak or a case; health education / information; alternative health information / Traditional Chinese Medicine; commercial advertisement / entertainment; and social issues. News unrelated to the specified infectious diseases also led to elevated microblog traffic. Our study showcases the diverse contexts from which increased social media traffic occur. Our results will facilitate better health communication as causes underlying increased social media traffic are revealed.	[Fung, Isaac Chun-Hai] Georgia So Univ, Jiann Ping Hsu Coll Publ Hlth, Dept Epidemiol, Statesboro, GA 30460 USA; [Hao, Yi; Cai, Jingxian; Schaible, Braydon James] Georgia So Univ, Jiann Ping Hsu Coll Publ Hlth, Dept Biostat, Statesboro, GA 30460 USA; [Ying, Yuchen] Univ Georgia, Dept Comp Sci, Athens, GA 30605 USA; [Yu, Cynthia Mengxi; Fu, King-Wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China; [Yu, Cynthia Mengxi] Peking Univ, Sch Journalism & Commun, Beijing 100871, Peoples R China; [Tse, Zion Tsz Ho] Univ Georgia, Coll Engn, Athens, GA 30602 USA	University System of Georgia; Georgia Southern University; University System of Georgia; Georgia Southern University; University System of Georgia; University of Georgia; University of Hong Kong; Peking University; University System of Georgia; University of Georgia	Fung, ICH (corresponding author), Georgia So Univ, Jiann Ping Hsu Coll Publ Hlth, Dept Epidemiol, Statesboro, GA 30460 USA.	cfung@georgiasouthern.edu	Fu, King-wa/A-2385-2010	Fu, King-wa/0000-0001-8157-5276; Fung, Isaac Chun-Hai/0000-0001-5496-2529; Tse, Zion/0000-0001-9741-1137				[Anonymous], 2014, LANCET, V383, P1013, DOI 10.1016/S0140-6736(14)60501-8; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Cook AR, 2010, EMERG INFECT DIS, V16, P1647, DOI 10.3201/eid1610.100840; Ding H, 2010, CHINA MEDIA RES, V6, P80; Fu KW, 2014, J INF TECHNOL POLITI, V11, P309, DOI 10.1080/19331681.2014.909344; Fu KW, 2013, CRISIS, V34, P406, DOI 10.1027/0227-5910/a000221; Fu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058356; Fu KW, 2013, IEEE INTERNET COMPUT, V17, P42, DOI 10.1109/MIC.2013.28; Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1; Fung ICH, 2013, WEST PAC SURVEILL RE, V4, P1, DOI [10.5365/wpsar.2013.4.3.005, 10.5365/WPSAR.2013.4.3.005]; Fung ICH, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-31; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guy S, 2012, SOCIAL MEDIA SYSTEMA, P1; Harris J.K., 2013, FRONT PUBLIC HLTH SE, V2, P1, DOI [https://doi.org/10.13023/FPHSSR.0201.05, DOI 10.13023/FPHSSR.0201.05, 10.2105/AJPH.2012.301166, DOI 10.2105/AJPH.2012.301166]; Harris JK, 2014, AM J PUBLIC HEALTH, V104, pE62, DOI 10.2105/AJPH.2013.301860; Harris JK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120215; Harris JK, 2013, AM J PUBLIC HEALTH, V103, P1700, DOI 10.2105/AJPH.2012.301166; Kim EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069305; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Ministry of Health of the People's Republic of China, 2009, PROCL NO 8 MIN HLTH; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Mozur P., 2013, WALL STR J; National Health Commission, 2013, PRC NATL STATUTORY R; Neiger BL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2775; Qu Y., 2011, P ACM 2011 C COMP SU, P25, DOI DOI 10.1145/1958824.1958830; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Thackeray R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-508; Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242; Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038; Wang MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073049; Wang S., 2014, AAAI WORKSH WORLD WI; Xu L, 2012, MAN SEVERELY ILL NEE, pA38; Yu LL, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P514, DOI 10.1109/SocialCom-PASSAT.2012.45	39	23	25	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126092	10.1371/journal.pone.0126092	http://dx.doi.org/10.1371/journal.pone.0126092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946020	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700111
J	Lehmann, R; Childs, L; Thomas, P; Abreu, M; Fuhr, L; Herzel, H; Leser, U; Relogio, A				Lehmann, Robert; Childs, Liam; Thomas, Philippe; Abreu, Monica; Fuhr, Luise; Herzel, Hanspeter; Leser, Ulf; Relogio, Angela			Assembly of a Comprehensive Regulatory Network for the Mammalian Circadian Clock: A Bioinformatics Approach	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; DOWN-REGULATION; BREAST-CANCER; CELL-CYCLE; EXPRESSION; GENES; BIOLOGY; MICRORNAS; RHYTHM; MODULATION	By regulating the timing of cellular processes, the circadian clock provides a way to adapt physiology and behaviour to the geophysical time. In mammals, a light-entrainable master clock located in the suprachiasmatic nucleus (SCN) controls peripheral clocks that are present in virtually every body cell. Defective circadian timing is associated with several pathologies such as cancer and metabolic and sleep disorders. To better understand the circadian regulation of cellular processes, we developed a bioinformatics pipeline encompassing the analysis of high-throughput data sets and the exploitation of published knowledge by text-mining. We identified 118 novel potential clock-regulated genes and integrated them into an existing high-quality circadian network, generating the to-date most comprehensive network of circadian regulated genes (NCRG). To validate particular elements in our network, we assessed publicly available ChIP-seq data for BMAL1, REV-ERB alpha/beta and ROR alpha/gamma proteins and found strong evidence for circadian regulation of Elavl1, Nme1, Dhx6, Med1 and Rbbp7 all of which are involved in the regulation of tumourigenesis. Furthermore, we identified Ncl and Ddx6, as targets of ROR gamma and REV-ERB alpha, beta, respectively. Most interestingly, these genes were also reported to be involved in miRNA regulation; in particular, NCL regulates several miRNAs, all involved in cancer aggressiveness. Thus, NCL represents a novel potential link via which the circadian clock, and specifically ROR gamma, regulates the expression of miRNAs, with particular consequences in breast cancer progression. Our findings bring us one step forward towards a mechanistic understanding of mammalian circadian regulation, and provide further evidence of the influence of circadian deregulation in cancer.	[Lehmann, Robert; Abreu, Monica; Fuhr, Luise; Herzel, Hanspeter; Relogio, Angela] Charite, ITB, D-10115 Berlin, Germany; [Lehmann, Robert; Abreu, Monica; Fuhr, Luise; Herzel, Hanspeter; Relogio, Angela] Humboldt Univ, D-10115 Berlin, Germany; [Childs, Liam; Thomas, Philippe; Leser, Ulf] Humboldt Univ, Inst Comp Sci, Knowledge Management Bioinformat, D-10099 Berlin, Germany; [Abreu, Monica; Fuhr, Luise; Relogio, Angela] Charite, Mol Krebsforschungszentrum MKFZ, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Relogio, A (corresponding author), Charite, ITB, Invalidenstr 43, D-10115 Berlin, Germany.	angela.relogio@charite.de	Abreu, Monica/F-1098-2017; Fuhr, Luise/F-2398-2017; Relógio, Angela/M-4959-2016; Abreu, Mónica/AAD-6568-2020	Fuhr, Luise/0000-0001-6698-5277; Relógio, Angela/0000-0002-9165-2439; Abreu, Mónica/0000-0003-0626-7999; Thomas, Philippe/0000-0001-9136-9660; Lehmann, Robert/0000-0001-7071-4226; Childs, Liam/0000-0002-2080-1804	BMBF; graduate school SOAMED; Berlin School of Integrative Oncology (BSIO) of Charite Universitatsmedizin Berlin (LF); Deutsche Forschungsgemeinschaft [SFB 618/A4]	BMBF(Federal Ministry of Education & Research (BMBF)); graduate school SOAMED; Berlin School of Integrative Oncology (BSIO) of Charite Universitatsmedizin Berlin (LF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the BMBF (eBio-CIRSPLICE grant to AR LF MA, eBio-OncoPath grant to LS, UL) and graduate school SOAMED (PT), the Berlin School of Integrative Oncology (BSIO) of Charite Universitatsmedizin Berlin (LF) and the Deutsche Forschungsgemeinschaft (SFB 618/A4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Anafi RC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001840; Arighi CN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bieler J, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145218; Bollinger T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13984; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen GC, 2001, BIOCHEM BIOPH RES CO, V284, P507, DOI 10.1006/bbrc.2001.5003; Chen RM, 2013, CURR BIOL, V23, P1959, DOI 10.1016/j.cub.2013.08.005; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Frade R, 2002, ONCOGENE, V21, P861, DOI 10.1038/sj.onc.1205177; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gattiker A, 2003, COMPUT BIOL CHEM, V27, P49, DOI 10.1016/S1476-9271(02)00094-4; Giuliano KA, 2006, METHOD ENZYMOL, V414, P601, DOI 10.1016/S0076-6879(06)14031-8; Hakenberg J, 2011, BIOINFORMATICS, V27, P2769, DOI 10.1093/bioinformatics/btr455; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Higashimoto M, 2007, BIOCHEM BIOPH RES CO, V360, P418, DOI 10.1016/j.bbrc.2007.06.061; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Iio A, 2013, BBA-GENE REGUL MECH, V1829, P1102, DOI 10.1016/j.bbagrm.2013.07.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Koike N, 2012, SCIENCE NEW YORK NY; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Korencic A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05782; Lee KH, 2013, MOL BIOL CELL, V24, P2248, DOI 10.1091/mbc.E12-12-0849; Levi F, 2007, COLD SPRING HARB SYM, V72, P465, DOI 10.1101/sqb.2007.72.030; Levi F, 2007, ADV DRUG DELIVER REV, V59, P1015, DOI 10.1016/j.addr.2006.11.001; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Pichiorri F, 2013, J EXP MED, V210, P951, DOI 10.1084/jem.20120950; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pyysalo S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S6; Relogio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004338; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Riccio A, 1999, NAT GENET, V23, P266, DOI 10.1038/15443; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shende VR, 2014, FEBS LETT, V588, P3015, DOI 10.1016/j.febslet.2014.05.058; Shende VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065300; Sikora-Wohlfeld W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003342; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takane H, 2001, LIFE SCI, V68, P1449, DOI 10.1016/S0024-3205(01)00943-2; Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Thomas P, 2012, NUCLEIC ACIDS RES, V40, pW585, DOI 10.1093/nar/gks563; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Wallach T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003398; Wright S, 1920, J AGRIC RES, V20, P0557; Yamamoto T, 2014, EUR J MED GENET, V57, P163, DOI 10.1016/j.ejmg.2014.02.001; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x; Yuan LJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.222; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	85	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126283	10.1371/journal.pone.0126283	http://dx.doi.org/10.1371/journal.pone.0126283			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945798	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700120
J	Sun, AQ; Tian, XP; Zhang, N; Xu, ZP; Deng, XY; Liu, M; Liu, X				Sun, Anqiang; Tian, Xiaopeng; Zhang, Nan; Xu, Zaipin; Deng, Xiaoyan; Liu, Ming; Liu, Xiao			Does Lower Limb Exercise Worsen Renal Artery Hemodynamics in Patients with Abdominal Aortic Aneurysm?	PLOS ONE			English	Article							STENT-GRAFTS; SHEAR-STRESS; OPEN REPAIR; MODEL; FLOW; QUANTIFICATION; FAILURE; RISK; REST; AAA	Renal artery stenosis (RAS) and renal complications emerge in some patients after endovascular aneurysm repair (EVAR) to treat abdominal aorta aneurysm (AAA). The mechanisms for the causes of these problems are not clear. We hypothesized that for EVAR patients, lower limb exercise could negatively influence the physiology of the renal artery and the renal function, by decreasing the blood flow velocity and changing the hemodynamics in the renal arteries. To evaluate this hypothesis, pre- and post-operative models of the abdominal aorta were reconstructed based on CT images. The hemodynamic environment was numerically simulated under rest and lower limb exercise conditions. The results revealed that in the renal arteries, lower limb exercise decreased the wall shear stress (WSS), increased the oscillatory shear index (OSI) and increased the relative residence time (RRT). EVAR further enhanced these effects. Because these parameters are related to artery stenosis and atherosclerosis, this preliminary study concluded that lower limb exercise may increase the potential risk of inducing renal artery stenosis and renal complications for AAA patients. This finding could help elucidate the mechanism of renal artery stenosis and renal complications after EVAR and warn us to reconsider the management and nursing care of AAA patients.	[Sun, Anqiang; Tian, Xiaopeng; Deng, Xiaoyan; Liu, Ming; Liu, Xiao] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China; [Zhang, Nan] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Xu, Zaipin] Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China	Beihang University; Capital Medical University; Guizhou University	Liu, X (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China.	liuxiao@buaa.edu.cn		, Nan/0000-0002-8309-4262	National Natural Science Foundation of China [11102014, 11472031, 11332003, 31200703]; Beijing Natural Science Foundation [7132086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) which provided funds to design and conduct the study to AS (11102014,11472031), XD (11332003) and XL (31200703). NZ received funding from Beijing Natural Science Foundation (7132086) (http://www.bjnsf.org/) to collect data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen MEAPM, 2002, RADIOLOGY, V224, P739, DOI 10.1148/radiol.2243011675; Alric P, 2003, J ENDOVASC THER, V10, P397, DOI 10.1583/1545-1550(2003)010<0397:LRFFEA>2.0.CO;2; Antonello M, 2013, J VASC SURG, V58, P886, DOI 10.1016/j.jvs.2013.02.249; Blanchard JF, 2000, AM J EPIDEMIOL, V151, P575; Bown MJ, 2005, EUR J VASC ENDOVASC, V30, P1, DOI 10.1016/j.ejvs.2005.02.048; Chiastra C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0193; Franks SC, 2007, EUR J VASC ENDOVASC, V33, P154, DOI 10.1016/j.ejvs.2006.10.017; Gallo D, 2012, J BIOMECH, V45, P2398, DOI 10.1016/j.jbiomech.2012.07.007; Greenhalgh RM, 2008, NEW ENGL J MED, V358, P494, DOI 10.1056/NEJMct0707524; Hedayati N, 2008, J VASC SURG, V47, P446, DOI 10.1016/j.jvs.2007.08.019; Khanafer KM, 2007, ANN VASC SURG, V21, P67, DOI 10.1016/j.avsg.2006.10.009; Les AS, 2010, ANN BIOMED ENG, V38, P1288, DOI 10.1007/s10439-010-9949-x; Li ZH, 2007, EUR J MECH B-FLUID, V26, P615, DOI 10.1016/j.euromechflu.2007.03.003; Morris L, 2004, J BIOMECH, V37, P1087, DOI 10.1016/j.jbiomech.2003.11.014; Patel D. J., 1980, BASIC HEMODYNAMICS I, P1; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; REED D, 1992, CIRCULATION, V85, P205, DOI 10.1161/01.CIR.85.1.205; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Suh GY, 2011, ANN BIOMED ENG, V39, P2186, DOI 10.1007/s10439-011-0313-6; Sun ZH, 2010, KOREAN J RADIOL, V11, P95, DOI 10.3348/kjr.2010.11.1.95; Sun ZH, 2009, CARDIOVASC INTER RAD, V32, P647, DOI 10.1007/s00270-009-9539-1; Tang BT, 2006, AM J PHYSIOL-HEART C, V291, pH668, DOI 10.1152/ajpheart.01301.2005; Wald R, 2006, J VASC SURG, V43, P460, DOI 10.1016/j.jvs.2005.11.053; Walsh PW, 2003, MED ENG PHYS, V25, P299, DOI 10.1016/S1350-4533(02)00216-3; Walsh SR, 2008, J ENDOVASC THER, V15, P73, DOI 10.1583/07-2299.1; Wang ZZ, 2012, BIORHEOLOGY, V49, P249, DOI 10.3233/BIR-2012-0607; Yue JN, 2013, CHINESE MED J-PEKING, V126, P431, DOI 10.3760/cma.j.issn.0366-6999.20122292	27	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125121	10.1371/journal.pone.0125121	http://dx.doi.org/10.1371/journal.pone.0125121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946196	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700057
J	Wang, W; Chen, SW; Zhu, J; Zuo, S; Ma, YY; Chen, ZY; Zhang, JL; Chen, GW; Liu, YC; Wang, PY				Wang, Wei; Chen, Shan-Wen; Zhu, Jing; Zuo, Shuai; Ma, Yuan-Yuan; Chen, Zi-Yi; Zhang, Jun-Ling; Chen, Guo-Wei; Liu, Yu-Cun; Wang, Peng-Yuan			Intestinal Alkaline Phosphatase Inhibits the Translocation of Bacteria of Gut-Origin in Mice with Peritonitis: Mechanism of Action	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CLAUDIN-2 EXPRESSION; VEGF EXPRESSION; INFLAMMATION; MICROBIOTA; COLITIS; DISEASE; LIPOPOLYSACCHARIDE; PERMEABILITY; INDUCTION	Exogenous intestinal alkaline phosphatase (IAP), an enzyme produced endogenously at the brush edge of the intestinal mucosa, may mitigate the increase in aberrant intestinal permeability increased during sepsis. The aim of this study was to test the efficacy of the inhibitory effect of IAP on acute intestinal inflammation and to study the molecular mechanisms underlying IAP in ameliorating intestinal permeability. We used an in vivo imaging method to evaluate disease status and the curative effect of IAP. Two Escherichia coli (E. coli) B21 strains, carrying EGFP labeled enhanced green fluorescent protein (EGFP) and RFP labeled red fluorescent protein (RFP), were constructed as tracer bacteria and were administered orally to C57/B6N mice to generate an injection peritonitis (IP) model. The IP model was established by injecting inflammatory lavage fluid. C57/B6N mice bearing the tracer bacteria were subsequently treated with (IP+IAP group), or without IAP (IP group). IAP was administered to the mice via tail vein injections. The amount of tracer bacteria in the blood, liver, and lungs at 24 h post-injection was analyzed via flow cytometry (FCM), in vivo imaging, and Western blotting. Intestinal barrier function was measured using a flux assay with the macro-molecule fluorescein isothiocyanate dextran, molecular weight 40kD, (FD40). To elucidate the molecular mechanism underlying the effects of IAP, we examined the levels of ERK phosphorylation, and the expression levels of proteins in the ERK-SP1-VEGF and ERK-Cdx-2-Claudin-2 pathways. We observed that IAP inhibited the expression of Claudin-2, a type of cation channel-forming protein, and VEGF, a cytokine that may increase intestinal permeability by reducing the levels of dephosphorylated ERK. In conclusion, exogenous IAP shows a therapeutic effect in an injection peritonitis model. This including inhibition of bacterial translocation. Moreover, we have established an imaging methodology for live-animals can effectively evaluate intestinal permeability and aberrant bacterial translocation in IP models.	[Wang, Wei; Chen, Shan-Wen; Zhu, Jing; Zuo, Shuai; Chen, Zi-Yi; Zhang, Jun-Ling; Chen, Guo-Wei; Liu, Yu-Cun; Wang, Peng-Yuan] Peking Univ, Hosp 1, Dept Surg, Beijing 100871, Peoples R China; [Ma, Yuan-Yuan] Peking Univ, Hosp 1, Ctr Expt Anim, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, PY (corresponding author), Peking Univ, Hosp 1, Dept Surg, Xi Shi Ku St, Beijing 100871, Peoples R China.	pengyuan_wang@bjmu.edu.cn			China Health and Medical Development Foundation (Grant: Research on Surgical Infection Mechanism and Control); Research Fund of Peking University First Hospital [201196005]	China Health and Medical Development Foundation (Grant: Research on Surgical Infection Mechanism and Control); Research Fund of Peking University First Hospital	Funding for this work came from the China Health and Medical Development Foundation (Grant: Research on Surgical Infection Mechanism and Control) and Research Fund of Peking University First Hospital, Grant No. 201196005.	Akcan A, 2008, WORLD J GASTROENTERO, V14, P918, DOI 10.3748/wjg.14.918; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Feng J, 2012, CELL SIGNAL, V24, P1116, DOI 10.1016/j.cellsig.2012.01.013; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Karatepe O, 2010, WORLD J GASTROENTERO, V16, P4313, DOI 10.3748/wjg.v16.i34.4313; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; Koutroubakis IE, 2004, DIGEST DIS SCI, V49, P1758, DOI 10.1007/s10620-004-9565-4; Mizumori M, 2009, J PHYSIOL-LONDON, V587, P3651, DOI 10.1113/jphysiol.2009.172270; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Possemiers S, 2009, CURR PHARM DESIGN, V15, P2051, DOI 10.2174/138161209788489159; Ramos MC, 2004, BIOL CHEM, V385, P75, DOI 10.1515/BC.2004.010; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Shizuma T, 2012, TURK J GASTROENTEROL, V23, P122, DOI 10.4318/tjg.2012.0321; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Taha Y, 2004, DIGEST DIS SCI, V49, P109, DOI 10.1023/B:DDAS.0000011611.92440.f2; Takeda Y, 2009, INFLAMM BOWEL DIS, V15, P1617, DOI 10.1002/ibd.20861; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; van Esch S, 2012, CONTRIB NEPHROL, V178, P264, DOI 10.1159/000337889; van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007; van Veen SQ, 2005, INFECT IMMUN, V73, P4309, DOI 10.1128/IAI.73.7.4309-4314.2005; Wardwell Leslie H, 2011, Curr Infect Dis Rep, V13, P28, DOI 10.1007/s11908-010-0147-7; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632	30	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124835	10.1371/journal.pone.0124835	http://dx.doi.org/10.1371/journal.pone.0124835			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946026	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700051
J	Elmore, BO; Triplett, KD; Hall, PR				Elmore, Bradley O.; Triplett, Kathleen D.; Hall, Pamela R.			Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing	PLOS ONE			English	Article							ACCESSORY GENE REGULATOR; LOW-DENSITY-LIPOPROTEIN; VIRULENCE DETERMINANTS; ALPHA-HEMOLYSIN; IMMUNE-RESPONSES; SKIN INFECTION; KNOCKOUT MICE; MOUSE MODEL; IN-VIVO; PROTEIN	Serum lipoproteins (LP) are increasingly being recognized as dual purpose molecules that contribute to both cholesterol homeostasis and host innate defense. In fact, very low LP levels are associated with increased risk of bacterial infection in critically ill patients. In this respect, we reported that apolipoprotein B100 (apoB100), the 4536 amino acid structural protein of very low density lipoprotein (VLDL) produced by the liver, limits Staphylococcus aureus pathogenesis. S. aureus uses quorum-sensing (QS) via the accessory gene regulator (agr) operon and an autoinducing peptide (AIP) to coordinate expression of over 200 virulence genes. ApoB100 prevents agr activation by binding and sequestering secreted AIP. Importantly, human serum LP are produced not only by the liver, but are also produced by enterocytes, in the form of chylomicrons, during uptake of dietary lipids. In contrast to apoB100 in VLDL, human enterocytes use apoB48, the N-terminal 2152 amino acids (48%) of apoB100, as the structural component of chylomicrons. Interestingly, enteral feeding of critically ill patients has been associated with decreased risk of infectious complications, suggesting chylomicrons could contribute to host innate defense in critically ill patients when serum LP production by the liver is limited during the acute phase response. Therefore, we hypothesized that apoB48 would be sufficient to antagonize S. aureus QS. As expected, isolated apoB48-LP bound immobilized AIP and antagonized agr-signaling. ApoB48-and apoB100-LP inhibited agr activation with IC50s of 3.5 and 2.3 nM, respectively, demonstrating a conserved AIP binding site. Importantly, apoB48-LP antagonized QS, limited morbidity and promoted bacterial clearance in a mouse model of S. aureus infection. This work demonstrates that both naturally occurring forms of apolipoprotein B can antagonize S. aureus QS, and may suggest a previously unrecognized role for chylomicrons and enterocytes in host innate defense against S. aureus QS-mediated pathogenesis.	[Elmore, Bradley O.; Triplett, Kathleen D.; Hall, Pamela R.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Hall, PR (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	phall@salud.unm.edu	Hall, Pamela/O-5402-2016	Hall, Pamela/0000-0003-2367-3382	National Institutes of Health [AI091917]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI091917 to PRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron N, 1998, P NATL ACAD SCI USA, V95, P15647, DOI 10.1073/pnas.95.26.15647; BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213; BHAKDI S, 1983, J BIOL CHEM, V258, P5899; BRAUNER E, 1989, J ANTIMICROB CHEMOTH, V23, P891, DOI 10.1093/jac/23.6.891; BUENO L, 1988, BAILLIERE CLIN GASTR, V2, P123, DOI 10.1016/0950-3528(88)90024-3; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; Daniels TF, 2009, INT J BIOL SCI, V5, P474; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Feingold KR, 2012, J LIPID RES, V53, P2487, DOI 10.1194/jlr.E033407; Femling JK, 2013, J TRAUMA ACUTE CARE, V74, P1067, DOI 10.1097/TA.0b013e3182826be0; Garber DW, 2000, J LIPID RES, V41, P1020; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; Hall PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003166; Han C, 2010, CLIN VACCINE IMMUNOL, V17, P1524, DOI 10.1128/CVI.00149-10; Han RL, 2010, MICROBIOL IMMUNOL, V54, P246, DOI 10.1111/j.1348-0421.2010.00203.x; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Huang EY, 2013, MICROBES INFECT, V15, P765, DOI 10.1016/j.micinf.2013.07.004; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Kattelmann KK, 2006, J AM DIET ASSOC, V106, P1226, DOI 10.1016/j.jada.2006.05.320; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Leardi S, 2000, Ann Ital Chir, V71, P233; Leslie JB, 2011, ADV PREV MED, V2011; LI ZJ, 2008, PLOS ONE, V3; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; McAdow M, 2012, INFECT IMMUN, V80, P3389, DOI 10.1128/IAI.00562-12; Mounkes LC, 2001, HUM GENE THER, V12, P1939, DOI 10.1089/104303401753204526; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Omae Y, 2013, J BIOL CHEM, V288, P25542, DOI 10.1074/jbc.M113.495051; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Park Y, 2001, LIPIDS, V36, P115, DOI 10.1007/s11745-001-0696-6; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Rothfork JM, 2003, J IMMUNOL, V171, P5389, DOI 10.4049/jimmunol.171.10.5389; Sampedro GR, 2014, J INFECT DIS, V210, P1012, DOI 10.1093/infdis/jiu223; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segrest JP, 1999, J LIPID RES, V40, P1401; SHIFF TS, 1971, J LIPID RES, V12, P596; Sigel S, 2012, EUR J IMMUNOL, V42, P2983, DOI 10.1002/eji.201242564; SIN YM, 1992, ANN RHEUM DIS, V51, P112, DOI 10.1136/ard.51.1.112; Smith EJ, 2011, INFECT IMMUN, V79, P3801, DOI 10.1128/IAI.05075-11; Smolenaars MMW, 2005, J LIPID RES, V46, P412, DOI 10.1194/jlr.M400374-JLR200; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; TENNYSON GE, 1989, P NATL ACAD SCI USA, V86, P500, DOI 10.1073/pnas.86.2.500; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; Vyroubal P, 2008, BIOMED PAP, V152, P181, DOI 10.5507/bp.2008.029; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002; YASUDA H, 1993, ANTIMICROB AGENTS CH, V37, P1749, DOI 10.1128/AAC.37.9.1749; Yoshikawa Yuka, 2004, Journal of Infection and Chemotherapy, V10, P268, DOI 10.1007/s10156-004-0336-0; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	77	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125027	10.1371/journal.pone.0125027	http://dx.doi.org/10.1371/journal.pone.0125027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942561	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943400024
J	Ferrao, PM; d'Avila-Levy, CM; Araujo-Jorge, TC; Degrave, WM; Goncalves, AD; Garzoni, LR; Lima, AP; Feige, JJ; Bailly, S; Mendonca-Lima, L; Waghabi, MC				Ferrao, Patricia Mello; d'Avila-Levy, Claudia Masini; Araujo-Jorge, Tania Cremonini; Degrave, Wim Maurits; Goncalves, Antonio da Silva; Garzoni, Luciana Ribeiro; Lima, Ana Paula; Feige, Jean Jacques; Bailly, Sabine; Mendonca-Lima, Leila; Waghabi, Mariana Caldas			Cruzipain Activates Latent TGF-beta from Host Cells during T-cruzi Invasion	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAJOR CYSTEINE PROTEINASE; PARASITE CYCLE COMPLETION; PROTEASE INHIBITORS; CHAGAS-DISEASE; MURINE MACROPHAGES; MAMMALIAN-CELLS; CATHEPSIN-B; MOUSE MODEL; INFECTION	Several studies indicate that the activity of cruzipain, the main lysosomal cysteine peptidase of Trypanosoma cruzi, contributes to parasite infectivity. In addition, the parasitic invasion process of mammalian host cells is described to be dependent on the activation of the host TGF-beta signaling pathway by T. cruzi. Here, we tested the hypothesis that cruzipain could be an important activator of latent TGF-beta and thereby trigger TGF-beta-mediated events crucial for the development of Chagas disease. We found that live epimastigotes of T. cruzi, parasite lysates and purified cruzipain were able to activate latent TGF-beta in vitro. This activation could be inhibited by the cysteine peptidase inhibitor Z-Phe-Ala-FMK. Moreover, transfected parasites overexpressing chagasin, a potent endogenous cruzipain inhibitor, prevented latent TGF-beta activation. We also observed that T. cruzi invasion, as well as parasite intracellular growth, were inhibited by the administration of Z-Phe-Ala-FMK or anti-TGF-beta neutralizing antibody to Vero cell cultures. We further demonstrated that addition of purified cruzipain enhanced the invasive activity of trypomastigotes and that this effect could be completely inhibited by addition of a neutralizing anti-TGF-beta antibody. Taken together, these results demonstrate that the activities of cruzipain and TGF-beta in the process of cell invasion are functionally linked. Our data suggest that cruzipain inhibition is an interesting chemotherapeutic approach for Chagas disease not only because of its trypanocidal activity, but also due to the inhibitory effect on TGF-beta activation.	[Ferrao, Patricia Mello; Degrave, Wim Maurits; Mendonca-Lima, Leila; Waghabi, Mariana Caldas] Fiocruz MS, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, BR-21045900 Rio De Janeiro, Brazil; [Ferrao, Patricia Mello; Garzoni, Luciana Ribeiro] Fiocruz MS, Inst Oswaldo Cruz, Lab Invest Cardiovasc, BR-21045900 Rio De Janeiro, Brazil; [d'Avila-Levy, Claudia Masini] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Araujo-Jorge, Tania Cremonini] Fiocruz MS, Inst Oswaldo Cruz, Lab Inovacoes Terapias Ensino & Bioprod, BR-21045900 Rio De Janeiro, Brazil; [Goncalves, Antonio da Silva] Fiocruz MS, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, BR-21045900 Rio De Janeiro, Brazil; [Lima, Ana Paula] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Bioquim & Biol Mol Peptidases, BR-21941 Rio De Janeiro, Brazil; [Feige, Jean Jacques; Bailly, Sabine] INSERM, Unite 1036, F-38054 Grenoble, France; [Feige, Jean Jacques; Bailly, Sabine] Univ Grenoble Alpes, F-38041 Grenoble, France; [Feige, Jean Jacques; Bailly, Sabine] CEA, DSV, iRTSV, Lab Biol Canc & Infect, F-38054 Grenoble, France; [Garzoni, Luciana Ribeiro; Waghabi, Mariana Caldas] Fiocruz MS, Programa Integrado Doenca Chagas, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Fundacao Oswaldo Cruz	Waghabi, MC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, BR-21045900 Rio De Janeiro, Brazil.	mariana@ioc.fiocruz.br	Mendonça-Lima, Leila/J-3390-2014; Feige, Jean-Jacques/M-8905-2017; Lima, Ana Paula CA/G-4122-2012; bailly, sabine/G-3540-2013; d'Avila-Levy, Claudia M/O-7192-2014	Mendonça-Lima, Leila/0000-0003-4388-5083; Feige, Jean-Jacques/0000-0002-1354-7692; bailly, sabine/0000-0003-1043-7030; d'Avila-Levy, Claudia M/0000-0001-8042-4695; LIMA, ANA PAULA C. A./0000-0003-4631-2694	INSERM-FIOCRUZ collaborative research program; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INSERM; CEA	INSERM-FIOCRUZ collaborative research program; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission)	This work was supported by the INSERM-FIOCRUZ collaborative research program, by grants from Instituto Oswaldo Cruz, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to the Brazilian laboratories, and by recurrent funding from INSERM and CEA to the French laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; [Anonymous], 2010, 1 WHO; Araujo-Jorge TC, 2012, CLIN PHARMACOL THER, V92, P613, DOI 10.1038/clpt.2012.102; ASLUND L, 1991, MOL BIOCHEM PARASIT, V45, P345, DOI 10.1016/0166-6851(91)90103-D; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; BOUTARD V, 1995, J IMMUNOL, V155, P2077; CAMPETELLA O, 1992, MOL BIOCHEM PARASIT, V50, P225, DOI 10.1016/0166-6851(92)90219-A; CAVALLESCO R, 1988, J IMMUNOL, V140, P617; Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995; Cunha-e-Silva NL, 2002, FEMS MICROBIOL LETT, V214, P7; dos Reis FCG, 2006, FEMS MICROBIOL LETT, V259, P215, DOI 10.1111/j.1574-6968.2006.00267.x; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Engel JC, 1998, J CELL SCI, V111, P597; Engel JC, 2000, J CELL SCI, V113, P1345; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Ferrao PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038736; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613; Guo M, 2002, J BIOL CHEM, V277, P14829, DOI 10.1074/jbc.M108180200; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; LIMA APCA, 1992, MOL BIOCHEM PARASIT, V56, P335, DOI 10.1016/0166-6851(92)90183-K; LIMA APCD, 1994, MOL BIOCHEM PARASIT, V67, P333, DOI 10.1016/0166-6851(94)00144-8; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Monteiro AC, 2006, J IMMUNOL, V177, P6325, DOI 10.4049/jimmunol.177.9.6325; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Ndao M, 2014, ANTIMICROB AGENTS CH, V58, P1167, DOI 10.1128/AAC.01855-13; Oliveira FL, 2012, PLOS NEGLECT TROP D, V6, pe1696, DOI [10.1371/journal.pntd.0001696, DOI 10.1371/JOURNAL.PNTD.0001696]; Omer FM, 2003, J EXP MED, V198, P1817, DOI 10.1084/jem.20030713; Santos ALS, 2006, AN ACAD BRAS CIENC, V78, P687, DOI 10.1590/S0001-37652006000400006; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Scharfstein J, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00396; Scharfstein Julio, 2008, V47, P140; Schnapp AR, 2002, INFECT IMMUN, V70, P5065, DOI 10.1128/IAI.70.9.5065-5074.2002; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SOARES MJ, 1992, J CELL SCI, V102, P157; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Uehara LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001958; Venturini G, 2000, BIOCHEM BIOPH RES CO, V270, P437, DOI 10.1006/bbrc.2000.2447; Waghabi MC, 2007, ANTIMICROB AGENTS CH, V51, P2905, DOI 10.1128/AAC.00022-07; Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09; Waghabi MC, 2005, AM J PATHOL, V167, P993, DOI 10.1016/S0002-9440(10)61189-3; Waghabi MC, 2005, CELL MICROBIOL, V7, P511, DOI 10.1111/j.1462-5822.2004.00481.x; Zech B, 1999, J BIOL CHEM, V274, P20931, DOI 10.1074/jbc.274.30.20931	53	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124832	10.1371/journal.pone.0124832	http://dx.doi.org/10.1371/journal.pone.0124832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938232	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000033
J	Hu, XM; Ye, JQ; Qin, AJ; Zou, HT; Shao, HX; Qian, K				Hu, Xuming; Ye, Jianqiang; Qin, Aijian; Zou, Haitao; Shao, Hongxia; Qian, Kun			Both MicroRNA-155 and Virus-Encoded MiR-155 Ortholog Regulate TLR3 Expression	PLOS ONE			English	Article							T-CELL RESPONSES; CODING REGIONS; TARGETING SOCS1; CUTTING EDGE; MICRO-RNA; IMMUNITY; CONTRIBUTES; SUPPRESSION; DEFICIENCY; ACTIVATION	MicroRNA-155 (miR-155) has been as an important controller of TLR3 signalling. However, the interactions between miR-155 and TLR3 are poorly understood. Here, we focused on the regulation of the relationship between miR-155 and TLR3. Sequence analyses and firefly luciferase reporter assay revealed that miR-155 target were present in the coding sequences (CDS) of TLR3. And the expression of the TLR3 protein could be inhibited by a miR-155 mimic or by a virally encoded orthologue in chick embryo fibroblast cells. Notably, endogenous miR-155 induction emerged a negative regulation on TLR3 expression in TLR2, 4 and 7 ligands stimulated HD11 cells, an avian macrophage cell line. Moreover, treatment with the miR-155 antagomir increased TLR3 levels while significantly decreased the abundance of TLR3 with miR-155 agomir. In addition, our data showed that miR-155 could inhibit IFN-beta production possibly though TLR3 signal pathway. All these findings might reveal a new mechanism by which miR-155 can regulate the TLR3 immune response.	[Hu, Xuming; Ye, Jianqiang; Qin, Aijian; Shao, Hongxia; Qian, Kun] Yangzhou Univ, Key Lab Avian Prevent Med, Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China; [Hu, Xuming; Qin, Aijian; Zou, Haitao; Shao, Hongxia; Qian, Kun] Yangzhou Univ, Key Lab Jiangsu Prevent Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Ye, Jianqiang; Qin, Aijian; Zou, Haitao; Shao, Hongxia; Qian, Kun] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Qin, AJ (corresponding author), Yangzhou Univ, Key Lab Avian Prevent Med, Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China.	aijian@yzu.edu.cn	ye, jianqiang/ABH-8988-2020		National Natural Science Foundation of China [31272560, 31472192]; Priority Academic Program Development of Jiangsu Higher Education Institutions and the Science; Major Basic Research of Natural Science Foundation of Jiangsu Higher Education Institutions of China [12KJA23001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions and the Science; Major Basic Research of Natural Science Foundation of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China (31272560, 31472192) http://www.nsfc.gov.cn/ AJQ; the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Science, http://www.ec.js.edu.cn/ AJQ; The Major Basic Research of Natural Science Foundation of Jiangsu Higher Education Institutions of China (Grant No. 12KJA23001), http://www.ec.js.edu.cn/col/col11321/index.html AJQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chin AI, 2010, CANCER RES, V70, P2595, DOI 10.1158/0008-5472.CAN-09-1162; Conforti R, 2010, CANCER RES, V70, P490, DOI 10.1158/0008-5472.CAN-09-1890; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Deng Y., 2013, MATH PROBL ENG, V2013, P9, DOI DOI 10.1371/J0URNAL.PGEN.1003336; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hu XM, 2014, VET RES COMMUN, V38, P149, DOI 10.1007/s11259-014-9598-x; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kohanbash G, 2012, SEMIN CANCER BIOL, V22, P70, DOI 10.1016/j.semcancer.2011.12.010; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shatz M, 2012, CANCER RES, V72, P3948, DOI 10.1158/0008-5472.CAN-11-4134; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Tabiasco J, 2006, J IMMUNOL, V177, P8708, DOI 10.4049/jimmunol.177.12.8708; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zhang J, 2012, FEBS LETT, V586, P3255, DOI 10.1016/j.febslet.2012.06.047; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	52	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126012	10.1371/journal.pone.0126012	http://dx.doi.org/10.1371/journal.pone.0126012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938551	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000129
J	Li, YL; Wang, XL; Chen, TT; Yao, FW; Li, CP; Tang, QL; Sun, M; Sun, GY; Hu, SN; Yu, J; Song, SH				Li, Yuli; Wang, Xiliang; Chen, Tingting; Yao, Fuwen; Li, Cuiping; Tang, Qingli; Sun, Min; Sun, Gaoyuan; Hu, Songnian; Yu, Jun; Song, Shuhui			RNA-Seq Based De Novo Transcriptome Assembly and Gene Discovery of Cistanche deserticola Fleshy Stem	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; GENOME-WIDE CHARACTERIZATION; PHENYLETHANOID GLYCOSIDES; ROOT TRANSCRIPTOME; MOLECULAR-CLONING; BIOSYNTHESIS; LIGNIN; 2-PHENYLETHANOL; RECONSTRUCTION; ANNOTATION	Backgrounds Cistanche deserticola is a completely non-photosynthetic parasitic plant with great medicinal value and mainly distributed in desert of Northwest China. Its dried fleshy stem is a crucial tonic in traditional Chinese medicine with roles of mainly improving male sexual function and strengthening immunity, but few mechanistic studies have been conducted partly due to the lack of genomic and transcriptomic resources. Results In this study, we performed deep transcriptome sequencing in fleshy stem of C. deserticola, and about 80 million reads were generated using Illumina pair-end sequencing on HiSeq2000 platform. Using trinity assembler, we obtained 95,787 transcript sequences with transcript lengths ranging from 200bp to 15,698bp, having an average length of 950 bases and the N50 length of 1,519 bases. 63,957 transcripts were identified actively expressed with FPKM >= 0.5, in which 30,098 transcripts were annotated with gene descriptions or gene ontology terms by sequence similarity analyses against several public databases (Uniprot, NR and Nt at NCBI, and KEGG). Furthermore, we identified key enzyme genes involved in biosynthesis of lignin and phenylethanoid glycosides (PhGs) which are known to be the primary active ingredients. Four phenylalanine ammonia-lyase (PAL) genes, the first key enzyme in lignin and PhG biosynthesis, were identified based on sequences comparison and phylogenetic analysis. Two biosynthesis pathways of PhGs were also proposed for the first time. Conclusions In all, we completed a global analysis of the C. deserticola fleshy stem transcriptome using RNA-seq technology. A collection of enzyme genes related to biosynthesis of lignin and phenylethanoid glysides were identified from the assembled and annotated transcripts, and the gene family of PAL was also predicted. The sequence data from this study will provide a valuable resource for conducting future phenylethanoid glysides biosynthesis researches and functional genomic studies in this important medicinal plant.	[Li, Yuli; Wang, Xiliang; Hu, Songnian; Yu, Jun; Song, Shuhui] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Tingting; Yao, Fuwen; Li, Cuiping; Sun, Min; Sun, Gaoyuan; Song, Shuhui] Chinese Acad Sci, Beijing Inst Genom, Core Genom Facil, Beijing, Peoples R China; [Li, Yuli; Wang, Xiliang; Yao, Fuwen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Qingli] HongKui CongRong Grp, Alashan, Inner Mongolia, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Song, SH (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	songshh@big.ac.cn			HongKui CongRong Group	HongKui CongRong Group	HongKui CongRong Group provided support in the form of salaries for author QT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Bagal UR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cao Rui, 2004, Zhongguo Zhong Yao Za Zhi, V29, P35; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Chen Shilin, 2011, Front Med, V5, P178, DOI 10.1007/s11684-011-0131-0; Cheng XY, 2006, J BIOTECHNOL, V121, P253, DOI 10.1016/j.jbiotec.2005.07.012; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; College JNM and Press SSaT, 1977, DICTIONARY OF CHINES, P895; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Dong Q, 2007, CARBOHYD RES, V342, P1343, DOI 10.1016/j.carres.2007.03.017; Gayral P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003457; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu L, 2013, ASIAN J ANDROL, V15, P838, DOI 10.1038/aja.2013.73; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halls C, 2008, TRENDS BIOTECHNOL, V26, P77, DOI 10.1016/j.tibtech.2007.11.002; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hou XM, 2013, MOL BIOL REP, V40, P4301, DOI 10.1007/s11033-013-2517-3; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; JIMENEZ C, 1994, NAT PROD REP, V11, P591, DOI 10.1039/np9941100591; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; LI Y, 2010, BMC BIOINFORMATICS, V11, P1, DOI DOI 10.1186/1471-2164-11-1; Li YL, 2014, RNA BIOL, V11, P1180, DOI 10.4161/rna.36281; Lin XH, 2011, PHYSIOL PLANTARUM, V143, P207, DOI 10.1111/j.1399-3054.2011.01500.x; Lu MC, 1998, J ETHNOPHARMACOL, V59, P161, DOI 10.1016/S0378-8741(97)00108-6; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo HM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-209; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Marita JM, 2001, J CHEM SOC PERK T 1, P2939, DOI 10.1039/b107219f; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Negre F, 2003, PLANT CELL, V15, P2992, DOI 10.1105/tpc.016766; Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ralph J, 2001, PHYTOCHEMISTRY, V57, P993, DOI 10.1016/S0031-9422(01)00109-1; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Sakai M, 2007, BIOSCI BIOTECH BIOCH, V71, P2408, DOI 10.1271/bbb.70090; Sarsenbayev K. N., 2013, World Applied Sciences Journal, V25, P1478; Shang QM, 2012, PLANTA, V236, P1093, DOI 10.1007/s00425-012-1659-1; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi R, 2010, PLANTA, V232, P1281, DOI 10.1007/s00425-010-1253-3; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Song J, 2005, ANN BOT-LONDON, V96, P399, DOI 10.1093/aob/mci196; Stalman M, 2003, J PLANT PHYSIOL, V160, P607, DOI 10.1078/0176-1617-00773; Stefanova NA, 2011, J ETHNOPHARMACOL, V138, P624, DOI 10.1016/j.jep.2011.10.017; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Tu P.-F., 1994, CHIN TRADIT HERB DRU, V24, P205; Tu PF, 1997, NAT PROD RES DEV, V9, P452; Tu PF, 1994, CHINA ACADEMIC JOURN, V19, P1; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Verdonk JC, 2003, PHYTOCHEMISTRY, V62, P997, DOI 10.1016/S0031-9422(02)00707-0; Vinardell MP, 2008, IND CROP PROD, V27, P220, DOI 10.1016/j.indcrop.2007.07.011; Wang T, 2012, AM J CHINESE MED, V40, P1123, DOI 10.1142/S0192415X12500838; Wang XW, 2001, CHIN PHARM J, V36, P29; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WANNER LA, 1995, PLANT MOL BIOL, V27, P327, DOI 10.1007/BF00020187; Watanabe S, 2002, BIOSCI BIOTECH BIOCH, V66, P943, DOI 10.1271/bbb.66.943; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Zhai LL, 2014, MOL BREEDING, V33, P611, DOI 10.1007/s11032-013-9978-x; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhu Liucun, 2014, Biomed Res Int, V2014, P750961, DOI 10.1155/2014/750961	74	13	16	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125722	10.1371/journal.pone.0125722	http://dx.doi.org/10.1371/journal.pone.0125722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938435	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000095
J	Tamura, K; Minami, K; Kudo, M; Iemoto, K; Takahashi, H; Seino, S				Tamura, Kanako; Minami, Kohtaro; Kudo, Maya; Iemoto, Keisuke; Takahashi, Harumi; Seino, Susumu			Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; OXIDATIVE STRESS; INSULIN-SECRETION; GLUCOSE; ISLET; HYPERGLYCEMIA; MECHANISMS; NEOGENESIS; GLP-1; REPLICATION	Glucagon-like peptide-1 (GLP-1) receptor agonists potentiate glucose-induced insulin secretion. In addition, they have been reported to increase pancreatic beta cell mass in diabetic rodents. However, the precise mode of action of GLP-1 receptor agonists still needs to be elucidated. Here we clarify the effects of the human GLP-1 analog liraglutide on beta cell fate and function by using an inducible Cre/loxP-based pancreatic beta cell tracing system and alloxan-induced diabetic mice. Liraglutide was subcutaneously administered once daily for 30 days. The changes in beta cell mass were examined as well as glucose tolerance and insulin secretion. We found that chronic liraglutide treatment improved glucose tolerance and insulin response to oral glucose load. Thirty-day treatment with liraglutide resulted in a 2-fold higher mass of pancreatic beta cells than that in vehicle group. Liraglutide increased proliferation rate of pancreatic beta cells and prevented beta cells from apoptotic cells death. However, the relative abundance of YFP-labeled beta cells to total beta cells was no different before and after liraglutide treatment, suggesting no or little contribution of neogenesis to the increase in beta cell mass. Liraglutide reduced oxidative stress in pancreatic islet cells of alloxan-induced diabetic mice. Furthermore, the beneficial effects of liraglutide in these mice were maintained two weeks after drug withdrawal. In conclusion, chronic liraglutide treatment improves hyperglycemia by ameliorating beta cell mass and function in alloxan-induced diabetic mice.	[Tamura, Kanako; Minami, Kohtaro; Kudo, Maya; Iemoto, Keisuke; Takahashi, Harumi; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan	Kobe University	Minami, K (corresponding author), Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan.	kminami@harbor.kobe-u.ac.jp; seino@med.kobe-u.ac.jp		Minami, Kohtaro/0000-0003-4698-6250	Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science and Technology, Japan; Novo Nordisk Pharma, Tokyo, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novo Nordisk Pharma, Tokyo, Japan	This study was supported by a CREST grant from the Japan Science and Technology Agency, Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sport, Science and Technology, Japan, and a grant by Novo Nordisk Pharma, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; GUTNIAK MK, 1994, DIABETES CARE, V17, P1039, DOI 10.2337/diacare.17.9.1039; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Kaneto H, 1996, BIOCHEM J, V320, P855, DOI 10.1042/bj3200855; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Madsbad S, 2009, BEST PRACT RES CL EN, V23, P463, DOI 10.1016/j.beem.2009.03.008; Minami K, 2011, DIABETOLOGIA, V54, pS26; Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Retnakaran R, 2014, DIABETES CARE, V37, P3270, DOI 10.2337/dc14-0893; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Shimoda M, 2011, DIABETOLOGIA, V54, P1098, DOI 10.1007/s00125-011-2069-9; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; UNGER RH, 1985, DIABETOLOGIA, V28, P119; Vilsboll T, 2008, DIABETIC MED, V25, P152, DOI 10.1111/j.1464-5491.2007.02333.x; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; YKIJARVINEN H, 1990, DIABETOLOGIA, V33, P579, DOI 10.1007/BF00400200; Zhang J, 2007, DIABETOLOGIA, V50, P1900, DOI 10.1007/s00125-007-0737-6	44	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126003	10.1371/journal.pone.0126003	http://dx.doi.org/10.1371/journal.pone.0126003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938469	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000127
J	Tobler, M; Ballen, C; Healey, M; Wilson, M; Olsson, M				Tobler, Michael; Ballen, Cissy; Healey, Mo; Wilson, Mark; Olsson, Mats			Oxidant Trade-Offs in Immunity: An Experimental Test in a Lizard	PLOS ONE			English	Article							OXIDATIVE STRESS; SEXUAL-DIMORPHISM; INNATE IMMUNITY; BIRDS; RED; SUSCEPTIBILITY; MITOCHONDRIA; INFLAMMATION; SUPEROXIDE; RESPONSES	Immune system functioning and maintenance entails costs which may limit investment into other processes such as reproduction. Yet, the proximate mechanisms and 'currencies' mediating the costs of immune responses remain elusive. In vertebrates, up-regulation of the innate immune system is associated with rapid phagocytic production of pro-oxidant molecules (so-called 'oxidative burst' responses). Oxidative burst responses are intended to eliminate pathogens but may also constitute an immunopathological risk as they may induce oxidative damage to self cells. To minimize the risk of infection and, at the same time, damage to self, oxidative burst activity must be carefully balanced. The current levels of pro-and antioxidants (i.e. the individual oxidative state) is likely to be a critical factor affecting this balance, but this has not yet been evaluated. Here, we perform an experiment on wild-caught painted dragon lizards (Ctenophorus pictus) to examine how the strength of immune-stimulated oxidative burst responses of phagocytes in whole blood relates to individual oxidative status under control conditions and during an in vivo immune challenge with Escherichia coli lipopolysaccharide (LPS). Under control conditions, oxidative burst responses were not predicted by the oxidative status of the lizards. LPS-injected individuals showed a strong increase in pro-oxidant levels and a strong decrease in antioxidant levels compared to control individuals demonstrating a shift in the pro-/antioxidant balance. Oxidative burst responses in LPS-injected lizards were positively related to post-challenge extracellular pro-oxidants (reflecting the level of cell activation) and negatively related to pre-challenge levels of mitochondrial superoxide (suggesting an immunoregulatory effect of this pro-oxidant). LPS-challenged males had higher oxidative burst responses than females, and in females oxidative burst responses seemed to depend more strongly on antioxidant status than in males. Our results confirm the idea that oxidative state may constrain the activity of the innate immune system. These constraints may have important consequences for the way selection acts on pro-oxidant generating processes.	[Tobler, Michael; Ballen, Cissy; Healey, Mo; Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Tobler, Michael] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Wilson, Mark] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	University of Sydney; Lund University; University of Wollongong	Tobler, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	michael.tobler@biol.lu.se	Tobler, Michael/B-2754-2013; Olsson, Mats/AAK-5565-2021; Wilson, Mark R/B-3254-2018	Tobler, Michael/0000-0001-5895-6302; Olsson, Mats/0000-0002-4130-1323; Wilson, Mark R/0000-0002-9551-7445; Ballen, Cissy/0000-0002-4693-6117	European Commission [PIOF-GA-2009-252635]; Australian Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); Australian Research Council(Australian Research Council)	This study was funded by the European Commission (Marie Curie International Outgoing Fellowship PIOF-GA-2009-252635 to MT) and the Australian Research Council (to MO).	Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballen C, 2012, J EXP BIOL, V215, P731, DOI 10.1242/jeb.062257; Bertrand S, 2006, FUNCT ECOL, V20, P1022, DOI 10.1111/j.1365-2435.2006.01191.x; Casagrande S, 2012, COMP BIOCHEM PHYS A, V163, P296, DOI 10.1016/j.cbpa.2012.07.018; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; French SS, 2008, GEN COMP ENDOCR, V155, P148, DOI 10.1016/j.ygcen.2007.04.007; Galeotti P, 2010, COMP BIOCHEM PHYS A, V157, P354, DOI [10.1016/J.cbpa.2010.08.005, 10.1016/j.cbpa.2010.08.005]; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Halliwell B, 2007, FREE RADICALS IN BIO; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; Hasselquist D, 2012, ANIM BEHAV, V83, P1303, DOI 10.1016/j.anbehav.2012.03.025; Huff GR, 2011, BRIT POULTRY SCI, V52, P446, DOI 10.1080/00071668.2011.600753; Janeway CA, 2005, IMMUNOBIOLOGY THE IM; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Klein, 2012, ECOIMMUNOLOGY, P497; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Massot M, 2011, FUNCT ECOL, V25, P848, DOI 10.1111/j.1365-2435.2011.01837.x; McKean KA, 2011, MECHANISMS OF LIFE H; Meylan S, 2010, GEN COMP ENDOCR, V169, P158, DOI 10.1016/j.ygcen.2010.08.002; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Olsson M, 2008, J EXP BIOL, V211, P1257, DOI 10.1242/jeb.015065; Olsson M, 2008, BIOL LETTERS, V4, P186, DOI 10.1098/rsbl.2007.0611; Olsson M, 2007, MOL ECOL, V16, P5307, DOI 10.1111/j.1365-294X.2007.03578.x; Olsson M, 2007, PHYSIOL BEHAV, V91, P531, DOI 10.1016/j.physbeh.2007.04.025; Olsson M, 2012, OECOLOGIA, V170, P917, DOI 10.1007/s00442-012-2383-z; Olsson M, 2012, J EXP BIOL, V215, P575, DOI 10.1242/jeb.059352; Olsson M, 2009, NATURWISSENSCHAFTEN, V96, P25, DOI 10.1007/s00114-008-0444-2; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Rainio MJ, 2015, COMP BIOCHEM PHYS C, V167, P24, DOI 10.1016/j.cbpc.2014.08.004; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Roth O, 2009, J EVOLUTION BIOL, V24, P1410; Schneeberger K, 2013, J EXP BIOL, V216, P4514, DOI 10.1242/jeb.090837; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Sild E, 2010, BEHAV ECOL SOCIOBIOL, V64, P2065, DOI 10.1007/s00265-010-1076-z; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Tobler M, 2011, BIOL LETTERS, V7, P906, DOI 10.1098/rsbl.2011.0350; Uller T, 2006, FUNCT ECOL, V20, P873, DOI 10.1111/j.1365-2435.2006.01163.x; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Zimmerman LM, 2013, J EXP BIOL, V216, P633, DOI 10.1242/jeb.078832; Zimmerman LM, 2010, J EXP BIOL, V213, P1477, DOI 10.1242/jeb.037770; Zuk M, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P1, DOI 10.1007/978-3-642-02155-8_1	57	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126155	10.1371/journal.pone.0126155	http://dx.doi.org/10.1371/journal.pone.0126155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938441	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000145
J	Zhang, J; Chen, M; Dong, XY; Lin, RZ; Fan, JH; Chen, ZD				Zhang, Jian; Chen, Min; Dong, Xiaoyu; Lin, Ruozhu; Fan, Jianhua; Chen, Zhiduan			Evaluation of Four Commonly Used DNA Barcoding Loci for Chinese Medicinal Plants of the Family Schisandraceae	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; CHEMICAL-CONSTITUENTS; COMMUNITY PHYLOGENY; MAXIMUM-LIKELIHOOD; TRNH-PSBA; IDENTIFICATION; RBCL; BIODIVERSITY; SEQUENCES; CHINENSIS	Many species of Schisandraceae are used in traditional Chinese medicine and are faced with contamination and substitution risks due to inaccurate identification. Here, we investigated the discriminatory power of four commonly used DNA barcoding loci (ITS, trnH-psbA, matK, and rbcL) and corresponding multi-locus combinations for 135 individuals from 33 species of Schisandraceae, using distance-, tree-, similarity-, and character-based methods, at both the family level and the genus level. Our results showed that the two spacer regions (ITS and trnH-psbA) possess higher species-resolving power than the two coding regions (matK and rbcL). The degree of species resolution increased with most of the multilocus combinations. Furthermore, our results implied that the best DNA barcode for the species discrimination at the family level might not always be the most suitable one at the genus level. Here we propose the combination of ITS+trnH-psbA+matK+rbcL as the most ideal DNA barcode for discriminating the medicinal plants of Schisandra and Kadsura, and the combination of ITS+trnH-psbA as the most suitable barcode for Illicium species. In addition, the closely related species Schisandra rubriflora Rehder & E. H. Wilson and Schisandra grandifloraHook.f. & Thomson, were paraphyletic with each other on phylogenetic trees, suggesting that they should not be distinct species. Furthermore, the samples of these two species from the southern Hengduan Mountains region formed a distinct cluster that was separated from the samples of other regions, implying the presence of cryptic diversity. The feasibility of DNA barcodes for identification of geographical authenticity was also verified here. The database and paradigm that we provide in this study could be used as reference for the authentication of traditional Chinese medicinal plants utilizing DNA barcoding.	[Zhang, Jian; Chen, Min; Fan, Jianhua; Chen, Zhiduan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Chen, Min] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Dong, Xiaoyu] Jiangsu Prov & Chinese Acad Sci, Nanjing Bot Garden Mem Sun Yat Sen, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Lin, Ruozhu] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Chen, ZD (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	zhiduan@ibcas.ac.cn			National Natural Science Foundation of China [31100171, 31270268]; Major Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-2]; National Basic Research Program of China [2014CB954101]; CAS International Research & Education Development Program [SAJC201315]; CAS External Cooperation Program of BIC [GJ II Z201321]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Innovation Program of Chinese Academy of Sciences; National Basic Research Program of China(National Basic Research Program of China); CAS International Research & Education Development Program; CAS External Cooperation Program of BIC	This research was supported by National Natural Science Foundation of China grant No. 31100171 and 31270268, Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2), and National Basic Research Program of China grant No. 2014CB954101. Field work was partially supported by CAS International Research & Education Development Program (grant No. SAJC201315) and CAS External Cooperation Program of BIC (grant No. GJ II Z201321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barthelson RA, 2006, AM J BOT, V93, P566, DOI 10.3732/ajb.93.4.566; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen SL, 2014, BIOTECHNOL ADV, V32, P1237, DOI 10.1016/j.biotechadv.2014.07.004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen Z.-D., 1998, ACTA PHYTOTAXONOMICA, V36, P1; Christina VLP, 2014, MOL ECOL RESOUR, V14, P60, DOI 10.1111/1755-0998.12167; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Cronquist A, 1981, INTEGRATED SYSTEM CL; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan JH, 2011, J SYST EVOL, V49, P330, DOI 10.1111/j.1759-6831.2011.00125.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; [高建平 Gao Jianping], 2003, [中国中药杂志, China Journal of Chinese Materia Medica], V28, P706; Hao G, 2000, PLANT SYST EVOL, V223, P81, DOI 10.1007/BF00985328; Hao G, 2001, BOT J LINN SOC, V135, P401, DOI 10.1006/bojl.2000.0420; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kim JS, 2012, GENES GENOM, V34, P283, DOI 10.1007/s13258-011-0201-3; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Law Y, 1996, FLORA REIPUBLICAE PO, V30, P231; Law Y, 2002, ACTA SCI NATURALIUM, V41, P67; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; [李庭古 LI Tinggu], 2006, [海洋湖沼通报, Transactions of Oceanology and Limnology], P58; Li XK, 2013, ACTA SOC BOT POL, V82, P283, DOI 10.5586/asbp.2013.032; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lin Q., 2001, B BOT RES, V21, P161; Lin Q, 2001, B BOT RES, V21, P322; Lin Qi, 2007, Bulletin of Botanical Research, V27, P6; [林祁 Lin Qi], 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P654; Liu Haitao, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1353; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu J, 2012, INT J MOL SCI, V13, P8740, DOI 10.3390/ijms13078740; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Liu JS, 2014, PHYTOMEDICINE, V21, P1092, DOI 10.1016/j.phymed.2014.01.015; Liu M, 2012, J MED PLANTS RES, V6, P3156; [刘玉壶 Liu Yuhu], 2002, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V41, P77; Liu YN, 2009, CHEM BIODIVERS, V6, P963, DOI 10.1002/cbdv.200700433; Liu Z, 2000, ACTA BOT SIN, V42, P758; Liu Z, 2006, INT J PLANT SCI, V167, P539, DOI 10.1086/501476; Lledo MD, 1998, SYST BOT, V23, P21, DOI 10.2307/2419571; Lohne C, 2007, BOT J LINN SOC, V154, P141, DOI 10.1111/j.1095-8339.2007.00659.x; Maddison WP, 2009, MESQUITE MODULAR SYS; Mahadani P, 2014, MOL BIOL REP, V41, P7217, DOI 10.1007/s11033-014-3606-7; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morris AB, 2007, SYST BOT, V32, P236, DOI 10.1600/036364407781179734; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; National Pharmacopoeia Committee, 2010, CHIN PHARM 2010, p[4, 61, 227]; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Panossian A, 2008, J ETHNOPHARMACOL, V118, P183, DOI 10.1016/j.jep.2008.04.020; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Pei Nan-Cai, 2012, Plant Diversity and Resources, V34, P263, DOI 10.3724/SP.J.1143.2012.11173; Perret C, 2011, ARCH PEDIATRIE, V18, P750, DOI 10.1016/j.arcped.2011.03.024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purushothaman N, 2014, GENET MOL RES, V13, P2959, DOI 10.4238/2014.April.16.4; QIU YL, 1993, ANN MO BOT GARD, V80, P587, DOI 10.2307/2399848; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Saunders R. M. K., 2000, SYSTEMATIC BOT MONOG, V58, P1, DOI DOI 10.2307/25027879; Saunders RMK, 1998, SYST BOT MONOGR, V54, P1, DOI DOI 10.2307/25096646; Saunders RMK, 1997, FL MALES 1, V13, P169; Smith A. C., 1947, SARGENTIA, V7, P1; Srirama R, 2010, J ETHNOPHARMACOL, V130, P208, DOI 10.1016/j.jep.2010.04.042; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steven F, 1989, HERBS SPICES MED PLA, V4, P135; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Theodoridis S, 2012, MOL ECOL RESOUR, V12, P620, DOI 10.1111/j.1755-0998.2012.03129.x; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wang GW, 2011, J ETHNOPHARMACOL, V136, P10, DOI 10.1016/j.jep.2011.04.051; Wang VH, 2006, CHEM BIODIVERS, V3, P359, DOI 10.1002/cbdv.200690039; [王彦涵 Wang Yanhan], 2003, [复旦学报. 自然科学版, Journal of Fudan University.Natural Sciences], V42, P550; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xia N, 2008, FLORA CHINA, V7, P39; Xia N, 2008, FLORA CHINA, V7, P32; Xia YG, 2015, PHYTOCHEM REV, V14, P155, DOI 10.1007/s11101-014-9343-7; Xu LJ, 2008, J SYST EVOL, V46, P692, DOI 10.3724/SP.J.1002.2008.07112; Yang HQ, 2012, ANN BOT FENN, V49, P319, DOI 10.5735/085.049.0603; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yuan QJ, 2015, MOL ECOL RESOUR, V15, P358, DOI 10.1111/1755-0998.12296; Zou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047276; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	112	23	28	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125574	10.1371/journal.pone.0125574	http://dx.doi.org/10.1371/journal.pone.0125574			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938480	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000077
J	Clark, LN; Chan, R; Cheng, R; Liu, XM; Park, N; Parmalee, N; Kisselev, S; Cortes, E; Torres, PA; Pastores, GM; Vonsattel, JP; Alcalay, R; Marder, K; Honig, LL; Fahn, S; Mayeux, R; Shelanski, M; Di Paolo, G; Lee, JH				Clark, Lorraine N.; Chan, Robin; Cheng, Rong; Liu, Xinmin; Park, Naeun; Parmalee, Nancy; Kisselev, Sergey; Cortes, Etty; Torres, Paola A.; Pastores, Gregory M.; Vonsattel, Jean P.; Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Fahn, Stanley; Mayeux, Richard; Shelanski, Michael; Di Paolo, Gilbert; Lee, Joseph H.			Gene-Wise Association of Variants in Four Lysosomal Storage Disorder Genes in Neuropathologically Confirmed Lewy Body Disease	PLOS ONE			English	Article							SPORADIC PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; ALZHEIMERS-DISEASE; GAUCHER-DISEASE; ALPHA-SYNUCLEIN; DEMENTIA; PATHOLOGY; BRAIN; BETA-GLUCOSIDASE-2; IDENTIFICATION	Objective Variants in GBA are associated with Lewy Body (LB) pathology. We investigated whether variants in other lysosomal storage disorder (LSD) genes also contribute to disease pathogenesis. Methods We performed a genetic analysis of four LSD genes including GBA, HEXA, SMPD1, and MCOLN1 in 231 brain autopsies. Brain autopsies included neuropathologically defined LBD without Alzheimer Disease (AD) changes (n = 59), AD without significant LB pathology (n = 71), Alzheimer disease and lewy body variant (ADLBV) (n = 68), and control brains without LB or AD neuropathology (n = 33). Sequencing of HEXA, SMPD1, MCOLN1 and GBA followed by 'gene wise' genetic association analysis was performed. To determine the functional effect, a biochemical analysis of GBA in a subset of brains was also performed. GCase activity was measured in a subset of brain samples (n = 64) that included LBD brains, with or without GBA mutations, and control brains. A lipidomic analysis was also performed in brain autopsies (n = 67) which included LBD (n = 34), ADLBV (n = 3), AD (n = 4), PD (n = 9) and control brains (n = 17), comparing GBA mutation carriers to non-carriers. Results In a 'gene-wise' analysis, variants in GBA, SMPD1 and MCOLN1 were significantly associated with LB pathology (p range: 0.03-4.14 x 10(-5)). Overall, the mean levels of GCase activity were significantly lower in GBA mutation carriers compared to non-carriers (p<0.001). A significant increase and accumulation of several species for the lipid classes, ceramides and sphingolipids, was observed in LBD brains carrying GBA mutations compared to controls (p range: p<0.05-p<0.01). Interpretation Our study indicates that variants in GBA, SMPD1 and MCOLN1 are associated with LB pathology. Biochemical data comparing GBA mutation carrier to non-carriers support these findings, which have important implications for biomarker development and therapeutic strategies.	[Clark, Lorraine N.; Chan, Robin; Cortes, Etty; Vonsattel, Jean P.; Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Mayeux, Richard; Shelanski, Michael; Di Paolo, Gilbert; Lee, Joseph H.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Clark, Lorraine N.; Chan, Robin; Liu, Xinmin; Parmalee, Nancy; Kisselev, Sergey; Vonsattel, Jean P.; Mayeux, Richard; Shelanski, Michael; Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Cheng, Rong; Park, Naeun; Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Lee, Joseph H.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Torres, Paola A.; Pastores, Gregory M.; Mayeux, Richard] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Torres, Paola A.; Pastores, Gregory M.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Alcalay, Roy; Marder, Karen; Honig, Lawrence L.; Fahn, Stanley; Mayeux, Richard] Columbia Univ, Dept Neurol, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Psychiat, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Stat, New York, NY USA; [Mayeux, Richard; Lee, Joseph H.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Clark, Lorraine N.; Mayeux, Richard; Lee, Joseph H.] Columbia Univ, Ctr Human Genet, New York, NY USA	Columbia University; Columbia University; Columbia University; New York University; New York University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Clark, LN (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	LC654@cumc.columbia.edu	Pastores, Gregory M./AAE-8647-2020; Lee, Joseph H/D-2441-2012	Lee, Joseph H/0000-0002-2000-4821	National Institutes of Health [NS050487, NS060113, P50AG08702]; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050487, R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health NS050487 (LNC) NS060113 (LNC), P50AG08702 (MS), www.nih.gov; The Parkinson's Disease Foundation (www.pdf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NACC NEUR NP DIAGN C; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Clark LN, 2007, NEUROLOGY, V69, P1270, DOI 10.1212/01.wnl.0000276989.17578.02; Clark LN, 2009, ARCH NEUROL-CHICAGO, V66, P578, DOI 10.1001/archneurol.2009.54; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Gan-Or Z, 2013, NEUROLOGY, V80, P1606, DOI 10.1212/WNL.0b013e31828f180e; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Hawkes CH, 2008, MOVEMENT DISORD, V23, P1799, DOI 10.1002/mds.22242; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Irun P, 2013, CLIN GENET, V84, P356, DOI 10.1111/cge.12076; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KOLLER WC, 1992, NEUROLOGY, V42, P27; Koller WC., 1992, NEUROLOGY, V42, P41; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 2000, ANN NY ACAD SCI, V920, P1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Suzuki K, 2007, ACTA NEUROPATHOL, V114, P481, DOI 10.1007/s00401-007-0264-z; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; TRIGGSRAINE B, 1995, AM J HUM GENET, V56, P870; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Winder-Rhodes SE, 2012, MOVEMENT DISORD, V27, P312, DOI 10.1002/mds.24029; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	38	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125204	10.1371/journal.pone.0125204	http://dx.doi.org/10.1371/journal.pone.0125204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933391	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100091
J	Gdalyahu, A; Lazaro, M; Penagarikano, O; Golshani, P; Trachtenberg, JT; Gescwind, DH				Gdalyahu, Amos; Lazaro, Maria; Penagarikano, Olga; Golshani, Peyman; Trachtenberg, Joshua T.; Gescwind, Daniel H.			The Autism Related Protein Contactin-Associated Protein-Like 2 (CNTNAP2) Stabilizes New Spines: An In Vivo Mouse Study	PLOS ONE			English	Article							STRUCTURAL PLASTICITY; LONG-TERM; EXPERIENCE; CORTEX; NEOCORTEX; SYNAPSES; CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2; IMPLICATE; DYNAMICS; EPILEPSY	The establishment and maintenance of neuronal circuits depends on tight regulation of synaptic contacts. We hypothesized that CNTNAP2, a protein associated with autism, would play a key role in this process. Indeed, we found that new dendritic spines in mice lacking CNTNAP2 were formed at normal rates, but failed to stabilize. Notably, rates of spine elimination were unaltered, suggesting a specific role for CNTNAP2 in stabilizing new synaptic circuitry.	[Gdalyahu, Amos; Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol,Brain Res Inst, Integrat Ctr Learning & Memory,Semel Inst Neurosc, Los Angeles, CA 90095 USA; [Lazaro, Maria; Penagarikano, Olga; Golshani, Peyman; Gescwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet & Neurobehav Genet, Dept Neurol,Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gdalyahu, A (corresponding author), Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	amos.gdalyahu@gmail.com	Penagarikano, Olga/AAJ-2223-2020	Penagarikano, Olga/0000-0001-8153-8221	ACE Network [5RO1MH081754, RO1MH10027]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754] Funding Source: NIH RePORTER	ACE Network; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This work was supported by ACE Network grant 5RO1MH081754 and the renewal RO1MH10027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 2012, P NATL ACAD SCI US; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Holtmaat A, 2008, BEHAV BRAIN RES, V192, P20, DOI 10.1016/j.bbr.2008.04.005; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Jiang MH, 2013, J NEUROSCI, V33, P19518, DOI 10.1523/JNEUROSCI.1745-13.2013; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Munoz-Cuevas FJ, 2013, NAT NEUROSCI, V16, P1367, DOI 10.1038/nn.3498; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sudarov A, 2013, EMBO MOL MED, V5, P591, DOI 10.1002/emmm.201202106; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yu XZ, 2013, NEURON, V80, P64, DOI 10.1016/j.neuron.2013.07.014	31	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125633	10.1371/journal.pone.0125633	http://dx.doi.org/10.1371/journal.pone.0125633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951243	Green Published, gold			2022-12-26	WOS:000354214400040
J	Schade, CP; Wright, N; Gupta, R; Latif, DA; Jha, A; Robinson, J				Schade, Charles P.; Wright, Nasandra; Gupta, Rahul; Latif, David A.; Jha, Ayan; Robinson, John			Self-Reported Household Impacts of Large-Scale Chemical Contamination of the Public Water Supply, Charleston, West Virginia, USA	PLOS ONE			English	Article							ALUMINUM SULFATE; NORTH CORNWALL; DRINKING-WATER; CAMELFORD; INCIDENT; POLLUTION	A January 2014 industrial accident contaminated the public water supply of approximately 300,000 homes in and near Charleston, West Virginia (USA) with low levels of a strongly-smelling substance consisting principally of 4-methylcyclohexane methanol (MCHM). The ensuing state of emergency closed schools and businesses. Hundreds of people sought medical care for symptoms they related to the incident. We surveyed 498 households by telephone to assess the episode's health and economic impact as well as public perception of risk communication by responsible officials. Thirty two percent of households (159/498) reported someone with illness believed to be related to the chemical spill, chiefly dermatological or gastrointestinal symptoms. Respondents experienced more frequent symptoms of psychological distress during and within 30 days of the emergency than 90 days later. Sixty-seven respondent households (13%) had someone miss work because of the crisis, missing a median of 3 days of work. Of 443 households reporting extra expenses due to the crisis, 46% spent less than $100, while 10% spent over $500 (estimated average about $206). More than 80% (401/485) households learned of the spill the same day it occurred. More than 2/3 of households complied fully with "do not use" orders that were issued; only 8% reported drinking water against advice. Household assessments of official communications varied by source, with local officials receiving an average "B" rating, whereas some federal and water company communication received a "D" grade. More than 90% of households obtained safe water from distribution centers or stores during the emergency. We conclude that the spill had major economic impact with substantial numbers of individuals reporting incident-related illnesses and psychological distress. Authorities were successful supplying emergency drinking water, but less so with risk communication.	[Schade, Charles P.] West Virginia Med Inst WVMI & Qual Insights, Charleston, WV 25304 USA; [Wright, Nasandra; Gupta, Rahul; Jha, Ayan; Robinson, John] Kanawha Charleston Hlth Dept, Charleston, WV USA; [Latif, David A.; Robinson, John] Univ Charleston, Dept Pharm, Charleston, WV USA		Schade, CP (corresponding author), West Virginia Med Inst WVMI & Qual Insights, Charleston, WV 25304 USA.	charlesschade@wvmi.org	Jha, Ayan/A-7875-2014	Jha, Ayan/0000-0001-9185-2249	Kanawha-Charleston Health Department, which is the local health department in Charleston, West Virginia	Kanawha-Charleston Health Department, which is the local health department in Charleston, West Virginia	The survey was sponsored by the Kanawha-Charleston Health Department, which is the local health department in Charleston, West Virginia.	Adams C, 2014, W VIRGINIA TESTING A; Altmann P, 1999, BMJ-BRIT MED J, V319, P807, DOI 10.1136/bmj.319.7213.807; [Anonymous], 2014, UNITED WAY PARTNER A; [Anonymous], 2014, CHARLESTON DAILY MAI; [Anonymous], 2011, SAFETY DATA SHEET CR; [Anonymous], 2014, HUFFINGTON POST; [Anonymous], 2014, QUESTIONS ANSWERS RE; [Anonymous], 2014, WVAW OPERATION LOG 1; Barwick R S, 2000, MMWR CDC Surveill Summ, V49, P1; Centers for Disease Control and Prevention, 2012, CRIS EM RISK COMM MA; Centers for Disease Control and Prevention, 2014, DIS RESP REC NEEDS C; Centers for Disease Control and Prevention, 2014, 2014 W VIRG CHEM REL; Centers for Disease Control and Prevention (CDC), 2014, BEH RISK FACT SURV S; COGGON D, 1991, BRIT MED J, V303, P1280, DOI 10.1136/bmj.303.6813.1280; Fowle SE, 1996, J EPIDEMIOL COMMUN H, V50, P18, DOI 10.1136/jech.50.1.18; Galarce EM, 2012, DISASTER MED PUBLIC, V6, P349, DOI 10.1001/dmp.2012.62; GOLDING J, 1991, BRIT MED J, V302, P1175, DOI 10.1136/bmj.302.6786.1175; Hilborn ED, 2013, MMWR-MORBID MORTAL W, V62, P714; Kahn JP, 2010, LONG HONED ALERT SYS; Kramer M H, 1996, MMWR CDC Surveill Summ, V45, P1; LAWSON R, 1991, BRIT MED J, V303, P1480, DOI 10.1136/bmj.303.6815.1480-b; Lee Sherline H, 2002, MMWR Surveill Summ, V51, P1; Levy D A, 1998, MMWR CDC Surveill Summ, V47, P1; MCMILLAN TM, 1993, J CHILD PSYCHOL PSYC, V34, P1449, DOI 10.1111/j.1469-7610.1993.tb02102.x; Moore Anne C., 1993, Morbidity and Mortality Weekly Report, V42, P1; OWEN PJ, 1995, J PUBLIC HEALTH MED, V17, P200, DOI 10.1093/oxfordjournals.pubmed.a043093; Owen PJ, 2002, BRIT MED J, V324, P1189, DOI 10.1136/bmj.324.7347.1189; ROWLAND A, 1990, J ROY SOC HEALTH, V110, P166, DOI 10.1177/146642409011000507; Rundblad G, 2014, INT J ENV RES PUB HE, V11, P11915, DOI 10.3390/ijerph111111915; Toccalino PL, 2012, SCI TOTAL ENVIRON, V431, P262, DOI 10.1016/j.scitotenv.2012.05.044; U.S. Bureau of the Census, 2011, 2010 CENS DEM PROF W; U.S. Census Bureau, 2014, STAT COUNT QUICK FAC; West Virginia Department of Health and Human Resources, 2014, ELK RIV CHEM SPILL H; West Virginia Department of Health and Human Resources, 2014, ELK RIV CHEM SPILL M; White K, 2014, MORE QUESTIONS ANSWE	35	20	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126744	10.1371/journal.pone.0126744	http://dx.doi.org/10.1371/journal.pone.0126744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH7KF	25951197	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400107
J	Han, CC; Wei, SH; He, F; Liu, DD; Wan, HF; Liu, HH; Li, L; Xu, HY; Du, XH; Xu, F				Han, Chunchun; Wei, Shouhai; He, Fang; Liu, Dandan; Wan, Huofu; Liu, Hehe; Li, Liang; Xu, Hongyong; Du, Xiaohui; Xu, Feng			The Regulation of Lipid Deposition by Insulin in Goose Liver Cells Is Mediated by the PI3K-AKT-mTOR Signaling Pathway	PLOS ONE			English	Article							MAMMALIAN TARGET; CARNITINE PALMITOYLTRANSFERASE; HEPATIC LIPOGENESIS; GENE-EXPRESSION; RESISTANCE; RAPAMYCIN; METABOLISM; GROWTH; TRIGLYCERIDES; STIMULATION	Background We previously showed that the fatty liver formations observed in overfed geese are accompanied by the activation of the PI3K-Akt-mTOR pathway and an increase in plasma insulin concentrations. Recent studies have suggested a crucial role for the PI3K-Akt-mTOR pathway in regulating lipid metabolism; therefore, we hypothesized that insulin affects goose hepatocellular lipid metabolism through the PI3K-Akt-mTOR signaling pathway. Methods Goose primary hepatocytes were isolated and treated with serum-free media supplemented with PI3K-Akt-mTOR pathway inhibitors (LY294002, rapamycin, and NVP-BEZ235, respectively) and 50 or 150 nmol/L insulin. Results Insulin induced strong effects on lipid accumulation as well as the mRNA and protein levels of genes involved in lipogenesis, fatty acid oxidation, and VLDL-TG assembly and secretion in primary goose hepatocytes. The stimulatory effect of insulin on lipogenesis was significantly decreased by treatment with PI3K-Akt-mTOR inhibitors. These inhibitors also rescued the insulin-induced down-regulation of fatty acid oxidation and VLDL-TG assembly and secretion. Conclusion These findings suggest that the stimulatory effect of insulin on lipid deposition is mediated by PI3K-Akt-mTOR regulation of lipogenesis, fatty acid oxidation, and VLDL-TG assembly and secretion in goose hepatocytes.	[Han, Chunchun; Wei, Shouhai; He, Fang; Liu, Dandan; Wan, Huofu; Liu, Hehe; Li, Liang; Xu, Hongyong; Du, Xiaohui; Xu, Feng] Sichuan Agr Univ, Inst Anim Breeding & Genet, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University	Han, CC (corresponding author), Sichuan Agr Univ, Inst Anim Breeding & Genet, Chengdu 611130, Sichuan, Peoples R China.	chunchunhai_510@163.com	Li, Liang/AAG-7614-2020	Li, Liang/0000-0001-9139-5025; du, xiaohui/0000-0001-6788-8997	National Natural Science Funds of China [31101712]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Funds of China [31101712]. Website: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2007, DIABETOLOGIA, V50, P2356, DOI 10.1007/s00125-007-0790-1; Au CS, 2004, METABOLISM, V53, P228, DOI 10.1016/j.metabol.2003.09.011; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; Brown AM, 2001, ARTERIOSCL THROM VAS, V21, P1656, DOI 10.1161/hq1001.096640; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Drynan L, 1996, BIOCHEM J, V317, P791, DOI 10.1042/bj3170791; Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Han CC, 2008, ASIAN AUSTRAL J ANIM, V21, P590, DOI 10.5713/ajas.2008.70472; Jackel-Cram C, 2010, J GEN VIROL, V91, P1388, DOI 10.1099/vir.0.017418-0; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauvoisin D, 2007, J CELL COMMUN SIGNAL, V1, P113, DOI 10.1007/s12079-007-0011-1; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Mori M, 2001, J LIPID RES, V42, P1771; Mourot J, 2000, COMP BIOCHEM PHYS B, V126, P81, DOI 10.1016/S0305-0491(00)00171-1; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Parent R, 2007, CANCER RES, V67, P4337, DOI 10.1158/0008-5472.CAN-06-3640; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Pavlic M, 2010, DIABETES, V59, P580, DOI 10.2337/db09-1297; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Saudemont A, 2009, CELL CYCLE, V8, P3307, DOI 10.4161/cc.8.20.9692; Seglen P., 1967, METHODS CELL BOIL, V13, P29; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Softic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038952; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Takashima Mototsugu, 2009, Kobe J Med Sci, V55, pE45; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	35	64	66	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0098759	10.1371/journal.pone.0098759	http://dx.doi.org/10.1371/journal.pone.0098759			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945932	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700001
J	Zhou, J; Lu, GD; Wang, HL; Zhang, JF; Duan, JA; Ma, HY; Wu, QN				Zhou, Jing; Lu, Guodi; Wang, Honglan; Zhang, Junfeng; Duan, Jinao; Ma, Hongyue; Wu, Qinan			Molecular Structure-Affinity Relationship of Bufadienolides and Human Serum Albumin In Vitro and Molecular Docking Analysis	PLOS ONE			English	Article							BINDING; ASSOCIATION; VERAPAMIL	The development of bufadienolides as anti-tumor agents is limited due to poor pharmacokinetic properties regarding drug half-lives and toxicity in vivo. These serious factors might be improved by increasing the drug/albumin-binding ratio. This study therefore investigated the relationship between the structural properties of nine bufadienolides and their affinities for human serum albumin (HSA) by a fluorescence spectroscopy-based analysis and molecular docking. Fluorescence quenching data showed that the interaction of each bufadienolide with HSA formed a non-fluorescent complex, while thermodynamic parameters revealed negative.S and.H values, corresponding to changes in enthalpy and entropy, respectively. The structural differences between the various bufadienolides markedly influenced their binding affinity for HSA. With the exception of a C = O bond at the C12 position that decreased the binding affinity for HSA, other polar groups tended to increase the affinity, especially a hydroxyl (OH) group at assorted bufadienolide sites. The rank order of binding affinities for drugs with tri-hydroxyl groups was as follows: 11-OH > 5-OH > 16-OH; in addition, 16-acetoxy (OAc), 10-aldehyde and 14-epoxy constituents notably enhanced the binding affinity. Among these groups, 11-OH and 16-acetyl were especially important for a seamless interaction between the bufadienolides and HSA. Furthermore, molecular docking analysis revealed that either an 11-OH or a 16-OAc group spatially close to a five-membered lactone ring significantly facilitated the anchoring of these compounds within site I of the HSA pocket via hydrogen bonding (H-bonding) with Tyr150 or Lys199, respectively. In summary, bufadienolide structure strongly affects binding with HSA, and 11-OH or 16-OAc groups improve the drug association with key amino acid residues. This information is valuable for the prospective development of bufadienolides with improved pharmacological profiles as novel anti-tumor drugs.	[Zhou, Jing; Lu, Guodi; Wang, Honglan; Duan, Jinao; Ma, Hongyue; Wu, Qinan] Nanjing Univ Chinese Med, Coll Pharm, Collaborat Innovat Ctr Chinese Med Resources Ind, Nanjing, Jiangsu, Peoples R China; [Zhang, Junfeng] Nanjing Univ Chinese Med, Coll Basic Med, Nanjing, Jiangsu, Peoples R China; [Lu, Guodi] Gansu Univ Tradit Chinese Med, Lanzhou, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Gansu University of Chinese Medicine	Ma, HY (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Collaborat Innovat Ctr Chinese Med Resources Ind, Nanjing, Jiangsu, Peoples R China.	hongyuema@126.com; qnwyjs@163.com		Wu, Qinan/0000-0002-7836-0941	National Science Fund [81102762, 30901894, 81274199]; Open Fund of Collaborative Innovation Center of Chinese Medicinal Resources Industrialization [ZDXM-1-14]; Six talent peaks project in Jiangsu Province [YY-015]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Science Fund; Open Fund of Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; Six talent peaks project in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Science Fund (81102762, 30901894 and 81274199) http://www.nsfc.gov.cn/; Open Fund of Collaborative Innovation Center of Chinese Medicinal Resources Industrialization (ZDXM-1-14) http://zyzyxt2011.njutcm.edu.cn; Six talent peaks project in Jiangsu Province (YY-015); A project founded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolli A, 2010, BIOCHEM BIOPH RES CO, V398, P444, DOI 10.1016/j.bbrc.2010.06.096; Bourassa P, 2011, EUR J MED CHEM, V46, P4344, DOI 10.1016/j.ejmech.2011.07.005; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Caruso IP, 2012, SPECTROCHIM ACTA A, V97, P449, DOI 10.1016/j.saa.2012.06.043; Farahani BV, 2015, SPECTROCHIM ACTA A, V135, P410, DOI 10.1016/j.saa.2014.06.078; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; He Y, 2008, J FLUORESC, V18, P433, DOI 10.1007/s10895-007-0283-0; JUSKO WJ, 1976, DRUG METAB REV, V5, P43, DOI 10.3109/03602537608995839; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu L, 2012, BIOORG MED CHEM LETT, V22, P154, DOI 10.1016/j.bmcl.2011.11.041; Lu Guo-di, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P768; Ma HY, 2013, TOXICOL IN VITRO, V27, P396, DOI 10.1016/j.tiv.2012.08.011; Ma HY, 2012, CARDIOVASC TOXICOL, V12, P83, DOI 10.1007/s12012-011-9142-y; Ma HY, 2012, EXP TOXICOL PATHOL, V64, P417, DOI 10.1016/j.etp.2010.10.007; Mallik R, 2008, J CHROMATOGR B, V876, P69, DOI 10.1016/j.jchromb.2008.10.022; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Qi Z, 2008, J PHARMACEUT BIOMED, V46, P699, DOI 10.1016/j.jpba.2007.10.016; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Steyn PS, 1998, NAT PROD REP, V15, P397; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Watabe M, 1996, J BIOL CHEM, V271, P14067, DOI 10.1074/jbc.271.24.14067; Xiao JB, 2010, MOL NUTR FOOD RES, V54, pS253, DOI 10.1002/mnfr.200900454; Yang F, 2014, INT J MOL SCI, V15, P3580, DOI 10.3390/ijms15033580; Zhang Y, 2008, ANAL CHIM ACTA, V610, P224, DOI 10.1016/j.aca.2008.01.029	27	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126669	10.1371/journal.pone.0126669	http://dx.doi.org/10.1371/journal.pone.0126669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946161	Green Submitted, gold, Green Published			2022-12-26	WOS:000354049700139
J	Cetinkaya, M; Cansev, M; Cekmez, F; Tayman, C; Canpolat, FE; Kafa, IM; Yaylagul, EO; Kramer, BW; Sarici, SU				Cetinkaya, Merih; Cansev, Mehmet; Cekmez, Ferhat; Tayman, Cuneyt; Canpolat, Fuat Emre; Kafa, Ilker Mustafa; Yaylagul, Esra Orenlili; Kramer, Boris W.; Sarici, Serdar Umit			Protective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat Model	PLOS ONE			English	Article							GENE-EXPRESSION; BCL-2; PATHOGENESIS; EXPOSURE; PATHWAY; LPS; BAX	Objective Histone acetylation and deacetylation may play a role in the pathogenesis of inflammatory lung diseases. We evaluated the preventive effect of valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, on neonatal hyperoxic lung injury. Methods Forty newborn rat pups were randomized in normoxia, normoxia+VPA, hyperoxia and hyperoxia+VPA groups. Pups in the normoxia and normoxia+VPA groups were kept in room air and received daily saline and VPA (30 mg/kg) injections, respectively, while those in hyperoxia and hyperoxia+VPA groups were exposed to 95% O2 and received daily saline and VPA (30 mg/kg) injections for 10 days, respectively. Growth, histopathological, biochemical and molecular biological indicators of lung injury, apoptosis, inflammation, fibrosis and histone acetylation were evaluated. Results VPA treatment during hyperoxia significantly improved weight gain, histopathologic grade, radial alveolar count and lamellar body membrane protein expression, while it decreased number of TUNEL(+) cells and active Caspase- 3 expression. Expressions of TGF beta 3 and phospho- SMAD2 proteins and levels of tissue proinflammatory cytokines as well as lipid peroxidation biomarkers were reduced, while anti- oxidative enzyme activities were enhanced by VPA treatment. VPA administration also reduced HDAC activity while increasing acetylated H3 and H4 protein expressions. Conclusions The present study shows for the first time that VPA treatment ameliorates lung damage in a neonatal rat model of hyperoxic lung injury. The preventive effect of VPA involves HDAC inhibition.	[Cetinkaya, Merih; Cekmez, Ferhat; Tayman, Cuneyt; Canpolat, Fuat Emre; Sarici, Serdar Umit] Gulhane Mil Med Acad, Dept Pediat, Div Neonatol, Ankara, Turkey; [Cansev, Mehmet] Uludag Univ, Sch Med, Dept Pharmacol, Bursa, Turkey; [Kafa, Ilker Mustafa] Uludag Univ, Sch Med, Dept Anat, Bursa, Turkey; [Yaylagul, Esra Orenlili] Uludag Univ, Sch Arts & Sci, Dept Biol, Bursa, Turkey; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, NL-6200 MD Maastricht, Netherlands	Gulhane Military Medical Academy; Uludag University; Uludag University; Uludag University; Maastricht University	Cetinkaya, M (corresponding author), Gulhane Mil Med Acad, Dept Pediat, Div Neonatol, Ankara, Turkey.	drmerih@yahoo.com	Canpolat, Fuat Emre/P-3992-2018; Yaylagül, Esra Örenlili/V-4209-2018; Kafa, İlker/AAG-7125-2021; Cetinkaya, Merih/AFP-9671-2022; Cansev, Mehmet/M-9071-2019; Kramer, Boris/AAO-3183-2021; Yaylagül, Esra Örenlili/ABH-4915-2020	Canpolat, Fuat Emre/0000-0001-9307-3003; Yaylagül, Esra Örenlili/0000-0002-5206-1185; Yaylagül, Esra Örenlili/0000-0002-5206-1185				Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Albertine K, 2008, PED AC SOC ANN M HON, P30602; ASKENAZI SS, 1979, ARCH DIS CHILD, V54, P614, DOI 10.1136/adc.54.8.614; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Biniwale MA, 2006, SEMIN PERINATOL, V30, P200, DOI 10.1053/j.semperi.2006.05.007; Cetinkaya M, 2013, PEDIATR RES, V74, P26, DOI 10.1038/pr.2013.68; Cohen J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r210; Collins JJP, 2013, AM J PHYSIOL-LUNG C, V304, pL438, DOI 10.1152/ajplung.00251.2012; Doyle DW, 2014, COCHRANE DB SYST REV, V13; Doyle DW, 2014, COCHRANE DB SYST REV, V5, DOI [10.1002/14651858.CD001146.pub4, DOI 10.1002/14651858.CD001146.PUB4]; Feng DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080657; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Husari AW, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-100; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; Kotecha S, 1996, J PEDIATR-US, V128, P464, DOI 10.1016/S0022-3476(96)70355-4; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Madurga A, 2013, AM J PHYSIOL-LUNG C, V305, pL893, DOI 10.1152/ajplung.00267.2013; Malaeb SN, 2014, CLIN PERINATOL, V41, P191, DOI 10.1016/j.clp.2013.09.006; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; O'Reilly MA, 2000, LAB INVEST, V80, P1845, DOI 10.1038/labinvest.3780195; Ozdulger A, 2003, SHOCK, V19, P366, DOI 10.1097/00024382-200304000-00012; Pfister RH, 2011, NEOREVIEWS, V12, pe635; Roullet FI, 2010, NEUROSCIENCE, V170, P514, DOI 10.1016/j.neuroscience.2010.06.069; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Shang Y, 2010, CHINESE MED J-PEKING, V123, P2682, DOI 10.3760/cma.j.issn.0366-6999.2010.19.012; Shanmugam Muthu K, 2013, Subcell Biochem, V61, P627, DOI 10.1007/978-94-007-4525-4_27; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Sonnemann J, 2014, BRIT J CANCER, V110, P656, DOI 10.1038/bjc.2013.742; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Tulloch Joanie K, 2012, J Pediatr Pharmacol Ther, V17, P31, DOI 10.5863/1551-6776-17.1.31; Unal E, 2007, HUM EXP TOXICOL, V26, P453, DOI 10.1177/0960327107076835	37	12	15	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126028	10.1371/journal.pone.0126028	http://dx.doi.org/10.1371/journal.pone.0126028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938838	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000132
J	Lamp, O; Derno, M; Otten, W; Mielenz, M; Nurnberg, G; Kuhla, B				Lamp, Ole; Derno, Michael; Otten, Winfried; Mielenz, Manfred; Nuernberg, Gerd; Kuhla, Bjoern			Metabolic Heat Stress Adaption in Transition Cows: Differences in Macronutrient Oxidation between Late-Gestating and Early-Lactating German Holstein Dairy Cows	PLOS ONE			English	Article							HIGH AMBIENT-TEMPERATURE; FEED-INTAKE; PLASMA 3-METHYLHISTIDINE; TECHNICAL-NOTE; DRY PERIOD; PROTEIN; CATTLE; SUPPLEMENTATION; NUTRIENTS; ADAPTATIONS	High ambient temperatures have severe adverse effects on biological functions of high-yielding dairy cows. The metabolic adaption to heat stress was examined in 14 German Holsteins transition cows assigned to two groups, one heat-stressed (HS) and one pair-fed (PF) at the level of HS. After 6 days of thermoneutrality and ad libitum feeding (P1), cows were challenged for 6 days (P2) by heat stress (temperature humidity index (THI) = 76) or thermoneutral pair-feeding in climatic chambers 3 weeks ante partum and again 3 weeks post-partum. On the sixth day of each period P1 or P2, oxidative metabolism was analyzed for 24 hours in open circuit respiration chambers. Water and feed intake, vital parameters and milk yield were recorded. Daily blood samples were analyzed for glucose, beta-hydroxybutyric acid, non-esterified fatty acids, urea, creatinine, methyl histidine, adrenaline and noradrenaline. In general, heat stress caused marked effects on water homeorhesis with impairments of renal function and a strong adrenergic response accompanied with a prevalence of carbohydrate oxidation over fat catabolism. Heat-stressed cows extensively degraded tissue protein as reflected by the increase of plasma urea, creatinine and methyl histidine concentrations. However, the acute metabolic heat stress response in dry cows differed from early-lactating cows as the prepartal adipose tissue was not refractory to lipolytic, adrenergic stimuli, and the rate of amino acid oxidation was lower than in the postpartal stage. Together with the lower endogenous metabolic heat load, metabolic adaption in dry cows is indicative for a higher heat tolerance and the prioritization of the nutritional requirements of the fast-growing near-term fetus. These findings indicate that the development of future nutritional strategies for attenuating impairments of health and performance due to ambient heat requires the consideration of the physiological stage of dairy cows.	[Lamp, Ole; Derno, Michael; Mielenz, Manfred; Kuhla, Bjoern] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Otten, Winfried] Leibniz Inst Farm Anim Biol FBN, Inst Behav Physiol, Dummerstorf, Germany; [Nuernberg, Gerd] Leibniz Inst Farm Anim Biol FBN, Inst Genet & Biometry, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Kuhla, B (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	b.kuhla@fbn-dummerstorf.de	Otten, Winfried/V-8376-2019; Mielenz, Manfred/ABB-2293-2021	Otten, Winfried/0000-0002-5613-5356; 	Leibniz Institute for Farm Animal Biology (FBN), Germany	Leibniz Institute for Farm Animal Biology (FBN), Germany	This study was supported by the core budget of the Leibniz Institute for Farm Animal Biology (FBN), Germany.	ALBIN RC, 1966, J ANIM SCI, V25, P107, DOI 10.2527/jas1966.251107x; ALVAREZ MB, 1973, J DAIRY SCI, V56, P189, DOI 10.3168/jds.S0022-0302(73)85145-8; Asai Hideki, 2005, Animal Science Journal, V76, P51, DOI 10.1111/j.1740-0929.2005.00237.x; BAIRD GD, 1972, BIOCHEM J, V128, P1311, DOI 10.1042/bj1281311; Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Baumgard LH, 2011, J DAIRY SCI, V94, P5620, DOI 10.3168/jds.2011-4462; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Baumgard LH, 2002, J ANIM SCI, V80, P1285; BEEDE DK, 1986, J ANIM SCI, V62, P543, DOI 10.2527/jas1986.622543x; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Bernabucci U, 2002, J DAIRY SCI, V85, P2173, DOI 10.3168/jds.S0022-0302(02)74296-3; BLUMENKRANTZ MJ, 1980, AM J CLIN NUTR, V33, P1567, DOI 10.1093/ajcn/33.7.1567; Blummel M, 1999, J ANIM PHYSIOL AN N, V81, P157, DOI 10.1046/j.1439-0396.1999.813205.x; Brouwer E., 1965, ENERGY METABOLISM FA, V11, P441, DOI DOI 10.1017/S1751731118001489; Chwalibog A, 1996, ARCH ANIM NUTR, V49, P255, DOI 10.1080/17450399609381888; COLLIER RJ, 1982, J DAIRY SCI, V65, P2213, DOI 10.3168/jds.S0022-0302(82)82484-3; Dale H, 1954, MISSOURI AGR EXP STA, P562; Derno M, 2005, J ANIM SCI, V83, P2590; Derno M, 2013, J DAIRY SCI, V96, P971, DOI 10.3168/jds.2012-5727; Derno M, 2009, J DAIRY SCI, V92, P2804, DOI 10.3168/jds.2008-1839; do Amaral BC, 2011, J DAIRY SCI, V94, P86, DOI 10.3168/jds.2009-3004; do Amaral BC, 2009, J DAIRY SCI, V92, P5988, DOI 10.3168/jds.2009-2343; Dunn RJH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064006; FUQUAY JW, 1981, J ANIM SCI, V52, P164, DOI 10.2527/jas1981.521164x; GfE, 2001, EMPFEHLUNGEN ZUR ENE; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Hahn GL, 1999, J ANIM SCI, V77, P10; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Kamiya M, 2006, ANIM SCI J, V77, P201, DOI 10.1111/j.1740-0929.2006.00338.x; Kamiya M, 2006, ASIAN AUSTRAL J ANIM, V19, P1159, DOI 10.5713/ajas.2006.1159; Khelil-Arfa H, 2014, J DAIRY SCI, V97, P2305, DOI 10.3168/jds.2013-7079; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Ma Y, 2011, PLACENTA, V32, P255, DOI 10.1016/j.placenta.2011.01.007; Marini JC, 2005, J DAIRY SCI, V88, P1778, DOI 10.3168/jds.S0022-0302(05)72852-6; Nardone A, 2010, LIVEST SCI, V130, P57, DOI 10.1016/j.livsci.2010.02.011; NRC, 1971, GUIDE ENV RES ANIMAL; Obitsu T, 2011, ANIM SCI J, V82, P531, DOI 10.1111/j.1740-0929.2011.00880.x; Pere MC, 2003, REPROD NUTR DEV, V43, P1, DOI 10.1051/rnd:2003002; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rhoads RP, 2013, J ANIM SCI, V91, P2492, DOI 10.2527/jas.2012-6120; Rungruang S, 2014, J DAIRY SCI, V97, P5023, DOI 10.3168/jds.2013-6970; Sawka MN, 2000, MED SCI SPORT EXER, V32, P332, DOI 10.1097/00005768-200002000-00012; SCHNEIDER PL, 1988, J ANIM SCI, V66, P112, DOI 10.2527/jas1988.661112x; Shwartz G, 2009, J DAIRY SCI, V92, P935, DOI 10.3168/jds.2008-1496; SILANIKOVE N, 1992, LIVEST PROD SCI, V30, P175, DOI 10.1016/S0301-6226(06)80009-6; SILANIKOVE N, 1994, EXP PHYSIOL, V79, P281, DOI 10.1113/expphysiol.1994.sp003764; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Smith BP, 2014, LARGE ANIMAL INTERNA; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Urdaz JH, 2006, J DAIRY SCI, V89, P2000, DOI 10.3168/jds.S0022-0302(06)72267-6; Walter K, 2010, LANDBAUFORSCHUNG APP, V60; WAYMAN O, 1962, J DAIRY SCI, V45, P1472, DOI 10.3168/jds.S0022-0302(62)89658-1; Weber C, 2013, J DAIRY SCI, V96, P165, DOI 10.3168/jds.2012-5574; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Windisch W, 1995, J ANIM PHYSIOL AN N, V74, P274, DOI 10.1111/j.1439-0396.1995.tb00461.x; Zhang FJ, 2014, J ANIM SCI, V92, P3026, DOI 10.2527/jas.2013-6932; Zimbelman RB, 2010, J DAIRY SCI, V93, P2387, DOI 10.3168/jds.2009-2557	61	50	51	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125264	10.1371/journal.pone.0125264	http://dx.doi.org/10.1371/journal.pone.0125264			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938406	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000054
J	Naghavian, R; Ghaedi, K; Kiani-Esfahani, A; Ganjalikhani-Hakemi, M; Etemadifar, M; Nasr-Esfahani, MH				Naghavian, Reza; Ghaedi, Kamran; Kiani-Esfahani, Abbas; Ganjalikhani-Hakemi, Mazdak; Etemadifar, Masoud; Nasr-Esfahani, Mohammad Hossein			miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis	PLOS ONE			English	Article							HELPER T-CELLS; MICRORNAS; TH17; EXPRESSION; ACTIVATION; PATHWAYS; DISEASE; T(H)17	Background One of the main issues in pathogenesis of MS is Th17/Treg imbalance. There are growing interests in nominating miRNAs involved in Th17 cell differentiation, suggesting them as new therapeutic agents that may reduce progression of different autoimmune diseases specially MS. Objectives We assessed transcript levels of miR-141 and miR-200a in MS patients, during relapsing and remitting phases. We also investigated possible role of miR-141, miR-200a in inducing differentiation to Th17 cells. Materials and Methods Forty RR-MS patient samples including relapsing (n=20) and remitting (n=20) phases were chosen. Expression level of miR-141 and miR-200a were measured by RT-q PCR and compared to healthy control group (n=10). In-silico analyses on miR-141 and miR-200a targetome showed involvement of both miRNAs in T helper cell differentiation pathways including TGF-beta, mTOR and JAK/STAT. Results We observed that percentage of ROR gamma t(+) CD4(+) T cells increase in relapsing phase while FOXP3(+) CD4(+) increase in remitting phase of MS patients. Furthermore, both miR-141 and miR-200a show up-regulation in relapsing phase of MS patients compared to remitting and control groups. Interestingly, expression level of target genes of miR-141 and miR-200a, which were assessed through in-silico methods, show down-regulation in relapsing phase of MS patients. Conclusions According to our results, miR-141 and miR-200a may be key miRNAs in progression of symptoms of MS through inducing differentiation of Th17 cells and inhibiting differentiation to Treg cells. Our data suggest that these miRNAs may probably inhibit negative regulators of Th17 cell differentiation, thus promoting its differentiation.	[Naghavian, Reza; Ghaedi, Kamran] Univ Isfahan, Fac Sci, Dept Biol, Div Cellular & Mol Biol, Esfahan, Iran; [Naghavian, Reza; Ghaedi, Kamran; Kiani-Esfahani, Abbas; Nasr-Esfahani, Mohammad Hossein] Royan Inst Biotechnol, ACECR, Cell Sci Res Ctr, Dept Cellular Biotechnol, Esfahan, Iran; [Etemadifar, Masoud] Isfahan Univ Med Sci, Sch Med, Dept Neurol, Esfahan, Iran; [Etemadifar, Masoud] Multiple Sclerosis & Neuroimmunol Res Ctr, Esfahan, Iran; [Ghaedi, Kamran; Ganjalikhani-Hakemi, Mazdak] Isfahan Univ Med Sci, Fac Med, Cellular & Mol Immunol Res Ctr, Esfahan, Iran; [Ganjalikhani-Hakemi, Mazdak] Isfahan Univ Med Sci, Sch Med, Dept Immunol, Esfahan, Iran	University of Isfahan; Academic Center for Education, Culture & Research (ACECR); Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science	Ghaedi, K (corresponding author), Univ Isfahan, Fac Sci, Dept Biol, Div Cellular & Mol Biol, Esfahan, Iran.	kamranghaedi@royaninstitute.org; mh_nasr@royaninstitute.org	Hakemi, Mazdak Ganjalikhani/V-7950-2017; Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020; , Nasr-Esfahani/AAR-2434-2021; Ghaedi, Kamran/X-9824-2018	Hakemi, Mazdak Ganjalikhani/0000-0002-4764-7616; Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; Ghaedi, Kamran/0000-0002-9790-5644	Cellular and Molecular Immunology Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran [292283]; Multiple Sclerosis and NeuroImmunology Research Center; University of Isfahan; Royan Institute [91000573]	Cellular and Molecular Immunology Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Multiple Sclerosis and NeuroImmunology Research Center; University of Isfahan; Royan Institute	This study was funded partly by a grant-inaid of research from Cellular and Molecular Immunology Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran (Grant no. 292283), Multiple Sclerosis and NeuroImmunology Research Center and University of Isfahan and mainly by Royan Institute (Grant no. 91000573) in support of RN for obtaining his M. Sc. degree from the University of Isfahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Edwards LJ, 2011, J NEUROL, V258, P1518, DOI 10.1007/s00415-011-5973-5; Etemadifar M, 2013, MULT SCLER J; Fenoglio C, 2011, NEUROSCI LETT, V504, P9, DOI 10.1016/j.neulet.2011.08.021; Fontenot JD., 2003, NAT IMMUNOL, V4, P4; Hakemi MG, 2011, IN VITRO CELL DEV-AN, V47, P581, DOI 10.1007/s11626-011-9444-1; Honardoost MA, 2014, GENE, V544, P128, DOI 10.1016/j.gene.2014.04.069; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Jadidi-Niaragh F, 2012, IMMUNOPHARM IMMUNOT, V34, P727, DOI 10.3109/08923973.2011.619987; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu X, 2014, J BIOL CHEM; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Sievers C, 2012, CLIN IMMUNOL, V144, P70, DOI 10.1016/j.clim.2012.04.002; Soldan SS, 2008, NEUROIMMUNE PHARM, P239; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	35	61	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124555	10.1371/journal.pone.0124555	http://dx.doi.org/10.1371/journal.pone.0124555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938517	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000029
J	Sun, HY; Hsueh, PR; Liu, WC; Su, YC; Chang, SY; Hung, CC; Chang, SC				Sun, Hsin-Yun; Hsueh, Po-Ren; Liu, Wen-Chun; Su, Yi-Ching; Chang, Sui-Yuan; Hung, Chien-Ching; Chang, Shan-Chwen			Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot. TB Test	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; INTERFERON-GAMMA; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALUE; DOUBLE-BLIND; DIAGNOSIS; ADULTS; ERA	Background Interferon-gamma release assays (IGRAs) have been used to identify individuals at risk for developing active tuberculosis (TB). However, data regarding the risk of TB development in HIV-infected patients testing positive for IGRAs remain sparse in the era of combination antiretroviral therapy. Methods Between 2011 and 2013, 608 HIV-infected patients without active TB undergoing T-Spot. TB testing were enrolled in this prospective observational study at a university hospital designated for HIV care in Taiwan with a declining TB incidence from 72 per 100,000 population in 2005 to 53 per 100,000 population in 2012. All of the subjects were followed until September 30, 2014. The national TB registry was accessed to identify any TB cases among those lost to follow-up. Results T-Spot. TB tested negative in 534 patients (87.8%), positive in 64 patients (10.5%), and indeterminate in 10 patients (1.6%). In multivariate analysis, positive T-Spot. TB was significantly associated with older age (adjusted odds ratio [AOR], 1.172 per 10-year increase; 95% confidence interval [CI], 1.022-1.344, P=0.023), past history of TB (AOR, 13.412; 95% CI, 6.106-29.460, P<0.001), and higher CD4 counts at enrollment (AOR, per 50-cell/mu l increase, 1.062; 95% CI, 1.017-1.109, P=0.007). Of the 64 patients testing positive for T-Spot. TB, none received isoniazid preventive therapy and all but 5 received combination antiretroviral therapy at the end of follow-up with the latest CD4 count and plasma HIV RNA load being 592.8 cells/mu L and 1.85 log(10) copies/mL, respectively. One patient (1.6%) developed active TB after 167 person-years of follow-up (PYFU), resulting in an incidence rate of 0.599 per 100 PFYU. None of the 534 patients testing negative for T-Spot. TB developed TB after 1380 PYFU, nor did the 24 patients with old TB and positive T-Spot. TB tests develop TB after 62.33 PYFU. Conclusions The risk of developing active TB in HIV-infected patients with positive T-Spot. TB receiving combination antiretroviral therapy is low in Taiwan where the national TB program has led to a sustained decrease in TB incidence.	[Sun, Hsin-Yun; Hsueh, Po-Ren; Liu, Wen-Chun; Su, Yi-Ching; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Sun, Hsin-Yun; Hsueh, Po-Ren; Liu, Wen-Chun; Su, Yi-Ching; Chang, Sui-Yuan; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsueh, Po-Ren; Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	hcc0401@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225; Hung, Chien-Ching/0000-0001-7345-0836; CHANG, SHAN-CHWEN/0000-0001-6505-4139; CHANG, SUI-YUAN/0000-0002-6009-6724; SUN, HSIN-YUN/0000-0003-0074-7721	Research Center for Biotechnologyy and Medicine Policy, Taiwan [DOH100-DC-1022]	Research Center for Biotechnologyy and Medicine Policy, Taiwan	This study was supported by grants from the Research Center for Biotechnologyy and Medicine Policy (grant number, DOH100-DC-1022), Taiwan. The funding source had no role in study design and conduct, data collection, analysis, or interpretation, or in the writing of the manuscript or the decision to submit it for publication.	Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Chan PC, 2014, J FORMOS MED ASSOC, V113, P775, DOI 10.1016/j.jfma.2014.03.003; Collins SE, 2015, INT J TUBERC LUNG D, V19, P50, DOI 10.5588/ijtld.14.0217; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Converse PJ, 1997, J INFECT DIS, V176, P144, DOI 10.1086/514016; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Golub JE, 2014, CLIN INFECT DIS OFFI; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hung CC, 2006, JPN J INFECT DIS, V59, P222; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Kim YJ, 2012, AIDS RES HUM RETROV, V28, P838, DOI [10.1089/aid.2011.0360, 10.1089/AID.2011.0360]; Lo YC, 2011, J FORMOS MED ASSOC, V110, P306, DOI 10.1016/S0929-6646(11)60046-6; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/j.1751-0813.1990.tb07730.x; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Ukwaja KN, 2014, NEW ENGL J MED, V370, P1661, DOI 10.1056/NEJMc1402073; van Asten L, 2003, AIDS, V17, P1201, DOI 10.1097/00002030-200305230-00012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wu PY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104945; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073069; Zhang LF, 2010, CHINESE MED J-PEKING, V123, P1117, DOI 10.3760/cma.j.issn.0366-6999.2010.09.003	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125260	10.1371/journal.pone.0125260	http://dx.doi.org/10.1371/journal.pone.0125260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938227	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000053
J	Thong, VD; Wasitthankasem, R; Tangkijvanich, P; Vongpunsawad, S; Poovorawan, Y				Vo Duy Thong; Wasitthankasem, Rujipat; Tangkijvanich, Pisit; Vongpunsawad, Sompong; Poovorawan, Yong			Prevalence of Thymine-Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection	PLOS ONE			English	Article							GENETIC-VARIATION; PEGINTERFERON ALPHA-2B; TREATMENT RESPONSE; RIBAVIRIN THERAPY; PLUS RIBAVIRIN; INTERFERON; POLYMORPHISMS; LAMBDA; LIVER	Background The interleukin-28B (IL28B) gene polymorphism is a strong baseline predictor of sustained virological response (SVR) in hepatitis C virus (HCV) treatment. The length of thymine-adenine dinucleotide repeats, or (TA)(n), in the regulatory region of IL28B can affect interferon transcription. In order to determine predictive values in HCV infection, we explored the correlation among factors including (TA)(n) genotypes, clinical features, interferon-lambda-3 (IFNL3) and interferon-lambda-4 (IFNL4) polymorphisms, and HCV treatment outcome. Methods Sera from 492 patients with chronic HCV infection, 101 individuals with spontaneous HCV clearance and 123 healthy blood donors (control group) were analyzed. Genotyping of the (TA)(n) was performed by direct sequencing. The rs12979860 (IFNL3) was identified using nested PCR and sequencing, while ss469415590 (IFNL4) was identified by real-time PCR. Results The distribution of (TA)(n) was similar between individuals with spontaneous HCV clearance and chronic HCV infection, but differed significantly from healthy controls. Individuals with both (TA)(n) alleles >= 12 had significantly higher SVR rate compared to individuals with at least one (TA)(n) <12 allele. This strong correlation was seen for patients infected with HCV-1, HCV-3, and HCV-6. The (TA)(n) genotypes were not associated with HCV viral load, ALT levels and liver stiffness, but were correlated with platelet counts (p<0.001). In contrast, rs12979860 (CC) and ss469415590 (TT/TT) genotypes were associated with higher SVR rated only in patients with HCV-1. Conclusions The (TA)(n) genotypes were not associated with spontaneous clearance of HCV infection but associated with treatment response in patients infected with HCV-1, HCV-3 and HCV-6. In contrast, IFNL3 and IFNL4 polymorphisms were predictive of treatment outcome only for patients infected with HCV-1.	[Vo Duy Thong; Wasitthankasem, Rujipat; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok 10330, Thailand; [Vo Duy Thong] Univ Med & Pharm, Fac Med, Dept Internal Med, Div Gastroenterol & Hepatol, Ho Chi Minh, Vietnam	Chulalongkorn University; Chulalongkorn University; Hochiminh City University of Medicine & Pharmacy	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	Thong, Vo Duy/E-7951-2015; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Duy Thong, Vo/0000-0002-4151-7861; Poovorawan, Yong/0000-0002-2337-6807	National Research University Project, Office of Higher Education Commission [WCU007-HR-57, WCU001-HR-57]; NSTDA; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093, RES560530155]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; Graduate Scholarship for Neighboring Countries of Chulalongkorn University; SCG; MK Restaurant Company Limited; Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University	National Research University Project, Office of Higher Education Commission; NSTDA; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; Graduate Scholarship for Neighboring Countries of Chulalongkorn University; SCG; MK Restaurant Company Limited; Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University(Chulalongkorn University)	This work was supported by grants WCU007-HR-57 and WCU001-HR-57 from the National Research University Project, Office of Higher Education Commission, the Research Chair Grant from NSTDA, CU56-HR01 from Chulalongkorn University Centenary Academic Development Project, RES560530093 and RES560530155 from the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University, DPG5480002 from the Outstanding Professor of the Thailand Research Fund, The Graduate Scholarship for Neighboring Countries of Chulalongkorn University, SCG and MK Restaurant Company Limited. This research was also supported by Ratchadaphiseksomphot Endowment Fund for a postdoctoral fellowship, Chulalongkorn University, to Rujipat Wasitthankasem. The authors also received funding from SCG and MK Restaurant Company Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2014, J MED VIROL, V86, P1482, DOI 10.1002/jmv.23957; Akkarathamrongsin S, 2010, HEPATOL RES, V40, P956, DOI 10.1111/j.1872-034X.2010.00702.x; Akkarathamrongsin S, 2010, J MED VIROL, V82, P257, DOI 10.1002/jmv.21680; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Antaki N, 2012, GUT, V61, P1640, DOI 10.1136/gutjnl-2012-302019; Aoki Y, 2014, J GASTROENTEROLOGY; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Berg CL, 2009, AM J TRANSPLANT, V9, P907, DOI 10.1111/j.1600-6143.2009.02567.x; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hiramine S, 2015, J GASTROENTEROLOGY; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Matsuura K, 2014, J GASTROEN HEPATOL, V29, P241, DOI 10.1111/jgh.12475; MCHUTCHISON JG, 2009, NEW ENGL J MED, V361, P580, DOI DOI 10.1056/NEJM0A0808010; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Seto WK, 2013, J VIRAL HEPATITIS, V20, P470, DOI 10.1111/jvh.12047; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125400	10.1371/journal.pone.0125400	http://dx.doi.org/10.1371/journal.pone.0125400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938236	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000063
J	Kuo, YT; Liu, YL; Adebayo, BO; Shih, PH; Lee, WH; Wang, LS; Liao, YF; Hsu, WM; Yeh, CT; Lin, CM				Kuo, Yung-Ting; Liu, Yen-Lin; Adebayo, Bamodu Oluwaseun; Shih, Ping-Hsiao; Lee, Wei-Hwa; Wang, Liang-Shun; Liao, Yung-Feng; Hsu, Wen-Ming; Yeh, Chi-Tai; Lin, Chien-Min			JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells	PLOS ONE			English	Article							SIDE POPULATION CELLS; UNFAVORABLE PROGNOSIS; DEMETHYLASE JARID1B; FAVORABLE PROGNOSIS; HISTONE DEMETHYLASE; DIFFERENTIATION; IDENTIFICATION; PREDICTS; LINES; MELANOMA	Neuroblastoma (NB) is a common neural crest-derived extracranial solid cancer in children. Among all childhood cancers, NB causes devastating loss of young lives as it accounts for 15% of childhood cancer mortality. Neuroblastoma, especially high-risk stage 4 NB with MYCN amplification has limited treatment options and associated with poor prognosis. This necessitates the need for novel effective therapeutic strategy. JARID1B, also known as KDM5B, is a histone lysine demethylase, identified as an oncogene in many cancer types. Clinical data obtained from freely-accessible databases show a negative correlation between JARID1B expression and survival rates. Here, we demonstrated for the first time the role of JARID1B in the enhancement of stem cell-like activities and drug resistance in NB cells. We showed that JARID1B may be overexpressed in either MYCN amplification (SK-N-BE(2)) or MYCN-non-amplified (SK-N-SH and SK-N-FI) cell lines. JARID1B expression was found enriched in tumor spheres of SK-N-BE(2) and SK-N-DZ. Moreover, SK-N-BE(2) spheroids were more resistant to chemotherapeutics as compared to parental cells. In addition, we demonstrated that JARID1B-silenced cells acquired a decreased propensity for tumor invasion and tumorsphere formation, but increased sensitivity to cisplatin treatment. Mechanistically, reduced JARID1B expression led to the downregulation of Notch/Jagged signaling. Collectively, we provided evidence that JARID1B via modulation of stemness-related signaling is a putative novel therapeutic target for treating malignant NB.	[Kuo, Yung-Ting; Shih, Ping-Hsiao] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Taipei, Taiwan; [Kuo, Yung-Ting; Adebayo, Bamodu Oluwaseun; Wang, Liang-Shun; Yeh, Chi-Tai] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Liu, Yen-Lin] Natl Taiwan Univ, Acad Sinica, Degree Program Translat Med, Taipei 10764, Taiwan; [Liu, Yen-Lin] Taipei Med Univ Hosp, Dept Pediat, Taipei, Taiwan; [Lee, Wei-Hwa] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan; [Wang, Liang-Shun] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Liao, Yung-Feng] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yeh, Chi-Tai] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lin, Chien-Min] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Academia Sinica - Taiwan; National Taiwan University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital	Yeh, CT (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	ctyeh@s.tmu.edu.tw; m513092004@s.tmu.edu.tw	Shih, Ping-Hsiao/GPG-2472-2022; Bamodu, Oluwaseun Adebayo/B-9784-2018; Liao, Yung-Feng/A-9761-2011	Shih, Ping-Hsiao/0000-0002-8387-105X; Bamodu, Oluwaseun Adebayo/0000-0001-8229-0408; KUO, Yung-Ting/0000-0002-4579-9421; HSU, WEN-MING/0000-0002-5145-9538	National Science Council of Taiwan [NSC-101-2314-B-038-010-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by National Science Council of Taiwan (NSC-101-2314-B-038-010-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEDLER JL, 1978, CANCER RES, V38, P3751; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chen ST, 2011, CANCER SCI, V102, P2191, DOI 10.1111/j.1349-7006.2011.02100.x; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Fang XG, 2014, STEM CELLS, V32, P2033, DOI 10.1002/stem.1730; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hooper C, 2007, NEUROSCI LETT, V415, P135, DOI 10.1016/j.neulet.2007.01.049; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Hsu WM, 2011, AM J PATHOL, V179, P1394, DOI 10.1016/j.ajpath.2011.05.025; Hsu WM, 2006, ANN SURG ONCOL, V13, P238, DOI 10.1245/ASO.2006.10.012; Hsu WM, 2005, ANN ONCOL, V16, P314, DOI 10.1093/annonc/mdi062; Hsu WM, 2005, INT J CANCER, V113, P920, DOI 10.1002/ijc.20693; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Kim M, 2002, CLIN CANCER RES, V8, P22; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Kuzbicki L, 2013, MELANOMA RES, V23, P8, DOI 10.1097/CMR.0b013e32835d5d6f; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Monajemzadeh M, 2014, APMIS, V122, P734, DOI 10.1111/apm.12207; Qi SQ, 2010, J PEDIATR SURG, V45, P2305, DOI 10.1016/j.jpedsurg.2010.08.022; Reynolds C P, 1988, Prog Clin Biol Res, V271, P291; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Shackleton M, 2010, NEW ENGL J MED, V363, P885, DOI 10.1056/NEJMcibr1006328; Shih YY, 2012, J MOL NEUROSCI, V47, P571, DOI 10.1007/s12031-011-9683-3; Sun Y, 2014, ONCOGENE, V33, P2987, DOI 10.1038/onc.2013.253; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Thompson PM, 2001, CANCER RES, V61, P679; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yang Chao-Ping, 2006, Acta Paediatr Taiwan, V47, P273; Zhang LH, 2014, ONCOL REP, V31, P1935, DOI 10.3892/or.2014.3006; Zweidler-McKay PA, 2008, CURR ONCOL REP, V10, P459, DOI 10.1007/s11912-008-0071-2	38	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125343	10.1371/journal.pone.0125343	http://dx.doi.org/10.1371/journal.pone.0125343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951238	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400028
J	Lempert, KM; Chen, YL; Fleming, SM				Lempert, Karolina M.; Chen, Yu Lin; Fleming, Stephen M.			Relating Pupil Dilation and Metacognitive Confidence during Auditory Decision-Making	PLOS ONE			English	Article							SIGNAL-DETECTION; NEURAL BASIS; UNCERTAINTY; ATTENTION; REPRESENTATION; INFORMATION; DYNAMICS; HUMANS; CHOICE; SYSTEM	The sources of evidence contributing to metacognitive assessments of confidence in decision-making remain unclear. Previous research has shown that pupil dilation is related to the signaling of uncertainty in a variety of decision tasks. Here we ask whether pupil dilation is also related to metacognitive estimates of confidence. Specifically, we measure the relationship between pupil dilation and confidence during an auditory decision task using a general linear model approach to take into account delays in the pupillary response. We found that pupil dilation responses track the inverse of confidence before but not after a decision is made, even when controlling for stimulus difficulty. In support of an additional post-decisional contribution to the accuracy of confidence judgments, we found that participants with better metacognitive ability - that is, more accurate appraisal of their own decisions - showed a tighter relationship between post-decisional pupil dilation and confidence. Together our findings show that a physiological index of uncertainty, pupil dilation, predicts both confidence and metacognitive accuracy for auditory decisions.	[Lempert, Karolina M.; Chen, Yu Lin] NYU, Dept Psychol, New York, NY 10003 USA; [Fleming, Stephen M.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fleming, Stephen M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	New York University; New York University; University of Oxford	Lempert, KM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	kml523@nyu.edu; sf102@nyu.edu		Fleming, Stephen/0000-0003-0233-4891	National Institutes of Health [R01AG039283]; Sir Henry Wellcome Fellowship from the Wellcome Trust [WT096185]; NATIONAL INSTITUTE ON AGING [R01AG039283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sir Henry Wellcome Fellowship from the Wellcome Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the National Institutes of Health (R01AG039283; www.nih.gov). SMF is supported by a Sir Henry Wellcome Fellowship from the Wellcome Trust (WT096185; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; AUDLEY RJ, 1964, BRIT MED BULL, V20, P27, DOI 10.1093/oxfordjournals.bmb.a070277; Barttfeld P, 2013, P NATL ACAD SCI USA, V110, P11577, DOI 10.1073/pnas.1301353110; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Brisson J, 2013, BEHAV RES METHODS, V45, P1322, DOI 10.3758/s13428-013-0327-0; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fleming SM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00443; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Gottlieb J, 2013, TRENDS COGN SCI, V17, P585, DOI 10.1016/j.tics.2013.09.001; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Hermans D, 2008, BEHAV RES THER, V46, P98, DOI 10.1016/j.brat.2007.11.001; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Link SW, 1992, WAVE THEORY DIFFEREN; Ma WJ, 2014, ANNU REV NEUROSCI, V37, P205, DOI 10.1146/annurev-neuro-071013-014017; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; O'Reilly JX, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00105; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Petrusic WM, 2003, PSYCHON B REV, V10, P177, DOI 10.3758/BF03196482; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Ratcliff R, 2009, PSYCHOL REV, V116, P59, DOI 10.1037/a0014086; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shea N, 2014, TRENDS COGN SCI, V18, P186, DOI 10.1016/j.tics.2014.01.006; Siegle GJ, 2003, NEUROIMAGE, V20, P114, DOI 10.1016/S1053-8119(03)00298-2; Stern ER, 2013, HUM BRAIN MAPP, V34, P1956, DOI 10.1002/hbm.22038; Vickers D., 1979, DECISION PROCESSES V; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Yu AJ, 2012, NAT NEUROSCI, V15, P933, DOI 10.1038/nn.3150	44	45	45	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126588	10.1371/journal.pone.0126588	http://dx.doi.org/10.1371/journal.pone.0126588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH7KF	25950839	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400102
J	Antonova, E; Chadwick, P; Kumari, V				Antonova, Elena; Chadwick, Paul; Kumari, Veena			More Meditation, Less Habituation? The Effect of Mindfulness Practice on the Acoustic Startle Reflex	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; PREPULSE INHIBITION; SCHIZOPHRENIC-PATIENTS; SUSTAINED ATTENTION; LOUD TONES; DEFICITS; PSYCHOSIS	Background Mindfulness as a mode of sustained and receptive attention promotes openness to each incoming stimulus, even if repetitive and/or aversive. Mindful attention has been shown to attenuate sensory habituation in expert meditators; however, others were not able to replicate this effect. The present study used acoustic startle reflex to investigate the effect of mindfulness practice intensity on sensory habituation. Methods Auditory Startle Response (ASR) to 36 startling probes (12 trials x 3 block with 40ms inter-block intervals), was measured using electromyography (EMG) in three groups of participants (N = 12/group): meditation-naive, moderate practice, and intensive practice. Results Intensive practice group showed attenuated startle habituation as evidenced by significantly less habituation over the entire experiment relative to the meditation-naive and moderate practice groups. Furthermore, there was a significant linear effect showing between-block habituation in meditation-naive and moderate practice groups, but not in the intensive practice group. However, the Block x Group interaction between the intensive practice and the meditation-naive groups was not significant. Moderate practice group was not significantly different from the meditation-naive in the overall measure of habituation, but showed significantly stronger habituation than both meditation-naive and intensive practice groups in Block 1. Greater practice intensity was significantly correlated with slower overall habituation and habituation rate in Blocks 2 and 3 in the intensive, but not in the moderate, practice group. Conclusions The study provides tentative evidence that intensive mindfulness practice attenuates acoustic startle habituation as measured by EMG, but the effect is modest. Moderate practice, on the other hand, appears to enhance habituation, suggesting the effect of mindfulness practice on startle habituation might be non-liner. Better understanding of the effect of mindful attention on startle habituation may shed new light on sensory information processing capacity of the human brain and its potential for de-automatisation of hardwired processes.	[Antonova, Elena; Chadwick, Paul; Kumari, Veena] Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Kumari, Veena] South London & Maudsley Natl Hlth Serv Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England	University of London; King's College London; University of London; King's College London	Antonova, E (corresponding author), Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	elena.antonova@kcl.ac.uk	Kumari, Veena/C-6842-2009	Kumari, Veena/0000-0002-9635-5505; Chadwick, Paul/0000-0002-6765-6325; Antonova, Elena/0000-0003-1624-3202	Templeton Positive Neuroscience Award	Templeton Positive Neuroscience Award	This work was supported by the Templeton Positive Neuroscience Award to Dr Elena Antonova (Grant number: PAHWPZA) (http://www.posneuroscience.org/research-awards.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A., 1993, BECK ANXIETY INVENTO; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECKER DE, 1981, PSYCHOPHYSIOLOGY, V18, P694, DOI 10.1111/j.1469-8986.1981.tb01846.x; BOLINO F, 1992, NEUROSCI LETT, V145, P126, DOI 10.1016/0304-3940(92)90002-O; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chadwick P, 2005, BEHAV COGN PSYCHOTH, V33, P351, DOI 10.1017/S1352465805002158; Chadwick P, 2009, BEHAV COGN PSYCHOTH, V37, P403, DOI 10.1017/S1352465809990166; CORNBLATT BA, 1988, PSYCHIAT RES, V26, P223, DOI 10.1016/0165-1781(88)90076-5; Deatherage G., 1975, J TRANSPERSONAL PSYC, V7, P133; Dunne J, 2011, CONTEMP BUDDHISM, V12, P71, DOI 10.1080/14639947.2011.564820; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; Grossman P, 2011, CONTEMP BUDDHISM, V12, P219, DOI 10.1080/14639947.2011.564841; Hammer TB, 2011, INT J NEUROPSYCHOPH, V14, P913, DOI 10.1017/S1461145711000034; Ivanovski B, 2007, ACTA NEUROPSYCHIATR, V19, P76, DOI 10.1111/j.1601-5215.2007.00175.x; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kabat-Zinn J, 2011, CONTEMP BUDDHISM, V12, P281, DOI 10.1080/14639947.2011.564844; KASAMATSU AKIRA, 1966, FOLIA PSYCHIAT NEUROL JAP, V20, P315, DOI 10.1111/j.1440-1819.1966.tb02646.x; Kumari V, 2005, NEUROIMAGE, V26, P1052, DOI 10.1016/j.neuroimage.2005.03.002; Kumari V, 2008, CORTEX, V44, P1206, DOI 10.1016/j.cortex.2007.11.007; Kumari V, 2008, NEUROPSYCHOPHARMACOL, V33, P2610, DOI 10.1038/sj.npp.1301670; Kumari V, 2007, INT J NEUROPSYCHOPH, V10, P463, DOI 10.1017/S1461145706007139; Kumari V, 2015, PSYCHOPHYSIOLOGY, V52, P714, DOI 10.1111/psyp.12391; Kumari V, 2012, SCHIZOPHR RES, V134, P232, DOI 10.1016/j.schres.2011.11.020; LaRowe SD, 2006, BIOL PSYCHOL, V72, P257, DOI 10.1016/j.biopsycho.2005.11.008; Levenson RW, 2012, EMOTION, V12, P650, DOI 10.1037/a0027472; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Lutz A, 2007, CAMB HANDB PSYCHOL, P499; MacCoon DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097551; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Martin JR, 1997, J PSYCHOTHER INTEGR, V7, P291, DOI 10.1023/B:JOPI.0000010885.18025.bc; Meincke U, 2004, PSYCHIAT RES, V126, P51, DOI 10.1016/j.psychres.2004.01.003; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Orr SP, 1997, BIOL PSYCHIAT, V41, P319, DOI 10.1016/S0006-3223(95)00671-0; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Sharma T, 2003, PSYCHIAT CLIN N AM, V26, P25, DOI 10.1016/S0193-953X(02)00084-9; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; van den Hurk PAM, 2010, INT J PSYCHOPHYSIOL, V78, P151, DOI 10.1016/j.ijpsycho.2010.07.002; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yorston G.A., 2001, MENTAL HLTH RELIG CU, V4, P209, DOI DOI 10.1080/713685624	43	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123512	10.1371/journal.pone.0123512	http://dx.doi.org/10.1371/journal.pone.0123512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946014	gold, Green Submitted, Green Published			2022-12-26	WOS:000354049700014
J	Cotterchio, M; Lowcock, E; Bider-Canfield, Z; Lemire, M; Greenwood, C; Gallinger, S; Hudson, T				Cotterchio, Michelle; Lowcock, Elizabeth; Bider-Canfield, Zoe; Lemire, Mathieu; Greenwood, Celia; Gallinger, Steven; Hudson, Thomas			Association between Variants in Atopy-Related Immunologic Candidate Genes and Pancreatic Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR-RELATED PROTEIN; CASE-CONTROL CONSORTIUM; ABO BLOOD-GROUP; POOLED ANALYSIS; METAANALYSIS; ALLERGIES; SUSCEPTIBILITY; MECHANISMS; ASTHMA	Background Many epidemiology studies report that atopic conditions such as allergies are associated with reduced pancreas cancer risk. The reason for this relationship is not yet understood. This is the first study to comprehensively evaluate the association between variants in atopy-related candidate genes and pancreatic cancer risk. Methods A population-based case-control study of pancreas cancer cases diagnosed during 2011-2012 (via Ontario Cancer Registry), and controls recruited using random digit dialing utilized DNA from 179 cases and 566 controls. Following an exhaustive literature review, SNPs in 180 candidate genes were pre-screened using dbGaP pancreas cancer GWAS data; 147 SNPs in 56 allergy-related immunologic genes were retained and genotyped. Logistic regression was used to estimate age-adjusted odd ratio (AOR) for each variant and false discovery rate was used to adjust Wald p-values for multiple testing. Subsequently, a risk allele score was derived based on statistically significant variants. Results 18 SNPs in 14 candidate genes (CSF2, DENND1B, DPP10, FLG, IL13, IL13RA2, LRP1B, NOD1, NPSR1, ORMDL3, RORA, STAT4, TLR6, TRA) were significantly associated with pancreas cancer risk. After adjustment for multiple comparisons, two LRP1B SNPs remained statistically significant; for example, LRP1B rs1449477 (AA vs. CC: AOR=0.37, 95% CI: 0.22-0.62; p (adjusted)=0.04). Furthermore, the risk allele score was associated with a significant reduction in pancreas cancer risk (p=0.0007). Conclusions Preliminary findings suggest certain atopy-related variants may be associated with pancreas cancer risk. Further studies are needed to replicate this, and to elucidate the biology behind the growing body of epidemiologic evidence suggesting allergies may reduce pancreatic cancer risk.	[Cotterchio, Michelle; Lowcock, Elizabeth; Bider-Canfield, Zoe] Canc Care Ontario, Prevent & Canc Control, Toronto, ON M5G 2L7, Canada; [Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Lemire, Mathieu; Hudson, Thomas] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Greenwood, Celia] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Gallinger, Steven] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Toronto Gen Hosp, Div Gen Surg, Toronto, ON M5G 2C4, Canada; [Hudson, Thomas] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	Cancer Care Ontario; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Lady Davis Institute; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Cotterchio, M (corresponding author), Canc Care Ontario, Prevent & Canc Control, Toronto, ON M5G 2L7, Canada.	michelle.cotterchio@cancercare.on.ca	Gallinger, Steven/E-4575-2013	Cotterchio, Michelle/0000-0003-2862-7895; Greenwood, Celia/0000-0002-2427-5696	Canadian Institutes of Health Research [MOP-106631]; National Institutes of Health [PACGENE consortium] [RO1 CA97075]; NATIONAL CANCER INSTITUTE [R01CA097075] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health [PACGENE consortium](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Institutes of Health Research [grant # MOP-106631 to M.C.] (http://www.cihr-irsc.gc.ca); and the National Institutes of Health [RO1 CA97075 to S.G., as part of PACGENE consortium] (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cotterchio M, 2014, CANCER EPIDEM BIOMAR, V23, P469, DOI 10.1158/1055-9965.EPI-13-0965; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Gandini S, 2005, CANCER EPIDEM BIOMAR, V14, P1908, DOI 10.1158/1055-9965.EPI-05-0119; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Lu YJ, 2010, GENE CHROMOSOME CANC, V49, P412, DOI 10.1002/gcc.20752; Lynch SM, 2009, AM J EPIDEMIOL, V170, P403, DOI 10.1093/aje/kwp134; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Olson SH, 2007, CANCER DETECT PREV, V31, P345, DOI 10.1016/j.cdp.2007.10.002; Olson SH, 2013, AM J EPIDEMIOL, V178, P691, DOI 10.1093/aje/kwt052; Olson SH, 2012, MOL CARCINOGEN, V51, P75, DOI 10.1002/mc.20816; Permuth-Wey J, 2009, FAM CANCER, V8, P109, DOI 10.1007/s10689-008-9214-8; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Prazeres H, 2011, ONCOGENE, V30, P1302, DOI 10.1038/onc.2010.512; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Risch HA, 2013, AM J EPIDEMIOL, V177, P1326, DOI 10.1093/aje/kws458; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	30	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125273	10.1371/journal.pone.0125273	http://dx.doi.org/10.1371/journal.pone.0125273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945796	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700060
J	Taha, H; Looi, CY; Arya, A; Wong, WF; Yap, LF; Hasanpourghadi, M; Mohd, MA; Paterson, IC; Ali, HM				Taha, Hairin; Looi, Chung Yeng; Arya, Aditya; Wong, Won Fen; Yap, Lee Fah; Hasanpourghadi, Mohadeseh; Mohd, Mustafa A.; Paterson, Ian C.; Ali, Hapipah Mohd			(6E, 10E) Isopolycerasoidol and (6E, 10E) Isopolycerasoidol Methyl Ester, Prenylated Benzopyran Derivatives from Pseuduvaria monticola Induce Mitochondrial-Mediated Apoptosis in Human Breast Adenocarcinoma Cells	PLOS ONE			English	Article							MALAYSIAN RAIN-FOREST; OXIDATIVE STRESS; MEMBRANE PERMEABILIZATION; ALKALOIDS; CANCER; PATHWAY; RUGOSA; AGENTS	Phytochemicals from Pseuduvaria species have been reported to display a wide range of biological activities. In the present study, a known benzopyran derivative, (6E, 10E) isopolycerasoidol (1), and a new benzopyran derivative, (6E, 10E) isopolycerasoidol methyl ester (2), were isolated from a methanol extract of Pseuduvaria monticola leaves. The structures of the isolated compounds were elucidated by spectroscopic methods including 1D and 2D NMR, IR, UV, and LCMS-QTOF, and by comparison with previously published data. The anti-proliferative and cytotoxic effects of these compounds on human breast cancer cell-lines (MCF-7 and MDA-MB-231) and a human normal breast epithelial cell line (MCF-10A) were investigated. MTT results revealed both (1) and (2) were efficient in reducing cell viability of breast cancer cells. Flow cytometry analysis demonstrated that (1) and (2) induced cell death via apoptosis, as demonstrated by an increase in phosphotidylserine exposure. Both compounds elevated ROS production, leading to reduced mitochondrial membrane potential and increased plasma membrane permeability in breast cancer cells. These effects occurred concomitantly with a dose-dependent activation of caspase 3/7 and 9, a down-regulation of the anti-apoptotic gene BCL2 and the accumulation of p38 MAPK in the nucleus. Taken together, our data demonstrate that (1) and (2) induce intrinsic mitochondrial- mediated apoptosis in human breast cancer cells, which provides the first pharmacological evidence for their future development as anticancer agents.	[Taha, Hairin; Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia; [Looi, Chung Yeng; Hasanpourghadi, Mohadeseh; Mohd, Mustafa A.] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Arya, Aditya] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Yap, Lee Fah; Paterson, Ian C.] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia; [Yap, Lee Fah; Paterson, Ian C.] Univ Malaya, Fac Dent, OCRCC, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Looi, CY (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	looicy@um.edu.my	Paterson, Ian/G-8688-2011; Yap, Lee-Fah/M-1065-2016; Looi, Chung Yeng/A-2623-2013; Mohd, Mustafa b Ali/B-9184-2010; Wong, Won Fen/D-3087-2012	Paterson, Ian/0000-0001-9156-401X; Yap, Lee-Fah/0000-0002-6815-3607; Looi, Chung Yeng/0000-0002-4830-3495; Mohd, Mustafa b Ali/0000-0002-4220-5384; Wong, Won Fen/0000-0003-1082-1956; Arya, Aditya/0000-0002-8747-3462; Hasanpourghadi, Mohadeseh/0000-0002-4548-0816	High Impact Research grant [UM-MOHE UM.C/625/1/HIR/MOHE/09]; University of Malaya [RP001D-13BIO, RP027A-14HTM]; IPS grant [PG064-2012B]	High Impact Research grant; University of Malaya(Universiti Malaya); IPS grant	This research is supported by a High Impact Research grant (UM-MOHE UM.C/625/1/HIR/MOHE/09), a University of Malaya research grant (RP001D-13BIO, RP027A-14HTM), and an IPS grant (PG064-2012B). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab I. A., 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/856029; Christodoulou MI, 2014, ANTI-CANCER AGENT ME, V14, P375, DOI 10.2174/18715206113139990089; Chung IM, 2012, IMMUNOPHARM IMMUNOT, V34, P152, DOI 10.3109/08923973.2011.589030; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; GONZALEZ MC, 1995, J NAT PRODUCTS, V58, P1278, DOI 10.1021/np50122a022; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Hodgkison R, 2004, BIOTROPICA, V36, P522, DOI 10.1646/1593; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Lim KP, 2011, J PATHOL, V223, P459, DOI 10.1002/path.2841; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Othman M, 2011, NAT PROD RES, V25, P1857, DOI 10.1080/14786419.2010.537274; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P16; Sharma B, 2010, J ETHNOPHARMACOL, V127, P457, DOI 10.1016/j.jep.2009.10.013; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sohur US, 1999, GENE EXPRESSION, V8, P219; Su YCF, 2008, MOL PHYLOGENET EVOL, V48, P188, DOI 10.1016/j.ympev.2008.03.028; Su YCF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-153; Taha H, 2014, FOOD CHEM TOXICOL, V66, P295, DOI 10.1016/j.fct.2014.01.054; Taha H, 2011, CHEM PHARM BULL, V59, P896, DOI 10.1248/cpb.59.896; Uadkla O, 2013, PHARM BIOL, V51, P400, DOI 10.3109/13880209.2012.734314; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wirasathien L, 2006, PHARM BIOL, V44, P274, DOI 10.1080/13880200600714111; ZafraPolo MC, 1996, J NAT PROD, V59, P913, DOI 10.1021/np960492m	27	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126126	10.1371/journal.pone.0126126	http://dx.doi.org/10.1371/journal.pone.0126126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946039	gold, Green Published			2022-12-26	WOS:000354049700112
J	Trivedi, S; Ranasinghe, C				Trivedi, Shubhanshi; Ranasinghe, Charani			The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8(+)T Cells Measured Using Fluidigm Dynamic Arrays	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; ANTIGEN-PRESENTING CELLS; T-CELLS; MUCOSAL IMMUNITY; DENDRITIC CELLS; EXPRESSION; VACCINE; TRAFFICKING; MIGRATION; AVIDITY	Thirty different genes including cytokines, chemokines, granzymes, perforin and specifically integrins were evaluated in Peyer's patch-KdGag(197-205)-specific CD8+ T cells (pools of 100 cells) using Fluidigm 48.48 Dynamic arrays following three different prime-boost immunization strategies. Data revealed that the route of prime or the booster immunization differentially influenced the integrin expression profile on gut KdGag(197-205)-specific CD8+ T cells. Specifically, elevated numbers of integrin alpha E and alpha D expressing gut KdGag197-205-specific CD8+ T cells were detected following mucosal but not systemic priming. Also, alpha E/beta 7 and alpha D/beta 2 heterodimerization were more noticeable in an intranasal (i.n.)/i.n. vaccination setting compared to i.n./intramuscular (i.m) or i.m./i.m. vaccinations. Moreover, in all vaccine groups tested alpha 4 appeared to hetero-dimerize more closely with beta 7 then beta 1. Also MIP-1 beta, RANTES, CCR5, perforin and integrin a4 bio-markers were significantly elevated in i.n./i.m. and i.m./i.m. immunization groups compared to purely mucosal i.n./i.n. delivery. Furthermore, when wild type (WT) BALB/c and IL-13 knockout (KO) mice were immunized using i.n./i.m. strategy, MIP-1 alpha, MIP-1 beta, RANTES, integrins a4, beta 1 and beta 7 mRNA expression levels were found to be significantly different, inmucosal verses systemic KdGag(197-205)-specific CD8(+) T cells. Interestingly, the numbers of gut KdGag(197-205)-specific CD8+ T cells expressing gut-homingmarkers alpha 4 beta 7 and CCR9 protein were also significantly elevated in IL-13 KO compared to WT control. Collectively, our findings further corroborate that the route of vaccine delivery, tissue microenvironment and IL-13 depleted cytokine milieu can significantly alter the antigen-specific CD8(+) T cell gene expression profiles and in turn modulate their functional avidities as well as homing capabilities.	[Trivedi, Shubhanshi; Ranasinghe, Charani] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Ranasinghe, C (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia.	charani.ranasinghe@anu.edu.au	trivedi, shubhanshi/AAT-9097-2020	trivedi, shubhanshi/0000-0001-6891-2290	NHMRC project [525431]; Bill and Melinda Gates Foundation GCE Phase I grant [OPP1015149]; ACH2 EOI grants;  [APP1000703]	NHMRC project(National Health and Medical Research Council (NHMRC) of Australia); Bill and Melinda Gates Foundation GCE Phase I grant; ACH2 EOI grants; 	This work was supported by NHMRC project grant 525431 (C.R.), development grant award APP1000703, Bill and Melinda Gates Foundation GCE Phase I grant OPP1015149 (C.R.) and ACH2 EOI grants (C.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Baaten Bas J G, 2013, Front Immunol, V4, P311, DOI 10.3389/fimmu.2013.00311; Belyakov IM, 2008, VIROLOGY, V381, P106, DOI 10.1016/j.virol.2008.08.019; Belyakov IM, 1998, P NATL ACAD SCI USA, V95, P1709, DOI 10.1073/pnas.95.4.1709; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; CHIN YH, 1991, IMMUNOLOGY, V74, P478; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Ebert EC, 1998, GUT, V42, P650, DOI 10.1136/gut.42.5.650; Eo SK, 2001, J IMMUNOL, V166, P5473, DOI 10.4049/jimmunol.166.9.5473; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Hamann A, 2000, EUR J IMMUNOL, V30, P3207, DOI 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L; Hathaway LJ, 2000, CELL MOL LIFE SCI, V57, P323, DOI 10.1007/PL00000693; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huleatt JW, 1996, IMMUNITY, V5, P263, DOI 10.1016/S1074-7613(00)80321-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jackson RJ, 2014, VACCINE, V32, P5703, DOI 10.1016/j.vaccine.2014.08.023; Jespers V, 2010, EXPERT REV VACCINES, V9, P381, DOI [10.1586/erv.10.21, 10.1586/ERV.10.21]; Kantele A, 1999, J IMMUNOL, V162, P5173; Kent SJ, 2005, VACCINE, V23, P5009, DOI 10.1016/j.vaccine.2005.05.032; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Lim SP, 1998, IMMUNOGENETICS, V48, P184, DOI 10.1007/s002510050422; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Ranasinghe C, 2013, MUCOSAL IMMUNOL, V6, P1068, DOI 10.1038/mi.2013.1; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Ranasinghe C, 2006, VACCINE, V24, P5881, DOI 10.1016/j.vaccine.2006.04.023; Ranasinghe C, 2011, VACCINE, V29, P3008, DOI 10.1016/j.vaccine.2011.01.106; Ranasinghe C, 2009, EUR J IMMUNOL, V39, P1819, DOI 10.1002/eji.200838995; Rose JR, 1998, J VIROL, V72, P726; Schon MP, 1999, J IMMUNOL, V162, P6641; Sheasley-O'Neill SL, 2007, J IMMUNOL, V178, P1512, DOI 10.4049/jimmunol.178.3.1512; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Takenaka S, 2009, CLIN VACCINE IMMUNOL, V16, P1615, DOI 10.1128/CVI.00216-09; Trivedi S, 2014, VIROLOGY, V468, P479, DOI 10.1016/j.virol.2014.09.004; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Wijesundara DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105366; Xi Y, 2012, MUCOSAL IMMUNOL, V5, P610, DOI 10.1038/mi.2012.35	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126487	10.1371/journal.pone.0126487	http://dx.doi.org/10.1371/journal.pone.0126487			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946028	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700135
J	Jiang, WX; Hu, YJ; Gao, L; He, ZY; Zhu, CL; Ma, R; Huang, ZW				Jiang, Wen-xin; Hu, Yue-jian; Gao, Li; He, Zhi-yan; Zhu, Cai-lian; Ma, Rui; Huang, Zheng-wei			The Impact of Various Time Intervals on the Supragingival Plaque Dynamic Core Microbiome	PLOS ONE			English	Article							BACTERIAL IDENTIFICATION; PYROSEQUENCING ANALYSIS; ORAL MICROBIOTA; DIVERSITY; HEALTH	Objective The aim of this study was to examine the influence of various time intervals on the composition of the supragingival plaque microbiome, especially the dynamic core microbiome, and to find a suitable observation interval for further studies on oral microbiota. Methods and Materials Eight qualified volunteers whose respective age ranges from 25 to 28 years participated in the present study. The supragingival plaque was collected from the buccogingival surface of the maxillary first molar at eight time slots with different intervals (day 0, 1 day, 3 days, 1 week, 2 weeks, 3 weeks, 1 month, and 3 months). Bioinformatic analyses was performed based on 16S rDNA pyrosequencing (454 sequencing platform) targeting at the hypervariable V4-V5 region, in order to assess the diversity and variation of the supragingival plaque microbiome. Results A total of 359,565 qualified reads for 64 samples were generated for subsequent analyses, which represents 8,452 operational taxonomic units identified at 3% dissimilarity. The dynamic core microbiome detected in the current study included five phyla, 12 genera and 13 species. At the genus level, the relative abundance of bacterial communities under the "1 day," "1 month," and "3 months" intervals was clustered into sub-category. At the species level, the number of overlapping species remained stable between the "1 month" and "3 months" intervals, whereas the number of dynamic core species became stable within only 1 week. Conclusions This study emphasized the impact of different time intervals (days, weeks and months) on the composition, commonality and diversity of the supragingival microbiome. The analyses found that for various types of studies, the time interval of a month is more suitable for observing the general composition of the supragingival microbiome, and that a week is better for observing the dynamic core microbiome.	[Jiang, Wen-xin; Hu, Yue-jian; Gao, Li; He, Zhi-yan; Zhu, Cai-lian; Ma, Rui; Huang, Zheng-wei] Shanghai Jiao Tong Univ, Dept Endodont, Peoples Hosp 9, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, ZW (corresponding author), Shanghai Jiao Tong Univ, Dept Endodont, Peoples Hosp 9, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China.	huangzhengwei@shsmu.edu.cn	Hu, Yue/HGE-1673-2022		National Science & Technology Pollar Program [2012BAL07B03]; National Natural Science Foundation of China [81070826/81371143]; Shanghai Rising-Star Program [12QH1401400]	National Science & Technology Pollar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by the National Science & Technology Pollar Program during the 12th Five-year plan Period (Grant No. 2012BAL07B03). This work was also supported by Grant No. 81070826/81371143 from the National Natural Science Foundation of China and was partly supported by Shanghai Rising-Star Program No. 12QH1401400. ZWH received the funding.	Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; He XS, 2009, INT J ORAL SCI, V1, P47, DOI 10.4248/ijos.09029; Hu YJ, 2013, INT J ORAL SCI, V5, P21, DOI 10.1038/ijos.2013.15; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056343; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Ling ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Pushalkar S, 2014, INT J ORAL SCI, V6, P219, DOI 10.1038/ijos.2014.46; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Tao Y, 2013, ARCH ORAL BIOL, V58, P1129, DOI 10.1016/j.archoralbio.2013.04.005; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102116; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Xin BC, 2013, ORAL DIS, V19, P401, DOI 10.1111/odi.12018; Xu X, 2014, ORAL CAVITY CONTAINS; Yamanaka W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042806; Yang F, 2013, J DENT RES, V92, P1106, DOI 10.1177/0022034513507065; Ye Y, 2013, CLIN MICROBIOL INFEC, V19, pE559, DOI 10.1111/1469-0691.12287; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	35	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124631	10.1371/journal.pone.0124631	http://dx.doi.org/10.1371/journal.pone.0124631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942317	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400019
J	Luna, JLV; Krenn, M; Ramirez, JAC; Mayr, W				Vargas Luna, Jose Luis; Krenn, Matthias; Cortes Ramirez, Jorge Armando; Mayr, Winfried			Dynamic Impedance Model of the Skin-Electrode Interface for Transcutaneous Electrical Stimulation	PLOS ONE			English	Article							NEURAL STIMULATION; STRATUM-CORNEUM; ELECTROPORATION; SYSTEM	Transcutaneous electrical stimulation can depolarize nerve or muscle cells applying impulses through electrodes attached on the skin. For these applications, the electrode-skin impedance is an important factor which influences effectiveness. Various models describe the interface using constant or current-depending resistive-capacitive equivalent circuit. Here, we develop a dynamic impedance model valid for a wide range stimulation intensities. The model considers electroporation and charge-dependent effects to describe the impedance variation, which allows to describe high-charge pulses. The parameters were adjusted based on rectangular, biphasic stimulation pulses generated by a stimulator, providing optionally current or voltage-controlled impulses, and applied through electrodes of different sizes. Both control methods deliver a different electrical field to the tissue, which is constant throughout the impulse duration for current-controlled mode or have a very current peak for voltage-controlled. The results show a predominant dependence in the current intensity in the case of both stimulation techniques that allows to keep a simple model. A verification simulation using the proposed dynamic model shows coefficient of determination of around 0.99 in both stimulation types. The presented method for fitting electrode-skin impedance can be simple extended to other stimulation waveforms and electrode configuration. Therefore, it can be embedded in optimization algorithms for designing electrical stimulation applications even for pulses with high charges and high current spikes.	[Vargas Luna, Jose Luis] Reykjavik Univ, Landspitali, Univ Hosp, Hlth Technol Ctr, Reykjavik, Iceland; [Vargas Luna, Jose Luis; Cortes Ramirez, Jorge Armando] Escuela Ingn & Ciencias Tecnol Monterrey, Monterrey, Nuevo Leon, Mexico; [Krenn, Matthias; Mayr, Winfried] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Landspitali National University Hospital; Reykjavik University; Tecnologico de Monterrey; Medical University of Vienna	Luna, JLV (corresponding author), Reykjavik Univ, Landspitali, Univ Hosp, Hlth Technol Ctr, Reykjavik, Iceland.	joseluis.vargasluna@gmail.com	Luna, José L Vargas/B-4295-2015	Luna, José L Vargas/0000-0002-5125-1999; Krenn, Matthias J./0000-0002-3398-3627	Vienna Science and Technology Fund (WWTF) [LS11-057]; Wings for Life Spinal Cord Research Foundation (WfL) [WFL-AT-007/11]	Vienna Science and Technology Fund (WWTF); Wings for Life Spinal Cord Research Foundation (WfL)	This work was supported by the Vienna Science and Technology Fund (WWTF), Proj. Nr. LS11-057 (www.wwtf.at), and the Wings for Life Spinal Cord Research Foundation (WfL), Proj. Nr. WFL-AT-007/11 (http://www.wingsforlife.com) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASI JJ, 1970, ANN NY ACAD SCI, V170, P509, DOI 10.1111/j.1749-6632.1970.tb17718.x; Birlea Sinziana I., 2008, IET Irish Signals and Systems Conference. ISSC 2008, P55, DOI 10.1049/cp:20080638; Chen CF, 2012, IEEE T NEUR SYS REH, V20, P574, DOI 10.1109/TNSRE.2012.2188305; CHIZMADZHEV YA, 1995, BIOPHYS J, V68, P749, DOI 10.1016/S0006-3495(95)80250-X; Chizmadzhev YA, 1998, BIOPHYS J, V74, P843, DOI 10.1016/S0006-3495(98)74008-1; Danner SM, 2011, ARTIF ORGANS, V35, P257, DOI 10.1111/j.1525-1594.2011.01213.x; Dorgan S J, 1999, IEEE Trans Rehabil Eng, V7, P341, DOI 10.1109/86.788470; Franks W, 2005, IEEE T BIO-MED ENG, V52, P1295, DOI 10.1109/TBME.2005.847523; Glisson T., 2011, INTRO CIRCUIT ANAL D; Grill WM, 1996, IEEE T BIO-MED ENG, V43, P161, DOI 10.1109/10.481985; GRILL WM, 1995, IEEE ENG MED BIOL, V14, P375, DOI 10.1109/51.395310; GRIMNES S, 1984, ACTA DERM-VENEREOL, V64, P93; GRIMNES S, 1983, MED BIOL ENG COMPUT, V21, P739, DOI 10.1007/BF02464037; Hofer C, 2002, ARTIF ORGANS, V26, P276, DOI 10.1046/j.1525-1594.2002.06951.x; Ivorra A, 2010, SER BIOMED ENG, P23, DOI 10.1007/978-3-642-05420-4_2; Jadoul A, 1999, ADV DRUG DELIVER REV, V35, P89, DOI 10.1016/S0169-409X(98)00065-9; Johnsen GK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031916; KANTOR G, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P784, DOI 10.1109/IEMBS.1994.415291; Keller T, 2008, J AUTOM CONTROL, V18, P35, DOI [10.2298/JAC0802035K, DOI 10.2298/JAC0802035K]; Krenn M, 2011, ARTIF ORGANS, V35, P253, DOI 10.1111/j.1525-1594.2011.01217.x; Krouchev NI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090480; Lackermeier A, 1996, P 18 ANN INT C IEEE, V5; Luna JLV, 2014, P IASTED INT C BIOM, P190; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; LYKKEN DT, 1970, PSYCHOPHYSIOLOGY, V7, P262, DOI 10.1111/j.1469-8986.1970.tb02232.x; PLIQUETT U, 1995, BBA-BIOMEMBRANES, V1239, P111, DOI 10.1016/0005-2736(95)00139-T; Reilly JP, 1992, ELECT SIMULATION ELE; SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x; Tortora G., 2002, PRINCIPIOS ANATOMIA; VANBOXTEL A, 1977, MED BIOL ENG COMPUT, V15, P679, DOI 10.1007/BF02457927; Vargas Luna JL, 2014, BIOMED TECH BERL, P1045, DOI DOI 10.1515/BMT-2014-5013; Vargas Luna JL, 2013, BIOMED TECH BERL, V58	32	32	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125609	10.1371/journal.pone.0125609	http://dx.doi.org/10.1371/journal.pone.0125609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942010	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400047
J	Beaudouin, R; Goussen, B; Piccini, B; Augustine, S; Devillers, J; Brion, F; Pery, ARR				Beaudouin, Remy; Goussen, Benoit; Piccini, Benjamin; Augustine, Starrlight; Devillers, James; Brion, Francois; Pery, Alexandre R. R.			An Individual-Based Model of Zebrafish Population Dynamics Accounting for Energy Dynamics	PLOS ONE			English	Article							DANIO-RERIO; LARVAL ZEBRAFISH; FEMALE ZEBRAFISH; RISK-ASSESSMENT; WILD ZEBRAFISH; SEX-RATIO; GROWTH; FISH; TEMPERATURE; ENERGETICS	Developing population dynamics models for zebrafish is crucial in order to extrapolate from toxicity data measured at the organism level to biological levels relevant to support and enhance ecological risk assessment. To achieve this, a dynamic energy budget for individual zebrafish (DEB model) was coupled to an individual based model of zebrafish population dynamics (IBM model). Next, we fitted the DEB model to new experimental data on zebrafish growth and reproduction thus improving existing models. We further analysed the DEB-model and DEB-IBM using a sensitivity analysis. Finally, the predictions of the DEB-IBM were compared to existing observations on natural zebrafish populations and the predicted population dynamics are realistic. While our zebrafish DEB-IBM model can still be improved by acquiring new experimental data on the most uncertain processes (e.g. survival or feeding), it can already serve to predict the impact of compounds at the population level.	[Beaudouin, Remy; Goussen, Benoit; Pery, Alexandre R. R.] Inst Natl Environm Ind & Risques INERIS, Unite Modeles Ecotoxicol & Toxicol METO, Verneuil En Halatte, France; [Piccini, Benjamin; Brion, Francois] Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol In Vitro & In Vivo ECOT, Verneuil En Halatte, France; [Augustine, Starrlight] Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark; [Devillers, James] CTIS, Rillieux La Pape, France; [Pery, Alexandre R. R.] AgroParisTech, Paris, France	Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne; Institut National de l'Environnement Industriel et des Risques (INERIS); Technical University of Denmark; AgroParisTech	Beaudouin, R (corresponding author), Inst Natl Environm Ind & Risques INERIS, Unite Modeles Ecotoxicol & Toxicol METO, Verneuil En Halatte, France.	remy.beaudouin@ineris.fr	GOUSSEN, Benoit/E-7687-2012; Beaudouin, Rémy/H-1491-2012; BRION, Francois/Q-8713-2018	GOUSSEN, Benoit/0000-0001-7204-7981; Beaudouin, Rémy/0000-0002-2855-1571; BRION, Francois/0000-0003-2341-4196	French Ministry in charge of Ecology and Sustainable Development, within the frameworks of the National Research Programme on Endocrine Disruption (PNRPE) [190]; Villum Fonden [00007178] Funding Source: researchfish	French Ministry in charge of Ecology and Sustainable Development, within the frameworks of the National Research Programme on Endocrine Disruption (PNRPE); Villum Fonden(Villum Fonden)	This study was funded by the French Ministry in charge of Ecology and Sustainable Development, within the frameworks of the National Research Programme on Endocrine Disruption (PNRPE) and of the Programme 190.	Affan Abu, 2005, Algae, V20, P43; [Anonymous], 2010, REFERENCE GROWTH CUR, P1199; [Anonymous], 2007, ESTIMATING THE APPRO, P957; [Anonymous], 2009, DEVELOPMENT AND VALI, P310; [Anonymous], 2008, RAPID GROWTH AND OUT, P239; Ashauer R, 2011, ENVIRON TOXICOL CHEM, V30, P2519, DOI 10.1002/etc.639; Augustine S, 2011, COMP BIOCHEM PHYS A, V159, P275, DOI 10.1016/j.cbpa.2011.03.016; Bagatto B, 2001, J EXP BIOL, V204, P4335; Bala N, 1999, ICLARM CONF PROC; Balasubramani A, 2008, CURRENT SCIENCE, V94, P10; Beaudouin R, 2008, J FISH BIOL, V73, P2468, DOI 10.1111/j.1095-8649.2008.02101.x; Beaudouin R, 2012, ECOTOXICOLOGY, V21, P1225, DOI 10.1007/s10646-012-0877-4; Beaudouin R, 2012, ECOTOXICOLOGY, V21, P155, DOI 10.1007/s10646-011-0775-1; Best J, 2010, ZEBRAFISH, V7, P289, DOI 10.1089/zeb.2010.0667; Billoir E, 2008, J THEOR BIOL, V254, P55, DOI 10.1016/j.jtbi.2008.05.006; Bodiguel X, 2009, J SEA RES, V62, P124, DOI 10.1016/j.seares.2009.02.006; Bois FY, 1997, JOURNAL OF STATISTIC, V2; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brion F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036069; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; de Kermoysan G, 2013, AQUAT TOXICOL, V144, P186, DOI 10.1016/j.aquatox.2013.09.034; Devillers J, 2014, IN SILICO BEES, P179; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; EATON RC, 1974, COPEIA, P204; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1; Forbes VE, 2011, HUM ECOL RISK ASSESS, V17, P287, DOI 10.1080/10807039.2011.552391; Freitas V, 2010, PHILOS T R SOC B, V365, P3553, DOI 10.1098/rstb.2010.0049; Gabsi F, 2014, ECOL MODEL, V280, P18, DOI 10.1016/j.ecolmodel.2013.06.018; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Godin J- G, 1997, BEHAVIOURAL ECOLOGY; Goussen B, 2015, CHEMOSPHERE, V120, P507, DOI 10.1016/j.chemosphere.2014.09.006; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hazlerigg CRE, 2014, ECOL MODEL, V280, P76, DOI 10.1016/j.ecolmodel.2013.12.016; Hisaoka KK, 1962, COPEIA, P302; Iwasaki Y, 2011, ENVIRON TOXICOL CHEM, V30, P2237, DOI 10.1002/etc.612; Jager T, 2005, FUNCT ECOL, V19, P136, DOI 10.1111/j.0269-8463.2005.00941.x; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kooijman SALM, 2014, J SEA RES, V94, P128, DOI 10.1016/j.seares.2014.06.005; Kooijman SALM, 1996, WATER RES, V30, P1711, DOI 10.1016/0043-1354(96)00054-1; Kooijman SALM, 2010, DYNAMIC ENERGY BUDGE, DOI [10.1111/j.1469-185X.2008.00053.x, DOI 10.1111/J.1469-185X.2008.00053.X]; Lenth R., 2019, Journal of Statistical Software, V60, P1; Li L, 2003, AQUACULT ENG, V27, P9, DOI 10.1016/S0144-8609(02)00037-7; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Markovich ML, 2007, ZEBRAFISH, V4, P69, DOI 10.1089/zeb.2006.9993; Martin BT, 2013, ECOTOXICOLOGY, V22, P574, DOI 10.1007/s10646-013-1049-x; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Pery ARR, 2014, ENVIRON SCI TECHNOL, V48, P781, DOI 10.1021/es404301q; R Core Team, 2013, R A LANGUAGE AND ENV; Rasband WS, 1997, IMAGEJ; Rice PJ, 2013, SCI TOTAL ENVIRON, V456, P61, DOI 10.1016/j.scitotenv.2013.02.051; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schilling Thomas F., 2002, P59; Sfakianakis DG, 2012, J BIOL RES-THESSALON, V17, P68; Spence R, 2007, J FISH BIOL, V71, P304, DOI 10.1111/j.1095-8649.2007.01492.x; Spence R, 2005, ANIM BEHAV, V69, P1317, DOI 10.1016/j.anbehav.2004.10.010; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spence R, 2006, BEHAV ECOL, V17, P779, DOI 10.1093/beheco/arl016; Stonedahl F, 2010, PROCEEDINGS OF THE M; Uusi-Heikkila S, 2010, J FISH BIOL, V77, P552, DOI 10.1111/j.1095-8649.2010.02698.x; Vosges M, 2010, AQUAT TOXICOL, V99, P479, DOI 10.1016/j.aquatox.2010.06.009; Wilensky U., 1999, NETLOGO; Wootton RJ, 1998, ECOLOGY OF TELEOST F; Wootton RJ, 1994, THE EVOLUTIONARY BIO, P571; Zimmer EI, 2012, ECOTOXICOLOGY, V21, P2195, DOI 10.1007/s10646-012-0973-5	69	27	27	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125841	10.1371/journal.pone.0125841	http://dx.doi.org/10.1371/journal.pone.0125841			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938409	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000104
J	Burgner, DP; Cooper, MN; Moore, HC; Stanley, FJ; Thompson, PL; de Klerk, NH; Carter, KW				Burgner, David P.; Cooper, Matthew N.; Moore, Hannah C.; Stanley, Fiona J.; Thompson, Peter L.; de Klerk, Nicholas H.; Carter, Kim W.			Childhood Hospitalisation with Infection and Cardiovascular Disease in Early-Mid Adulthood: A Longitudinal Population-Based Study	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; CHILDREN; DYSFUNCTION; BURDEN; RISK	Background Pathogen-specific and overall infection burden may contribute to atherosclerosis and cardiovascular disease (CVD), but the effect of infection severity and timing is unknown. We investigated whether childhood infection-related hospitalisation (IRH, a marker of severity) was associated with subsequent adult CVD hospitalisation. Methods Using longitudinal population-based statutorily-collected administrative health data from Western Australia (1970-2009), we identified adults hospitalised with CVD (ischaemic heart disease, ischaemic stroke, and peripheral vascular disease) and matched them (10:1) to population controls. We used Cox regression to assess relationships between number and type of childhood IRH and adulthood CVD hospitalisation, adjusting for sex, age, Indigenous status, socioeconomic status, and birth weight. Results 631 subjects with CVD-related hospitalisation in adulthood (>= 18 years) were matched with 6310 controls. One or more childhood (< 18 years) IRH was predictive of adult CVD-related hospitalisation (adjusted hazard ratio, 1.3; 95% CI 1.1-1.6; P < 0.001). The association showed a dose-response; >= 3 childhood IRH was associated with a 2.2 times increased risk of CVD-related hospitalisation in adulthood (adjusted hazard ratio, 2.2; 95% CI 1.7-2.9; P < 0.001). The association was observed across all clinical diagnostic groups of infection (upper respiratory tract infection, lower respiratory tract infection, infectious gastroenteritis, urinary tract infection, skin and soft tissue infection, and other viral infection), and individually with CVD diagnostic categories (ischaemic heart disease, ischaemic stroke and peripheral vascular disease). Conclusions Severe childhood infection is associated with CVD hospitalisations in adulthood in a dose-dependent manner, independent of population-level risk factors.	[Burgner, David P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David P.; Stanley, Fiona J.] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, WA, Australia; [Burgner, David P.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Burgner, David P.] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Cooper, Matthew N.; Moore, Hannah C.; de Klerk, Nicholas H.] Univ Western Australia, Telethon Kids Inst, Div Populat Sci, Subiaco, WA, Australia; [Thompson, Peter L.] Sir Charles Gairdner Hosp, Dept Cardiovasc Med, Nedlands, WA 6009, Australia; [Thompson, Peter L.] Univ Western Australia, Sch Med & Pharmacol & Populat Hlth, Crawley, WA, Australia; [Carter, Kim W.] Univ Western Australia, Telethon Kids Inst, McCusker Charitable Fdn Bioinformat Ctr, Subiaco, WA, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Western Australia; University of Melbourne; Monash University; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia	Burgner, DP (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	david.burgner@mcri.edu.au	Moore, Hannah/AAA-4107-2019; Moore, Hannah C/W-4727-2018; de Klerk, Nicholas H/D-8388-2016; Cooper, Matthew N/J-4420-2014; Moore, Hannah/AHH-1092-2022	Moore, Hannah/0000-0001-6434-8290; Moore, Hannah C/0000-0001-6434-8290; de Klerk, Nicholas H/0000-0001-9223-0767; Cooper, Matthew N/0000-0003-1139-3682; Moore, Hannah/0000-0001-6434-8290; Burgner, David/0000-0002-8304-4302	Victorian Government's Operational Infrastructure Support Program; University of Western Australia Research Development Award; National Health and Medical Research Council, Australia [APP1064629]; National Heart Foundation, Australia [100026]; National Health and Medical Research Council, Australia; McCusker Charitable Foundation Bioinformatics Centre	Victorian Government's Operational Infrastructure Support Program; University of Western Australia Research Development Award; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation, Australia(National Heart Foundation of Australia); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); McCusker Charitable Foundation Bioinformatics Centre	The research was supported by the Victorian Government's Operational Infrastructure Support Program and a University of Western Australia Research Development Award. DPB is supported by a Senior Research Fellowship from the National Health and Medical Research Council (APP1064629), Australia and by an honorary Future Leader Fellowship from the National Heart Foundation (100026), Australia. HCM is supported by an Early Career Fellowship from the National Health and Medical Research Council, Australia. KWC is supported by the McCusker Charitable Foundation Bioinformatics Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2009, BRAIN BEHAV IMMUN, V23, P663, DOI 10.1016/j.bbi.2008.12.006; Anand SS, 2006, INT J EPIDEMIOL, V35, P1239, DOI 10.1093/ije/dyl163; [Anonymous], 2012, NAT BEST PRACT GUID; Australian Bureau of Statistics, 2001, TECHN PAP CENS POP H; Biering-Sorensen S, 2012, PAEDIATR PERINAT EP, V26, P226, DOI 10.1111/j.1365-3016.2011.01255.x; Blair Eve M, 2005, BMC Pediatr, V5, P13, DOI 10.1186/1471-2431-5-13; Brown A, 2010, HEART LUNG CIRC, V19, P299, DOI 10.1016/j.hlc.2010.02.022; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Charakida M, 2005, CIRCULATION, V111, P1660, DOI 10.1161/01.CIR.0000160365.18879.1C; Elixhauser A, 2006, CLIN CLASSIFICATION; Haas MJ, 2010, DIABETES-METAB RES, V26, P90, DOI 10.1002/dmrr.1057; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; JOLLY DL, 1993, J PAEDIATR CHILD H, V29, P438; Kyle RG, 2011, ARCH DIS CHILD, V96, P221, DOI 10.1136/adc.2009.180125; Leffondre K, 2003, STAT MED, V22, P3781, DOI 10.1002/sim.1674; Leffondre K, 2010, STAT MED, V29, P839, DOI 10.1002/sim.3764; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Liuba P, 2003, EUR HEART J, V24, P517, DOI 10.1016/S0195-668X(02)00750-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Moore HC, 2012, J PAEDIATR CHILD H, V48, P520, DOI 10.1111/j.1440-1754.2011.02229.x; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Odermarsky M, 2008, EUR J CLIN INVEST, V38, P381, DOI 10.1111/j.1365-2362.2008.01952.x; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Parnaby MG, 2010, J PAEDIATR CHILD H, V46, P527, DOI 10.1111/j.1440-1754.2010.01841.x; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Saxena S, 1999, BRIT MED J, V318, P642, DOI 10.1136/bmj.318.7184.642; STANLEY FJ, 1994, PAEDIATR PERINAT EP, V8, P433, DOI 10.1111/j.1365-3016.1994.tb00482.x; Truong QA, 2012, AM HEART J, V163, P972, DOI 10.1016/j.ahj.2012.03.010; Zhu JH, 2001, CIRCULATION, V103, P45	30	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125342	10.1371/journal.pone.0125342	http://dx.doi.org/10.1371/journal.pone.0125342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938548	gold, Green Published			2022-12-26	WOS:000353943000058
J	Origer, A; Le Bihan, E; Baumann, M				Origer, Alain; Le Bihan, Etienne; Baumann, Michele			A Social Gradient in Fatal Opioids and Cocaine Related Overdoses?	PLOS ONE			English	Article							NEW-YORK-CITY; DRUG OVERDOSE; INCOME-DISTRIBUTION; HARM-REDUCTION; MORTALITY; HEALTH; RISK; INEQUALITIES; BARCELONA; POVERTY	Background To determine the existence of a social gradient in fatal overdose cases related to nonprescribed opioids and cocaine use, recorded in Luxembourg between 1994 and 2011. Methods Overdose cases were individually matched with four controls in a nested case-control study design, according to sex, year of birth, drug administration route and duration of drug use. The study sample, composed of 272 cases and 1,056 controls, was stratified according to a Social Inequality Accumulation Score (SIAS), based on educational attainment, employment, income, financial situation of subjects and the professional status of their father or legal guardian. Least squares linear regression analysis on overdose mortality rates and ridit scores were applied to determine the Relative Index of Inequality (RII) of the study sample. Results A negative linear relationship between the overdose mortality rate and the relative socioeconomic position was observed. We found a difference in mortality of 29.22 overdose deaths per 100 drug users in the lowest socioeconomic group compared to the most advantaged group. In terms of the Relative Inequality Index, the overdose mortality rate of opioid and cocaine users with lowest socioeconomic profiles was 9.88 times as high as that of their peers from the highest socioeconomic group (95% CI 6.49-13.26). Conclusions Our findings suggest the existence of a marked social gradient in opioids and cocaine related overdose fatalities. Harm reduction services should integrate socially supportive offers, not only because of their general aim of social (re) integration but crucially in order to meet their most important objective, that is to reduce drug-related mortality.	[Origer, Alain] Minist Hlth, Drug Coordinat Off, Luxembourg, Luxembourg; [Origer, Alain; Le Bihan, Etienne; Baumann, Michele] Univ Luxembourg, Res Unit INSIDE, Inst Hlth & Behav, Walferdange, Luxembourg	University of Luxembourg	Origer, A (corresponding author), Minist Hlth, Drug Coordinat Off, Luxembourg, Luxembourg.	alain.origer@ms.etat.lu						Arias LC, 1998, MED CLIN-BARCELONA, V110, P161; Bergenstrom A, 2008, SUBST USE MISUSE, V43, P73, DOI 10.1080/10826080701205109; Borrell C, 2002, INJURY PREV, V8, P297, DOI 10.1136/ip.8.4.297; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Cai TX, 2012, BIOSTATISTICS, V13, P89, DOI 10.1093/biostatistics/kxr021; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; DAVOLI M, 1993, INT J EPIDEMIOL, V22, P273, DOI 10.1093/ije/22.2.273; EMCDDA, 2011, MORTALITY RELATED TO; Farrell M, 1996, ADDICTION, V91, P321, DOI 10.1111/j.1360-0443.1996.tb02282.x; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Galea S, 2003, DRUG ALCOHOL DEPEN, V70, P139, DOI 10.1016/S0376-8716(02)00342-3; HARLOW KC, 1990, PUBLIC HEALTH REP, V105, P455; ILLSLEY R, 1990, SOC SCI MED, V31, P229, DOI 10.1016/0277-9536(90)90269-X; Jones R, 2002, ADDICTION, V97, P1517, DOI 10.1046/j.1360-0443.2002.00244.x; Langendam MW, 2001, AM J PUBLIC HEALTH, V91, P774, DOI 10.2105/AJPH.91.5.774; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MARMOT MG, 1986, LANCET, V2, P274; Marzuk PM, 1997, AM J DRUG ALCOHOL AB, V23, P221, DOI 10.3109/00952999709040943; O'Driscoll PT, 2001, AM J PUBLIC HEALTH, V91, P984, DOI 10.2105/AJPH.91.6.984; Origer A, 2014, INT J DRUG POLICY; Origer A, 2014, EUR ADDICT RES, V20, P87, DOI 10.1159/000355170; Pasarin M, 1999, Gac Sanit, V13, P431; Pauly B, 2008, INT J DRUG POLICY, V19, P4, DOI 10.1016/j.drugpo.2007.11.005; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; Sporer KA, 2003, BMJ-BRIT MED J, V326, P442, DOI 10.1136/bmj.326.7386.442; Torralba L, 1996, ADDICTION, V91, P419, DOI 10.1111/j.1360-0443.1996.tb02291.x; United Nations Office on Drugs and Crime, 2013, WORLD DRUG REPORT 20; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; WILKINSON RG, 1989, J SOC POLICY, V18, P307, DOI 10.1017/S0047279400017591; World Health Organization, 2009, GLOBAL HEALTH RISKS	32	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125568	10.1371/journal.pone.0125568	http://dx.doi.org/10.1371/journal.pone.0125568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938451	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000076
J	Park, JW; Benatti, TR; Marconi, T; Yu, QY; Solis-Gracia, N; Mora, V; da Silva, JA				Park, Jong-Won; Benatti, Thiago R.; Marconi, Thiago; Yu, Qingyi; Solis-Gracia, Nora; Mora, Victoria; da Silva, Jorge A.			Cold Responsive Gene Expression Profiling of Sugarcane and Saccharum spontaneum with Functional Analysis of a Cold Inducible Saccharum Homolog of NOD26-Like Intrinsic Protein to Salt and Water Stress	PLOS ONE			English	Article							BORER ELDANA-SACCHARINA; SILICON DISTRIBUTION; RESISTANCE; TRANSPORTER; TOLERANCE; DROUGHT; LEPIDOPTERA; ANNOTATION; CULTIVARS; DIVERSITY	Transcriptome analysis of sugarcane hybrid CP72-1210 (cold susceptible) and Saccharum spontaneum TUS05-05 (cold tolerant) using Sugarcane Assembled Sequences (SAS) from SUCEST-FUN Database showed that a total of 35,340 and 34,698 SAS genes, respectively, were expressed before and after chilling stress. The analysis revealed that more than 600 genes are differentially expressed in each genotype after chilling stress. Blast2Go annotation revealed that the major difference in gene expression profiles between CP72-1210 and TUS05-05 after chilling stress are present in the genes related to the transmembrane transporter activity. To further investigate the relevance of transmembrane transporter activity against abiotic stress tolerance, a S. spontaneum homolog of a NOD26-like major intrinsic protein gene (SspNIP2) was selected for functional analysis, of which expression was induced after chilling stress in the cold tolerant TUS05-05. Quantitative real-time PCR showed that SspNIP2 expression was increased similar to 2.5 fold at 30 minutes after cold treatment and stayed induced throughout the 24 hours of cold treatment. The amino acid sequence analysis of the cloned SspNIP2 confirmed the presence of six transmembrane domains and two NPA (Asn-Pro-Ala) motifs, signature features of major intrinsic protein families. Amino acid analysis confirmed that four amino acids, comprising the ar/R (aromatic residue/arginine) region responsible for the substrate specificity among MIPs, are conserved among monocot silicon transporters and SspNIP2. Salinity stress test on SspNIP2 transgenic tobacco plants resulted in more vigorous transgenic lines than the non-transgenic tobacco plants, suggesting some degree of tolerance to salt stress conferred by SspNIP2. SspNIP2-transgenic plants, exposed to 2 weeks of water stress without irrigation, developed various degrees of water stress symptom. The water stress test confirmed that the SspNIP2 transgenic lines had lower evapotranspiration rates than non-transgenic lines, suggesting that SspNIP2 transgenic lines showed a slight tolerance to the early water stress compared to wild type plants.	[Park, Jong-Won; Benatti, Thiago R.; Marconi, Thiago; Solis-Gracia, Nora; Mora, Victoria; da Silva, Jorge A.] Texas A&M Syst, Texas A&M AgriLife Res, Weslaco, TX USA; [Yu, Qingyi] Texas A&M Syst, Texas A&M AgriLife Res, Dallas, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	da Silva, JA (corresponding author), Texas A&M Syst, Texas A&M AgriLife Res, Weslaco, TX USA.	jadasilva@tamu.edu	Marconi, Thiago/C-4829-2012; Yu, Qingyi/E-8899-2019	Marconi, Thiago/0000-0002-2241-8753; da Silva, Jorge/0000-0001-7628-5549; Yu, Qingyi/0000-0001-5393-5764	Texas Emerging Technology Fund, Bioenergy Grant from the Office of Economic Development and Tourism, division within the Office of the Governor of the State of Texas	Texas Emerging Technology Fund, Bioenergy Grant from the Office of Economic Development and Tourism, division within the Office of the Governor of the State of Texas	Texas Emerging Technology Fund (Awarded to JAD), Bioenergy Grant from the Office of Economic Development and Tourism, division within the Office of the Governor of the State of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken K., 2010, GENETICS GENOMICS BR, P419; Amalraj VA, 2006, GENET RESOUR CROP EV, V53, P35, DOI 10.1007/s10722-004-0581-1; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Berding N, 1987, SUGARCANE IMPROVEMEN, P143, DOI DOI 10.1016/B978-0-444-42769-4.50009-6; Daniels J, 1975, SUGARCANE BREED NEWS, V36, P24; Daniels SJ, 1987, SUGARCANE IMPROVEMEN, V11, P7, DOI DOI 10.1016/B978-0-444-42769-4.50007-2; Danielson JAH, 2010, ADV EXP MED BIOL, V679, P19; de Camargo MS, 2013, CROP PROT, V53, P72, DOI 10.1016/j.cropro.2013.06.006; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Edme SJ, 2006, HEREDITY, V97, P366, DOI 10.1038/sj.hdy.6800888; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; Gao XP, 2006, J PLANT NUTR, V29, P1637, DOI 10.1080/01904160600851494; Giordano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085050; Gong HJ, 2006, PLANT CELL ENVIRON, V29, P1970, DOI 10.1111/j.1365-3040.2006.01572.x; Gunes A, 2007, PLANT SOIL, V290, P103, DOI 10.1007/s11104-006-9137-9; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hodnett GL, 2010, CROP SCI, V50, P1188, DOI 10.2135/cropsci2009.09.0486; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Johanson U, 2002, MOL BIOL EVOL, V19, P456, DOI 10.1093/oxfordjournals.molbev.a004101; Kawar PG, 2009, INDIAN J BIOTECHNOL, V8, P67; Keeping MG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00289; Keeping MG, 2013, PLANT SOIL, V363, P297, DOI 10.1007/s11104-012-1325-1; Khan F A, 2009, Genet Mol Res, V8, P1376, DOI 10.4238/vol8-4gmr665; Kvedaras OL, 2007, B ENTOMOL RES, V97, P175, DOI 10.1017/S0007485307004853; Lam E, 2009, GCB BIOENERGY, V1, P251, DOI 10.1111/j.1757-1707.2009.01016.x; Liang YC, 1999, PLANT SOIL, V209, P217, DOI 10.1023/A:1004526604913; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Liang YC, 2006, ENVIRON EXP BOT, V57, P212, DOI 10.1016/j.envexpbot.2005.05.012; Ma JF, 2008, CELL MOL LIFE SCI, V65, P3049, DOI 10.1007/s00018-008-7580-x; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2002, PLANT PHYSIOL, V130, P2111, DOI 10.1104/pp.010348; Ma JF, 2010, ADV EXP MED BIOL, V679, P99; Manners JM, 2011, ADV BOT RES, V60, P89, DOI 10.1016/B978-0-12-385851-1.00003-2; Martin F, SURVEY GERMPLASM NEE; Mitani N, 2009, PLANT CELL PHYSIOL, V50, P5, DOI 10.1093/pcp/pcn110; MUKHERJEE SUNIL KUMAR, 1957, BOT GAZ, V119, P55, DOI 10.1086/335962; Nair NV, 2002, EUPHYTICA, V127, P219, DOI 10.1023/A:1020234428681; Perrone I, 2012, PLANTA, V235, P1383, DOI 10.1007/s00425-011-1581-y; Priest HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087499; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Ramdoyal K, 2001, MANAGING PLANT GENET, P307; Sacala E, 2009, J ELEM, V14, P619, DOI 10.5601/jelem.2009.14.3.20; Savant NK, 1999, J PLANT NUTR, V22, P1853, DOI 10.1080/01904169909365761; Savvas D, 2009, ENVIRON EXP BOT, V65, P11, DOI 10.1016/j.envexpbot.2008.07.004; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Stevenson GC, 1965, GENETICS BREEDING SU; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tuna AL, 2008, ENVIRON EXP BOT, V62, P10, DOI 10.1016/j.envexpbot.2007.06.006; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wallace IS, 2005, BIOCHEMISTRY-US, V44, P16826, DOI 10.1021/bi0511888; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yamaji N, 2008, PLANT CELL, V20, P1381, DOI 10.1105/tpc.108.059311; Yamaji N, 2012, PLANT PHYSIOL, V160, P1491, DOI 10.1104/pp.112.204578; Zuccarini P, 2008, BIOL PLANTARUM, V52, P157, DOI 10.1007/s10535-008-0034-3	57	40	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125810	10.1371/journal.pone.0125810	http://dx.doi.org/10.1371/journal.pone.0125810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938773	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000102
J	Loprinzi, PD; Swenor, BK; Ramulu, PY				Loprinzi, Paul D.; Swenor, Bonnielin K.; Ramulu, Pradeep Y.			Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional Study	PLOS ONE			English	Article							UNCORRECTED REFRACTIVE ERROR; VISUAL IMPAIRMENT; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIOR; UNITED-STATES; RISK-FACTORS; PREVALENCE; POPULATION; VISION; MACULOPATHY	Background We have a limited understanding of the effects of age-related macular degeneration (AMD) on physical activity (PA), and we have no prevalence estimates of the daily movement patterns among Americans with AMD. Therefore, we examined the association between AMD and PA and provided estimates of the daily movement patterns of Americans with AMD. Methods Data from the 2005-2006 National Health and Nutrition Examination Survey were used, including 1,656 adults (40-85 yrs). Retinal imaging was performed to classify individuals as no AMD, early AMD, or late AMD. Participants wore an ActiGraph 7164 accelerometer for 7 days to measure PA behavior. Results 93.2% of participants with late AMD were in the least desirable group (not sufficiently active and having a negative light intensity-sedentary behavior balance). After adjustments (including age), participants with late AMD, as compared to those with no AMD, engaged in 50% less moderate-to-vigorous physical activity (MVPA) (RR = 0.50; 95% CI: 0.28-0.90). When visual acuity was entered into the model along with the other covariates, the association between late AMD and MVPA was no longer significant (RR = 0.54; 95% CI: 0.29-1.01), suggesting that visual acuity may partially mediate this relationship. Conclusions Individuals with late AMD engage in very little moderate-to-vigorous physical activity. Visually acuity, in part, explains the relationship between late AMD and PA.	[Loprinzi, Paul D.] Univ Mississippi, Ctr Hlth Behav Res, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA; [Swenor, Bonnielin K.; Ramulu, Pradeep Y.] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA	University of Mississippi; Johns Hopkins University; Johns Hopkins Medicine	Loprinzi, PD (corresponding author), Univ Mississippi, Ctr Hlth Behav Res, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA.	pdloprin@olemiss.edu	Swenor, Bonnie/ABH-1542-2021	Swenor, Bonnie/0000-0002-6044-0951	Research to Prevent Blindness; National Institutes of Health [EY015025, EY022976]; NATIONAL EYE INSTITUTE [K12EY015025, R01EY022976] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Research to Prevent Blindness (http://www.rpbusa.org/rpb/) and National Institutes of Health grants EY015025 and EY022976 (PYR; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilante K, 2001, OPTOMETRY VISION SCI, V78, P290, DOI 10.1097/00006324-200105000-00012; Bandello F, 2007, INVEST OPHTH VIS SCI, V48, P96, DOI 10.1167/iovs.06-0283; BULLIMORE MA, 1991, INVEST OPHTH VIS SCI, V32, P2020; Cackett P, 2008, BRIT J OPHTHALMOL, V92, P1564, DOI 10.1136/bjo.2008.143875; Casten Robin J, 2004, Curr Opin Ophthalmol, V15, P181, DOI 10.1097/01.icu.0000120710.35941.3f; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Hassan SE, 2002, OPTOMETRY VISION SCI, V79, P697, DOI 10.1097/00006324-200211000-00007; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Hochberg C, 2012, INVEST OPHTH VIS SCI, V53, P3201, DOI 10.1167/iovs.12-9469; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Knudtson MD, 2006, BRIT J OPHTHALMOL, V90, P1461, DOI 10.1136/bjo.2006.103796; Ko F, 2012, JAMA-J AM MED ASSOC, V308, P2361, DOI 10.1001/jama.2012.85685; LAATIKAINEN L, 1995, ACTA OPHTHALMOL SCAN, V73, P105; Loprinzi PD, 2013, MAYO CLIN PROC, V88, P942, DOI 10.1016/j.mayocp.2013.05.015; Loprinzi PD, 2013, OBESITY FACTS, V6, P380, DOI 10.1159/000354752; Loprinzi PD, 2013, J PHYS ACT HEALTH; Mares JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P470, DOI 10.1001/archophthalmol.2010.314; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; Munch IC, 2013, INVEST OPHTH VIS SCI, V54, P3932, DOI 10.1167/iovs.12-10785; Rani PK, 2012, MIDDLE EAST AFR J OP, V19, P129, DOI 10.4103/0974-9233.92129; Richman J, 2010, ARCH OPHTHALMOL-CHIC, V128, P1576, DOI 10.1001/archophthalmol.2010.275; Rosenberg T, 1996, ACTA OPHTHALMOL SCAN, V74, P399; Rovner BW, 2009, ALZHEIMERS DEMENT, V5, P12, DOI 10.1016/j.jalz.2008.06.001; Scilley K, 2002, OPHTHALMOLOGY, V109, P1235, DOI 10.1016/S0161-6420(02)01060-6; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Subhi Y, 2014, CLIN OPHTHALMOL, V8, P15, DOI 10.2147/OPTH.S55080; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; West SK, 1997, INVEST OPHTH VIS SCI, V38, P72; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Wiliams RA, 1998, ARCH OPHTHALMOL-CHIC, V116, P514; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P101, DOI 10.1167/iovs.08-2165; Willis JR, 2013, JAMA OPHTHALMOL, V131, P1049, DOI 10.1001/jamaophthalmol.2013.316; Willis JR, 2012, ARCH OPHTHALMOL-CHIC, V130, P329, DOI 10.1001/archopthalmol.2011.1773; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701	39	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125394	10.1371/journal.pone.0125394	http://dx.doi.org/10.1371/journal.pone.0125394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933421	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100105
J	Obure, CD; Sweeney, S; Darsamo, V; Michaels-Igbokwe, C; Guinness, L; Terris-Prestholt, F; Muketo, E; Nhlabatsi, Z; Warren, CE; Mayhew, S; Watts, C; Vassall, A				Obure, Carol Dayo; Sweeney, Sedona; Darsamo, Vanessa; Michaels-Igbokwe, Christine; Guinness, Lorna; Terris-Prestholt, Fern; Muketo, Esther; Nhlabatsi, Zelda; Warren, Charlotte E.; Mayhew, Susannah; Watts, Charlotte; Vassall, Anna		Integra Initiative	The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings	PLOS ONE			English	Article							HIV/AIDS	Objective To present evidence on the total costs and unit costs of delivering six integrated sexual reproductive health and HIV services in a high and medium HIV prevalence setting, in order to support policy makers and planners scaling up these essential services. Design A retrospective facility based costing study conducted in 40 non-government organization and public health facilities in Kenya and Swaziland. Methods Economic and financial costs were collected retrospectively for the year 2010/11, from each study site with an aim to estimate the cost per visit of six integrated HIV and SRH services. A full cost analysis using a combination of bottom-up and step-down costing methods was conducted from the health provider's perspective. The main unit of analysis is the economic unit cost per visit for each service. Costs are converted to 2013 International dollars. Results The mean cost per visit for the HIV/SRH services ranged from $Int 14.23 (PNC visit) to $Int 74.21 (HIV treatment visit). We found considerable variation in the unit costs per visit across settings with family planning services exhibiting the least variation ($Int 6.71-52.24) and STI treatment and HIV treatment visits exhibiting the highest variation in unit cost ranging from ($Int 5.44-281.85) and ($Int 0.83-314.95), respectively. Unit costs of visits were driven by fixed costs while variability in visit costs across facilities was explained mainly by technology used and service maturity. Conclusion For all services, variability in unit costs and cost components suggest that potential exists to reduce costs through better use of both human and capital resources, despite the high proportion of expenditure on drugs and medical supplies. Further work is required to explore the key drivers of efficiency and interventions that may facilitate efficiency improvements.	[Obure, Carol Dayo; Sweeney, Sedona; Darsamo, Vanessa; Michaels-Igbokwe, Christine; Guinness, Lorna; Terris-Prestholt, Fern; Mayhew, Susannah; Watts, Charlotte; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Warren, Charlotte E.] Populat Council, Nairobi, Kenya; [Muketo, Esther] Family Hlth Opt Kenya, Nairobi, Kenya; [Nhlabatsi, Zelda] Family Life Assoc Swaziland, Manzini, Swaziland	University of London; London School of Hygiene & Tropical Medicine	Obure, CD (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	dayoobure@gmail.com	Guinness, Lorna/AAN-3875-2020	Guinness, Lorna/0000-0002-1013-4200; Vassall, Anna/0000-0002-2911-1375; Michaels-Igbokwe, Christine/0000-0003-0469-7055; Mayhew, Susannah/0000-0002-2433-3809; Terris-Prestholt, Fern/0000-0003-1693-5196	Bill and Melinda Gates Foundation [48733]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this study was provided by the Bill and Melinda Gates Foundation (Grant No: 48733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew I, 2003, REPROD HEALTH MATTER, V11, P51, DOI 10.1016/S0968-8080(03)22101-7; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bratt JH, 2011, TROP MED INT HEALTH, V16, P110, DOI 10.1111/j.1365-3156.2010.02640.x; Central Statistics Office, 2007, SWAZ DEM HLTH SURV 2, DOI [10.1371/journal.pone.0117219, DOI 10.1371/JOURNAL.PONE.0117219]; Church K, 2009, STUD FAMILY PLANN, V40, P171, DOI 10.1111/j.1728-4465.2009.00201.x; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gleneagles G, 2005, GLENEAGLES COMMINIQU; Government of Kenya, 2009, NAT REPR HLTH HIV AI; Government of Swaziland, 2009, NAT STRAT FRAM NSF H; Government of Swaziland, 2013, SWAZ HIV INC MEAS SU; Homan R., 2007, STRENGTHENING FINANC; Homan R, 2006, LINKING REPROD HLTH; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kanavos P, 1999, J Health Serv Res Policy, V4, P122; Liambila W, 2008, FEASIBILITY ACCEPTAB; Lush L, 2002, INT FAM PLAN PERSPEC, V28, P71, DOI 10.2307/3088238; Martinson N, 2009, JAIDS J ACQUIRED IMM, V50; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; National AIDS/STI Control Program, 2009, 2007 KEN AIDS IND SU; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Shade SB, 2013, AIDS, V27, pS87, DOI 10.1097/QAD.0000000000000038; Sweeney S, 2011, SEX TRANSM INFECT; UNFPA, 2004, NEW YORK CALL COMM L; UNFPA, 2004, GLION CALL ACT FAM P; UNGASS, 2001, UN GEN ASS SPEC SESS; Warren CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-973; World Bank, PPP CONV FACT GDP LC	30	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124476	10.1371/journal.pone.0124476	http://dx.doi.org/10.1371/journal.pone.0124476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25933414	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000353887100042
J	Penzo, M; Rocchi, L; Brugiere, S; Carnicelli, D; Onofrillo, C; Coute, Y; Brigotti, M; Montanaro, L				Penzo, Marianna; Rocchi, Laura; Brugiere, Sabine; Carnicelli, Domenica; Onofrillo, Carmine; Coute, Yohann; Brigotti, Maurizio; Montanaro, Lorenzo			Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation	FASEB JOURNAL			English	Article						mRNA translation; pseudouridylation; ribosomal proteins	LINKED DYSKERATOSIS-CONGENITA; MESSENGER-RNA TRANSLATION; MEDIATED TRANSLATION; CANCER; IDENTIFICATION; METHYLATION; MECHANISM; COMPONENT; DEFECTS	Dyskerin is a pseudouridine (psi) synthase involved in fundamental cellular processes including uridine modification in rRNA and small nuclear RNA and telomere stabilization. Dyskerin functions are altered in X-linked dyskeratosis congenita (X-DC) and cancer. Dyskerin's role in rRNA pseudouridylation has been suggested to underlie the alterations in mRNA translation described in cells lacking dyskerin function, although relevant direct evidences are currently lacking. Our purpose was to establish definitely whether defective dyskerin function might determine an intrinsic ribosomal defect leading to an altered synthetic activity. Therefore, ribosomes from dyskerin-depleted human cells were purified and 1) added to a controlled reticulocyte cell-free system devoid of ribosomes to study mRNA translation; 2) analyzed for protein contamination and composition by mass spectrometry, 3) analyzed for global pseudouridylation levels. Ribosomes purified from dyskerin-depleted cells showed altered translational fidelity and internal ribosome entry site (IRES)-mediated translation. These ribosomes displayed reduced uridine modification, whereas they were not different in terms of protein contamination or ribosomal protein composition with respect to ribosomes from matched control cells with full dyskerin activity. In conclusion, lack of dyskerin function in human cells induces a defect in rRNA uridine modification, which is sufficient to alter ribosome activity.-Penzo, M., Rocchi, L., Brugiere, S., Carnicelli, D., Onofrillo, C., Coute, Y., Brigotti, M., Montanaro, L. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation.	[Penzo, Marianna; Rocchi, Laura; Carnicelli, Domenica; Onofrillo, Carmine; Brigotti, Maurizio; Montanaro, Lorenzo] Univ Bologna, Dept Expt Diagnost & Specialty Med, Alma Mater Studiorum, I-40138 Bologna, Italy; [Brugiere, Sabine; Coute, Yohann] Univ Grenoble Alpes, Grenoble, France; [Brugiere, Sabine; Coute, Yohann] Inst Reg Travail Social, Commissariat Energie Atom, Grenoble, France; [Brugiere, Sabine; Coute, Yohann] INSERM, Biol Grande Echelle, Grenoble, France	University of Bologna; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Montanaro, L (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Alma Mater Studiorum, Via Massarenti 9, I-40138 Bologna, Italy.	maurizio.brigotti@unibo.it; lorenzo.montanaro@unibo.it	Montanaro, Lorenzo/I-4236-2019; Onofrillo, Carmine/X-7557-2019; Couté, Yohann/G-2695-2015; Brigotti, Maurizio/AAB-9007-2022; PENZO, MARIANNA/AAC-3264-2021	Montanaro, Lorenzo/0000-0001-9776-9518; Onofrillo, Carmine/0000-0002-1076-6419; Couté, Yohann/0000-0003-3896-6196; Brigotti, Maurizio/0000-0001-7429-744X; PENZO, MARIANNA/0000-0002-1738-9767; Onofrillo, Carmine/0000-0003-2537-6672; Sabine, BRUGIERE/0000-0002-0757-0968	Association for International Cancer Research [09-0083]; Associazione Italiana per la Ricerca sul Cancro [IG-11416]; Italian Ministry of Education, University and National Research Project [20104AE23N_002]; PRIME-XS project [262067]; European Union 7th Framework Programme; Pallotti Legacy for research on cancer; Worldwide Cancer Research [09-0083] Funding Source: researchfish	Association for International Cancer Research; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and National Research Project; PRIME-XS project; European Union 7th Framework Programme; Pallotti Legacy for research on cancer; Worldwide Cancer Research	The authors are in debt to Drs. D. Ruggero, B. Mazumder and J.-J. Diaz for providing reagents, and to Drs. O. Gandrillon, S. Giraud, A. T. Thu Lefebvre, and L. Grossier (Centre de Genetique et de Physiologie Moleculaire et Cellulaire, Lyon, France) for help in the preliminary part of the study and for discussion. The authors thank the Center for Applied Biomedical Research of S. Orsola-Malpighi University Hospital in Bologna for making available several instruments. This work has been supported by grants from the Association for International Cancer Research (09-0083), Associazione Italiana per la Ricerca sul Cancro (IG-11416), the Italian Ministry of Education, University and National Research Project (Grant 20104AE23N_002), the PRIME-XS project (Grant 262067), funded by the European Union 7th Framework Programme (awarded to L.M.), and Funds from the Pallotti Legacy for research on cancer (to L.M. and M.B.). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (31) with the data set identifier PXD001274.	ALLEN EH, 1962, J BIOL CHEM, V237, P760; Armistead J, 2014, FEBS LETT, V588, P1491, DOI 10.1016/j.febslet.2014.03.024; Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Marcel V, 2013, CANCER CELL, V24, P318, DOI 10.1016/j.ccr.2013.08.013; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; MORRISEY J, 1972, ARCH BIOCHEM BIOPHYS, V152, P385, DOI 10.1016/0003-9861(72)90228-7; Narla A, 2011, INT J HEMATOL, V93, P144, DOI 10.1007/s12185-011-0776-0; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Parry EM, 2011, J MED GENET, V48, P327, DOI 10.1136/jmg.2010.085100; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Rocchi L, 2013, NUCLEIC ACIDS RES, V41, P8308, DOI 10.1093/nar/gkt587; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; SIERRA JM, 1974, P NATL ACAD SCI USA, V71, P2693, DOI 10.1073/pnas.71.7.2693; Thumati NR, 2013, HUM MUTAT, V34, P1698, DOI 10.1002/humu.22447; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	31	37	39	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3472	3482		10.1096/fj.15-270991	http://dx.doi.org/10.1096/fj.15-270991			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25934701				2022-12-26	WOS:000358796900033
J	Chen, X; Li, XL; Zheng, J; Zhao, JS; He, JM; Zhang, GQ; Tang, XM				Chen, Xi; Li, Xingli; Zheng, Jun; Zhao, Junshi; He, Jianmei; Zhang, Guoqiang; Tang, Xuemin			Club Drugs and HIV/STD Infection: An Exploratory Analysis among Men Who Have Sex with Men in Changsha, China	PLOS ONE			English	Article							METHAMPHETAMINE USE; HIV-INFECTION; RISK BEHAVIOR; SUBSTANCE USE; PREVALENCE; SYPHILIS; GAY; PREDICTORS; SHANGHAI; PATTERNS	Objective To evaluate current club drug use and its potential association with the transmission of HIV/STD among Changsha men who have sex with men (MSM). Method A cross-sectional survey was conducted by using self-administered questionnaires including information regarding socio-demographics, club drug use, high-risk behaviors, and HIV/STD infections. Multiple methods including venue-based, peer referral using "snowball" techniques, and internet advertisements were used to recruit study participants. Results Of the 826 participants, 177 (21.4%) reported that they had used club drugs at some time before or during sex in the past six months. MSM with young age, low education level, and seeking partners through the internet or bars were the main population who used drugs. Poppers were the most common drug used among Changsha MSM. The prevalence of HIV, syphilis, and herpes simplex virus-2 were higher among drug users. There were no significant differences in unprotected sexual intercourse and condom use between drug users and non-users. Compared with non-users, risk behaviors such as group sex, multiple sex partners, and sex with foreigners were more frequent among drug users. Conclusion Club drug use is common among Changsha MSM, and is related to unsafe sex activities and HIV/STD infection. It is necessary to build novel targeted HIV prevention strategies to monitor and reduce club drug use among MSM.	[Chen, Xi; Zheng, Jun; Zhao, Junshi; He, Jianmei; Zhang, Guoqiang] Hunan Prov Ctr Dis Prevent & Control, Dept AIDS STI Control & Prevent, Changsha, Hunan, Peoples R China; [Li, Xingli; Tang, Xuemin] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University	Li, XL (corresponding author), Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	lixingli@csu.edu.cn			Natural Science Foundation of China [81202257]; National Science and Technology Major Project of China [2012ZX10001-001]; Foundation of Central South University for Outstanding Young Teachers [2013JSJJ032]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Foundation of Central South University for Outstanding Young Teachers	This work funded by the Natural Science Foundation of China(NO.81202257) and National Science and Technology Major Project of China (NO:2012ZX10001-001) and Foundation of Central South University for Outstanding Young Teachers (No. 2013JSJJ032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai HL, 2011, J BIOMED RES, V25, P17, DOI 10.1016/S1674-8301(11)60002-X; Barrett SP, 2006, HUM PSYCHOPHARM CLIN, V21, P255, DOI 10.1002/hup.766; Bolding G, 2006, ADDICTION, V101, P1622, DOI 10.1111/j.1360-0443.2006.01571.x; Carey JW, 2009, AIDS BEHAV, V13, P1084, DOI 10.1007/s10461-008-9403-3; Ding Ying-ying, 2012, Fudan Xuebao (Yixueban), V39, P551, DOI 10.3969/j.issn.1672-8467.2012.06.001; Ding YY, 2013, DRUG ALCOHOL DEPEN, V131, P278, DOI 10.1016/j.drugalcdep.2012.12.019; Drumright LN, 2006, JAIDS-J ACQ IMM DEF, V43, P344, DOI 10.1097/01.qai.0000230530.02212.86; Halkitis PN, 2007, DRUG ALCOHOL DEPEN, V89, P153, DOI 10.1016/j.drugalcdep.2006.12.028; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Li XF, 2010, CHINESE J AIDS STD, V16, P449; Li XH, 2009, AIDS PATIENT CARE ST, V23, P877, DOI 10.1089/apc.2009.0015; Li Y, 2012, AIDS BEHAV, V16, P491, DOI 10.1007/s10461-012-0157-6; Liu SS, 2012, SEX TRANSM DIS, V39, P251, DOI 10.1097/OLQ.0b013e31824a0903; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; McCambridge J, 2005, ADDICTION, V100, P1140, DOI 10.1111/j.1360-0443.2005.001127.x; Ministry of Health, 2009, PEOPL REP CHIN 2009; Operario D, 2006, PREV SCI, V7, P19, DOI 10.1007/s11121-005-0018-x; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Rudy ET, 2009, SEX TRANSM DIS, V36, P693, DOI 10.1097/OLQ.0b013e3181ad54a3; Schwarcz S, 2007, AM J PUBLIC HEALTH, V97, P1067, DOI 10.2105/AJPH.2005.072249; Semple SJ, 2009, ARCH SEX BEHAV, V38, P583, DOI 10.1007/s10508-007-9292-y; Spindler HH, 2007, SEX TRANSM DIS, V34, P586, DOI 10.1097/01.olq.0000258339.17325.93; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Xu JJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/725361; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Xu JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-3	29	29	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126320	10.1371/journal.pone.0126320	http://dx.doi.org/10.1371/journal.pone.0126320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950912	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400079
J	Jin, XN; Fu, ZY; Lv, PQ; Peng, Q; Ding, D; Li, WH; Tang, JH				Jin, Xining; Fu, Zhiyuan; Lv, Panqing; Peng, Qian; Ding, Dong; Li, Weihua; Tang, Jihua			Identification and Characterization of microRNAs during Maize Grain Filling	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; STRESS; LEAF; DURATION; MIRNAS; PREDICTION; OSSPL14; GROWTH	The grain filling rate is closely associated with final grain yield of maize during the period of maize grain filling. To identify the key microRNAs (miRNAs) and miRNA-dependent gene regulation networks of grain filling in maize, a deep-sequencing technique was used to research the dynamic expression patternsof miRNAs at four distinct developmental grain filling stages in Zhengdan 958, which is an elite hybrid and cultivated widely in China. The sequencing result showed that the expression amount of almost all miRNAs was changing with the development of the grain filling and formed in seven groups. After normalization, 77 conserved miRNAs and 74 novel miRNAs were co-detected in these four samples. Eighty-one out of 162 targets of the conserved miRNAs belonged to transcriptional regulation (81, 50%), followed by oxidoreductase activity (18, 11%), signal transduction (16, 10%) and development (15, 9%). The result showed that miRNA 156, 393, 396 and 397, with their respective targets, might play key roles in the grain filling rate by regulating maize growth, development and environment stress response. The result also offered novel insights into the dynamic change of miRNAs during the developing process of maize kernels and assistedin the understanding of how miRNAs are functioning about the grain filling rate.	[Jin, Xining; Fu, Zhiyuan; Lv, Panqing; Peng, Qian; Ding, Dong; Li, Weihua; Tang, Jihua] Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China.	tangjihua1@163.com		fu, zhiyuan/0000-0002-9078-5133	National Basic Research Program of China [2014CB138203]; National High Technology Research and Development program [2012AA10A305]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development program(National High Technology Research and Development Program of China)	Funding: This work was supported by the National Basic Research Program of China (2014CB138203) and the National High Technology Research and Development program (2012AA10A305).	Baliga RS, 2012, CIRCULATION, V125, P2922, DOI 10.1161/CIRCULATIONAHA.112.100586; Butt V. S., 1980, The biochemistry of plants. A comprehensive treatise. Volume 2. Metabolism and respiration., P81; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039578; Earl HJ, 2012, CROP SCI, V52, P1795, DOI 10.2135/cropsci2011.11.0615; Gasura E, 2010, SCOND RUFORUM BIENNI; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jin XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059353; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Lisanti S, 2013, FIELD CROP RES, V154, P1, DOI 10.1016/j.fcr.2013.08.009; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Lu DL, 2014, FOOD CHEM, V143, P313, DOI 10.1016/j.foodchem.2013.07.089; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Mecchia MA, 2013, MECH DEVELOP, V130, P2, DOI 10.1016/j.mod.2012.07.005; Meng FR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-140; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; NASS HG, 1975, CAN J PLANT SCI, V55, P673, DOI 10.4141/cjps75-107; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Pierce EA, 2012, IDENTIFICATION AND C, DOI [10.1074/jbc.M110.155739, DOI 10.1074/JBC.M110.155739]; PONELEIT CG, 1979, CROP SCI, V19, P385, DOI 10.2135/cropsci1979.0011183X001900030027x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; SOFIELD I, 1977, AUST J PLANT PHYSIOL, V4, P785, DOI 10.1071/PP9770785; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Turlapati PV, 2011, PLANTA, V233, P439, DOI 10.1007/s00425-010-1298-3; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wiegand C, 1980, AGRONOMY ABSTRACTS 7; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666	49	19	19	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125800	10.1371/journal.pone.0125800	http://dx.doi.org/10.1371/journal.pone.0125800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951054	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400048
J	Ludewig, K; Donath, TW; Zelle, B; Eckstein, RL; Mosner, E; Otte, A; Jensen, K				Ludewig, Kristin; Donath, Tobias W.; Zelle, Bianka; Eckstein, R. Lutz; Mosner, Eva; Otte, Annette; Jensen, Kai			Effects of Reduced Summer Precipitation on Productivity and Forage Quality of Floodplain Meadows at the Elbe and the Rhine River	PLOS ONE			English	Article							NORTHERN UPPER RHINE; SPECIES RICHNESS; LAND-USE; RESTORATION SUCCESS; ALLUVIAL GRASSLANDS; BIOMASS PRODUCTION; PLANT-MATERIAL; WATER-STRESS; NITROGEN; IMPACT	Background Floodplain meadows along rivers are semi-natural habitats and depend on regular land use. When used non-intensively, they offer suitable habitats for many plant species including rare ones. Floodplains are hydrologically dynamic ecosystems with both periods of flooding and of dry conditions. In German floodplains, dry periods may increase due to reduced summer precipitation as projected by climate change scenarios. Against this background, the question arises, how the forage quantity and quality of these meadows might change in future. Methods We report results of two field trials that investigated effects of experimentally reduced summer precipitation on hay quantity and quality of floodplain meadows at the Rhine River (2011-2012) and at two Elbe tributaries (2009-2011). We measured annual yield, the amount of hay biomass, and contents of crude protein, crude fibre, energy, fructan, nitrogen, phosphorus, and potassium. Results The annual yield decreased under precipitation reduction at the Rhine River. This was due to reduced productivity in the second cut hay at the Rhine River in which, interestingly, the contents of nitrogen and crude protein increased. The first cut at the Rhine River was unaffected by the treatments. At the Elbe tributaries, the annual yield and the hay quantity and quality of both cuts were only marginally affected by the treatments. Conclusion We conclude that the yield of floodplain meadows may become less reliable in future since the annual yield decreased under precipitation reduction at the Rhine River. However, the first and agriculturally more important cut was almost unaffected by the precipitation reduction, which is probably due to sufficient soil moisture from winter/spring. As long as future water levels of the rivers will not decrease during spring, at least the use of the hay from the first cut of floodplain meadows appears reliable under climate change.	[Ludewig, Kristin; Jensen, Kai] Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany; [Ludewig, Kristin; Donath, Tobias W.; Zelle, Bianka; Eckstein, R. Lutz; Otte, Annette] Univ Giessen, Res Ctr Biosyst Land Use & Nutr IFZ, Inst Landscape Ecol & Resource Management, D-35390 Giessen, Germany; [Mosner, Eva] BfG, Koblenz, Germany	University of Hamburg; Justus Liebig University Giessen	Ludewig, K (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany.	Kristin.Ludewig@uni-hamburg.de	Mosner, Eva C/T-5519-2017; Jensen, Kai/L-6657-2015; Eckstein, Lutz/A-9241-2012; Donath, Tobias W./B-2856-2012; Ludewig, Kristin/X-4204-2019	Mosner, Eva C/0000-0002-5950-2270; Jensen, Kai/0000-0002-0543-070X; Donath, Tobias W./0000-0003-1874-1096; Ludewig, Kristin/0000-0003-2665-2712	Federal Ministry of Education and Research within KLIMZUG-NORD [01LR0805D]; Federal Ministry of Transport, Building and Urban Development within KLIWAS; Landwirtschaftskammer Niedersachsen; Estuary and Wetland Research Graduate School Hamburg (ESTRADE) - Hamburg Science and Research Foundation of the State Excellence Initiative (LExI)	Federal Ministry of Education and Research within KLIMZUG-NORD; Federal Ministry of Transport, Building and Urban Development within KLIWAS; Landwirtschaftskammer Niedersachsen; Estuary and Wetland Research Graduate School Hamburg (ESTRADE) - Hamburg Science and Research Foundation of the State Excellence Initiative (LExI)	Funding: The Elbe study was funded by the Federal Ministry of Education and Research within the research project KLIMZUG-NORD (grant number 01LR0805D) and the Rhine study was financed by the Federal Ministry of Transport, Building and Urban Development within the research project KLIWAS. The Landwirtschaftskammer Niedersachsen gave financial support for analysing samples from the Elbe tributaries. KL was further supported by the Estuary and Wetland Research Graduate School Hamburg (ESTRADE), which was funded by the Hamburg Science and Research Foundation as member of the State Excellence Initiative (LExI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, STANDARDLISTE FARN B; Bailey SR, 2013, ANIM PROD SCI, V53, P1182, DOI 10.1071/AN13266; Beltman B, 2007, J VEG SCI, V18, P625, DOI 10.1111/j.1654-1103.2007.tb02576.x; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bissels S, 2005, PHYTOCOENOLOGIA, V35, P469, DOI 10.1127/0340-269X/2005/0035-0469; Bissels S, 2004, BIOL CONSERV, V118, P641, DOI 10.1016/j.biocon.2003.10.013; Bloor JMG, 2012, PERSPECT PLANT ECOL, V14, P193, DOI 10.1016/j.ppees.2011.12.001; Bloor JMG, 2010, ECOSYSTEMS, V13, P888, DOI 10.1007/s10021-010-9363-0; Boger K, 1991, BOT NATURSCHUTZ HESS, V3; BROADFOOT WM, 1969, FOREST SCI, V15, P46; Brum OB, 2009, REV BRAS ZOOTECN, V38, P596, DOI 10.1590/S1516-35982009000400002; Brunotte E, 2009, NATURSCHUTZ BIOL VIE, V87, P3; Butof A, 2012, GLOBAL CHANGE BIOL, V18, P127, DOI 10.1111/j.1365-2486.2011.02539.x; Burkart M, 2001, GLOBAL ECOL BIOGEOGR, V10, P449, DOI 10.1046/j.1466-822x.2001.00270.x; Burmeier S, 2010, PLANT SOIL, V333, P351, DOI 10.1007/s11104-010-0350-1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Conradt T, 2012, REG ENVIRON CHANGE, V12, P633, DOI 10.1007/s10113-012-0279-4; Donath TW, 2007, BIOL CONSERV, V138, P224, DOI 10.1016/j.biocon.2007.04.020; Donath TW, 2015, AGR ECOSYST ENVIRON, V200, P102, DOI 10.1016/j.agee.2014.11.004; Donath TW, 2004, AGR ECOSYST ENVIRON, V104, P439, DOI 10.1016/j.agee.2004.01.039; Donath TW, 2003, APPL VEG SCI, V6, P13, DOI 10.1111/j.1654-109X.2003.tb00560.x; Duru M, 2014, ECOL INDIC, V36, P152, DOI 10.1016/j.ecolind.2013.07.015; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Franke C, 2003, GRUNLAND UNTEREN MIT; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Hejcman M, 2010, PLANT SOIL, V333, P163, DOI 10.1007/s11104-010-0332-3; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Holzel N, 2001, J VEG SCI, V12, P209, DOI 10.2307/3236605; HSIAO TC, 1974, AGR METEOROL, V14, P59, DOI 10.1016/0002-1571(74)90011-9; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Isselstein J., 2005, Agronomy Research, V3, P139; Jacob D, 2008, 0811 UBA UMW BUND; Jensen K, 2011, KLIMABERICHT METROPO, P143; Jensen K, 1999, APPL VEG SCI, V2, P79, DOI 10.2307/1478884; Jensen K, 2006, BASIC APPL ECOL, V7, P383, DOI 10.1016/j.baae.2006.05.008; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Kleinebecker T, 2014, J ECOL, V102, P456, DOI 10.1111/1365-2745.12202; Kleinebecker T, 2011, PLANT ECOL, V212, P1563, DOI 10.1007/s11258-011-9931-1; Kreyling J, 2008, ECOSYSTEMS, V11, P752, DOI 10.1007/s10021-008-9157-9; Leyer I, 2005, J APPL ECOL, V42, P239, DOI 10.1111/j.1365-2664.2005.01009.x; Liira J, 2008, J VEG SCI, V19, P3, DOI 10.3170/2007-8-18308; Longland AC, 2012, J SCI FOOD AGR, V92, P1878, DOI 10.1002/jsfa.5555; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; National Research Council, 2001, NUTR REQ DAIR CATTL, DOI DOI 10.17226/19014; Opitz von Boberfeld W, 1994, GRUNLANDLEHRE BIOL O; Pan JJ, 2010, PLANT ECOL, V206, P139, DOI 10.1007/s11258-009-9630-3; Schmiede R, 2012, APPL VEG SCI, V15, P290, DOI 10.1111/j.1654-109X.2011.01168.x; Seffer J, 2008, 1724 EUR COMM; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tallowin JRB, 1999, GRASS FORAGE SCI, V54, P99, DOI 10.1046/j.1365-2494.1999.00171.x; Tanuwidjaja D., 2010, WATER QUALITY TECHNO; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Toogood SE, 2008, PLANT ECOL, V197, P285, DOI 10.1007/s11258-007-9378-6; Venterink HO, 2006, APPL VEG SCI, V9, P163; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; Walter J, 2012, AGR ECOSYST ENVIRON, V148, P1, DOI 10.1016/j.agee.2011.11.015; Weih M, 2011, ANN BOT-LONDON, V108, P1347, DOI 10.1093/aob/mcr227; Wesche K, 2012, BIOL CONSERV, V150, P76, DOI 10.1016/j.biocon.2012.02.015; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3	62	10	12	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124140	10.1371/journal.pone.0124140	http://dx.doi.org/10.1371/journal.pone.0124140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950730	gold, Green Submitted, Green Published			2022-12-26	WOS:000354214400012
J	Raso, GM; Pirozzi, C; Bianca, RDD; Simeoli, R; Santoro, A; Lama, A; Di Guida, F; Russo, R; De Caro, C; Sorrentino, R; Calignano, A; Meli, R				Raso, Giuseppina Mattace; Pirozzi, Claudio; Bianca, Roberta d'Emmanuele di Villa; Simeoli, Raffaele; Santoro, Anna; Lama, Adriano; Di Guida, Francesca; Russo, Roberto; De Caro, Carmen; Sorrentino, Raffaella; Calignano, Antonio; Meli, Rosaria			Palmitoylethanolamide Treatment Reduces Blood Pressure in Spontaneously Hypertensive Rats: Involvement of Cytochrome P450-Derived Eicosanoids and Renin Angiotensin System	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; MESENTERIC-ARTERY; ARACHIDONIC-ACID; INHIBITION; PROTECTS; KIDNEY	Palmitoylethanolamide (PEA), a peroxisome proliferator-activated receptor-a agonist, has been demonstrated to reduce blood pressure and kidney damage secondary to hypertension in spontaneously hypertensive rat (SHR). Currently, no information is available concerning the putative effect of PEA on modulating vascular tone. Here, we investigate the mechanisms underpinning PEA blood pressure lowering effect, exploring the contribution of epoxyeicosatrienoic acids, CYP-dependent arachidonic acid metabolites, as endotheliumderived hyperpolarizing factors (EDHF), and renin angiotensin system (RAS) modulation. To achieve this aim SHR and Wistar-Kyoto rats were treated with PEA (30 mg/kg/day) for five weeks. Functional evaluations on mesenteric bed were performed to analyze EDHFmediated vasodilation. Moreover, mesenteric bed and carotid were harvested to measure CYP2C23 and CYP2J2, the key isoenzymes in the formation of epoxyeicosatrienoic acids, and the soluble epoxide hydrolase, which is responsible for their degradation in the corresponding diols. Effect of PEA on RAS modulation was investigated by analyzing angiotensin converting enzyme and angiotensin receptor 1 expression. Here, we showed that EDHF-mediated dilation in response to acetylcholine was increased in mesenteric beds of PEA-treated SHR. Western blot analysis revealed that the increase in CYP2C23 and CYP2J2 observed in SHR was significantly attenuated in mesenteric beds of PEA-treated SHR, but unchanged in the carotids. Interestingly, in both vascular tissues, PEA significantly decreased the soluble epoxide hydrolase protein level, accompanied by a reduced serum concentration of its metabolite 14-15 dihydroxyeicosatrienoic acid, implying a reduction in epoxyeicosatrienoic acid hydrolisis. Moreover, PEA treatment down-regulated angiotensin receptor 1 and angiotensin converting enzyme expression, indicating a reduction in angiotensin II-mediated effects. Consistently, a damping of the activation of angiotensin receptor 1 underlying pathways in mesenteric beds was shown in basal conditions in PEA-treated SHR. In conclusion, our data demonstrate the involvement of epoxyeicosatrienoic acids and renin angiotensin system in the blood pressure lowering effect of PEA.	[Raso, Giuseppina Mattace; Pirozzi, Claudio; Bianca, Roberta d'Emmanuele di Villa; Simeoli, Raffaele; Santoro, Anna; Lama, Adriano; Di Guida, Francesca; Russo, Roberto; De Caro, Carmen; Sorrentino, Raffaella; Calignano, Antonio; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Simeoli, Raffaele] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England	University of Naples Federico II; University of London; Queen Mary University London	Raso, GM (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	mattace@unina.it	Pirozzi, Claudio/S-2760-2016; russo, roberto/A-3193-2012; Simeoli, Raffaele/J-1101-2018; De, Carmen/AAH-2150-2019; Lama, Adriano/AAC-1964-2020; Calignano, Antonio/K-2542-2018	russo, roberto/0000-0001-5950-1617; Simeoli, Raffaele/0000-0002-3989-7703; Lama, Adriano/0000-0002-5816-1400; Pirozzi, Claudio/0000-0002-3409-5744; Meli, Rosaria/0000-0002-6246-6813; CALIGNANO, Antonio/0000-0002-1742-3179; SORRENTINO, RAFFAELLA/0000-0002-0284-5424; DE CARO, Carmen/0000-0003-3549-5958; Mattace Raso, Giuseppina/0000-0002-5254-139X; D'EMMANUELE DI VILLA BIANCA, Roberta/0000-0003-0992-6400; Santoro, Anna/0000-0002-2276-5659	 [Calignano_002_001-RICDIPLE2]		The authors received no specific funding for this work. They used Department funding (Calignano_002_001-RICDIPLE2-Prof. A. Calignano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Ai D, 2010, KIDNEY INT, V77, P88, DOI 10.1038/ki.2009.349; Bader J, 2001, J MOL MED, V79, P76, DOI 10.1007/s001090100210; Bianca RDD, 2011, J PHARMACOL EXP THER, V337, P59, DOI 10.1124/jpet.110.176016; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Fornage M, 2002, HYPERTENSION, V40, P485, DOI 10.1161/01.HYP.0000032278.75806.68; FUJII K, 1992, CIRC RES, V70, P660, DOI 10.1161/01.RES.70.4.660; Gauthier KM, 2005, HYPERTENSION, V45, P666, DOI 10.1161/01.HYP.0000153462.06604.5d; Goto K, 2000, HYPERTENSION, V36, P581, DOI 10.1161/01.HYP.36.4.581; Goto K, 2004, CLIN EXP PHARMACOL P, V31, P650, DOI 10.1111/j.1440-1681.2004.04054.x; Halcox JPJ, 2001, AM J PHYSIOL-HEART C, V280, pH2470, DOI 10.1152/ajpheart.2001.280.6.H2470; Honing MLH, 2000, HYPERTENSION, V35, P1314, DOI 10.1161/01.HYP.35.6.1314; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010; Kahonen M, 1999, EUR J PHARMACOL, V368, P213, DOI 10.1016/S0014-2999(99)00031-X; Kang KT, 2014, TOX RESEARCH, V30, P141, DOI 10.5487/TR.2014.30.3.141; Kher Vijay, 2009, J Assoc Physicians India, V57, P518; LUSCHER TF, 1994, J HYPERTENS, V12, pS105; MacKenzie A, 2011, PHARMACOL THERAPEUT, V131, P187, DOI 10.1016/j.pharmthera.2010.11.001; Miyoshi A, 1997, AM J HYPERTENS, V10, P1083; Nishikawa Y, 1999, AM J PHYSIOL-HEART C, V277, pH1252, DOI 10.1152/ajpheart.1999.277.3.H1252; OKUNISHI H, 1993, JPN J PHARMACOL, V62, P207, DOI 10.1254/jjp.62.207; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Raso GM, 2007, J ENDOCRINOL, V194, P611, DOI 10.1677/JOE-07-0159; Raso GM, 2013, PHARMACOL RES, V76, P67, DOI 10.1016/j.phrs.2013.07.007; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Shimizu A, 1998, Nihon Ronen Igakkai Zasshi, V35, P451; Spieker LE, 2005, HANDB EXP PHARM, V170, P619; Strobbe E, 2013, INVEST OPHTH VIS SCI, V54, P968, DOI 10.1167/iovs.12-10899; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhao XY, 2006, AM J PHYSIOL-HEART C, V290, pH2187, DOI 10.1152/ajpheart.00937.2005; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0123602	10.1371/journal.pone.0123602	http://dx.doi.org/10.1371/journal.pone.0123602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951330	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400007
J	Wang'ondu, R; Teal, S; Park, R; Heston, L; Delecluse, H; Miller, G				Wang'ondu, Ruth; Teal, Stuart; Park, Richard; Heston, Lee; Delecluse, Henri; Miller, George			DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA	PLOS ONE			English	Article							TIP60 HISTONE ACETYLTRANSFERASE; EARLY ANTIGEN COMPLEX; BASIC DOMAIN; AMINO-ACIDS; PROTEIN; ACTIVATION; PHOSPHORYLATION; ATM; CHROMATIN; KINASE	Epstein Barr virus (EBV), like other oncogenic viruses, modulates the activity of cellular DNA damage responses (DDR) during its life cycle. Our aim was to characterize the role of early lytic proteins and viral lytic DNA replication in activation of DNA damage signaling during the EBV lytic cycle. Our data challenge the prevalent hypothesis that activation of DDR pathways during the EBV lytic cycle occurs solely in response to large amounts of exogenous double stranded DNA products generated during lytic viral DNA replication. In immunofluorescence or immunoblot assays, DDR activation markers, specifically phosphorylated ATM (pATM), H2AX (gamma H2AX), or 53BP1 (p53BP1), were induced in the presence or absence of viral DNA amplification or replication compartments during the EBV lytic cycle. In assays with an ATM inhibitor and DNA damaging reagents in Burkitt lymphoma cell lines,gamma H2AX induction was necessary for optimal expression of early EBV genes, but not sufficient for lytic reactivation. Studies in lytically reactivated EBV-positive cells in which early EBV proteins, BGLF4, BGLF5, or BALF2, were not expressed showed that these proteins were not necessary for DDR activation during the EBV lytic cycle. Expression of ZEBRA, a viral protein that is necessary for EBV entry into the lytic phase, induced pATMfoci and gamma H2AX independent of other EBV gene products. ZEBRA mutants deficient in DNA binding, Z(R183E) and Z(S186E), did not induce foci of pATM. ZEBRA co-localized with HP1 beta, a heterochromatin associated protein involved in DNA damage signaling. We propose a model of DDR activation during the EBV lytic cycle in which ZEBRA induces ATM kinase phosphorylation, in a DNA binding dependent manner, to modulate gene expression. ATM and H2AX phosphorylation induced prior to EBV replication may be critical for creating a microenvironment of viral and cellular gene expression that enables lytic cycle progression.	[Wang'ondu, Ruth] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Teal, Stuart; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Park, Richard; Heston, Lee; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Delecluse, Henri] German Canc Res Ctr, Heidelberg, Germany; [Delecluse, Henri] Inserm Unit, Heidelberg, Germany; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Helmholtz Association; German Cancer Research Center (DKFZ); Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	George.Miller@yale.edu		Delecluse, Henri-Jacques/0000-0002-1744-6274; wangondu, ruth/0000-0002-4586-8933	National Institutes of Health [CA16038, CA12055]; National Institutes of Health Medical Scientist Training Program Training Grant [TG2T32GM07205]; Wellesley College; NATIONAL CANCER INSTITUTE [P01CA016038, R37CA012055, R01CA012055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellesley College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants CA16038 and CA12055 to G.M. R.W. was supported by National Institutes of Health Medical Scientist Training Program Training Grant TG2T32GM07205 and a Horton Hallowell Fellowship Stipend from Wellesley College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bai L, 2007, BIOCHEM BIOPH RES CO, V359, P817, DOI 10.1016/j.bbrc.2007.05.197; Bailey SG, 2009, J VIROL, V83, P11116, DOI 10.1128/JVI.00512-09; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; Chang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039217; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Chen MR, 2000, J VIROL, V74, P3093, DOI 10.1128/JVI.74.7.3093-3104.2000; Chen YL, 2009, CELL CYCLE, V8, P58, DOI 10.4161/cc.8.1.7411; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; Daigle D, 2011, J VIROL, V85, P5628, DOI 10.1128/JVI.02659-10; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; El-Guindy AS, 2004, J VIROL, V78, P7634, DOI 10.1128/JVI.78.14.7634-7644.2004; El-Guindy A, 2007, J VIROL, V81, P3303, DOI 10.1128/JVI.02445-06; El-Guindy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004307; El-Guindy A, 2013, J VIROL, V87, P208, DOI 10.1128/JVI.01995-12; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Feederle R, 2009, J VIROL, V83, P10877, DOI 10.1128/JVI.00525-09; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Francis AL, 1997, J VIROL, V71, P3054, DOI 10.1128/JVI.71.4.3054-3061.1997; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Hagemeier SR, 2012, J VIROL, V86, P13360, DOI 10.1128/JVI.01850-12; Hau PM, 2015, J VIROL, V89, P652, DOI 10.1128/JVI.01437-14; HENLE G, 1971, INT J CANCER, V8, P272, DOI 10.1002/ijc.2910080212; HESTON L, 1982, NATURE, V295, P160, DOI 10.1038/295160a0; Heston L, 2006, J VIROL, V80, P9115, DOI 10.1128/JVI.00909-06; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kofod-Olsen E, 2008, J GEN VIROL, V89, P106, DOI 10.1099/vir.0.83224-0; Kofod-Olsen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059223; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Lilley CE, 2010, BBA-GENE REGUL MECH, V1799, P319, DOI 10.1016/j.bbagrm.2009.06.007; Lomonte P, 2004, J VIROL, V78, P6744, DOI 10.1128/JVI.78.13.6744-6757.2004; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McFadden K, 2013, CURR TOP MICROBIOL, V371, P229, DOI 10.1007/978-3-642-37765-5_9; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; NYORMOI O, 1976, P NATL ACAD SCI USA, V73, P1745, DOI 10.1073/pnas.73.5.1745; OLD LJ, 1966, P NATL ACAD SCI USA, V56, P1699, DOI 10.1073/pnas.56.6.1699; Park R, 2008, VIROLOGY, V382, P145, DOI 10.1016/j.virol.2008.09.009; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; Philpott NJ, 1996, BLOOD; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; RAABTRAUB N, 1987, INT J CANCER, V39, P25, DOI 10.1002/ijc.2910390106; Ramasubramanyan S, 2012, J VIROL, V86, P1809, DOI 10.1128/JVI.06334-11; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; TOKUYASU KT, 1983, J CELL BIOL, V97, P562, DOI 10.1083/jcb.97.2.562; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; WOLF H, 1973, NATURE-NEW BIOL, V244, P245, DOI 10.1038/newbio244245a0; Wu CC, 2010, NUCLEIC ACIDS RES, V38, P1932, DOI 10.1093/nar/gkp1169; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; ZHANG CX, 1988, J VIROL, V62, P1862, DOI 10.1128/JVI.62.6.1862-1869.1988; Zhang Y, 2006, INT J RADIAT ONCOL, V65, P859, DOI 10.1016/j.ijrobp.2006.03.019	77	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126088	10.1371/journal.pone.0126088	http://dx.doi.org/10.1371/journal.pone.0126088			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950714	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400067
J	Nasedkin, A; Marcellini, M; Religa, TL; Freund, SM; Menzel, A; Fersht, AR; Jemth, P; van der Spoel, D; Davidsson, J				Nasedkin, Alexandr; Marcellini, Moreno; Religa, Tomasz L.; Freund, Stefan M.; Menzel, Andreas; Fersht, Alan R.; Jemth, Per; van der Spoel, David; Davidsson, Jan			Deconvoluting Protein (Un)folding Structural Ensembles Using X-Ray Scattering, Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulation	PLOS ONE			English	Article							NMR; PATHWAY; INTERMEDIATE; RELAXATION; ALIGNMENT; NANOSECONDS; PREDICTION; SOLVATION; TRANSIENT; MODEL	The folding and unfolding of protein domains is an apparently cooperative process, but transient intermediates have been detected in some cases. Such (un) folding intermediates are challenging to investigate structurally as they are typically not long-lived and their role in the (un) folding reaction has often been questioned. One of the most well studied (un) folding pathways is that of Drosophila melanogaster Engrailed homeodomain (EnHD): this 61-residue protein forms a three helix bundle in the native state and folds via a helical intermediate. Here we used molecular dynamics simulations to derive sample conformations of EnHD in the native, intermediate, and unfolded states and selected the relevant structural clusters by comparing to small/wide angle X-ray scattering data at four different temperatures. The results are corroborated using residual dipolar couplings determined by NMR spectroscopy. Our results agree well with the previously proposed (un) folding pathway. However, they also suggest that the fully unfolded state is present at a low fraction throughout the investigated temperature interval, and that the (un) folding intermediate is highly populated at the thermal midpoint in line with the view that this intermediate can be regarded to be the denatured state under physiological conditions. Further, the combination of ensemble structural techniques with MD allows for determination of structures and populations of multiple interconverting structures in solution.	[Nasedkin, Alexandr; Davidsson, Jan] Uppsala Univ, Dept Chem, Angstrom Lab, SE-75110 Uppsala, Sweden; [Marcellini, Moreno; van der Spoel, David] Uppsala Univ, Uppsala Ctr Computat Chem, Dept Cell & Mol Biol, Sci Life Lab, SE-75124 Uppsala, Sweden; [Religa, Tomasz L.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Freund, Stefan M.; Fersht, Alan R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University; Uppsala University; Case Western Reserve University; MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Uppsala University	Davidsson, J (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Box 523, SE-75110 Uppsala, Sweden.	jan.davidsson@kemi.uu.se	van der Spoel, David/AAD-9820-2019; van der Spoel, David/A-5471-2008; Fersht, Alan R/B-2189-2008; Menzel, Andreas/C-4388-2012	van der Spoel, David/0000-0002-7659-8526; van der Spoel, David/0000-0002-7659-8526; Menzel, Andreas/0000-0002-0489-609X; Nasedkin, Alexandr/0000-0003-3448-7737; Marcellini, Moreno/0000-0002-1434-5611	Swedish Research Council [NT 2012-5096, NT 2012-3908]; MRC [MC_UP_A024_1010] Funding Source: UKRI; Medical Research Council [MC_UP_A024_1010] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Per Jemth and Jan Davidsson were funded by the Swedish Research Council, grants NT 2012-5096 (P.J.) and NT 2012-3908 (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bjorling A, 2015, J CHEM THEORY COMPUT, V11, P780, DOI 10.1021/ct5009735; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Caleman C, 2011, P NATL ACAD SCI USA, V108, P6838, DOI 10.1073/pnas.1017903108; Cho JH, 2010, J AM CHEM SOC, V132, P450, DOI 10.1021/ja909052h; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Czaplewski C, 2002, INT J QUANTUM CHEM, V88, P41, DOI 10.1002/qua.10077; Daura X, 1998, J MOL BIOL, V280, P925, DOI 10.1006/jmbi.1998.1885; Davidsson J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.245503; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Fletcher CM, 1996, J BIOMOL NMR, V8, P292, DOI 10.1007/BF00410328; Huang JR, 2014, J AM CHEM SOC, V136, P7068, DOI 10.1021/ja502030n; Ihee H, 2010, INT REV PHYS CHEM, V29, P453, DOI 10.1080/0144235X.2010.498938; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jensen MR, 2014, P NATL ACAD SCI USA, V111, pE1557, DOI 10.1073/pnas.1323876111; Jensen MR, 2013, CURR OPIN STRUC BIOL, V23, P426, DOI 10.1016/j.sbi.2013.02.007; Jones G, 2002, GENETIC EVOLUTIONARY; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juraszek J, 2006, P NATL ACAD SCI USA, V103, P15859, DOI 10.1073/pnas.0606692103; KARPLUS M, 1994, PROTEIN SCI, V3, P650; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kozak M, 2010, J PHYS CHEM LETT, V1, P3128, DOI 10.1021/jz101178t; Kraft P, 2009, IEEE T NUCL SCI, V56, P758, DOI 10.1109/TNS.2008.2009448; Krivov SV, 2004, P NATL ACAD SCI USA, V101, P14766, DOI 10.1073/pnas.0406234101; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Makowski Lee, 2010, Journal of Structural and Functional Genomics, V11, P9, DOI 10.1007/s10969-009-9075-x; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022; Neutze R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195508; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Religa TL, 2008, J BIOMOL NMR, V40, P189, DOI 10.1007/s10858-008-9223-9; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Rhee YM, 2004, P NATL ACAD SCI USA, V101, P6456, DOI 10.1073/pnas.0307898101; Seibert MM, 2005, J MOL BIOL, V354, P173, DOI 10.1016/j.jmb.2005.09.030; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P11391, DOI 10.1073/pnas.1303273110; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Teilum K, 2006, P NATL ACAD SCI USA, V103, P6877, DOI 10.1073/pnas.0509100103; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; TROPP J, 1980, J CHEM PHYS, V72, P6035, DOI 10.1063/1.439059; Westenhoff S, 2010, ACTA CRYSTALLOGR A, V66, P207, DOI 10.1107/S0108767309054361; Zhang HY, 2013, J CHEM THEORY COMPUT, V9, P4542, DOI 10.1021/ct400404q; Zhang HY, 2012, J PHYS CHEM B, V116, P12684, DOI 10.1021/jp308416p; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	57	8	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125662	10.1371/journal.pone.0125662	http://dx.doi.org/10.1371/journal.pone.0125662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946337	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700081
J	Qiu, XL; Dao, HH; Wang, MJ; Heston, A; Garcia, KM; Sangal, A; Dowling, AR; Faulkner, LD; Molitor, SC; Elias, CF; Hill, JW				Qiu, Xiaoliang; Dao, Hoangha; Wang, Mengjie; Heston, Amelia; Garcia, Kaitlyn M.; Sangal, Alisha; Dowling, Abigail R.; Faulkner, Latrice D.; Molitor, Scott C.; Elias, Carol F.; Hill, Jennifer W.			Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; ANOREXIGENIC PROOPIOMELANOCORTIN NEURONS; EARLY MENOPAUSAL TRANSITION; OBESITY-INDUCED INFERTILITY; HYPOGONADOTROPIC HYPOGONADISM; GLUCOSE-HOMEOSTASIS; REPRODUCTIVE AXIS; PREOPTIC AREA; DIFFERENTIAL REGULATION; MENSTRUAL-CYCLE	Reproduction requires adequate energy stores for parents and offspring to survive. Kiss1 neurons, which are essential for fertility, have the potential to serve as the central sensors of metabolic factors that signal to the reproductive axis the presence of stored calories. Paradoxically, obesity is often accompanied by infertility. Despite excess circulating levels of insulin and leptin, obese individuals exhibit resistance to both metabolic factors in many neuron types. Thus, resistance to insulin or leptin in Kiss1 neurons could lead to infertility. Single deletion of the receptors for either insulin or the adipokine leptin from Kiss1 neurons does not impair adult reproductive dysfunction. However, insulin and leptin signaling pathways may interact in such a way as to obscure their individual functions. We hypothesized that in the presence of genetic or obesity-induced concurrent insulin and leptin resistance, Kiss1 neurons would be unable to maintain reproductive function. We therefore induced a chronic hyperinsulinemic and hyperleptinemic state in mice lacking insulin receptors in Kiss1 neurons through high fat feeding and examined the impact on fertility. In an additional, genetic model, we ablated both leptin and insulin signaling in Kiss1 neurons (IR/LepR(Kiss) mice). Counter to our hypothesis, we found that the addition of leptin insensitivity did not alter the reproductive phenotype of IRKiss mice. We also found that weight gain, body composition, glucose and insulin tolerance were normal in mice of both genders. Nonetheless, leptin and insulin receptor deletion altered pubertal timing as well as LH and FSH levels in mid-puberty in a reciprocal manner. Our results confirm that Kiss1 neurons do not directly mediate the critical role that insulin and leptin play in reproduction. However, during puberty kisspeptin neurons may experience a critical window of susceptibility to the influence of metabolic factors that can modify the onset of fertility.	[Qiu, Xiaoliang] SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Dao, Hoangha; Molitor, Scott C.] Univ Toledo, Dept Bioengn, Toledo, OH 43606 USA; [Wang, Mengjie; Heston, Amelia; Garcia, Kaitlyn M.; Sangal, Alisha; Faulkner, Latrice D.; Hill, Jennifer W.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Dept Physiol & Pharmacol, Toledo, OH 43606 USA; [Dowling, Abigail R.] Cornell Univ, Ctr Reprod Genom, Ithaca, NY USA; [Elias, Carol F.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hill, Jennifer W.] Univ Toledo, Coll Med, Dept Obstet Gynecol, Toledo, OH 43606 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Cornell University; University of Michigan System; University of Michigan; University System of Ohio; University of Toledo	Hill, JW (corresponding author), Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.	JenniferW.Hill@utoledo.edu	Wang, xiaoxiao/GQQ-2846-2022; Hill, Jennifer/AAD-8415-2019; Qiu, Xiaoliang/O-6171-2019; Qiu, Xiaoliang/C-5905-2016	Hill, Jennifer/0000-0001-7482-9215; Elias, Carol F/0000-0001-9878-9203; Molitor, Scott/0000-0001-8476-9658	NIH [HD056491, HD071529, HD69702]; deArce-Koch Fund award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081792, R21HD071529, R01HD069702] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD056491, R00HD056491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); deArce-Koch Fund award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by NIH grants HD056491, HD071529, and a deArce-Koch Fund award to Dr. Hill, and NIH grant HD69702 to Dr. Elias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Sanchez-Garrido MA, 2014, ENDOCRINOLOGY, V155, P1067, DOI 10.1210/en.2013-1584; Backholer K, 2010, ENDOCRINOLOGY, V151, P2233, DOI 10.1210/en.2009-1190; Backholer K, 2010, NEUROENDOCRINOLOGY, V91, P27, DOI 10.1159/000260060; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; BICKNELL RJ, 1988, J EXP BIOL, V139, P51; BINGEL AS, 1969, J REPROD FERTIL, V19, P215; Bosch MA, 2012, J COMP NEUROL, V520, P2143, DOI 10.1002/cne.23032; Bouret SG, 2012, J NEUROSCI, V32, P1244, DOI 10.1523/JNEUROSCI.2277-11.2012; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Brown RE, 2008, MOL CELL ENDOCRINOL, V281, P64, DOI 10.1016/j.mce.2007.10.011; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Caron E, 2010, J COMP NEUROL, V518, P459, DOI 10.1002/cne.22219; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Castellano JM, 2006, DIABETES, V55, P2602, DOI 10.2337/db05-1584; CHAN SJ, 1984, P NATL ACAD SCI-BIOL, V81, P5046, DOI 10.1073/pnas.81.16.5046; Chen J, 2014, MOL ENDOCRINOL, V28, P1276, DOI 10.1210/me.2013-1410; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; Cravo RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058698; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Dandona P, 2011, J CLIN ENDOCR METAB, V96, P2643, DOI 10.1210/jc.2010-2724; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; Donato J, 2011, NEUROENDOCRINOLOGY, V93, P9, DOI 10.1159/000322472; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Evans MC, 2014, J NEUROENDOCRINOL, V26, P468, DOI 10.1111/jne.12166; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Finn PD, 1998, ENDOCRINOLOGY, V139, P4652, DOI 10.1210/en.139.11.4652; Forbes S, 2009, NEUROSCI LETT, V460, P143, DOI 10.1016/j.neulet.2009.05.060; Frazao R, 2014, AM J PHYSIOL-ENDOC M, V306, pE606, DOI 10.1152/ajpendo.00211.2013; Frazao R, 2013, J NEUROSCI, V33, P2807, DOI 10.1523/JNEUROSCI.1610-12.2013; Fu LY, 2010, J NEUROSCI, V30, P10205, DOI 10.1523/JNEUROSCI.2098-10.2010; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; George JT, 2010, NEUROENDOCRINOLOGY, V91, P302, DOI 10.1159/000299767; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Hakansson ML, 1998, J NEUROSCI, V18, P559; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hill JW, 2009, ENDOCRINOLOGY, V150, P4874, DOI 10.1210/en.2009-0454; Hofstra J, 2008, NETH J MED, V66, P103; Jain A, 2007, J CLIN ENDOCR METAB, V92, P2468, DOI 10.1210/jc.2006-2274; Kapoor D, 2005, CLIN ENDOCRINOL, V63, P239, DOI 10.1111/j.1365-2265.2005.02299.x; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; King JC, 1998, BIOL REPROD, V58, P323, DOI 10.1095/biolreprod58.2.323; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kovacs P, 2003, NEUROENDOCRINOLOGY, V78, P90, DOI 10.1159/000071964; Kovacs P, 2002, NEUROENDOCRINOLOGY, V76, P357, DOI 10.1159/000067585; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lomniczi A, 2013, NAT NEUROSCI, V16, P281, DOI 10.1038/nn.3319; Louis GW, 2011, ENDOCRINOLOGY, V152, P2302, DOI 10.1210/en.2011-0096; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Luque RM, 2007, AM J PHYSIOL-ENDOC M, V292, pE891, DOI 10.1152/ajpendo.00258.2006; Lustig Robert H, 2008, Pediatr Endocrinol Rev, V6, P220; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; MARSHALL JC, 1991, RECENT PROG HORM RES, V47, P155; Masterson SP, 2010, J NEUROPHYSIOL, V104, P1758, DOI 10.1152/jn.00010.2010; Matsuwaki T, 2010, ENDOCRINOLOGY, V151, P5489, DOI 10.1210/en.2010-0687; McMinn JE, 2004, MAMM GENOME, V15, P677, DOI 10.1007/s00335-004-2340-1; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Mittelman-Smith MA, 2012, ENDOCRINOLOGY, V153, P2800, DOI 10.1210/en.2012-1045; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Nazarians-Armavil A, 2013, MOL ENDOCRINOL, V27, P990, DOI 10.1210/me.2012-1338; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pellitero S, 2012, OBES SURG, V22, P1835, DOI 10.1007/s11695-012-0734-9; Piet R, 2013, J NEUROSCI, V33, P10828, DOI 10.1523/JNEUROSCI.1021-13.2013; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P91, DOI 10.1055/s-0029-1211143; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Qiu J, 2014, CELL METAB, V19, P682, DOI 10.1016/j.cmet.2014.03.004; Qiu XL, 2013, ENDOCRINOLOGY, V154, P1337, DOI 10.1210/en.2012-2056; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Quennell JH, 2009, ENDOCRINOLOGY, V150, P2805, DOI 10.1210/en.2008-1693; Randolph JF, 2003, J CLIN ENDOCR METAB, V88, P1516, DOI 10.1210/jc.2002-020777; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Roa J, 2009, ENDOCRINOLOGY, V150, P5016, DOI 10.1210/en.2009-0096; Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P2622, DOI 10.1210/jc.2003-031578; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; SMITH LF, 1966, AM J MED, V40, P662, DOI 10.1016/0002-9343(66)90145-8; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279; STEGER RW, 1990, DIABETES, V39, P942, DOI 10.2337/diabetes.39.8.942; STEGER RW, 1993, NEUROENDOCRINOLOGY, V57, P525, DOI 10.1159/000126401; Tanaka T, 2000, BIOL REPROD, V62, P1256, DOI 10.1095/biolreprod62.5.1256; Tena-Sempere M, 2008, NAT CLIN PRACT ENDOC, V4, P666, DOI 10.1038/ncpendmet1003; Tolson KP, 2014, J CLIN INVEST, V124, P3075, DOI 10.1172/JCI71075; Tomar R, 2006, DIABETES CARE, V29, P1120, DOI 10.2337/dc06-0197; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; VERMEULEN A, 1993, J CLIN ENDOCR METAB, V76, P1140, DOI 10.1210/jc.76.5.1140; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Wu S, 2014, DIABETES, V63, P1270, DOI 10.2337/db13-1514; Xu J, 2009, ENDOCRINOLOGY, V150, P4231, DOI 10.1210/en.2009-0190; Yeung EH, 2013, INT J OBESITY, V37, P237, DOI 10.1038/ijo.2012.9; Yura S, 2000, J CLIN INVEST, V105, P749, DOI 10.1172/JCI8353; Zhang CG, 2013, AM J PHYSIOL-ENDOC M, V305, pE1384, DOI 10.1152/ajpendo.00406.2013; Zhang C, 2013, AM J PHYSIOL-ENDOC M, V304, pE1237, DOI 10.1152/ajpendo.00058.2013; Zhang CG, 2009, J NEUROSCI, V29, P10552, DOI 10.1523/JNEUROSCI.2962-09.2009; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	116	32	33	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0121974	10.1371/journal.pone.0121974	http://dx.doi.org/10.1371/journal.pone.0121974			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946091	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700005
J	Bogaert, P; Bochenek, T; Prokop, A; Pilc, A				Bogaert, Petronille; Bochenek, Tomasz; Prokop, Anna; Pilc, Andrzej			A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives	PLOS ONE			English	Article							IMPACT	The problem of drug shortages has been reported worldwide, gaining prominence in multiple domains and several countries in recent years. The aim of the study was to analyze, characterise and assess this problem in Belgium and France, while also adopting a wider perspective from the European Union. A qualitative methodological approach was employed, including semi-structured interviews with the representatives of respective national health authorities, pharmaceutical companies and wholesalers, as well as hospital and community pharmacists. The research was conducted in early 2014. Four themes, which were identified through the interviews, were addressed in the paper, i.e. a) defining drug shortages, b) their dynamics and perception, c) their determinants, d) the role of the European and national institutions in coping with the problem. Three groups of determinants of drug shortages were identified throughout this study: manufacturing problems, distribution and supply problems, and problems related to economic aspects. Currently, the Member States of the European Union are striving to resolve the problem very much on their own, although a far more focused and dedicated collaboration may well prove instrumental in coping with drug shortages throughout Europe more effectively. To the best of the authors' knowledge, this is the first qualitative study to investigate the characteristics, key determinants, and the problem drivers of drug shortages, focusing on this particular group of countries, while also adopting the European Union's perspective.	[Bogaert, Petronille; Bochenek, Tomasz] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Drug Management, Krakow, Poland; [Prokop, Anna] Jagiellonian Univ, Coll Med, Fac Med, Chair Epidemiol & Prevent Med, Krakow, Poland; [Pilc, Andrzej] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences	Bochenek, T (corresponding author), Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Drug Management, Krakow, Poland.	mxbochen@cyf-kr.edu.pl	Pilc, Andrzej/A-3948-2008	Pilc, Andrzej/0000-0002-4045-0597				Agence nationale de securite du medicament et des produits de sante, 2014, INF SEC RUPT STOCK A; All-Party Pharmacy Group, 2012, REP APPG INQ MED SHO, P30; American Hospital Association, 2011, AHA SURV DRUG SHORT, P14; [Anonymous], 2011, LANCET ONCOL, V12, P313, DOI 10.1016/S1470-2045(11)70087-0; [Anonymous], 2010, LANCET, V376, P1712, DOI 10.1016/S0140-6736(10)62116-2; ASHP Drug Shortage Resource Center, 2014, DRUG SHORT CURR SHOR; ASHP Expert Panel on Drug Product Shortages, 2009, Am J Health Syst Pharm, V66, P1399, DOI 10.2146/ajhp090026; Autorite de la concurrence, 2012, AV 12 A 18 20 JUILL, P34; Bible JR, 2014, JPEN-PARENTER ENTER, V38, p65S, DOI 10.1177/0148607114550317; Birgli AG, 2013, EV MED SHORT EUR MOR; Canadian Agency for Drugs and Technologies in Health, 2011, ENV SCAN; Canadian Pharmacists Association, 2010, CAN DRUG SHORT SURV; Center for Drug Evaluation and Research, 2012, MAN POL PROC MAPP, P21; Chave J, 2013, MED SHORTAGES, P18; Costelloe E.M., 2014, IR J MED SCI; Dal Moro F, 2013, PREV MED, V57, P146, DOI 10.1016/j.ypmed.2013.04.019; De Weerdt E, 2015, REGUL TOXICOL PHARM, V71, P251, DOI 10.1016/j.yrtph.2015.01.005; European Association of Hospital Pharmacists, 2013, MED SHORT EUR HOSP; European Association of Pharmaceutical Full-line Wholesalers, 2013, MED SHORT EUR THEIR; European Federation of Pharmaceutical Industries and Associations, EFPIA GOOD PRACT RED, P6; European Medicines Agency, 2013, MED SHORT SHORT CAT; European Medicines Agency, 2012, EMA5907452012, P6; Federal Agency for Medicines and Health Products, 2014, FAGG ONB GEN; Food and Drug Administration, 2013, PERM DISC INT MAN CE; Fox E, 2014, DRUG STATUS UPDATE C, P4; Generics and Biosimilarrs Initiative, 2012, UK DRUG SHORT AR FAR; Gesundheit Osterreich GmbH, 2014, WHO COLL CTR PHARM P; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; Gray A, 2012, B WORLD HEALTH ORGAN, V90, P157; Huys Isabelle, 2013, Int J Pharm Pract, V21, P1, DOI 10.1111/ijpp.12012; IMS Institute for Healthcare Informatics, 2011, DRUG SHORT CLOS LOOK; Institute for Safe Medication Practices, 2010, DRUG SHORT NAT SURV; ISPE, 2013, REP ISPE DRUG SHORT; Jensen V, 2002, AM J HEALTH-SYST PH, V59, P1423, DOI 10.1093/ajhp/59.15.1423; Johnson Thomas J, 2011, S D Med, V64, P14; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, pe13; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Kosarek L, 2011, OCHSNER J, V11, P143; Kweder SL, 2013, CLIN PHARMACOL THER, V93, P245, DOI 10.1038/clpt.2012.235; Linthorst GE, 2013, JIMD REP, V8, P51, DOI 10.1007/8904_2012_160; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Mazzoleni G, 1999, POLIT COMMUN, V16, P247, DOI 10.1080/105846099198613; McBride A, 2013, AM J HEALTH-SYST PH, V70, P609, DOI 10.2146/ajhp120563; Milmo S, 2013, PHARM TECHNOL, V2013, P32; Morrissey John, 2012, Trustee, V65, P10; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Pharmaceutical Group of European Union, MED SHORT EUR COMM P, P4; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Schulman R, 2011, IMPACT DRUG SHORTAGE; Transcriber Lite, TRANSCR ONL TRANSCR; U.S. Food and Drug Administration, DRUG SHORT; US Food and Drug Administration, 2011, REV FDAS APPR MED PR; Ventola C Lee, 2011, P T, V36, P740; VERBI GmbH, MAXQDA QUAL DAT AN S; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220	55	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125691	10.1371/journal.pone.0125691	http://dx.doi.org/10.1371/journal.pone.0125691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942432	Green Published, Green Submitted			2022-12-26	WOS:000353943400050
J	Li, WW; Goto, K; Matsubara, Y; Ito, S; Muroyama, R; Li, Q; Kato, N				Li, Wenwen; Goto, Kaku; Matsubara, Yasuo; Ito, Sayaka; Muroyama, Ryosuke; Li, Qiang; Kato, Naoya			The Characteristic Changes in Hepatitis B Virus X Region for Hepatocellular Carcinoma: A Comprehensive Analysis Based on Global Data	PLOS ONE			English	Article							CORE PROMOTER MUTATIONS; PROTEIN TARGETS; CELL-DEATH; WILD-TYPE; GENOTYPES; RISK; INCREASE; ASSOCIATIONS; REPLICATION; APOPTOSIS	Objectives Mutations in hepatitis B virus (HBV) X region (HBx) play important roles in hepatocarcino-genesis while the results remain controversial. We sought to clarify potential hepatocellular carcinoma (HCC)-characteristic mutations in HBx from HBV genotype C-infected patients and the distribution of those mutations in different disease phases and genotypes. Methods HBx sequences downloaded from an online global HBV database were screened and then classified into Non-HCC or HCC group by diagnosis information. Patients' data of patient age, gender, country or area, and viral genotype were also extracted. Logistic regression was performed to evaluate the effects of mutations on HCC risk. Results 1) Full length HBx sequences (HCC: 161; Non-HCC: 954) originated from 1115 human sera across 29 countries/areas were extracted from the downloaded 5956 HBx sequences. Genotype C occupied 40.6% of Non-HCC (387/954) and 89.4% of HCC (144/161). 2) Sixteen nucleotide positions showed significantly different distributions between genotype C HCC and Non-HCC groups. 3) Logistic regression showed that mutations A1383C (OR: 2.32, 95% CI: 1.34-4.01), R1479C/T (OR: 1.96, 95% CI: 1.05-3.64; OR: 5.15, 95% CI: 2.53-10.48), C1485T (OR: 2.40, 95% CI: 1.41-4.08), C1631T (OR: 4.09, 95% CI: 1.41-11.85), C1653T (OR: 2.58, 95% CI: 1.59-4.19), G1719T (OR: 2.11, 95% CI: 1.19-3.73), and T1800C (OR: 23.59, 95% CI: 2.25-247.65) were independent risk factors for genotype C HBV-related HCC, presenting different trends among individual disease phases. 4) Several genotype C HCC risk mutations pre-existed, even as major types, in early disease phases with other genotypes. Conclusions Mutations associated with HCC risk were mainly located in HBx transactivation domain, viral promoter, protein/miRNA binding sites, and the area for immune epitopes. Furthermore, the signatures of these mutations were unique to disease phases leading to HCC, suggesting molecular counteractions between the virus and host during hepatocarcinogenesis.	[Li, Wenwen; Goto, Kaku; Matsubara, Yasuo; Ito, Sayaka; Muroyama, Ryosuke; Kato, Naoya] Univ Tokyo, Inst Med Sci, Div Adv Genome Med, Adv Clin Res Ctr, Tokyo, Japan; [Li, Qiang] Shandong Univ, Affiliated Infect Dis Hosp, Jinan 250100, Shandong, Peoples R China	University of Tokyo; Shandong University	Kato, N (corresponding author), Univ Tokyo, Inst Med Sci, Div Adv Genome Med, Adv Clin Res Ctr, Tokyo, Japan.	kato-2im@ims.u-tokyo.ac.jp	Li, Qiang/AAS-2836-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The study was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Health and Labor Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan.	Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chayama K, 1998, HEPATOLOGY, V27, P1711, DOI 10.1002/hep.510270634; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Geng X, 2012, P NATL ACAD SCI USA, V109, P18465, DOI 10.1073/pnas.1204652109; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Gunther S, 1998, J GEN VIROL, V79, P375; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kim HJ, 2008, J MED VIROL, V80, P1337, DOI 10.1002/jmv.21219; Koike K, 2002, ONCOLOGY-BASEL, V62, P29, DOI 10.1159/000048273; Kuang SY, 2004, P NATL ACAD SCI USA, V101, P3575, DOI 10.1073/pnas.0308232100; Lee JH, 2011, CLIN VACCINE IMMUNOL, V18, P914, DOI 10.1128/CVI.00474-10; Li CF, 2014, PROTEIN CELL, V5, P348, DOI 10.1007/s13238-014-0039-y; Liang TJ, 2010, J AM COLL SURGEONS, V211, P580, DOI 10.1016/j.jamcollsurg.2010.06.020; Liu CJ, 2013, SEMIN LIVER DIS, V33, P97, DOI 10.1055/s-0033-1345716; Liu NN, 2013, J VIROL, V87, P13370, DOI 10.1128/JVI.02130-13; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Lu YW, 2005, BIOCHEM BIOPH RES CO, V338, P1551, DOI 10.1016/j.bbrc.2005.10.117; Malik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039028; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; Nishizono A, 1997, J MED VIROL, V53, P266, DOI 10.1002/(SICI)1096-9071(199711)53:3<266::AID-JMV15>3.0.CO;2-F; Pujol FH, 2009, CANCER LETT, V286, P80, DOI 10.1016/j.canlet.2009.07.013; Rui E, 2005, J VIROL METHODS, V126, P65, DOI 10.1016/j.jviromet.2005.01.022; Shin-I T, 2008, HEPATOL RES, V38, P234, DOI 10.1111/j.1872-034X.2007.00262.x; Shinkai N, 2007, J CLIN MICROBIOL, V45, P3191, DOI 10.1128/JCM.00411-07; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Takahashi K, 1998, ARCH VIROL, V143, P2313, DOI 10.1007/s007050050463; Wong GLH, 2013, ALIMENT PHARM THER, V37, P517, DOI 10.1111/apt.12207; Xie Y, 2014, TUMOUR BIOL; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859	33	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125555	10.1371/journal.pone.0125555	http://dx.doi.org/10.1371/journal.pone.0125555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942596	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943400045
J	Bernichtein, S; Pigat, N; Capiod, T; Boutillon, F; Verkarre, V; Camparo, P; Viltard, M; Mejean, A; Oudard, S; Souberbielle, JC; Friedlander, G; Goffin, V				Bernichtein, Sophie; Pigat, Natascha; Capiod, Thierry; Boutillon, Florence; Verkarre, Virginie; Camparo, Philippe; Viltard, Melanie; Mejean, Arnaud; Oudard, Stephane; Souberbielle, Jean-Claude; Friedlander, Gerard; Goffin, Vincent			High Milk Consumption Does Not Affect Prostate Tumor Progression in Two Mouse Models of Benign and Neoplastic Lesions	PLOS ONE			English	Article							DAIRY PRODUCT INTAKE; CANCER RISK; BASAL/STEM CELLS; VITAMIN-D; CALCIUM; DIET; ADENOCARCINOMA; PROLACTIN; NUTRITION; METAANALYSIS	Epidemiological studies that have investigated whether dairy (mainly milk) diets are associated with prostate cancer risk have led to controversial conclusions. In addition, no existing study clearly evaluated the effects of dairy/milk diets on prostate tumor progression, which is clinically highly relevant in view of the millions of men presenting with prostate pathologies worldwide, including benign prostate hyperplasia (BPH) or high-grade prostatic intraepithelial neoplasia (HGPIN). We report here a unique interventional animal study to address this issue. We used two mouse models of fully penetrant genetically-induced prostate tumorigenesis that were investigated at the stages of benign hyperplasia (probasin-Prl mice, Pb-Prl) or pre-cancerous PIN lesions (KIMAP mice). Mice were fed high milk diets (skim or whole) for 15 to 27 weeks of time depending on the kinetics of prostate tumor development in each model. Prostate tumor progression was assessed by tissue histopathology examination, epithelial proliferation, stromal inflammation and fibrosis, tumor invasiveness potency and expression of various tumor markers relevant for each model (c-Fes, Gprc6a, activated Stat5 and p63). Our results show that high milk consumption (either skim or whole) did not promote progression of existing prostate tumors when assessed at early stages of tumorigenesis (hyperplasia and neoplasia). For some parameters, and depending on milk type, milk regimen could even exhibit slight protective effects towards prostate tumor progression by decreasing the expression of tumor-related markers like Ki-67 and Gprc6a. In conclusion, our study suggests that regular milk consumption should not be considered detrimental for patients presenting with early-stage prostate tumors.	[Bernichtein, Sophie; Pigat, Natascha; Capiod, Thierry; Boutillon, Florence; Camparo, Philippe; Goffin, Vincent] INSERM, U1151, Inst Necker Enfants Malad, PRL GH Pathophysiol Lab, Paris, France; [Souberbielle, Jean-Claude; Friedlander, Gerard] INSERM, U1151, Inst Necker Enfants Malad, Phosphate Homeostasis Lab, Paris, France; [Verkarre, Virginie] Hop Necker Enfants Malad, Dept Pathol, Paris, France; [Mejean, Arnaud] Hop Europeen Georges Pompidou, Dept Urol, Paris, France; [Oudard, Stephane] Hop Europeen Georges Pompidou, Dept Med Oncol, Paris, France; [Souberbielle, Jean-Claude; Friedlander, Gerard] Hop Europeen Georges Pompidou, Dept Physiol, Paris, France; [Bernichtein, Sophie; Pigat, Natascha; Capiod, Thierry; Boutillon, Florence; Verkarre, Virginie; Camparo, Philippe; Mejean, Arnaud; Oudard, Stephane; Souberbielle, Jean-Claude; Friedlander, Gerard; Goffin, Vincent] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Verkarre, Virginie; Mejean, Arnaud; Oudard, Stephane; Souberbielle, Jean-Claude; Friedlander, Gerard] AP HP, Paris, France; [Viltard, Melanie] Inst European Expertise Physiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Goffin, V (corresponding author), INSERM, U1151, Inst Necker Enfants Malad, PRL GH Pathophysiol Lab, Paris, France.	vincent.goffin@inserm.fr	CAPIOD, Thierry/K-4234-2017; GOFFIN, Vincent/G-3322-2013	CAPIOD, Thierry/0000-0002-8448-7041; GOFFIN, Vincent/0000-0002-8021-3086; Friedlander, Gerard/0000-0002-6854-4261; OUDARD, Stephane/0000-0003-0893-285X	Institut Europeen d'Expertise en Physiologie (grant "Milk and Prostate cancer"); Inserm; University Paris Descartes	Institut Europeen d'Expertise en Physiologie (grant "Milk and Prostate cancer"); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes	Institut Europeen d'Expertise en Physiologie (http://www.ieepworld.fr) funded the study (grant "Milk and Prostate cancer" allocated to VG) and participated in study design. This funder had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Inserm and University Paris Descartes also supported this study (recurrent funding allocated to VG's Laboratory). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2008, BRIT J CANCER, V98, P1574, DOI 10.1038/sj.bjc.6604331; Allen NE, 2007, CANCER EPIDEM BIOMAR, V16, P1121, DOI 10.1158/1055-9965.EPI-06-1062; Aune D, 2012, ANN ONCOL, V23, P37, DOI 10.1093/annonc/mdr269; Aune D, 2015, AM J CLIN NUTR, V101, P87, DOI 10.3945/ajcn.113.067157; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bernichtein S, 2015, PROSTATE IN PRESS; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; Crowe FL, 2008, AM J CLIN NUTR, V87, P1405, DOI 10.1093/ajcn/87.5.1405; Dahm CC, 2012, AM J CLIN NUTR, V96, P1354, DOI 10.3945/ajcn.112.034157; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Duan WM, 2005, ONCOGENE, V24, P1510, DOI 10.1038/sj.onc.1208229; Ferlay J, PROSTATE CANCER INCI; Gabril MY, 2005, MOL THER, V11, P348, DOI 10.1016/j.ymthe.2004.12.005; Gathirua-Mwangi WG, 2014, EUR J CANCER PREV, V23, P96, DOI 10.1097/CEJ.0b013e3283647394; Goffin V, 2011, NAT REV UROL, V8, P597, DOI 10.1038/nrurol.2011.143; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grant WB, 2004, EUR UROL, V45, P271, DOI 10.1016/j.eururo.2003.08.018; Iso H, 2007, ASIAN PAC J CANCER P, V8, P35; Kindblom J, 2003, ENDOCRINOLOGY, V144, P2269, DOI 10.1210/en.2002-0187; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Mandair D, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-30; Miyata Y, 2012, PROSTATE, V72, P201, DOI 10.1002/pros.21422; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Park SY, 2007, AM J EPIDEMIOL, V166, P1259, DOI 10.1093/aje/kwm269; Park SW, 2014, WORLD J MENS HEALTH, V32, P76, DOI 10.5534/wjmh.2014.32.2.76; Park Y, 2007, AM J EPIDEMIOL, V166, P1270, DOI 10.1093/aje/kwm268; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P428, DOI 10.1158/1055-9965.EPI-11-1004; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Qin LQ, 2004, MED HYPOTHESES, V62, P133, DOI 10.1016/S0306-9877(03)00295-0; Raimondi S, 2010, PROSTATE, V70, P1054, DOI 10.1002/pros.21139; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Sackmann-Sala L, 2014, AM J PATHOL, V184, P3105, DOI 10.1016/j.ajpath.2014.07.020; Saikali Z, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-10; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Schultz C, 2011, MATURITAS, V70, P339, DOI 10.1016/j.maturitas.2011.08.007; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SNOWDON DA, 1984, AM J EPIDEMIOL, V120, P244, DOI 10.1093/oxfordjournals.aje.a113886; Song Y, 2013, J NUTR, V143, P189, DOI 10.3945/jn.112.168484; Torniainen S, 2007, CANCER EPIDEM BIOMAR, V16, P956, DOI 10.1158/1055-9965.EPI-06-0985; Travis RC, 2013, INT J CANCER, V132, P1901, DOI 10.1002/ijc.27836; Tseng M, 2005, AM J CLIN NUTR, V81, P1147; World Cancer Research Fund International, 2014, CONTINUOUS UPDATE PR; Zhang QY, 2012, CANCER RES, V72, P2589, DOI 10.1158/0008-5472.CAN-11-3795	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125423	10.1371/journal.pone.0125423	http://dx.doi.org/10.1371/journal.pone.0125423			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938513	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943000068
J	Fonteh, AN; Ormseth, C; Chiang, JR; Cipolla, M; Arakaki, X; Harrington, MG				Fonteh, Alfred N.; Ormseth, Cora; Chiang, Jiarong; Cipolla, Matthew; Arakaki, Xianghong; Harrington, Michael G.			Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer's Disease	PLOS ONE			English	Article							ACID SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASES; HUMAN BRAIN; CERAMIDE; ROLES; MECHANISMS; EXOCYTOSIS; MOUSE; EXPRESSION; APOPTOSIS	Sphingolipids are important inmany brain functions but their role in Alzheimer's disease (AD) is not completely defined. A major limit is availability of fresh brain tissue with defined AD pathology. The discovery that cerebrospinal fluid (CSF) contains abundant nanoparticles that include synaptic vesicles and large dense core vesicles offer an accessible sample to study these organelles, while the supernatant fluid allows study of brain interstitial metabolism. Our objective was to characterize sphingolipids in nanoparticles representative of membrane vesicle metabolism, and in supernatant fluid representative of interstitial metabolism from study participants with varying levels of cognitive dysfunction. We recently described the recruitment, diagnosis, and CSF collection from cognitively normal or impaired study participants. Using liquid chromatography tandem mass spectrometry, we report that cognitively normal participants had measureable levels of sphingomyelin, ceramide, and dihydroceramide species, but that their distribution differed between nanoparticles and supernatant fluid, and further differed in those with cognitive impairment. In CSF from AD compared with cognitively normal participants: a) total sphingomyelin levels were lower in nanoparticles and supernatant fluid; b) levels of ceramide species were lower in nanoparticles and higher in supernatant fluid; c) three sphingomyelin species were reduced in the nanoparticle fraction. Moreover, three sphingomyelin species in the nanoparticle fraction were lower in mild cognitive impairment compared with cognitively normal participants. The activity of acid, but not neutral sphingomyelinase was significantly reduced in the CSF from AD participants. The reduction in acid sphingomylinase in CSF from AD participants was independent of depression and psychotropic medications. Acid sphingomyelinase activity positively correlated with amyloid beta 42 concentration in CSF from cognitively normal but not impaired participants. In dementia, altered sphingolipidmetabolism, decreased acid sphingomyelinase activity and its lost association with CSF amyloid beta 42 concentration, underscores the potential of sphingolipids as disease biomarkers, and acid sphingomyelinase as a target for AD diagnosis and/or treatment.	[Fonteh, Alfred N.; Ormseth, Cora; Chiang, Jiarong; Cipolla, Matthew; Arakaki, Xianghong; Harrington, Michael G.] Huntington Med Res Inst, Mol Neurol Program, Pasadena, CA 91101 USA	Huntington Medical Research Institutes	Fonteh, AN (corresponding author), Huntington Med Res Inst, Mol Neurol Program, 99 N El Molino Ave, Pasadena, CA 91101 USA.	afonteh@hmri.org		Harrington, Michael/0000-0002-7923-8032	L.K. Whittier Foundation; Helen Posthuma Foundations; Jerry Dunlevy Family	L.K. Whittier Foundation; Helen Posthuma Foundations; Jerry Dunlevy Family	This work was supported by the L.K. Whittier Foundation, the Jerry Dunlevy Family, and the Helen Posthuma Foundations. The funders had no role in the study design, data collection and analysis, or decision to publish.	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Alessenko AV, 2004, BIOCHEM SOC T, V32, P144, DOI 10.1042/BST0320144; Babenko NA, 2014, ARCH GERONTOL GERIAT, V58, P420, DOI 10.1016/j.archger.2013.12.005; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bazan NG, 2005, MOL NEUROBIOL, V31, P219, DOI 10.1385/MN:31:1-3:219; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; BERG L, 1988, ANN NEUROL, V23, P477, DOI 10.1002/ana.410230509; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chen SD, 2012, FREE RADICAL RES, V46, P940, DOI 10.3109/10715762.2012.674640; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Cowart LA, 2003, J BIOL CHEM, V278, P30328, DOI 10.1074/jbc.M300656200; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Fagan AM, 2011, ARCH NEUROL-CHICAGO, V68, P1137, DOI 10.1001/archneurol.2011.105; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Fonteh AN, 2006, DIS MARKERS, V22, P39, DOI 10.1155/2006/202938; Fonteh AN, 2013, J LIPID RES, V54, P2884, DOI 10.1194/jlr.M037622; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Han XL, 2007, J NEUROCHEM, V103, P171, DOI 10.1111/j.1471-4159.2007.04708.x; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harrington MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079378; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; Hsiao JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055138; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Juhl K, 2003, AM J PHYSIOL-ENDOC M, V285, pE73, DOI 10.1152/ajpendo.00086.2003; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 2014, TRENDS PHARMACOL SCI, V35, P293, DOI 10.1016/j.tips.2014.04.003; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Kosicek M, 2012, NEUROSCI LETT, V516, P302, DOI 10.1016/j.neulet.2012.04.019; Kosicek M, 2010, ANAL BIOANAL CHEM, V398, P2929, DOI 10.1007/s00216-010-4273-8; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; Li X, 2014, J MOL MED, V92, P473, DOI 10.1007/s00109-014-1120-y; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; Ma MT, 2010, J NEURAL TRANSM, V117, P301, DOI 10.1007/s00702-009-0355-1; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Martin V, 2010, J ALZHEIMERS DIS, V19, P489, DOI 10.3233/JAD-2010-1242; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mencarelli C, 2013, CELL MOL LIFE SCI, V70, P181, DOI 10.1007/s00018-012-1038-x; Mielke MM, 2014, NEUROBIOL AGING, V35, P2486, DOI 10.1016/j.neurobiolaging.2014.05.019; Mielke MM, 2010, J NEUROVIROL, V16, P445, DOI 10.3109/13550284.2010.525599; Mielke MM, 2010, NEUROMOL MED, V12, P331, DOI 10.1007/s12017-010-8121-y; Morris JC, 1996, ACTA NEUROL SCAND, V93, P41; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Muhle C, 2013, Handb Exp Pharmacol, P431, DOI 10.1007/978-3-7091-1511-4_22; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Roe CM, 2011, ARCH NEUROL-CHICAGO, V68, P1145, DOI 10.1001/archneurol.2011.192; Rohrbough J, 2004, J NEUROSCI, V24, P7789, DOI 10.1523/JNEUROSCI.1146-04.2004; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; Takizawa C, 2015, J ALZHEIMERS DIS, V43, P1271, DOI 10.3233/JAD-141134; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wei S, 2003, NEUROSCIENCE, V121, P891, DOI 10.1016/S0306-4522(03)00525-6; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhang HD, 2009, NEUROBIOL AGING, V30, P1245, DOI 10.1016/j.neurobiolaging.2007.11.013	80	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125597	10.1371/journal.pone.0125597	http://dx.doi.org/10.1371/journal.pone.0125597			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938590	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000080
J	Goldsmith, F; Keenan, MJ; Raggio, AM; Ye, X; Hao, Z; Durham, H; Geaghan, J; Jia, WP; Martin, RJ; Ye, JP				Goldsmith, Felicia; Keenan, Michael J.; Raggio, Anne M.; Ye, Xin; Hao, Zheng; Durham, Holiday; Geaghan, James; Jia, Weiping; Martin, Roy J.; Ye, Jianping			Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PEPTIDASE-4 INHIBITOR SITAGLIPTIN; RESISTANT STARCH; IV INHIBITOR; EFFICACY; SAFETY; MICE; EXENATIDE; OXIDATION; AGONISTS	Sitagliptin (SG) increases serum GLP-1 (Glucagon-like peptide-1) through inhibition of the hormone degradation. Resistant starch (RS) induces GLP-1 expression by stimulating L-cells in the intestine. Sitagliptin and resistant starch may have a synergistic interaction in the induction of GLP-1. This possibility was tested in current study in a mouse model of type 2 diabetes. Hyperglycemia was induced in the diet-induced obese mice by a signal injection of streptozotocin (STZ). Sitagliptin (0.4g/100g diet) was tested in the mice (n = 55) with dietary RS (HAM-RS2) at three dosages (0, 15, or 28g/100g diet). Energy and glucose metabolism were monitored in the evaluation of synergistic activity, and GLP-1 activity was determined in the GLP-1 receptor knockout (KO) mice. In the wild type mice, body weight and adiposity were reduced by sitagliptin, which was enhanced by RS (28g). Serum GLP-1 was induced and energy expenditure was enhanced by sitagliptin. Fasting glucose, insulin, and leptin levels were decreased by sitagliptin. The sitagliptin effects were lost in the KO mice (n = 25) although induction of serum GLP-1 by sitagliptin was even stronger in KO mice. The data suggests that sitagliptin is able to reduce adiposity and insulin resistance through induction of energy expenditure. The effect of sitagliptin is partially enhanced by RS. GLP-1 receptor may regulate serum GLP-1 by facilitating the hormone clearance.	[Goldsmith, Felicia; Keenan, Michael J.; Raggio, Anne M.; Durham, Holiday; Geaghan, James] Louisiana State Univ, Ctr Agr, Baton Rouge, LA 70803 USA; [Ye, Xin; Hao, Zheng; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70808 USA; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China; [Martin, Roy J.] Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Martin, Roy J.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Shanghai Jiao Tong University; University of California System; University of California Davis	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	Merck project [39102]; National Institute of Health research [DK085495, DK068036]; Major International (Regional) Joint Research Project of National Natural Science Foundation of China [81220108006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068036, R01DK085495, R01DK068036] Funding Source: NIH RePORTER	Merck project; National Institute of Health research(National Institute for Health Research (NIHR)); Major International (Regional) Joint Research Project of National Natural Science Foundation of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Felicia Goldsmith, Michael J. Keenan, and Anne M. Raggio are supported by Merck project (39102). Zheng Hao, Xin Ye, and Jianping Ye are supported by the National Institute of Health research projects (DK085495; DK068036). Weiping Jia is supported by the Major International (Regional) Joint Research Project of National Natural Science Foundation of China (81220108006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boschmann M, 2009, J CLIN ENDOCR METAB, V94, P846, DOI 10.1210/jc.2008-1400; Bradley DP, 2010, NUTRITION, V26, P243, DOI 10.1016/j.nut.2009.07.008; Brown DX, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/381713; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Charrier JA, 2013, OBESITY, V21, P2350, DOI 10.1002/oby.20362; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; ENGLYST HN, 1987, AM J CLIN NUTR, V46, P873, DOI 10.1093/ajcn/46.6.873; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Gerich J, 2010, DIABETES RES CLIN PR, V90, P131, DOI 10.1016/j.diabres.2010.07.006; Higgins Janine A, 2004, Nutr Metab (Lond), V1, P8, DOI 10.1186/1743-7075-1-8; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Madsbad S, 2009, BEST PRACT RES CL EN, V23, P463, DOI 10.1016/j.beem.2009.03.008; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Osaka T, 2005, PEPTIDES, V26, P1623, DOI 10.1016/j.peptides.2005.02.016; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Sangle GV, 2012, ENDOCRINOLOGY, V153, P564, DOI 10.1210/en.2011-1732; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254	21	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126177	10.1371/journal.pone.0126177	http://dx.doi.org/10.1371/journal.pone.0126177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938560	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000149
J	Wang, LQ; Liang, T				Wang, Lingqing; Liang, Tao			Distribution Characteristics of Phosphorus in the Sediments and Overlying Water of Poyang Lake	PLOS ONE			English	Article							SUBMERGED MACROPHYTES; NITROGEN DYNAMICS; EUTROPHICATION; FORMS; SHALLOW; TAIHU; PHYTOPLANKTON; FRACTIONATION; LIMITATION; INTERFACE	Phosphorus (P) is a key indicator of the aquatic organism growth and eutrophication in lakes. The distribution and speciation of P and its release characteristics from sediments were investigated by analyzing sediment and water samples collected during high flow and low flow periods. Results showed that the average concentrations (ranges) of total phosphorus (TP) in the surface and deep water were 0.06 mg L-1 (0.03-0.13 mg L-1) and 0.15 mg L-1 (0.06-0.33 mg L-1), respectively, while the average concentration (range) of TP in sediments was 709.17 mg kg(-1) (544.76-932.11 mg kg(-1)). The concentrations of TP and different forms of P varied spatially in the surface sediments, displaying a decreasing trend from south to north. P also varied topographically from estuarine areas to lake areas. The vertical distribution of TP and different forms of P were observed to decrease as depth increased. The P concentrations during the low flow period were higher than those during the high flow period. Inorganic phosphorus (IP) was the dominant form of P, accounting for 61%-82% of TP. The concentration of bioavailable phosphorus in sediments was relatively large, indicating a high risk of release to overlying water. The simulation experiment of P release from sediments showed that the release was relatively fast in the first 0-5 min and then decreased to a plateau after 1 hr. Approximately 84-89% of the maximum amount of P was released during the first hour.	[Wang, Lingqing; Liang, Tao] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wang, LQ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.	wanglq@igsnrr.ac.cn; liangt@igsnrr.ac.cn	Wang, Lingqing/AAF-7692-2020	Liang, Tao/0000-0002-4218-7278; Wang, Lingqing/0000-0001-5123-9423	National Key Project for Basic Research [2012CB417004]; National Natural Scientific Foundation of China [41401591, 41171390]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by the National Key Project for Basic Research (No. 2012CB417004) and the National Natural Scientific Foundation of China (No. 41401591 and 41171390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MAM, 2011, ENVIRON MONIT ASSESS, V178, P203, DOI 10.1007/s10661-010-1682-2; Abell JM, 2010, ECOSYSTEMS, V13, P966, DOI 10.1007/s10021-010-9367-9; ABRAMS MM, 1995, J ENVIRON QUAL, V24, P132, DOI 10.2134/jeq1995.00472425002400010019x; Ahlgren J, 2011, WATER RES, V45, P565, DOI 10.1016/j.watres.2010.09.020; Bridgeman TB, 2012, J GREAT LAKES RES, V38, P90, DOI 10.1016/j.jglr.2011.09.010; Carvalho L, 2008, AQUAT ECOL, V42, P203, DOI 10.1007/s10452-008-9189-4; Dunne EJ, 2013, ECOL ENG, V61, P224, DOI 10.1016/j.ecoleng.2013.09.039; Filbrun JE, 2013, LAKE RESERV MANAGE, V29, P165, DOI 10.1080/10402381.2013.823469; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; Guo H, 2012, J HYDROL, V416, P19, DOI 10.1016/j.jhydrol.2011.11.027; Han HJ, 2014, ECOL ENG, V73, P146, DOI 10.1016/j.ecoleng.2014.09.016; Kolzau S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096065; Liu L, 2012, ENVIRON EARTH SCI, V65, P945, DOI 10.1007/s12665-011-1295-2; McCulloch J, 2013, CHEM GEOL, V354, P216, DOI 10.1016/j.chemgeo.2013.06.011; Mehner T, 2008, ECOSYSTEMS, V11, P1142, DOI 10.1007/s10021-008-9185-5; Muller B, 2008, SCI TOTAL ENVIRON, V402, P232, DOI 10.1016/j.scitotenv.2008.04.049; Nurnberg GK, 2013, J GREAT LAKES RES, V39, P259, DOI 10.1016/j.jglr.2013.03.016; Nyenje PM, 2010, SCI TOTAL ENVIRON, V408, P447, DOI 10.1016/j.scitotenv.2009.10.020; Pedro T, 2013, INT J SEDIMENT RES, V28, P90, DOI 10.1016/S1001-6279(13)60021-9; Ribeiro DC, 2008, CHEMOSPHERE, V70, P1256, DOI 10.1016/j.chemosphere.2007.07.064; Ruban V, 2001, FRESEN J ANAL CHEM, V370, P224, DOI 10.1007/s002160100753; Rydin E, 2000, WATER RES, V34, P2037, DOI 10.1016/S0043-1354(99)00375-9; Sallade YE, 1997, J ENVIRON QUAL, V26, P1571, DOI 10.2134/jeq1997.00472425002600060017x; Schelske CL, 2009, SCIENCE, V324, P722, DOI 10.1126/science.324_722; Small GE, 2014, HYDROBIOLOGIA, V731, P95, DOI 10.1007/s10750-013-1569-7; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Su J, 2014, WATER AIR SOIL POLL, V225, P1; Wang CH, 2013, J ENVIRON MANAGE, V122, P31, DOI 10.1016/j.jenvman.2013.03.007; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454; Wang SR, 2012, J ENVIRON MANAGE, V113, P355, DOI 10.1016/j.jenvman.2012.09.007; Wang Z, 2012, FRESEN ENVIRON BULL, V21, P3693; Xiang SL, 2011, INT J SEDIMENT RES, V26, P230, DOI 10.1016/S1001-6279(11)60089-9; Xie YX, 2007, PEDOSPHERE, V17, P200, DOI 10.1016/S1002-0160(07)60026-5; Xing W, 2013, ECOL ENG, V54, P16, DOI 10.1016/j.ecoleng.2013.01.026; Zhang JQ, 2012, ENVIRON POLLUT, V164, P227, DOI 10.1016/j.envpol.2012.01.021; Zhou F, 2013, INT J NUMER METH FL, V73, P266, DOI 10.1002/fld.3800; Zhou F, 2013, WATER RESOUR RES, V49, P1914, DOI 10.1002/wrcr.20179; Zhu MY, 2013, ENVIRON SCI POLLUT R, V20, P1803, DOI 10.1007/s11356-012-1084-9; Zhu MY, 2013, ENVIRON POLLUT, V173, P216, DOI 10.1016/j.envpol.2012.10.016; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	40	35	37	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125859	10.1371/journal.pone.0125859	http://dx.doi.org/10.1371/journal.pone.0125859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938758	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000111
J	Xie, XY; Lin, W; Xing, CF; Yang, YF; Chi, Q; Zhang, H; Li, Y; Li, ZP; Yang, Y; Yang, ZB; Li, MY				Xie, Xiangyang; Lin, Wen; Xing, Chuanfeng; Yang, Yanfang; Chi, Qiang; Zhang, Hui; Li, Ying; Li, Zhiping; Yang, Yang; Yang, Zhenbo; Li, Mingyuang			In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; DOUBLE-BLIND; ALCOHOL DEPENDENCE; ORAL NALMEFENE; RELEASE; NALTREXONE; DRUG; EFFICACY; SAFETY; TOXICITY	Poor patient compliance, untoward reactions and unstable blood drug levels after the bolus administration are impeding the pharmacotherapy for insobriety. A long-acting preparation may address these limitations. The aim of this paper was to further investigate the in vitro characteristics and in vivo performances of nalmefene microspheres. Nalmefene was blended with poly (lactide-co-glycolide) (PLGA) to prepare the target microspheres by an O/O emulsification solvent evaporation method. The prepared microspheres exhibited a controlled release profile of nalmefene in vitro over 4 weeks, which was well fitted with a first-order model. In vitro degradation study showed that the drug release in vitro was dominated by both drug diffusion and polymer degradation mechanisms. Pharmacokinetics study indicated that the prepared microspheres could provide a relatively constant of nalmefene plasma concentration for at least one month in rats. The in vivo pharmacokinetics profile was well correlated with the in vitro drug release. Pharmacodynamics studies revealed that the drug loaded microspheres could produce a long-acting antagonism efficacy on rats. These results demonstrated the promising application of injectable PLGA microspheres containing nalmefene for the long-term treatment of alcohol dependence.	[Xie, Xiangyang; Yang, Yang] Wuhan Gen Hosp Guangzhou Mil Command, Dept Pharm, Wuhan, Peoples R China; [Lin, Wen] Huangshi Love & Hlth Hosp Hubei Prov, Dept Clin Lab, Huangshi, Peoples R China; [Xing, Chuanfeng] Dalian Merro Pharmaceut Factory, Dalian, Peoples R China; [Yang, Yanfang] Chinese Acad Med Sci, Beijing Key Lab Drug Delivery Technol & Novel For, Inst Mat Med, Beijing 100730, Peoples R China; [Yang, Yanfang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chi, Qiang] Chinese Peoples Liberat Army, Clin 215, Dept Pharm, Hosp 406, Dalian, Peoples R China; [Zhang, Hui; Li, Ying; Li, Zhiping; Yang, Yang; Yang, Zhenbo; Li, Mingyuang] Beijing Inst Pharmacol & Toxicol, Dept Pharmaceut, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Yang, Y (corresponding author), Wuhan Gen Hosp Guangzhou Mil Command, Dept Pharm, Wuhan, Peoples R China.	xxysypu@163.com			National Natural Science Foundation of China [81202466, 81402874]; Important National Science & Technology Specific Projects of China [2012ZX09301003-001-009]; Natural Science Foundation of Hubei Province [2014CFC1039]; Dalian Merro Pharmaceutical Co. Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science & Technology Specific Projects of China; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Dalian Merro Pharmaceutical Co. Ltd	This work is supported by the by the National Natural Science Foundation of China (Grant No. 81202466 and 81402874), the Important National Science & Technology Specific Projects (Grant No. 2012ZX09301003-001-009) of China and Natural Science Foundation of Hubei Province (Grant No. 2014CFC1039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dalian Merro Pharmaceutical Co. Ltd provided support in the form of a salary for the author CX, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akala EO, 2011, DRUG DEV IND PHARM, V37, P673, DOI 10.3109/03639045.2010.535540; Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P2254, DOI 10.1038/sj.npp.1300811; Bartus RT, 2003, NEUROPSYCHOPHARMACOL, V28, P1973, DOI 10.1038/sj.npp.1300274; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; Chick J, 2000, ALCOHOL ALCOHOLISM, V35, P587, DOI 10.1093/alcalc/35.6.587; CHOU JZ, 1993, J CHROMATOGR-BIOMED, V613, P359, DOI 10.1016/0378-4347(93)80155-W; Corrao G, 1999, ALCOHOL ALCOHOLISM, V34, P873, DOI 10.1093/alcalc/34.6.873; Costantini LC, 2004, INT J PHARM, V283, P35, DOI 10.1016/j.ijpharm.2004.05.034; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Diab R, 2010, DRUG DEV IND PHARM, V36, P456, DOI 10.3109/03639040903261989; DIXON R, 1987, J CLIN PHARMACOL, V27, P233, DOI 10.1002/j.1552-4604.1987.tb02191.x; Dunbar JL, 2006, ALCOHOL CLIN EXP RES, V30, P480, DOI 10.1111/j.1530-0277.2006.00052.x; Emami J, 2006, J PHARM PHARM SCI, V9, P169; Fang WB, 2005, J ANAL TOXICOL, V29, P169, DOI 10.1093/jat/29.3.169; Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015; Gual A, 2014, DRUG TODAY, V50, P347, DOI 10.1358/dot.2014.50.5.2132323; Gual A, 2013, EUR NEUROPSYCHOPHARM, V23, P1432, DOI 10.1016/j.euroneuro.2013.02.006; He GA, 2001, ACTA PHARMACOL SIN, V22, P530; Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5; Kim BK, 2002, J MICROENCAPSUL, V19, P811, DOI 10.1080/0265204021000022770; Li ZP, 2011, INT J PHARMACEUT, V410, P48, DOI 10.1016/j.ijpharm.2011.03.016; Luquiens A, 2014, PATIENT PREFER ADHER, V8, P1347, DOI 10.2147/PPA.S57358; Martin GW, 2012, CAN J PSYCHIAT, V57, P350, DOI 10.1177/070674371205700604; Mason BJ, 1999, ARCH GEN PSYCHIAT, V56, P719, DOI 10.1001/archpsyc.56.8.719; MASON BJ, 1994, ALCOHOL CLIN EXP RES, V18, P1162, DOI 10.1111/j.1530-0277.1994.tb00098.x; Morita T, 2001, J CONTROL RELEASE, V73, P213, DOI 10.1016/S0168-3659(01)00280-2; Muller CA, 2014, EXPERT OPIN PHARMACO, V15, P471, DOI 10.1517/14656566.2014.876008; Oslin DW, 2008, ALCOHOL CLIN EXP RES, V32, P1299, DOI 10.1111/j.1530-0277.2008.00698.x; Qandil Amjad M., 2013, Journal of Pharmaceutical Investigation, V43, P171, DOI 10.1007/s40005-013-0065-4; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rohsenow DJ, 2000, ALCOHOL CLIN EXP RES, V24, P1542, DOI 10.1097/00000374-200010000-00012; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Spanagel R, 2013, CURR TOP BEHAV NEURO, V13, P583, DOI 10.1007/7854_2012_205; Tamura T, 2002, EUR J PHARM BIOPHARM, V53, P241, DOI 10.1016/S0939-6411(01)00244-2; Volpicelli JR, 1997, ARCH GEN PSYCHIAT, V54, P737; WAGNER JG, 1963, J PHARM SCI, V52, P610, DOI 10.1002/jps.2600520629; Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2; Wang S, 2012, BIOL PHARM BULL, V35, P1898, DOI 10.1248/bpb.b110726; Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022; Wu XG, 2006, CHEM PHARM BULL, V54, P977, DOI 10.1248/cpb.54.977; Xie XY, 2015, PHARM DEV TECHNOL, V20, P633, DOI 10.3109/10837450.2014.892131; Xie XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114835; Yang Y, 2011, PHARMAZIE, V66, P694, DOI 10.1691/ph.2011.1007; Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004	45	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125953	10.1371/journal.pone.0125953	http://dx.doi.org/10.1371/journal.pone.0125953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938514	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000119
J	Kader, R; Govender, R; Seedat, S; Koch, JR; Parry, C				Kader, Rehana; Govender, Rajen; Seedat, Soraya; Koch, John Randy; Parry, Charles			Understanding the Impact of Hazardous and Harmful Use of Alcohol and/or Other Drugs on ARV Adherence and Disease Progression	PLOS ONE			English	Article							HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; MENTAL-DISORDERS; PROBLEM DRINKING; SOUTH-AFRICA; PREDICTORS; NONADHERENCE; PREVALENCE; HIV/AIDS	The objective of this study was to understand the impact of hazardous and harmful use of alcohol and/or other drugs on ARV adherence and disease progression among HIV patients. A cross-sectional study design was used. A total of 1503 patients attending HIV clinics in Cape Town, South Africa were screened for problematic substance use. A sub-sample of 607 patients (303 patients who screened positive for problematic substance use and 304 who did not) participated in this study. Hazardous or harmful alcohol use and problematic drug use predicted missing and stopping ARVs which, in turn, was associated with a decrease in CD4 counts and more rapid HIV-disease progression and poorer health outcomes in people living with HIV/AIDS (PLWHA). The findings of this study underscore the need for an integrated approach to managing substance-use disorders in PLWHA.	[Kader, Rehana; Parry, Charles] MRC, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa; [Govender, Rajen] Univ Cape Town, Ctr Social Sci Res, ZA-7925 Cape Town, South Africa; [Govender, Rajen] Univ Cape Town, Dept Sociol, ZA-7925 Cape Town, South Africa; [Seedat, Soraya; Parry, Charles] Univ Stellenbosch, Dept Psychiat, ZA-7600 Stellenbosch, South Africa; [Koch, John Randy] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA	University of Cape Town; University of Cape Town; Stellenbosch University; Virginia Commonwealth University	Kader, R (corresponding author), MRC, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa.	kaderrehana@gmail.com	Parry, Charles/A-2906-2009; Govender, Rajen/Y-4477-2019	Parry, Charles/0000-0001-9787-2785; Govender, Rajen/0000-0003-2720-7653; Seedat, Soraya/0000-0002-5118-786X	US President's Emergency Fund for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC) [5U2GPS001137]	US President's Emergency Fund for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC)	This research has been supported by the US President's Emergency Fund for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC), under the terms of Co-operative agreement grant number 5U2GPS001137. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or PEPFAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman A., 2005, DUDIT MANUAL DRUG US; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1111/j.1525-1497.2001.00122.x; Dada S, 2013, MONITORING ALCOHOL T, V34; Do NT, 2010, AIDS RES HUM RETROV, V26, P685, DOI 10.1089/aid.2009.0222; Farley John, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P218, DOI 10.1177/1545109710371133; Freeman M, 2007, AIDS CARE, V19, P1201, DOI 10.1080/09540120701426482; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Kader R, 2012, AFR J PSYCHIATRY, V15, P346, DOI [10.4314/ajpsy.v15i5.43, http://dx.doi.org/10.4314/ajpsy.v15i5.43]; Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006; Mellins CA, 2003, AIDS PATIENT CARE ST, V17, P407, DOI 10.1089/108729103322277420; Mellins CA, 2009, AIDS CARE, V21, P168, DOI 10.1080/09540120802001705; Mohammed H, 2004, AIDS PATIENT CARE ST, V18, P289, DOI 10.1089/108729104323076025; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Olley BO, 2003, SAMJ S AFR MED J, V93, P928; Palepu A, 2008, J CRIT CARE, V23, P275, DOI 10.1016/j.jcrc.2007.04.001; Parry C.D., 2010, AFRICAN J DRUG ALCOH, V9, P81; Parry C. D. H., 2006, AFRICAN J DRUG ALCOH, V5, P140; Parry CD, 2007, CURR OPIN PSYCHIATR, V20, P235; Parsons JT, 2008, HEALTH PSYCHOL, V27, P628, DOI 10.1037/a0012664; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Peretti-Watel P, 2003, SUBST ALCOHOL DEP S1, V82, pS71; Schlebusch L, 2010, AFR J PSYCHIATRY, V13, P280; Schneider M., 2012, J AIDS CLIN RES, VS1:005, DOI [10.4712/2155-6113.S1-005, DOI 10.4172/2155-6113.S1-005]; Sebit M B, 2003, East Afr Med J, V80, P503; Sullivan LE, 2008, ADDICTION, V103, P1461, DOI 10.1111/j.1360-0443.2008.02245.x; Turner BJ, 2001, J GEN INTERN MED, V16, P625, DOI 10.1046/j.1525-1497.2001.016009625.x; Van Dyk AC, 2010, AJAR-AFR J AIDS RES, V9, P235, DOI 10.2989/16085906.2010.530177; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Wagner GJ, 2000, AIDS CARE, V12, P405, DOI 10.1080/09540120050123800; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yunusa MA, 2011, AFR J DRUG ALCOHOL S, V10, P11	35	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125088	10.1371/journal.pone.0125088	http://dx.doi.org/10.1371/journal.pone.0125088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933422	Green Published, gold			2022-12-26	WOS:000353887100077
J	Lhuillier, C; Barjon, C; Niki, T; Gelin, A; Praz, F; Morales, O; Souquere, S; Hirashima, M; Wei, M; Dellis, O; Busson, P				Lhuillier, Claire; Barjon, Clement; Niki, Toshiro; Gelin, Aurore; Praz, Francoise; Morales, Olivier; Souquere, Sylvie; Hirashima, Mitsuomi; Wei, Ming; Dellis, Olivier; Busson, Pierre			Impact of Exogenous Galectin-9 on Human T Cells CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; GLYCAN-BINDING; TIM-3; APOPTOSIS; DEATH; INFLAMMATION; AUTOIMMUNITY; INVOLVEMENT; SUPPRESSES; RESISTANCE	Galectin-9 (gal-9) is a multifunctional beta-galactoside-binding lectin, frequently released in the extracellular medium, where it acts as a pleiotropic immune modulator. Despite its overall immunosuppressive effects, a recent study has reported bimodal action of gal-9 on human resting blood T cells with apoptosis occurring in the majority of them, followed by a wave of activation and expansion of Th1 cells in the surviving population. Our knowledge of the signaling events triggered by exogenous gal-9 in T cells remains limited. One of these events is cytosolic calcium (Ca2+) release reported in some murine and human T cells. The aim of this study was to investigate the contribution of Ca2+ mobilization to apoptotic and nonapoptotic effects of exogenous gal-9 in human T cells. We found that the T cell receptor (TCR)-CD3 complex and the Lck kinase were required for Ca2+ mobilization but not for apoptosis induction in Jurkat cells. These data were confirmed in human CD4(+) T cells from peripheral blood as follows: a specific Lck chemical inhibitor abrogated Ca2+ mobilization but not apoptosis induction. Moreover, Lck activity was also required for the production of Th1-type cytokines, i.e. interleukin-2 and interferon-gamma, which resulted from gal-9 stimulation in peripheral CD4(+) T cells. These findings indicate that gal-9 acts on T cells by two distinct pathways as follows: one mimicking antigen-specific activation of the TCR with a mandatory contribution of proximal elements of the TCR complex, especially Lck, and another resulting in apoptosis that is independent of this complex.	[Lhuillier, Claire; Barjon, Clement; Souquere, Sylvie; Dellis, Olivier; Busson, Pierre] Univ Paris 11, F-91400 Orsay, France; [Lhuillier, Claire; Barjon, Clement; Gelin, Aurore; Busson, Pierre] Inst Gustave Roussy, CNRS, UMR 8126, F-94805 Villejuif, France; [Lhuillier, Claire; Barjon, Clement; Wei, Ming] Ecole Natl Vet Alfort, Cellvax, F-94704 Maisons Alfort, France; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa 7610793, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] GalPharma Co Ltd, Takamatsu, Kagawa 7610301, Japan; [Praz, Francoise] Ctr Rech St Antoine, INSERM, UMR S 938, F-75012 Paris, France; [Praz, Francoise] Univ Paris 06, Sorbonne Univ, UMR S 938, Ctr Rech St Antoine, F-75012 Paris, France; [Morales, Olivier] Inst Biol Lille, CNRS, UMR Grp IRCV 8161, F-59021 Lille, France; [Souquere, Sylvie] Inst Gustave Roussy, UMR 8122, F-94805 Villejuif, France; [Dellis, Olivier] INSERM, UMR S 757, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ecole Nationale Veterinaire d'Alfort (ENVA); Kagawa University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm)	Busson, P (corresponding author), Univ Paris 11, 15 Rue Georges Clemenceau, F-91400 Orsay, France.	pierre.busson@gustaveroussy.fr	MORALES, Olivier/AAR-5337-2020; Dellis, Olivier/E-8501-2011; PRAZ, Françoise/A-7291-2008; PRAZ, Françoise/AAF-7761-2020	Dellis, Olivier/0000-0003-0377-9163; PRAZ, Françoise/0000-0002-5353-8889; PRAZ, Françoise/0000-0002-5353-8889; Busson, Pierre/0000-0003-1027-3400; MORALES, Olivier/0000-0002-2135-3265	Institut National du Cancer Grant INCa-DHOS; Ligue Nationale Contre le Cancer (Comite du Val de Marne); Association Nationale Recherche-Technologie; Association pour la Recherche Contre le Cancer	Institut National du Cancer Grant INCa-DHOS; Ligue Nationale Contre le Cancer (Comite du Val de Marne)(Ligue nationale contre le cancer); Association Nationale Recherche-Technologie; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by Institut National du Cancer Grant INCa-DHOS 2010 and the Ligue Nationale Contre le Cancer (Comite du Val de Marne). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Association Nationale Recherche-Technologie.; Supported by a fellowship from Association pour la Recherche Contre le Cancer.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Barjon C, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-16; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Djillani A, 2014, BBA-MOL CELL RES, V1843, P2341, DOI 10.1016/j.bbamcr.2014.03.012; Dong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015114; Golden-Mason L, 2013, J VIROL, V87, P4835, DOI 10.1128/JVI.01085-12; Gooden MJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065616; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Leitner J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003253; Lequin D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-225; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Moritoki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060807; Mrizak D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju363; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Pace KE, 1999, J IMMUNOL, V163, P3801; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; POPPEMA S, 1991, AM J PATHOL, V138, P1479; Proust R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043200; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Reddy PBJ, 2011, J IMMUNOL, V187, P5745, DOI 10.4049/jimmunol.1102105; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Stachlewitz RF, 2005, J PHARMACOL EXP THER, V315, P36, DOI 10.1124/jpet.105.089169; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Tribulatti MV, 2009, J LEUKOCYTE BIOL, V86, P371, DOI 10.1189/jlb.0908529; Walzel H, 2000, GLYCOBIOLOGY, V10, P131, DOI 10.1093/glycob/10.2.131; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wiersma VR, 2012, J INVEST DERMATOL, V132, P2302, DOI 10.1038/jid.2012.133; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	61	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16797	16811		10.1074/jbc.M115.661272	http://dx.doi.org/10.1074/jbc.M115.661272			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25947381	hybrid, Green Published			2022-12-26	WOS:000357572800026
J	Watt, D; Dixit, R; Cavalli, V				Watt, Dana; Dixit, Ram; Cavalli, Valeria			JIP3 Activates Kinesin-1 Motility to Promote Axon Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; kinesin; molecular motor; neurite outgrowth; regeneration; JIP3; KHC; motility	SCAFFOLD PROTEIN; HEAVY-CHAIN; LIGHT-CHAINS; VESICLE TRANSPORT; MOTOR; KINASE; BINDING; DYNEIN; UNC-16; EXPRESSION	Background: Axon growth and regeneration depend on kinesin-1-dependent transport. Results: JIP3 binding to KHC promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Conclusion: JIP3 regulation of kinesin-1 motility is critical for axon elongation and regeneration. Significance: Regulation of intracellular transport is important for proper neuronal development. Kinesin-1 is a molecular motor responsible for cargo transport along microtubules and plays critical roles in polarized cells, such as neurons. Kinesin-1 can function as a dimer of two kinesin heavy chains (KHC), which harbor the motor domain, or as a tetramer in combination with two accessory light chains (KLC). To ensure proper cargo distribution, kinesin-1 activity is precisely regulated. Both KLC and KHC subunits bind cargoes or regulatory proteins to engage the motor for movement along microtubules. We previously showed that the scaffolding protein JIP3 interacts directly with KHC in addition to its interaction with KLC and positively regulates dimeric KHC motility. Here we determined the stoichiometry of JIP3-KHC complexes and observed approximately four JIP3 molecules binding per KHC dimer. We then determined whether JIP3 activates tetrameric kinesin-1 motility. Using an in vitro motility assay, we show that JIP3 binding to KLC engages kinesin-1 with microtubules and that JIP3 binding to KHC promotes kinesin-1 motility along microtubules. We tested the in vivo relevance of these findings using axon elongation as a model for kinesin-1-dependent cellular function. We demonstrate that JIP3 binding to KHC, but not KLC, is essential for axon elongation in hippocampal neurons as well as axon regeneration in sensory neurons. These findings reveal that JIP3 regulation of kinesin-1 motility is critical for axon elongation and regeneration.	[Watt, Dana; Cavalli, Valeria] Washington Univ, Dept Anat & Neurobiol, Sch Med, St Louis, MO 63110 USA; [Dixit, Ram] Washington Univ, Dept Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Cavalli, V (corresponding author), Washington Univ, Dept Anat & Neurobiol, Sch Med, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu			National Institutes of Health, NINDS [R01 NS082446]; National Science Foundation [MCB-1121287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS082446 (to V. C.). This work was also supported by National Science Foundation Grant MCB-1121287 (to R. D.).	Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Bilimoria PM, 2010, J NEUROSCI, V30, P16766, DOI 10.1523/JNEUROSCI.1362-10.2010; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Campbell PD, 2013, GENE EXPR PATTERNS, V13, P271, DOI 10.1016/j.gep.2013.05.002; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cherny D, 2010, EMBO J, V29, P2161, DOI 10.1038/emboj.2010.103; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Edwards SL, 2013, GENETICS, V194, P143, DOI 10.1534/genetics.112.147348; Falzone TL, 2010, HUM MOL GENET, V19, P4399, DOI 10.1093/hmg/ddq363; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; GOLDBERG DJ, 1987, DEV BIOL, V124, P35, DOI 10.1016/0012-1606(87)90456-8; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; GRIFFIN JW, 1976, J NEUROBIOL, V7, P355, DOI 10.1002/neu.480070407; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Ha HY, 2005, DEV BIOL, V277, P184, DOI 10.1016/j.ydbio.2004.09.019; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; Iwanaga A, 2007, NEUROSCI LETT, V429, P43, DOI 10.1016/j.neulet.2007.09.057; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; JOHNSON CS, 1990, CELL MOTIL CYTOSKEL, V16, P204, DOI 10.1002/cm.970160307; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kuribayashi J, 2010, BRAIN RES, V1362, P133, DOI 10.1016/j.brainres.2010.09.053; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Mar FM, 2014, J NEUROSCI, V34, P5965, DOI 10.1523/JNEUROSCI.4680-13.2014; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Morfini GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065235; Moua P, 2011, DEVELOPMENT, V138, P1087, DOI 10.1242/dev.048645; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rishal I, 2012, CELL REP, V1, P608, DOI 10.1016/j.celrep.2012.05.013; Schlager MA, 2014, CELL REP, V8, P1248, DOI 10.1016/j.celrep.2014.07.052; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Sun T, 2013, J BIOL CHEM, V288, P14531, DOI 10.1074/jbc.M113.464453; Suzuki A, 2010, FEBS LETT, V584, P2801, DOI 10.1016/j.febslet.2010.05.020; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; Watanabe TM, 2010, BIOCHEMISTRY-US, V49, P4654, DOI 10.1021/bi9021582; Willemsen MH, 2014, J MED GENET, V51, P487, DOI 10.1136/jmedgenet-2013-102182; Williams LS, 2014, DEVELOPMENT, V141, P176, DOI 10.1242/dev.097592; Wong YL, 2010, P NATL ACAD SCI USA, V107, P11781, DOI 10.1073/pnas.1005854107; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Xu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1760; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Zhang H, 2014, METHODS, V67, P169, DOI 10.1016/j.ymeth.2014.01.010; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	78	21	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15512	15525		10.1074/jbc.M115.651885	http://dx.doi.org/10.1074/jbc.M115.651885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944905	Green Published, hybrid			2022-12-26	WOS:000356527400017
J	Gong, WM; Gohla, RM; Bowlin, KM; Koyano-Nakagawa, N; Garry, DJ; Shi, XZ				Gong, Wuming; Gohla, Rachel M.; Bowlin, Kathy M.; Koyano-Nakagawa, Naoko; Garry, Daniel J.; Shi, Xiaozhong			Kelch Repeat and BTB Domain Containing Protein 5 ( Kbtbd5) Regulates Skeletal Muscle Myogenesis through the E2F1-DP1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; NEMALINE MYOPATHY; RETINOBLASTOMA PROTEIN; TRANSCRIPTIONAL ACTIVITY; EMBRYONIC-DEVELOPMENT; NUCLEAR-LOCALIZATION; EXPRESSION ANALYSIS; CELL-FUNCTION; MICE LACKING; RNA-SEQ	We have previously isolated a muscle-specific Kelch gene, Kelch repeat and BTB domain containing protein 5 (Kbtbd5)/Kelch-like protein 40 (Klhl40). In this report, we identified DP1 as a direct interacting factor for Kbtbd5 using a yeast two-hybrid screen and in vitro binding assays. Our studies demonstrate that Kbtbd5 interacts and regulates the cytoplasmic localization of DP1. GST pulldown assays demonstrate that the dimerization domain of DP1 interacts with all three of the Kbtbd5 domains. We further show that Kbtbd5 promotes the ubiquitination and degradation of DP1, thereby inhibiting E2F1-DP1 activity. To investigate the in vivo function of Kbtbd5, we used gene disruption technology and engineered Kbtbd5 null mice. Targeted deletion of Kbtbd5 resulted in postnatal lethality. Histological studies reveal that the Kbtbd5 null mice have smaller muscle fibers, a disorganized sarcomeric structure, increased extracellular matrix, and decreased numbers of mitochondria compared with wild-type controls. RNA sequencing and quantitative PCR analyses demonstrate the up-regulation of E2F1 target apoptotic genes (Bnip3 and p53inp1) in Kbtbd5 null skeletal muscle. Consistent with these observations, the cellular apoptosis in Kbtbd5 null mice was increased. Breeding of Kbtbd5 null mouse into the E2F1 null background rescues the lethal phenotype of the Kbtbd5 null mice but not the growth defect. The expression of Bnip3 and p53inp1 in Kbtbd5 mutant skeletal muscle are also restored to control levels in the E2F1 null background. In summary, our studies demonstrate that Kbtbd5 regulates skeletal muscle myogenesis through the regulation of E2F1-DP1 activity.	[Gong, Wuming; Gohla, Rachel M.; Bowlin, Kathy M.; Koyano-Nakagawa, Naoko; Garry, Daniel J.; Shi, Xiaozhong] Univ Minnesota Twin Cities, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shi, XZ (corresponding author), Univ Minnesota, Lillehei Heart Inst, 2231 6th St ,SE 4-136 CCRB, Minneapolis, MN 55455 USA.	shixz@umn.edu	Gong, Wuming/GQH-1435-2022; Regan, Clinton/E-6250-2012	Gong, Wuming/0000-0002-3147-4028; 	National Institutes of Health [5R01AR047850, 5R01AR055906]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047850, R01AR055906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AR047850 and 5R01AR055906.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Bowlin KM, 2013, DIFFERENTIATION, V86, P184, DOI 10.1016/j.diff.2013.08.002; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; delaLuna S, 1996, J CELL SCI, V109, P2443; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Dhume A, 2006, CELL MOTIL CYTOSKEL, V63, P493, DOI 10.1002/cm.20141; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Geng Y, 1996, ONCOGENE, V12, P1173; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Kohn MJ, 2004, MOL CELL BIOL, V24, P7197, DOI 10.1128/MCB.24.16.7197-7205.2004; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lavia P, 1999, BIOESSAYS, V21, P221; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Magae J, 1996, J CELL SCI, V109, P1717; Magae J, 1999, ONCOGENE, V18, P593, DOI 10.1038/sj.onc.1202345; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Masuhiro Y, 2008, J BIOL CHEM, V283, P31575, DOI 10.1074/jbc.M800328200; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ohta T, 2001, CANCER RES, V61, P1347; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Shi XZ, 2010, STEM CELLS, V28, P462, DOI 10.1002/stem.274; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Wang J, 1996, J CELL BIOCHEM, V62, P405; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yurkova N, 2008, CIRC RES, V102, P472, DOI 10.1161/CIRCRESAHA.107.164731	70	13	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15350	15361		10.1074/jbc.M114.629956	http://dx.doi.org/10.1074/jbc.M114.629956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25940086	Green Published, hybrid			2022-12-26	WOS:000356177300045
J	Advani, S; Rix, LN; Aherne, DM; Alwany, MA; Bailey, DM				Advani, Sahir; Rix, Laura N.; Aherne, Danielle M.; Alwany, Magdy A.; Bailey, David M.			Distance from a Fishing Community Explains Fish Abundance in a No-Take Zone with Weak Compliance	PLOS ONE			English	Article							MARINE PROTECTED AREAS; REEF FISH; PREDATORY FISH; RESERVES; HABITAT; CORAL; MANAGEMENT; NETWORKS; PATTERNS; RECOVERY	There are numerous examples of no-take marine reserves effectively conserving fish stocks within their boundaries. However, no-take reserves can be rendered ineffective and turned into 'paper parks' through poor compliance and weak enforcement of reserve regulations. Long-term monitoring is thus essential to assess the effectiveness of marine reserves in meeting conservation and management objectives. This study documents the present state of the 15-year old no-take zone (NTZ) of South El Ghargana within the Nabq Managed Resource Protected Area, South Sinai, Egyptian Red Sea. Previous studies credited willing compliance by the local fishing community for the increased abundances of targeted fish within the designated NTZ boundaries compared to adjacent fished or take-zones. We compared benthic habitat and fish abundance within the NTZ and the adjacent take sites open to fishing, but found no significant effect of the reserve. Instead, the strongest evidence was for a simple negative relationship between fishing pressure and distance from the closest fishing village. The abundance of targeted piscivorous fish increased significantly with increasing distance from the village, while herbivorous fish showed the opposite trend. This gradient was supported by a corresponding negative correlation between the amount of discarded fishing gear observed on the reef and increasing distance from the village. Discarded fishing gear within the NTZ suggested decreased compliance with the no-take regulations. Our findings indicate that due to non-compliance the no-take reserve is no longer functioning effectively, despite its apparent initial successes and instead a gradient of fishing pressure exists with distance from the nearest fishing community.	[Advani, Sahir; Rix, Laura N.; Aherne, Danielle M.; Bailey, David M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Alwany, Magdy A.] Suez Canal Univ, Fac Sci, Dept Marine Sci, Ismailia, Egypt	University of Glasgow; Egyptian Knowledge Bank (EKB); Suez Canal University	Advani, S (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	s.advani@fisheries.ubc.ca	Rix, Laura/B-3121-2019; Advani, Sahir/K-7939-2019; Rix, Laura/U-6264-2019; Bailey, David/A-6240-2008	Rix, Laura/0000-0002-1888-6597; Advani, Sahir/0000-0003-2522-5364; Bailey, David/0000-0002-0824-8823	University of Glasgow; Royal Geographical Society; Glasgow Natural History Society; Gilchrist Educational Trust	University of Glasgow; Royal Geographical Society; Glasgow Natural History Society; Gilchrist Educational Trust	SA DMA LNR were supported by the University of Glasgow. Additional funding for this research was provided by the Royal Geographical Society, Glasgow Natural History Society, and the Gilchrist Educational Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Ban NC, 2009, CONSERV BIOL, V23, P899, DOI 10.1111/j.1523-1739.2009.01185.x; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bates D., 2013, LME4 LINEAR MIXED EF; Bergseth B.J., 2013, FISH FISH; Clarke K, 2006, PRIMER V6 1 10 USER; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edgar GJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P730, DOI 10.1111/j.1466-8238.2010.00642.x; Galal N, 2002, MAR FRESHWATER RES, V53, P199, DOI 10.1071/MF01158; Galal N, 2012, PROCEEDINGS OF THE 1; Galal N., 1999, THESIS; Grafen A, 2002, MODERN STATISTICS FO; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2003, ECOL APPL, V13, pS117; Hansen GJA, 2011, BIOL CONSERV, V144, P1866, DOI 10.1016/j.biocon.2011.04.002; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1996, ENVIRON BIOL FISH, V46, P15, DOI 10.1007/BF00001693; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lamb RW, 2010, MAR ECOL PROG SER, V408, P169, DOI 10.3354/meps08509; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Miller KI, 2014, OCEAN COAST MANAGE, V96, P51, DOI 10.1016/j.ocecoaman.2014.05.003; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NCH Software, 2011, VIDEOPAD VIDEO EDITO; Pearson M.P., 1998, PARKS, V8, P29, DOI DOI 10.1111/1365-2664.12736; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; R Core Team, 2013, R A LANGUAGE AND ENV; Rife AN, 2013, CONSERV LETT, V6, P200, DOI 10.1111/j.1755-263X.2012.00303.x; ROBERTS CM, 1993, AMBIO, V22, P363; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Russ GR, 1999, CORAL REEFS, V18, P307, DOI 10.1007/s003380050203; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Samy M, 2011, ANIM BIODIV CONSERV, V34, P165; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; SHPIGEL M, 1989, MAR ECOL PROG SER, V58, P17, DOI 10.3354/meps058017; Walmsley SF, 2003, ENVIRON CONSERV, V30, P388, DOI 10.1017/S0376892903000407; Williamson DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114395	50	25	25	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126098	10.1371/journal.pone.0126098	http://dx.doi.org/10.1371/journal.pone.0126098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950815	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000354214400068
J	Dao, HT; Smith-Keune, C; Wolanski, E; Jones, CM; Jerry, DR				Hoc Tan Dao; Smith-Keune, Carolyn; Wolanski, Eric; Jones, Clive M.; Jerry, Dean R.			Oceanographic Currents and Local Ecological Knowledge Indicate, and Genetics Does Not Refute, a Contemporary Pattern of Larval Dispersal for The Ornate Spiny Lobster, Panulirus ornatus in the South-East Asian Archipelago	PLOS ONE			English	Article							WESTERN ROCK LOBSTER; PAPUA-NEW-GUINEA; POPULATION-STRUCTURE; DNA POLYMORPHISM; INDIAN-OCEAN; FABRICIUS; CONNECTIVITY; CIRCULATION; SOFTWARE; DIFFERENTIATION	Here we utilize a combination of genetic data, oceanographic data, and local ecological knowledge to assess connectivity patterns of the ornate spiny lobster Panulirus ornatus (Fabricius, 1798) in the South-East Asian archipelago from Vietnam to Australia. Partial mitochondrial DNA control region and 10 polymorphic microsatellites did not detect genetic structure of 216 wild P. ornatus samples from Australia, Indonesia and Vietnam. Analyses show no evidence for genetic differentiation among populations (mtDNA control region sequences phi(ST) = -0.008; microsatellite loci F-ST = 0.003). A lack of evidence for regional or localized mtDNA haplotype clusters, or geographic clusters of microsatellite genotypes, reveals a pattern of high gene flow in P. ornatusthroughout the South-East Asian Archipelago. This lack of genetic structure may be due to the oceanography-driven connectivity of the pelagic lobster larvae between spawning grounds in Papua New Guinea, the Philippines and, possibly, Indonesia. The connectivity cycle necessitates three generations. The lack of genetic structure of P. ornatuspopulation in the South-East Asian archipelago has important implications for the sustainable management of this lobster in that the species within the region needs to be managed as one genetic stock.	[Hoc Tan Dao; Smith-Keune, Carolyn; Jones, Clive M.; Jerry, Dean R.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4810, Australia; [Hoc Tan Dao; Smith-Keune, Carolyn; Wolanski, Eric; Jones, Clive M.; Jerry, Dean R.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4810, Australia; [Wolanski, Eric; Jerry, Dean R.] James Cook Univ, TropWATER, Townsville, Qld 4810, Australia; [Hoc Tan Dao] Vietnam Acad Sci & Technol, Inst Oceanog, Nha Trang, Vietnam	James Cook University; James Cook University; James Cook University; Vietnam Academy of Science & Technology (VAST)	Dao, HT (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4810, Australia.	hoctan.dao@my.jcu.edu.au	Jones, Clive/D-2991-2009; Jerry, Dean R/B-3053-2012	Jones, Clive/0000-0002-6319-2068; Jerry, Dean/0000-0003-3735-1798	Australia Centre for International Agricultural Research (ACIAR) [SMAR/2008/021]	Australia Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res)	This work was funded by Australia Centre for International Agricultural Research (ACIAR) through project SMAR/2008/021). CMJ is the author who received the funding (the project leader). The funder has contributed in sampling and preparation of the manuscript.	Abdullah MF, 2013, PACIFIC SCI, V68; Adamkewicz SL, 1996, AM MALACOL BULL, V13, P97; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Brown R. S., 2009, W ROCK LOBSTER LOW P, P1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CHITTLEBOROUGH RG, 1975, AUST J MAR FRESH RES, V26, P317; Chow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029280; Condie SA, 2011, CONT SHELF RES, V31, P1427, DOI 10.1016/j.csr.2011.06.005; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cravatte S, 2011, PROG OCEANOGR, V88, P116, DOI 10.1016/j.pocean.2010.12.015; Dao HT, 2013, CONSERV GENET RESOUR, V5, P43, DOI 10.1007/s12686-012-9728-0; Dawson MN, 1998, MOL MAR BIOL BIOTECH, V7, P145; Dennis DM, 2001, MAR FRESHWATER RES, V52, P1175, DOI 10.1071/MF01186; Dennis DM, 1997, MAR FRESHWATER RES, V48, P663, DOI 10.1071/MF97184; Ellison J., 2009, COASTAL WETLANDS INT, P565; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 2005, EVOLUTIONARY BIOINFO, V1, P1; Farhadi A, 2013, ICES J MAR SCI, V70, P1491, DOI 10.1093/icesjms/fst097; Feutry P, 2013, MOL ECOL, V22, P1518, DOI 10.1111/mec.12192; Fischer HB., 1979, MIXING INLAND COASTA; FORBES AMG, 1983, AUST J MAR FRESH RES, V34, P11; Garcia-Rodriguez FJ, 2008, MAR ECOL PROG SER, V361, P203, DOI 10.3354/meps07381; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gopal K, 2006, MAR ECOL PROG SER, V319, P191, DOI 10.3354/meps319191; Gordon A.L., 2005, OCEANOGRAPHY, V18, P13, DOI [10.5670/oceanog.2005.18, DOI 10.5670/OCEANOG.2005.18]; Holthuis L.B., 1991, MARINE LOBSTERS WORL, V13, P1; Inoue N, 2007, FISHERIES SCI, V73, P550, DOI 10.1111/j.1444-2906.2007.01367.x; Jones C. M., 2010, J MAR BIOL ASS INDIA, V52, P292; Juinio-Menez Marie Antonette, 2004, ACIAR Proceedings, V120, P3; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liang WD, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004609; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P3343, DOI 10.1029/90JC01951; MACFARLANE JW, 1986, AUST J MAR FRESH RES, V37, P55; Manh D, 2003, VIETNAM J MECH, V25, P153; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mayer B, 2010, DYNAM ATMOS OCEANS, V50, P301, DOI 10.1016/j.dynatmoce.2010.03.002; Metzger EJ, 2010, DYNAM ATMOS OCEANS, V50, P275, DOI 10.1016/j.dynatmoce.2010.04.002; MOORE R, 1984, AUST J MAR FRESH RES, V35, P197; Nguyen Van Long, 2009, ACIAR Proceedings Series, P52; Ovenden JR, 2013, MAR FRESHWATER RES, V64, P201, DOI 10.1071/MF12314; Palero F, 2008, MOL PHYLOGENET EVOL, V48, P708, DOI 10.1016/j.ympev.2008.04.022; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEARCE AF, 1994, BIOPHYSICS MARINE LA, P279; Phillips B.F., 2010, Journal of the Marine Biological Association of India, V52, P189; Phillips BF, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P1, DOI 10.1002/9781118517444; Phillips B, 2011, RECENT ADVANCES AND NEW SPECIES IN AQUACULTURE, P22; Pitcher C.R., 2005, BIOL LARVAL TRANSPOR, P144; Potemra JT, 2009, ENCY OCEAN SCI, P305, DOI [10.1016/B978-012374473-9.00598-1, DOI 10.1016/B978-012374473-9.00598-1]; Pritchard JK, 2000, GENETICS, V155, P945; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Sarver SK, 1998, J CRUSTACEAN BIOL, V18, P177, DOI 10.2307/1549532; Schiller A, 2008, PROG OCEANOGR, V76, P334, DOI 10.1016/j.pocean.2008.01.003; TAJIMA F, 1989, GENETICS, V123, P585; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson AP, 1996, MAR FRESHWATER RES, V47, P889, DOI 10.1071/MF9960889; Tolley KA, 2005, MAR ECOL PROG SER, V297, P225, DOI 10.3354/meps297225; Turnbull C, 2004, ECOLOGICAL ASSESSMEN, P1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villanoy Cesar L., 2004, ACIAR Proceedings, V120, P49; WILLIAMS KC, 2004, P WORKSH HELD I OC N	65	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124568	10.1371/journal.pone.0124568	http://dx.doi.org/10.1371/journal.pone.0124568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4RU	25951344	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000367788800004
J	Pritchett, D; Jagannath, A; Brown, LA; Tam, SKE; Hasan, S; Gatti, S; Harrison, PJ; Bannerman, DM; Foster, RG; Peirson, SN				Pritchett, David; Jagannath, Aarti; Brown, Laurence A.; Tam, Shu K. E.; Hasan, Sibah; Gatti, Silvia; Harrison, Paul J.; Bannerman, David M.; Foster, Russell G.; Peirson, Stuart N.			Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATOR; GROUP-II; SUPRACHIASMATIC NUCLEUS; PARAVENTRICULAR NUCLEUS; RHYTHM DISRUPTION; PREFRONTAL CORTEX; AGONIST LY379268; GENE-EXPRESSION; MESSENGER-RNA; RAT RETINA	Sleep and/or circadian rhythmdisruption (SCRD) is seen in up to 80% of schizophrenia patients. The co-morbidity of schizophrenia and SCRD may in part stem from dysfunction in common brainmechanisms, which include the glutamate system, and in particular, the group II metabotropic glutamate receptorsmGlu2 andmGlu3 (encoded by the genes Grm2 and Grm3). These receptors are relevant to the pathophysiology and potential treatment of schizophrenia, and have also been implicated in sleep and circadian function. In the present study, we characterised the sleep and circadian rhythms of Grm2/3 double knockout (Grm2/3(-/-)) mice, to provide further evidence for the involvement of group II metabotropic glutamate receptors in the regulation of sleep and circadian rhythms. We report several novel findings. Firstly, Grm2/3(-/-) mice demonstrated a decrease in immobility-determined sleep time and an increase in immobility-determined sleep fragmentation. Secondly, Grm2/3(-/-) mice showed heightened sensitivity to the circadian effects of light, manifested as increased period lengthening in constant light, and greater phase delays in response to nocturnal light pulses. Greater light-induced phase delays were also exhibited by wildtype C57Bl/6J mice following administration of the mGlu2/3 negative allosteric modulator RO4432717. These results confirm the involvement of group II metabotropic glutamate receptors in photic entrainment and sleep regulation pathways. Finally, the diurnal wheel-running rhythms of Grm2/3(-/-) mice were perturbed under a standard light/dark cycle, but their diurnal rest-activity rhythms were unaltered in cages lacking running wheels, as determined with passive infrared motion detectors. Hence, when assessing the diurnal rest-activity rhythms of mice, the choice of assay can have amajor bearing on the results obtained.	[Pritchett, David; Jagannath, Aarti; Brown, Laurence A.; Tam, Shu K. E.; Hasan, Sibah; Foster, Russell G.; Peirson, Stuart N.] Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Jagannath, Aarti; Gatti, Silvia] F Hoffmann La Roche & Cie AG, Neurosci Ophthalmol & Rare Dis, Pharma Res & Early Dev pRED Innovat Ctr, Basel, Switzerland; [Harrison, Paul J.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Bannerman, David M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; Roche Holding; University of Oxford; University of Oxford	Foster, RG (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	russell.foster@eye.ox.ac.uk; stuart.peirson@eye.ox.ac.uk	Jagannath, Aarti/GQA-7297-2022	Harrison, Paul/0000-0002-6719-1126; FOSTER, RUSSELL/0000-0001-6055-2067; Jagannath, Aarti/0000-0003-2132-8200; Brown, Laurence/0000-0001-8116-4100; Bannerman, David/0000-0002-3024-7595	University of Oxford Christopher Welch Scholarship; Wellcome Trust [098461/Z/12/Z, 074385, 087736]; University of Oxford Sleep and Circadian Neuroscience Institute (SCNi); Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); F. Hoffman-La Roche; Medical Research Council [G0801747] Funding Source: researchfish; MRC [G0801747] Funding Source: UKRI	University of Oxford Christopher Welch Scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); University of Oxford Sleep and Circadian Neuroscience Institute (SCNi); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); F. Hoffman-La Roche; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: DP holds a University of Oxford Christopher Welch Scholarship. This work was supported by a Wellcome Trust Strategic Award (098461/Z/12/Z) to RGF and the University of Oxford Sleep and Circadian Neuroscience Institute (SCNi). RGF and SNP are also funded by the Biotechnology and Biological Sciences Research Council (BBSRC). PJH is also funded by the Medical Research Council (MRC). DMB is a Wellcome Trust Senior Research Fellow (Grant no. 074385 and 087736). F. Hoffman-La Roche provided support in the form of salaries for authors AJ and SG, but had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABE H, 1991, NEUROSCI LETT, V127, P9, DOI 10.1016/0304-3940(91)90881-S; Ahnaou A, 2014, BEHAV BRAIN RES, V270, P56, DOI 10.1016/j.bbr.2014.05.003; Ahnaou A, 2009, EUR J PHARMACOL, V603, P62, DOI 10.1016/j.ejphar.2008.11.018; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 2002, METHODS, V28, P465, DOI 10.1016/S1046-2023(02)00266-9; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; Cohrs S, 2008, CNS DRUGS, V22, P939, DOI 10.2165/00023210-200822110-00004; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; Corti C, 2007, BIOL PSYCHIAT, V62, P747, DOI 10.1016/j.biopsych.2006.12.005; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Cui LN, 2001, AM J PHYSIOL-REG I, V281, pR1283, DOI 10.1152/ajpregu.2001.281.4.R1283; De Filippis B, 2015, NEUROPHARMACOLOGY, V89, P19, DOI 10.1016/j.neuropharm.2014.08.010; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Dong EH, 2012, BRAIN RES, V1452, P85, DOI 10.1016/j.brainres.2012.03.003; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Feinberg I, 2005, J PHARMACOL EXP THER, V312, P826, DOI 10.1124/jpet.104.076547; Feinberg I, 2002, PHARMACOL BIOCHEM BE, V73, P467, DOI 10.1016/S0091-3057(02)00843-2; Fell MJ, 2011, J PHARMACOL EXP THER, V336, P165, DOI 10.1124/jpet.110.172957; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Gannon RL, 2011, NEUROPHARMACOLOGY, V60, P209, DOI 10.1016/j.neuropharm.2010.08.022; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; Green E, 2006, AM J MED GENET B, V141B, P697; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Gu GB, 2008, BRAIN RES, V1197, P47, DOI 10.1016/j.brainres.2007.12.057; Haak LL, 2006, BRAIN RES BULL, V71, P97, DOI 10.1016/j.brainresbull.2006.08.006; Haak LL, 1999, J NEUROPHYSIOL, V81, P1308, DOI 10.1152/jn.1999.81.3.1308; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; HARTVEIT E, 1995, EUR J NEUROSCI, V7, P1472, DOI 10.1111/j.1460-9568.1995.tb01142.x; Harvey AG, 2009, CLIN PSYCHOL-SCI PR, V16, P256, DOI 10.1111/j.1468-2850.2009.01164.x; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hermes MLHJ, 1996, J PHYSIOL-LONDON, V496, P749, DOI 10.1113/jphysiol.1996.sp021724; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jha SK, 2005, PHYSIOL BEHAV, V86, P415, DOI 10.1016/j.physbeh.2005.06.033; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kandaswamy R, 2013, JAMA PSYCHIAT, V70, P591, DOI 10.1001/jamapsychiatry.2013.38; Kodama T, 1998, BRAIN RES, V780, P178, DOI 10.1016/S0006-8993(97)01308-5; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Koulen P, 1996, EUR J NEUROSCI, V8, P2177, DOI 10.1111/j.1460-9568.1996.tb00739.x; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lane TA, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-102; Lavreysen H, 2013, J PHARMACOL EXP THER, V346, P514, DOI 10.1124/jpet.113.204990; LIOU SY, 1986, BRAIN RES BULL, V16, P527, DOI 10.1016/0361-9230(86)90182-6; Lopez-Rodriguez F, 2007, ARCH MED RES, V38, P52, DOI 10.1016/j.arcmed.2006.07.004; Lyon L, 2008, SYNAPSE, V62, P842, DOI 10.1002/syn.20553; Lyon L, 2011, NEUROPSYCHOPHARMACOL, V36, P2616, DOI 10.1038/npp.2011.145; Makoff A, 1996, MOL BRAIN RES, V40, P55, DOI 10.1016/0169-328X(96)00037-X; Manoach DS, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.021.2009; Cid JM, 2012, J MED CHEM, V55, P8770, DOI 10.1021/jm3010724; Martin J, 2001, SCHIZOPHR RES, V47, P77, DOI 10.1016/S0920-9964(00)00029-3; Martin JL, 2005, J PSYCHIATR RES, V39, P251, DOI 10.1016/j.jpsychires.2004.08.011; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Michel S, 2013, EUR J NEUROSCI, V37, P964, DOI 10.1111/ejn.12109; MIKKELSEN JD, 1995, NEUROCHEM INT, V27, P263, DOI 10.1016/0197-0186(95)00039-B; Monti JM, 2013, PROG NEURO-PSYCHOPH, V43, P209, DOI 10.1016/j.pnpbp.2012.12.021; Morrison AR, 2000, BIOL SIGNAL RECEPT, V9, P283; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nathan PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P408, DOI 10.1016/S0893-133X(99)00018-4; Naylor E, 2011, J ELECTROANAL CHEM, V656, P106, DOI 10.1016/j.jelechem.2010.12.031; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; Ohnuma T, 1998, MOL BRAIN RES, V56, P207, DOI 10.1016/S0169-328X(98)00063-1; Oliver PL, 2012, CURR BIOL, V22, P314, DOI 10.1016/j.cub.2011.12.051; Pilorz V, 2009, PHYSIOL BEHAV, V96, P57, DOI 10.1016/j.physbeh.2008.08.010; Pritchett D, 2012, J NEURAL TRANSM, V119, P1061, DOI 10.1007/s00702-012-0817-8; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Saint-Mleux B, 2007, J NEUROSCI, V27, P6412, DOI 10.1523/JNEUROSCI.1432-07.2007; Salt TE, 1998, EXP BRAIN RES, V121, P181, DOI 10.1007/s002210050450; Sanford LD, 2006, NEUROSCIENCE, V141, P2167, DOI 10.1016/j.neuroscience.2006.05.064; Sanford L D, 1998, Sleep Res Online, V1, P109; Sanford LD, 2002, BRAIN RES, V956, P276, DOI 10.1016/S0006-8993(02)03552-7; Sartorius LJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2626, DOI 10.1038/sj.npp.1301669; Schwartz JRL, 2008, CURR NEUROPHARMACOL, V6, P367, DOI 10.2174/157015908787386050; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Sun X, 2001, EUR J NEUROSCI, V14, P1257, DOI 10.1046/j.0953-816x.2001.0001755.x; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tamminga CA, 1998, CRIT REV NEUROBIOL, V12, P21, DOI 10.1615/CritRevNeurobiol.v12.i1-2.20; Tang XD, 2005, SLEEP, V28, P923, DOI 10.1093/sleep/28.8.923; TOMINAGA K, 1994, NEUROREPORT, V5, P1901, DOI 10.1097/00001756-199410000-00015; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Turner JP, 2003, NEUROSCIENCE, V122, P459, DOI 10.1016/j.neuroscience.2003.08.014; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Vinson PN, 2012, NEUROPHARMACOLOGY, V62, P1461, DOI 10.1016/j.neuropharm.2011.05.005; Woltering TJ, 2010, BIOORG MED CHEM LETT, V20, P6969, DOI 10.1016/j.bmcl.2010.09.125; Wright RA, 2013, NEUROPHARMACOLOGY, V66, P89, DOI 10.1016/j.neuropharm.2012.01.019; Wulff K, 2006, CHRONOBIOL INT, V23, P485, DOI 10.1080/07420520500545987; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Wulff K, 2009, CURR OPIN GENET DEV, V19, P237, DOI 10.1016/j.gde.2009.03.007; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Zhang L, 2006, NEUROSCIENCE, V141, P2059, DOI 10.1016/j.neuroscience.2006.05.042	97	24	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125523	10.1371/journal.pone.0125523	http://dx.doi.org/10.1371/journal.pone.0125523			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950516	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400033
J	Amitay, S; Moore, DR; Molloy, K; Halliday, LF				Amitay, Sygal; Moore, David R.; Molloy, Katharine; Halliday, Lorna F.			Feedback Valence Affects Auditory Perceptual Learning Independently of Feedback Probability	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; PERFORMANCE FEEDBACK; REWARD; DOPAMINE; ACTIVATION; MOTIVATION; CORTEX; MEMORY; SIGN	Previous studies have suggested that negative feedback is more effective in driving learning than positive feedback. We investigated the effect on learning of providing varying amounts of negative and positive feedback while listeners attempted to discriminate between three identical tones; an impossible task that nevertheless produces robust learning. Four feedback conditions were compared during training: 90% positive feedback or 10% negative feedback informed the participants that they were doing equally well, while 10% positive or 90% negative feedback informed them they were doing equally badly. In all conditions the feedback was random in relation to the listeners' responses (because the task was to discriminate three identical tones), yet both the valence (negative vs. positive) and the probability of feedback (10% vs. 90%) affected learning. Feedback that informed listeners they were doing badly resulted in better post-training performance than feedback that informed them they were doing well, independent of valence. In addition, positive feedback during training resulted in better post-training performance than negative feedback, but only positive feedback indicating listeners were doing badly on the task resulted in learning. As we have previously speculated, feedback that better reflected the difficulty of the task was more effective in driving learning than feedback that suggested performance was better than it should have been given perceived task difficulty. But contrary to expectations, positive feedback was more effective than negative feedback in driving learning. Feedback thus had two separable effects on learning: feedback valence affected motivation on a subjectively difficult task, and learning occurred only when feedback probability reflected the subjective difficulty. To optimize learning, training programs need to take into consideration both feedback valence and probability.	[Amitay, Sygal; Moore, David R.; Molloy, Katharine] MRC, Inst Hearing Res, Nottingham, England; [Halliday, Lorna F.] UCL, Div Psychol & Language Sci, Dev Sci, London, England	University of London; University College London	Amitay, S (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	sygal@ihr.mrc.ac.uk		Halliday, Lorna/0000-0003-1883-7741; Amitay, Sygal/0000-0001-9482-3435	Medical Research Council, UK [U135097130]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by the Medical Research Council, UK (Grant U135097130; http://www.mrc.ac.uk/), which supported SA, DRM and KM through intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2012, VISION RES, V61, P100, DOI 10.1016/j.visres.2011.12.013; Aberg KC, 2012, J VISION, V12, DOI 10.1167/12.3.3; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Amitay S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068928; Amitay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009816; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BUSS AH, 1956, J EXP PSYCHOL, V52, P283, DOI 10.1037/h0045981; BUSS AH, 1954, J EXP PSYCHOL, V48, P433, DOI 10.1037/h0054709; Cook R, 2009, P NATL ACAD SCI USA, V106, P9530, DOI 10.1073/pnas.0903378106; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dobres J, 2012, J VISION, V12, DOI 10.1167/12.8.9; Elliott R, 1997, NEUROPSYCHOLOGIA, V35, P1395, DOI 10.1016/S0028-3932(97)00055-9; Eppinger B, 2011, J COGNITIVE NEUROSCI, V23, P41, DOI 10.1162/jocn.2009.21364; HARACKIEWICZ JM, 1979, J PERS SOC PSYCHOL, V37, P1352, DOI 10.1037/0022-3514.37.8.1352; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Herzog MH, 1999, VISION RES, V39, P4232, DOI 10.1016/S0042-6989(99)00138-8; Herzog MH, 2006, VISION RES, V46, P3761, DOI 10.1016/j.visres.2006.04.024; Ilgen DR, 2000, APPL PSYCHOL-INT REV, V49, P550, DOI 10.1111/1464-0597.00031; Imai T, 2003, HUM BRAIN MAPP, V18, P260, DOI 10.1002/hbm.10083; Jones PR, J EXP PSYCHOL LEARN; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; KOESTNER R, 1987, J PERS SOC PSYCHOL, V53, P383, DOI 10.1037/0022-3514.53.2.383; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu JJ, 2010, J VISION, V10, DOI 10.1167/10.10.29; Martin RS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00304; MEYER WJ, 1962, J COMP PHYSIOL PSYCH, V55, P532, DOI 10.1037/h0049119; Micheyl C, 2009, ATTEN PERCEPT PSYCHO, V71, P5, DOI 10.3758/APP.71.1.5; Opitz B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00008; PENNEY RK, 1961, J COMP PHYSIOL PSYCH, V54, P449, DOI 10.1037/h0045445; Petrov AA, 2006, VISION RES, V46, P3177, DOI 10.1016/j.visres.2006.03.022; PODSAKOFF PM, 1989, ORGAN BEHAV HUM DEC, V44, P45, DOI 10.1016/0749-5978(89)90034-4; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Sailer U, 2010, BRAIN RES, V1342, P85, DOI 10.1016/j.brainres.2010.04.051; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; Unger K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00186; Van-Dijk D, 2004, APPL PSYCHOL-INT REV, V53, P113, DOI 10.1111/j.1464-0597.2004.00163.x; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Warden CJ, 1927, J COMP PSYCHOL, V7, P117, DOI 10.1037/h0073058; Wenger MJ, 2006, PSYCHON B REV, V13, P656, DOI 10.3758/BF03193977; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wright BA, 1997, J NEUROSCI, V17, P3956; Zaltz Yael, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P241	52	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126412	10.1371/journal.pone.0126412	http://dx.doi.org/10.1371/journal.pone.0126412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946173	Green Submitted, gold, Green Published			2022-12-26	WOS:000354049700128
J	Caballero, S; Duchene, S; Garavito, MF; Slikas, B; Baker, CS				Caballero, Susana; Duchene, Sebastian; Garavito, Manuel F.; Slikas, Beth; Baker, C. Scott			Initial Evidence for Adaptive Selection on the NADH Subunit Two of Freshwater Dolphins by Analyses of Mitochondrial Genomes	PLOS ONE			English	Article							TUCUXI SOTALIA-FLUVIATILIS; COMPLEX I; QUINONE OXIDOREDUCTASE; PHYLOGENETIC ANALYSIS; SWISS-MODEL; OSMOREGULATION; EVOLUTION; MEMBRANE; WHALES; ADAPTATION	A small number of cetaceans have adapted to an entirely freshwater environment, having colonized rivers in Asia and South America from an ancestral origin in the marine environment. This includes the 'river dolphins', early divergence from the odontocete lineage, and two species of true dolphins (Family Delphinidae). Successful adaptation to the freshwater environment may have required increased demands in energy involved in processes such as the mitochondrial osmotic balance. For this reason, riverine odontocetes provide a compelling natural experiment in adaptation of mammals from marine to freshwater habitats. Here we present initial evidence of positive selection in the NADH dehydrogenase subunit 2 of riverine odontocetes by analyses of full mitochondrial genomes, using tests of selection and protein structure modeling. The codon model with highest statistical support corresponds to three discrete categories for amino acid sites, those under positive, neutral, and purifying selection. With this model we found positive selection at site 297 of the NADH dehydrogenase subunit 2 (d(N)/d(S)>1.0,) leading to a substitution of an Ala or Val from the ancestral state of Thr. A phylogenetic reconstruction of 27 cetacean mitogenomes showed that an Ala substitution has evolved at least four times in cetaceans, once or more in the three 'river dolphins' (Families Pontoporidae, Lipotidae and Inidae), once in the riverine Sotalia fluviatilis (but not in its marine sister taxa), once in the riverine Orcaella brevirostris from the Mekong River (but not in its marine sister taxa) and once in two other related marine dolphins. We located the position of this amino acid substitution in an alpha-helix channel in the trans-membrane domain in both the E. coli structure and Sotalia fluviatilis model. In E. coli this position is located in a helix implicated in a proton translocation channel of respiratory complex 1 and may have a similar role in the NADH dehydrogenases of cetaceans.	[Caballero, Susana; Duchene, Sebastian] Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Dept Biol Sci, Bogota, Colombia; [Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Garavito, Manuel F.] Univ Los Andes, Grp Invest Bioquim & Biol Mol Parasitos, Dept Biol Sci, Bogota, Colombia; [Slikas, Beth; Baker, C. Scott] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Slikas, Beth; Baker, C. Scott] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA	Universidad de los Andes (Colombia); University of Sydney; Universidad de los Andes (Colombia); Oregon State University; Oregon State University	Caballero, S (corresponding author), Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Dept Biol Sci, Bogota, Colombia.	sj.caballero26@uniandes.edu.co		Duchene, Sebastian/0000-0002-2863-0907	Universidad de los Andes (Fondo de Capacitacion y Proyecto Profesor Asistente, Facultad de Ciencias); Cetacean Conservation and Genomics Laboratory, Hatfield Marine Science Center	Universidad de los Andes (Fondo de Capacitacion y Proyecto Profesor Asistente, Facultad de Ciencias); Cetacean Conservation and Genomics Laboratory, Hatfield Marine Science Center	Financial support for this work was provided by Universidad de los Andes (Fondo de Capacitacion y Proyecto Profesor Asistente, Facultad de Ciencias), the Cetacean Conservation and Genomics Laboratory, Hatfield Marine Science Center and private funds.	Alexander A, 2013, GENOME BIOL EVOL, V5, P113, DOI 10.1093/gbe/evs126; [Anonymous], 1994, HDB MARINE MAMMALS 1; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Batista AP, 2012, IUBMB LIFE, V64, P492, DOI 10.1002/iub.1050; Beasley I, 2005, MAR MAMMAL SCI, V21, P365, DOI 10.1111/j.1748-7692.2005.tb01239.x; BERTA A, 2006, MARINE MAMMALS EVOLU; Beuchat CA, 1996, AM J PHYSIOL-REG I, V271, pR157, DOI 10.1152/ajpregu.1996.271.1.R157; Bielawski Joseph P, 2013, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1901s101; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Caballero S, 2007, MAR MAMMAL SCI, V23, P358, DOI 10.1111/j.1748-7692.2007.00110.x; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Carr T, 2000, MAR MAMMAL SCI, V16, P447, DOI 10.1111/j.1748-7692.2000.tb00936.x; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; da Silva Vera M.F., 1996, Mammalian Species, V527, P1; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Drummond A., 2011, GENEIOUS V5 5; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FEBRY R, 1987, J EXP BIOL, V128, P63; Finch TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092587; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hrbek T, 2014, PLOS ONE, V9; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marroig G., 1997, J COMP BIOL, V2, P103; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P15; Moparthi VK, 2014, BBA-BIOENERGETICS, V1837, P178, DOI 10.1016/j.bbabio.2013.09.012; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nielsen R, 1998, GENETICS, V148, P929; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1_6; Roberts PG, 2012, J BIOL CHEM, V287, P34743, DOI 10.1074/jbc.M112.384560; Rosas-Rodriguez JA, 2010, LIFE SCI, V87, P515, DOI 10.1016/j.lfs.2010.08.003; Ruiz-Garcia M, 2008, POPULATION GENETICS; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smith BD, 2002, RAFFLES B ZOOL, P173; Tomasco IH, 2011, MOL PHYLOGENETICS EV; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; TUNDISI JG, 1999, AGUAS DOCES BRASIL C, P153; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Vinothkumar K.R., 2014, NATURE; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Whitehead A, 2011, J HERED, V102, P499, DOI 10.1093/jhered/esq077; Whitehead A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-11; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123543	10.1371/journal.pone.0123543	http://dx.doi.org/10.1371/journal.pone.0123543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946045	Green Published, gold			2022-12-26	WOS:000354049700015
J	Hsieh, TJ; Lin, HY; Tu, ZJ; Huang, BS; Wu, SC; Lin, CH				Hsieh, Tung-Ju; Lin, Hsien-Ya; Tu, Zhijay; Huang, Bo-Shun; Wu, Shang-Chuen; Lin, Chun-Hung			Structural Basis Underlying the Binding Preference of Human Galectins-1,-3 and-7 for Gal beta 1-3/4GlcNAc	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; FLUORESCENCE POLARIZATION; RECOGNITION; LECTIN; AFFINITY; LACTOSE; SITE; SPECIFICITY; EXPRESSION; GROWTH	Galectins represent beta-galactoside-binding proteins and are known to bind Gal beta 1-3/4GlcNAc disaccharides (abbreviated as LN1 and LN2, respectively). Despite high sequence and structural homology shared by the carbohydrate recognition domain (CRD) of all galectin members, how each galectin displays different sugar-binding specificity still remains ambiguous. Herein we provided the first structural evidence of human galectins-1, 3-CRD and 7 in complex with LN1. Galectins-1 and 3 were shown to have higher affinity for LN2 than for LN1, while galectin-7 displayed the reversed specificity. In comparison with the previous LN2-complexed structures, the results indicated that the average glycosidic torsion angle of galectin-bound LN1 (psi(LN1) approximate to 135 degrees) was significantly differed from that of galectin-bound LN2 (psi(LN2) approximate to -108 degrees), i.e. the GlcNAc moiety adopted a different orientation to maintain essential interactions. Furthermore, we also identified an Arg-Asp/Glu-Glu-Arg salt-bridge network and the corresponding loop (to position the second Asp/Glu residue) critical for the LN1/2-binding preference.	[Hsieh, Tung-Ju; Lin, Hsien-Ya; Tu, Zhijay; Huang, Bo-Shun; Wu, Shang-Chuen; Lin, Chun-Hung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Chun-Hung] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Lin, Hsien-Ya; Huang, Bo-Shun; Lin, Chun-Hung] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Wu, Shang-Chuen; Lin, Chun-Hung] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Lin, CH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	chunhung@gate.sinica.edu.tw	Wu, Shang-Chuen/ABB-1477-2020; Lin, Chun-Hung/AAM-9711-2021	Wu, Shang-Chuen/0000-0002-5284-5596; Lin, Chun-Hung/0000-0002-6795-8825	Academia Sinica; Ministry of Science and Technology [AS-022316, NSC-103-2113-M-001-023-MY3, NSC-102-2113-M-001001-MY3, NSC-102-2923-M-001001-MY3]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Academia Sinica, and Ministry of Science and Technology grants: AS-022316 (to C.-H. Lin), NSC-103-2113-M-001-023-MY3 (to C.-H. Lin), NSC-102-2113-M-001001-MY3 (to C.-H. Lin), and NSC-102-2923-M-001001-MY3 (to C.-H. Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WM, 1989, BIOCHEM J, V259, P291, DOI 10.1042/bj2590291; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; Bonzi J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7194; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Collins PM, 2007, ACTA CRYSTALLOGR D, V63, P415, DOI 10.1107/S090744490605270X; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Dings RPM, 2012, J MED CHEM, V55, P5121, DOI 10.1021/jm300014q; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Echeverria I, 2011, BIOPHYS J, V100, P2283, DOI 10.1016/j.bpj.2011.03.032; Elantak L, 2012, J BIOL CHEM, V287, P44703, DOI 10.1074/jbc.M112.395152; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng L, 2010, FASEB J, V24, P3861, DOI 10.1096/fj.10-159111; Guardia CMA, 2011, J CHEM INF MODEL, V51, P1918, DOI 10.1021/ci200180h; Hasehira K, 2012, MOL CELL PROTEOMICS, V11, P1913, DOI 10.1074/mcp.M112.020586; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Houzelstein D, 2013, J HISTOCHEM CYTOCHEM, V61, P348, DOI 10.1369/0022155413478612; Munoz FJ, 2010, ORG BIOMOL CHEM, V8, P2986, DOI 10.1039/b927139b; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lohr M, 2007, FOLIA BIOL-PRAGUE, V53, P109; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Mandal TK, 2002, PROTEIN ENG, V15, P979, DOI 10.1093/protein/15.12.979; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Saint-Lu N, 2012, ARTERIOSCL THROM VAS, V32, P894, DOI 10.1161/ATVBAHA.111.240309; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Saraboji K, 2012, BIOCHEMISTRY-US, V51, P296, DOI 10.1021/bi201459p; Schrodinger L., 2020, PYMOL; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; Sorme P, 2003, METHOD ENZYMOL, V362, P504; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tsai CM, 2011, J IMMUNOL, V187, P1643, DOI 10.4049/jimmunol.1100297; Urashima T, 2012, ANIMAL, V6, P369, DOI 10.1017/S1751731111001248; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vidal P, 2013, CHEM-EUR J, V19, P14581, DOI 10.1002/chem.201301244; Wartchow CA, 2011, J COMPUT AID MOL DES, V25, P669, DOI 10.1007/s10822-011-9439-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022	50	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125946	10.1371/journal.pone.0125946	http://dx.doi.org/10.1371/journal.pone.0125946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945972	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700098
J	Fuchs, RT; Sun, ZY; Zhuang, FL; Robb, GB				Fuchs, Ryan T.; Sun, Zhiyi; Zhuang, Fanglei; Robb, G. Brett			Bias in Ligation-Based Small RNA Sequencing Library Construction Is Determined by Adaptor and RNA Structure	PLOS ONE			English	Article							MICRORNAS; IDENTIFICATION; EXPRESSION; MIRBASE; GALAXY	High-throughput sequencing (HTS) has become a powerful tool for the detection of and sequence characterization of microRNAs (miRNA) and other small RNAs (sRNA). Unfortunately, the use of HTS data to determine the relative quantity of different miRNAs in a sample has been shown to be inconsistent with quantitative PCR and Northern Blot results. Several recent studies have concluded that the major contributor to this inconsistency is bias introduced during the construction of sRNA libraries for HTS and that the bias is primarily derived from the adaptor ligation steps, specifically where single stranded adaptors are sequentially ligated to the 3' and 5'-end of sRNAs using T4 RNA ligases. In this study we investigated the effects of ligation bias by using a pool of randomized ligation substrates, defined mixtures of miRNA sequences and several combinations of adaptors in HTS library construction. We show that like the 3' adaptor ligation step, the 5' adaptor ligation is also biased, not because of primary sequence, but instead due to secondary structures of the two ligation substrates. We find that multiple secondary structural factors influence final representation in HTS results. Our results provide insight about the nature of ligation bias and allowed us to design adaptors that reduce ligation bias and produce HTS results that more accurately reflect the actual concentrations of miRNAs in the defined starting material.	[Fuchs, Ryan T.; Sun, Zhiyi; Zhuang, Fanglei; Robb, G. Brett] New England Biolabs Inc, RNA Res Div, Ipswich, MA 01938 USA	New England Biolabs	Robb, GB (corresponding author), New England Biolabs Inc, RNA Res Div, Ipswich, MA 01938 USA.	robb@neb.com		Robb, Gregory Brett/0000-0002-2382-2256; Sun, Zhiyi/0000-0002-6106-5356	New England Biolabs, Inc.	New England Biolabs, Inc.	This research was funded by New England Biolabs, Inc. The funder had no role in experimental design, data collection and analysis, decision to publish or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Jackson TJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-569; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEVITZ R, 1990, EMBO J, V9, P1383, DOI 10.1002/j.1460-2075.1990.tb08253.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; SILBER R, 1972, P NATL ACAD SCI USA, V69, P3009, DOI 10.1073/pnas.69.10.3009; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Sun GH, 2011, RNA, V17, P2256, DOI 10.1261/rna.028621.111; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104; Zhuang FL, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/360358; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909	33	102	104	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126049	10.1371/journal.pone.0126049	http://dx.doi.org/10.1371/journal.pone.0126049			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942392	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943400058
J	Guo, LX; Xu, XM; Liang, FR; Yuan, JP; Peng, J; Wu, CF; Wang, JH				Guo, Lian-Xian; Xu, Xiao-Ming; Liang, Fu-Rui; Yuan, Jian-Ping; Peng, Juan; Wu, Chou-Fei; Wang, Jiang-Hai			Morphological Observations and Fatty Acid Composition of Indoor-Cultivated Cordyceps sinensis at a High-Altitude Laboratory on Sejila Mountain, Tibet	PLOS ONE			English	Article							OPHIOCORDYCEPS-SINENSIS; MEDICINE; FUNGI	Cordyceps sinensis, a caterpillar entomopathogenic fungus-host larva complex, is a rare medicinal herb found in the Qinghai-Tibetan Plateau and its surrounding high-altitude areas. The alternation of generations in the life cycle, whatever the fungus or its host insect, requires special growth conditions. However, it is difficult to simulate the growth conditions of C. sinensis, which hinders its artificial cultivation. In this work, the life cycle from the host larva to C. sinensis was observed in an indoor-cultivation laboratory at 4,200 m a.s.l. on Sejila Mountain, Tibet. Comparative examinations between indoor-cultivated and wild C. sinensisdemonstrated that the indoor-cultivated C. sinensispreferred to germinate multiple long, slim stromata at diverse positions on dead larvae, including but not limited to their heads. Their fatty acid composition shows a significant difference in the levels of polyunsaturated fatty acids (PUFAs). In indoor-cultivated C. sinensis, PUFAs constituted 24.59% and 49.43%, respectively, of neutral and polar lipids; meanwhile, in wild C. sinensis, PUFAs represented 34.34% and 61.25% of neutral and polar lipids, respectively. These observations and fatty acid data suggest that environmental factors, particularly temperature, soil pressure and light intensity, strongly affect the growth of C. sinensis. Our new findings may provide important information for improving techniques for the large-scale artificial cultivation of C. sinensis.	[Guo, Lian-Xian] Guangdong Med Coll, Sch Publ Hlth, Dongguan, Guangdong, Peoples R China; [Guo, Lian-Xian; Xu, Xiao-Ming; Liang, Fu-Rui; Yuan, Jian-Ping; Peng, Juan; Wu, Chou-Fei; Wang, Jiang-Hai] Sun Yat Sen Univ, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Provincial Key Laboratory of Marine Resources & Coastal Engineering; Sun Yat Sen University	Wu, CF (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China.	wuchf3@mail.sysu.edu.cn; wangjhai@mail.sysu.edu.cn	Yuan, Jian-Ping/M-2920-2016; 吴, 酬飞/AAL-7440-2021		Specialized Research Fund for the Doctoral Program of Higher Education [20090171110015]; natural science foundation of China [81303155]; Program for Dongguan Higher Education, Science and Research, and Health Care Institutions [2011108102022]; Guangdong Medical College [B2010011]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); natural science foundation of China(National Natural Science Foundation of China (NSFC)); Program for Dongguan Higher Education, Science and Research, and Health Care Institutions; Guangdong Medical College	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20090171110015), natural science foundation of China (No. 81303155), the Program for Dongguan Higher Education, Science and Research, and Health Care Institutions (No. 2011108102022) and the funding (No. B2010011) from the Guangdong Medical College.	An JM, 2003, J SHANXI TU, V17, P72; Chen D, 2009, SCI CHINA SER D, V52, P655, DOI 10.1007/s11430-009-0068-1; Chen YQ, 2002, PLANTA MED, V68, P635, DOI 10.1055/s-2002-32892; Dong YZ, 2014, PLOS ONE, DOI [10.1371/journal.pone.0109083, DOI 10.1371/J0URNAL.P0NE.0109083]; Guo L., 2012, BIOMEDICINE PREVENTI, V2, P42, DOI [10.1016/j.bionut.2011.07.002, DOI 10.1016/J.BIONUT.2011.07.002]; Guo LX, 2014, FOOD SCI TECH, V30, P52; [何苏琴 He Suqin], 2011, [微生物学通报, Microbiology], V38, P1730; Lei W, 2013, J MICROBIOL, V51, P229, DOI 10.1007/s12275-013-2241-7; Li Jun-Feng, 2011, Huanjing Kunchong Xuebao, V33, P195; Li L, 1993, Zhongguo Zhong Yao Za Zhi, V18, P80; [李明财 LI MingCai], 2008, [生态学报, Acta Ecologica Sinica], V28, P3160; Li WQ, 2014, CHIN HERB MED, V6, P217, DOI 10.1016/S1674-6384(14)60031-9; Li Y, 2011, J MICROBIOL, V49, P913, DOI 10.1007/s12275-011-1193-z; Liang HH, 2008, J MICROBIOL, V46, P549, DOI 10.1007/s12275-008-0107-1; [刘飞 LIU Fei], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P302; Morgan-Kiss RM, 2006, MICROBIOL MOL BIOL R, V70, P222, DOI 10.1128/MMBR.70.1.222-252.2006; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Quan QM, 2014, PLOS ONE, DOI [10.1371/journal.pone.0092293, DOI 10.1371/J0URNAL.P0NE.0092293]; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Shrestha UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106405; Tu Y., 2010, EDIBLE FUNGI CHINA, V29, P24; Weinstein RN, 2000, MYCOLOGIA, V92, P222, DOI 10.2307/3761554; Winkler D, 2008, ECON BOT, V62, P291, DOI 10.1007/s12231-008-9038-3; Xing XK, 2008, MYCOLOGIA, V100, P616, DOI 10.3852/07-007R2; Yang Y.X., 1990, ZOOL RES, V3, P237; Yu Yong-xin, 2004, Journal of Fungal Research, V2, P42; Yue K, 2013, J PHARM PHARMACOL, V65, P474, DOI 10.1111/j.2042-7158.2012.01601.x; Zeng W, 2003, CHONGQING J RES CHIN, V48, P5; Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2; Zhang YongJun, 2001, Journal of Southwest Agricultural University, V23, P144; Zhao J, 2014, J PHARMACEUT BIOMED, V87, P271, DOI 10.1016/j.jpba.2013.04.025; Zhiwen Zou, 2010, Proceedings of the 2010 3rd International Conference on Biomedical Engineering and Informatics (BMEI 2010), P2560, DOI 10.1109/BMEI.2010.5639714; Zhou XW, 2014, CRIT REV BIOTECHNOL, V34, P233, DOI 10.3109/07388551.2013.791245; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zou ZW, 2010, J HUNAN U SCI TECHNO, V25, P114, DOI DOI 10.3969/J.ISSN.1672-9102.2010.01.025	35	16	20	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126095	10.1371/journal.pone.0126095	http://dx.doi.org/10.1371/journal.pone.0126095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938484	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000137
J	Zhang, SH; Poon, E; Xie, DQ; Boheler, KR; Li, RA; Wong, HS				Zhang, Shaohong; Poon, Ellen; Xie, Dongqing; Boheler, Kenneth R.; Li, Ronald A.; Wong, Hau-San			Consensus Comparative Analysis of Human Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; GENE ONTOLOGY; EXPRESSION; CATEGORIES; CLUSTERS; SYSTEM	Global transcriptional analyses have been performed with human embryonic stem cells (hESC) derived cardiomyocytes (CMs) to identify molecules and pathways important for human CM differentiation, but variations in culture and profiling conditions have led to greatly divergent results among different studies. Consensus investigation to identify genes and gene sets enriched in multiple studies is important for revealing differential gene expression intrinsic to human CM differentiation independent of the above variables, but reliable methods of conducting such comparison are lacking. We examined differential gene expression between hESC and hESC-CMs from multiple microarray studies. For single gene analysis, we identified genes that were expressed at increased levels in hESC-CMs in seven data-sets and which have not been previously highlighted. For gene set analysis, we developed a new algorithm, consensus comparative analysis (CSSCMP), capable of evaluating enrichment of gene sets from heterogeneous data sources. Based on both theoretical analysis and experimental validation, CSSCMP is more efficient and less susceptible to experimental variations than traditional methods. We applied CSSCMP to hESC-CM microarray data and revealed novel gene set enrichment (e.g., glucocorticoid stimulus), and also identified genes that might mediate this response. Our results provide important molecular information intrinsic to hESC-CM differentiation. Data and Matlab codes can be downloaded from S1 Data.	[Zhang, Shaohong; Xie, Dongqing] Guangzhou Univ, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China; [Poon, Ellen; Boheler, Kenneth R.; Li, Ronald A.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China; [Wong, Hau-San] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China	Guangzhou University; University of Hong Kong; City University of Hong Kong	Wong, HS (corresponding author), City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China.	cshswong@cityu.edu.hk	Poon, Ellen/ABD-6962-2020	Poon, Ellen/0000-0002-9280-3681; WONG, Hau-San/0000-0002-1530-7529	Research Grant Council of HKSAR [T13-706/11, HKU772913, HKU17113514]; National Natural Science Foundation of China [61202273]; Department of Education in Guangdong province [2013KJCX0144]; Construction Program of Key laboratory of Guangzhou Municipal Bureau of Science and Technology [2014SY000022]; Outstanding Young Teachers in Higher Education Institutions of Guangdong Province [Guangzhou University] [Yq201401]; Guangzhou Education Bureau [1201410760]; City University of Hong Kong [7004220]	Research Grant Council of HKSAR(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education in Guangdong province; Construction Program of Key laboratory of Guangzhou Municipal Bureau of Science and Technology; Outstanding Young Teachers in Higher Education Institutions of Guangdong Province [Guangzhou University]; Guangzhou Education Bureau; City University of Hong Kong(City University of Hong Kong)	The work described in this paper was partially supported by grants from the Research Grant Council of HKSAR [Project No. T13-706/11, HKU772913 and HKU17113514], National Natural Science Foundation of China [Project No. 61202273], Department of Education in Guangdong province [Project No. 2013KJCX0144], Construction Program of Key laboratory of Guangzhou Municipal Bureau of Science and Technology [Project No. 2014SY000022], from the funding of Outstanding Young Teachers in Higher Education Institutions of Guangdong Province [Project No. Yq201401, Guangzhou University], research project of Guangzhou Education Bureau [Project No. 1201410760], and City University of Hong Kong [Project No. 7004220]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Khodiyar VK, 2011, DEV BIOL, V354, P9, DOI 10.1016/j.ydbio.2011.03.011; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moore JC, 2008, BIOCHEM BIOPH RES CO, V372, P553, DOI 10.1016/j.bbrc.2008.05.076; Poon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077784; Qin M, 2012, J MOL CELL CARDIOL, V53, P880, DOI 10.1016/j.yjmcc.2012.10.003; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Synnergren J., 2011, METHODOLOGICAL ADV C; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Synnergren J, 2012, PHYSIOL GENOMICS, V44, P245, DOI 10.1152/physiolgenomics.00118.2011; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Vinh N.X., 2009, ICML; Wei TC, 2011, GENE EXPR PATTERNS, V11, P384, DOI 10.1016/j.gep.2011.05.001; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang SH, 2012, IEEE ACM T COMPUT BI, V9, P1257, DOI 10.1109/TCBB.2012.34; Zhang SH, 2012, PATTERN RECOGN, V45, P2214, DOI 10.1016/j.patcog.2011.11.017; Zhou YP, 2011, CELL MOL LIFE SCI, V68, P4033, DOI 10.1007/s00018-011-0787-2	30	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125442	10.1371/journal.pone.0125442	http://dx.doi.org/10.1371/journal.pone.0125442			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938587	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000069
J	Jackson, HM; Onos, KD; Pepper, KW; Graham, LC; Akeson, EC; Byers, C; Reinholdt, LG; Frankel, WN; Howell, GR				Jackson, Harriet M.; Onos, Kristen D.; Pepper, Keating W.; Graham, Leah C.; Akeson, Ellen C.; Byers, Candice; Reinholdt, Laura G.; Frankel, Wayne N.; Howell, Gareth R.			DBA/2J Genetic Background Exacerbates Spontaneous Lethal Seizures but Lessens Amyloid Deposition in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; PRECURSOR PROTEIN; CELL-DEATH; DISTAL CHROMOSOME-1; ALPHA-SECRETASE; MICE; NEURODEGENERATION; STRAINS; SYSTEM; SUSCEPTIBILITY	Alzheimer's disease (AD) is a leading cause of dementia in the elderly and is characterized by amyloid plaques, neurofibrillary tangles (NFTs) and neuronal dysfunction. Early onset AD (EOAD) is commonly caused by mutations in amyloid precursor protein (APP) or genes involved in the processing of APP including the presenilins (e.g. PSEN1 or PSEN2). In general, mouse models relevant to EOAD recapitulate amyloidosis, show only limited amounts of NFTs and neuronal cell dysfunction and low but significant levels of seizure susceptibility. To investigate the effect of genetic background on these phenotypes, we generated APP(swe) and PSEN1(de9) transgenic mice on the seizure prone inbred strain background, DBA/2J. Previous studies show that the DBA/2J genetic background modifies plaque deposition in the presence of mutant APP but the impact of PSEN1(de9) has not been tested. Our study shows that DBA/2J. APP(swe)PSEN1(de9) mice are significantly more prone to premature lethality, likely to due to lethal seizures, compared to B6. APP(swe)PSEN1(de9) mice-70% of DBA/2J. APP(swe)PSEN1(de9) mice die between 2-3 months of age. Of the DBA/2J. APP(swe)PSEN1(de9) mice that survived to 6 months of age, plaque deposition was greatly reduced compared to age-matched B6. APP(swe)PSEN1(de9) mice. The reduction in plaque deposition appears to be independent of microglia numbers, reactive astrocytosis and complement C5 activity.	[Jackson, Harriet M.; Onos, Kristen D.; Pepper, Keating W.; Graham, Leah C.; Akeson, Ellen C.; Byers, Candice; Reinholdt, Laura G.; Frankel, Wayne N.; Howell, Gareth R.] Jackson Lab, Bar Harbor, ME 04609 USA; [Graham, Leah C.; Howell, Gareth R.] Tufts Univ, Sackler Sch Med, Boston, MA 02111 USA	Jackson Laboratory; Tufts University	Howell, GR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	gareth.howell@jax.org	Jackson, Harriet/HGT-8937-2022	Onos, Kristen/0000-0001-6443-6557; Byers, Candice/0000-0003-2526-2843	NIH [EY021525]; Jane B. Cook Charitable Trust; NATIONAL EYE INSTITUTE [R01EY021525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane B. Cook Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH EY021525 (G.R.H.) and the Jane B. Cook 1983 Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; [Anonymous], 1984, METHODS AND FINDINGS, V6, P531; Bessaih T, 2012, EPILEPSIA, V53, P1429, DOI 10.1111/j.1528-1167.2012.03512.x; Bubier JA, 2012, NEUROTHERAPEUTICS, V9, P338, DOI 10.1007/s13311-012-0111-3; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cowley TR, 2013, NEUROCHEM RES, V38, P1190, DOI 10.1007/s11064-012-0884-0; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Ferraro TN, 2001, GENOMICS, V75, P35, DOI 10.1006/geno.2001.6577; Frankel WN, 2009, TRENDS GENET, V25, P361, DOI 10.1016/j.tig.2009.07.001; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Grundman M, 2013, J NUTR HEALTH AGING, V17, P51, DOI 10.1007/s12603-013-0002-2; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; Howell GR, 2008, PROG BRAIN RES, V173, P303, DOI 10.1016/S0079-6123(08)01122-9; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Menendez M, 2005, BRAIN DEV-JPN, V27, P246, DOI 10.1016/j.braindev.2004.07.008; Morihara T, 2014, P NATL ACAD SCI USA, V111, P2638, DOI 10.1073/pnas.1307345111; Mukherjee P, 2000, J NEUROIMMUNOL, V105, P124, DOI 10.1016/S0165-5728(99)00261-1; Nilsson UR, 1967, THE JOURNAL OF EXPER, V125, P1; Norton S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; OOI YM, 1979, NATURE, V282, P207, DOI 10.1038/282207a0; Osaka H, 1999, NEUROSCIENCE, V88, P1073, DOI 10.1016/S0306-4522(98)00372-8; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Pasinetti GM, 1996, NEUROBIOL DIS, V3, P197, DOI 10.1006/nbdi.1996.0020; Ramaglia V, 2007, J NEUROSCI, V27, P7663, DOI 10.1523/JNEUROSCI.5623-06.2007; Ryman D, 2008, NEUROBIOL AGING, V29, P1190, DOI 10.1016/j.neurobiolaging.2007.02.017; Ryman Davis, 2006, Current Alzheimer Research, V3, P465, DOI 10.2174/156720506779025198; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Scharfman HE, 2012, EPILEPSY CURR, V12, P178, DOI 10.5698/1535-7511-12.5.178; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Srivastava A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-367; Sun WZ, 2013, J PHYSIOL-LONDON, V591, P241, DOI 10.1113/jphysiol.2012.240168; Turner JG, 1998, HEARING RES, V118, P101, DOI 10.1016/S0378-5955(98)00024-0; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Wang Xiao-lin, 2009, Fudan Xuebao (Yixueban), V36, P79; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282; Wolff D, 2005, THE PRINCIPLES OF CL, P455; Xing SQ, 2009, AM J PHYSIOL-HEART C, V296, pH1907, DOI 10.1152/ajpheart.00681.2008	59	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125897	10.1371/journal.pone.0125897	http://dx.doi.org/10.1371/journal.pone.0125897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933409	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100140
J	An, HZ; Hu, M; Li, PF; Geng, GD; Zhang, QQ; Zhang, SQ				An, Hongzhou; Hu, Mei; Li, Pengfei; Geng, Guangdong; Zhang, Qingqin; Zhang, Suqin			Chromosomal Behavior during Meiosis in the Progeny of Triticum timopheevii x Hexaploid Wild Oat	PLOS ONE			English	Article							AVENA-SATIVA L; CYTOGENETIC ANALYSIS; WHEAT; AESTIVUM; HYBRIDS; ELYMUS; INHERITANCE; RESISTANCE; RUST; HYBRIDIZATION	The meiotic behavior of pollen mother cells (PMCs) of the F-2 and F-3 progeny from Triticum timopheevii x hexaploid wild oat was investigated by cytological analysis and sequential C-banding-genomic in situ hybridization (GISH) in the present study. A cytological analysis showed that the chromosome numbers of the F-2 and F-3 progeny ranged from 28 to 41. A large number of univalents, lagging chromosomes, chromosome bridges and micronuclei were found at the metaphase I, anaphase I, anaphase II and tetrad stages in the F-2 and F-3 progeny. The averages of univalents were 3.50 and 2.73 per cell, and those of lagging chromosomes were 3.37 and 1.87 in the F-2 and F-3 progeny, respectively. The PMC meiotic indices of the F-2 and F-3 progeny were 12.22 and 20.34, respectively, indicating considerable genetic instability. A sequential C-banding-GISH analysis revealed that some chromosomes and fragments from the hexaploid wild oat were detected at metaphase I and anaphase I in the progeny, showing that the progeny were of true intergeneric hybrid origin. The alien chromosomes 6A, 7A, 3C and 2D were lost during transmission from F-2 to F-3. In addition, partial T. timopheevii chromosomes appeared in the form of univalents or lagging chromosomes, which might result from large genome differences between the parents, and the wild oat chromosome introgression interfered with the wheat homologues' normally pairing.	[An, Hongzhou; Hu, Mei; Li, Pengfei; Geng, Guangdong; Zhang, Qingqin; Zhang, Suqin] Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China; [An, Hongzhou; Hu, Mei; Li, Pengfei; Zhang, Qingqin; Zhang, Suqin] Natl Wheat Improvement Ctr, Guizhou Subctr, Guiyang, Guizhou, Peoples R China	Guizhou University	Zhang, SQ (corresponding author), Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China.	zsqin2002@163.com			National Natural Science Foundation of China [31160224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	31160224, National Natural Science Foundation of China (http://www.nsfc.gov.cn/), SZ. The funding has supported data collection and analysis, decision to publish, and preparation of the manuscript.	Backhouse WO, 1916, J GENET, V6, P91, DOI 10.1007/BF02981869; BADAEVA ED, 1991, THEOR APPL GENET, V82, P227, DOI 10.1007/BF00226218; BADAEVA ED, 1986, PLANT SYST EVOL, V154, P183, DOI 10.1007/BF00990122; Badaeva ED, 2000, RUSS J GENET+, V36, P1401, DOI 10.1023/A:1009019323942; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; COX TS, 1985, CROP SCI, V25, P106, DOI 10.2135/cropsci1985.0011183X002500010027x; DVORAK J, 1984, CAN J GENET CYTOL, V26, P128; FINCH RA, 1980, HEREDITY, V44, P201, DOI 10.1038/hdy.1980.17; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Gernand D, 2005, PLANT CELL, V17, P2431, DOI 10.1105/tpc.105.034249; GUPTA SB, 1969, CAN J GENET CYTOL, V11, P133, DOI 10.1139/g69-017; Herrmann M, 1996, EUPHYTICA, V89, P405; HUTCHINSON J, 1982, THEOR APPL GENET, V64, P31, DOI 10.1007/BF00303647; Islam AKMR, 1975, P 3 INT BARL GEN S, P260; JELLEN EN, 1993, GENOME, V36, P1129, DOI 10.1139/g93-151; Kashkush K, 2002, GENETICS, V160, P1651; KIHARA H., 1929, CYTOLOGIA [TOKYO], V1, P1; KNOTT DR, 1968, CAN J GENET CYTOL, V10, P695, DOI 10.1139/g68-087; KONAREV AV, 1981, THEOR APPL GENET, V59, P117, DOI 10.1007/BF00285901; LAURIE DA, 1987, THEOR APPL GENET, V73, P403, DOI 10.1007/BF00262508; Le HT, 1989, PLANT MOL BIO REP, V7, P150, DOI DOI 10.1007/BF02669631; Leighty CE, 1927, J HERED, V18, P433, DOI 10.1093/oxfordjournals.jhered.a102767; LIMIN AE, 1990, GENOME, V33, P581, DOI 10.1139/g90-085; LINARES C, 1992, THEOR APPL GENET, V83, P650, DOI 10.1007/BF00226911; LUBY JJ, 1985, THEOR APPL GENET, V69, P367, DOI 10.1007/BF00570904; MASLOVA MA, 1986, GENETIKA+, V22, P282; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MUJEEB KA, 1978, J HERED, V69, P179, DOI 10.1093/oxfordjournals.jhered.a108920; Muramatsu M, 1983, P 6 INT WHEAT GEN S, P1041; Oehler E, 1935, MOLECULAR AND GENERA, V68, P187; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PLOURDE A, 1989, THEOR APPL GENET, V78, P436, DOI 10.1007/BF00265309; RILEY R, 1967, GENET RES, V9, P259, DOI 10.1017/S0016672300010569; SADASIVAIAH RS, 1981, CAN J GENET CYTOL, V23, P131, DOI 10.1139/g81-015; SAPRA VT, 1973, CROP SCI, V13, P301, DOI 10.2135/cropsci1973.0011183X001300030004x; SHARMA HC, 1983, EUPHYTICA, V32, P17, DOI 10.1007/BF00036860; SHARMA HC, 1986, THEOR APPL GENET, V71, P750, DOI 10.1007/BF00263274; Suenaga K., 1994, Bulletin of the National Institute of Agrobiological Resources, P83; SUNESON CA, 1967, CROP SCI, V7, P168; TSITSIN NV, 1965, EUPHYTICA, V14, P326, DOI 10.1007/BF00149519; Wakar BA, 1934, THEOR APPL GENET, V6, P211; Wan Y, 2002, THEOR APPL GENET, V104, P828, DOI 10.1007/s00122-001-0793-0; Wang XE, 2001, THEOR APPL GENET, V102, P651, DOI 10.1007/s001220051693; Weigel R, 1995, THEOR APPL GENET, V91, P1237, DOI 10.1007/BF00220934; Wilson S, 1873, T BOT SOC EDINBURGH, V12, P286, DOI [10.1080/03746607309469536, DOI 10.1080/03746607309469536]; Xie Q, 2013, GENET MOL RES, V12, P2537, DOI 10.4238/2013.January.4.16; YAMAMORI M, 1994, THEOR APPL GENET, V89, P643, DOI 10.1007/BF00222461; YEN ST, 1977, CAN J GENET CYTOL, V19, P739, DOI 10.1139/g77-080; Zheng HM, 2013, THESIS; Zheng Z., 2009, THESIS	50	5	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126398	10.1371/journal.pone.0126398	http://dx.doi.org/10.1371/journal.pone.0126398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950431	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400087
J	Cukic, I; Bates, TC				Cukic, Iva; Bates, Timothy C.			The Association between Neuroticism and Heart Rate Variability Is Not Fully Explained by Cardiovascular Disease and Depression	PLOS ONE			English	Article							CARDIAC VAGAL TONE; MYOCARDIAL-INFARCTION; RISK-FACTORS; UK HEALTH; MORTALITY; ANXIETY; DISORDERS; PERSONALITY; AGE	Neuroticism is associated with cardiovascular disease, autonomic reactivity, and depression. Here we address the extent to which neuroticism accounts for the excess heart disease risk associated with depression and test whether cardiac autonomic tone plays a role as mediator. Subjects were derived from a nationally representative sample (n = 1,255: mean age 54.5, SD = 11.5). Higher neuroticism was associated with reduced heart rate variability equally under rest and stress. The baseline structural equation model revealed significant paths from neuroticism to heart rate variability, cardiovascular disease and depression, and between depression and cardiovascular disease, controlling for age, sex, height, weight, and BMI. Dropping both the neuroticism to heart rate variability, and neuroticism to heart disease paths significantly reduced the model fit (p < .001 in each case). We conclude that neuroticism has independent associations with both autonomic reactivity and cardiovascular disease, over and above its associations with depression and other related variables.				icukic@staffmail.ed.ac.uk; tim.bates@ed.ac.uk	Bates, Timothy C/C-9637-2010; Cukic, Iva/HGE-8252-2022	Bates, Timothy C/0000-0002-1153-9007; Cukic, Iva/0000-0002-2010-1648	John D. and Catherine T. Mac-Arthur Foundation Research Network on Successful Midlife Development; National Institute on Aging [P01-AG020166]; General Clinical Research Centers Program [M01-RR023942, M01-RR00865]; Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, M01RR000865, M01RR023942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG051426, P01AG020166] Funding Source: NIH RePORTER	John D. and Catherine T. Mac-Arthur Foundation Research Network on Successful Midlife Development; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The MIDUS I study (Midlife in the U.S.) was supported by the John D. and Catherine T. Mac-Arthur Foundation Research Network on Successful Midlife Development. The MIDUS II research was supported by a grant from the National Institute on Aging (P01-AG020166) to conduct a longitudinal follow-up of the MIDUS I investigation.; The research was further supported by the following grants M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program and 1UL1RR025011 (UW) from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health.	Aberg MAI, 2012, BRIT J PSYCHIAT, V201, P352, DOI 10.1192/bjp.bp.111.103416; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Berntson GG, 2004, DYNAMIC ELECTROCARDIOGRAPHY, P57, DOI 10.1002/9780470987483.ch7; BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; BOOTSMA M, 1994, AM J PHYSIOL, V266, pH1565, DOI 10.1152/ajpheart.1994.266.4.H1565; Brim OG, 2004, HOW HEALTHY ARE WE A; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Camm AJ, 1996, CIRCULATION, V93, P1043; CARNEY RM, 1995, AM J CARDIOL, V76, P562, DOI 10.1016/S0002-9149(99)80155-6; de Jonge P, 2012, BRIT J PSYCHIAT, V201, P337, DOI 10.1192/bjp.bp.112.110502; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; DYKES FD, 1986, PEDIATR RES, V20, P301, DOI 10.1203/00006450-198604000-00005; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Eysenck HJ, 1990, BIOLOGICAL DIMENSION; GROSSMAN P, 1993, PSYCHOPHYSIOLOGY, V30, P486, DOI 10.1111/j.1469-8986.1993.tb02072.x; Hagger-Johnson G, 2012, PSYCHOSOM MED, V74, P596, DOI 10.1097/PSY.0b013e31825c85ca; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; Jokela M, 2014, J BEHAV MED, V37, P881, DOI 10.1007/s10865-013-9548-z; Keltikangas-Jarvinen L, 2008, THE REINFORCEMENT SE; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Koelsch S, 2007, EUR J NEUROSCI, V26, P3328, DOI 10.1111/j.1460-9568.2007.05889.x; Koelsch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031441; KOLLAI M, 1992, BRIT J PSYCHIAT, V161, P831, DOI 10.1192/bjp.161.6.831; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Love GD, 2010, J AGING HEALTH, V22, P1059, DOI 10.1177/0898264310374355; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Nakaya N, 2005, CLIN EXP HYPERTENS, V27, P297, DOI 10.1081/CEH-200048930; Neale MC, 1999, STATISTICAL MODELING; Ori Z, 1992, Cardiol Clin, V10, P499; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; R. Core Team, 2015, R A LANGUAGE AND ENV; RECHLIN T, 1994, J AFFECT DISORDERS, V32, P271, DOI 10.1016/0165-0327(94)90091-4; Riese H, 2009, J PERS, V77, P1561, DOI 10.1111/j.1467-6494.2009.00592.x; Rottenberg J, 2007, BIOL PSYCHOL, V74, P200, DOI 10.1016/j.biopsycho.2005.08.010; Schwartz AR, 2003, PSYCHOSOM MED, V65, P22, DOI 10.1097/01.PSY.0000046075.79922.61; Shipley BA, 2007, PSYCHOSOM MED, V69, P923, DOI 10.1097/PSY.0b013e31815abf83; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Tulen JHM, 1996, J AFFECT DISORDERS, V40, P61, DOI 10.1016/0165-0327(96)00042-0; TURNER JR, 1987, INT J PSYCHOPHYSIOL, V5, P301, DOI 10.1016/0167-8760(87)90061-4; TURNER JR, 1986, INT J PSYCHOPHYSIOL, V3, P307, DOI 10.1016/0167-8760(86)90039-5; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1	56	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125882	10.1371/journal.pone.0125882	http://dx.doi.org/10.1371/journal.pone.0125882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH7KF	25951236	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400052
J	Fagnocchi, L; Bottini, S; Golfieri, G; Fantappie, L; Ferlicca, F; Antunes, A; Guadagnuolo, S; Del Tordello, E; Siena, E; Serruto, D; Scarlato, V; Muzzi, A; Delany, I				Fagnocchi, Luca; Bottini, Silvia; Golfieri, Giacomo; Fantappie, Laura; Ferlicca, Francesca; Antunes, Ana; Guadagnuolo, Serafina; Del Tordello, Elena; Siena, Emilio; Serruto, Davide; Scarlato, Vincenzo; Muzzi, Alessandro; Delany, Isabel			Global Transcriptome Analysis Reveals Small RNAs Affecting Neisseria meningitidis Bacteremia	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; REGULATORY RNAS; CATABOLITE REPRESSION; POSITIVE REGULATION; MOLECULAR-BIOLOGY; GENE-EXPRESSION; CHAPERONE HFQ; VIRULENCE; BINDING; MECHANISM	Most bacterial small RNAs (sRNAs) are post-transcriptional regulators involved in adaptive responses, controlling gene expression by modulating translation or stability of their target mRNAs often in concert with the RNA chaperone Hfq. Neisseria meningitides, the leading cause of bacterial meningitis, is able to adapt to different host niches during human infection. However, only a few sRNAs and their functions have been fully described to date. Recently, transcriptional expression profiling of N. meningitides in human blood ex vivo revealed 91 differentially expressed putative sRNAs. Here we expanded this analysis by performing a global transcriptome study after exposure of N. meningitides to physiologically relevant stress signals (e.g. heat shock, oxidative stress, iron and carbon source limitation). and we identified putative sRNAs that were differentially expressed in vitro. A set of 98 putative sRNAs was obtained by analyzing transcriptome data and 8 new sRNAs were validated, both by Northern blot and by primer extension techniques. Deletion of selected sRNAs caused attenuation of N. meningitides infection in the in vivo infant rat model, leading to the identification of the first sRNAs influencing meningococcal bacteremia. Further analysis indicated that one of the sRNAs affecting bacteremia responded to carbon source availability through repression by a GntR-like transcriptional regulator. Both the sRNA and the GntR-like regulator are implicated in the control of gene expression from a common network involved in energy metabolism.	[Fagnocchi, Luca; Bottini, Silvia; Golfieri, Giacomo; Fantappie, Laura; Ferlicca, Francesca; Antunes, Ana; Guadagnuolo, Serafina; Del Tordello, Elena; Siena, Emilio; Serruto, Davide; Muzzi, Alessandro; Delany, Isabel] Novartis Vaccines & Diagnot, Siena, Italy; [Scarlato, Vincenzo] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of Bologna	Delany, I (corresponding author), GlaxoSmithKline, Siena, Italy.	isabel.x.delany@gsk.com	Fagnocchi, Luca/M-2715-2017; Scarlato, Vincenzo/B-8558-2019	Fagnocchi, Luca/0000-0002-9551-5474; Scarlato, Vincenzo/0000-0003-4227-677X	Novartis fellowship from the Ph.D. program in Functional Biology of Molecular and Cellular Systems of the University of Bologna; Novartis fellowship from the Ph.D. program of the University of Siena; Novartis	Novartis fellowship from the Ph.D. program in Functional Biology of Molecular and Cellular Systems of the University of Bologna; Novartis fellowship from the Ph.D. program of the University of Siena; Novartis(Novartis)	L. Fagnocchi, GG and SG are recipients of a Novartis fellowship from the Ph.D. program in Functional Biology of Molecular and Cellular Systems of the University of Bologna. SB is recipient of a Novartis fellowship from the Ph.D. program of the University of Siena. The authors FF, EDT, ES, DS, AM, and ID are employed by the funding organization, Novartis, that provided support in the form of salaries for said authors and fellowships associated with the universities. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Barriere C, 2005, J BACTERIOL, V187, P3752, DOI 10.1128/JB.187.11.3752-3761.2005; Beisel CL, 2012, EMBO J, V31, P1961, DOI 10.1038/emboj.2012.52; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Campos E, 2004, J BACTERIOL, V186, P1720, DOI 10.1128/JB.186.6.1720-1728.2004; Catenazzi MCE, 2014, MOL MICROBIOL, V93, P346, DOI 10.1111/mmi.12664; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Del Tordello E, 2012, J BACTERIOL, V194, P6217, DOI 10.1128/JB.01055-12; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Fagnocchi L, 2012, J BACTERIOL, V194, P460, DOI 10.1128/JB.06161-11; Fantappie L, 2011, MOL MICROBIOL, V80, P507, DOI 10.1111/j.1365-2958.2011.07592.x; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Geissmann T, 2006, HANDB EXP PHARM, V173, P9; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Hopkins JF, 2011, NUCLEIC ACIDS RES, V39, P5193, DOI 10.1093/nar/gkr062; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koeberling O, 2011, CLIN VACCINE IMMUNOL, V18, P736, DOI 10.1128/CVI.00542-10; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Leyn SA, 2011, J BIOL CHEM, V286, P35782, DOI 10.1074/jbc.M111.267963; Loh E, 2013, NATURE, V502, P237, DOI 10.1038/nature12616; LU Z, 1989, NUCLEIC ACIDS RES, V17, P4883, DOI 10.1093/nar/17.12.4883; Lucchetti R, 2010, COMPUT OPER RES, V37, P1406, DOI 10.1016/j.cor.2009.02.020; Maki K, 2010, MOL MICROBIOL, V76, P782, DOI 10.1111/j.1365-2958.2010.07141.x; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Metruccio MME, 2009, J BACTERIOL, V191, P1330, DOI 10.1128/JB.00849-08; Moretti S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-361; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Park JM, 2012, GENE, V504, P116, DOI 10.1016/j.gene.2012.04.074; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schielke S, 2011, INT J MED MICROBIOL, V301, P325, DOI 10.1016/j.ijmm.2010.11.007; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Smith H, 2001, INFECT IMMUN, V69, P6565, DOI 10.1128/IAI.69.11.6565-6572.2001; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; TAYLOR DE, 1988, ANN INST PASTEUR MIC, V139, P665, DOI 10.1016/0769-2609(88)90071-3; Tinsley C, 2001, CURR OPIN MICROBIOL, V4, P47, DOI 10.1016/S1369-5274(00)00163-6; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; VALENTINHANSEN P, 1985, NUCLEIC ACIDS RES, V13, P5927, DOI 10.1093/nar/13.16.5927; Vanderpool CK, 2011, BIOCHIMIE, V93, P1943, DOI 10.1016/j.biochi.2011.07.016; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; VANROOIJEN RJ, 1990, J BIOL CHEM, V265, P18499; Veld RAGHI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029002; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; VONBODMAN SB, 1992, P NATL ACAD SCI USA, V89, P643, DOI 10.1073/pnas.89.2.643; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; YAMADA M, 1988, J MOL BIOL, V203, P569, DOI 10.1016/0022-2836(88)90193-3; Yoshida K, 1995, DNA Res, V2, P61, DOI 10.1093/dnares/2.2.61; Zeng G, 1996, J BACTERIOL, V178, P7080, DOI 10.1128/jb.178.24.7080-7089.1996; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhou YX, 2011, J CELL PHYSIOL, V226, P968, DOI 10.1002/jcp.22483	85	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126325	10.1371/journal.pone.0126325	http://dx.doi.org/10.1371/journal.pone.0126325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951061	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400080
J	Sullivan, DJ; Liu, Y; Mott, BT; Kaludov, N; Martinov, MN				Sullivan, David J.; Liu, Yi; Mott, Bryan T.; Kaludov, Nikola; Martinov, Martin N.			Discovery of Novel Liver-Stage Antimalarials through Quantum Similarity	PLOS ONE			English	Article							MOLECULAR-INTERACTIONS; CETHROMYCIN; POTENT; DRUG	Without quantum theory any understanding of molecular interactions is incomplete. In principal, chemistry, and even biology, can be fully derived from non-relativistic quantum mechanics. In practice, conventional quantum chemical calculations are computationally too intensive and time consuming to be useful for drug discovery on more than a limited basis. A previously described, original, quantum-based computational process for drug discovery and design bridges this gap between theory and practice, and allows the application of quantum methods to large-scale in silico identification of active compounds. Here, we show the results of this quantum-similarity approach applied to the discovery of novel liver-stage antimalarials. Testing of only five of the model-predicted compounds in vitro and in vivo hepatic stage drug inhibition assays with P. berghei identified four novel chemical structures representing three separate quantum classes of liver-stage antimalarials. All four compounds inhibited liver-stage Plasmodium as a single oral dose in the quantitative PCR mouse liver-stage sporozoites-challenge model. One of the newly identified compounds, cethromycin [ABT-773], a macrolide-quinoline hybrid, is a drug with an extensive (over 5,000 people) safety profile warranting its exploitation as a new weapon for the current effort of malaria eradication. The results of our molecular modeling exceed current state-of-the-art computational methods. Drug discovery through quantum similarity is data-driven, agnostic to any particular target or disease process that can evaluate multiple phenotypic, target-specific, or co-crystal structural data. This allows the incorporation of additional pharmacological requirements, as well as rapid exploration of novel chemical spaces for therapeutic applications.	[Sullivan, David J.; Liu, Yi] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Micorbiol & Immunol, Baltimore, MD 21205 USA; [Mott, Bryan T.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Kaludov, Nikola; Martinov, Martin N.] Gradient Biomodeling LLC, Park City, UT USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Sullivan, DJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Micorbiol & Immunol, Baltimore, MD 21205 USA.	dsulliv7@jhmi.edu; martinov.mn@gradientbiomodeling.com		Mott, Bryan/0000-0002-1912-6362	Bill & Melinda Gates Foundation [OPP1069420]; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Gradient Biomodeling LLC	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Gradient Biomodeling LLC	Funding: The research was supported by the Bill & Melinda Gates Foundation round 9 Grand Challenges Explorations award (OPP1069420) to DJS and MNM. DJS also acknowledges support from the Johns Hopkins Malaria Research Institute and The Bloomberg Family Foundation. Gradient Biomodeling LLC provided support in the form of salaries for authors NK and MM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	[Anonymous], 2007, Drugs R D, V8, P95; Breneman C, 1996, USE ELECTROSTATIC PO; Carbo R, 2001, FUNDAMENTALS MOL SIM; CIOSLOWSKI J, 1993, J PHYS CHEM-US, V97, P10948, DOI 10.1021/j100144a008; Cioslowski J, 1996, J PHYS CHEM-US, V100, P6156, DOI 10.1021/jp952814l; CIOSLOWSKI J, 1994, J CHEM PHYS, V101, P366, DOI 10.1063/1.468143; da Cruz FP, 2012, J INFECT DIS, V205, P1278, DOI 10.1093/infdis/jis184; Derbyshire ER, 2012, P NATL ACAD SCI USA, V109, P8511, DOI 10.1073/pnas.1118370109; Deza M. M., 2009, ENCY DISTANCES; English ML, 2012, ANTIMICROB AGENTS CH, V56, P2037, DOI 10.1128/AAC.05596-11; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Gershenfeld N., 1999, NATURE MATH MODELING; GLENDENING ED, 1994, J CHEM PHYS, V100, P2900, DOI 10.1063/1.466432; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Liapikou A, 2014, NEW ANTIMICROBIAL AP; Mahmoudi N, 2008, ANTIMICROB AGENTS CH, V52, P1215, DOI 10.1128/AAC.01043-07; Mansour H, 2013, ANN PHARMACOTHER, V47, P368, DOI 10.1345/aph.1R435; Martin YC, 2010, QUANTITATIVE DRUG DESIGN: A CRITICAL INTRODUCTION, SECOND EDITION, P1, DOI 10.1201/9781420071009-f; MARTINOV M, 1995, MOL PHYS, V85, P121, DOI 10.1080/00268979500100981; Matta C. F., 2007, QUANTUM THEORY ATOMS; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Mulliken RS, 1965, J CHEM PHYS, V43; Parr R. G., 1989, DENSITY FUNCTIONAL T; Plata DJ, 2004, TETRAHEDRON, V60, P10171, DOI 10.1016/j.tet.2004.09.027; Rafie S, 2010, PHARMACOTHERAPY, V30, P290, DOI 10.1592/phco.30.3.290; Schrodinger Erwin., 1946, WHAT IS LIFE; Sullivan DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-274; Whittle M, 2004, J CHEM INF COMP SCI, V44, P1840, DOI 10.1021/ci049867x; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Williamson TP, 2012, CHEM BIOL DRUG DES, V80, P810, DOI 10.1111/cbdd.12040; YUAN YF, 1995, FUZZY SET SYST, V69, P125, DOI 10.1016/0165-0114(94)00229-Z; Zartler E, 2008, FRAGMENT BASED DISCO	34	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125593	10.1371/journal.pone.0125593	http://dx.doi.org/10.1371/journal.pone.0125593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951139	gold, Green Published, Green Submitted			2022-12-26	WOS:000354214400037
J	van Asch, B; Pereira-Castro, I; Rei, FT; da Costa, LT				van Asch, Barbara; Pereira-Castro, Isabel; Rei, Fernando Trindade; da Costa, Luis Teixeira			Marked Genetic Differentiation between Western Iberian and Italic Populations of the Olive Fly: Southern France as an Intermediate Area	PLOS ONE			English	Article							BACTROCERA-OLEAE; FRUIT-FLY; HAPLOTYPES; HISTORY	The olive fly, Bactrocera oleae, is the most important pest affecting the olive industry, to which it is estimated to cause average annual losses in excess of one billion dollars. As with other insects with a wide distribution, it is generally accepted that the understanding of B. oleae population structure and dynamics is fundamental for the design and implementation of effective monitoring and control strategies. However, and despite important advances in the past decade, a clear picture of B. oleae's population structure is still lacking. In the Mediterranean basin, where more than 95% of olive production is concentrated, evidence from several studies suggests the existence of three distinct sub-populations, but the geographical limits of their distributions, and the level of interpenetration and gene flow among them remain ill-characterized. Here we use mitochondrial haplotype analysis to show that one of the Mediterranean mitochondrial lineages displays geographically correlated substructure and demonstrate that Italic populations, though markedly distinct from their Iberian and Le-vantine counterparts are more diverse than previously described. Finally, we show that this distinction does not result from extant hypothetical geographic limits imposed by the Alps or the Pyrenees nor, more generally, does it result from any sharp boundary, as intermixing is observed in a broad area, albeit at variable levels. Instead, Bayesian phylogeographic analysis suggests the interplay between isolation-mediated differentiation during glacial periods and bi-directional dispersal and population intermixing in the interglacials has played a major role in shaping current olive fly population structure.	[van Asch, Barbara; Pereira-Castro, Isabel] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Oporto, Portugal; [Rei, Fernando Trindade; da Costa, Luis Teixeira] Univ Evora, ICAAM, Evora, Portugal	Universidade do Porto; University of Evora	da Costa, LT (corresponding author), Univ Evora, ICAAM, Evora, Portugal.	luisteixeiracosta@gmail.com	van Asch, Barbara/AAW-5154-2021; van Asch, Barbara/HDN-5674-2022; Pereira-Castro, Isabel/F-6487-2010	van Asch, Barbara/0000-0002-0171-879X; van Asch, Barbara/0000-0002-0171-879X; Pereira-Castro, Isabel/0000-0003-4149-4310; Rei, Fernando/0000-0001-7830-829X	Portuguese national funds through Foundation for Science and Technology (FCT) [PEst-C/AGR/UI0115/2011, ALENT-07-0324-FEDER-001747]; FEDER; FCT [SFRH/BPD/73108/2010, Ciencia2008-ICAAM]; Luis Teixeira da Costa	Portuguese national funds through Foundation for Science and Technology (FCT); FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Luis Teixeira da Costa	This work was funded by Portuguese national funds through Foundation for Science and Technology (FCT: www.fct.pt) under Strategic Project PEst-C/AGR/UI0115/2011 and project ALENT-07-0324-FEDER-001747, as well as by FEDER Funds through the latter project and Operational Programme for Competitiveness Factors-COMPETE. BA and LTC were funded by FCT grants SFRH/BPD/73108/2010 and Ciencia2008-ICAAM, respectively. Additional funding was provided by Luis Teixeira da Costa, to overcome arbitrary limitations imposed by the Portuguese finance minister in April 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ameri TK, 2011, ARAB J GEOSCI, V4, P945, DOI 10.1007/s12517-010-0159-5; Augustinos AA, 2005, GENETICA, V125, P231, DOI 10.1007/s10709-005-8692-y; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dogac E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056067; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLETCHER BS, 1976, ENTOMOL EXP APPL, V20, P183, DOI 10.1111/j.1570-7458.1976.tb02632.x; Haniotakis G., 2005, IOBC WPRS B, V28, P1; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Leps J, 2003, MULTIVARIATE ANAL EC; Matallanas B, 2013, J APPL ENTOMOL, V137, P624, DOI 10.1111/jen.12037; Montiel Bueno A., 2002, Bulletin OILB/SROP, V25, P147; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; Rice R. E., 2003, California Agriculture, V57, P122, DOI 10.3733/ca.v057n04p122; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Segura MD, 2008, J APPL ENTOMOL, V132, P706, DOI 10.1111/j.1439-0418.2008.01366.x; Skouras PJ, 2007, PEST MANAG SCI, V63, P42, DOI 10.1002/ps.1306; van Asch B, 2012, GENETICA, V140, P181, DOI 10.1007/s10709-012-9669-2; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Zygouridis NE, 2009, HEREDITY, V102, P402, DOI 10.1038/hdy.2008.125	27	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126702	10.1371/journal.pone.0126702	http://dx.doi.org/10.1371/journal.pone.0126702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951107	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400104
J	Wang, Q; Wang, ZL; Chu, LY; Li, X; Kan, PC; Xin, X; Zhu, Y; Yang, P				Wang, Qin; Wang, Zhenlian; Chu, LinYang; Li, Xu; Kan, Pengcheng; Xin, Xin; Zhu, Yu; Yang, Ping			The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines	PLOS ONE			English	Article							DOWN-REGULATION	Chemotherapy resistance is one of the major obstacles to effective glioma therapy. Currently, the mechanism underlying chemotherapy resistance is unclear. A recent study showed that miR-106a is an important molecule involved in chemotherapy resistance. To explore the effects and mechanisms of miR-106a on multidrug resistance reversal in human glioma cells, we silenced miR-106a expression in the cisplatin-resistant U87 (U87/DDP) and the gefitinib-resistant U251 (U251/G) glioma cell lines and measured the resulting drug sensitivity, cell apoptosis rate and rhodamine 123 content. In addition, we detected decreased expression of P-glycoprotein, MDR1, MRP1, GST-pi, CDX2, ERCC1, RhoE, Bcl-2, Survivin and Topo-II, as well as reduced production of IL-6, IL-8 and TGF-beta in these cell lines. Furthermore, we found decreased expression of p-AKT and transcriptional activation of NF-kappa B, Twist, AP-1 and Snail in these cell lines. These results suggest that miR-106a is a promising therapeutic target for the treatment of human multidrug resistant glioma.	[Wang, Qin; Li, Xu; Kan, Pengcheng; Xin, Xin; Zhu, Yu; Yang, Ping] Tianjin Huanhu Hosp, Dept Clin Lab, Tianjin Key Lab Cerebral Vessels & Neural Degener, Tianjin 300060, Peoples R China; [Wang, Zhenlian] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Dept Nursing, Changzhou 213164, Peoples R China; [Wang, Zhenlian] Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325003, Peoples R China; [Chu, LinYang] Anhui Med Univ, Affiliated Anhui Prov Hosp, Dept Orthoped 2, Hefei 230001, Peoples R China	Changzhou University; Wenzhou Medical University; Anhui Medical University	Wang, ZL (corresponding author), Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Dept Nursing, Changzhou 213164, Peoples R China.	wangzhenlian1980@126.com; tjhhhospitallab@126.com			National Natural Science Foundation of China [81201657]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by National Natural Science Foundation of China (Grant No. 81201657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besse B, 2013, J CLIN ONCOL, V31, P1050, DOI 10.1200/JCO.2012.43.0900; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Chikamori K, 2006, LEUKEMIA, V20, P1809, DOI 10.1038/sj.leu.2404351; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Cohen AL, 2015, CANCER TREAT RES, V163, P15, DOI 10.1007/978-3-319-12048-5_2; Conseil G, 2005, PHARMACOGENET GENOM, V15, P523, DOI 10.1097/01.fpc.0000167333.38528.ec; Cui X, 2012, DRUG EVALUATION, V32, P27; Draheim V, 2010, EUR J PHARM SCI, V41, P201, DOI 10.1016/j.ejps.2010.06.005; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; Hu Yuanjie, 2014, Oncoscience, V1, P205; Huh JH, 2013, BRIT J CANCER, V109, P452, DOI 10.1038/bjc.2013.305; Ivkovic TC, 2013, EXP MOL PATHOL, V94, P148, DOI 10.1016/j.yexmp.2012.11.002; Jiang X, 2011, CELL BIOCHEM FUNCT, V29, P164, DOI 10.1002/cbf.1728; Kasinski AL, 2012, CANCER RES, V72, P5576, DOI 10.1158/0008-5472.CAN-12-2001; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Li K, 2009, BIOCHEM BIOPH RES CO, V379, P212, DOI 10.1016/j.bbrc.2008.12.044; Liao B, 2013, J BIOL CHEM, V286, P17359; Qian CF, 2015, MOL MED REP, V11, P1951, DOI 10.3892/mmr.2014.2951; Song ZB, 2013, J THORAC DIS, V5, P400, DOI 10.3978/j.issn.2072-1439.2013.07.28; Takakura Y, 2010, CANCER RES, V70, P6767, DOI 10.1158/0008-5472.CAN-09-4701; Tartarone A, 2013, LUNG CANCER, V81, P328, DOI 10.1016/j.lungcan.2013.05.020; Wang XY, 2015, GENET TEST MOL BIOMA, V19, P59, DOI 10.1089/gtmb.2014.0228; Wang Z, 2015, ONCOGENE, V34, P1407, DOI 10.1038/onc.2014.75; Yang G, 2011, J MOL MED, V89, P1037, DOI 10.1007/s00109-011-0775-x; Zhou N, 2012, J INT NEUROLOGY NEUR, V2, P192; Zhu Y, 2014, ASIAN PAC J CANCER P, V15, P3219, DOI 10.7314/APJCP.2014.15.7.3219	27	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125473	10.1371/journal.pone.0125473	http://dx.doi.org/10.1371/journal.pone.0125473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950430	gold, Green Submitted, Green Published			2022-12-26	WOS:000354214400032
J	Wu, MC; Tian, CQ; Cheng, HM; Xu, L; Wang, P; Zhu, GP				Wu, Ming-Cai; Tian, Chang-Qing; Cheng, Hong-Mei; Xu, Lei; Wang, Peng; Zhu, Guo-Ping			A Novel Type II NAD(+)-Specific Isocitrate Dehydrogenase from the Marine Bacterium Congregibacter litoralis KT71	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; ACUTE MYELOID-LEUKEMIA; DEPENDENT ISOCITRATE; MOLECULAR CHARACTERIZATION; CELLULAR DEFENSE; REVEALS; SPECIFICITY; MUTATIONS; MECHANISM	In most living organisms, isocitrate dehydrogenases (IDHs) convert isocitrate into alpha-ketoglutarate (alpha-KG). Phylogenetic analyses divide the IDH protein family into two subgroups: types I and II. Based on cofactor usage, IDHs are either NAD(+)-specific (NAD-IDH) or NADP(+)-specific (NADP-IDH); NADP-IDH evolved from NAD-IDH. Type I IDHs include NAD-IDHs and NADP-IDHs; however, no type II NAD-IDHs have been reported to date. This study reports a novel type II NAD-IDH from the marine bacterium Congregibacter litoralis KT71 (CIIDH, GenBank accession no. EAQ96042). His-tagged recombinant ClIDH was produced in Escherichia coli and purified; the recombinant enzyme was NAD(+)-specific and showed no detectable activity with NADP(+). The Km values of the enzyme for NAD(+) were 262.6 +/- 7.4 mu M or 309.1 +/- 11.2 mu M with Mg2+ or Mn2+ as the divalent cation, respectively. The coenzyme specificity of a ClIDH Asp487Arg/Leu488His mutant was altered, and the preference of the mutant for NADP(+) was approximately 24-fold higher than that for NAD(+), suggesting that CIIDH is an NAD(+)-specific ancestral enzyme in the type II IDH subgroup. Gel filtration and analytical ultracentrifugation analyses revealed the homohexameric structure of CIIDH, which is the first IDH hexamer discovered thus far. A 163-amino acid segment of CIIDH is essential to maintain its polymerization structure and activity, as a truncated version lacking this region forms a non-functional monomer. CIIDH was dependent on divalent cations, the most effective being Mn2+. The maximal activity of purified recombinant CIIDH was achieved at 35 degrees C and pH 7.5, and a heat inactivation experiment showed that a 20-min incubation at 33 degrees C caused a 50% loss of CIIDH activity. The discovery of a NAD(+)-specific, type II IDH fills a gap in the current classification of IDHs, and sheds light on the evolution of type II IDHs.	[Wu, Ming-Cai; Tian, Chang-Qing; Cheng, Hong-Mei; Xu, Lei; Wang, Peng; Zhu, Guo-Ping] Anhui Normal Univ, Inst Mol Biol & Biotechnol, Wuhu 241000, Anhui, Peoples R China; [Wu, Ming-Cai; Xu, Lei] Wannan Med Coll, Anhui Prov Key Lab Act Biol Macromol, Wuhu 241002, Anhui, Peoples R China	Anhui Normal University; Wannan Medical College	Wang, P (corresponding author), Anhui Normal Univ, Inst Mol Biol & Biotechnol, 1 Beijing East Rd, Wuhu 241000, Anhui, Peoples R China.	wangpeng1219@yahoo.com; gpz1996@yahoo.com	Wang, Peng/I-8770-2018; Xu, Lei/F-4545-2011; Wang, Peng/AAW-9052-2020	Wang, Peng/0000-0002-5598-0996; Xu, Lei/0000-0002-8416-3362; Wang, Peng/0000-0002-5598-0996	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31400003, 31170005]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424110004]; Natural Science Foundation of Anhui Province of China [1308085QC67]; Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China [KJ2013A128]	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province); Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China	This study was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31400003, 31170005), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424110004), the Natural Science Foundation of Anhui Province of China (1308085QC67), and the Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China (KJ2013A128).	Aoshima M, 2004, MOL MICROBIOL, V51, P791, DOI 10.1046/j.1365-2958.2003.03863.x; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Cvitkovitch DG, 1997, J BACTERIOL, V179, P650, DOI 10.1128/jb.179.3.650-655.1997; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Huang YC, 2005, J BIOL CHEM, V280, P30349, DOI 10.1074/jbc.M505828200; Imabayashi F, 2006, PROTEINS, V63, P100, DOI 10.1002/prot.20867; Inoue H, 2002, FEMS MICROBIOL LETT, V214, P127, DOI 10.1111/j.1574-6968.2002.tb11335.x; Jennings GT, 1997, BIOCHEMISTRY-US, V36, P13743, DOI 10.1021/bi970916r; Kalinina OV, 2006, PROTEINS, V64, P1001, DOI 10.1002/prot.21027; Kim HJ, 2005, FREE RADICAL RES, V39, P441, DOI 10.1080/10715760500066265; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Quartararo CE, 2013, BIOCHEMISTRY-US, V52, P1765, DOI 10.1021/bi400037w; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Spring S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004866; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Steen IH, 2001, J BIOL CHEM, V276, P43924, DOI 10.1074/jbc.M105999200; Stokke R, 2007, ARCH MICROBIOL, V187, P361, DOI 10.1007/s00203-006-0200-y; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vinekar R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S2; Wang P, 2012, FEMS MICROBIOL LETT, V327, P134, DOI 10.1111/j.1574-6968.2011.02467.x; Wang P, 2011, BIOCHIMIE, V93, P1470, DOI 10.1016/j.biochi.2011.04.021; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang BB, 2009, BIOCHIMIE, V91, P1405, DOI 10.1016/j.biochi.2009.07.011; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125229	10.1371/journal.pone.0125229	http://dx.doi.org/10.1371/journal.pone.0125229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942017	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400027
J	Kaur, K; Bakke, MJ; Nilsen, F; Horsberg, TE				Kaur, Kiranpreet; Bakke, Marit Jorgensen; Nilsen, Frank; Horsberg, Tor Einar			Identification and Molecular Characterization of Two Acetylcholinesterases from the Salmon Louse, Lepeophtheirus salmonis	PLOS ONE			English	Article							CDNA-ENCODING ACETYLCHOLINESTERASE; MOSQUITO CULEX-PIPIENS; DROSOPHILA-MELANOGASTER; INSECTICIDE RESISTANCE; INSENSITIVE ACETYLCHOLINESTERASE; BLATTELLA-GERMANICA; POINT MUTATIONS; GENE; COCKROACH; DIPTERA	Acetylcholinesterase (AChE) is an important enzyme in cholinergic synapses. Most arthropods have two genes (ace1 and ace2), but only one encodes the predominant synaptic AChE, the main target for organophosphates. Resistance towards organophosphates is widespread in the marine arthropod Lepeophtheirus salmonis. To understand this trait, it is essential to characterize the gene(s) coding for AChE(s). The full length cDNA sequences encoding two AChEs in Lepeophtheirus salmonis were molecularly characterized in this study. The two ace genes were highly similar (83.5% similarity at protein level). Alignment to the Lepeophtheirus salmonis genome revealed that both genes were located close to each other (separated by just 26.4 kbp on the Lepeophtheirus salmonis genome), resulting from a recent gene duplication. Both proteins had all the typical features of functional AChE and clustered together with AChE-type 1 proteins in other species, an observation that has not been described in other arthropods. We therefore concluded the presence of two versions of ace1 gene in Lepeophtheirus salmonis, named ace1a and ace1b. Ace1a was predominantly expressed in different developmental stages compared to ace1b and was possibly active in the cephalothorax, indicating that ace1a is more likely to play the major role in cholinergic synaptic transmission. The study is essential to understand the role of AChEs in resistance against organophosphates in Lepeophtheirus salmonis.	[Kaur, Kiranpreet; Bakke, Marit Jorgensen; Horsberg, Tor Einar] NMBU Sch Vet Sci, Sea Lice Res Ctr, NO-0033 Oslo, Norway; [Nilsen, Frank] Univ Bergen, Dept Biol, Sea Lice Res Ctr, NO-5020 Bergen, Norway	Norwegian University of Life Sciences; University of Bergen	Kaur, K (corresponding author), NMBU Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dep, NO-0033 Oslo, Norway.	kiran.kaur@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Research Council through Centre for Innovation, Sea Lice Research Centre [203513/O30]	Norwegian Research Council through Centre for Innovation, Sea Lice Research Centre	The study was financially supported by the Norwegian Research Council through a Centre for Innovation, the Sea Lice Research Centre, grant number 203513/O30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; Bourguet D, 1996, J NEUROCHEM, V67, P2115, DOI 10.1046/j.1471-4159.1996.67052115.x; Charpentier A, 2001, PESTIC BIOCHEM PHYS, V70, P100, DOI 10.1006/pest.2001.2549; Chen ZZ, 2001, INSECT BIOCHEM MOLEC, V31, P805, DOI 10.1016/S0965-1748(00)00186-7; Combes D, 2001, INT REV CYTOL, V209, P207; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; FOURNIER D, 1992, EUR J BIOCHEM, V203, P513, DOI 10.1111/j.1432-1033.1992.tb16577.x; Gao JR, 2002, INSECT BIOCHEM MOLEC, V32, P765, DOI 10.1016/S0965-1748(01)00159-X; GIBNEY G, 1988, J BIOL CHEM, V263, P1140; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; HALL LMC, 1991, CELL MOL NEUROBIOL, V11, P131, DOI 10.1007/BF00712805; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; HEITKEMPER MM, 1983, AM J PHYSIOL, V244, pG58, DOI 10.1152/ajpgi.1983.244.1.G58; Huang Y, 1997, Chin J Biotechnol, V13, P177; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Kaur K., 2015, PLOS ONE IN PRESS; Kim JI, 2006, INSECT MOL BIOL, V15, P513, DOI 10.1111/j.1365-2583.2006.00666.x; Kim YH, 2010, INSECT MOL BIOL, V19, P765, DOI 10.1111/j.1365-2583.2010.01036.x; Kim YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048838; Kim YH, 2013, INSECT BIOCHEM MOLEC, V43, P47, DOI 10.1016/j.ibmb.2012.11.004; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; LEWIS PR, 1966, J CELL SCI, V1, P381; Li F, 2002, GENOME, V45, P1134, DOI 10.1139/G02-085; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; Nakajima K, 2000, J CHEM NEUROANAT, V18, P31, DOI 10.1016/S0891-0618(99)00058-7; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seong KM, 2012, INSECT MOL BIOL, V21, P149, DOI 10.1111/j.1365-2583.2011.01118.x; Temeyer KB, 2007, DNA SEQUENCE, V18, P85, DOI 10.1080/10425170601060558; Temeyer KB, 2010, VET PARASITOL, V172, P114, DOI 10.1016/j.vetpar.2010.04.016; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Vontas JG, 2002, INSECT MOL BIOL, V11, P329, DOI 10.1046/j.1365-2583.2002.00343.x; Walsh SB, 2001, BIOCHEM J, V359, P175, DOI 10.1042/0264-6021:3590175; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Zhang YX, 2014, INSECT BIOCHEM MOLEC, V46, P25, DOI 10.1016/j.ibmb.2014.01.004; Zhu KY, 1995, INSECT BIOCHEM MOLEC, V25, P1129, DOI 10.1016/0965-1748(95)00055-0	46	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125362	10.1371/journal.pone.0125362	http://dx.doi.org/10.1371/journal.pone.0125362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938836	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000061
J	Paljarvi, T; Martikainen, P; Pensola, T; Leinonen, T; Herttua, K; Makela, P				Paljarvi, Tapio; Martikainen, Pekka; Pensola, Tiina; Leinonen, Taina; Herttua, Kimmo; Makela, Pia			Life Course Trajectories of Labour Market Participation among Young Adults Who Experienced Severe Alcohol-Related Health Outcomes: A Retrospective Cohort Study	PLOS ONE			English	Article							SUBSTANCE USE; OCCUPATIONAL ATTAINMENT; EDUCATIONAL-ATTAINMENT; SOCIAL DETERMINANTS; BINGE DRINKING; PARENTAL HOME; UNEMPLOYMENT; RISK; DEPENDENCE; CHILDHOOD	Background Long-term employment trajectories of young problem drinkers are poorly understood. Methods We constructed retrospective labour market participation histories at ages 18-34 of 64 342 persons born in 1969-1982. Beginning from the year of each subject's 18th birthday, we extracted information from the records of Statistics Finland on educational attainment, main type of economic activity, months in employment, and months in unemployment for a minimum of seven years (range 7-16 years). We used information on the timing of alcohol-related hospitalizations and deaths in the same period to define problem drinkers with early onset limited course, early onset persistent course, and late onset problem drinking. Results Early onset limited course problem drinkers improved their employment considerably by age, whereas early onset persistent problem drinkers experienced a constant decline in their employment by age. From the age of 18 to 34, early onset persistent problem drinkers were in employment merely 12% of the time, in comparison with 39% among the early onset limited course problem drinkers, and 58% among the general population. Conclusions These results indicate that young adults who were retrospectively defined as having early onset persistent course problem drinking were extensively marginalized from the labour market early on during their life course, and that their employment trajectory was significantly worse compared to other problem drinkers.	[Paljarvi, Tapio; Makela, Pia] Natl Inst Hlth & Welf, Alcohol & Drugs Unit, Helsinki, Finland; [Martikainen, Pekka; Leinonen, Taina; Herttua, Kimmo] Univ Helsinki, Populat Res Unit, Helsinki, Finland; [Martikainen, Pekka] Max Planck Inst Demog Res, Rostock, Germany; [Pensola, Tiina] Finnish Inst Occupat Hlth, Hlth & Work Abil, Helsinki, Finland; [Herttua, Kimmo] Univ Southern Denmark, Ctr Maritime Hlth & Soc, Esbjerg, Denmark	Finland National Institute for Health & Welfare; University of Helsinki; Max Planck Society; Finnish Institute of Occupational Health; University of Southern Denmark	Paljarvi, T (corresponding author), Natl Inst Hlth & Welf, Alcohol & Drugs Unit, Helsinki, Finland.	tapio.paljarvi@thl.fi	Mäkelä, Pia/C-5679-2015	Mäkelä, Pia/0000-0002-3343-2139; Paljarvi, Tapio/0000-0002-5324-9825; Herttua, Kimmo/0000-0003-2004-779X; Martikainen, Pekka/0000-0001-9374-1438	Academy of Finland [259289]; Commission of the European Communities Seventh Framework Programme [278511]	Academy of Finland(Academy of Finland); Commission of the European Communities Seventh Framework Programme	This work was supported by a grant from the Academy of Finland (grant no. 259289) and the Commission of the European Communities Seventh Framework Programme (grant no. 278511). This study is part of the DEMETRIQ project. The study does not necessarily reflect the Commission's views and in no way anticipates the Commission's future policy in this area. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	[Anonymous], 2009, MONOGR SOC RES CHILD, V74, pVII, DOI 10.1111/j.1540-5834.2009.00528.x; [Anonymous], 2008, YEARBOOK OF ALCOHOL, P95; Bauld L, 2013, POLICY STUD-UK, V34, P360, DOI 10.1080/01442872.2013.804303; Berg N, 2013, ARCHITECT, V102, P48; Bernhardt E, 2005, ACTA SOCIOL, V48, P99, DOI 10.1177/0001699305053765; Caspi A, 1998, AM SOCIOL REV, V63, P424, DOI 10.2307/2657557; Chassin L, 2002, J CONSULT CLIN PSYCH, V70, P67, DOI 10.1037//0022-006X.70.1.67; Chatterji P, 2006, ECON EDUC REV, V25, P482, DOI 10.1016/j.econedurev.2005.05.005; Clark DB, 2004, ADDICTION, V99, P5, DOI 10.1111/j.1360-0443.2004.00851.x; Cloud W, 2008, SUBST USE MISUSE, V43, P1971, DOI 10.1080/10826080802289762; Dieckhoff M, 2011, ACTA SOCIOL, V54, P233, DOI 10.1177/0001699311412798; Ettner SL, 1997, SOC SCI MED, V44, P251, DOI 10.1016/S0277-9536(96)00160-8; FORCIER MW, 1988, J OCCUP ENVIRON MED, V30, P246; Grant JD, 2012, ALCOHOL CLIN EXP RES, V36, P1412, DOI 10.1111/j.1530-0277.2012.01752.x; Haan P, 2009, J HEALTH ECON, V28, P1116, DOI 10.1016/j.jhealeco.2009.09.001; Hammer T, 2007, INT J SOC WELF, V16, P249, DOI 10.1111/j.1468-2397.2006.00467.x; Harford TC, 2005, ALCOHOL CLIN EXP RES, V29, P810, DOI 10.1097/01.ALC.0000164381.67723.76; Henkel Dieter, 2011, Curr Drug Abuse Rev, V4, P4; Hicks BM, 2012, ADDICTION, V107, P540, DOI 10.1111/j.1360-0443.2011.03617.x; Hicks BM, 2010, ALCOHOL CLIN EXP RES, V34, P819, DOI 10.1111/j.1530-0277.2010.01154.x; JESSOR R, 1987, BRIT J ADDICT, V82, P331; Johnson JL, 1999, PEDIATRICS, V103, P1085; King KM, 2006, ADDICTION, V101, P1730, DOI 10.1111/j.1360-0443.2006.01507.x; MacDonald Z, 2001, ECONOMICA, V68, P427, DOI 10.1111/1468-0335.00254; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Meier MH, 2013, DEV PSYCHOPATHOL, V25, P785, DOI 10.1017/S0954579413000175; Mossakowski KN, 2008, SOC SCI MED, V67, P947, DOI 10.1016/j.socscimed.2008.05.019; MULLAHY J, 1993, J LABOR ECON, V11, P494, DOI 10.1086/298305; Oesterle S, 2011, J STUD ALCOHOL DRUGS, V72, P763, DOI 10.15288/jsad.2011.72.763; Osler M, 2006, AM J EPIDEMIOL, V163, P654, DOI 10.1093/aje/kwj084; Paljarvi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098620; Pitkanen T, 2008, ADDICTION, V103, P48, DOI 10.1111/j.1360-0443.2008.02176.x; Remes H, 2012, ADV LIFE COURSE RES, V17, P199, DOI 10.1016/j.alcr.2012.09.001; Schulenberg J, 1996, J STUD ALCOHOL, V57, P289, DOI 10.15288/jsa.1996.57.289; Sloan FA, 2009, AM J PUBLIC HEALTH, V99, P2261, DOI 10.2105/AJPH.2007.127621; Staff J, 2008, J STUD ALCOHOL DRUGS, V69, P848, DOI 10.15288/jsad.2008.69.848; Staff J, 2010, DEV PSYCHOPATHOL, V22, P917, DOI 10.1017/S0954579410000544; Stone AL, 2012, ADDICT BEHAV, V37, P747, DOI 10.1016/j.addbeh.2012.02.014; Strandh M, 2014, EUR J PUBLIC HEALTH, V24, P440, DOI 10.1093/eurpub/cku005; WHO, 1994, LEXICON OF ALCOHOL A, P34	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126215	10.1371/journal.pone.0126215	http://dx.doi.org/10.1371/journal.pone.0126215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938764	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000152
J	Zhang, F; Qin, W; Zhang, JP; Hu, CQ				Zhang, Fan; Qin, Wei; Zhang, Jing-Pu; Hu, Chang-Qin			Antibiotic Toxicity and Absorption in Zebrafish Using Liquid Chromatography-Tandem Mass Spectrometry	PLOS ONE			English	Article							MODEL; CEPHALOSPORINS; HEART; HPLC	Evaluation of drug toxicity is necessary for drug safety, but in vivo drug absorption is varied; therefore, a rapid, sensitive and reliable method for measuring drugs is needed. Zebrafish are acceptable drug toxicity screening models; we used these animals with a liquid chromatography- tandem mass spectrometry (LC-MS/MS) method in a multiple reaction monitoring mode to quantify drug uptake in zebrafish to better estimate drug toxicity. Analytes were recovered from zebrafish homogenate by collecting supernatant. Measurements were confirmed for drugs in the range of 10-1,000 ng/mL. Four antibiotics with different polarities were tested to explore any correlation of drug polarity, absorption, and toxicity. Zebrafish at 3 days post-fertilization (dpf) absorbed more drug than those at 6 h post-fertilization (hpf), and different developmental periods appeared to be differentially sensitive to the same compound. By observing abnormal embryos and LD50 values, zebrafish embryos at 6 hpf were considered to be suitable for evaluating embryotoxicity. Also, larvae at 3 dpf were adapted to measure acute drug toxicity in adult mammals. Thus, we can exploit zebrafish to study drug toxicity and can reliably quantify drug uptake with LC-MS/MS. This approach will be helpful for future studies of toxicology in zebrafish.	[Zhang, Fan; Hu, Chang-Qin] Peking Union Med Coll, Grad Sch, Natl Inst Food & Drug Control, Beijing 100021, Peoples R China; [Qin, Wei; Zhang, Jing-Pu] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Qin, Wei; Zhang, Jing-Pu] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JP (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zjp5577@126.com; hucq@nifdc.org.cn			National S&T Major Special Project on Major New Drug Innovation [2012ZX09301-002-001-021]	National S&T Major Special Project on Major New Drug Innovation	This study was supported by National S&T Major Special Project on Major New Drug Innovation (No. 2012ZX09301-002-001-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454; [Anonymous], 2011, GUID BIOAN METH VAL; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chen Qiu-xia, 2011, Yaoxue Xuebao, V46, P1026; Chen YH, 2012, REPROD TOXICOL, V33, P233, DOI 10.1016/j.reprotox.2011.12.008; Czeizel AE, 2001, AM J OBSTET GYNECOL, V184, P1289, DOI 10.1067/mob.2001.113905; Diekmann H., 2013, DRUG DISCOV TODAY DI, V10, P31; Fako VE, 2009, ADV DRUG DELIVER REV, V61, P478, DOI 10.1016/j.addr.2009.03.008; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; He QX, 2012, DRUG CHEM TOXICOL, V35, P149, DOI 10.3109/01480545.2011.589447; Hermsen SAB, 2012, TOXICOL SCI, V127, P303, DOI 10.1093/toxsci/kfs092; Hill A, 2011, ZEBRAFISH METHODS AS, DOI [10.1002/9781118102138.ch8, DOI 10.1002/9781118102138.CH8]; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hill AJ, 2009, J PHARMACOL TOX MET, V62, P22; Hong YL, 2006, CHIN J PHARM ANAL, V26, P1050; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang CC, 2013, ASSAY DRUG DEV TECHN, V11, P561, DOI 10.1089/adt.2013.548; Hung MW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/605303; Jones M, 2009, TOXICOLOGY, V262, P13, DOI 10.1016/j.tox.2009.04.013; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Kamel AM, 2002, J AM SOC MASS SPECTR, V13, P543, DOI 10.1016/S1044-0305(02)00356-2; Kawahara G, 2013, DRUG DISCOV TODAY TE, V10, P91; Lee SH, 2013, J APPL TOXICOL, V33, P466, DOI 10.1002/jat.1768; Li AP, 2001, DRUG DISCOV TODAY, V6, P357, DOI 10.1016/S1359-6446(01)01712-3; Li AP, 2004, CHEM-BIOL INTERACT, V150, P3, DOI 10.1016/j.cbi.2004.09.008; Li J, 2010, RAPID COMMUN MASS SP, V24, P2143, DOI 10.1002/rcm.4626; Li SZ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r115; Mattison Donald, 2006, Gend Med, V3, P169, DOI 10.1016/S1550-8579(06)80205-6; Nemutlu E, 2009, TALANTA, V80, P117, DOI 10.1016/j.talanta.2009.06.034; Qin Wei, 2012, Yichuan, V34, P1165, DOI 10.3724/SP.J.1005.2012.01165; Ruzilawati AB, 2007, J PHARMACEUT BIOMED, V43, P1831, DOI 10.1016/j.jpba.2006.12.010; Samanidou VF, 2004, J CHROMATOGR B, V809, P175, DOI 10.1016/j.jchromb.2004.06.019; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Shi XJ, 2009, TOXICOL SCI, V110, P334, DOI 10.1093/toxsci/kfp111; Soraya S, 2013, AM J NEURODEGENER DI, V1, P32; Tong Jun-wei, 2011, Yaoxue Xuebao, V46, P50; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Veinotte CJ, 2014, DIS MODEL MECH, V7, P745, DOI 10.1242/dmm.015784; Zhang JP, 2013, CHEM RES TOXICOL, V26, P1168, DOI 10.1021/tx400089y; Zhang JP, 2010, ARCH PHARM, V343, P553, DOI 10.1002/ardp.201000005; Zhang Na, 2012, Yaoxue Xuebao, V47, P223; Zhao Zhuang, 2011, Yaoxue Xuebao, V46, P928	42	39	41	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124805	10.1371/journal.pone.0124805	http://dx.doi.org/10.1371/journal.pone.0124805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938774	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000032
J	Zhang, P; Leger, AJ; Baleja, JD; Rana, R; Corlin, T; Nguyen, N; Koukos, G; Bohm, A; Covic, L; Kuliopulos, A				Zhang, Ping; Leger, Andrew J.; Baleja, James D.; Rana, Rajashree; Corlin, Tiffany; Nga Nguyen; Koukos, Georgios; Bohm, Andrew; Covic, Lidija; Kuliopulos, Athan			Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; cell surface receptor; cell-penetrating peptide (CPP); chemical biology; drug delivery system; G protein-coupled receptor (GPCR); nuclear magnetic resonance (NMR); receptor structure-function; signal transduction; thrombin	RESOLUTION CRYSTAL-STRUCTURE; PEPDUCIN-BASED INTERVENTION; LIGHT-DEPENDENT CHANGES; THROMBIN-RECEPTOR; AGONIST PEPDUCIN; STRUCTURAL BASIS; CYTOPLASMIC END; PAR1; RHODOPSIN; GPCR	Background: Intracellular parts of GPCRs have yet to be effectively exploited as allosteric modulators. Results: The structure and mechanism of action of a lipidated pepducin agonist is determined. Conclusion: The pepducin requires the H8 helix and TM7 tyrosine propeller to stabilize the on-state and trigger receptor-G protein signaling. Significance: This work provides critical insight into the identification of allosteric modulators to this major drug target class. G protein-coupled receptors (GPCRs) are remarkably versatile signaling systems that are activated by a large number of different agonists on the outside of the cell. However, the inside surface of the receptors that couple to G proteins has not yet been effectively modulated for activity or treatment of diseases. Pepducins are cell-penetrating lipopeptides that have enabled chemical and physical access to the intracellular face of GPCRs. The structure of a third intracellular (i3) loop agonist, pepducin, based on protease-activated receptor-1 (PAR1) was solved by NMR and found to closely resemble the i3 loop structure predicted for the intact receptor in the on-state. Mechanistic studies revealed that the pepducin directly interacts with the intracellular H8 helix region of PAR1 and allosterically activates the receptor through the adjacent (D/N)PXXYYY motif through a dimer-like mechanism. The i3 pepducin enhances PAR1/G subunit interactions and induces a conformational change in fluorescently labeled PAR1 in a very similar manner to that induced by thrombin. As pepducins can potentially be made to target any GPCR, these data provide insight into the identification of allosteric modulators to this major drug target class.	Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Hemostasis & Thrombosis Res,Mol Oncol Res Ins, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Med Ctr, Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Koukos, Georgios/B-1544-2009	Koukos, Georgios/0000-0002-9470-0651; Corlin, Tiffany/0000-0002-3971-3492	National Institutes of Health from the NHLBI [P50 HL110789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL110789] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 HL110789 from the NHLBI (to A. K.).	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15493, DOI 10.1021/bi011545o; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15483, DOI 10.1021/bi011546g; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fontanini KB, 2010, BIOPHYS J, V98, p278A, DOI 10.1016/j.bpj.2009.12.1520; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; Janz JM, 2011, J AM CHEM SOC, V133, P15878, DOI 10.1021/ja206661w; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; O'Callaghan K, 2012, BLOOD, V119, P1717, DOI 10.1182/blood-2011-04-347518; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Swift S, 2000, J BIOL CHEM, V275, P2627, DOI 10.1074/jbc.275.4.2627; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Tsuji M, 2013, ORG BIOMOL CHEM, V11, P3030, DOI 10.1039/c3ob27445d; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918; Zweemer AJM, 2014, MOL PHARMACOL, V86, P358, DOI 10.1124/mol.114.093328	66	27	28	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15785	15798		10.1074/jbc.M115.636316	http://dx.doi.org/10.1074/jbc.M115.636316			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25934391	Green Published, hybrid			2022-12-26	WOS:000356527400039
J	Bourassa, S; Fournier, F; Nehme, B; Kelly, I; Tremblay, A; Lemelin, V; Lamarche, B; Couture, P; Droit, A				Bourassa, Sylvie; Fournier, Frederic; Nehme, Benjamin; Kelly, Isabelle; Tremblay, Andre; Lemelin, Valery; Lamarche, Benoit; Couture, Patrick; Droit, Arnaud			Evaluation of iTRAQ and SWATH-MS for the Quantification of Proteins Associated with Insulin Resistance in Human Duodenal Biopsy Samples	PLOS ONE			English	Article							LABEL-FREE; GENES; METABOLISM; EXPRESSION; SHOTGUN	Insulin resistance (IR) is associated with increased production of triglyceride-rich lipoproteins of intestinal origin. In order to assess whether insulin resistance affects the proteins involved in lipid metabolism, we used two mass spectrometry based quantitative proteomics techniques to compare the intestinal proteome of 14 IR patients to that of 15 insulin sensitive (IS) control patients matched for age and waist circumference. A total of 3886 proteins were identified by the iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) mass spectrometry approach and 2290 by the SWATH-MS strategy (Serial Window Acquisition of Theoretical Spectra). Using these two methods, 208 common proteins were identified with a confidence corresponding to FDR < 1%, and quantified with p-value < 0.05. The quantification of those 208 proteins has a Pearson correlation coefficient (r(2)) of 0.728 across the two techniques. Gene Ontology analyses of the differentially expressed proteins revealed that annotations related to lipid metabolic process and oxidation reduction process are overly represented in the set of under-expressed proteins in IR subjects. Furthermore, both methods quantified proteins of relevance to IR. These data also showed that SWATH-MS is a promising and compelling alternative to iTRAQ for protein quantitation of complex mixtures.	[Bourassa, Sylvie; Fournier, Frederic; Nehme, Benjamin; Kelly, Isabelle; Droit, Arnaud] Univ Laval, CHU Quebec, Res Ctr, Prote Ctr, Quebec City, PQ, Canada; [Bourassa, Sylvie; Fournier, Frederic; Nehme, Benjamin; Kelly, Isabelle; Droit, Arnaud] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Tremblay, Andre; Lemelin, Valery; Lamarche, Benoit; Couture, Patrick] Univ Laval, Ctr Hosp Univ Laval, Res Ctr, Lipid Res Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Droit, A (corresponding author), Univ Laval, CHU Quebec, Res Ctr, Prote Ctr, Quebec City, PQ, Canada.	Arnaud.Droit@crchuq.ulaval.ca	Droit, Arnaud/AGZ-6283-2022; Lamarche, Benoit/ABA-4785-2021	Droit, Arnaud/0000-0001-7922-790X; Lamarche, Benoit/0000-0002-4443-5378; Couture, Patrick/0000-0002-8414-3847; Fournier, Frederic/0000-0001-5785-5403				Achouri Y, 2005, BIOCHIMIE, V87, P1149, DOI 10.1016/j.biochi.2005.04.015; ARNOLD TP, 1993, BIOCHEM J, V295, P155, DOI 10.1042/bj2950155; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Couture P, 2014, J LIPID RES, V55, P128, DOI 10.1194/jlr.M040071; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Falick Arnold M, 2011, J Biomol Tech, V22, P21; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lally S, 2007, ATHEROSCLEROSIS, V193, P343, DOI 10.1016/j.atherosclerosis.2006.09.031; Lally S, 2007, METABOLISM, V56, P430, DOI 10.1016/j.metabol.2006.10.028; Lambert JP, 2013, NAT METHODS, V10, P1239, DOI [10.1038/NMETH.2702, 10.1038/nmeth.2702]; Law KP, 2013, EXPERT REV PROTEOMIC, V10, P551, DOI 10.1586/14789450.2013.858022; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu NQ, 2013, J PROTEOME RES, V12, P4627, DOI 10.1021/pr4005794; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Megger DA, 2013, BBA-PROTEINS PROTEOM, V1834, P1581, DOI 10.1016/j.bbapap.2013.04.001; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Phillips C, 2006, ATHEROSCLEROSIS, V187, P57, DOI 10.1016/j.atherosclerosis.2005.08.020; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; Tsakiridis T, 1999, MICROSC RES TECHNIQ, V47, P79, DOI 10.1002/(SICI)1097-0029(19991015)47:2<79::AID-JEMT1>3.0.CO;2-S; Veilleux A, 2014, ARTERIOSCL THROM VAS, V34, P644, DOI 10.1161/ATVBAHA.113.302993; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Zhang FL, 2014, J PROTEOMICS, V102, P125, DOI 10.1016/j.jprot.2014.03.007; Zhang H, 2011, DIABETOLOGIA, V54, P2368, DOI 10.1007/s00125-011-2212-7	34	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125934	10.1371/journal.pone.0125934	http://dx.doi.org/10.1371/journal.pone.0125934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950531	gold, Green Submitted, Green Published			2022-12-26	WOS:000354214400055
J	Chen, L; Chu, C; Lu, J; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Lu, Jing; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; INTERACTION NETWORKS; MUTUAL INFORMATION; WEB SERVER; PREDICTION; PROTEINS; MODEL; IDENTIFICATION; TOOL	Drug-target interaction (DTI) is a key aspect in pharmaceutical research. With the ever-increasing new drug data resources, computational approaches have emerged as powerful and labor-saving tools in predicting new DTIs. However, so far, most of these predictions have been based on structural similarities rather than biological relevance. In this study, we proposed for the first time a "GO and KEGG enrichment score" method to represent a certain category of drug molecules by further classification and interpretation of the DTI database. A benchmark dataset consisting of 2,015 drugs that are assigned to nine categories ((1) G protein-coupled receptors, (2) cytokine receptors, (3) nuclear receptors, (4) ion channels, (5) transporters, (6) enzymes, (7) protein kinases, (8) cellular antigens and (9) pathogens) was constructed by collecting data from KEGG. We analyzed each category and each drug for its contribution in GO terms and KEGG pathways using the popular feature selection "minimum redundancy maximum relevance (mRMR)" method, and key GO terms and KEGG pathways were extracted. Our analysis revealed the top enriched GO terms and KEGG pathways of each drug category, which were highly enriched in the literature and clinical trials. Our results provide for the first time the biological relevance among drugs, targets and biological functions, which serves as a new basis for future DTI predictions.	[Chen, Lei; Cai, Yu-Dong] Shanghai Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Chu, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Lu, Jing] Yantai Univ, Sch Pharm, Dept Med Chem, Yantai, Shandong, Peoples R China; [Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yantai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Chu, Chen/J-6527-2019; Chen, Lei/A-2275-2011	Chu, Chen/0000-0001-8084-0867; Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 61202021, 61373028, 61303099]; Innovation Program of the Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation	Support was provided by the National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (31371335, 61202021, 61373028, 61303099), the Innovation Program of the Shanghai Municipal Education Commission (12YZ120, 12ZZ087), and the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2014, BBA-PROTEINS PROTEOM, V1844, P207, DOI 10.1016/j.bbapap.2013.05.021; Chen L, 2013, CURR BIOINFORM, V8, P545, DOI 10.2174/1574893611308050004; Chen L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/723780; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2009, J PROTEOME RES, V8, P5212, DOI 10.1021/pr900554a; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Drews J, 1996, NAT BIOTECHNOL, V14, P1516, DOI 10.1038/nbt1196-1516; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029491; Huang T, 2012, BIOCHIMIE, V94, P1017, DOI 10.1016/j.biochi.2011.12.024; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kotelnikova Ekaterina, 2010, Journal of Bioinformatics and Computational Biology, V8, P593, DOI 10.1142/S0219720010004732; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Li J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S3; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Li ZC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-325; Liu XP, 2013, BIOINFORMATICS, V29, P1910, DOI 10.1093/bioinformatics/btt303; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Palczewski K, 2013, ANNU REV NEUROSCI, V36, P139, DOI 10.1146/annurev-neuro-062012-170313; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Prado-Prado F, 2012, CURR TOP MED CHEM, V12, P1843; Ramaker JM, 2013, J NEUROSCI, V33, P10165, DOI 10.1523/JNEUROSCI.1146-13.2013; Schaal W, 2013, BIOINFORMATICS, V29, P2369, DOI 10.1093/bioinformatics/btt390; Thomas MC, 2006, ELEMENTS INFORM THEO; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Zessin K-H, 2006, J Vet Med B Infect Dis Vet Public Health, V53, P7, DOI 10.1111/j.1439-0450.2006.01011.x; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	45	51	53	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126492	10.1371/journal.pone.0126492	http://dx.doi.org/10.1371/journal.pone.0126492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951454	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400096
J	Johnson, L; Zhu, J; Scott, ER; Wineinger, NE				Johnson, Lucia; Zhu, Jonathan; Scott, Erick R.; Wineinger, Nathan E.			An Examination of the Relationship between Lipid Levels and Associated Genetic Markers across Racial/Ethnic Populations in the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PREDICTION	Large genome-wide association studies have reported hundreds of genetic markers associated with lipid levels. However, the discovery and estimated effect of variants at these loci, derived from samples of exclusively European descent, may not generalize to the majority of the world populations. We examined the collective strength of association among these loci in a diverse set of U.S. populations from the Multi-Ethnic Study of Atherosclerosis. We constructed a genetic risk score for each lipid outcome based on previously identified lipid-associated genetic markers, and examined the relationship between the genetic risk scores and corresponding outcomes. We discover this relationship was often moderated by race/ethnicity. Our findings provide insight into the generalizability and predictive utility of large sample size meta-analyses results when leveraging data from a single population. We hope these findings will encourage researchers to investigate genetic susceptibility in more diverse populations and explore the source of such discrepancies. Until then, we caution clinicians, genetic counselors, and genetic testing consumers when interpreting genetic data on complex traits.	[Johnson, Lucia; Zhu, Jonathan; Wineinger, Nathan E.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Scott, Erick R.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wineinger, NE (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	wineinger.nathan@scrippshealth.org			National Institutes of Health (NIH)/National Center for Advanced Translational Sciences [UL1TR001114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Center for Advanced Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported by the National Institutes of Health (NIH)/National Center for Advanced Translational Sciences, grant UL1TR001114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Avins AL, 1998, JAMA-J AM MED ASSOC, V279, P445, DOI 10.1001/jama.279.6.445; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Fava C, 2014, EUR J HUM GENET; Frazier-Wood AC, 2013, HUM GENET, V132, P405, DOI 10.1007/s00439-012-1256-1; Go AS., 2014, CIRCULATION, V129, pe28; Health N, 2010, NATL HLTH NUTR EXAMI, V7, P2009; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Keaton JM, 2014, HUM GENET, V133, P1487, DOI 10.1007/s00439-014-1486-5; Kirk P, 2013, J COMPUT BIOL, V20, P979, DOI 10.1089/cmb.2013.0018; Klimentidis Y, 2014, DIABETOLOGIA, V57, P2530, DOI 10.1007/s00125-014-3380-z; Klimentidis YC, 2014, J CLIN ENDOCR METAB, V99, pE1814, DOI 10.1210/jc.2014-1818; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Lin SX, 2011, METAB SYNDR RELAT D, V9, P35, DOI 10.1089/met.2010.0050; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wineinger Nathan E., 2013, Frontiers in Genetics, V4, P86, DOI 10.3389/fgene.2013.00086; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zaitlen N, 2014, NAT GENET, V46, P1356, DOI 10.1038/ng.3139	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126361	10.1371/journal.pone.0126361	http://dx.doi.org/10.1371/journal.pone.0126361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951326	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400084
J	Kunze, S; Dalke, C; Fuchs, H; Klaften, M; Rossler, U; Hornhardt, S; Gomolka, M; Puk, O; Sabrautzki, S; Kulka, U; de Angelis, MH; Graw, J				Kunze, Sarah; Dalke, Claudia; Fuchs, Helmut; Klaften, Matthias; Roessler, Ute; Hornhardt, Sabine; Gomolka, Maria; Puk, Oliver; Sabrautzki, Sibylle; Kulka, Ulrike; de Angelis, Martin Hrabe; Graw, Jochen			New Mutation in the Mouse Xpd/Ercc2 Gene Leads to Recessive Cataracts	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; AGE-RELATED CATARACT; DNA-REPAIR; ENU MUTAGENESIS; GENOME-WIDE; XPD; MICE; POLYMORPHISMS; CANCER; XRCC1	Cataracts are the major eye disorder and have been associated mainly with mutations in lens-specific genes, but cataracts are also frequently associated with complex syndromes. In a large-scale high-throughput ENU mutagenesis screen we analyzed the offspring of paternally treated C3HeB/FeJ mice for obvious dysmorphologies. We identified a mutant suffering from rough coat and small eyes only in homozygotes; homozygous females turned out to be sterile. The mutation was mapped to chromosome 7 between the markers 116J6.1 and D7Mit294; 4 other markers within this interval did not show any recombination among 160 F2-mutants. The critical interval (8.6 Mb) contains 3 candidate genes (Apoe, Six5, Opa3); none of them showed a mutation. Using exome sequencing, we identified a c. 2209T> C mutation in the Xpd/Ercc2 gene leading to a Ser737Pro exchange. During embryonic development, the mutant eyes did not show major changes. Postnatal histological analyses demonstrated small cortical vacuoles; later, cortical cataracts developed. Since XPD/ERCC2 is involved in DNA repair, we checked also for the presence of the repair-associated histone gamma H2AX in the lens. During the time, when primary lens fiber cell nuclei are degraded, gamma H2AX was strongly expressed in the cell nuclei; later, it demarcates clearly the border of the lens cortex to the organelle-free zone. Moreover, we analyzed also whether seemingly healthy heterozygotes might be less efficient in repair of DNA damage induced by ionizing radiation than wild types. Peripheral lymphocytes irradiated by 1Gy Cs-137 showed 6 hrs after irradiation significantly more gamma H2AX foci in heterozygotes than in wild types. These findings demonstrate the importance of XPD/ERCC2 not only for lens fiber cell differentiation, but also for the sensitivity to ionizing radiation. Based upon these data, we hypothesize that variations in the human XPD/ERCC2 gene might increase the susceptibility for several disorders besides Xeroderma pigmentosum in heterozygotes under particular environmental conditions.	[Kunze, Sarah; Dalke, Claudia; Puk, Oliver; Graw, Jochen] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Fuchs, Helmut; Klaften, Matthias; Sabrautzki, Sibylle; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Fuchs, Helmut; Puk, Oliver; de Angelis, Martin Hrabe; Graw, Jochen] Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Roessler, Ute; Hornhardt, Sabine; Gomolka, Maria; Kulka, Ulrike] Fed Off Radiat Protect, Dept SG Radiat Protect & Hlth, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Fac Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Graw, J (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	graw@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Graw, Jochen/D-9336-2013; Dalke, Claudia/D-5913-2015	de Angelis, Martin Hrabe/0000-0002-7898-2353; Dalke, Claudia/0000-0002-8040-4464; Graw, Jochen/0000-0003-0298-9660; Kulka, Ulrike/0000-0002-7734-3162; Kunze, Sarah/0000-0002-6575-1097	National Genome Network Grants (NGFN) [BMBF 01KW9923, BMBF 01GS0850]; EUMODIC (European Mouse Disease Clinic) [LSHG-2006-037188]	National Genome Network Grants (NGFN); EUMODIC (European Mouse Disease Clinic)	Funding: This project was supported by National Genome Network Grants (NGFN, NGFN plus; grant identifications: BMBF 01KW9923, and BMBF 01GS0850) and by EUMODIC (European Mouse Disease Clinic; grant identification: LSHG-2006-037188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Aigner B, 2011, MAMM GENOME, V22, P495, DOI 10.1007/s00335-011-9328-4; Andressoo JO, 2006, PLOS BIOL, V4, P1821, DOI 10.1371/journal.pbio.0040322; Andressoo JO, 2006, CANCER CELL, V10, P121, DOI 10.1016/j.ccr.2006.05.027; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Churchill A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/rstb.2010.0227; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dickey JS, 2012, NUCLEIC ACIDS RES, V40, P10274, DOI 10.1093/nar/gks795; EHLING UH, 1985, MUTAT RES, V150, P393, DOI 10.1016/0027-5107(85)90136-8; Franco RS, 2012, TRANSFUS MED HEMOTH, V39, P302, DOI 10.1159/000342232; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Godon C, 2012, EMBO J, V31, P3550, DOI 10.1038/emboj.2012.193; Govindaraj V, 2015, REPROD BIOMED ONLINE, V30, P303, DOI 10.1016/j.rbmo.2014.11.010; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Klaften M, 2005, NUCLEIC ACIDS RES, V33, pW496, DOI 10.1093/nar/gki430; KRATOCHVILOVA J, 1981, J HERED, V72, P302, DOI 10.1093/oxfordjournals.jhered.a109511; Kuo LJ, 2008, IN VIVO, V22, P305; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Luo YF, 2011, CURR EYE RES, V36, P632, DOI 10.3109/02713683.2011.571358; Menck CFM, 2014, GENET MOL BIOL, V37, P220, DOI 10.1590/S1415-47572014000200008; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Padma G, 2011, MOL VIS, V17, P127; Puk O, 2013, MAMM GENOME, V24, P295, DOI 10.1007/s00335-013-9470-2; Puk O, 2011, MOL VIS, V17, P1164; Puk O, 2011, INVEST OPHTH VIS SCI, V52, P2571, DOI 10.1167/iovs.10-6443; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Tuteja N, 2001, CRIT REV BIOCHEM MOL, V36, P261, DOI 10.1080/20014091074192; Unal M, 2007, EXP EYE RES, V85, P328, DOI 10.1016/j.exer.2007.06.003; van de Ven M, 2012, DNA REPAIR, V11, P874, DOI 10.1016/j.dnarep.2012.08.003; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Zhang Y, 2012, OPHTHALMOLOGY, V119, P900, DOI 10.1016/j.ophtha.2011.11.004; Zhu ML, 2014, SCI REP-UK, V4, DOI 10.1038/srep06281	37	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125304	10.1371/journal.pone.0125304	http://dx.doi.org/10.1371/journal.pone.0125304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951169	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400027
J	Grouzmann, E; Tschopp, O; Triponez, F; Matter, M; Bilz, S; Brandle, M; Drechser, T; Sigrist, S; Zulewski, H; Henzen, C; Fischli, S; Abid, K				Grouzmann, Eric; Tschopp, Oliver; Triponez, Frederic; Matter, Maurice; Bilz, Stefan; Braendle, Michael; Drechser, Tilman; Sigrist, Sarah; Zulewski, Henryk; Henzen, Christoph; Fischli, Stefan; Abid, Karim			Catecholamine Metabolism in Paraganglioma and Pheochromocytoma: Similar Tumors in Different Sites?	PLOS ONE			English	Article							PHENYLETHANOLAMINE N-METHYLTRANSFERASE; ADRENALINE; EPINEPHRINE; CHROMAFFIN; ENZYMES; ELEMENT; CRISIS; CELLS	Pheochromocytoma (PHEO) and paraganglioma (PGL) are catecholamine-producing neuroendocrine tumors that arise respectively inside or outside the adrenal medulla. Several reports have shown that adrenal glucocorticoids (GC) play an important regulatory role on the genes encoding the main enzymes involved in catecholamine (CAT) synthesis i.e. tyrosine hydroxylase (TH), dopamine beta-hydroxylase (DBH) and phenylethanolamine N-methyltransferase (PNMT). To assess the influence of tumor location on CAT metabolism, 66 tissue samples (53 PHEO, 13 PGL) and 73 plasma samples (50 PHEO, 23 PGL) were studied. Western blot and qPCR were performed for TH, DBH and PNMT expression. We found a significantly lower intra-tumoral concentration of CAT and metanephrines (MNs) in PGL along with a downregulation of TH and PNMT at both mRNA and protein level compared with PHEO. However, when PHEO were partitioned into noradrenergic (NorAd) and mixed tumors based on an intra-tumoral CAT ratio (NE/E > 90%), PGL and NorAd PHEO sustained similar TH, DBH and PNMT gene and protein expression. CAT concentration and composition were also similar between NorAd PHEO and PGL, excluding the use of CAT or MNs to discriminate between PGL and PHEO on the basis of biochemical tests. We observed an increase of TH mRNA concentration without correlation with TH protein expression in primary cell culture of PHEO and PGL incubated with dexamethasone during 24 hours; no changes were monitored for PNMT and DBH at both mRNA and protein level in PHEO and PGL. Altogether, these results indicate that long term CAT synthesis is not driven by the close environment where the tumor develops and suggest that GC alone is not sufficient to regulate CAT synthesis pathway in PHEO/PGL.	[Grouzmann, Eric; Abid, Karim] CHU Vaudois, Catecholamine & Peptides Lab, Serv Biomed, CH-1011 Lausanne, Switzerland; [Tschopp, Oliver] Univ Zurich Hosp, Div Endocrinol Diabet & Metab, CH-8091 Zurich, Switzerland; [Triponez, Frederic] Univ Hosp Geneva HUG, Dept Thorac & Endocrine Surg, Geneva, Switzerland; [Matter, Maurice] CHU Vaudois, Div Visceral Surg, CH-1011 Lausanne, Switzerland; [Bilz, Stefan; Braendle, Michael; Drechser, Tilman; Sigrist, Sarah] Kantonsspital, Clin Endocrinol Diabet Bone Dis & Metab, St Gallen, Switzerland; [Zulewski, Henryk] Univ Basel Hosp, Div Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland; [Henzen, Christoph; Fischli, Stefan] KantonsSpital Luzern, Div Endocrinol & Diabet, Luzern, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; Lucerne Cantonal Hospital	Abid, K (corresponding author), CHU Vaudois, Catecholamine & Peptides Lab, Serv Biomed, CH-1011 Lausanne, Switzerland.	Karim-alexandre.abid@chuv.ch	Maurice Joseph, César Matter/J-6717-2017; Tschopp, Oliver/H-7545-2018; Triponez, Frederic/A-6237-2013	Maurice Joseph, César Matter/0000-0003-1816-3003; Triponez, Frederic/0000-0001-7808-496X; Tschopp, Oliver/0000-0002-7733-7934; Abid, Karim/0000-0003-0025-7335; Bilz, Stefan/0000-0002-7716-2791				AXELROD J, 1970, NATURE, V225, P1059, DOI 10.1038/2251059a0; BETITO K, 1992, J NEUROCHEM, V58, P1853, DOI 10.1111/j.1471-4159.1992.tb10062.x; BORNSTEIN SR, 1994, J CLIN ENDOCR METAB, V78, P225, DOI 10.1210/jcem.78.1.7507122; Castro-Vega LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7044; Druce MR, 2011, HORM METAB RES, V43, P292, DOI 10.1055/s-0030-1270520; Dunand M, 2014, CLIN BIOCHEM, V47, P1121, DOI 10.1016/j.clinbiochem.2014.04.003; Dunand M, 2013, ANAL CHEM, V85, P3539, DOI 10.1021/ac4004584; Eisenhofer G, 2005, CLIN CHEM, V51, P735, DOI 10.1373/clinchem.2004.045484; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Evinger MJ, 2007, EXP CELL RES, V313, P772, DOI 10.1016/j.yexcr.2006.11.013; Favier J, 2015, NAT REV ENDOCRINOL, V11, P101, DOI 10.1038/nrendo.2014.188; FUNAHASHI H, 1994, J SURG ONCOL, V57, P196, DOI 10.1002/jso.2930570312; Grouzmann E, 2012, J CLIN ENDOCR METAB, V97, P2773, DOI 10.1210/jc.2012-1557; Haase Matthias, 2011, ENDOCR DEV, V20, P28, DOI 10.1159/000321211; Her S, 2003, MOL PHARMACOL, V64, P1180, DOI 10.1124/mol.64.5.1180; Huynh TT, 2006, ANN NY ACAD SCI, V1073, P241, DOI 10.1196/annals.1353.026; Jeong KH, 2000, ENDOCRINOLOGY, V141, P1142, DOI 10.1210/en.141.3.1142; Kim CH, 2011, J BIOL CHEM, V286, P9196, DOI 10.1074/jbc.M110.192351; KIMURA N, 1992, VIRCHOWS ARCH A, V421, P25, DOI 10.1007/BF01607135; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Rani CSS, 2013, J NEUROCHEM, V126, P19, DOI 10.1111/jnc.12294; Rosas AL, 2008, EUR J ENDOCRINOL, V158, P423, DOI 10.1530/EJE-07-0778; ROSS ME, 1990, J NEUROSCI, V10, P520; Tai TC, 2002, MOL PHARMACOL, V61, P1385, DOI 10.1124/mol.61.6.1385; Takahashi N, 2011, INT J CARDIOL, V146, pE41, DOI 10.1016/j.ijcard.2008.12.183; Wong DL, 2003, ENDOCR PATHOL, V14, P25, DOI 10.1385/EP:14:1:25; Wong DL, 2012, CELL MOL NEUROBIOL, V32, P737, DOI 10.1007/s10571-011-9768-0; WURTMAN RJ, 1966, J BIOL CHEM, V241, P2301; Yi DW, 2010, ENDOCRINE, V37, P213, DOI 10.1007/s12020-009-9303-y	30	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125426	10.1371/journal.pone.0125426	http://dx.doi.org/10.1371/journal.pone.0125426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946206	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000354049700069
J	Landau, U; Asis, L; Williams, LE				Landau, Udi; Asis, Lior; Williams, Leor Eshed			The ERECTA, CLAVATA and class III HD-ZIP Pathways Display Synergistic Interactions in Regulating Floral Meristem Activities	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; STEM-CELL MAINTENANCE; RECEPTOR-LIKE KINASE; FLOWER DEVELOPMENT; GENE ENCODES; ARABIDOPSIS DEVELOPMENT; SIGNALING PATHWAY; ORGAN FORMATION; PROTEIN-KINASE; WUSCHEL	In angiosperms, the production of flowers marks the beginning of the reproductive phase. At the emergence of flower primordia on the flanks of the inflorescence meristem, the WUSCHEL (WUS) gene, which encodes a homeodomain transcription factor starts to be expressed and establishes de novo stem cell population, founder of the floral meristem (FM). Similarly to the shoot apical meristem a precise spatial and temporal expression pattern of WUS is required and maintained through strict regulation by multiple regulatory inputs to maintain stem cell homeostasis. However, following the formation of a genetically determined fixed number of floral organs, this homeostasis is shifted towards organogenesis and the FM is terminated. In here we performed a genetic study to test how a reduction in ERECTA, CLAVATA and class III HD-ZIP pathways affects floral meristem activity and flower development. We revealed strong synergistic phenotypes of extra flower number, supernumerary whorls, total loss of determinacy and extreme enlargement of the meristem as compared to any double mutant combination indicating that the three pathways, CLV3, ER and HD-ZIPIII distinctively regulate meristem activity and that they act in parallel. Our findings yield several new insights into stem cell-driven development. We demonstrate the crucial requirement for coupling floral meristem termination with carpel formation to ensure successful reproduction in plants. We also show how regulation of meristem size and alternation in spatial structure of the meristem serve as a mechanism to determine flower organogenesis. We propose that the loss of FM determinacy due to the reduction in CLV3, ER and HD-ZIPIII activity is genetically separable from the AGAMOUS core mechanism of meristem termination.	[Landau, Udi; Asis, Lior; Williams, Leor Eshed] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Williams, LE (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel.	leor.williams@mail.huji.ac.il		Eshed Williams, Leor/0000-0002-2766-2608	Israel Science Foundation [1351/10]; Vaadia-BARD [IS-4336]; MARIE CURIE IRG [249270]	Israel Science Foundation(Israel Science Foundation); Vaadia-BARD(US-Israel Binational Science Foundation); MARIE CURIE IRG(European Commission)	This work was supported by the Israel Science Foundation 1351/10 (http://www.isf.org.il/English/), Vaadia-BARD IS-4336 (http://www.bardisus.com/) and the MARIE CURIE IRG 249270 (http://cordis.europa.eu/mariecurie-actions/irg/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla E. R, 2010, ARABIDOPSIS BOOK, V8, pe0127, DOI [DOI 10.1199/TAB.0127, 10.1199/tab.0127]; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Carles CC, 2004, GENETICS, V167, P1893, DOI 10.1534/genetics.104.028787; Carles CC, 2009, GENE DEV, V23, P2723, DOI 10.1101/gad.1812609; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Das P, 2009, DEVELOPMENT, V136, P1605, DOI 10.1242/dev.035436; Durbak AR, 2011, GENETICS, V189, P177, DOI 10.1534/genetics.111.130930; Engelhorn J, 2014, ANN BOT-LONDON, V114, P1497, DOI 10.1093/aob/mcu185; Fiume E, 2010, METHODS MOL BIOL, V655, P131, DOI 10.1007/978-1-60761-765-5_9; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Gross-Hardt R, 2003, J CELL SCI, V116, P1659, DOI 10.1242/jcs.00406; Reyes-Olalde JI, 2013, TRENDS PLANT SCI, V18, P644, DOI 10.1016/j.tplants.2013.08.002; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Krizek BA, 2011, J EXP BOT, V62, P3311, DOI 10.1093/jxb/err127; Kwiatkowska D, 2006, J EXP BOT, V57, P571, DOI 10.1093/jxb/erj042; Laux T, 1996, DEVELOPMENT, V122, P87; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Mandel T, 2014, DEVELOPMENT, V141, P830, DOI 10.1242/dev.104687; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Ming F, 2009, GENE DEV, V23, P1705, DOI 10.1101/gad.1834409; Mizukami Y, 1997, PLANT CELL, V9, P393, DOI 10.1105/tpc.9.3.393; Muller R., 2011, F1000 BIOL REP, V3, P13, DOI [10.3410/B3-13, DOI 10.3410/B3-13]; Ni WM, 2004, PLANT PHYSIOL, V134, P1574, DOI 10.1104/pp.103.031971; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Prunet N, 2009, PLANT PHYSIOL, V150, P1764, DOI 10.1104/pp.109.141812; ROE JL, 1993, CELL, V75, P939, DOI 10.1016/0092-8674(93)90537-Z; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Sablowski R, 2007, J EXP BOT, V58, P899, DOI 10.1093/jxb/erm002; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Shpak ED, 2013, J INTEGR PLANT BIOL, V55, P1238, DOI 10.1111/jipb.12108; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sun B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00017; Sun B, 2010, BIOCHEM SOC T, V38, P613, DOI 10.1042/BST0380613; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Talbot MJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-36; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2013, PLANT CELL PHYSIOL, V54, P343, DOI 10.1093/pcp/pcs109; Uchida N, 2012, PLANT SIGNAL BEHAV, V7, P1506, DOI 10.4161/psb.22080; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397; Zuniga-Mayo VM, 2012, PLANT SIGNAL BEHAV, V7, P1501, DOI 10.4161/psb.21901	50	16	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125408	10.1371/journal.pone.0125408	http://dx.doi.org/10.1371/journal.pone.0125408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946150	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700067
J	Mendenhall, AR; Tedesco, PM; Sands, B; Johnson, TE; Brent, R				Mendenhall, Alexander R.; Tedesco, Patricia M.; Sands, Bryan; Johnson, Thomas E.; Brent, Roger			Single Cell Quantification of Reporter Gene Expression in Live Adult Caenorhabditis elegans Reveals Reproducible Cell-Specific Expression Patterns and Underlying Biological Variation	PLOS ONE			English	Article							C. ELEGANS; NEMATODE; H1.1; HERITABILITY; CHROMOSOME; MOLECULES; SEQUENCES; CHROMATIN; TRANSGENE; LONGEVITY	In multicellular organisms such as Caenorhabditis elegans, differences in complex phenotypes such as lifespan correlate with the level of expression of particular engineered reporter genes. In single celled organisms, quantitative understanding of responses to extracellular signals and of cell-to-cell variation in responses has depended on precise measurement of reporter gene expression. Here, we developed microscope-based methods to quantify reporter gene expression in cells of Caenorhabditis elegans with low measurement error. We then quantified expression in strains that carried different configurations of Phsp-16.2-fluorescent-protein reporters, in whole animals, and in all 20 cells of the intestine tissue, which is responsible for most of the fluorescent signal. Some animals bore more recently developed single copy Phsp-16.2 reporters integrated at defined chromosomal sites, others, "classical" multicopy reporter gene arrays integrated at random sites. At the level of whole animals, variation in gene expression was similar: strains with single copy reporters showed the same amount of animal-to-animal variation as strains with multicopy reporters. At the level of cells, in animals with single copy reporters, the pattern of expression in cells within the tissue was highly stereotyped. In animals with multicopy reporters, the cell-specific expression pattern was also stereotyped, but distinct, and somewhat more variable. Our methods are rapid and gentle enough to allow quantification of expression in the same cells of an animal at different times during adult life. They should allow investigators to use changes in reporter expression in single cells in tissues as quantitative phenotypes, and link those to molecular differences. Moreover, by diminishing measurement error, they should make possible dissection of the causes of the remaining, real, variation in expression. Understanding such variation should help reveal its contribution to differences in complex phenotypic outcomes in multicellular organisms.	[Mendenhall, Alexander R.; Sands, Bryan; Brent, Roger] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Tedesco, Patricia M.; Johnson, Thomas E.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Johnson, Thomas E.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Johnson, Thomas E.] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA	Fred Hutchinson Cancer Center; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Mendenhall, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	amendenh@fhcrc.org; rbrent@fhcrc.org			US National Institute of General Medical Sciences [R01 GM97479]; US National Institute on Aging [K99 AG045341]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG045341] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work was supported by grant R01 GM97479 to RB from the US National Institute of General Medical Sciences (http://www.nigms.nih.gov/) and grant K99 AG045341 to AM from the US National Institute on Aging (http://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Boyle TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-275; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Daddysman MK, 2013, J PHYS CHEM B, V117, P1241, DOI 10.1021/jp310348s; DELBRUCK M, 1945, J BACTERIOL, V50, P131; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Gadella T.W.J., 2009, LAB TECHNIQUES BIOCH; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; HOSONO R, 1980, EXP GERONTOL, V15, P285, DOI 10.1016/0531-5565(80)90032-7; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jedrusik MA, 2001, DEVELOPMENT, V128, P1069; Jedrusik MA, 2007, MOL CELL BIOL, V27, P2229, DOI 10.1128/MCB.01713-06; JONES D, 1989, DNA-J MOLEC CELL BIO, V8, P481, DOI 10.1089/dna.1.1989.8.481; Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lewontin RC, 1966, SYST ZOOL, V15, P141, DOI DOI 10.2307/2411632; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; MACMORRIS M, 1994, MOL CELL BIOL, V14, P484, DOI 10.1128/MCB.14.1.484; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Mendenhall AR, 2012, J GERONTOL A-BIOL, V67, P726, DOI 10.1093/gerona/glr225; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; MOVVA NR, 1978, J BACTERIOL, V133, P81, DOI 10.1128/JB.133.1.81-84.1978; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; NORDSTROM K, 1972, J BACTERIOL, V110, P562; Over RS, 2014, MOL PLANT, V7, P481, DOI 10.1093/mp/sst164; Peng HC, 2009, BIOINFORMATICS, V25, P695, DOI 10.1093/bioinformatics/btp046; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Sands B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109940; Seewald AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011426; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Sturtevant AH, 1925, GENETICS, V10, P117; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; UHLIN BE, 1975, J BACTERIOL, V124, P641, DOI 10.1128/JB.124.2.641-649.1975; Wustner D, 2010, TRAFFIC, V11, P440, DOI 10.1111/j.1600-0854.2010.01040.x; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	53	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124289	10.1371/journal.pone.0124289	http://dx.doi.org/10.1371/journal.pone.0124289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946008	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700038
J	Noguchi, TQP; Morimatsu, M; Iwane, AH; Yanagida, T; Uyeda, TQP				Noguchi, Taro Q. P.; Morimatsu, Masatoshi; Iwane, Atsuko H.; Yanagida, Toshio; Uyeda, Taro Q. P.			The Role of Structural Dynamics of Actin in Class-Specific Myosin Motility	PLOS ONE			English	Article							F-ACTIN; SLIDING MOVEMENT; 3-DIMENSIONAL STRUCTURE; V MOTOR; FILAMENTS; BINDING; STATE; MUSCLE; POLYMERIZATION; DICTYOSTELIUM	The structural dynamics of actin, including the tilting motion between the small and large domains, are essential for proper interactions with actin-binding proteins. Gly146 is situated at the hinge between the two domains, and we previously showed that a G146V mutation leads to severe motility defects in skeletal myosin but has no effect on motility of myosin V. The present study tested the hypothesis that G146V mutation impaired rotation between the two domains, leading to such functional defects. First, our study showed that depolymerization of G146V filaments was slower than that of wild-type filaments. This result is consistent with the distinction of structural states of G146V filaments from those of the wild type, considering the recent report that stabilization of actin filaments involves rotation of the two domains. Next, we measured intramolecular FRET efficiencies between two fluorophores in the two domains with or without skeletal muscle heavy meromyosin or the heavy meromyosin equivalent of myosin V in the presence of ATP. Single-molecule FRET measurements showed that the conformations of actin subunits of control and G146V actin filaments were different in the presence of skeletal muscle heavy meromyosin. This altered conformation of G146V subunits may lead to motility defects in myosin II. In contrast, distributions of FRET efficiencies of control and G146V subunits were similar in the presence of myosin V, consistent with the lack of motility defects in G146V actin with myosin V. The distribution of FRET efficiencies in the presence of myosin V was different from that in the presence of skeletal muscle heavy meromyosin, implying that the roles of actin conformation in myosin motility depend on the type of myosin.	[Noguchi, Taro Q. P.; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Noguchi, Taro Q. P.; Uyeda, Taro Q. P.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Noguchi, Taro Q. P.] Natl Inst Technol, Miyakonojo Coll, Dept Chem Sci & Engn, Miyakonojo, Miyazaki, Japan; [Morimatsu, Masatoshi; Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Nanobiol Labs, Suita, Osaka, Japan; [Iwane, Atsuko H.; Yanagida, Toshio] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Uyeda, Taro Q. P.] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 232, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Osaka University; RIKEN; Yokohama City University	Noguchi, TQP (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	t-noguchi@cc.miyakonojo-nct.ac.jp		Iwane, Atsuko/0000-0003-2641-2268	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for JSPS Fellows and Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to T.N., and the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/) to T.U. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; ELZINGA M, 1975, J BIOL CHEM, V250, P5897; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; Kim E, 1998, BIOCHEMISTRY-US, V37, P17801, DOI 10.1021/bi981286b; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kubota H, 2009, J BIOL CHEM, V284, P35251, DOI 10.1074/jbc.M109.013565; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; LOSCALZO J, 1975, P NATL ACAD SCI USA, V72, P3412, DOI 10.1073/pnas.72.9.3412; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; Morimatsu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045864; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Noguchi TQP, 2012, J BIOL CHEM, V287, P24339, DOI 10.1074/jbc.M111.321752; Noguchi TQP, 2010, BIOCHEM BIOPH RES CO, V396, P1006, DOI 10.1016/j.bbrc.2010.05.047; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; OOSAWA F, 1973, COLD SPRING HARB SYM, V37, P277, DOI 10.1101/SQB.1973.037.01.038; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Steinmetz MO, 2000, J MOL BIOL, V303, P171, DOI 10.1006/jmbi.2000.4129; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; TAKASHI R, 1988, BIOCHEMISTRY-US, V27, P938, DOI 10.1021/bi00403a015; Tokuraku K, 2009, J MOL BIOL, V386, P149, DOI 10.1016/j.jmb.2008.12.008; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l	48	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126262	10.1371/journal.pone.0126262	http://dx.doi.org/10.1371/journal.pone.0126262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945499	Green Submitted, gold, Green Published			2022-12-26	WOS:000354049700119
J	Li, SC; Khan, M; Caplin, M; Meyer, T; Oberg, K; Giandomenico, V				Li, Su-Chen; Khan, Mohid; Caplin, Martyn; Meyer, Tim; Oberg, Kjell; Giandomenico, Valeria			Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs	PLOS ONE			English	Article							DOWN-REGULATION; CANCER; EXPRESSION; BIOMARKERS; ENDOCRINE; METFORMIN; SERUM; MIRNAS; CELLS	We previously detected and investigated nine altered microRNAs in small intestinal neuroendocrine tumor (SI-NET) tissues at different stages of disease. The aims of this study are to: 1) analyze whether SI-NET tissue microRNAs can be also detected in patient serum samples, 2) investigate a potential somatostatin analogs (SSAs) role on microRNA levels regulation in SSA-treated patient samples and 3) elucidate whether the serum microRNA levels in samples collected in different hospitals are predictable and steady. Our results show that tissue microRNAs are detectable in patient serum samples, and miR-96, -182, -183, -196a and -200a levels are lower in SI-NET untreated patients than in SSA-treated patients at all different stages. Conversely, miR-31, -129-5p, -133a and -215 levels do not show any difference in untreated SI-NET patients and SSA-treated patients at all different stages. Our findings also show that miR-200a exhibits an atypical behavior with high levels in both untreated and SSA-treated patients at liver metastasis stage, and unequivocally never at the earlier stages. Serum samples collected in two hospitals keep alike microRNA level pattern, elucidating that the results are not dependent on samples handling. In conclusion, SI-NET tissue microRNAs are always detectable in untreated and SSA-treated patient serum samples, SSAs play an unknown role in eliciting SSA-treated patients' microRNA levels higher than in untreated patients, and this study enlightens that miR-200a might be involved in the liver metastasis during SI-NET progression.	[Li, Su-Chen; Oberg, Kjell; Giandomenico, Valeria] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Khan, Mohid; Caplin, Martyn] Royal Free Hosp, Ctr Gastroenterol, Neuroendocrine Tumor Unit, London NW3 2QG, England; [Khan, Mohid] Royal Marsden NHS Fdn Trust, London, England; [Meyer, Tim] UCL, Dept Oncol, UCL Canc Inst, London, England; [Oberg, Kjell; Giandomenico, Valeria] Univ Uppsala Hosp, Sci Life Lab, Endocrine Oncol Clin, Uppsala, Sweden	Uppsala University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Royal Marsden NHS Foundation Trust; University of London; University College London; Uppsala University; Uppsala University Hospital	Giandomenico, V (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	valeria.giandomenico@medsci.uu.se	Oberg, Kjell/AAG-7118-2019		Lions Cancer Research; Erik, Karin and Gosta Selander Foundation	Lions Cancer Research; Erik, Karin and Gosta Selander Foundation	This work was supported by funding from the Lions Cancer Research, and Erik, Karin and Gosta Selander Foundation. The funders had no role in study design, data collection analysis and interpretation of data, decision to publish or preparation of the manuscript.	Ahlman H, 2001, ANN ONCOL, V12, pS63, DOI 10.1093/annonc/12.suppl_2.S63; Bao B, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.05; Burney S, 2014, J PANCREAS, V15, P313, DOI 10.6092/1590-8577/2677; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chang AI, 2015, CURR CANC DRUG TARGE; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HE L, 2004, NAT REV GENET, V5, P522; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Li SC, 2013, MODERN PATHOL, V26, P685, DOI 10.1038/modpathol.2012.216; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luzi E, 2011, ENDOCR PRACT, V17, P58, DOI 10.4158/EP11062.RA; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Oberg KE, 2010, ANN ONCOL, V21, P72, DOI 10.1093/annonc/mdq290; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pulito C, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.03; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Ruebel K, 2010, MODERN PATHOL, V23, P367, DOI 10.1038/modpathol.2009.161; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Singh Pankaj K, 2011, Mol Cell Pharmacol, V3, P125; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Taal B G, 2004, Neuroendocrinology, V80 Suppl 1, P3, DOI 10.1159/000080731; Vicentini C, 2014, MOLECULES, V19, P2458, DOI 10.3390/molecules19022458; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	33	32	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125553	10.1371/journal.pone.0125553	http://dx.doi.org/10.1371/journal.pone.0125553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942502	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400044
J	Loganathan, T; Lee, WS; Lee, KF; Jit, M; Ng, CW				Loganathan, Tharani; Lee, Way-Seah; Lee, Kok-Foo; Jit, Mark; Ng, Chiu-Wan			Household Catastrophic Healthcare Expenditure and Impoverishment Due to Rotavirus Gastroenteritis Requiring Hospitalization in Malaysia	PLOS ONE			English	Article							COST-EFFECTIVENESS; VACCINATION; IMPACT; COUNTRIES; DISEASE; BURDEN; ASIA	Background While healthcare costs for rotavirus gastroenteritis requiring hospitalization may be burdensome on households in Malaysia, exploration on the distribution and catastrophic impact of these expenses on households are lacking. Objectives We assessed the economic burden, levels and distribution of catastrophic healthcare expenditure, the poverty impact on households and inequities related to healthcare payments for acute gastroenteritis requiring hospitalization in Malaysia. Methods A two-year prospective, hospital-based study was conducted from 2008 to 2010 in an urban (Kuala Lumpur) and rural (Kuala Terengganu) setting in Malaysia. All children under the age of 5 years admitted for acute gastroenteritis were included. Patients were screened for rotavirus and information on healthcare expenditure was obtained. Results Of the 658 stool samples collected at both centers, 248 (38%) were positive for rotavirus. Direct and indirect costs incurred were significantly higher in Kuala Lumpur compared with Kuala Terengganu (US$222 Vs. US$45; p<0.001). The mean direct and indirect costs for rotavirus gastroenteritis consisted 20% of monthly household income in Kuala Lumpur, as compared with only 5% in Kuala Terengganu. Direct medical costs paid out-of-pocket caused 141 (33%) households in Kuala Lumpur to experience catastrophic expenditure and 11 (3%) households to incur poverty. However in Kuala Terengganu, only one household (0.5%) experienced catastrophic healthcare expenditure and none were impoverished. The lowest income quintile in Kuala Lumpur was more likely to experience catastrophic payments compared to the highest quintile (87% vs 8%). The concentration index for out-of-pocket healthcare payments was closer to zero at Kuala Lumpur (0.03) than at Kuala Terengganu (0.24). Conclusions While urban households were wealthier, healthcare expenditure due to gastroenteritis had more catastrophic and poverty impact on the urban poor. Universal rotavirus vaccination would reduce both disease burden and health inequities in Malaysia.	[Loganathan, Tharani; Ng, Chiu-Wan] Univ Malaya, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia; [Lee, Way-Seah] Univ Malaya, Dept Paediat, Kuala Lumpur 50603, Malaysia; [Lee, Way-Seah] Univ Malaya, Paediat & Child Hlth Res Grp, Kuala Lumpur 50603, Malaysia; [Lee, Kok-Foo] Hosp Sultanah Nur Zahirah, Dept Paediat, Kuala Terengganu, Malaysia; [Jit, Mark] Publ Hlth England, Modeling & Econ Unit, London, England; [Jit, Mark] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Universiti Malaya; Universiti Malaya; Universiti Malaya; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Loganathan, T (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr Clin Epidemiol & Evidence Based Med, Kuala Lumpur 50603, Malaysia.	drtharani@gmail.com	Loganathan, Tharani/L-8836-2018; LEE, WAY SEAH/B-8844-2010; NG, CHIU WAN/B-5218-2010; Jit, Mark/HDM-7797-2022; NG, CHIU WAN/B-9222-2010	Loganathan, Tharani/0000-0001-6690-000X; LEE, WAY SEAH/0000-0001-9163-2828; NG, CHIU WAN/0000-0002-7687-2310; Jit, Mark/0000-0001-6658-8255	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]; Merck Sharp and Dohme Co. Ltd	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant; Merck Sharp and Dohme Co. Ltd	The economic evaluation is part of the STeMM Programme supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant number E000010-20001). The data collection, specimen testing and genotyping was funded by Merck Sharp and Dohme Co. Ltd. to Way-Seah Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 3 NAT HLTH MORB SURV; [Anonymous], EPU MEAN MONTHL GROS; [Anonymous], WORLD DEV IND DAT CO; [Anonymous], 2010, WORLD HLTH REP; [Anonymous], 2002, GEN PROT 1 HOSP BAS; [Anonymous], WORLD HLTH REP 2013, DOI [10.1186/1478-4505-11-47, DOI 10.1186/1478-4505-11-47]; [Anonymous], GDP GNI CURR CONST P; [Anonymous], 1996, NAT HLTH MORB SURV; [Anonymous], 2008, ANAL HLTH EQUITY USI; Chai PF, 2009, VACCINE, V27, pF112, DOI 10.1016/j.vaccine.2009.08.069; Chee Heng Leng, 2007, HLTH CARE MALAYSIA D; Deogaonkar R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-878; Department of Statistics, 2009, HOUS INC BAS AM SURV; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Hsu VP, 2005, J INFECT DIS, V192, pS80, DOI 10.1086/431494; Jaafar S, 2013, HLTH SYSTEMS TRANSIT; Kananatu K, 2002, Asia Pac J Public Health, V14, P23; Lee WS, 2007, J PAEDIATR CHILD H, V43, P818, DOI 10.1111/j.1440-1754.2007.01160.x; Lee WS, 2012, HUM VACC IMMUNOTHER, V8, P1401, DOI 10.4161/hv.21577; Mirzayeva R, 2009, VACCINE, V27, pF120, DOI 10.1016/j.vaccine.2009.09.039; O'Donnell OA, 2008, CATASTROPHIC PAYMENT, P203; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Phua KB, 2009, VACCINE, V27, P5936, DOI 10.1016/j.vaccine.2009.07.098; Rheingans R, 2012, VACCINE, V30, pA15, DOI 10.1016/j.vaccine.2012.01.018; Savedoff WD, 2011, ACHIEVING UNIVERSAL; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Verguet S, 2013, VACCINE, V31, P4902, DOI 10.1016/j.vaccine.2013.07.014; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; World Health Organization, 2013, ROT VACC; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	31	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125878	10.1371/journal.pone.0125878	http://dx.doi.org/10.1371/journal.pone.0125878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PT	25941805	Green Accepted, gold, Green Published			2022-12-26	WOS:000353943400055
J	Chiang, CI; Huang, YL; Huang, CY; Shiue, HS; Chen, WJ; Pu, YS; Lin, YC; Hsueh, YM				Chiang, Chien-I; Huang, Ya-Li; Huang, Chao-Yuan; Shiue, Horng-Sheng; Chen, Wei-Jen; Pu, Yeong-Shiau; Lin, Ying-Chin; Hsueh, Yu-Mei			XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma	PLOS ONE			English	Article							BLADDER-CANCER RISK; BASE EXCISION-REPAIR; LOW ARSENIC EXPOSURE; ARG399GLN POLYMORPHISM; GENETIC POLYMORPHISMS; TOBACCO-SMOKE; DNA-ADDUCTS; METAANALYSIS; 8-HYDROXY-2'-DEOXYGUANOSINE; SUSCEPTIBILITY	The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospital-based case-control study that included 168 cases of UC and 336 age-and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/Arg genotype were positively correlated to UC (OR[95%CI] = 2.27 [1.20-4.27] and 1.59 [1.06-2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/A-C haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8-OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC.	[Chiang, Chien-I; Chen, Wei-Jen; Hsueh, Yu-Mei] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Huang, Ya-Li; Hsueh, Yu-Mei] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan; [Huang, Chao-Yuan; Pu, Yeong-Shiau] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Shiue, Horng-Sheng] Chang Gung Mem Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Shiue, Horng-Sheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; Taipei Med Univ, Shung Ho Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Wan Fang Hosp, Dept Hlth Examinat, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Hsueh, YM (corresponding author), Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan.	ymhsueh@tmu.edu.tw	Chen, Wei-Jen/AAF-1739-2019	Chen, Wei-Jen/0000-0003-0683-7904; PU, YEONG-SHIAU/0000-0002-2859-3966; HUANG, CHAO-YUAN/0000-0002-9322-6062	National Science Council of ROC [NSC 862314-B-038-038, NSC 87-2314-B-038-029, NSC-882314-B-038-112, NSC-89-2314-B038-049, SC-892320-B038-013]; NSC [100-2314-B-038-026];  [NSC-90-2320-B-038-021];  [NSC-913112-B-038-0019];  [NSC-92-3112-B-038-001];  [NSC-93-3112-B-038-001];  [NSC-94-2314-B-038-023];  [NSC-95-2314-B-038-007];  [NSC-96-2314-B038-003];  [NSC-97-2314-B-038-015-MY3 (1-3)];  [NSC-97-2314-B-038-015-MY3 (2-3)];  [NSC-97-2314-B-038-015-MY3 (3-3))]	National Science Council of ROC(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); ; ; ; ; ; ; ; ; ; 	This study was supported by grants from the National Science Council of the ROC (NSC 862314-B-038-038, NSC 87-2314-B-038-029, NSC-882314-B-038-112, NSC-89-2314-B038-049, SC-892320-B038-013, NSC-90-2320-B-038-021, NSC-913112-B-038-0019, NSC-92-3112-B-038-001, NSC-93-3112-B-038-001, NSC-94-2314-B-038-023, NSC-95-2314-B-038-007, NSC-96-2314-B038-003, NSC-97-2314-B-038-015-MY3 (1-3), NSC-97-2314-B-038-015-MY3 (2-3), NSC-97-2314-B-038-015-MY3 (3-3)), and NSC 100-2314-B-038-026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay T, 2003, UROL INT, V71, P271, DOI 10.1159/000072677; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benhamou S, 2003, MUTAGENESIS, V18, P445, DOI 10.1093/mutage/geg020; Bjerregaard BK, 2006, INT J CANCER, V119, P2412, DOI 10.1002/ijc.22169; Bureau of Health Promotion, 2012, CANC REG ANN REP; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chiang CI, 2014, TOXICOL APPL PHARM; Chiang HC, 2012, SCI TOTAL ENVIRON, V414, P134, DOI 10.1016/j.scitotenv.2011.11.039; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; Chung CJ, 2008, TOXICOL APPL PHARM, V226, P14, DOI 10.1016/j.taap.2007.08.021; Chung CJ, 2011, SCI TOTAL ENVIRON, V409, P1638, DOI 10.1016/j.scitotenv.2011.01.046; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064001; FIELDING S, 1989, MUTAT RES, V214, P147, DOI 10.1016/0027-5107(89)90208-X; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Frosina G, 2004, FREE RADICAL RES, V38, P1037, DOI 10.1080/10715760400011445; Ghorbanihaghjo A, 2013, J HEALTH POPUL NUTR, V31, P343; Giberti C, 2010, BIOMED ENVIRON SCI, V23, P300, DOI 10.1016/S0895-3988(10)60067-0; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Lao T, 2008, MUTAGENESIS, V23, P523, DOI 10.1093/mutage/gen046; Lei YC, 2002, MUTAT RES-GEN TOX EN, V519, P93, DOI 10.1016/S1383-5718(02)00127-4; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Liu C, 2013, CRIT REV EUKAR GENE, V23, P339; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Lowe FJ, 2009, CLIN CHEM LAB MED, V47, P311, DOI 10.1515/CCLM.2009.069; Lunn RM, 1999, CANCER RES, V59, P2557; Mao YQ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-58; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Nia AB, 2001, CARCINOGENESIS, V22, P395, DOI 10.1093/carcin/22.3.395; PHILLIPS DH, 1993, ENVIRON HEALTH PERSP, V99, P45, DOI 10.2307/3431456; Pu YS, 2007, TOXICOL APPL PHARM, V218, P99, DOI 10.1016/j.taap.2006.09.021; Pylvas M, 2011, ANTICANCER RES, V31, P1411; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Saito S, 2000, RES COMMUN MOL PATH, V107, P39; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Wada T, 2006, ANTICANCER RES, V26, P3403; Wang CY, 2008, UROLOGY, V72, P869, DOI 10.1016/j.urology.2007.12.059; Wang YF, 2003, DNA REPAIR, V2, P901, DOI 10.1016/S1568-7864(03)00085-5; Welty C.J., 2014, UROL ONCOL, V32, P25, DOI DOI 10.1016/J.UR0L0NC.2012.09.001; Weng HC, 2009, MUTAT RES-GEN TOX EN, V679, P59, DOI 10.1016/j.mrgentox.2009.07.005; Yang DF, 2014, GENE, V534, P17, DOI 10.1016/j.gene.2013.10.038; Yuen JWM, 2008, NUTR CANCER, V60, P109, DOI 10.1080/01635580701525869; Zhang F, 2013, TUMOR BIOL, V34, P2659, DOI 10.1007/s13277-013-0816-x; Zhuo WL, 2013, EXP BIOL MED, V238, P66, DOI 10.1258/ebm.2012.012209	50	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124066	10.1371/journal.pone.0124066	http://dx.doi.org/10.1371/journal.pone.0124066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938407	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000014
J	Da Costa, S; Bourquin, NMP; Knebel, JF; Saenz, M; Van der Zwaag, W; Clarke, S				Da Costa, Sandra; Bourquin, Nathalie M. -P.; Knebel, Jean-Francois; Saenz, Melissa; Van der Zwaag, Wietske; Clarke, Stephanie			Representation of Sound Objects within Early-Stage Auditory Areas: A Repetition Effect Study Using 7T fMRI	PLOS ONE			English	Article							ENVIRONMENTAL SOUNDS; TONOTOPIC ORGANIZATION; HUMAN BRAIN; NATURAL SOUNDS; ANIMAL VOCALIZATIONS; CYTOCHROME-OXIDASE; TEMPORAL DYNAMICS; CORTICAL NETWORKS; PLANUM TEMPORALE; COMPLEX SOUNDS	Environmental sounds are highly complex stimuli whose recognition depends on the interaction of top-down and bottom-up processes in the brain. Their semantic representations were shown to yield repetition suppression effects, i. e. a decrease in activity during exposure to a sound that is perceived as belonging to the same source as a preceding sound. Making use of the high spatial resolution of 7T fMRI we have investigated the representations of sound objects within early-stage auditory areas on the supratemporal plane. The primary auditory cortex was identified by means of tonotopic mapping and the non-primary areas by comparison with previous histological studies. Repeated presentations of different exemplars of the same sound source, as compared to the presentation of different sound sources, yielded significant repetition suppression effects within a subset of early-stage areas. This effect was found within the right hemisphere in primary areas A1 and R as well as two non-primary areas on the antero-medial part of the planum temporale, and within the left hemisphere in A1 and a non-primary area on the medial part of Heschl's gyrus. Thus, several, but not all early-stage auditory areas encode the meaning of environmental sounds.	[Da Costa, Sandra; Bourquin, Nathalie M. -P.; Clarke, Stephanie] Univ Lausanne, CHU Vaudois, Dept Neurosci Clin, Serv Neuropsychol & Neurorehabil, Lausanne, Switzerland; [Knebel, Jean-Francois] Univ Lausanne, CHU Vaudois, Natl Ctr Competence Res,SYNAPSY Synapt Bases Ment, Serv Neuropsychol & Neurorehabil,Dept Neurosci Cl, Lausanne, Switzerland; [Saenz, Melissa] Univ Lausanne, CHU Vaudois, Dept Neurosci Clin, Lab Rech Neuroimagerie, Lausanne, Switzerland; [Van der Zwaag, Wietske] Ecole Polytech Fed Lausanne, Ctr Imagerie Biomed, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Da Costa, S (corresponding author), Univ Lausanne, CHU Vaudois, Dept Neurosci Clin, Serv Neuropsychol & Neurorehabil, Lausanne, Switzerland.	Sandra.Borges-Da-Costa@chuv.ch	van der Zwaag, Wietske/AAU-6268-2020; Clarke, Stephanie/A-2845-2009; van der Zwaag, Wietske/I-4568-2015; Da Costa Monney, Sandra/AAB-5050-2022	van der Zwaag, Wietske/0000-0003-3223-9721; Clarke, Stephanie/0000-0001-9393-5718; Knebel, Jean-Francois/0000-0003-1665-1724; Da Costa, Sandra/0000-0003-1376-9233	Swiss National Science Foundation Grant [320030B-141177]; Foundation Biaggi de Blasys grant	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); Foundation Biaggi de Blasys grant	Swiss National Science Foundation Grant 320030B-141177 and the Foundation Biaggi de Blasys grant to SC http://www.snf.ch/fr/encouragement/carrieres/professeurs-boursiers-fns/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2003, EXP BRAIN RES, V153, P591, DOI 10.1007/s00221-003-1616-0; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; Altmann CF, 2010, NEUROPSYCHOLOGIA, V48, P2824, DOI 10.1016/j.neuropsychologia.2010.05.024; Andics A, 2013, NEUROIMAGE, V69, P277, DOI 10.1016/j.neuroimage.2012.12.033; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Barrett DJK, 2006, NEUROIMAGE, V32, P968, DOI 10.1016/j.neuroimage.2006.03.050; Baumann S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00011; Baumann S, 2010, NEUROIMAGE, V50, P1099, DOI 10.1016/j.neuroimage.2009.12.103; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; Bourquin NMP, 2013, NEUROIMAGE, V73, P40, DOI 10.1016/j.neuroimage.2013.01.026; Bourquin NMP, 2012, NEUROIMAGE, V62, P1800, DOI 10.1016/j.neuroimage.2012.04.055; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Cammoun L, 2015, BRAIN STRUCT FUNCT, V220, P3537, DOI 10.1007/s00429-014-0872-z; Chandrasekaran B, 2011, J COGNITIVE NEUROSCI, V23, P2690, DOI 10.1162/jocn.2011.21631; Chevillet M, 2011, J NEUROSCI, V31, P9345, DOI 10.1523/JNEUROSCI.1448-11.2011; Clarke S, 1998, EUR J NEUROSCI, V10, P741, DOI 10.1046/j.1460-9568.1998.00043.x; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Clarke S, 1996, NEUROPSYCHOLOGIA, V34, P587, DOI 10.1016/0028-3932(95)00142-5; Da Costa S, 2015, BRAIN TOPOGR, V28, P66, DOI 10.1007/s10548-014-0388-0; Da Costa S, 2013, J NEUROSCI, V33, P1858, DOI 10.1523/JNEUROSCI.4405-12.2013; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; De Lucia M, 2012, NEUROIMAGE, V60, P1704, DOI 10.1016/j.neuroimage.2012.01.131; De Lucia M, 2010, CEREB CORTEX, V20, P1676, DOI 10.1093/cercor/bhp230; De Martino F, 2015, CEREB CORTEX, V25, P3394, DOI 10.1093/cercor/bhu150; De Martino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060514; Dick F, 2012, J NEUROSCI, V32, P16095, DOI 10.1523/JNEUROSCI.1712-12.2012; Doehrmann O, 2008, NEUROPSYCHOLOGIA, V46, P2776, DOI 10.1016/j.neuropsychologia.2008.05.011; Engel LR, 2009, NEUROIMAGE, V47, P1778, DOI 10.1016/j.neuroimage.2009.05.041; Engel SA, 2012, NEUROIMAGE, V62, P1195, DOI 10.1016/j.neuroimage.2011.09.059; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Giordano BL, 2013, CEREB CORTEX, V23, P2025, DOI 10.1093/cercor/bhs162; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gotts SJ, 2012, COGN NEUROSCI-UK, V3, P227, DOI 10.1080/17588928.2012.670617; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2006, NEURON, V49, P170, DOI 10.1016/j.neuron.2006.01.004; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hackett TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00072; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Hart HC, 2004, HUM BRAIN MAPP, V21, P178, DOI 10.1002/hbm.10156; Henson RN, 2014, TRENDS COGN SCI, V18, P376, DOI 10.1016/j.tics.2014.03.004; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Knebel JF, 2008, BRAIN TOPOGR, V20, P284, DOI 10.1007/s10548-008-0046-5; Langers DRM, 2012, CEREB CORTEX, V22, P2024, DOI 10.1093/cercor/bhr282; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Latinus M, 2012, BRAIN TOPOGR, V25, P194, DOI 10.1007/s10548-011-0207-9; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Lewis JW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00027; Lewis JW, 2009, J NEUROSCI, V29, P2283, DOI 10.1523/JNEUROSCI.4145-08.2009; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Marie D, 2015, BRAIN STRUCT FUNCT, V220, P729, DOI 10.1007/s00429-013-0680-x; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Moerel M, 2012, J NEUROSCI, V32, P14205, DOI 10.1523/JNEUROSCI.1388-12.2012; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Murray MM, 2008, NEUROIMAGE, V39, P847, DOI 10.1016/j.neuroimage.2007.09.002; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Renvall H, 2012, NEUROIMAGE, V62, P1877, DOI 10.1016/j.neuroimage.2012.06.010; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Salomon R, 2014, BRAIN TOPOGR, V27, P209, DOI 10.1007/s10548-013-0298-6; Schadwinkel S, 2010, EUR J NEUROSCI, V32, P1970, DOI 10.1111/j.1460-9568.2010.07459.x; Schadwinkel S, 2010, CEREB CORTEX, V20, P2863, DOI 10.1093/cercor/bhq037; Sharda M, 2012, NEUROSCIENCE, V214, P49, DOI 10.1016/j.neuroscience.2012.03.053; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Striem-Amit E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017832; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; van der Zwaag W, 2011, NEUROIMAGE, V54, P1803, DOI 10.1016/j.neuroimage.2010.10.032; van der Zwaag W, 2009, J MAGN RESON IMAGING, V30, P1171, DOI 10.1002/jmri.21951; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Viceic D, 2006, NEUROREPORT, V17, P1659, DOI 10.1097/01.wnr.0000239962.75943.dd; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Woods DL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00042; Woods DL, 2009, CURR OPIN OTOLARYNGO, V17, P407, DOI 10.1097/MOO.0b013e3283303330; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044	101	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124072	10.1371/journal.pone.0124072	http://dx.doi.org/10.1371/journal.pone.0124072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938430	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000015
J	Gilbert, JA; Long, EF; Brooks, RP; Friedland, GH; Moll, AP; Townsend, JP; Galvani, AP; Shenoi, SV				Gilbert, Jennifer A.; Long, Elisa F.; Brooks, Ralph P.; Friedland, Gerald H.; Moll, Anthony P.; Townsend, Jeffrey P.; Galvani, Alison P.; Shenoi, Sheela V.			Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; DRUG-RESISTANT TUBERCULOSIS; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; MDR-TB; HIV; SETTINGS; IMPACT; MODEL; TRANSMISSION	The WHO recommends integrating interventions to address the devastating TB/HIV co-epidemics in South Africa, yet integration has been poorly implemented and TB/HIV control efforts need strengthening. Identifying infected individuals is particularly difficult in rural settings. We used mathematical modeling to predict the impact of community-based, integrated TB/HIV case finding and additional control strategies on South Africa's TB/HIV epidemics. We developed a model incorporating TB and HIV transmission to evaluate the effectiveness of integrating TB and HIV interventions in rural South Africa over 10 years. We modeled the impact of a novel screening program that integrates case finding for TB and HIV in the community, comparing it to status quo and recommended TB/HIV control strategies, including GeneXpert, MDR-TB treatment decentralization, improved first-line TB treatment cure rate, isoniazid preventive therapy, and expanded ART. Combining recommended interventions averted 27% of expected TB cases (95% CI 18-40%) 18% HIV (95% CI 13-24%), 60% MDR-TB (95% CI 34-83%), 69% XDR-TB (95% CI 34-90%), and 16% TB/HIV deaths (95% CI 12-29). Supplementing these interventions with annual community-based TB/HIV case finding averted a further 17% of TB cases (44% total; 95% CI 31-56%), 5% HIV (23% total; 95% CI 17-29%), 8% MDR-TB (68% total; 95% CI 40-88%), 4% XDR-TB (73% total; 95% CI 38-91%), and 8% TB/HIV deaths (24% total; 95% CI 16-39%). In addition to increasing screening frequency, we found that improving TB symptom questionnaire sensitivity, second-line TB treatment delays, default before initiating TB treatment or ART, and second-line TB drug efficacy were significantly associated with even greater reductions in TB and HIV cases. TB/HIV epidemics in South Africa were most effectively curtailed by simultaneously implementing interventions that integrated community-based TB/HIV control strategies and targeted drug-resistant TB. Strengthening existing TB and HIV treatment programs is needed to further reduce disease incidence.	[Gilbert, Jennifer A.; Friedland, Gerald H.; Galvani, Alison P.] Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT 06520 USA; [Gilbert, Jennifer A.; Galvani, Alison P.] Yale Univ, Ctr Infect Dis Modeling & Anal, Sch Publ Hlth, New Haven, CT USA; [Long, Elisa F.] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA USA; [Brooks, Ralph P.; Friedland, Gerald H.; Moll, Anthony P.; Shenoi, Sheela V.] Yale Univ, Sch Med, Dept Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA; [Moll, Anthony P.] Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Townsend, Jeffrey P.] Yale Univ, Dept Biostat, New Haven, CT USA; [Townsend, Jeffrey P.; Galvani, Alison P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Townsend, Jeffrey P.; Galvani, Alison P.] Yale Univ, Program Computat Biol & Informat, New Haven, CT USA	Yale University; Yale University; University of California System; University of California Los Angeles; Yale University; Yale University; Yale University; Yale University	Gilbert, JA (corresponding author), Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT 06520 USA.	jennifer.gilbert@yale.edu	Townsend, Jeffrey/H-2747-2019; Shenoi, Sheela/GRY-6103-2022; Shenoi, Sheela/Z-2641-2019; Long, Elisa/AFQ-5915-2022	Townsend, Jeffrey/0000-0002-9890-3907; Shenoi, Sheela/0000-0001-7654-4344; 	National Institute on Drug Abuse [R01DA015612, R01DA025932]; Gilead Foundation [157201]; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention [1U01GH000524-01]; National Institutes of Health [2U01GM087719, 5U01GM105627]; National Institute of Allergy and Infectious Diseases [1K23AI089260]; National Institutes of Health's Fogarty International Clinical Research Program [R24TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025932, R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Gilead Foundation(Gilead Sciences); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health's Fogarty International Clinical Research Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JAG was supported by the National Institute on Drug Abuse (R01DA015612, http://www.drugabuse.gov). GHF was supported by the National Institute on Drug Abuse (R01DA025932, http://www.drugabuse.gov). GHF, RPB, and SVS were supported by the Gilead Foundation (157201, http://www.gilead.com). GHF, RPB, APM, APG, and SVS were supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention (1U01GH000524-01, http://www.cdc.gov). APG was supported by the National Institutes of Health (2U01GM087719 and 5U01GM105627, http://nih.gov). SVS was supported by the National Institute of Allergy and Infectious Diseases (1K23AI089260, http://www.niaid.nih.gov) and the National Institutes of Health's Fogarty International Clinical Research Program (R24TW007988, http://nih.gov). Staff from the CDC participated in preparation of the manuscript. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2014, NAT TUB MAN GUID; [Anonymous], 2013, S AFR ANT TREATM GUI; [Anonymous], 2011, MULT RES TUB POL FRA; [Anonymous], 2003, LAB MED, DOI DOI 10.1046/J.1439-0477.2003.03049.X; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Chehab JC, 2012, INT J TUBERC LUNG D, V16, P903, DOI 10.5588/ijtld.11.0722; Churchyard G, 2014, 21 C RETR OPP INF BO; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2012, MODELLING TUBERCULOS; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Friedland G, 2012, 43 UN WORLD C LUNG H; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Houben RMGJ, 2014, INT J TUBERC LUNG D, V18, P509, DOI 10.5588/ijtld.13.0773; Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111; Johnson LF, 2012, S AFR J HIV MED, P22; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; MARTIN DJ, 1995, J ACQ IMMUN DEF SYND, V8, P386; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Mills HL, 2013, SCI TRANSL MED, V5; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Republic of South Africa, 2011, NAT STRAT PLAN HIV S; Republic of South Africa, 2011, MAN DRUG RES TUB POL; Republic of South Africa Department of Health, 2014, NAT CONS GUID PREV M; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shenoi SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031786; South Africa Department of Health, 2006, THE KZN OUTBR; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, ANT THER HIV INF AD; WHO, 1998, LABORATORY SERVICES; WHO, 2015, TB DIAGN LAB SER INF; WHO, 2014, WHO TB BURD EST; WHO, 2008, EPI SEM 2008; WHO, 2011, TECHN OP PRACT CONS; World Health Organization, 2012, WHO POL COLL TB HIV; Yaesoubi R, 2013, P NATL ACAD SCI USA, V110, P9457, DOI 10.1073/pnas.1218770110	68	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126267	10.1371/journal.pone.0126267	http://dx.doi.org/10.1371/journal.pone.0126267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938501	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000157
J	Hernandez, EG; Granados, J; Partida-Rodriguez, O; Valenzuela, O; Rascon, E; Magana, U; Escamilla-Tilch, M; Lopez-Reyes, A; Nieves-Ramirez, M; Gonzalez, E; Moran, P; Rojas, L; Valadez, A; Luna, A; Estrada, FJ; Maldonado, C; Ximenez, C				Hernandez, Eric G.; Granados, Julio; Partida-Rodriguez, Oswaldo; Valenzuela, Olivia; Rascon, Edgar; Magana, Ulises; Escamilla-Tilch, Monica; Lopez-Reyes, Alberto; Nieves-Ramirez, Miriam; Gonzalez, Enrique; Moran, Patricia; Rojas, Liliana; Valadez, Alicia; Luna, Alexandra; Estrada, Francisco J.; Maldonado, Carmen; Ximenez, Cecilia			Prevalent HLA Class II Alleles in Mexico City Appear to Confer Resistance to the Development of Amebic Liver Abscess	PLOS ONE			English	Article							ENTAMOEBA-HISTOLYTICA TROPHOZOITES; B-ALLELES; INCREASED FREQUENCY; STR LOCI; HAPLOTYPES; DIVERSITY; INFECTION; GENES; SUSCEPTIBILITY; POLYMORPHISM	Amebiasis is an endemic disease and a public health problem throughout Mexico, although the incidence rates of amebic liver abscess (ALA) vary among the geographic regions of the country. Notably, incidence rates are high in the northwestern states (especially Sonora with a rate of 12.57/100,000 inhabitants) compared with the central region (Mexico City with a rate of 0.69/100,000 inhabitants). These data may be related to host genetic factors that are partially responsible for resistance or susceptibility. Therefore, we studied the association of the HLA-DRB1 and HLA-DQB1 alleles with resistance or susceptibility to ALA in two Mexican populations, one each from Mexico City and Sonora. Ninety ALA patients were clinically diagnosed by serology and sonography. Genomic DNA was extracted from peripheral blood mononuclear cells. To establish the genetic identity of both populations, 15 short tandem repeats (STRs) were analyzed with multiplexed PCR, and the allelic frequencies of HLA were studied by PCR-SSO using LUMINEX technology. The allele frequencies obtained were compared to an ethnically matched healthy control group (146 individuals). We observed that both affected populations differed genetically from the control group. We also found interesting trends in the population from Mexico City. HLA-DQB1* 02 allele frequencies were higher in ALA patients compared to the control group (0.127 vs 0.047; p= 0.01; pc= NS; OR= 2.9, 95% CI= 1.09-8.3). The less frequent alleles in ALA patients were HLA-DRB1* 08 (0.118 vs 0.238 in controls; p= 0.01; pc= NS; OR= 0.42, 95% CI= 0.19-0.87) and HLA-DQB1*04 (0.109 vs 0.214; p= 0.02; pc= NS; OR= 0.40, 95% CI= 0.20-0.94). The haplotype HLA-DRB1*08/-DQB1*04 also demonstrated a protective trend against the development of this disease (0.081 vs. 0.178; p= 0.02; pc= NS; OR= 0.40, 95% CI= 0.16-0.93). These trends suggest that the prevalent alleles in the population of Mexico City may be associated with protection against the development of ALA.	[Hernandez, Eric G.; Partida-Rodriguez, Oswaldo; Nieves-Ramirez, Miriam; Gonzalez, Enrique; Moran, Patricia; Rojas, Liliana; Valadez, Alicia; Ximenez, Cecilia] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Inmunol, Mexico City, DF, Mexico; [Granados, Julio; Escamilla-Tilch, Monica] SSa, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Div Inmunogenet, Mexico City, DF, Mexico; [Valenzuela, Olivia; Rascon, Edgar; Magana, Ulises] Univ Sonora, Dept Ciencias Quim Biol, Hermosillo 83000, Sonora, Mexico; [Lopez-Reyes, Alberto] SSa, Inst Nacl Rehabil, Lab Sinovioanalisis Mol, Mexico City, DF, Mexico; [Luna, Alexandra; Estrada, Francisco J.] Univ Panamer, Escuela Med, Lab Biol Mol, Mexico City, DF, Mexico; [Maldonado, Carmen] SSa, Hosp Infantil Mexico Federico Gomez, Lab Invest Inmunol & Prote, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad de Sonora; Universidad Panamericana - Ciudad de Mexico; Hospital Infantil de Mexico Federico Gomez	Ximenez, C (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Inmunol, Mexico City, DF, Mexico.	cximenez2005@yahoo.com.mx	Valenzuela, Olivia/C-6062-2014; Estrada-Mena, Francisco/AAI-2437-2020; luna, alexandra/AAA-5836-2021	Valenzuela, Olivia/0000-0002-4456-2107; Estrada-Mena, Francisco/0000-0002-0833-3630; Rascon, Edgar/0000-0001-9254-1012; XIMENEZ, CECILIA/0000-0003-0574-4538; Monica, Escamilla-Tilch/0000-0003-4216-2174; Maldonado-Bernal, Carmen/0000-0003-0663-2888; Rojas-Velazquez, Liliana/0000-0001-7369-6262; GONZALEZ RIVAS, ENRIQUE/0000-0002-1144-9503; Hernandez, Eric Gregorio/0000-0002-4188-2826; Lopez-Reyes, Alberto/0000-0002-2575-2589	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN204208, IN206405, IN218214]; Programa de Apoyo a Proyectos para la Innovacion y Mejoramiento de la Ensenanza [200105]; Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia [79220]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Programa de Apoyo a Proyectos para la Innovacion y Mejoramiento de la Ensenanza; Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (IN204208 CX, IN206405 CX, IN218214 EG), the Programa de Apoyo a Proyectos para la Innovacion y Mejoramiento de la Ensenanza (200105 CX), and the Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia (79220 CX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves D, 2006, HUM BIOL, V78, P65, DOI 10.1353/hub.2006.0021; Alaez C, 2001, GENES IMMUN, V2, P216, DOI 10.1038/sj.gene.6363765; [Anonymous], 1997, Epidemiol Bull, V18, P13; [Anonymous], 1997, Wkly Epidemiol Rec, V72, P97; ARELLANO J, 1991, PARASITE IMMUNOL, V13, P23, DOI 10.1111/j.1365-3024.1991.tb00260.x; Arellano J, 1996, PARASITE IMMUNOL, V18, P491, DOI 10.1046/j.1365-3024.1996.d01-16.x; Arnaiz-Villena A, 2005, TISSUE ANTIGENS, V65, P379, DOI 10.1111/j.1399-0039.2005.00356.x; Arnaiz-Villena A, 2000, TISSUE ANTIGENS, V56, P405, DOI 10.1034/j.1399-0039.2000.560503.x; Barquera R, 2008, MOL IMMUNOL, V45, P1171, DOI 10.1016/j.molimm.2007.07.042; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Burgos-Vargas R, 1990, STATE ART REV, P237; Camacho MV, 2007, FORENSIC SCI INT, V173, P241, DOI 10.1016/j.forsciint.2007.02.006; Camorlinga-Ponce M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027212; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Choudhuri G, 2012, INDIAN J GASTROENTER, V31, P153, DOI 10.1007/s12664-012-0192-2; Deghaide NHS, 1998, DIGEST DIS SCI, V43, P246, DOI 10.1023/A:1018829600200; del Puerto F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001587; DENIS M, 1989, J LEUKOCYTE BIOL, V46, P270, DOI 10.1002/jlb.46.3.270; Duggal P, 2004, J INFECT DIS, V189, P520, DOI 10.1086/381272; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; Fernandez P, M MEX DEM SOC 1996 M; Gorodezky C, 2001, HUM IMMUNOL, V62, P979, DOI 10.1016/S0198-8859(01)00296-8; Hernandez-Gutierrez S, 2005, FORENSIC SCI INT, V151, P97; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Huston CD, 2004, TRENDS PARASITOL, V20, P23, DOI 10.1016/j.pt.2003.10.013; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; LIN JY, 1992, J IMMUNOL, V148, P3999; Macias-Vega M, 2013, REV ESP MED LEGAL, V39, P48; Maizels Rick M., 2009, Journal of Biology (London), V8, P62, DOI 10.1186/jbiol166; Middleton D, 2000, HUM IMMUNOL, V61, P1285, DOI 10.1016/S0198-8859(00)00186-5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moatter T, 2010, INDIAN J HUM GENET, V16, P48; Mondal D, 2006, T ROY SOC TROP MED H, V100, P1032, DOI 10.1016/j.trstmh.2005.12.012; Moran P, 2007, 5 EUR C TROP MED INT; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Nieto A, 2000, TISSUE ANTIGENS, V55, P195, DOI 10.1034/j.1399-0039.2000.550301.x; Perez-Miranda AM, 2005, FORENSIC SCI INT, V152, P259, DOI 10.1016/j.forsciint.2004.09.118; Ramos F, 2005, AM J TROP MED HYG, V73, P87, DOI 10.4269/ajtmh.2005.73.87; Sanchez CS, 2005, J FORENSIC SCI, V50, P1499; Secretaria de Salud, 2001, INF EP MORB 2000, P15; Shankarkumar U., 2002, Indian Journal of Malariology, V39, P76; Singh N, 1997, EMERG INFECT DIS, V3, P41; Valenzuela O, 2007, ANN TROP MED PARASIT, V101, P533, DOI 10.1179/136485907X193851; Vargas-Alarcon G, 2003, IMMUNOGENETICS, V54, P756, DOI 10.1007/s00251-002-0522-0; Vargas-Alarcon G, 2007, MOL IMMUNOL, V44, P747, DOI 10.1016/j.molimm.2006.04.014; Vivanco-Cid H, 2007, PARASITE IMMUNOL, V29, P467, DOI 10.1111/j.1365-3024.2007.00963.x; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; Wong-Baeza I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/254521; Zuniga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074442	51	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126195	10.1371/journal.pone.0126195	http://dx.doi.org/10.1371/journal.pone.0126195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938667	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000151
J	Selim, S; Elo, K; Jaakkola, S; Karikoski, N; Boston, R; Reilas, T; Sarkijarvi, S; Saastamoinen, M; Kokkonen, T				Selim, Shaimaa; Elo, Kari; Jaakkola, Seija; Karikoski, Ninja; Boston, Ray; Reilas, Tiina; Sarkijarvi, Susanna; Saastamoinen, Markku; Kokkonen, Tuomo			Relationships among Body Condition, Insulin Resistance and Subcutaneous Adipose Tissue Gene Expression during the Grazing Season in Mares	PLOS ONE			English	Article							HORMONE CONCENTRATIONS; LIPID CONCENTRATIONS; CYTOKINE EXPRESSION; BLOOD HORMONE; RISK-FACTORS; WEIGHT-GAIN; DAIRY-COWS; HORSES; SENSITIVITY; ADIPONECTIN	Obesity and insulin resistance have been shown to be risk factors for laminitis in horses. The objective of the study was to determine the effect of changes in body condition during the grazing season on insulin resistance and the expression of genes associated with obesity and insulin resistance in subcutaneous adipose tissue (SAT). Sixteen Finnhorse mares were grazing either on cultivated high-yielding pasture (CG) or semi-natural grassland (NG) from the end of May to the beginning of September. Body measurements, intravenous glucose tolerance test (IVGTT), and neck and tailhead SAT gene expressions were measured in May and September. At the end of grazing, CG had higher median body condition score (7 vs. 5.4, interquartile range 0.25 vs. 0.43; P=0.05) and body weight (618 kg vs. 572 kg +/- 10.21 (mean +/- SEM); P=0.02), and larger waist circumference (P=0.03) than NG. Neck fat thickness was not different between treatments. However, tailhead fat thickness was smaller in CG compared to NG in May (P=0.04), but this difference disappeared in September. Greater basal and peak insulin concentrations, and faster glucose clearance rate (P=0.03) during IVGTT were observed in CG compared to NG in September. A greater decrease in plasma non-esterified fatty acids during IVGTT (P<0.05) was noticed in CG compared to NG after grazing. There was down-regulation of insulin receptor, retinol binding protein 4, leptin, and monocyte chemoattractant protein-1, and up-regulation of adiponectin (ADIPOQ), adiponectin receptor 1 and stearoyl-CoA desaturase (SCD) gene expressions in SAT of both groups during the grazing season (P<0.05). Positive correlations were observed between ADIPOQ and its receptors and between SCD and ADIPOQ in SAT (P<0.01). In conclusion, grazing on CG had a moderate effect on responses during IVGTT, but did not trigger insulin resistance. Significant temporal differences in gene expression profiles were observed during the grazing season.	[Selim, Shaimaa; Elo, Kari; Jaakkola, Seija; Kokkonen, Tuomo] Univ Helsinki, Dept Agr Sci, FI-00014 Helsinki, Finland; [Karikoski, Ninja] Univ Helsinki, Dept Equine & Small Anim Med, FI-00014 Helsinki, Finland; [Boston, Ray] Univ Penn, Dept Clin Studies, New Bolton Ctr, Sch Vet Med, Philadelphia, PA 19104 USA; [Reilas, Tiina; Sarkijarvi, Susanna; Saastamoinen, Markku] Nat Resources Inst Finland Luke, Dept Green Technol, FI-32100 Ypaja, Finland	University of Helsinki; University of Helsinki; University of Pennsylvania; Natural Resources Institute Finland (Luke)	Elo, K (corresponding author), Univ Helsinki, Dept Agr Sci, POB 28, FI-00014 Helsinki, Finland.	kari.elo@helsinki.fi	Selim, Shaimaa/AEN-5582-2022	Selim, Shaimaa/0000-0001-7013-8273; Kokkonen, Tuomo Juhani/0000-0001-7176-1120; Elo, Kari/0000-0002-0925-2138; Jaakkola, Seija/0000-0002-0986-1590	Ministry of Agriculture and Forestry of Finland; Raisio plc Research Foundation; Niemi Saatio Foundation	Ministry of Agriculture and Forestry of Finland; Raisio plc Research Foundation; Niemi Saatio Foundation	Funding was received from the Ministry of Agriculture and Forestry of Finland to MS and the first author (S. Selim) was financially supported by Raisio plc Research Foundation and Niemi Saatio Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asplin KE, 2007, VET J, V174, P530, DOI 10.1016/j.tvjl.2007.07.003; Bailey SR, 2007, JAVMA-J AM VET MED A, V231, P1365, DOI 10.2460/javma.231.9.1365; Bamford NJ, 2014, DOMEST ANIM ENDOCRIN, V47, P101, DOI 10.1016/j.domaniend.2013.11.001; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bruynsteen L, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-240; Burns TA, 2010, J VET INTERN MED, V24, P932, DOI 10.1111/j.1939-1676.2010.0551.x; Carter RA, 2009, EQUINE VET J, V41, P171, DOI 10.2746/042516408X342975; Carter RA, 2008, THESIS VIRGINIA POLY; Carter RA, 2009, AM J VET RES, V70, P1250, DOI 10.2460/ajvr.70.10.1250; Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029; de Laat MA, 2010, EQUINE VET J, V42, P129, DOI 10.2746/042516409X475779; de Laat MA, 2013, VET J, V197, P302, DOI 10.1016/j.tvjl.2012.12.026; Dobrzyn P, 2010, BBA-BIOENERGETICS, V1797, P1189, DOI 10.1016/j.bbabio.2010.02.007; Firshman AM, 2007, EQUINE VET J, V39, P567, DOI 10.2746/042516407X238512; Fitzgerald BP, 2000, BIOL REPROD, V63, P335, DOI 10.1095/biolreprod63.1.335; Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383; Frank N, 2010, J VET INTERN MED, V24, P1167, DOI 10.1111/j.1939-1676.2010.0547.x; Frank N, 2010, J VET INTERN MED, V24, P467, DOI 10.1111/j.1939-1676.2010.0503.x; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gentry LR, 2002, J ANIM SCI, V80, P2695; Geor RJ, 2009, VET CLIN N AM-EQUINE, V25, P51, DOI 10.1016/j.cveq.2009.02.001; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Gordon ME, 2007, VET J, V173, P91, DOI 10.1016/j.tvjl.2005.11.004; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Johnson PJ, 2010, VET CLIN N AM-EQUINE, V26, P239, DOI 10.1016/j.cveq.2010.04.004; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kearns CF, 2006, VET J, V172, P460, DOI 10.1016/j.tvjl.2005.05.002; Kronfeld DS, 2005, JAVMA-J AM VET MED A, V226, P712, DOI 10.2460/javma.2005.226.712; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; McFarlane D, 2004, AM J VET RES, V65, P1463, DOI 10.2460/ajvr.2004.65.1463; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Quinn RW, 2008, J EQUINE VET SCI, V28, P728, DOI 10.1016/j.jevs.2008.10.020; Radin MJ, 2009, VET CLIN PATH, V38, P136, DOI 10.1111/j.1939-165X.2009.00133.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Saleri R, 2011, ANIMAL, V5, P1938, DOI 10.1017/S175173111100084X; Salin S, 2012, J DAIRY SCI, V95, P3812, DOI 10.3168/jds.2011-5206; Sarkijarvi S., 2010, Grassland in a changing world. Proceedings of the 23rd General Meeting of the European Grassland Federation, Kiel, Germany, 29th August - 2nd September 2010, P1000; Sarkijarvi S., 2012, FORAGES GRAZING HORS, P45, DOI DOI 10.3920/978-90-8686-755-4_2; Sarkijarvi S, 2012, EAAP SCI SERIES, P231; Schuhler S, 2006, PEPTIDES, V27, P301, DOI 10.1016/j.peptides.2005.03.060; Selim S, 2014, PHYSIOL GENOMICS, V46, P328, DOI 10.1152/physiolgenomics.00115.2013; Shiang K., 2004, SAS CALCULATIONS ARE; Suagee JK, 2013, J ANIM PHYSIOL AN N, V97, P245, DOI 10.1111/j.1439-0396.2011.01261.x; Suagee JK, 2011, DOMEST ANIM ENDOCRIN, V40, P173, DOI 10.1016/j.domaniend.2010.11.002; Treiber KH, 2005, AM J VET RES, V66, P2114, DOI 10.2460/ajvr.2005.66.2114; Treiber K, 2009, VET IMMUNOL IMMUNOP, V129, P216, DOI 10.1016/j.vetimm.2008.11.004; Treiber KH, 2006, JAVMA-J AM VET MED A, V228, P1538, DOI 10.2460/javma.228.10.1538; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Ungru J, 2012, VET REC, V171, P528, DOI 10.1136/vr.100911; Vick MM, 2007, J ANIM SCI, V85, P1144, DOI 10.2527/jas.2006-673; Vick MM, 2008, AM J VET RES, V69, P130, DOI 10.2460/ajvr.69.1.130; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yao-Borengasser A, 2008, J CLIN ENDOCR METAB, V93, P4431, DOI 10.1210/jc.2008-0782	57	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125968	10.1371/journal.pone.0125968	http://dx.doi.org/10.1371/journal.pone.0125968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938677	Green Published, gold			2022-12-26	WOS:000353943000122
J	von Kanel, R; Margani, A; Stauber, S; Meyer, FA; Biasiutti, FD; Vokt, F; Wissmann, T; Lammle, B; Lukas, PS				von Kaenel, Roland; Margani, Angelina; Stauber, Stefanie; Meyer, Fiorenza A.; Biasiutti, Franziska Demarmels; Voekt, Franziska; Wissmann, Thomas; Laemmle, Bernhard; Lukas, Paul S.			Depressive Symptoms as a Novel Risk Factor for Recurrent Venous Thromboembolism: A Longitudinal Observational Study in Patients Referred for Thrombophilia Investigation	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACUTE MYOCARDIAL-INFARCTION; POSTTRAUMATIC-STRESS-DISORDER; PULMONARY-EMBOLISM; PSYCHOLOGICAL DISTRESS; HOSPITAL ANXIETY; META-ANALYSIS; THROMBOSIS; ASSOCIATION; MORTALITY	Background Increasing evidence suggests that psychosocial factors, including depression predict incident venous thromboembolism (VTE) against a background of genetic and acquired risk factors. The role of psychosocial factors for the risk of recurrent VTE has not previously been examined. We hypothesized that depressive symptoms in patients with prior VTE are associated with an increased risk of recurrent VTE. Methods In this longitudinal observational study, we investigated 271 consecutive patients, aged 18 years or older, referred for thrombophilia investigation with an objectively diagnosed episode of VTE. Patients completed the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). During the observation period, they were contacted by phone and information on recurrent VTE, anticoagulation therapy, and thromboprophylaxis in risk situations was collected. Results Clinically relevant depressive symptoms (HADS-D score >= 8) were present in 10% of patients. During a median observation period of 13 months (range 5-48), 27 (10%) patients experienced recurrent VTE. After controlling for sociodemographic and clinical factors, a 3point increase on the HADS-D score was associated with a 44% greater risk of recurrent VTE (OR 1.44, 95% CI 1.02, 2.06). Compared to patients with lower levels of depressive symptoms (HADS-D score: range 0-2), those with higher levels (HADS-D score: range 316) had a 4.1-times greater risk of recurrent VTE (OR 4.07, 95% CI 1.55, 10.66). Conclusions The findings suggest that depressive symptoms might contribute to an increased risk of recurrent VTE independent of other prognostic factors. An increased risk might already be present at subclinical levels of depressive symptoms.	[von Kaenel, Roland] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [von Kaenel, Roland; Stauber, Stefanie; Biasiutti, Franziska Demarmels; Laemmle, Bernhard] Univ Bern, Bern, Switzerland; [von Kaenel, Roland; Margani, Angelina; Meyer, Fiorenza A.; Voekt, Franziska; Wissmann, Thomas; Lukas, Paul S.] Univ Bern, Dept Clin Res, Bern, Switzerland; [von Kaenel, Roland] Clin Barmelweid, Dept Psychosomat Med, Barmelweid, Switzerland; [Stauber, Stefanie] Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr, Dept Cardiol, CH-3010 Bern, Switzerland; [Biasiutti, Franziska Demarmels; Laemmle, Bernhard] Univ Hosp Bern, Inselspital, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Biasiutti, Franziska Demarmels; Laemmle, Bernhard] Univ Hosp Bern, Inselspital, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Laemmle, Bernhard] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Lukas, Paul S.] Sanat Kilchberg, Privatklin Psychiat & Psychotherapie, Kilchberg, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Johannes Gutenberg University of Mainz	von Kanel, R (corresponding author), Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland.	roland.vonkaenel@insel.ch	von Känel, Roland/B-1811-2019; Laemmle, Bernhard/AAJ-1216-2020	von Känel, Roland/0000-0002-8929-5129; Laemmle, Bernhard/0000-0003-4538-5154				Austin AW, 2013, SEMIN THROMB HEMOST, V39, P902, DOI 10.1055/s-0033-1357487; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Bush DE, 2001, AM J CARDIOL, V88, P337, DOI 10.1016/S0002-9149(01)01675-7; Cannegieter SC, 2013, J THROMB HAEMOST, V11, P161, DOI 10.1111/jth.12263; Cesarone MR, 2002, ANGIOLOGY, V53, P1, DOI 10.1177/000331970205300101; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Enga KF, 2012, THROMB HAEMOSTASIS, V107, P485, DOI 10.1160/TH11-09-0667; Fiscella K, 2004, MED CARE, V42, P939, DOI 10.1097/00005650-200410000-00001; Frasure-Smith N, 2010, POSTGRAD MED J, V86, P193, DOI 10.1136/hrt.2009.186957; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Halperin Demian, 2007, Dialogues Clin Neurosci, V9, P47; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Herrmann C., 1995, HADS D HOSP ANXIETY; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Hu ZP, 2005, DRUGS, V65, P1239, DOI 10.2165/00003495-200565090-00005; Huang CQ, 2010, AGE AGEING, V39, P23, DOI 10.1093/ageing/afp187; Kaatz S, 2011, CLEV CLIN J MED, V78, P609, DOI 10.3949/ccjm.78a.10175; Kahn SR, 2005, ARCH INTERN MED, V165, P1173, DOI 10.1001/archinte.165.10.1173; Kahn SR, 2004, J THROMB HAEMOST, V2, P2146, DOI 10.1111/j.1538-7836.2004.00957.x; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Klok FA, 2010, CHEST, V138, P1432, DOI 10.1378/chest.09-2482; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Lippi G, 2009, SEMIN THROMB HEMOST, V35, P597, DOI 10.1055/s-0029-1242713; Liu XS, 2013, INT PSYCHOGERIATR, V25, P913, DOI 10.1017/S1041610212002268; Lukas PS, 2012, THROMB RES, V130, P374, DOI 10.1016/j.thromres.2012.04.011; Lukas PS, 2009, THROMB HAEMOSTASIS, V102, P1219, DOI 10.1160/TH09-05-0316; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; National Institute for Health and Clinical Excellence (NICE), TREAT DEPR AD; Noble S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004561; Peeters PJHL, 2014, J THROMB HAEMOST, V12, P444, DOI 10.1111/jth.12523; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Robicsek O, 2011, ISR MED ASSOC J, V13, P548; Rose AJ, 2013, CHEST, V143, P751, DOI 10.1378/chest.12-1119; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosengren A, 2008, J THROMB HAEMOST, V6, P558, DOI 10.1111/j.1538-7836.2007.02857.x; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sajid MS, 2008, INT J ANGIOL, V17, P119, DOI 10.1055/s-0031-1278293; Teles JS, 2012, EINSTEIN-SAO PAULO, V10, P110, DOI 10.1590/S1679-45082012000100024; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; van Korlaar IM, 2004, THROMB RES, V114, P11, DOI 10.1016/j.thromres.2004.04.007; von Kanel R, 2012, J THROMB HAEMOST, V10, P1547, DOI 10.1111/j.1538-7836.2012.04801.x; von Kanel R, 2006, PSYCHOSOM MED, V68, P598, DOI 10.1097/01.psy.0000221229.43272.9d; Watanabe H, 2008, INT J CARDIOL, V129, P152, DOI 10.1016/j.ijcard.2007.06.039; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Wu CS, 2013, J CLIN PSYCHOPHARM, V33, P31, DOI 10.1097/JCP.0b013e3182777425; Xu QY, 2011, OBES RES CLIN PRACT, V5, pE267, DOI 10.1016/j.orcp.2011.04.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoller B, 2012, THROMB RES, V129, P577, DOI 10.1016/j.thromres.2011.07.050	51	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125858	10.1371/journal.pone.0125858	http://dx.doi.org/10.1371/journal.pone.0125858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938663	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000110
J	Marotta, L; Micciche, S; Fujiwara, Y; Iyetomi, H; Aoyama, H; Gallegati, M; Mantegna, RN				Marotta, Luca; Micciche, Salvatore; Fujiwara, Yoshi; Iyetomi, Hiroshi; Aoyama, Hideaki; Gallegati, Mauro; Mantegna, Rosario N.			Bank-Firm Credit Network in Japan: An Analysis of a Bipartite Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE	We investigate the networked nature of the Japanese credit market. Our investigation is performed with tools of network science. In our investigation we perform community detection with an algorithm which is identifying communities composed of both banks and firms. We show that the communities obtained by directly working on the bipartite network carry information about the networked nature of the Japanese credit market. Our analysis is performed for each calendar year during the time period from 1980 to 2011. To investigate the time evolution of the networked structure of the credit market we introduce a new statistical method to track the time evolution of detected communities. We then characterize the time evolution of communities by detecting for each time evolving set of communities the overexpression of attributes of firms and banks. Specifically, we consider as attributes the economic sector and the geographical location of firms and the type of banks. In our 32-year-long analysis we detect a persistence of the over-expression of attributes of communities of banks and firms together with a slow dynamic of changes from some specific attributes to new ones. Our empirical observations show that the credit market in Japan is a networked market where the type of banks, geographical location of firms and banks, and economic sector of the firm play a role in shaping the credit relationships between banks and firms.	[Marotta, Luca; Micciche, Salvatore; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500044, Japan; [Iyetomi, Hiroshi] Niigata Univ, Dept Math, Niigata, Japan; [Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Gallegati, Mauro] Univ Politecn Marche, Dipartimento Sci Econ & Sociali, Ancona, Italy; [Mantegna, Rosario N.] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Mantegna, Rosario N.] Cent European Univ, Dept Econ, Budapest, Hungary	University of Palermo; University of Hyogo; Niigata University; Kyoto University; Marche Polytechnic University; Central European University; Central European University	Mantegna, RN (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	rn.mantegna@gmail.com	Mantegna, Rosario N/H-3652-2014; Miccichè, Salvatore/B-6575-2008; GALLEGATI, MAURO/A-4091-2016	Mantegna, Rosario N/0000-0003-4177-171X; Miccichè, Salvatore/0000-0003-3779-592X; 	JSPS [24243027, 25282094, 25400393]; Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; European Community Seventh Framework Programme [255987 (FOC-II), 297149 (FOC-INCO)]; Zengin Foundation for Studies on Economics and Finance; Kyoto University; Program for Interaction-based Initiative Team Studies: SPIRITS, Program for Promoting the Enhancement of Research Universities, MEXT, Japan; EU; INET	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; European Community Seventh Framework Programme(European Commission); Zengin Foundation for Studies on Economics and Finance; Kyoto University; Program for Interaction-based Initiative Team Studies: SPIRITS, Program for Promoting the Enhancement of Research Universities, MEXT, Japan; EU(European Commission); INET	LM, SM, MG, and RNM acknowledge support from the EU project CRISIS and the INET project "New tools in the credit network modeling with agents' heterogeneity." This work is partially supported by Grant-in-Aid for Scientific Research (KAKENHI) grant numbers 24243027, 25282094, and 25400393 by JSPS, the Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS, by the European Community Seventh Framework Programme (FP7/2007-2013) under Socio-economic Sciences and Humanities, grant agreement no. 255987 (FOC-II) and 297149 (FOC-INCO), by Zengin Foundation for Studies on Economics and Finance, and by the Kyoto University Supporting Program for Interaction-based Initiative Team Studies: SPIRITS, as part of the Program for Promoting the Enhancement of Research Universities, MEXT, Japan.	Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Bargigli L, 2012, ECONOMICS DISCUSSION; De Masi G, 2011, EVOL INST ECON REV, V7, P209, DOI 10.14441/eier.7.209; Easley D, 2010, NETWORKS CROWDS MARK; Fujiwara Y, 2009, ECONOMICS-KIEL, V3, P7; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Larremore DB, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012805; Matsuura Y, 2013, FRONT ARTIF INTEL AP, V255, P399, DOI 10.3233/978-1-61499-264-6-399; Melamed D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097823; Murata Tsuyoshi, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P50, DOI 10.1109/CSE.2009.81; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Suzuki Kenta, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P312, DOI 10.1109/CSE.2009.451; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019	15	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123079	10.1371/journal.pone.0123079	http://dx.doi.org/10.1371/journal.pone.0123079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933413	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100014
J	Allis, CD				Allis, C. David			"Modifying" My Career toward Chromatin Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; epigenetics; histone; histone acetylation; histone modification	PEDIATRIC GLIOBLASTOMA; REPEATING UNIT; YEAST		Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@mail.rockefeller.edu			NIMH NIH HHS [P50 MH096890] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mukhopadhyay R., 2015, ASBMB TODAY IN PRESS, V14; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938	9	2	2	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15904	15908		10.1074/jbc.X115.663229	http://dx.doi.org/10.1074/jbc.X115.663229			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944906	Green Published, hybrid			2022-12-26	WOS:000356930100001
J	Pollard, RD; Blesso, CN; Zabalawi, M; Fulp, B; Gerelus, M; Zhu, XW; Lyons, EW; Nuradin, N; Francone, OL; Li, XA; Sahoo, D; Thomas, MJ; Sorci-Thomas, MG				Pollard, Ricquita D.; Blesso, Christopher N.; Zabalawi, Manal; Fulp, Brian; Gerelus, Mark; Zhu, Xuewei; Lyons, Erica W.; Nuradin, Nebil; Francone, Omar L.; Li, Xiang-An; Sahoo, Daisy; Thomas, Michael J.; Sorci-Thomas, Mary G.			Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; cholesterol metabolism; extracellular matrix protein; high-density lipoprotein (HDL); scavenger receptor	APOLIPOPROTEIN-A-I; CHOLESTEROL EFFLUX CAPACITY; APOA-I; SR-BI; SELECTIVE UPTAKE; HDL CHOLESTEROL; CELL-SURFACE; WILD-TYPE; LDLR-/; BINDING	Background: Extracellular matrix protein PCPE2 is linked to alterations in HDL size and concentration. Results: PCPE2 protects against diet-induced atherosclerosis by promoting HDL catabolism, reverse cholesterol transport, and SR-BI-mediated uptake of HDL-cholesteryl ester. Conclusion: PCPE2 mediates HDL function by reducing lipid and immune cell accumulation in the artery. Significance: These findings establish a role for the extracellular matrix glycoprotein PCPE2 in SR-BI-mediated HDL function and the prevention of atherosclerosis. Studies in human populations have shown a significant correlation between procollagen C-endopeptidase enhancer protein 2 (PCPE2) single nucleotide polymorphisms and plasma HDL cholesterol concentrations. PCPE2, a 52-kDa glycoprotein located in the extracellular matrix, enhances the cleavage of C-terminal procollagen by bone morphogenetic protein 1 (BMP1). Our studies here focused on investigating the basis for the elevated concentration of enlarged plasma HDL in PCPE2-deficient mice to determine whether they protected against diet-induced atherosclerosis. PCPE2-deficient mice were crossed with LDL receptor-deficient mice to obtain LDLr-/-, PCPE2(-/-) mice, which had elevated HDL levels compared with LDLr-/- mice with similar LDL concentrations. We found that LDLr-/-, PCPE2(-/-) mice had significantly more neutral lipid and CD68+ infiltration in the aortic root than LDLr-/- mice. Surprisingly, in light of their elevated HDL levels, the extent of aortic lipid deposition in LDLr-/-, PCPE2(-/-) mice was similar to that reported for LDLr-/-, apoA-I-/- mice, which lack any apoA-I/HDL. Furthermore, LDLr-/-, PCPE2(-/-) mice had reduced HDL apoA-I fractional clearance and macrophage to fecal reverse cholesterol transport rates compared with LDLr-/- mice, despite a 2-fold increase in liver SR-BI expression. PCPE2 was shown to enhance SR-BI function by increasing the rate of HDL-associated cholesteryl ester uptake, possibly by optimizing SR-BI localization and/or conformation. We conclude that PCPE2 is atheroprotective and an important component of the reverse cholesterol transport HDL system.	[Nuradin, Nebil; Sahoo, Daisy; Thomas, Michael J.; Sorci-Thomas, Mary G.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Nuradin, Nebil; Sahoo, Daisy; Thomas, Michael J.; Sorci-Thomas, Mary G.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Pollard, Ricquita D.; Zabalawi, Manal; Fulp, Brian; Gerelus, Mark; Zhu, Xuewei; Lyons, Erica W.] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27101 USA; [Pollard, Ricquita D.; Zabalawi, Manal; Fulp, Brian; Gerelus, Mark; Zhu, Xuewei; Lyons, Erica W.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27101 USA; [Blesso, Christopher N.] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06268 USA; [Francone, Omar L.] Shire Human Genet Therapies, Lexington, MA 02421 USA; [Li, Xiang-An] Univ Kentucky, Dept Pediat, Lexington, KY 40506 USA	Medical College of Wisconsin; Medical College of Wisconsin; Wake Forest University; Wake Forest University; University of Connecticut; Shire Pharmaceuticals Limited; University of Kentucky	Sorci-Thomas, MG (corresponding author), Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	msthomas@mcw.edu	Blesso, Christopher/AAK-3357-2020; Blesso, Christopher/N-9495-2014	Blesso, Christopher/0000-0002-4434-4839; Lyons, Erica/0000-0002-8917-321X; Gerelus, Mark/0000-0001-8986-4523; Sorci-Thomas, Mary/0000-0002-6464-5006	North Carolina Biotechnology [2007-IDG-1021]; National Institutes of Health (NIH) Shared Instrumentation Grant [1S10RR027940]; NIH Shared Instrumentation Grant [1S10RR17846]; NIH from NCI [5P30CA12197]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027940, S10RR017846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091797, R01HL112270, R01HL127649, R01HL058012, R01HL112276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113832] Funding Source: NIH RePORTER	North Carolina Biotechnology; National Institutes of Health (NIH) Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The mass spectrometers used for these studies were acquired with funds from several agencies: TSQ Discovery Max LC-MS/MS and Advion Nanomate from North Carolina Biotechnology Grant 2007-IDG-1021, TSQ Quantum XLS GC-MS/MS from National Institutes of Health (NIH) Shared Instrumentation Grant 1S10RR027940, and Waters Q-TOF mass spectrometer from NIH Shared Instrumentation Grant 1S10RR17846. The MS analyses were performed in the Mass Spectrometer Facility of the Comprehensive Cancer Center of Wake Forest University School of Medicine, supported in part by NIH Grant 5P30CA12197 from NCI.	Alexander E. T., 2014, ARTERIOSCLER THROMB, V31, P320; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH234, DOI 10.1152/ajpheart.00227.2012; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Batta AK, 1999, J LIPID RES, V40, P1148; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bhat S, 2010, BIOCHEMISTRY-US, V49, P5213, DOI 10.1021/bi1003734; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Brier S, 2010, J BIOL CHEM, V285, P32251, DOI 10.1074/jbc.M110.149112; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Chadwick AC, 2013, CURR OPIN ENDOCRINOL, V20, P124, DOI 10.1097/MED.0b013e32835ed575; Chadwick AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045660; Chau P, 2007, BIOCHEMISTRY-US, V46, P8445, DOI 10.1021/bi700028u; Chau PL, 2006, BIOCHEMISTRY-US, V45, P3981, DOI 10.1021/bi052535g; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Cuchel M, 2010, ARTERIOSCL THROM VAS, V30, P526, DOI 10.1161/ATVBAHA.109.196105; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Francone OL, 2011, J LIPID RES, V52, P1974, DOI 10.1194/jlr.M016527; Gaboriaud C, 2011, BIOCHEM J, V439, P185, DOI 10.1042/BJ20111027; Getz GS, 2011, J LIPID RES, V52, P1861, DOI 10.1194/jlr.R020149; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Harder CJ, 2006, J LIPID RES, V47, P492, DOI 10.1194/jlr.M500444-JLR200; Heinzel K, 2007, EUR J IMMUNOL, V37, P2562, DOI 10.1002/eji.200637474; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Huggins KW, 2001, J LIPID RES, V42, P1457; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kartz GA, 2014, BIOCHEMISTRY-US, V53, P6173, DOI 10.1021/bi500706x; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Krieger M, 1999, CURR OPIN LIPIDOL, V10, P491, DOI 10.1097/00041433-199912000-00003; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Kwiterovich PO, 1998, AM J CARDIOL, V82, p13Q; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manavalan APC, 2014, J BIOL CHEM, V289, P4683, DOI 10.1074/jbc.M113.499129; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Miles RR, 2013, J BIOL CHEM, V288, P6386, DOI 10.1074/jbc.M112.410092; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Puppione DL, 2006, BBA-PROTEINS PROTEOM, V1764, P1363, DOI 10.1016/j.bbapap.2006.06.001; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Rohrl C, 2013, BBA-MOL CELL BIOL L, V1831, P1626, DOI [10.1016/j.bbalip.2013.07.014, 10.1016/j.bbalip2013.07.014]; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; Schwenke DC, 2002, J LIPID RES, V43, P1927, DOI 10.1194/jlr.M200261-JLR200; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sorci-Thomas MG, 2013, J CARDIOVASC PHARM, V62, P239, DOI 10.1097/FJC.0b013e31829d48a5; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Sorci-Thomas MG, 2012, BBA-MOL CELL BIOL L, V1821, P502, DOI 10.1016/j.bbalip.2011.08.019; Sorci-Thomas MG, 2000, J BIOL CHEM, V275, P12156, DOI 10.1074/jbc.275.16.12156; SorciThomas MG, 1996, J LIPID RES, V37, P673; Steiglitz BM, 2001, CYTOGENET CELL GENET, V95, P244, DOI 10.1159/000059356; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Sviridov D, 2009, J LIPID RES, V50, P1257, DOI 10.1194/jlr.E900003-JLR200; Tavori H, 2015, J LIPID RES, V56, P635, DOI 10.1194/jlr.M056408; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Tsukamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069725; Vadon-Le Goff S, 2011, J BIOL CHEM, V286, P38932, DOI 10.1074/jbc.M111.274944; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195; Weiss T, 2010, J BIOL CHEM, V285, P33867, DOI 10.1074/jbc.M110.141366; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wilhelm AJ, 2010, J BIOL CHEM, V285, P36158, DOI 10.1074/jbc.M110.134130; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Zabalawi M, 2003, AM J PATHOL, V163, P1201, DOI 10.1016/S0002-9440(10)63480-3; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhu J, 2009, J LIPID RES, V50, P1330, DOI 10.1194/jlr.M900034-JLR200	92	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15496	15511		10.1074/jbc.M115.646240	http://dx.doi.org/10.1074/jbc.M115.646240			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947382	hybrid, Green Published			2022-12-26	WOS:000356527400016
J	Matsumura, R; Hirakawa, J; Sato, K; Ikeda, T; Nagai, M; Fukuda, M; Imai, Y; Kawashima, H				Matsumura, Ryuji; Hirakawa, Jotaro; Sato, Kaori; Ikeda, Toshiaki; Nagai, Motoe; Fukuda, Minoru; Imai, Yasuyuki; Kawashima, Hiroto			Novel Antibodies Reactive with Sialyl Lewis X in Both Humans and Mice Define Its Critical Role in Leukocyte Trafficking and Contact Hypersensitivity Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH ENDOTHELIAL VENULES; SELECTIN LIGAND BIOSYNTHESIS; LYMPH-NODE ADDRESSIN; P-SELECTIN; VASCULAR ADDRESSIN; O-GLYCANS; EXPRESSION; RECRUITMENT; ADHESION; ANTIGEN	Sialyl Lewis X (sLe(x)) antigen functions as a common carbohydrate determinant recognized by all three members of the selectin family. However, its expression and function in mice remain undefined due to the poor reactivity of conventional anti-sLe(x) monoclonal antibodies (mAbs) with mouse tissues. Here, we developed novel anti-sLe(x) mAbs, termed F1 and F2, which react well with both human and mouse sLe(x), by immunizing fucosyltransferase (FucT)-IV and FucT-VII doubly deficient mice with 6-sulfo-sLe(x)-expressing cells transiently transfected with an expression vector encoding CMP-N-acetylneuraminic acid hydroxylase. F1 and F2 specifically bound both the N-acetyl and the N-glycolyl forms of sLe(x) as well as 6-sulfo-sLe(x), a major ligand for L-selectin expressed in high endothelial venules, and efficiently blocked physiological lymphocyte homing to lymph nodes in mice. Importantly, both of the mAbs inhibited contact hypersensitivity responses not only when administered in the L-selectin-dependent sensitization phase but also when administered in the elicitation phase in mice. When administered in the latter phase, F1 and F2 efficiently blocked rolling of mouse leukocytes along blood vessels expressing P-and E-selectin in the auricular skin in vivo. Consistent with these findings, the mAbs blocked P-and E-selectin-dependent leukocyte rolling in a flow chamber assay. Taken together, these results indicate that novel anti-sLe(x) mAbs reactive with both human and mouse tissues, with the blocking ability against leukocyte trafficking mediated by all three selectins, have been established. These mAbs should be useful in determining the role of sLe(x) antigen under physiological and pathological conditions.	[Matsumura, Ryuji; Hirakawa, Jotaro; Sato, Kaori; Ikeda, Toshiaki; Nagai, Motoe; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Lab Microbiol & Immunol, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Hirakawa, Jotaro; Kawashima, Hiroto] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Biochem, Tokyo 1428501, Japan; [Fukuda, Minoru] Sanford Burnham Med Res Inst, Glycobiol Unit, La Jolla, CA 92037 USA	University of Shizuoka; Hoshi University; Sanford Burnham Prebys Medical Discovery Institute	Kawashima, H (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Biochem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	h-kawashima@hoshi.ac.jp	Regan, Clinton/E-6250-2012; Imai, Yasuyuki/E-8701-2010	Imai, Yasuyuki/0000-0002-8937-0221	National Institutes of Health [U54GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K14955] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs. Yoko Ishihara (Kurume University, School of Medicine) and Toshio Nishikawa (Tokyo Women's Medical University) for providing the human tonsil tissue sections. We also thank Koichiro Tsuboi and Hiroaki Matsuura (University of Shizuoka, School of Pharmaceutical Sciences) for technical support and Drs. Richard D. Cummings, David F. Smith, and Jamie Heimburg-Molinaro (Emory University School of Medicine) at the Consortium for Functional Glycomics (supported by National Institutes of Health Grant U54GM62116) for performing the glycan array analysis and for providing the FucT-IV and FucT-VII DKO mice.	Arata-Kawai H, 2011, AM J PATHOL, V178, P423, DOI 10.1016/j.ajpath.2010.11.009; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima Hiroto, 2013, Methods Mol Biol, V1022, P51, DOI 10.1007/978-1-62703-465-4_5; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAWADA M, 1993, BIOCHEM BIOPH RES CO, V193, P337, DOI 10.1006/bbrc.1993.1629; SAWADA R, 1993, J BIOL CHEM, V268, P12675; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; TAMATANI T, 1995, AM J PHYSIOL-HEART C, V269, pH1282, DOI 10.1152/ajpheart.1995.269.4.H1282; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	31	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15313	15326		10.1074/jbc.M115.650051	http://dx.doi.org/10.1074/jbc.M115.650051			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25944902	Green Published, hybrid			2022-12-26	WOS:000356177300042
J	Li, Y; Yuan, GL; Wei, ZX				Li, Yong; Yuan, Gonglin; Wei, Zengxin			A Limited-Memory BFGS Algorithm Based on a Trust-Region Quadratic Model for Large-Scale Nonlinear Equations	PLOS ONE			English	Article							GRADIENT-METHOD; SEGMENTATION; CONVERGENCE	In this paper, a trust-region algorithm is proposed for large-scale nonlinear equations, where the limited-memory BFGS (L-M-BFGS) update matrix is used in the trust-region sub-problem to improve the effectiveness of the algorithm for large-scale problems. The global convergence of the presented method is established under suitable conditions. The numerical results of the test problems show that the method is competitive with the norm method.	[Yuan, Gonglin; Wei, Zengxin] Guangxi Univ, Coll Math & Informat Sci, Nanning 530004, Guangxi, Peoples R China; [Li, Yong] Baise Univ, Dept Math, Baise, Guangxi, Peoples R China	Guangxi University; Baise University	Yuan, GL (corresponding author), Guangxi Univ, Coll Math & Informat Sci, Nanning 530004, Guangxi, Peoples R China.	glyuan@gxu.edu.cn	Yuan, Gonglin/HGE-6598-2022	Yuan, Gonglin/0000-0003-2667-5834	Program for Excellent Talents in Guangxi Higher Education Institutions [201261]; Guangxi Higher Education Institutions [YB2014389]; Guangxi NSF [2012GXNSFAA053002]; China NSF [11261006, 11161003]; QFRC visitor funds of the University of Technology Sydney; Guangxi talents in China, Guangxi Colleges and Universities Key Laboratory of Mathematics and Its Applications	Program for Excellent Talents in Guangxi Higher Education Institutions; Guangxi Higher Education Institutions; Guangxi NSF; China NSF(National Natural Science Foundation of China (NSFC)); QFRC visitor funds of the University of Technology Sydney; Guangxi talents in China, Guangxi Colleges and Universities Key Laboratory of Mathematics and Its Applications	Program for Excellent Talents in Guangxi Higher Education Institutions (Grant No. 201261), Guangxi Higher Education Institutions (NO. YB2014389), Guangxi NSF (Grant No. 2012GXNSFAA053002) and China NSF (Grant No. 11261006 and 11161003).; This work is supported by the QFRC visitor funds of the University of Technology Sydney, study abroad funds of Guangxi talents in China, Guangxi Colleges and Universities Key Laboratory of Mathematics and Its Applications, the Program for Excellent Talents in Guangxi Higher Education Institutions (Grant No. 201261), Guangxi Higher Education Institutions (NO. YB2014389), the Guangxi NSF (Grant No. 2012GXNSFAA053002) and the China NSF (Grant No. 11261006 and 11161003). The authors thank the referees for their valuable comments which greatly improve our paper.	[Anonymous], NUMERICAL ANAL; BERTSEKAS D, 1995, NONLINEAR PROGRAMMIN; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Dolan ED, 2002, MATH PROGRAM, V91, P201, DOI 10.1007/s101070100263; Fan JY, 2003, J COMPUT MATH, V21, P625; Fu ZJ, 2015, IEICE T COMMUN, VE98B, P190, DOI 10.1587/transcom.E98.B.190; GOMESRUGGIERO MA, 1992, SIAM J SCI STAT COMP, V13, P459, DOI 10.1137/0913025; GRIEWANK A, 1986, J AUST MATH SOC B, V28, P75, DOI 10.1017/S0334270000005208; Gu B, 2013, IEEE T NEUR NET LEAR, V24, P1304, DOI 10.1109/TNNLS.2013.2250300; Gu GZ, 2002, SIAM J NUMER ANAL, V40, P1763, DOI 10.1137/S0036142901397423; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Li DH, 1999, SIAM J NUMER ANAL, V37, P152, DOI 10.1137/S0036142998335704; Li J, 2015, IEEE T INF FOREN SEC, V10, P507, DOI 10.1109/TIFS.2014.2381872; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MORE JJ, 1981, ACM T MATH SOFTWARE, V7, P17, DOI 10.1145/355934.355936; More JJ, 1983, MATH PROGRAMMING STA, P258; Ortega J. M., 2000, ITERATIVE SOLUTION N; Raydan M, 1997, SIAM J OPTIMIZ, V7, P26, DOI 10.1137/S1052623494266365; Toint A, 2000, TRUST REGION METHOD; Wang YJ, 2004, THEORY ALGOITHM NONL; Wen XZ, 2015, IEEE T CIRC SYST VID, V25, P508, DOI 10.1109/TCSVT.2014.2358031; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; Yamashita N., 2001, TOPICS NUMERICAL ANA, P239; Yuan GL, 2008, COMPUT MATH APPL, V55, P116, DOI 10.1016/j.camwa.2006.12.081; Yuan GL, 2013, NUMER FUNC ANAL OPT, V34, P914, DOI 10.1080/01630563.2013.777350; Yuan GL, 2013, OPTIMIZATION, V62, P85, DOI 10.1080/02331934.2011.564621; Yuan GL, 2011, INT J COMPUT MATH, V88, P2109, DOI 10.1080/00207160.2010.526206; Yuan GL, 2011, MATH COMPUT MODEL, V54, P367, DOI 10.1016/j.mcm.2011.02.021; Yuan GL, 2011, COMPUTING, V92, P317, DOI 10.1007/s00607-011-0146-z; Yuan GL, 2009, J COMPUT APPL MATH, V233, P519, DOI 10.1016/j.cam.2009.08.001; Yuan GL, 2009, J COMPUT APPL MATH, V230, P44, DOI 10.1016/j.cam.2008.10.062; Yuan GL, 2009, ANN OPER RES, V166, P73, DOI 10.1007/s10479-008-0420-4; Yuan YX., 1997, OPTIMIZATION THEORY; Yuan YX., 1998, INFORMATION, V1, P7; Zhang H, 2014, IEEE T GEOSCI REMOTE, V52, P4391, DOI 10.1109/TGRS.2013.2281854; Zhang JL, 2003, MATH METHOD OPER RES, V58, P283, DOI 10.1007/s001860300302; Zhu DT, 2005, APPL MATH COMPUT, V161, P875, DOI 10.1016/j.amc.2003.12.074	38	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0120993	10.1371/journal.pone.0120993	http://dx.doi.org/10.1371/journal.pone.0120993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4RU	25950725	gold, Green Published, Green Submitted			2022-12-26	WOS:000367788800001
J	Yoshida, Y; Miyata, T; Matsumoto, M; Shirotani-Ikejima, H; Uchida, Y; Ohyama, Y; Kokubo, T; Fujimura, Y				Yoshida, Yoko; Miyata, Toshiyuki; Matsumoto, Masanori; Shirotani-Ikejima, Hiroko; Uchida, Yumiko; Ohyama, Yoshifumi; Kokubo, Tetsuro; Fujimura, Yoshihiro			A Novel Quantitative Hemolytic Assay Coupled with Restriction Fragment Length Polymorphisms Analysis Enabled Early Diagnosis of Atypical Hemolytic Uremic Syndrome and Identified Unique Predisposing Mutations in Japan	PLOS ONE			English	Article							FACTOR-H AUTOANTIBODIES; THROMBOTIC MICROANGIOPATHIES; SACCHAROMYCES-CEREVISIAE; ABNORMALITIES; PROTECTION; UNIVERSITY; REVEALS; CFHR1; SERUM; C3	For thrombotic microangiopathies (TMAs), the diagnosis of atypical hemolytic uremic syndrome (aHUS) is made by ruling out Shiga toxin-producing Escherichia coli (STEC)-associated HUS and ADAMTS13 activity-deficient thrombotic thrombocytopenic purpura (TTP), often using the exclusion criteria for secondary TMAs. Nowadays, assays for ADAMTS13 activity and evaluation for STEC infection can be performed within a few hours. However, a confident diagnosis of aHUS often requires comprehensive gene analysis of the alternative complement activation pathway, which usually takes at least several weeks. However, predisposing genetic abnormalities are only identified in approximately 70% of aHUS. To facilitate the diagnosis of complement-mediated aHUS, we describe a quantitative hemolytic assay using sheep red blood cells (RBCs) and human citrated plasma, spiked with or without a novel inhibitory anti-complement factor H (CFH) monoclonal antibody. Among 45 aHUS patients in Japan, 24% (11/45) had moderate-to-severe (>= 50%) hemolysis, whereas the remaining 76% (34/45) patients had mild or no hemolysis (< 50%). The former group is largely attributed to CFH-related abnormalities, and the latter group has C3-p. I1157T mutations (16/34), which were identified by restriction fragment length polymorphism (RFLP) analysis. Thus, a quantitative hemolytic assay coupled with RFLP analysis enabled the early diagnosis of complement-mediated aHUS in 60% (27/45) of patients in Japan within a week of presentation. We hypothesize that this novel quantitative hemolytic assay would be more useful in a Caucasian population, who may have a higher proportion of CFH mutations than Japanese patients.	[Yoshida, Yoko; Matsumoto, Masanori; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan; [Miyata, Toshiyuki; Shirotani-Ikejima, Hiroko; Uchida, Yumiko] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Ohyama, Yoshifumi; Kokubo, Tetsuro] Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa 232, Japan	Nara Medical University; National Cerebral & Cardiovascular Center - Japan; Yokohama City University	Fujimura, Y (corresponding author), Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan.	yoshifuji325@naramed-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Alexion Pharmaceuticals; Grants-in-Aid for Scientific Research [25461456] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Alexion Pharmaceuticals; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This study was supported by research grants from the Ministry of Health, Labour and Welfare of Japan, from Japan Society for the Promotion of Science, and from the Takeda Science Foundation. YF received a research grant from Alexion Pharmaceuticals and the patent royalty for the ADAMTS13 assay from Alfresa Pharma Corporation. MM received the patent royalty for the ADAMTS13 assay from Alfresa Pharma Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campistol JM, 2013, NEFROLOGIA, V33, P27, DOI 10.3265/Nefrologia.pre2012.Nov.11781; Coppo Paul, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P36; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Fan XP, 2013, MOL IMMUNOL, V54, P238, DOI 10.1016/j.molimm.2012.12.006; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Fujimura Y, 2010, INTERNAL MED, V49, P7, DOI 10.2169/internalmedicine.49.2706; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kavanagh D, 2010, PEDIATR NEPHROL, V25, P2431, DOI 10.1007/s00467-010-1555-5; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Maga TK, 2010, HUM MUTAT, V31, pE1445, DOI 10.1002/humu.21256; Matsumoto T, 2014, INT J HEMATOL, V100, P444, DOI 10.1007/s12185-014-1655-2; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Ohtsuki K, 2010, NUCLEIC ACIDS RES, V38, P1805, DOI 10.1093/nar/gkp1172; Ohyama Y, 2010, GENES CELLS, V15, P1169, DOI 10.1111/j.1365-2443.2010.01452.x; Oka M, 2013, NIHON SHONI JINZOBYO, V26, P285; Roumenina LT, 2014, METHODS MOL BIOL, V1100, P237, DOI 10.1007/978-1-62703-724-2_19; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Sawai T, 2014, CLIN EXP NEPHROL, V18, P4, DOI 10.1007/s10157-013-0911-8; Schramm EC, 2015, BLOOD IN PRESS, DOI [10.1182/blood-2014-10-609073, DOI 10.1182/BLOOD-2014-10-609073]; Scully M, 2014, BRIT J HAEMATOL, V164, P759, DOI 10.1111/bjh.12718; Strobel S, 2010, NEPHROL DIAL TRANSPL, V25, P136, DOI 10.1093/ndt/gfp388; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Udagawa T, 2014, CEN CASE REP, V3, P110, DOI 10.1007/s13730-013-0097-7; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	35	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124655	10.1371/journal.pone.0124655	http://dx.doi.org/10.1371/journal.pone.0124655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25951460	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400018
J	Grioni, S; Agnoli, C; Sieri, S; Pala, V; Ricceri, F; Masala, G; Saieva, C; Panico, S; Mattiello, A; Chiodini, P; Tumino, R; Frasca, G; Iacoviello, L; de Curtis, A; Vineis, P; Krogh, V				Grioni, Sara; Agnoli, Claudia; Sieri, Sabina; Pala, Valeria; Ricceri, Fulvio; Masala, Giovanna; Saieva, Calogero; Panico, Salvatore; Mattiello, Amalia; Chiodini, Paolo; Tumino, Rosario; Frasca, Graziella; Iacoviello, Licia; de Curtis, Amalia; Vineis, Paolo; Krogh, Vittorio			Espresso Coffee Consumption and Risk of Coronary Heart Disease in a Large Italian Cohort	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; CYP1A2 GENOTYPE; SERUM-LIPIDS; CAFFEINE; METAANALYSIS; CHOLESTEROL; CANCER; QUESTIONNAIRE; ASSOCIATION	Background The relationship between coffee consumption and coronary heart disease (CHD) has been investigated in several studies with discrepant results. We examined the association between Italian-style (espresso and mocha) coffee consumption and CHD risk. Methods We investigated 12,800 men and 30,449 women without history of cardiovascular disease recruited to the EPICOR prospective cohort study. Coffee consumption was assessed at baseline. In a random sub-cohort of 1472 subjects, plasma triglycerides, and total, LDL and HDL cholesterol were determined to investigate the effect of coffee consumption on plasma lipids. Results After a mean follow up of 10.9 years, 804 cases of CHD (500 acute events, 56 fatal events and 248 revascularizations, all first events) were identified. Multivariable adjusted hazard ratios for CHD were: 1.18 (95% CI 0.87-1.60) for drinking 1-2 cups/day, 1.37 (95% CI 1.03-1.82) for > 2-4 cups/day and 1.52 (95% CI 1.11-2.07) for over 4 cups/day (P trend < 0.001) compared to reference (< 1 cup/day). Plasma triglycerides, and total, LDL and HDL cholesterol did not vary significantly (ANOVA) with coffee consumption. Conclusion Consumption of over 2 cups/day of Italian-style coffee is associated with increased CHD risk, but coffee consumption was not associated with plasma lipid changes, so the adverse effect of consumption appears unrelated to lipid profile.	[Grioni, Sara; Agnoli, Claudia; Sieri, Sabina; Pala, Valeria; Krogh, Vittorio] Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Ricceri, Fulvio; Vineis, Paolo] Human Genet Fdn, Turin, Italy; [Ricceri, Fulvio] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Ricceri, Fulvio] Ctr Canc Prevent, Turin, Italy; [Masala, Giovanna; Saieva, Calogero] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Panico, Salvatore; Mattiello, Amalia] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Chiodini, Paolo] Univ Naples 2, Dept Med & Publ Hlth, Naples, Italy; [Tumino, Rosario; Frasca, Graziella] Prov Hlth Ctr 7, Dept Prevent, Canc Registry, Ragusa, Italy; [Iacoviello, Licia; de Curtis, Amalia] IRCCS, Ist Neurol Mediterraneo, Dept Epidemiol & Prevent, Lab Mol & Nutr Epidemiol, Pozzilli, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Naples Federico II; Universita della Campania Vanvitelli; IRCCS Neuromed; Imperial College London	Sieri, S (corresponding author), Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy.	sabina.sieri@istitutotumori.mi.it	Krogh, Vittorio/K-2628-2016; Panico, Salvatore/K-6506-2016; Ricceri, Fulvio/I-9910-2018; de curtis, amalia/AAC-2829-2020; Chiodini, Paolo/E-7290-2014; Siani, Alfonso/B-7925-2015; Grioni, Sara/K-5320-2016; Sieri, Sabina/K-4667-2016; Agnoli, Claudia/K-5916-2016; Iacoviello, Licia/AGX-7071-2022; Masala, Giovanna/AAC-5474-2022; Iacoviello, Licia/K-4676-2016; Pala, Valeria/K-4738-2016; Saieva, Calogero/AAC-2611-2019; Mattiello, Amalia AM/K-5112-2016; Krogh, Vittorio/AAA-9171-2019	Krogh, Vittorio/0000-0003-0122-8624; Panico, Salvatore/0000-0002-5498-8312; Ricceri, Fulvio/0000-0001-8749-9737; de curtis, amalia/0000-0001-5104-0318; Chiodini, Paolo/0000-0003-0139-2264; Grioni, Sara/0000-0002-5891-8426; Sieri, Sabina/0000-0001-5201-172X; Agnoli, Claudia/0000-0003-4472-1179; Iacoviello, Licia/0000-0003-0514-5885; Masala, Giovanna/0000-0002-5758-9069; Iacoviello, Licia/0000-0003-0514-5885; Pala, Valeria/0000-0001-5438-970X; Saieva, Calogero/0000-0002-0117-1608; Mattiello, Amalia AM/0000-0003-3676-7353; Krogh, Vittorio/0000-0003-0122-8624; Persichillo, Mariarosaria/0000-0002-9731-0173; tumino, rosario/0000-0003-2666-414X	Compagnia di San Paolo; Italian Association for Cancer Research (AIRC)	Compagnia di San Paolo(Compagnia di San Paolo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	EPICOR is supported by Compagnia di San Paolo. The Italian EPIC collaboration is supported by the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo A, 2006, EUR J CARDIOV PREV R, V13, P268, DOI 10.1097/01.hjr.0000214604.53372.2b; BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933; Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a; Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9; Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68; CASIGLIA E, 1992, J HUM HYPERTENS, V6, P95; Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135; DAmicis A, 1996, INT J EPIDEMIOL, V25, P513, DOI 10.1093/ije/25.3.513; Echeverri D, 2010, INT J VASC MED, V2010, DOI 10.1155/2010/834060; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939; Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8; Grubben MJ, 2000, AM J CLIN NUTR, V71, P480; Happonen P, 2004, J NUTR, V134, P2381, DOI 10.1093/jn/134.9.2381; Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353; LACROIX AZ, 1986, NEW ENGL J MED, V315, P977, DOI 10.1056/NEJM198610163151601; Lane JD, 2002, PSYCHOSOM MED, V64, P595, DOI 10.1097/01.PSY.0000021946.90613.DB; Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664; Masala G, 2008, J HYPERTENS, V26, P2112, DOI 10.1097/HJH.0b013e32830ef75c; McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520; Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299; Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899; Pala V, 2003, TUMORI J, V89, P594, DOI 10.1177/030089160308900603; Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; ROSE G, 1965, LANCET, V1, P673; Rosner SA, 2007, AM J EPIDEMIOL, V165, P288, DOI 10.1093/aje/kwk013; Salvini S., 1998, BANCA DATI COMPOSIZI; Sesso HD, 1999, AM J EPIDEMIOL, V149, P162, DOI 10.1093/oxfordjournals.aje.a009782; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Silletta MG, 2007, CIRCULATION, V116, P2944, DOI 10.1161/CIRCULATIONAHA.107.712976; Sofi F, 2007, NUTR METAB CARDIOVAS, V17, P209, DOI 10.1016/j.numecd.2006.07.013; Tavani A, 2004, PREV MED, V39, P128, DOI 10.1016/j.ypmed.2004.01.010; Tavani A, 2001, EUR J EPIDEMIOL, V17, P1131, DOI 10.1023/A:1021276932160; Urgert R, 1996, J ROY SOC MED, V89, P618, DOI 10.1177/014107689608901107; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051	40	32	33	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126550	10.1371/journal.pone.0126550	http://dx.doi.org/10.1371/journal.pone.0126550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946046	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700136
J	Li, Y; Canback, B; Johansson, T; Tunlid, A; Prentice, HC				Li, Yuan; Canback, Bjorn; Johansson, Tomas; Tunlid, Anders; Prentice, Honor C.			Evidence for Positive Selection within the PgiC1 Locus in the Grass Festuca ovina	PLOS ONE			English	Article							HUMAN PHOSPHOGLUCOSE ISOMERASE; AMINO-ACID SITES; DNA POLYMORPHISM; FITNESS DIFFERENCES; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURES; BALANCING SELECTION; SWISS-MODEL; RECOMBINATION; GENE	The dimeric metabolic enzyme phosphoglucose isomerase (PGI, EC 5.3.1.9) plays an essential role in energy production. In the grass Festuca ovina, field surveys of enzyme variation suggest that genetic variation at cytosolic PGI (PGIC) may be adaptively important. In the present study, we investigated the molecular basis of the potential adaptive significance of PGIC in F. ovina by analyzing cDNA sequence variation within the PgiC1 gene. Two, complementary, types of selection test both identified PGIC1 codon (amino acid) sites 200 and 173 as candidate targets of positive selection. Both candidate sites involve chargechanging amino acid polymorphisms. On the homology-modeled F. ovina PGIC1 3-D protein structure, the two candidate sites are located on the edge of either the inter-monomer boundary or the inter-domain cleft; examination of the homology-modeled PGIC1 structure suggests that the amino acid changes at the two candidate sites are likely to influence the inter-monomer interaction or the domain-domain packing. Biochemical studies in humans have shown that mutations at several amino acid sites that are located close to the candidate sites in F. ovina, at the inter-monomer boundary or the inter-domain cleft, can significantly change the stability and/or kinetic properties of the PGI enzyme. Molecular evolutionary studies in a wide range of other organisms suggest that PGI amino acid sites with similar locations to those of the candidate sites in F. ovina may be the targets of positive/balancing selection. Candidate sites 200 and 173 are the only sites that appear to discriminate between the two most common PGIC enzyme electromorphs in F. ovina: earlier studies suggest that these electromorphs are implicated in local adaptation to different grassland microhabitats. Our results suggest that PGIC1 sites 200 and 173 are under positive selection in F. ovina.	[Li, Yuan; Canback, Bjorn; Johansson, Tomas; Tunlid, Anders; Prentice, Honor C.] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Li, Y (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Yuan.Li@biol.lu.se		Prentice, Honor C./0000-0003-2548-0525; LI, YUAN/0000-0001-5846-3727	Swedish Research Council [621-2008-5617]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grant 621-2008-5617 (to H.C.P. and A.T.) from the Swedish Research Council (http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2003, GENETICS, V164, P1229; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bengtsson Karin, 1988, ACTA PHYTOGEOGR SUEC, P21; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cordeiro AT, 2003, BBA-PROTEINS PROTEOM, V1645, P117, DOI 10.1016/S1570-9639(02)00464-8; Dahlhoff EP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P718, DOI 10.1086/590165; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Filatov DA, 1999, GENETICS, V153, P1423; Ghatnekar L, 1999, HEREDITY, V83, P451, DOI 10.1038/sj.hdy.6885750; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guex N., 1996, Experientia (Basel), V52, pA26; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jeffery CJ, 2001, BIOCHEMISTRY-US, V40, P1560, DOI 10.1021/bi0018483; Kallioniemi E, 2011, FUNCT ECOL, V25, P1032, DOI 10.1111/j.1365-2435.2011.01854.x; Kawabe A, 2000, GENETICS, V156, P1339; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Li ZH, 2012, EVOLUTION, V66, P831, DOI 10.1111/j.1558-5646.2011.01466.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin HY, 2009, BBA-PROTEINS PROTEOM, V1794, P315, DOI 10.1016/j.bbapap.2008.11.004; Liu F, 1999, GENETICS, V151, P343; Mugal CF, 2014, MOL BIOL EVOL, V31, P212, DOI 10.1093/molbev/mst192; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2003, MOL BIOL EVOL, V20, P1231, DOI 10.1093/molbev/msg147; Nielsen R, 1998, GENETICS, V148, P929; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Orsini L, 2009, J EVOLUTION BIOL, V22, P367, DOI 10.1111/j.1420-9101.2008.01653.x; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P223, DOI 10.1093/molbev/msi009; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; PRENTICE HC, 1995, J ECOL, V83, P391, DOI 10.2307/2261593; Prentice HC, 2000, J ECOL, V88, P331, DOI 10.1046/j.1365-2745.2000.00454.x; Read J, 2001, J MOL BIOL, V309, P447, DOI 10.1006/jmbi.2001.4680; RICHARDSON BJ, 1986, ALLOZYME ELECTROPHOR; RIDDOCH BJ, 1993, BIOL J LINN SOC, V50, P1, DOI 10.1111/j.1095-8312.1993.tb00915.x; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoville SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040035; SHAW PJ, 1977, J MOL BIOL, V109, P475, DOI 10.1016/S0022-2836(77)80025-9; SHAW PJ, 1976, FEBS LETT, V65, P50, DOI 10.1016/0014-5793(76)80619-9; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Somarowthu S, 2011, BIOCHEMISTRY-US, V50, P9283, DOI 10.1021/bi201089v; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terauchi R, 1997, GENETICS, V147, P1899; TURESSON GOTE, 1930, HEREDITAS, V13, P177; Vallenback P, 2008, MOL PHYLOGENET EVOL, V46, P890, DOI 10.1016/j.ympev.2007.11.031; Vallenback P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013529; Vallenback P, 2010, GENETICA, V138, P355, DOI 10.1007/s10709-009-9425-4; Wang BQ, 2009, J MOL EVOL, V68, P433, DOI 10.1007/s00239-009-9237-2; Watt Ward B., 2003, P319; Watt WB, 2013, ANN NY ACAD SCI, V1289, P1, DOI 10.1111/nyas.12139; WATT WB, 1983, GENETICS, V103, P725; WATT WB, 1977, GENETICS, V87, P177; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	70	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125831	10.1371/journal.pone.0125831	http://dx.doi.org/10.1371/journal.pone.0125831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946223	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700092
J	Liu, P; Paulson, JB; Forster, CL; Shapiro, SL; Ashe, KH; Zahs, KR				Liu, Peng; Paulson, Jennifer B.; Forster, Colleen L.; Shapiro, Samantha L.; Ashe, Karen H.; Zahs, Kathleen R.			Characterization of a Novel Mouse Model of Alzheimer's Disease-Amyloid Pathology and Unique beta-Amyloid Oligomer Profile	PLOS ONE			English	Article							APP TRANSGENIC MICE; PRECURSOR PROTEIN; FIBRILLAR OLIGOMERS; ALPHA-SYNUCLEIN; SENILE PLAQUES; NEURONAL LOSS; BRAIN; DEPOSITS; MEMORY; ABNORMALITIES	Amyloid plaques composed of beta-amyloid (A beta) protein are a pathological hallmark of Alzheimer's disease. We here report the generation and characterization of a novel transgenic mouse model of A beta toxicity. The rTg9191 mice harbor a transgene encoding the 695 aminoacid isoform of human amyloid precursor protein (APP) with the Swedish and London mutations (APP(NLI)) linked to familial Alzheimer's disease, under the control of a tetracycline-response element, as well as a transgene encoding the tetracycline transactivator, under the control of the promoter for calcium-calmodulin kinase II alpha. In these mice, APPNLI is expressed at a level four-fold that of endogenous mouse APP and its expression is restricted to fore-brain regions. Transgene expression was suppressed by 87% after two months of doxycycline administration. Histologically, we showed that (1) A beta plaques emerged in cerebral cortex and hippocampus as early as 8 and 10.5-12.5 months of age, respectively; (2) plaque deposition progressed in an age-dependent manner, occupying up to 19% of cortex at similar to 25 months of age; and (3) neuropathology-such as abnormal neuronal architecture, tau hyperphosphorylation and misfolding, and neuroinflammation-was observed in the vicinity of neuritic plaques. Biochemically, we determined total A beta production at varied ages of mice, and we showed that mice produced primarily fibrillar A beta assemblies recognized by conformation-selective OC antibodies, but few non-fibrillar oligomers (e.g., A beta* 56) detectable by A11 antibodies. Finally, we showed that expression of the tetracycline transactivator resulted in reduced brain weight and smaller dentate-gyrus size. Collectively, these data indicate that rTg9191 mice may serve as a model for studying the neurological effects of the fibrillar A beta assemblies in situ.	[Liu, Peng; Paulson, Jennifer B.; Shapiro, Samantha L.; Ashe, Karen H.; Zahs, Kathleen R.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Forster, Colleen L.] Univ Minnesota, Acad Hlth Ctr Biol Mat Procurement Network BioNet, Minneapolis, MN USA; [Liu, Peng; Paulson, Jennifer B.; Forster, Colleen L.; Shapiro, Samantha L.; Ashe, Karen H.; Zahs, Kathleen R.] Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN USA; [Ashe, Karen H.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Ashe, Karen H.] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Liu, P (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.	liuxx726@umn.edu; zahsx001@umn.edu			National Institute for Neurological Diseases and Stroke within the National Institutes of Health [NS33249]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033249] Funding Source: NIH RePORTER	National Institute for Neurological Diseases and Stroke within the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute for Neurological Diseases and Stroke (NS33249) within the National Institutes of Health (http://www.ninds.nih.gov/) to KHA and a gift from B. Grossman to KHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; D'Amore JD, 2003, J NEUROPATH EXP NEUR, V62, P137, DOI 10.1093/jnen/62.2.137; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Liu P, 2011, J ALZHEIMERS DIS, V26, P657, DOI 10.3233/JAD-2011-110383; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Paulson JB, 2008, AM J PATHOL, V173, P762, DOI 10.2353/ajpath.2008.080175; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Sherman MA, 2011, METHODS MOL BIOL, V670, P45, DOI 10.1007/978-1-60761-744-0_4; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Su JH, 1996, BRAIN RES, V739, P79, DOI 10.1016/S0006-8993(96)00811-6; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Vehmas AK, 2003, NEUROBIOL AGING, V24, P321, DOI 10.1016/S0197-4580(02)00090-8; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yang FS, 2000, BRAIN RES, V853, P381, DOI 10.1016/S0006-8993(99)02207-6	44	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126317	10.1371/journal.pone.0126317	http://dx.doi.org/10.1371/journal.pone.0126317			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946042	gold, Green Submitted, Green Published			2022-12-26	WOS:000354049700124
J	Yun, BH; Choi, YR; Choi, YS; Cho, S; Lee, BS; Seo, SK				Yun, Bo Hyon; Choi, Yun Rak; Choi, Young Sik; Cho, SiHyun; Lee, Byung Seok; Seo, Seok Kyo			Age at First Delivery and Osteoporosis Risk in Korean Postmenopausal Women: The 2008-2011 Korea National Health and Nutrition Examination Survey (KNHANES)	PLOS ONE			English	Article							BONE-MINERAL ACQUISITION; OVARIAN-FUNCTION; MASS; PREGNANCY; ADOLESCENCE; HYSTERECTOMY; DIAGNOSIS; DENSITY; BLACK	It has been reported in several studies that there may be a significant correlation between reproductive history and the risk of osteoporosis due to the effect of estrogen. Under this hypothesis, however, it is unclear whether the age at first delivery has any major influences on the risk of osteoporosis. Therefore, this study aimed to investigate the relationship between the age at first delivery and the risk of osteoporosis in Korean menopausal women. This study was performed using data from the 2008-2011 Korea National Health and Nutrition Examination Survey and included 2,530 Korean postmenopausal women. The diagnosis of osteoporosis was made using the World Health Organization T-score criteria (T-score <= -2.5, at the femoral neck or lumbar spine). Participants were categorized into 3 groups according to age at first delivery: <= 23, 24-29, and >= 30 years. Older age, lower body mass index, lower calcium intake, later menarche, and earlier menopause increased the risk of osteoporosis, whereas hormone therapy and oral contraceptive use were associated with a decreased risk of osteoporosis. Postmenopausal women whose first delivery occurred at age 24-29 years were shown to have a significantly increased risk of osteoporosis (odds ratio, 2.124; 95% confidence interval, 1.096-4.113; P = 0.026) compared to those who first gave birth after the age of 30 years. These findings suggest that postmenopausal women whose first delivery occurred in their mid to late 20s, a period during which bone mass slowly accumulates to the peak, are at an increased risk of osteoporosis.	[Yun, Bo Hyon; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Yun, Bo Hyon; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea; [Choi, Yun Rak] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Cho, SiHyun] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Seo, SK (corresponding author), Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	tudeolseo@yuhs.ac	Choi, Yun-Rak/AAG-9914-2019	Yun, Bo Hyon/0000-0001-5703-797X; Choi, Young Sik/0000-0002-1157-4822; Cho, SiHyun/0000-0003-2718-6645; LEE, Byung Seok/0000-0001-6001-2079; Seo, Seok Kyo/0000-0003-3404-0484				Abrams SA, 2003, HORM RES, V60, P71, DOI 10.1159/000074505; Ahn EH, 2002, YONSEI MED J, V43, P53, DOI 10.3349/ymj.2002.43.1.53; Bachrach LK, 1999, J CLIN ENDOCR METAB, V84, P4702, DOI 10.1210/jc.84.12.4702; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Chesnut CH, 2001, JAMA-J AM MED ASSOC, V286, P2865, DOI 10.1001/jama.286.22.2865; Chevalley T, 2009, J CLIN ENDOCR METAB, V94, P3424, DOI 10.1210/jc.2009-0241; Cho GJ, 2012, MENOPAUSE, V19, P456, DOI 10.1097/gme.0b013e3182337150; Chon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089721; Ferrari S, 2012, OSTEOPOROSIS INT, V23, P2735, DOI 10.1007/s00198-012-2030-x; FOX KM, 1993, J BONE MINER RES, V8, P901; JOHNSTON CC, 1993, OSTEOPOROSIS INT, V3, pS54, DOI 10.1007/BF01621864; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Miglioli L, 2007, OSTEOPOROSIS INT, V18, P101, DOI 10.1007/s00198-006-0203-1; Moorman PG, 2011, OBSTET GYNECOL, V118, P1271, DOI 10.1097/AOG.0b013e318236fd12; Nysom K, 2000, BONE MARROW TRANSPL, V25, P191, DOI 10.1038/sj.bmt.1702131; ORTOLANI S, 1993, OSTEOPOROSIS INT, V3, pS61, DOI 10.1007/BF01621866; Raisz LG, 2005, NEW ENGL J MED, V353, P164, DOI 10.1056/NEJMcp042092; RECKER RR, 1992, JAMA-J AM MED ASSOC, V268, P2403, DOI 10.1001/jama.268.17.2403; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Sabatier JP, 1996, OSTEOPOROSIS INT, V6, P141, DOI 10.1007/BF01623938; Schnatz PF, 2010, MENOPAUSE, V17, P1161, DOI 10.1097/gme.0b013e3181e0efb3; Sowers MF, 2000, OBSTET GYNECOL, V96, P189, DOI 10.1016/S0029-7844(00)00903-0; Szulc P, 2000, BONE, V26, P123, DOI 10.1016/S8756-3282(99)00255-0; TEEGARDEN D, 1995, J BONE MINER RES, V10, P711, DOI 10.1002/jbmr.5650100507; Wang MC, 1997, J BONE MINER RES, V12, P1922, DOI 10.1359/jbmr.1997.12.11.1922	27	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123665	10.1371/journal.pone.0123665	http://dx.doi.org/10.1371/journal.pone.0123665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946162	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700018
J	Zhu, M; Lu, B; Cao, QH; Wu, ZF; Xu, Z; Li, WS; Yao, XQ; Liu, FK				Zhu, Miao; Lu, Bo; Cao, Qinhong; Wu, Zhenfeng; Xu, Zhe; Li, Weisu; Yao, Xuequan; Liu, Fukun			IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; DEFICIENCY PROTECTS; CARDIAC FIBROSIS; TRANSCRIPTION 3; INTERLEUKIN-11; APOPTOSIS; PATHOGENESIS; INDUCTION; CELLS; IDENTIFICATION	Background The protective role of IL-11, an IL-6 family cytokine, has been implicated in ischemia/reperfusion injury (IRI) in the heart and kidney, but its role has not been elucidated in liver IRI. This study was designed to evaluate the effects of IL-11 and its mechanism of action on liver IRI in a mouse model. Methods A partial (70%) warm liver IRI was induced by interrupting the artery/portal vein blood supply to the left/middle liver lobes. IL-11 mRNA expression of ischemic liver after reperfusion was analyzed. Signal transducer and activator of transcription 3 (STAT3) was analyzed following IL-11 treatment in vivo and in vitro. Next, IL-11 was injected intraperitoneally (ip) 1 hour before ischemia. Liver injury was assessed based on serum alanine aminotransferase levels and histopathology. Apoptosis and inflammation were also determined in the ischemic liver. To analyze the role of STAT3 in IL-11 treatment, STAT3 siRNA or non-specific (NS) siRNA was used in vitro and in vivo. Results IL-11 mRNA expression was significantly increased after reperfusion in the ischemic liver. STAT3, as a target of IL-11, was activated in hepatocytes after IL-11 treatment in vivo and in vitro. Next, effects of IL-11/STAT3 signaling pathway were assessed in liver IRI, which showed IL-11 treatment significantly attenuated liver IRI, as evidenced by reduced hepatocellular function and hepatocellular necrosis/apoptosis. In addition, IL-11 treatment significantly inhibited the gene expressions of pro-inflammatory cytokines (TNF-alpha and IL-10) and chemokines (IP-10 and MCP-1). To determine the role of STAT3 in the hepatoprotective effects of IL-11, STAT3 siRNA or NS siRNA was used prior to IL-11 treatment. The results showed STAT3 knockdown abrogated the protective effects of IL-11 in vitro and in vivo. Conclusions This work provides first-time evidence for the protective effect of IL-11 treatment on hepatocyte in liver IRI, through the activation of the STAT3 pathway.	[Zhu, Miao; Cao, Qinhong; Wu, Zhenfeng; Xu, Zhe; Li, Weisu; Yao, Xuequan; Liu, Fukun] Nanjing Univ TCM, Affiliated Hosp, Dept Surg Oncol, Nanjing, Jiangsu, Peoples R China; [Lu, Bo] Yixing Peoples Hosp, Dept Gen Surg, Yixing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Liu, FK (corresponding author), Nanjing Univ TCM, Affiliated Hosp, Dept Surg Oncol, 155 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China.	fukunliu@126.com						Dinasarapu AR, 2013, BIOINFORMATICS, V29, P2735, DOI 10.1093/bioinformatics/btt469; Du XX, 1997, AM J PHYSIOL-GASTR L, V272, pG545, DOI 10.1152/ajpgi.1997.272.3.G545; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Gordon MS, 1995, BLOOD, V87, P3615; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Kawakami T, 2006, INT J MOL MED, V18, P537; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Kimura R, 2007, CYTOKINE, V38, P107, DOI 10.1016/j.cyto.2007.05.011; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Liu J, 2012, TRANSPLANTATION, V94, P211, DOI 10.1097/TP.0b013e318259d38e; Lou LX, 2013, LIVER TRANSPLANT, V19, P1078, DOI 10.1002/lt.23693; Naugler KM, 2008, AM J PHYSIOL-GASTR L, V294, pG728, DOI 10.1152/ajpgi.00002.2007; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; Noda T, 1998, AM J PHYSIOL-GASTR L, V274, pG270, DOI 10.1152/ajpgi.1998.274.2.G270; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711; Rao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065568; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Reynolds C H, 2000, Oncology (Williston Park), V14, P32; Ropeleski MJ, 2003, GASTROENTEROLOGY, V124, P1358, DOI 10.1016/S0016-5085(03)00282-8; Sands BE, 2002, ALIMENT PHARM THERAP, V16, P399, DOI 10.1046/j.1365-2036.2002.01179.x; Sano T, 2011, TRANSPLANTATION, V91, P1082, DOI 10.1097/TP.0b013e31821457cb; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Shah KA, 1997, INT J EXP PATHOL, V78, P355, DOI 10.1046/j.1365-2613.1997.420369.x; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spehlmann ME, 2013, J IMMUNOL, V191, P837, DOI 10.4049/jimmunol.1201716; SUZUKI S, 1991, TRANSPLANTATION, V52, P978, DOI 10.1097/00007890-199112000-00008; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Timofeeva OA, 2013, P NATL ACAD SCI USA, V110, P1267, DOI 10.1073/pnas.1211805110; Trepicchio W L, 1998, Expert Opin Investig Drugs, V7, P1501, DOI 10.1517/13543784.7.9.1501; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; Wen TC, 2001, NEUROSCI LETT, V303, P153, DOI 10.1016/S0304-3940(01)01711-6; YIN TG, 1994, EXP HEMATOL, V22, P467; Yue S, 2014, J IMMUNOL, V192, P5343, DOI 10.4049/jimmunol.1400280	42	10	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126296	10.1371/journal.pone.0126296	http://dx.doi.org/10.1371/journal.pone.0126296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946003	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700122
J	De Rosa, FG; Corcione, S; Filippini, C; Raviolo, S; Fossati, L; Montrucchio, C; Aldieri, C; Petrolo, A; Cavallo, R; Di Perri, G				De Rosa, Francesco G.; Corcione, Silvia; Filippini, Claudia; Raviolo, Stefania; Fossati, Lucina; Montrucchio, Chiara; Aldieri, Chiara; Petrolo, Alessia; Cavallo, Rossana; Di Perri, Giovanni			The Effect on Mortality of Fluconazole or Echinocandins Treatment in Internal Medicine Wards	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; INVASIVE CANDIDIASIS; CANDIDEMIA; EPIDEMIOLOGY; MANAGEMENT; OUTCOMES; MULTICENTER; PREDICTORS; CARE; SURVEILLANCE	The incidence of candidemia has increased over the past two decades, with an increased number of cases in Internal Medicine and a prevalence ranging from 24% to 57%. This single-center retrospective study was performed to evaluate the epidemiology and the risk factors associated with mortality of candidemia in patients admitted to Internal Medicine wards (IMWs) of the City of Health and Sciences, Molinette Hospital, Turin, from January 2004 to December 2012. For each patient, demographic, clinical and microbiological data were collected. A case of candidemia was defined as a patient with at least one blood culture positive for Candida spp. Amongst 670 episodes of candidemia, 274 (41%) episodes occurred in IMWs. The mortality was 39% and was associated at multivariate analysis with sepsis, cirrhosis and neurologic diseases, whilst removal of central venous catheter <= 48h was significantly associated with survival. In the 77 patients treated with early antifungal therapy the mortality was 29% and was not significantly different with caspofungin or fluconazole, whilst in patients with definitive therapy the mortality was significantly lower with echinocandins compared to fluconazole (11.7% Vs. 39%; p=0.0289), a finding confirmed by multivariate analysis. The mortality was significantly associated with sepsis, cirrhosis and neurologic diseases, whilst CVC removal <= 48h was associated with survival. In patients with early therapy, fluconazole or caspofungin were equally effective. However, echinocandins were significantly more effective as definitive treatment, a finding not explained by differences in treatment delays. Further studies are needed to understand the full potential of these different therapeutic strategies in IMWs.	[De Rosa, Francesco G.; Corcione, Silvia; Raviolo, Stefania; Montrucchio, Chiara; Aldieri, Chiara; Petrolo, Alessia; Di Perri, Giovanni] Univ Turin, Infect Dis Amedeo di Savoia Hosp, Dept Med Sci, Turin, Italy; [Filippini, Claudia] Univ Turin, Molinette Hosp, City Hlth & Sci, Dept Anesthesia & Crit Care, Turin, Italy; [Fossati, Lucina; Cavallo, Rossana] Univ Turin, Dept Publ Hlth & Pediat Sci, City Hlth & Sci, Lab Microbiol & Virol, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	De Rosa, FG (corresponding author), Univ Turin, Infect Dis Amedeo di Savoia Hosp, Dept Med Sci, Turin, Italy.	francescogiuseppe.derosa@unito.it	Cavallo, Rossana/AAL-4279-2020; Di Perri, Giovanni/AAC-1882-2019; DE ROSA, Francesco Giuseppe/AAC-7275-2022	Cavallo, Rossana/0000-0001-8655-8707; DE ROSA, Francesco Giuseppe/0000-0001-8338-0130; corcione, silvi/0000-0003-2949-4297; Filippini, Claudia/0000-0003-0194-142X				Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Bassetti M, 2013, CLIN MICROBIOL INFEC, V19, pE281, DOI 10.1111/1469-0691.12155; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Cisterna R, 2010, J CLIN MICROBIOL, V48, P4200, DOI 10.1128/JCM.00920-10; CLSI, 2012, M100S22 CLSI; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; De Rosa FG, 2013, J ANTIMICROB CHEMOTH, V68, P927, DOI 10.1093/jac/dks480; Fernandez-Ruiz M, 2014, CLIN INFECT DIS, V58, P1413, DOI 10.1093/cid/ciu158; Fortun J, 2012, J INFECTION, V65, P64, DOI 10.1016/j.jinf.2012.02.011; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Guimaraes T, 2012, INT J INFECT DIS, V16, pE442, DOI 10.1016/j.ijid.2012.02.005; Ha YE, 2012, ANTIMICROB AGENTS CH, V56, P3950, DOI 10.1128/AAC.06258-11; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; Luzzati R, 2000, EUR J CLIN MICROBIOL, V19, P602, DOI 10.1007/s100960000325; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Poikonen E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-312; Reboli AC, 2007, NEW ENGL J MED, V356, P2472, DOI 10.1056/NEJMoa066906; Scudeller L, 2014, INFECTION, V42, P263, DOI 10.1007/s15010-013-0558-0; Tortorano AM, 2013, INFECTION, V41, P655, DOI 10.1007/s15010-013-0455-6; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125149	10.1371/journal.pone.0125149	http://dx.doi.org/10.1371/journal.pone.0125149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938486	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000047
J	Guha, G; Lu, WL; Li, S; Liang, XB; Kulesz-Martin, MF; Mahmud, T; Indra, AK; Ganguli-Indra, G				Guha, Gunjan; Lu, Wanli; Li, Shan; Liang, Xiaobo; Kulesz-Martin, Molly F.; Mahmud, Taifo; Indra, Arup Kumar; Ganguli-Indra, Gitali			Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells	PLOS ONE			English	Article							PROLIFERATION MARKERS; MITOTIC CATASTROPHE; SENESCENT CELLS; METASTATIC HEAD; PARP CLEAVAGE; APOPTOSIS; PROTEIN; PHOSPHORYLATION; INHIBITION; EXPRESSION	Pactamycin, although putatively touted as a potent antitumor agent, has never been used as an anticancer drug due to its high cytotoxicity. In this study, we characterized the effects of two novel biosynthetically engineered analogs of pactamycin, de-6MSA-7-demethyl-7-deoxypactamycin (TM-025) and 7-demethyl-7-deoxypactamycin (TM-026), in head and neck squamous cell carcinoma (HNSCC) cell lines SCC25 and SCC104. Both TM-025 and TM-026 exert growth inhibitory effects on HNSCC cells by inhibiting cell proliferation. Interestingly, unlike their parent compound pactamycin, the analogs do not inhibit synthesis of nascent protein in a cell-based assay. Furthermore, they do not induce apoptosis or autophagy in a dose- or a time-dependent manner, but induce mild senescence in the tested cell lines. Cell cycle analysis demonstrated that both analogs significantly induce cell cycle arrest of the HNSCC cells at S-phase resulting in reduced accumulation of G(2)/M-phase cells. The pactamycin analogs induce expression of cell cycle regulatory proteins including master regulator p53, its downstream target p21(Cip1/WAF1), p27(kip21), p19, cyclin E, total and phospho Cdc2 (Tyr15) and Cdc25C. Besides, the analogs mildly reduce cyclin D1 expression without affecting expression of cyclin B, Cdk2 and Cdk4. Specific inhibition of p53 by pifithrin-alpha reduces the percentage of cells accumulated in S-phase, suggesting contribution of p53 to S-phase increase. Altogether, our results demonstrate that Pactamycin analogs TM-025 and TM-026 induce senescence and inhibit proliferation of HNSCC cells via accumulation in S-phase through possible contribution of p53. The two PCT analogs can be widely used as research tools for cell cycle inhibition studies in proliferating cancer cells with specific mechanisms of action.	[Guha, Gunjan; Lu, Wanli; Li, Shan; Liang, Xiaobo; Mahmud, Taifo; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Lu, Wanli; Mahmud, Taifo; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Mol & Cell Biol Program, Corvallis, OR 97331 USA; [Kulesz-Martin, Molly F.; Indra, Arup Kumar] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Indra, Arup Kumar] Oregon Hlth & Sci Univ, Environm Hlth Sci Ctr, Portland, OR 97201 USA	Oregon State University; Oregon State University; Oregon Health & Science University; Oregon Health & Science University	Indra, AK (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	arup.indra@oregonstate.edu; indrag@onid.orst.edu	Indra, Arup/AAG-2376-2019; Mahmud, Taifo/A-1492-2015; Guha, Gunjan/D-8197-2011; Indra, Gitali/G-2963-2016	Indra, Arup/0000-0001-6137-7555; Mahmud, Taifo/0000-0001-9639-526X; Guha, Gunjan/0000-0002-9224-0241; 	National Institutes of Health (NIH); Oregon Health & Science University (OHSU) Medical Research Foundation grant; College of Pharmacy General Research Fund; National Institute of Environmental Health Sciences (NIEHS) center grant [ES00210]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health & Science University (OHSU) Medical Research Foundation grant; College of Pharmacy General Research Fund; National Institute of Environmental Health Sciences (NIEHS) center grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by grant 5R01AR056008-03 (AI) from the National Institutes of Health (NIH), Oregon Health & Science University (OHSU) Medical Research Foundation grant (AI), College of Pharmacy General Research Fund and the National Institute of Environmental Health Sciences (NIEHS) center grant (ES00210) to Environmental Health Sciences Center, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Aziz N, 2011, FERTIL STERIL, V95, P2481, DOI 10.1016/j.fertnstert.2011.03.095; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bhakta D, 2012, FOOD CHEM TOXICOL, V50, P2062, DOI 10.1016/j.fct.2012.03.045; Bharti AC, 2005, METH MOLEC MED, V111, P69; BHUYAN BK, 1962, APPL MICROBIOL, V10, P302, DOI 10.1128/AEM.10.4.302-304.1962; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brown ET, 2008, RADIAT RES, V169, P595, DOI 10.1667/RR1129.1; Camats M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008513; Camphausen K, 2003, CANCER RES, V63, P1990; Cheng Y, 2009, ARCH BIOCHEM BIOPHYS, V490, P70, DOI 10.1016/j.abb.2009.08.011; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; COHEN LB, 1969, BIOCHEMISTRY-US, V8, P1327, DOI 10.1021/bi00832a005; Cong F, 2012, ANNU REV PHARMACOL, V52, P57, DOI 10.1146/annurev-pharmtox-010611-134639; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dotto GP, 2000, BIOCHIM BIOPHYS ACTA, P1471; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Ghaffari AR, 2011, HEPAT MON, V11, P463; Gillespie V, 2011, VET PATHOL, V48, P283, DOI 10.1177/0300985810380397; Grevelman EG, 2005, ANN ONCOL, V16, P352, DOI 10.1093/annonc/mdi088; Gruber HE, 1999, BIOTECH HISTOCHEM, V74, P141, DOI 10.3109/10520299909047966; Guha G, 2010, FOOD CHEM TOXICOL, V48, P2133, DOI 10.1016/j.fct.2010.05.017; Han YH, 2008, TOXICOL IN VITRO, V22, P1605, DOI 10.1016/j.tiv.2008.06.014; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanessian S, 2011, ANGEW CHEM INT EDIT, V50, P3497, DOI 10.1002/anie.201008079; Hanessian S, 2013, BIOORGAN MED CHEM, V21, P1775, DOI 10.1016/j.bmc.2013.01.037; Hanessian S, 2012, J ORG CHEM, V77, P9458, DOI 10.1021/jo301638z; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hu D, 2012, ARCH OTOLARYNGOL, V138, P412, DOI 10.1001/archoto.2012.20; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jessus C, 1995, Prog Cell Cycle Res, V1, P215; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kachnic LA, 1999, J BIOL CHEM, V274, P13111, DOI 10.1074/jbc.274.19.13111; Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6; Kaldis P, 2005, CELL CYCLE, V4, P1491, DOI 10.4161/cc.4.11.2124; Kang JY, 2009, MOL CELLS, V28, P489, DOI 10.1007/s10059-009-0141-9; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Konishi T, 2011, J RADIAT RES, V52, P433, DOI 10.1269/jrr.10097; KUNG AL, 1990, CANCER RES, V50, P7307; Kuroda J, 2005, INT J ONCOL, V26, P361; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Lehner B, 2011, CELL TISSUE RES, V345, P313, DOI 10.1007/s00441-011-1213-7; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Lin JT, 2012, ADV THER, V29, P71, DOI 10.1007/s12325-011-0085-2; Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016; Malinowski JT, 2013, SCIENCE, V340, P180, DOI 10.1126/science.1234756; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; Monroe MM, 2011, J ONCOL, V2011, DOI 10.1155/2011/762780; Moreno-Otero R, 2011, CURR DRUG SAF, V6, P197, DOI 10.2174/157488611797579221; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Nakashima N, 2012, LUNG CANCER, V76, P228, DOI 10.1016/j.lungcan.2011.10.007; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Olivero OA, 2005, MUTAGENESIS, V20, P139, DOI 10.1093/mutage/gei019; Otoguro K, 2010, J ANTIBIOT, V63, P381, DOI 10.1038/ja.2010.50; Pactamycin White F., 1962, CANCER CHEMOTH REP, V24, P75; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Portugal J, 2009, TUMORI J, V95, P409; Price KAR, 2012, CURR TREAT OPTION ON, V13, P35, DOI 10.1007/s11864-011-0176-y; Prueksaritanond Nisa, 2012, J Med Assoc Thai, V95 Suppl 3, pS55; Romero Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-341; Roninson IB, 2003, CANCER RES, V63, P2705; Sanderson RJ, 2002, BMJ-BRIT MED J, V325, P822, DOI 10.1136/bmj.325.7368.822; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sharpe RJ, 2013, J AM CHEM SOC, V135, P17990, DOI 10.1021/ja409944u; Singh R, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-4; Sultana S, 2012, J PHARM PHARMACOL, V64, P872, DOI 10.1111/j.2042-7158.2012.01470.x; TABER R, 1971, J VIROL, V8, P395, DOI 10.1128/JVI.8.4.395-401.1971; Tamaki T, 2003, J INT MED RES, V31, P6, DOI 10.1177/147323000303100102; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tokgoz SA, 2012, J LARYNGOL OTOL, V126, P464, DOI 10.1017/S0022215112000382; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Wang GH, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/634868; Wells NJ, 1999, J CELL SCI, V112, P3361; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Yin XF, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-46; Zhang YX, 2000, CANCER RES, V60, P2025; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182; Zhang Z, 2002, CHEM RES TOXICOL, V15, P950, DOI 10.1021/tx0255018	93	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125322	10.1371/journal.pone.0125322	http://dx.doi.org/10.1371/journal.pone.0125322			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938491	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000057
J	Pianta, TJ; Endre, ZH; Pickering, JW; Buckley, NA; Peake, PW				Pianta, Timothy J.; Endre, Zoltan H.; Pickering, John W.; Buckley, Nicholas A.; Peake, Philip W.			Kinetic Estimation of GFR Improves Prediction of Dialysis and Recovery after Kidney Transplantation	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; CYSTATIN-C; CREATININE CLEARANCE; RENAL-FUNCTION; BIOMARKERS; EQUATION; INJURY; IMPACT	Background The early prediction of delayed graft function (DGF) would facilitate patient management after kidney transplantation. Methods In a single-centre retrospective analysis, we investigated kinetic estimated GFR under non-steady-state conditions, KeGFR, in prediction of DGF. KeGFR(sCr) was calculated at 4h, 8h and 12h in 56 recipients of deceased donor kidneys from initial serum creatinine (sCr) concentrations, estimated creatinine production rate, volume of distribution, and the difference between consecutive sCr values. The utility of KeGFR(sCr) for DGF prediction was compared with, sCr, plasma cystatin C (pCysC), and KeGFR(pCysC) similarly derived from pCysC concentrations. Results At 4h, the KeGFR(sCr) area under the receiver operator characteristic curve (AUC) for DGF prediction was 0.69 (95% CI: 0.56-0.83), while sCr was not useful (AUC 0.56, (CI: 0.41-0.72). Integrated discrimination improvement analysis showed that the KeGFRsCr improved a validated clinical prediction model at 4h, 8h, and 12h, increasing the AUC from 0.68 (0.52-0.83) to 0.88 (0.78-0.99) at 12h (p = 0.01). KeGFR(pCysC) also improved DGF prediction. In contrast, sCr provided no improvement at any time point. Conclusions Calculation of KeGFR from sCr facilitates early prediction of DGF within 4 hours of renal transplantation.	[Pianta, Timothy J.; Endre, Zoltan H.; Peake, Philip W.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Pianta, Timothy J.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Endre, Zoltan H.; Pickering, John W.] Univ Otago, Dept Med, Christchurch, New Zealand; [Buckley, Nicholas A.] Univ Sydney, Clin Pharmacol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Melbourne; University of Otago; University of Sydney	Pianta, TJ (corresponding author), Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	timothy.pianta@nh.org.au	Pickering, John/ABC-8089-2021; Buckley, Nicholas A/D-4030-2012; Pickering, John W/A-9453-2009; Endre, Zoltan/A-3331-2009	Pickering, John/0000-0001-9475-0344; Buckley, Nicholas A/0000-0002-6326-4711; Pickering, John W/0000-0001-9475-0344; Pianta, Timothy/0000-0002-9196-4889; Endre, Zoltan/0000-0002-4782-8695	National Health and Medical Research Council (NHMRC, Australia) [1011772]; Jacquot Research Entry Scholarship; University of New South Wales Australian Postgraduate Award	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Jacquot Research Entry Scholarship; University of New South Wales Australian Postgraduate Award	The research was in part funded by the National Health and Medical Research Council (NHMRC, Australia) project grant 1011772 www.nhmrc.gov.au. Stipend support for TJP was provided by the Jacquot Research Entry Scholarship and a University of New South Wales Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapal M, 2014, KIDNEY INT, V86, P1130, DOI 10.1038/ki.2014.188; Chen S, 2013, J AM SOC NEPHROL, V24, P877, DOI 10.1681/ASN.2012070653; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Fonseca I, 2014, TRANSPLANTATION, V97, P1058, DOI 10.1097/01.TP.0000438626.91095.50; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hall IE, 2011, TRANSPLANTATION, V91, P48, DOI 10.1097/TP.0b013e3181fc4b3a; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jeldres C, 2009, CUAJ-CAN UROL ASSOC, V3, P377; JONES JD, 1974, CLIN CHEM, V20, P1204; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; OH MS, 1993, NEPHRON, V63, P255, DOI 10.1159/000187206; Pianta TJ, 2015, TRANSPLANTATION, V99, P171, DOI 10.1097/TP.0000000000000256; Pianta TJ, 2013, BIOMARK MED, V7, P441, DOI [10.2217/BMM.13.51, 10.2217/bmm.13.51]; Pickering JW, 2012, CLIN J AM SOC NEPHRO, V7, P1355, DOI 10.2215/CJN.09590911; Rodrigo E, 2012, AM J TRANSPLANT, V12, P240, DOI 10.1111/j.1600-6143.2011.03810.x; SCHLOERB PR, 1960, AM J PHYSIOL, V199, P661, DOI 10.1152/ajplegacy.1960.199.4.661; Schneider AG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.017; Singh RP, 2011, CLIN TRANSPLANT, V25, P255, DOI 10.1111/j.1399-0012.2010.01241.x; Sjostrom P, 2005, SCAND J CLIN LAB INV, V65, P111, DOI 10.1080/00365510510013523; Tenstad O, 1996, SCAND J CLIN LAB INV, V56, P409, DOI 10.3109/00365519609088795; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Yashiro M, 2012, CLIN EXP NEPHROL, V16, P570, DOI 10.1007/s10157-012-0602-x; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125669	10.1371/journal.pone.0125669	http://dx.doi.org/10.1371/journal.pone.0125669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938452	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000086
J	Rioult-Pedotti, MS; Pekanovic, A; Atiemo, CO; Marshall, J; Luft, AR				Rioult-Pedotti, Mengia-Seraina; Pekanovic, Ana; Atiemo, Clement Osei; Marshall, John; Luft, Andreas Ruediger			Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation	PLOS ONE			English	Article							D1-D2 RECEPTOR HETEROMER; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; D-1; D1; PHARMACOLOGY; INHIBITION; MODULATION; MECHANISMS; DEPRESSION	Dopaminergic neurons in the ventral tegmental area, the major midbrain nucleus projecting to the motor cortex, play a key role in motor skill learning and motor cortex synaptic plasticity. Dopamine D1 and D2 receptor antagonists exert parallel effects in the motor system: they impair motor skill learning and reduce long-term potentiation. Traditionally, D1 and D2 receptor modulate adenylyl cyclase activity and cyclic adenosine monophosphate accumulation in opposite directions via different G-proteins and bidirectionally modulate protein kinase A (PKA), leading to distinct physiological and behavioral effects. Here we show that D1 and D2 receptor activity influences motor skill acquisition and long term synaptic potentiation via phospholipase C (PLC) activation in rat primary motor cortex. Learning a new forelimb reaching task is severely impaired in the presence of PLC, but not PKA-inhibitor. Similarly, long term potentiation in motor cortex, a mechanism involved in motor skill learning, is reduced when PLC is inhibited but remains unaffected by the PKA inhibitor. Skill learning deficits and reduced synaptic plasticity caused by dopamine antagonists are prevented by co-administration of a PLC agonist. These results provide evidence for a role of intracellular PLC signaling in motor skill learning and associated cortical synaptic plasticity, challenging the traditional view of bidirectional modulation of PKA by D1 and D2 receptors. These findings reveal a novel and important action of dopamine in motor cortex that might be a future target for selective therapeutic interventions to support learning and recovery of movement resulting from injury and disease.	[Rioult-Pedotti, Mengia-Seraina; Pekanovic, Ana; Atiemo, Clement Osei; Luft, Andreas Ruediger] Univ Zurich, Dept Neurol, Clin Neurorehabil, Zurich, Switzerland; [Rioult-Pedotti, Mengia-Seraina; Pekanovic, Ana; Atiemo, Clement Osei; Luft, Andreas Ruediger] Rehabil Initiat & Technol Ctr Zurich RITZ, Zurich, Switzerland; [Luft, Andreas Ruediger] Univ Zurich Hosp, Dept Neurol, Div Vasc Neurol & Neurorehabil, CH-8091 Zurich, Switzerland; [Rioult-Pedotti, Mengia-Seraina; Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	University of Zurich; University of Zurich; University Zurich Hospital; Brown University	Rioult-Pedotti, MS (corresponding author), Univ Zurich, Dept Neurol, Clin Neurorehabil, Zurich, Switzerland.	yfpgin@gmail.com	Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021		Swiss National Science Foundation [310030_135471]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding came from the Swiss National Science Foundation 310030_135471. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Chun LS, 2013, MOL PHARMACOL, V84, P190, DOI 10.1124/mol.113.085175; DREHER JK, 1989, BRAIN RES, V487, P267, DOI 10.1016/0006-8993(89)90831-7; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friedman E, 1997, MOL PHARMACOL, V51, P6, DOI 10.1124/mol.51.1.6; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; George Susan R, 2007, ScientificWorldJournal, V7, P58; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Hasbi A, 2014, FASEB J, V28, P4806, DOI 10.1096/fj.14-254037; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Lee SM, 2014, J PHARMACOL EXP THER, V351, P9, DOI 10.1124/jpet.114.214411; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lisman J., 2014, BRAIN RES; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Medvedev IO, 2013, J NEUROSCI, V33, P18125, DOI 10.1523/JNEUROSCI.2382-13.2013; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; Nolan EB, 2007, SYNAPSE, V61, P279, DOI 10.1002/syn.20371; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Perreault ML, 2014, DEV NEUROSCI-BASEL, V36, P287, DOI 10.1159/000360158; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; PLAZNIK A, 1989, PSYCHOPHARMACOLOGY, V99, P558, DOI 10.1007/BF00589908; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sahu A, 2009, MOL PHARMACOL, V75, P447, DOI 10.1124/mol.108.053017; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Surmeier DJ, 2011, NEUROSCIENCE, V198, P3, DOI 10.1016/j.neuroscience.2011.08.051; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Undieh AS, 2010, PHARMACOL THERAPEUT, V128, P37, DOI 10.1016/j.pharmthera.2010.05.003; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H	43	39	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0124986	10.1371/journal.pone.0124986	http://dx.doi.org/10.1371/journal.pone.0124986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938462	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000353943000036
J	Lemming, D; Borsbo, B; Sjors, A; Lind, EB; Arendt-Nielsen, L; Graven-Nielsen, T; Gerdle, B				Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Arendt-Nielsen, Lars; Graven-Nielsen, Thomas; Gerdle, Bjorn			Single-Point but Not Tonic Cuff Pressure Pain Sensitivity Is Associated with Level of Physical Fitness - A Study of Non-Athletic Healthy Subjects	PLOS ONE			English	Article							SEX-DIFFERENCES; EXERCISE; PERCEPTION; ALGOMETRY; THRESHOLD; GENDER; WOMEN; HYPERSENSITIVITY; SENSITIZATION; METAANALYSIS	Exercise is often used for pain rehabilitation but the link between physical activity level and pain sensitivity is still not fully understood. Pressure pain sensitivity to cuff algometry and conditioned pain modulation (CPM) were evaluated in highly active men (n=22), normally active men (n=26), highly active women (n=27) and normally active women (n=23) based on the Godin Leisure-Time Exercise Questionnaire. Cuff pressure pain sensitivity was assessed at the arm and lower leg. The subjects scored the pain intensity on an electronic Visual Analogue Scale (VAS) during ten minutes with 25 kPa constant cuff pressure and two minutes with zero pressure. The maximal VAS score and area under the VAS-curve were extracted. Pressure pain thresholds (PPT) were recorded by manual pressure algometry on the ipsilateral tibialis anterior muscle before, during and after the tonic arm stimulation. Tonic cuff stimulation of the arm and leg resulted in higher VAS peak scores in women compared with men (p<0.04). In all groups the PPTs were reduced during and after the cuff stimulation compared with baseline (p=0.001). PPT were higher in men compared with women (p=0.03) and higher in highly physical active compared with normal active (p=0.048). Besides the well-known gender difference in pressure pain sensitivity this study demonstrates that a high physical fitness degree in non-athletic subjects is associated with increased pressure pain thresholds but does not affect cuff pressure pain sensitivity in healthy people.	[Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Gerdle, Bjorn] Linkoping Univ, Dept Pain, SE-58185 Linkoping, Sweden; [Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Gerdle, Bjorn] Linkoping Univ, Rehabil Ctr, SE-58185 Linkoping, Sweden; [Lemming, Dag; Borsbo, Bjorn; Sjors, Anna; Lind, Eva-Britt; Gerdle, Bjorn] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Arendt-Nielsen, Lars; Graven-Nielsen, Thomas] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Lab Expt Pain Res, DK-9220 Aalborg, Denmark	Linkoping University; Linkoping University; Linkoping University; Aalborg University	Lemming, D (corresponding author), Linkoping Univ, Dept Pain, SE-58185 Linkoping, Sweden.	dag.lemming@liu.se	Arendt-Nielsen, Lars/T-4885-2018	Sjors Dahlman, Anna/0000-0003-2530-4126; Arendt-Nielsen, Lars/0000-0003-0892-1579; Graven-Nielsen, Thomas/0000-0002-7787-4860	Swedish Research Council [K2011-69X-21874-01-6]; Swedish Council for Working Life and Social Research [2010-0913]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Swedish Research Council (K2011-69X-21874-01-6) and the Swedish Council for Working Life and Social Research (2010-0913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Chesterton LS, 2007, CLIN J PAIN, V23, P760, DOI 10.1097/AJP.0b013e318154b6ae; Chesterton LS, 2003, PAIN, V101, P259, DOI 10.1016/S0304-3959(02)00330-5; Ferreira ML, 2010, PHYS THER, V90, P1383, DOI 10.2522/ptj.20090332; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Finocchietti S, 2011, EUR J PAIN, V15, P36, DOI 10.1016/j.ejpain.2010.05.010; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Goodin BR, 2009, PSYCHOSOM MED, V71, P1018, DOI 10.1097/PSY.0b013e3181bc62ba; Hoffman MD, 2004, ARCH PHYS MED REHAB, V85, P1183, DOI 10.1016/j.apmr.2003.09.010; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JENSEN K, 1986, PAIN, V25, P313, DOI 10.1016/0304-3959(86)90235-6; Jespersen A, 2007, PAIN, V131, P57, DOI 10.1016/j.pain.2006.12.012; Jespersen A, 2013, PAIN MED, V14, P297, DOI 10.1111/pme.12021; Koltyn KF, 1998, BRIT J SPORT MED, V32, P20, DOI 10.1136/bjsm.32.1.20; Koltyn KF, 2002, SPORTS MED, V32, P477, DOI 10.2165/00007256-200232080-00001; Lemming D, 2012, J REHABIL MED, V44, P648, DOI 10.2340/16501977-1006; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; Oono Y, 2011, J OROFAC PAIN, V25, P364; Polianskis R, 2002, J PAIN, V3, P28, DOI 10.1054/jpai.2002.27140; Polianskis R, 2001, EUR J PAIN, V5, P267, DOI 10.1053/eujp.2001.0245; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Ring C, 2008, BIOL PSYCHOL, V78, P123, DOI 10.1016/j.biopsycho.2008.01.008; Schmitz AK, 2013, EUR J PAIN, V17, P124, DOI 10.1002/j.1532-2149.2012.00169.x; Skou ST, 2013, PAIN, V154, P1588, DOI 10.1016/j.pain.2013.04.033; Tesarz J, 2013, PAIN, V154, P1022, DOI 10.1016/j.pain.2013.03.014; Tesarz J, 2012, PAIN, V153, P1253, DOI 10.1016/j.pain.2012.03.005; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6	29	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125432	10.1371/journal.pone.0125432	http://dx.doi.org/10.1371/journal.pone.0125432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933412	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100112
J	Erion, KA; Berdan, CA; Burritt, NE; Corkey, BE; Deeney, JT				Erion, Karel A.; Berdan, Charles A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.			Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic -Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (-cell); calcium imaging; insulin secretion; lipid; metabolism; type 2 diabetes; hyperinsulinemia	LONG-TERM EXPOSURE; BETA-CELL; GENE-EXPRESSION; PROINSULIN BIOSYNTHESIS; AMPLIFYING PATHWAYS; FATTY-ACIDS; HYPERINSULINEMIA; ISLETS; MOUSE; GLUCOKINASE	Background: Fasting insulin secretion is increased in obesity and type 2 diabetes. Results: Culture of -cells in excess nutrients resulted in increased lipid stores and a left-shifted dose-response curve of glucose-stimulated insulin secretion due to an enhanced sensitivity of exocytosis to Ca2+. Conclusion: Intracellular lipid modulates the dose response of glucose-stimulated insulin secretion. Significance: A shift in -cell glucose sensitivity may contribute to hyperinsulinemia. Hyperinsulinemia (HI) is elevated plasma insulin at basal glucose. Impaired glucose tolerance is associated with HI, although the exact cause and effect relationship remains poorly defined. We tested the hypothesis that HI can result from an intrinsic response of the -cell to chronic exposure to excess nutrients, involving a shift in the concentration dependence of glucose-stimulated insulin secretion. INS-1 (832/13) cells were cultured in either a physiological (4 mm) or high (11 mm) glucose concentration with or without concomitant exposure to oleate. Isolated rat islets were also cultured with or without oleate. A clear hypersensitivity to submaximal glucose concentrations was evident in INS-1 cells cultured in excess nutrients such that the 25% of maximal (S-0.25) glucose-stimulated insulin secretion was significantly reduced in cells cultured in 11 mm glucose (S-0.25 = 3.5 mm) and 4 mm glucose with oleate (S-0.25 = 4.5 mm) compared with 4 mm glucose alone (S-0.25 = 5.7 mm). The magnitude of the left shift was linearly correlated with intracellular lipid stores in INS-1 cells (r(2) = 0.97). We observed no significant differences in the dose responses for glucose stimulation of respiration, NAD(P)H autofluorescence, or Ca2+ responses between left- and right-shifted -cells. However, a left shift in the sensitivity of exocytosis to Ca2+ was documented in permeabilized INS-1 cells cultured in 11 versus 4 mm glucose (S-0.25 = 1.1 and 1.7 m, respectively). Our results suggest that the sensitivity of exocytosis to triggering is modulated by a lipid component, the levels of which are influenced by the culture nutrient environment.	[Erion, Karel A.; Berdan, Charles A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Boston University	Deeney, JT (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, 650 Albany St X-810, Boston, MA 02118 USA.	jdeeney@bu.edu	Regan, Clinton/E-6250-2012	Deeney, Jude/0000-0003-0988-9419	National Institutes of Health [R01 DK35914, T32 DK007201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201, R01DK035914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK35914 (to B. E. C.) and T32 DK007201 (to K. A. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Antunes CM, 2000, DIABETES, V49, P2028, DOI 10.2337/diabetes.49.12.2028; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; BYRNE MM, 1995, AM J PHYSIOL-ENDOC M, V268, pE21, DOI 10.1152/ajpendo.1995.268.1.E21; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Cunningham BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE702, DOI 10.1152/ajpendo.1996.271.4.E702; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Deeney JT, 2001, J BIOL CHEM, V276, P36946, DOI 10.1074/jbc.M105056200; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Gohring I, 2014, J BIOL CHEM, V289, P3786, DOI 10.1074/jbc.M113.507335; Greaves J, 2010, BIOCHEM SOC T, V38, P163, DOI 10.1042/BST0380163; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Heindel U, 2003, FEBS LETT, V544, P57, DOI 10.1016/S0014-5793(03)00449-6; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kotronen A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1709, DOI 10.1152/ajpendo.00444.2007; Lai AL, 2011, J BIOL CHEM, V286, P25291, DOI 10.1074/jbc.M111.258848; LENZEN S, 1987, ACTA ENDOCRINOL-COP, V115, P21, DOI 10.1530/acta.0.1150021; Ling ZD, 1996, DIABETES, V45, P1774, DOI 10.2337/diabetes.45.12.1774; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; MEISTAS MT, 1983, AM J PHYSIOL, V245, pE155, DOI 10.1152/ajpendo.1983.245.2.E155; Miles PDG, 1998, J CLIN INVEST, V101, P202, DOI 10.1172/JCI1256; Ning J, 2011, AM J PHYSIOL-ENDOC M, V301, pE391, DOI 10.1152/ajpendo.00164.2011; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; OBITABOT ET, 1993, J SURG RES, V55, P575, DOI 10.1006/jsre.1993.1187; Olofsson CS, 2007, DIABETES, V56, P1888, DOI 10.2337/db06-1150; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Reed MA, 2011, J CLIN ENDOCR METAB, V96, P2525, DOI 10.1210/jc.2011-0165; Rituper B, 2012, CELL CALCIUM, V52, P250, DOI 10.1016/j.ceca.2012.05.009; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; SAKO Y, 1990, DIABETES, V39, P1580, DOI 10.2337/diabetes.39.12.1580; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Skelly RH, 1998, BIOCHEM J, V331, P553, DOI 10.1042/bj3310553; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Zhou YP, 1999, METABOLISM, V48, P857, DOI 10.1016/S0026-0495(99)90219-6	58	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16191	16201		10.1074/jbc.M114.620351	http://dx.doi.org/10.1074/jbc.M114.620351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25934392	hybrid, Green Published			2022-12-26	WOS:000356930100023
J	Sosanya, NM; Cacheaux, LP; Workman, ER; Niere, F; Perrone-Bizzozero, NI; Raab-Graham, KF				Sosanya, Natasha M.; Cacheaux, Luisa P.; Workman, Emily R.; Niere, Farr; Perrone-Bizzozero, Nora I.; Raab-Graham, Kimberly F.			Mammalian Target of Rapamycin (mTOR) Tagging Promotes Dendritic Branch Variability through the Capture of Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) mRNAs by the RNA-binding Protein HuD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; mammalian target of rapamycin (mTOR); mRNA decay; neuron; protein synthesis; RNA-binding protein; dendritic branch; in situ hybridization; synaptic tagging and capture; translational control	LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAY; CYTOPLASMIC POLYADENYLATION; UP-REGULATION; POLY(A) TAIL; GAP-43 GENE; MEMORY; TRANSLATION	Background: Memory requires protein synthesis of dendritic CaMKII. Results: HuD directs CaMKII expression in a branch-specific manner. mTOR inhibition reduces HuD binding and promotes deadenylation of CaMKII mRNA. Conclusion: mTOR activity tags synapses, allowing HuD to capture CaMKII in a branch-specific manner. Significance: mTOR and HuD provide a molecular model for the synaptic tagging and capture hypothesis. The fate of a memory, whether stored or forgotten, is determined by the ability of an active or tagged synapse to undergo changes in synaptic efficacy requiring protein synthesis of plasticity-related proteins. A synapse can be tagged, but without the capture of plasticity-related proteins, it will not undergo long lasting forms of plasticity (synaptic tagging and capture hypothesis). What the tag is and how plasticity-related proteins are captured at tagged synapses are unknown. Ca2+/calmodulin-dependent protein kinase II (CaMKII) is critical in learning and memory and is synthesized locally in neuronal dendrites. The mechanistic (mammalian) target of rapamycin (mTOR) is a protein kinase that increases CaMKII protein expression; however, the mechanism and site of dendritic expression are unknown. Herein, we show that mTOR activity mediates the branch-specific expression of CaMKII, favoring one secondary, daughter branch over the other in a single neuron. mTOR inhibition decreased the dendritic levels of CaMKII protein and mRNA by shortening its poly(A) tail. Overexpression of the RNA-stabilizing protein HuD increased CaMKII protein levels and preserved its selective expression in one daughter branch over the other when mTOR was inhibited. Unexpectedly, deleting the third RNA recognition motif of HuD, the domain that binds the poly(A) tail, eliminated the branch-specific expression of CaMKII when mTOR was active. These results provide a model for one molecular mechanism that may underlie the synaptic tagging and capture hypothesis where mTOR is the tag, preventing deadenylation of CaMKII mRNA, whereas HuD captures and promotes its expression in a branch-specific manner.	[Sosanya, Natasha M.; Cacheaux, Luisa P.; Workman, Emily R.; Niere, Farr; Raab-Graham, Kimberly F.] Univ Texas Austin, Ctr Learning & Memory, Dept Neurosci, Austin, TX 78712 USA; [Sosanya, Natasha M.; Raab-Graham, Kimberly F.] Univ Texas Austin, Inst Cell Biol, Austin, TX 78712 USA; [Workman, Emily R.; Raab-Graham, Kimberly F.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Sosanya, Natasha M.] US Army Inst Surg Res, Joint Base San Antonio Ft Sam, Houston, TX 78234 USA; [Perrone-Bizzozero, Nora I.] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci Psychiat & Behav Sci, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Defense; United States Army; University of New Mexico; University of New Mexico's Health Sciences Center	Raab-Graham, KF (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Dept Neurosci, 1 Univ Stn,C7000, Austin, TX 78712 USA.	Kimberly@mail.clm.utexas.edu	Regan, Clinton/E-6250-2012	Niere, Farr/0000-0003-0287-0889; Raab-Graham, Kimberly/0000-0001-6502-057X	National Science Foundation (NSF) [IOS 1026527, IOS 1355158]; National Institutes of Health [R01 NS30255, DA034897]; NSF Postdoctoral Research Fellowship in Biology [DBI-1103738, DBI-1306528]; Direct For Biological Sciences [1306528] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030255] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Postdoctoral Research Fellowship in Biology(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation (NSF) Grants IOS 1026527 and IOS 1355158 (to K. F. R.-G.) and by National Institutes of Health Grants R01 NS30255 and DA034897 (to N. I. P.-B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NSF Postdoctoral Research Fellowship in Biology DBI-1103738.; Supported by NSF Postdoctoral Research Fellowship in Biology DBI-1306528.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Bolognani F, 2004, NEUROSCI LETT, V371, P152, DOI 10.1016/j.neulet.2004.08.074; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Farris S, 2014, J NEUROSCI, V34, P4481, DOI 10.1523/JNEUROSCI.4944-13.2014; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim S, 2015, ELIFE, V4, DOI 10.7554/eLife.04158; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Merianda TT, 2013, J NEUROSCI, V33, P13735, DOI 10.1523/JNEUROSCI.0962-13.2013; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Sosanya NM, 2015, NEUROBIOL DIS, V73, P96, DOI 10.1016/j.nbd.2014.09.011; Sosanya NM, 2013, J CELL BIOL, V202, P53, DOI 10.1083/jcb.201212089; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tiruchinapalli DM, 2008, RNA BIOL, V5, P157, DOI 10.4161/rna.5.3.6782; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	48	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16357	16371		10.1074/jbc.M114.599399	http://dx.doi.org/10.1074/jbc.M114.599399			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944900	hybrid, Green Published			2022-12-26	WOS:000356930100037
J	Cheng, H; Treglown, L; Montgomery, S; Furnham, A				Cheng, Helen; Treglown, Luke; Montgomery, Scott; Furnham, Adrian			Associations between Familial Factor, Trait Conscientiousness, Gender and the Occurrence of Type 2 Diabetes in Adulthood: Evidence from a British Cohort	PLOS ONE			English	Article							PERSONALITY-TRAITS; GLYCEMIC CONTROL; METAANALYSIS; HEALTH; RISK	Objective To investigate social, familial, and psychological factors in influencing the occurrence of type 2 diabetes in adulthood. Method Some 17,415 babies born in Great Britain in 1958 and followed up at 7, 11, 33, and 50 years of age. The prevalence of type 2 diabetes at age 50 years was the outcome measure. Results Some 5,032 participants with data on parental social class, childhood cognitive ability tests scores at age 11 years, educational qualifications at age 33 years, personality traits, occupational levels, and type 2 diabetes (all measured at age 50 years) were included in the study. Available information also included whether cohort members' parents or siblings had diabetes. Using logistic regression analyses, results showed that sex (OR= 0.63: 0.42-0.92, p<. 05), family history (OR= 3.40: 1.76-6.55, p<. 01), and trait conscientiousness (OR= 0.76: 0.64-0.90, p<. 001) were all significantly and independently associated with the occurrence of type 2 diabetes in adulthood. It appears that the occurrence of type 2 diabetes is greater among men than women (4.3% vs 2.5%). Conclusion Familial (genetic and non-genetic) and psychological factors are significantly associated with the prevalence of type 2 diabetes in adulthood.	[Cheng, Helen; Treglown, Luke; Furnham, Adrian] UCL, Dept Psychol, London WC1E 6BT, England; [Cheng, Helen] Univ London, ESRC Ctr Learning & Life Chances Knowledge Econ &, Inst Educ, London WC1H 0AL, England; [Treglown, Luke] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Montgomery, Scott] Univ Orebro, Fac Med & Hlth, Clin Epidemiol & Biostat, S-70182 Orebro, Sweden; [Montgomery, Scott] UCL, Res Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Furnham, Adrian] BI Norwegian Business Sch, N-0484 Oslo, Norway	University of London; University College London; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London; UCL Institute of Education; University of Bath; Orebro University; University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Dept Psychol, Mortimer St, London WC1E 6BT, England.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020; Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494	ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Boini S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-124; Busch CP, 2001, CLIN GENET, V60, P243, DOI 10.1034/j.1399-0004.2001.600401.x; Davie R., 1972, FROM BIRTH TO 7; Douglas James W.B, 1964, HOME SCH; Ferri E., 2003, CHANGING BRITAIN CHA; Fogelman K., 1976, BRITAINS 16 YEAR OLD; Friedman HS, 2014, ANNU REV PSYCHOL, V65, P719, DOI 10.1146/annurev-psych-010213-115123; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Hall PA, 2009, J PSYCHOSOM RES, V67, P297, DOI 10.1016/j.jpsychores.2009.05.015; Jennings A, 2014, J NUTR, V144, P202, DOI 10.3945/jn.113.184358; Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007; Jokela M, 2013, HLTH PSYCHOL; Keweloh WC, 2012, DIABETOLOGIA, V55, pS391; Leete R, 1977, POPULATION TRENDS, V8, P1; MARSH C, 1986, KEY VARIABLES SOCIAL; Matthews G., 2009, PERSONALITY TRAITS; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; Olsson GM, 2008, DIABETES CARE, V31, P514, DOI 10.2337/dc07-1399; Plewis I, 2004, NATL CHILD DEV STUDY; Shim U, 2014, ACTA DIABETOL, V51, P421, DOI 10.1007/s00592-013-0529-z; Skinner TC, 2014, DIABETIC MED, V31, P487, DOI 10.1111/dme.12339; Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479; Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; United States of America. Department of Health and Human Services. Centers for Disease Control and Prevention Incidence of Diabetes, 2004, DAT NAT HLTH INT SUR; Wilkinson R., 2003, THE SOLID FACTS; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036	30	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0122701	10.1371/journal.pone.0122701	http://dx.doi.org/10.1371/journal.pone.0122701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5BQ	25946160	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700007
J	Kumorek, M; Kubies, D; Filova, E; Houska, M; Kasoju, N; Mazl Chanova, E; Matejka, R; Kryslova, M; Bacakova, L; Rypacek, F				Kumorek, Marta; Kubies, Dana; Filova, Elena; Houska, Milan; Kasoju, Naresh; Mazl Chanova, Eliska; Matejka, Roman; Kryslova, Marketa; Bacakova, Lucie; Rypacek, Frantisek			Cellular Responses Modulated by FGF-2 Adsorbed on Albumin/Heparin Layer-by-Layer Assemblies	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; POLYELECTROLYTE MULTILAYER FILMS; MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; OSTEOGENIC DIFFERENTIATION; BIOLOGICAL-ACTIVITY; PROTEIN ADSORPTION; CROSS-LINKING; HEPARIN; SURFACE	In a typical cell culture system, growth factors immobilized on the cell culture surfaces can serve as a reservoir of bio-signaling molecules, without the need to supplement them additionally into the culture medium. In this paper, we report on the fabrication of albumin/heparin (Alb/Hep) assemblies for controlled binding of basic fibroblast growth factor (FGF-2). The surfaces were constructed by layer-by-layer adsorption of polyelectrolytes albumin and heparin and were subsequently stabilized by covalent crosslinking with glutaraldehyde. An analysis of the surface morphology by atomic force microscopy showed that two Alb/Hep bilayers are required to cover the surface of substrate. The formation of the Alb/Hep assemblies was monitored by the surface plasmon resonance (SPR), the infrared multiinternal reflection spectroscopy (FTIR MIRS) and UV/VIS spectroscopy. The adsorption of FGF-2 on the cross-linked Alb/Hep was followed by SPR. The results revealed that FGF-2 binds to the Alb/Hep assembly in a dose and time-dependent manner up to the surface concentration of 120 ng/cm(2). The bioactivity of the adsorbed FGF-2 was assessed in experiments in vitro, using calf pulmonary arterial endothelial cells (CPAE). CPAE cells could attach and proliferate on Alb/Hep surfaces. The adsorbed FGF-2 was bioactive and stimulated both the proliferation and the differentiation of CPAE cells. The improvement was more pronounced at a lower FGF-2 surface concentration (30 ng/cm(2)) than on surfaces with a higher concentration of FGF-2 (120 ng/cm(2)).	[Kumorek, Marta; Kubies, Dana; Houska, Milan; Kasoju, Naresh; Mazl Chanova, Eliska; Rypacek, Frantisek] Acad Sci Czech Republ Vvi, Inst Macromolecular Chem, Dept Biomat & Bioanalogous Syst, Prague, Czech Republic; [Filova, Elena; Matejka, Roman; Kryslova, Marketa; Bacakova, Lucie] Acad Sci Czech Republic, Inst Physiol, Dept Biomat & Tissue Engn, Vvi, Prague, Czech Republic; [Matejka, Roman] Charles Univ Prague, Fac Med 3, Dept Med Biophys & Informat, Prague, Czech Republic; [Matejka, Roman] Czech Tech Univ, Fac Biomed Engn, Dept Biomed Technol, Kladno, Czech Republic	Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Czech Technical University Prague	Kubies, D (corresponding author), Acad Sci Czech Republ Vvi, Inst Macromolecular Chem, Dept Biomat & Bioanalogous Syst, Prague, Czech Republic.	kubies@imc.cas.cz	Matějka, Roman/ABG-1381-2020; Kubies, Dana/H-7307-2014; Rypacek, Frantisek/G-7872-2014; Chanova, Eliska Mazl/H-6751-2014; Matějka, Roman/I-9977-2018; Kumorek, Marta/H-7374-2014; Filova, Elena/C-2209-2012; Bacakova, Lucie/C-2664-2012; Houska, Milan/H-6809-2014; Kasoju, Naresh/A-5295-2009	Matějka, Roman/0000-0001-9596-3069; Chanova, Eliska Mazl/0000-0003-0240-1206; Matějka, Roman/0000-0001-9596-3069; Bacakova, Lucie/0000-0002-1818-9484; Houska, Milan/0000-0001-6668-8870; Kasoju, Naresh/0000-0002-8700-0729	Ministry of Education, Youth and Sports, Czech Republic [EE2.3.30.0029]; Grant Agency of the Czech Republic [P108/11/1857, P108/12/P624]; European Regional Development Fund (Project BIOCEV: Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University) [CZ.1.05/1.1.00/02.0109]	Ministry of Education, Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Regional Development Fund (Project BIOCEV: Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University)	The study was funded by the Ministry of Education, Youth and Sports, Czech Republic (grant number EE2.3.30.0029), by the Grant Agency of the Czech Republic (grant number P108/11/1857 and grant number P108/12/P624), and by the European Regional Development Fund (Project BIOCEV: Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, grant number CZ.1.05/1.1.00/02.0109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almodovar J, 2014, BIOMATERIALS, V35, P3975, DOI 10.1016/j.biomaterials.2014.01.012; Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799; ARAKAWA T, 1994, ARCH BIOCHEM BIOPHYS, V308, P267, DOI 10.1006/abbi.1994.1037; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Arisaka Y, 2013, BIOMATERIALS, V34, P4214, DOI 10.1016/j.biomaterials.2013.02.056; Bjornmalm M, 2014, J CONTROL RELEASE, V190, P139, DOI 10.1016/j.jconrel.2014.04.030; Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O; Brynda E, 1996, J COLLOID INTERF SCI, V183, P18, DOI 10.1006/jcis.1996.0514; Brynda E, 2000, J BIOMED MATER RES, V51, P249, DOI 10.1002/(SICI)1097-4636(200008)51:2<249::AID-JBM14>3.3.CO;2-O; Brynda E, 2000, LANGMUIR, V16, P4352, DOI 10.1021/la991558r; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Cai P, 2013, COLLOID SURFACE A, V434, P110, DOI 10.1016/j.colsurfa.2013.05.041; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Chanana M, 2005, NANO LETT, V5, P2605, DOI 10.1021/nl0521219; Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804; da Costa DS, 2012, J MATER CHEM, V22, P7172, DOI 10.1039/c2jm15762d; De Cock LJ, 2012, SOFT MATTER, V8, P1146, DOI 10.1039/c1sm06618h; Emmenegger CR, 2009, LANGMUIR, V25, P6328, DOI 10.1021/la900083s; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Filova E, 2009, J BIOMED MATER RES A, V90A, P55, DOI 10.1002/jbm.a.32065; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Gesellchen Frank, 2005, V305, P17; Girard JP, 1996, J BIOL CHEM, V271, P4511; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459; Hardy P. M., 1979, J CHEM SOC P1, V1, P2282; Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600; Houska M, 1997, J COLLOID INTERF SCI, V188, P243, DOI 10.1006/jcis.1996.4576; Houska M, 2008, J BIOMED MATER RES A, V86A, P769, DOI 10.1002/jbm.a.31663; Ito Y, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P265; Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186; Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Krishnan A, 2005, COLLOID SURFACE B, V43, P95, DOI 10.1016/j.colsurfb.2005.04.003; Lee HT, 2003, MOL VIS, V9, P624; Ma QL, 2012, INT J NANOMED, V7, P1965, DOI 10.2147/IJN.S29538; Macdonald M, 2008, J CONTROL RELEASE, V131, P228, DOI 10.1016/j.jconrel.2008.07.032; Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w; Magoshi T, 2002, BIOMACROMOLECULES, V3, P976, DOI 10.1021/bm0200377; Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4; Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Mirow N, 2007, ARTIF ORGANS, V31, P466, DOI 10.1111/j.1525-1594.2007.00386.x; Ranjan A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/30/305102; Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297; Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Seyrek E, 2003, BIOMACROMOLECULES, V4, P273, DOI 10.1021/bm025664a; She Z, 2012, BIOMACROMOLECULES, V13, P2174, DOI 10.1021/bm3005879; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Takayama S, 1997, J PERIODONTAL RES, V32, P667, DOI 10.1111/j.1600-0765.1997.tb00577.x; Tanghetti E, 2002, ONCOGENE, V21, P3889, DOI 10.1038/sj.onc.1205407; TSUBOI R, 1990, J CELL BIOL, V110, P511, DOI 10.1083/jcb.110.2.511; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wang HG, 2013, J BIOMED MATER RES A, V101, P413, DOI 10.1002/jbm.a.34339; Wang JS, 1996, J ORTHOP RES, V14, P316, DOI 10.1002/jor.1100140222; Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037; Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668; Yan Y, 2014, CHEM MATER, V26, P452, DOI 10.1021/cm402126n; Zeiger AS, 2013, ACTA BIOMATER, V9, P7354, DOI 10.1016/j.actbio.2013.02.035; Zhang DM, 2010, J RAMAN SPECTROSC, V41, P952, DOI 10.1002/jrs.2548	66	11	12	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125484	10.1371/journal.pone.0125484	http://dx.doi.org/10.1371/journal.pone.0125484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945799	Green Published, Green Submitted, gold			2022-12-26	WOS:000354049700072
J	Mira, PM; Crona, K; Greene, D; Meza, JC; Sturmfels, B; Barlow, M				Mira, Portia M.; Crona, Kristina; Greene, Devin; Meza, Juan C.; Sturmfels, Bernd; Barlow, Miriam			Rational Design of Antibiotic Treatment Plans: A Treatment Strategy for Managing Evolution and Reversing Resistance	PLOS ONE			English	Article							SELECTION; PATHS	The development of reliable methods for restoring susceptibility after antibiotic resistance arises has proven elusive. A greater understanding of the relationship between antibiotic administration and the evolution of resistance is key to overcoming this challenge. Here we present a data-driven mathematical approach for developing antibiotic treatment plans that can reverse the evolution of antibiotic resistance determinants. We have generated adaptive landscapes for 16 genotypes of the TEM beta-lactamase that vary from the wild type genotype "TEM-1" through all combinations of four amino acid substitutions. We determined the growth rate of each genotype when treated with each of 15 beta-lactam antibiotics. By using growth rates as a measure of fitness, we computed the probability of each amino acid substitution in each beta-lactam treatment using two different models named the Correlated Probability Model (CPM) and the Equal Probability Model (EPM). We then performed an exhaustive search through the 15 treatments for substitution paths leading from each of the 16 genotypes back to the wild type TEM-1. We identified optimized treatment paths that returned the highest probabilities of selecting for reversions of amino acid substitutions and returning TEM to the wild type state. For the CPM model, the optimized probabilities ranged between 0.6 and 1.0. For the EPM model, the optimized probabilities ranged between 0.38 and 1.0. For cyclical CPM treatment plans in which the starting and ending genotype was the wild type, the probabilities were between 0.62 and 0.7. Overall this study shows that there is promise for reversing the evolution of resistance through antibiotic treatment plans.	[Mira, Portia M.; Meza, Juan C.; Barlow, Miriam] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Crona, Kristina; Greene, Devin] Amer Univ, Dept Math & Stat, Washington, DC 20016 USA; [Sturmfels, Bernd] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Sturmfels, Bernd] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Sturmfels, Bernd] Univ Calif Berkeley, EECS, Berkeley, CA 94720 USA	University of California System; University of California Merced; American University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Barlow, M (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	Miriam.barlow@gmail.com		Mira, Portia/0000-0003-4093-2809; Meza, Juan/0000-0003-4543-0349				Barlow M, 2002, GENETICS, V160, P823; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P923, DOI 10.3934/mbe.2010.7.923; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P527, DOI 10.3934/mbe.2010.7.527; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Chevin LM, 2011, BIOL LETTERS, V7, P210, DOI 10.1098/rsbl.2010.0580; Crona K, 2013, J THEOR BIOL, V317, P1, DOI 10.1016/j.jtbi.2012.09.028; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; Goulart CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056040; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Jacoby G, 2014, BETA LACTAMASE CLASS; Kim S, 2014, P NATL ACAD SCI USA, V111, P14494, DOI 10.1073/pnas.1409800111; KIMURA M, 1962, GENETICS, V47, P713; Kummerer K, 2003, J ANTIMICROB CHEMOTH, V52, P5, DOI 10.1093/jac/dkg293; LI WH, 1984, MOL BIOL EVOL, V1, P213; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Mroczkowska JE, 2008, ANTIMICROB AGENTS CH, V52, P2340, DOI 10.1128/AAC.00018-08; Schenk MF, 2014, EVOLUTIONARY APPL, DOI [10.1111/eva12200, DOI 10.1111/EVA12200]; Shoja MM, 2007, MED HYPOTHESES, V69, P467, DOI 10.1016/j.mehy.2006.12.019; Unckless RL, 2009, GENETICS, V183, P1079, DOI 10.1534/genetics.109.106757; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	22	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0122283	10.1371/journal.pone.0122283	http://dx.doi.org/10.1371/journal.pone.0122283			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946134	Green Submitted, gold, Green Published			2022-12-26	WOS:000354049700006
J	Roncalli, V; Cieslak, MC; Passamaneck, Y; Christie, AE; Lenz, PH				Roncalli, Vittoria; Cieslak, Matthew C.; Passamaneck, Yale; Christie, Andrew E.; Lenz, Petra H.			Glutathione S-Transferase (GST) Gene Diversity in the Crustacean Calanus finmarchicus - Contributors to Cellular Detoxification	PLOS ONE			English	Article							NOVO ASSEMBLED TRANSCRIPTOME; INSECTICIDE-RESISTANCE; ALEXANDRIUM SPP.; PROTEIN EVOLUTION; TOXIC ALEXANDRIUM; DRUG-RESISTANCE; MARINE COPEPODS; STRESS-RESPONSE; NORTH-ATLANTIC; RNA-SEQ	Detoxification is a fundamental cellular stress defense mechanism, which allows an organism to survive or even thrive in the presence of environmental toxins and/or pollutants. The glutathione S-transferase (GST) superfamily is a set of enzymes involved in the detoxification process. This highly diverse protein superfamily is characterized by multiple gene duplications, with over 40 GST genes reported in some insects. However, less is known about the GST superfamily in marine organisms, including crustaceans. The availability of two de novo transcriptomes for the copepod, Calanus finmarchicus, provided an opportunity for an in depth study of the GST superfamily in a marine crustacean. The transcriptomes were searched for putative GST-encoding transcripts using known GST proteins from three arthropods as queries. The identified transcripts were then translated into proteins, analyzed for structural domains, and annotated using reciprocal BLAST analysis. Mining the two transcriptomes yielded a total of 41 predicted GST proteins belonging to the cytosolic, mitochondrial or microsomal classes. Phylogenetic analysis of the cytosolic GSTs validated their annotation into six different subclasses. The predicted proteins are likely to represent the products of distinct genes, suggesting that the diversity of GSTs in C. finmarchicus exceeds or rivals that described for insects. Analysis of relative gene expression in different developmental stages indicated low levels of GST expression in embryos, and relatively high expression in late copepodites and adult females for several cytosolic GSTs. A diverse diet and complex life history are factors that might be driving the multiplicity of GSTs in C. finmarchicus, as this copepod is commonly exposed to a variety of natural toxins. Hence, diversity in detoxification pathway proteins may well be key to their survival.	[Roncalli, Vittoria; Cieslak, Matthew C.; Christie, Andrew E.; Lenz, Petra H.] Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Passamaneck, Yale] Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Christie, AE (corresponding author), Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	crabman@pbrc.hawaii.edu; petra@pbrc.hawaii.edu	Lenz, Petra H/ABE-4940-2021	Roncalli, Vittoria/0000-0003-3024-7568	National Science Foundation [OCE-1040597, IOS-1353023, ABI-1062432]; Cades Foundation of Honolulu, Hawaii; Mount Desert Island Biological Laboratory's David W. Towle Fellowship	National Science Foundation(National Science Foundation (NSF)); Cades Foundation of Honolulu, Hawaii; Mount Desert Island Biological Laboratory's David W. Towle Fellowship	This research is based upon work supported by the National Science Foundation under grants OCE-1040597 to PHL, IOS-1353023 to AEC and ABI-1062432 to Indiana University, as well as by the Cades Foundation of Honolulu, Hawaii. VR acknowledges the Mount Desert Island Biological Laboratory's David W. Towle Fellowship for Graduate Student Research for supporting her Summer 2012 field work conducted at the Mount Desert Island Biological Laboratory (Bar Harbor, Maine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdalla AM, 2002, PROTEIN ENG, V15, P827, DOI 10.1093/protein/15.10.827; Anderson DM, 1997, LIMNOL OCEANOGR, V42, P1009, DOI 10.4319/lo.1997.42.5_part_2.1009; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; Ayres C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029237; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bratbak G, 2011, CONT SHELF RES, V31, P1500, DOI 10.1016/j.csr.2011.06.014; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; Bucklin A, 1996, OPHELIA, V44, P29, DOI 10.1080/00785326.1995.10429837; Campbell RG, 2005, DEEP-SEA RES PT II, V52, P2817, DOI 10.1016/j.dsr2.2005.06.008; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; Christie AE, 2014, GEN COMP ENDOCR, V202, P76, DOI 10.1016/j.ygcen.2014.04.003; Christie AE, 2014, GEN COMP ENDOCR, V195, P28, DOI 10.1016/j.ygcen.2013.10.003; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; da Fonseca RR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-281; Dale T, 2001, MAR BIOL, V139, P561; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gettings RM, 2014, DEEP-SEA RES PT II, V103, P120, DOI 10.1016/j.dsr2.2013.05.012; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hansen BH, 2011, SCI TOTAL ENVIRON, V409, P704, DOI 10.1016/j.scitotenv.2010.10.035; Hansen BH, 2010, AQUAT TOXICOL, V99, P212, DOI 10.1016/j.aquatox.2010.04.018; Hansen BH, 2009, J TOXICOL ENV HEAL A, V72, P131, DOI 10.1080/15287390802537313; Harris RP, 2000, ICES J MAR SCI, V57, P1708, DOI 10.1006/jmsc.2000.0959; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Head EJH, 2000, MAR ECOL PROG SER, V193, P53, DOI 10.3354/meps193053; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Ianora A., 2012, HDB MARINE NATURAL P, P711, DOI [10.1007/978-90-481-3834-0_13, DOI 10.1007/978-90-481-3834-0_13]; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauritano C, 2013, HARMFUL ALGAE, V28, P23, DOI 10.1016/j.hal.2013.05.004; Lauritano C, 2012, MAR ENVIRON RES, V76, P22, DOI 10.1016/j.marenvres.2011.09.015; Lauritano C, 2011, J EXP MAR BIOL ECOL, V404, P79, DOI 10.1016/j.jembe.2011.05.009; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Lee KW, 2012, COMP BIOCHEM PHYS A, V161, P145, DOI 10.1016/j.cbpa.2011.10.019; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; Lenz PH, 2012, COMP BIOCHEM PHYS D, V7, P110, DOI 10.1016/j.cbd.2011.12.001; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Mauchline J, 1998, ADV MAR BIOL, V33, P1; McLellan LI, 1999, DRUG RESIST UPDATE, V2, P153, DOI 10.1054/drup.1999.0083; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Mittapalli O, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2001; Morel F, 2011, DRUG METAB REV, V43, P281, DOI 10.3109/03602532.2011.556122; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Pal R, 2012, COMP BIOCHEM PHYS D, V7, P28, DOI 10.1016/j.cbd.2011.10.004; Planque B, 1997, OCEANOL ACTA, V20; Qin GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058410; Rajarapu SP, 2013, COMP BIOCHEM PHYS B, V165, P66, DOI 10.1016/j.cbpb.2013.02.010; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STOECKER DK, 1990, J PLANKTON RES, V12, P891, DOI 10.1093/plankt/12.5.891; Tarrant AM, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0091-8; Teegarden GJ, 2003, J PLANKTON RES, V25, P429, DOI 10.1093/plankt/25.4.429; Teegarden GJ, 2001, MAR ECOL PROG SER, V218, P213, DOI 10.3354/meps218213; Teegarden GJ, 2008, HARMFUL ALGAE, V7, P33, DOI 10.1016/j.hal.2007.05.010; TURNER J T, 1983, Marine Ecology, V4, P359, DOI 10.1111/j.1439-0485.1983.tb00119.x; Turner JT, 2014, HARMFUL ALGAE, V32, P81, DOI 10.1016/j.hal.2013.12.001; Unal E, 2010, PROG OCEANOGR, V87, P175, DOI 10.1016/j.pocean.2010.09.017; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yang Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/493825; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604	85	44	47	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123322	10.1371/journal.pone.0123322	http://dx.doi.org/10.1371/journal.pone.0123322			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25945801	Green Submitted, Green Published, gold			2022-12-26	WOS:000354049700012
J	Zuo, HW; Wu, PP; Wu, DX; Sun, GL				Zuo, Hongwei; Wu, Panpan; Wu, Dexiang; Sun, Genlou			Origin and Reticulate Evolutionary Process of Wheatgrass Elymus trachycaulus (Triticeae: Poaceae)	PLOS ONE			English	Article							ALLOPOLYPLOID TRAGOPOGON-MISCELLUS; NORTH-AMERICAN ELYMUS; BRASSICA-NAPUS; PHYLOGENETIC-RELATIONSHIPS; HOMEOLOGOUS RECOMBINATION; GENOME CONSTITUTION; MOLECULAR EVOLUTION; LENGTH POLYMORPHISM; GENETIC DIVERSITY; RAPD VARIATION	To study origin and evolutionary dynamics of tetraploid Elymus trachycaulus that has been cytologically defined as containing StH genomes, thirteen accessions of E. trachycaulus were analyzed using two low-copy nuclear gene Pepc (phosphoenolpyruvate carboxylase) and Rpb2 (the second largest subunit of RNA polymerase II), and one chloroplast region trnL-trnF (spacer between the tRNA Leu (UAA) gene and the tRNA-Phe (GAA) gene). Our chloroplast data indicated that Pseudoroegneria (St genome) was the maternal donor of E. trachycaulus. Rpb2 data indicated that the St genome in E. trachycaulus was originated from either P. strigosa, P. stipifolia, P. spicata or P. geniculate. The Hordeum (H genome)like sequences of E. trachycaulus are polyphyletic in the Pepc tree, suggesting that the H genome in E. trachycaulus was contributed by multiple sources, whether due to multiple origins or introgression resulting from subsequent hybridization. Failure to recovering St copy of Pepc sequence in most accessions of E. trachycaulus might be caused by genome convergent evolution in allopolyploids. Multiple copies of H-like Pepc sequence from each accession with relative large deletions and insertions might be caused by either instability of Pepc sequence in H-genome or incomplete concerted evolution. Our results highlighted complex evolutionary history of E. trachycaulus.	[Zuo, Hongwei; Wu, Panpan; Wu, Dexiang; Sun, Genlou] Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Saint Marys University - Canada	Wu, DX (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China.	genlou.sun@smu.ca; dexiangwu198@163.com			Anhui Agricultural University; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-05249]; Senate Research Grant at Saint Mary's University, Canada	Anhui Agricultural University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Senate Research Grant at Saint Mary's University, Canada	This project was supported in part by an internal grant from Anhui Agricultural University, a discovery grant (RGPIN-2014-05249) from the Natural Sciences and Engineering Research Council of Canada, and a Senate Research Grant at Saint Mary's University, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKWORTH ME, 1994, P 2 INT TRIT S LOG U, P189; BOWDEN WM, 1965, CAN J BOTANY, V43, P1421, DOI 10.1139/b65-151; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Clegg MT, 1997, P NATL ACAD SCI USA, V94, P7791, DOI 10.1073/pnas.94.15.7791; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Dandy J.E., 1975, HYBRIDIZATION FLORA, P444; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; DEWEY DR, 1976, AM J BOT, V63, P626, DOI 10.2307/2441825; DEWEY DR, 1968, B TORREY BOT CLUB, V95, P454, DOI 10.2307/2483477; DEWEY DR, 1975, BOT GAZ, V136, P122, DOI 10.1086/336792; DEWEY DR, 1968, AM J BOT, V55, P1133, DOI 10.2307/2440735; DEWEY DR, 1982, GRASSES GRASSLANDS S, P51; Diaz O, 2000, GENET RESOUR CROP EV, V47, P11, DOI 10.1023/A:1008719119756; Feldman M, 1997, GENETICS, V147, P1381; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gaudett M, 2005, PLANT SYST EVOL, V250, P81, DOI 10.1007/s00606-004-0199-y; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; HITCHCOCK AS, 1951, USDA MISC PUBL, V200; JAASKA V, 1992, HEREDITAS, V117, P11, DOI 10.1111/j.1601-5223.1992.tb00002.x; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; JENSEN KB, 1990, GENOME, V33, P563, DOI 10.1139/g90-083; JENSEN KB, 1995, INT J PLANT SCI, V156, P731, DOI 10.1086/297295; JUKES T H, 1969, P21; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knapp EE, 1996, RESTOR ECOL, V4, P1, DOI 10.1111/j.1526-100X.1996.tb00101.x; Koh J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-97; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Liu Bao, 2002, Current Genomics, V3, P489, DOI 10.2174/1389202023350255; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Liu ZQ, 2006, GENETICS, V174, P1583, DOI 10.1534/genetics.106.064071; Love A., 1984, Feddes Repertorium, V95, P425; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2008, MOL PHYLOGENET EVOL, V47, P598, DOI 10.1016/j.ympev.2008.02.008; McMillan E, 2004, THEOR APPL GENET, V108, P535, DOI 10.1007/s00122-003-1453-3; MURRY LE, 1980, AM J BOT, V67, P1374, DOI 10.2307/2442139; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; Ohno S., 1970, EVOLUTION GENE DUPLI; Ozkan H, 2002, ISRAEL J PLANT SCI, V50, pS65, DOI 10.1560/E282-PV55-G4XT-DRWJ; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Redinbaugh MG, 2000, GENOME, V43, P846, DOI 10.1139/gen-43-5-846; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Sun G, 2005, PLANT SYST EVOL, V256, P179, DOI 10.1007/s00606-005-0368-7; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, GENET RESOUR CROP EV, V54, P1737, DOI 10.1007/s10722-006-9183-4; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun G, 2009, BREEDING SCI, V59, P487, DOI 10.1270/jsbbs.59.487; Sun GL, 2001, PLANT SYST EVOL, V227, P235, DOI 10.1007/s006060170051; Sun GL, 1998, HEREDITAS, V129, P275, DOI 10.1111/j.1601-5223.1998.00275.x; Sun GL, 1998, GENOME, V41, P455, DOI 10.1139/gen-41-3-455; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Tate JA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-80; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORABINEJAD J, 1993, GENOME, V36, P147, DOI 10.1139/g93-018; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; von Bothmer R., 1994, P 2 INT TRIT S UT ST, P1; Wang R.R.-C., 1994, P 2 INT TRIT S LOG U, P20; Wilson BK, 2001, CAN J BOT, V79, P139, DOI 10.1139/cjb-79-2-139; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Yan C, 2014, GENOME, V57, P97, DOI 10.1139/gen-2014-0002; Yan C, 2012, MOL PHYLOGENET EVOL, V64, P441, DOI 10.1016/j.ympev.2012.04.017; Yan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026853	77	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125417	10.1371/journal.pone.0125417	http://dx.doi.org/10.1371/journal.pone.0125417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946188	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700068
J	Holm, JB; Sorobetea, D; Kiilerich, P; Ramayo-Caldas, Y; Estelle, J; Ma, T; Madsen, L; Kristiansen, K; Svensson-Frej, M				Holm, Jacob Bak; Sorobetea, Daniel; Kiilerich, Pia; Ramayo-Caldas, Yuliaxis; Estelle, Jordi; Ma, Tao; Madsen, Lise; Kristiansen, Karsten; Svensson-Frej, Marcus			Chronic Trichuris muris Infection Decreases Diversity of the Intestinal Microbiota and Concomitantly Increases the Abundance of Lactobacilli	PLOS ONE			English	Article							REGULATORY T-CELLS; GUT MICROBIOTA; MOUSE MODEL; HYGIENE HYPOTHESIS; HELMINTH; INDUCTION; SUSCEPTIBILITY; COLONIZATION; INFLAMMATION; SUPPRESSION	The intestinal microbiota is vital for shaping the local intestinal environment as well as host immunity and metabolism. At the same time, epidemiological and experimental evidence suggest an important role for parasitic worm infections in maintaining the inflammatory and regulatory balance of the immune system. In line with this, the prevalence of persistent worm infections is inversely correlated with the incidence of immune-associated diseases, prompting the use of controlled parasite infections for therapeutic purposes. Despite this, the impact of parasite infection on the intestinal microbiota, as well as potential downstream effects on the immune system, remain largely unknown. We have assessed the influence of chronic infection with the large-intestinal nematode Trichuris muris, a close relative of the human pathogen Trichuris trichiura, on the composition of the murine intestinal microbiota by 16S ribosomal-RNA gene-based sequencing. Our results demonstrate that persistent T. muris infection dramatically affects the large-intestinal microbiota, most notably with a drop in the diversity of bacterial communities, as well as a marked increase in the relative abundance of the Lactobacillus genus. In parallel, chronic T. muris infection resulted in a significant shift in the balance between regulatory and inflammatory T cells in the intestinal adaptive immune system, in favour of inflammatory cells. Together, these data demonstrate that chronic parasite infection strongly influences the intestinal microbiota and the adaptive immune system. Our results illustrate the complex interactions between these factors in the intestinal tract, and contribute to furthering the understanding of this interplay, which is of crucial importance considering that 500 million people globally are suffering from these infections and their potential use for therapeutic purposes.	[Holm, Jacob Bak; Kiilerich, Pia; Ma, Tao; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, Copenhagen, Denmark; [Sorobetea, Daniel; Svensson-Frej, Marcus] Lund Univ, Fac Med, Dept Expt Med Sci, Immunol Sect, Lund, Sweden; [Ramayo-Caldas, Yuliaxis; Estelle, Jordi] INRA, Genet Anim & Biol Integrat GABI UMR1313, Jouy En Josas, France; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway	University of Copenhagen; Lund University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, Copenhagen, Denmark.	kk@bio.ku.dk; marcus.svensson_frej@med.lu.se	Holm, Jacob Bak B/B-8677-2019; Caldas, Yuliaxis Ramayo/B-6337-2014; Kristiansen, Karsten/J-5148-2014; Madsen, Lise/C-6246-2012; Estellé, Jordi/A-7976-2008; Holm, Jacob Bak/H-6899-2013	Holm, Jacob Bak B/0000-0003-1756-0875; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; Estellé, Jordi/0000-0002-6241-1732; Holm, Jacob Bak/0000-0003-1756-0875; Svensson-Frej, Marcus/0000-0002-3934-464X	Novo Nordisk Foundation; Carlsberg Foundation; Swedish Medical Research Council; European Union in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship [267196]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship	This work was supported by grants from the Novo Nordisk Foundation (www.novonordiskfonden.dk), The Carlsberg Foundation (www.carlsbergfondet.dk), and the Swedish Medical Research Council (www.vr.se). Yuliaxis Ramayo-Caldas was funded by the European Union, in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship (under grant agreement no 267196; www.agreenskills.eu). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bager P, 2010, J ALLERGY CLIN IMMUN, V125, P123, DOI 10.1016/j.jaci.2009.08.006; Bollrath J, 2013, SEMIN IMMUNOL, V25, P352, DOI 10.1016/j.smim.2013.09.002; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; CALLENDER JEM, 1992, LANCET, V339, P181, DOI 10.1016/0140-6736(92)90246-Y; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cenit MC, 2014, BIOCH BIOPHYSICA ACT; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; Dea-Ayuela MA, 2008, INT IMMUNOPHARMACOL, V8, P28, DOI 10.1016/j.intimp.2007.10.003; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott DE, 2004, EUR J IMMUNOL, V34, P2690, DOI 10.1002/eji.200324833; ELSE KJ, 1992, IMMUNOLOGY, V75, P232; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Houlden A, PLOS ONE; Humphreys NE, 2004, PARASITE IMMUNOL, V26, P187, DOI 10.1111/j.0141-9838.2004.00702.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jang SO, 2012, ALLERGY ASTHMA IMMUN, V4, P150, DOI 10.4168/aair.2012.4.3.150; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kim HJ, 2012, EXP DERMATOL, V21, P672, DOI 10.1111/j.1600-0625.2012.01539.x; Kondrashova A, 2013, APMIS, V121, P478, DOI 10.1111/apm.12023; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kramer A, 2013, J HOSP INFECT, V83, pS29, DOI 10.1016/S0195-6701(13)60007-9; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; NOKES C, 1992, P ROY SOC B-BIOL SCI, V247, P77, DOI 10.1098/rspb.1992.0011; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Reynolds L, 2014, GUT MICROBES, V5, DOI [10.4161/gmic.32130, DOI 10.4161/GMIC.32130]; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470	71	121	122	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125495	10.1371/journal.pone.0125495	http://dx.doi.org/10.1371/journal.pone.0125495			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942314	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400039
J	Foulon, S; Pingault, JB; Larroque, B; Melchior, M; Falissard, B; Cote, SM				Foulon, Stephanie; Pingault, Jean-Baptiste; Larroque, Beatrice; Melchior, Maria; Falissard, Bruno; Cote, Sylvana M.			Developmental Predictors of Inattention-Hyperactivity from Pregnancy to Early Childhood	PLOS ONE			English	Article							RISK-FACTORS; DIFFICULTIES QUESTIONNAIRE; DEPRESSION SCALE; FAMILY INCOME; AGE; DISORDER; CHILDREN; BEHAVIOR; POPULATION; VALIDITY	Objective The objective of the study was to characterize the developmental sequence of pre-and postnatal risk factors for inattention-hyperactivity symptoms in preschoolers. Materials and Methods Longitudinal data came from a French population based birth cohort study (EDEN; N = 1311 mother-child pairs followed from the pregnancy onwards). Inattention-hyperactivity symptoms were assessed with the Strengths and Difficulties Questionnaire when participating children were 3 years of age. Potential risk factors were classified in four domains (fetal exposures and child somatic characteristics, child temperament, child neurodevelopmental status, psychosocial environment) and four periods (before pregnancy, prenatal/birth, infancy, toddlerhood). Their role as potential moderator or mediator was tested with path analysis to determine the developmental sequence. Results A low family socioeconomic status before pregnancy was the main environmental risk factor for inattention-hyperactivity symptoms at 3 years, and its effect occurred via two pathways. The first was a risk pathway, where lower SES was associated with higher maternal depression and anxiety during pregnancy; then to higher maternal and child distress and dysregulation in infancy; and in turn to higher levels of inattention-hyperactivity at 3 years. The second was a protective pathway, where higher SES was associated with longer duration of breastfeeding during infancy; then to better child neurodevelopmental status in toddlerhood; and in turn to lower levels of inattention-hyperactivity at 3 years. Discussion This study identified psychosocial factors at several developmental periods that represent potential targets for preventing the emergence of inattention-hyperactivity symptoms in early childhood.	[Foulon, Stephanie; Falissard, Bruno; Cote, Sylvana M.] Univ Paris Descartes & Paris Sud, INSERM, U669, Paris, France; [Pingault, Jean-Baptiste] UCL, Div Psychol & Language Sci, London, England; [Pingault, Jean-Baptiste] Kings Coll London, MRC Social, Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Cote, Sylvana M.] Univ Montreal, Int Lab Child & Adolescent Hlth Dev, Montreal, PQ, Canada; [Cote, Sylvana M.] Tomsk State Univ, Tomsk, Russia; [Larroque, Beatrice] Beaujon Hosp, Epidemiol & Clin Res Unit, Clichy, France; [Larroque, Beatrice] INSERM, UMR S953, Paris, France; [Melchior, Maria] Pierre Louis Inst Epidemiol & Publ Hlth, INSERM, Social Epidemiol Res Team, UMR S 1136, Paris, France; [Melchior, Maria] Univ Paris 06, Sorbonne Univ, Pierre Louis Inst Epidemiol & Publ Hlth, Social Epidemiol Res Team,UMR S 1136, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; King's College London; Universite de Montreal; Tomsk State University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Cote, SM (corresponding author), Univ Paris Descartes & Paris Sud, INSERM, U669, Paris, France.	sylvana.cote.1@umontreal.ca	Cote, Silvana Maria/O-1356-2014; Côté, Sylvana M./T-4600-2019; Melchior, Maria/E-3992-2017	Côté, Sylvana M./0000-0001-7944-0647; Foulon, Stephanie/0000-0002-0213-0736; Pingault, Jean-Baptiste/0000-0003-2557-4716	Fondation pour la Recherche Medicale (FRM); French Ministry of Research: IFR program; INSERM Human Nutrition National Research Program; Diabetes National Research Program (via a collaboration with the Association for Diabetes Research); French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; French National Institute for Health Education (INPES); Nestle; Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR nonthematic program); National Institute of Research in Public Health (IRESP: TGIR cohort sante program); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec [16031]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministry of Research: IFR program(Ministry of Research, France); INSERM Human Nutrition National Research Program; Diabetes National Research Program (via a collaboration with the Association for Diabetes Research); French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET)(French National Research Agency (ANR)); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; French National Institute for Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Nestle(Nestle SA); Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR nonthematic program)(French National Research Agency (ANR)); National Institute of Research in Public Health (IRESP: TGIR cohort sante program); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec	The EDEN study was supported by grants from Fondation pour la Recherche Medicale (FRM), French Ministry of Research: IFR program, INSERM Human Nutrition National Research Program, Diabetes National Research Program (via a collaboration with the Association for Diabetes Research), French Ministry of Health Perinatality Program, French Agency for Environment Security (AFFSET), French National Institute for Population Health Surveillance (INVS), Paris-Sud University, French National Institute for Health Education (INPES), Nestle, Mutuelle Generale de l'Education Nationale (MGEN), French Speaking Association for the Study of Diabetes and Metabolism (Alfediam), National Agency for Research (ANR nonthematic program) and the National Institute of Research in Public Health (IRESP: TGIR cohort sante 2008 program). Dr. Pingault received a post-doctoral fellowship from the Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la recherche et de la Sante du Quebec (# 16031) attributed to Dr. Cote. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate B, 1997, J AM ACAD CHILD PSY, V36, P1211, DOI 10.1097/00004583-199709000-00013; Bertrais S, 1999, REV EPIDEMIOL SANTE, V47, P263; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Bor W, 1997, AUST NZ J PSYCHIAT, V31, P664, DOI 10.3109/00048679709062679; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; Donovan CL, 2000, CLIN PSYCHOL REV, V20, P509, DOI 10.1016/S0272-7358(99)00040-9; Drouillet P, 2009, PAEDIATR PERINAT EP, V23, P76, DOI 10.1111/j.1365-3016.2008.00982.x; Essex MJ, 2006, ARCH GEN PSYCHIAT, V63, P1246, DOI 10.1001/archpsyc.63.11.1246; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Green N, 2004, MENTAL HLTH CHILDREN; Harvey EA, 2007, J ABNORM CHILD PSYCH, V35, P97, DOI 10.1007/s10802-006-9087-y; Haute Autorite de Sante (French National Authority for Health), 2005, PROP PORT DEP IND CH; Hu L., STRUCTURAL EQUATION, V6, P1; Julvez J, 2007, ACTA PAEDIATR, V96, P842, DOI 10.1111/j.1651-2227.2007.00273.x; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Langley K, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-26; Larsson H, 2014, J CHILD PSYCHOL PSYC, V55, P428, DOI 10.1111/jcpp.12140; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MCGEE R, 1992, J ABNORM CHILD PSYCH, V20, P487, DOI 10.1007/BF00916811; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Pingault JB, 2013, MOL PSYCHIATR, V18, P806, DOI 10.1038/mp.2012.87; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; Smidts DP, 2007, CORTEX, V43, P710, DOI 10.1016/S0010-9452(08)70500-8; Snowling M, 2009, J CHILD PSYCHOL PSYC, V50, P1039, DOI 10.1111/j.1469-7610.2009.02145.x; Spira EG, 2005, J CHILD PSYCHOL PSYC, V46, P755, DOI 10.1111/j.1469-7610.2005.01466.x; Theunissen MHC, 2013, PEDIATRICS, V131, pE446, DOI 10.1542/peds.2012-0089; van Dam NT, 2011, PSYCHIAT RES, V186, P128, DOI 10.1016/j.psychres.2010.08.018; Willoughby MT, 2012, J ABNORM CHILD PSYCH, V40, P1301, DOI 10.1007/s10802-012-9641-8; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676	33	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125996	10.1371/journal.pone.0125996	http://dx.doi.org/10.1371/journal.pone.0125996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938453	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000126
J	He, HW; Wang, LH; Zhou, WQ; Zhang, ZY; Wang, LX; Xu, S; Wang, D; Dong, J; Tang, CP; Tang, H; Yi, XM; Ge, JP				He, Haowei; Wang, Linhui; Zhou, Wenquan; Zhang, Zhengyu; Wang, Longxin; Xu, Song; Wang, Dong; Dong, Jie; Tang, Chaopeng; Tang, Hao; Yi, Xiaoming; Ge, Jingping			MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HISTOLOGIC SUBTYPES; GENE-EXPRESSION; CANCER CELLS; PROGNOSTIC VALUE; INVASION; MIGRATION; ACTIVATION; SURVIVAL; MIR-210	Objective This study aims to profile dysregulated microRNA (miRNA) expression in clear cell renal cell carcinoma (ccRCC) and to identify key regulatory miRNAs in ccRCC. Methods and Results miRNA expression profiles in nine pairs of ccRCC tumor samples at three different stages and the adjacent, non-tumorous tissues were investigated using miRNA arrays. Eleven miRNAs were identified to be commonly dysregulated, including three up-regulated (miR-487a, miR-491-3p and miR-452) and eight down-regulated (miR-125b, miR-142-3p, miR-199a-5p, miR-22, miR-299-3p, miR-29a, miR-429, and miR-532-5p) in tumor tissues as compared with adjacent normal tissues. The 11 miRNAs and their predicted target genes were analyzed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and three key miRNAs (miR-199a-5p, miR-22 and miR-429) were identified by microRNA-gene network analysis. Dysregulation of the three key miRNAs were further validated in another cohort of 15 ccRCC samples, and the human kidney carcinoma cell line 786-O, as compared with five normal kidney samples. Further investigation showed that over-expression of miR-199a-5p significantly inhibited the invasion ability of 786-O cells. Luciferase reporter assays indicated that miR-199a-5p regulated expression of TGFBR1 and JunB by directly interacting with their 3' untranslated regions. Transfection of miR-199a-5p successfully suppressed expression of TGFBR1 and JunB in the human embryonic kidney 293T cells, further confirming the direct regulation of miR-199a-5p on these two genes. Conclusions This study identified 11 commonly dysregulated miRNAs in ccRCC, three of which (miR-199a-5p, miR-22 and miR-429) may represent key miRNAs involved in the pathogenesis of ccRCC. Further studies suggested that miR-199a-5p plays an important role in inhibition of cell invasion of ccRCC cells by suppressing expression of TGFBR1 and JunB.	[He, Haowei; Zhou, Wenquan; Zhang, Zhengyu; Wang, Longxin; Xu, Song; Wang, Dong; Dong, Jie; Tang, Chaopeng; Tang, Hao; Yi, Xiaoming; Ge, Jingping] Nanjing Univ, Sch Med, Jinling Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Linhui] Second Mil Med Univ, Changzheng Hosp, Dept Urol, Shanghai, Peoples R China	Nanjing University; Naval Medical University	Ge, JP (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China.	hehaowei1982@hotmail.com	tang, chaopeng/GQA-7639-2022; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022	he, haowei/0000-0002-0358-4983				Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Chow TFF, 2010, J UROLOGY, V183, P743, DOI 10.1016/j.juro.2009.09.086; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Goncalves JP, 2011, BIOINFORMATICS, V27, P3149, DOI 10.1093/bioinformatics/btr546; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Guo MM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0542-7; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kong Y, 2012, INT J BIOCHEM CELL B, V44, P2321, DOI 10.1016/j.biocel.2012.08.006; Li B, 2013, ONCOL REP, V29, P1932, DOI 10.3892/or.2013.2300; Liu D, 2012, J BIOMED RES, V26, P389, DOI 10.7555/JBR.26.20120029; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Rini BI, 2008, CURR OPIN ONCOL, V20, P300, DOI 10.1097/CCO.0b013e3282f9782b; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Schachter LR, 2007, J ENDOUROL, V21, P819, DOI 10.1089/end.2006.9937; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Shen WW, 2013, J MOL MED, V91, P989, DOI 10.1007/s00109-013-1037-x; Su SF, 2013, ONCOGENE, V32, P4694, DOI 10.1038/onc.2012.483; Sun TW, 2011, EUR J CANCER, V47, P2552, DOI 10.1016/j.ejca.2011.05.021; Taccoen X, 2007, EUR UROL, V51, P980, DOI 10.1016/j.eururo.2006.10.025; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; Vaziri SAJ, 2009, ANTICANCER RES, V29, P2961; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wang W, 2012, WORLD J GASTROENTERO, V18, P5442, DOI 10.3748/wjg.v18.i38.5442; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zhu CL, 2013, CLIN BIOCHEM, V46, P49, DOI 10.1016/j.clinbiochem.2012.09.002; Zhu XC, 2012, INT J MOL MED, V30, P1321, DOI 10.3892/ijmm.2012.1140	45	43	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125672	10.1371/journal.pone.0125672	http://dx.doi.org/10.1371/journal.pone.0125672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938468	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000087
J	Igarashi, J; Fukuda, N; Inoue, T; Nakai, S; Saito, K; Fujiwara, K; Matsuda, H; Ueno, T; Matsumoto, Y; Watanabe, T; Nagase, H; Bando, T; Sugiyama, H; Itoh, T; Soma, M				Igarashi, Jun; Fukuda, Noboru; Inoue, Takashi; Nakai, Shigeki; Saito, Kosuke; Fujiwara, Kyoko; Matsuda, Hiroyuki; Ueno, Takahiro; Matsumoto, Yoshiaki; Watanabe, Takayoshi; Nagase, Hiroki; Bando, Toshikazu; Sugiyama, Hiroshi; Itoh, Toshio; Soma, Masayoshi			Preclinical Study of Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Human TGF-beta 1 Promoter for Hypertrophic Scars in a Common Marmoset Primate Model	PLOS ONE			English	Article							TRANSCRIPTIONAL INHIBITION; DNA; EXPRESSION; RECOGNITION; COLLAGEN	We report a preclinical study of a pyrrole-imidazole (PI) polyamide that targets the human transforming growth factor (hTGF)-beta 1 gene as a novel transcriptional gene silencer in a common marmoset primate model. We designed and then synthesized PI polyamides to target the hTGF-beta 1 promoter. We examined effects of seven PI polyamides (GB1101-1107) on the expression of hTGF-beta 1 mRNA stimulated with phorbol 12-myristate 13-acetate (PMA) in human vascular smooth muscle cells. GB1101, GB1105 and GB1106 significantly inhibited hTGF-beta 1 mRNA expression. We examined GB1101 as a PI polyamide to hTGF-beta 1 for hypertrophic scars in marmosets in vivo. Injection of GB1101 completely inhibited hypertrophic scar formation at 35 days post-incision and inhibited cellular infiltration, TGF-beta 1 and vimentin staining, and epidermal thickness. Mismatch polyamide did not affect hypertrophic scarring or histological changes. Epidermis was significantly thinner with GB1101 than with water and mismatch PI polyamides. We developed the PI polyamides for practical ointment medicines for the treatment of hypertrophic scars. FITC-labeled GB1101 with solbase most efficiently distributed in the nuclei of epidermal keratinocytes, completely suppressed hypertropic scarring at 42 days after incision, and considerably inhibited epidermal thickness and vimentin-positive fibroblasts. PI polyamides targeting hTGF-beta 1 promoter with solbase ointment will be practical medicines for treating hypertrophic scars after surgical operations and skin burns.	[Igarashi, Jun; Nakai, Shigeki; Saito, Kosuke; Fujiwara, Kyoko; Matsuda, Hiroyuki; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Gen Med, Tokyo, Japan; [Fukuda, Noboru] Nihon Univ, Grad Sch, Adv Res Inst Sci & Humanities, Div Life Sci, Tokyo, Japan; [Fukuda, Noboru; Ueno, Takahiro; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan; [Inoue, Takashi; Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki, Kanagawa, Japan; [Matsumoto, Yoshiaki] Nihon Univ, Coll Pharm, Dept Clin Pharmacokinet, Chiba, Japan; [Watanabe, Takayoshi; Nagase, Hiroki] Chiba Canc Ctr, Res Inst, Dept Canc Genet, Chiba 2608717, Japan; [Bando, Toshikazu; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch, Dept Chem, Kyoto, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Chiba Cancer Center; Kyoto University	Fukuda, N (corresponding author), Nihon Univ, Grad Sch, Adv Res Inst Sci & Humanities, Div Life Sci, Tokyo, Japan.	fukuda.noboru@nihon-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011	Sugiyama, Hiroshi/0000-0001-8923-5946; Inoue, Takashi/0000-0003-4691-7255; Fukuda, Noboru/0000-0003-0098-054X	"Strategic Research Base Development" Program for Private Universities by MEXT; N. Research Project in Nihon University	"Strategic Research Base Development" Program for Private Universities by MEXT; N. Research Project in Nihon University	This work was partially supported by a Grant from the "Strategic Research Base Development" Program for Private Universities subsidized by MEXT (2010-2013) and the N. Research Project in Nihon University (2009-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeu T, 2003, PATHOL RES PRACT, V199, P469, DOI 10.1078/0344-0338-00447; Chen M, 2010, MOL THER, V18, P519, DOI 10.1038/mt.2009.263; Chu YH, 2008, CONNECT TISSUE RES, V49, P92, DOI 10.1080/03008200801913924; Ehley JA, 2002, MOL CELL BIOL, V22, P1723, DOI 10.1128/MCB.22.6.1723-1733.2002; Fujimoto K, 2002, NUCLEIC ACIDS RES, V30, P3748, DOI 10.1093/nar/gkf486; Fukuda N, 2006, J AM SOC NEPHROL, V17, P422, DOI 10.1681/ASN.2005060650; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hargrove AE, 2012, J MED CHEM, V55, P5425, DOI 10.1021/jm300380a; Hasegawa T, 2005, J DERMATOL SCI, V39, P33, DOI 10.1016/j.jdermsci.2005.01.013; KIM SJ, 1989, J BIOL CHEM, V264, P402; Lai YM, 2005, J PHARMACOL EXP THER, V315, P571, DOI 10.1124/jpet.105.089086; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Meier Karen, 2006, Expert Opin Emerg Drugs, V11, P39, DOI 10.1517/14728214.11.1.39; Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Peterson C, 2011, EUR J CLIN PHARMACOL, V67, P437, DOI 10.1007/s00228-011-1011-x; Roques Claude, 2008, Int J Low Extrem Wounds, V7, P137, DOI 10.1177/1534734608320786; Serie K, 2012, PERITON DIALYSIS INT, V32, P462, DOI 10.3747/pdi.2011.00092; Shigeki S, 1997, SCAND J PLAST RECONS, V31, P151, DOI 10.3109/02844319709085482; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Washio H, 2011, J INVEST DERMATOL, V131, P1987, DOI 10.1038/jid.2011.150; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X; Yao EH, 2009, CARDIOVASC RES, V81, P797, DOI 10.1093/cvr/cvn355; Zhao R, 2013, MATRIX BIOL, V32, P265, DOI 10.1016/j.matbio.2013.02.004	24	23	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125295	10.1371/journal.pone.0125295	http://dx.doi.org/10.1371/journal.pone.0125295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938472	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000056
J	Sun, DX; Tan, XD; Gao, F; Xu, J; Cui, DX; Dai, XW				Sun, Da-Xin; Tan, Xiao-Dong; Gao, Feng; Xu, Jin; Cui, Dong-Xu; Dai, Xian-Wei			Use of an Autologous Liver Round Ligament Flap Zeros Postoperative Bile Leak after Curative Resection of Hilar Cholangiocarcinoma	PLOS ONE			English	Article							RISK-FACTORS; HEPATECTOMY; MANAGEMENT; TRANSPLANTATION; GRAFT	Background Postoperative bile leak is a major surgical morbidity after curative resection with hepaticojejunostomy for hilar cholangiocarcinoma, especially in Bismuth-Corlette types III and IV. This retrospective study assessed the effectiveness and safety of an autologous hepatic round ligament flap (AHRLF) for reducing bile leak after hilar hepaticojejunostomy. Methods Nine type III and IV hilar cholangiocarcinoma patients were consecutively hospitalized for elective perihilar partial hepatectomy with hilar hepaticojejunostomy using an AHRLF between October 2009 and September 2013. The AHRLF was harvested to reinforce the perihilar hepaticojejunostomy. Main outcome measures included operative time, blood loss, postoperative recovery times, morbidity, bile leak, R0 resection rate, and overall survival. Results All patients underwent uneventful R0 resection with hilar hepaticojejunostomy. No patient experienced postoperative bile leak. Conclusions The AHRLF was associated with lack of bile leak after curative perihilar hepatectomy with hepaticojejunostomy for hilar cholangiocarcinoma, without compromising oncologic safety, and is recommended in selected patients.	[Sun, Da-Xin; Tan, Xiao-Dong; Gao, Feng; Xu, Jin; Cui, Dong-Xu; Dai, Xian-Wei] China Med Univ, Dept Gen Surg, Shengjing Hosp, Shenyang 110000, Liaoning, Peoples R China	China Medical University	Dai, XW (corresponding author), China Med Univ, Dept Gen Surg, Shengjing Hosp, Shenyang 110000, Liaoning, Peoples R China.	daixianwei@126.com						Suarez-Munoz MA, 2013, WORLD J GASTRO ONCOL, V5, P132, DOI 10.4251/wjgo.v5.i7.132; Aydin M, 2005, HEPATO-GASTROENTEROL, V52, P1019; Capussotti L, 2006, ARCH SURG-CHICAGO, V141, P690, DOI 10.1001/archsurg.141.7.690; Chen XP, 2009, BRIT J SURG, V96, P1167, DOI 10.1002/bjs.6618; Cheng QB, 2012, EJSO-EUR J SURG ONC, V38, P1197, DOI 10.1016/j.ejso.2012.08.009; COSTALAT G, 1991, SURG ENDOSC-ULTRAS, V5, P154, DOI 10.1007/BF02653225; DeOliveira ML, 2011, HEPATOLOGY, V53, P1363, DOI 10.1002/hep.24227; Geng ZM, 2013, MED SCI MONITOR, V19, P648, DOI 10.12659/MSM.889379; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Iannitti DA, 2006, J AM COLL SURGEONS, V203, P857, DOI 10.1016/j.jamcollsurg.2006.08.021; Ikegami T, 2008, J HEPATO-BILIARY-PAN, V15, P581, DOI 10.1007/s00534-007-1319-1; Izbicki JR, 2013, J GASTROINTEST SURG, V17, P581, DOI 10.1007/s11605-012-2109-x; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Lambe G, 2012, BRIT J SURG, V99, P964, DOI 10.1002/bjs.8759; Liang YL, 2012, WORLD J GASTROENTERO, V18, P5205, DOI 10.3748/wjg.v18.i37.5205; Lu BC, 2013, WSPOLCZESNA ONKOL, V17, P298, DOI 10.5114/wo.2013.35274; Nagino M, 2001, WORLD J SURG, V25, P1277, DOI 10.1007/s00268-001-0110-8; Nakatsuka Hideki, 2013, Gan To Kagaku Ryoho, V40, P1903; Okumura K, 2013, HEPATO-GASTROENTEROL, V60, P1717, DOI 10.5754/hge11295; Popescu I, 2014, LANGENBECK ARCH SURG, V399, P693, DOI 10.1007/s00423-014-1210-x; Ramia JM, 2013, WORLD J GASTRO ONCOL, V5, P113, DOI 10.4251/wjgo.v5.i7.113; Robles R, 2013, WORLD J GASTROENTERO, V19, P9209, DOI 10.3748/wjg.v19.i48.9209; Sanjay P, 2013, J GASTROINTEST SURG, V17, P829, DOI 10.1007/s11605-012-2055-7; Strucker B, 2013, WORLD J SURG, V37, P2629, DOI 10.1007/s00268-013-2161-z; Tsao JI, 2000, ANN SURG, V232, P166, DOI 10.1097/00000658-200008000-00003; Uchiyama K, 2003, ARCH SURG-CHICAGO, V138, P1012, DOI 10.1001/archsurg.138.9.1012; Wahab MA, 2006, HEPATO-GASTROENTEROL, V53, P5; Welling TH, 2014, LIVER TRANSPLANT, V20, P81, DOI 10.1002/lt.23757; Wu CT, 2013, HEPATOB PANCREAT DIS, V12, P651, DOI 10.1016/S1499-3872(13)60102-2; Ying DJ, 1997, SURG RADIOL ANAT, V19, P293, DOI 10.1007/BF01637594; Zhang CH, 2011, ANZ J SURG, V81, P572, DOI 10.1111/j.1445-2197.2011.05799.x	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125977	10.1371/journal.pone.0125977	http://dx.doi.org/10.1371/journal.pone.0125977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938440	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000125
J	Lee, EJ; Park, EY; Mun, H; Chang, E; Ko, JY; Kim, DY; Park, JH				Lee, Eun Ji; Park, Eun Young; Mun, HyoWon; Chang, EunSun; Ko, Je Yeong; Kim, Do Yeon; Park, Jong Hoon			Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation	FASEB JOURNAL			English	Article						ADPKD; sRAGE; MAPK	CYST GROWTH; IN-VITRO; RAGE; ACTIVATION; PROTEINS; ADPKD; PKD1; INACTIVATION; PATHOGENESIS; INFLAMMATION	Autosomal polycystic kidney disease (ADPKD) is a highly prevalent genetic renal disorder in which epithelial-lining fluid-filledcysts appear in kidneys. It is accompanied by hyperactivation of cell proliferation, interstitial inflammation, and fibrosis around the cyst lining cells, finally reaching end-stage renal disease. Previously, we found high expression of ligands stimulating the receptor for advanced glycation end products (RAGE) in ADPKD mice. Furthermore, gene silencing of RAGE was revealed to cause reduction of cystogenesis via down-regulation of cell proliferation in vitro, and intravenous administration of anti-RAGE adenovirus in vivo also displayed alleviation of the disease. Here, we attempted to identify the role of soluble RAGE (sRAGE) in inhibiting the progression of ADPKD using 2 different ADPKD mouse models. sRAGE is an endogenously expressed form of RAGE that has no membrane-anchoring domain, thereby giving it the ability to neutralize the ligands that stimulate RAGE signals. Both overexpression of sRAGE and sRAGE treatment blocked RAGE-mediated cell proliferation in vitro. In addition, sRAGE-injected ADPKD mice showed reduced cysts accompanied by enhanced renal function, inhibition of cell proliferation, inflammation, and fibrosis. These positive therapeutic effects of sRAGE displayed little liver toxicity, suggesting it as a new potential therapeutic target of ADPKD with low side effects.-Lee, E. J., Park, E. Y., Mun, H., Chang, E., Ko, J. Y., Kim, D. Y., Park, J. H. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.	[Lee, Eun Ji; Park, Eun Young; Mun, HyoWon; Chang, EunSun; Ko, Je Yeong; Kim, Do Yeon; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea	Sookmyung Women's University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea.	parkjh@sookmyung.ac.kr			Bio & Medical Technology Development Program [2010-0019867, 2012M3A9D1054519]; Basic Science Research Program [2012 R1A1A2043225, 2013R1A2A1A01011908]; Mid-career Researcher Program of the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea [2012-043084]	Bio & Medical Technology Development Program; Basic Science Research Program; Mid-career Researcher Program of the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea	This work was supported by the Bio & Medical Technology Development Program (2010-0019867 and 2012M3A9D1054519), Basic Science Research Program (2012 R1A1A2043225 and 2013R1A2A1A01011908), and Mid-career Researcher Program (2012-043084) of the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT and Future Planning of Korea.	Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ko JY, 2013, BMB REP, V46, P73, DOI 10.5483/BMBRep.2013.46.2.022; Lariviere WB, 2015, TRANSL RES, V165, P488, DOI 10.1016/j.trsl.2014.11.003; Lee EJ, 2014, NEPHROLOGY, V19, P471, DOI 10.1111/nep.12261; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lin LG, 2012, J CANCER RES CLIN, V138, P11, DOI 10.1007/s00432-011-1067-0; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Nakamura T, 2012, AM J MED SCI, V343, P46, DOI 10.1097/MAJ.0b013e31821f0552; Nakamura T, 2011, BLOOD PURIFICAT, V32, P139, DOI 10.1159/000325731; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Norman J, 2011, BBA-MOL BASIS DIS, V1812, P1327, DOI 10.1016/j.bbadis.2011.06.012; Novalic Z, 2012, J AM SOC NEPHROL, V23, P842, DOI 10.1681/ASN.2011040340; Park EY, 2014, J BIOL CHEM, V289, P9254, DOI 10.1074/jbc.M113.514166; Park EY, 2010, AM J NEPHROL, V32, P169, DOI 10.1159/000315859; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Raphael KL, 2009, KIDNEY INT, V75, P626, DOI 10.1038/ki.2008.659; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Ta MHT, 2013, NEPHROLOGY, V18, P317, DOI 10.1111/nep.12045; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; Zhu P, 2013, INT J MOL MED, V31, P763, DOI 10.3892/ijmm.2013.1286	29	16	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3506	3514		10.1096/fj.15-272302	http://dx.doi.org/10.1096/fj.15-272302			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25934702				2022-12-26	WOS:000358796900036
J	Caliz, J; Montes-Borrego, M; Triado-Margarit, X; Metsis, M; Landa, BB; Casamayor, EO				Caliz, Joan; Montes-Borrego, Miguel; Triado-Margarit, Xavier; Metsis, Madis; Landa, Blanca B.; Casamayor, Emilio O.			Influence of Edaphic, Climatic, and Agronomic Factors on the Composition and Abundance of Nitrifying Microorganisms in the Rhizosphere of Commercial Olive Crops	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; MANAGEMENT-SYSTEMS; BULK SOIL; COMMUNITIES; DIVERSITY; BACTERIA; OXIDATION; ORCHARDS; LAKES	The microbial ecology of the nitrogen cycle in agricultural soils is an issue of major interest. We hypothesized a major effect by farm management systems (mineral versus organic fertilizers) and a minor influence of soil texture and plant variety on the composition and abundance of microbial nitrifiers. We explored changes in composition (16S rRNA gene) of ammonia-oxidizing archaea (AOA), bacteria (AOB), and nitrite-oxidizing bacteria (NOB), and in abundance of AOA and AOB (qPCR of amoA genes) in the rhizosphere of 96 olive orchards differing in climatic conditions, agricultural practices, soil properties, and olive variety. Majority of archaea were 1.1b thaumarchaeota (soil crenarchaeotic group, SCG) closely related to the AOA genus Nitrososphaera. Most AOB (97%) were identical to Nitrosospira tenuis and most NOB (76%) were closely related to Nitrospira sp. Common factors shaping nitrifiers assemblage composition were pH, soil texture, and olive variety. AOB abundance was positively correlated with altitude, pH, and clay content, whereas AOA abundances showed significant relationships with organic nitrogen content and exchangeable K. The abundances of AOA differed significantly among soil textures and olive varieties, and those of AOB among soil management systems and olive varieties. Overall, we observed minor effects by orchard management system, soil cover crop practices, plantation age, or soil organic matter content, and major influence of soil texture, pH, and olive tree variety.	[Caliz, Joan; Triado-Margarit, Xavier; Casamayor, Emilio O.] CSIC, CEAB, Biogeodynam & Biodivers Grp, Blanes, Girona, Spain; [Montes-Borrego, Miguel; Landa, Blanca B.] CSIC, Inst Sustainable Agr, Campus Excelencia Int Agroalimentario ceiA3, Cordoba, Spain; [Metsis, Madis] Tallinn Univ, Inst Math & Nat Sci, EE-10120 Tallinn, Estonia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Tallinn University	Casamayor, EO (corresponding author), CSIC, CEAB, Biogeodynam & Biodivers Grp, Blanes, Girona, Spain.	casamayor@ceab.csic.es	Cáliz, Joan/AAC-5071-2020; Casamayor, Emilio/A-3676-2010; Metsis, Madis/F-7080-2016; Triadó-Margarit, Xavier/I-1604-2015; Landa, Blanca B/K-9629-2014	Cáliz, Joan/0000-0001-5714-7431; Casamayor, Emilio/0000-0001-7074-3318; Metsis, Madis/0000-0003-1667-677X; Triadó-Margarit, Xavier/0000-0001-5339-3221; Landa, Blanca B/0000-0002-9511-3731; Beck, Michael/0000-0002-5107-9973	'Consejeria de Economia, Innovacion y Ciencia'-Junta de Andalucia [P10-AGR-5908]; 'Interprofesional del Aceite de Oliva Espanol-Fundacion CITOLIVA'; Spanish Office of Science (MINECO) [AGL-2012-37521]; DARKNESS (MINECO) [CGL2012-32747]; Fondo Europeo de Desarrollo Regional (FEDER)	'Consejeria de Economia, Innovacion y Ciencia'-Junta de Andalucia(Junta de Andalucia); 'Interprofesional del Aceite de Oliva Espanol-Fundacion CITOLIVA'; Spanish Office of Science (MINECO); DARKNESS (MINECO); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	Funding: This research was supported by grants P10-AGR-5908 from 'Consejeria de Economia, Innovacion y Ciencia'-Junta de Andalucia, 'Interprofesional del Aceite de Oliva Espanol-Fundacion CITOLIVA' and AGL-2012-37521 from the Spanish Office of Science (MINECO) to BBL, DARKNESS CGL2012-32747 (MINECO) to EOC, and Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2013, SOIL BIOL BIOCHEM, V57, P30, DOI 10.1016/j.soilbio.2012.08.003; Aranda S, 2011, PLANT SOIL, V343, P329, DOI 10.1007/s11104-011-0721-2; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bodirsky BL, 2013, NATURE COMMUNICATION, V5, P3858; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Castro J, 2008, SOIL TILL RES, V98, P56, DOI 10.1016/j.still.2007.10.002; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Dias ACF, 2012, SOIL BIOL BIOCHEM, V50, P85, DOI 10.1016/j.soilbio.2012.03.006; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fernandez-Escobar R, 2009, EUR J AGRON, V31, P223, DOI 10.1016/j.eja.2009.08.001; Fernandez-Guerra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047330; Fowler D., 2013, PHIL T R SOC B, P368, DOI [10.1098/rstb.2013.0164.20130164-20130164, DOI 10.1098/RSTB.2013.0164.20130164-20130164]; Glaser K, 2010, FEMS MICROBIOL ECOL, V74, P575, DOI 10.1111/j.1574-6941.2010.00970.x; Gomez JA, 2003, SOIL USE MANAGE, V19, P127, DOI 10.1079/SUM2002179; IOC, 2013, WORLD OL OIL FIG; Landa BB, 2014, ENV MICROBIOL REP, V6, P196, DOI 10.1111/1758-2229.12148; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luna GM, 2009, CURR MICROBIOL, V59, P356, DOI 10.1007/s00284-009-9445-4; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Merbt SN, 2015, MICROB ECOL, V69, P66, DOI 10.1007/s00248-014-0464-8; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Montes-Borrego M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096397; Montes-Borrego M, 2013, AGR ECOSYST ENVIRON, V181, P169, DOI 10.1016/j.agee.2013.09.021; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Palomares-Rius JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116890; Palomares-Rius JE, 2012, SOIL BIOL BIOCHEM, V45, P168, DOI 10.1016/j.soilbio.2011.11.009; Ponti L, 2014, P NATL ACAD SCI USA, V111, P5598, DOI 10.1073/pnas.1314437111; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sliwinski MK, 2004, APPL ENVIRON MICROB, V70, P1821, DOI 10.1128/AEM.70.3.1821-1826.2004; Soriano MA, 2014, RENEW AGR FOOD SYST, V29, P83, DOI 10.1017/S1742170512000361; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Vila-Costa M, 2014, MICROB ECOL, V68, P60, DOI 10.1007/s00248-014-0417-2; Vitousek PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0119; Wessen E, 2010, APPL SOIL ECOL, V45, P193, DOI 10.1016/j.apsoil.2010.04.003; Zhou JB, 2006, PEDOSPHERE, V16, P245, DOI 10.1016/S1002-0160(06)60050-7; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	52	29	29	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125787	10.1371/journal.pone.0125787	http://dx.doi.org/10.1371/journal.pone.0125787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950678	Green Published, gold, Green Submitted			2022-12-26	WOS:000354214400045
J	Segueni, N; Vigne, S; Palmer, G; Bourigault, ML; Olleros, ML; Vesin, D; Garcia, I; Ryffel, B; Quesniaux, VFJ; Gabay, C				Segueni, Noria; Vigne, Solenne; Palmer, Gaby; Bourigault, Marie-Laure; Olleros, Maria L.; Vesin, Dominique; Garcia, Irene; Ryffel, Bernhard; Quesniaux, Valerie F. J.; Gabay, Cem			Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; TUBERCULOSIS INFECTION; DEFICIENT MICE; IMMUNE-RESPONSE; T-CELLS; RECEPTOR; INNATE; INTERLEUKIN-1; LIGANDS; SKIN	IL-36 cytokines are members of the IL-1 family of cytokines that stimulate dendritic cells and T cells leading to enhanced T helper 1 responses in vitro and in vivo; however, their role in host defense has not been fully addressed thus far. The objective of this study was to examine the role of IL-36R signaling in the control of mycobacterial infection, using models of systemic attenuated M. bovis BCG infection and virulent aerogenic M. tuberculosis infection. IL-36 gamma expression was increased in the lung of M. bovis BCG infected mice. However, IL-36R deficient mice infected with M. bovis BCG showed similar survival and control of the infection as compared to wild-type mice, although their lung pathology and CXCL1 response were transiently different. While highly susceptible TNF-alpha deficient mice succumbed with overwhelming M. tuberculosis infection, and IL-1RI deficient mice showed intermediate susceptibility, IL-36R-deficient mice controlled the infection, with bacterial burden, lung inflammation and pathology, similar to wild-type controls. Therefore, IL-36R signaling has only limited influence in the control of mycobacterial infection.	[Segueni, Noria; Bourigault, Marie-Laure; Ryffel, Bernhard; Quesniaux, Valerie F. J.] CNRS, UMR7355, F-45071 Orleans, France; [Segueni, Noria; Bourigault, Marie-Laure; Ryffel, Bernhard; Quesniaux, Valerie F. J.] Univ Orleans, Expt & Mol Immunol & Neurogenet, Orleans, France; [Vigne, Solenne; Palmer, Gaby; Gabay, Cem] Univ Hosp Geneva, Dept Internal Med Specialties, Div Rheumatol, Geneva, Switzerland; [Vigne, Solenne; Palmer, Gaby; Olleros, Maria L.; Vesin, Dominique; Garcia, Irene; Gabay, Cem] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Ryffel, Bernhard] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Geneva; University of Geneva; University of Cape Town	Gabay, C (corresponding author), Univ Hosp Geneva, Dept Internal Med Specialties, Div Rheumatol, Geneva, Switzerland.	cem.gabay@hcuge.ch	palmer, gaby/AAA-7117-2021	palmer, gaby/0000-0001-7567-1798	Swiss National Science Foundation [310030_152638, 310030_134691, 310030_46833]; LPG; Rheumasearch Foundation; Institute of Arthritis Research; CNRS International Associated Laboratory "TB IMMUNITY" [236]; Region Centre (France) [2013-00085470]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); LPG; Rheumasearch Foundation; Institute of Arthritis Research; CNRS International Associated Laboratory "TB IMMUNITY"; Region Centre (France)(Region Centre-Val de Loire)	This work was supported by grants from the Swiss National Science Foundation (310030_152638 to CG, 310030_134691 to GP, 310030_46833 to IG), LPG to IG, the Rheumasearch Foundation, the Institute of Arthritis Research, the CNRS International Associated Laboratory "TB IMMUNITY" (LIA No 236), and the Region Centre (No 2013-00085470) (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann M, 2012, J BIOL CHEM, V287, P41684, DOI 10.1074/jbc.M112.385443; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bourigault ML, 2013, IMMUN INFLAMM DIS, V1, P47, DOI 10.1002/iid3.9; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Dietrich D, 2014, NAT REV RHEUMATOL, V10, P639, DOI 10.1038/nrrheum.2014.156; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Gresnigt MS, 2013, EUR J IMMUNOL, V43, P416, DOI 10.1002/eji.201242711; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Labow M, 1997, J IMMUNOL, V159, P2452; Lamacchia C, 2007, J AM ASSOC LAB ANIM, V46, P21; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Mohan AK, 2003, CURR OPIN RHEUMATOL, V15, P179, DOI 10.1097/00002281-200305000-00002; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Mutamba S, 2012, EUR J IMMUNOL, V42, P607, DOI 10.1002/eji.201142035; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Olleros ML, 2010, J HEPATOL, V53, P1059, DOI 10.1016/j.jhep.2010.05.029; Olleros ML, 2009, J INFECT DIS, V199, P1053, DOI 10.1086/597204; Parsanejad R, 2008, J INTERF CYTOK RES, V28, P703, DOI 10.1089/jir.2008.0139; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079	43	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126058	10.1371/journal.pone.0126058	http://dx.doi.org/10.1371/journal.pone.0126058			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950182	Green Submitted, Green Published, gold			2022-12-26	WOS:000354214400064
J	Hale, C; Yeung, A; Goulding, D; Pickard, D; Alasoo, K; Powrie, F; Dougan, G; Mukhopadhyay, S				Hale, Christine; Yeung, Amy; Goulding, David; Pickard, Derek; Alasoo, Kaur; Powrie, Fiona; Dougan, Gordon; Mukhopadhyay, Subhankar			Induced Pluripotent Stem Cell Derived Macrophages as a Cellular System to Study Salmonella and Other Pathogens	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; IN-VITRO; DIFFERENTIATION; RECEPTORS; RECOGNITION; EXPRESSION; IMMUNITY; VECTORS; DISEASE; MODEL	A number of pathogens, including several human-restricted organisms, persist and replicate within macrophages (M phi s) as a key step in pathogenesis. The mechanisms underpinning such host-restricted intracellular adaptations are poorly understood, in part, due to a lack of appropriate model systems. Here we explore the potential of human induced pluripotent stem cell derived macrophages (iPSDMs) to study such pathogen interactions. We show iPSDMs express a panel of established M phi-specific markers, produce cytokines, and polarise into classical and alternative activation states in response to IFN-gamma and IL-4 stimulation, respectively. iPSDMs also efficiently phagocytosed inactivated bacterial particles as well as live Salmonella Typhi and S. Typhimurium and were able to kill these pathogens. We conclude that iPSDMs can support productive Salmonella infection and propose this as a flexible system to study host/pathogen interactions. Furthermore, iPSDMs can provide a flexible and practical cellular platform for assessing host responses in multiple genetic backgrounds.	[Hale, Christine; Yeung, Amy; Goulding, David; Pickard, Derek; Alasoo, Kaur; Powrie, Fiona; Dougan, Gordon; Mukhopadhyay, Subhankar] Wellcome Trust Sanger Inst, Cambridge, England; [Powrie, Fiona; Mukhopadhyay, Subhankar] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England	Wellcome Trust Sanger Institute; University of Oxford	Mukhopadhyay, S (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	sm21@sanger.ac.uk	Alasoo, Kaur/H-7082-2019	Alasoo, Kaur/0000-0002-1761-8881; Mukhopadhyay, Subhankar/0000-0002-7110-6473	Wellcome Trust funding; BBSRC [BB/I005609/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I005609/1] Funding Source: researchfish	Wellcome Trust funding(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust funding to GD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrat S, 2014, ANNU REV CELL DEV BI, V30, P79, DOI 10.1146/annurev-cellbio-100913-013439; Beutner C, 2013, GENE THER, V20, P797, DOI 10.1038/gt.2012.100; Beutner C, 2010, NAT PROTOC, V5, P1481, DOI 10.1038/nprot.2010.90; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Haga E, 2014, J IMMUNOL, V193, P2024, DOI 10.4049/jimmunol.1303473; Haruta M, 2013, GENE THER, V20, P504, DOI 10.1038/gt.2012.59; Jansen AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002131; Jiang Y, 2012, STEM CELLS, V30, P599, DOI 10.1002/stem.1053; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; McKelvie ND, 2004, VACCINE, V22, P3243, DOI 10.1016/j.vaccine.2004.05.014; Monack DM, 2012, CURR OPIN MICROBIOL, V15, P100, DOI 10.1016/j.mib.2011.10.013; Mukhopadhyay S, 2004, J LEUKOCYTE BIOL, V76, P577, DOI 10.1189/jlb.0104014; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Panicker LM, 2014, STEM CELLS, V32, P2338, DOI 10.1002/stem.1732; Panicker LM, 2012, P NATL ACAD SCI USA, V109, P18054, DOI 10.1073/pnas.1207889109; Pluddemann A, 2011, IMMUNOL REV, V240, P11, DOI 10.1111/j.1600-065X.2010.00989.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Senju S, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27927; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Weinstein DL, 1998, INFECT IMMUN, V66, P2310, DOI 10.1128/IAI.66.5.2310-2318.1998; Wilson RP, 2011, INFECT IMMUN, V79, P830, DOI 10.1128/IAI.00961-10; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9	30	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124307	10.1371/journal.pone.0124307	http://dx.doi.org/10.1371/journal.pone.0124307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946027	Green Published, gold			2022-12-26	WOS:000354049700039
J	Sato, M; Kawano, M; Ohkura, M; Gengyo-Ando, K; Nakai, J; Hayashi, Y				Sato, Masaaki; Kawano, Masako; Ohkura, Masamichi; Gengyo-Ando, Keiko; Nakai, Junichi; Hayashi, Yasunori			Generation and Imaging of Transgenic Mice that Express G-CaMP7 under a Tetracycline Response Element	PLOS ONE			English	Article							NEURAL ACTIVITY; RESOLUTION; INDICATOR; SEQUENCES; MOUSE	The spatiotemporally controlled expression of G-CaMP fluorescent calcium indicator proteins can facilitate reliable imaging of brain circuit activity. Here, we generated a transgenic mouse line that expresses G-CaMP7 under a tetracycline response element. When crossed with a forebrain-specific tetracycline-controlled transactivator driver line, the mice expressed G-CaMP7 in defined cell populations in a tetracycline-controlled manner, notably in pyramidal neurons in layer 2/3 of the cortex and in the CA1 area of the hippocampus; this expression allowed for imaging of the in vivo activity of these circuits. This mouse line thus provides a useful genetic tool for controlled G-CaMP expression in vivo.	[Sato, Masaaki; Kawano, Masako; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Sato, Masaaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ohkura, Masamichi; Gengyo-Ando, Keiko; Nakai, Junichi; Hayashi, Yasunori] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; Japan Science & Technology Agency (JST); Saitama University	Sato, M (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	msato@brain.riken.jp	Hayashi, Yasunori/C-2249-2008; Nakai, Junichi/GQZ-6415-2022; Ohkura, Masamichi/J-6976-2012; Gengyo-Ando, Keiko/AAC-4504-2019; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Sato, Masaaki/0000-0002-5206-3375; Ohkura, Masamichi/0000-0002-3659-7780	Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) [21800091, 24700403, 25116528, 26115530]; MEXT/JSPS [22110006]; Human Frontier Science Program; Regional Innovation Cluster Program; Grants-in-Aid for Scientific Research [26282217, 15K14330, 15K14308, 26640002] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program(Human Frontier Science Program); Regional Innovation Cluster Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 21800091, 24700403, 25116528 and 26115530 to M.S., MEXT/JSPS KAKENHI Grant 22110006 and a Human Frontier Science Program grant to Y.H. and the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) to J.N., M.O. and K.G.-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kanemaru K, 2014, CELL REP, V8, P311, DOI 10.1016/j.celrep.2014.05.056; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Murray SA, 2012, MAMM GENOME, V23, P587, DOI 10.1007/s00335-012-9430-2; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Schonig K, 2013, TRANSGENIC RES, V22, P251, DOI 10.1007/s11248-012-9660-9; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	27	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125354	10.1371/journal.pone.0125354	http://dx.doi.org/10.1371/journal.pone.0125354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946002	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700062
J	Yimer, YT; Yalew, AW				Yimer, Yesunesh Teshome; Yalew, Alemayehu Worku			Magnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, Ethiopia	PLOS ONE			English	Article							CRITERIA; INCOME	Background The public health approach to antiretroviral treatment management encourages the public private partnership in resource limited countries like Ethiopia. As a result, some private health facilities are accredited to provide antiretroviral treatment free services. Evidence on magnitude and predictors of treatment failure are crucial for timely actions. However, there are few studies in this regard. Objective To assess the magnitude and predictors of ART failure in private health facilities in Addis Ababa, Ethiopia. Methods The study followed retrospective cohort design, with 525 adult antiretroviral treatment clients who started the treatment since October 2009 and have at least six months follow up until December 31, 2013. Kaplan Meier survival analysis and Cox proportional hazard model were used for analysis. Results Treatment failure, using the three WHO antiretroviral treatment failure criteria, was 19.8%. The immunologic, clinical, and virologic failures were 15%, 6.3% and 1.3% respectively. The mean and median survival times in months were 41.17 with 95% Confidence Interval (CI) [39.69, 42.64] and 49.00, 95% CI [47.71, 50.29] respectively. The multivariate cox regression analysis showed years since HIV diagnosis (Adjusted Hazard Ratio (AHR)=13.87 with 95% CI [6.65, 28.92]), disclosure (AHR=0.59, 95% CI [0.36, 0.96]), WHO stage at start (AHR=1.84, 95% CI [1.16, 2.93]), weight at baseline (AHR=0.58, 95% CI [0.38, 0.89]), and functionality status at last visit (AHR=2.57, 95% CI [1.59, 4.15]) were independent predictors of treatment failure. Conclusion The study showed that the treatment failure is high among the study subjects. The predictors for antiretroviral treatment failure were years since HIV diagnosis, weight at start, WHO stage at start, status at last visit and disclosure. Recommendations Facilities need to monitor antiretroviral treatment clients to avoid disease progression and drug resistance.	[Yimer, Yesunesh Teshome] Clinton Hlth Access Initiat, Addis Ababa, Ethiopia; [Yalew, Alemayehu Worku] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Yimer, YT (corresponding author), Clinton Hlth Access Initiat, Addis Ababa, Ethiopia.	yesunesh.teshome@yahoo.com						Abdulwadud O, 2011, ETHIOP J HEALTH DEV, V25, P110; AIDSlnfo, 2011, GUIDELINES USE ANTIR; Anteneh T, 2010, THESIS ADDIS CONTINE; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; Boyd MA, 2010, CURR OPIN HIV AIDS, V5, P83, DOI 10.1097/COH.0b013e328333b8c0; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Chaiwarith R, 2007, INT J INFECT DIS, V11, P413, DOI 10.1016/j.ijid.2006.11.003; Deepak KK, 2007, COSTS SUCCESSFUL PUB; Ejaz I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-122; Elliott JH, 2008, AIDS, V22, P2053, DOI 10.1097/QAD.0b013e328309520d; Federal HIV/AIDS Prevention and Control Office | Federal Ministry of Health, 2010, STRAT PLAN 2 INT MUL; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Giulia C, 2011, BMC HLTH SERVICES RE; Health and Nutrition Research Institute Federal Ministry of Health, 2012, FED MIN HLTH HIV REL; Holly ER, 2013, CLIN INFECT DIS, V53, P1283; Hosseinipour M, 4 IAS C HIV PATH TRE; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Kassa D, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-18; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Konings E, 2012, B WORLD HEALTH ORGAN, V90, P659, DOI 10.2471/BLT.11.089599; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Ministry of Health, 2005, GUID IMPL ANT THER E; Misganaw A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1007; Misgena DK, 2011, ETHIOP J HEALTH DEV, V25, P61; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Rao P, 2011, JAIDS-J ACQ IMM DEF, V57, pS116, DOI 10.1097/QAI.0b013e31821ed719; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Selamawit E, 2009, THESIS ADDIS ABABA U; UNAIDS, 2012, COUNTR PROGR REP HIV; World Health Organization, REC ANT THER HIV INF, DOI [10.1128/JCM.00593-14, DOI 10.1128/JCM.00593-14]; World Health Organization, REC ANT THER HIV INF	34	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126026	10.1371/journal.pone.0126026	http://dx.doi.org/10.1371/journal.pone.0126026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946065	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700101
J	Marcan, M; Kos, B; Miklavcic, D				Marcan, Marija; Kos, Bor; Miklavcic, Damijan			Effect of Blood Vessel Segmentation on the Outcome of Electroporation-Based Treatments of Liver Tumors	PLOS ONE			English	Article							ELECTRIC-FIELD DISTRIBUTION; IRREVERSIBLE ELECTROPORATION; ELECTROCHEMOTHERAPY; CONDUCTIVITY; ABLATION; TISSUES; CELLS; MODEL	Electroporation-based treatments rely on increasing the permeability of the cell membrane by high voltage electric pulses applied to tissue via electrodes. To ensure that the whole tumor is covered with sufficiently high electric field, accurate numerical models are built based on individual patient anatomy. Extraction of patient's anatomy through segmentation of medical images inevitably produces some errors. In order to ensure the robustness of treatment planning, it is necessary to evaluate the potential effect of such errors on the electric field distribution. In this work we focus on determining the effect of errors in automatic segmentation of hepatic vessels on the electric field distribution in electroporation-based treatments in the liver. First, a numerical analysis was performed on a simple 'sphere and cylinder' model for tumors and vessels of different sizes and relative positions. Second, an analysis of two models extracted from medical images of real patients in which we introduced variations of an error of the automatic vessel segmentation method was performed. The results obtained from a simple model indicate that ignoring the vessels when calculating the electric field distribution can cause insufficient coverage of the tumor with electric fields. Results of this study indicate that this effect happens for small (10 mm) and medium-sized (30 mm) tumors, especially in the absence of a central electrode inserted in the tumor. The results obtained from the real-case models also show higher negative impact of automatic vessel segmentation errors on the electric field distribution when the central electrode is absent. However, the average error of the automatic vessel segmentation did not have an impact on the electric field distribution if the central electrode was present. This suggests the algorithm is robust enough to be used in creating a model for treatment parameter optimization, but with a central electrode.	[Marcan, Marija; Kos, Bor; Miklavcic, Damijan] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia	University of Ljubljana	Miklavcic, D (corresponding author), Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia.	damijan.miklavcic@fe.uni-lj.si	Miklavčič, Damijan/A-9497-2008	Miklavčič, Damijan/0000-0003-3506-9449; Kos, Bor/0000-0001-6219-7046	Slovenian Research Agency (ARRS)	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (ARRS). Research was conducted in the scope of the Electroporation in Biology and Medicine (EBAM) European Associated Laboratory (LEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corovic S, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-16; Cukjati D, 2007, BIOELECTROCHEMISTRY, V70, P501, DOI 10.1016/j.bioelechem.2006.11.001; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Edhemovic I, 2014, J SURG ONCOL, V110, P320, DOI 10.1002/jso.23625; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Garcia PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103083; Golberg A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-13; Golberg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08485; Golberg A, 2013, IEEE T BIO-MED ENG, V60, P707, DOI 10.1109/TBME.2013.2238672; Haemmerich D, 2009, PHYSIOL MEAS, V30, P459, DOI 10.1088/0967-3334/30/5/003; Kos B, 2010, J MEMBRANE BIOL, V236, P147, DOI 10.1007/s00232-010-9274-1; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; Mali B, 2013, RADIOL ONCOL, V47, P32, DOI 10.2478/raon-2013-0002; Marcan M, 2014, RADIOL ONCOL, V48, P267, DOI 10.2478/raon-2014-0022; Marieb EN, 2007, HUMAN ANATOMY PHYSL; Martin RCG, 2013, ANN SURG ONCOL, V20, pS443, DOI 10.1245/s10434-012-2736-1; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Miklavcic D, 2006, EJC SUPPL, V4, P45, DOI 10.1016/j.ejcsup.2006.08.006; Miklavcic D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-29; Miklavcic D, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-10; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Pavliha D, 2013, J MEMBRANE BIOL, V246, P833, DOI 10.1007/s00232-013-9567-2; Pavliha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069068; Pavliha D, 2012, BIOELECTROCHEMISTRY, V87, P265, DOI 10.1016/j.bioelechem.2012.01.007; Pavlin M, 2005, BIOPHYS J, V88, P4378, DOI 10.1529/biophysj.104.048975; Pavlin M, 2003, BIOPHYS J, V85, P719, DOI 10.1016/S0006-3495(03)74515-9; Pluim JPW, FREQUENCY DEPENDENT; Pucihar G, 2011, IEEE T BIO-MED ENG, V58, P3279, DOI 10.1109/TBME.2011.2167232; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Sel D, 2005, IEEE T BIO-MED ENG, V52, P816, DOI 10.1109/TBME.2005.845212; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zupanic A, 2012, PHYS MED BIOL, V57, P5425, DOI 10.1088/0031-9155/57/17/5425	35	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125591	10.1371/journal.pone.0125591	http://dx.doi.org/10.1371/journal.pone.0125591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25941806	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943400046
J	Prideaux, M; Dallas, SL; Zhao, N; Johnsrud, ED; Veno, PA; Guo, DY; Mishina, YJ; Harris, SE; Bonewald, LF				Prideaux, Matthew; Dallas, Sarah L.; Zhao, Ning; Johnsrud, Erica D.; Veno, Patricia A.; Guo, Dayong; Mishina, Yuji; Harris, Stephen E.; Bonewald, Lynda F.			Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms	PLOS ONE			English	Article							OSTEOCLAST FORMATION; EXPRESSION; PROTEIN; SCLEROSTIN; PTH; MIGRATION; OSTEOBLASTS; CULTURE; MLO-A5; MATRIX	Parathyroid Hormone (PTH) can exert both anabolic and catabolic effects on the skeleton, potentially through expression of the PTH type1 receptor (PTH1R), which is highly expressed in osteocytes. To determine the cellular and molecular mechanisms responsible, we examined the effects of PTH on osteoblast to osteocyte differentiation using primary osteocytes and the IDG-SW3 murine cell line, which differentiate from osteoblast to osteocyte-like cells in vitro and express GFP under control of the dentin matrix 1 (Dmp1) promoter. PTH treatment resulted in an increase in some osteoblast and early osteocyte markers and a decrease in mature osteocyte marker expression. The gene expression profile of PTH-treated Day 28 IDG-SW3 cells was similar to PTH treated primary osteocytes. PTH treatment induced striking changes in the morphology of the Dmp1-GFP positive cells in IDG-SW3 cultures and primary cells from Dmp1-GFP transgenic mice. The cells changed from a more dendritic to an elongated morphology and showed increased cell motility. E11/gp38 has been shown to be important for cell migration, however, deletion of the E11/gp38/ podoplanin gene had no effect on PTH-induced motility. The effects of PTH on motility were reproduced using cAMP, but not with protein kinase A (PKA), exchange proteins activated by cAMP (Epac), protein kinase C (PKC) or phosphatidylinositol-4,5-bisphosphonate 3-kinase (Pi3K) agonists nor were they blocked by their antagonists. However, the effects of PTH were mediated through calcium signaling, specifically through L-type channels normally expressed in osteoblasts but decreased in osteocytes. PTH was shown to increase expression of this channel, but decrease the T-type channel that is normally more highly expressed in osteocytes. Inhibition of L-type calcium channel activity attenuated the effects of PTH on cell morphology and motility but did not prevent the downregulation of mature osteocyte marker expression. Taken together, these results show that PTH induces loss of the mature osteocyte phenotype and promotes the motility of these cells. These two effects are mediated through different mechanisms. The loss of phenotype effect is independent and the cell motility effect is dependent on calcium signaling.	[Prideaux, Matthew; Dallas, Sarah L.; Zhao, Ning; Johnsrud, Erica D.; Veno, Patricia A.; Guo, Dayong; Bonewald, Lynda F.] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 65211 USA; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Peridont & Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Missouri System; University of Missouri Kansas City; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio	Bonewald, LF (corresponding author), Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 65211 USA.	bonewaldl@umkc.edu	Bonewald, Lynda/Q-3638-2019		National Institutes of Health NIA [PO1AG039355]; NIAMS [PO1AR046798];  [R01 AR051517];  [R21 AR054449]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051517, P01AR046798, R21AR054449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG039355] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the National Institutes of Health NIA PO1AG039355 (LFB, SLD) and NIAMS. R01 AR051517 (SLD), R21 AR054449 (SLD) and NIAMS PO1AR046798 (LFB, SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Alos N, 2005, BONE, V37, P589, DOI 10.1016/j.bone.2005.05.006; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Barber Mark A, 2006, Bull Cancer, V93, pE44; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; BELANGER LF, 1969, CALC TISS RES, V4, P1, DOI 10.1007/BF02279101; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bellido T, 2013, BONE, V54, P250, DOI 10.1016/j.bone.2012.09.016; Berdiaki A, 2010, IUBMB LIFE, V62, P377, DOI 10.1002/iub.320; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Dallas SL, 2009, CELLS TISSUES ORGANS, V189, P6, DOI 10.1159/000151745; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; Datsis GA, 2011, FEBS J, V278, P3782, DOI 10.1111/j.1742-4658.2011.08300.x; EGAN JJ, 1991, J CELL BIOCHEM, V45, P101, DOI 10.1002/jcb.240450117; FERMOR B, 1995, J BONE MINER RES, V10, P1935; Hong SH, 2011, VET COMP ONCOL, V9, P207, DOI 10.1111/j.1476-5829.2010.00249.x; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Ito N., 2012, J STEROID BIOCH MOL; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kennedy OD, 2012, J AM ACAD ORTHOP SUR, V20, P670, DOI 10.5435/JAAOS-20-10-670; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; Krempien B, 1978, Adv Exp Med Biol, V103, P437; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2010, J BONE MINER RES, V25, P2371, DOI 10.1002/jbmr.182; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Mak IWY, 2013, BONE, V55, P198, DOI 10.1016/j.bone.2013.02.020; MATTHEWS JL, 1981, CLIN ORTHOP RELAT R, P27; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Papanicolaou SE, 2009, BIORHEOLOGY, V46, P389, DOI 10.3233/BIR-2009-0550; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rosser J, 2012, METHODS MOL BIOL, V816, P67, DOI 10.1007/978-1-61779-415-5_6; Saraiva L, 2004, EUR J PHARMACOL, V491, P101, DOI 10.1016/j.ejphar.2004.03.035; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; Shen XL, 2004, EXP CELL RES, V294, P420, DOI 10.1016/j.yexcr.2003.11.028; St John HC, 2015, BONE, V72, P81, DOI 10.1016/j.bone.2014.11.010; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Tazawa K, 2004, J BONE MINER METAB, V22, P524, DOI 10.1007/s00774-004-0519-x; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Torreggiani E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075204; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; VANDERPLAS A, 1994, J BONE MINER RES, V9, P1697; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Wysolmerski JJ, 2013, BONE, V54, P230, DOI 10.1016/j.bone.2013.01.025; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050099	68	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125731	10.1371/journal.pone.0125731	http://dx.doi.org/10.1371/journal.pone.0125731			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942444	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400051
J	Barongo, MB; Stahl, K; Bett, B; Bishop, RP; Fevre, EM; Aliro, T; Okoth, E; Masembe, C; Knobel, D; Ssematimba, A				Barongo, Mike B.; Stahl, Karl; Bett, Bernard; Bishop, Richard P.; Fevre, Eric M.; Aliro, Tony; Okoth, Edward; Masembe, Charles; Knobel, Darryn; Ssematimba, Amos			Estimating the Basic Reproductive Number (R-0) for African Swine Fever Virus (ASFV) Transmission between Pig Herds in Uganda	PLOS ONE			English	Article							INFECTIOUS-DISEASES; INFLUENZA; EPIDEMIC; AUSTRALIA; OUTBREAKS	African swine fever (ASF) is a highly contagious, lethal and economically devastating haemorrhagic disease of domestic pigs. Insights into the dynamics and scale of virus transmission can be obtained from estimates of the basic reproduction number (R-0). We estimate R-0 for ASF virus in small holder, free-range pig production system in Gulu, Uganda. The estimation was based on data collected from outbreaks that affected 43 villages (out of the 289 villages with an overall pig population of 26,570) between April 2010 and November 2011. A total of 211 outbreaks met the criteria for inclusion in the study. Three methods were used, specifically; (i) GIS-based identification of the nearest infectious neighbour based on the Euclidean distance between outbreaks, (ii) epidemic doubling time, and (iii) a compartmental susceptible-infectious (SI) model. For implementation of the SI model, three approaches were used namely; curve fitting (CF), a linear regression model (LRM) and the SI/N proportion. The R-0 estimates from the nearest infectious neighbour and epidemic doubling time methods were 3.24 and 1.63 respectively. Estimates from the SI-based method were 1.58 for the CF approach, 1.90 for the LRM, and 1.77 for the SI/N proportion. Since all these values were above one, they predict the observed persistence of the virus in the population. We hypothesize that the observed variation in the estimates is a consequence of the data used. Higher resolution and temporally better defined data would likely reduce this variation. This is the first estimate of R-0 for ASFV in a free range smallholder pig keeping system in sub-Saharan Africa and highlights the requirement for more efficient application of available disease control measures.	[Barongo, Mike B.] Makerere Univ, ICT Div, Dept Acad Registrar, Kampala, Uganda; [Barongo, Mike B.; Bett, Bernard; Bishop, Richard P.; Fevre, Eric M.; Okoth, Edward; Ssematimba, Amos] Int Livestock Res Inst, Nairobi, Kenya; [Stahl, Karl] Natl Vet Inst, Dept Dis Control & Epidemiol, S-75007 Uppsala, Sweden; [Aliro, Tony] Minist Agr Anim Ind & Fisheries, Entebbe, Uganda; [Masembe, Charles] Makerere Univ, Dept Biol Sci, Coll Nat & Appl Sci, Kampala, Uganda; [Knobel, Darryn] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Ssematimba, Amos] Gulu Univ, Fac Sci, Dept Math, Gulu, Uganda	Makerere University; CGIAR; International Livestock Research Institute (ILRI); National Veterinary Institute SVA; Makerere University; University of Pretoria	Barongo, MB (corresponding author), Makerere Univ, ICT Div, Dept Acad Registrar, Kampala, Uganda.	mbarongo@acadreg.mak.ac.ug	Ssematimba, Amos/S-3217-2019; Knobel, Darryn/O-7057-2014	Ssematimba, Amos/0000-0002-5407-2478; Masembe, Charles/0000-0002-9581-0414; Knobel, Darryn/0000-0002-0425-3799; Fevre, Eric/0000-0001-8931-4986	Commonwealth Scientific and Industrial Research Organisation (CSIRO); Consortium of International Agricultural Research Centers (CGIAR) Research Program for Agriculture for Nutrition and Health; Wellcome Trust [085308]; Swedish research council FORMAS [221-2009-1984]; CISA-INIA Grant [TF069018]; Australian Agency for International Development (AusAID) Africa; Australia Food Security Initiative	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Consortium of International Agricultural Research Centers (CGIAR) Research Program for Agriculture for Nutrition and Health(CGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); CISA-INIA Grant; Australian Agency for International Development (AusAID) Africa(CGIAR); Australia Food Security Initiative	This study was funded by support from the following institutions: 1. The Commonwealth Scientific and Industrial Research Organisation (CSIRO)-Australian Agency for International Development (AusAID) Africa-Australia Food Security Initiative (MBB, EAO, RPB); 2. Consortium of International Agricultural Research Centers (CGIAR) Research Program for Agriculture for Nutrition and Health, led by IFPRI (BB, AS); 3. Wellcome Trust (grant 085308) (EMF); 4. the Swedish research council FORMAS (Grant No. 221-2009-1984) (KS, CM, TA); and 5. CISA-INIA Grant no. TF069018 (MBB, RPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliro T, 2012, EPIZONE 6 ANN M VIR; Anderson RM, 1991, INFECT DIS HUMANS DY; Bett B, 2014, TRANSBOUND EMERG DIS, V61, P60, DOI 10.1111/tbed.12003; Brooks-Pollock E, 2015, EPIDEMICS-NETH, V10, P1, DOI 10.1016/j.epidem.2014.08.005; Chiew M, 2014, B WORLD HEALTH ORGAN, V92, P171, DOI 10.2471/BLT.13.125724; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; de Koeijer A, 2004, J MATH BIOL, V48, P1, DOI 10.1007/s00285-003-0206-x; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dixon L.K., 2000, VIRUS TAXONOMY; Eble PL, 2008, PREV VET MED, V83, P98, DOI 10.1016/j.prevetmed.2007.06.004; FAO, 2013, EMPRES WATCH AFR SWI, V28; FAO, 2011, VAL CHAIN APPR AN DI; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; Ferreira HCD, 2013, VET MICROBIOL, V165, P296, DOI 10.1016/j.vetmic.2013.03.026; Ferreira HCDC, 2012, VET MICROBIOL, V160, P327, DOI 10.1016/j.vetmic.2012.06.025; Food and Agriculture Organization, 2008, EMPRES WATCH AFR SWI; Gallardo C, 2011, AFR J BIOTECHNOL, V10, P3488; Gulenkin VM, 2011, PREV VET MED, V102, P167, DOI 10.1016/j.prevetmed.2011.07.004; Hage JJ, 1996, VET MICROBIOL, V53, P169, DOI 10.1016/S0378-1135(96)01245-X; Iglesias I., 2015, TRANSBOUND EMERG DIS; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; MAAIF and UBOS, 2009, NAT LIV CENS REP 200; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; Muwonge A, 2012, TROP ANIM HEALTH PRO, V44, P1593, DOI 10.1007/s11250-012-0112-6; Nantima N, 2015, TROP ANIM HEALTH PRO, V47, P589, DOI 10.1007/s11250-015-0768-9; OIE, 2010, AFR SWIN FEV 1 4; Penrith M.L., 2005, INFECT DIS LIVESTOCK, P1087, DOI [10.4102/jsava.v76i4.435, DOI 10.4102/JSAVA.V76I4.435]; Penrith ML, 2013, VIRUS RES, V173, P228, DOI 10.1016/j.virusres.2012.10.011; Penrith ML, 2009, ONDERSTEPOORT J VET, V76, P91; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Stegeman A, 1999, PREV VET MED, V42, P219, DOI 10.1016/S0167-5877(99)00077-X; Tejler E., 2012, OUTBREAKS AFRICAN SW; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; Veness C, 2007, CALCULATE DISTANCE B; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Ward MP, 2009, EPIDEMIOL INFECT, V137, P219, DOI 10.1017/S0950268808000885; Wearing J, 2005, PLOS MED, V2; Zsak L, 2005, J CLIN MICROBIOL, V43, P112, DOI 10.1128/JCM.43.1.112-119.2005	43	31	32	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125842	10.1371/journal.pone.0125842	http://dx.doi.org/10.1371/journal.pone.0125842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938429	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000105
J	Gao, H; Guddeti, RR; Matsuzawa, Y; Liu, LP; Su, LX; Guo, D; Nie, SP; Du, J; Zhang, M				Gao, Hai; Guddeti, Raviteja Reddy; Matsuzawa, Yasushi; Liu, Li-Ping; Su, Li-Xiao; Guo, Duo; Nie, Shao-Ping; Du, Jie; Zhang, Ming			Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; BIOMARKERS; QUANTIFICATION; BIOLOGY; CANCER	Background and Objective MicroRNAs (miRNAs) have been shown to be associated with various physiological and pathological conditions, including inflammation and cardiovascular disease, but little is known about their relationship with the presence of coronary artery disease (CAD) and disease severity. Methods A total of 195 consecutive subjects who underwent coronary angiography for chest pain evaluation were enrolled in this study. In CAD patients severity of coronary lesions was assessed by the number of diseased vessels and the Synergy between PCI with Taxus and Cardiac surgery score (SYNTAX score). Plasma levels of miRNA-145 were quantified by real-time quantitative polymerase chain reaction test, and logarithmic transformation of miRNA-145 levels (Ln_miRNA-145) was used for analyses due to its skewed distribution. Results Of the 195 total subjects 167 patients were diagnosed as having CAD. Ln_miRNA-145 was significantly lower in CAD patients compared with the non-CAD group (-6.11 +/- 0.92 vs. -5.06 +/- 1.25; p < 0.001). In multivariable linear regression analyses CAD was significantly associated with lower Ln_miRNA-145 (Estimate, -0.50; standard error (SE), 0.11; p < 0.0001). Furthermore, among CAD patients, three-vessel disease, higher SYNTAX scores and STEMI were significantly associated with lower Ln_miRNA-145 ([Estimate, -0.40; SE, 0.07; p < 0.0001]; [Estimate, -0.02, SE, 0.10; p = 0.005] and [Estimate, -0.35, SE, 0.10; p < 0.001] respectively). Conclusions Lower plasma levels of miRNA-145 were significantly associated with the presence as well as severity of CAD. As a potential biomarker for CAD, plasma miRNA-145 may be useful in predicting CAD and its severity in patients presenting with chest pain.	[Gao, Hai; Nie, Shao-Ping; Du, Jie; Zhang, Ming] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Guddeti, Raviteja Reddy; Matsuzawa, Yasushi] Mayo Coll Med, Div Cardiovasc Dis, Rochester, MN USA; [Gao, Hai; Nie, Shao-Ping; Du, Jie; Zhang, Ming] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Liu, Li-Ping] Tsinghua Univ, Dept Nephrol, Hosp 1, Beijing 100084, Peoples R China; [Su, Li-Xiao] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Newark, NJ 07102 USA; [Guo, Duo] Capital Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Beijing, Peoples R China	Capital Medical University; Mayo Clinic; Tsinghua University; Rutgers State University Newark; Rutgers State University New Brunswick; Capital Medical University	Zhang, M (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China.	zhangming2279@hotmail.com	liu, li/HGC-0900-2022; Nie, S/K-1124-2019		Beijing Novel Star Project on Science and Technology of China [2009B38]; Basic and Clinical Research Cooperation Fund of Capital Medical University [2014A18]	Beijing Novel Star Project on Science and Technology of China; Basic and Clinical Research Cooperation Fund of Capital Medical University	This work was supported by Beijing Novel Star Project on Science and Technology of China, No. 2009B38 and The Basic and Clinical Research Cooperation Fund of Capital Medical University, No. 2014A18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; FISHER L, 1983, CIRCULATION, V68, P939, DOI 10.1161/01.CIR.68.5.939; FISHER LD, 1981, CIRCULATION, V63, P987, DOI 10.1161/01.CIR.63.5.987; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Head SJ, 2014, HEART, V100, P169, DOI 10.1136/heartjnl-2012-302482; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; Ishida M, 2001, ATHEROSCLEROSIS, V154, P345, DOI 10.1016/S0021-9150(00)00498-6; Johnson Jason Lee, 2007, Expert Rev Cardiovasc Ther, V5, P265, DOI 10.1586/14779072.5.2.265; Kaudewitz D, 2013, THROMB HAEMOSTASIS, V110, P609, DOI 10.1160/TH13-05-0368; Li CW, 2012, CLIN BIOCHEM, V45, P727, DOI 10.1016/j.clinbiochem.2012.04.013; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lovren F, 2012, CIRCULATION, V126, pS81, DOI 10.1161/CIRCULATIONAHA.111.084186; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pleister A, 2013, BIOMARK MED, V7, P287, DOI [10.2217/bmm.13.8, 10.2217/BMM.13.8]; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Schober A, 2012, THROMB HAEMOSTASIS, V107, P603, DOI 10.1160/TH12-02-0122; Schroen B, 2012, CARDIOVASC RES, V93, P605, DOI 10.1093/cvr/cvr268; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang CX, 2009, CELL CYCLE, V8, P3469, DOI 10.4161/cc.8.21.9837	33	47	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123477	10.1371/journal.pone.0123477	http://dx.doi.org/10.1371/journal.pone.0123477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938589	Green Submitted, gold, Green Published			2022-12-26	WOS:000353943000010
J	Sathanoori, R; Sward, K; Olde, B; Erlinge, D				Sathanoori, Ramasri; Sward, Karl; Olde, Bjorn; Erlinge, David			The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells	PLOS ONE			English	Article							P38 MAPK PATHWAY; P2X(7) RECEPTOR; FATTY-ACIDS; ADHESION MOLECULES; OXIDATIVE STRESS; UP-REGULATION; EXPRESSION; ACTIVATION; RELEASE; DYSFUNCTION	Endothelial cells lining the blood vessels are principal players in vascular inflammatory responses. Dysregulation of endothelial cell function caused by hyperglycemia, dyslipidemia, and hyperinsulinemia often result in impaired vasoregulation, oxidative stress, inflammation, and altered barrier function. Various stressors including high glucose stimulate the release of nucleotides thus initiating signaling via purinergic receptors. However, purinergic modulation of inflammatory responses in endothelial cells caused by high glucose and palmitate remains unclear. In the present study, we investigated whether the effect of high glucose and palmitate is mediated by P2X7 and P2X4 and if they play a role in endothelial cell dysfunction. Transcript and protein levels of inflammatory genes as well as reactive oxygen species production, endothelial-leukocyte adhesion, and cell permeability were investigated in human umbilical vein endothelial cells exposed to high glucose and palmitate. We report high glucose and palmitate to increase levels of extracellular ATP, expression of P2X7 and P2X4, and inflammatory markers. Both P2X7 and P2X4 antagonists inhibited high glucose and palmitate-induced interleukin-6 levels with the former having a significant effect on interleukin-8 and cyclooxygenase-2. The effect of the antagonists was confirmed with siRNA knockdown of the receptors. In addition, P2X7 mediated both high glucose and palmitate-induced increase in reactive oxygen species levels and decrease in endothelial nitric oxide synthase. Blocking P2X7 inhibited high glucose and palmitate-induced expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 as well as leukocyte-endothelial cell adhesion. Interestingly, high glucose and palmitate enhanced endothelial cell permeability that was dependent on both P2X7 and P2X4. Furthermore, antagonizing the P2X7 inhibited high glucose and palmitate-mediated activation of p38-mitogen activated protein kinase. These findings support a novel role for P2X7 and P2X4 coupled to induction of inflammatory molecules in modulating high glucose and palmitate-induced endothelial cell activation and dysfunction.	[Sathanoori, Ramasri; Olde, Bjorn; Erlinge, David] Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden; [Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University	Sathanoori, R (corresponding author), Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden.	Ramasri.Sathanoori@med.lu.se		Sward, Karl/0000-0002-7255-5510	Swedish Heart and Lung Foundation; Swedish Scientific Research Council; ALF; Skane University Hospital funds	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Scientific Research Council(Swedish Research Council); ALF; Skane University Hospital funds	The Swedish Heart and Lung Foundation, Swedish Scientific Research Council, ALF, and Skane University Hospital funds supported this work.	Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; Blasi C, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/346501; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boden G, 2011, OBESITY, V19, P1366, DOI 10.1038/oby.2011.71; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bodin P, 1998, INFLAMM RES, V47, P351, DOI 10.1007/s000110050341; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Chai WD, 2007, ENDOCRINOLOGY, V148, P1622, DOI 10.1210/en.2006-1068; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Chiao CW, 2013, CLIN SCI, V125, P131, DOI 10.1042/CS20120479; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Erdogdu O, 2013, J MOL ENDOCRINOL, V50, P229, DOI 10.1530/JME-12-0166; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008; Gao Z, 2014, BIOCHEM PHARMACOL, V91, P474, DOI 10.1016/j.bcp.2014.08.009; Garcia-Hernandez MH, 2011, CELL IMMUNOL, V269, P135, DOI 10.1016/j.cellimm.2011.03.022; Gidlof O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037491; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Glass R, 2002, CELL MOL LIFE SCI, V59, P870, DOI 10.1007/s00018-002-8474-y; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hernandez-Olmos V, 2012, J MED CHEM, V55, P9576, DOI 10.1021/jm300845v; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Hung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070210; Kado S, 1999, ACTA DIABETOL, V36, P67, DOI 10.1007/s005920050147; Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892; Kawano A, 2012, BIOCHEM BIOPH RES CO, V419, P374, DOI 10.1016/j.bbrc.2012.01.156; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim SW, 2011, BIOCHEM BIOPH RES CO, V415, P602, DOI 10.1016/j.bbrc.2011.10.115; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Krogmann A, 2011, MICROVASC RES, V81, P52, DOI 10.1016/j.mvr.2010.11.008; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; Miyoshi T, 2010, IMMUNOLOGY, V131, P331, DOI 10.1111/j.1365-2567.2010.03303.x; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Parodi J, 2002, CIRC RES, V90, P570, DOI 10.1161/01.RES.0000012582.11979.8B; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Robinson LE, 2014, J BIOL CHEM, V289, P31983, DOI 10.1074/jbc.M114.574699; Sakowicz-Burkiewicz M, 2013, IMMUNOBIOLOGY, V218, P591, DOI 10.1016/j.imbio.2012.07.010; Sathanoori R, 2015, PURINERG SIGNAL, V11, P139, DOI 10.1007/s11302-014-9442-3; Seye Cheikh I, 2006, Purinergic Signal, V2, P471, DOI 10.1007/s11302-006-9015-1; Shiraki A, 2012, ATHEROSCLEROSIS, V221, P375, DOI 10.1016/j.atherosclerosis.2011.12.039; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Solini A, 2004, ARTERIOSCL THROM VAS, V24, P1240, DOI 10.1161/01.ATV.0000133193.11078.c0; Solini A, 2013, J PATHOL, V231, P342, DOI 10.1002/path.4237; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Sugiyama T, 2004, INVEST OPHTH VIS SCI, V45, P1026, DOI 10.1167/iovs.03-1062; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Tang Y, 2008, J PHARMACOL SCI, V107, P419, DOI 10.1254/jphs.08073FP; Toulme E, 2012, J BIOL CHEM, V287, P14734, DOI 10.1074/jbc.M111.329334; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Troseid M, 2009, DIABETES CARE, V32, P486, DOI 10.2337/dc08-1710; Trueblood KE, 2011, AM J PHYSIOL-CELL PH, V301, pC1213, DOI 10.1152/ajpcell.00265.2011; Trang T, 2012, EXP NEUROL, V234, P354, DOI 10.1016/j.expneurol.2011.11.012; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wende AR, 2012, CURR HYPERTENS REP, V14, P517, DOI 10.1007/s11906-012-0307-2; Wesselius A, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-64; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213; Witting PK, 2007, CELL PHYSIOL BIOCHEM, V20, P255, DOI 10.1159/000107512; Xu H, 2013, BRAIN RES BULL, V94, P63, DOI 10.1016/j.brainresbull.2013.02.002; Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1; Zhu MM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-13	79	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125111	10.1371/journal.pone.0125111	http://dx.doi.org/10.1371/journal.pone.0125111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938443	gold, Green Published, Green Submitted			2022-12-26	WOS:000353943000045
J	Yang, N; Yao, Z; Miao, L; Liu, J; Gao, X; Fan, H; Hu, YJ; Zhang, H; Xu, Y; Qu, AJ; Wang, G				Yang, Ning; Yao, Zhi; Miao, Li; Liu, Jia; Gao, Xia; Fan, Hui; Hu, Yanjin; Zhang, Heng; Xu, Yuan; Qu, Aijuan; Wang, Guang			Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENDOPLASMIC-RETICULUM STRESS; POLYCYSTIC-OVARY-SYNDROME; PLASMA HOMOCYSTEINE; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; THYROID-DISORDERS; ADIPOSE-TISSUE; HYPERHOMOCYSTEINEMIA; ATHEROSCLEROSIS	Objective Hypothyroidism (HO) can induce significant metabolic dysfunction and increase cardiovascular disease risk. In the present study, we investigated the relationship between homocysteine (Hcy) and insulin resistance (IR) in patients with HO or subclinical hypothyroidism (SHO). Methods A total of 270 subjects were enrolled. All subjects were divided into the following three groups: HO, SHO and control. Plasma levels of Hcy were measured, and each patient's homeostatic index of insulin resistance (HOMA-IR) was calculated. Statistical analyses were carried out to evaluate the correlations among groups and to determine the predictors of IR in patients with HO or SHO. Results The HOMA-IR value was significantly higher in the HO group than in the SHO and control groups. Plasma levels of Hcy were markedly increased in the HO group compared with those of the SHO group and controls. In addition, plasma levels of Hcy were positively correlated with the HOMA-IR values in both the HO and SHO groups. Multiple linear regression models showed that plasma levels of Hcy and free thyroxine (FT4) were the only predictors of HOMA-IR in patients with HO or SHO. Conclusions Plasma levels of Hcy and HOMA-IR were increased in patients with HO or SHO. Our results suggest that HO and SHO may increase the risk for atherogenesis and cardiovascular disease by increased IR. The increased IR induced by hyperhomocysteinemia in patients with HO or SHO may partially explain this adverse effect.	[Yang, Ning; Yao, Zhi; Miao, Li; Liu, Jia; Gao, Xia; Fan, Hui; Hu, Yanjin; Zhang, Heng; Xu, Yuan; Wang, Guang] Capital Med Univ, Dept Endocrinol, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Qu, Aijuan] Capital Med Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Qu, AJ (corresponding author), Capital Med Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China.	aijuanqu@ccmu.edu.cn; drwg6688@126.com			Major National Basic Research Program of China [2011CB503904]; Beijing Natural Science Foundation [7142060]; Chinese National Natural Science Foundation [81270369, 81070244]	Major National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Our work was supported by grants from the Major National Basic Research Program of China (No. 2011CB503904), the Beijing Natural Science Foundation (No.7142060) and the Chinese National Natural Science Foundation (No. 81270369, 81070244) to Guang Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamashmoos SA, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-423; Bautista LE, 2002, J CLIN EPIDEMIOL, V55, P882, DOI 10.1016/S0895-4356(02)00434-1; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; Catena C, 2015, AM J HYPERTENS, V28, P943, DOI 10.1093/ajh/hpu248; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; Cui RZ, 2008, ATHEROSCLEROSIS, V198, P412, DOI 10.1016/j.atherosclerosis.2007.09.029; Deyneli O, 2014, ANN ENDOCRINOL-PARIS, V75, P220, DOI 10.1016/j.ando.2014.06.002; Dimitriadis G, 2006, J CLIN ENDOCR METAB, V91, P4930, DOI 10.1210/jc.2006-0478; Duntas LH, 2012, MED CLIN N AM, V96, P269, DOI 10.1016/j.mcna.2012.01.012; Edirimanne VER, 2007, CAN J PHYSIOL PHARM, V85, P1236, DOI 10.1139/Y07-112; Falk E, 2001, LIPIDS, V36, pS3, DOI 10.1007/s11745-001-0676-x; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gursu MF, 2002, ARCH MED RES, V33, P305, DOI 10.1016/S0188-4409(01)00379-4; He LY, 2010, AM J PHYSIOL-ENDOC M, V299, pE1061, DOI 10.1152/ajpendo.00367.2010; Ichiki T, 2010, VASC PHARMACOL, V52, P151, DOI 10.1016/j.vph.2009.09.004; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; Johnstone T, 2014, AUST VET J, V92, P437, DOI 10.1111/avj.12237; Jones DD, 2010, AM J MED, V123, P502, DOI 10.1016/j.amjmed.2009.12.023; Karrowni W, 2013, ARTERIOSCL THROM VAS, V33, P2245, DOI 10.1161/ATVBAHA.113.301585; Kim SR, 2002, MED HYPOTHESES, V59, P660, DOI 10.1016/S0306-9877(02)00211-6; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Liu J, 2014, J HUM HYPERTENS, V28, P743, DOI 10.1038/jhh.2014.22; Maratou E, 2009, EUR J ENDOCRINOL, V160, P785, DOI 10.1530/EJE-08-0797; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Morris MS, 2001, ATHEROSCLEROSIS, V155, P195, DOI 10.1016/S0021-9150(00)00537-2; Neves Celestino, 2008, Rev Port Cardiol, V27, P1211; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Rodondi N, 2006, AM J MED, V119, P541, DOI 10.1016/j.amjmed.2005.09.028; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Sadeghian Saeed, 2006, BMC Cardiovasc Disord, V6, P38, DOI 10.1186/1471-2261-6-38; Schachter M, 2003, HUM REPROD, V18, P721, DOI 10.1093/humrep/deg190; Setola E, 2004, EUR J ENDOCRINOL, V151, P483, DOI 10.1530/eje.0.1510483; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Wang DJ, 2012, CELL BIOL INT, V36, P511, DOI 10.1042/CBI20110235; Wang G, 2005, ATHEROSCLEROSIS, V179, P395, DOI 10.1016/j.atherosclerosis.2004.10.033; Wang G, 2004, CHINESE MED J-PEKING, V117, P1650; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Yilmaz N, 2008, J OBSTET GYNAECOL RE, V34, P384, DOI 10.1111/j.1447-0756.2007.00699.x	43	51	55	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125922	10.1371/journal.pone.0125922	http://dx.doi.org/10.1371/journal.pone.0125922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938439	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000115
J	Bawa, P; Zackaria, S; Verma, M; Gupta, S; Srivatsan, R; Chaudhary, B; Srinivasan, S				Bawa, Pushpinder; Zackaria, Sajna; Verma, Mohit; Gupta, Saurabh; Srivatsan, R.; Chaudhary, Bibha; Srinivasan, Subhashini			Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; BREAST-CANCER; TUMOR-SUPPRESSOR; HUMAN GENOME; CELLS; PROGRESSION; BIOCONDUCTOR; ENHANCER; PCAT-1; GENES	Recently, large numbers of normal human tissues have been profiled for non-coding RNAs and more than fourteen thousand long intergenic non-coding RNAs (lincRNAs) are found expressed in normal human tissues. The functional roles of these normal lincRNAs (nlincRNAs) in the regulation of protein coding genes in normal and disease biology are yet to be established. Here, we have profiled two RNA-seq datasets including cancer and matched non-neoplastic tissues from 12 individuals from diverse demography for both coding genes and nlincRNAs. We find 130 nlincRNAs significantly regulated in cancer, with 127 regulated in the same direction in the two datasets. Interestingly, according to Illumina Body Map, significant numbers of these nlincRNAs display baseline null expression in normal prostate tissues but are specific to other tissues such as thyroid, kidney, liver and testis. A number of the regulated nlincRNAs share loci with coding genes, which are either co-regulated or oppositely regulated in all cancer samples studied here. For example, in all cancer samples i) the nlincRNA, TCONS_00029157, and a neighboring tumor suppressor factor, SIK1, are both down regulated; ii) several thyroid-specific nlincRNAs in the neighborhood of the thyroid-specific gene TPO, are both up-regulated; and iii) the TCONS_00010581, an isoform of HEIH, is down-regulated while the neighboring EZH2 gene is up-regulated in cancer. Several nlincRNAs from a prostate cancer associated chromosomal locus, 8q24, are up-regulated in cancer along with other known prostate cancer associated genes including PCAT-1, PVT1, and PCAT-92. We observe that there is significant bias towards up-regulation of nlincRNAs with as high as 118 out of 127 up-regulated in cancer, even though regulation of coding genes is skewed towards down-regulation. Considering that all reported cancer associated lincRNAs (clincRNAs) are biased towards up-regulation, we conclude that this bias may be functionally relevant.	[Bawa, Pushpinder; Zackaria, Sajna; Verma, Mohit; Gupta, Saurabh; Srivatsan, R.; Chaudhary, Bibha; Srinivasan, Subhashini] IBAB, Bangalore, Karnataka, India; [Bawa, Pushpinder] Manipal Univ, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Srinivasan, S (corresponding author), IBAB, Bangalore, Karnataka, India.	ssubha@ibab.ac.in	Bawa, Pushpinder/AAH-2397-2021; Verma, Mohit/ABB-7093-2020; Bawa, Pushpinder Singh/AAV-4265-2021	Verma, Mohit/0000-0002-0438-5396; Bawa, Pushpinder Singh/0000-0002-8370-3638; Gupta, Saurabh/0000-0002-5984-852X	Department of Biotechnology, Government of India; Department of Information technology, Government of India; DST-FIST, Government of India; Department of Information Technology, Government of Karnataka	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Information technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India); DST-FIST, Government of India(Department of Science & Technology (India)); Department of Information Technology, Government of Karnataka	This study was funded by the Department of Biotechnology, Government of India; Department of Information technology, Government of India; DST-FIST, Government of India; and Department of Information Technology, Government of Karnataka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basu A, 2012, PROSTATE, V72, P597, DOI 10.1002/pros.21463; Bensen JT, 2013, PROSTATE, V73, P11, DOI 10.1002/pros.22532; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burdova A, 2014, BIOMED PAP, V158, P502, DOI 10.5507/bp.2014.065; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Cheng W, 2013, CANCER LETT, V339, P8, DOI 10.1016/j.canlet.2013.07.008; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Couch FJ, 2009, CANCER EPIDEM BIOMAR, V18, P3044, DOI 10.1158/1055-9965.EPI-09-0306; Fan C, 2013, INT J BIOL MARKER, V28, P71, DOI 10.5301/JBM.2013.10568; Ge XS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0588-6; Han Y, 2015, INT J CANCER, V136, P1210, DOI 10.1002/ijc.29066; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Perez-Stable CM, 2000, MOL CELL ENDOCRINOL, V167, P43, DOI 10.1016/S0303-7207(00)00300-2; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Shaw RJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286pe55; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Tessema M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034850; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; White NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0429-8; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	34	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122143	10.1371/journal.pone.0122143	http://dx.doi.org/10.1371/journal.pone.0122143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933431	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100007
J	Wu, YB; Span, LM; Nygren, P; Zhu, H; Moore, DT; Cheng, H; Roder, H; DeGrado, WF; Bennett, JS				Wu, Yibing; Span, Lisa M.; Nygren, Patrik; Zhu, Hua; Moore, David T.; Cheng, Hong; Roder, Heinrich; DeGrado, William F.; Bennett, Joel S.			The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin IIb3 to Initiate Outside-in Signaling in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; platelet; signal transduction; Src; Src homology 3 domain (SH3 domain)	FAMILY KINASES; STRUCTURAL BASIS; SH3 DOMAINS; ACTIVATION; MECHANISM; PHOSPHORYLATION; IDENTIFICATION; CYTOSKELETON; RECOGNITION; THROMBIN	It is currently believed that inactive tyrosine kinase c-Src in platelets binds to the cytoplasmic tail of the 3 integrin subunit via its SH3 domain. Although a recent NMR study supports this contention, it is likely that such binding would be precluded in inactive c-Src because an auto-inhibitory linker physically occludes the 3 tail binding site. Accordingly, we have re-examined c-Src binding to 3 by immunoprecipitation as well as NMR spectroscopy. In unstimulated platelets, we detected little to no interaction between c-Src and 3. Following platelet activation, however, c-Src was co-immunoprecipitated with 3 in a time-dependent manner and underwent progressive activation as well. We then measured chemical shift perturbations in the N-15-labeled SH3 domain induced by the C-terminal 3 tail peptide NITYRGT and found that the peptide interacted with the SH3 domain RT-loop and surrounding residues. A control peptide whose last three residues where replaced with those of the 1 cytoplasmic tail induced only small chemical shift perturbations on the opposite face of the SH3 domain. Next, to mimic inactive c-Src, we found that the canonical polyproline peptide RPLPPLP prevented binding of the 3 peptide to the RT- loop. Under these conditions, the 3 peptide induced chemical shift perturbations similar to the negative control. We conclude that the primary interaction of c-Src with the 3 tail occurs in its activated state and at a site that overlaps with PPII binding site in its SH3 domain. Interactions of inactive c-Src with 3 are weak and insensitive to 3 tail mutations.	[Wu, Yibing; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Span, Lisa M.; Nygren, Patrik; Zhu, Hua; Bennett, Joel S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Moore, David T.; Roder, Heinrich] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Cheng, Hong; Roder, Heinrich] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; Fox Chase Cancer Center	Bennett, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Hematol Oncol Div, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu	Regan, Clinton/E-6250-2012; Roder, Heinrich/B-3455-2009; Nygren, Patrik/B-7319-2015	Roder, Heinrich/0000-0003-1860-2491; Nygren, Patrik/0000-0002-9233-2859	National Institutes of Health [P01 HL40387, R01 GM056250, P01 CA06927, GM054616]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, R01GM054616, R01GM056250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grants P01 HL40387 (to J. S. B. and W. F. D.), R01 GM056250 (to H. R.), P01 CA06927 to the Fox Chase Cancer Center, and GM054616. The Spectroscopy Support Facility at the Fox Chase Cancer Center provided access to NMR instrumentation. The authors declare that they have no conflicts of interest with the contents of this article.	Ablooglu AJ, 2009, BLOOD, V113, P3585, DOI 10.1182/blood-2008-09-180687; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Katyal P, 2013, PROTEIN SCI, V22, P1358, DOI 10.1002/pro.2323; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Moore DT, 2012, P NATL ACAD SCI USA, V109, P793, DOI 10.1073/pnas.1117220108; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Perez Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01295; PUMIGLIA KM, 1993, BIOCHEM J, V294, P253, DOI 10.1042/bj2940253; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Satoh K, 2009, AM J PHYSIOL-GASTR L, V296, pG1382, DOI 10.1152/ajpgi.90536.2008; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Senis YA, 2014, BLOOD, V124, P2013, DOI 10.1182/blood-2014-01-453134; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Xiao R, 2013, BLOOD, V121, P700, DOI 10.1182/blood-2012-07-440644; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU H, 1993, FEBS LETT, V324, P87, DOI 10.1016/0014-5793(93)81538-B; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	34	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15825	15834		10.1074/jbc.M115.648428	http://dx.doi.org/10.1074/jbc.M115.648428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947380	hybrid, Green Published			2022-12-26	WOS:000356527400042
J	Habtemichael, EN; Alcazar-Roman, A; Rubin, BR; Grossi, LR; Belman, JP; Julca, O; Loffler, MG; Li, HJ; Chi, NW; Samuel, VT; Bogan, JS				Habtemichael, Estifanos N.; Alcazar-Roman, Abel; Rubin, Bradley R.; Grossi, Laura R.; Belman, Jonathan P.; Julca, Omar; Loeffler, Michael G.; Li, Hongjie; Chi, Nai-Wen; Samuel, Varman T.; Bogan, Jonathan S.			Coordinated Regulation of Vasopressin Inactivation and Glucose Uptake by Action of TUG Protein in Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESPONSIVE AMINOPEPTIDASE; GLUT4 STORAGE-VESICLES; SKELETAL-MUSCLE; MAMMALIAN-CELLS; GLUT4-CONTAINING VESICLES; TRANSPORTER TRANSLOCATION; 3T3-L1 ADIPOCYTES; DILEUCINE MOTIF; TRAFFICKING; COMPARTMENT	In adipose and muscle cells, insulin stimulates the exocytic translocation of vesicles containing GLUT4, a glucose transporter, and insulin-regulated aminopeptidase (IRAP), a transmembrane aminopeptidase. A substrate of IRAP is vasopressin, which controls water homeostasis. The physiological importance of IRAP translocation to inactivate vasopressin remains uncertain. We previously showed that in skeletal muscle, insulin stimulates proteolytic processing of the GLUT4 retention protein, TUG, to promote GLUT4 translocation and glucose uptake. Here we show that TUG proteolysis also controls IRAP targeting and regulates vasopressin action in vivo. Transgenic mice with constitutive TUG proteolysis in muscle consumed much more water than wild-type control mice. The transgenic mice lost more body weight during water restriction, and the abundance of renal AQP2 water channels was reduced, implying that vasopressin activity is decreased. To compensate for accelerated vasopressin degradation, vasopressin secretion was increased, as assessed by the cosecreted protein copeptin. IRAP abundance was increased in T-tubule fractions of fasting transgenic mice, when compared with controls. Recombinant IRAP bound to TUG, and this interaction was mapped to a short peptide in IRAP that was previously shown to be critical for GLUT4 intracellular retention. In cultured 3T3-L1 adipocytes, IRAP was present in TUG-bound membranes and was released by insulin stimulation. Together with previous results, these data support a model in which TUG controls vesicle translocation by interacting with IRAP as well as GLUT4. Furthermore, the effect of IRAP to reduce vasopressin activity is a physiologically important consequence of vesicle translocation, which is coordinated with the stimulation of glucose uptake.	[Habtemichael, Estifanos N.; Alcazar-Roman, Abel; Rubin, Bradley R.; Grossi, Laura R.; Belman, Jonathan P.; Julca, Omar; Loeffler, Michael G.; Li, Hongjie; Samuel, Varman T.; Bogan, Jonathan S.] Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, POB 208020, New Haven, CT 06520 USA; [Rubin, Bradley R.; Grossi, Laura R.; Belman, Jonathan P.; Julca, Omar; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Chi, Nai-Wen] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Chi, Nai-Wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Samuel, Varman T.] Vet Adm Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Bogan, JS (corresponding author), Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Regan, Clinton/E-6250-2012; Bogan, Jonathan S/A-1575-2010; Loffler, Michael/F-1748-2013	Bogan, Jonathan S/0000-0001-6463-8466; Alcazar-Roman, Abel R./0000-0003-1668-1886; Belman, Jonathan/0000-0002-1051-6938; Loffler, Michael/0000-0002-6529-9723	National Institutes of Health [P30 DK45735]; Yale Mouse Metabolic Phenotyping Center (National Institutes of Health) [U24 DK059635]; Physiology Core of the George M. O'Brien Kidney Center at Yale (National Institutes of Health) [P30 DK079310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092661, U24DK059635, P30DK079310, P30DK045735, F30DK093198, T32DK007058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG041383] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000702, I01BX000901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Mouse Metabolic Phenotyping Center (National Institutes of Health); Physiology Core of the George M. O'Brien Kidney Center at Yale (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. Vassily Ogryzko for the BirA construct and Drs. Mark Knepper, Gerald Shulman, and Charisse Orme for helpful discussions and assistance. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30 DK45735), the Yale Mouse Metabolic Phenotyping Center (National Institutes of Health Grant U24 DK059635), and the Physiology Core of the George M. O'Brien Kidney Center at Yale (National Institutes of Health Grant P30 DK079310), as well as services provided by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Bankir L, 2013, NAT REV NEPHROL, V9, P223, DOI 10.1038/nrneph.2013.22; Belman JP, 2015, J BIOL CHEM, V290, P4447, DOI 10.1074/jbc.M114.603977; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Cartee G, 2015, DIABETOLOGIA, V58, P19, DOI 10.1007/s00125-014-3395-5; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Enhorning S, 2011, J CLIN ENDOCR METAB, V96, pE1065, DOI 10.1210/jc.2010-2981; Fraser JA, 2011, J GEN PHYSIOL, V138, P95, DOI 10.1085/jgp.201110617; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gross DN, 2004, MOL CELL BIOL, V24, P7151, DOI 10.1128/MCB.24.16.7151-7162.2004; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hou JC, 2006, J BIOL CHEM, V281, P33457, DOI 10.1074/jbc.M601583200; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Katagiri H, 2002, MOL ENDOCRINOL, V16, P1049, DOI 10.1210/me.16.5.1049; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Loffler MG, 2013, J BIOL CHEM, V288, P20135, DOI 10.1074/jbc.M113.458075; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Miranda CA, 2014, AM J PHYSIOL-RENAL, V306, pF359, DOI 10.1152/ajprenal.00330.2013; Mironova E, 2015, AM J PHYSIOL-RENAL, V308, pF237, DOI 10.1152/ajprenal.00246.2014; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sun HY, 2012, J BIOL CHEM, V287, P42071, DOI 10.1074/jbc.M112.410985; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; Wagenmakers AJM, 2016, J PHYSIOL-LONDON, V594, P2207, DOI 10.1113/jphysiol.2014.284513; Wallis MG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1092, DOI 10.1152/ajpendo.00440.2007; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Watson RT, 2008, J CELL SCI, V121, P1243, DOI 10.1242/jcs.017517; Willnow TE, 2011, CURR OPIN LIPIDOL, V22, P79, DOI 10.1097/MOL.0b013e3283416f2b; Wilson JLL, 2013, CLIN EXP NEPHROL, V17, P751, DOI 10.1007/s10157-013-0789-5; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zorzano Antonio, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0324s31	63	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14454	14461		10.1074/jbc.C115.639203	http://dx.doi.org/10.1074/jbc.C115.639203			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25944897	Green Published, hybrid			2022-12-26	WOS:000355754600016
J	Bosshard, SC; Stuker, F; von Deuster, C; Schroeter, A; Rudin, M				Bosshard, Simone C.; Stuker, Florian; von Deuster, Constantin; Schroeter, Aileen; Rudin, Markus			BOLD fMRI of C-Fiber Mediated Nociceptive Processing in Mouse Brain in Response to Thermal Stimulation of the Forepaws	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; LASTING LOCAL-ANESTHESIA; CAPSAICIN-RECEPTOR; FUNCTIONAL MRI; IN-VIVO; SOMATOSENSORY STIMULATION; QUATERNARY LIDOCAINE; VANILLOID RECEPTOR; ANESTHETIZED RATS; NOXIOUS HEAT	Functional magnetic resonance imaging (fMRI) in rodents enables non-invasive studies of brain function in response to peripheral input or at rest. In this study we describe a thermal stimulation paradigm using infrared laser diodes to apply noxious heat to the forepaw of mice in order to study nociceptive processing. Stimulation at 45 and 46 degrees C led to robust BOLD signal changes in various brain structures including the somatosensory cortices and the thalamus. The BOLD signal amplitude scaled with the temperature applied but not with the area irradiated by the laser beam. To demonstrate the specificity of the paradigm for assessing nociceptive signaling we administered the quaternary lidocaine derivative QX-314 to the forepaws, which due to its positive charge cannot readily cross biological membranes. However, upon activation of TRPV1 channels following the administration of capsaicin the BOLD signal was largely abolished, indicative of a selective block of the C-fiber nociceptors due to QX-314 having entered the cells via the now open TRPV1 channels. This demonstrates that the cerebral BOLD response to thermal noxious paw stimulation is specifically mediated by C-fibers.	[Bosshard, Simone C.; Stuker, Florian; von Deuster, Constantin; Schroeter, Aileen; Rudin, Markus] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Bosshard, Simone C.; Stuker, Florian; von Deuster, Constantin; Schroeter, Aileen; Rudin, Markus] ETH, Zurich, Switzerland; [Bosshard, Simone C.; Rudin, Markus] Univ Zurich, Ctr Neurosci, Zurich, Switzerland; [Rudin, Markus] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Zurich; ETH Zurich; University of Zurich; University of Zurich	Rudin, M (corresponding author), Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.	rudin@biomed.ee.ethz.ch			Swiss National Science Foundation Grant [141202]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF))	MR received a Swiss National Science Foundation Grant (141202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Ahrens ET, 2001, NMR BIOMED, V14, P318, DOI 10.1002/nbm.709; Arendt-Nielsen L, 2003, NEUROPHYSIOL CLIN, V33, P259, DOI 10.1016/j.neucli.2003.10.005; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bosshard SC, 2012, PAIN, V153, P1450, DOI 10.1016/j.pain.2012.04.001; Bosshard SC, 2010, PAIN, V151, P655, DOI 10.1016/j.pain.2010.08.025; BRAMMER A, 1993, LAB ANIM, V27, P250, DOI 10.1258/002367793780745354; CAHALAN MD, 1979, BIOPHYS J, V27, P39, DOI 10.1016/S0006-3495(79)85201-7; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; DEADY JE, 1981, ANESTH ANALG, V60, P380; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Goloshevsky AG, 2008, BRAIN RES, V1195, P67, DOI 10.1016/j.brainres.2007.11.036; HANSEN TD, 1989, J CEREBR BLOOD F MET, V9, P323, DOI 10.1038/jcbfm.1989.50; Heindl-Erdmann C, 2010, NEUROREPORT, V21, P29, DOI 10.1097/WNR.0b013e3283324faf; Lahti KM, 1999, MAGNET RESON MED, V41, P412, DOI 10.1002/(SICI)1522-2594(199902)41:2<412::AID-MRM28>3.0.CO;2-3; Lee SY, 2005, ARCH PHARM RES, V28, P405, DOI 10.1007/BF02977669; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Lim TKY, 2007, ANESTHESIOLOGY, V107, P305, DOI 10.1097/01.anes.0000270758.77314.b4; MANNING BH, 1994, NEUROSCIENCE, V63, P289, DOI 10.1016/0306-4522(94)90023-X; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Morrow TJ, 1998, PAIN, V75, P355, DOI 10.1016/S0304-3959(98)00016-5; Mueggler T, 2003, J NEUROSCI, V23, P8231; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Nair G, 2004, MAGN RESON MED, V52, P430, DOI 10.1002/mrm.20158; Nakamura T, 2003, ANESTHESIOLOGY, V99, P1189, DOI 10.1097/00000542-200311000-00028; NARASHASHI T, 1969, Journal of Neurobiology, V1, P3, DOI 10.1002/neu.480010103; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; Ries CR, 2009, ANESTHESIOLOGY, V111, P122, DOI 10.1097/ALN.0b013e3181a9160e; Schroeter A, 2014, NEUROIMAGE, V94, P372, DOI 10.1016/j.neuroimage.2014.01.046; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Stancak A, 2003, CLIN NEUROPHYSIOL, V114, P1936, DOI 10.1016/S1388-2457(03)00201-3; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Weiss T, 2008, NEUROIMAGE, V41, P1372, DOI 10.1016/j.neuroimage.2008.03.047; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X	47	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0126513	10.1371/journal.pone.0126513	http://dx.doi.org/10.1371/journal.pone.0126513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950440	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000354214400099
J	Dooley, LM; Abdalmula, A; Washington, EA; Kaufman, C; Tudor, EM; Ghosh, P; Itescu, S; Kimpton, WG; Bailey, SR				Dooley, Laura M.; Abdalmula, Anwar; Washington, Elizabeth A.; Kaufman, Claire; Tudor, Elizabeth M.; Ghosh, Peter; Itescu, Silviu; Kimpton, Wayne G.; Bailey, Simon R.			Effect of Mesenchymal Precursor Cells on the Systemic Inflammatory Response and Endothelial Dysfunction in an Ovine Model of Collagen-Induced Arthritis	PLOS ONE			English	Article							ADJUVANT-INDUCED ARTHRITIS; MARROW MONONUCLEAR-CELLS; HIGH-DENSITY-LIPOPROTEIN; REGULATORY T-CELLS; STEM-CELLS; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR EVENTS; RAT MODEL; IN-VIVO; INTERLEUKIN-10	Background and Aim Mesenchymal precursor cells (MPC) are reported to possess immunomodulatory properties that may prove beneficial in autoimmune and other inflammatory conditions. However, their mechanism of action is poorly understood. A collagen-induced arthritis model has been previously developed which demonstrates local joint inflammation and systemic inflammatory changes. These include not only increased levels of inflammatory markers, but also vascular endothelial cell dysfunction, characterised by reduced endothelium-dependent vasodilation. This study aimed to characterise the changes in systemic inflammatory markers and endothelial function following the intravenous administration of MPC, in the ovine model. Methods Arthritis was induced in sixteen adult sheep by administration of bovine type II collagen into the hock joint following initial sensitisation. After 24h, sheep were administered either 150 million allogeneic ovine MPCs intravenously, or saline only. Fibrinogen and serum amyloid-A were measured in plasma to assess systemic inflammation, along with pro-inflammatory and anti-inflammatory cytokines. Animals were necropsied two weeks following arthritis induction. Coronary and digital arterial segments were mounted in a Mulvaney-Halpern wire myograph. The relaxant response to endothelium-dependent and endothelium-independent vasodilators was used to assess endothelial dysfunction. Results and Conclusion Arthritic sheep treated with MPC demonstrated a marked spike in plasma IL-10, 24h following MPC administration. They also showed significantly reduced plasma levels of the inflammatory markers, fibrinogen and serum amyloid A, and increased HDL. Coronary arteries from RA sheep treated with MPCs demonstrated a significantly greater maximal relaxation to bradykinin when compared to untreated RA sheep (253.6 +/- 17.1% of pre-contracted tone vs. 182.3 +/- 27.3% in controls), and digital arteries also demonstrated greater endothelium-dependent vasodilation. This study demonstrated that MPCs given intravenously are able to attenuate systemic inflammatory changes associated with a monoarthritis, including the development of endothelial dysfunction.	[Dooley, Laura M.; Abdalmula, Anwar; Washington, Elizabeth A.; Kaufman, Claire; Tudor, Elizabeth M.; Kimpton, Wayne G.; Bailey, Simon R.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Ghosh, Peter; Itescu, Silviu] Mesoblast Ltd, Melbourne, Vic, Australia	University of Melbourne	Bailey, SR (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.	bais@unimelb.edu.au	Bailey, Simon/H-7606-2019; Washington, Elizabeth A/K-5185-2015	Washington, Elizabeth A/0000-0002-2905-0912; Kimpton, Wayne/0000-0002-1518-2316; Tudor, Elizabeth/0000-0002-2100-6992; Bailey, Simon/0000-0001-9348-5497; Dooley, Laura/0000-0002-8639-4295	Mesoblast Ltd.; Australian Postgraduate Award scholarship	Mesoblast Ltd.; Australian Postgraduate Award scholarship	Funding: This study was funded by Mesoblast Ltd. Co-authors PG and SI received salary from Mesoblast Ltd. Co-authors PG and SI, representing Mesoblast Ltd., had a role in the initial study design and protocol, and in the preparation of the manuscript. LMD was supported by an Australian Postgraduate Award scholarship.	Abdalmula A, 2014, VET IMMUNOL IMMUNOP, V159, P83, DOI 10.1016/j.vetimm.2014.03.007; Abdalmula AM, 2014, THESIS; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bergholm R, 2002, ARTERIOSCL THROM VAS, V22, P1637, DOI 10.1161/01.ATV.0000033516.73864.4E; Can C, 2002, LIFE SCI, V71, P401, DOI 10.1016/S0024-3205(02)01700-9; Caplan AI, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, P243, DOI 10.1016/B978-0-12-374729-7.00029-9; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Choi HK, 2005, J RHEUMATOL, V32, P2311; Dooley LM, 2014, J VASC RES, V51, P90, DOI 10.1159/000358367; Egan CG, 2004, J PHYSIOL-LONDON, V557, P635, DOI 10.1113/jphysiol.2004.062984; EGAN PJ, 1994, VET IMMUNOL IMMUNOP, V41, P259, DOI 10.1016/0165-2427(94)90101-5; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Finnegan A, 2003, ARTHRITIS RES THER, V5, pR18, DOI 10.1186/ar601; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101; Gabay C, 2006, ARTHRITIS RESEARCH T, V8; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Ghosh P, 2012, J NEUROSURG-SPINE, V16, P479, DOI 10.3171/2012.1.SPINE11852; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Goldschlager T, 2011, SPINE, V36, P615, DOI 10.1097/BRS.0b013e3181dfcec9; Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Hahn BH, 2007, J AUTOIMMUN, V28, P69, DOI 10.1016/j.jaut.2007.02.004; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Haruna Y, 2006, ARTHRITIS RHEUM-US, V54, P1847, DOI 10.1002/art.21891; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Houtgraaf JH, 2013, CIRC RES, V113, P153, DOI 10.1161/CIRCRESAHA.112.300730; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Isomaki P, 1996, ARTHRITIS RHEUM-US, V39, P386, DOI 10.1002/art.1780390306; Jazayeri JA, 2010, INT IMMUNOPHARMACOL, V10, P1, DOI 10.1016/j.intimp.2009.09.019; Khan F, 2010, NAT REV RHEUMATOL, V6, P253, DOI 10.1038/nrrheum.2010.44; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; KUHN FE, 1991, AM J CARDIOL, V68, P1425, DOI 10.1016/0002-9149(91)90274-O; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; MARTIN HM, 1995, GENE, V159, P187, DOI 10.1016/0378-1119(95)00123-N; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Ozbalkan Z, 2010, ATHEROSCLEROSIS, V212, P377, DOI 10.1016/j.atherosclerosis.2010.03.035; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prati C, 2011, ARTHRITIS RHEUM-US, V63, P2309, DOI 10.1002/art.30391; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/RME.13.2, 10.2217/rme.13.2]; Sakuta T, 2010, ARTHRITIS RHEUM-US, V62, P1319, DOI 10.1002/art.27384; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sattar N, 1998, ATHEROSCLEROSIS, V138, P229, DOI 10.1016/S0021-9150(98)00037-9; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; Stamatelopoulos KS, 2010, ATHEROSCLEROSIS, V212, P305, DOI 10.1016/j.atherosclerosis.2010.05.007; Sudano I, 2010, SWISS MED WKLY, V140, P139, DOI [smw-12966, 10.4414/smw.2010.13122]; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; THORP BH, 1992, CLIN EXP RHEUMATOL, V10, P143; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vaudo G, 2004, ANN RHEUM DIS, V63, P31, DOI 10.1136/ard.2003.007740; Waerhaug K, 2008, CRITICAL CARE, V12; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Winter P, 2003, VET REC, V152, P558, DOI 10.1136/vr.152.18.558; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Yang B, 2013, STROKE, V44, P3463, DOI 10.1161/STROKEAHA.111.000821; ZEIHER AM, 1994, CIRCULATION, V89, P2525, DOI 10.1161/01.CIR.89.6.2525; Zemse SM, 2010, AM J PHYSIOL-HEART C, V299, pH1160, DOI 10.1152/ajpheart.00763.2009	80	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0124144	10.1371/journal.pone.0124144	http://dx.doi.org/10.1371/journal.pone.0124144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950840	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400013
J	Kruse, V; Hamann, C; Monecke, S; Cyganek, L; Elsner, L; Hubscher, D; Walter, L; Streckfuss-Bomeke, K; Guan, K; Dressel, R				Kruse, Vanessa; Hamann, Carina; Monecke, Sebastian; Cyganek, Lukas; Elsner, Leslie; Huebscher, Daniela; Walter, Lutz; Streckfuss-Boemeke, Katrin; Guan, Kaomei; Dressel, Ralf			Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1	PLOS ONE			English	Article							TERATOMA FORMATION; SURFACE-ANTIGENS; IMMUNOGENICITY; HISTOCOMPATIBILITY; TUMORIGENICITY; ENGRAFTMENT; IMMUNOSUPPRESSION; DIFFERENTIATION; CYTOTOXICITY; RECOGNITION	Human induced pluripotent stem cells (hiPSCs) could be used to generate autologous cells for therapeutic purposes, which are expected to be tolerated by the recipient. However, iPSC-derived grafts are at risk of giving rise to teratomas in the host, if residuals of tumorigenic cells are not rejected by the recipient. We have analyzed the susceptibility of hiPSC lines to allogeneic and autologous natural killer (NK) cells. IL-2-activated, in contrast to resting NK cells killed hiPSC lines efficiently (P= 1.69x10(-39)). Notably, the specific lysis of the individual hiPSC lines by IL-2-activated NK cells was significantly different (P= 1.72x10(-6)) and ranged between 46% and 64% in Cr-51-release assays when compared to K562 cells. The hiPSC lines were killed by both allogeneic and autologous NK cells although autologous NK cells were less efficient (P= 8.63x10(-6)). Killing was partly dependent on the activating NK receptor DNAM-1 (P= 8.22x10(-7)). The DNAM-1 ligands CD112 and CD155 as well as the NKG2D ligands MICA and MICB were expressed on the hiPSC lines. Low amounts of human leukocyte antigen (HLA) class I proteins, which serve as ligands for inhibitory and activating NK receptors were also detected. Thus, the susceptibility to NK cell killing appears to constitute a common feature of hiPSCs. Therefore, NK cells might reduce the risk of teratoma formation even after autologous transplantations of pluripotent stem cell-derived grafts that contain traces of pluripotent cells.	[Kruse, Vanessa; Cyganek, Lukas; Huebscher, Daniela; Streckfuss-Boemeke, Katrin; Guan, Kaomei] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Hamann, Carina; Monecke, Sebastian; Elsner, Leslie; Dressel, Ralf] Univ Med Ctr Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Hamann, Carina; Monecke, Sebastian; Cyganek, Lukas; Huebscher, Daniela; Streckfuss-Boemeke, Katrin; Guan, Kaomei; Dressel, Ralf] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Germany; [Walter, Lutz] German Primate Ctr, Primate Genet Lab, Gottingen, Germany	University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research; Deutsches Primatenzentrum (DPZ)	Guan, K (corresponding author), Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany.	kguan@med.uni-goettingen.de; rdresse@gwdg.de	Kruse, Vanessa/ABC-9442-2021; Guan, Kaomei/G-8882-2018; Streckfuss-bömeke, Katrin/L-1734-2015; Streckfuß-Bömeke, Katrin/H-1375-2016; Walter, Lutz/I-2606-2017; Dressel, Ralf/R-7065-2016	Guan, Kaomei/0000-0002-0753-3083; Walter, Lutz/0000-0001-9408-3131; Dressel, Ralf/0000-0002-1651-1214; Cyganek, Lukas/0000-0001-9120-1382	Deutsche Forschungsgemeinschaft [SFB 1002, TP A04, TP C05]; Bundesministerium fur Bildung und Forschung (DZHK); Bundesministerium fur Bildung und Forschung [01GN0819]; Gottingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (DZHK); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Gottingen University	Funding: This work was supported by the Deutsche Forschungsgemeinschaft (SFB 1002, TP A04 and TP C05) and the Bundesministerium fur Bildung und Forschung (DZHK and 01GN0819). In addition, the authors acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Chen HF, 2015, CELL TRANSPLANT, V24, P845, DOI 10.3727/096368913X674639; de Almeida PE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4903; de Almeida PE, 2013, CIRC RES, V112, P549, DOI 10.1161/CIRCRESAHA.111.249243; Deuse T, 2011, CIRCULATION, V124, pS3, DOI 10.1161/CIRCULATIONAHA.111.020727; Deuse T, 2011, J CELL SCI, V124, P3029, DOI 10.1242/jcs.087718; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dressel R, 2011, SEMIN IMMUNOPATHOL, V33, P573, DOI 10.1007/s00281-011-0266-8; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, METHOD ENZYMOL, V420, P391, DOI 10.1016/S0076-6879(06)20019-3; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Elsner L, 2010, J CELL MOL MED, V14, P992, DOI [10.1111/j.1582-4934.2008.00677.x, 10.1111/j.1582-4934.2009.00677.x]; Frenzel LP, 2009, STEM CELLS, V27, P307, DOI 10.1634/stemcells.2008-0528; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hasenkamp J, 2006, SCAND J IMMUNOL, V64, P444, DOI 10.1111/j.1365-3083.2006.01803.x; Kaneko S, 2013, CELL STEM CELL, V12, P385, DOI 10.1016/j.stem.2013.03.008; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Koch CA, 2006, J IMMUNOL, V177, P4803, DOI 10.4049/jimmunol.177.7.4803; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Liao Mei-Chih, 2014, World J Stem Cells, V6, P248, DOI 10.4252/wjsc.v6.i2.248; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Mizukami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098319; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Perez-Cunningham J, 2014, TRANSPLANTATION, V97, P992, DOI 10.1097/TP.0000000000000063; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pick M, 2012, STEM CELLS, V30, P2700, DOI 10.1002/stem.1242; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Scheiner ZS, 2014, J BIOL CHEM, V289, P4571, DOI 10.1074/jbc.R113.509588; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Streckfuss-Bomeke K, 2013, EUR HEART J, V34, P2618, DOI 10.1093/eurheartj/ehs203; Suarez-Alvarez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010192; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian L, 1997, BIOL REPROD, V57, P561, DOI 10.1095/biolreprod57.3.561; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Tseng HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011590; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zakrzewski JL, 2014, NAT BIOTECHNOL, V32, P786, DOI 10.1038/nbt.2960; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; ZIEGLER A, 1979, NATURE, V279, P243, DOI 10.1038/279243a0	59	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2015	10	5							e0125544	10.1371/journal.pone.0125544	http://dx.doi.org/10.1371/journal.pone.0125544			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH7KF	25950680	Green Published, Green Submitted, gold			2022-12-26	WOS:000354214400034
J	Lehne, M; Engel, P; Rohrmeier, M; Menninghaus, W; Jacobs, AM; Koelsch, S				Lehne, Moritz; Engel, Philipp; Rohrmeier, Martin; Menninghaus, Winfried; Jacobs, Arthur M.; Koelsch, Stefan			Reading a Suspenseful Literary Text Activates Brain Areas Related to Social Cognition and Predictive Inference	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; LANGUAGE NETWORK; FRONTAL GYRUS; OPTIMIZED EPI; HARRY POTTER; FMRI; COMPREHENSION; WORD; EXPERIENCE; RETRIEVAL	Stories can elicit powerful emotions. A key emotional response to narrative plots (e.g., novels, movies, etc.) is suspense. Suspense appears to build on basic aspects of human cognition such as processes of expectation, anticipation, and prediction. However, the neural processes underlying emotional experiences of suspense have not been previously investigated. We acquired functional magnetic resonance imaging (fMRI) data while participants read a suspenseful literary text (E.T.A. Hoffmann's "The Sandman") subdivided into short text passages. Individual ratings of experienced suspense obtained after each text passage were found to be related to activation in the medial frontal cortex, bilateral frontal regions (along the inferior frontal sulcus), lateral premotor cortex, as well as posterior temporal and temporo-parietal areas. The results indicate that the emotional experience of suspense depends on brain areas associated with social cognition and predictive inference.	[Lehne, Moritz; Engel, Philipp; Menninghaus, Winfried; Jacobs, Arthur M.; Koelsch, Stefan] Free Univ Berlin, Cluster Languages Emot, Berlin, Germany; [Rohrmeier, Martin] Tech Univ Dresden, Inst Kunst & Mus Wissensch, Dresden, Germany; [Menninghaus, Winfried] Max Planck Inst Empir Aesthet, Frankfurt, Germany; [Jacobs, Arthur M.] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, Berlin, Germany	Free University of Berlin; Technische Universitat Dresden; Free University of Berlin	Lehne, M (corresponding author), Free Univ Berlin, Cluster Languages Emot, Berlin, Germany.	mlehne@uos.de	Lehne, Moritz/AAE-8752-2020; Koelsch, Stefan/AAV-1556-2020	Jacobs, Arthur/0000-0002-7910-3955; Rohrmeier, Martin Alois/0000-0002-4323-7257; Koelsch, Stefan/0000-0002-8714-3404	Excellence Initiative of the German Federal Ministry of Education and Research; Zukunftskonzept at TU Dresden; Exzellenzinitiative of the Deutsche Forschungsgemeinschaft	Excellence Initiative of the German Federal Ministry of Education and Research; Zukunftskonzept at TU Dresden; Exzellenzinitiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research was funded by the Excellence Initiative of the German Federal Ministry of Education and Research (http://www.bmbf.de/en/1321.php). Financial support for MR has been generously provided in part by the Zukunftskonzept at TU Dresden funded by the Exzellenzinitiative of the Deutsche Forschungsgemeinschaft.	Altmann U, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00192; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Appel M, 2010, MEDIA PSYCHOL, V13, P101, DOI 10.1080/15213261003799847; Bae BC, 2009, LECT NOTES COMPUT SC, V5915, P304; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Bitan T, 2006, NEUROIMAGE, V33, P991, DOI 10.1016/j.neuroimage.2006.07.007; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; BREWER WF, 1982, J PRAGMATICS, V6, P473, DOI 10.1016/0378-2166(82)90021-2; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; CAPLAN D, 1995, NEUROLOGY, V45, P293, DOI 10.1212/WNL.45.2.293; Carroll N, 1996, THEORIZING MOVING IM, P94; Chow HM, 2008, NEUROIMAGE, V40, P940, DOI 10.1016/j.neuroimage.2007.11.044; Clos M, 2013, NEUROIMAGE, V83, P174, DOI 10.1016/j.neuroimage.2013.06.041; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; COMISKY P, 1982, HUM COMMUN RES, V9, P49, DOI 10.1111/j.1468-2958.1982.tb00682.x; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DEMB JB, 1995, J NEUROSCI, V15, P5870; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ferstl EC, 2001, COGNITIVE BRAIN RES, V11, P325, DOI 10.1016/S0926-6410(01)00007-6; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fill A, 2007, PRINZIP SPANNUNG SPA; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; Freud Sigmund, 1955, STANDARD EDITION COM, VXVII, P219; Friese U, 2008, J COGNITIVE NEUROSCI, V20, P2110, DOI 10.1162/jocn.2008.20141; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; GERRIG RJ, 1994, POETICS, V22, P459, DOI 10.1016/0304-422X(94)90021-3; Hanich J, 2014, PSYCHOL AESTHET CREA, V8, P130, DOI 10.1037/a0035690; Hasson U, 2007, CEREB CORTEX, V17, P2899, DOI 10.1093/cercor/bhm016; Hsu CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118179; Hsu CT, 2015, BRAIN LANG, V142, P96, DOI 10.1016/j.bandl.2015.01.011; Hsu CT, 2015, CORTEX, V63, P282, DOI 10.1016/j.cortex.2014.09.002; Hsu CT, 2014, NEUROREPORT, V25, P1356, DOI 10.1097/WNR.0000000000000272; Jacobs A. M., 2011, GEHIRN GEDICHT WIE W, P492; Jacobs AM, 2015, COGNITIVE NEUROSCIENCE OF NATURAL LANGUAGE USE, P135; Jennett C, 2008, INT J HUM-COMPUT ST, V66, P641, DOI 10.1016/j.ijhcs.2008.04.004; Jin H, 2009, INT J PSYCHOPHYSIOL, V71, P142, DOI 10.1016/j.ijpsycho.2008.08.009; Joffily M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003094; Joubert S, 2004, BRAIN LANG, V89, P9, DOI 10.1016/S0093-934X(03)00403-6; Koelsch S, 2008, NEUROREPORT, V19, P1815, DOI 10.1097/WNR.0b013e32831a8722; Kuijpers MM, 2012, STOR S JUN 2012; Lehne M, ART AESTHET IN PRESS; Lehne M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00079; Lehne M, 2014, SOC COGN AFFECT NEUR, V9, P1515, DOI 10.1093/scan/nst141; Levinson Jerrold, 1997, MUSIC MEANING, P215; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; Lindenberg R, 2007, NEUROPSYCHOLOGIA, V45, P2407, DOI 10.1016/j.neuropsychologia.2007.02.008; Loker A, 1976, FILM AND SUSPENSE; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Noppeney U, 2004, NEUROPSYCHOLOGIA, V42, P1269, DOI 10.1016/j.neuropsychologia.2003.12.014; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rabkin ES, 1973, NARRATIVE SUSPENSE S; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schubotz RI, 2004, NEUROPSYCHOLOGY, V18, P638, DOI 10.1037/0894-4105.18.4.638; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Sieborger FT, 2007, BRAIN RES, V1166, P77, DOI 10.1016/j.brainres.2007.05.079; Steinbeis N, 2009, CEREB CORTEX, V19, P619, DOI 10.1093/cercor/bhn110; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Truffaut F, 1967, HITCHCOCK; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Virtue S, 2008, J COGNITIVE NEUROSCI, V20, P2274, DOI 10.1162/jocn.2008.20160; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wallentin M, 2011, NEUROIMAGE, V58, P963, DOI 10.1016/j.neuroimage.2011.06.077; Weiskopf N, 2007, MAGN RESON MATER PHY, V20, P39, DOI 10.1007/s10334-006-0067-6; Wendell BA, 2011, ANN NY ACAD SCI, V1224, P63, DOI 10.1111/j.1749-6632.2010.05954.x; Wood G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-38; Wulff H.J., 1996, SUSPENSE CONCEPTUALI, P93; Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013; Yarkoni Tal, 2008, Neuroimage, V41, P1408, DOI 10.1016/j.neuroimage.2008.03.062; ZILLMANN D, 1975, J RES PERS, V9, P307, DOI 10.1016/0092-6566(75)90005-7; Zillmann D., 1980, ENTERTAINMENT FUNCTI, P133	91	31	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0124550	10.1371/journal.pone.0124550	http://dx.doi.org/10.1371/journal.pone.0124550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CH5BQ	25946306	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700045
J	Mikobi, TM; Tshilobo, PL; Aloni, MN; Lelo, GM; Akilimali, PZ; Muyembe-Tamfum, JJ; Race, V; Matthijs, G; Mwamba, JMM				Mikobi, Tite Minga; Tshilobo, Prosper Lukusa; Aloni, Michel Ntetani; Lelo, Georges Mvumbi; Akilimali, Pierre Zalagile; Muyembe-Tamfum, Jean Jacques; Race, Valerie; Matthijs, Gert; Mwamba, Jean Marie Mbuyi			Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients	PLOS ONE			English	Article							GENE-CLUSTER HAPLOTYPES; PLATELET ACTIVATION; INCREASED ADHESIVE; FETAL-HEMOGLOBIN; LEG ULCERATION; DISEASE; HEMOLYSIS; ASSOCIATION; NEUTROPHILS; BIOMARKERS	Background Sickle cell anemia is an inflammatory disease and is characterized by chronic hemolysis. We sought to evaluate the association of lactate dehydrogenase levels with specific clinical phenotypes and laboratory variables in patients with sickle cell anemia. Methods The present cross-sectional study was conducted in Sickle Cell Centre of Yolo in Kinshasa, the Democratic Republic of Congo. Two hundred and eleven patients with Sickle Cell Anemia in steady state were recruited. Seventy-four participants with normal Hb (Hb-AA) were selected as a control group. Results The average rates of hemoglobin, hematocrit, and red blood cells tended to be significantly lower in subjects with Hb-SS (p<0.001). The average rates of white blood cells, platelets, reticulocytes and serum LDH were significantly higher in subjects with Hb-SS (p<0.001). The average rates of Hb, HbF, hematocrit and red blood cells of Hb-SS patients with asymptomatic clinical phenotype were significantly higher than those of the two other phenotypes. However, the average rates of white blood cells, platelets, reticulocytes, and LDH of Hb-SS patients with the severe clinical phenotype are higher than those of two other clinical phenotypes. Significant correlations were observed between Hb and white blood cell in severe clinical phenotype (r3 = -0.37 *) between Hb and red blood cells in the three phenotypes (r1 = 0.69 * r2 * = 0.69, r3 = 0.83 *), and finally between Hb and reticulocytes in the asymptomatic clinical phenotype and severe clinical phenotype (r1 = -0.50 * r3 = 0.45 *). A significant increase in LDH was observed in patients with leg ulcer, cholelithiasis and aseptic necrosis of the femoral head. Conclusion The increase in serum LDH is accompanied by changes in hematological parameters. In our midst, serum LDH may be considered as an indicator of the severity of the disease.	[Mikobi, Tite Minga; Lelo, Georges Mvumbi] Univ Kinshasa, Dept Sci Bases, Lab Biochem & Mol Biol, Fac Med, Kinshasa, DEM REP CONGO; [Mwamba, Jean Marie Mbuyi] Univ Kinshasa, Human Genet Unit, Dept Paediat, Univ Hosp Kinshasa,Sch Med, Kinshasa, DEM REP CONGO; [Aloni, Michel Ntetani] Univ Kinshasa, Div Hematooncol & Nephrol, Dept Paediat, Univ Hosp Kinshasa,Sch Med, Kinshasa, DEM REP CONGO; [Akilimali, Pierre Zalagile] Univ Kinshasa, Sch Publ Hlth, Div Biostat & Epidemiol, Kinshasa, DEM REP CONGO; [Muyembe-Tamfum, Jean Jacques] Inst Natl Rech Sci Biomed, Kinshasa, DEM REP CONGO; [Race, Valerie; Matthijs, Gert] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Tshilobo, Prosper Lukusa] Univ Kinshasa, Fac Med, Univ Hosp Kinshasa, Div Hematoimmuno Rheumatol,Dept Internal Med, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Universite de Kinshasa; Universite de Kinshasa; Universite de Kinshasa; KU Leuven; Universite de Kinshasa	Mikobi, TM (corresponding author), Univ Kinshasa, Dept Sci Bases, Lab Biochem & Mol Biol, Fac Med, Kinshasa, DEM REP CONGO.	tite.mikobi@gmail.com	Akilimali, Pierre Z/D-2564-2018	Akilimali, Pierre Z/0000-0002-3828-6214; Matthijs, Gert/0000-0001-6710-1912; LUKUSA TSHILOBO, PROSPER/0000-0002-5414-2915	World Bank	World Bank(The World Bank India)	This research project was supported by the World Bank through its scholarship program Robert S McNamara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasa B, 2010, TRANSFUSION MED, V20, P62, DOI 10.1111/j.1365-3148.2009.00943.x; Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Aloni MN, 2014, HEMOGLOBIN, V38, P196, DOI 10.3109/03630269.2014.896810; Ballas SK, 2012, AM J HEMATOL, V87, P338, DOI 10.1002/ajh.22259; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Bonds DR, 2005, BLOOD REV, V19, P99, DOI 10.1016/j.blre.2004.04.002; Bowers AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068929; Browne PV, 1996, J LAB CLIN MED, V127, P340, DOI 10.1016/S0022-2143(96)90181-X; Canalli AA, 2008, HAEMATOLOGICA, V93, P605, DOI 10.3324/haematol.12119; Connes P, 2014, BRIT J HAEMATOL, V165, P564, DOI 10.1111/bjh.12786; Cumming V, 2008, BRIT J HAEMATOL, V142, P119, DOI 10.1111/j.1365-2141.2008.07115.x; Darbari DS, 2012, J PEDIATR-US, V160, P286, DOI 10.1016/j.jpeds.2011.07.018; De Montalembert M, 2007, Med Trop (Mars), V67, P612; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Enosolease M E, 2005, Niger Postgrad Med J, V12, P102; Frelinger AL, 2014, PLATELETS, V25, P27, DOI 10.3109/09537104.2013.770136; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Hatzipantelis ES, 2013, INT J HEMATOL, V98, P158, DOI 10.1007/s12185-013-1392-y; Kasschau MR, 1996, BLOOD, V87, P771, DOI 10.1182/blood.V87.2.771.bloodjournal872771; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Maier-Redelsperger M, 2004, BLOOD CELL MOL DIS, V33, P15, DOI 10.1016/j.bcmd.2004.03.005; Mouele R, 1999, EUR J HAEMATOL, V63, P136; Mpalampa L, 2012, BMC BLOOD DISORDER, V12, P11, DOI [10.1186/1471-2326-12-11, DOI 10.1186/1471-2326-12-11]; Mukherjee MB, 2004, HEMOGLOBIN, V28, P157, DOI 10.1081/HEM-120034247; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Novelli EM, 2012, AM J HEMATOL, V87, P326, DOI 10.1002/ajh.22274; Ohno K, 2014, THROMB RES, V134, P889, DOI 10.1016/j.thromres.2014.07.035; Olaniyi J A, 2010, Ann Ib Postgrad Med, V8, P30; Omoti C E, 2005, Niger Postgrad Med J, V12, P149; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D R, 1984, Blood, V63, P921; Rahimi Z, 2003, AM J HEMATOL, V74, P156, DOI 10.1002/ajh.10422; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Rodgers GP, 2001, DISORDERS HEMOGLOBIN, P1028; Sakamoto TM, 2013, MICROVASC RES, V90, P173, DOI 10.1016/j.mvr.2013.10.002; Saraf SL, 2014, BRIT J HAEMATOL, V164, P729, DOI 10.1111/bjh.12690; Sawadogo D, 2004, ADV HEMATOL, V2014, DOI [10.1155/2014/273860, DOI 10.1155/2014/273860]; Sebastiani P, 2007, BLOOD, V110, P2727, DOI 10.1182/blood-2007-04-084921; Smith Wally R, 2003, Pain Manag Nurs, V4, P106, DOI 10.1016/S1524-9042(02)54211-9; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Stojanovic KS, 2012, CLIN BIOCHEM, V45, P1578, DOI 10.1016/j.clinbiochem.2012.07.114; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Tshilolo L, 2009, J CLIN PATHOL, V62, P35, DOI 10.1136/jcp.2008.058958; Tshilolo L, 2012, ANEMIA, V2012, DOI 10.1155/2012/105349; van der Land V, 2013, THROMB RES, V132, P712, DOI 10.1016/j.thromres.2013.10.006; Wembonyama S, 2007, REPUBLIC MED TROPICA, V67, P447	47	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0123568	10.1371/journal.pone.0123568	http://dx.doi.org/10.1371/journal.pone.0123568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946088	Green Published, gold, Green Submitted			2022-12-26	WOS:000354049700016
J	Strong, CL; Guerra, HP; Mathew, KR; Roy, N; Simpson, LR; Schiller, MR				Strong, Christy L.; Guerra, Horacio P.; Mathew, Kiran R.; Roy, Nervik; Simpson, Lacy R.; Schiller, Martin R.			Damaging the Integrated HIV Proviral DNA with TALENs	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ZINC-FINGER-NUCLEASES; HUMAN POL-MU; IN-VIVO; BINDING SPECIFICITY; EFFECTOR NUCLEASES; HIGH-EFFICIENCY; LATENT HIV-1; GENE-THERAPY; BREAK REPAIR	HIV-1 integrates its proviral DNA genome into the host genome, presenting barriers for virus eradication. Several new gene-editing technologies have emerged that could potentially be used to damage integrated proviral DNA. In this study, we use transcription activator-like effector nucleases (TALENs) to target a highly conserved sequence in the transactivation response element (TAR) of the HIV-1 proviral DNA. We demonstrated that TALENs cleave a DNA template with the HIV-1 proviral target site in vitro. A GFP reporter, under control of HIV-1 TAR, was efficiently inactivated by mutations introduced by transfection of TALEN plasmids. When infected cells containing the full-length integrated HIV-1 proviral DNA were transfected with TALENs, the TAR region accumulated indels. When one of these mutants was tested, the mutated HIV-1 proviral DNA was incapable of producing detectable Gag expression. TALEN variants engineered for degenerate recognition of select nucleotide positions also cleaved proviral DNA in vitro and the full-length integrated proviral DNA genome in living cells. These results suggest a possible design strategy for the therapeutic considerations of incomplete target sequence conservation and acquired resistance mutations. We have established a new strategy for damaging integrated HIV proviral DNA that may have future potential for HIV-1 proviral DNA eradication.	[Schiller, Martin R.] Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA; Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Schiller, MR (corresponding author), Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [P20-GM103440, R25-DK078385]; National Science Foundation [EPS-0814372]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK078385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health (P20-GM103440, R25-DK078385) and National Science Foundation (EPS-0814372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aubert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016825; Aza A, 2013, NUCLEIC ACIDS RES, V41, P253, DOI 10.1093/nar/gks1054; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; BERG J, 1991, J VIROL METHODS, V34, P173, DOI 10.1016/0166-0934(91)90097-J; BERG J, 1991, P NATL ACAD SCI USA, V88, P4723, DOI 10.1073/pnas.88.11.4723; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P1717, DOI 10.1534/g3.113.007260; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Chayot R, 2012, DNA REPAIR, V11, P22, DOI 10.1016/j.dnarep.2011.09.016; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Das AT, 2007, J VIROL, V81, P7742, DOI 10.1128/JVI.00392-07; Dhamija Neeru, 2013, Subcell Biochem, V61, P479, DOI 10.1007/978-94-007-4525-4_21; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Dueva R, 2013, TRANSL CANCER RES, V2, P163, DOI 10.3978/j.issn.2218-676X.2013.05.02; Dupuy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078678; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Frank S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-773; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gaudet D, 2010, ATHEROSCLEROSIS SUPP, V11, P55, DOI 10.1016/j.atherosclerosissup.2010.03.004; Grabarz A, 2012, AM J CANCER RES, V2, P249; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Holkers M, 2014, METHODS, V69, P179, DOI 10.1016/j.ymeth.2014.02.017; Holkers M, 2012, NUCLEIC ACIDS RES, V40, P1984, DOI 10.1093/nar/gkr976; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Martin MJ, 2013, NUCLEIC ACIDS RES, V41, P9105, DOI 10.1093/nar/gkt681; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; LEITNER T, 2005, HIV SEQUENCE COMPEND; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091606, 10.1371/journal.pone.0085755, 10.1371/journal.pone.0089315, 10.1371/journal.pone.0098300]; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Ma K, 2014, BIOTECHNOL LETT, V36, P471, DOI 10.1007/s10529-013-1387-z; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mariyanna L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031576; Matreyek Kenneth A, 2012, Expert Rev Anti Infect Ther, V10, P855, DOI 10.1586/eri.12.68; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Nakajima K, 2013, BIOL OPEN, V2, P1364, DOI 10.1242/bio.20136676; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; PARKIN NT, 1988, EMBO J, V7, P2831, DOI 10.1002/j.1460-2075.1988.tb03139.x; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Peterson CW, 2013, GENE THER, V20, P695, DOI 10.1038/gt.2012.98; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Reyon Deepak, 2012, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1215s100; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholze H, 2010, VIRULENCE, V1, P428, DOI 10.4161/viru.1.5.12863; Sgarbanti M, 2013, CURR OPIN VIROL, V3, P394, DOI 10.1016/j.coviro.2013.06.001; Shan L, 2013, BIOESSAYS, V35, P544, DOI 10.1002/bies.201200170; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigal A, 2012, CELL HOST MICROBE, V12, P132, DOI 10.1016/j.chom.2012.07.005; Stone D, 2013, CURR OPIN HIV AIDS, V8, P217, DOI 10.1097/COH.0b013e32835f736c; Sun N, 2014, BIOTECHNOL BIOENG, V111, P683, DOI 10.1002/bit.25154; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Takasu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073458; Ul Ain Q, 2015, J CONTROL RELEASE, V205, P120, DOI 10.1016/j.jconrel.2014.12.036; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Weber ND, 2013, MOL THER, V21, P1819, DOI 10.1038/mt.2013.208; Wei CX, 2013, J GENET GENOMICS, V40, P281, DOI 10.1016/j.jgg.2013.03.013; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005; Zhu HB, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt721	83	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0125652	10.1371/journal.pone.0125652	http://dx.doi.org/10.1371/journal.pone.0125652			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	25946221	gold, Green Published, Green Submitted			2022-12-26	WOS:000354049700080
J	Gates-Hollingsworth, MA; Perry, MR; Chen, HJ; Needham, J; Houghton, RL; Raychaudhuri, S; Hubbard, MA; Kozel, TR				Gates-Hollingsworth, Marcellene A.; Perry, Mark R.; Chen, Hongjing; Needham, James; Houghton, Raymond L.; Raychaudhuri, Syamal; Hubbard, Mark A.; Kozel, Thomas R.			Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; RHESUS-MONKEY; PATHOLOGY	Inhalational anthrax is a serious biothreat. Effective antibiotic treatment of inhalational anthrax requires early diagnosis; the further the disease has progressed, the less the likelihood for cure. Current means for diagnosis such as blood culture require several days to a result and require advanced laboratory infrastructure. An alternative approach to diagnosis is detection of a Bacillus anthracis antigen that is shed into blood and can be detected by rapid immunoassay. The goal of the study was to evaluate detection of poly-gamma-D-glutamic acid ( PGA), the capsular antigen of B. anthracis, as a biomarker surrogate for blood culture in a rabbit model of inhalational anthrax. The mean time to a positive blood culture was 26 +/- 5.7 h ( mean +/- standard deviation), whereas the mean time to a positive ELISA was 22 +/- 4.2 h; P = 0.005 in comparison with blood culture. A lateral flow immunoassay was constructed for detection of PGA in plasma at concentrations of less than 1 ng PGA/ml. Use of the lateral flow immunoassay for detection of PGA in the rabbit model found that antigen was detected somewhat earlier than the earliest time point at which the blood culture became positive. The low cost, ease of use, and rapid time to result of the lateral flow immunoassay format make an immunoassay for PGA a viable surrogate for blood culture for detection of infection in individuals who have a likelihood of exposure to B. anthracis.	[Gates-Hollingsworth, Marcellene A.; Hubbard, Mark A.; Kozel, Thomas R.] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Perry, Mark R.] Battelle Biomed Res Ctr, Columbus, OH USA; [Chen, Hongjing; Needham, James; Houghton, Raymond L.; Raychaudhuri, Syamal] InBios Int Inc, Seattle, WA USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Kozel, TR (corresponding author), Univ Nevada, Sch Med, Reno, NV 89557 USA.	tkozel@medicine.nevada.edu	Hubbard, Mark/T-5856-2018	Hubbard, Mark/0000-0002-3337-8558	Public Health Service from the National Institutes of Health [AI059348, AI061200, AI093365]; InBios International Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059348, R01AI093365, U01AI061200] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; InBios International Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Public Health Service grants AI059348, AI061200 and AI093365 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. InBios International Inc. provided support in the form of salaries for authors HC, JN, RLH and SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AuCoin DP, 2009, DIAGN MICR INFEC DIS, V64, P229, DOI 10.1016/j.diagmicrobio.2009.02.001; Boyer AE, 2009, INFECT IMMUN, V77, P3432, DOI 10.1128/IAI.00346-09; FRITZ DL, 1995, LAB INVEST, V73, P691; Government Accountability Office, 2003, BIOT PUBL HLTH RESP; Heller MB, 2002, EMERG INFECT DIS, V8, P1096, DOI 10.3201/eid0810.020376; Hubbard MA, 2013, MOL IMMUNOL, V55, P337, DOI 10.1016/j.molimm.2013.03.010; Kao LM, 2006, ANTIMICROB AGENTS CH, V50, P3535, DOI 10.1128/AAC.00090-06; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Lucey D, 2005, MANDELL DOUGLAS BENN, V6th, P3618; Savransky V, 2013, INFECT IMMUN, V81, P1152, DOI 10.1128/IAI.01289-12; U. S. Food and Drug Administration, 2012, FDA APPR RAX TREAT I; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	14	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126304	10.1371/journal.pone.0126304	http://dx.doi.org/10.1371/journal.pone.0126304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942409	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400067
J	Huang, JC; Lin, HYH; Lim, LM; Chen, SC; Chang, JM; Hwang, SJ; Tsai, JC; Hung, CC; Chen, HC				Huang, Jiun-Chi; Lin, Hugo You-Hsien; Lim, Lee-Moay; Chen, Szu-Chia; Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Hung, Chi-Chih; Chen, Hung-Chun			Body Mass Index, Mortality, and Gender Difference in Advanced Chronic Kidney Disease	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; RENAL-FAILURE; RISK-FACTORS; ASSOCIATION; OUTCOMES; OBESITY; FAT; PREDICTORS; SURVIVAL; WEIGHT	Background and Aim A higher body mass index (BMI) appears to be reversely associated with mortality in dialysis patients. Moreover, although women have better survival in chronic kidney disease (CKD), this survival advantage is cancelled in dialysis. The association between BMI and mortality and the gender difference remain controversial in advanced CKD. Methods This study enrolled 3,320 patients (1,938 men and 1,382 women) from southern Taiwan who had CKD stages 3-5 with a BMI of 15.0-35.0 kg/m(2). Results During a median 2.9-year follow-up, there were 328 (16.9%) all-cause mortality and 319 (16.5%) cardiovascular (CV) events and death in male patients, 213 (15.4%) all-cause mortality and 224 (16.2%) CV events and death in female patients. Compared with the reference BMI of 27.6-30.0 kg/m(2) in an adjusted Cox model, lower-BMI groups in men, BMI 15.0-20.0 kg/m(2) and 20.1-22.5 kg/m(2), were associated with higher risks of all-cause mortality: hazard ratios (HRs) 3.19 (95% confidence interval [CI], 1.97-5.18) and 2.01 (95% CI, 1.29-3.14), respectively. Higher-BMI group in men, BMI 30.1-35.0 kg/m(2), was associated with a higher risk of all-cause mortality: HR 1.72 (95% CI, 1.02-2.96). Likewise, lower-and higher-BMI groups in men were associated with a higher risk of CV events and death. In women, these associations between BMI and poor outcomes were not observed. Conclusions In advanced CKD, there was a reverse J-shaped association between BMI and all-cause mortality, and a U-shaped association between BMI and CV outcomes in men. Neutral associations between BMI and poor outcomes were detected in women. Gender could modify the effect of BMI on mortality in patients with CKD.	[Huang, Jiun-Chi; Chen, Szu-Chia; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Jiun-Chi; Lim, Lee-Moay; Chen, Szu-Chia; Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Hung, Chi-Chih; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Lin, Hugo You-Hsien] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Hung, Chi-Chih; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Health Research Institutes - Taiwan	Tsai, JC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	jerchia@kmu.edu.tw; chichi@cc.kmu.edu.tw	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860; Hsu, ShuChien/0000-0002-5321-4681				Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Annuk M, 2001, NEPHROL DIAL TRANSPL, V16, P302, DOI 10.1093/ndt/16.2.302; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Carrero JJ, 2011, NEPHROL DIAL TRANSPL, V26, P270, DOI 10.1093/ndt/gfq386; Carrero JJ, 2010, KIDNEY BLOOD PRESS R, V33, P383, DOI 10.1159/000320389; Caulin-Glaser T, 1998, J AM COLL CARDIOL, V31, P1555, DOI 10.1016/S0735-1097(98)00145-4; Chen SC, 2013, CLIN J AM SOC NEPHRO, V8, P1915, DOI 10.2215/CJN.02350213; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055643; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Cigarran S, 2013, J RENAL NUTR, V23, pE89, DOI 10.1053/j.jrn.2012.08.007; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P49, DOI 10.1053/j.ajkd.2008.04.002; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Fleischmann E, 1999, KIDNEY INT, V55, P1560, DOI 10.1046/j.1523-1755.1999.00389.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Kakiya R, 2006, KIDNEY INT, V70, P549, DOI 10.1038/sj.ki.5000331; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Kalantar-Zadeh K, 2005, AM J CLIN NUTR, V81, P543; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kwan BCH, 2007, CLIN J AM SOC NEPHRO, V2, P992, DOI 10.2215/CJN.04221206; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Madero M, 2007, AM J KIDNEY DIS, V50, P404, DOI 10.1053/j.ajkd.2007.06.004; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Persky AM, 2000, P SOC EXP BIOL MED, V223, P59, DOI 10.1046/j.1525-1373.2000.22308.x; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P1266, DOI 10.1093/ndt/17.7.1266; Stenvinkel P, 2001, BLOOD PURIFICAT, V19, P53, DOI 10.1159/000014479; Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILSON DO, 1989, AM REV RESPIR DIS, V139, P1435, DOI 10.1164/ajrccm/139.6.1435; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	42	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0126668	10.1371/journal.pone.0126668	http://dx.doi.org/10.1371/journal.pone.0126668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942584	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943400072
J	Li, XL; Liu, ZY; Wang, Z; Wu, XH; Li, XL; Hu, J; Shi, HX; Guo, FH; Zhang, Y; Hou, XY				Li, Xiliang; Liu, Zhiying; Wang, Zhen; Wu, Xinhong; Li, Xinle; Hu, Jing; Shi, Hongxiao; Guo, Fenghui; Zhang, Yong; Hou, Xiangyang			Pathways of Leymus chinensis Individual Aboveground Biomass Decline in Natural Semiarid Grassland Induced by Overgrazing: A Study at the Plant Functional Trait Scale	PLOS ONE			English	Article							INNER-MONGOLIA; ECOSYSTEM-FUNCTION; CLIMATE-CHANGE; ROOT BIOMASS; LEAF TRAITS; LAND-USE; PRODUCTIVITY; DEGRADATION; DIVERSITY; HERBIVORE	Natural grassland productivity, which is based on an individual plant's aboveground biomass (AB) and its interaction with herbivores, can obviously affect terrestrial ecosystem services and the grassland's agricultural production. As plant traits have been linked to both AB and ecosystem success, they may provide a useful approach to understand the changes in individual plants and grassland productivity in response to grazing on a generic level. Unfortunately, the current lack of studies on how plant traits affect AB affected by herbivores leaves a major gap in our understanding of the mechanism of grassland productivity decline. This study, therefore, aims to analyze the paths of overgrazing-induced decline in the individual AB of Leymus chinensis (the dominant species of meadow-steppe grassland in northern China) on a plant functional trait scale. Using a paired-sampling approach, we compared the differences in the functional traits of L. chinensis in long-term grazing-excluded and experimental grazing grassland plots over a continuous period of approximately 20 years (located in meadow steppe lands in Hailar, Inner Mongolia, China). We found a highly significant decline in the individual height and biomass (leaf, stem, and the whole plant) of L. chinensis as a result of overgrazing. Biomass allocation and leaf mass per unit area were significantly affected by the variation in individual size. Grazing clearly enhanced the sensitivity of the leaf-to-stem biomass ratio in response to variation in individual size. Moreover, using a method of standardized major axis estimation, we found that the biomass in the leaves, stems, and the plant as a whole had highly significant allometric scaling with various functional traits. Also, the slopes of the allometric equations of these relationships were significantly altered by grazing. Therefore, a clear implication of this is that grazing promotes an asymmetrical response of different plant functional traits to variation in individual plant size, which influences biomass indirectly. Furthermore, we detected paths of individual AB decline in L. chinensis induced by grazing by fitting to a structural equation model. These results indicate that grazing causes AB decline primarily through a 'bottomup' effect on plant height and stem traits. However, leaf traits, via the process of allometric scaling, affect plant AB indirectly.	[Li, Xiliang; Liu, Zhiying; Wang, Zhen; Wu, Xinhong; Hu, Jing; Shi, Hongxiao; Guo, Fenghui; Zhang, Yong; Hou, Xiangyang] Chinese Acad Agr Sci, Inst Grassland Res, Minist Agr, Key Lab Grassland Resources & Utilizat, Hohhot, Peoples R China; [Li, Xiliang; Liu, Zhiying; Hu, Jing; Guo, Fenghui] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Li, Xinle] China Acad Forestry, Expt Ctr Desert Forestry, Dengkou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Chinese Academy of Forestry	Hou, XY (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Minist Agr, Key Lab Grassland Resources & Utilizat, Hohhot, Peoples R China.	houxy16@126.com			National Key Basic Research Development Program of China [2014CB138800]; International Science and Technology Cooperation Project of China [2012DFA31290]; Central Non-profit Research Institutes Fundamental Research Funds of China [1610332015020]; Natural Science Foundation of Inner Mongolia Autonomous Region of china [2014BS0328]	National Key Basic Research Development Program of China(National Basic Research Program of China); International Science and Technology Cooperation Project of China; Central Non-profit Research Institutes Fundamental Research Funds of China; Natural Science Foundation of Inner Mongolia Autonomous Region of china	This study was financially supported by the National Key Basic Research Development Program of China (2014CB138800), the International Science and Technology Cooperation Project of China (2012DFA31290), Central Non-profit Research Institutes Fundamental Research Funds of China (1610332015020) and Natural Science Foundation of Inner Mongolia Autonomous Region of china (2014BS0328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallo B, 2011, PLANT BIOSYST, V145, P584, DOI 10.1080/11263504.2011.578836; Badger M. R., 2013, ACIAR Proceedings Series, P20; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Bullock JM, 2001, J APPL ECOL, V38, P253, DOI 10.1046/j.1365-2664.2001.00599.x; Byrne Barbara M., 2013, STRUCTURAL EQUATION; Chen ShuangYan, 2013, PLoS ONE, V8, pe67974, DOI 10.1371/journal.pone.0067974; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Cruz P, 2010, RANGELAND ECOL MANAG, V63, P350, DOI 10.2111/08-016.1; Desurmont GA, 2014, ECOL APPL, V24, P759, DOI 10.1890/13-0157.1; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Edwards KF, 2013, ECOL LETT, V16, P56, DOI 10.1111/ele.12012; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Garcia CAM, 2014, APPL VEG SCI, V17, P470, DOI 10.1111/avsc.12092; Guo YJ, 2012, J ARID ENVIRON, V78, P128, DOI 10.1016/j.jaridenv.2011.11.003; Hassani N, 2008, Pak J Biol Sci, V11, P1733, DOI 10.3923/pjbs.2008.1733.1737; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Bisigato AJ, 2009, AUSTRAL ECOL, V34, P545, DOI 10.1111/j.1442-9993.2009.01958.x; Kemp DR, 2013, P NATL ACAD SCI USA, V110, P8369, DOI 10.1073/pnas.1208063110; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Li SY, 2012, REG ENVIRON CHANGE, V12, P461, DOI 10.1007/s10113-011-0264-3; Lu X, 2014, IEEE EMERGING TECHNO, P1, DOI DOI 10.1109/IGBSG.2014.6835217; Ma LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035165; Mcintire EJB, 2002, J ECOL, V90, P348, DOI 10.1046/j.1365-2745.2001.00672.x; Milchunas DG, 2013, J ARID ENVIRON, V92, P81, DOI 10.1016/j.jaridenv.2013.01.012; Niu KC, 2009, FUNCT ECOL, V23, P274, DOI 10.1111/j.1365-2435.2008.01502.x; Osem Y, 2004, J ECOL, V92, P297, DOI 10.1111/j.0022-0477.2004.00859.x; Parresol BR, 1999, FOREST SCI, V45, P573; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Tian DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042833; Tilman David, 1996, P3; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Veen G. F., 2014, OIKOS; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058432; Wu GL, 2010, PLANT SOIL, V332, P331, DOI 10.1007/s11104-010-0299-0; Zheng SX, 2010, BIOGEOSCIENCES, V7, P1117, DOI 10.5194/bg-7-1117-2010; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x; Zuo XA, 2012, J ARID LAND, V4, P151, DOI 10.3724/SP.J.1227.2012.00151	44	24	32	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0124443	10.1371/journal.pone.0124443	http://dx.doi.org/10.1371/journal.pone.0124443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942588	gold, Green Submitted, Green Published			2022-12-26	WOS:000353943400015
J	Li, Y; Liu, Y; Peng, XP; Liu, W; Zhao, FY; Feng, DD; Han, JZ; Huang, YH; Luo, SW; Li, L; Yue, SJ; Cheng, QM; Huang, XT; Luo, ZQ				Li, Yang; Liu, Yong; Peng, XiangPing; Liu, Wei; Zhao, FeiYan; Feng, DanDan; Han, JianZhong; Huang, YanHong; Luo, SiWei; Li, Lian; Yue, Shao Jie; Cheng, QingMei; Huang, XiaoTing; Luo, ZiQiang			NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury	PLOS ONE			English	Article							METHYL-D-ASPARTATE; IONOTROPIC GLUTAMATE RECEPTORS; MEMANTINE; INFLAMMATION; NEUROINFLAMMATION; NEUTROPHILS; MECHANISMS; PREVENTION; EXPRESSION; MIGRATION	Background Glutamate is a major neurotransmitter in the central nervous system (CNS). Large amount of glutamate can overstimulate N-methyl-D-aspartate receptor (NMDAR), causing neuronal injury and death. Recently, NMDAR has been reported to be found in the lungs. The aim of this study is to examine the effects of memantine, a NMDAR channel blocker, on bleomycin-induced lung injury mice. Methods C57BL/6 mice were intratracheally injected with bleomycin (BLM) to induce lung injury. Mice were randomized to receive saline, memantine (Me), BLM, BLM plus Me. Lungs and BALF were harvested on day 3 or 7 for further evaluation. Results BLM caused leukocyte infiltration, pulmonary edema and increase in cytokines, and imposed significant oxidative stress (MDA as a marker) in lungs. Memantine significantly mitigated the oxidative stress, lung inflammatory response and acute lung injury caused by BLM. Moreover, activation of NMDAR enhances CD11b expression on neutrophils. Conclusions Memantine mitigates oxidative stress, lung inflammatory response and acute lung injury in BLM challenged mice.	[Li, Yang; Liu, Yong; Peng, XiangPing; Liu, Wei; Zhao, FeiYan; Feng, DanDan; Han, JianZhong; Huang, YanHong; Li, Lian; Cheng, QingMei; Huang, XiaoTing; Luo, ZiQiang] Cent South Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China; [Yue, Shao Jie] Cent South Univ, Xiangya Hosp, Dept Pediat, Changsha, Hunan, Peoples R China; [Liu, Wei] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Luo, SiWei] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Luo, ZQ (corresponding author), Cent South Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China.	luozq1962@163.com	huang, yan/GWM-4747-2022; luo, ziqiang/AAO-8299-2020; Zhao, Fei-yan/AAP-7791-2020	Zhao, Fei-yan/0000-0002-5587-929X	National Natural Science Foundation of China [81270121, 30870916, 81100057]; China Hnan Provincial Science & Technology Department, Provincial Natural Science Foundation of Hunan [12JJ2049]; Education Department of Hunan Province, Innovation Fund for Institution of Higher Education of Hunan Province [11K076]; Central South University, The Open-End Fund for Valuable and Precision Instrument of Central South University [2012-02, 2012-12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Hnan Provincial Science & Technology Department, Provincial Natural Science Foundation of Hunan; Education Department of Hunan Province, Innovation Fund for Institution of Higher Education of Hunan Province; Central South University, The Open-End Fund for Valuable and Precision Instrument of Central South University	Funding from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grant numbers 81270121, 30870916, 81100057; China Hnan Provincial Science & Technology Department, Provincial Natural Science Foundation of Hunan (http://www.hnst.gov.cn/zxgz/zkjj/) grant number 12JJ2049; the Education Department of Hunan Province, Innovation Fund for Institution of Higher Education of Hunan Province (http://gov.hnedu.cn/index.html) grant number 11K076; and Central South University, The Open-End Fund for the Valuable and Precision Instrument of Central South University http://www.csu.edu.cn/) grant number 2012-02,2012-12. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Boldyrev AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P128, DOI 10.1134/S0006297912020022; Bozic M, 2015, EXPERT OPIN THER TAR, V19, P399, DOI 10.1517/14728222.2014.983900; CHOI DW, 1987, J NEUROSCI, V7, P369; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Crespi F, 2000, NEUROSCI LETT, V287, P219, DOI 10.1016/S0304-3940(00)01174-5; da Cunha AA, 2010, CHEST, V137, P297, DOI 10.1378/chest.09-1570; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; Dickman KG, 2004, AM J RESP CELL MOL, V30, P139, DOI 10.1165/rcmb.2003-0177OC; Dik WA, 2003, THORAX, V58, P765, DOI 10.1136/thorax.58.9.765; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Ehrlich M, 1999, J THORAC CARDIOV SUR, V117, P285, DOI 10.1016/S0022-5223(99)70424-1; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Hamasato EK, 2013, INT IMMUNOPHARMACOL, V16, P436, DOI 10.1016/j.intimp.2013.04.019; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kuhlmann CRW, 2009, NEUROSCI LETT, V449, P168, DOI 10.1016/j.neulet.2008.10.096; Lindblad SS, 2012, NEUROSIGNALS, V20, P61, DOI 10.1159/000329551; Liu CH, 2011, PHARMACOL BIOCHEM BE, V99, P371, DOI 10.1016/j.pbb.2011.05.016; Ma Ling, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P12, DOI 10.11817/j.issn.1672-7347.2014.01.003; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, P9; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Naruoka T, 2013, EUR J PHARMACOL, V718, P138, DOI 10.1016/j.ejphar.2013.08.041; Nassar T, 2011, AM J PHYSIOL-LUNG C, V301, P13; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Pundir M, 2013, J SURG RES, V183, P668, DOI 10.1016/j.jss.2013.01.040; Reijerkerk A, 2010, J NEUROCHEM, V113, P447, DOI 10.1111/j.1471-4159.2010.06598.x; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Said SI, 2000, FREE RADICAL BIO MED, V28, P1300, DOI 10.1016/S0891-5849(00)00289-6; Said SI, 1996, P NATL ACAD SCI USA, V93, P4688, DOI 10.1073/pnas.93.10.4688; Said SI, 1998, ANN NY ACAD SCI, V865, P226, DOI 10.1111/j.1749-6632.1998.tb11182.x; Sener G, 2007, PULM PHARMACOL THER, V20, P642, DOI 10.1016/j.pupt.2006.07.003; Shang LH, 2010, NITRIC OXIDE-BIOL CH, V23, P327, DOI 10.1016/j.niox.2010.09.004; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tejero-Taldo MI, 2004, J PHARMACOL EXP THER, V311, P8, DOI 10.1124/jpet.104.070003; Tobwala S, 2013, FREE RADICAL RES, V47, P740, DOI 10.3109/10715762.2013.819974; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Wang MJ, 2009, AM J RESP CELL MOL, V40, P260, DOI 10.1165/rcmb.2008-0135OC; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Yan JQ, 2014, J NEUROSCI RES, V92, P634, DOI 10.1002/jnr.23329; Yang HH, 2012, AM J RESP CELL MOL, V46, P407, DOI 10.1165/rcmb.2011-0226OC; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	50	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2015	10	5							e0125873	10.1371/journal.pone.0125873	http://dx.doi.org/10.1371/journal.pone.0125873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PT	25942563	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943400053
J	Fisher, JJ; Hajek, AE				Fisher, Joanna J.; Hajek, Ann E.			Maternal Exposure of a Beetle to Pathogens Protects Offspring against Fungal Disease	PLOS ONE			English	Article							RED FLOUR BEETLE; LIFE-HISTORY; IMMUNITY; ANOPLOPHORA; DROSOPHILA; INFECTION; SURVIVAL; BACTERIA; DEFENSE; INSECT	Maternal exposure to an immune challenge can convey enhanced immunity to invertebrate offspring in the next generation. We investigated whether maternal exposure of the Asian longhorned beetle, Anoplophora glabripennis, to two species of the fungus Metarhizium or the bacterium Serratia marcescens elicited transgenerational immune priming (TGIP). We tested specificity of this protection and whether occurrence of TGIP was dependent on maternal exposure to living versus dead pathogens. Our results show that TGIP occurred and protected offspring against Metarhizium brunneum. Maternal exposure to S. marcescens provided non-specific protection to offspring against a fungal pathogen, but TGIP in response to Metarhizium only occurred when offspring were exposed to the same fungal species that was used to prime mothers. Moreover, TGIP in response to M. brunneum occurred only after maternal exposure to living rather than dead fungus. Our findings suggest that occurrence of TGIP could be both specific and dependent on whether the pathogen was alive.	[Fisher, Joanna J.; Hajek, Ann E.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University	Fisher, JJ (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jjf236@cornell.edu		Fisher, Joanna/0000-0002-7060-9749	Alphawood foundation; Litwin foundation	Alphawood foundation; Litwin foundation	This work was supported by the Alphawood and Litwin foundations. AEH received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabbs T, 2015, PEST MANAG SCI, V71, P7, DOI 10.1002/ps.3907; Contreras-Garduno J, 2014, MICROBES INFECT, V16, P261, DOI 10.1016/j.micinf.2013.11.010; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Freitak D, 2014, VIRULENCE, V5, P547, DOI 10.4161/viru.28367; Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Haack Robert A., 2006, Great Lakes Entomologist, V39, P169; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Huang CC, 1999, DEV COMP IMMUNOL, V23, P545, DOI 10.1016/S0145-305X(99)00038-5; Kaya HK, 2012, INSECT PATHOLOGY, 2ND EDITION, P1, DOI 10.1016/B978-0-12-384984-7.00001-4; Klein Michael G., 1997, P101, DOI 10.1016/B978-012432555-5/50009-9; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Kurtz J, 2006, TRENDS IMMUNOL, V27, P493, DOI 10.1016/j.it.2006.09.001; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Lopez JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0454; Lorenz LM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-382; Milutinovic B, 2014, J INNATE IMMUN, V6, P306, DOI 10.1159/000355211; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2012, ISJ-INVERT SURVIV J, V9, P200; Reber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035372; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2009, BIOL LETTERS, V5, P798, DOI 10.1098/rsbl.2009.0458; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; SAS Institute, 2010, JMP VERS 9 0 02; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Trauer U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063392; Ugine TA, 2011, J ECON ENTOMOL, V104, P1942, DOI 10.1603/EC11139; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Yokoi Kakeru, 2012, Results Immunol, V2, P72, DOI 10.1016/j.rinim.2012.03.002; Zanchi C, 2012, P ROY SOC B-BIOL SCI, V279, P3223, DOI 10.1098/rspb.2012.0493; Zanchi C, 2011, J ANIM ECOL, V80, P1174, DOI 10.1111/j.1365-2656.2011.01872.x	35	17	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125197	10.1371/journal.pone.0125197	http://dx.doi.org/10.1371/journal.pone.0125197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938586	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000049
J	Haustein, M; Hannes, T; Trieschmann, J; Verhaegh, R; Koster, A; Hescheler, J; Brockmeier, K; Adelmann, R; Khalil, M				Haustein, Moritz; Hannes, Tobias; Trieschmann, Jan; Verhaegh, Rabea; Koester, Annette; Hescheler, Juergen; Brockmeier, Konrad; Adelmann, Roland; Khalil, Markus			Excitation-Contraction Coupling in Zebrafish Ventricular Myocardium Is Regulated by Trans-Sarcolemmal Ca2+ Influx and Sarcoplasmic Reticulum Ca2+ Release	PLOS ONE			English	Article							FORCE-FREQUENCY-RELATIONSHIP; MODEL; MYOCYTES; EXCHANGE; SLICES	Zebrafish (Danio rerio) have become a popular model in cardiovascular research mainly due to identification of a large number of mutants with structural defects. In recent years, cardiomyopathies and other diseases influencing contractility of the heart have been studied in zebrafish mutants. However, little is known about the regulation of contractility of the zebrafish heart on a tissue level. The aim of the present study was to elucidate the role of trans-sarcolemmal Ca2+-flux and sarcoplasmic reticulum Ca2+-release in zebrafish myocardium. Using isometric force measurements of fresh heart slices, we characterised the effects of changes of the extracellular Ca2+-concentration, trans-sarcolemmal Ca2+-flux via L-type Ca2+-channels and Na+-Ca2+-exchanger, and Ca2+-release from the sarcoplasmic reticulum as well as beating frequency and beta-adrenergic stimulation on contractility of adult zebrafish myocardium. We found an overall negative force-frequency relationship (FFR). Inhibition of L-type Ca2+-channels by verapamil (1 mu M) decreased force of contraction to 22 +/- 7% compared to baseline (n=4, p<0.05). Ni2+ was the only substance to prolong relaxation (5 mM, time after peak to 50% relaxation: 73 +/- 3 ms vs. 101 +/- 8 ms, n=5, p<0.05). Surprisingly though, inhibition of the sarcoplasmic Ca2+-release decreased force development to 54 +/- 3% in ventricular (n=13, p<0.05) and to 52 +/- 8% in atrial myocardium (n=5, p<0.05) suggesting a substantial role of SR Ca2+-release in force generation. In line with this finding, we observed significant post pause potentiation after pauses of 5 s (169 +/- 7% force compared to baseline, n=8, p<0.05) and 10 s (198 +/- 9% force compared to baseline, n=5, p<0.05) and mildly positive lusitropy after beta-adrenergic stimulation. In conclusion, force development in adult zebrafish ventricular myocardium requires not only trans-sarcolemmal Ca2+-flux, but also intact sarcoplasmic reticulum Ca2+-cycling. In contrast to mammals, FFR is strongly negative in the zebrafish heart. These aspects need to be considered when using zebrafish to model human diseases of myocardial contractility.	[Haustein, Moritz; Hannes, Tobias; Brockmeier, Konrad; Adelmann, Roland] Univ Cologne, Fac Med, Cologne Heart Ctr, Dept Paediat Cardiol, D-50931 Cologne, North Rhine Wes, Germany; [Hannes, Tobias; Trieschmann, Jan; Koester, Annette; Hescheler, Juergen] Univ Cologne, Fac Med, Inst Neurophysiol, D-50931 Cologne, North Rhine Wes, Germany; [Verhaegh, Rabea] Univ Hosp Essen, Inst Physiol Chem, Essen, North Rhine Wes, Germany; [Khalil, Markus] Univ Giessen & Marburg, Dept Paediat Cardiol, Univ Hosp Giessen & Marburg, D-35390 Giessen, Hessen, Germany	University of Cologne; University of Cologne; University of Duisburg Essen; University Hospital of Giessen & Marburg	Hannes, T (corresponding author), Univ Cologne, Fac Med, Cologne Heart Ctr, Dept Paediat Cardiol, D-50931 Cologne, North Rhine Wes, Germany.	tobias.hannes@uk-koeln.de	Khalil, Markus/AFS-7292-2022	Khalil, Markus/0000-0001-8897-7200; Haustein, Moritz/0000-0003-4493-6161; Hannes, Tobias/0000-0002-8550-2282	Universitat zu Koln [288/2013]	Universitat zu Koln	Koeln Fortune 288/2013 Fund of Universitat zu Koln, http://www.medfak.uni-koeln.de/195.html?&L=0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus JA, 2000, J PHARMACOL TOX MET, V44, P395, DOI 10.1016/S1056-8719(00)00121-0; Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Barrionuevo WR, 1999, AM J PHYSIOL-REG I, V276, pR505, DOI 10.1152/ajpregu.1999.276.2.R505; Bergson P, 2011, MOL PHARMACOL, V79, P411, DOI 10.1124/mol.110.069492; Bers DM, 2001, EXCITATION CONTRACTI; Bovo E, 2013, PFLUG ARCH EUR J PHY, V465, P1775, DOI 10.1007/s00424-013-1312-2; Brette F, 2008, BIOCHEM BIOPH RES CO, V374, P143, DOI 10.1016/j.bbrc.2008.06.109; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Endoh M, 2004, EUR J PHARMACOL, V500, P73, DOI 10.1016/j.ejphar.2004.07.013; HAN XQ, 1995, CIRC RES, V76, P664, DOI 10.1161/01.RES.76.4.664; Haverinen J, 2009, AM J PHYSIOL-REG I, V297, pR1180, DOI 10.1152/ajpregu.00022.2009; Hinde AK, 1999, CELL CALCIUM, V25, P321, DOI 10.1054/ceca.1999.0035; Hove-Madsen L, 1998, AM J PHYSIOL-REG I, V275, pR2070, DOI 10.1152/ajpregu.1998.275.6.R2070; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; MALECOT CO, 1987, CIRC RES, V60, P560, DOI 10.1161/01.RES.60.4.560; MORAD M, 1971, J PHYSIOL-LONDON, V219, P167, DOI 10.1113/jphysiol.1971.sp009656; Pieperhoff S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096771; Pillekamp F, 2007, CELL PHYSIOL BIOCHEM, V20, P837, DOI 10.1159/000110443; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; SCHWINGER RHG, 1992, AM HEART J, V123, P116, DOI 10.1016/0002-8703(92)90755-K; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shiels HA, 2006, J GEN PHYSIOL, V128, P37, DOI 10.1085/jgp.200609543; Shiels HA, 1997, J EXP BIOL, V200, P1607; Shiels HA, 2002, COMP BIOCHEM PHYS A, V132, P811, DOI 10.1016/S1095-6433(02)00050-8; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Wang K, 2014, PROG BIOPHYS MOL BIO, V115, P314, DOI 10.1016/j.pbiomolbio.2014.08.006; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Zhang PC, 2011, AM J PHYSIOL-REG I, V300, pR56, DOI 10.1152/ajpregu.00377.2010; Zhao L, 2008, CARDIOVASC RES, V80, P200, DOI 10.1093/cvr/cvn177	31	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0125654	10.1371/journal.pone.0125654	http://dx.doi.org/10.1371/journal.pone.0125654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938412	Green Published, Green Submitted, gold			2022-12-26	WOS:000353943000084
J	Kim, I; Kim, MH; Lim, S				Kim, Inah; Kim, Myoung-Hee; Lim, Sinye			Reproductive Hazards Still Persist in the Microelectronics Industry: Increased Risk of Spontaneous Abortion and Menstrual Aberration among Female Workers in the Microelectronics Industry in South Korea	PLOS ONE			English	Article							ETHYLENE-GLYCOL ETHERS; SEMICONDUCTOR WORKERS; ELECTRONICS WORKERS; HISTORICAL COHORT; HEALTH; FABRICATION; PREGNANCY	Objectives Despite the global expansion of supply chains and changes to the production process, few studies since the mid-1990s and 2000s have examined reproductive risks of the microelectronics industry; we examined the reproductive risks among female microelectronics workers in South Korea. Methods Based on claim data from the National Health Insurance (2008-2012), we estimated agespecific rates of spontaneous abortion (SAB) and menstrual aberration (MA) among women aged 20 to 39 years. We compared data between microelectronics workers and three different control groups: economically inactive women, the working population as a whole, and workers employed in the bank industry. For an effect measure, age-stratified relative risks (RRs) were estimated. Results Female workers in the microelectronics industry showed significantly higher risk for SAB and MA compared to control groups. The RRs for SAB with reference to economically inactive women, working population, and bank workers in their twenties were 1.57, 1.40, and 1.37, respectively, and the RRs for MA among females in their twenties were 1.54, 1.38, and 1.48, respectively. For women in their thirties, RRs for SAB were 1.58, 1.67, and 1.13, and those for MA were 1.25, 1.35, and 1.23 compared to the three control populations, respectively. All RRs were statistically significant at a level of 0.05, except for the SAB case comparison with bank workers in their thirties. Conclusions Despite technical innovations and health and safety measures, female workers in microelectronics industry in South Korea have high rates of SAB and MA, suggesting continued exposure to reproductive hazards. Further etiologic studies based on primary data collection and careful surveillance are required to confirm these results.	[Kim, Inah] Hanyang Univ, Dept Occupat & Environm Med, Coll Med, Seoul 133791, South Korea; [Kim, Myoung-Hee] Peoples Hlth Inst, Seoul, South Korea; [Lim, Sinye] Kyung Hee Univ, Dept Occupat & Environm Med, Coll Med, Seoul, South Korea	Hanyang University; Kyung Hee University	Kim, MH (corresponding author), Peoples Hlth Inst, Seoul, South Korea.	mhkim1871@gmail.com			National Research Foundation of Korea Grant; Korean government [NRF-2013S1A3A2055212]; People's Health Institute	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean government(Korean Government); People's Health Institute	MH Kim was partly supported by the National Research Foundation of Korea Grant (website http://www.nrf.re.kr/) funded by the Korean government (NRF-2013S1A3A2055212). The rest of the financial support came from the People's Health Institute (website http://health.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUMONT JJ, 1995, AM J IND MED, V28, P735; Bonde JP, 2013, SCAND J WORK ENV HEA, V39, P325, DOI 10.5271/sjweh.3337; Burdorf A, 2006, OCCUP MED-OXFORD, V56, P516, DOI 10.1093/occmed/kql113; Byun K, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-21; Chen PC, 2002, EPIDEMIOLOGY, V13, P191, DOI 10.1097/00001648-200203000-00014; Correa A, 1996, AM J EPIDEMIOL, V143, P707; Darnton A., 2010, FURTHER STUDY CANC C, VVolume 135; ESKENAZI B, 1995, AM J IND MED, V28, P817; ESKENAZI B, 1995, AM J IND MED, V28, P833; Evermann A., 2014, ICT SECTOR SPOTLIGHT; Figa-Talamanca I, 2006, OCCUP MED-OXFORD, V56, P521, DOI 10.1093/occmed/kql114; Financial Supervisory Service, 2014, REP KOR CORP FIL DAT; GOLD EB, 1995, AM J IND MED, V28, P799; Hsieh GY, 2005, OCCUP ENVIRON MED, V62, P510, DOI 10.1136/oem.2004.016014; 이복임, 2008, Korean Journal of Health Promotion, V8, P31; J-O Kong, 2012, J KOREAN SOC OCCUP E, V22, P32; Jang TW, 2012, J OCCUP HEALTH, V54, P452, DOI 10.1539/joh.12-0148-OA; JOFFE M, 1985, INT J EPIDEMIOL, V14, P118, DOI 10.1093/ije/14.1.118; Jung J, 2000, ASS WORKING ENV PREG; Kim Dong-Won, 2014, COMMUNICATION; Kim EA, 2011, SAF HEALTH WORK, V2, P122, DOI 10.5491/SHAW.2011.2.2.122; Kim I, 2012, INT J OCCUP ENV HEAL, V18, P147, DOI 10.1179/1077352512Z.00000000019; Kim MH, 2014, INT J OCCUP ENV HEAL, V20, P95, DOI 10.1179/2049396713Y.0000000050; Kim Y, 1996, SCAND J WORK ENV HEA, V22, P387, DOI 10.5271/sjweh.159; Kumar S, 2011, REPROD SCI, V18, P915, DOI 10.1177/1933719111413298; LaDou J, 1998, Int J Occup Environ Health, V4, P1; Lee HE, 2011, SAF HEALTH WORK, V2, P135, DOI 10.5491/SHAW.2011.2.2.135; Lin CC, 2008, INT J OCCUP ENV HEAL, V14, P112, DOI 10.1179/oeh.2008.14.2.112; Park H, 2011, SAF HEALTH WORK, V2, P39, DOI 10.5491/SHAW.2011.2.1.39; Park J-S, 1994, KOREA J PREVENTIVE M, V27, P242; Park SH, 2011, SAF HEALTH WORK, V2, P210, DOI 10.5491/SHAW.2011.2.3.210; PASTIDES H, 1988, J OCCUP ENVIRON MED, V30, P543; SCHENKER MB, 1995, AM J IND MED, V28, P639; Shin Y, 1994, KOR J OCCUP MED, V6, P69; Smith T., 2006, CHALLENGING CHIP LAB; Statistic Korea, 2011, DAT RES POP 5 YEAR A; Statistic Korea, 2014, DAT SOC INS SUBSCR; Statistics Korea, 2010, DAT POP CENC; Sung TI, 2008, REPROD TOXICOL, V25, P115, DOI 10.1016/j.reprotox.2007.08.004; Sung TI, 2009, BIRTH DEFECTS RES A, V85, P119, DOI 10.1002/bdra.20496; SWAN SH, 1995, AM J IND MED, V28, P751; Whelan EA, 2007, EPIDEMIOLOGY, V18, P350, DOI 10.1097/01.ede.0000259988.77314.a4; Windham G, 2007, CURRENT OCCUPATIONAL; Yang C-Y, 2003, J KOREAN SOC OCCUP E, V13, P273	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0123679	10.1371/journal.pone.0123679	http://dx.doi.org/10.1371/journal.pone.0123679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938673	Green Submitted, Green Published, gold			2022-12-26	WOS:000353943000011
J	Riepsamen, A; Wu, L; Lau, L; Listijono, D; Ledger, W; Sinclair, D; Homer, H				Riepsamen, Angelique; Wu, Lindsay; Lau, Laurin; Listijono, Dave; Ledger, William; Sinclair, David; Homer, Hayden			Nicotinamide Impairs Entry into and Exit from Meiosis I in Mouse Oocytes	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; APC(CDH1) ACTIVITY; METAPHASE-I; ARREST; APC/C; PROMETAPHASE; INHIBITION; ACTIVATION; ORGANIZATION; PROGRESSION	Following exit from meiosis I, mammalian oocytes immediately enter meiosis II without an intervening interphase, accompanied by rapid reassembly of a bipolar spindle that maintains condensed chromosomes in a metaphase configuration (metaphase II arrest). Here we study the effect of nicotinamide (NAM), a non-competitive pan-sirtuin inhibitor, during meiotic maturation in mouse oocytes. Sirtuins are a family of seven NAD(+)-dependent deacetylases (Sirt1-7), which are involved in multiple cellular processes and are emerging as important regulators in oocytes and embryos. We found that NAM significantly delayed entry into meiosis I associated with delayed accumulation of the Cdk1 co-activator, cyclin B1. GVBD was also inhibited by the Sirt2-specific inhibitor, AGK2, and in a very similar pattern to NAM, supporting the notion that as in somatic cells, NAM inhibits sirtuins in oocytes. NAM did not affect subsequent spindle assembly, chromosome alignment or the timing of first polar body extrusion (PBE). Unexpectedly, however, in the majority of oocytes with a polar body, chromatin was decondensed and a nuclear structure was present. An identical phenotype was observed when flavopiridol was used to induce Cdk1 inactivation during late meiosis I prior to PBE, but not if Cdk1 was inactivated after PBE when metaphase II arrest was already established, altogether indicating that NAM impaired establishment rather than maintenance of metaphase II arrest. During meiosis I exit in NAM-treated medium, we found that cyclin B1 levels were lower and inhibitory Cdk1 phosphorylation was increased compared with controls. Although activation of the anaphase-promoting complex-Cdc20 (APC-Cdc20) occurred on-time in NAM-treated oocytes, Cdc20 levels were higher in very late meiosis I, pointing to exaggerated APC-Cdc20-mediated proteolysis as a reason for lower cyclin B1 levels. Collectively, therefore, our data indicate that by disrupting Cdk1 regulation, NAM impairs entry into meiosis I and the establishment of metaphase II arrest.	[Riepsamen, Angelique; Lau, Laurin; Listijono, Dave; Ledger, William; Homer, Hayden] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Wu, Lindsay; Sinclair, David] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Sinclair, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Sinclair, David] Harvard Univ, Sch Med, Glenn Labs Biol Mech Aging, Boston, MA USA	University of New South Wales Sydney; University of New South Wales Sydney; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Homer, H (corresponding author), Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.	h.homer@unsw.edu.au	Wu, Lindsay/GQI-1179-2022; Wu, Lindsay/AAA-1486-2021; Ledger, William/L-9089-2017; Homer, Hayden/K-1517-2014	Wu, Lindsay/0000-0002-1599-7574; Wu, Lindsay/0000-0002-1599-7574; Sinclair, David/0000-0002-9936-436X; Riepsamen, Angelique/0000-0002-7633-6294; Ledger, William/0000-0001-6465-4343; Homer, Hayden/0000-0002-3104-0449	Clive Foundation; National Health and Medical Research Council [APP1078134]; University of New South Wales Major Research Equipment and Infrastructure Initiative [RG134872]; Cancer Institute of New South Wales; Vera Ramaciotti Foundation [ES2013/0076]; NATIONAL INSTITUTE ON AGING [R37AG028730] Funding Source: NIH RePORTER	Clive Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Major Research Equipment and Infrastructure Initiative; Cancer Institute of New South Wales; Vera Ramaciotti Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by research grants from the Clive and Vera Ramaciotti Foundations (http://www.perpetual.com.au/ramaciotti/, ES2013/0076), the National Health and Medical Research Council (http://www.nhmrc.gov.au/, APP1078134), and the University of New South Wales Major Research Equipment and Infrastructure Initiative (RG134872) to HH. LW is supported by an Early Career Fellowship from Cancer Institute of New South Wales (http://www.cancerinstitute.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2014, J CELL BIOL, V206, P843, DOI 10.1083/jcb.201406033; Adhikari D, 2014, MOL CELL ENDOCRINOL, V382, P480, DOI 10.1016/j.mce.2013.07.027; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gosden R, 2010, J CLIN INVEST, V120, P973, DOI 10.1172/JCI41294; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Holt JE, 2013, CURR TOP DEV BIOL, V102, P207, DOI 10.1016/B978-0-12-416024-8.00007-6; Homer H, 2013, BIOLOGY AND PATHOLOGY OF THE OOCYTE: ROLE IN FERTILITY, MEDICINE, AND NUCLEAR REPROGRAMMING, 2ND EDITION, P119; Homer H, 2013, REPRODUCTION, V146, pR61, DOI 10.1530/REP-13-0163; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Howe K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112151; Jin F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001147; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Lane SIR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4444; Lee AR, 2013, J REPROD DEVELOP, V59, P238, DOI 10.1262/jrd.2012-171; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077960; Madgwick S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-4; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagai T, 2013, J CELL SCI, V126, P4369, DOI 10.1242/jcs.127209; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; Tatone C, OXID MED CE IN PRESS; TSAI FCH, 1994, FERTIL STERIL, V61, P376; Wilding M, 1999, ZYGOTE, V7, P255, DOI 10.1017/S0967199499000647; Zhang L, 2014, FASEB J, V28, P1435, DOI 10.1096/fj.13-244111; Zhou X, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-22	42	15	19	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126194	10.1371/journal.pone.0126194	http://dx.doi.org/10.1371/journal.pone.0126194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938585	gold, Green Published			2022-12-26	WOS:000353943000150
J	Western, MJ; Peacock, OJ; Stathi, A; Thompson, D				Western, Max J.; Peacock, Oliver J.; Stathi, Afroditi; Thompson, Dylan			The Understanding and Interpretation of Innovative Technology-Enabled Multidimensional Physical Activity Feedback in Patients at Risk of Future Chronic Disease	PLOS ONE			English	Article							HEALTH BEHAVIOR; ENERGY-EXPENDITURE; INACTIVITY; EXERCISE; ARMBAND	Background Innovative physical activity monitoring technology can be used to depict rich visual feedback that encompasses the various aspects of physical activity known to be important for health. However, it is unknown whether patients who are at risk of chronic disease would understand such sophisticated personalised feedback or whether they would find it useful and motivating. The purpose of the present study was to determine whether technology-enabled multidimensional physical activity graphics and visualisations are comprehensible and usable for patients at risk of chronic disease. Method We developed several iterations of graphics depicting minute-by-minute activity patterns and integrated physical activity health targets. Subsequently, patients at moderate/high risk of chronic disease (n=29) and healthcare practitioners (n=15) from South West England underwent full 7-days activity monitoring followed by individual semi-structured interviews in which they were asked to comment on their own personalised visual feedback Framework analysis was used to gauge their interpretation and of personalised feedback, graphics and visualisations. Results We identified two main components focussing on (a) the interpretation of feedback designs and data and (b) the impact of personalised visual physical activity feedback on facilitation of health behaviour change. Participants demonstrated a clear ability to understand the sophisticated personal information plus an enhanced physical activity knowledge. They reported that receiving multidimensional feedback was motivating and could be usefully applied to facilitate their efforts in becoming more physically active. Conclusion Multidimensional physical activity feedback can be made comprehensible, informative and motivational by using appropriate graphics and visualisations. There is an opportunity to exploit the full potential created by technological innovation and provide sophisticated personalised physical activity feedback as an adjunct to support behaviour change.	[Western, Max J.; Peacock, Oliver J.; Stathi, Afroditi; Thompson, Dylan] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England	University of Bath	Thompson, D (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	D.Thompson@bath.ac.uk	STATHI, AFRODITI/AAM-4377-2020	STATHI, AFRODITI/0000-0003-2162-777X; Western, Max James/0000-0003-1107-8498	National Preventative Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; Stroke Association; Wellcome Trust; Welsh Assembly Government; World Cancer Research Fund; Medical Research Council [MR/J00040X/1] Funding Source: researchfish; MRC [MR/J00040X/1] Funding Source: UKRI	National Preventative Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Wellcome Trust(Wellcome Trust); Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the project was provided by the National Preventative Research Initiative (NPRI, http://www.mrc.ac.uk/research/initiatives/national-prevention-research-initiative-npri/). Funding partners are: Alzheimer's Research Trust, Alzheimer's Society, Biotechnology and Biological Sciences Research Council, British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; The Stroke Association; Wellcome Trust; Welsh Assembly Government and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Chu S, 2014, INTERNATIONAL DIGITA; Consolvo S, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P54; Consolvo S, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P405; Design Council T, 2007, ELEVEN LESSONS MANAG; DiClemente CC, 2001, AM J HEALTH BEHAV, V25, P217, DOI 10.5993/AJHB.25.3.8; Dombrowski SU, 2012, HEALTH PSYCHOL REV, V6, P7, DOI 10.1080/17437199.2010.513298; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; Erikssen G, 2001, SPORTS MED, V31, P571, DOI 10.2165/00007256-200131080-00001; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; KIRSCHENBAUM DS, 1987, CLIN PSYCHOL REV, V7, P77, DOI 10.1016/0272-7358(87)90005-5; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee J.-M., 2014, MED SCI SPORTS EXERC; Michie S, 2013, HEALTH PSYCHOL, V32, P581, DOI 10.1037/a0030205; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Standage M., 2012, ADV MOTIVATION SPORT, P233, DOI DOI 10.5040/; Thompson D, 2015, EXERCISE AND SPORT S; Thompson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056427; Turner JE, 2010, AM J CLIN NUTR, V92, P1009, DOI 10.3945/ajcn.2010.29471; van Gemert-Pijnen JE, 2011, JOURNAL OF MEDICAL I, V13; Weinstein ND, 1998, HEALTH PSYCHOL, V17, P290, DOI 10.1037/0278-6133.17.3.290; Yardley L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4055	30	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126156	10.1371/journal.pone.0126156	http://dx.doi.org/10.1371/journal.pone.0126156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH3PP	25938455	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000353943000146
J	Yan, LM; Zhang, J; Guo, H; Yan, SC; Chen, QX; Zhang, FX; Fang, Q				Yan, Liming; Zhang, Jie; Guo, Hong; Yan, Shicui; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin			Aquareovirus NS80 Initiates Efficient Viral Replication by Retaining Core Proteins within Replication-Associated Viral Inclusion Bodies	PLOS ONE			English	Article							GRASS CARP REOVIRUS; RICE-DWARF-VIRUS; MU-NS; SIGMA-NS; BLUETONGUE VIRUS; MAMMALIAN REOVIRUSES; RNA-SYNTHESIS; STRANDED-RNA; IN-VITRO; ROTAVIRUS	Viral inclusion bodies (VIBs) are specific intracellular compartments for reoviruses replication and assembly. Aquareovirus nonstructural protein NS80 has been identified to be the major constituent for forming globular VIBs in our previous study. In this study, we investigated the role of NS80 in viral structural proteins expression and viral replication. Immunofluorescence assays showed that NS80 could retain five core proteins or inner-capsid proteins (VP1-VP4 and VP6), but not outer-capsid proteins (VP5 and VP7), within VIBs in co-transfected or infected cells. Further co-immunoprecipitation analysis confirmed that NS80 could interact with each core protein respectively. In addition, we found that newly synthesized viral RNAs co-localized with VIBs. Furthermore, time-course analysis of viral structural proteins expression showed that the expression of NS80 was detected first, followed by the detection of inner shell protein VP3, and then of other inner-capsid proteins, suggesting that VIBs were essential for the formation of viral core frame or progeny virion. Moreover, knockdown of NS80 by shRNA not only inhibited the expression of aquareovirus structural proteins, but also inhibited viral infection. These results indicated that NS80-based VIBs were formed at earlier stage of infection, and NS80 was able to coordinate the expression of viral structural proteins and viral replication.	[Yan, Liming; Zhang, Jie; Guo, Hong; Yan, Shicui; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Yan, Liming; Yan, Shicui; Chen, Qingxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	qfang@wh.iov.cn	fang, qin/GQA-8223-2022		National Natural Science Foundation of China [31172434, 31372565, 31370190]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China 31172434, 31372565, and 31370190.	ACS G, 1971, J VIROL, V8, P684, DOI 10.1128/JVI.8.5.684-689.1971; Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; BANERJEE AK, 1970, J VIROL, V6, P1; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; BROOKES SM, 1993, J GEN VIROL, V74, P525, DOI 10.1099/0022-1317-74-3-525; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; Criglar JM, 2014, J VIROL, V88, P786, DOI 10.1128/JVI.03022-13; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; DALES S, 1963, P NATL ACAD SCI USA, V50, P268, DOI 10.1073/pnas.50.2.268; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; EATON BT, 1987, VIROLOGY, V157, P107, DOI 10.1016/0042-6822(87)90319-9; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fan C, 2010, ARCH VIROL, V155, P1755, DOI 10.1007/s00705-010-0753-6; Fan Liming, 2014, Virologica Sinica, V29, P86, DOI 10.1007/s12250-014-3366-5; Fang Q, 2008, ARCH VIROL, V153, P675, DOI 10.1007/s00705-008-0048-3; FANG Q, 1989, Virologica Sinica, V4, P315; Gillian AL, 2000, J VIROL, V74, P5939, DOI 10.1128/JVI.74.13.5939-5948.2000; Guo H, 2013, VIRUS RES, V171, P129, DOI 10.1016/j.virusres.2012.11.011; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Javed Amjad, 2004, Methods Mol Biol, V285, P29; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Ke F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063737; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; LEVIN DH, 1970, NATURE, V227, P603, DOI 10.1038/227603a0; Li Xiaoming, 2013, Virologica Sinica, V28, P318, DOI 10.1007/s12250-013-3341-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez T, 2005, J GEN VIROL, V86, P1609, DOI 10.1099/vir.0.80827-0; MCNULTY MS, 1976, J GEN VIROL, V33, P503, DOI 10.1099/0022-1317-33-3-503; Mertens PPC, 2011, VIRUS TAXONOMY, P497; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Modrof J, 2005, J VIROL, V79, P10023, DOI 10.1128/JVI.79.15.10023-10031.2005; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PETRIE BL, 1984, VIRUS RES, V1, P133, DOI 10.1016/0168-1702(84)90069-8; Rangel AAC, 1999, J GEN VIROL, V80, P2399, DOI 10.1099/0022-1317-80-9-2399; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shao L, 2011, VIROLOGY J, V8; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055334; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Shimizu T, 2009, PLANT BIOTECHNOL J, V7, P24, DOI 10.1111/j.1467-7652.2008.00366.x; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; SKEHEL JJ, 1969, VIROLOGY, V39, P822, DOI 10.1016/0042-6822(69)90019-1; SPENDLOVE RS, 1963, J IMMUNOL, V90, P548; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Wei TY, 2006, J GEN VIROL, V87, P429, DOI 10.1099/vir.0.81425-0; Wen DW, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-133; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Yan LM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-89; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6	66	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2015	10	5							e0126127	10.1371/journal.pone.0126127	http://dx.doi.org/10.1371/journal.pone.0126127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH3PP	25938226	Green Published, gold, Green Submitted			2022-12-26	WOS:000353943000143
